Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific nTPM"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific nTPM"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific nTPM"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific nTPM"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific nTPM"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific nTPM"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific nTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific nTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Blood expression cluster"	"Tissue expression cluster"	"Cell line expression cluster"	"Single cell expression cluster"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [nTPM]"	"Tissue RNA - adrenal gland [nTPM]"	"Tissue RNA - amygdala [nTPM]"	"Tissue RNA - appendix [nTPM]"	"Tissue RNA - basal ganglia [nTPM]"	"Tissue RNA - bone marrow [nTPM]"	"Tissue RNA - breast [nTPM]"	"Tissue RNA - cerebellum [nTPM]"	"Tissue RNA - cerebral cortex [nTPM]"	"Tissue RNA - cervix [nTPM]"	"Tissue RNA - choroid plexus [nTPM]"	"Tissue RNA - colon [nTPM]"	"Tissue RNA - duodenum [nTPM]"	"Tissue RNA - endometrium 1 [nTPM]"	"Tissue RNA - epididymis [nTPM]"	"Tissue RNA - esophagus [nTPM]"	"Tissue RNA - fallopian tube [nTPM]"	"Tissue RNA - gallbladder [nTPM]"	"Tissue RNA - heart muscle [nTPM]"	"Tissue RNA - hippocampal formation [nTPM]"	"Tissue RNA - hypothalamus [nTPM]"	"Tissue RNA - kidney [nTPM]"	"Tissue RNA - liver [nTPM]"	"Tissue RNA - lung [nTPM]"	"Tissue RNA - lymph node [nTPM]"	"Tissue RNA - medulla oblongata [nTPM]"	"Tissue RNA - midbrain [nTPM]"	"Tissue RNA - ovary [nTPM]"	"Tissue RNA - pancreas [nTPM]"	"Tissue RNA - parathyroid gland [nTPM]"	"Tissue RNA - pituitary gland [nTPM]"	"Tissue RNA - placenta [nTPM]"	"Tissue RNA - pons [nTPM]"	"Tissue RNA - prostate [nTPM]"	"Tissue RNA - rectum [nTPM]"	"Tissue RNA - retina [nTPM]"	"Tissue RNA - salivary gland [nTPM]"	"Tissue RNA - seminal vesicle [nTPM]"	"Tissue RNA - skeletal muscle [nTPM]"	"Tissue RNA - skin 1 [nTPM]"	"Tissue RNA - small intestine [nTPM]"	"Tissue RNA - smooth muscle [nTPM]"	"Tissue RNA - spinal cord [nTPM]"	"Tissue RNA - spleen [nTPM]"	"Tissue RNA - stomach 1 [nTPM]"	"Tissue RNA - testis [nTPM]"	"Tissue RNA - thalamus [nTPM]"	"Tissue RNA - thymus [nTPM]"	"Tissue RNA - thyroid gland [nTPM]"	"Tissue RNA - tongue [nTPM]"	"Tissue RNA - tonsil [nTPM]"	"Tissue RNA - urinary bladder [nTPM]"	"Tissue RNA - vagina [nTPM]"	"Tissue RNA - white matter [nTPM]"	"Cell RNA - A-431 [nTPM]"	"Cell RNA - A549 [nTPM]"	"Cell RNA - AF22 [nTPM]"	"Cell RNA - AN3-CA [nTPM]"	"Cell RNA - ASC diff [nTPM]"	"Cell RNA - ASC TERT1 [nTPM]"	"Cell RNA - BEWO [nTPM]"	"Cell RNA - BJ [nTPM]"	"Cell RNA - BJ hTERT+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [nTPM]"	"Cell RNA - CACO-2 [nTPM]"	"Cell RNA - CAPAN-2 [nTPM]"	"Cell RNA - Daudi [nTPM]"	"Cell RNA - EFO-21 [nTPM]"	"Cell RNA - fHDF/TERT166 [nTPM]"	"Cell RNA - GAMG [nTPM]"	"Cell RNA - HaCaT [nTPM]"	"Cell RNA - HAP1 [nTPM]"	"Cell RNA - HBEC3-KT [nTPM]"	"Cell RNA - HBF TERT88 [nTPM]"	"Cell RNA - HDLM-2 [nTPM]"	"Cell RNA - HEK 293 [nTPM]"	"Cell RNA - HEL [nTPM]"	"Cell RNA - HeLa [nTPM]"	"Cell RNA - Hep G2 [nTPM]"	"Cell RNA - HHSteC [nTPM]"	"Cell RNA - HL-60 [nTPM]"	"Cell RNA - HMC-1 [nTPM]"	"Cell RNA - HSkMC [nTPM]"	"Cell RNA - hTCEpi [nTPM]"	"Cell RNA - hTEC/SVTERT24-B [nTPM]"	"Cell RNA - hTERT-HME1 [nTPM]"	"Cell RNA - hTERT-RPE1 [nTPM]"	"Cell RNA - HUVEC TERT2 [nTPM]"	"Cell RNA - JURKAT [nTPM]"	"Cell RNA - K-562 [nTPM]"	"Cell RNA - Karpas-707 [nTPM]"	"Cell RNA - LHCN-M2 [nTPM]"	"Cell RNA - MCF7 [nTPM]"	"Cell RNA - MOLT-4 [nTPM]"	"Cell RNA - NB-4 [nTPM]"	"Cell RNA - NTERA-2 [nTPM]"	"Cell RNA - OE19 [nTPM]"	"Cell RNA - PC-3 [nTPM]"	"Cell RNA - REH [nTPM]"	"Cell RNA - RH-30 [nTPM]"	"Cell RNA - RPMI-8226 [nTPM]"	"Cell RNA - RPTEC TERT1 [nTPM]"	"Cell RNA - RT4 [nTPM]"	"Cell RNA - SCLC-21H [nTPM]"	"Cell RNA - SH-SY5Y [nTPM]"	"Cell RNA - SiHa [nTPM]"	"Cell RNA - SK-BR-3 [nTPM]"	"Cell RNA - SK-MEL-30 [nTPM]"	"Cell RNA - SuSa [nTPM]"	"Cell RNA - T-47d [nTPM]"	"Cell RNA - THP-1 [nTPM]"	"Cell RNA - TIME [nTPM]"	"Cell RNA - U-138 MG [nTPM]"	"Cell RNA - U-2 OS [nTPM]"	"Cell RNA - U-2197 [nTPM]"	"Cell RNA - U-251 MG [nTPM]"	"Cell RNA - U-266/70 [nTPM]"	"Cell RNA - U-266/84 [nTPM]"	"Cell RNA - U-698 [nTPM]"	"Cell RNA - U-87 MG [nTPM]"	"Cell RNA - U-937 [nTPM]"	"Cell RNA - WM-115 [nTPM]"	"Blood RNA - basophil [nTPM]"	"Blood RNA - classical monocyte [nTPM]"	"Blood RNA - eosinophil [nTPM]"	"Blood RNA - gdT-cell [nTPM]"	"Blood RNA - intermediate monocyte [nTPM]"	"Blood RNA - MAIT T-cell [nTPM]"	"Blood RNA - memory B-cell [nTPM]"	"Blood RNA - memory CD4 T-cell [nTPM]"	"Blood RNA - memory CD8 T-cell [nTPM]"	"Blood RNA - myeloid DC [nTPM]"	"Blood RNA - naive B-cell [nTPM]"	"Blood RNA - naive CD4 T-cell [nTPM]"	"Blood RNA - naive CD8 T-cell [nTPM]"	"Blood RNA - neutrophil [nTPM]"	"Blood RNA - NK-cell [nTPM]"	"Blood RNA - non-classical monocyte [nTPM]"	"Blood RNA - plasmacytoid DC [nTPM]"	"Blood RNA - T-reg [nTPM]"	"Blood RNA - total PBMC [nTPM]"	"Brain RNA - amygdala [nTPM]"	"Brain RNA - basal ganglia [nTPM]"	"Brain RNA - cerebellum [nTPM]"	"Brain RNA - cerebral cortex [nTPM]"	"Brain RNA - hippocampal formation [nTPM]"	"Brain RNA - hypothalamus [nTPM]"	"Brain RNA - medulla oblongata [nTPM]"	"Brain RNA - midbrain [nTPM]"	"Brain RNA - pons [nTPM]"	"Brain RNA - spinal cord [nTPM]"	"Brain RNA - thalamus [nTPM]"	"Brain RNA - white matter [nTPM]"	"Single Cell Type RNA - Adipocytes [nTPM]"	"Single Cell Type RNA - Alveolar cells type 1 [nTPM]"	"Single Cell Type RNA - Alveolar cells type 2 [nTPM]"	"Single Cell Type RNA - Astrocytes [nTPM]"	"Single Cell Type RNA - B-cells [nTPM]"	"Single Cell Type RNA - Basal keratinocytes [nTPM]"	"Single Cell Type RNA - Basal prostatic cells [nTPM]"	"Single Cell Type RNA - Basal respiratory cells [nTPM]"	"Single Cell Type RNA - Basal squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Bipolar cells [nTPM]"	"Single Cell Type RNA - Breast glandular cells [nTPM]"	"Single Cell Type RNA - Breast myoepithelial cells [nTPM]"	"Single Cell Type RNA - Cardiomyocytes [nTPM]"	"Single Cell Type RNA - Cholangiocytes [nTPM]"	"Single Cell Type RNA - Club cells [nTPM]"	"Single Cell Type RNA - Collecting duct cells [nTPM]"	"Single Cell Type RNA - Cone photoreceptor cells [nTPM]"	"Single Cell Type RNA - Cytotrophoblasts [nTPM]"	"Single Cell Type RNA - dendritic cells [nTPM]"	"Single Cell Type RNA - Distal enterocytes [nTPM]"	"Single Cell Type RNA - Distal tubular cells [nTPM]"	"Single Cell Type RNA - Ductal cells [nTPM]"	"Single Cell Type RNA - Early spermatids [nTPM]"	"Single Cell Type RNA - Endometrial ciliated cells [nTPM]"	"Single Cell Type RNA - Endometrial stromal cells [nTPM]"	"Single Cell Type RNA - Endothelial cells [nTPM]"	"Single Cell Type RNA - Enteroendocrine cells [nTPM]"	"Single Cell Type RNA - Erythroid cells [nTPM]"	"Single Cell Type RNA - Excitatory neurons [nTPM]"	"Single Cell Type RNA - Exocrine glandular cells [nTPM]"	"Single Cell Type RNA - Extravillous trophoblasts [nTPM]"	"Single Cell Type RNA - Fibroblasts [nTPM]"	"Single Cell Type RNA - Gastric mucus-secreting cells [nTPM]"	"Single Cell Type RNA - Glandular and luminal cells [nTPM]"	"Single Cell Type RNA - granulocytes [nTPM]"	"Single Cell Type RNA - Granulosa cells [nTPM]"	"Single Cell Type RNA - Hepatic stellate cells [nTPM]"	"Single Cell Type RNA - Hepatocytes [nTPM]"	"Single Cell Type RNA - Hofbauer cells [nTPM]"	"Single Cell Type RNA - Horizontal cells [nTPM]"	"Single Cell Type RNA - Inhibitory neurons [nTPM]"	"Single Cell Type RNA - Intestinal goblet cells [nTPM]"	"Single Cell Type RNA - Ionocytes [nTPM]"	"Single Cell Type RNA - Kupffer cells [nTPM]"	"Single Cell Type RNA - Langerhans cells [nTPM]"	"Single Cell Type RNA - Late spermatids [nTPM]"	"Single Cell Type RNA - Leydig cells [nTPM]"	"Single Cell Type RNA - Macrophages [nTPM]"	"Single Cell Type RNA - Melanocytes [nTPM]"	"Single Cell Type RNA - Microglial cells [nTPM]"	"Single Cell Type RNA - monocytes [nTPM]"	"Single Cell Type RNA - Muller glia cells [nTPM]"	"Single Cell Type RNA - NK-cells [nTPM]"	"Single Cell Type RNA - Oligodendrocyte precursor cells [nTPM]"	"Single Cell Type RNA - Oligodendrocytes [nTPM]"	"Single Cell Type RNA - Pancreatic endocrine cells [nTPM]"	"Single Cell Type RNA - Paneth cells [nTPM]"	"Single Cell Type RNA - Peritubular cells [nTPM]"	"Single Cell Type RNA - Plasma cells [nTPM]"	"Single Cell Type RNA - Prostatic glandular cells [nTPM]"	"Single Cell Type RNA - Proximal enterocytes [nTPM]"	"Single Cell Type RNA - Proximal tubular cells [nTPM]"	"Single Cell Type RNA - Respiratory ciliated cells [nTPM]"	"Single Cell Type RNA - Rod photoreceptor cells [nTPM]"	"Single Cell Type RNA - Sertoli cells [nTPM]"	"Single Cell Type RNA - Skeletal myocytes [nTPM]"	"Single Cell Type RNA - Smooth muscle cells [nTPM]"	"Single Cell Type RNA - Spermatocytes [nTPM]"	"Single Cell Type RNA - Spermatogonia [nTPM]"	"Single Cell Type RNA - Squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Suprabasal keratinocytes [nTPM]"	"Single Cell Type RNA - Syncytiotrophoblasts [nTPM]"	"Single Cell Type RNA - T-cells [nTPM]"	"Single Cell Type RNA - Theca cells [nTPM]"	"Single Cell Type RNA - Undifferentiated cells [nTPM]"	"Single Cell Type RNA - Urothelial cells [nTPM]"
DUSP22	"JKAP, JSP1, MKPX, VHX"	ENSG00000112679	"Dual specificity phosphatase 22"	Q9NRW4	6	291630-351355	"Enzymes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RPMI-8226: 270.6;U-266/70: 130.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031394	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 59: Non-specific - Translation"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 51: Myeloid cells - Hemostasis"	"Nucleoplasm, Vesicles"		"HPA031394: AB_10604114"	"unprognostic (7.34e-3)"	"unprognostic (7.94e-3)"	"unprognostic (1.37e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.46e-1)"	"unprognostic (1.70e-2)"	"unprognostic (9.08e-3)"	"unprognostic (2.48e-1)"	"unprognostic (9.06e-2)"	"unprognostic (5.56e-3)"	"unprognostic (3.10e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.77e-1)"	"unprognostic (3.97e-2)"	"unprognostic (3.07e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.09e-1)"	36.9	16.4	25.6	27.7	29.1	23.7	33.0	27.4	28.8	31.6	21.2	47.8	22.5	28.9	12.2	45.7	25.9	21.3	42.1	25.1	27.1	32.4	32.7	38.5	32.4	32.3	28.5	19.6	40.8	13.2	21.2	27.3	30.3	23.2	16.1	7.8	30.4	15.1	52.3	41.4	33.7	22.0	28.0	43.9	32.7	44.9	29.3	15.0	28.1	37.7	30.5	30.3	36.8	42.7	13.7	8.3	17.3	25.9	19.5	21.5	22.8	9.9	8.0	8.6	10.3	8.8	15.1	28.4	23.3	10.3	18.3	9.4	21.9	18.3	6.1	68.6	25.1	19.3	7.1	24.7	9.9	7.0	24.4	16.2	54.1	6.2	11.3	14.1	24.8	24.0	18.3	92.2	7.2	8.2	10.3	25.1	10.4	10.0	18.7	20.2	11.7	270.6	16.2	5.8	29.7	11.6	8.5	3.4	29.6	37.4	17.6	8.9	34.2	7.7	10.1	7.8	6.0	130.0	98.6	40.0	3.0	19.0	17.7	36.4	32.5	13.6	8.6	26.5	6.2	40.4	6.7	9.1	33.5	33.3	6.1	8.8	21.8	5.9	25.1	28.8	15.9	19.6	25.6	29.1	27.4	28.8	25.1	27.1	32.3	28.5	30.3	28.0	29.3	42.7	45.5	16.0	21.3	5.5	53.7	26.5	22.0	33.3	14.2	5.7	19.4	17.5	40.8	10.0	30.7	5.5	0.0	10.8	51.1	11.7	21.5	24.2	13.4	18.6	8.2	33.4	9.5	8.2	8.5	51.4	7.7	21.9	15.3	12.9	33.0	8.8	21.8	25.0	30.1	0.0	6.1	14.7	32.6	38.6	43.0	20.5	15.5	47.1	46.2	21.5	78.4	14.9	36.0	7.1	25.9	29.2	12.4	9.4	59.7	16.5	23.2	18.2	39.7	3.2	26.3	11.6	22.8	34.5	73.8	42.5	37.1	6.6	21.3	6.8	15.4	27.9
IRF4	"LSIRF, MUM1"	ENSG00000137265	"Interferon regulatory factor 4"	Q15306	6	391752-411443	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 29.2;cervix: 19.0;lymphoid tissue: 26.1"	"Cell type enhanced"	"Detected in some"		"B-cells: 57.2;dendritic cells: 66.8;Langerhans cells: 109.7;Melanocytes: 44.4;monocytes: 56.1;Plasma cells: 235.6"	"Cancer enriched"	"Detected in many"	9	"melanoma: 27.0"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"memory B-cell: 10.4;myeloid DC: 10.6;naive B-cell: 10.8;plasmacytoid DC: 12.1;T-reg: 5.8"	"Group enriched"	"Detected in many"	5	"B-cells: 10.8;dendritic cells: 12.1;T-cells: 5.8"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 221.4;Karpas-707: 197.8;RPMI-8226: 200.0;U-266/70: 177.2;U-266/84: 141.3;WM-115: 109.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA002038, HPA002698, CAB013508"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 2: Immune cells - Immune response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Nucleoplasm	Cytosol	"CAB013508: , HPA002038: AB_1079148, HPA002698: AB_1851893"	"prognostic favorable (6.44e-4)"	"unprognostic (1.88e-3)"	"unprognostic (1.00e-3)"	"unprognostic (1.72e-4)"	"unprognostic (2.74e-1)"	"prognostic favorable (1.64e-6)"	"unprognostic (4.72e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.89e-2)"	"unprognostic (5.74e-4)"	"unprognostic (8.51e-2)"	"unprognostic (1.12e-1)"	"unprognostic (9.18e-7)"	"unprognostic (2.38e-1)"	"unprognostic (6.24e-2)"	"unprognostic (2.90e-1)"	"unprognostic (3.65e-2)"	3.1	0.4	0.1	15.9	0.1	29.2	3.2	0.1	0.2	19.0	0.2	6.9	7.6	1.5	0.3	0.9	0.7	2.5	1.0	0.1	0.1	0.4	2.4	2.2	23.2	0.3	0.1	0.6	0.1	0.0	0.3	0.1	0.2	0.5	6.8	0.0	4.5	0.4	0.2	6.8	10.2	0.7	0.2	17.4	7.2	1.1	0.1	7.0	1.1	0.1	26.1	6.3	2.4	0.2	0.4	0.0	0.0	0.0	22.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	221.4	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	197.8	0.0	0.0	0.1	0.1	1.2	0.0	0.0	26.1	0.0	200.0	0.0	0.0	0.4	0.0	0.0	0.2	32.0	0.6	0.1	0.3	0.0	0.0	0.1	0.0	0.3	177.2	141.3	58.4	0.2	0.0	109.0	0.1	1.8	0.0	0.6	1.5	0.0	10.4	1.0	1.0	10.6	10.8	1.7	0.7	0.0	0.3	1.5	12.1	5.8	1.5	0.1	0.1	0.1	0.2	0.1	0.1	0.3	0.1	0.2	0.2	0.1	0.2	0.8	0.0	5.3	0.0	57.2	8.3	0.1	0.0	0.0	0.0	0.6	1.5	1.2	1.5	0.0	0.0	0.0	0.0	66.8	0.2	0.0	0.1	0.0	0.3	0.9	0.6	0.0	0.0	0.1	0.7	0.0	1.8	1.5	0.4	0.0	0.0	1.1	0.5	0.3	0.0	0.1	0.1	0.0	0.6	109.7	0.2	3.4	21.7	44.4	0.0	56.1	0.0	0.0	0.0	0.3	0.1	0.1	0.0	235.6	0.2	0.0	0.1	0.0	0.0	0.0	0.4	0.9	0.0	1.0	0.4	4.3	0.1	29.8	0.0	0.1	0.1
EXOC2	"FLJ11026, SEC5L1, Sec5p"	ENSG00000112685	"Exocyst complex component 2"	Q96KP1	6	485154-693139	"Predicted intracellular proteins, RAS pathway related proteins, Transporters"	"Exocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 75.8;Inhibitory neurons: 80.1;Microglial cells: 68.4;Oligodendrocytes: 73.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA032093			Approved	Vesicles		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Vesicles		"HPA032093: AB_10611964"	"unprognostic (1.61e-1)"	"unprognostic (4.69e-1)"	"unprognostic (1.52e-1)"	"unprognostic (9.32e-2)"	"unprognostic (1.91e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.82e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.30e-1)"	"unprognostic (5.32e-2)"	"unprognostic (2.02e-1)"	"unprognostic (8.79e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.38e-2)"	"unprognostic (2.20e-1)"	10.2	8.3	11.0	11.5	11.7	6.6	10.9	11.4	11.2	10.1	11.6	9.1	8.6	8.7	5.2	12.2	6.5	8.9	11.6	11.2	11.5	9.3	10.3	11.3	13.4	11.6	11.6	7.8	6.6	11.6	8.2	18.0	12.5	7.9	10.0	13.4	8.0	7.9	10.1	11.8	9.3	9.2	11.0	13.1	8.9	16.1	11.3	18.6	14.2	10.4	14.1	10.8	9.1	14.4	21.0	15.2	26.0	28.5	23.2	20.8	15.7	18.5	21.5	21.7	25.8	20.4	11.0	15.5	44.0	22.3	32.7	17.7	29.2	32.2	25.7	48.4	30.9	19.8	18.5	20.4	29.1	21.2	18.8	18.1	25.9	15.5	18.0	21.4	36.9	30.0	39.4	11.1	27.3	18.1	28.6	20.6	26.4	18.6	15.1	26.6	22.5	31.3	19.5	22.4	25.4	14.9	14.8	9.0	29.1	48.4	23.2	12.9	54.1	19.6	14.1	24.6	17.4	27.2	56.8	16.4	19.8	17.4	61.0	11.6	9.0	10.2	17.1	11.0	20.9	13.5	17.2	18.3	14.1	14.5	16.2	15.7	2.8	14.8	17.7	11.1	21.1	14.4	11.0	11.7	11.4	11.2	11.2	11.5	11.6	11.6	12.5	11.0	11.3	14.4	12.6	3.2	14.5	35.6	15.9	4.8	3.8	6.2	6.2	9.0	10.1	9.3	8.6	2.8	6.5	5.5	8.4	16.0	18.5	6.1	7.9	6.2	11.0	7.3	7.0	11.1	2.4	8.2	75.8	5.1	7.1	7.6	6.1	8.2	5.1	11.8	8.6	8.2	10.0	8.4	80.1	6.8	12.2	9.0	5.8	3.8	6.8	8.7	5.4	68.4	10.8	4.6	13.4	49.3	73.4	6.9	5.1	9.1	11.3	6.4	4.1	8.2	9.0	9.3	0.0	7.3	8.9	21.8	17.5	9.9	7.7	12.9	18.3	7.4	5.9	6.0
HUS1B		ENSG00000188996	"HUS1 checkpoint clamp component B"	Q8NHY5	6	655939-656963	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"testis: 2.1"	"Group enriched"	"Detected in some"	4	"Sertoli cells: 6.6;Spermatocytes: 19.3;Spermatogonia: 8.0"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEK 293: 1.8;U-266/84: 2.2;WM-115: 2.2"	"Not detected"	"Not detected"							"HPA034511, HPA063449"			Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA034511: AB_2674203, HPA063449: AB_2685014"	"unprognostic (3.56e-4)"	"unprognostic (3.68e-2)"	"unprognostic (4.81e-2)"	"unprognostic (1.95e-1)"	"unprognostic (3.45e-2)"	"unprognostic (1.36e-1)"	"unprognostic (4.95e-2)"	"unprognostic (6.53e-2)"	"unprognostic (9.44e-2)"	"unprognostic (8.46e-2)"	"unprognostic (8.76e-3)"	"unprognostic (1.43e-1)"	"unprognostic (4.13e-10)"	"unprognostic (7.99e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.30e-1)"	0.4	0.3	0.4	0.1	0.4	0.7	0.3	0.3	0.5	0.8	0.5	0.3	0.2	0.4	0.1	0.6	0.3	0.1	0.4	0.3	0.3	0.5	0.6	0.6	0.0	0.4	0.2	0.5	0.1	0.0	0.5	0.1	0.4	0.8	0.0	0.2	0.4	0.0	0.2	0.6	0.3	0.1	0.0	0.6	0.2	2.1	0.3	0.1	0.4	0.1	0.0	0.4	0.7	0.6	0.3	0.0	0.0	0.7	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.3	0.0	0.1	0.2	0.0	0.1	0.0	0.2	0.0	0.1	0.5	1.8	0.4	0.0	0.0	0.1	0.0	0.6	0.0	0.1	0.1	0.1	0.0	0.0	0.4	0.7	0.4	0.2	0.0	0.2	1.0	1.1	0.0	0.6	0.3	0.3	1.0	0.1	0.2	0.4	0.0	0.1	0.0	0.3	0.2	0.0	0.0	0.1	0.2	0.3	0.6	0.1	0.9	2.2	0.4	0.0	0.2	2.2	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.2	0.1	0.0	0.1	0.1	0.3	0.0	0.0	0.0	0.2	0.1	0.1	0.4	0.4	0.3	0.5	0.3	0.3	0.4	0.2	0.4	0.0	0.3	0.6	1.1	0.0	0.0	0.0	0.8	0.6	0.8	1.0	0.6	0.7	1.3	1.3	0.2	1.5	0.2	0.0	0.0	1.5	1.7	0.3	0.0	1.3	0.6	0.5	0.4	1.2	0.0	0.0	0.0	0.6	1.1	0.5	0.0	0.9	0.0	0.5	2.2	0.2	0.8	0.0	0.0	0.1	0.0	0.0	0.4	0.6	0.9	0.5	0.0	0.0	2.6	0.4	2.1	0.0	0.0	1.3	0.1	1.2	0.1	0.7	0.3	0.1	0.1	1.4	6.6	0.7	1.3	19.3	8.0	0.2	1.7	1.5	1.5	0.8	0.3	0.5
FOXQ1	HFH1	ENSG00000164379	"Forkhead box Q1"	Q9C009	6	1312098-1314758	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"stomach 1: 107.2;urinary bladder: 53.5"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 60.4;Basal respiratory cells: 24.9;Collecting duct cells: 40.5;Gastric mucus-secreting cells: 67.2;Suprabasal keratinocytes: 45.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 39.0;HaCaT: 44.7;Hep G2: 93.8;OE19: 117.1;RT4: 38.2"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA059700			Supported	Nucleoplasm		Yes	NA				"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 61: Squamous epithelial cells - Keratinization"	Nucleoplasm		"HPA059700: AB_2684107"	"unprognostic (2.04e-3)"	"unprognostic (3.44e-1)"	"unprognostic (1.10e-1)"	"unprognostic (7.18e-2)"	"unprognostic (1.50e-3)"	"unprognostic (2.15e-1)"	"unprognostic (3.26e-2)"	"unprognostic (1.15e-3)"	"unprognostic (1.04e-2)"	"unprognostic (1.06e-1)"	"unprognostic (7.65e-3)"	"prognostic favorable (6.68e-4)"	"unprognostic (1.49e-2)"	"unprognostic (3.16e-3)"	"unprognostic (2.82e-1)"	"unprognostic (3.93e-2)"	"unprognostic (1.96e-2)"	0.3	0.0	6.9	0.2	5.2	0.0	1.4	7.1	7.1	6.7	3.8	0.8	10.4	0.9	0.3	11.3	3.9	5.4	0.0	4.7	5.1	9.8	6.4	4.0	0.0	5.6	6.0	0.0	6.5	0.1	2.5	1.1	6.0	8.9	0.4	0.1	30.4	1.1	0.2	25.7	0.6	0.0	5.3	0.0	107.2	0.2	7.5	0.6	3.6	0.6	8.0	53.5	16.9	4.7	16.0	1.4	0.0	0.0	0.0	0.0	0.0	0.7	13.5	0.1	0.1	39.0	22.6	0.0	0.7	0.0	0.1	44.7	0.0	1.7	0.0	0.0	1.1	0.0	8.2	93.8	0.0	0.0	2.4	0.0	16.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	117.1	0.8	0.0	0.0	0.0	0.4	38.2	0.3	0.0	3.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	15.5	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.9	5.2	7.1	7.1	4.7	5.1	5.6	6.0	6.0	5.3	7.5	4.7	0.3	16.0	10.6	0.0	0.0	60.4	3.2	24.9	6.8	0.0	5.3	5.1	0.8	0.0	16.8	40.5	0.0	0.0	0.0	0.0	1.9	3.0	0.0	5.2	3.0	0.4	0.0	0.0	1.2	13.4	0.0	1.4	67.2	14.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.1	0.0	2.9	0.0	0.0	0.7	1.8	15.9	0.0	0.0	0.0	0.0	0.5	11.8	0.0	0.0	0.2	0.6	0.0	6.2	5.0	0.0	0.0	0.0	1.6	0.0	0.0	22.2	45.5	0.0	0.3	0.0	0.0	3.9
FOXF2	"FKHL6, FREAC2"	ENSG00000137273	"Forkhead box F2"	Q12947	6	1389576-1395603	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 40.2"	"Cell type enhanced"	"Detected in some"		"Endothelial cells: 5.2;Fibroblasts: 7.9;Microglial cells: 19.7;Smooth muscle cells: 5.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 70.4;HEK 293: 24.3;U-2197: 28.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"									NA	NA				"Cluster 57: Non-specific - Angiogenesis"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"				"unprognostic (2.14e-2)"	"unprognostic (2.03e-1)"	"unprognostic (8.33e-2)"	"unprognostic (1.68e-1)"	"unprognostic (5.39e-2)"	"unprognostic (3.32e-2)"	"unprognostic (8.12e-2)"	"unprognostic (1.11e-1)"	"unprognostic (9.89e-3)"	"unprognostic (2.53e-1)"	"unprognostic (4.50e-2)"	"unprognostic (8.76e-2)"	"unprognostic (8.75e-7)"	"unprognostic (1.03e-1)"	"unprognostic (4.74e-2)"	"unprognostic (2.08e-2)"	"unprognostic (8.29e-2)"	1.8	0.4	8.1	1.8	6.0	0.0	2.4	5.5	10.3	1.0	5.1	40.2	6.0	0.2	0.8	9.6	0.5	1.5	0.7	6.1	5.2	0.2	0.1	17.8	0.4	10.1	6.0	0.1	1.0	0.6	7.6	9.1	10.0	10.8	9.3	0.1	1.3	0.6	1.0	1.4	18.7	3.5	5.1	0.0	17.8	0.9	7.1	0.0	3.7	3.5	1.8	11.1	2.1	6.9	1.6	3.4	1.0	0.8	3.2	4.9	0.1	15.6	70.4	6.3	2.9	0.3	0.0	0.0	3.3	4.6	6.8	11.9	12.2	0.6	2.8	0.0	24.3	0.0	5.7	0.0	6.1	0.0	0.4	0.8	5.0	0.0	5.9	10.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.1	0.1	0.1	0.0	0.0	0.0	6.9	0.2	0.0	3.7	0.0	5.2	1.3	0.0	0.2	0.0	5.8	11.0	28.7	2.8	0.3	0.0	0.0	0.0	4.7	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.1	6.0	5.5	10.3	6.1	5.2	10.1	6.0	10.0	5.1	7.1	6.9	0.5	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.2	0.0	0.1	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	1.0	5.2	0.0	0.0	1.1	0.0	1.5	7.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.4	2.5	0.1	1.8	19.7	0.0	0.0	0.0	0.0	0.2	0.1	0.0	2.6	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.6	5.5	0.2	1.5	0.3	0.1	0.1	0.1	0.0	0.0	0.0
FOXC1	"ARA, FKHL7, FREAC3, IGDA, IHG1, IRID1"	ENSG00000054598	"Forkhead box C1"	Q12948	6	1609915-1613897	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Angiogenesis, Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Repressor"	"Deafness, Disease variant, Peters anomaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"salivary gland: 154.4"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 93.7;Breast myoepithelial cells: 59.4;Endothelial cells: 64.7;Hepatic stellate cells: 65.7;Urothelial cells: 64.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 92.4;HEK 293: 91.8;RPTEC TERT1: 35.9"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"spinal cord: 18.0"	HPA040670			Supported	Nucleoplasm,Cytosol		NA	NA				"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm	Cytosol	"HPA040670: AB_10673412"	"unprognostic (2.65e-2)"	"unprognostic (1.15e-2)"	"prognostic unfavorable (3.53e-4)"	"unprognostic (3.22e-2)"	"unprognostic (3.22e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.30e-2)"	"unprognostic (1.54e-2)"	"unprognostic (4.04e-3)"	"unprognostic (1.58e-1)"	"unprognostic (2.33e-3)"	"unprognostic (9.55e-2)"	"unprognostic (1.11e-2)"	"unprognostic (6.48e-2)"	"unprognostic (2.04e-1)"	"unprognostic (3.83e-3)"	"unprognostic (3.74e-1)"	12.3	6.0	7.7	1.2	8.3	0.6	9.0	7.1	9.3	6.3	11.0	1.7	0.9	3.7	1.7	4.8	5.0	7.5	14.0	6.0	6.5	19.9	1.2	3.3	1.7	9.0	7.4	4.7	3.6	1.6	9.5	4.1	8.7	8.6	0.9	0.3	154.4	6.4	2.4	11.1	1.6	2.3	7.1	0.4	1.7	2.0	9.2	8.3	5.6	2.9	2.2	9.4	5.6	7.1	18.0	2.0	0.6	92.4	4.2	4.6	2.9	8.9	10.3	5.4	4.3	6.7	3.7	0.0	10.0	5.2	3.9	19.9	8.8	6.5	4.5	5.7	91.8	3.7	5.3	3.3	2.8	1.4	6.0	15.6	8.7	7.3	8.3	2.8	7.9	0.6	2.7	0.1	2.3	3.8	0.0	2.0	0.3	8.9	7.6	0.0	3.7	0.5	35.9	13.3	3.4	8.0	10.9	0.1	6.4	4.5	2.6	1.5	2.0	11.5	7.1	5.9	9.6	0.4	0.8	0.0	3.2	4.5	10.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	7.7	8.3	7.1	9.3	6.0	6.5	9.0	7.4	8.7	7.1	9.2	7.1	93.7	0.0	0.6	0.0	0.4	17.7	31.9	26.3	13.6	0.0	42.2	59.4	7.1	0.0	23.6	11.0	0.0	5.3	1.9	0.9	1.9	3.9	0.6	8.6	1.1	64.7	0.0	0.0	0.0	17.1	0.6	21.2	1.5	3.8	0.0	0.7	65.7	0.4	1.3	0.0	0.0	1.5	8.2	1.3	5.5	1.4	16.1	2.7	1.8	23.4	0.0	0.3	0.0	0.5	0.1	16.2	0.1	28.2	0.1	9.5	0.0	7.4	34.9	0.0	0.0	19.2	40.4	0.7	3.1	11.2	6.5	0.8	1.1	4.4	0.6	64.9
GMDS	"GMD, SDR3E1"	ENSG00000112699	"GDP-mannose 4,6-dehydratase"	O60547	6	1623806-2245605	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Lyase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 106.0;salivary gland: 105.4;stomach 1: 97.1"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 208.5;Gastric mucus-secreting cells: 276.8;Intestinal goblet cells: 367.6;Proximal enterocytes: 190.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"OE19: 246.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031528	Enhanced					NA	NA		72000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 37: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 27: Mucus-secreting cells - Mucin production"			"HPA031528: AB_10601016"	"unprognostic (5.94e-2)"	"unprognostic (3.92e-2)"	"unprognostic (1.12e-1)"	"prognostic favorable (5.89e-4)"	"unprognostic (4.37e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.10e-3)"	"unprognostic (7.15e-2)"	"unprognostic (2.29e-1)"	"unprognostic (8.02e-2)"	"unprognostic (2.38e-1)"	"unprognostic (4.41e-1)"	"prognostic favorable (5.93e-4)"	"unprognostic (2.45e-1)"	"unprognostic (2.84e-1)"	"unprognostic (6.68e-2)"	"unprognostic (1.12e-1)"	10.7	7.6	8.6	30.1	7.1	9.1	14.6	5.8	7.1	29.4	9.7	87.7	106.0	7.8	10.4	65.8	11.5	20.5	9.5	7.6	7.0	19.6	31.1	9.0	14.2	6.6	6.9	6.7	43.8	20.5	12.9	7.1	6.7	18.3	82.4	1.5	105.4	8.0	5.1	10.6	87.3	10.3	6.1	11.4	97.1	9.2	7.3	13.9	11.9	4.9	20.8	13.7	14.2	6.2	45.9	10.6	7.4	52.6	11.8	32.0	17.9	12.5	25.7	22.7	21.2	23.1	26.1	21.7	37.3	13.6	22.4	18.3	22.9	43.8	26.2	30.0	28.8	21.0	11.2	110.3	13.2	34.2	22.5	35.6	14.9	18.0	37.2	21.9	26.9	73.0	13.9	9.8	14.7	26.3	49.0	40.1	11.4	246.4	36.0	24.8	16.8	112.4	55.4	59.5	41.4	9.9	11.5	17.7	28.8	33.6	16.4	21.4	11.7	17.4	13.1	17.7	22.5	22.1	33.6	23.1	11.4	23.6	23.4	7.0	12.9	1.5	7.8	8.3	10.3	10.5	9.4	7.5	14.5	5.0	7.6	10.8	3.8	13.1	6.8	6.1	13.2	8.3	8.6	7.1	5.8	7.1	7.6	7.0	6.6	6.9	6.7	6.1	7.3	6.2	19.7	0.0	4.5	40.8	19.8	4.2	20.1	38.3	27.3	3.7	33.1	19.3	2.9	12.8	40.5	38.6	0.0	18.7	6.5	104.1	119.3	36.5	5.7	7.8	7.3	23.0	111.7	9.7	208.5	69.7	30.8	12.4	276.8	11.9	4.5	13.2	18.2	19.6	13.5	8.4	167.5	367.6	50.8	10.9	7.6	4.6	12.2	11.0	23.2	143.4	14.7	3.3	9.2	83.9	50.2	47.0	85.5	16.6	53.1	40.7	190.7	38.1	38.3	0.7	13.1	5.8	16.6	6.5	33.1	20.1	6.1	16.7	18.6	13.4	165.1	43.5
MYLK4	SgK085	ENSG00000145949	"Myosin light chain kinase family member 4"	Q86YV6	6	2663629-2750922	"Enzymes, Metabolic proteins, Predicted membrane proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	17	"skeletal muscle: 30.1;tongue: 72.1"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 7.8;Inhibitory neurons: 7.2;Microglial cells: 4.7;Oligodendrocyte precursor cells: 8.0;Proximal tubular cells: 4.5"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"HEL: 7.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA015860	Uncertain		Approved	"Nucleoli,Golgi apparatus,Vesicles"		NA	NA				"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 36: HEL - Hemostasis"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Golgi apparatus"	"Nucleoli, Vesicles"	"HPA015860: AB_2147922"	"unprognostic (1.75e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.87e-1)"	"unprognostic (5.22e-3)"	"unprognostic (1.85e-1)"	"unprognostic (2.99e-2)"	"unprognostic (7.48e-2)"	"unprognostic (2.80e-1)"	"unprognostic (5.32e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.02e-2)"	"unprognostic (2.91e-1)"	"unprognostic (2.74e-3)"	"unprognostic (1.43e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.19e-2)"	"unprognostic (4.63e-2)"	1.2	0.5	0.6	0.3	0.6	0.8	1.0	0.6	0.9	0.6	0.7	0.4	0.3	0.6	0.7	1.3	0.5	0.4	1.4	0.7	0.7	3.0	0.5	1.2	0.4	0.4	0.5	0.4	0.9	0.9	1.3	0.6	0.4	0.7	0.3	0.8	2.4	0.6	30.1	1.4	0.6	0.3	0.4	0.6	0.6	0.4	0.6	0.3	0.8	72.1	0.7	0.6	0.8	0.6	0.1	0.1	0.3	0.6	0.5	0.6	0.3	0.4	0.8	0.2	0.2	0.3	0.6	0.6	0.9	0.4	0.1	1.0	0.1	0.2	0.3	0.1	0.3	7.2	0.4	0.0	0.2	0.2	0.3	0.8	0.3	0.0	0.6	0.3	0.3	0.1	0.0	0.0	0.1	0.3	0.0	0.8	0.1	0.2	0.0	0.5	0.0	0.0	0.4	0.1	0.5	0.3	0.1	0.1	0.3	0.5	0.2	0.5	0.4	0.2	0.0	0.1	0.2	0.2	0.1	0.0	0.1	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.6	0.6	0.9	0.7	0.7	0.4	0.5	0.4	0.4	0.6	0.6	0.5	3.2	1.1	1.6	0.5	0.1	0.1	0.5	0.6	1.0	0.6	0.3	1.9	1.5	1.0	0.0	0.0	0.3	0.1	0.2	0.0	0.3	0.4	0.1	0.7	0.6	1.2	0.0	7.8	0.2	0.0	0.5	0.0	0.2	0.0	0.6	1.1	0.2	0.3	1.7	7.2	0.0	0.0	0.8	1.2	0.2	0.3	0.4	0.0	4.7	1.1	0.3	0.0	8.0	2.9	0.0	0.0	1.5	0.0	0.2	0.1	4.5	0.3	0.3	0.0	0.8	0.3	0.0	0.3	0.3	0.9	0.3	0.2	0.4	0.3	0.2
WRNIP1	"bA420G6.2, CFAP93, FAP93, FLJ22526, WHIP"	ENSG00000124535	"WRN helicase interacting protein 1"	Q96S55	6	2765393-2786952	"Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, DNA replication, Immunity, Innate immunity"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031752, HPA031753"	Enhanced		Approved	Nucleoplasm		No	No			"Cluster 34: Basophils - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoplasm		"HPA031752: AB_10603004, HPA031753: AB_2674028"	"unprognostic (5.52e-2)"	"unprognostic (5.95e-2)"	"unprognostic (6.83e-3)"	"unprognostic (8.35e-3)"	"unprognostic (7.66e-2)"	"unprognostic (7.10e-2)"	"unprognostic (5.63e-3)"	"unprognostic (3.40e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.81e-1)"	"unprognostic (6.29e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.37e-1)"	"unprognostic (2.61e-2)"	"unprognostic (1.85e-1)"	"unprognostic (2.29e-1)"	23.7	31.1	45.6	22.6	47.0	49.0	28.8	47.8	46.8	29.2	46.2	29.7	23.6	26.7	37.1	48.3	35.6	24.6	39.5	47.8	46.7	35.7	33.0	30.3	34.7	44.4	44.8	30.1	43.9	46.4	43.1	43.3	43.5	28.5	29.1	45.8	46.1	26.8	44.0	37.2	27.4	23.8	43.6	28.7	29.1	31.5	47.4	43.9	39.0	76.3	34.7	32.1	31.7	45.1	86.8	42.7	42.5	70.1	44.1	37.7	56.5	38.9	54.2	69.8	69.2	67.8	39.4	77.4	103.1	50.4	75.6	65.9	70.2	78.1	67.8	77.9	77.5	80.9	50.3	107.4	50.1	51.4	53.8	38.7	62.7	64.4	69.5	48.5	89.8	71.8	62.8	27.2	51.6	84.5	76.7	92.7	36.5	59.3	52.5	60.3	62.2	78.4	75.3	52.5	127.8	36.5	45.9	46.1	93.7	66.7	59.4	57.1	49.4	52.1	39.4	45.8	95.8	34.8	65.3	59.8	20.4	55.0	72.1	9.4	1.6	2.3	4.0	1.8	1.2	2.3	2.7	2.8	1.3	1.3	3.1	3.0	0.7	2.6	0.9	2.6	4.2	1.4	45.6	47.0	47.8	46.8	47.8	46.7	44.4	44.8	43.5	43.6	47.4	45.1	16.4	19.2	14.6	14.0	12.4	32.5	13.4	20.1	23.9	24.8	22.3	19.4	23.7	24.3	12.3	11.0	8.4	30.4	11.8	29.6	3.9	14.5	45.0	21.9	19.7	20.9	39.7	26.1	23.5	13.5	25.6	15.1	11.7	17.5	9.5	12.7	28.2	25.0	12.4	8.4	20.8	21.2	24.4	16.2	17.9	13.4	22.4	12.4	21.4	23.4	15.0	20.0	10.3	26.2	23.0	18.0	16.3	22.2	10.2	18.5	14.8	13.7	24.1	17.4	6.6	19.9	17.8	22.1	23.9	32.4	32.1	25.4	12.5	20.5	25.0	16.3
SERPINB1	"anti-elastase, EI, ELANH2, PI2"	ENSG00000021355	"Serpin family B member 1"	P30740	6	2832332-2841959	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 466.8;esophagus: 478.3"	"Cell type enhanced"	"Detected in many"		"Exocrine glandular cells: 1424.3;Pancreatic endocrine cells: 1067.8;Urothelial cells: 984.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 125.3;OE19: 162.5;U-937: 144.9"					"Low region specificity"	"Detected in all"			"HPA018871, HPA018882, HPA052642"	Enhanced		Supported	"Cytoplasmic bodies"	"Secreted to blood"	NA	NA		24000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	"Cytoplasmic bodies"		"HPA018871: AB_1856724, HPA018882: , HPA052642: AB_2681896"	"unprognostic (1.13e-2)"	"unprognostic (1.93e-1)"	"unprognostic (6.07e-2)"	"unprognostic (1.75e-2)"	"unprognostic (5.14e-3)"	"unprognostic (9.67e-2)"	"unprognostic (3.59e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.88e-2)"	"unprognostic (1.08e-3)"	"unprognostic (9.07e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.28e-1)"	36.6	54.4	10.7	69.7	14.4	466.8	25.0	11.1	14.0	55.6	17.3	77.7	140.4	15.6	22.2	478.3	35.8	57.4	26.8	10.7	12.7	33.2	32.1	81.7	51.3	15.1	13.0	18.1	232.1	29.8	32.9	27.0	14.6	15.9	87.5	13.4	99.6	16.9	54.2	15.8	107.3	24.9	13.6	67.4	97.9	7.1	13.7	31.9	30.7	22.9	122.8	88.6	112.4	14.8	42.9	49.7	2.7	0.3	10.6	21.8	41.2	11.8	36.1	14.5	26.1	47.1	125.3	0.3	86.6	26.6	15.6	26.8	4.8	11.4	11.1	59.4	7.5	76.6	16.0	37.0	37.2	13.5	46.2	26.8	18.4	7.3	3.3	7.2	48.7	0.0	27.1	9.9	13.4	19.9	1.7	35.4	4.5	162.5	22.1	3.9	0.5	44.4	51.0	9.3	8.8	4.8	28.8	11.2	64.2	5.9	5.6	43.2	29.1	4.6	10.4	10.2	3.6	0.1	2.2	0.5	17.4	144.9	2.4	118.0	207.1	109.4	53.3	103.7	45.8	43.5	48.1	48.4	150.4	32.3	47.4	50.6	182.3	85.1	82.8	48.6	58.5	175.8	10.7	14.4	11.1	14.0	10.7	12.7	15.1	13.0	14.6	13.6	13.7	14.8	79.9	240.4	269.9	0.7	90.7	35.1	165.1	699.1	38.1	4.2	55.0	51.2	17.6	72.9	420.9	46.0	2.1	124.5	120.8	264.1	56.7	490.3	1.7	210.6	28.7	118.9	96.3	176.3	0.9	1424.3	149.1	89.1	345.1	104.5	452.2	32.1	124.9	20.2	183.0	10.1	0.9	263.1	109.9	332.7	308.2	3.5	34.8	387.3	71.2	15.9	589.7	48.3	139.0	4.5	6.6	1067.8	308.4	27.8	65.2	147.5	333.7	81.3	343.8	17.2	13.1	109.7	67.2	2.0	11.2	461.5	38.1	99.7	112.9	59.2	242.6	984.3
SERPINB9	"CAP3, PI9"	ENSG00000170542	"Serpin family B member 9"	P50453	6	2887270-2903309	"Predicted intracellular proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 41.1;placenta: 52.3"	"Cell type enriched"	"Detected in many"	5	"Langerhans cells: 1527.7"	"Cancer enriched"	"Detected in all"	5	"testis cancer: 46.3"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 225.3;SuSa: 227.6;U-698: 98.8"					"Low region specificity"	"Detected in all"			HPA030067	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA		3400000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm	Cytosol	"HPA030067: AB_2673295"	"unprognostic (6.82e-3)"	"unprognostic (8.59e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.25e-1)"	"unprognostic (4.06e-1)"	"unprognostic (1.50e-1)"	"unprognostic (3.12e-2)"	"unprognostic (9.48e-2)"	"unprognostic (2.12e-2)"	"unprognostic (3.83e-3)"	"unprognostic (1.06e-1)"	"unprognostic (9.85e-2)"	"prognostic unfavorable (1.66e-6)"	"unprognostic (9.90e-2)"	"unprognostic (8.56e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.76e-2)"	11.6	11.0	6.4	35.4	6.7	18.9	5.3	7.5	7.9	7.8	5.9	5.3	4.4	4.4	3.1	9.2	8.3	11.3	9.1	6.3	8.0	5.2	16.3	26.4	40.9	8.8	7.8	3.0	2.4	6.7	8.8	52.3	8.7	5.2	6.5	4.7	4.3	2.8	2.4	2.7	10.8	5.9	8.4	28.2	5.0	8.7	7.2	13.8	7.6	1.8	41.1	17.0	7.4	8.2	0.2	9.8	0.3	0.1	0.7	0.3	225.3	1.9	0.5	2.3	3.4	2.9	18.8	38.2	22.8	2.1	0.1	0.1	27.6	0.0	2.0	12.4	2.7	3.8	3.3	5.5	12.9	0.0	0.1	10.1	0.1	4.1	0.0	0.2	50.2	3.4	17.8	0.3	1.9	0.9	0.0	0.3	31.7	0.1	0.1	3.7	0.1	0.4	1.6	0.1	1.5	0.5	22.7	0.1	0.0	227.6	0.1	0.6	52.5	0.0	0.4	0.1	0.1	0.2	49.5	98.8	0.0	0.1	0.1	4.7	48.6	0.3	43.6	100.8	36.3	22.4	31.3	41.7	16.1	24.9	28.7	41.4	7.6	51.3	62.7	17.0	35.7	37.9	6.4	6.7	7.5	7.9	6.3	8.0	8.8	7.8	8.7	8.4	7.2	8.2	26.2	19.2	17.6	12.1	105.1	35.3	2.2	4.2	1.8	1.5	13.8	6.7	5.3	1.5	12.1	5.5	0.0	83.1	100.8	4.7	0.0	15.8	1.0	68.0	10.8	44.1	15.5	11.6	21.4	0.2	143.7	35.6	3.6	82.2	46.3	2.2	66.4	7.1	17.9	8.4	23.1	2.7	2.0	59.6	1527.7	4.9	4.4	232.6	88.9	92.8	99.8	5.3	43.3	1.0	3.2	9.3	6.0	17.7	115.7	2.5	0.1	2.4	10.4	3.0	13.1	55.3	14.6	0.4	2.2	3.8	36.9	270.2	100.6	8.1	3.4	6.9
SERPINB6	"CAP, DFNB91, PI6, PTI"	ENSG00000124570	"Serpin family B member 6"	P35237	6	2948159-2972165	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"Protease inhibitor, Serine protease inhibitor"	"Deafness, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 563.0;Late spermatids: 1154.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA009668, HPA012736"	Enhanced		Approved	Centrosome		NA	NA		4800000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 31: Spermatids - Spermatogenesis"	Centrosome		"HPA009668: AB_1079919, HPA012736: AB_1856729"	"unprognostic (3.44e-1)"	"unprognostic (1.03e-1)"	"unprognostic (8.72e-2)"	"unprognostic (1.96e-3)"	"unprognostic (2.72e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.66e-3)"	"unprognostic (1.96e-2)"	"unprognostic (7.63e-2)"	"prognostic favorable (4.81e-4)"	"unprognostic (3.51e-1)"	"unprognostic (1.54e-1)"	"prognostic unfavorable (2.21e-4)"	"unprognostic (1.59e-1)"	"unprognostic (5.08e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.10e-2)"	122.7	170.7	101.1	66.9	108.4	66.6	107.9	103.6	134.3	135.9	103.8	133.7	191.2	95.9	82.2	131.5	118.9	77.7	243.9	98.6	104.2	136.7	63.3	151.7	52.7	111.7	107.1	169.7	282.5	94.4	92.0	133.5	110.6	160.4	103.3	56.4	92.5	95.6	232.0	50.9	210.3	89.4	105.8	164.5	115.0	203.8	106.7	26.7	101.3	266.8	47.2	107.7	95.5	115.4	156.2	99.6	32.2	134.3	85.6	189.2	99.2	142.1	170.7	109.9	127.3	35.0	108.5	0.8	161.6	161.7	124.8	228.8	90.3	144.1	102.2	204.9	41.2	90.7	111.8	60.0	148.5	1.1	53.0	109.4	98.5	104.8	26.9	191.1	263.7	0.5	118.7	2.0	198.0	110.7	0.5	1.5	19.1	175.5	188.8	10.1	59.3	130.7	138.7	37.1	1.5	82.5	116.9	17.3	162.4	118.6	75.3	73.8	188.7	111.1	41.4	252.0	97.1	3.0	0.6	2.7	85.4	90.8	117.8	60.6	104.9	121.2	51.5	107.6	25.7	27.3	28.9	35.5	103.6	22.9	33.7	56.1	8.6	86.0	90.7	10.3	5.0	91.1	101.1	108.4	103.6	134.3	98.6	104.2	111.7	107.1	110.6	105.8	106.7	115.4	127.8	51.3	69.6	34.3	33.0	20.5	68.4	141.8	23.9	28.4	62.4	63.0	142.6	42.9	141.6	75.4	20.9	146.4	56.8	237.9	99.7	194.6	563.0	89.4	91.4	137.5	73.0	29.9	14.2	338.3	346.6	84.9	108.6	47.8	104.5	83.5	232.7	31.9	182.3	30.3	21.5	169.7	114.0	181.9	70.2	1154.3	83.3	124.2	64.0	92.8	151.8	172.4	46.4	31.7	56.2	318.5	237.0	85.0	17.4	99.3	418.3	216.4	174.2	50.4	78.9	119.7	104.6	233.2	33.1	34.0	26.3	161.4	42.2	65.0	206.5	94.9
NQO2	"DHQV, DIA6, NMOR2, QR2"	ENSG00000124588	"N-ribosyldihydronicotinamide:quinone reductase 2"	P16083	6	2987987-3019755	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hepatocytes: 202.5;Proximal tubular cells: 730.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 240.2"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021283, HPA021332"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA		6000000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 16: U-266 - Nucleosome"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol	Nucleoplasm	"HPA021283: AB_1854600, HPA021332: AB_1854601"	"unprognostic (7.11e-3)"	"unprognostic (1.43e-3)"	"unprognostic (2.41e-1)"	"unprognostic (3.01e-2)"	"unprognostic (1.00e-2)"	"unprognostic (3.58e-1)"	"prognostic unfavorable (8.40e-4)"	"unprognostic (1.77e-1)"	"unprognostic (1.15e-1)"	"unprognostic (4.90e-2)"	"unprognostic (6.59e-2)"	"unprognostic (3.60e-2)"	"unprognostic (8.28e-2)"	"unprognostic (2.03e-1)"	"unprognostic (3.32e-2)"	"unprognostic (3.96e-1)"	"unprognostic (2.02e-1)"	60.0	121.5	48.1	27.0	48.8	72.1	45.0	61.1	65.4	32.6	64.3	28.2	35.3	25.8	32.9	32.8	30.0	31.5	76.5	48.5	49.6	190.3	124.2	30.4	19.5	61.8	47.9	29.8	42.6	33.5	21.2	28.6	61.4	28.1	19.6	31.1	61.9	28.9	123.6	50.7	35.6	19.8	42.9	39.3	36.1	18.2	51.5	18.3	26.8	144.9	18.2	31.8	29.0	53.2	45.7	75.7	42.1	95.3	73.0	42.9	45.4	40.5	51.2	37.1	40.9	80.0	16.1	36.9	144.7	71.1	86.4	33.7	45.4	28.5	28.9	95.9	37.1	23.6	83.0	77.3	59.7	24.4	73.9	27.8	34.2	44.9	40.9	53.4	36.8	47.9	142.3	24.1	30.8	95.5	27.0	44.4	54.9	87.6	59.8	49.3	50.1	108.2	56.6	24.0	11.4	15.9	59.5	25.9	128.9	75.0	35.4	16.9	60.7	34.8	14.4	45.9	18.1	45.4	116.7	12.3	43.3	69.5	72.7	25.2	91.8	52.8	33.1	64.2	24.4	12.1	29.6	29.8	61.7	9.1	17.8	19.6	240.2	30.0	60.8	6.5	37.2	43.2	48.1	48.8	61.1	65.4	48.5	49.6	61.8	47.9	61.4	42.9	51.5	53.2	30.3	9.6	16.1	9.8	16.3	35.2	41.5	32.7	12.5	34.8	34.2	32.1	72.8	47.1	21.3	25.8	10.4	42.6	18.2	21.2	162.4	29.1	51.6	15.1	21.4	28.0	4.8	43.8	47.0	63.4	53.9	51.5	33.1	9.0	13.9	11.0	25.7	202.5	76.6	42.1	46.7	23.3	30.5	44.7	105.7	62.8	35.8	75.4	67.6	19.7	148.6	54.0	20.6	10.6	9.1	55.8	18.3	41.0	15.0	38.6	103.7	730.3	28.7	22.5	26.3	35.0	42.9	24.8	11.4	35.4	41.2	31.2	20.8	21.9	25.4	41.8
RIPK1	RIP	ENSG00000137275	"Receptor interacting serine/threonine kinase 1"	Q13546	6	3063824-3115187	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Apoptosis, Host-virus interaction, Inflammatory response, Necrosis"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010302, HPA015257"	Supported		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 7: Non-specific - Mitochondria"	"Plasma membrane, Cytosol"		"CAB010302: AB_2178118, HPA015257: AB_1856294"	"unprognostic (1.24e-1)"	"unprognostic (6.83e-2)"	"unprognostic (1.87e-1)"	"unprognostic (7.75e-2)"	"unprognostic (6.08e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.96e-1)"	"unprognostic (9.46e-2)"	"unprognostic (1.46e-1)"	"unprognostic (5.00e-2)"	"unprognostic (3.29e-1)"	"unprognostic (9.65e-3)"	"unprognostic (3.44e-1)"	"unprognostic (9.01e-2)"	"unprognostic (1.38e-2)"	"prognostic favorable (6.71e-4)"	18.5	12.0	1.9	9.3	1.9	0.5	16.2	1.8	3.8	12.8	2.4	17.5	12.3	14.5	5.3	17.6	12.8	10.6	11.8	1.8	1.9	13.7	23.6	13.5	10.1	2.2	1.9	8.5	17.4	12.2	12.3	10.9	2.0	13.7	13.0	2.4	16.4	8.9	11.7	20.7	19.9	11.9	2.0	19.4	16.5	5.3	2.0	11.9	14.4	5.0	13.0	15.5	13.7	1.9	14.4	9.8	12.9	12.4	27.6	19.2	5.5	21.4	30.8	22.8	26.7	12.4	8.0	13.8	20.9	30.1	23.2	14.3	17.9	17.2	24.3	27.8	9.4	16.7	4.5	6.9	17.2	15.6	20.1	24.8	15.1	20.4	15.3	17.6	20.6	6.2	19.4	4.6	22.0	17.8	10.7	7.7	8.8	17.4	12.7	11.8	10.9	14.5	17.3	27.2	11.3	12.2	14.7	7.8	22.4	26.0	15.2	8.7	25.1	20.6	12.1	8.2	16.4	9.8	15.3	13.5	8.9	7.0	27.7	0.1	0.4	0.9	0.6	0.9	1.0	0.3	0.9	1.7	1.0	1.2	0.7	0.7	0.0	1.5	0.5	0.5	1.7	0.8	1.9	1.9	1.8	3.8	1.8	1.9	2.2	1.9	2.0	2.0	2.0	1.9	28.6	6.4	12.0	17.3	14.7	11.0	10.3	6.6	16.5	4.4	14.7	17.8	8.6	17.2	16.7	9.2	12.5	8.9	21.9	27.1	5.9	9.4	2.0	10.5	14.0	16.7	6.6	7.2	23.1	12.9	7.7	18.3	27.0	13.4	10.8	8.7	10.0	14.6	11.6	5.0	26.7	17.7	4.1	6.7	11.1	0.8	6.8	15.3	3.6	11.2	13.8	6.6	12.3	14.6	16.2	13.8	11.7	6.0	22.3	11.3	12.7	8.7	17.4	21.4	19.7	32.5	17.9	1.2	2.8	20.5	9.9	11.9	20.8	10.6	11.3	14.5
BPHL	"Bph-rp, MCNAA, VACVase"	ENSG00000137274	"Biphenyl hydrolase like"	Q86WA6	6	3118374-3153578	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 110.4;liver: 84.8"	"Cell type enhanced"	"Detected in many"		"Proximal enterocytes: 99.7;Proximal tubular cells: 336.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036752, HPA036753"	Enhanced		Approved	Mitochondria		NA	NA		14000	"Cluster 44: Non-specific - Transcription"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria		"HPA036752: AB_10673662, HPA036753: AB_2675291"	"unprognostic (2.93e-1)"	"unprognostic (1.29e-1)"	"unprognostic (8.88e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.72e-3)"	"unprognostic (1.84e-1)"	"unprognostic (8.65e-2)"	"unprognostic (3.14e-2)"	"unprognostic (1.94e-1)"	"prognostic favorable (5.97e-4)"	"unprognostic (4.59e-2)"	"unprognostic (9.46e-3)"	"prognostic favorable (5.16e-7)"	"unprognostic (1.60e-2)"	"unprognostic (1.51e-2)"	"unprognostic (6.98e-2)"	"unprognostic (5.20e-2)"	24.1	15.3	9.4	3.9	9.8	3.5	11.2	9.5	14.5	9.3	11.8	10.6	33.8	7.0	28.8	13.2	11.1	8.9	11.6	10.1	10.8	110.4	84.8	5.2	4.4	9.8	10.2	6.5	11.5	10.8	12.7	5.0	10.7	6.8	9.4	4.2	11.3	4.7	15.5	11.2	32.8	5.8	8.6	3.9	10.0	5.0	9.8	4.8	5.5	12.5	5.9	9.0	9.1	10.8	12.0	13.8	26.8	30.6	22.5	16.2	10.2	7.1	8.7	8.6	11.4	12.4	15.3	18.6	19.7	9.2	21.4	22.1	11.7	8.0	7.6	24.8	10.5	2.7	5.4	21.8	7.9	6.3	1.8	16.9	14.1	6.3	6.0	17.7	15.5	18.8	7.2	3.0	19.9	18.2	14.8	8.3	22.5	21.1	21.9	16.1	17.7	27.9	19.7	30.3	31.7	23.3	13.2	9.0	58.4	39.4	25.6	2.2	7.7	12.5	3.4	13.1	4.9	8.6	27.8	20.4	3.5	4.0	18.4	13.6	9.8	0.0	8.2	12.9	10.9	17.5	9.7	8.4	15.3	12.8	9.1	12.7	0.6	14.6	7.8	8.4	5.4	7.5	9.4	9.8	9.5	14.5	10.1	10.8	9.8	10.2	10.7	8.6	9.8	10.8	15.9	6.4	9.3	11.1	8.2	8.9	8.6	26.0	10.8	11.1	15.1	19.0	4.8	31.5	19.3	16.5	20.9	28.6	5.6	13.6	70.5	28.1	0.5	13.6	14.0	9.1	16.1	6.9	9.3	13.5	32.2	12.2	11.2	8.2	2.5	31.8	6.1	70.9	23.7	16.8	12.8	14.9	38.7	2.2	8.3	1.6	14.9	8.0	32.0	10.3	13.9	12.2	7.2	9.0	4.7	19.6	14.8	13.9	4.5	8.4	99.7	336.3	38.2	6.9	6.6	19.0	12.5	6.8	20.6	13.9	9.2	14.0	7.6	32.9	19.0	8.1
TUBB2A	"dJ40E16.7, TUBB, TUBB2"	ENSG00000137267	"Tubulin beta 2A class IIa"	Q13885	6	3153497-3157544	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 364.3"	"Cell type enhanced"	"Detected in many"		"Horizontal cells: 516.5;Suprabasal keratinocytes: 368.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"B-cells: 3.2;monocytes: 1.6;T-cells: 3.2"	"Cell line enhanced"	"Detected in all"		"AF22: 241.1;CACO-2: 247.6;SuSa: 365.5;WM-115: 280.1"	"Low region specificity"	"Detected in all"							"CAB015339, HPA043640, HPA046280"	Supported		Approved	"Microtubules,Cytokinetic bridge,Mitotic spindle"		Yes	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 61: Squamous epithelial cells - Keratinization"	Microtubules	"Cytokinetic bridge, Mitotic spindle"	"CAB015339: AB_2210539, HPA043640: AB_2678594, HPA046280: AB_2679612"	"unprognostic (2.57e-1)"	"unprognostic (9.86e-3)"	"unprognostic (5.90e-3)"	"unprognostic (7.98e-3)"	"unprognostic (4.02e-3)"	"unprognostic (1.67e-1)"	"unprognostic (1.82e-3)"	"unprognostic (7.53e-2)"	"unprognostic (1.48e-3)"	"unprognostic (9.99e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.42e-2)"	"prognostic favorable (4.65e-4)"	"unprognostic (2.39e-2)"	"unprognostic (1.79e-1)"	"unprognostic (3.10e-2)"	"prognostic unfavorable (1.61e-4)"	58.8	17.8	266.1	19.3	251.1	67.5	47.8	130.1	287.5	32.7	10.0	78.0	24.2	50.8	28.0	90.6	23.5	21.5	29.4	248.3	364.3	31.1	67.0	16.4	11.0	292.6	212.2	15.5	39.4	2.2	56.3	23.9	334.3	17.5	8.2	49.9	52.2	15.6	22.3	151.4	34.9	41.7	131.6	7.7	41.0	9.5	204.4	6.4	10.0	11.8	9.6	23.6	51.2	169.4	55.9	45.3	241.1	53.6	30.6	34.0	14.5	119.8	44.7	80.6	115.7	247.6	18.4	27.4	72.9	115.5	80.2	26.0	86.6	26.8	28.0	134.1	57.7	9.4	11.4	77.0	31.6	1.5	8.4	35.1	31.1	85.1	5.3	28.9	37.3	10.6	33.7	8.8	74.2	25.1	14.9	2.8	207.2	16.0	58.3	12.4	22.6	18.9	28.0	27.4	57.6	52.9	30.5	8.5	179.7	365.5	19.1	2.0	76.0	53.9	56.7	117.3	65.8	3.2	4.6	18.8	19.7	7.0	280.1	0.0	1.1	0.0	2.2	1.6	2.4	3.2	2.1	3.1	0.5	0.6	1.0	2.0	0.3	0.4	1.3	0.2	3.2	1.2	266.1	251.1	130.1	287.5	248.3	364.3	292.6	212.2	334.3	131.6	204.4	169.4	125.3	16.0	13.1	43.1	31.6	311.4	63.3	87.0	132.6	105.6	32.0	134.6	20.4	42.9	62.7	12.9	16.7	6.0	53.4	87.0	217.2	54.0	60.9	46.7	29.6	40.6	73.1	322.3	59.9	182.4	50.4	96.2	185.0	57.9	34.9	10.1	12.5	55.6	50.8	516.5	73.0	103.9	73.2	6.3	164.4	32.9	20.8	36.7	129.9	24.4	72.7	261.0	0.0	18.1	23.0	103.4	181.8	15.4	15.8	34.9	126.3	40.4	50.3	86.2	6.6	95.6	87.9	32.4	14.9	140.6	368.5	6.2	58.9	6.4	60.0	54.7
TUBB2B	"bA506K6.1, DKFZp566F223, MGC8685"	ENSG00000137285	"Tubulin beta 2B class IIb"	Q9BVA1	6	3223324-3231730	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	Neurogenesis		"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 387.9;choroid plexus: 154.0"	"Group enriched"	"Detected in many"	4	"Distal tubular cells: 414.8;Horizontal cells: 430.7;Muller glia cells: 847.3;Skeletal myocytes: 350.1"	"Cancer enriched"	"Detected in many"	9	"glioma: 216.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 541.9;CACO-2: 415.3;NTERA-2: 268.0;RPMI-8226: 277.7;SCLC-21H: 797.7;SH-SY5Y: 390.2;SuSa: 245.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043640, HPA046280"	Supported		Supported	"Microtubules,Cytokinetic bridge,Mitotic spindle"		Yes	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 70: Brain - Nervous system development"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 5: Muller glia cells - Visual perception"	Microtubules	"Cytokinetic bridge, Mitotic spindle"	"HPA043640: AB_2678594, HPA046280: AB_2679612"	"unprognostic (2.66e-2)"	"unprognostic (3.41e-1)"	"unprognostic (5.92e-3)"	"prognostic unfavorable (1.94e-4)"	"unprognostic (6.81e-2)"	"unprognostic (3.26e-2)"	"unprognostic (9.03e-3)"	"unprognostic (8.33e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.02e-1)"	"unprognostic (3.78e-3)"	"unprognostic (3.34e-2)"	"unprognostic (2.03e-2)"	"unprognostic (6.24e-3)"	"unprognostic (6.04e-2)"	"unprognostic (3.58e-4)"	"unprognostic (2.30e-3)"	4.0	7.2	298.1	8.1	324.5	1.0	5.0	348.4	387.9	9.9	154.0	17.0	2.4	4.2	45.5	2.4	3.3	3.8	4.6	258.8	356.9	11.6	1.0	1.4	8.1	363.3	349.9	1.1	5.7	0.0	35.1	4.4	354.5	3.7	2.6	65.3	10.8	4.6	6.2	3.9	6.1	7.3	337.2	0.7	4.5	1.0	369.1	2.3	0.9	1.6	5.7	2.6	5.6	383.9	0.0	8.2	541.9	164.2	0.6	0.2	0.9	5.1	7.4	20.8	45.0	415.3	2.0	0.9	5.6	5.7	0.0	1.3	212.8	0.7	12.0	1.6	98.3	0.2	0.0	33.2	1.1	0.1	6.1	3.1	0.0	2.3	0.0	7.6	1.4	0.5	6.8	1.2	7.6	0.3	1.5	0.4	268.0	1.0	17.6	0.6	26.3	277.7	2.9	0.8	797.7	390.2	0.3	1.7	4.3	245.9	3.2	0.0	0.0	1.9	89.9	6.3	2.2	51.6	0.1	0.0	0.8	0.1	30.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	298.1	324.5	348.4	387.9	258.8	356.9	363.3	349.9	354.5	337.2	369.1	383.9	3.6	0.0	0.0	109.4	1.9	8.7	2.3	1.8	4.6	63.5	3.9	31.9	40.1	5.7	0.3	7.3	16.7	0.7	1.0	0.9	414.8	15.4	5.8	2.7	3.3	7.6	66.7	0.0	2.4	3.5	1.2	18.7	7.1	3.9	0.0	0.5	0.7	0.6	3.0	430.7	19.4	1.0	24.4	0.0	12.4	7.1	0.3	1.0	92.5	9.4	3.6	847.3	0.0	37.2	21.6	12.0	0.1	0.0	8.4	3.9	0.2	2.0	0.0	43.1	0.0	350.1	19.1	1.3	6.2	3.1	2.7	0.8	0.6	0.0	0.6	1.1
PSMG4	"C6orf86, PAC4"	ENSG00000180822	"Proteasome assembly chaperone 4"	Q5JS54	6	3231403-3303373	"Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA067652, HPA074376, HPA075846"	Approved		Approved	Nucleoplasm,Mitochondria		No	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 50: Non-specific - Ribosome"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Mitochondria"		"HPA067652: AB_2685880, HPA074376: , HPA075846: "	"unprognostic (3.13e-3)"	"unprognostic (6.00e-2)"	"unprognostic (3.60e-1)"	"unprognostic (4.11e-2)"	"unprognostic (4.11e-1)"	"unprognostic (2.20e-1)"	"unprognostic (6.52e-3)"	"unprognostic (1.57e-2)"	"unprognostic (6.96e-2)"	"unprognostic (6.74e-3)"	"unprognostic (7.40e-3)"	"unprognostic (3.02e-2)"	"prognostic unfavorable (7.45e-4)"	"unprognostic (1.59e-1)"	"unprognostic (8.18e-2)"	"unprognostic (2.54e-1)"	"unprognostic (3.48e-2)"	20.3	18.3	12.8	8.2	15.7	13.8	20.0	19.8	13.7	16.9	5.0	24.1	14.1	18.9	18.6	19.9	18.4	6.9	15.1	11.5	14.6	20.1	26.9	13.7	10.2	17.6	16.0	16.6	33.4	12.0	22.2	7.0	18.1	19.3	6.9	9.9	20.2	13.4	37.1	20.8	16.8	9.5	13.5	14.4	21.4	16.2	15.9	9.3	21.1	11.1	7.7	19.8	16.8	23.8	61.8	29.0	17.5	42.8	15.3	23.1	29.5	27.2	20.0	25.9	41.4	25.1	20.6	21.0	73.1	16.4	20.2	28.9	15.0	18.9	16.9	34.7	65.2	16.9	33.4	66.6	19.2	48.7	16.9	19.8	20.1	18.8	27.8	14.8	32.4	39.9	65.0	15.1	14.0	58.2	27.6	88.9	21.4	31.3	57.7	36.5	9.5	116.2	21.1	24.0	74.3	21.3	12.9	16.7	61.4	16.5	22.0	21.0	31.7	21.4	20.4	24.6	26.6	48.7	76.4	39.4	15.2	34.1	29.3	16.2	35.5	24.4	25.3	36.9	29.4	50.2	42.1	30.8	28.4	52.1	40.9	35.7	8.9	32.3	36.3	33.9	39.4	23.9	12.8	15.7	19.8	13.7	11.5	14.6	17.6	16.0	18.1	13.5	15.9	23.8	45.2	22.4	21.2	18.6	25.3	27.9	29.1	44.2	38.7	32.0	53.1	88.4	21.9	37.1	26.9	44.1	8.4	39.3	15.2	23.6	84.1	43.9	31.4	23.6	25.9	35.2	22.8	18.5	9.6	87.5	37.8	30.4	15.8	17.1	22.2	38.8	28.2	64.5	35.1	25.2	17.8	31.1	28.5	19.2	21.1	13.3	37.0	18.4	30.2	5.6	35.7	22.0	32.0	21.6	15.7	57.8	25.8	23.0	18.9	47.0	47.3	67.2	22.6	29.4	46.0	45.5	54.0	29.6	78.2	39.6	38.2	12.0	23.7	30.0	35.4	27.1
SLC22A23	"C6orf85, FLJ22174"	ENSG00000137266	"Solute carrier family 22 member 23"	A1A5C7	6	3268962-3457050	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 50.9"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 86.8;Late spermatids: 229.3;Oligodendrocytes: 285.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"T-47d: 31.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014697	Approved		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA				"Cluster 45: Intestine - Brush border"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nucleoplasm, Vesicles"	Cytosol	"HPA014697: AB_1844371"	"unprognostic (4.58e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.05e-1)"	"prognostic favorable (6.57e-4)"	"unprognostic (5.16e-3)"	"unprognostic (3.25e-3)"	"unprognostic (1.40e-1)"	"unprognostic (4.53e-3)"	"unprognostic (9.74e-2)"	"unprognostic (2.87e-2)"	"unprognostic (1.07e-2)"	"unprognostic (2.62e-2)"	"prognostic unfavorable (2.39e-4)"	"unprognostic (8.91e-2)"	"unprognostic (4.30e-1)"	"unprognostic (4.06e-2)"	"unprognostic (1.74e-1)"	7.3	3.4	17.7	4.5	28.9	9.6	8.4	25.4	25.0	9.1	1.8	18.4	20.7	4.1	12.2	23.7	11.0	4.9	3.6	16.2	18.6	7.7	18.1	8.3	4.4	29.9	29.7	4.1	15.5	27.1	8.8	8.5	30.4	18.6	14.8	4.8	14.6	2.4	8.9	17.1	22.4	2.8	22.1	6.3	26.5	11.5	30.2	7.2	5.6	7.8	5.9	4.3	15.5	50.9	4.3	10.1	20.1	22.6	7.2	7.8	26.6	0.7	0.3	1.2	0.5	22.5	0.7	1.0	2.5	4.8	18.2	6.1	4.2	10.8	0.4	3.5	13.1	10.4	3.9	18.9	1.0	0.7	0.6	2.0	21.3	19.4	1.0	4.3	0.7	5.4	9.6	5.3	0.7	5.3	1.0	2.4	7.1	23.2	3.9	2.2	1.3	18.1	0.1	26.9	2.4	0.3	5.7	7.8	7.0	20.9	31.8	0.2	5.6	12.0	4.0	15.9	2.6	12.7	0.2	0.4	21.2	0.7	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.1	0.0	0.2	17.7	28.9	25.4	25.0	16.2	18.6	29.9	29.7	30.4	22.1	30.2	50.9	22.6	6.4	17.5	46.7	1.0	11.6	5.0	18.7	4.6	8.0	9.5	8.1	2.8	10.0	18.0	5.5	8.4	16.1	0.5	43.3	0.0	2.9	86.8	11.6	2.5	8.2	4.2	11.0	59.9	8.0	1.3	1.9	39.8	4.1	0.0	13.1	6.4	12.7	12.9	0.0	67.4	49.7	12.2	13.0	3.0	229.3	1.8	4.8	3.6	77.8	6.4	8.6	0.0	45.8	285.5	6.1	20.5	0.7	0.4	13.9	34.3	4.2	42.0	3.5	0.0	4.5	2.6	2.5	1.2	10.3	12.6	9.2	1.3	0.1	25.3	4.5
PXDC1	C6orf145	ENSG00000168994	"PX domain containing 1"	Q5TGL8	6	3722614-3751713	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 168.7"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 103.6;Basal prostatic cells: 115.1;Extravillous trophoblasts: 131.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	4	"memory B-cell: 1.2"	"Lineage enriched"	"Detected in single"	4	"B-cells: 1.2"	"Cell line enhanced"	"Detected in many"		"HHSteC: 151.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA019246			Approved	"Plasma membrane"		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane"		"HPA019246: AB_2670113"	"unprognostic (1.55e-1)"	"unprognostic (1.87e-2)"	"prognostic unfavorable (3.64e-4)"	"prognostic unfavorable (1.14e-4)"	"unprognostic (2.82e-2)"	"unprognostic (3.80e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.48e-1)"	"unprognostic (6.73e-2)"	"unprognostic (6.08e-2)"	"unprognostic (2.32e-1)"	"unprognostic (2.13e-1)"	"unprognostic (2.01e-2)"	"unprognostic (6.17e-3)"	"unprognostic (1.10e-1)"	"unprognostic (2.97e-1)"	"unprognostic (2.84e-1)"	68.0	14.9	33.7	14.7	34.6	1.4	50.5	35.1	36.5	30.3	49.3	37.2	29.9	31.4	15.6	25.5	28.3	48.3	36.0	33.0	35.2	25.9	168.7	47.6	13.0	39.5	36.1	19.2	26.7	14.2	13.9	61.8	36.4	29.8	7.7	3.1	39.3	19.8	16.9	38.7	26.5	26.7	36.9	19.0	28.5	5.6	35.7	7.4	44.6	15.6	6.7	46.3	28.7	36.0	44.5	17.5	28.6	19.9	87.9	66.4	99.4	75.6	57.7	62.6	48.2	30.6	8.8	0.0	49.0	123.9	48.0	34.4	5.7	20.8	29.3	43.2	6.6	0.0	14.7	26.8	151.4	0.1	0.2	59.0	67.2	38.8	83.2	52.7	70.2	3.0	0.1	5.9	49.7	2.7	0.1	0.5	1.3	9.0	27.3	2.5	16.0	2.1	24.4	35.7	3.1	1.6	51.7	52.4	115.5	38.3	4.6	2.7	77.8	56.9	24.7	22.2	54.4	0.1	0.1	0.2	13.6	0.1	40.5	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	33.7	34.6	35.1	36.5	33.0	35.2	39.5	36.1	36.4	36.9	35.7	36.0	103.6	48.1	8.6	8.1	8.1	48.3	115.1	11.8	40.9	0.6	28.0	27.7	8.1	18.6	11.7	7.3	0.0	32.8	1.5	0.6	11.7	33.2	0.5	4.7	18.3	39.6	0.0	5.3	0.1	51.6	131.0	62.1	14.8	5.6	3.8	1.6	45.7	68.7	25.1	0.0	2.6	1.4	8.2	9.7	80.8	0.9	22.7	31.6	24.9	9.4	22.0	16.0	0.0	11.1	2.5	77.6	0.1	18.0	4.4	55.8	25.7	20.4	9.6	0.8	0.0	38.7	33.4	0.6	4.5	17.5	33.1	78.4	3.2	0.4	1.2	47.4
FAM50B	"D6S2654E, X5L"	ENSG00000145945	"Family with sequence similarity 50 member B"	Q9Y247	6	3849373-3851320	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatogonia: 43.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 88.3;MCF7: 27.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA064111, HPA067817"	Approved		Enhanced	"Nucleoplasm,Cytokinetic bridge,Midbody"		Yes	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 47: Non-specific - Unknown function"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Nucleoplasm	"Cytokinetic bridge, Midbody"	"HPA064111: AB_2685191, HPA067817: AB_2685904"	"unprognostic (1.15e-1)"	"unprognostic (7.76e-2)"	"unprognostic (4.28e-2)"	"unprognostic (4.43e-2)"	"unprognostic (2.12e-3)"	"unprognostic (2.69e-1)"	"unprognostic (2.38e-2)"	"unprognostic (7.13e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.15e-1)"	"unprognostic (2.90e-1)"	"prognostic favorable (4.01e-6)"	"unprognostic (1.60e-1)"	"unprognostic (3.22e-1)"	"unprognostic (1.34e-1)"	"unprognostic (9.39e-2)"	6.9	9.1	11.7	3.7	14.3	1.8	7.0	12.3	15.1	8.3	8.5	10.2	6.6	9.7	3.9	6.6	8.8	3.7	18.0	12.5	13.6	9.8	12.9	5.3	5.1	11.7	11.1	9.3	9.2	4.2	10.4	1.7	11.5	6.4	1.4	5.5	10.2	5.8	32.1	7.1	6.5	2.8	11.2	7.1	8.1	14.0	13.0	3.9	9.8	8.8	3.5	9.7	6.3	12.6	6.6	8.7	0.1	0.0	4.9	4.7	0.4	7.6	3.7	5.1	6.5	0.0	11.7	7.0	8.0	5.5	2.0	4.9	0.0	3.0	3.8	88.3	4.6	0.0	21.1	0.0	5.2	0.0	0.1	5.2	6.0	4.0	1.1	1.6	5.1	0.0	0.0	0.0	4.6	27.5	0.0	9.8	1.9	4.0	4.1	0.0	0.0	0.0	2.5	0.0	11.8	10.3	12.4	7.7	0.4	0.0	8.4	7.8	7.2	0.0	0.9	10.1	0.0	0.0	19.7	0.0	2.7	0.6	14.1	5.7	7.9	4.4	11.3	10.8	26.7	25.0	21.8	14.6	10.5	20.8	17.7	11.2	3.3	33.8	17.7	17.3	36.0	9.0	11.7	14.3	12.3	15.1	12.5	13.6	11.7	11.1	11.5	11.2	13.0	12.6	11.4	16.0	7.0	2.6	8.3	6.4	5.7	10.2	15.4	18.1	8.7	13.5	19.8	17.2	8.3	12.9	4.2	4.2	9.3	2.3	33.2	13.5	31.5	6.8	5.0	6.7	1.2	6.7	2.5	11.1	6.9	8.0	7.1	3.3	3.8	7.5	11.0	21.6	10.1	15.2	2.6	3.5	8.2	6.8	4.7	28.8	8.4	5.6	12.4	1.0	8.7	20.9	4.1	1.0	4.6	8.5	5.1	10.9	6.9	3.3	7.4	36.9	6.8	16.0	0.0	13.0	8.4	38.3	43.9	12.5	6.7	1.0	6.1	7.8	3.8	2.1
PRPF4B	"KIAA0536, PR4H, Prp4"	ENSG00000112739	"Pre-mRNA processing factor 4B"	Q13523	6	4021267-4064983	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020638	Approved		Supported	"Nuclear speckles"		NA	NA				"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 20: HeLa - Mitochondria"	"Cluster 52: Non-specific - Transcription"	"Nuclear speckles"		"HPA020638: AB_1855774"	"unprognostic (1.03e-1)"	"unprognostic (2.66e-1)"	"unprognostic (4.95e-2)"	"unprognostic (2.20e-1)"	"unprognostic (3.59e-3)"	"unprognostic (1.21e-2)"	"prognostic unfavorable (2.27e-4)"	"unprognostic (8.68e-3)"	"unprognostic (3.41e-2)"	"unprognostic (4.45e-3)"	"unprognostic (2.17e-1)"	"unprognostic (1.07e-1)"	"unprognostic (9.50e-3)"	"unprognostic (8.90e-2)"	"unprognostic (2.34e-1)"	"unprognostic (7.63e-3)"	"prognostic favorable (6.82e-5)"	9.1	7.2	4.8	11.3	5.4	27.3	8.1	7.5	6.7	5.8	5.2	8.6	10.2	9.9	10.1	8.4	4.4	6.1	5.0	4.7	5.1	4.2	4.3	6.8	14.2	5.4	5.5	8.4	6.8	4.2	3.3	7.6	5.3	6.3	8.6	15.9	8.4	5.5	16.3	13.3	9.0	5.6	4.9	11.2	8.1	3.8	5.5	8.8	6.5	4.5	10.0	6.7	7.0	6.9	6.0	3.9	14.4	12.1	8.3	7.3	12.3	7.7	3.4	4.7	5.2	6.9	7.1	8.1	5.7	5.1	4.8	12.8	10.1	6.8	7.1	4.4	11.1	6.7	19.1	11.5	3.6	11.2	10.6	5.7	6.9	5.4	6.6	11.0	5.1	6.5	11.6	3.1	7.4	2.7	7.2	26.3	6.0	3.8	4.3	9.9	6.1	11.2	8.4	10.2	7.9	7.3	4.7	3.9	5.5	16.9	9.6	7.9	7.3	11.2	6.5	4.3	8.2	7.5	7.9	6.9	3.2	7.6	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	5.4	7.5	6.7	4.7	5.1	5.4	5.5	5.3	4.9	5.5	6.9	122.4	109.0	103.2	35.6	110.5	83.5	64.0	43.1	69.4	88.6	80.4	49.5	79.1	61.5	75.1	97.5	89.6	61.8	151.3	94.9	72.4	64.4	15.6	115.9	143.5	85.8	75.3	79.1	42.8	56.8	49.9	78.7	88.2	113.4	90.5	96.2	61.1	85.8	41.1	106.0	49.8	88.8	50.8	71.6	49.4	20.6	98.8	71.4	35.6	49.6	97.4	81.2	118.4	50.8	68.1	62.8	61.5	89.1	101.9	62.8	55.5	89.5	71.7	184.0	59.2	105.3	85.8	66.1	76.5	66.7	91.4	63.6	106.2	93.1	87.7	65.2
FAM217A	"C6orf146, MGC43581"	ENSG00000145975	"Family with sequence similarity 217 member A"	Q8IXS0	6	4049434-4087344	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"testis: 14.9"	"Group enriched"	"Detected in some"	15	"Early spermatids: 246.0;Late spermatids: 418.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"							HPA035455	Uncertain					NA	NA				"Cluster 83: Testis - Spermatogenesis"		"Cluster 25: Spermatids - Spermatogenesis"			"HPA035455: AB_10669905"	"unprognostic (5.93e-2)"	"unprognostic (3.70e-2)"	"unprognostic (1.24e-1)"	"unprognostic (8.18e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.53e-2)"	"unprognostic (2.99e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.09e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.85e-1)"	"unprognostic (4.54e-1)"	"unprognostic (6.55e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.53e-2)"	"unprognostic (5.51e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	246.0	0.0	0.0	0.2	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	418.8	2.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	20.9	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ECI2	"ACBD2, DRS1, HCA88, PECI"	ENSG00000198721	"Enoyl-CoA delta isomerase 2"	O75521	6	4115693-4135597	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 422.7"	"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 293.6;Distal tubular cells: 428.4;Proximal tubular cells: 577.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022130, HPA031626"	Enhanced		Enhanced	Peroxisomes,Mitochondria		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Peroxisomes, Mitochondria"		"HPA022130: AB_1855176, HPA031626: AB_2673965"	"unprognostic (2.36e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.71e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.00e-2)"	"prognostic unfavorable (2.85e-4)"	"unprognostic (1.17e-3)"	"unprognostic (4.97e-2)"	"unprognostic (9.49e-2)"	"unprognostic (3.95e-3)"	"unprognostic (3.17e-2)"	"unprognostic (5.75e-2)"	"prognostic favorable (2.04e-6)"	"unprognostic (1.40e-1)"	"unprognostic (1.23e-1)"	"unprognostic (8.45e-2)"	"unprognostic (1.34e-1)"	53.6	123.6	43.9	21.0	47.7	21.5	65.0	46.5	63.7	60.0	50.5	53.3	64.0	44.9	102.1	26.7	49.2	40.1	150.9	42.4	47.8	236.0	422.7	28.6	20.0	45.0	45.6	71.4	159.8	53.2	52.6	37.7	44.2	45.2	55.4	31.8	29.9	36.3	198.4	22.7	59.6	35.5	45.3	30.1	103.5	30.9	49.0	33.5	37.0	236.4	21.8	31.6	26.8	45.5	82.8	45.1	72.8	161.0	89.7	131.4	8.8	114.0	116.7	122.1	107.7	34.0	12.4	3.6	139.6	126.0	111.0	41.6	83.6	67.4	179.5	30.4	95.8	44.0	59.7	186.8	51.3	40.4	20.7	90.6	40.6	106.2	58.4	166.0	262.9	136.2	146.2	31.1	118.6	33.4	113.9	100.7	49.5	8.1	158.7	108.8	90.8	1.5	67.2	16.8	1.8	33.7	6.8	48.2	107.6	131.0	109.8	18.9	268.6	92.4	49.8	82.7	69.8	46.8	88.7	8.4	47.9	34.7	73.0	19.2	36.4	17.4	41.5	28.4	57.1	45.8	48.8	58.3	58.9	51.9	59.8	59.2	1.2	66.0	43.3	45.3	57.9	41.1	43.9	47.7	46.5	63.7	42.4	47.8	45.0	45.6	44.2	45.3	49.0	45.5	61.0	28.9	25.2	17.0	24.4	18.2	48.6	50.3	22.2	14.3	33.3	41.0	165.8	78.6	40.1	36.8	12.5	293.6	29.3	32.0	428.4	53.2	63.1	60.8	43.1	48.0	52.1	77.6	10.7	175.5	29.0	55.2	34.7	57.0	23.4	68.6	53.9	162.2	64.3	18.5	11.9	41.6	20.3	22.0	19.2	50.6	63.3	23.5	35.6	14.0	34.7	77.7	21.6	8.5	18.2	80.4	37.5	50.8	28.3	24.7	120.6	577.0	83.6	46.4	26.3	46.8	33.9	46.5	35.6	24.9	12.8	101.9	41.2	224.0	60.8	22.3
CDYL	"CDYL1, DKFZP586C1622"	ENSG00000153046	"Chromodomain Y like"	Q9Y232	6	4706159-4955551	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis, Transcription, Transcription regulation"	"Lyase, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 6.8"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035578	Enhanced		Supported	"Nuclear speckles"		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 52: Non-specific - Ribosome"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	"Nuclear speckles"		"HPA035578: AB_2674685"	"unprognostic (1.25e-1)"	"unprognostic (8.99e-2)"	"unprognostic (6.03e-2)"	"unprognostic (2.38e-3)"	"prognostic favorable (1.53e-4)"	"unprognostic (1.92e-1)"	"prognostic unfavorable (2.20e-4)"	"unprognostic (2.62e-2)"	"prognostic unfavorable (7.52e-4)"	"unprognostic (2.06e-1)"	"unprognostic (2.05e-2)"	"unprognostic (2.09e-1)"	"unprognostic (5.21e-3)"	"unprognostic (1.90e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.60e-2)"	"unprognostic (3.94e-1)"	14.0	6.0	6.9	10.2	6.8	20.0	11.5	5.0	6.7	15.0	4.9	13.0	7.0	15.2	10.5	16.8	10.6	8.4	10.4	6.0	6.4	7.2	5.6	8.9	12.1	6.6	6.2	9.9	7.5	12.4	5.1	18.2	6.0	7.6	13.2	6.7	9.0	11.9	19.5	17.8	9.0	14.5	5.6	9.6	9.2	9.0	6.7	9.3	9.7	12.7	12.9	15.6	13.0	6.9	23.7	22.1	30.1	25.5	23.3	15.9	34.4	23.1	17.9	21.3	22.9	18.0	17.2	5.3	22.1	17.6	33.3	19.8	24.2	28.2	24.9	16.4	20.2	20.9	21.0	16.4	28.5	27.9	21.7	12.5	49.8	25.0	37.5	12.9	20.6	19.2	37.9	16.2	10.8	22.9	14.8	25.9	32.6	17.9	21.3	19.0	26.2	43.7	14.7	20.5	25.5	15.4	28.5	24.9	36.9	86.5	15.0	26.3	28.1	25.2	21.6	18.5	26.8	33.7	57.8	18.4	8.3	17.7	28.1	5.3	1.3	0.6	1.5	0.6	1.1	1.0	1.1	1.2	1.6	1.1	0.7	1.1	0.4	1.6	0.8	6.8	0.1	1.3	6.9	6.8	5.0	6.7	6.0	6.4	6.6	6.2	6.0	5.6	6.7	6.9	32.7	19.2	9.4	28.7	18.4	37.3	23.9	11.9	10.8	16.7	31.2	35.8	18.8	14.3	12.0	14.7	22.9	12.9	64.5	44.7	15.6	10.8	62.8	26.9	43.2	22.9	32.3	41.5	52.3	10.4	22.0	18.7	6.1	60.3	5.7	24.3	18.9	11.7	10.5	45.4	41.5	26.6	6.1	17.3	57.9	74.9	5.9	28.1	8.8	101.2	22.7	25.4	19.6	54.3	64.1	16.8	41.8	8.2	22.3	30.1	4.6	10.7	12.1	25.7	6.6	29.7	20.9	10.4	25.3	9.8	41.9	63.8	17.5	10.9	22.6	56.9
RPP40	"bA428J1.3, RNASEP1"	ENSG00000124787	"Ribonuclease P/MRP subunit p40"	O75818	6	4994717-5004063	"Enzymes, Predicted intracellular proteins"	"rRNA processing, tRNA processing"	"Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Theca cells: 30.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035685, HPA035686"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"HPA035685: AB_2674734, HPA035686: AB_10670153"	"unprognostic (2.93e-2)"	"unprognostic (3.22e-2)"	"unprognostic (1.94e-1)"	"prognostic unfavorable (6.10e-6)"	"unprognostic (8.00e-2)"	"unprognostic (4.78e-2)"	"prognostic unfavorable (5.41e-4)"	"unprognostic (1.20e-1)"	"unprognostic (1.72e-2)"	"unprognostic (6.44e-2)"	"unprognostic (8.17e-2)"	"unprognostic (9.57e-2)"	"prognostic unfavorable (7.54e-8)"	"unprognostic (1.54e-1)"	"unprognostic (5.10e-1)"	"unprognostic (4.08e-2)"	"unprognostic (2.19e-1)"	5.2	11.4	4.4	4.3	4.4	4.9	6.7	4.2	5.7	5.1	3.7	3.4	2.9	4.1	3.6	8.6	3.2	2.9	3.4	4.4	5.3	3.5	7.4	2.0	5.8	4.4	4.5	3.6	3.9	3.8	3.5	3.4	4.6	2.8	3.1	0.7	2.6	2.7	5.6	6.1	2.4	4.6	4.6	4.6	3.0	6.0	5.4	4.7	3.4	3.3	5.4	8.0	5.3	4.7	13.0	21.2	6.6	18.7	11.9	15.1	20.7	12.5	6.3	23.4	18.4	29.0	9.7	27.8	53.6	13.1	32.2	13.4	13.7	19.3	20.9	10.6	27.4	17.5	12.8	39.5	14.0	22.8	9.6	11.8	16.2	23.5	23.0	5.2	23.4	25.2	28.1	5.4	17.3	36.8	11.6	39.0	10.9	15.2	34.0	24.4	12.5	51.0	12.2	13.8	23.5	6.8	11.7	11.1	13.2	17.3	20.2	18.7	11.2	30.6	20.7	20.9	29.1	9.7	43.7	22.0	5.8	37.8	16.1	0.0	7.1	0.0	3.3	11.9	4.9	8.1	5.7	4.1	12.9	7.2	7.6	7.1	0.0	8.6	3.9	6.4	9.1	5.2	4.4	4.4	4.2	5.7	4.4	5.3	4.4	4.5	4.6	4.6	5.4	4.7	7.3	0.0	1.1	2.0	5.3	12.4	10.4	20.6	6.8	0.2	6.3	9.3	4.5	0.0	9.5	1.8	0.0	13.3	3.6	2.2	11.7	7.9	8.1	9.1	13.7	10.9	3.0	2.5	3.6	9.4	14.5	5.8	4.6	4.6	0.0	11.7	6.4	5.5	11.5	0.0	3.1	4.2	6.1	2.5	4.7	3.7	5.6	3.2	8.8	1.9	3.7	1.2	3.1	3.5	3.1	4.3	2.1	4.9	5.7	7.7	0.7	15.1	10.6	0.5	0.0	8.3	8.4	15.1	24.1	12.6	14.8	9.6	3.6	30.8	7.4	7.7
PPP1R3G		ENSG00000219607	"Protein phosphatase 1 regulatory subunit 3G"	B7ZBB8	6	5085341-5089487	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 5.9;liver: 6.2"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 18.5;Glandular and luminal cells: 7.2"	"Cancer enhanced"	"Detected in many"		"liver cancer: 5.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 3.3;PC-3: 3.9;THP-1: 14.6"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA056393	Uncertain					NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 15: Liver - Metabolism"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 41: Macrophages - Immune response"			"HPA056393: AB_2683115"	"unprognostic (1.99e-2)"	"unprognostic (5.50e-3)"	"unprognostic (2.10e-1)"	"unprognostic (5.29e-2)"	"unprognostic (1.70e-2)"	"unprognostic (1.38e-1)"	"unprognostic (6.56e-3)"	"unprognostic (8.64e-3)"	"unprognostic (1.81e-2)"	"unprognostic (2.98e-1)"	"unprognostic (1.04e-2)"	"unprognostic (3.71e-1)"	"unprognostic (7.60e-2)"	"unprognostic (1.33e-2)"	"unprognostic (5.56e-2)"	"unprognostic (3.17e-3)"	"unprognostic (1.27e-1)"	2.3	3.0	2.3	0.3	2.1	0.1	1.4	1.5	2.7	2.1	0.9	2.0	0.2	1.2	1.0	1.8	1.0	0.3	5.9	2.0	1.8	0.6	6.2	0.3	0.5	2.3	2.3	0.8	0.1	0.3	0.2	0.7	1.9	1.2	0.5	0.2	0.6	1.4	0.5	1.2	0.5	0.5	1.6	2.8	0.6	0.2	2.2	0.2	0.3	0.2	0.4	2.8	2.1	1.7	0.0	0.2	0.1	0.0	1.6	1.0	0.0	0.3	0.4	0.2	0.3	0.0	0.3	0.0	3.3	0.6	0.0	0.0	0.1	0.0	0.6	0.0	0.1	0.1	0.3	0.4	0.2	0.1	0.1	0.1	0.1	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	3.9	0.1	0.0	0.0	0.4	0.4	0.0	0.0	0.5	0.0	0.0	0.3	0.0	14.6	0.0	0.0	0.0	0.8	0.5	2.0	1.7	0.0	0.6	0.0	0.1	0.1	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.2	2.3	2.1	1.5	2.7	2.0	1.8	2.3	2.3	1.9	1.6	2.2	1.7	4.2	0.0	0.0	0.0	0.4	0.5	0.5	0.4	0.0	0.5	0.2	0.1	18.5	0.0	0.1	3.7	0.0	0.8	0.0	1.3	0.0	0.3	0.0	1.2	2.0	1.9	1.2	0.0	0.0	0.0	0.4	3.7	0.0	7.2	0.0	1.4	2.9	0.0	4.5	0.0	0.0	0.9	0.0	4.0	4.7	0.2	0.9	1.8	0.0	0.0	1.2	0.2	0.0	0.0	0.0	0.6	1.8	3.0	1.8	0.4	0.0	2.1	0.2	0.2	0.0	2.0	2.5	0.1	0.9	0.2	0.3	0.8	0.2	0.5	1.4	1.2
LYRM4	"C6orf149, CGI-203, ISD11"	ENSG00000214113	"LYR motif containing 4"	Q9HD34	6	5103629-5260950	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA030362	Approved		Supported	"Nuclear bodies"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 32: Non-specific - Translation"	"Nuclear bodies"		"HPA030362: AB_10601546"	"unprognostic (2.41e-2)"	"unprognostic (3.72e-2)"	"unprognostic (7.68e-2)"	"unprognostic (8.58e-2)"	"unprognostic (1.30e-1)"	"unprognostic (8.73e-2)"	"unprognostic (1.85e-3)"	"unprognostic (4.58e-2)"	"unprognostic (7.83e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.26e-1)"	"unprognostic (2.79e-3)"	"unprognostic (1.43e-1)"	"unprognostic (2.76e-1)"	"unprognostic (9.80e-2)"	"unprognostic (5.23e-1)"	16.9	18.8	22.8	14.6	22.5	19.0	19.0	21.4	31.0	16.2	24.0	14.7	7.7	18.1	18.1	13.4	19.1	11.2	20.5	22.3	22.1	14.5	13.6	12.1	22.9	22.7	21.7	27.1	19.4	15.9	20.4	14.2	22.3	12.3	16.2	15.9	13.0	10.2	14.4	17.1	10.4	16.6	22.3	15.9	14.1	16.0	21.8	20.8	19.5	11.0	21.8	16.9	14.2	24.1	28.9	27.4	41.1	32.0	41.3	60.1	37.1	27.1	44.0	36.9	38.0	57.8	19.2	44.7	51.7	35.8	51.6	25.4	58.9	34.2	41.0	79.4	45.9	19.7	20.9	77.4	25.9	52.2	19.2	47.9	53.1	33.1	43.3	34.9	35.8	42.4	64.3	15.2	32.1	15.6	49.6	70.5	39.6	45.9	42.1	49.2	30.8	82.2	38.6	23.4	55.2	35.6	23.8	14.6	65.5	58.6	39.8	44.7	29.5	39.2	26.3	32.9	44.8	22.4	82.4	42.7	19.0	36.6	54.2	1.9	18.8	2.1	11.7	19.8	15.6	31.3	17.5	13.3	34.4	26.2	26.6	24.6	4.3	23.6	17.5	23.0	19.1	17.6	22.8	22.5	21.4	31.0	22.3	22.1	22.7	21.7	22.3	22.3	21.8	24.1	75.6	25.6	16.2	28.4	45.0	73.5	55.6	80.9	25.0	16.4	51.9	48.4	29.1	28.6	33.9	18.4	8.4	49.5	23.0	12.3	31.3	44.1	38.8	26.0	29.3	40.3	32.3	32.0	103.4	43.8	72.2	37.6	11.2	19.0	41.3	39.6	41.7	35.9	65.2	11.8	57.4	26.5	32.6	46.8	93.0	91.7	46.3	31.7	69.4	32.8	74.2	45.1	23.7	80.4	50.8	34.1	15.3	35.3	32.6	108.9	7.2	90.0	26.6	16.8	32.9	32.2	34.8	79.4	78.7	32.1	82.8	47.2	29.5	43.9	38.6	63.5
FARS2	"dJ236A3.1, FARS1, mtPheRS"	ENSG00000145982	"Phenylalanyl-tRNA synthetase 2, mitochondrial"	O95363	6	5261044-5829192	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Disease variant, Hereditary spastic paraplegia, Neurodegeneration, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Astrocytes: 110.4;Early spermatids: 77.4;Excitatory neurons: 217.0;Inhibitory neurons: 122.6;Late spermatids: 78.8;Microglial cells: 106.8;Oligodendrocyte precursor cells: 186.5;Oligodendrocytes: 122.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018148, HPA028836"	Approved					NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA018148: AB_1848426, HPA028836: AB_10601377"	"unprognostic (2.73e-1)"	"unprognostic (4.08e-3)"	"prognostic favorable (5.14e-4)"	"unprognostic (2.68e-1)"	"unprognostic (1.94e-2)"	"unprognostic (5.34e-3)"	"unprognostic (1.82e-1)"	"unprognostic (4.31e-3)"	"unprognostic (7.18e-2)"	"unprognostic (1.02e-2)"	"unprognostic (8.91e-2)"	"unprognostic (2.50e-1)"	"prognostic favorable (1.24e-6)"	"unprognostic (2.81e-2)"	"unprognostic (2.83e-1)"	"unprognostic (2.02e-2)"	"unprognostic (1.57e-1)"	9.4	12.0	8.1	9.6	10.9	11.7	11.0	6.1	10.8	8.8	22.9	10.6	7.4	9.2	7.3	9.8	14.9	6.8	16.0	8.4	9.6	14.2	14.4	9.6	12.4	5.8	6.7	7.8	10.3	13.2	9.8	8.9	6.5	7.3	11.3	6.8	8.4	8.6	19.7	11.4	7.9	9.8	6.1	9.8	9.9	11.7	10.8	12.5	14.4	17.9	11.0	8.8	8.9	8.6	14.2	13.4	14.1	14.7	17.1	20.5	11.6	15.1	17.9	19.4	19.2	18.0	10.7	19.7	23.1	14.9	18.9	13.9	18.2	23.9	20.2	59.5	12.2	7.9	11.0	16.1	8.9	18.9	11.4	16.5	24.0	21.9	15.8	11.4	23.6	21.8	23.7	4.5	14.6	14.5	20.6	21.2	8.7	21.7	12.9	20.0	17.6	38.9	18.7	16.4	23.9	11.8	14.1	11.0	17.6	18.4	22.1	20.6	13.7	20.7	9.4	12.3	19.8	9.3	34.2	10.9	11.6	11.1	26.6	0.1	14.7	5.2	23.1	16.7	20.3	20.0	20.5	21.2	26.0	17.5	22.3	22.1	1.1	24.6	11.9	15.5	28.0	17.6	8.1	10.9	6.1	10.8	8.4	9.6	5.8	6.7	6.5	6.1	10.8	8.6	10.4	9.6	13.7	110.4	15.7	14.8	18.5	17.7	10.2	8.8	8.9	12.1	18.4	12.8	8.5	9.2	2.1	19.5	10.5	6.9	27.4	14.6	77.4	10.2	7.6	10.9	10.7	13.9	217.0	12.9	20.9	10.5	13.3	7.2	22.2	14.3	11.4	12.0	15.8	0.0	122.6	9.4	14.2	12.5	11.6	78.8	6.2	17.4	5.4	106.8	9.4	14.2	8.2	186.5	122.4	7.8	8.6	7.2	16.1	6.6	7.4	30.7	19.3	11.1	0.0	10.1	10.8	19.2	9.4	13.3	13.2	10.7	16.2	24.2	11.9	13.2
NRN1	NRN	ENSG00000124785	"Neuritin 1"	Q9NPD7	6	5997999-6007605	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 98.9;parathyroid gland: 81.0"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 262.9;Endothelial cells: 115.3;Excitatory neurons: 71.9;Extravillous trophoblasts: 64.7;Hepatic stellate cells: 160.3"	"Cancer enhanced"	"Detected in all"		"glioma: 38.7"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	7	"MAIT T-cell: 2.6;neutrophil: 2.2"	"Group enriched"	"Detected in many"	7	"granulocytes: 2.2;T-cells: 2.6"	"Cell line enhanced"	"Detected in many"		"ASC diff: 140.0;ASC TERT1: 107.6;fHDF/TERT166: 147.5;JURKAT: 134.8;REH: 196.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA		23000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 14: REH - Unknown function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"				"unprognostic (6.24e-2)"	"unprognostic (2.47e-2)"	"unprognostic (1.35e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.26e-2)"	"unprognostic (5.57e-2)"	"unprognostic (4.70e-3)"	"unprognostic (2.02e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.67e-2)"	"unprognostic (3.35e-1)"	"prognostic unfavorable (4.79e-5)"	"unprognostic (1.26e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.90e-1)"	"unprognostic (4.37e-3)"	66.4	5.1	49.1	6.4	44.9	0.5	64.2	46.0	80.8	16.2	17.0	21.3	3.7	9.4	4.0	8.2	13.6	11.2	19.7	98.9	27.7	8.2	4.4	15.6	9.6	30.4	29.9	4.7	2.9	81.0	12.3	42.1	32.5	10.1	4.7	23.4	8.7	7.4	17.3	18.8	10.8	10.5	22.1	15.7	10.3	0.6	60.1	3.6	9.4	16.1	3.5	13.8	17.0	45.9	16.7	0.6	1.4	0.1	140.0	107.6	19.1	2.6	0.0	11.8	16.1	0.2	0.1	0.0	2.5	147.5	25.0	0.5	43.3	0.0	11.4	26.1	21.2	13.7	0.0	0.0	0.0	58.0	43.7	17.3	0.0	10.5	0.0	0.1	57.4	134.8	0.2	0.6	42.5	0.1	89.7	2.6	0.1	0.0	0.0	196.3	47.7	0.4	0.2	0.2	24.9	9.2	0.0	0.8	13.9	0.2	0.4	16.4	12.1	56.4	1.6	21.4	36.5	0.1	2.2	0.9	85.8	0.2	8.9	0.0	0.1	0.0	0.1	0.1	2.6	0.3	0.2	0.3	0.0	0.0	0.0	0.0	2.2	0.0	0.1	0.2	0.0	0.1	49.1	44.9	46.0	80.8	98.9	27.7	30.4	29.9	32.5	22.1	60.1	45.9	262.9	0.0	1.3	7.2	1.6	10.5	0.1	0.0	1.2	6.7	1.4	2.4	2.5	1.5	0.0	0.0	2.1	1.5	1.0	0.0	0.0	0.1	0.1	0.0	0.1	115.3	0.0	0.0	71.9	0.5	64.7	15.9	0.0	0.1	0.0	0.0	160.3	0.9	1.8	3.3	3.0	0.0	0.0	4.1	21.5	0.4	0.9	1.4	16.0	8.4	0.5	4.5	0.0	13.6	8.3	0.2	0.0	0.0	1.4	0.4	0.0	0.0	0.0	20.2	0.0	4.4	18.3	0.4	0.3	0.6	11.2	1.4	1.9	0.1	0.0	0.7
F13A1	F13A	ENSG00000124491	"Coagulation factor XIII A chain"	P00488	6	6144084-6321013	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Blood coagulation, Hemostasis"	"Acyltransferase, Transferase"	"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 232.8;placenta: 489.2"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 863.3;Langerhans cells: 205.1;Macrophages: 232.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"classical monocyte: 141.1;myeloid DC: 179.6"	"Group enriched"	"Detected in many"	184	"dendritic cells: 179.6;granulocytes: 50.2;monocytes: 141.1"	"Cell line enhanced"	"Detected in some"		"AF22: 24.0;LHCN-M2: 8.9;RH-30: 43.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"HPA001804, CAB002155"	Enhanced				"Secreted to blood"	NA	NA		1400000000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 28: Placenta - Pregnancy"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 4: Macrophages - Innate immune response"			"CAB002155: AB_564077, HPA001804: AB_1078792"	"unprognostic (4.44e-1)"	"unprognostic (5.90e-2)"	"unprognostic (2.65e-2)"	"unprognostic (3.93e-2)"	"unprognostic (5.02e-2)"	"unprognostic (3.75e-2)"	"unprognostic (5.27e-2)"	"unprognostic (1.96e-1)"	"unprognostic (2.68e-2)"	"unprognostic (6.84e-3)"	"unprognostic (4.96e-2)"	"unprognostic (1.97e-1)"	"prognostic unfavorable (6.61e-6)"	"unprognostic (2.79e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.57e-1)"	"unprognostic (2.54e-3)"	232.8	57.9	2.6	52.3	4.2	16.1	46.9	1.3	13.0	50.4	28.5	45.9	9.7	18.5	5.6	51.2	29.1	52.7	39.2	2.1	3.6	21.0	3.0	38.7	30.0	8.3	4.6	10.7	10.0	13.3	8.1	489.2	6.9	8.8	63.9	21.6	18.8	13.4	10.3	22.7	22.0	89.6	2.6	8.8	25.4	17.8	3.7	20.9	17.1	32.8	12.5	144.5	12.1	4.0	0.0	0.1	24.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	8.9	0.0	0.1	0.2	0.0	0.0	0.0	0.0	43.8	0.8	0.0	0.0	0.3	0.3	0.1	0.0	0.0	0.1	0.0	4.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	50.2	141.1	1.4	0.5	25.4	0.6	0.4	0.3	0.4	179.6	0.4	0.4	0.2	32.9	0.3	0.7	12.5	0.3	364.9	2.6	4.2	1.3	13.0	2.1	3.6	8.3	4.6	6.9	2.6	3.7	4.0	2.0	0.0	1.9	0.3	1.8	18.7	0.0	0.0	0.6	0.1	0.3	0.4	10.6	5.7	0.0	0.0	0.0	5.0	4.5	0.0	0.0	0.0	5.1	0.6	10.6	3.8	0.0	1.3	3.9	0.0	5.6	13.7	0.0	0.4	1.3	0.0	2.9	0.9	863.3	0.0	1.4	0.0	0.0	92.4	205.1	5.8	4.4	232.0	19.6	64.6	53.1	0.9	6.2	0.5	0.7	0.1	0.0	0.7	1.2	0.0	0.0	11.0	2.2	6.5	59.2	2.5	3.3	1.6	0.9	1.2	15.2	10.1	2.6	0.4	0.0	0.1
LY86	"dJ80N2.1, MD-1"	ENSG00000112799	"Lymphocyte antigen 86"	O95711	6	6588108-6654983	"Predicted secreted proteins"	"Immunity, Inflammatory response, Innate immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 78.4"	"Group enriched"	"Detected in many"	9	"B-cells: 124.9;Hofbauer cells: 191.7;Kupffer cells: 199.1;Langerhans cells: 118.6;Macrophages: 149.8;Microglial cells: 105.9;monocytes: 155.6"	"Cancer enhanced"	"Detected in all"		"glioma: 22.1"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"classical monocyte: 426.6;myeloid DC: 426.1"	"Group enriched"	"Detected in all"	43	"B-cells: 335.1;dendritic cells: 426.1;monocytes: 426.6"	"Cell line enhanced"	"Detected in some"		"Daudi: 69.5;NB-4: 44.7;RPMI-8226: 245.0;THP-1: 103.8;U-937: 45.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB025000, HPA044895"	Approved				"Secreted to blood"	NA	NA		77000	"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 16: Immune cells - Immune response"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 57: B-cells - Immune response"			"CAB025000: , HPA044895: AB_2679138"	"unprognostic (1.82e-1)"	"unprognostic (2.49e-3)"	"unprognostic (2.01e-2)"	"unprognostic (7.88e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.93e-1)"	"unprognostic (2.53e-1)"	"unprognostic (1.46e-3)"	"unprognostic (3.52e-2)"	"unprognostic (3.17e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.16e-1)"	"unprognostic (5.82e-2)"	"unprognostic (1.17e-1)"	"prognostic unfavorable (5.61e-4)"	"unprognostic (1.11e-1)"	"unprognostic (4.20e-2)"	9.7	10.3	14.0	30.9	13.5	29.2	7.4	14.7	22.0	8.2	14.2	7.6	4.9	3.8	2.8	3.1	4.3	14.6	2.9	13.5	15.8	3.1	13.3	29.7	72.1	17.8	15.4	3.3	3.0	3.4	2.3	14.5	18.7	3.8	11.1	1.2	5.5	6.2	0.7	3.4	16.8	11.1	17.8	52.7	6.2	1.8	18.0	15.1	1.5	1.1	78.4	15.6	1.1	24.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	69.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	44.7	0.0	0.0	0.0	8.0	0.0	245.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.2	103.8	0.2	0.0	0.1	0.0	0.0	0.0	0.0	30.3	0.0	45.8	0.0	4.1	426.6	3.5	1.0	234.9	0.7	335.1	1.1	1.1	426.1	248.8	4.7	2.7	9.1	5.3	88.3	16.3	1.8	221.1	14.0	13.5	14.7	22.0	13.5	15.8	17.8	15.4	18.7	17.8	18.0	24.8	1.2	0.0	15.0	1.6	124.9	2.0	0.0	0.0	0.0	0.0	0.9	3.7	1.5	1.5	1.3	0.0	0.0	1.4	9.8	0.0	0.0	0.0	3.4	0.4	0.1	5.4	0.0	3.8	3.8	0.0	1.8	2.1	0.0	0.0	1.3	0.0	4.2	1.3	191.7	0.0	0.6	0.3	0.0	199.1	118.6	15.4	0.3	149.8	0.0	105.9	155.6	0.0	4.1	0.5	0.2	0.0	0.0	0.0	1.2	0.0	0.0	0.2	0.7	0.4	6.6	0.4	0.2	5.3	0.2	0.3	2.4	1.9	3.6	0.0	0.2	0.2
RREB1	HNT	ENSG00000124782	"Ras responsive element binding protein 1"	Q92766	6	7107597-7251980	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA001756, HPA034843"	Approved		Supported	"Nucleoli fibrillar center,Nuclear speckles"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 65: Plasmacytoid DCs - Unknown function"	"Nuclear speckles"	"Nucleoli fibrillar center"	"HPA001756: AB_1856477, HPA034843: AB_2674357"	"unprognostic (1.69e-1)"	"unprognostic (3.16e-2)"	"unprognostic (2.93e-1)"	"unprognostic (5.05e-2)"	"unprognostic (7.38e-2)"	"unprognostic (1.23e-3)"	"unprognostic (2.53e-1)"	"unprognostic (1.32e-2)"	"unprognostic (2.45e-2)"	"unprognostic (6.51e-2)"	"unprognostic (3.31e-2)"	"unprognostic (1.16e-1)"	"prognostic favorable (1.41e-4)"	"unprognostic (1.21e-2)"	"unprognostic (1.60e-1)"	"unprognostic (9.54e-2)"	"unprognostic (2.92e-1)"	10.9	12.1	4.3	7.8	3.6	31.6	10.8	4.4	2.2	10.2	12.5	10.8	11.9	7.8	5.6	26.2	8.7	6.4	8.3	2.7	4.2	8.2	18.3	9.1	6.5	9.1	6.6	9.8	18.1	12.2	6.3	8.1	6.5	8.1	9.8	5.7	15.0	6.2	16.6	16.2	13.1	6.2	5.4	10.7	10.7	11.6	7.6	9.2	12.0	7.9	7.9	7.9	14.2	5.5	13.1	12.3	10.3	11.9	9.5	6.3	40.1	5.2	7.3	6.2	7.6	20.3	10.0	6.6	10.9	9.9	6.9	9.3	14.7	16.5	5.9	9.2	11.3	24.8	9.6	23.5	13.1	15.0	18.5	10.5	12.7	9.3	13.8	4.2	7.5	15.2	44.6	0.1	6.5	16.5	8.8	35.2	4.9	10.6	10.0	13.1	12.4	10.4	9.0	25.1	2.8	2.6	12.4	16.0	11.1	15.3	12.3	31.0	13.0	11.4	7.1	8.8	6.4	4.1	4.7	9.0	3.3	11.4	9.3	5.5	2.7	6.6	1.5	2.1	1.3	2.2	1.0	1.0	1.7	1.0	1.6	1.3	2.0	3.3	2.4	5.7	0.5	1.7	4.3	3.6	4.4	2.2	2.7	4.2	9.1	6.6	6.5	5.4	7.6	5.5	39.3	25.6	28.7	44.4	19.0	31.5	22.4	30.1	27.9	0.9	27.0	16.9	24.2	31.5	31.4	36.8	70.9	25.8	31.9	62.7	7.9	14.7	46.2	35.5	24.7	22.5	31.8	31.1	3.9	16.3	32.8	16.3	30.1	63.0	10.1	20.7	30.7	70.4	33.4	0.0	0.7	35.7	14.2	66.1	54.9	9.0	19.9	42.1	23.2	78.7	32.6	9.5	13.4	2.0	0.9	22.3	36.3	19.2	27.7	37.1	34.5	16.8	23.9	27.5	52.6	25.5	15.2	13.7	17.4	48.9	34.7	45.8	15.7	27.4	45.0	54.3
SSR1	TRAPA	ENSG00000124783	"Signal sequence receptor subunit 1"	P43307	6	7268306-7347446	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011276, HPA017062"	Enhanced		Supported	"Endoplasmic reticulum"		NA	NA		1600000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"	"Endoplasmic reticulum"		"HPA011276: AB_1857503, HPA017062: AB_1857505"	"unprognostic (2.27e-1)"	"unprognostic (2.10e-1)"	"unprognostic (5.98e-3)"	"unprognostic (1.57e-2)"	"unprognostic (3.10e-2)"	"unprognostic (1.79e-1)"	"prognostic unfavorable (4.92e-4)"	"unprognostic (7.83e-2)"	"unprognostic (2.27e-2)"	"unprognostic (4.72e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.08e-1)"	"prognostic unfavorable (5.79e-6)"	"unprognostic (3.17e-1)"	"unprognostic (2.56e-2)"	"unprognostic (6.51e-3)"	"unprognostic (2.19e-2)"	64.0	64.4	20.3	89.6	24.6	101.9	70.3	25.4	24.8	88.5	35.7	65.3	65.6	62.7	74.2	71.6	50.8	64.5	41.2	19.0	28.9	58.6	95.5	56.7	68.4	27.6	25.2	67.0	67.9	49.4	25.8	71.5	27.2	59.2	76.4	36.6	79.7	56.0	28.3	42.6	62.4	76.9	23.7	62.4	68.2	38.5	27.8	55.9	84.8	29.1	84.2	74.4	32.8	34.7	122.2	121.7	92.3	171.7	244.9	173.1	144.4	274.5	225.5	183.4	219.1	167.5	98.5	162.9	472.1	282.5	168.3	107.0	112.0	156.6	251.6	172.2	94.6	174.3	130.6	350.7	253.4	325.6	189.6	154.2	169.0	210.2	429.2	140.4	205.2	80.4	199.3	191.1	204.6	146.4	89.6	86.6	78.2	136.5	137.2	120.1	116.0	615.7	161.3	171.5	124.6	57.9	167.0	91.1	263.4	276.8	147.9	141.7	183.1	196.1	149.0	153.3	238.1	195.7	312.1	130.4	95.3	180.4	367.1	146.1	169.5	114.5	82.9	121.9	105.6	73.0	91.7	93.9	199.9	56.1	86.3	86.9	93.3	85.7	110.1	139.3	109.4	214.7	20.3	24.6	25.4	24.8	19.0	28.9	27.6	25.2	27.2	23.7	27.8	34.7	54.0	28.9	48.1	32.3	106.1	77.8	62.1	120.2	69.4	75.4	85.3	46.1	48.5	84.4	93.7	130.6	100.1	78.2	118.6	65.4	15.6	96.0	16.1	48.7	96.0	69.6	62.3	80.8	38.6	103.0	208.5	95.4	68.8	74.3	47.5	64.0	78.1	148.1	130.0	70.7	41.3	130.4	81.4	157.3	251.5	12.4	78.6	129.7	94.3	35.6	131.5	64.1	87.6	49.8	47.8	71.9	47.0	73.0	302.1	111.2	61.5	67.1	57.8	104.2	26.3	57.6	71.6	53.4	58.7	96.0	75.4	121.8	83.6	61.2	93.6	70.4
CAGE1	"bA69L16.7, CT95, CTAG3"	ENSG00000164304	"Cancer antigen 1"	Q8TC20	6	7326656-7389742	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	23	"testis: 5.0"	"Group enriched"	"Detected in some"	9	"Early spermatids: 151.3;Late spermatids: 59.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA029832	Uncertain					NA	NA				"Cluster 74: Testis - Spermatogenesis"		"Cluster 23: Spermatids - Flagellum & Golgi organization"			"HPA029832: AB_10602412"	"unprognostic (1.34e-1)"	"unprognostic (4.82e-2)"	"unprognostic (1.80e-2)"	"unprognostic (2.25e-4)"	"unprognostic (4.80e-2)"	"unprognostic (4.24e-1)"	"unprognostic (2.44e-3)"	"unprognostic (3.88e-2)"	"unprognostic (2.79e-2)"	"unprognostic (8.80e-2)"	"unprognostic (1.09e-2)"	"unprognostic (3.23e-1)"	"unprognostic (4.38e-6)"	"unprognostic (4.71e-2)"	"unprognostic (3.29e-2)"	"unprognostic (1.62e-4)"	"unprognostic (1.60e-1)"	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	1.3	0.3	0.7	0.8	0.0	0.4	0.6	0.6	0.3	0.0	0.3	0.0	0.0	0.1	1.6	0.6	0.0	0.1	151.3	0.5	0.5	0.4	0.0	0.0	1.4	0.0	0.2	0.3	1.5	0.8	0.0	0.1	0.0	0.0	0.2	0.0	1.6	1.0	0.0	0.3	0.9	59.2	0.3	1.2	0.0	1.0	0.1	0.1	1.0	0.0	2.5	0.1	0.0	0.4	0.6	0.6	0.3	0.1	0.1	0.6	0.0	1.0	0.5	11.2	2.0	0.0	0.3	0.1	1.5	0.4	0.4	0.6
RIOK1	"AD034, bA288G3.1, FLJ30006, RRP10"	ENSG00000124784	"RIO kinase 1"	Q9BRS2	6	7389793-7418037	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ribosome biogenesis"	"Hydrolase, Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017866, HPA051446"	Enhanced		Supported	Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Cytosol		"HPA017866: AB_2669670, HPA051446: AB_2681488"	"unprognostic (2.33e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.38e-1)"	"unprognostic (1.03e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.51e-1)"	"prognostic unfavorable (3.41e-5)"	"unprognostic (2.23e-1)"	"prognostic unfavorable (4.43e-4)"	"unprognostic (3.45e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.87e-1)"	"prognostic unfavorable (5.85e-5)"	"unprognostic (2.33e-1)"	"unprognostic (2.09e-1)"	"unprognostic (6.12e-3)"	"unprognostic (2.59e-2)"	12.1	9.3	4.1	10.8	4.1	20.6	11.0	5.0	5.3	10.0	3.7	7.9	6.5	10.5	5.2	11.4	8.2	7.5	8.0	4.2	5.1	6.4	7.9	7.1	14.0	4.7	5.1	10.9	10.2	7.3	4.7	11.4	4.6	8.0	8.6	7.3	7.0	8.1	11.5	9.1	6.3	10.8	4.2	9.4	7.0	19.9	4.5	15.7	7.3	10.3	15.9	14.9	7.6	4.7	20.4	11.7	18.3	45.8	27.0	22.6	28.7	25.6	16.6	22.1	18.5	33.1	10.0	51.8	43.3	19.7	19.4	20.3	45.7	19.5	29.0	35.8	49.6	28.3	18.3	39.4	23.0	81.5	37.5	17.2	27.2	24.1	50.4	11.5	20.1	38.6	72.1	12.3	21.0	26.7	56.8	50.2	39.6	36.3	26.1	42.9	23.3	56.6	13.8	19.9	60.8	30.4	20.8	13.3	41.6	48.4	18.9	28.4	19.9	24.4	18.9	17.5	38.3	17.1	33.0	75.7	7.7	44.0	38.7	12.0	11.5	9.0	14.9	15.6	18.0	21.5	15.4	15.9	20.5	23.0	17.8	19.2	2.3	26.7	14.0	17.3	16.2	11.3	4.1	4.1	5.0	5.3	4.2	5.1	4.7	5.1	4.6	4.2	4.5	4.7	22.2	6.4	26.4	5.5	27.5	52.8	32.3	29.5	38.1	10.0	18.9	22.0	22.8	4.3	35.2	7.3	10.4	34.1	25.3	9.9	3.9	15.9	74.8	14.9	28.4	24.8	7.2	17.9	10.2	11.7	34.7	29.8	16.8	19.1	33.6	13.4	19.2	10.2	22.6	5.0	12.0	17.4	20.3	11.2	25.1	12.5	19.9	19.7	17.8	11.2	15.1	8.9	6.2	13.0	8.4	12.2	8.2	19.9	27.0	33.7	7.1	9.3	20.9	13.7	19.7	33.8	23.9	58.9	75.4	33.7	64.8	27.9	29.0	23.9	16.9	23.8
DSP	"DPI, DPII, KPPS2, PPKS2"	ENSG00000096696	Desmoplakin	P15924	6	7541617-7586714	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Cardiomyopathy, Disease variant, Epidermolysis bullosa, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 460.7;skin 1: 854.8"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 902.0;Cardiomyocytes: 729.7;Squamous epithelial cells: 1657.5;Suprabasal keratinocytes: 2018.0"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 314.1"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	13	"naive B-cell: 2.0"	"Lineage enriched"	"Detected in single"	20	"B-cells: 2.0"	"Cell line enhanced"	"Detected in many"		"BEWO: 278.0;HaCaT: 302.6;HBEC3-KT: 217.5;hTCEpi: 666.3;SuSa: 204.1"	"Region enriched"	"Detected in single"	23	"hippocampal formation: 11.6"	"Region enhanced"	"Detected in many"		"spinal cord: 9.5"	"CAB037324, HPA045840, HPA054950"	Enhanced		Supported	"Cell Junctions"		NA	NA		100000000	"Cluster 21: B-cells - Adaptive immune response"	"Cluster 31: Skin - Epidermis development"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Cell Junctions"		"CAB037324: , HPA045840: AB_2679468, HPA054950: AB_2682645"	"unprognostic (1.65e-1)"	"unprognostic (3.09e-1)"	"unprognostic (6.13e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.05e-2)"	"unprognostic (3.82e-2)"	"unprognostic (7.03e-3)"	"unprognostic (1.28e-1)"	"unprognostic (2.64e-2)"	"unprognostic (5.02e-2)"	"unprognostic (2.94e-2)"	"prognostic favorable (1.53e-9)"	"unprognostic (2.45e-1)"	"unprognostic (2.88e-1)"	"unprognostic (8.38e-2)"	"prognostic unfavorable (1.82e-4)"	5.2	11.6	4.2	7.0	1.8	0.6	65.8	2.5	3.5	151.0	19.3	46.0	52.0	5.4	27.5	460.7	16.3	7.8	84.9	3.4	0.9	22.4	41.9	6.1	3.7	1.6	2.0	2.0	111.5	54.9	9.0	63.3	1.5	29.9	43.5	21.2	125.1	11.7	3.4	854.8	42.3	2.9	2.4	3.2	48.1	1.5	2.2	37.1	41.5	0.6	78.7	13.1	286.1	0.9	132.2	38.9	0.0	0.1	5.6	8.2	278.0	25.5	21.8	12.4	12.0	110.8	33.5	0.1	35.8	40.9	10.0	302.6	46.1	217.5	2.2	0.1	54.1	0.0	21.5	149.5	0.0	0.6	0.9	1.9	666.3	11.0	121.7	30.0	0.0	0.6	0.2	0.2	22.0	61.4	0.1	1.0	5.6	62.6	19.6	0.1	0.1	32.9	45.3	34.8	12.6	0.3	28.5	59.9	0.2	204.1	71.0	0.3	0.0	4.8	1.2	0.3	0.3	0.1	0.2	0.2	0.2	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	1.8	2.5	3.5	3.4	0.9	1.6	2.0	1.5	2.4	2.2	0.9	7.6	51.3	17.0	0.0	7.5	902.0	164.5	157.3	278.3	4.4	184.5	126.4	729.7	97.2	197.5	60.7	14.6	273.0	1.2	357.1	1.9	160.6	1.8	306.5	42.4	46.9	174.6	0.0	0.1	111.9	273.1	51.2	237.0	560.1	3.8	532.2	4.6	186.6	27.5	0.0	0.9	204.7	111.9	1.9	77.8	1.3	0.9	5.9	101.4	3.7	2.6	14.7	0.0	0.0	0.1	167.4	284.2	0.0	5.7	204.0	180.7	12.0	176.6	28.6	0.0	0.4	67.4	1.3	2.7	1657.5	2018.0	385.7	8.1	0.3	247.8	269.9
SNRNP48	"C6orf151, dJ336K20B.1, dJ512B11.2, FLJ32234"	ENSG00000168566	"Small nuclear ribonucleoprotein U11/U12 subunit 48"	Q6IEG0	6	7590198-7611967	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029234	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	Cytosol	"HPA029234: AB_10604097"	"prognostic unfavorable (8.30e-4)"	"unprognostic (3.46e-2)"	"unprognostic (2.65e-1)"	"unprognostic (9.65e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.54e-1)"	"unprognostic (9.46e-3)"	"unprognostic (2.55e-1)"	"unprognostic (9.87e-3)"	"unprognostic (1.62e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.03e-1)"	"prognostic unfavorable (4.16e-4)"	"unprognostic (1.55e-1)"	"unprognostic (8.70e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.03e-1)"	5.4	3.8	4.8	5.5	5.1	10.4	6.9	8.5	6.7	7.0	4.4	5.4	5.7	6.4	4.6	4.7	5.7	4.0	7.2	4.6	5.0	6.0	7.3	4.5	7.3	5.7	4.9	7.7	5.7	3.7	3.6	5.3	5.9	5.8	5.5	7.3	5.3	4.4	9.7	6.3	6.7	5.4	4.7	6.1	5.4	2.7	5.1	7.1	5.8	7.1	5.9	5.6	5.8	5.9	10.0	7.9	16.2	30.3	8.5	12.5	10.9	11.2	10.4	12.0	13.1	16.9	8.1	23.6	11.8	9.4	11.5	12.6	20.2	12.1	18.2	18.2	19.8	17.0	24.1	32.7	8.9	20.5	10.9	8.8	18.3	13.5	10.2	14.2	10.5	20.8	24.1	3.6	16.8	5.7	33.7	29.6	21.9	17.1	8.8	35.8	13.9	31.6	10.8	8.7	25.0	6.8	21.8	5.6	19.6	29.7	10.9	7.2	11.8	15.8	7.1	9.5	19.6	5.8	34.6	14.5	5.3	16.1	28.9	0.1	0.7	0.4	0.7	0.5	1.2	0.6	0.8	0.9	0.9	1.1	0.7	1.3	2.3	1.1	0.3	1.0	0.7	0.6	4.8	5.1	8.5	6.7	4.6	5.0	5.7	4.9	5.9	4.7	5.1	5.9	18.6	19.2	10.3	8.1	15.7	35.7	20.2	13.6	12.0	18.7	12.6	14.6	32.1	15.7	17.3	9.2	20.9	16.3	22.7	19.2	11.7	18.0	2.5	18.0	14.8	20.5	11.4	17.7	20.4	20.1	15.6	18.0	8.2	19.6	24.1	16.8	20.3	23.4	15.9	5.0	18.8	18.2	0.0	15.1	22.1	2.5	17.7	14.9	8.8	13.1	21.7	15.5	19.6	14.6	23.8	12.1	17.9	16.6	11.5	21.4	27.1	20.1	8.5	17.8	6.6	20.9	23.2	16.1	17.0	11.5	34.0	16.3	18.5	11.2	17.1	20.1
BMP6	"VGR, VGR1"	ENSG00000153162	"Bone morphogenetic protein 6"	P22004	6	7726099-7881728	"Predicted secreted proteins"	"Chondrogenesis, Differentiation, Osteogenesis"	"Cytokine, Developmental protein, Growth factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 23.0;Hepatic stellate cells: 16.8;Inhibitory neurons: 22.8;Microglial cells: 74.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.1"	"Lineage enriched"	"Detected in single"	11	"granulocytes: 1.1"	"Cell line enhanced"	"Detected in many"		"EFO-21: 37.0;HUVEC TERT2: 149.6;Karpas-707: 81.6;SiHa: 70.0;TIME: 74.3;U-266/84: 41.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB002773, HPA062683"	Approved		Approved	Mitochondria	"Secreted to blood"	No	No	4970000	46000	"Cluster 46: Basophils - DNA binding"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Mitochondria		"CAB002773: , HPA062683: AB_2684832"	"prognostic favorable (6.45e-4)"	"unprognostic (2.99e-1)"	"unprognostic (4.20e-1)"	"unprognostic (6.71e-2)"	"unprognostic (2.44e-1)"	"unprognostic (7.27e-2)"	"unprognostic (4.66e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.26e-1)"	"unprognostic (6.94e-2)"	"unprognostic (2.80e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.82e-2)"	"unprognostic (8.29e-2)"	"unprognostic (2.95e-1)"	"unprognostic (2.29e-3)"	16.5	3.1	5.1	2.2	5.9	0.4	12.7	3.9	6.2	3.2	7.8	3.7	3.0	3.5	0.6	2.0	2.4	2.1	5.1	3.9	3.7	17.8	1.9	9.1	1.5	4.9	4.5	8.2	0.6	0.6	4.6	18.1	4.7	2.8	2.7	0.1	2.3	2.6	3.1	3.5	3.0	2.3	4.8	4.6	4.7	2.2	5.7	0.9	1.5	1.3	2.4	3.3	3.0	4.1	0.9	2.4	0.3	0.0	0.4	0.3	0.0	2.0	0.1	0.0	0.0	0.0	0.0	0.0	37.0	1.1	1.6	0.5	1.1	0.2	0.0	0.0	5.7	15.9	21.8	1.4	0.8	1.1	16.7	0.0	0.0	0.7	2.4	9.6	149.6	0.0	0.0	81.6	0.0	0.3	0.0	0.0	0.8	0.5	12.0	0.6	0.0	15.3	0.5	0.0	12.3	0.0	70.0	0.0	0.0	9.3	0.0	0.0	74.3	0.0	4.7	0.5	2.6	11.3	41.3	0.1	2.3	0.0	1.4	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.5	5.1	5.9	3.9	6.2	3.9	3.7	4.9	4.5	4.7	4.8	5.7	4.1	23.0	0.0	0.5	1.6	1.1	0.3	0.0	0.0	0.0	0.0	0.1	0.1	3.5	0.0	1.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.1	0.8	0.2	8.9	0.0	0.0	7.8	0.0	0.1	2.0	0.0	2.0	0.0	1.5	16.8	0.6	0.3	0.0	22.8	0.0	0.0	0.8	2.1	4.2	0.0	1.5	1.8	74.0	0.7	0.0	0.0	0.0	0.3	0.1	0.0	0.0	6.8	0.3	0.0	0.0	0.3	0.0	0.0	4.7	0.4	0.1	1.3	0.1	0.1	0.3	0.4	0.4	0.0	0.0
TXNDC5	"EndoPDI, ERp46, FLJ21353, FLJ90810, Hcc-2, MGC3178, PDIA15"	ENSG00000239264	"Thioredoxin domain containing 5"	Q8NBS9	6	7881517-7910788	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	42	"Plasma cells: 677.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	14	"memory B-cell: 13.0;naive B-cell: 6.9;plasmacytoid DC: 26.7"	"Group enriched"	"Detected in many"	21	"B-cells: 13.0;dendritic cells: 26.7"	"Cell line enhanced"	"Detected in all"		"RPMI-8226: 2833.2;U-266/84: 6053.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034677, HPA034678"	Enhanced		Approved	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA		6900000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 16: U-266 - Nucleosome"	"Cluster 55: Plasma cells - Humoral immune response"	"Endoplasmic reticulum"		"HPA034677: AB_2674275, HPA034678: AB_2674276"	"unprognostic (3.15e-1)"	"unprognostic (1.09e-2)"	"unprognostic (4.27e-2)"	"unprognostic (5.43e-2)"	"unprognostic (6.95e-2)"	"unprognostic (1.20e-2)"	"unprognostic (6.07e-2)"	"unprognostic (5.81e-2)"	"unprognostic (3.56e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.11e-1)"	"prognostic unfavorable (1.16e-4)"	"unprognostic (1.05e-1)"	"unprognostic (7.98e-2)"	"unprognostic (6.23e-2)"	"unprognostic (1.08e-2)"	97.4	74.8	21.1	173.0	23.4	61.8	163.4	22.0	22.5	132.2	52.7	266.2	263.5	80.5	85.8	78.2	63.9	98.6	63.3	19.8	23.2	63.1	133.3	90.9	194.2	25.0	24.7	96.4	154.6	68.6	42.5	134.0	23.2	73.2	213.6	4.4	219.3	93.6	25.1	32.9	193.9	121.9	24.9	250.6	287.6	28.3	26.4	54.1	69.6	29.2	263.8	190.9	57.0	25.9	166.1	159.0	111.5	365.9	911.2	388.1	175.9	361.5	349.7	246.2	265.2	238.8	119.0	176.1	620.7	557.2	273.6	127.3	195.5	178.6	280.3	148.8	166.6	267.6	128.3	435.9	268.5	307.2	255.0	266.7	256.8	236.6	259.2	542.1	1334.0	109.7	170.5	1216.5	171.7	147.7	75.2	185.7	142.8	260.5	340.6	128.0	160.4	2833.2	201.1	149.6	168.7	90.5	462.4	280.2	209.4	514.9	143.5	133.9	369.7	280.5	194.2	243.0	386.5	1408.7	6053.9	305.0	144.7	191.7	392.2	0.0	0.4	0.0	0.9	0.7	0.7	13.0	0.2	0.7	1.0	6.9	0.2	0.4	0.0	0.0	0.1	26.7	0.9	0.5	21.1	23.4	22.0	22.5	19.8	23.2	25.0	24.7	23.2	24.9	26.4	25.9	1.3	0.0	4.8	0.0	14.6	0.9	0.2	0.4	3.4	0.0	1.8	1.3	0.2	0.0	2.0	0.0	0.0	0.9	5.6	1.2	0.0	9.0	0.1	1.1	6.9	3.2	4.9	11.2	0.0	10.7	1.9	4.1	6.1	2.3	1.3	0.6	3.9	4.9	1.5	0.0	0.0	15.9	0.0	0.8	0.7	0.0	0.0	1.3	3.6	0.0	1.8	0.1	0.0	0.0	0.0	9.5	1.5	0.4	677.7	0.4	3.2	0.5	1.7	0.5	6.6	0.5	4.2	0.1	0.1	3.9	0.1	1.2	2.0	0.2	5.8	0.2
BLOC1S5	"dJ303A1.3, MU, MUTED"	ENSG00000188428	"Biogenesis of lysosomal organelles complex 1 subunit 5"	Q8TDH9	6	8013567-8064396	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Proximal tubular cells: 41.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"CAB025613, HPA077525"	Uncertain		Supported	Vesicles		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Vesicles		"CAB025613: , HPA077525: AB_2686843"	"unprognostic (1.54e-1)"	"unprognostic (8.21e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.92e-1)"	"unprognostic (5.06e-2)"	"prognostic unfavorable (8.12e-4)"	"unprognostic (4.24e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.47e-2)"	"unprognostic (2.87e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.62e-3)"	"unprognostic (1.83e-1)"	"unprognostic (1.13e-1)"	"unprognostic (6.16e-2)"	"unprognostic (7.60e-3)"	6.8	7.0	3.6	6.3	4.2	3.9	10.5	3.9	4.7	8.1	3.0	6.4	4.2	7.0	6.9	6.6	6.4	6.1	6.0	3.3	4.7	15.7	11.4	5.9	9.9	4.4	4.2	9.9	4.7	9.6	3.1	6.8	4.5	6.5	5.8	5.2	4.7	9.2	6.5	6.4	5.0	6.6	4.0	7.4	6.0	3.7	3.9	15.6	10.1	8.6	10.6	6.2	5.3	4.6	6.1	7.0	14.7	18.9	15.7	18.8	9.6	6.7	9.4	9.5	9.4	13.6	5.8	21.8	43.9	8.6	10.8	5.4	10.8	5.4	13.6	20.6	11.5	13.1	4.8	25.8	13.4	23.2	14.8	8.4	13.4	9.6	14.4	14.5	17.3	17.3	27.7	3.9	13.6	6.7	26.6	15.1	7.9	14.3	9.4	21.5	17.0	33.8	17.6	5.4	13.5	7.2	6.8	10.3	21.3	26.4	12.9	11.8	7.2	15.1	10.7	8.9	5.9	16.5	37.3	19.7	6.2	17.9	15.9	16.2	9.4	18.3	11.8	12.3	15.7	18.9	15.3	15.2	16.6	17.7	15.2	15.9	2.3	19.6	6.7	7.2	15.2	11.8	3.6	4.2	3.9	4.7	3.3	4.7	4.4	4.2	4.5	4.0	3.9	4.6	18.1	12.8	6.9	0.0	14.6	6.0	8.3	6.8	8.6	7.0	7.1	9.9	7.3	0.0	7.9	25.8	2.1	12.5	15.6	5.9	35.2	9.9	7.5	11.5	12.4	10.7	1.8	7.2	0.0	8.7	9.2	10.6	7.7	19.5	16.5	14.5	0.0	0.0	7.8	6.7	0.0	6.9	2.0	0.0	6.1	7.8	9.6	11.0	3.6	0.0	10.7	13.2	12.3	0.0	0.0	10.1	3.9	12.4	7.3	8.4	6.7	41.8	7.7	8.4	0.0	12.4	9.3	5.8	14.4	8.9	7.5	8.2	12.7	22.5	6.6	7.5
EEF1E1	"AIMP3, P18"	ENSG00000124802	"Eukaryotic translation elongation factor 1 epsilon 1"	O43324	6	8073360-8102559	"Predicted intracellular proteins, Predicted membrane proteins"	"Protein biosynthesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 244.3;Late spermatids: 231.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA027901, HPA057866"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA		18000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 34: Spermatids - Unknown function"	"Nucleoplasm, Cytosol"		"HPA027901: AB_10611960, HPA057866: AB_2683547"	"unprognostic (9.39e-3)"	"prognostic favorable (3.16e-4)"	"unprognostic (2.23e-1)"	"unprognostic (2.36e-2)"	"unprognostic (1.42e-2)"	"unprognostic (8.21e-2)"	"prognostic unfavorable (1.55e-7)"	"unprognostic (1.79e-1)"	"unprognostic (5.67e-2)"	"prognostic favorable (3.24e-4)"	"unprognostic (1.13e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.97e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.13e-1)"	15.5	29.6	26.6	21.5	26.4	57.8	26.5	33.5	33.4	14.9	24.2	18.4	12.0	19.3	26.3	22.6	15.0	13.6	19.1	27.0	31.5	50.6	20.3	13.8	31.7	30.7	34.6	14.7	28.3	31.3	23.9	17.3	31.6	17.8	20.9	25.4	20.0	18.2	22.8	12.3	12.7	19.2	26.7	16.4	23.0	57.5	30.5	25.9	20.6	24.7	31.2	26.4	13.9	30.0	129.5	67.1	104.8	71.9	35.0	56.5	63.6	105.7	67.0	94.4	97.0	111.8	52.5	140.9	229.3	69.8	169.8	51.9	122.3	123.9	156.8	79.6	160.6	113.9	92.0	196.4	63.9	228.2	79.2	47.4	113.5	117.4	116.2	66.4	136.2	113.8	283.3	35.9	91.2	54.0	98.0	183.2	95.8	123.9	107.8	117.9	61.0	221.0	156.3	98.5	156.7	48.0	45.6	100.5	131.9	141.5	79.7	75.7	70.2	77.0	76.7	70.7	156.3	58.4	290.7	199.3	43.1	95.8	126.0	16.2	22.2	14.2	25.7	31.8	36.8	42.9	34.4	34.8	61.2	46.9	38.1	39.5	2.3	30.7	25.5	26.8	45.8	29.3	26.6	26.4	33.5	33.4	27.0	31.5	30.7	34.6	31.6	26.7	30.5	30.0	31.9	16.0	30.0	0.0	39.7	65.9	61.4	99.1	60.3	34.4	43.1	54.1	23.5	21.5	63.4	60.7	10.4	78.7	23.5	11.8	140.8	67.9	244.3	59.0	31.0	34.1	40.1	43.5	0.0	89.0	76.6	30.8	32.1	71.0	15.8	45.4	24.3	30.0	49.7	30.3	0.0	36.6	75.3	31.1	33.4	231.1	26.4	31.3	42.7	0.0	32.6	44.7	29.9	0.0	0.0	69.0	12.9	23.7	48.0	81.3	7.5	186.7	45.9	21.8	13.1	32.8	38.9	131.2	92.2	59.3	76.1	32.3	34.1	69.9	42.0	44.8
SLC35B3	"C6orf196, CGI-19, dJ453H5.1, PAPST2"	ENSG00000124786	"Solute carrier family 35 member B3"	Q9H1N7	6	8411435-8435561	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054661, HPA057801"	Approved					NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 27: Mucus-secreting cells - Mucin production"			"HPA054661: AB_2682561, HPA057801: AB_2683532"	"unprognostic (2.84e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.10e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.19e-1)"	"unprognostic (4.93e-2)"	"unprognostic (5.23e-3)"	"unprognostic (5.00e-2)"	"unprognostic (9.45e-2)"	"unprognostic (9.27e-2)"	"unprognostic (3.43e-1)"	"unprognostic (2.32e-1)"	"unprognostic (2.20e-1)"	"unprognostic (3.08e-3)"	"unprognostic (3.88e-3)"	11.3	9.7	6.0	10.2	7.6	4.6	12.9	6.3	10.6	12.2	7.2	24.2	14.8	9.4	43.0	10.3	9.6	15.1	10.3	6.3	6.2	16.4	23.4	10.6	12.2	7.2	6.6	8.1	18.4	14.6	12.0	14.7	7.1	12.1	24.9	5.2	15.0	17.4	5.7	10.7	16.9	9.4	6.4	13.4	17.9	8.8	6.6	9.9	18.2	4.5	11.8	12.3	10.9	9.4	14.8	7.7	10.4	14.1	23.4	35.7	8.5	37.9	31.4	13.5	17.3	24.7	13.9	12.5	20.9	27.7	19.5	10.6	11.5	10.3	22.6	18.0	8.4	6.1	6.1	15.0	24.5	9.1	13.2	24.4	14.3	14.3	15.5	17.5	18.5	7.4	13.2	5.1	30.5	10.2	6.9	13.7	8.2	20.6	9.2	6.2	9.7	12.6	36.7	13.2	9.9	8.4	9.8	8.6	17.9	29.6	6.5	18.4	15.9	22.3	6.4	15.9	17.2	12.8	23.9	6.3	12.8	10.0	29.6	5.4	4.5	4.8	6.2	3.5	6.9	4.2	6.2	6.6	4.0	5.8	7.0	5.5	5.2	10.8	5.8	2.7	7.0	4.3	6.0	7.6	6.3	10.6	6.3	6.2	7.2	6.6	7.1	6.4	6.6	9.4	13.3	6.4	10.6	21.9	14.9	13.5	13.0	29.4	10.8	5.7	20.9	10.3	9.1	20.0	27.5	29.5	4.2	21.1	18.5	42.8	7.9	20.5	9.9	28.6	19.4	15.1	14.9	5.5	19.5	24.3	29.1	21.8	28.1	15.5	6.3	11.5	18.5	23.6	19.9	10.1	17.7	47.3	36.7	15.1	10.4	7.6	15.5	11.3	21.4	24.4	16.7	7.1	13.4	30.7	65.7	15.4	33.4	12.0	22.2	22.6	31.1	27.5	46.8	3.7	13.1	9.9	15.7	32.1	14.2	13.7	17.6	16.4	13.1	10.7	33.5	22.9
TFAP2A	"AP-2, AP2TF, TFAP2"	ENSG00000137203	"Transcription factor AP-2 alpha"	P05549	6	10393186-10419659	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 32.8;skin 1: 66.7"	"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 167.9;Cytotrophoblasts: 285.8;Extravillous trophoblasts: 260.6;Squamous epithelial cells: 147.7;Syncytiotrophoblasts: 700.1"	"Cancer enhanced"	"Detected in many"		"melanoma: 45.6"	"Group enriched"	"Detected in many"	4	"cerebellum: 4.1;medulla oblongata: 3.0;midbrain: 1.3;pons: 2.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 104.7;hTCEpi: 97.3;SuSa: 97.3"	"Group enriched"	"Detected in some"	4	"cerebellum: 3.9;pons and medulla: 1.0"	"Low region specificity"	"Detected in many"			"CAB000326, HPA056871"	Enhanced		Enhanced	Nucleoplasm		NA	NA				"Cluster 31: Skin - Epidermis development"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Nucleoplasm		"CAB000326: AB_667767, HPA056871: AB_2683262"	"unprognostic (5.97e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.31e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.87e-2)"	"unprognostic (1.27e-1)"	"unprognostic (7.62e-5)"	"prognostic unfavorable (1.09e-4)"	"unprognostic (1.45e-1)"	"unprognostic (2.76e-2)"	"unprognostic (3.33e-3)"	"unprognostic (2.82e-1)"	"unprognostic (1.40e-11)"	"unprognostic (1.46e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.72e-4)"	"unprognostic (2.25e-2)"	0.5	0.4	0.4	0.1	0.3	0.1	32.8	4.1	0.4	7.5	0.2	1.1	0.5	0.3	21.8	29.9	0.4	0.2	0.9	0.3	0.1	7.4	0.1	0.5	0.4	3.0	1.3	0.4	0.2	0.6	0.4	29.6	2.1	9.8	0.5	8.1	23.5	9.3	0.5	66.7	0.8	0.1	0.5	0.1	1.4	2.2	0.5	0.2	0.5	0.1	5.1	3.5	16.6	0.6	51.8	17.8	0.1	87.9	0.4	0.0	19.7	40.2	30.3	31.7	31.4	2.1	19.3	3.2	4.9	12.0	17.5	53.2	4.3	66.1	30.9	104.7	45.2	0.4	44.5	0.0	0.0	1.7	1.5	0.0	97.3	0.1	66.6	18.3	0.0	0.9	3.3	0.1	0.3	12.2	0.0	17.2	0.5	3.3	24.7	5.9	5.0	2.2	18.8	21.8	12.5	0.3	44.1	82.7	82.3	97.3	56.0	1.7	0.0	9.9	2.7	7.1	25.3	0.1	5.1	0.8	5.1	1.7	59.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	4.1	0.4	0.3	0.1	3.0	1.3	2.1	0.5	0.5	0.6	0.5	0.0	0.0	0.0	0.4	130.6	45.5	50.3	167.9	25.9	98.2	65.7	2.7	0.0	30.5	31.3	2.1	285.8	0.5	1.0	7.9	2.2	5.3	1.2	0.7	2.1	1.2	0.0	0.0	0.4	260.6	4.2	0.0	1.5	0.0	0.1	0.0	0.0	20.4	80.8	0.0	0.5	46.8	0.0	6.1	3.8	0.6	0.5	124.5	0.0	0.0	4.3	0.0	0.0	0.1	3.7	0.5	0.0	1.2	58.2	0.1	0.3	21.5	4.6	0.0	0.3	4.1	6.5	16.8	147.7	138.4	700.1	0.3	0.3	0.5	46.7
GCNT2	"bA360O19.2, bA421M1.1, CCAT, GCNT5, IGNT, II, NACGT1, NAGCT1, ULG3"	ENSG00000111846	"Glucosaminyl (N-acetyl) transferase 2 (I blood group)"	Q8N0V5	6	10492223-10629368	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"	"Cataract, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"prostate: 13.5"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 76.9;Endometrial ciliated cells: 79.1;Glandular and luminal cells: 105.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"basophil: 1.9"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"EFO-21: 44.2;Hep G2: 19.7;SK-MEL-30: 17.1;SuSa: 21.4"	"Region enriched"	"Detected in all"	4	"basal ganglia: 61.1"	"Low region specificity"	"Detected in all"			HPA026776	Approved		Approved	"Golgi apparatus"		No	No		750000	"Cluster 41: Basophils - Cellular respiration"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 44: Endometrium - Transcription"	"Golgi apparatus"		"HPA026776: AB_1849573"	"unprognostic (2.47e-1)"	"unprognostic (6.87e-3)"	"unprognostic (3.12e-1)"	"unprognostic (1.42e-2)"	"unprognostic (9.31e-2)"	"unprognostic (2.51e-1)"	"unprognostic (4.11e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.11e-2)"	"unprognostic (6.28e-4)"	"unprognostic (3.96e-2)"	"unprognostic (1.58e-3)"	"unprognostic (6.54e-2)"	"unprognostic (6.32e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.53e-1)"	0.6	0.3	0.7	1.0	0.6	0.3	10.1	2.5	1.1	4.2	4.5	3.6	5.2	1.4	0.2	1.4	0.8	1.5	6.6	0.8	1.1	5.7	5.1	3.9	1.8	1.2	1.0	0.3	1.3	0.4	1.4	2.6	1.4	13.5	2.0	0.3	4.2	0.3	0.7	1.4	5.8	1.6	0.9	1.5	5.9	2.5	0.9	0.5	1.2	1.8	2.4	1.0	0.7	1.0	6.3	4.9	1.5	4.8	0.0	0.0	9.6	0.0	4.1	1.1	0.5	11.0	5.2	3.5	44.2	0.0	3.2	0.3	0.4	5.1	2.9	3.1	1.8	0.5	2.6	19.7	0.0	1.7	4.7	0.0	0.0	0.5	0.0	2.4	9.1	0.0	0.4	0.0	0.4	0.0	0.0	4.0	4.4	0.0	3.6	0.2	3.8	6.0	16.0	2.9	4.0	1.2	0.0	14.4	17.1	21.4	0.3	0.8	6.4	0.8	0.5	0.0	5.0	0.1	0.0	2.4	0.8	0.3	2.3	1.9	1.1	0.5	0.1	0.8	0.0	0.7	0.1	0.1	0.8	0.4	0.1	0.2	0.1	0.2	0.2	0.2	0.0	0.3	0.7	0.6	2.5	1.1	0.8	1.1	1.2	1.0	1.4	0.9	0.9	1.0	1.4	76.9	32.4	1.0	9.5	4.6	6.6	15.5	9.6	5.1	30.5	16.1	18.4	2.8	28.6	7.3	0.0	27.9	6.4	15.5	11.7	2.9	4.3	79.1	5.5	11.0	2.4	25.9	0.7	24.7	2.1	2.0	16.8	105.5	2.5	0.0	12.8	32.0	15.8	3.3	11.8	5.6	6.1	7.7	9.4	8.2	0.3	7.8	49.8	52.5	11.1	2.4	0.0	18.6	1.1	12.0	11.9	0.0	1.0	16.6	44.3	13.4	27.9	0.6	0.0	0.7	2.2	6.2	27.6	11.2	1.7	10.9	3.1	0.0	16.3	8.1
C6orf52		ENSG00000137434	"Chromosome 6 open reading frame 52"	Q5T4I8	6	10671418-10694797	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in many"		"testis: 13.7"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 46.4;Endometrial ciliated cells: 44.9;Late spermatids: 27.3;Respiratory ciliated cells: 37.7;Spermatocytes: 36.1;Spermatogonia: 20.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"T-reg: 3.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"NB-4: 6.1;U-266/84: 6.4"					"Not detected"	"Not detected"			HPA051142	Uncertain		Approved	"Nuclear speckles,Intermediate filaments"		No	No			"Cluster 35: T-regs - Unknown function"	"Cluster 43: Testis - Unknown function"	"Cluster 24: NB-4 - Immune response"	"Cluster 49: Ciliated cells - Cilium organization"	"Nuclear speckles"	"Intermediate filaments"	"HPA051142: AB_2681359"	"unprognostic (1.14e-2)"	"unprognostic (2.21e-2)"	"unprognostic (1.63e-1)"	"prognostic favorable (6.50e-5)"	"unprognostic (9.12e-2)"	"unprognostic (2.96e-1)"	"unprognostic (1.11e-3)"	"unprognostic (1.67e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.23e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.46e-2)"	"unprognostic (2.17e-2)"	"unprognostic (3.92e-2)"	"unprognostic (9.31e-3)"	"unprognostic (7.65e-2)"	1.0	1.8	2.2	0.5	2.2	0.3	1.1	2.3	4.0	0.7	3.1	0.8	3.3	0.5	3.5	0.6	3.3	0.2	0.6	2.2	2.5	4.4	0.7	1.0	0.4	2.6	2.7	1.1	2.2	0.3	2.0	0.2	2.6	2.0	0.3	0.8	0.8	0.5	0.5	1.3	0.7	0.3	2.4	0.7	1.6	13.7	2.3	0.5	0.8	0.2	0.6	0.6	0.5	2.8	1.0	2.0	1.8	1.7	0.6	0.0	3.3	0.3	0.0	0.2	0.4	2.7	1.6	0.2	2.9	0.0	2.8	0.2	1.8	0.0	0.6	1.2	4.5	0.8	0.5	0.5	0.0	1.2	0.5	0.3	2.6	0.7	1.0	0.4	0.0	1.9	3.6	0.3	0.7	6.1	1.5	6.1	1.9	1.4	2.3	1.3	0.4	0.9	0.8	0.5	3.8	2.1	0.8	0.5	3.9	2.3	0.2	1.0	0.7	1.4	0.5	1.0	1.4	2.6	6.4	1.4	2.3	0.9	1.6	0.0	0.2	2.4	0.6	0.5	0.2	0.2	0.7	0.6	0.5	0.3	0.3	0.3	0.3	0.7	0.3	0.4	3.1	0.3	2.2	2.2	2.3	4.0	2.2	2.5	2.6	2.7	2.6	2.4	2.3	2.8	0.7	0.0	2.7	3.3	1.2	1.5	2.0	4.2	0.0	1.6	3.2	3.7	1.3	1.5	2.6	3.7	2.1	2.9	0.2	1.6	5.9	4.1	46.4	44.9	0.9	1.9	3.0	0.0	0.9	6.1	2.3	1.1	2.0	2.5	0.0	0.6	1.4	1.9	1.2	1.7	1.0	1.2	0.0	0.3	1.0	27.3	2.1	0.6	3.6	0.0	1.6	3.3	1.0	0.0	3.5	2.8	2.7	0.0	2.5	2.0	1.3	9.6	37.7	0.9	0.0	1.1	2.1	36.1	20.4	0.6	1.4	1.4	0.4	0.4	1.7	1.0
PAK1IP1	"bA421M1.5, FLJ20624, hPIP1, MAK11, PIP1, WDR84"	ENSG00000111845	"PAK1 interacting protein 1"	Q9NWT1	6	10694972-10709782	"Predicted intracellular proteins"	"Ribosome biogenesis"	"Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030111, HPA030112"	Supported		Supported	Nucleoli		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoli		"HPA030111: AB_2732454, HPA030112: AB_10603125"	"unprognostic (9.41e-2)"	"unprognostic (3.79e-1)"	"unprognostic (1.67e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.17e-2)"	"prognostic unfavorable (1.35e-6)"	"unprognostic (7.23e-2)"	"unprognostic (9.29e-3)"	"unprognostic (1.06e-3)"	"unprognostic (2.14e-2)"	"unprognostic (2.12e-1)"	"prognostic unfavorable (7.02e-8)"	"unprognostic (8.14e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.10e-1)"	13.5	10.3	5.6	7.6	5.7	10.6	12.4	5.7	8.1	9.3	5.5	8.4	4.2	10.3	7.2	16.3	8.4	5.2	9.6	5.7	6.2	9.3	11.3	7.3	7.8	5.7	6.0	8.0	9.6	5.7	6.7	7.0	5.9	37.8	7.3	4.9	9.2	5.7	15.2	8.8	7.1	8.1	5.8	8.2	7.8	5.7	5.9	7.0	7.5	9.7	9.6	11.5	9.9	6.9	35.3	13.7	17.2	29.9	21.3	19.4	24.9	22.4	18.7	33.7	32.9	30.2	15.4	35.6	54.9	19.4	41.4	18.4	35.8	29.2	48.1	20.9	23.3	19.4	12.4	35.2	31.1	54.5	24.3	17.9	25.2	32.6	55.3	11.1	22.9	19.2	60.2	10.0	28.3	21.2	27.4	49.5	37.4	32.7	24.1	27.9	22.4	55.0	24.4	21.0	25.7	22.4	16.8	42.7	51.1	28.9	18.9	19.6	19.6	26.9	19.5	29.2	56.4	23.3	68.7	38.9	11.0	36.3	51.7	2.0	8.1	2.9	9.4	12.4	9.6	10.0	8.3	9.4	11.7	7.2	11.1	13.5	0.4	9.9	10.3	13.7	5.9	6.8	5.6	5.7	5.7	8.1	5.7	6.2	5.7	6.0	5.9	5.8	5.9	6.9	22.6	19.2	12.3	8.8	18.5	66.4	54.2	47.3	30.1	13.2	18.6	28.3	18.6	17.2	35.0	11.0	4.2	24.9	24.8	10.3	19.6	43.3	12.4	26.0	35.0	24.1	5.4	31.1	9.9	26.9	32.0	32.0	14.8	34.3	35.5	16.6	15.0	21.7	36.6	13.5	10.9	12.7	42.7	16.1	12.6	8.4	21.5	18.2	12.4	6.5	22.1	12.0	12.3	9.5	12.5	31.3	7.7	20.7	18.2	56.5	5.1	27.0	17.7	11.8	6.6	40.9	31.4	27.3	44.2	29.3	49.9	17.5	16.3	23.1	24.0	28.6
TMEM14C	"bA421M1.6, C6orf53, HSPC194, NET26"	ENSG00000111843	"Transmembrane protein 14C"	Q9P0S9	6	10722915-10731129	"Predicted membrane proteins"	"Heme biosynthesis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 3: Monocytes - Immune response regulation"				"unprognostic (4.08e-3)"	"unprognostic (1.10e-1)"	"unprognostic (2.82e-2)"	"unprognostic (3.53e-2)"	"unprognostic (3.77e-1)"	"unprognostic (4.61e-2)"	"prognostic unfavorable (3.66e-4)"	"unprognostic (2.83e-1)"	"unprognostic (2.38e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.32e-1)"	"unprognostic (5.93e-2)"	"unprognostic (3.39e-3)"	"unprognostic (1.84e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.34e-1)"	95.8	124.6	30.4	22.6	31.5	59.8	87.2	33.8	37.5	90.5	41.6	91.1	42.5	94.0	42.7	64.0	84.7	40.3	104.8	28.1	33.8	93.5	70.3	67.0	29.7	32.0	31.4	88.0	66.7	60.3	52.5	37.3	32.7	86.8	37.6	25.8	80.4	41.8	123.8	60.3	63.3	34.2	33.3	51.3	81.3	32.6	33.1	33.7	79.2	70.6	26.5	80.2	73.4	35.0	123.7	70.1	53.7	80.4	103.4	115.5	52.4	70.8	114.5	80.5	89.5	71.6	88.2	81.8	151.8	81.6	159.5	57.3	30.1	85.1	62.4	53.7	51.0	52.4	67.8	109.4	127.3	41.0	36.6	103.5	91.1	60.6	98.7	88.6	42.8	21.4	130.4	29.8	110.3	67.2	27.8	114.4	64.4	59.0	73.6	51.4	71.5	132.7	113.0	51.3	44.8	58.5	70.3	109.8	134.4	105.7	68.3	49.0	102.3	106.6	64.7	44.4	109.5	69.3	132.7	38.6	61.4	52.8	114.2	48.2	39.2	68.2	10.9	39.4	32.1	31.2	27.0	16.3	70.5	23.7	26.2	22.2	4.0	32.0	35.6	66.1	32.2	31.6	30.4	31.5	33.8	37.5	28.1	33.8	32.0	31.4	32.7	33.3	33.1	35.0	163.2	115.4	77.3	15.7	59.1	99.4	135.2	318.8	99.6	41.0	167.4	219.2	129.3	151.5	171.0	156.3	8.4	239.7	60.3	148.4	270.1	200.0	4.8	132.3	159.6	122.7	122.4	472.5	10.0	138.6	275.2	158.9	66.3	128.2	137.1	104.4	124.2	142.5	390.8	16.8	14.6	177.6	189.2	151.5	228.0	15.0	179.3	146.3	193.9	9.4	288.6	199.5	8.2	7.1	18.0	206.3	192.6	190.7	90.8	163.9	274.4	310.4	128.3	51.5	177.5	114.3	160.3	41.5	99.0	134.2	115.5	195.2	56.7	176.2	204.5	141.8
TMEM14B	MGC1223	ENSG00000137210	"Transmembrane protein 14B"	Q9NUH8	6	10747759-10852753	"Predicted membrane proteins"	Neurogenesis	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"																	NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"				"unprognostic (5.45e-3)"	"unprognostic (6.80e-2)"	"unprognostic (1.63e-1)"	"prognostic unfavorable (6.51e-4)"	"unprognostic (5.45e-1)"	"unprognostic (2.58e-3)"	"prognostic unfavorable (9.35e-5)"	"unprognostic (1.63e-1)"	"unprognostic (3.75e-3)"	"prognostic favorable (7.41e-4)"	"unprognostic (2.14e-1)"	"unprognostic (1.58e-1)"	"unprognostic (8.24e-2)"	"unprognostic (4.77e-2)"	"unprognostic (4.83e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.07e-1)"	78.4	101.1	58.2	45.0	60.6	186.3	74.8	62.9	81.2	51.8	77.6	60.3	53.7	46.5	78.0	47.4	72.0	48.7	132.8	59.8	60.6	81.9	91.0	45.2	70.9	61.1	59.3	50.1	64.3	77.3	40.3	41.5	60.5	65.5	58.8	151.6	86.1	44.1	146.5	46.0	59.2	42.6	61.0	42.2	64.4	27.5	60.4	78.6	128.1	141.5	57.5	52.2	41.4	63.6	376.2	155.9	72.9	106.7	80.0	102.8	106.4	77.9	136.6	163.8	193.2	153.8	171.8	130.8	187.1	93.1	375.9	81.8	65.5	135.1	253.4	89.3	89.6	107.9	123.1	235.2	120.0	163.2	102.1	83.6	76.7	174.6	174.9	92.3	91.6	120.1	267.2	54.1	135.0	134.7	144.4	182.0	110.1	198.6	118.9	120.1	97.1	304.9	198.7	91.7	117.9	88.0	95.7	188.6	251.3	139.0	132.3	145.0	91.7	120.0	150.0	82.3	268.6	128.4	289.4	175.7	98.5	92.4	190.1	178.1	112.1	161.2	86.1	109.8	121.5	121.7	120.7	100.1	136.3	114.7	130.3	111.5	64.4	117.0	122.3	168.6	141.0	154.9	58.2	60.6	62.9	81.2	59.8	60.6	61.1	59.3	60.5	61.0	60.4	63.6	103.2	80.1	77.2	21.5	95.4	82.0	92.1	169.9	90.5	85.5	157.9	206.8	141.4	144.4	113.8	88.3	60.5	177.1	89.7	94.1	365.9	183.3	18.9	190.4	73.2	83.5	80.5	399.9	19.9	220.9	183.0	97.0	68.3	101.9	82.4	90.2	70.6	156.3	210.0	107.7	21.2	143.2	130.2	121.0	132.6	53.5	96.3	110.1	120.9	9.4	265.8	239.0	52.5	17.1	18.1	261.3	102.5	75.2	102.5	145.8	142.0	309.5	247.6	196.1	26.3	95.6	92.8	46.5	129.9	103.9	100.7	105.9	99.4	133.3	164.3	109.0
MAK	"dJ417M14.2, RP62"	ENSG00000111837	"Male germ cell associated kinase"	P20794	6	10762723-10838553	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Differentiation, Spermatogenesis, Transcription, Transcription regulation"	"Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"	"Disease variant, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	22	"retina: 118.9"	"Group enriched"	"Detected in many"	5	"Cone photoreceptor cells: 369.1;Early spermatids: 119.7;Rod photoreceptor cells: 330.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			"Immune cell enriched"	"Detected in single"	9	"neutrophil: 6.3"	"Lineage enriched"	"Detected in single"	9	"granulocytes: 6.3"	"Cell line enhanced"	"Detected in single"		"HDLM-2: 1.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 79: Retina - Phototransduction"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 9: Photoreceptor cells - Phototransduction"				"unprognostic (1.23e-3)"	"unprognostic (8.77e-3)"	"unprognostic (2.44e-1)"	"unprognostic (3.81e-2)"	"unprognostic (6.62e-2)"	"unprognostic (1.35e-3)"	"unprognostic (1.97e-2)"	"unprognostic (2.53e-1)"	"unprognostic (3.21e-2)"	"unprognostic (2.42e-2)"	"unprognostic (1.13e-3)"	"unprognostic (6.73e-2)"	"unprognostic (6.59e-5)"	"unprognostic (1.55e-1)"	"unprognostic (8.40e-2)"	"unprognostic (7.71e-3)"	"unprognostic (4.59e-2)"	0.3	0.1	0.2	0.6	0.0	0.6	0.4	1.5	0.4	0.3	5.4	0.0	0.1	0.4	0.0	0.2	5.4	0.4	0.1	0.1	0.0	0.2	0.0	0.7	0.1	0.7	0.9	0.1	0.2	4.6	0.8	0.1	0.1	0.2	0.0	118.9	0.2	0.0	0.1	0.3	0.1	0.0	0.2	0.7	0.3	4.7	0.2	0.0	0.2	0.0	0.1	0.1	0.1	0.4	0.7	0.0	0.3	0.2	0.0	0.0	0.4	0.0	0.0	0.2	0.3	0.0	0.4	0.1	0.1	0.0	0.4	0.1	0.1	0.0	0.1	1.3	0.4	0.0	0.0	0.0	0.0	0.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.1	0.4	0.2	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.5	0.2	0.0	0.1	0.0	0.2	0.2	0.1	0.0	0.1	0.2	0.0	0.2	0.2	0.0	0.1	0.0	0.1	0.1	0.4	0.6	0.3	0.3	0.3	0.3	0.1	0.3	0.2	0.3	0.4	0.3	0.5	6.3	0.2	0.6	0.3	0.1	0.1	0.2	0.0	1.5	0.4	0.1	0.0	0.7	0.9	0.1	0.2	0.2	0.4	2.1	0.0	6.4	16.3	1.5	0.4	2.3	0.8	2.8	14.6	4.0	3.9	0.9	0.0	5.3	3.7	369.1	0.5	0.5	0.1	0.0	0.4	119.7	43.3	1.7	1.8	0.0	1.3	45.6	0.2	1.0	2.2	1.1	3.8	2.5	0.3	1.1	0.1	0.2	5.0	39.4	0.0	2.0	0.6	0.7	47.1	0.6	1.3	1.8	12.2	1.3	23.6	0.0	30.7	21.5	0.1	0.0	0.4	1.0	1.1	0.0	0.1	48.9	330.1	0.0	5.4	1.5	15.2	5.5	0.7	0.4	0.8	0.8	0.3	0.0	0.8
GCM2	"GCMB, hGCMb"	ENSG00000124827	"Glial cells missing transcription factor 2"	O75603	6	10873223-10882041	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	358	"parathyroid gland: 262.9"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 1.3;Early spermatids: 2.6;Excitatory neurons: 2.3;Inhibitory neurons: 1.7;Oligodendrocyte precursor cells: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA				"Cluster 48: Parathyroid gland - membrane proteins"		"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"								"unprognostic (1.55e-1)"					"unprognostic (4.94e-1)"				"unprognostic (2.18e-2)"	"unprognostic (7.17e-2)"	"unprognostic (2.63e-3)"		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	262.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.1	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SYCP2L	"C6orf177, dJ62D2.1, NO145"	ENSG00000153157	"Synaptonemal complex protein 2 like"	Q5T4T6	6	10886831-10979320	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	21	"parathyroid gland: 68.7"	"Group enriched"	"Detected in many"	4	"Astrocytes: 21.5;dendritic cells: 9.5;Early spermatids: 17.1;Excitatory neurons: 28.5;granulocytes: 10.8;Inhibitory neurons: 23.1;Microglial cells: 13.1;Oligodendrocyte precursor cells: 14.1;Oligodendrocytes: 12.4;Spermatogonia: 8.7"	"Cancer enhanced"	"Detected in single"		"testis cancer: 1.4"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	7	"basophil: 1.7;eosinophil: 3.4;plasmacytoid DC: 4.2"	"Group enriched"	"Detected in many"	17	"dendritic cells: 4.2;granulocytes: 3.4"	"Cell line enhanced"	"Detected in some"		"HL-60: 13.4;HMC-1: 38.7;K-562: 10.7;NB-4: 15.3;SuSa: 8.1;THP-1: 11.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA034679			Supported	Nucleoplasm		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm		"HPA034679: AB_10669729"	"unprognostic (3.25e-1)"	"unprognostic (2.58e-2)"	"unprognostic (3.23e-1)"	"unprognostic (3.72e-5)"	"unprognostic (2.20e-1)"	"unprognostic (1.21e-2)"	"unprognostic (5.57e-3)"	"unprognostic (4.23e-1)"	"unprognostic (6.03e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.40e-1)"	"unprognostic (3.04e-1)"	"unprognostic (1.21e-3)"	"unprognostic (1.07e-2)"	"unprognostic (1.86e-1)"	"unprognostic (3.85e-2)"	"unprognostic (2.74e-2)"	0.6	0.3	0.6	0.6	0.9	0.7	0.5	0.8	1.4	0.5	0.0	0.3	0.1	0.4	2.6	0.2	0.4	0.5	1.2	0.8	0.2	1.1	0.1	1.7	0.5	0.2	0.1	0.8	1.7	68.7	0.4	1.1	0.2	0.6	0.2	0.7	0.3	0.2	0.2	0.5	0.3	0.2	0.0	0.6	0.3	3.2	0.3	0.1	1.2	0.9	0.3	0.3	0.3	1.2	0.0	1.0	1.9	0.1	0.1	0.0	5.6	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	4.5	0.2	0.2	0.1	6.4	0.0	0.0	0.0	0.0	13.4	38.7	0.0	1.0	0.0	0.0	0.3	0.0	0.4	10.7	0.1	0.0	0.1	3.4	15.3	0.7	0.0	0.1	0.2	0.4	0.0	0.2	0.0	0.7	3.5	0.0	3.5	0.0	8.1	0.1	11.4	0.0	0.0	0.7	0.0	0.2	0.3	0.0	0.1	0.1	0.1	1.1	1.7	0.0	3.4	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.6	0.9	0.8	1.4	0.8	0.2	0.2	0.1	0.2	0.0	0.3	1.2	1.1	0.0	1.3	21.5	0.3	0.1	0.0	0.2	0.0	2.1	0.3	0.0	0.4	0.0	0.1	0.0	0.0	2.9	9.5	0.0	0.0	0.2	17.1	0.1	0.4	1.4	0.0	2.1	28.5	0.2	2.0	2.9	0.0	0.4	10.8	1.5	0.0	0.0	0.5	3.3	23.1	0.0	0.0	0.0	0.5	3.2	1.2	1.0	0.0	13.1	1.0	0.6	0.0	14.1	12.4	0.6	0.0	1.5	0.0	0.5	0.0	0.0	0.7	0.1	0.0	0.6	0.3	3.1	8.7	0.0	0.0	1.4	0.6	0.1	0.0	0.1
ELOVL2	Ssc2	ENSG00000197977	"ELOVL fatty acid elongase 2"	Q9NXB9	6	10980759-11044305	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 52.5;placenta: 35.3;retina: 27.9"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 95.0;Cone photoreceptor cells: 29.2;Extravillous trophoblasts: 19.7;Sertoli cells: 19.7;Spermatocytes: 23.0"	"Group enriched"	"Detected in many"	8	"breast cancer: 11.9;glioma: 25.8;liver cancer: 24.0;melanoma: 14.2;prostate cancer: 9.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+ RasG12V: 29.9;GAMG: 31.2;HBF TERT88: 29.0;Hep G2: 23.4;RH-30: 31.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA				"Cluster 15: Liver - Metabolism"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 33: Fibroblasts - ECM organization"				"prognostic favorable (6.73e-5)"	"unprognostic (4.20e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.28e-5)"	"unprognostic (4.06e-2)"	"unprognostic (4.09e-3)"	"unprognostic (1.89e-1)"	"unprognostic (5.73e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.56e-1)"	"unprognostic (6.92e-3)"	"unprognostic (1.78e-2)"	"unprognostic (1.04e-12)"	"unprognostic (9.98e-4)"	"unprognostic (8.86e-2)"	"unprognostic (3.41e-1)"	"unprognostic (9.47e-2)"	1.2	0.9	8.6	1.5	10.7	0.0	4.8	10.0	13.9	0.2	4.0	0.5	0.2	0.5	2.3	0.4	0.2	0.6	3.2	9.0	8.8	0.2	52.5	0.2	0.5	10.6	9.3	0.2	2.6	9.7	2.9	35.3	9.8	5.3	0.1	27.9	0.7	0.4	1.0	0.2	0.3	0.7	9.6	0.0	0.1	11.5	8.8	1.1	1.8	0.9	0.9	2.0	0.1	14.1	0.0	5.3	20.1	0.0	0.0	0.0	11.5	0.4	1.0	17.7	29.9	0.0	0.0	0.0	0.0	1.1	31.2	0.0	21.3	0.0	29.0	0.0	18.2	0.1	0.4	23.4	0.9	0.4	4.8	0.2	0.0	13.7	0.0	1.0	0.0	0.9	1.2	0.0	0.4	0.1	12.1	0.2	3.8	0.0	17.4	16.6	31.8	0.0	0.0	0.3	8.0	9.1	0.0	0.0	7.5	16.1	3.7	9.3	0.0	0.0	0.0	0.0	7.4	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.6	10.7	10.0	13.9	9.0	8.8	10.6	9.3	9.8	9.6	8.8	14.1	0.5	0.0	0.0	95.0	0.1	0.1	0.0	0.0	0.0	2.2	7.8	1.3	1.2	8.6	0.0	0.0	29.2	2.3	0.0	0.0	0.0	7.2	10.1	0.0	0.5	1.9	0.0	0.0	2.5	1.0	19.7	8.0	0.0	0.0	0.0	0.3	0.0	17.5	1.2	0.0	5.9	0.0	0.0	0.0	0.0	14.9	0.9	0.1	0.0	6.5	0.0	4.9	0.0	4.5	16.8	1.0	0.0	0.4	0.0	1.9	0.0	0.1	0.0	11.8	19.7	0.1	3.9	23.0	8.9	0.2	0.0	1.6	0.1	0.0	0.0	0.1
SMIM13	C6orf228	ENSG00000224531	"Small integral membrane protein 13"	P0DJ93	6	11093834-11138733	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 75.1;Syncytiotrophoblasts: 65.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA065706	Enhanced		Approved	"Nucleoplasm,Nuclear membrane,Golgi apparatus"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 15: Liver - Metabolism"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	"Nucleoplasm, Nuclear membrane, Golgi apparatus"		"HPA065706: AB_2685539"	"unprognostic (6.89e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.58e-1)"	"unprognostic (7.11e-3)"	"unprognostic (4.01e-1)"	"unprognostic (2.57e-1)"	"unprognostic (3.59e-2)"	"unprognostic (2.10e-2)"	"unprognostic (2.15e-1)"	"unprognostic (6.66e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.37e-1)"	"prognostic unfavorable (1.03e-5)"	"unprognostic (1.04e-2)"	"unprognostic (2.76e-1)"	"unprognostic (9.22e-2)"	"unprognostic (3.45e-2)"	4.7	4.6	15.4	3.4	16.1	2.9	3.4	21.4	23.8	4.3	5.6	4.1	3.6	5.0	3.4	4.8	2.9	4.1	6.6	16.7	18.0	4.3	9.7	3.5	3.0	17.6	16.7	4.1	3.0	6.4	4.1	12.7	19.3	4.6	3.6	17.1	3.7	4.8	11.5	4.9	3.1	5.2	15.8	2.9	3.1	3.4	20.0	3.4	3.0	14.2	3.0	4.9	3.7	19.4	9.9	8.3	12.6	10.6	12.7	14.4	13.2	26.7	11.3	13.4	14.9	11.1	3.1	12.1	35.9	8.6	13.3	8.6	26.3	9.3	24.0	7.1	19.1	12.7	9.1	8.8	16.9	23.8	2.9	17.4	25.5	13.7	18.0	10.6	14.4	11.0	18.3	5.0	25.7	5.4	10.1	14.0	5.9	6.5	7.1	13.5	23.1	17.2	8.2	7.6	29.4	16.3	5.6	18.2	32.4	17.2	4.6	9.9	20.7	20.3	15.0	8.6	18.1	9.5	33.0	17.1	4.8	9.9	31.8	0.3	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.4	0.1	0.0	15.4	16.1	21.4	23.8	16.7	18.0	17.6	16.7	19.3	15.8	20.0	19.4	14.3	12.8	1.5	12.4	9.1	75.1	17.1	13.7	10.8	16.4	10.6	10.3	12.7	12.8	5.2	11.0	20.9	29.3	14.4	5.7	3.9	5.2	10.3	11.8	15.6	11.4	3.6	11.8	26.8	7.4	36.6	11.9	6.1	12.0	10.8	4.2	7.9	25.6	13.5	30.3	31.4	8.1	10.2	8.1	29.4	4.3	2.8	12.0	16.0	10.3	6.3	7.6	7.2	18.6	28.0	10.5	3.1	4.1	14.6	18.8	5.8	7.8	4.6	15.2	0.0	7.7	9.8	16.8	24.8	12.7	39.5	65.1	12.9	10.4	8.7	16.2
ERVFRD-1	"envFRD, ERVFRDE1, HERV-FRD, HERV-W/FRD, syncytin-2"	ENSG00000244476	"Endogenous retrovirus group FRD member 1, envelope"	P60508	6	11102489-11111725	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"placenta: 37.0"	"Cell type enriched"	"Detected in some"	56	"Syncytiotrophoblasts: 575.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"SuSa: 38.8"									HPA011812			Uncertain	"Nucleoplasm,Plasma membrane,Actin filaments,Cytosol"		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 28: Placenta - Pregnancy"	"Cluster 12: NES - Nervous system development"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	"Plasma membrane, Actin filaments"	"Nucleoplasm, Cytosol"	"HPA011812: AB_1857702"	"unprognostic (1.99e-1)"	"unprognostic (3.29e-4)"	"unprognostic (4.75e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.19e-3)"	"unprognostic (3.35e-1)"	"unprognostic (6.44e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.30e-2)"	"unprognostic (2.78e-3)"	"unprognostic (5.80e-4)"	"unprognostic (3.40e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.95e-2)"	"unprognostic (1.37e-2)"	0.3	0.4	0.6	0.1	0.4	0.2	0.4	1.8	0.6	0.4	0.0	0.3	0.5	0.3	1.0	0.3	0.2	0.4	0.1	0.6	0.7	0.5	0.2	0.6	0.0	0.6	0.4	0.0	0.0	7.5	0.0	37.0	0.5	0.3	0.2	0.2	0.2	0.2	0.0	0.5	0.5	0.2	0.1	0.0	0.3	0.1	0.6	0.4	0.0	0.4	0.0	0.5	0.2	0.6	0.0	0.1	0.0	0.0	0.0	0.0	9.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	38.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.6	0.4	1.8	0.6	0.6	0.7	0.6	0.4	0.5	0.1	0.6	0.6	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.6	0.0	0.6	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.1	0.3	0.0	0.0	10.1	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.1	0.0	0.0	0.0	575.5	0.4	0.5	0.0	0.0
NEDD9	"CAS-L, CASS2, HEF1"	ENSG00000111859	"Neural precursor cell expressed, developmentally down-regulated 9"	Q14511	6	11183298-11382348	"Plasma proteins, Predicted intracellular proteins"	"Cell adhesion, Cell cycle, Cell division, Growth regulation, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Adipocytes: 323.2;Alveolar cells type 1: 471.1;Glandular and luminal cells: 337.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"EFO-21: 137.3;HSkMC: 67.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA009689, CAB009720, HPA038768, HPA039270, HPA072955"	Uncertain		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	Yes			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 44: Endometrium - Transcription"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"CAB009720: , HPA009689: , HPA038768: AB_2676196, HPA039270: AB_2676422, HPA072955: "	"unprognostic (2.83e-3)"	"unprognostic (2.33e-2)"	"unprognostic (1.08e-2)"	"unprognostic (6.93e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.62e-1)"	"unprognostic (9.54e-2)"	"unprognostic (3.05e-2)"	"unprognostic (2.09e-1)"	"unprognostic (2.90e-1)"	"unprognostic (1.64e-1)"	"unprognostic (5.59e-3)"	"unprognostic (2.25e-2)"	"unprognostic (2.37e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.05e-1)"	94.7	8.6	8.3	23.3	8.1	8.6	64.2	6.4	12.3	26.6	14.4	30.7	15.5	19.2	17.5	14.5	22.7	31.4	32.7	7.7	6.4	33.8	20.7	91.9	25.8	8.3	7.3	8.3	17.1	9.5	8.1	69.2	8.5	22.4	30.2	9.8	26.7	29.8	27.2	20.6	38.1	25.8	7.4	25.2	23.5	6.9	9.7	22.2	25.6	12.0	22.2	34.5	15.3	7.9	4.4	29.0	26.4	0.4	17.7	2.3	27.7	6.6	8.2	12.2	22.4	9.3	1.9	9.2	137.3	14.7	1.5	12.6	36.0	13.5	15.8	4.1	1.0	0.8	4.4	62.3	8.3	10.1	0.4	67.7	4.0	7.9	1.3	4.4	21.0	0.8	0.1	7.6	27.7	1.3	5.8	4.0	4.1	34.6	2.9	1.6	0.7	5.4	6.1	39.8	0.6	4.8	1.1	31.2	55.5	29.3	2.3	7.7	53.8	8.2	14.3	0.8	16.5	7.8	34.8	11.4	0.2	7.9	36.6	24.2	13.3	37.3	18.3	28.5	14.7	10.9	12.2	17.5	14.1	12.3	6.4	9.9	80.9	12.3	50.6	8.7	12.1	17.1	8.3	8.1	6.4	12.3	7.7	6.4	8.3	7.3	8.5	7.4	9.7	7.9	323.2	471.1	135.1	11.1	34.9	60.5	235.6	83.5	98.4	4.7	43.1	38.0	14.2	50.1	89.0	44.1	25.0	56.3	45.9	103.4	9.8	62.0	8.2	244.8	24.8	148.1	108.3	2.5	18.2	19.8	42.6	37.2	107.6	337.0	64.5	15.7	86.7	21.6	14.7	10.1	11.3	108.4	12.2	29.8	28.9	4.3	7.5	51.4	24.9	34.7	15.4	84.1	64.9	8.0	4.9	69.1	43.6	29.0	34.8	66.1	100.5	26.7	64.4	12.4	26.3	8.8	30.0	2.1	1.1	11.4	20.6	42.8	59.4	37.2	46.6	90.3
TMEM170B		ENSG00000205269	"Transmembrane protein 170B"	Q5T4T1	6	11537749-11583524	"Predicted membrane proteins"	"Wnt signaling pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 25.2"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 39.2;Excitatory neurons: 57.3;Inhibitory neurons: 52.3;Kupffer cells: 36.8;Macrophages: 31.5;monocytes: 45.8;Oligodendrocyte precursor cells: 31.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"THP-1: 22.1;U-937: 16.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055134	Uncertain		Approved	Centrosome		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 32: U-937 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Centrosome		"HPA055134: AB_2682709"	"unprognostic (1.32e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.71e-4)"	"unprognostic (6.67e-2)"	"unprognostic (2.51e-1)"	"unprognostic (2.43e-1)"	"unprognostic (4.62e-3)"	"unprognostic (8.22e-2)"	"unprognostic (6.82e-2)"	"unprognostic (2.45e-5)"	"unprognostic (3.49e-1)"	"unprognostic (1.26e-1)"	"unprognostic (4.27e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.56e-4)"	"unprognostic (3.97e-2)"	7.0	2.8	8.1	4.3	9.0	25.2	2.3	8.6	10.7	1.6	2.2	2.3	0.7	2.4	3.1	1.3	1.6	1.7	2.1	10.2	6.9	3.7	8.7	3.8	1.7	8.4	7.7	2.2	1.9	2.9	2.7	2.5	9.1	1.9	1.1	9.5	1.5	2.0	6.2	0.9	1.2	2.9	6.8	3.9	1.5	3.4	7.7	1.9	2.6	7.3	1.2	1.5	0.9	7.4	0.9	1.5	8.8	7.9	1.6	0.1	1.8	0.8	2.0	1.2	1.4	0.5	0.5	7.3	4.0	0.5	2.3	0.0	10.0	0.6	3.1	2.1	5.3	4.1	1.0	1.2	0.5	6.6	4.1	0.6	0.1	1.3	0.0	2.0	0.8	6.7	0.2	0.1	1.8	1.3	8.0	11.3	2.5	0.8	1.2	4.1	8.4	1.2	0.9	1.8	6.0	5.1	0.5	2.9	3.3	12.4	2.9	22.1	0.1	1.6	1.9	3.2	2.1	6.3	13.4	6.4	1.4	16.6	2.2	0.9	0.8	0.5	0.0	0.5	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.3	0.0	0.2	0.9	0.0	0.1	8.1	9.0	8.6	10.7	10.2	6.9	8.4	7.7	9.1	6.8	7.7	7.4	2.7	3.2	2.0	39.2	2.9	1.8	0.6	0.2	0.6	13.2	2.2	1.8	6.5	1.5	1.5	0.0	4.2	2.1	11.8	0.5	5.9	0.6	0.5	1.9	1.8	2.3	1.8	0.8	57.3	1.4	0.3	2.3	0.5	2.1	1.3	5.1	2.2	8.4	7.0	25.2	52.3	0.3	0.0	36.8	13.2	0.4	0.9	31.5	0.0	21.5	45.8	13.7	2.1	31.7	27.1	0.9	0.3	1.5	0.5	1.1	0.0	5.4	0.1	8.3	6.6	4.1	3.7	7.5	4.8	0.2	0.9	1.9	1.4	1.7	0.8	0.5
ADTRP	"AIG1L, C6orf105, dJ413H6.1"	ENSG00000111863	"Androgen dependent TFPI regulating protein"	Q96IZ2	6	11712054-11807046	"Predicted membrane proteins"	"Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 98.5;parathyroid gland: 92.9"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 116.4;Distal tubular cells: 52.8;Early spermatids: 141.6;Late spermatids: 168.0;Paneth cells: 87.0;Proximal enterocytes: 127.0;Undifferentiated cells: 52.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"naive CD4 T-cell: 14.8;T-reg: 13.5"	"Lineage enriched"	"Detected in many"	5	"T-cells: 14.8"	"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 93.9;RPMI-8226: 41.2;TIME: 57.7;U-138 MG: 42.4;U-266/84: 47.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA048113	Uncertain		Uncertain	Nucleoli		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 56: Intestine - Transmembrane transport"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 45: Enterocytes - Digestion"	Nucleoli		"HPA048113: AB_2680268"	"unprognostic (6.82e-3)"	"unprognostic (1.41e-1)"	"unprognostic (1.58e-1)"	"unprognostic (8.14e-3)"	"unprognostic (3.04e-3)"	"unprognostic (1.41e-2)"	"unprognostic (4.00e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.85e-2)"	"unprognostic (2.72e-1)"	"unprognostic (5.41e-3)"	"unprognostic (2.90e-1)"	"prognostic unfavorable (1.13e-5)"	"unprognostic (2.61e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.95e-2)"	"unprognostic (1.26e-1)"	0.5	0.2	1.9	14.2	2.1	1.1	3.3	0.6	2.2	0.4	35.2	80.7	82.4	0.3	13.7	1.5	0.6	1.6	0.3	2.0	0.0	9.8	1.4	11.1	9.4	0.1	0.1	0.2	0.8	92.9	0.0	2.4	0.1	0.4	58.5	0.6	0.8	24.4	1.0	18.9	98.5	2.6	0.1	1.3	38.2	22.6	0.4	2.6	0.5	0.1	12.7	10.2	0.3	1.1	4.1	0.0	0.0	0.0	0.5	0.9	0.1	1.5	0.8	1.0	0.7	3.6	1.9	0.1	1.7	0.7	2.4	1.9	0.0	11.2	1.4	0.1	0.0	0.3	0.8	0.1	0.3	0.1	0.2	0.0	20.4	10.4	23.6	17.5	93.9	0.7	23.0	0.0	3.1	0.1	0.2	0.6	0.3	0.1	5.8	0.0	0.3	41.2	1.7	0.2	0.1	0.2	1.5	0.0	0.8	2.8	0.0	0.8	57.7	42.4	2.0	0.7	2.6	1.2	47.1	0.0	7.9	1.3	0.2	2.7	0.0	0.0	0.0	0.3	2.6	0.2	3.7	0.3	0.1	0.2	14.8	1.3	0.3	0.1	0.2	0.2	13.5	1.7	1.9	2.1	0.6	2.2	2.0	0.0	0.1	0.1	0.1	0.1	0.4	1.1	0.2	0.0	1.1	0.7	4.0	5.1	0.3	3.9	0.6	0.0	0.1	1.9	0.1	0.0	2.6	5.5	0.0	0.2	0.1	116.4	52.8	0.7	141.6	0.2	0.0	0.3	5.4	2.7	13.1	2.4	0.2	1.1	32.1	0.1	5.7	0.0	0.0	0.2	11.4	0.0	0.4	40.7	2.0	0.8	1.5	168.0	1.8	3.1	1.8	0.0	27.9	0.0	1.0	1.0	0.1	7.9	87.0	0.7	7.8	0.6	127.0	0.7	0.8	0.0	0.0	0.2	1.2	1.6	0.7	0.4	5.7	0.1	6.2	0.0	52.3	0.5
HIVEP1	"CIRIP, CRYBP1, MBP-1, PRDII-BF1, Schnurri-1, ZAS1, ZNF40, ZNF40A"	ENSG00000095951	"HIVEP zinc finger 1"	P15822	6	12008762-12164999	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 94.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050724, HPA067457"	Approved		Supported	"Nucleoplasm,Nuclear bodies,Mitochondria,Cytosol"		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 16: U-266 - Nucleosome"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Nucleoplasm	"Nuclear bodies, Mitochondria, Cytosol"	"HPA050724: AB_2616457, HPA067457: "	"unprognostic (2.55e-1)"	"unprognostic (5.85e-2)"	"unprognostic (1.15e-1)"	"unprognostic (6.03e-2)"	"unprognostic (1.75e-2)"	"unprognostic (5.65e-3)"	"unprognostic (4.83e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.85e-1)"	"unprognostic (5.69e-2)"	"unprognostic (1.98e-1)"	"unprognostic (4.40e-2)"	"unprognostic (3.01e-2)"	"unprognostic (2.21e-1)"	"unprognostic (4.49e-2)"	"unprognostic (2.38e-1)"	7.2	2.3	0.8	8.0	3.0	16.7	5.5	0.7	3.0	7.4	6.5	6.4	5.0	5.9	4.5	7.4	6.1	7.3	3.8	2.2	0.8	4.5	11.7	6.3	8.0	1.3	2.8	6.5	6.7	10.5	3.3	4.9	0.5	6.9	6.6	5.8	4.8	5.8	2.8	5.7	5.2	6.2	0.0	6.0	4.9	4.8	1.2	9.1	4.9	6.2	8.3	9.3	3.3	1.6	8.1	5.9	7.5	4.2	5.8	7.3	7.2	6.4	5.5	5.2	5.7	3.8	4.2	6.7	13.6	7.8	12.4	7.6	7.4	9.2	7.1	14.6	4.3	3.1	5.6	3.7	4.7	3.7	2.5	5.1	9.0	10.6	16.3	11.0	15.5	4.6	32.9	7.5	11.5	6.0	5.9	3.3	6.4	2.8	2.7	3.2	9.8	10.7	3.1	8.7	7.1	5.2	15.9	12.8	4.3	16.6	7.6	4.7	25.2	13.0	5.8	12.3	7.4	30.0	27.3	12.0	4.0	4.8	5.5	2.4	1.8	2.1	1.2	2.0	0.9	3.1	2.0	0.8	1.2	4.8	3.4	2.1	11.7	3.3	5.2	9.0	4.4	0.7	0.8	3.0	0.7	3.0	2.2	0.8	1.3	2.8	0.5	0.0	1.2	1.6	40.2	28.9	16.9	74.7	35.6	32.2	25.4	7.4	30.7	20.4	12.3	10.9	10.4	17.2	17.6	7.3	12.5	3.4	18.7	17.5	3.9	5.6	2.5	37.7	16.4	20.3	10.8	6.5	94.6	7.2	1.8	25.2	22.4	51.0	7.6	7.0	6.4	12.3	5.9	21.9	68.3	14.4	4.1	9.6	47.9	1.8	3.7	23.1	19.6	44.0	29.6	13.1	5.2	59.3	25.0	11.5	10.3	4.5	33.6	25.2	6.7	2.5	16.7	9.7	0.0	21.0	17.1	3.9	3.5	18.7	33.4	5.2	18.8	6.6	8.6	23.7
EDN1	ET1	ENSG00000078401	"Endothelin 1"	P05305	6	12290361-12297194	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"		"Vasoactive, Vasoconstrictor"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 44.6"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 749.7;Ductal cells: 316.3;Glandular and luminal cells: 289.7;Pancreatic endocrine cells: 268.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	6	"non-classical monocyte: 4.9"	"Lineage enriched"	"Detected in single"	6	"monocytes: 4.9"	"Cell line enhanced"	"Detected in many"		"EFO-21: 660.4;HUVEC TERT2: 446.8;T-47d: 137.5;TIME: 334.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA031976, CAB032500, CAB037291"	Approved		Approved	"Nucleoplasm,Nucleoli,Golgi apparatus"	"Secreted to blood"	NA	Yes	9740		"Cluster 14: Monocytes - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 22: Epithelial cell types - Mixed function"	"Nucleoli, Golgi apparatus"	Nucleoplasm	"CAB032500: AB_2096241, CAB037291: AB_259277, HPA031976: AB_10602489"	"unprognostic (1.51e-2)"	"unprognostic (2.38e-1)"	"unprognostic (3.95e-2)"	"unprognostic (9.72e-2)"	"unprognostic (3.40e-1)"	"unprognostic (1.91e-1)"	"unprognostic (6.24e-2)"	"unprognostic (2.94e-3)"	"unprognostic (1.42e-1)"	"unprognostic (8.92e-2)"	"unprognostic (4.19e-2)"	"unprognostic (3.17e-1)"	"unprognostic (8.02e-3)"	"unprognostic (2.09e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.47e-1)"	44.6	1.8	14.7	7.3	13.8	4.7	23.6	13.6	18.2	6.2	9.7	10.6	10.4	7.0	6.3	12.1	9.4	13.5	7.8	12.6	12.2	7.7	3.1	36.6	5.6	15.1	13.6	2.6	9.6	1.4	1.1	18.5	15.2	5.5	14.5	1.0	12.1	8.9	7.6	11.8	9.8	11.3	13.1	12.3	10.4	4.7	15.7	1.7	3.4	6.4	2.4	9.9	5.9	14.2	10.3	57.6	1.1	0.1	0.3	0.2	0.2	18.2	16.0	15.0	12.4	74.6	8.6	0.0	660.4	7.2	9.2	5.4	0.0	10.6	11.0	0.8	0.0	0.0	2.1	2.3	0.8	0.0	0.0	0.4	6.2	3.0	2.1	4.7	446.8	0.0	0.0	0.0	56.8	1.6	0.2	0.3	0.6	10.4	0.7	0.2	5.1	0.1	35.3	9.4	0.6	0.0	1.8	53.1	0.1	117.2	137.5	0.8	334.3	37.1	30.1	0.7	23.5	0.3	0.4	1.3	0.3	0.0	1.6	0.0	0.0	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	4.9	0.1	0.0	0.0	14.7	13.8	13.6	18.2	12.6	12.2	15.1	13.6	15.2	13.1	15.7	14.2	190.7	173.1	23.8	2.9	0.8	189.9	749.7	99.9	151.4	0.2	68.7	26.8	2.2	8.6	110.6	38.6	0.0	1.8	0.8	189.7	3.9	316.3	13.3	187.2	16.3	236.8	15.6	2.7	3.6	218.9	0.4	9.0	22.4	289.7	1.3	0.8	169.2	1.8	1.8	1.7	3.0	43.8	12.2	5.0	6.7	19.8	5.6	5.3	8.8	6.5	10.9	0.3	0.0	3.5	0.6	268.5	145.7	0.4	0.4	185.8	119.6	8.3	27.4	0.4	6.6	1.8	21.8	1.0	0.6	53.7	64.5	0.8	9.7	0.1	196.6	141.8
PHACTR1	"dJ257A7.2, KIAA1733, RPEL1"	ENSG00000112137	"Phosphatase and actin regulator 1"	Q9C0D0	6	12716554-13287843	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		"Actin-binding, Protein phosphatase inhibitor"	Epilepsy	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 38.0;brain: 52.1"	"Group enriched"	"Detected in many"	4	"Excitatory neurons: 1954.8;Inhibitory neurons: 523.7"	"Cancer enriched"	"Detected in many"	5	"melanoma: 10.2"	"Group enriched"	"Detected in many"	6	"basal ganglia: 52.1;cerebral cortex: 27.3;hippocampal formation: 14.8"	"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 37.8"	"Group enriched"	"Detected in many"	18	"B-cells: 13.6;dendritic cells: 37.8;granulocytes: 18.7"	"Cell line enhanced"	"Detected in many"		"HMC-1: 74.6;SK-MEL-30: 79.5;U-266/70: 176.1;U-266/84: 133.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029755, HPA029756, HPA029757"	Enhanced		Uncertain	"Plasma membrane"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane"		"HPA029755: AB_10600089, HPA029756: AB_10601852, HPA029757: AB_10669870"	"unprognostic (7.86e-2)"	"unprognostic (7.49e-2)"	"unprognostic (2.74e-2)"	"unprognostic (2.80e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.29e-1)"	"unprognostic (7.72e-2)"	"unprognostic (4.80e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.22e-1)"	"unprognostic (3.67e-4)"	"unprognostic (1.53e-1)"	"prognostic unfavorable (5.48e-6)"	"unprognostic (1.31e-1)"	"unprognostic (1.43e-1)"	"unprognostic (5.00e-2)"	"unprognostic (1.16e-1)"	5.1	2.0	4.3	12.6	52.1	38.0	1.5	0.0	27.3	1.1	0.0	2.0	2.8	1.1	2.5	1.7	2.4	6.0	18.1	14.8	0.0	7.5	2.6	13.9	14.9	0.0	0.0	1.6	6.0	0.4	4.0	2.6	0.0	1.1	2.0	7.8	1.0	0.7	0.4	3.3	3.0	2.5	0.0	11.2	3.7	1.9	0.0	3.5	1.1	0.7	23.9	4.1	1.0	5.4	0.2	0.3	4.5	0.3	0.0	0.1	14.7	1.5	5.0	4.1	7.7	0.3	0.3	0.9	1.2	0.6	6.4	0.3	0.0	0.2	5.3	17.3	0.6	39.5	0.6	0.2	0.5	38.1	74.6	1.7	0.1	0.0	0.7	0.3	6.2	2.1	18.6	31.1	4.1	0.0	0.4	22.4	5.1	0.0	0.0	17.7	10.2	2.9	2.9	0.5	18.3	5.8	0.1	9.9	79.5	6.1	21.2	8.6	6.8	0.6	1.1	0.0	0.4	176.1	133.7	33.5	2.3	9.8	26.0	0.2	1.3	1.5	0.1	1.1	0.1	9.9	0.1	0.0	6.7	13.6	0.0	0.1	18.7	0.1	0.9	37.8	0.0	0.9	4.3	52.1	0.0	27.3	14.8	0.0	0.0	0.0	0.0	0.0	0.0	5.4	12.6	67.3	48.5	265.1	131.6	3.7	1.4	0.8	1.2	43.5	2.1	3.9	10.4	4.3	8.3	62.5	4.2	1.4	79.4	0.7	31.3	0.7	59.9	5.5	2.8	12.9	1.8	13.7	1954.8	2.9	2.3	8.6	0.5	15.0	81.2	2.7	13.6	1.1	83.1	180.0	523.7	0.2	0.0	138.2	91.5	79.8	4.7	188.5	48.0	114.3	20.5	28.4	6.2	186.5	247.8	0.8	0.2	6.4	59.6	1.0	0.3	1.0	5.1	14.0	0.0	4.0	4.3	2.0	4.8	2.1	3.1	1.9	8.6	6.6	1.0	0.8
TBC1D7	"dJ257A7.3, FLJ32666"	ENSG00000145979	"TBC1 domain family member 7"	Q9P0N9	6	13266542-13328583	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Cancer enhanced"	"Detected in all"		"melanoma: 13.9"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-MEL-30: 320.4;U-266/84: 174.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034748	Approved					NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 10: Non-specific - Unknown function"			"HPA034748: AB_10671232"	"unprognostic (9.53e-2)"	"unprognostic (8.39e-2)"	"unprognostic (3.18e-1)"	"unprognostic (1.81e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.46e-1)"	"unprognostic (3.95e-3)"	"unprognostic (5.54e-2)"	"unprognostic (9.30e-2)"	"prognostic favorable (4.98e-5)"	"unprognostic (4.36e-2)"	"unprognostic (1.66e-1)"	"prognostic unfavorable (2.03e-7)"	"unprognostic (1.57e-1)"	"unprognostic (3.46e-2)"	"unprognostic (3.48e-1)"	"unprognostic (2.78e-2)"	9.4	12.0	14.3	9.7	15.9	26.5	11.5	13.0	26.3	10.8	9.9	15.2	14.5	8.4	20.0	17.1	6.6	10.3	31.7	14.3	12.9	21.4	17.5	11.0	13.9	11.8	11.6	7.7	10.2	12.4	10.7	14.4	13.4	12.4	16.5	11.5	12.2	7.0	16.2	13.8	10.8	10.1	10.7	12.3	9.8	14.0	12.7	16.9	8.0	14.5	15.6	10.0	11.4	15.8	26.2	25.5	36.0	36.8	27.5	15.7	24.9	11.5	13.3	24.0	26.8	51.8	23.0	18.1	75.0	19.3	55.8	20.8	24.5	29.0	21.9	28.4	29.1	50.3	16.5	45.8	63.6	32.7	73.6	21.4	40.6	29.7	19.3	24.0	40.5	57.2	57.3	23.7	30.8	42.8	42.2	78.5	24.4	32.4	24.6	61.7	15.7	77.7	54.1	35.1	69.4	30.8	28.4	55.4	320.4	71.3	53.6	19.1	29.4	24.6	30.8	13.6	16.2	55.8	174.2	86.2	23.1	34.1	51.1	28.2	21.6	27.0	11.6	20.0	7.6	15.4	9.9	10.5	43.3	14.5	9.1	11.1	42.2	21.4	13.7	42.2	14.6	10.4	14.3	15.9	13.0	26.3	14.3	12.9	11.8	11.6	13.4	10.7	12.7	15.8	11.0	12.8	13.9	3.9	16.2	7.5	9.9	37.2	11.4	6.5	15.7	20.6	30.6	15.7	28.8	16.5	4.2	41.0	15.0	12.9	33.2	16.4	8.1	15.2	12.7	12.4	9.0	57.4	8.4	14.3	23.3	9.9	15.8	15.7	9.5	14.4	12.1	15.2	24.2	10.1	9.5	18.3	50.8	12.9	23.0	5.8	4.4	31.3	10.6	4.7	13.9	8.9	13.4	6.6	7.3	22.2	18.3	5.3	21.9	11.6	13.1	56.1	16.4	8.0	13.1	5.6	20.2	14.7	34.3	21.7	8.9	46.9	11.3	14.4	16.4	13.4
GFOD1	"ADG-90, C6orf114, FLJ20330"	ENSG00000145990	"Glucose-fructose oxidoreductase domain containing 1"	Q9NXC2	6	13357830-13487662	"Predicted intracellular proteins, Predicted secreted proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 26.1"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 100.9;Cardiomyocytes: 108.2;Excitatory neurons: 133.2;Inhibitory neurons: 106.2;NK-cells: 142.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"eosinophil: 15.5;NK-cell: 13.1"	"Group enriched"	"Detected in many"	5	"granulocytes: 15.5;NK-cells: 13.1"	"Cell line enhanced"	"Detected in many"		"HEL: 30.5;HMC-1: 46.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029096	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"	"Secreted - unknown location"	No	No			"Cluster 49: Eosinophils - Unknown function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA029096: AB_10602320"	"unprognostic (5.00e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.08e-1)"	"prognostic unfavorable (2.29e-5)"	"unprognostic (8.49e-2)"	"unprognostic (1.95e-3)"	"unprognostic (1.36e-2)"	"unprognostic (2.81e-1)"	"unprognostic (2.34e-2)"	"unprognostic (3.11e-2)"	"unprognostic (6.49e-2)"	"unprognostic (1.15e-1)"	"prognostic unfavorable (6.72e-5)"	"unprognostic (9.79e-2)"	"unprognostic (1.61e-1)"	"unprognostic (3.56e-1)"	"unprognostic (4.66e-3)"	10.5	2.0	14.3	2.8	21.6	12.7	9.6	11.2	26.1	5.0	0.0	6.2	1.8	3.6	0.8	8.6	4.4	4.3	16.7	24.5	3.7	2.3	7.2	9.7	4.3	3.0	1.5	1.5	1.5	1.7	3.5	3.9	2.3	4.0	2.8	2.1	3.6	1.4	12.0	5.5	6.5	4.9	0.6	8.8	7.9	0.6	2.5	3.0	2.7	9.7	4.2	6.2	5.8	16.9	12.5	1.3	1.0	2.1	1.7	1.8	1.3	1.0	0.5	0.7	0.4	0.4	0.9	16.8	16.6	1.2	1.0	10.9	3.4	5.4	0.7	1.2	6.0	30.5	7.2	6.6	2.4	9.0	46.3	0.9	4.1	1.6	4.5	2.6	9.5	4.5	0.9	1.5	1.3	4.1	2.0	5.2	1.8	4.3	3.3	6.9	2.1	8.8	0.6	2.4	5.5	1.0	4.0	0.7	4.0	2.1	0.9	0.9	12.2	1.6	3.2	3.5	5.6	13.4	8.3	19.8	1.4	5.3	0.4	0.2	0.4	15.5	1.5	0.9	0.2	2.7	0.2	0.7	0.2	1.9	0.1	0.5	0.3	13.1	0.9	0.1	0.1	1.0	14.3	21.6	11.2	26.1	24.5	3.7	3.0	1.5	2.3	0.6	2.5	16.9	100.9	0.0	1.8	33.0	14.3	20.3	4.9	14.5	19.9	43.8	7.4	3.7	108.2	10.0	14.4	0.0	0.0	1.5	46.1	18.2	0.0	5.3	0.1	3.8	1.0	49.0	8.4	31.2	133.2	3.1	34.7	9.1	2.0	8.0	4.5	0.2	51.4	19.5	2.5	1.7	106.2	11.2	8.2	15.7	31.3	0.3	2.5	21.4	12.4	42.2	4.7	2.1	142.2	58.8	56.6	30.5	31.7	1.2	14.5	3.1	10.6	0.3	13.6	2.7	13.1	19.9	17.5	0.0	3.3	34.6	22.4	0.7	23.4	1.0	4.4	4.7
SIRT5		ENSG00000124523	"Sirtuin 5"	Q9NXA8	6	13574227-13615158	"Metabolic proteins, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 52.5;Distal tubular cells: 52.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021798, HPA022002, HPA022992"	Approved		Supported	Mitochondria		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA021798: AB_1856911, HPA022002: AB_1856913, HPA022992: AB_1856915"	"unprognostic (8.53e-2)"	"unprognostic (7.79e-2)"	"unprognostic (4.71e-2)"	"unprognostic (5.26e-3)"	"unprognostic (6.19e-2)"	"unprognostic (1.63e-1)"	"unprognostic (8.72e-2)"	"unprognostic (1.38e-1)"	"unprognostic (8.54e-3)"	"unprognostic (2.77e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.65e-1)"	"prognostic favorable (8.76e-10)"	"unprognostic (2.39e-1)"	"unprognostic (6.88e-2)"	"unprognostic (6.86e-2)"	"unprognostic (2.36e-3)"	7.2	6.0	9.4	5.2	10.6	5.8	6.6	10.4	12.2	5.4	13.5	8.1	7.7	6.1	5.6	5.6	9.2	5.2	28.6	10.5	10.6	11.5	33.5	5.4	8.3	9.2	9.6	10.1	6.7	16.2	7.3	5.6	9.9	6.4	8.7	6.1	10.6	6.8	33.4	7.9	9.8	5.9	8.4	9.6	8.2	6.8	10.9	8.2	9.0	38.0	7.2	6.0	5.4	11.1	10.5	8.9	8.1	10.4	5.7	8.9	7.6	5.1	5.3	6.1	8.0	12.9	11.1	14.1	35.7	4.3	10.9	16.9	7.4	11.1	7.6	5.9	10.3	8.5	5.6	20.5	11.0	6.7	6.7	7.8	19.9	4.5	19.9	12.7	10.3	20.3	13.8	4.6	6.5	12.3	8.2	13.2	7.7	16.9	13.7	15.4	4.4	24.4	10.3	11.0	13.7	4.5	4.3	7.9	25.9	25.0	11.6	4.9	8.6	6.6	3.4	4.2	5.8	11.6	15.4	10.7	4.5	7.3	8.4	0.7	6.0	16.7	9.9	9.2	10.7	14.0	13.0	9.5	6.3	12.7	11.8	10.8	2.6	11.8	17.3	5.9	10.7	7.9	9.4	10.6	10.4	12.2	10.5	10.6	9.2	9.6	9.9	8.4	10.9	11.1	16.6	28.9	3.2	30.0	8.2	4.1	11.4	14.9	10.8	7.3	9.7	9.9	52.5	15.7	16.8	11.0	0.0	20.5	6.6	9.4	52.8	13.0	2.9	13.1	5.4	12.3	6.1	15.8	36.6	6.7	10.5	6.7	6.6	8.1	0.0	23.5	9.7	25.7	9.4	1.7	39.2	13.2	8.2	13.9	3.8	2.0	8.1	8.4	5.4	14.0	6.3	11.6	10.3	15.1	25.8	7.2	13.4	5.7	4.7	6.2	18.1	34.1	22.5	7.2	0.0	9.8	6.6	8.5	12.0	9.8	4.5	10.7	7.9	13.2	15.0	9.0
NOL7	"C6orf90, dJ223E5.2, NOP27, PQBP3, RARG-1"	ENSG00000225921	"Nucleolar protein 7"	Q9UMY1	6	13615335-13632739	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029185	Supported		Supported	"Nucleoli,Mitotic chromosome,Mitochondria"		Yes	Yes			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 72: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoli, Mitotic chromosome"	Mitochondria	"HPA029185: AB_10601274"	"unprognostic (8.76e-2)"	"unprognostic (8.94e-2)"	"unprognostic (8.38e-2)"	"unprognostic (1.15e-2)"	"unprognostic (3.75e-1)"	"unprognostic (5.77e-2)"	"unprognostic (2.50e-3)"	"unprognostic (1.57e-1)"	"unprognostic (4.64e-2)"	"prognostic favorable (3.64e-5)"	"unprognostic (1.26e-1)"	"unprognostic (2.03e-2)"	"unprognostic (8.04e-3)"	"unprognostic (2.58e-1)"	"unprognostic (1.17e-1)"	"unprognostic (4.86e-2)"	"unprognostic (4.79e-2)"	44.3	43.9	29.5	21.7	30.8	29.5	42.0	32.2	34.0	37.5	28.2	44.8	26.8	37.7	23.4	38.2	35.5	16.6	48.2	28.7	31.1	58.5	37.9	32.2	25.8	30.9	31.4	40.7	48.9	40.2	35.9	21.1	31.0	35.1	19.8	16.6	38.0	19.2	44.5	36.9	36.4	16.0	30.8	37.8	37.9	41.7	30.7	15.2	37.1	17.1	20.3	41.4	34.9	33.8	71.7	37.2	31.7	42.7	26.9	26.1	74.4	71.8	29.3	48.4	44.4	60.0	24.9	97.8	137.4	34.4	57.7	46.5	46.9	42.4	47.8	57.5	105.0	91.2	36.3	104.0	45.4	112.0	61.4	25.5	41.5	42.5	24.2	29.8	33.6	45.5	135.7	22.2	44.7	38.1	70.6	147.6	42.1	37.0	74.1	74.4	46.8	140.5	57.9	21.7	92.5	60.3	40.9	88.0	94.9	36.2	53.6	42.8	65.7	48.0	51.9	57.8	108.3	66.2	123.2	100.2	30.7	70.7	75.6	34.5	59.6	82.1	59.2	76.4	68.2	104.0	84.7	71.4	73.2	87.8	90.7	69.0	27.4	61.9	82.9	91.4	96.0	67.9	29.5	30.8	32.2	34.0	28.7	31.1	30.9	31.4	31.0	30.8	30.7	33.8	103.1	93.0	73.5	10.4	112.5	90.8	117.3	151.0	50.1	62.1	78.9	97.0	214.9	68.6	112.0	57.0	22.9	137.4	71.5	72.7	123.3	188.7	202.3	105.8	95.0	109.2	37.1	89.4	14.0	261.2	153.8	90.9	58.1	91.6	90.6	67.0	61.1	61.8	115.1	48.8	17.1	97.8	130.2	52.6	81.8	38.9	82.6	78.5	101.4	8.4	119.7	124.2	78.2	13.6	19.0	175.0	94.3	79.4	138.8	121.7	81.2	163.6	135.6	61.7	65.7	92.5	119.4	186.3	112.9	70.8	90.5	155.3	99.5	99.2	91.0	117.2
RANBP9	RanBPM	ENSG00000010017	"RAN binding protein 9"	Q96S59	6	13621498-13711835	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 113.6;Excitatory neurons: 132.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033767, HPA050007, HPA076784"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm	Cytosol	"CAB033767: AB_2176959, HPA050007: AB_2680990, HPA076784: "	"unprognostic (3.59e-2)"	"unprognostic (6.57e-2)"	"unprognostic (4.37e-2)"	"unprognostic (2.67e-1)"	"unprognostic (1.78e-1)"	"prognostic favorable (9.97e-4)"	"unprognostic (1.30e-1)"	"unprognostic (4.61e-2)"	"unprognostic (5.87e-3)"	"prognostic favorable (2.47e-4)"	"unprognostic (1.61e-1)"	"unprognostic (6.74e-2)"	"unprognostic (3.51e-1)"	"unprognostic (7.19e-3)"	"unprognostic (1.52e-1)"	"unprognostic (3.49e-1)"	"unprognostic (3.09e-1)"	21.8	20.3	23.3	16.7	25.2	57.3	18.3	22.2	32.4	28.3	21.5	27.5	13.2	20.6	22.2	69.1	15.3	24.6	20.0	25.5	22.6	18.7	26.4	17.9	18.5	20.3	24.3	19.7	17.4	24.1	16.7	20.0	22.7	21.3	18.0	21.0	24.3	17.2	60.5	27.7	15.5	23.5	22.0	15.1	17.9	106.4	21.7	29.7	16.5	39.5	30.8	21.6	38.2	25.4	38.1	16.3	38.7	39.3	51.9	47.8	41.0	45.6	51.6	47.2	49.5	24.8	21.9	33.4	73.0	54.0	35.7	20.3	30.5	26.8	64.6	58.0	27.5	33.6	29.9	45.9	71.7	53.0	24.5	48.7	33.8	56.0	45.9	37.4	39.0	58.3	73.3	26.2	53.1	38.5	62.1	42.0	17.1	36.2	22.6	49.1	30.2	47.1	37.7	43.2	47.9	33.7	36.9	66.3	67.0	73.4	35.6	44.6	38.3	42.3	30.2	34.7	47.4	63.5	82.3	44.9	19.4	32.8	80.1	0.3	0.5	1.8	0.7	0.7	1.4	0.7	1.5	0.7	0.5	0.7	1.3	0.9	0.8	1.2	0.8	0.8	3.6	0.4	23.3	25.2	22.2	32.4	25.5	22.6	20.3	24.3	22.7	22.0	21.7	25.4	17.2	19.2	30.5	58.1	12.5	24.9	7.8	13.5	13.1	25.1	23.3	15.0	40.1	12.8	19.2	18.4	14.6	17.9	22.3	21.7	1.9	8.2	113.6	23.5	21.8	24.0	13.2	11.6	132.9	10.8	9.1	19.8	10.2	29.6	10.1	19.5	16.8	18.3	18.0	6.7	78.3	14.5	12.2	28.0	32.3	99.9	15.8	21.8	17.8	73.1	14.9	22.8	15.5	74.9	75.6	16.6	7.3	24.8	18.3	15.5	12.2	11.4	19.8	17.5	6.6	16.5	18.5	85.4	41.9	19.3	26.1	28.5	22.9	14.3	12.0	17.7
MCUR1	"C6orf79, CCDC90A, FLJ20958"	ENSG00000050393	"Mitochondrial calcium uniporter regulator 1"	Q96AQ8	6	13786557-13814568	"Predicted intracellular proteins, Predicted membrane proteins"	"Calcium transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"retina: 81.6"	"Cell type enhanced"	"Detected in all"		"Proximal tubular cells: 238.5;Rod photoreceptor cells: 293.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA078654	Approved					NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 77: Retina - Visual perception"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 46: Photoreceptor cells - Phototransduction"			"HPA078654: "	"unprognostic (1.82e-3)"	"unprognostic (1.58e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.19e-3)"	"unprognostic (8.62e-2)"	"unprognostic (2.25e-3)"	"unprognostic (2.01e-3)"	"unprognostic (2.16e-1)"	"unprognostic (4.83e-2)"	"prognostic favorable (5.51e-4)"	"unprognostic (3.40e-1)"	"unprognostic (5.77e-2)"	"prognostic favorable (3.32e-4)"	"unprognostic (5.86e-2)"	"unprognostic (2.68e-1)"	"unprognostic (4.05e-2)"	"unprognostic (2.39e-1)"	9.7	5.4	20.2	7.2	21.0	7.1	10.0	19.6	32.6	7.8	18.5	10.8	19.1	7.0	13.1	10.0	4.6	5.5	12.2	20.9	21.3	22.6	9.2	8.6	6.6	21.0	20.8	3.9	12.6	9.0	5.9	8.7	22.0	6.4	9.7	81.6	9.1	7.6	19.3	18.3	16.5	5.1	20.0	7.6	6.4	4.8	22.5	8.1	16.0	15.8	9.4	6.2	7.7	19.7	23.4	6.9	34.4	34.6	19.8	17.0	21.8	21.0	19.9	22.4	23.4	24.0	11.3	31.6	41.0	15.1	35.2	10.2	21.5	17.7	25.4	21.2	13.1	32.3	12.2	24.0	19.4	32.4	12.6	11.9	16.9	29.1	20.9	16.7	8.1	38.7	24.4	16.3	15.8	9.7	40.1	49.0	22.2	59.9	9.0	29.2	30.3	45.2	27.4	14.2	22.0	24.9	14.0	35.4	58.1	53.1	13.2	14.6	11.5	33.5	18.8	24.2	29.3	20.0	71.9	45.4	15.6	19.0	46.4	4.2	1.3	0.3	1.5	1.2	1.8	1.9	2.1	2.2	3.2	1.7	1.6	1.5	0.8	1.7	1.7	2.0	1.3	2.9	20.2	21.0	19.6	32.6	20.9	21.3	21.0	20.8	22.0	20.0	22.5	19.7	40.5	16.0	25.0	13.1	33.2	44.7	24.2	16.9	39.3	48.0	62.8	54.1	43.6	28.6	15.1	57.0	120.9	45.3	27.2	75.0	138.9	27.4	48.9	29.3	83.5	38.7	15.6	62.9	16.7	31.7	66.9	30.5	7.1	31.3	7.0	16.7	28.2	72.4	91.6	26.9	11.5	49.6	24.4	34.7	80.2	6.8	22.1	60.1	51.6	10.3	36.6	50.4	25.7	7.5	13.4	29.2	91.3	27.1	80.7	60.2	161.6	238.5	11.2	293.7	19.7	20.7	34.5	13.1	52.4	47.3	57.4	86.2	21.0	31.0	37.5	31.1
RNF182	MGC33993	ENSG00000180537	"Ring finger protein 182"	Q8N6D2	6	13924446-13980310	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 24.7;choroid plexus: 12.7"	"Cell type enriched"	"Detected in some"	4	"Astrocytes: 85.2"	"Cancer enhanced"	"Detected in many"		"glioma: 5.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HeLa: 81.3;RPTEC TERT1: 67.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012309	Approved		Approved	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA				"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 20: HeLa - Mitochondria"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Nucleoplasm, Golgi apparatus"	Vesicles	"HPA012309: AB_1856349"	"unprognostic (1.29e-1)"	"unprognostic (1.06e-2)"	"unprognostic (2.74e-1)"	"prognostic unfavorable (4.66e-5)"	"unprognostic (6.16e-2)"	"unprognostic (2.08e-1)"	"unprognostic (9.01e-2)"	"unprognostic (6.12e-2)"	"unprognostic (1.71e-2)"	"unprognostic (4.21e-1)"	"unprognostic (6.04e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.05e-1)"	"unprognostic (9.33e-5)"	"unprognostic (6.66e-3)"	"unprognostic (1.33e-3)"	"unprognostic (1.26e-1)"	1.1	0.1	12.2	0.1	13.3	8.4	0.6	22.5	17.7	0.8	12.7	0.2	0.2	0.6	1.1	0.3	1.2	0.2	0.3	17.6	12.2	1.1	0.0	3.3	0.2	16.9	17.7	0.3	1.7	5.8	1.8	1.3	16.5	0.4	0.1	8.8	1.3	2.1	0.2	0.4	0.3	0.3	14.2	0.2	0.2	3.7	24.7	1.5	1.3	0.1	0.0	0.3	0.4	12.2	0.2	6.5	12.0	0.0	4.1	5.0	0.7	6.3	8.6	17.0	16.4	0.3	0.1	0.0	0.1	6.8	18.5	0.0	14.3	0.1	30.9	0.0	4.7	0.4	81.3	0.0	0.0	0.1	0.0	2.8	0.0	26.3	0.2	19.5	0.3	3.5	0.5	0.0	11.9	0.2	0.1	2.2	6.9	0.1	23.9	3.8	2.9	1.0	67.3	0.0	14.2	13.7	0.6	0.0	24.8	4.4	0.0	2.4	6.5	20.7	4.4	0.2	14.3	0.0	0.0	0.0	14.1	0.0	30.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.2	13.3	22.5	17.7	17.6	12.2	16.9	17.7	16.5	14.2	24.7	12.2	0.2	0.0	0.0	85.2	0.1	0.3	0.1	0.0	0.0	19.3	0.2	0.0	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.6	0.4	0.1	0.2	0.0	9.7	8.6	0.0	0.1	0.4	0.0	0.1	0.0	5.4	0.0	0.1	0.1	15.2	1.5	0.1	0.0	0.0	0.3	1.4	0.3	0.0	0.0	5.6	0.0	14.7	0.0	2.5	0.4	0.1	0.0	0.0	0.0	0.1	0.0	1.1	0.1	1.3	6.6	0.0	1.3	5.7	3.2	0.0	0.0	0.3	0.3	0.0	0.1	0.1
CD83	"BL11, HB15"	ENSG00000112149	"CD83 molecule"	Q01151	6	14117256-14136918	"CD markers, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 209.6"	"Cell type enhanced"	"Detected in many"		"B-cells: 668.5;Langerhans cells: 1390.2;Macrophages: 539.4;monocytes: 513.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 79.1;HDLM-2: 71.9;U-698: 121.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB002509, HPA041454, HPA073595"	Enhanced		Approved	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 41: Macrophages - Immune response"	Vesicles	"Golgi apparatus"	"CAB002509: AB_563641, HPA041454: AB_2677489, HPA073595: "	"unprognostic (2.22e-3)"	"unprognostic (1.92e-2)"	"unprognostic (1.22e-1)"	"unprognostic (6.39e-2)"	"unprognostic (5.83e-2)"	"unprognostic (3.02e-2)"	"unprognostic (1.00e-2)"	"unprognostic (9.05e-3)"	"unprognostic (9.05e-2)"	"unprognostic (3.91e-2)"	"unprognostic (7.37e-2)"	"unprognostic (6.68e-2)"	"prognostic favorable (3.49e-4)"	"unprognostic (2.30e-1)"	"unprognostic (7.07e-2)"	"unprognostic (1.40e-2)"	"unprognostic (2.46e-2)"	10.2	19.9	14.7	34.9	13.9	209.6	7.0	16.1	17.9	26.2	23.0	5.2	4.6	7.3	4.0	4.5	5.1	17.0	4.8	15.6	19.2	18.7	14.9	39.9	51.3	20.2	16.6	16.5	4.2	6.6	7.2	9.2	21.0	8.3	9.2	5.0	19.5	13.8	1.3	5.0	11.5	6.9	16.7	20.1	5.7	5.2	21.0	38.0	5.3	2.9	70.2	15.5	15.4	21.6	18.1	0.8	12.7	17.7	18.2	4.2	0.4	5.1	17.6	8.3	14.4	1.3	11.6	79.1	14.6	1.3	16.8	2.0	4.8	5.5	27.0	71.9	7.6	10.6	21.4	2.1	0.6	15.8	16.5	4.8	2.3	8.0	2.6	2.5	0.2	26.4	2.4	0.0	0.8	6.5	12.6	29.7	5.3	3.2	3.7	12.1	28.1	10.9	6.0	17.2	2.8	5.2	1.0	0.6	13.5	7.3	3.0	12.3	0.4	12.8	8.1	1.9	12.0	0.7	0.2	121.5	2.8	21.6	19.7	0.0	3.1	2.0	4.4	19.0	4.8	19.7	4.0	3.7	9.0	31.0	2.8	3.3	2.2	5.0	29.3	3.2	6.2	4.4	14.7	13.9	16.1	17.9	15.6	19.2	20.2	16.6	21.0	16.7	21.0	21.6	41.3	19.2	77.9	5.2	668.5	49.5	16.0	10.0	41.5	4.2	26.5	46.4	30.9	2.8	8.2	11.0	6.2	1.5	100.4	5.4	3.9	0.9	0.9	29.0	24.1	39.1	24.0	3.0	5.6	1.6	2.4	31.1	11.2	74.8	238.8	8.1	2.9	1.1	145.6	1.7	6.1	7.3	4.1	83.0	1390.2	1.9	0.3	539.4	44.4	13.1	513.6	3.5	1.0	2.5	1.3	2.1	0.4	0.0	20.4	26.2	1.7	17.7	4.9	2.7	0.0	17.2	17.0	2.1	10.2	17.2	38.5	2.7	69.2	21.0	11.6	3.5
JARID2	JMJ	ENSG00000008083	"Jumonji and AT-rich interaction domain containing 2"	Q92833	6	15246069-15522042	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Chromatin regulator, Developmental protein, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 57.8"	"Cell type enhanced"	"Detected in all"		"Langerhans cells: 195.0"	"Cancer enhanced"	"Detected in all"		"testis cancer: 34.8"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"JURKAT: 73.8;SuSa: 78.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA063889, CAB069890"	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 41: Macrophages - Immune response"	"Nucleoplasm, Mitochondria"		"CAB069890: AB_10000529, HPA063889: AB_2685143"	"unprognostic (5.06e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.05e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.43e-1)"	"unprognostic (4.87e-3)"	"unprognostic (6.35e-2)"	"unprognostic (2.57e-2)"	"unprognostic (1.30e-2)"	"unprognostic (2.18e-1)"	"unprognostic (3.60e-2)"	"unprognostic (3.26e-3)"	"unprognostic (7.04e-2)"	"unprognostic (4.48e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.99e-1)"	7.3	4.7	6.7	9.2	7.1	57.8	6.0	23.6	8.7	5.3	3.7	5.0	5.7	5.0	6.7	13.7	3.9	4.4	6.4	7.5	6.2	4.1	3.6	7.2	9.0	7.1	6.8	5.7	3.5	3.6	4.4	7.1	7.8	4.5	4.6	20.0	6.4	3.3	11.8	13.4	6.8	4.1	5.2	10.6	7.0	16.0	8.0	20.0	3.8	4.3	9.8	5.8	6.8	8.2	12.4	8.5	34.0	19.6	4.1	4.0	33.5	3.5	8.3	4.5	5.5	8.8	9.4	6.5	12.3	7.1	6.8	6.3	8.0	20.1	4.1	13.0	12.4	23.3	10.6	11.6	4.6	23.9	26.3	5.7	12.3	6.6	26.2	13.4	4.7	73.8	30.5	10.8	2.7	12.6	47.6	44.6	36.4	6.1	3.8	20.9	10.4	18.6	4.2	13.0	26.2	15.0	7.3	24.9	32.1	78.1	8.7	25.0	8.5	20.6	11.4	11.5	12.3	6.9	17.8	11.7	7.0	21.9	26.6	10.1	3.8	3.2	3.4	2.4	2.9	2.5	1.6	2.1	3.1	3.4	2.1	2.9	13.2	4.9	2.7	4.4	1.4	2.1	6.7	7.1	23.6	8.7	7.5	6.2	7.1	6.8	7.8	5.2	8.0	8.2	30.1	6.4	12.8	175.3	40.7	80.4	10.7	23.0	31.9	74.2	28.3	23.1	10.5	15.7	17.1	5.5	87.6	27.0	62.9	10.0	1.9	8.2	89.2	30.7	18.0	27.1	26.8	50.9	125.9	4.4	25.0	17.6	19.9	77.5	25.3	14.8	15.7	13.8	24.0	154.8	124.4	16.4	16.2	61.3	195.0	40.8	8.7	89.5	26.6	97.4	49.1	134.0	54.6	136.7	136.6	15.6	9.3	8.6	34.9	6.8	16.6	3.8	8.7	89.7	6.6	18.1	23.6	9.4	71.1	43.4	151.6	25.2	43.2	17.4	14.7	15.4
DTNBP1	"BLOC1S8, DBND, Dysbindin, HPS7, My031"	ENSG00000047579	"Dystrobrevin binding protein 1"	Q96EV8	6	15522807-15663058	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Sensory transduction"		"Albinism, Hermansky-Pudlak syndrome, Schizophrenia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"retina: 127.0"	"Cell type enhanced"	"Detected in all"		"Rod photoreceptor cells: 173.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028053, HPA029615, HPA029616"	Approved		Enhanced	Microtubules,Midbody		Yes	No			"Cluster 48: NK-cells - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 46: Photoreceptor cells - Phototransduction"	Microtubules	Midbody	"HPA028053: AB_10599296, HPA029615: AB_10599945, HPA029616: AB_10602413"	"unprognostic (2.83e-1)"	"prognostic favorable (2.82e-4)"	"unprognostic (1.62e-1)"	"unprognostic (1.20e-1)"	"unprognostic (4.93e-2)"	"unprognostic (1.29e-2)"	"prognostic unfavorable (8.72e-4)"	"prognostic favorable (6.34e-5)"	"unprognostic (1.36e-1)"	"unprognostic (4.28e-3)"	"unprognostic (2.21e-3)"	"unprognostic (2.08e-1)"	"unprognostic (1.88e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.75e-1)"	"unprognostic (8.81e-3)"	"unprognostic (1.09e-2)"	16.2	9.3	40.8	17.6	60.1	16.7	14.8	35.1	46.6	13.2	32.5	26.0	11.8	13.5	18.3	11.3	11.6	12.6	21.5	42.8	45.7	18.0	8.6	14.7	29.3	40.2	41.9	11.0	11.9	21.0	11.5	14.9	40.8	13.8	16.4	127.0	13.7	14.8	26.8	13.6	17.4	17.8	38.0	22.1	17.1	12.0	44.3	21.4	13.2	16.0	30.9	19.8	12.5	37.8	30.6	12.9	10.9	23.7	15.5	17.8	16.6	15.3	20.0	36.0	32.4	17.6	13.7	42.9	40.5	21.8	29.6	10.4	21.8	16.3	32.6	27.3	28.9	30.2	15.4	25.7	27.3	30.6	24.8	16.9	24.7	18.5	26.8	16.6	32.2	29.0	29.3	10.2	22.1	35.9	31.9	48.7	7.7	25.4	18.6	37.7	21.2	33.4	33.7	31.7	22.1	9.5	12.1	28.4	36.4	25.1	20.6	19.4	15.2	20.5	13.4	21.2	28.6	27.7	57.3	30.9	9.5	27.1	39.5	11.1	10.1	14.4	19.5	12.4	13.1	24.8	16.5	17.2	11.0	31.3	15.5	12.6	11.6	49.3	9.0	30.8	12.1	11.5	40.8	60.1	35.1	46.6	42.8	45.7	40.2	41.9	40.8	38.0	44.3	37.8	23.2	12.8	11.3	35.3	42.6	29.1	16.5	12.5	11.4	47.2	14.3	13.1	29.3	15.7	11.4	14.7	58.4	41.4	29.6	18.6	37.2	37.5	50.5	16.3	9.8	31.7	13.8	5.5	36.3	35.8	17.9	16.9	14.3	14.5	54.6	54.1	20.0	6.0	54.8	25.2	38.6	17.5	8.2	18.5	32.4	26.6	10.2	22.1	37.4	39.4	29.8	55.2	64.9	26.7	36.3	26.5	12.1	15.4	20.2	12.9	27.2	81.6	13.0	173.4	6.6	12.3	20.8	22.3	18.3	8.6	22.0	16.7	29.1	11.0	19.2	12.0
MYLIP	"IDOL, MIR"	ENSG00000007944	"Myosin regulatory light chain interacting protein"	Q8WY64	6	16129086-16148248	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Syncytiotrophoblasts: 352.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 57.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 7: Non-specific - Mitochondria"				"unprognostic (1.54e-1)"	"unprognostic (4.84e-3)"	"unprognostic (2.79e-1)"	"unprognostic (9.65e-3)"	"unprognostic (1.07e-1)"	"unprognostic (2.07e-2)"	"unprognostic (1.11e-2)"	"prognostic favorable (6.44e-6)"	"unprognostic (2.75e-2)"	"unprognostic (2.67e-2)"	"unprognostic (5.44e-3)"	"unprognostic (1.03e-2)"	"prognostic favorable (3.67e-4)"	"unprognostic (1.42e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.35e-1)"	"prognostic favorable (4.11e-5)"	37.0	18.9	12.8	12.8	20.0	92.1	30.2	12.5	16.4	42.2	13.6	24.3	12.9	40.3	30.6	18.1	32.6	21.3	14.2	13.4	13.3	21.6	4.9	29.5	22.8	13.7	14.3	35.8	15.5	24.6	8.2	63.4	12.0	16.4	16.5	4.7	25.7	23.1	41.1	25.7	24.5	28.4	12.3	30.8	22.7	15.0	15.7	15.2	50.2	22.8	15.4	25.0	24.7	22.4	3.4	6.0	2.8	3.3	28.3	6.9	7.3	2.4	5.4	5.4	12.0	18.4	3.3	16.0	11.5	3.9	4.0	8.2	13.0	4.4	4.9	5.2	12.8	10.2	7.1	3.8	4.1	7.4	10.0	11.5	5.5	2.6	2.2	2.8	12.5	3.4	29.8	18.6	2.1	12.6	0.2	40.6	8.0	8.4	5.7	3.5	12.9	57.9	6.7	40.0	13.5	6.2	2.9	31.2	17.1	23.9	5.8	18.8	3.5	2.6	6.2	2.2	6.1	16.0	7.5	8.1	1.6	20.9	9.0	6.1	1.5	7.8	5.8	1.8	5.4	4.2	3.7	4.1	1.1	3.3	4.0	3.9	9.4	2.6	1.5	0.5	2.3	1.2	12.8	20.0	12.5	16.4	13.4	13.3	13.7	14.3	12.0	12.3	15.7	22.4	102.6	22.4	50.2	5.5	67.7	98.0	38.9	8.8	126.3	9.3	67.6	117.0	90.7	50.1	17.7	22.0	0.0	134.2	78.5	49.5	9.8	22.1	47.5	82.7	56.2	70.9	84.3	52.6	17.1	18.4	80.0	79.6	54.0	77.7	35.5	35.1	41.4	1.4	32.0	11.8	8.4	41.1	10.2	61.7	121.2	20.2	38.5	56.0	80.0	7.5	27.3	16.9	56.7	3.0	55.3	7.6	32.4	61.7	30.2	28.1	27.8	21.1	25.7	7.8	138.1	90.8	96.7	53.0	22.6	100.9	84.0	352.3	103.8	3.9	45.4	35.1
GMPR		ENSG00000137198	"Guanosine monophosphate reductase"	P36959	6	16238587-16295549	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Purine metabolism"	Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 358.6;tongue: 205.0"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 86.1;Endometrial ciliated cells: 118.2;Erythroid cells: 367.1;Melanocytes: 92.5"	"Cancer enhanced"	"Detected in all"		"melanoma: 95.4"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 14.9"	"Group enriched"	"Detected in all"	6	"granulocytes: 14.9;monocytes: 5.0;NK-cells: 9.6"	"Cell line enhanced"	"Detected in many"		"HEL: 193.1;HMC-1: 314.7;SK-MEL-30: 74.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000904, HPA021476"	Uncertain					NA	NA		950000	"Cluster 34: Basophils - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 6: Erythroid cells - Oxygen transport"			"HPA000904: AB_1078998, HPA021476: AB_1849858"	"unprognostic (2.74e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.14e-1)"	"unprognostic (4.97e-3)"	"unprognostic (3.52e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.06e-1)"	"prognostic favorable (8.07e-4)"	"unprognostic (4.12e-1)"	"prognostic favorable (2.06e-4)"	"unprognostic (3.15e-1)"	"unprognostic (2.86e-1)"	"prognostic favorable (2.94e-5)"	"unprognostic (3.01e-1)"	"unprognostic (1.81e-1)"	"unprognostic (7.31e-2)"	"unprognostic (2.17e-1)"	10.0	23.3	28.5	2.8	31.9	29.7	6.5	32.4	21.6	6.6	35.7	15.5	2.7	13.3	16.5	5.3	56.9	3.7	101.7	19.6	38.2	25.5	5.9	9.1	2.5	36.8	45.6	38.0	18.3	14.2	24.9	7.8	35.0	63.1	3.4	2.2	21.5	9.0	358.6	12.4	6.0	9.9	39.7	12.5	36.5	52.3	41.3	6.5	4.4	205.0	1.6	5.2	3.7	33.2	0.0	0.0	0.3	0.0	2.7	2.1	0.1	3.9	15.7	27.2	55.2	1.6	0.4	0.0	8.8	6.0	19.1	0.1	6.7	0.8	4.5	0.0	5.0	193.1	0.1	0.0	11.8	0.8	314.7	3.7	2.8	8.5	0.0	22.2	49.5	0.7	43.9	0.3	4.8	3.8	0.2	4.1	2.0	0.2	7.5	0.0	41.9	0.0	36.1	5.4	9.4	1.2	1.9	3.2	74.4	12.1	3.0	1.4	12.5	0.4	0.2	1.3	7.5	2.3	0.0	0.0	0.9	20.3	21.8	14.9	3.3	0.4	0.7	5.0	1.2	0.2	0.1	0.5	1.5	1.5	0.0	0.2	3.3	9.6	1.7	1.5	0.0	16.0	28.5	31.9	32.4	21.6	19.6	38.2	36.8	45.6	35.0	39.7	41.3	33.2	4.6	0.0	0.0	8.8	1.3	5.1	30.2	0.7	0.6	0.7	5.3	3.8	52.8	35.8	2.7	20.2	0.0	25.3	0.6	1.4	86.1	12.4	16.0	118.2	8.7	6.8	7.8	367.1	3.8	4.9	2.8	10.2	9.2	78.9	55.3	38.9	17.9	5.0	8.9	0.0	11.5	3.2	4.1	6.4	2.1	16.3	34.5	47.4	92.5	2.8	9.2	9.8	2.1	3.0	1.7	3.0	1.2	80.9	1.4	69.9	2.2	15.5	6.4	0.8	0.0	12.6	7.4	6.5	17.2	1.3	1.8	6.8	3.5	19.4	3.8	8.3
ATXN1	"ATX1, D6S504E, SCA1"	ENSG00000124788	"Ataxin 1"	P54253	6	16299112-16761491	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"DNA-binding, Repressor, RNA-binding"	"Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 582.5;Inhibitory neurons: 519.0;Oligodendrocyte precursor cells: 318.2;Oligodendrocytes: 466.8"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"cerebral cortex: 14.4"	"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"U-266/70: 30.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008335, HPA070756"	Approved		Supported	Nucleoplasm,Nucleoli,Cytosol		Yes	No			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm	"Nucleoli, Cytosol"	"HPA008335: AB_1845129, HPA070756: AB_2686306"	"unprognostic (1.01e-1)"	"unprognostic (4.77e-2)"	"unprognostic (1.23e-1)"	"unprognostic (5.64e-3)"	"unprognostic (4.54e-1)"	"unprognostic (1.95e-2)"	"unprognostic (7.74e-2)"	"unprognostic (4.51e-2)"	"unprognostic (4.06e-1)"	"unprognostic (1.11e-2)"	"unprognostic (3.87e-2)"	"unprognostic (2.69e-2)"	"unprognostic (1.41e-3)"	"unprognostic (1.67e-3)"	"unprognostic (2.33e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.29e-3)"	4.1	4.0	3.2	5.9	5.3	2.6	4.1	0.0	14.4	8.4	0.0	8.8	3.8	10.9	4.3	5.0	6.2	5.7	5.8	8.4	0.0	4.1	4.7	6.9	4.2	0.0	1.3	5.4	4.8	5.5	6.5	4.9	0.0	7.4	3.8	13.9	4.6	6.2	14.6	5.7	4.8	7.5	0.0	5.7	5.3	3.0	3.9	2.6	6.1	14.8	3.1	6.7	6.6	0.8	4.5	2.6	0.9	0.0	4.4	5.9	5.8	4.8	11.2	2.9	3.3	2.8	2.8	0.2	6.3	9.3	3.7	4.2	0.3	3.0	4.2	2.6	4.7	0.7	4.4	9.0	7.0	4.2	7.0	4.6	5.7	6.1	5.1	11.2	5.9	0.9	0.0	5.3	2.4	2.3	0.3	4.8	0.9	1.4	4.3	0.3	5.8	4.0	4.0	7.6	0.3	2.5	4.4	5.5	9.1	8.4	3.6	7.2	9.1	4.0	6.1	4.8	4.4	30.7	19.2	0.2	2.6	4.3	10.0	0.2	0.5	0.1	0.7	0.4	0.5	0.1	0.5	0.7	0.2	0.0	0.0	0.4	1.3	0.0	0.2	0.1	0.4	0.3	3.2	5.3	0.0	14.4	8.4	0.0	0.0	1.3	0.0	0.0	3.9	0.8	16.0	48.1	25.9	206.3	20.7	91.4	72.2	22.8	48.9	39.8	20.7	14.4	35.9	25.8	26.0	11.0	100.1	0.6	48.4	23.6	7.9	16.7	4.3	80.5	144.4	21.7	1.2	5.7	582.5	8.5	4.0	32.9	22.4	75.8	38.7	67.4	17.2	25.2	22.4	38.7	519.0	16.5	2.0	39.6	79.1	3.3	10.5	41.7	32.0	217.4	42.3	24.1	33.0	318.2	466.8	32.3	16.3	28.2	82.6	56.6	13.9	8.8	33.2	99.9	52.6	19.0	41.6	1.0	6.9	60.9	48.7	0.4	61.5	6.4	7.7	63.8
STMND1	FLJ23152	ENSG00000230873	"Stathmin domain containing 1"	H3BQB6	6	17102050-17131378	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"fallopian tube: 17.8;gallbladder: 5.3;testis: 5.7"	"Cell type enhanced"	"Detected in some"		"Endometrial ciliated cells: 93.8;Respiratory ciliated cells: 72.8;Spermatocytes: 18.7;Spermatogonia: 23.8"	"Group enriched"	"Detected in some"	6	"breast cancer: 4.1;endometrial cancer: 1.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"HEK 293: 2.4;SCLC-21H: 6.0;T-47d: 7.1"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA067970	Enhanced		Approved	"Actin filaments"		NA	NA				"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 6: T47d - Mammary gland"	"Cluster 49: Ciliated cells - Cilium organization"	"Actin filaments"		"HPA067970: AB_2685934"	"unprognostic (7.70e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.70e-2)"	"unprognostic (2.09e-3)"	"unprognostic (6.88e-2)"	"unprognostic (6.64e-2)"	"unprognostic (4.29e-2)"	"unprognostic (4.22e-2)"		"unprognostic (3.13e-2)"	"unprognostic (1.22e-1)"	"unprognostic (9.72e-2)"	"unprognostic (5.29e-4)"	"unprognostic (7.14e-2)"	"unprognostic (1.10e-2)"	"unprognostic (2.19e-2)"		0.0	0.0	0.2	0.1	0.2	0.0	3.0	0.3	0.4	0.8	2.2	0.9	0.1	0.5	0.3	0.0	17.8	5.3	0.0	0.3	0.2	0.0	0.1	2.4	0.0	0.5	0.5	0.0	3.5	0.0	0.5	0.1	0.3	0.0	0.8	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.5	0.0	0.0	5.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.2	0.5	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	6.0	0.0	0.0	0.0	0.0	0.5	7.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.4	0.1	0.1	0.2	0.0	0.0	0.2	0.2	0.3	0.4	0.3	0.2	0.5	0.5	0.3	0.5	0.2	0.6	0.0	0.0	1.3	0.0	0.0	0.0	1.7	2.9	0.0	0.1	5.0	1.4	0.7	2.8	8.3	0.0	0.0	0.0	0.0	1.2	0.0	0.6	1.3	93.8	0.9	0.5	1.8	0.0	0.5	0.2	0.0	0.4	0.0	2.3	0.0	0.7	0.0	0.3	0.0	0.0	0.2	0.7	2.0	0.0	0.4	2.8	0.0	0.3	0.0	0.0	0.0	1.4	0.0	0.0	0.1	0.6	0.3	0.4	0.0	0.7	0.0	0.0	72.8	0.0	6.6	1.3	2.7	18.7	23.8	0.0	0.9	0.0	0.3	0.0	1.8	0.6
RBM24	"dJ259A10.1, FLJ30829, RNPC6"	ENSG00000112183	"RNA binding motif protein 24"	Q9BX46	6	17281361-17293871	"Predicted intracellular proteins"	"Differentiation, mRNA processing, mRNA splicing, Translation regulation"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"heart muscle: 142.1;skeletal muscle: 313.0;tongue: 105.7"	"Cell type enriched"	"Detected in many"	5	"Cardiomyocytes: 193.2"	"Cancer enhanced"	"Detected in many"		"testis cancer: 5.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"LHCN-M2: 58.7;RH-30: 59.7;T-47d: 28.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA066927, HPA067231"	Enhanced		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Nucleoplasm	Cytosol	"HPA066927: AB_2685750, HPA067231: AB_2685808"	"unprognostic (9.05e-3)"	"unprognostic (2.57e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.67e-3)"	"unprognostic (1.53e-1)"	"unprognostic (4.54e-4)"	"unprognostic (3.34e-2)"	"unprognostic (1.33e-2)"	"unprognostic (2.97e-3)"	"unprognostic (3.38e-2)"	"unprognostic (2.98e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.16e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.33e-4)"	5.4	0.5	3.7	1.7	4.1	0.1	3.7	0.1	5.7	13.9	2.5	9.7	1.6	31.2	16.8	7.4	24.0	2.6	142.1	4.5	4.9	0.9	1.1	1.3	0.5	1.6	1.9	2.1	0.2	2.1	5.5	0.6	0.7	9.9	7.4	0.4	4.1	5.8	313.0	1.4	3.6	29.3	0.6	1.2	2.1	4.2	3.0	0.8	2.1	105.7	0.3	8.8	3.6	2.2	1.5	9.3	12.0	0.0	0.0	0.0	0.0	18.7	6.8	12.4	13.0	0.0	1.1	0.0	5.7	13.4	19.5	0.0	11.5	0.4	22.3	0.0	0.4	0.0	1.0	6.4	0.5	0.0	1.1	6.4	0.0	2.4	0.5	15.8	1.6	0.0	0.0	0.0	58.7	2.8	0.0	0.2	4.1	0.0	1.4	0.1	59.7	0.0	0.0	0.0	7.8	0.9	0.2	0.0	0.2	9.3	28.2	0.4	0.0	4.2	10.0	0.0	16.2	0.0	0.0	0.1	0.3	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	4.1	0.1	5.7	4.5	4.9	1.6	1.9	0.7	0.6	3.0	2.2	1.1	0.0	0.0	0.0	0.0	1.1	0.2	1.1	0.0	2.3	3.2	0.8	193.2	0.0	1.8	0.0	0.0	0.1	0.1	4.3	0.0	0.0	0.6	33.5	13.6	1.5	4.8	0.0	11.6	0.0	13.4	6.4	0.0	9.9	1.3	0.5	0.4	0.0	0.3	1.7	6.6	4.5	0.0	0.0	0.7	1.9	0.0	0.3	1.8	1.9	0.0	0.7	0.0	0.5	0.4	0.3	2.2	0.7	0.0	0.3	0.0	0.6	21.9	0.0	6.6	23.9	19.7	0.4	7.3	0.2	1.0	0.8	0.5	0.0	3.0	0.1
CAP2		ENSG00000112186	"Cyclase associated actin cytoskeleton regulatory protein 2"	P40123	6	17393505-17557790	"Cancer-related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 577.1;tongue: 313.0"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 126.5;Excitatory neurons: 158.1;Inhibitory neurons: 137.2"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"amygdala: 26.1;basal ganglia: 40.9;cerebral cortex: 87.2;hippocampal formation: 50.2;white matter: 32.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"LHCN-M2: 101.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050530, HPA054147"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA050530: AB_2681159, HPA054147: AB_2682400"	"unprognostic (7.27e-2)"	"unprognostic (5.71e-3)"	"unprognostic (1.63e-2)"	"unprognostic (1.55e-1)"	"unprognostic (4.86e-1)"	"unprognostic (2.23e-2)"	"unprognostic (9.94e-2)"	"unprognostic (3.58e-2)"	"unprognostic (7.72e-2)"	"unprognostic (1.65e-1)"	"unprognostic (6.43e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.06e-2)"	"unprognostic (1.47e-1)"	"unprognostic (8.05e-2)"	"unprognostic (1.75e-3)"	17.8	11.6	26.1	7.6	40.9	0.0	10.7	0.9	87.2	15.4	2.9	32.6	4.1	28.5	17.8	21.7	16.8	11.4	113.6	50.2	11.1	8.7	4.5	4.7	1.7	3.2	3.8	4.5	4.2	7.5	5.1	8.8	2.7	25.1	9.6	9.1	7.7	30.7	577.1	2.6	8.9	42.7	0.0	3.1	9.8	1.5	9.1	3.1	5.5	313.0	2.3	14.5	6.4	32.3	15.5	24.6	44.4	55.1	0.3	0.1	10.4	52.3	42.7	46.6	43.0	8.1	6.9	0.0	48.9	62.1	60.5	8.2	21.3	20.9	66.8	0.1	7.9	0.0	15.4	26.5	4.3	0.0	0.0	3.5	9.9	23.1	10.3	72.3	2.2	0.0	0.0	0.1	101.6	25.2	0.0	0.0	17.0	0.8	15.6	5.2	59.1	1.1	23.6	6.4	6.1	10.9	19.0	59.2	31.3	82.8	65.0	11.2	0.2	36.6	31.6	1.0	47.6	0.0	0.0	0.2	11.7	0.1	48.4	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.1	40.9	0.9	87.2	50.2	11.1	3.2	3.8	2.7	0.0	9.1	32.3	2.0	3.2	1.5	9.8	0.0	1.9	4.3	6.2	5.7	16.4	10.2	8.4	126.5	4.3	5.4	1.8	4.2	16.5	0.0	1.9	3.9	2.7	0.1	13.9	13.7	2.7	6.0	0.0	158.1	0.7	12.2	7.9	0.0	5.8	0.0	22.8	3.9	2.4	2.2	8.4	137.2	1.3	2.0	0.0	2.2	0.0	0.6	0.3	0.0	10.3	0.0	6.3	0.0	16.6	7.2	3.7	1.9	4.9	0.0	1.9	0.0	16.7	33.9	2.2	32.9	25.5	43.4	0.1	3.2	2.1	0.9	37.5	0.3	0.3	1.6	0.6
FAM8A1	AHCP	ENSG00000137414	"Family with sequence similarity 8 member A1"	Q9UBU6	6	17600302-17611715	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	4	"Early spermatids: 759.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 5.5"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044698, HPA073675"	Approved		Approved	"Golgi apparatus"		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 29: Early spermatids - Spermatogenesis"	"Golgi apparatus"		"HPA044698: AB_2679051, HPA073675: AB_2732236"	"unprognostic (4.06e-1)"	"unprognostic (2.32e-1)"	"unprognostic (9.11e-2)"	"unprognostic (6.90e-2)"	"unprognostic (1.99e-2)"	"unprognostic (5.17e-3)"	"unprognostic (6.13e-2)"	"unprognostic (1.93e-2)"	"unprognostic (2.04e-2)"	"unprognostic (1.09e-3)"	"unprognostic (4.44e-2)"	"unprognostic (3.50e-1)"	"unprognostic (1.56e-2)"	"unprognostic (3.85e-2)"	"unprognostic (3.71e-1)"	"unprognostic (7.59e-2)"	"unprognostic (2.98e-1)"	18.6	16.1	16.3	10.7	17.3	31.6	19.1	19.0	19.5	20.4	16.6	19.9	16.9	27.3	18.9	13.9	20.6	21.1	14.8	17.4	20.3	24.0	77.9	18.9	10.4	18.2	17.2	27.8	15.0	22.3	13.0	14.9	18.2	20.9	22.8	27.1	23.0	22.3	18.9	14.0	16.7	24.8	20.2	14.3	12.7	17.2	21.1	17.1	23.2	21.7	8.2	14.5	12.6	20.6	9.5	3.7	13.5	32.3	45.6	42.6	11.1	15.0	20.4	7.6	13.1	21.4	3.1	8.1	35.2	25.6	8.3	7.6	20.5	13.0	9.9	6.9	29.1	9.8	12.5	46.2	20.1	6.2	9.6	22.6	20.7	8.7	6.0	24.2	17.0	8.9	20.2	16.2	12.0	11.7	4.6	19.2	5.6	11.6	5.6	12.1	13.0	25.0	25.6	7.5	4.1	21.4	11.7	25.0	23.7	23.1	29.0	9.5	13.3	9.7	3.4	14.9	5.5	13.4	12.0	8.0	8.8	7.1	13.4	2.6	0.3	1.0	1.1	0.4	1.2	0.0	0.5	1.0	0.2	0.1	0.7	1.1	5.5	1.5	0.2	0.2	0.4	0.3	16.3	17.3	19.0	19.5	17.4	20.3	18.2	17.2	18.2	20.2	21.1	20.6	16.8	19.2	27.1	8.8	7.0	13.4	9.7	6.6	14.2	27.6	15.1	13.5	15.3	21.5	12.1	29.5	14.6	10.0	15.7	63.4	5.9	9.2	759.2	26.4	24.0	14.1	12.0	4.2	17.1	7.9	12.0	23.0	10.7	20.6	1.3	8.6	25.4	77.5	6.2	15.2	17.9	10.8	8.2	24.4	6.4	187.8	36.7	8.6	5.4	3.7	8.7	19.3	14.4	8.0	13.8	7.5	25.7	30.9	12.8	7.5	30.4	12.4	20.5	16.7	32.9	20.3	18.7	46.6	18.0	14.3	15.9	12.2	14.0	9.7	16.7	7.8
NUP153	HNUP153	ENSG00000124789	"Nucleoporin 153"	P49790	6	17615035-17706925	"Metabolic proteins, Predicted intracellular proteins, Transporters"	"Host-virus interaction, mRNA transport, Protein transport, Translocation, Transport, Viral penetration into host nucleus, Virus entry into host cell"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027896, HPA027897, HPA027898, HPA027899"	Supported		Enhanced	"Nuclear membrane"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	"Nuclear membrane"		"HPA027896: AB_10611243, HPA027897: AB_10601108, HPA027898: AB_10601682, HPA027899: "	"unprognostic (2.49e-1)"	"unprognostic (5.37e-1)"	"unprognostic (3.17e-2)"	"unprognostic (6.20e-3)"	"unprognostic (3.36e-1)"	"unprognostic (7.64e-3)"	"unprognostic (2.53e-2)"	"unprognostic (6.49e-2)"	"unprognostic (1.95e-2)"	"unprognostic (7.16e-3)"	"unprognostic (1.99e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.49e-1)"	"unprognostic (3.60e-2)"	"unprognostic (3.66e-1)"	"unprognostic (5.40e-2)"	"unprognostic (8.69e-2)"	16.5	10.3	5.4	18.2	6.1	45.6	16.7	12.5	7.4	15.2	10.1	12.8	10.1	17.0	11.6	16.2	15.0	14.9	11.2	6.2	6.3	13.1	23.4	13.9	23.9	6.1	7.1	18.6	13.2	17.9	9.2	18.9	6.4	12.0	13.1	15.7	12.0	13.1	25.1	15.9	12.8	14.4	6.3	17.8	11.6	26.7	6.8	25.2	13.8	19.5	27.6	18.7	14.5	9.7	55.6	27.2	57.7	50.8	24.9	29.3	57.8	42.3	39.3	61.8	65.7	45.5	24.9	104.3	69.7	37.7	51.9	39.4	68.1	41.0	99.0	56.2	52.7	55.6	29.4	47.0	18.6	81.0	50.2	31.0	32.5	64.9	46.5	23.6	37.0	34.5	131.7	32.5	41.9	29.5	60.5	50.1	45.6	20.8	29.5	80.1	74.2	97.9	27.3	53.1	64.6	37.5	36.0	58.3	36.2	90.5	37.8	29.0	34.8	63.2	36.2	30.2	66.7	41.8	63.8	102.8	15.6	36.8	76.1	1.2	1.3	3.2	2.8	1.2	3.7	1.7	3.5	3.4	1.9	2.1	2.1	2.1	3.4	3.0	1.8	1.1	1.7	1.3	5.4	6.1	12.5	7.4	6.2	6.3	6.1	7.1	6.4	6.3	6.8	9.7	28.9	19.2	23.2	39.8	31.4	76.3	37.9	11.1	51.2	14.2	32.5	18.7	14.3	11.5	11.9	16.5	16.7	20.9	24.0	19.4	1.9	8.8	27.3	69.3	56.8	23.3	20.9	44.0	53.0	6.0	21.7	31.8	23.4	91.0	3.8	17.7	13.6	30.7	17.5	16.8	48.8	13.6	12.2	15.6	36.7	19.6	17.4	27.5	21.4	47.8	12.7	7.2	20.6	37.2	50.5	13.4	7.0	14.7	27.9	41.7	10.1	9.8	23.4	12.7	13.1	55.1	26.4	30.4	22.3	51.8	79.3	23.9	35.8	11.7	16.8	35.1
KIF13A	bA500C11.2	ENSG00000137177	"Kinesin family member 13A"	Q9H1H9	6	17759183-17987635	"Predicted intracellular proteins"	"Cell cycle, Cell division, Protein transport, Transport"	"Motor protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 104.5"	"Group enriched"	"Detected in many"	4	"Oligodendrocyte precursor cells: 831.4;Oligodendrocytes: 453.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 5.9"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 5.9"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029253, HPA029254"	Uncertain					NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 68: Oligodendrocytes - Mixed function"			"HPA029253: AB_10611115, HPA029254: AB_10602094"	"unprognostic (1.03e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.67e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.08e-2)"	"unprognostic (1.44e-1)"	"prognostic unfavorable (5.06e-4)"	"unprognostic (2.96e-1)"	"unprognostic (8.40e-3)"	"unprognostic (1.44e-3)"	"unprognostic (1.45e-1)"	"unprognostic (1.54e-1)"	"unprognostic (2.64e-3)"	"unprognostic (1.77e-2)"	"unprognostic (3.17e-1)"	"unprognostic (1.14e-1)"	"unprognostic (4.44e-2)"	24.1	20.0	23.9	10.3	29.7	19.4	21.3	25.9	24.4	23.6	31.2	29.4	27.4	25.4	13.1	20.1	18.9	17.7	47.8	21.2	22.9	14.1	16.0	25.3	5.3	24.6	25.8	20.2	14.7	21.2	11.9	11.9	25.3	23.7	25.4	21.6	17.2	18.6	104.5	28.6	23.5	22.4	21.5	8.1	14.5	8.6	27.1	8.3	27.9	72.5	7.4	29.9	24.3	33.9	24.8	18.0	21.3	13.1	28.4	27.0	25.3	33.6	57.0	28.9	29.5	6.5	5.9	0.2	26.3	58.4	36.5	24.3	16.3	42.6	36.2	2.5	9.8	10.6	44.9	32.1	18.9	0.4	10.3	21.5	34.9	31.3	47.1	37.2	23.8	0.1	39.5	0.3	31.8	10.0	0.1	1.5	16.9	5.7	11.0	12.6	29.1	0.2	18.1	62.1	5.8	11.5	27.7	20.6	38.4	36.7	29.9	1.5	16.8	52.6	15.2	17.4	31.8	0.2	0.1	0.2	18.9	0.8	39.2	2.1	1.3	1.2	0.0	1.1	0.0	0.2	0.0	0.0	0.5	0.2	0.0	0.0	5.9	0.1	0.5	0.1	0.0	0.2	23.9	29.7	25.9	24.4	21.2	22.9	24.6	25.8	25.3	21.5	27.1	33.9	29.9	35.3	44.4	149.5	4.3	57.2	39.6	9.2	21.1	32.9	20.5	23.1	67.7	17.2	12.8	20.2	18.8	4.1	2.8	20.3	11.7	5.9	20.9	14.5	27.9	28.6	12.5	20.4	134.4	8.7	4.0	24.0	13.7	16.5	5.1	9.7	15.4	25.5	11.9	5.0	42.2	27.2	6.1	22.3	14.7	10.5	15.5	18.9	17.8	105.9	21.1	37.6	5.2	831.4	453.8	9.2	27.4	24.8	0.6	38.4	18.2	10.9	23.5	26.8	26.3	32.7	35.3	6.8	14.9	8.1	45.6	9.0	2.2	2.9	32.7	38.0
NHLRC1	"bA204B7.2, EPM2B"	ENSG00000187566	"NHL repeat containing E3 ubiquitin protein ligase 1"	Q6VVB1	6	18120440-18122677	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Autophagy, Ubl conjugation pathway"	Transferase	"Disease variant, Epilepsy, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Erythroid cells: 5.0;Exocrine glandular cells: 3.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"EFO-21: 6.8;K-562: 6.1;SCLC-21H: 6.1"	"Low region specificity"	"Detected in all"							HPA066030			Uncertain	Vesicles		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 15: Liver - Metabolism"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 4: Macrophages - Innate immune response"	Vesicles		"HPA066030: "	"unprognostic (1.61e-1)"	"unprognostic (1.39e-1)"	"unprognostic (7.95e-2)"	"prognostic unfavorable (9.01e-4)"	"unprognostic (6.95e-3)"	"unprognostic (2.45e-1)"	"unprognostic (1.09e-1)"	"unprognostic (3.69e-1)"	"unprognostic (2.39e-1)"	"unprognostic (7.17e-2)"	"unprognostic (5.07e-3)"	"unprognostic (1.28e-1)"	"unprognostic (2.32e-2)"	"unprognostic (3.19e-1)"	"unprognostic (2.33e-1)"	"unprognostic (2.77e-2)"	"prognostic favorable (5.30e-4)"	1.2	1.4	2.0	0.8	2.3	1.1	2.0	1.5	2.6	0.8	0.8	1.5	1.4	0.8	2.6	1.1	1.4	0.6	1.8	2.4	1.9	0.8	4.1	1.2	0.6	2.5	1.8	1.4	1.8	1.2	1.2	0.5	2.7	1.2	1.3	2.0	2.3	1.0	2.6	3.8	1.9	0.8	1.6	1.1	1.3	0.7	2.0	1.0	1.6	1.5	0.8	0.9	0.8	3.6	2.6	1.5	0.6	0.0	1.3	1.2	0.0	2.6	0.8	0.9	0.5	0.1	2.1	0.0	6.8	1.9	0.2	3.0	0.0	1.7	0.7	0.1	0.9	0.4	1.0	0.1	2.0	0.0	1.7	2.1	2.5	1.0	0.9	0.6	2.1	0.0	6.1	0.1	2.1	2.8	0.0	0.0	0.0	0.3	1.5	0.0	0.0	0.1	1.4	2.8	6.1	0.1	5.3	4.3	1.6	0.6	3.1	1.7	0.4	0.2	1.3	1.8	0.1	0.1	0.0	0.1	0.1	0.0	2.6	0.5	4.4	0.4	0.6	4.9	0.8	2.3	1.1	0.5	4.7	1.3	1.5	1.0	0.3	1.6	2.3	0.6	1.3	1.8	2.0	2.3	1.5	2.6	2.4	1.9	2.5	1.8	2.7	1.6	2.0	3.6	0.8	0.0	2.2	0.3	0.2	1.9	1.4	1.4	1.8	0.4	1.5	2.0	0.9	1.5	2.3	0.0	0.0	0.4	0.0	0.2	0.0	2.9	0.0	0.6	1.3	0.3	3.5	5.0	1.0	3.7	0.0	0.8	1.5	0.5	1.3	0.8	0.4	1.1	1.2	0.0	0.7	0.3	0.0	0.8	0.6	0.0	0.6	1.5	1.8	1.0	0.5	1.1	0.0	1.5	1.2	2.0	0.3	0.0	0.0	0.2	0.6	1.2	0.8	1.0	0.0	0.3	0.8	0.2	0.2	1.3	1.8	0.4	0.1	1.1	0.5	0.5
TPMT		ENSG00000137364	"Thiopurine S-methyltransferase"	P51580	6	18128311-18155077	"Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"		"Methyltransferase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 76.4;liver: 68.8;thyroid gland: 76.9"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 144.6;Proximal tubular cells: 307.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019851, HPA062364"	Enhanced					NA	NA		39000	"Cluster 7: Monocytes - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA019851: AB_1858213, HPA062364: "	"unprognostic (6.24e-2)"	"unprognostic (3.16e-2)"	"unprognostic (5.46e-3)"	"prognostic unfavorable (8.45e-5)"	"unprognostic (4.98e-2)"	"unprognostic (2.25e-1)"	"unprognostic (8.16e-2)"	"unprognostic (4.36e-3)"	"unprognostic (9.62e-2)"	"prognostic favorable (1.41e-4)"	"unprognostic (4.49e-2)"	"unprognostic (3.40e-2)"	"prognostic favorable (1.10e-4)"	"unprognostic (7.56e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.07e-1)"	"unprognostic (8.39e-3)"	5.8	16.4	9.2	12.9	12.2	10.0	10.0	10.5	12.2	7.7	9.6	34.5	34.5	6.9	17.5	10.3	7.0	10.4	12.2	10.4	9.7	76.4	68.8	9.3	10.0	9.8	9.7	4.5	11.6	18.0	7.5	5.6	9.9	10.8	35.1	13.1	12.1	6.6	13.2	10.3	28.9	10.5	9.3	11.0	12.2	6.7	9.9	9.2	76.9	11.7	10.1	15.9	7.4	9.8	24.5	7.3	7.9	19.9	12.9	24.9	19.5	27.7	30.8	23.3	36.2	17.1	5.9	3.1	20.3	37.0	18.0	12.0	11.3	20.0	38.6	16.2	16.2	20.0	12.0	25.2	14.1	9.3	17.4	14.5	21.2	26.0	16.5	15.1	32.9	13.5	40.6	5.6	17.2	11.1	9.6	12.7	13.2	33.9	20.7	11.9	19.6	13.8	27.2	24.8	13.0	10.0	18.3	31.9	36.9	19.9	22.9	9.0	14.0	53.1	10.3	28.0	40.0	8.1	38.9	8.0	19.0	12.3	54.5	8.7	22.1	7.2	11.6	46.7	14.9	2.7	9.2	11.1	32.3	2.6	8.1	11.2	2.2	10.4	40.7	6.5	16.2	17.2	9.2	12.2	10.5	12.2	10.4	9.7	9.8	9.7	9.9	9.3	9.9	9.8	13.9	16.0	15.5	4.6	12.6	42.7	41.3	23.0	13.6	15.3	20.9	15.0	22.9	25.8	15.8	35.0	22.9	20.7	20.5	144.6	115.4	52.7	1.2	38.4	15.3	14.3	24.0	18.1	18.7	37.4	25.3	11.3	14.8	39.4	22.9	4.3	17.5	86.5	44.9	6.7	13.2	34.8	22.4	48.5	60.9	2.8	4.1	41.1	24.9	9.4	32.6	33.5	29.9	11.1	10.2	76.8	106.6	10.1	9.7	38.8	80.8	307.6	12.2	19.5	0.0	9.3	13.9	0.7	7.7	19.5	34.5	17.5	21.1	9.5	50.7	78.9
KDM1B	"AOF1, bA204B7.3, C6orf193, dJ298J15.2, FLJ33898, FLJ34109, FLJ43328, LSD2"	ENSG00000165097	"Lysine demethylase 1B"	Q8NB78	6	18155329-18223854	"Enzymes, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, Developmental protein, Oxidoreductase, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"dendritic cells: 3.7;granulocytes: 7.2;monocytes: 8.6"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031269, HPA055597"	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 21: OE19 - Mitochondria"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Nucleoplasm		"HPA031269: AB_10601587, HPA055597: "	"unprognostic (1.93e-1)"	"unprognostic (7.53e-2)"	"prognostic favorable (6.94e-4)"	"unprognostic (2.57e-2)"	"unprognostic (7.25e-2)"	"unprognostic (1.08e-1)"	"unprognostic (5.57e-3)"	"unprognostic (1.32e-2)"	"unprognostic (8.41e-2)"	"unprognostic (6.84e-2)"	"unprognostic (2.16e-1)"	"unprognostic (3.17e-2)"	"unprognostic (6.68e-2)"	"unprognostic (3.02e-2)"	"unprognostic (2.90e-1)"	"unprognostic (7.36e-2)"	"unprognostic (3.53e-1)"	5.9	7.6	5.6	11.4	7.6	27.2	6.3	5.3	7.8	7.6	7.6	14.1	8.0	5.7	3.7	9.1	13.4	6.0	6.8	6.6	5.9	7.8	7.4	8.8	10.4	6.9	6.7	6.7	5.9	3.2	5.8	4.6	6.1	5.2	12.2	12.0	5.7	4.7	17.3	11.2	8.9	6.9	6.2	10.5	5.6	15.7	5.6	10.8	27.2	9.1	9.4	7.7	8.1	9.4	15.1	9.7	11.2	23.0	13.8	20.5	24.5	11.7	12.6	7.5	10.2	16.3	7.4	34.1	31.6	19.2	22.8	15.5	17.8	20.8	16.0	31.6	14.6	17.2	8.6	15.0	6.7	25.5	17.5	10.3	23.4	21.5	17.7	12.1	7.7	15.9	38.3	5.2	12.7	12.6	14.1	10.5	3.8	31.6	12.8	26.8	20.3	24.4	10.7	19.8	34.2	10.6	9.7	23.5	22.9	11.7	22.3	20.3	6.5	16.9	9.5	11.9	15.5	5.2	15.9	20.0	6.4	18.9	37.8	1.2	4.6	7.2	0.5	8.6	0.3	1.2	0.5	0.5	3.7	1.3	0.5	0.2	4.9	0.3	6.9	1.6	0.7	1.3	5.6	7.6	5.3	7.8	6.6	5.9	6.9	6.7	6.1	6.2	5.6	9.4	4.9	0.0	8.2	14.7	8.7	12.7	5.7	3.8	7.4	5.0	7.6	6.6	10.4	11.5	10.4	1.8	10.4	2.7	3.0	23.0	1.9	6.6	0.7	36.2	10.0	4.2	6.7	3.8	19.0	4.3	5.1	5.8	8.2	15.5	2.5	3.3	4.2	7.7	7.5	5.0	10.8	9.6	10.2	36.7	11.7	0.7	3.7	20.6	7.2	22.5	27.7	6.6	8.2	16.1	23.8	7.2	21.2	6.8	3.7	5.4	6.2	11.2	21.0	15.5	0.0	6.9	6.2	0.7	18.2	9.7	15.9	1.4	5.6	3.1	10.6	6.6
DEK	D6S231E	ENSG00000124795	"DEK proto-oncogene"	P35659	6	18223860-18264548	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins"		"Chromatin regulator, DNA-binding"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015226, HPA054505, HPA057799"	Supported		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 42: Non-specific - Transcription"	"Cluster 9: Intestine - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	Cytosol	"CAB015226: , HPA054505: AB_2682508, HPA057799: AB_2683530"	"unprognostic (6.35e-2)"	"unprognostic (6.11e-2)"	"unprognostic (5.04e-3)"	"unprognostic (1.40e-2)"	"unprognostic (3.66e-1)"	"unprognostic (5.02e-3)"	"prognostic unfavorable (9.65e-4)"	"unprognostic (1.76e-1)"	"unprognostic (1.48e-2)"	"unprognostic (1.61e-3)"	"unprognostic (6.49e-3)"	"unprognostic (1.12e-2)"	"prognostic unfavorable (3.45e-4)"	"unprognostic (1.59e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.31e-1)"	"unprognostic (3.78e-1)"	50.8	43.0	17.3	82.4	20.1	158.6	63.1	29.6	25.4	48.1	19.8	74.8	76.9	74.2	29.9	65.4	45.6	49.0	61.0	17.3	18.3	46.0	68.0	53.2	125.5	19.5	20.4	61.4	40.3	43.3	19.3	67.7	20.8	56.2	74.2	46.3	37.3	56.1	116.0	49.8	86.8	63.9	18.2	63.8	58.7	22.1	19.5	116.8	102.3	73.4	112.8	59.3	43.0	26.1	450.1	118.6	330.9	276.6	68.9	118.4	184.2	347.4	210.9	338.9	457.1	190.7	165.5	504.2	390.2	181.8	269.1	251.1	260.7	196.2	591.3	346.5	221.3	305.7	179.9	260.0	70.3	499.2	238.2	58.2	98.1	238.2	198.2	164.7	170.9	188.1	392.9	0.6	236.5	156.2	380.3	222.1	208.6	177.4	131.8	471.7	459.7	299.8	184.2	239.6	196.1	183.8	328.9	290.5	224.6	218.4	277.8	212.7	168.7	382.7	220.0	223.9	474.1	32.4	77.0	540.3	95.0	251.3	380.8	116.2	78.2	41.8	69.6	74.9	83.1	66.3	72.5	78.0	72.9	56.1	55.6	55.7	93.4	70.9	92.9	49.0	75.2	67.8	17.3	20.1	29.6	25.4	17.3	18.3	19.5	20.4	20.8	18.2	19.5	26.1	149.7	121.8	130.8	16.3	126.2	271.2	189.8	128.8	146.3	70.3	143.3	161.3	218.8	161.5	112.0	79.1	81.3	284.2	174.5	156.7	82.2	172.0	17.4	118.8	157.7	156.6	88.5	448.8	10.4	173.1	235.4	159.6	85.1	170.6	111.2	195.1	105.7	125.1	190.9	26.9	18.6	188.1	67.1	185.3	300.7	26.2	189.5	219.1	101.4	31.9	263.3	136.2	212.1	26.2	37.1	136.9	117.3	191.5	44.0	252.9	140.0	129.5	89.0	138.8	210.4	189.1	197.0	87.2	220.7	169.9	233.6	108.6	189.1	138.6	232.5	209.2
RNF144B	"bA528A10.3, IBRDC2, P53RFP"	ENSG00000137393	"Ring finger protein 144B"	Q7Z419	6	18387350-18468870	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Apoptosis, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 56.9"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 634.4;Langerhans cells: 296.9;Suprabasal keratinocytes: 1501.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"non-classical monocyte: 71.9"	"Group enriched"	"Detected in many"	9	"dendritic cells: 18.4;granulocytes: 36.7;monocytes: 71.9"	"Cell line enhanced"	"Detected in many"		"Daudi: 192.8;hTCEpi: 59.1;HUVEC TERT2: 55.6;TIME: 56.1;U-698: 160.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB046013, HPA054127, HPA072469"	Uncertain		Approved	Nucleoli,Mitochondria		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 59: Non-specific - Translation"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 41: Macrophages - Immune response"	Nucleoli	Mitochondria	"CAB046013: AB_11126028, HPA054127: AB_2682391, HPA072469: "	"unprognostic (2.24e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.56e-1)"	"unprognostic (4.07e-2)"	"unprognostic (2.55e-1)"	"unprognostic (4.48e-3)"	"unprognostic (5.89e-2)"	"unprognostic (1.18e-2)"	"unprognostic (6.55e-2)"	"unprognostic (2.87e-3)"	"unprognostic (2.44e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.39e-1)"	"unprognostic (3.91e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.21e-1)"	9.4	2.0	7.4	15.6	7.4	24.0	29.1	7.9	9.0	9.5	9.1	4.2	1.8	5.7	4.7	8.4	11.8	6.2	8.1	6.4	7.7	14.0	15.5	19.4	11.3	11.8	11.9	1.6	3.2	2.9	1.7	15.1	9.4	13.1	2.8	5.0	16.9	7.3	56.9	21.1	3.3	6.2	8.9	13.1	5.7	2.3	10.5	5.1	40.9	14.1	12.9	9.4	7.1	8.7	4.6	1.0	0.4	0.0	0.3	2.0	9.8	5.3	5.7	11.0	11.8	0.1	0.4	192.8	50.7	2.3	0.6	16.3	0.1	16.0	15.5	0.9	1.4	0.2	0.2	4.2	0.2	0.2	0.2	2.7	59.1	4.3	13.2	4.9	55.6	4.3	0.1	0.0	2.7	2.0	1.5	0.0	1.6	0.6	1.1	0.7	1.7	11.8	33.2	10.6	1.9	0.2	1.2	23.9	18.5	1.5	28.2	0.5	56.1	8.6	1.9	0.8	1.2	0.0	0.1	160.6	1.0	0.4	0.7	0.4	20.7	12.9	0.5	38.9	1.6	4.6	0.8	0.6	13.3	3.6	1.6	1.0	36.7	0.6	71.9	18.4	0.5	7.1	7.4	7.4	7.9	9.0	6.4	7.7	11.8	11.9	9.4	8.9	10.5	8.7	28.8	44.8	15.0	34.9	21.7	634.4	48.8	86.0	14.8	0.9	35.7	26.3	12.8	17.2	48.3	38.6	2.1	14.1	9.8	2.2	19.6	8.6	2.1	49.0	5.8	34.6	1.2	3.8	2.3	8.9	3.7	7.8	10.7	58.5	3.8	0.1	47.2	21.9	15.0	0.0	99.0	1.8	14.2	109.4	296.9	1.8	1.2	171.7	60.5	92.8	54.1	17.9	1.0	3.5	2.5	5.2	3.6	3.0	3.4	112.3	0.9	20.6	36.7	1.2	0.0	9.0	7.8	2.2	3.2	30.0	1501.1	1.5	4.9	0.1	2.3	42.6
ID4	bHLHb27	ENSG00000172201	"Inhibitor of DNA binding 4, HLH protein"	P47928	6	19837370-19842197	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"thyroid gland: 274.7"	"Cell type enhanced"	"Detected in many"		"Breast myoepithelial cells: 246.6;Endometrial ciliated cells: 438.4;Endometrial stromal cells: 362.6;Glandular and luminal cells: 335.3;Muller glia cells: 391.8;Smooth muscle cells: 368.8"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 111.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 45.0;AN3-CA: 50.7;EFO-21: 105.1;HEK 293: 66.0;SCLC-21H: 117.0;SuSa: 37.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA075639			Supported	Nucleoplasm		NA	NA				"Cluster 57: Non-specific - Angiogenesis"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm		"HPA075639: "	"unprognostic (3.25e-3)"	"unprognostic (7.37e-3)"	"unprognostic (1.80e-1)"	"unprognostic (6.34e-3)"	"unprognostic (4.17e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.05e-1)"	"unprognostic (2.87e-1)"	"unprognostic (1.65e-2)"	"prognostic favorable (2.49e-4)"	"unprognostic (7.26e-2)"	"unprognostic (1.66e-3)"	"unprognostic (2.41e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.03e-3)"	"unprognostic (2.57e-3)"	74.6	5.0	50.1	7.5	47.6	0.2	41.7	33.6	55.4	41.0	22.8	9.8	7.2	30.0	9.4	21.7	70.3	10.2	75.7	48.0	59.6	30.8	4.4	27.8	5.0	42.8	60.8	48.4	19.1	2.5	36.4	22.2	42.2	29.7	6.7	19.4	27.1	44.0	3.6	107.8	11.9	21.0	43.6	20.2	19.8	23.0	58.5	2.0	274.7	3.1	2.1	31.4	33.1	40.2	0.0	0.6	45.0	50.7	1.2	0.1	0.1	5.8	0.1	0.4	0.0	0.0	0.0	0.0	105.1	14.1	0.2	20.3	0.0	0.0	0.4	0.0	66.0	0.0	0.0	0.5	0.3	0.0	0.5	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.2	8.1	6.3	0.0	0.0	0.0	0.2	7.6	14.2	117.0	1.5	0.0	1.8	7.2	37.6	3.2	0.0	0.0	0.2	5.6	0.1	1.6	0.0	0.1	1.1	1.6	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	50.1	47.6	33.6	55.4	48.0	59.6	42.8	60.8	42.2	43.6	58.5	40.2	31.8	96.1	53.0	229.9	1.9	83.1	190.8	16.7	232.8	11.2	143.8	246.6	42.5	7.2	19.6	68.0	2.1	9.9	2.9	15.6	50.9	18.0	2.1	438.4	362.6	19.9	91.6	0.0	1.8	3.3	9.5	83.9	118.3	335.3	0.0	17.6	23.9	0.0	2.7	3.3	1.2	23.4	22.4	0.6	24.8	7.9	8.1	5.3	88.9	2.8	0.0	391.8	0.0	0.5	0.3	1.4	27.1	0.0	1.4	93.6	8.2	76.0	8.4	13.7	0.0	76.3	368.8	1.2	44.9	119.6	78.6	5.9	6.1	0.7	7.8	42.4
MBOAT1	"dJ434O11.1, LPEAT1, MGC44669, OACT1"	ENSG00000172197	"Membrane bound O-acyltransferase domain containing 1"	Q6ZNC8	6	20099684-20212469	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Gastric mucus-secreting cells: 18.8;Langerhans cells: 25.2;Oligodendrocytes: 41.5;Respiratory ciliated cells: 19.1;Suprabasal keratinocytes: 15.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HaCaT: 42.2;HEL: 40.6;T-47d: 31.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"									NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 48: Smooth muscle cells - ECM organization"				"unprognostic (1.26e-2)"	"unprognostic (4.18e-2)"	"unprognostic (2.06e-2)"	"unprognostic (5.85e-3)"	"unprognostic (3.88e-2)"	"unprognostic (5.31e-2)"	"unprognostic (2.55e-2)"	"unprognostic (6.57e-3)"	"unprognostic (1.87e-1)"	"unprognostic (1.62e-3)"	"prognostic unfavorable (9.15e-4)"	"unprognostic (2.90e-2)"	"unprognostic (5.59e-2)"	"unprognostic (5.17e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.70e-1)"	"unprognostic (4.24e-2)"	7.3	3.3	1.4	6.0	3.6	11.1	12.5	4.6	2.4	13.3	1.9	19.2	13.8	14.2	5.8	10.5	21.7	8.4	5.9	1.1	2.1	6.1	4.5	7.4	5.4	7.4	3.8	12.5	5.8	5.7	2.4	4.0	6.3	9.3	18.9	1.2	8.1	5.3	1.9	6.8	16.4	8.4	4.6	7.3	15.2	1.4	4.1	2.7	7.6	2.2	5.2	8.6	10.9	9.4	4.5	4.7	8.3	6.6	0.9	2.7	0.6	7.1	2.0	4.4	5.1	2.3	19.0	0.0	14.5	6.8	3.9	42.2	7.6	3.6	6.3	11.3	4.5	40.6	7.9	0.1	5.5	10.6	11.9	1.2	3.6	1.9	8.1	2.3	2.4	7.1	5.4	7.2	1.0	4.7	6.3	10.1	2.1	4.4	2.3	2.0	9.1	25.0	5.9	8.7	0.4	5.3	1.4	8.6	9.0	15.9	31.2	5.3	2.0	6.0	4.2	3.6	3.4	9.7	20.9	0.1	0.6	7.9	7.9	39.9	27.6	66.8	3.9	33.3	20.2	2.6	9.1	7.2	15.1	1.6	2.6	2.6	34.4	4.4	41.1	18.5	13.5	7.9	1.4	3.6	4.6	2.4	1.1	2.1	7.4	3.8	6.3	4.6	4.1	9.4	1.3	3.2	0.5	0.3	1.7	11.0	0.9	3.5	4.6	0.0	2.4	1.3	0.4	0.0	6.6	0.0	0.0	0.1	3.7	3.5	1.9	2.7	0.0	4.7	3.1	2.5	0.0	8.4	1.1	1.2	0.1	6.4	18.8	7.5	0.0	1.9	1.1	0.0	1.5	0.0	0.5	2.0	2.0	1.0	25.2	0.0	0.3	4.4	8.8	6.5	4.5	1.3	0.0	0.0	41.5	1.5	7.7	0.0	1.5	0.8	5.5	0.0	19.1	0.1	0.0	1.0	3.6	0.0	0.1	5.4	15.5	0.3	6.4	10.4	3.0	1.8
E2F3		ENSG00000112242	"E2F transcription factor 3"	O00716	6	20401879-20493714	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Cell cycle, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 67.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029779, HPA065012"			Supported	"Nucleoplasm,Nuclear speckles,Cytosol"		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 56: Bipolar cells - Visual perception"	"Nucleoplasm, Nuclear speckles"	Cytosol	"HPA029779: AB_2732448, HPA065012: AB_2685403"	"unprognostic (4.10e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.80e-3)"	"unprognostic (2.96e-1)"	"unprognostic (9.14e-2)"	"unprognostic (8.99e-3)"	"unprognostic (9.13e-2)"	"unprognostic (1.10e-1)"	"prognostic favorable (1.69e-4)"	"unprognostic (1.14e-2)"	"unprognostic (5.64e-2)"	"prognostic unfavorable (1.63e-8)"	"unprognostic (1.23e-1)"	"unprognostic (2.16e-1)"	"unprognostic (3.50e-1)"	"unprognostic (5.99e-3)"	6.5	4.9	4.8	9.8	5.2	19.8	4.1	2.8	5.7	3.3	3.0	5.4	5.2	3.6	3.9	4.9	2.5	6.4	5.1	6.4	4.6	5.8	4.4	4.9	11.0	3.7	4.6	1.4	2.1	3.1	1.8	5.6	4.2	3.3	6.3	6.1	2.7	3.1	10.0	2.6	5.7	6.0	3.7	8.4	3.6	3.4	5.5	8.6	8.5	9.3	9.5	8.5	2.7	3.8	14.3	11.6	32.2	35.1	10.9	11.9	22.0	18.9	16.8	18.2	19.9	14.3	8.8	32.3	35.2	18.2	16.9	14.6	37.8	17.4	30.3	12.2	25.3	58.1	20.4	16.3	11.6	38.6	33.0	9.7	12.6	17.7	21.6	18.8	12.7	29.8	65.3	19.4	20.9	15.0	43.6	43.2	24.2	11.0	11.9	46.5	27.8	36.5	21.8	25.1	22.9	42.2	17.3	24.1	26.3	20.0	12.4	23.4	17.2	28.6	17.4	14.2	30.5	12.1	40.1	38.3	7.1	23.2	41.3	5.6	2.3	1.1	1.6	1.6	2.0	0.4	1.0	2.4	2.6	0.4	0.8	1.8	7.2	3.5	1.1	1.1	1.6	1.1	4.8	5.2	2.8	5.7	6.4	4.6	3.7	4.6	4.2	3.7	5.5	3.8	4.8	0.0	2.6	53.8	10.6	9.2	12.3	7.0	7.4	34.1	11.9	7.2	10.6	4.3	10.6	7.3	22.9	8.3	15.0	12.0	9.8	7.6	12.2	3.9	14.1	8.5	12.0	17.2	67.7	6.9	13.8	9.2	12.8	10.6	20.3	32.3	14.6	4.7	17.1	32.0	31.9	11.7	4.1	47.2	17.7	5.7	2.8	28.7	5.4	27.2	23.8	2.9	15.5	37.7	2.9	14.8	10.3	3.0	19.1	22.1	4.5	25.1	2.2	9.0	0.0	9.0	11.5	3.0	4.7	16.5	8.9	3.1	15.3	5.7	13.8	18.4
CDKAL1	FLJ20342	ENSG00000145996	"CDK5 regulatory subunit associated protein 1 like 1"	Q5VV42	6	20534457-21232404	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"tRNA processing"	Transferase	"Diabetes mellitus"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"Astrocytes: 133.2;Excitatory neurons: 159.5;Inhibitory neurons: 134.1;Microglial cells: 198.6;Oligodendrocyte precursor cells: 198.5;Oligodendrocytes: 255.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	5	"SCLC-21H: 188.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"				"unprognostic (9.64e-2)"	"unprognostic (7.23e-3)"	"unprognostic (8.40e-2)"	"prognostic unfavorable (1.03e-4)"	"unprognostic (1.05e-1)"	"unprognostic (1.51e-2)"	"unprognostic (3.47e-2)"	"unprognostic (4.25e-3)"	"unprognostic (6.72e-3)"	"unprognostic (1.61e-3)"	"unprognostic (1.42e-1)"	"unprognostic (3.73e-2)"	"unprognostic (5.79e-3)"	"unprognostic (3.11e-2)"	"unprognostic (1.75e-2)"	"unprognostic (1.83e-2)"	"unprognostic (2.60e-2)"	5.6	4.0	3.6	5.8	5.7	9.5	6.9	7.2	4.3	6.6	5.8	5.2	4.6	8.1	5.8	4.9	6.8	6.3	4.7	3.5	4.9	5.6	5.4	5.5	8.2	6.5	4.9	8.5	5.7	6.5	4.0	6.6	6.5	5.5	6.5	5.3	5.9	4.9	14.0	7.4	5.1	6.4	4.8	7.2	5.8	6.7	4.9	9.6	9.4	9.5	8.6	5.7	5.1	9.0	8.7	5.3	12.1	15.6	6.7	9.0	12.8	9.0	8.2	13.0	17.1	9.8	7.7	20.7	22.0	7.7	14.1	8.6	16.5	9.1	17.3	37.3	9.1	17.7	9.1	13.3	8.7	17.6	11.7	8.2	9.4	12.5	11.5	8.0	12.0	12.6	23.3	8.2	9.7	7.3	22.4	21.0	8.5	8.9	5.8	13.1	16.1	19.5	16.6	9.9	188.5	11.1	10.0	16.0	13.2	10.2	11.7	8.8	11.7	15.2	10.4	6.1	16.8	12.9	36.8	17.7	5.5	9.9	26.0	1.5	3.3	3.1	6.4	5.3	5.3	7.0	6.3	6.5	4.4	6.4	7.7	7.1	1.5	10.3	11.2	4.6	7.4	3.5	3.6	5.7	7.2	4.3	3.5	4.9	6.5	4.9	6.5	4.8	4.9	9.0	13.9	6.4	4.6	133.2	19.5	10.5	10.9	5.2	9.1	8.7	8.7	6.0	9.0	4.3	8.1	7.3	6.2	9.4	12.2	4.6	11.7	8.3	15.4	16.9	13.6	12.2	33.4	6.7	159.5	7.8	10.0	9.4	13.3	18.5	13.3	12.5	8.2	6.4	7.1	11.8	134.1	8.5	14.2	6.1	7.6	6.3	8.7	9.5	3.6	198.6	13.2	6.0	10.3	198.5	255.4	8.8	5.8	4.5	20.8	4.1	5.4	10.7	4.7	10.8	6.6	14.2	9.7	13.3	11.8	9.5	10.5	9.0	17.4	5.0	7.1	6.3
SOX4		ENSG00000124766	"SRY-box transcription factor 4"	Q06945	6	21593751-21598619	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 73.4"	"Cell type enhanced"	"Detected in many"		"Ductal cells: 1128.5;Granulosa cells: 1047.5;Ionocytes: 1320.3;Pancreatic endocrine cells: 1288.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 45.7"	"Group enriched"	"Detected in all"	5	"dendritic cells: 45.7;granulocytes: 33.3;monocytes: 22.0"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 254.1;MOLT-4: 229.9"	"Region enhanced"	"Detected in all"		"olfactory bulb: 54.2"					HPA029901	Approved		Supported	Nucleoplasm,Mitochondria		NA	Yes			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 34: Non-specific - Transcription"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm	Mitochondria	"HPA029901: AB_10601592"	"unprognostic (4.01e-2)"	"unprognostic (3.06e-1)"	"unprognostic (9.28e-2)"	"unprognostic (5.18e-2)"	"unprognostic (5.00e-2)"	"unprognostic (1.08e-2)"	"prognostic unfavorable (2.57e-5)"	"unprognostic (1.78e-1)"	"unprognostic (8.01e-3)"	"unprognostic (1.98e-2)"	"unprognostic (3.88e-3)"	"unprognostic (1.18e-1)"	"unprognostic (8.73e-3)"	"unprognostic (3.66e-2)"	"unprognostic (3.31e-1)"	"unprognostic (2.01e-1)"	"unprognostic (9.27e-2)"	11.8	4.3	4.7	9.2	5.0	24.0	17.9	8.8	6.7	21.5	2.8	11.9	12.5	57.8	15.0	5.4	13.5	20.4	6.4	4.2	6.5	16.8	6.4	19.3	5.8	3.5	5.0	51.7	10.2	3.6	4.1	6.1	4.1	14.5	14.4	6.4	17.5	6.8	3.5	8.8	11.6	17.4	4.0	5.4	17.5	9.9	7.1	73.4	8.6	6.1	7.4	21.1	7.7	4.2	8.5	24.4	60.5	254.1	22.0	5.5	98.7	3.8	7.8	4.6	4.1	16.7	16.5	2.9	100.2	6.2	3.5	25.1	32.0	17.9	3.3	36.6	66.8	2.7	11.5	11.2	3.5	9.0	2.1	9.6	18.1	2.1	7.3	64.1	72.3	138.8	0.6	0.2	5.2	20.6	229.9	21.6	45.3	12.7	23.1	99.7	5.3	0.4	44.1	78.3	78.9	141.2	35.9	41.1	14.0	74.9	20.1	30.9	55.7	7.1	23.1	1.7	18.6	1.5	0.1	71.8	2.4	30.6	28.5	33.3	19.3	2.1	0.5	11.7	0.1	7.0	0.3	0.3	8.7	6.6	2.2	1.6	0.8	7.4	22.0	45.7	2.1	4.7	4.7	5.0	8.8	6.7	4.2	6.5	3.5	5.0	4.1	4.0	7.1	4.2	235.0	198.7	50.4	0.7	36.2	112.5	129.2	660.7	676.7	99.7	586.1	676.5	297.4	423.2	457.3	154.5	12.5	74.8	104.4	247.6	66.5	1128.5	6.1	669.0	624.2	264.5	340.8	114.3	3.2	604.4	409.4	247.3	313.0	650.9	60.6	1047.5	119.2	6.8	35.5	48.8	4.6	263.0	1320.3	78.0	266.7	12.2	12.2	94.0	243.7	3.7	91.4	189.1	17.5	70.4	1.0	1288.2	153.8	11.3	40.9	151.1	76.7	132.5	162.1	31.6	6.6	234.2	439.9	4.9	236.8	400.7	93.1	30.2	36.6	69.6	299.4	272.5
PRL		ENSG00000172179	Prolactin	P01236	6	22287244-22302826	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"	Lactation	Hormone	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	1022	"pituitary gland: 37505.3"	"Group enriched"	"Detected in some"	5	"Early spermatids: 13.8;Late spermatids: 28.4;Rod photoreceptor cells: 14.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Daudi: 31.0;SCLC-21H: 8.9;U-937: 5.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB023353, HPA042416, HPA062017"	Enhanced				"Secreted to blood"	NA	NA	53900000	7200000		"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 25: Spermatids - Spermatogenesis"			"CAB023353: AB_617369, HPA042416: AB_2677987, HPA062017: AB_2684660"	"unprognostic (1.66e-1)"	"unprognostic (4.08e-3)"	"unprognostic (5.89e-3)"	"unprognostic (4.83e-3)"	"unprognostic (2.87e-1)"			"unprognostic (1.11e-4)"	"unprognostic (4.54e-1)"	"unprognostic (1.57e-1)"	"unprognostic (3.79e-2)"			"unprognostic (4.29e-5)"	"unprognostic (2.20e-1)"			3.2	11.2	0.3	1.4	0.0	0.0	1.2	0.6	0.1	0.8	0.1	2.7	0.1	11.5	0.0	11.7	1.6	0.1	4.6	0.0	0.2	2.4	9.6	2.1	0.0	0.9	0.7	4.0	5.5	0.0	37505.3	36.6	1.1	2.3	0.0	33.7	3.6	0.0	2.4	7.7	2.5	2.2	0.0	4.0	19.3	4.0	1.0	4.0	14.2	0.0	0.0	0.4	1.6	0.1	0.0	0.0	0.3	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	31.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.9	0.1	0.4	0.0	0.2	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	5.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.1	0.3	0.0	0.6	0.1	0.0	0.2	0.9	0.7	1.1	0.0	1.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.1	0.0	0.1	0.0	0.0	13.8	0.1	3.5	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	28.4	0.3	0.0	0.0	0.0	0.1	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.6	0.0	2.5	1.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0
HDGFL1	"dJ309H15.1, Hdgfrp1, HRP-1, PWWP1"	ENSG00000112273	"HDGF like 1"	Q5TGJ6	6	22569566-22571666	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	215	"testis: 91.1"	"Group enriched"	"Detected in some"	5	"Early spermatids: 130.5;Late spermatids: 120.2;Spermatocytes: 165.6"	"Cancer enriched"	"Detected in some"	41	"testis cancer: 21.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	8	"K-562: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA045679, HPA063707"	Enhanced		Approved	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA				"Cluster 74: Testis - Spermatogenesis"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoplasm, Nucleoli fibrillar center"		"HPA045679: AB_2679415, HPA063707: AB_2685099"						"unprognostic (1.55e-1)"									"unprognostic (6.18e-2)"		"unprognostic (4.03e-2)"	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	91.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	130.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	120.2	5.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.1	0.0	0.0	6.6	0.0	0.0	165.6	24.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NRSN1	"p24, VMP"	ENSG00000152954	"Neurensin 1"	Q8IZ57	6	24126186-24154900	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	22	"brain: 542.9;choroid plexus: 474.7"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 139.1;Horizontal cells: 121.1;Inhibitory neurons: 111.9;Oligodendrocyte precursor cells: 69.9"	"Cancer enriched"	"Detected in single"	17	"glioma: 3.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	11	"SCLC-21H: 11.2;SH-SY5Y: 9.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019681, HPA061006"	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane, Cytosol"		"HPA019681: , HPA061006: AB_2684413"	"unprognostic (1.22e-1)"		"unprognostic (4.26e-2)"	"unprognostic (8.00e-3)"	"unprognostic (8.01e-3)"					"unprognostic (1.70e-1)"	"unprognostic (4.53e-3)"	"unprognostic (7.29e-2)"	"unprognostic (1.36e-3)"	"unprognostic (2.40e-3)"	"unprognostic (1.45e-1)"	"unprognostic (1.57e-1)"		0.0	4.9	276.8	0.4	315.2	0.2	0.0	108.9	281.1	0.1	474.7	1.2	0.4	0.2	0.0	0.1	0.0	0.2	0.0	138.2	466.8	0.1	0.0	0.0	0.1	263.2	332.8	0.0	1.2	0.0	23.5	0.0	468.0	0.0	0.4	22.6	0.1	0.0	0.7	0.1	0.3	0.3	194.7	0.1	0.4	0.3	459.9	0.0	0.1	0.0	0.1	0.0	0.1	542.9	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.5	0.4	0.1	0.1	0.1	0.1	0.2	0.0	0.1	0.0	0.0	0.2	0.0	0.0	11.2	9.2	0.0	0.0	0.2	0.1	0.0	0.9	0.1	0.1	0.1	0.0	0.0	0.3	0.5	0.2	0.3	0.0	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	276.8	315.2	108.9	281.1	138.2	466.8	263.2	332.8	468.0	194.7	459.9	542.9	0.0	0.0	0.0	17.3	0.0	0.0	0.0	0.0	0.0	27.9	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.8	0.0	0.1	0.0	0.0	139.1	0.0	0.0	0.0	0.0	1.2	0.0	0.1	0.0	0.0	0.0	121.1	111.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	12.2	0.0	23.7	0.0	69.9	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DCDC2	"DCDC2A, DFNB66, KIAA1154, NPHP19, RU2"	ENSG00000146038	"Doublecortin domain containing 2"	Q9UHG0	6	24171755-24358059	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cilium biogenesis/degradation, Neurogenesis"		"Ciliopathy, Deafness, Disease variant, Nephronophthisis, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 15.1;kidney: 23.2;pancreas: 26.2"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 62.9;Collecting duct cells: 79.1;Distal tubular cells: 56.7;Ductal cells: 135.9;Endometrial ciliated cells: 160.3;Glandular and luminal cells: 102.4;Proximal tubular cells: 54.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 71.8;EFO-21: 48.3;Hep G2: 82.3;RPTEC TERT1: 254.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA031582, HPA031583, HPA031584"	Enhanced		Supported	"Microtubules,Mitotic spindle,Centriolar satellite,Cytosol"		Yes	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 44: Endometrium - Transcription"	Cytosol	"Microtubules, Mitotic spindle, Centriolar satellite"	"HPA031582: AB_10600901, HPA031583: AB_2673944, HPA031584: AB_2673945"	"unprognostic (8.65e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.66e-1)"	"unprognostic (6.70e-2)"	"unprognostic (1.08e-2)"	"unprognostic (3.22e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.90e-1)"	"unprognostic (7.87e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.67e-2)"	"unprognostic (5.22e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.12e-2)"	"unprognostic (2.99e-2)"	0.0	1.3	0.8	0.0	1.2	0.1	4.4	0.3	0.8	1.6	15.1	0.7	0.6	4.4	5.3	0.0	7.6	3.9	0.0	0.8	1.0	23.2	2.2	3.4	0.0	2.2	2.7	0.2	26.2	8.2	1.2	0.6	1.7	1.2	0.6	1.4	0.4	2.3	0.3	0.1	0.1	0.1	2.0	0.1	1.8	3.7	1.1	0.1	8.2	0.2	0.0	0.4	0.0	1.6	0.0	8.8	0.5	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.0	71.8	0.2	0.0	48.3	0.0	0.1	0.0	0.0	0.1	0.1	0.0	8.2	0.0	0.0	82.3	0.0	0.0	0.0	0.0	0.0	9.7	0.0	1.4	0.0	0.2	0.1	0.0	0.3	10.8	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	254.5	0.3	5.2	0.5	0.0	1.3	0.0	0.2	12.3	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.5	0.5	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.8	1.2	0.3	0.8	0.8	1.0	2.2	2.7	1.7	2.0	1.1	1.6	0.2	19.2	14.4	3.9	1.4	0.1	0.6	0.3	0.0	0.0	20.3	11.7	0.3	62.9	6.1	79.1	0.0	0.4	0.0	1.2	56.7	135.9	40.1	160.3	5.3	0.4	3.6	0.0	11.3	8.4	0.0	1.3	3.6	102.4	0.0	4.1	0.0	1.0	0.5	0.0	8.3	2.9	0.0	0.0	0.0	14.6	0.3	1.0	0.0	1.0	2.0	2.3	0.0	1.0	0.5	27.9	4.1	0.4	0.0	1.3	0.0	54.3	37.1	0.1	0.0	0.0	2.4	32.3	2.6	0.0	0.1	0.1	1.1	5.6	2.7	0.9
KAAG1	"RU2, RU2AS"	ENSG00000146049	"Kidney associated antigen 1"	Q9UBP8	6	24356903-24358285	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"kidney: 4.6;pancreas: 1.2"	"Group enriched"	"Detected in some"	4	"Endometrial ciliated cells: 3.7;Glandular and luminal cells: 2.7;Proximal tubular cells: 1.1;Spermatocytes: 2.2"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 1.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"CACO-2: 5.2;EFO-21: 4.1;Hep G2: 5.3"									HPA036021	Approved					NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 44: Endometrium - Transcription"			"HPA036021: AB_10601918"	"unprognostic (7.57e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.47e-2)"	"unprognostic (5.77e-2)"		"unprognostic (1.87e-1)"	"unprognostic (2.26e-1)"	"unprognostic (2.65e-1)"	"unprognostic (3.32e-2)"	"unprognostic (3.58e-2)"	"unprognostic (3.05e-1)"	"unprognostic (3.05e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.23e-2)"	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.1	4.6	0.9	0.0	0.0	0.1	0.3	0.0	1.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.1	0.1	0.3	0.0	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.3	3.7	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	2.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.1	2.2	0.1	0.0	0.0	0.0	0.0	0.2	0.2	0.1
MRS2	MRS2L	ENSG00000124532	"Magnesium transporter MRS2"	Q9HD23	6	24402908-24426194	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017642	Uncertain					NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA017642: AB_2669628"	"unprognostic (2.12e-3)"	"unprognostic (1.22e-1)"	"unprognostic (5.64e-3)"	"prognostic unfavorable (5.32e-4)"	"unprognostic (7.23e-2)"	"unprognostic (8.57e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.20e-1)"	"unprognostic (3.89e-3)"	"prognostic favorable (5.14e-11)"	"unprognostic (8.75e-2)"	"unprognostic (2.94e-2)"	"unprognostic (8.32e-2)"	"unprognostic (2.53e-1)"	"unprognostic (8.56e-2)"	"prognostic unfavorable (8.03e-4)"	"unprognostic (1.55e-3)"	14.6	17.0	10.7	12.0	11.8	6.7	14.3	17.1	13.7	10.9	15.4	14.1	15.4	10.3	14.1	14.1	10.2	9.3	30.7	11.2	12.2	24.2	20.5	10.9	14.9	10.8	11.7	12.3	18.8	22.5	13.4	16.4	11.2	12.8	15.4	30.1	15.9	13.4	52.9	12.3	12.1	10.7	10.9	11.4	15.7	6.3	12.2	8.7	16.3	49.4	14.8	13.2	11.5	11.4	36.7	21.0	24.7	46.3	15.9	14.4	54.8	16.6	19.3	20.5	18.5	80.9	16.9	21.2	67.3	14.6	32.2	21.8	25.6	31.6	22.0	26.8	44.9	33.6	16.4	93.7	23.0	38.7	30.0	22.8	24.7	20.9	16.7	23.8	22.2	27.2	49.5	0.0	22.6	28.9	37.1	35.3	64.6	20.6	18.9	0.2	4.3	48.4	90.5	37.1	39.3	23.7	28.1	84.9	46.5	72.0	43.3	26.3	9.6	9.1	13.8	18.9	30.8	37.4	68.1	29.4	11.3	45.4	38.3	3.4	16.8	7.3	11.6	20.2	14.9	14.4	12.4	12.5	24.8	11.9	13.4	12.6	1.9	15.3	18.8	14.8	11.5	12.1	10.7	11.8	17.1	13.7	11.2	12.2	10.8	11.7	11.2	10.9	12.2	11.4	10.5	35.3	20.0	18.6	18.0	7.1	13.6	18.8	16.5	33.5	15.7	10.4	55.6	20.0	16.4	20.2	39.6	46.5	23.3	13.6	52.8	22.6	0.6	15.7	11.5	11.3	9.6	17.1	33.7	19.1	24.6	14.8	13.3	12.9	12.0	23.3	11.4	14.4	21.9	50.5	35.6	15.4	22.4	15.8	10.0	0.7	12.2	14.8	7.2	9.4	19.6	21.8	16.5	15.1	16.5	15.9	14.9	16.6	19.7	14.7	20.0	40.7	14.4	43.6	19.7	9.2	12.9	5.4	11.6	22.7	11.2	25.3	13.1	27.2	22.3	15.7
GPLD1		ENSG00000112293	"Glycosylphosphatidylinositol specific phospholipase D1"	P80108	6	24424565-24495205	"Enzymes, Metabolic proteins, Plasma proteins, Predicted secreted proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"liver: 46.1"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 68.8;Excitatory neurons: 62.4;Hepatocytes: 66.8;Inhibitory neurons: 78.3;Oligodendrocyte precursor cells: 33.2"	"Cancer enriched"	"Detected in some"	11	"liver cancer: 6.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Daudi: 7.6;U-698: 8.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008625, HPA012500"	Uncertain				"Secreted to blood"	NA	NA	103000000000	3100000000	"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"CAB008625: AB_1621070, HPA012500: AB_1849931"	"unprognostic (6.80e-3)"	"unprognostic (2.27e-1)"	"unprognostic (1.59e-1)"	"unprognostic (4.81e-5)"	"unprognostic (3.65e-1)"	"unprognostic (1.02e-1)"	"prognostic favorable (1.12e-4)"	"unprognostic (6.37e-4)"	"unprognostic (7.93e-2)"	"unprognostic (2.86e-2)"	"unprognostic (6.07e-4)"	"unprognostic (2.68e-1)"	"unprognostic (5.28e-4)"	"unprognostic (2.20e-1)"	"unprognostic (9.98e-2)"	"unprognostic (3.73e-2)"	"unprognostic (1.22e-1)"	4.2	0.9	2.0	0.6	1.7	0.9	1.3	7.6	4.7	1.1	0.1	1.0	0.5	1.6	1.7	1.1	0.9	0.6	0.5	1.3	2.4	0.6	46.1	0.9	0.9	1.8	1.9	1.2	0.6	2.5	1.7	0.2	1.9	1.8	0.6	6.2	0.4	4.8	1.7	8.6	0.4	1.4	0.6	0.6	0.7	1.4	1.4	5.1	2.4	0.6	1.3	1.1	1.5	2.1	0.5	0.7	0.8	1.2	0.0	0.0	2.0	0.1	0.2	0.2	0.1	3.5	0.1	7.6	0.8	0.1	0.2	0.1	1.2	0.2	0.1	0.9	2.1	1.1	0.9	3.2	0.0	1.4	0.2	0.0	0.1	0.0	0.0	0.8	0.0	1.8	0.5	0.3	0.1	0.5	0.7	0.5	2.9	0.5	0.3	1.4	0.2	0.1	0.4	3.4	2.0	2.3	0.9	0.1	0.4	0.6	0.4	0.3	0.1	0.7	0.9	0.1	1.0	2.4	3.4	8.1	0.1	0.3	0.3	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.3	0.1	0.1	0.0	0.2	0.1	0.0	2.0	1.7	7.6	4.7	1.3	2.4	1.8	1.9	1.9	0.6	1.4	2.1	0.4	0.0	3.7	24.8	1.1	0.0	0.7	2.8	0.6	19.6	0.7	0.4	11.6	0.0	1.7	1.8	68.8	0.3	1.6	0.1	0.0	0.4	3.5	0.5	0.6	1.2	1.8	7.4	62.4	0.4	0.3	1.3	0.0	0.3	0.0	2.1	1.4	66.8	0.1	15.2	78.3	0.3	0.0	1.3	0.0	3.4	3.1	0.1	0.0	9.4	0.1	4.0	3.1	33.2	3.1	0.1	0.1	3.4	3.1	0.3	0.1	0.5	1.1	10.9	0.0	3.6	1.4	0.5	5.8	0.3	0.6	0.0	0.5	0.9	0.5	2.6
ALDH5A1	"SSADH, SSDH"	ENSG00000112294	"Aldehyde dehydrogenase 5 family member A1"	P51649	6	24494867-24537207	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 98.8"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 90.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Daudi: 136.6;U-698: 173.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029715, HPA029716"	Enhanced		Supported	Mitochondria		NA	NA		50000	"Cluster 30: Non-specific - Translation"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Mitochondria		"HPA029715: AB_10599994, HPA029716: AB_10601876"	"unprognostic (7.43e-2)"	"unprognostic (1.12e-3)"	"unprognostic (1.80e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.23e-1)"	"unprognostic (3.27e-1)"	"prognostic favorable (7.61e-6)"	"unprognostic (2.38e-2)"	"unprognostic (2.17e-2)"	"prognostic favorable (6.20e-4)"	"unprognostic (1.43e-2)"	"unprognostic (1.21e-1)"	"prognostic favorable (3.68e-4)"	"unprognostic (1.04e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.00e-2)"	"unprognostic (1.08e-2)"	9.4	6.1	27.8	5.9	28.9	4.4	5.2	25.0	32.7	5.4	18.8	8.5	11.8	4.8	3.7	7.3	19.0	5.1	14.5	26.5	32.8	27.8	98.8	6.4	13.6	26.7	35.0	7.3	8.2	19.4	5.8	2.4	27.3	8.2	7.1	11.0	5.2	5.2	57.9	9.5	8.0	3.1	29.4	6.8	7.7	4.5	34.0	26.8	17.0	33.8	12.9	6.7	8.4	24.9	11.5	9.3	6.5	10.1	0.1	0.0	11.7	0.8	2.0	2.4	1.6	35.1	2.5	136.6	21.1	1.0	2.2	0.1	10.5	1.3	1.5	14.7	20.2	20.7	5.9	42.4	1.6	32.2	2.7	1.0	4.4	0.2	0.0	7.1	0.1	34.7	10.4	0.0	1.8	23.3	40.4	19.0	2.7	18.4	5.5	46.1	1.4	1.3	7.7	19.6	11.7	10.5	12.1	1.2	13.2	2.8	19.4	17.5	0.2	1.1	6.7	0.3	7.1	19.4	32.2	173.7	0.2	9.8	1.4	0.3	0.0	0.1	1.0	0.0	1.9	2.2	1.4	1.5	0.1	2.0	3.8	3.4	0.2	0.8	0.1	2.4	0.9	0.7	27.8	28.9	25.0	32.7	26.5	32.8	26.7	35.0	27.3	29.4	34.0	24.9	2.9	16.0	25.3	14.0	9.7	1.7	5.6	8.2	2.2	12.9	7.5	3.4	34.8	11.5	9.4	7.3	16.7	6.1	7.4	6.1	1.9	1.6	0.8	15.2	5.0	3.7	8.4	16.0	18.1	1.0	5.2	3.5	5.6	5.4	7.0	13.5	6.8	90.7	3.9	16.8	32.4	11.7	2.0	3.8	1.8	0.3	3.4	1.7	1.8	8.4	0.2	11.8	3.1	11.6	2.4	1.3	7.7	4.5	12.2	4.1	13.4	26.8	12.8	6.9	0.0	6.9	2.3	1.7	6.6	8.7	3.0	1.9	5.4	8.0	17.0	13.1
KIAA0319	NMIG	ENSG00000137261	KIAA0319	Q5VV43	6	24544104-24646191	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted membrane proteins, Predicted secreted proteins"	Neurogenesis	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 12.3;pituitary gland: 4.1"	"Group enriched"	"Detected in some"	8	"Astrocytes: 119.5;Early spermatids: 65.6;Excitatory neurons: 129.2;Inhibitory neurons: 72.7;Late spermatids: 96.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 1.6"	"Lineage enhanced"	"Detected in single"		"granulocytes: 1.6"	"Cell line enhanced"	"Detected in some"		"A-431: 2.0;A549: 2.0;GAMG: 2.1;HDLM-2: 2.4;HeLa: 1.9;SCLC-21H: 3.8;U-266/84: 3.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015607, HPA076313"	Enhanced	Supported	Approved	Vesicles	"Secreted in brain"	NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 65: Brain - Ion transport"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Vesicles		"HPA015607: AB_1852299, HPA076313: AB_2732308"	"unprognostic (1.64e-1)"	"unprognostic (2.81e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.72e-2)"	"unprognostic (4.65e-2)"	"unprognostic (9.70e-2)"	"unprognostic (2.21e-5)"	"unprognostic (7.88e-4)"	"unprognostic (9.53e-4)"	"unprognostic (1.44e-6)"	"unprognostic (1.20e-1)"	"unprognostic (6.97e-2)"	"unprognostic (3.13e-1)"	"unprognostic (3.41e-2)"	0.0	0.4	10.0	0.2	10.3	0.0	0.1	4.3	10.4	0.1	0.6	0.4	0.0	0.0	0.0	0.0	1.6	0.2	0.0	9.2	5.8	0.0	0.0	0.6	0.0	7.2	7.4	0.0	1.4	0.1	4.1	0.0	7.6	0.4	0.4	1.2	0.2	0.0	0.0	0.7	0.2	0.1	2.7	0.2	0.8	1.1	12.3	0.0	0.0	0.0	0.1	0.0	0.0	4.8	2.0	2.0	0.1	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.8	0.6	0.9	0.0	2.1	0.8	0.3	0.0	0.0	2.4	1.0	0.0	1.9	0.1	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.1	0.0	1.0	0.0	0.1	0.0	0.5	0.0	0.0	0.2	0.1	0.1	0.1	0.0	0.3	0.0	0.1	3.8	0.2	0.0	1.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.1	0.4	0.3	3.2	0.1	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	10.0	10.3	4.3	10.4	9.2	5.8	7.2	7.4	7.6	2.7	12.3	4.8	0.1	3.2	0.5	119.5	0.6	0.0	0.0	0.5	0.0	3.6	0.1	0.1	1.4	0.0	1.5	0.0	0.0	0.0	0.0	1.4	0.0	0.4	65.6	2.6	0.1	0.0	10.2	0.0	129.2	0.0	0.0	0.3	0.5	0.1	0.0	0.1	0.0	0.0	0.0	0.0	72.7	0.8	0.0	0.0	0.0	96.8	0.6	0.2	0.0	5.6	0.6	0.3	0.0	5.0	3.1	0.3	0.1	0.7	0.0	0.2	0.0	0.1	10.9	0.9	0.0	0.1	0.0	1.2	1.5	0.0	0.0	0.7	0.1	0.1	0.3	0.3
TDP2	TTRAP	ENSG00000111802	"Tyrosyl-DNA phosphodiesterase 2"	O95551	6	24649979-24666930	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"DNA damage, DNA repair, Host-virus interaction"	"Hydrolase, Nuclease"	"Mental retardation, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 183.2"	"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 530.9;Paneth cells: 428.1;Proximal enterocytes: 637.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"basophil: 75.6;neutrophil: 228.9"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 228.9"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB073398, HPA074011"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies"	"Intracellular and membrane"	No	No			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 9: Intestine - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 45: Enterocytes - Digestion"	"Nucleoplasm, Nuclear bodies"		"CAB073398: , HPA074011: AB_2686651"	"unprognostic (2.46e-2)"	"unprognostic (2.10e-3)"	"unprognostic (1.83e-1)"	"unprognostic (2.19e-2)"	"unprognostic (2.58e-1)"	"unprognostic (4.66e-3)"	"unprognostic (4.13e-3)"	"unprognostic (3.24e-1)"	"unprognostic (5.78e-3)"	"prognostic favorable (2.53e-7)"	"unprognostic (1.20e-2)"	"prognostic unfavorable (1.86e-4)"	"unprognostic (1.40e-2)"	"unprognostic (1.42e-1)"	"unprognostic (9.70e-3)"	"unprognostic (1.14e-1)"	"prognostic favorable (1.47e-5)"	24.4	23.7	27.4	34.3	28.4	21.8	27.3	30.4	36.4	20.6	30.4	141.6	120.1	19.7	25.3	18.6	22.6	28.6	28.2	28.0	28.9	77.9	51.2	24.5	38.9	28.2	29.5	21.3	29.5	25.7	20.3	20.1	28.7	56.5	127.4	18.9	21.9	21.7	21.9	21.1	183.2	24.6	28.3	27.9	26.2	25.3	32.1	37.5	21.7	26.3	37.7	27.2	16.5	28.3	47.7	37.1	41.5	48.1	63.0	64.0	32.4	41.4	53.1	38.9	51.9	50.8	26.3	57.0	70.1	43.8	90.0	34.2	51.2	47.3	52.9	73.6	53.1	53.4	37.7	84.2	40.1	82.8	49.5	43.1	43.7	40.7	36.5	46.0	63.9	54.1	48.8	23.7	59.2	34.1	64.7	52.8	37.1	54.7	31.8	55.5	43.7	61.6	67.0	66.5	52.2	29.8	33.6	84.5	71.0	42.2	38.9	47.4	48.0	37.6	31.3	28.3	61.4	33.7	107.9	77.1	26.0	107.5	61.3	75.6	13.9	29.4	25.0	14.8	30.8	20.0	28.8	27.9	13.2	14.5	24.0	26.2	228.9	29.0	16.5	12.4	31.9	22.7	27.4	28.4	30.4	36.4	28.0	28.9	28.2	29.5	28.7	28.3	32.1	28.3	24.0	6.4	16.7	23.5	24.1	14.1	25.1	37.0	18.8	12.7	19.8	20.2	23.4	37.1	29.6	22.0	6.2	18.4	23.0	530.9	49.0	35.4	140.6	19.4	16.6	22.5	52.7	20.8	25.9	36.0	23.6	18.3	14.3	19.7	24.1	15.7	27.5	31.4	68.4	6.7	25.8	168.9	30.5	28.9	20.0	80.2	18.0	33.5	12.4	15.0	61.7	19.5	38.1	11.6	21.2	21.4	428.1	23.3	10.7	37.0	637.5	175.8	30.5	15.8	32.9	19.1	20.4	9.0	32.7	10.4	16.6	44.3	28.5	15.7	119.3	31.9
ACOT13	"HT012, THEM2"	ENSG00000112304	"Acyl-CoA thioesterase 13"	Q9NPJ3	6	24667035-24705065	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 30.6"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 847.1;Proximal tubular cells: 525.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019881, HPA057134"	Enhanced		Approved	"Cell Junctions"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 16: U-266 - Nucleosome"	"Cluster 29: Early spermatids - Spermatogenesis"	"Cell Junctions"		"HPA019881: AB_1857978, HPA057134: "	"unprognostic (3.61e-1)"	"unprognostic (1.62e-1)"	"unprognostic (6.02e-2)"	"unprognostic (1.80e-2)"	"unprognostic (9.57e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.71e-1)"	"prognostic favorable (2.53e-6)"	"unprognostic (3.67e-2)"	"unprognostic (1.64e-2)"	"unprognostic (7.16e-2)"	"unprognostic (5.97e-2)"	"unprognostic (4.86e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.13e-2)"	6.3	6.1	7.2	4.8	7.5	3.4	3.8	7.9	7.3	3.4	6.0	9.1	6.5	3.1	3.7	3.4	3.6	4.9	12.0	6.6	7.8	19.2	30.6	4.6	5.2	7.2	7.8	3.9	6.6	7.2	5.1	3.0	7.4	6.5	7.4	9.6	5.0	3.3	12.2	5.5	6.1	3.1	7.1	4.8	5.5	7.0	8.2	5.1	5.7	10.3	3.4	3.5	3.1	7.4	5.9	7.6	7.6	13.6	10.5	13.1	4.2	4.8	5.8	3.5	5.4	10.1	7.5	11.1	16.2	5.5	18.4	6.4	6.7	9.7	5.4	17.4	6.2	10.4	7.7	7.0	5.3	6.7	4.6	7.6	9.4	4.7	9.0	8.5	8.3	11.3	17.0	5.7	7.0	6.1	12.1	12.9	5.1	11.7	5.9	10.4	6.6	14.0	11.7	5.4	15.0	5.2	5.7	19.1	14.1	8.8	13.2	5.5	9.7	6.2	3.5	1.7	4.6	10.7	29.3	11.1	6.5	23.8	19.1	4.8	5.3	3.6	4.4	5.7	6.1	6.9	4.9	5.0	4.7	4.9	5.7	5.1	6.2	4.6	5.8	3.7	5.3	4.8	7.2	7.5	7.9	7.3	6.6	7.8	7.2	7.8	7.4	7.1	8.2	7.4	27.9	67.3	41.7	19.6	19.7	17.2	26.6	66.4	18.8	18.7	29.4	32.3	94.6	45.8	46.9	31.3	16.7	56.8	22.6	88.4	158.5	43.2	847.1	34.0	31.3	24.0	54.7	37.2	12.1	40.2	31.1	26.2	23.9	31.8	14.5	30.3	21.4	215.5	86.7	5.0	14.3	85.8	67.1	24.5	23.7	131.5	19.6	35.0	26.6	14.0	68.9	41.7	18.6	15.6	18.7	29.2	130.7	24.0	25.4	23.2	47.1	525.2	56.8	31.8	26.3	50.6	64.2	117.1	27.3	19.5	23.4	40.0	20.5	43.4	69.4	28.6
C6orf62	"DKFZP564G182, FLJ12619, XTP12"	ENSG00000112308	"Chromosome 6 open reading frame 62"	Q9GZU0	6	24704861-24719998	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Kupffer cells: 354.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030564, HPA030566"	Supported		Approved	Cytosol		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 16: U-266 - Nucleosome"	"Cluster 7: Non-specific - Mitochondria"	Cytosol		"HPA030564: AB_10600000, HPA030566: AB_10599425"	"unprognostic (2.07e-2)"	"unprognostic (2.92e-1)"	"unprognostic (7.10e-2)"	"unprognostic (6.70e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.02e-2)"	"prognostic unfavorable (5.77e-5)"	"unprognostic (1.18e-1)"	"unprognostic (3.67e-1)"	"prognostic favorable (4.04e-4)"	"unprognostic (4.16e-3)"	"unprognostic (3.94e-2)"	"unprognostic (3.08e-2)"	"unprognostic (9.01e-2)"	"unprognostic (4.03e-1)"	"unprognostic (1.93e-2)"	"prognostic favorable (3.62e-6)"	110.0	82.6	105.0	115.1	108.3	118.0	87.3	101.8	112.5	60.7	92.1	76.5	90.3	70.6	100.7	56.6	76.6	62.7	59.7	94.2	103.9	92.9	107.5	96.5	144.3	121.4	120.6	93.8	121.8	71.2	45.4	87.4	106.2	84.2	76.8	151.0	94.0	75.4	84.1	93.5	93.1	69.2	107.8	156.2	110.3	125.0	126.8	133.1	85.5	58.3	143.0	73.7	36.9	109.6	154.6	73.9	108.2	169.8	106.6	142.2	118.5	178.0	172.6	204.4	211.2	91.8	116.7	177.9	258.3	172.0	230.8	114.5	103.7	137.1	221.0	301.2	61.9	194.0	104.8	112.7	191.0	235.0	201.4	106.0	267.6	138.6	182.8	152.2	162.0	97.8	160.6	121.6	199.3	96.3	160.4	325.9	118.0	79.9	86.0	127.8	126.0	164.7	131.2	165.5	170.9	99.5	219.8	239.4	349.4	105.4	197.1	174.2	192.7	214.7	108.8	83.7	239.4	289.6	494.0	213.6	75.9	294.8	209.8	214.5	246.5	271.9	211.0	253.7	227.1	204.4	215.0	229.7	192.9	170.8	216.6	241.0	177.8	223.4	277.4	198.1	226.3	522.4	105.0	108.3	101.8	112.5	94.2	103.9	121.4	120.6	106.2	107.8	126.8	109.6	136.4	83.3	76.7	67.3	91.1	57.5	53.0	56.7	58.6	56.6	107.7	86.7	36.6	94.4	56.3	93.8	50.1	50.8	147.9	105.8	37.2	63.4	147.2	83.1	92.0	85.9	95.9	128.6	50.9	74.0	62.2	78.0	86.6	112.8	55.2	122.8	86.7	132.8	90.1	42.1	39.4	89.3	48.8	354.8	105.3	53.9	54.0	138.8	49.8	94.6	120.8	43.6	96.8	35.2	53.1	83.2	84.9	47.4	54.3	98.3	90.2	71.5	80.5	63.3	52.6	120.5	64.9	98.9	101.6	103.2	56.0	75.2	95.7	61.6	98.8	63.3
GMNN	Gem	ENSG00000112312	"Geminin DNA replication inhibitor"	O75496	6	24774931-24786099	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cell cycle"	"DNA replication inhibitor"	"Cancer-related genes, Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 231.4"	"Cell type enhanced"	"Detected in all"		"Glandular and luminal cells: 184.8;Paneth cells: 300.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011458, CAB047327, CAB047328, HPA049977, HPA054597"	Enhanced		Supported	Nucleoplasm,Cytosol		Yes	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 25: Pancreas - Digestion"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	Cytosol	"CAB011458: AB_2110946, CAB047327: , CAB047328: , HPA049977: AB_2680978, HPA054597: AB_2682538"	"unprognostic (1.37e-1)"	"unprognostic (3.43e-3)"	"unprognostic (3.91e-3)"	"unprognostic (1.52e-2)"	"unprognostic (1.28e-1)"	"unprognostic (4.37e-2)"	"unprognostic (2.90e-3)"	"unprognostic (8.29e-2)"	"unprognostic (1.23e-3)"	"prognostic favorable (4.13e-4)"	"prognostic unfavorable (9.77e-4)"	"unprognostic (1.33e-2)"	"prognostic unfavorable (7.82e-5)"	"unprognostic (2.25e-1)"	"unprognostic (7.92e-2)"	"unprognostic (3.63e-2)"	"unprognostic (5.90e-3)"	10.1	7.7	16.9	17.2	18.2	68.9	24.2	19.5	23.7	11.1	13.5	41.6	17.8	10.6	5.8	16.6	16.5	7.9	8.0	14.7	20.2	24.6	18.2	8.9	30.4	17.0	20.2	14.6	231.4	8.4	11.1	16.5	17.8	41.5	44.4	16.3	8.7	24.9	7.4	40.3	16.1	12.5	16.4	19.1	22.6	37.4	19.8	37.4	10.8	14.3	23.7	28.4	13.9	15.5	110.9	64.2	159.2	66.2	22.2	23.5	106.0	106.0	55.9	124.4	135.5	125.1	38.8	110.1	131.3	34.4	91.3	63.3	139.4	78.1	133.0	41.2	145.4	151.5	109.3	207.4	20.7	119.1	53.1	19.1	25.1	75.9	29.5	25.8	62.2	84.6	193.9	56.9	88.9	86.3	224.9	128.2	87.3	89.6	50.2	128.9	124.4	141.2	53.5	94.6	127.3	78.3	47.5	77.4	95.2	89.1	81.3	72.0	30.9	75.7	76.8	88.3	182.6	62.8	207.6	210.3	23.1	220.9	111.2	5.5	5.2	17.1	4.4	6.9	5.6	9.2	8.5	6.9	7.6	4.6	6.1	6.9	3.0	5.9	5.0	9.4	15.9	5.6	16.9	18.2	19.5	23.7	14.7	20.2	17.0	20.2	17.8	16.4	19.8	15.5	24.0	6.4	15.6	8.8	17.0	33.0	28.4	57.4	18.8	9.5	51.0	52.5	12.1	18.6	68.1	44.1	2.1	83.2	19.9	72.6	9.8	113.6	94.8	84.8	30.6	18.4	25.9	66.2	3.5	112.3	136.3	17.7	12.2	184.8	13.3	36.4	13.9	17.4	54.0	11.8	5.3	66.3	10.2	10.7	13.2	28.0	9.6	15.2	23.2	5.6	12.6	30.9	6.2	5.5	3.2	31.8	300.5	10.9	41.6	25.6	20.8	20.6	25.2	13.7	19.7	8.0	21.9	158.8	58.8	26.8	63.5	48.7	19.1	30.4	156.5	30.1
ARMH2	C6orf229	ENSG00000260286	"Armadillo like helical domain containing 2"	H3BNL8	6	24797335-24798917	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"testis: 13.4"	"Cell type enriched"	"Detected in single"	9	"Endometrial ciliated cells: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 2.5"	"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 74: Testis - Spermatogenesis"		"Cluster 49: Ciliated cells - Cilium organization"										"unprognostic (1.28e-1)"							"unprognostic (1.16e-1)"				0.0	0.0	0.2	0.1	0.2	0.0	0.0	0.4	0.2	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.2	0.0	0.0	1.1	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.6	0.0	13.4	0.2	0.0	0.1	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.4	0.3	0.1	0.3	0.1	0.7	0.5	0.3	0.5	0.2	0.7	0.5	0.3	2.5	0.2	0.1	0.2	0.2	0.0	0.2	0.2	0.4	0.2	0.1	0.2	0.1	0.1	0.1	0.1	0.2	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AL512428.1		ENSG00000282804	"Novel protein"		6	24797373-24809798	"Predicted intracellular proteins"				"No human protein/transcript evidence"	"No human protein/transcript evidence"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																	NA	NA			"Cluster 9: Neutrophils - Innate immune response"																								0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.4	0.1	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.2	0.4	0.2	0.4	0.1	0.1	0.2	0.1	0.2	0.3	0.4	0.8	0.0	0.0	0.5	0.3	0.0	0.0	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
RIPOR2	"C6orf32, DIFF48, FAM65B, KIAA0386, MYONAP"	ENSG00000111913	"RHO family interacting cell polarization regulator 2"	Q9Y4F9	6	24804282-25042170	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cell adhesion, Chemotaxis, Differentiation, Hearing, Myogenesis"	"Developmental protein, Signal transduction inhibitor"	"Deafness, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 82.6"	"Cell type enhanced"	"Detected in many"		"B-cells: 57.4;dendritic cells: 98.4;Respiratory ciliated cells: 83.1;Syncytiotrophoblasts: 82.8;T-cells: 38.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 951.9"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 951.9"	"Cell line enhanced"	"Detected in many"		"AF22: 30.9;Daudi: 73.5;fHDF/TERT166: 73.2;U-266/70: 25.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 7: Non-specific - Mitochondria"				"unprognostic (4.05e-3)"	"unprognostic (1.34e-3)"	"unprognostic (3.55e-2)"	"unprognostic (1.91e-2)"	"unprognostic (1.47e-2)"	"unprognostic (1.75e-2)"	"unprognostic (5.89e-4)"	"unprognostic (2.62e-2)"	"unprognostic (1.54e-1)"	"unprognostic (4.40e-3)"	"unprognostic (1.64e-1)"	"unprognostic (1.74e-2)"	"unprognostic (8.55e-2)"	"unprognostic (3.33e-2)"	"unprognostic (2.30e-2)"	"unprognostic (9.79e-2)"	"unprognostic (1.14e-1)"	13.1	3.7	15.9	49.1	22.4	27.6	6.1	0.4	16.7	13.5	2.5	3.7	2.7	46.3	2.6	3.2	14.8	8.6	3.1	14.0	9.1	3.0	4.3	20.7	82.6	4.5	9.5	2.7	2.5	0.9	13.0	6.0	3.2	6.1	3.8	3.7	8.2	4.5	19.5	5.2	17.5	17.7	4.6	55.9	6.7	6.4	9.2	41.0	2.9	7.6	71.0	10.2	7.4	4.9	1.1	0.1	30.9	0.6	0.3	0.2	11.3	8.8	15.5	3.7	5.4	0.4	0.5	73.5	2.0	73.2	0.5	0.9	0.0	0.0	0.7	7.3	0.4	17.8	1.2	0.3	0.6	0.4	1.3	3.2	0.3	0.0	0.4	0.2	0.0	3.2	1.0	12.2	0.2	0.2	17.0	0.8	2.3	1.2	2.1	18.5	3.0	0.7	0.1	0.4	1.5	0.3	0.6	0.3	5.7	10.3	0.3	0.5	0.3	0.7	3.3	0.8	0.9	25.4	0.6	2.4	0.8	1.0	5.1	414.0	100.8	334.5	128.6	127.3	134.8	188.3	131.8	136.6	68.7	176.3	171.6	136.8	951.9	125.7	173.8	57.7	124.9	168.1	15.9	22.4	0.4	16.7	14.0	9.1	4.5	9.5	3.2	4.6	9.2	4.9	7.3	3.2	14.6	0.0	57.4	0.0	0.0	0.0	0.0	0.0	3.3	1.7	0.0	0.0	18.6	5.5	0.0	4.1	98.4	0.0	1.9	0.1	0.0	16.4	10.5	2.8	0.0	0.0	0.0	0.2	1.9	2.7	0.0	10.7	12.6	0.6	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	15.6	0.0	0.0	3.1	83.1	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	82.8	38.0	1.7	0.0	0.0
CARMIL1	"CARMIL, dJ501N12.1, FLJ20048, LRRC16, LRRC16A"	ENSG00000079691	"Capping protein regulator and myosin 1 linker 1"	Q5VZK9	6	25279078-25620530	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 27.9;Collecting duct cells: 35.0;Distal tubular cells: 46.9;Endometrial ciliated cells: 37.3;Glandular and luminal cells: 39.3;Granulosa cells: 31.8;Proximal tubular cells: 58.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 36.0;RPTEC TERT1: 34.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029038, HPA029039"	Enhanced		Supported	Cytosol		NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 50: Fibroblasts - ECM organization"	Cytosol		"HPA029038: AB_10601668, HPA029039: AB_10611382"	"unprognostic (2.34e-2)"	"unprognostic (9.45e-2)"	"unprognostic (2.07e-2)"	"unprognostic (4.71e-2)"	"unprognostic (3.94e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.66e-3)"	"unprognostic (3.82e-1)"	"unprognostic (4.02e-1)"	"unprognostic (7.15e-3)"	"unprognostic (8.25e-3)"	"unprognostic (5.86e-2)"	"unprognostic (1.28e-3)"	"unprognostic (3.08e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.31e-1)"	4.4	3.9	2.7	2.8	4.1	0.7	6.5	6.4	5.9	5.2	0.0	10.7	15.3	2.5	7.1	4.3	5.5	5.8	3.7	2.2	2.5	8.5	2.1	8.0	3.6	1.0	3.5	4.3	4.5	5.1	1.2	4.6	0.8	3.3	10.0	1.0	5.3	2.7	0.4	5.9	15.8	2.7	1.3	2.8	7.4	11.4	3.2	7.6	5.2	2.0	3.7	5.2	3.7	1.2	12.9	12.7	3.5	4.5	3.2	1.6	12.1	4.3	9.7	4.5	7.9	13.7	9.4	4.4	13.8	6.9	13.2	13.7	13.6	12.2	3.3	11.1	7.2	10.7	14.0	1.7	8.9	0.5	1.6	1.7	8.2	8.7	13.3	5.6	0.2	1.6	0.3	3.5	2.9	10.0	0.7	0.0	4.8	22.7	5.2	1.5	2.1	36.0	34.7	11.5	9.0	1.9	19.1	32.4	12.4	10.1	7.8	0.3	0.2	3.3	5.8	15.8	4.4	0.5	0.2	7.0	5.2	3.9	12.6	0.0	0.4	0.0	0.0	0.5	0.0	0.2	0.1	0.1	0.4	1.3	1.0	0.1	0.0	0.6	1.3	0.9	0.0	0.1	2.7	4.1	6.4	5.9	2.2	2.5	1.0	3.5	0.8	1.3	3.2	1.2	3.2	19.2	27.9	0.0	7.7	0.0	0.0	0.0	0.0	0.0	17.5	11.6	0.0	0.0	4.3	35.0	0.0	20.8	0.4	0.0	46.9	16.7	0.0	37.3	7.0	4.0	0.0	0.0	0.0	15.6	7.9	12.8	0.0	39.3	8.8	31.8	0.0	0.0	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	3.6	0.0	0.0	0.0	0.0	17.6	0.0	0.0	7.6	0.0	0.0	58.8	3.6	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	10.9	1.6	14.9	0.0	0.0
SCGN	"CALBL, DJ501N12.8, SECRET, SEGN"	ENSG00000079689	"Secretagogin, EF-hand calcium binding protein"	O76038	6	25652201-25701783	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 43.5;pancreas: 67.1;pituitary gland: 38.5"	"Cell type enriched"	"Detected in some"	5	"Enteroendocrine cells: 600.1"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 38.2;renal cancer: 22.6"	"Group enriched"	"Detected in many"	4	"cerebellum: 23.6;hippocampal formation: 14.5;hypothalamus: 43.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 3.4;CACO-2: 6.4;HEL: 4.6;Hep G2: 3.6;SCLC-21H: 24.7"	"Region enriched"	"Detected in many"	16	"olfactory bulb: 82.0"	"Region enriched"	"Detected in some"	9	"olfactory bulb: 137.1"	"CAB004005, HPA006641, CAB044060, CAB062563, CAB068232"	Enhanced	Supported	Supported	Cytosol	"Intracellular and membrane"	NA	NA				"Cluster 22: Non-specific - Unknown function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 17: Intestinal endocrine cells - Hormone signaling"	Cytosol		"CAB004005: , CAB044060: , CAB062563: AB_2665612, CAB068232: AB_2665613, HPA006641: AB_1079874"	"unprognostic (8.15e-2)"		"unprognostic (4.31e-3)"		"unprognostic (1.46e-1)"		"unprognostic (1.25e-2)"	"unprognostic (4.70e-1)"			"unprognostic (1.78e-2)"	"unprognostic (2.01e-1)"	"unprognostic (5.14e-2)"	"unprognostic (5.41e-2)"	"unprognostic (9.45e-2)"	"unprognostic (1.19e-1)"		3.7	3.5	1.7	3.4	1.2	0.2	3.3	23.6	2.9	0.1	0.1	16.9	12.4	0.0	0.0	0.2	0.1	0.9	11.7	14.5	43.5	1.4	4.1	0.8	0.1	1.7	2.3	0.3	67.1	0.1	38.5	3.3	6.1	2.0	19.2	1.0	2.5	0.1	0.0	0.6	11.5	1.2	1.4	0.0	18.9	0.6	0.9	0.4	1.9	0.0	0.0	0.1	0.1	0.5	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	6.4	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	4.6	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	24.7	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.1	0.0	0.3	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	1.2	23.6	2.9	14.5	43.5	1.7	2.3	6.1	1.4	0.9	0.5	1.9	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	1.0	0.6	0.5	107.2	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.3	0.1	0.0	0.0	2.2	600.1	0.0	0.2	0.4	0.2	0.3	9.2	0.0	0.0	0.9	3.3	0.5	0.1	0.0	1.8	14.3	4.1	0.0	0.0	0.2	0.6	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.1	4.8	3.7	0.0	0.0	3.7	1.1	3.1	0.0	0.0	13.1	0.0	9.1	0.2	1.1	0.0	0.0	0.0	0.1	0.5	2.2	0.3
H2AC1	"bA317E16.2, H2AFR, HIST1H2AA"	ENSG00000164508	"H2A clustered histone 1"	Q96QV6	6	25726063-25726562	"Plasma proteins, Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	19	"testis: 6.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA041189	Supported		Approved	Nucleoplasm		NA	NA				"Cluster 83: Testis - Spermatogenesis"			Nucleoplasm		"HPA041189: AB_2677357"													"unprognostic (4.53e-1)"					0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
H2BC1	"bA317E16.3, H2BFU, HIST1H2BA, STBP, TSH2B"	ENSG00000146047	"H2B clustered histone 1"	Q96A08	6	25726777-25727345	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	18	"testis: 6.4"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	5	"testis cancer: 0.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB011603, HPA042205, HPA043013"	Enhanced					NA	NA				"Cluster 78: Testis - Spermatogenesis"					"CAB011603: AB_2118143, HPA042205: AB_2677900, HPA043013: AB_2678269"															"unprognostic (3.94e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SLC17A4	KIAA2138	ENSG00000146039	"Solute carrier family 17 member 4"	Q9Y2C5	6	25754699-25781199	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Group enriched"	"Detected in some"	8	"gallbladder: 16.3;intestine: 31.9;liver: 47.3;pancreas: 22.7"	"Group enriched"	"Detected in some"	5	"Cholangiocytes: 94.4;Distal enterocytes: 133.5;Hepatocytes: 41.8;Paneth cells: 44.1;Proximal enterocytes: 51.2"	"Group enriched"	"Detected in some"	6	"liver cancer: 11.0;renal cancer: 7.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	7	"RPTEC TERT1: 1.4"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	8	"cerebellum: 1.5"	HPA055564	Approved					NA	NA				"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA055564: AB_2682852"			"unprognostic (6.52e-2)"				"unprognostic (5.64e-3)"			"unprognostic (1.72e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.19e-3)"	"unprognostic (1.40e-1)"	"unprognostic (1.38e-1)"	"unprognostic (7.27e-3)"			0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.6	0.0	0.0	0.0	20.6	28.7	0.0	0.0	0.0	0.0	16.3	0.0	0.0	0.0	3.7	47.3	0.0	0.0	0.0	0.0	0.0	22.7	0.0	0.0	0.1	0.2	0.0	26.7	0.0	0.0	0.0	0.0	0.0	31.9	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	94.4	0.0	0.0	0.0	0.0	0.0	133.5	0.0	8.3	0.8	0.0	0.0	0.0	13.1	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.7	41.8	0.1	0.0	0.0	11.7	0.0	0.8	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	44.1	0.0	0.0	0.0	51.2	1.0	0.0	0.0	0.0	0.0	0.1	0.4	0.1	0.0	0.0	0.0	0.1	0.0	11.5	0.0
SLC17A1	"NAPI-1, NPT1"	ENSG00000124568	"Solute carrier family 17 member 1"	Q14916	6	25782915-25832052	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	49	"kidney: 169.3;liver: 49.4"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 13.5;Hepatocytes: 10.3;Proximal tubular cells: 49.2"	"Group enriched"	"Detected in some"	150	"liver cancer: 7.6;renal cancer: 19.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	647	"RPTEC TERT1: 64.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA050513			Approved	"Golgi apparatus"		NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Golgi apparatus"		"HPA050513: AB_2681152"			"unprognostic (6.98e-2)"		"unprognostic (2.99e-1)"		"unprognostic (1.03e-1)"				"unprognostic (1.26e-1)"		"unprognostic (2.71e-3)"	"unprognostic (1.32e-1)"	"unprognostic (2.37e-1)"	"unprognostic (4.74e-1)"		0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	169.3	49.4	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	64.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.5	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	13.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	10.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	49.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.1	0.0	0.0
SLC17A3	NPT4	ENSG00000124564	"Solute carrier family 17 member 3"	O00476	6	25833066-25882286	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"kidney: 164.3"	"Cell type enriched"	"Detected in some"	13	"Proximal tubular cells: 197.8"	"Cancer enriched"	"Detected in some"	17	"renal cancer: 57.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	210	"RPTEC TERT1: 114.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"				"unprognostic (5.31e-3)"				"unprognostic (1.56e-2)"		"unprognostic (2.51e-1)"	"unprognostic (4.65e-2)"			"unprognostic (5.05e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.34e-1)"	"unprognostic (4.49e-1)"		0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	164.3	37.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	114.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	1.5	0.0	1.8	0.0	0.0	0.2	0.1	7.9	0.1	1.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.8	1.1	15.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	197.8	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.8	0.2	0.0	0.1
SLC17A2	NPT3	ENSG00000112337	"Solute carrier family 17 member 2"	O00624	6	25912754-25930691	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	165	"liver: 79.5"	"Cell type enriched"	"Detected in some"	20	"Hepatocytes: 30.9"	"Cancer enriched"	"Detected in some"	8	"liver cancer: 14.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	21	"Hep G2: 3.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA038270	Uncertain					NA	NA				"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"			"HPA038270: AB_10672511"							"prognostic favorable (8.54e-4)"						"unprognostic (1.90e-2)"		"unprognostic (4.14e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	79.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	30.9	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TRIM38	"RNF15, RORET"	ENSG00000112343	"Tripartite motif containing 38"	O00635	6	25962802-25991231	"Enzymes, Predicted intracellular proteins"	"Immunity, Innate immunity, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA031685	Approved		Approved	"Plasma membrane,Cell Junctions,Centrosome"		NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 16: Immune cells - Immune response"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 57: B-cells - Immune response"	Centrosome	"Plasma membrane, Cell Junctions"	"HPA031685: AB_10603218"	"unprognostic (6.62e-2)"	"unprognostic (1.65e-3)"	"unprognostic (3.34e-1)"	"unprognostic (2.72e-2)"	"unprognostic (1.25e-1)"	"unprognostic (6.51e-2)"	"unprognostic (7.79e-2)"	"unprognostic (3.27e-2)"	"unprognostic (2.78e-2)"	"prognostic favorable (8.95e-5)"	"unprognostic (2.81e-2)"	"unprognostic (6.28e-2)"	"unprognostic (2.73e-1)"	"unprognostic (3.36e-1)"	"unprognostic (4.49e-2)"	"prognostic favorable (8.20e-5)"	"prognostic favorable (4.94e-9)"	7.1	6.0	1.8	10.8	1.8	13.0	6.1	1.6	2.4	7.3	3.4	5.8	6.6	7.3	9.6	7.8	7.4	6.6	3.7	1.7	1.9	9.9	5.6	9.3	13.6	3.0	2.1	4.6	3.2	2.9	2.0	6.3	2.7	7.0	7.3	0.4	6.1	6.2	7.6	5.2	8.9	6.1	2.4	14.3	5.8	2.1	2.7	7.7	5.5	3.0	14.6	7.0	7.0	2.7	4.8	2.6	0.4	5.6	13.0	17.3	4.6	5.9	11.7	11.2	18.5	2.0	5.0	10.5	9.4	7.3	10.8	7.3	3.6	5.8	6.6	10.7	2.3	4.8	4.6	2.0	17.2	5.7	9.4	17.4	4.2	6.9	2.5	9.2	9.8	5.0	3.2	5.7	13.5	2.3	5.5	6.4	1.8	0.0	3.5	8.3	5.4	11.2	13.3	9.3	0.1	0.1	4.4	9.1	16.2	0.6	1.3	7.3	10.1	2.0	3.4	3.5	4.0	6.5	5.1	11.7	5.4	6.9	12.6	12.1	10.2	4.7	6.9	12.5	6.6	13.1	5.8	6.2	9.8	15.1	5.4	6.0	11.4	6.5	11.7	9.0	7.9	7.1	1.8	1.8	1.6	2.4	1.7	1.9	3.0	2.1	2.7	2.4	2.7	2.7	37.6	25.6	47.1	0.3	120.2	14.9	56.9	16.1	24.5	0.6	20.1	12.8	6.0	18.6	32.4	46.0	0.0	23.5	88.5	48.3	17.6	28.5	1.1	48.4	28.1	39.9	18.1	10.3	0.1	14.9	23.5	25.5	24.5	69.4	35.5	52.4	35.0	17.5	32.6	0.0	0.1	33.3	16.2	94.0	32.7	2.8	19.9	81.3	10.6	34.7	113.2	0.2	107.1	0.0	0.2	20.4	47.4	18.8	34.3	39.7	48.3	69.5	22.7	1.1	6.6	23.1	28.2	0.3	0.5	42.7	9.2	21.2	53.1	23.0	25.6	94.7
H1-1	"H1.1, H1a, H1F1, HIST1H1A"	ENSG00000124610	"H1.1 linker histone, cluster member"	Q02539	6	26017032-26017787	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	7	"brain: 1.0"	"Group enriched"	"Detected in some"	4	"Cardiomyocytes: 3.3;Cytotrophoblasts: 1.2;Extravillous trophoblasts: 4.2;Hofbauer cells: 2.0"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"hypothalamus: 1.0"	"Immune cell enhanced"	"Detected in single"		"T-reg: 1.7"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in single"		"REH: 1.0"	"Not detected"	"Not detected"							"HPA043753, HPA056830"	Enhanced		Supported	Nucleoplasm		NA	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 65: Brain - Ion transport"	"Cluster 14: REH - Unknown function"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"HPA043753: AB_2678654, HPA056830: "		"unprognostic (3.80e-1)"					"unprognostic (1.82e-1)"			"unprognostic (1.15e-1)"				"unprognostic (1.96e-1)"	"unprognostic (1.21e-1)"	"unprognostic (3.05e-1)"		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.4	0.8	0.1	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.3	1.7	0.1	0.0	0.0	0.0	0.4	0.2	1.0	0.1	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	1.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.0
H3C1	"H3/A, H3FA, HIST1H3A"	ENSG00000275714	"H3 clustered histone 1"	P68431	6	26020451-26020958	"Disease related genes, Predicted intracellular proteins"		DNA-binding	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"bone marrow: 7.8;brain: 18.9"	"Cell type enhanced"	"Detected in some"		"dendritic cells: 1.7;Plasma cells: 1.8"	"Low cancer specificity"	"Detected in some"			"Region enhanced"	"Detected in many"		"cerebellum: 18.9"	"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"U-2 OS: 4.0"									HPA042570	Approved					NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 24: Non-specific - Transcription regulation"			"HPA042570: AB_2678056"	"unprognostic (3.07e-1)"	"unprognostic (3.47e-2)"	"unprognostic (4.60e-2)"	"unprognostic (2.36e-5)"	"unprognostic (2.85e-2)"	"unprognostic (3.48e-1)"	"unprognostic (3.48e-1)"	"unprognostic (4.02e-2)"	"unprognostic (5.03e-3)"	"unprognostic (4.39e-2)"	"unprognostic (6.34e-3)"	"unprognostic (2.00e-2)"	"unprognostic (8.85e-3)"	"unprognostic (1.58e-2)"	"unprognostic (1.39e-1)"	"unprognostic (8.15e-2)"	"unprognostic (3.21e-2)"	0.2	0.4	2.5	0.1	0.8	7.8	0.1	18.9	3.9	0.3	0.0	0.2	0.0	0.1	0.9	0.3	0.2	0.1	0.3	1.0	4.2	0.1	0.2	0.3	0.4	2.6	5.8	0.1	0.0	0.0	0.2	0.1	2.7	0.1	0.2	0.1	0.0	0.0	0.0	0.4	0.2	0.1	0.9	0.2	0.2	2.9	1.4	0.6	0.1	0.0	0.1	0.1	0.1	0.5	0.8	0.0	0.7	0.0	0.5	0.2	0.0	1.0	0.0	0.7	1.7	0.0	0.3	0.6	0.4	0.0	0.3	0.0	1.0	0.2	1.4	0.3	1.2	1.0	0.4	0.0	0.0	0.1	1.0	0.0	0.0	0.1	0.0	0.0	0.7	0.8	0.2	0.1	0.0	2.2	2.0	1.2	0.9	0.4	0.9	1.1	0.5	0.0	0.7	0.5	0.7	1.0	0.7	1.6	0.2	0.0	0.1	0.9	0.0	0.0	4.0	0.3	0.4	0.3	0.1	0.0	0.4	1.4	1.3	13.6	1.5	4.3	3.5	1.5	3.0	2.2	2.6	2.0	3.1	3.1	1.8	1.7	13.5	8.0	0.9	4.9	3.5	1.3	2.5	0.8	18.9	3.9	1.0	4.2	2.6	5.8	2.7	0.9	1.4	0.5	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0
H4C1	"H4FA, HIST1H4A"	ENSG00000278637	"H4 clustered histone 1"	P62805	6	26021649-26022050	"Disease related genes, Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"brain: 22.1"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in many"	8	"cerebellum: 22.1"	"Group enriched"	"Detected in some"	6	"eosinophil: 2.9;neutrophil: 10.5"	"Lineage enriched"	"Detected in many"	9	"granulocytes: 10.5"	"Cell line enhanced"	"Detected in many"		"MOLT-4: 10.1;NB-4: 8.4;REH: 9.1"	"Not detected"	"Not detected"							"CAB021887, HPA042201"	Supported					NA	NA		25000000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 14: REH - Unknown function"	"Cluster 24: Non-specific - Transcription regulation"			"CAB021887: AB_2279758, HPA042201: AB_2677898"	"unprognostic (5.71e-2)"	"unprognostic (3.41e-1)"	"unprognostic (3.49e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.75e-2)"		"unprognostic (1.23e-1)"		"unprognostic (1.23e-3)"				"unprognostic (9.76e-2)"	"unprognostic (5.99e-2)"		"unprognostic (6.42e-2)"	0.1	0.0	0.9	1.0	0.3	1.7	0.1	22.1	2.8	0.2	0.0	0.1	1.1	0.1	0.3	0.5	0.0	0.3	0.1	0.5	0.3	0.1	0.1	0.3	0.7	0.1	2.0	0.1	0.0	0.0	0.0	0.1	2.2	0.0	0.1	0.0	0.1	0.0	0.1	0.1	0.2	0.1	0.4	0.2	0.1	0.1	0.9	3.4	0.5	0.0	0.9	0.2	0.0	0.6	2.9	1.1	2.2	0.0	0.4	0.0	0.0	0.2	0.7	0.9	1.4	0.0	4.0	2.0	0.7	0.0	0.1	3.4	1.5	0.0	0.3	0.3	1.1	1.8	1.0	0.0	0.0	0.4	4.1	0.0	0.0	0.3	0.0	0.0	0.9	2.3	0.9	3.0	0.0	0.9	10.1	8.4	1.7	0.6	0.0	9.1	1.5	1.6	0.0	0.2	3.0	1.3	1.1	4.3	0.1	0.0	2.3	2.1	0.0	2.2	5.6	2.1	2.4	1.2	2.0	0.0	1.0	3.3	4.3	0.0	0.8	2.9	0.9	0.7	0.2	0.3	0.9	0.3	0.7	0.5	0.3	0.2	10.5	1.1	0.1	0.4	1.1	0.1	0.9	0.3	22.1	2.8	0.5	0.3	0.1	2.0	2.2	0.4	0.9	0.6	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0
H4C2	"H4/I, H4FI, HIST1H4B"	ENSG00000278705	"H4 clustered histone 2"	P62805	6	26026815-26027252	"Disease related genes, Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"brain: 87.0"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in all"	6	"cerebellum: 87.0"	"Immune cell enriched"	"Detected in many"	6	"neutrophil: 43.0"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 43.0"	"Low cell line specificity"	"Detected in some"			"Low region specificity"	"Detected in many"							HPA042201	Supported					NA	NA		25000000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 24: Non-specific - Transcription regulation"			"HPA042201: AB_2677898"	"unprognostic (1.16e-1)"	"unprognostic (2.18e-2)"	"unprognostic (2.12e-1)"	"unprognostic (6.31e-3)"	"unprognostic (2.32e-1)"	"unprognostic (1.52e-1)"	"unprognostic (6.07e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.52e-1)"	"unprognostic (7.87e-2)"	"unprognostic (2.56e-1)"	"unprognostic (6.30e-2)"	"unprognostic (1.69e-3)"	"unprognostic (4.39e-2)"	"unprognostic (3.17e-1)"	"unprognostic (4.50e-2)"	"unprognostic (1.58e-2)"	0.3	0.0	5.5	0.0	4.2	1.9	0.2	87.0	12.2	0.5	9.6	0.2	0.1	0.1	0.0	0.1	0.4	0.0	0.1	2.5	8.2	0.2	0.4	0.2	0.6	5.2	9.1	0.2	0.1	0.0	0.1	0.1	13.8	0.2	0.0	0.2	0.4	0.0	0.2	0.1	0.1	0.0	7.0	0.2	0.2	0.2	15.2	2.0	0.4	0.0	0.1	0.1	0.2	6.2	0.9	0.0	0.1	1.8	0.0	0.0	0.0	1.4	0.1	0.8	0.5	0.3	0.2	0.7	0.2	0.3	0.5	0.2	0.4	0.0	0.5	0.3	1.9	2.4	1.2	1.1	0.0	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	2.6	0.2	1.4	2.4	1.9	0.4	0.4	0.3	1.7	0.8	1.5	0.0	0.6	0.5	0.3	0.2	1.0	0.0	0.0	0.2	1.2	0.0	0.5	1.2	1.0	1.8	1.4	1.5	1.2	0.7	0.7	0.9	0.0	0.9	1.3	1.7	1.2	1.5	2.7	1.8	1.3	0.7	6.7	1.4	0.8	43.0	0.3	2.4	2.3	1.3	0.5	5.5	4.2	87.0	12.2	2.5	8.2	5.2	9.1	13.8	7.0	15.2	6.2	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0
H3C2	"H3/l, H3FL, HIST1H3B"	ENSG00000286522	"H3 clustered histone 2"	P68431	6	26031589-26032099	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"		DNA-binding	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	13	"bone marrow: 6.4;brain: 4.1;choroid plexus: 1.6;lymphoid tissue: 1.7"	"Not detected"	"Not detected"							"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"U-266/84: 8.4"									HPA042570	Approved					NA	NA			"Cluster 39: Non-specific - mRNA processing"		"Cluster 16: U-266 - Nucleosome"				"HPA042570: AB_2678056"																		0.0	0.1	1.3	0.1	0.8	6.4	0.1	0.3	1.0	0.0	1.6	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.6	0.7	0.0	0.0	0.0	0.5	1.0	2.2	0.0	0.0	0.0		0.1	2.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.1	4.1	1.7	0.1	0.2	0.0	0.0		3.2	1.2	2.7	1.1	2.5	0.0	0.2	0.0	0.1	0.4	0.4	0.4	0.6	0.9	2.0	1.4	0.2	0.7	0.4	0.9	0.7	0.9	1.4	2.7	2.1	4.0	0.8	0.0	1.6	1.4	1.6	0.0	0.3	0.0	0.0	0.5	0.6	4.3	3.8	0.6	0.6	5.0	5.0	2.0	0.5	1.9	2.9	1.8	5.6	0.3	0.0	1.3	1.1	3.9	1.0	0.3	0.0	1.8	1.0	0.9	0.8	3.1	0.4	1.2	6.3	8.4	2.6	2.1	2.9	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.4	1.3	0.8	0.3	1.0	0.6	0.7	1.0	2.2	2.2	0.6	4.1	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
H2AC4	"H2A/m, H2AFM, HIST1H2AB"	ENSG00000278463	"H2A clustered histone 4"	P04908	6	26033092-26033618	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 1.5;brain: 2.0"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"Hep G2: 2.7;U-2 OS: 1.4"	"Not detected"	"Not detected"							HPA041189	Supported		Approved	Nucleoplasm		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"HPA041189: AB_2677357"	"unprognostic (9.53e-3)"	"unprognostic (3.93e-2)"	"unprognostic (5.40e-2)"	"unprognostic (5.96e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.43e-1)"	"unprognostic (7.13e-2)"	"unprognostic (2.58e-1)"	"unprognostic (2.49e-1)"	"unprognostic (1.04e-3)"		"unprognostic (3.28e-1)"		"unprognostic (7.78e-2)"	"unprognostic (1.47e-1)"		"unprognostic (1.47e-3)"	0.2	0.0	0.5	0.0	0.4	1.5	0.0	2.0	0.5	0.2	0.4	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.6	0.0	0.1	0.2	0.3	0.8	1.2	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.3	0.3	0.1	0.7	1.9	0.4	0.0	0.0	0.0	0.0	0.1	0.9	0.1	0.3	0.1	1.2	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.1	0.6	0.3	0.0	0.0	0.2	0.1	0.0	0.1	0.3	0.9	0.5	0.2	2.7	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.3	0.0	0.4	0.7	0.7	1.2	0.0	1.0	0.4	0.2	0.5	0.0	0.9	0.1	0.1	0.7	0.0	0.0	0.0	0.2	0.3	0.0	0.1	1.4	0.1	0.1	0.6	0.9	0.0	0.2	1.2	0.1	0.0	0.0	1.0	0.1	0.4	0.0	1.5	0.4	0.6	0.5	0.7	0.1	0.2	0.2	0.5	0.0	0.0	0.2	0.0	0.5	0.4	2.0	0.5	0.6	0.6	0.8	1.2	0.7	0.3	1.9	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0
H2BC3	"H2B/f, H2BFF, HIST1H2BB"	ENSG00000276410	"H2B clustered histone 3"	P33778	6	26043227-26043713	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 1.1;brain: 2.6;lymphoid tissue: 1.1;testis: 1.3"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"colorectal cancer: 0.6"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 6.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"K-562: 1.3;Karpas-707: 1.3;MOLT-4: 1.6;NB-4: 1.7;THP-1: 2.0;U-266/84: 2.2"									"HPA042205, HPA043013, HPA048671"	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 24: NB-4 - Immune response"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	Cytosol	"HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488"	"unprognostic (2.92e-2)"	"unprognostic (9.15e-2)"		"unprognostic (3.29e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.36e-1)"		"unprognostic (1.26e-1)"		"unprognostic (6.10e-2)"		"unprognostic (1.03e-1)"		"unprognostic (2.66e-1)"	"unprognostic (2.58e-1)"			0.0	0.0	0.5	0.0	0.5	1.1	0.0	2.1	0.6	0.0	0.4	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	1.3	0.0	0.0	0.0	0.2	0.9	1.2	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.6	0.1	0.0	1.3	2.6	1.1	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.3	0.4	0.0	0.0	0.0	0.4	0.0	0.4	0.0	0.0	0.0	0.2	0.1	0.0	0.4	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.2	0.0	0.1	0.4	0.2	1.3	1.3	0.0	0.0	1.6	1.7	0.7	0.2	0.6	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	2.0	0.0	0.1	0.1	0.1	0.3	0.3	2.2	0.0	0.2	0.5	0.4	2.6	0.5	0.5	0.8	0.1	2.2	1.4	2.4	0.9	1.9	0.9	1.2	0.5	2.0	0.1	0.2	6.4	1.9	0.3	0.5	0.5	2.1	0.6	0.2	1.3	0.9	1.2	0.9	0.6	2.6	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0
H3C3	"H3.1, H3/c, H3FC, HIST1H3C"	ENSG00000287080	"H3 clustered histone 3"	P68431	6	26045384-26045869	"Disease related genes, Predicted intracellular proteins"		DNA-binding	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 4.2;brain: 1.8"	"Not detected"	"Not detected"							"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-937: 6.5"									HPA042570	Approved					NA	NA			"Cluster 40: NK-cells - Unknown function"		"Cluster 32: U-937 - Innate immune response"				"HPA042570: AB_2678056"																		0.1	0.0	0.6	0.0	0.4	4.2	0.0	0.3	0.5	0.0	0.5	0.3	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.4	0.7	0.0	0.1	0.1	0.6	0.7	1.8	0.0	0.0	0.0		0.1	1.6	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.4	0.0	0.2	0.7	1.8	1.1	0.0	0.0	0.1	0.2		1.1	1.7	0.3	0.8	0.0	0.3	0.0	0.0	1.2	0.5	3.3	2.8	0.0	0.2	0.0	0.0	0.5	1.8	0.7	0.0	0.2	2.4	2.3	0.2	2.5	0.2	2.0	0.2	1.6	1.0	0.3	0.2	1.0	0.0	0.4	0.8	0.3	0.0	0.0	0.0	0.0	2.7	3.3	1.4	1.8	2.7	2.8	0.0	0.2	0.7	3.6	0.0	1.0	3.1	1.8	0.3	0.1	0.8	1.0	0.0	0.0	0.0	1.2	2.1	1.5	0.1	0.0	0.8	6.5	2.0	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.2	0.3	0.3	0.5	0.1	0.6	0.1	1.1	0.0	0.2	1.1	0.5	0.6	0.4	0.3	0.5	0.4	0.7	0.7	1.8	1.6	0.4	1.8	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
H1-2	"H1.2, H1c, H1F2, H1s-1, HIST1H1C"	ENSG00000187837	"H1.2 linker histone, cluster member"	P16403	6	26055740-26056470	"Plasma proteins, Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 49.3;Cytotrophoblasts: 42.7;Extravillous trophoblasts: 68.1;Hofbauer cells: 75.5;Syncytiotrophoblasts: 298.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"basophil: 258.6;eosinophil: 458.7;neutrophil: 229.3"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 458.7"	"Cell line enhanced"	"Detected in many"		"K-562: 334.2;SiHa: 311.1;U-2 OS: 601.6;U-266/70: 673.7;U-266/84: 661.8"	"Low region specificity"	"Detected in all"							"CAB011507, HPA055907"	Supported		Supported	"Nucleoplasm,Nucleoli rim"		NA	NA		5500000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 16: U-266 - Nucleosome"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Nucleoli rim"		"CAB011507: AB_2117984, HPA055907: AB_2682966"	"unprognostic (4.43e-2)"	"unprognostic (1.57e-3)"	"unprognostic (1.31e-2)"	"unprognostic (2.96e-2)"	"unprognostic (5.47e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.07e-1)"	"prognostic unfavorable (1.12e-4)"	"unprognostic (1.45e-1)"	"prognostic unfavorable (1.56e-4)"	"unprognostic (1.85e-1)"	"unprognostic (8.93e-2)"	"unprognostic (3.08e-1)"	"prognostic favorable (8.06e-5)"	72.2	47.6	67.1	27.2	55.3	229.5	71.7	148.8	64.2	116.1	84.5	54.5	33.6	14.6	42.0	70.3	41.3	18.9	154.7	51.1	60.1	236.3	130.0	60.5	31.5	64.6	70.4	89.4	60.5	8.7	15.2	43.8	56.7	132.9	44.2	22.0	39.8	16.4	227.4	65.0	42.8	7.9	57.4	56.6	73.4	26.8	71.4	62.0	59.7	99.1	27.8	29.5	90.6	76.7	39.9	27.5	20.5	21.9	49.9	10.0	0.7	19.5	30.8	87.9	92.6	14.9	28.1	3.1	109.6	25.6	32.8	17.3	6.4	15.0	24.3	38.7	23.4	16.5	27.8	17.5	14.7	7.8	38.4	70.4	19.9	11.5	19.2	27.3	13.8	17.6	334.2	243.3	43.7	17.3	20.8	18.3	11.5	96.3	41.4	10.8	9.5	129.1	52.8	28.1	52.6	17.9	311.1	53.0	22.0	19.1	65.8	12.5	6.8	41.1	601.6	12.5	9.0	673.7	661.8	31.3	29.9	253.6	14.4	258.6	14.3	458.7	19.3	14.2	24.4	57.7	31.9	21.4	30.5	76.8	29.4	23.1	229.3	20.2	18.9	31.6	48.3	22.1	67.1	55.3	148.8	64.2	51.1	60.1	64.6	70.4	56.7	57.4	71.4	76.7	14.9	0.0	0.0	0.0	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	49.3	0.0	0.0	0.0	0.0	42.7	29.2	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	68.1	9.4	0.0	0.0	0.0	0.0	0.0	0.0	75.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.6	0.0	0.0	0.0	0.0	298.4	4.5	0.0	0.0	0.0
HFE	"HFE1, HLA-H"	ENSG00000010704	"Homeostatic iron regulator"	Q30201	6	26087281-26098343	"Disease related genes, Human disease related genes, Predicted membrane proteins"	"Ion transport, Iron transport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Kupffer cells: 25.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A549: 39.2;T-47d: 54.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017276, HPA053470"	Approved		Supported	"Nucleoplasm,Plasma membrane"		No	No			"Cluster 14: Monocytes - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 6: T47d - Mammary gland"	"Cluster 4: Macrophages - Innate immune response"	"Plasma membrane"	Nucleoplasm	"HPA017276: AB_1850677, HPA053470: AB_2682163"	"unprognostic (6.96e-2)"	"unprognostic (7.87e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.24e-2)"	"unprognostic (6.07e-3)"	"unprognostic (7.58e-2)"	"unprognostic (4.23e-1)"	"unprognostic (1.77e-1)"	"unprognostic (8.21e-3)"	"unprognostic (1.78e-1)"	"unprognostic (3.31e-3)"	"unprognostic (1.82e-1)"	"unprognostic (1.33e-2)"	"unprognostic (2.12e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.17e-1)"	9.6	7.9	1.3	5.3	2.1	0.6	7.8	1.4	1.9	6.7	9.3	5.8	5.9	4.9	12.4	4.8	4.5	8.1	3.7	1.5	1.5	6.7	15.4	7.5	3.6	2.4	1.7	7.3	6.3	15.4	1.2	6.1	2.2	6.8	6.9	1.3	6.9	9.6	2.3	2.8	5.0	6.0	1.7	8.6	8.3	1.7	1.9	1.7	9.9	3.0	3.1	7.4	3.2	2.8	17.2	39.2	0.7	18.6	27.3	21.1	0.1	12.2	28.5	15.1	23.6	3.3	34.3	1.8	32.4	20.2	22.9	10.7	0.0	14.2	19.1	4.6	0.2	0.5	8.1	2.6	5.6	0.0	0.7	21.6	4.0	16.7	1.4	13.2	10.4	0.0	0.7	0.4	13.0	7.2	0.1	0.2	0.9	8.1	0.0	2.3	0.0	0.3	12.5	11.5	0.1	0.1	7.3	0.0	10.2	0.3	54.0	1.9	8.2	10.6	1.1	10.7	10.6	0.2	0.4	0.2	15.9	0.2	23.5	1.3	10.7	0.0	1.5	10.4	1.2	3.3	1.6	2.1	4.7	1.3	0.4	1.0	1.9	0.2	9.2	0.3	0.3	3.8	1.3	2.1	1.4	1.9	1.5	1.5	2.4	1.7	2.2	1.7	1.9	2.8	3.9	3.2	5.1	1.0	1.7	1.7	2.6	3.7	6.2	1.0	3.7	2.2	3.2	2.8	6.7	5.5	2.1	1.7	0.5	3.8	0.0	4.1	0.1	1.8	2.3	3.4	1.8	2.7	0.1	3.4	0.8	4.6	8.2	1.5	2.5	3.0	6.8	12.2	11.1	0.0	0.1	4.0	4.1	25.4	7.6	0.2	3.7	7.4	0.0	2.8	3.8	2.9	2.1	0.0	3.3	2.4	0.9	6.0	0.3	2.6	2.9	2.7	5.9	1.7	0.0	5.7	2.4	0.2	1.1	3.4	3.4	1.8	1.0	2.8	3.3	1.9
H4C3	"dJ221C16.1, H4/g, H4FG, HIST1H4C"	ENSG00000197061	"H4 clustered histone 3"	P62805	6	26103933-26104337	"Disease related genes, Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	47	"brain: 238.7"	"Group enriched"	"Detected in some"	5	"Cardiomyocytes: 200.9;Cytotrophoblasts: 584.5;Extravillous trophoblasts: 700.1;Hofbauer cells: 264.1;Syncytiotrophoblasts: 220.3"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 12.8"	"Region enriched"	"Detected in all"	5	"cerebellum: 238.7"	"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEK 293: 39.5;PC-3: 21.4"									HPA042201	Supported					NA	Yes		25000000	"Cluster 6: Non-specific - Transcription"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 24: Non-specific - Transcription regulation"			"HPA042201: AB_2677898"	"unprognostic (1.28e-1)"	"unprognostic (5.91e-4)"	"unprognostic (6.95e-2)"	"unprognostic (8.93e-3)"	"unprognostic (5.84e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.38e-1)"	"unprognostic (4.31e-3)"	"unprognostic (3.79e-1)"	"unprognostic (1.01e-2)"	"unprognostic (2.30e-2)"	"unprognostic (1.32e-1)"	"prognostic unfavorable (5.74e-6)"	"unprognostic (2.42e-2)"	"unprognostic (3.02e-1)"	"unprognostic (2.82e-1)"	"unprognostic (2.79e-3)"	0.2	0.2	28.3	0.9	52.6	5.0	0.2	238.7	33.5	0.4	0.6	1.0	0.3	0.6	0.0	0.7	0.5	0.1	0.1	21.1	37.6	0.6	0.6	0.2	2.1	8.1	28.8	0.4	0.4	0.1	0.2	0.4	19.4	0.2	1.1	0.4	1.8	0.3	0.1	0.3	0.5	0.0	25.9	1.0	0.4	0.6	39.9	3.7	1.2	0.0	1.7	0.8	0.1	39.1	2.3	2.1	0.8	3.3	0.0	0.4	0.0	1.3	1.0	0.7	1.6	3.3	0.6	0.8	1.0	0.4	0.9	1.2	2.5	0.7	0.6	1.9	39.5	1.5	4.5	5.0	1.0	1.8	1.3	1.7	0.0	0.5	0.0	0.0	0.9	0.6	2.3	1.6	0.6	1.1	8.9	4.4	2.1	1.5	21.4	2.5	1.2	3.7	1.4	0.2	2.2	1.4	1.1	1.5	0.9	0.9	1.0	5.4	0.6	2.3	2.4	1.1	1.9	3.1	3.2	4.4	1.4	3.3	1.2	605.5	279.8	218.0	343.5	117.8	331.0	645.7	432.0	285.4	218.9	559.1	496.9	378.6	509.7	325.0	128.7	317.6	322.8	2335.9	28.3	52.6	238.7	33.5	21.1	37.6	8.1	28.8	19.4	25.9	39.9	39.1	25.3	0.0	0.0	0.0	13.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	200.9	0.0	0.0	0.0	0.0	584.5	76.4	0.0	0.0	0.0	0.0	0.0	0.0	41.5	0.0	0.0	0.0	0.0	700.1	54.9	0.0	0.0	0.0	0.0	0.0	0.0	264.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	37.3	0.0	0.0	0.0	0.0	220.3	13.0	0.0	0.0	0.0
H1-6	"H1FT, H1t, HIST1H1T"	ENSG00000187475	"H1.6 linker histone, cluster member"	P22492	6	26107412-26108135	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	11	"brain: 2.2;choroid plexus: 1.6;testis: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Immune cell enriched"	"Detected in single"	13	"neutrophil: 1.3"	"Lineage enriched"	"Detected in single"	13	"granulocytes: 1.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"HPA065718, HPA068266"	Enhanced					NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 49: Ciliated cells - Cilium organization"					"HPA065718: AB_2685543, HPA068266: AB_2685967"	"unprognostic (1.06e-2)"	"unprognostic (1.80e-2)"		"unprognostic (9.52e-2)"		"unprognostic (9.94e-2)"		"unprognostic (5.12e-1)"		"unprognostic (1.57e-1)"	"unprognostic (7.48e-3)"	"unprognostic (6.51e-2)"	"unprognostic (6.86e-3)"	"unprognostic (1.14e-1)"	"unprognostic (2.46e-1)"		"unprognostic (6.28e-3)"	0.0	0.0	0.3	0.1	1.0	0.0	0.1	0.3	0.8	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.4	0.0	0.1	0.0	0.0	1.1	0.5	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	1.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.4	0.3	1.0	0.3	0.8	0.5	0.4	1.1	0.5	0.6	0.3	0.8	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0
H2BC4	"H2B.1, H2B/l, H2BFL, HIST1H2BC"	ENSG00000180596	"H2B clustered histone 4"	P62807	6	26114873-26123926	"Plasma proteins, Predicted intracellular proteins"		"Antibiotic, Antimicrobial, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	5	"Syncytiotrophoblasts: 42.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	18	"neutrophil: 923.6"	"Lineage enriched"	"Detected in all"	26	"granulocytes: 923.6"	"Cell line enhanced"	"Detected in all"		"K-562: 39.8;SiHa: 75.8;U-2 OS: 51.9;U-266/70: 42.8;U-266/84: 57.1"									"HPA042205, HPA043013, HPA048671"	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 16: U-266 - Nucleosome"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Nucleoplasm	Cytosol	"HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488"	"unprognostic (8.30e-3)"	"unprognostic (2.60e-2)"	"unprognostic (2.37e-2)"	"unprognostic (9.26e-2)"	"unprognostic (3.20e-2)"	"unprognostic (5.08e-2)"	"unprognostic (4.72e-1)"	"unprognostic (6.45e-2)"	"unprognostic (9.22e-2)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (9.01e-4)"	"unprognostic (2.08e-1)"	"prognostic unfavorable (1.75e-5)"	"unprognostic (5.41e-2)"	"unprognostic (7.38e-2)"	"unprognostic (2.49e-1)"	"unprognostic (6.60e-3)"	4.3	3.4	9.5	6.0	17.4	25.0	6.7	11.4	8.8	9.1	9.9	3.1	3.2	1.2	3.6	14.7	7.1	4.6	3.6	10.5	15.0	5.3	13.1	8.0	2.9	20.3	10.9	2.6	2.6	0.9	5.8	7.2	16.3	21.8	2.3	1.5	7.5	0.9	14.5	6.7	3.0	1.2	21.5	5.1	7.0	6.4	9.4	14.9	3.6	8.0	2.3	3.5	10.2	27.6	7.0	4.0	2.1	2.0	1.9	1.1	2.6	6.8	2.5	4.5	3.7	5.6	4.1	2.7	12.5	2.3	3.3	5.2	2.8	2.8	2.2	6.3	2.3	2.2	6.1	9.6	2.6	3.4	8.4	27.3	1.7	1.9	1.1	2.2	1.8	2.1	39.8	21.1	8.6	8.0	7.5	7.2	2.2	7.4	12.4	3.3	3.0	16.3	7.8	1.7	9.4	3.0	75.8	5.8	2.6	5.5	31.8	3.1	5.6	5.5	51.9	3.4	2.8	42.8	57.1	13.2	2.3	8.6	3.8	52.5	9.3	49.9	9.2	10.5	12.4	19.1	13.3	13.0	6.6	35.1	10.3	7.7	923.6	10.5	10.4	22.0	9.3	19.2	9.5	17.4	11.4	8.8	10.5	15.0	20.3	10.9	16.3	21.5	9.4	27.6	1.3	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	5.2	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	7.7	0.9	0.0	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	42.8	0.4	0.0	0.0	0.0
H2AC6	"H2AFL, HIST1H2AC"	ENSG00000180573	"H2A clustered histone 6"	Q93077	6	26124145-26139116	"Cancer-related genes, Predicted intracellular proteins"		DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 65.4"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 10.9;Cardiomyocytes: 23.3;Cytotrophoblasts: 14.3;Extravillous trophoblasts: 28.5;Hofbauer cells: 16.2;Syncytiotrophoblasts: 75.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 1552.9"	"Lineage enriched"	"Detected in all"	14	"granulocytes: 1552.9"	"Cell line enhanced"	"Detected in many"		"U-266/84: 61.0"					"Low region specificity"	"Detected in all"			HPA041189	Supported		Approved	Nucleoplasm		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 70: Brain - Nervous system development"	"Cluster 16: U-266 - Nucleosome"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"HPA041189: AB_2677357"	"unprognostic (4.89e-2)"	"unprognostic (1.97e-1)"	"unprognostic (7.15e-3)"	"unprognostic (1.34e-1)"	"unprognostic (4.70e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.25e-1)"	"unprognostic (1.37e-1)"	"unprognostic (8.16e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.61e-3)"	"unprognostic (1.75e-1)"	"unprognostic (1.19e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.20e-1)"	"unprognostic (5.89e-3)"	14.0	12.7	26.8	5.0	39.2	12.9	10.7	38.1	38.5	21.6	24.1	13.1	11.5	4.7	11.3	28.1	10.8	10.3	11.2	34.5	41.7	21.5	30.2	22.9	5.5	37.9	34.4	12.7	7.2	0.9	10.5	5.2	33.9	26.0	5.3	3.9	10.8	2.1	20.2	16.7	13.2	2.1	52.1	21.2	13.8	4.7	30.6	18.1	12.7	4.7	2.0	12.0	28.6	65.4	13.2	30.7	0.1	0.0	14.4	8.8	1.5	8.4	2.4	4.0	4.1	10.3	3.7	0.0	36.8	4.2	1.8	4.0	0.0	0.8	2.7	18.4	3.5	1.8	21.5	3.8	10.8	0.7	8.8	26.5	4.5	1.4	4.5	10.9	1.4	0.7	23.1	11.9	3.9	20.0	2.9	3.4	1.3	10.4	13.9	2.3	0.2	25.6	13.2	8.7	3.2	3.2	29.5	4.0	13.4	7.1	33.3	2.4	3.2	6.9	20.5	3.6	1.7	32.7	61.0	4.7	2.0	28.4	1.1	440.2	31.9	324.6	28.0	24.6	25.7	61.7	29.7	19.4	28.3	109.5	34.9	19.6	1552.9	33.7	65.6	79.9	33.8	662.0	26.8	39.2	38.1	38.5	34.5	41.7	37.9	34.4	33.9	52.1	30.6	65.4	10.9	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.3	0.0	0.0	0.0	0.0	14.3	7.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	28.5	4.3	0.0	0.0	0.0	0.0	0.0	0.0	16.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	75.9	1.1	0.0	0.0	0.0
H1-4	"H1.4, H1e, H1F4, H1s-4, HIST1H1E"	ENSG00000168298	"H1.4 linker histone, cluster member"	P10412	6	26156329-26157115	"Disease related genes, Predicted intracellular proteins"		DNA-binding	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"bone marrow: 52.3;brain: 53.8"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 11.2;Cytotrophoblasts: 8.0;dendritic cells: 18.6;Extravillous trophoblasts: 11.3;Hofbauer cells: 7.7;Plasma cells: 6.7;Syncytiotrophoblasts: 7.3"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebellum: 53.8"	"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 10.5;U-266/70: 12.5;U-266/84: 15.1;U-87 MG: 12.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011506, HPA055907"	Supported		Supported	"Nuclear speckles"		NA	Yes		8300000	"Cluster 6: Non-specific - Transcription"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 16: U-266 - Nucleosome"	"Cluster 24: Non-specific - Transcription regulation"	"Nuclear speckles"		"CAB011506: AB_470256, HPA055907: AB_2682966"	"unprognostic (6.96e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.06e-2)"	"unprognostic (1.86e-1)"	"unprognostic (9.62e-2)"	"unprognostic (1.04e-2)"	"unprognostic (5.78e-3)"	"unprognostic (2.31e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.37e-1)"	"unprognostic (7.72e-13)"	"unprognostic (4.54e-3)"	"unprognostic (3.46e-2)"	"unprognostic (1.30e-3)"	"unprognostic (2.18e-2)"	1.7	0.3	0.4	0.3	2.4	52.3	2.7	53.8	26.5	3.2	7.3	1.7	0.3	0.5	0.3	1.2	0.7	0.4	0.6	2.8	11.7	2.1	1.1	1.2	2.5	11.8	0.0	1.8	1.8	0.3	1.9	0.9	3.2	2.5	0.4	0.0	3.0	0.2	0.4	4.1	2.7	0.1	5.0	1.4	1.4	1.4	5.5	2.7	0.9	0.1	0.5	0.9	2.8	11.4	2.6	0.3	0.5	5.5	0.1	0.0	6.6	0.0	0.4	1.2	0.9	0.1	1.6	1.3	0.7	0.1	0.5	1.2	0.3	0.7	0.5	1.8	1.6	0.9	0.5	0.4	0.1	0.8	1.1	0.1	0.3	0.3	0.6	0.1	0.5	1.4	4.4	7.0	0.2	0.5	8.6	7.8	2.0	0.8	0.8	4.0	1.3	10.5	0.3	0.0	4.0	0.9	3.3	0.8	1.2	0.6	1.1	2.8	0.5	2.5	3.8	1.5	2.6	12.5	15.1	6.1	12.6	2.3	1.2	257.4	43.0	106.3	66.4	42.1	76.6	73.6	52.1	61.6	49.0	119.6	39.4	37.1	60.4	70.7	39.5	48.6	56.9	31.4	0.4	2.4	53.8	26.5	2.8	11.7	11.8	0.0	3.2	5.0	5.5	11.4	3.6	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.2	0.0	0.0	0.0	0.0	8.0	18.6	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	11.3	2.5	0.0	0.0	0.0	0.0	0.0	0.0	7.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	7.3	1.8	0.0	0.0	0.0
H2BC5	"H2B/b, H2BFB, HIST1H2BD"	ENSG00000158373	"H2B clustered histone 5"	P58876	6	26158146-26171349	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"cervix: 151.7"	"Group enriched"	"Detected in some"	4	"Cardiomyocytes: 22.4;Syncytiotrophoblasts: 39.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-266/70: 117.9;U-266/84: 134.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA042205, HPA043013, HPA048671, CAB062336"	Supported		Approved	Nucleoplasm,Cytosol		NA	Yes			"Cluster 6: Non-specific - Transcription"	"Cluster 72: Non-specific - Transcription"	"Cluster 16: U-266 - Nucleosome"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Nucleoplasm	Cytosol	"CAB062336: AB_10622324, HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488"	"unprognostic (2.39e-2)"	"unprognostic (1.58e-2)"	"prognostic unfavorable (3.84e-4)"	"unprognostic (1.32e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.83e-2)"	"unprognostic (1.54e-1)"	"unprognostic (8.10e-2)"	"unprognostic (2.28e-1)"	"unprognostic (3.54e-2)"	"unprognostic (3.68e-3)"	"unprognostic (2.17e-1)"	"unprognostic (4.74e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.56e-1)"	"unprognostic (3.91e-2)"	"unprognostic (1.34e-2)"	25.4	13.4	17.8	7.6	21.9	53.8	18.5	48.7	19.2	151.7	41.8	34.6	11.0	6.3	27.7	37.6	53.5	15.3	31.4	17.9	29.7	67.2	62.9	36.8	9.2	22.2	23.7	101.8	15.7	2.1	30.5	9.3	28.0	144.0	17.1	9.7	28.9	3.6	18.5	44.1	23.3	4.3	27.5	35.4	26.1	11.3	23.8	35.2	25.2	7.3	4.1	17.9	95.5	33.9	17.9	39.7	12.0	6.8	91.2	8.3	3.6	15.5	8.9	19.6	12.3	13.3	14.5	8.1	95.2	18.5	21.8	27.9	6.8	6.6	9.2	36.6	16.9	5.4	33.7	14.5	9.8	7.2	14.7	59.7	10.3	5.5	7.7	7.6	4.9	7.5	57.1	43.3	3.6	64.2	16.4	18.1	12.6	76.1	18.2	6.5	7.6	54.4	18.7	12.8	38.1	16.1	96.8	25.1	15.9	23.1	63.4	2.6	3.0	24.4	63.4	9.9	3.3	117.9	134.9	20.5	3.1	33.2	5.0	35.3	2.3	16.9	8.1	5.1	10.4	13.4	12.3	13.5	5.6	20.0	11.4	8.7	24.8	10.5	6.9	19.3	8.9	2.4	17.8	21.9	48.7	19.2	17.9	29.7	22.2	23.7	28.0	27.5	23.8	33.9	1.6	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.4	0.0	0.0	0.0	0.0	7.1	2.1	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	7.5	1.5	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	39.4	0.3	0.0	0.0	0.0
H2BC6	"H2B.h, H2B/h, H2BFH, HIST1H2BE"	ENSG00000274290	"H2B clustered histone 6"	P62807	6	26172059-26184655	"Plasma proteins, Predicted intracellular proteins"		"Antibiotic, Antimicrobial, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 1.8;Cytotrophoblasts: 1.0;dendritic cells: 1.8;Extravillous trophoblasts: 1.1;Hofbauer cells: 1.0;Plasma cells: 1.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"NB-4: 5.3;REH: 5.1"									"HPA042205, HPA043013, HPA048671"	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 24: NB-4 - Immune response"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	Cytosol	"HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488"	"unprognostic (2.14e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.27e-1)"	"unprognostic (7.06e-3)"	"unprognostic (8.28e-2)"	"unprognostic (1.31e-1)"	"unprognostic (7.98e-2)"	"unprognostic (3.16e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.69e-2)"	"unprognostic (3.78e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.55e-6)"	"unprognostic (3.03e-2)"	"unprognostic (4.86e-2)"	"unprognostic (2.30e-1)"	"unprognostic (3.11e-2)"	0.8	0.4	1.6	0.5	2.0	2.7	0.6	3.0	1.5	3.6	3.6	0.7	0.4	0.4	0.4	0.7	0.6	0.4	0.6	1.6	0.3	1.0	0.6	1.3	0.9	1.9	0.8	0.9	0.2	0.1	0.7	0.3	0.4	2.6	0.5	1.1	1.3	0.2	0.8	1.7	0.3	0.2	1.8	0.9	0.8	0.5	0.6	2.9	0.5	0.6	0.6	0.4	2.1	1.5	0.3	2.1	1.9	0.5	1.6	0.2	0.2	1.9	0.6	0.3	0.1	0.5	1.3	0.4	0.8	0.3	0.9	2.7	0.3	0.7	0.3	0.9	0.5	0.2	1.0	0.1	0.1	0.1	1.6	0.4	0.1	0.4	0.1	0.6	0.2	0.5	1.4	1.0	0.0	1.0	3.0	5.3	1.5	1.0	0.5	5.1	0.1	1.5	0.8	1.1	1.5	2.2	2.3	0.8	0.5	0.8	1.6	1.0	0.5	0.8	1.5	0.6	1.2	1.3	2.7	0.3	0.4	0.8	0.3	2.9	0.6	1.0	0.7	0.5	0.5	1.0	0.7	0.9	0.2	1.2	0.6	0.6	2.1	0.6	0.6	1.2	1.1	0.3	1.6	2.0	3.0	1.5	1.6	0.3	1.9	0.8	0.4	1.8	0.6	1.5	1.8	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	1.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.8	0.3	0.0	0.0	0.0
H4C4	"H4/b, H4FB, HIST1H4D"	ENSG00000277157	"H4 clustered histone 4"	P62805	6	26188710-26189112	"Disease related genes, Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"brain: 33.9"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	4	"naive B-cell: 3.4"	"Lineage enriched"	"Detected in single"	4	"B-cells: 3.4"	"Cell line enhanced"	"Detected in many"		"HEK 293: 5.2;HeLa: 5.0;RT4: 8.9"									HPA042201	Supported					NA	NA		25000000	"Cluster 24: B-cells - Unknown function"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 15: RT4 - Unknown function"	"Cluster 65: Plasmacytoid DCs - Unknown function"			"HPA042201: AB_2677898"	"unprognostic (1.33e-1)"	"unprognostic (1.81e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.98e-2)"	"unprognostic (2.06e-2)"	"unprognostic (7.63e-2)"	"unprognostic (3.80e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.92e-1)"	"unprognostic (5.37e-2)"	"unprognostic (3.53e-2)"	"unprognostic (1.30e-1)"	"unprognostic (7.77e-4)"	"unprognostic (1.56e-1)"	"unprognostic (5.44e-2)"	"unprognostic (1.17e-1)"	"unprognostic (6.11e-3)"	0.1	0.5	10.8	0.0	19.0	0.8	0.8	33.9	11.4	0.3	5.0	0.2	0.0	0.2	0.3	0.6	0.7	0.1	0.2	7.9	3.4	0.2	0.4	0.4	0.2	4.0	3.3	0.1	0.1	0.1	0.3	0.2	6.7	1.1	0.2	0.1	0.1	0.1	0.0	0.2	0.2	0.1	15.4	0.6	0.2	0.4	9.7	2.0	0.5	0.0	0.1	0.0	0.3	5.6	1.0	1.1	0.8	0.0	1.3	0.0	0.5	0.7	0.4	1.9	0.9	1.8	0.4	4.0	0.3	0.0	1.5	0.5	2.3	0.4	0.6	0.3	5.2	0.6	5.0	1.7	0.0	0.4	0.1	0.4	0.0	0.2	0.7	0.0	1.6	0.5	1.3	1.1	0.0	1.9	1.5	2.7	1.4	0.9	0.3	0.4	0.0	0.5	0.5	8.9	0.5	0.3	0.8	0.5	0.5	0.6	0.9	0.3	0.0	0.4	2.9	0.3	1.1	1.2	1.2	0.0	0.8	1.1	0.7	0.0	0.3	0.0	0.2	0.0	0.1	0.4	0.8	0.2	0.2	3.4	0.1	0.2	0.4	0.1	0.2	0.0	0.0	0.3	10.8	19.0	33.9	11.4	7.9	3.4	4.0	3.3	6.7	15.4	9.7	5.6	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0
AL031777.2		ENSG00000282988	"Novel protein"		6	26195595-26199293	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Low tissue specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 5.1;Extravillous trophoblasts: 6.7;Hofbauer cells: 9.1;Syncytiotrophoblasts: 20.7"					"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"basophil: 16.9;neutrophil: 30.6"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 30.6"	"Cell line enhanced"	"Detected in some"		"K-562: 6.9;SiHa: 7.7;T-47d: 4.6;U-2 OS: 5.1;U-266/70: 9.3;U-266/84: 5.6"									HPA041189	Uncertain		Approved	Nucleoplasm		NA	Yes			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 16: U-266 - Nucleosome"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Nucleoplasm		"HPA041189: AB_2677357"																		0.6	0.3	0.5	0.2	0.6	1.5	1.1	1.3	1.2	2.0	1.6	0.7	0.3	0.1	0.0	3.4	0.4	0.1	0.4	0.6	0.5	0.8	1.9	2.2	0.3	1.2	0.8	0.4	0.1	0.1	0.3	0.3	1.1	2.5	0.3	0.1	0.5	0.0	0.0	0.8	0.6	0.1	1.0	2.0	0.5	0.7	1.0	0.8	0.4	0.0	0.1	0.4	2.4	1.4	0.2	0.7	0.2	0.7	1.5	0.1	0.5	0.6	0.1	1.2	0.4	0.2	0.5	0.1	2.0	0.1	0.5	1.4	0.1	0.0	0.2	2.6	0.2	0.4	2.1	0.3	0.1	0.1	0.9	1.0	0.0	0.1	0.3	0.2	0.0	0.6	6.9	1.5	0.0	1.0	0.1	0.4	0.2	2.6	1.6	0.2	0.1	3.0	0.0	0.0	0.6	0.2	7.7	0.5	0.3	0.3	4.6	0.0	0.0	0.7	5.1	0.0	0.0	9.3	5.6	0.7	0.0	1.9	0.7	16.9	0.6	5.1	1.6	0.7	3.6	2.1	0.8	1.1	2.3	4.7	0.8	0.5	30.6	0.9	1.5	5.2	2.3	1.1	0.5	0.6	1.3	1.2	0.6	0.5	1.2	0.8	1.1	1.0	1.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	6.7	0.4	0.0	0.0	0.0	0.0	0.0	0.0	9.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.7	0.0	0.0	0.0	0.0
H3C4	"H3/b, H3FB, HIST1H3D"	ENSG00000197409	"H3 clustered histone 4"	P68431	6	26196784-26197286	"Disease related genes, Predicted intracellular proteins"		DNA-binding	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 12.2;brain: 15.9"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 5.7;MOLT-4: 5.4;U-266/70: 11.7;U-266/84: 6.9"									HPA042570	Approved					NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 43: Cardiomyocytes - Nuclear processes"			"HPA042570: AB_2678056"	"unprognostic (8.64e-2)"	"unprognostic (1.27e-2)"	"unprognostic (9.06e-3)"	"unprognostic (2.00e-1)"	"unprognostic (6.59e-2)"	"unprognostic (1.43e-2)"	"unprognostic (8.62e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.95e-1)"	"unprognostic (2.69e-2)"	"unprognostic (2.80e-1)"	"unprognostic (1.32e-1)"	"prognostic unfavorable (1.78e-6)"	"unprognostic (2.44e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.28e-1)"	"unprognostic (4.94e-2)"	0.6	0.8	4.3	0.1	4.1	12.2	0.6	15.9	3.2	2.3	5.7	1.0	0.6	0.2	0.0	2.0	0.9	0.5	0.5	1.1	2.6	0.9	1.5	1.4	0.4	4.8	5.2	0.8	0.2	0.0	0.6	0.2	4.8	2.8	0.0	0.1	1.0	0.1	0.0	0.7	0.7	0.1	6.7	1.7	0.6	0.8	4.5	1.8	0.6	0.0	0.3	0.7	2.8	10.9	1.5	0.0	0.2	1.2	0.8	0.3	0.7	0.0	0.3	1.6	1.1	2.9	0.6	2.7	1.3	0.4	0.0	0.4	0.7	0.1	0.0	1.5	0.2	0.1	1.3	2.0	0.1	0.9	1.8	0.1	0.1	1.2	0.3	0.0	0.5	1.1	1.2	5.7	0.0	0.6	5.4	4.6	0.2	0.1	0.9	2.7	0.3	3.1	0.0	0.0	0.8	0.1	0.0	1.0	0.8	0.0	0.6	1.6	1.4	0.3	2.9	0.0	1.5	11.7	6.9	0.6	1.5	0.3	0.4	14.8	1.6	4.2	3.4	1.6	8.6	8.3	2.5	3.5	3.9	13.0	2.6	4.6	22.2	3.2	3.5	5.1	3.3	0.9	4.3	4.1	15.9	3.2	1.1	2.6	4.8	5.2	4.8	6.7	4.5	10.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
H2AC7	"H2A.3, H2A/g, H2AFG, HIST1H2AD"	ENSG00000196866	"H2A clustered histone 7"	P20671	6	26198784-26199293	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 6.8"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 17.9"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-266/70: 17.5;U-266/84: 6.3"					"Low region specificity"	"Detected in all"			HPA041189	Supported		Approved	Nucleoplasm		NA	Yes			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 29: U-266 - Adaptive immune response"		Nucleoplasm		"HPA041189: AB_2677357"	"unprognostic (5.03e-2)"	"unprognostic (1.11e-2)"	"unprognostic (7.27e-2)"	"unprognostic (3.56e-1)"	"unprognostic (9.17e-2)"	"unprognostic (1.45e-1)"	"unprognostic (9.09e-3)"	"unprognostic (6.72e-2)"	"unprognostic (1.92e-1)"	"unprognostic (4.34e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.88e-2)"	"unprognostic (1.10e-9)"	"unprognostic (2.00e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.27e-1)"	"unprognostic (2.14e-2)"	0.7	0.2	0.4	0.3	1.7	2.9	0.6	4.1	2.1	3.3	3.6	0.5	0.0	0.1	0.0	2.5	0.6	0.3	0.4	1.0	1.9	0.6	1.2	2.1	0.5	3.1	1.7	0.7	0.1	0.0	0.3	0.2	2.1	2.1	0.1	0.0	0.5	0.0	0.0	1.1	0.5	0.0	3.9	1.2	0.6	0.3	3.0	1.8	0.3	0.0	0.3	0.3	2.8	6.8	1.1	0.0	0.2	0.2	0.0	0.0	0.2	0.7	0.1	1.1	0.0	1.3	0.4	0.7	1.2	0.2	0.1	0.3	0.0	0.1	0.2	0.0	1.0	0.3	1.4	1.3	0.0	0.1	0.9	0.0	0.0	0.1	0.0	0.1	0.0	0.7	2.5	1.3	0.0	0.0	3.7	1.5	1.1	0.0	1.1	1.0	0.4	0.9	0.4	0.1	1.4	0.2	0.6	0.8	0.1	0.0	1.4	0.3	0.0	1.1	3.1	0.0	1.0	17.5	6.3	2.2	1.0	1.3	0.4	2.3	0.3	3.8	1.3	1.9	1.3	2.7	2.0	4.0	1.1	7.6	1.9	1.9	17.9	1.8	2.2	6.2	2.7	0.8	0.4	1.7	4.1	2.1	1.0	1.9	3.1	1.7	2.1	3.9	3.0	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
H2BC7	"H2B/g, H2BFG, HIST1H2BF"	ENSG00000277224	"H2B clustered histone 7"	P62807	6	26199520-26200715	"Plasma proteins, Predicted intracellular proteins"		"Antibiotic, Antimicrobial, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"prostate: 7.4"	"Cell type enhanced"	"Detected in single"		"Hofbauer cells: 1.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 2.4"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"U-266/70: 24.8;U-266/84: 18.8"	"Low region specificity"	"Detected in all"							"HPA042205, HPA043013, HPA048671"	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	Cytosol	"HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488"	"unprognostic (1.15e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.38e-2)"	"unprognostic (4.58e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.47e-1)"	"unprognostic (6.80e-3)"	"unprognostic (3.15e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.95e-1)"	"unprognostic (7.27e-3)"	"unprognostic (4.29e-11)"	"unprognostic (4.88e-3)"	"unprognostic (4.45e-1)"	"unprognostic (1.15e-2)"	"unprognostic (1.30e-1)"	0.9	0.2	0.6	0.2	1.1	1.2	1.6	4.0	0.9	3.3	1.5	1.4	0.0	0.1	0.0	3.2	1.8	0.2	0.4	0.8	0.6	1.4	0.6	1.7	0.3	1.9	1.7	0.8	0.2	0.0	0.6	0.2	2.4	7.4	0.2	0.6	1.1	0.0	0.0	0.9	0.7	0.0	2.1	2.3	0.7	0.6	1.2	1.7	0.6	0.1	0.4	0.4	4.5	2.4	0.5	0.3	0.2	0.5	0.3	0.0	0.2	0.2	0.1	0.7	0.1	0.7	0.1	0.6	1.0	0.0	0.3	1.0	0.5	0.1	0.3	0.8	0.2	0.4	1.8	0.2	0.1	0.1	0.9	0.3	0.1	0.2	0.1	0.0	0.1	0.5	2.0	4.5	0.0	0.1	4.0	1.6	0.6	0.8	0.6	1.5	0.7	3.0	0.1	0.1	2.4	0.4	4.9	0.9	0.1	0.3	4.4	0.2	0.1	0.3	2.2	0.0	0.6	24.8	18.8	1.3	0.1	1.2	0.5	0.0	0.0	0.6	0.2	0.1	0.6	0.2	0.2	0.3	0.1	1.0	0.2	0.5	2.4	0.2	0.3	0.3	0.2	0.5	0.6	1.1	4.0	0.9	0.8	0.6	1.9	1.7	2.4	2.1	1.2	2.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0
H4C5	"H4/j, H4FJ, HIST1H4E"	ENSG00000276966	"H4 clustered histone 5"	P62805	6	26204552-26206038	"Disease related genes, Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"brain: 69.4"	"Group enriched"	"Detected in some"	4	"Cardiomyocytes: 1.2;Cytotrophoblasts: 2.7;dendritic cells: 1.8;Extravillous trophoblasts: 1.6;Hofbauer cells: 4.6;Plasma cells: 1.3;Syncytiotrophoblasts: 3.4"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	4	"cerebellum: 69.4"	"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MOLT-4: 6.1;U-266/70: 11.3"									HPA042201	Supported					NA	NA		25000000	"Cluster 27: Non-specific - Gene expression"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"			"HPA042201: AB_2677898"	"unprognostic (8.62e-2)"	"unprognostic (4.86e-2)"	"unprognostic (5.71e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.57e-1)"	"unprognostic (5.08e-3)"	"unprognostic (7.99e-2)"	"unprognostic (1.21e-1)"	"unprognostic (6.57e-2)"	"unprognostic (2.34e-3)"	"unprognostic (4.34e-2)"	"prognostic unfavorable (2.00e-6)"	"unprognostic (1.28e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.40e-1)"	"unprognostic (4.92e-2)"	0.8	0.5	12.1	0.4	14.5	2.1	0.8	69.4	14.4	3.8	0.5	1.9	0.9	0.5	0.8	2.6	2.7	0.2	1.1	10.8	8.1	3.1	1.0	1.0	0.5	3.9	3.2	2.8	0.5	0.2	2.2	0.5	6.9	7.5	0.5	1.5	1.3	0.3	0.0	1.9	0.9	0.2	15.2	1.5	1.6	2.0	7.2	1.9	1.5	0.0	0.4	0.6	3.6	16.8	1.1	0.7	1.3	3.1	0.5	0.0	0.7	1.1	0.3	0.5	0.4	0.4	1.1	0.4	1.5	0.3	0.7	1.9	0.7	0.1	0.7	0.9	0.8	0.3	1.5	0.7	0.0	0.5	1.2	0.3	0.0	0.4	0.3	0.3	0.4	1.0	2.3	2.6	0.1	0.4	6.1	2.8	1.3	0.5	1.0	2.7	1.4	2.7	0.5	0.4	3.7	0.9	0.8	1.3	0.4	0.4	1.2	0.5	0.5	1.5	2.1	0.4	0.9	11.3	4.7	1.7	0.3	1.1	1.1	2.7	2.1	1.8	2.0	1.8	2.9	2.5	3.0	2.0	3.1	5.4	3.2	2.6	2.6	2.3	5.5	2.7	2.0	1.2	12.1	14.5	69.4	14.4	10.8	8.1	3.9	3.2	6.9	15.2	7.2	16.8	0.5	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	2.7	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.2	0.0	0.0	0.0
H2BC8	"H2B.1A, H2B/a, H2BFA, HIST1H2BG"	ENSG00000273802	"H2B clustered histone 8"	P62807	6	26215159-26216692	"Plasma proteins, Predicted intracellular proteins"		"Antibiotic, Antimicrobial, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 23.9"	"Group enriched"	"Detected in some"	4	"Cytotrophoblasts: 7.3;Extravillous trophoblasts: 7.4;Hofbauer cells: 22.5;Syncytiotrophoblasts: 24.1"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 23.4"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"K-562: 9.6;SiHa: 10.5;T-47d: 21.2;U-266/70: 19.6"									"HPA042205, HPA043013, HPA048671"	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 6: T47d - Mammary gland"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Nucleoplasm	Cytosol	"HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488"	"unprognostic (1.40e-2)"	"unprognostic (1.34e-2)"	"unprognostic (4.55e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.05e-1)"	"unprognostic (4.19e-2)"	"unprognostic (1.63e-2)"	"unprognostic (8.54e-2)"	"unprognostic (6.69e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.36e-2)"	"unprognostic (2.79e-2)"	"prognostic unfavorable (1.70e-8)"	"unprognostic (1.15e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.97e-2)"	3.1	0.9	1.5	1.2	1.4	6.7	13.2	8.0	1.8	23.9	4.8	5.9	1.1	0.9	2.0	9.1	4.3	0.9	3.3	1.5	1.9	4.3	3.1	7.5	1.6	1.4	2.2	5.7	1.1	0.1	2.9	1.1	3.6	19.7	2.0	1.6	6.9	0.5	0.1	13.2	3.2	0.4	2.8	7.1	3.7	1.8	1.9	4.1	2.6	0.0	1.4	1.6	18.4	4.6	3.0	0.1	1.4	0.0	4.4	0.2	0.4	3.7	0.3	2.3	0.9	0.4	2.6	0.0	3.7	0.3	1.0	3.2	1.3	1.2	1.3	2.6	1.6	0.8	1.5	1.4	0.7	0.3	2.4	1.7	0.6	0.7	0.1	0.1	0.5	0.1	9.6	0.2	0.0	2.2	2.8	2.1	1.5	7.1	1.9	1.8	0.8	5.4	1.3	0.7	8.5	1.3	10.5	3.8	1.2	3.7	21.2	0.9	0.3	0.0	1.2	0.3	0.5	19.6	0.1	0.0	0.3	1.3	0.7	18.1	1.3	3.2	2.0	0.9	6.4	4.4	3.2	4.0	5.1	5.3	1.5	1.3	5.8	1.4	1.8	16.0	3.0	2.2	1.5	1.4	8.0	1.8	1.5	1.9	1.4	2.2	3.6	2.8	1.9	4.6	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	7.3	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	7.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	22.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	24.1	0.2	0.0	0.0	0.0
H2AC8	"H2A.1, H2A/a, H2AFA, HIST1H2AE"	ENSG00000277075	"H2A clustered histone 8"	P04908	6	26216975-26217483	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 41.2;breast: 40.7"	"Group enriched"	"Detected in some"	9	"Cytotrophoblasts: 6.5;Extravillous trophoblasts: 5.5;Hofbauer cells: 18.0;Syncytiotrophoblasts: 13.8"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 40.9"	"Group enriched"	"Detected in all"	5	"cerebellum: 41.2;white matter: 17.5"	"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-266/70: 37.0"									"CAB012242, HPA041189"	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 50: Non-specific - Ribosome"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"CAB012242: AB_470265, HPA041189: AB_2677357"	"unprognostic (4.26e-2)"	"unprognostic (1.55e-2)"	"unprognostic (4.66e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.45e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.48e-2)"	"unprognostic (7.22e-2)"	"unprognostic (1.24e-2)"	"unprognostic (6.99e-2)"	"unprognostic (1.21e-3)"	"unprognostic (1.30e-2)"	"unprognostic (7.64e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.41e-1)"	"unprognostic (2.20e-1)"	"unprognostic (9.36e-2)"	4.3	2.4	2.1	1.6	5.6	19.3	40.7	41.2	6.0	14.7	4.6	7.9	3.6	1.6	16.7	8.6	7.8	1.8	4.2	5.1	3.7	11.6	5.7	7.9	2.9	2.3	1.1	6.8	1.0	0.4	3.4	1.6	3.7	32.9	2.1	1.5	4.7	1.2	0.2	16.5	4.6	0.6	1.7	9.5	5.2	4.3	3.3	9.4	5.8	0.1	0.8	2.2	17.4	17.5	4.1	0.0	3.0	0.0	4.9	0.9	0.8	1.3	2.0	4.3	2.9	2.0	3.3	0.2	10.8	0.4	3.9	3.4	1.5	2.0	1.7	4.5	3.7	2.7	5.9	2.6	0.9	0.3	4.1	8.4	0.9	1.8	0.2	1.2	2.1	0.8	11.4	2.9	0.4	7.5	9.3	7.9	3.5	14.1	3.7	7.3	2.4	14.7	1.8	2.3	11.9	5.0	10.9	3.7	2.4	2.0	14.9	4.1	0.0	0.2	0.8	1.8	1.8	37.0	0.0	0.0	1.5	5.5	2.7	18.2	2.2	8.2	2.8	2.6	4.1	4.7	3.3	4.6	5.9	6.0	1.7	2.3	10.1	4.5	1.6	17.6	4.4	10.4	2.1	5.6	41.2	6.0	5.1	3.7	2.3	1.1	3.7	1.7	3.3	17.5	0.6	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	6.5	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	5.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	18.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.8	0.2	0.0	0.0	0.0
H3C6	"H3.1, H3/d, H3FD, HIST1H3E"	ENSG00000274750	"H3 clustered histone 6"	P68431	6	26224199-26227473	"Disease related genes, Predicted intracellular proteins"		DNA-binding	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Hofbauer cells: 1.0;Syncytiotrophoblasts: 1.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"EFO-21: 10.5;hTERT-RPE1: 7.5;SCLC-21H: 11.9;T-47d: 7.3"					"Low region specificity"	"Detected in all"			HPA042570	Approved					NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 24: Non-specific - Transcription regulation"			"HPA042570: AB_2678056"	"unprognostic (2.42e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.78e-3)"	"unprognostic (9.07e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.65e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.90e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.39e-2)"	"unprognostic (1.76e-2)"	"unprognostic (1.42e-1)"	"unprognostic (4.88e-2)"	"unprognostic (1.07e-1)"	"unprognostic (7.66e-2)"	0.6	3.5	1.0	1.0	1.5	0.4	1.8	3.9	3.2	1.2	2.7	2.9	4.7	0.8	4.9	2.8	1.5	1.0	6.0	1.1	1.5	1.6	2.9	0.5	1.3	2.0	1.7	1.0	0.7	1.5	0.6	0.9	2.4	3.4	1.9	0.2	1.9	0.7	5.1	1.2	4.7	0.4	1.9	2.2	2.6	1.4	1.4	1.2	2.6	3.7	0.9	1.2	1.2	3.4	1.9	2.0	2.8	1.3	3.3	1.6	0.2	1.3	1.5	0.7	0.5	0.6	1.1	0.0	10.5	0.5	1.0	2.3	0.0	0.3	0.6	2.9	2.5	0.4	1.0	0.6	1.0	0.1	1.7	2.3	2.4	0.3	0.7	7.5	1.1	0.2	0.3	2.2	1.9	1.8	0.4	0.1	0.2	1.4	1.9	1.4	0.6	0.3	5.7	1.1	11.9	1.4	1.9	3.0	3.4	0.4	7.3	1.2	0.6	1.3	0.4	0.4	0.3	0.8	0.3	0.2	0.6	0.1	0.7	0.2	0.7	0.0	0.5	0.6	0.7	0.5	0.7	0.7	0.5	0.9	0.6	0.7	2.7	0.2	0.6	1.7	1.3	0.5	1.0	1.5	3.9	3.2	1.1	1.5	2.0	1.7	2.4	1.9	1.4	3.4	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0
H1-3	"H1.3, H1d, H1F3, H1s-2, HIST1H1D"	ENSG00000124575	"H1.3 linker histone, cluster member"	P16402	6	26234212-26234987	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 21.1;brain: 24.1"	"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 4.4;dendritic cells: 23.3;Extravillous trophoblasts: 18.3;Hofbauer cells: 7.5;Plasma cells: 7.3"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebellum: 24.1"	"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"BEWO: 5.8;MOLT-4: 9.9;NB-4: 4.3;REH: 4.0;SiHa: 3.8;U-266/70: 4.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA055907	Supported					NA	NA		4000000	"Cluster 21: B-cells - Adaptive immune response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 24: NB-4 - Immune response"	"Cluster 24: Non-specific - Transcription regulation"			"HPA055907: AB_2682966"	"unprognostic (8.78e-2)"	"unprognostic (1.01e-4)"	"unprognostic (8.69e-2)"	"unprognostic (5.67e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.11e-2)"	"unprognostic (2.13e-1)"	"unprognostic (3.06e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.14e-2)"	"unprognostic (8.96e-2)"	"unprognostic (3.61e-8)"	"unprognostic (8.78e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.23e-3)"	"unprognostic (1.33e-2)"	1.2	0.1	1.3	0.2	0.5	21.1	1.1	24.1	4.6	1.7	3.4	1.5	0.0	0.1	0.1	0.7	0.4	0.0	0.4	0.5	1.4	0.6	0.3	1.3	1.9	2.5	1.8	0.3	0.0	0.0	0.1	0.5	4.5	1.4	0.7	0.0	0.5	0.0	0.0	2.4	2.5	0.1	3.8	1.3	0.6	0.3	2.6	5.5	0.5	0.0	0.4	0.2	3.8	7.0	0.7	0.5	0.1	0.0	0.2	0.0	5.8	0.3	0.2	0.7	0.5	0.1	0.6	0.0	0.1	0.1	0.3	0.7	0.2	0.0	0.3	0.1	0.0	0.2	0.1	0.0	0.1	0.0	0.4	0.0	0.1	0.1	0.2	0.0	0.2	0.8	1.7	1.7	0.1	0.0	9.9	4.3	0.5	0.0	1.7	4.0	0.1	2.2	0.0	0.0	1.9	0.3	3.8	1.6	0.0	0.5	0.7	0.9	0.0	0.2	0.0	0.1	0.6	4.8	2.5	0.3	0.6	1.2	0.5	22.3	7.5	6.5	31.4	4.4	21.9	32.1	28.7	21.7	18.2	46.7	37.1	30.6	2.6	25.8	6.9	32.8	23.4	14.1	1.3	0.5	24.1	4.6	0.5	1.4	2.5	1.8	4.5	3.8	2.6	7.0	3.5	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	4.4	23.3	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	18.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	3.6	3.6	0.0	0.0	0.0
H4C6	"H4, H4/c, H4FC, HIST1H4F"	ENSG00000274618	"H4 clustered histone 6"	P62805	6	26240393-26240793	"Disease related genes, Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	8	"brain: 7.4"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"ovarian cancer: 1.2"	"Group enriched"	"Detected in many"	4	"cerebral cortex: 5.1;white matter: 7.4"	"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"MOLT-4: 4.5;REH: 1.9"									HPA042201	Supported					NA	NA		25000000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 43: Cardiomyocytes - Nuclear processes"			"HPA042201: AB_2677898"										"unprognostic (1.47e-1)"				"unprognostic (1.17e-2)"	"unprognostic (2.05e-1)"			0.0	0.0	0.4	0.0	0.5	0.9	0.0	0.5	5.1	0.0	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.9	0.7	0.0	0.0	0.0	0.3	1.3	0.7	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.2	0.6	0.7	0.0	0.0	0.0	0.0	0.0	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.9	4.5	0.6	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.8	3.5	3.0	2.4	2.3	5.5	3.9	4.0	3.8	6.9	3.2	2.3	10.7	2.1	2.0	6.4	1.1	1.5	0.4	0.5	0.5	5.1	0.9	0.7	1.3	0.7	0.7	1.5	0.6	7.4	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0
H4C7	"H4/l, H4FL, HIST1H4G"	ENSG00000275663	"H4 clustered histone 7"	Q99525	6	26246611-26246996	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA042201	Supported					NA	NA									"HPA042201: AB_2677898"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
H3C7	"H3/i, H3FI, HIST1H3F"	ENSG00000277775	"H3 clustered histone 7"	P68431	6	26250142-26250635	"Disease related genes, Predicted intracellular proteins"		DNA-binding	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 1.6;brain: 3.7;choroid plexus: 2.1"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in many"		"ovarian cancer: 2.7"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	5	"memory B-cell: 1.8"	"Lineage enriched"	"Detected in single"	5	"B-cells: 1.8"	"Cell line enhanced"	"Detected in some"		"NB-4: 4.3;U-266/84: 6.2"									"HPA042570, CAB070190"	Approved					NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 16: U-266 - Nucleosome"	"Cluster 24: Non-specific - Transcription regulation"			"CAB070190: AB_10001790, HPA042570: AB_2678056"	"unprognostic (1.91e-1)"	"unprognostic (2.02e-2)"	"unprognostic (2.00e-1)"	"unprognostic (2.04e-1)"	"unprognostic (6.10e-3)"	"unprognostic (1.91e-6)"		"unprognostic (9.73e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.13e-2)"		"unprognostic (2.14e-1)"		"unprognostic (1.00e-1)"	"unprognostic (3.33e-1)"	"unprognostic (5.22e-2)"	"unprognostic (2.60e-4)"	0.0	0.1	0.6	0.2	0.6	1.6	0.0	1.2	0.7	0.0	2.1	0.2	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.5	0.4	0.0	0.0	0.0	0.4	1.9	0.9	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	1.0	0.2	0.1	0.0	1.8	0.8	0.0	0.0	0.0	0.0	0.0	3.7	0.8	0.0	1.1	0.0	0.0	0.0	0.8	0.6	0.0	1.1	0.3	0.0	0.0	0.1	0.6	0.0	0.3	0.4	0.0	0.5	0.0	0.9	0.2	0.8	2.6	0.0	0.0	0.0	1.3	0.0	0.0	0.3	0.0	0.0	0.6	0.8	1.2	1.2	0.0	0.9	1.9	4.3	0.1	0.0	1.1	2.1	0.0	0.6	0.0	0.3	2.2	0.5	0.8	0.4	0.0	0.1	1.6	1.6	0.0	0.2	0.0	0.1	1.1	1.2	6.2	0.0	1.2	1.5	0.5	0.0	0.1	0.0	0.1	0.0	0.0	1.8	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.1	0.6	0.6	1.2	0.7	0.5	0.4	1.9	0.9	1.4	1.0	1.8	3.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0
H2BC9	"H2B/j, H2BFJ, HIST1H2BH"	ENSG00000275713	"H2B clustered histone 9"	Q93079	6	26251651-26253710	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 4.2;vagina: 4.3"	"Cell type enriched"	"Detected in some"	4	"Extravillous trophoblasts: 29.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	4	"basophil: 3.7;neutrophil: 3.0"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 3.7"	"Cell line enhanced"	"Detected in many"		"U-266/70: 16.9"									"HPA042205, HPA043013, HPA048671"	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Nucleoplasm	Cytosol	"HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488"	"unprognostic (5.83e-2)"	"unprognostic (6.27e-3)"	"unprognostic (4.50e-2)"	"unprognostic (9.18e-2)"	"unprognostic (5.52e-2)"	"prognostic unfavorable (7.52e-4)"	"unprognostic (5.06e-3)"	"unprognostic (3.08e-3)"	"unprognostic (1.58e-2)"	"unprognostic (2.75e-2)"	"unprognostic (1.86e-1)"	"unprognostic (3.22e-1)"	"unprognostic (2.96e-8)"	"unprognostic (1.60e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.40e-2)"	"unprognostic (1.95e-3)"	0.5	0.2	0.4	0.6	0.4	1.4	0.6	0.3	0.5	1.9	0.8	2.0	3.0	0.4	0.8	4.2	0.8	0.3	0.2	0.3	0.4	0.9	0.2	1.6	0.8	0.8	0.7	0.1	0.0	0.1	0.1	0.2	0.7	3.5	0.8	0.0	1.3	0.0	0.0	0.6	1.7	0.1	0.6	3.7	0.7	0.6	0.7	2.9	1.0	0.1	0.5	0.4	4.3	1.1	1.8	0.1	7.0	0.0	0.0	0.1	1.1	0.9	0.3	1.2	0.6	2.4	1.1	0.0	1.7	0.1	1.8	3.4	0.0	0.6	1.7	0.9	0.1	1.3	6.1	0.4	0.0	0.0	4.0	0.3	0.3	0.4	0.5	0.0	0.3	1.0	2.7	6.2	0.1	2.0	3.8	2.7	1.6	0.0	1.8	4.0	0.0	0.9	0.0	2.7	3.2	2.9	4.2	1.4	0.6	0.3	2.0	3.3	0.0	0.6	0.0	0.7	3.1	16.9	4.5	0.0	0.5	1.5	3.8	3.7	0.2	0.6	0.3	0.0	0.1	0.6	0.2	0.4	0.6	0.3	0.0	0.1	3.0	0.8	0.1	0.2	0.4	5.2	0.4	0.4	0.3	0.5	0.3	0.4	0.8	0.7	0.7	0.6	0.7	1.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	29.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	7.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.2	0.0	0.0	0.0
H3C8	"H3/h, H3FH, HIST1H3G"	ENSG00000273983	"H3 clustered histone 8"	P68431	6	26269405-26271815	"Disease related genes, Predicted intracellular proteins"		DNA-binding	"Disease variant"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 1.1;Extravillous trophoblasts: 1.8;Hofbauer cells: 1.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 2.7;SiHa: 6.8;U-266/70: 6.3"									HPA042570	Approved					NA	NA					"Cluster 29: U-266 - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"			"HPA042570: AB_2678056"	"unprognostic (1.88e-1)"	"prognostic favorable (8.75e-4)"	"unprognostic (3.14e-1)"	"unprognostic (2.58e-1)"	"unprognostic (6.94e-2)"	"unprognostic (8.74e-2)"	"unprognostic (1.39e-1)"	"unprognostic (7.72e-2)"	"unprognostic (2.47e-1)"	"unprognostic (2.02e-2)"	"unprognostic (3.26e-1)"	"unprognostic (2.53e-2)"	"unprognostic (1.21e-3)"	"unprognostic (3.60e-2)"	"unprognostic (1.64e-1)"	"unprognostic (3.90e-2)"	"unprognostic (7.23e-2)"	0.0	0.0	0.1	0.0	0.1	0.4	0.3	0.1	0.1	0.1	0.1	0.3	0.4	0.0	0.4	0.2	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.2	0.2	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.3	0.1	0.1	0.2	0.4	0.1	0.0	0.2	0.0	0.2	0.2	0.7	0.0	0.7	0.0	0.0	0.1	0.3	0.3	0.1	0.7	0.3	2.7	0.0	0.0	0.3	0.0	0.7	2.2	0.9	0.4	0.5	0.6	0.0	0.1	1.9	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.2	0.0	0.2	0.5	0.0	1.5	0.0	1.6	0.8	0.3	1.3	2.4	0.0	0.6	0.0	1.0	0.5	0.5	0.2	0.3	6.8	2.1	0.0	0.0	0.1	0.4	0.2	0.3	0.0	0.0	0.1	6.3	0.2	0.0	0.3	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.2	0.2	0.1	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0
H2BC10	"H2B/k, H2BFK, HIST1H2BI"	ENSG00000278588	"H2B clustered histone 10"	P62807	6	26272931-26273412	"Plasma proteins, Predicted intracellular proteins"		"Antibiotic, Antimicrobial, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"bone marrow: 2.1;brain: 3.4;choroid plexus: 1.7;lymphoid tissue: 2.1"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"colorectal cancer: 1.5"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"MOLT-4: 8.7;THP-1: 3.7"									"HPA042205, HPA043013, HPA048671"	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	Cytosol	"HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488"	"unprognostic (1.59e-1)"	"unprognostic (7.10e-2)"	"unprognostic (8.53e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.80e-1)"	"unprognostic (2.03e-2)"		"unprognostic (1.02e-1)"		"unprognostic (7.22e-3)"				"unprognostic (4.82e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.01e-2)"	0.3	0.0	0.1	0.2	0.3	2.1	0.1	3.4	0.9	0.3	1.7	0.2	0.0	0.0	0.0	0.2	0.1	0.1	0.1	0.3	0.4	0.1	0.1	0.4	0.9	1.4	1.2	0.0	0.0	0.0	0.0	0.1	1.4	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.4	0.0	0.9	0.4	0.1	0.3	1.5	2.1	0.2	0.0	0.2	0.1	0.4	1.9	1.1	0.4	0.6	0.0	0.0	0.0	0.1	0.5	0.3	0.9	2.5	0.4	0.1	0.5	0.3	0.2	0.4	0.6	0.9	0.2	0.4	1.6	0.0	0.2	0.5	0.3	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.8	1.3	0.0	2.2	0.0	0.3	8.7	1.5	1.6	0.3	0.0	2.3	0.0	2.7	0.0	0.2	0.2	0.5	0.6	0.5	0.0	0.0	0.0	3.7	0.5	0.4	0.0	0.3	1.8	1.9	0.3	0.0	0.5	0.3	1.2	0.0	0.2	0.0	1.2	0.5	0.7	0.7	1.2	1.6	0.2	1.4	0.4	0.3	0.3	0.1	0.0	0.1	0.5	0.1	0.1	0.3	3.4	0.9	0.3	0.4	1.4	1.2	1.4	0.9	1.5	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0
H4C8	"H4/h, H4FH, HIST1H4H"	ENSG00000158406	"H4 clustered histone 8"	P62805	6	26277609-26285638	"Disease related genes, Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	20	"brain: 51.4"	"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 1.8;dendritic cells: 3.4;Extravillous trophoblasts: 1.5;Hofbauer cells: 1.8;Plasma cells: 1.3;Syncytiotrophoblasts: 10.4"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebellum: 51.4"	"Group enriched"	"Detected in some"	7	"eosinophil: 4.2;neutrophil: 8.9"	"Lineage enriched"	"Detected in single"	9	"granulocytes: 8.9"	"Cell line enhanced"	"Detected in many"		"MOLT-4: 17.5;U-266/84: 29.8"	"Low region specificity"	"Detected in single"							HPA042201	Supported					NA	NA		25000000	"Cluster 49: Eosinophils - Unknown function"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 16: U-266 - Nucleosome"	"Cluster 24: Non-specific - Transcription regulation"			"HPA042201: AB_2677898"	"unprognostic (4.39e-1)"	"unprognostic (1.62e-1)"	"unprognostic (3.08e-3)"	"unprognostic (5.00e-2)"	"unprognostic (3.01e-1)"	"unprognostic (2.03e-2)"	"prognostic unfavorable (6.84e-4)"	"unprognostic (5.40e-2)"	"unprognostic (1.36e-1)"	"unprognostic (4.71e-2)"	"unprognostic (1.71e-3)"	"unprognostic (1.11e-1)"	"prognostic unfavorable (6.18e-6)"	"unprognostic (7.44e-2)"	"unprognostic (8.16e-2)"	"unprognostic (6.55e-2)"	"unprognostic (6.36e-2)"	0.5	0.2	5.7	0.1	5.2	0.9	0.3	51.4	8.6	1.3	1.9	0.9	0.6	0.2	0.0	1.2	0.2	0.7	0.6	4.5	7.3	0.2	0.6	0.5	0.0	5.3	4.9	0.4	0.3	0.0	0.1	0.2	4.6	0.4	0.0	0.0	0.3	0.0	2.5	0.8	0.2	0.0	9.5	0.1	0.2	0.4	5.5	1.1	0.3	0.0	0.7	0.2	0.6	18.4	3.1	3.6	0.4	0.4	1.0	0.0	2.4	4.7	0.0	0.0	0.0	3.5	0.9	2.1	5.8	0.3	0.1	1.9	0.0	0.7	0.3	3.6	1.5	3.8	8.3	4.2	2.2	1.4	2.7	2.7	0.0	1.7	1.5	0.0	3.5	0.9	4.2	0.0	1.9	3.5	17.5	10.9	1.6	0.2	3.6	11.5	2.3	1.4	0.0	3.1	2.8	1.2	4.9	4.9	2.4	0.0	6.0	5.7	0.8	2.5	6.3	1.7	7.7	2.9	29.8	3.1	1.1	7.4	2.6	0.0	0.2	4.2	0.0	0.9	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	8.9	0.0	0.0	0.5	0.0	1.1	5.7	5.2	51.4	8.6	4.5	7.3	5.3	4.9	4.6	9.5	5.5	18.4	0.7	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.8	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	10.4	0.3	0.0	0.0	0.0
BTN3A2	BTN3.2	ENSG00000186470	"Butyrophilin subfamily 3 member A2"	P78410	6	26365159-26378320	"Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 88.3"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 117.2;NK-cells: 239.9;T-cells: 108.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 87.5"									CAB019392	Uncertain					NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 64: Macrophages - Immune response"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"			"CAB019392: "	"unprognostic (3.77e-2)"	"unprognostic (1.17e-2)"	"unprognostic (3.73e-2)"	"unprognostic (2.86e-2)"	"unprognostic (3.66e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.40e-1)"	"unprognostic (3.89e-1)"	"unprognostic (4.04e-2)"	"unprognostic (1.30e-3)"	"unprognostic (1.12e-1)"	"unprognostic (8.45e-2)"	"prognostic unfavorable (4.24e-4)"	"unprognostic (5.13e-2)"	"unprognostic (4.45e-2)"	"unprognostic (4.42e-2)"	"unprognostic (1.48e-3)"	19.4	27.3	8.6	41.9	8.5	9.5	18.4	7.6	8.7	18.1	7.9	29.0	29.3	21.7	21.0	13.5	22.0	25.0	13.8	7.3	9.3	15.8	23.6	41.0	45.5	13.1	8.9	29.6	10.4	10.4	12.7	18.4	9.9	14.9	31.7	2.4	19.4	14.9	8.4	21.7	32.9	20.8	10.5	88.3	32.6	7.1	8.7	38.3	14.4	10.7	44.6	22.9	17.0	10.9	10.6	4.8	6.4	6.7	37.4	42.9	2.2	10.2	48.2	18.8	52.6	2.7	34.4	30.6	35.5	16.2	27.5	9.2	9.4	18.6	17.1	18.5	13.2	33.1	19.1	20.1	20.7	18.9	26.5	27.0	7.5	17.9	8.5	43.9	36.0	54.0	8.5	41.1	13.1	1.4	16.2	30.4	0.4	8.6	3.6	24.3	11.5	87.5	17.1	6.5	4.2	12.8	8.2	7.5	25.7	1.9	7.5	14.0	22.4	17.7	4.0	7.6	11.3	86.1	79.7	17.7	32.2	33.2	17.5	67.7	26.7	57.6	128.3	35.9	96.1	64.5	81.3	113.8	19.2	53.4	81.8	100.1	40.0	98.8	47.5	13.5	111.2	71.3	8.6	8.5	7.6	8.7	7.3	9.3	13.1	8.9	9.9	10.5	8.7	10.9	62.5	32.1	22.2	2.3	61.3	10.3	12.2	8.6	13.1	0.7	16.0	9.9	7.5	17.2	7.4	12.9	0.0	14.3	117.2	21.8	1.9	25.6	0.2	23.6	21.3	46.0	10.1	25.2	1.0	13.7	17.3	20.2	15.8	14.7	47.4	23.4	40.0	9.8	17.8	0.0	2.5	37.9	10.2	54.0	10.0	1.9	11.1	37.1	3.6	20.6	52.7	7.0	239.9	7.1	1.7	10.6	16.9	10.5	76.6	13.2	50.5	3.8	11.8	1.4	13.1	15.7	10.2	1.5	0.2	8.3	13.4	3.3	108.0	51.0	25.5	16.8
BTN2A2	"BT2.2, BTF2, BTN2.2"	ENSG00000124508	"Butyrophilin subfamily 2 member A2"	Q8WVV5	6	26383096-26394874	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"B-cells: 30.3;Plasma cells: 30.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 72.8;U-266/70: 58.9"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA051504	Uncertain		Approved	Mitochondria		NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 16: Immune cells - Immune response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 57: B-cells - Immune response"	Mitochondria		"HPA051504: AB_2681510"	"prognostic favorable (1.01e-4)"	"unprognostic (4.93e-3)"	"unprognostic (1.37e-2)"	"unprognostic (6.78e-2)"	"unprognostic (9.26e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.78e-1)"	"unprognostic (8.04e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.22e-2)"	"unprognostic (6.67e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.73e-2)"	"unprognostic (3.45e-1)"	"unprognostic (6.54e-2)"	"unprognostic (2.90e-1)"	"unprognostic (1.36e-3)"	7.2	13.5	5.4	21.9	6.9	4.3	8.7	14.4	6.0	7.9	21.2	8.0	7.2	10.2	7.5	5.1	8.4	8.5	4.9	6.8	5.9	7.5	6.1	16.2	32.1	7.5	6.9	10.4	5.2	17.5	5.7	4.0	7.8	8.3	10.5	2.9	12.1	6.8	2.8	11.0	11.3	10.9	6.5	21.8	10.4	6.1	6.2	15.2	7.5	4.2	36.6	8.2	6.9	6.9	10.6	6.6	13.2	14.2	4.4	6.8	0.9	11.4	29.7	17.4	30.0	4.2	4.1	9.6	12.1	20.5	14.1	9.5	10.7	8.7	23.1	29.9	17.9	15.0	13.2	8.4	9.1	3.4	5.1	14.5	2.7	33.5	11.3	20.7	16.3	18.5	12.3	72.8	7.9	4.6	12.1	4.4	5.0	0.4	6.6	28.1	18.7	29.8	12.7	5.9	12.6	17.6	7.4	2.8	31.1	7.5	13.5	6.6	19.5	6.4	7.3	5.6	17.7	58.9	38.8	16.9	6.4	13.4	16.3	2.1	13.7	2.4	6.1	14.6	5.8	24.1	5.0	5.7	23.9	29.4	4.1	5.1	12.4	8.7	6.3	9.7	10.3	7.9	5.4	6.9	14.4	6.0	6.8	5.9	7.5	6.9	7.8	6.5	6.2	6.9	8.1	9.6	12.6	0.0	30.3	3.8	7.3	6.5	6.2	0.6	5.2	5.1	2.5	2.8	8.5	3.7	0.0	2.3	15.0	0.6	0.0	8.6	0.4	8.8	4.5	13.1	1.8	3.6	0.0	5.6	0.8	5.0	3.6	7.5	19.6	9.6	6.1	3.8	8.4	0.0	0.0	7.8	12.2	16.0	24.2	0.6	6.5	17.1	7.2	0.0	15.4	14.3	7.2	0.0	0.0	8.3	0.8	4.9	30.7	6.4	2.6	2.3	10.2	0.7	0.0	5.0	4.4	0.3	1.5	4.5	4.5	1.0	10.0	10.6	2.1	4.2
BTN3A1	"BT3.1, BTF5, BTN3.1, CD277"	ENSG00000026950	"Butyrophilin subfamily 3 member A1"	O00481	6	26402237-26415208	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"dendritic cells: 59.1;NK-cells: 73.2;Plasma cells: 47.6;T-cells: 50.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"							HPA012565	Approved		Uncertain	Vesicles		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Vesicles		"HPA012565: AB_1845494"	"unprognostic (2.82e-2)"	"unprognostic (6.43e-2)"	"unprognostic (1.45e-3)"	"unprognostic (4.72e-3)"	"unprognostic (1.41e-2)"	"unprognostic (1.42e-1)"	"unprognostic (3.10e-2)"	"unprognostic (9.31e-2)"	"unprognostic (9.81e-2)"	"unprognostic (8.60e-3)"	"unprognostic (1.19e-1)"	"unprognostic (2.41e-1)"	"prognostic unfavorable (4.15e-5)"	"unprognostic (2.45e-1)"	"unprognostic (5.02e-2)"	"unprognostic (3.26e-2)"	"prognostic favorable (4.81e-4)"	19.2	20.7	10.2	44.8	11.1	29.6	20.1	9.8	10.5	21.2	10.3	24.8	28.5	28.0	16.0	11.9	22.5	30.5	12.1	9.1	12.1	12.8	18.9	41.4	63.4	16.4	10.9	35.1	13.1	13.1	13.7	19.2	12.5	16.5	28.8	3.6	23.9	13.5	12.8	24.9	35.1	21.3	12.2	84.0	31.3	5.0	11.4	33.1	11.5	14.5	52.6	20.0	17.4	12.0	7.4	6.2	9.3	9.5	25.9	27.5	1.2	6.2	24.1	13.5	39.4	0.3	16.7	19.7	20.4	11.2	20.9	5.1	3.0	9.7	8.2	19.5	6.4	10.4	8.5	4.7	11.8	9.5	9.3	15.0	5.6	11.8	5.4	20.4	19.3	31.0	2.5	25.3	5.5	0.6	17.6	6.6	1.0	3.3	2.1	24.2	4.0	45.2	8.3	9.4	4.9	9.8	3.4	7.1	13.5	1.4	6.5	4.0	4.8	10.3	2.6	3.1	5.9	41.8	45.9	7.3	15.6	21.4	8.4	53.8	11.1	28.8	44.7	11.7	40.4	18.8	27.8	42.3	9.1	10.5	24.1	32.0	23.9	40.5	12.9	4.3	36.0	28.0	10.2	11.1	9.8	10.5	9.1	12.1	16.4	10.9	12.5	12.2	11.4	12.0	24.8	16.0	6.5	0.0	27.1	4.2	3.9	3.5	2.2	4.3	8.6	8.1	4.2	11.5	8.5	5.5	0.0	5.5	59.1	8.2	0.0	7.4	0.1	5.5	10.4	18.0	4.8	13.3	0.0	3.2	4.3	9.9	9.2	10.3	25.9	14.0	11.7	3.9	7.2	0.0	0.0	17.3	2.0	19.2	6.1	0.8	3.7	15.4	1.8	0.0	13.7	1.9	73.2	0.0	0.0	2.2	6.3	2.6	47.6	5.4	15.9	1.3	6.7	0.4	0.0	6.7	5.5	0.0	0.1	3.6	3.3	1.5	50.1	8.4	7.4	5.0
BTN3A3	"BTF3, BTN3.3"	ENSG00000111801	"Butyrophilin subfamily 3 member A3"	O00478	6	26440472-26453415	"Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"dendritic cells: 26.9;NK-cells: 33.0;Plasma cells: 30.5;T-cells: 27.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 62.8;BJ hTERT+ SV40 Large T+ RasG12V: 43.8"									"HPA007904, HPA011871"	Enhanced					NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 64: Macrophages - Immune response"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 63: NK-cells & T-cells - Immune response"			"HPA007904: AB_1078307, HPA011871: AB_1845496"	"unprognostic (1.18e-2)"	"unprognostic (6.54e-3)"	"unprognostic (1.54e-1)"	"unprognostic (1.19e-2)"	"unprognostic (2.30e-2)"	"unprognostic (8.60e-2)"	"unprognostic (5.13e-3)"	"unprognostic (8.08e-2)"	"unprognostic (7.88e-2)"	"prognostic favorable (1.80e-4)"	"unprognostic (4.45e-2)"	"unprognostic (1.13e-1)"	"prognostic unfavorable (2.42e-5)"	"unprognostic (3.49e-2)"	"unprognostic (2.14e-2)"	"unprognostic (5.26e-2)"	"unprognostic (4.54e-3)"	14.9	19.6	7.4	20.0	7.0	5.5	12.0	6.5	7.9	16.6	8.0	15.0	17.5	16.7	18.7	8.3	20.3	20.3	9.0	7.2	9.0	8.9	20.6	33.7	29.2	10.0	7.2	19.5	4.8	5.0	12.2	10.2	7.6	9.4	14.6	1.8	12.3	11.2	5.8	11.6	16.7	17.1	9.0	47.2	16.3	3.3	7.5	21.5	9.2	14.4	22.8	16.7	9.5	8.2	4.1	1.8	1.8	1.6	33.2	62.8	0.5	5.4	29.7	12.0	43.8	0.0	12.3	25.0	24.5	9.0	11.1	2.9	2.6	9.7	5.8	21.4	4.2	11.5	11.8	1.3	24.2	6.4	2.1	33.4	3.8	10.5	3.9	19.3	24.1	9.4	0.5	3.7	6.7	0.0	16.7	5.3	0.1	0.0	2.9	16.7	3.3	24.9	9.4	3.3	2.2	3.9	3.3	3.1	6.2	0.4	0.8	3.5	15.0	5.8	1.3	6.5	3.8	4.1	1.0	2.5	15.4	12.0	6.2	49.0	15.7	13.4	54.7	23.2	43.7	19.3	37.6	55.5	12.4	14.0	36.3	49.0	11.6	45.9	24.6	6.4	46.2	33.3	7.4	7.0	6.5	7.9	7.2	9.0	10.0	7.2	7.6	9.0	7.5	8.2	20.3	9.6	7.7	0.3	15.9	1.8	1.9	2.8	8.0	0.2	3.6	2.8	4.9	0.0	5.2	0.0	0.0	2.5	26.9	6.4	1.9	5.3	4.6	4.2	9.4	22.1	1.2	9.9	1.4	2.3	1.6	11.1	7.1	4.3	3.8	8.7	15.7	4.0	4.3	0.0	2.1	8.9	0.0	20.8	4.0	18.0	4.1	12.4	3.6	2.8	12.6	2.3	33.0	1.5	0.4	2.4	3.9	2.2	30.5	2.0	12.8	1.1	3.3	0.0	6.6	4.9	4.0	0.4	0.3	3.1	2.0	0.5	27.1	12.3	6.2	1.9
BTN2A1	"BT2.1, BTF1, BTN2.1"	ENSG00000112763	"Butyrophilin subfamily 2 member A1"	Q7KYR7	6	26457904-26476621	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA019208	Approved		Approved	"Plasma membrane"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 64: Macrophages - Immune response"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 43: Cardiomyocytes - Nuclear processes"	"Plasma membrane"		"HPA019208: AB_1845492"	"unprognostic (1.86e-1)"	"unprognostic (3.48e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.87e-1)"	"unprognostic (2.29e-1)"	"unprognostic (6.17e-2)"	"unprognostic (5.74e-3)"	"unprognostic (1.22e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.26e-2)"	"unprognostic (6.90e-3)"	"unprognostic (5.14e-2)"	"prognostic unfavorable (5.90e-5)"	"unprognostic (1.97e-1)"	"unprognostic (4.89e-2)"	"unprognostic (7.92e-2)"	"prognostic favorable (4.52e-5)"	16.1	17.3	10.8	11.4	10.7	16.8	13.3	19.9	13.1	15.5	11.4	17.7	9.8	16.7	8.3	8.9	16.1	10.2	16.0	11.1	15.2	13.6	9.1	18.4	13.9	12.1	13.2	15.2	8.9	4.8	11.9	19.0	13.7	13.3	11.0	4.5	9.5	14.4	11.7	8.2	15.0	16.9	12.0	25.7	12.2	11.7	13.5	10.6	10.5	10.1	11.4	17.3	13.3	12.2	16.4	14.5	28.9	18.3	12.7	10.2	1.4	36.1	30.1	42.3	38.7	13.5	11.0	13.3	47.3	24.5	54.9	7.0	22.1	8.9	40.2	18.4	21.6	7.9	15.3	16.0	19.9	11.8	21.2	13.9	8.2	47.1	15.2	25.1	15.3	25.4	13.5	20.6	35.7	6.7	19.9	18.2	9.7	4.8	11.9	17.0	27.3	13.6	16.5	7.3	28.9	16.4	11.2	14.8	26.4	17.8	4.3	9.9	21.3	32.1	16.6	28.1	40.8	16.1	40.4	11.1	12.8	22.0	52.1	43.6	9.0	30.2	11.1	5.2	9.8	8.6	9.3	12.4	8.4	6.2	8.6	11.0	51.7	9.9	8.8	8.9	16.0	7.2	10.8	10.7	19.9	13.1	11.1	15.2	12.1	13.2	13.7	12.0	13.5	12.2	21.2	16.0	14.7	7.5	20.0	8.0	8.0	8.5	9.1	8.0	11.8	10.9	17.6	7.2	11.7	9.2	6.2	6.1	35.4	16.0	3.9	10.9	3.2	18.1	17.7	22.1	9.0	4.6	8.9	12.8	11.2	14.7	18.8	20.8	24.6	13.3	21.8	6.2	11.6	3.3	10.2	14.8	12.2	17.9	16.7	6.2	12.8	18.4	10.6	10.3	21.9	6.0	25.7	10.6	7.8	16.4	10.2	12.8	18.9	13.1	11.4	4.7	26.9	2.3	39.5	12.4	24.4	8.7	12.9	7.3	8.1	11.8	25.0	14.9	12.9	17.9
BTN1A1	"BT, BTN, BTN1"	ENSG00000124557	"Butyrophilin subfamily 1 member A1"	Q13410	6	26501221-26510422	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	39	"breast: 32.5"	"Cell type enriched"	"Detected in some"	43	"Breast glandular cells: 111.9"	"Cancer enhanced"	"Detected in single"		"breast cancer: 0.6"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"memory B-cell: 2.1;naive B-cell: 1.9"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in single"	5	"CACO-2: 4.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA011126, CAB037340"	Supported				"Intracellular and membrane"	NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 5: Breast - Unknown function"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 30: Mammary glandular cells - Lactation"			"CAB037340: , HPA011126: AB_1845491"	"unprognostic (4.07e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.90e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.77e-2)"		"unprognostic (5.50e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.24e-3)"	"unprognostic (2.85e-1)"	"unprognostic (1.88e-1)"	"unprognostic (5.35e-10)"	"unprognostic (4.62e-2)"	"unprognostic (1.38e-1)"	"unprognostic (4.14e-2)"	"unprognostic (5.31e-4)"	0.0	0.0	0.0	0.3	0.0	0.0	32.5	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.6	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.3	0.1	0.3	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	2.1	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.6	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	111.9	1.8	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0
HMGN4	"HMG17L3, NHC"	ENSG00000182952	"High mobility group nucleosomal binding domain 4"	O00479	6	26538366-26546933	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"B-cells: 39.3;Basal squamous epithelial cells: 38.7;Plasma cells: 51.5;Squamous epithelial cells: 34.8;T-cells: 32.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA077364			Uncertain	Nucleoplasm		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 16: U-266 - Nucleosome"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA077364: AB_2686835"	"unprognostic (1.91e-1)"	"unprognostic (2.48e-2)"	"unprognostic (5.88e-2)"	"unprognostic (8.81e-2)"	"unprognostic (4.10e-2)"	"unprognostic (6.02e-2)"	"unprognostic (4.00e-3)"	"unprognostic (1.96e-1)"	"unprognostic (1.78e-1)"	"unprognostic (3.22e-1)"	"unprognostic (7.81e-3)"	"unprognostic (2.09e-1)"	"unprognostic (3.06e-2)"	"unprognostic (1.64e-1)"	"unprognostic (8.02e-3)"	"unprognostic (9.01e-2)"	"unprognostic (6.07e-3)"	39.6	34.5	21.3	49.2	21.5	33.0	54.3	21.5	26.5	45.4	30.4	52.7	40.7	56.6	50.2	35.2	46.0	38.4	38.1	21.4	24.3	48.6	19.9	46.0	68.7	22.4	22.9	50.1	26.3	58.4	22.3	41.2	22.5	47.0	55.8	18.6	33.2	56.7	38.6	31.4	48.9	66.9	22.8	52.4	32.8	31.3	23.0	70.6	57.0	32.6	71.6	55.3	35.8	24.2	81.3	29.7	60.2	79.3	78.6	118.0	37.4	67.0	116.1	99.2	138.0	30.6	50.5	94.4	104.0	95.1	101.0	37.4	100.2	85.0	109.3	118.9	94.1	96.7	42.3	58.9	86.9	85.2	98.9	87.6	114.0	80.0	132.7	93.0	95.5	121.2	92.8	152.8	91.5	40.7	151.0	114.9	36.2	68.0	51.9	53.8	66.6	168.8	77.9	54.6	95.0	85.4	55.4	45.0	138.6	71.0	50.1	45.6	71.2	68.5	52.1	63.5	61.7	100.4	276.9	79.3	33.1	190.1	91.1	182.8	42.1	81.9	81.8	41.5	80.5	71.7	85.2	85.8	57.2	61.2	71.0	70.2	62.5	75.7	53.9	47.9	93.6	92.5	21.3	21.5	21.5	26.5	21.4	24.3	22.4	22.9	22.5	22.8	23.0	24.2	4.2	3.2	5.8	6.8	39.3	7.5	4.0	3.1	38.7	0.5	5.6	3.0	2.1	7.2	7.5	1.8	0.0	3.5	13.9	2.9	5.9	2.2	0.4	3.9	10.0	4.8	0.0	16.8	16.1	1.4	10.1	11.8	13.3	5.7	8.8	1.8	3.3	0.7	4.0	0.0	13.9	2.3	2.0	5.1	11.1	0.4	1.5	16.3	8.8	6.5	7.5	2.6	8.2	17.1	13.5	2.6	1.9	2.6	51.5	3.7	4.3	7.8	1.1	0.8	0.0	4.4	8.3	0.6	1.2	34.8	5.1	8.1	32.5	2.5	1.9	2.1
ABT1	Esf2	ENSG00000146109	"Activator of basal transcription 1"	Q9ULW3	6	26596953-26600739	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"DNA-binding, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA077039			Approved	Vesicles		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Vesicles		"HPA077039: AB_2732328"	"unprognostic (1.32e-1)"	"unprognostic (3.94e-2)"	"unprognostic (3.05e-1)"	"unprognostic (1.15e-3)"	"unprognostic (1.77e-1)"	"unprognostic (7.74e-2)"	"unprognostic (2.55e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.85e-2)"	"prognostic favorable (1.89e-4)"	"unprognostic (2.30e-3)"	"unprognostic (2.93e-2)"	"unprognostic (7.25e-3)"	"unprognostic (7.20e-2)"	"unprognostic (9.57e-2)"	"unprognostic (1.49e-1)"	"prognostic favorable (3.80e-4)"	9.3	8.0	6.5	9.5	6.7	23.2	9.3	7.8	7.7	8.9	6.5	10.1	10.0	10.8	6.3	13.9	9.2	5.9	8.7	6.5	6.4	8.2	13.0	7.9	15.8	6.4	6.4	9.2	9.4	8.3	7.3	10.7	6.4	8.2	6.7	4.7	9.0	6.7	9.6	14.3	11.6	5.7	6.4	14.8	9.9	8.0	6.6	13.0	7.3	7.1	10.5	9.3	9.7	6.8	23.3	11.9	16.3	28.4	8.9	9.3	23.9	13.4	13.6	20.0	19.5	21.6	10.0	33.8	30.0	11.1	15.9	14.5	19.0	19.5	11.7	18.9	38.7	22.2	11.2	40.6	14.3	30.6	21.7	12.4	17.9	15.9	9.4	9.3	17.5	26.2	39.3	22.1	11.2	23.6	35.6	39.1	16.8	14.9	15.9	21.4	13.2	35.8	12.5	18.7	21.4	17.2	8.3	21.6	32.9	8.6	20.8	24.6	15.1	15.2	11.2	12.2	27.3	25.8	40.9	30.9	7.2	37.6	23.8	76.1	41.6	53.8	66.1	40.2	63.3	66.5	63.8	66.2	39.7	70.2	67.4	60.8	37.2	57.5	41.7	37.1	76.3	88.1	6.5	6.7	7.8	7.7	6.5	6.4	6.4	6.4	6.4	6.4	6.6	6.8	22.4	16.0	15.5	3.3	41.8	59.9	35.8	65.2	34.1	16.2	23.1	22.2	7.1	21.5	31.8	11.0	2.1	96.0	50.8	16.1	41.1	39.4	39.7	12.1	14.0	31.6	34.0	26.9	4.4	38.7	97.5	21.1	16.8	17.3	29.1	17.7	25.4	21.2	42.2	15.2	4.3	25.3	50.8	21.2	22.6	81.8	27.7	22.2	16.0	2.8	32.3	22.0	78.2	3.5	4.5	35.9	19.5	23.7	29.4	31.6	27.9	24.4	21.8	17.2	19.7	15.1	23.4	29.6	41.2	28.3	59.8	109.5	44.3	24.5	29.5	33.6
ZNF322	"bA457M11.2, bA457M11.3, HCG12, ZNF322A, ZNF388, ZNF489"	ENSG00000181315	"Zinc finger protein 322"	Q6U7Q0	6	26634383-26659752	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043161, HPA046692"	Approved		Supported	Nucleoplasm,Centrosome,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 21: Non-specific - Transcription"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	"Centrosome, Cytosol"	"HPA043161: AB_2678346, HPA046692: AB_2679755"	"unprognostic (1.01e-2)"	"unprognostic (2.81e-1)"	"unprognostic (5.20e-2)"	"unprognostic (3.39e-3)"	"prognostic favorable (1.28e-4)"	"unprognostic (1.21e-1)"	"unprognostic (9.35e-2)"	"prognostic favorable (8.57e-4)"	"unprognostic (5.24e-2)"	"unprognostic (3.52e-2)"	"unprognostic (2.53e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.08e-1)"	"unprognostic (3.55e-1)"	"unprognostic (3.24e-2)"	"unprognostic (5.71e-2)"	7.8	12.0	11.0	7.8	11.9	1.3	12.8	12.1	12.4	15.4	10.9	8.8	9.3	15.5	13.3	8.6	11.4	9.8	7.7	10.2	12.0	11.8	9.3	9.9	9.9	11.8	11.5	17.9	8.2	17.7	7.1	11.2	12.4	14.9	10.9	14.3	8.7	13.9	6.6	6.0	8.1	10.5	12.0	11.7	9.1	11.1	11.6	10.1	15.3	12.8	9.7	10.8	7.4	15.0	9.3	6.8	26.2	31.0	17.3	22.5	9.7	12.3	16.1	16.6	20.1	13.3	5.5	11.0	28.5	10.6	20.8	11.5	19.7	7.4	20.8	17.3	18.0	19.5	8.7	13.2	19.5	0.0	17.3	14.1	27.0	10.7	12.3	20.8	14.4	13.5	23.3	11.7	18.3	5.2	14.1	16.9	7.8	8.5	8.4	15.4	18.6	16.0	10.1	14.5	21.3	22.7	14.5	13.6	25.9	12.8	12.5	12.8	14.4	27.8	11.0	11.4	12.4	12.2	25.8	10.8	5.8	2.9	28.4	3.3	8.4	10.8	10.5	7.2	7.6	11.2	5.3	6.9	6.9	9.0	6.1	9.1	8.0	17.8	11.9	7.8	4.5	5.1	11.0	11.9	12.1	12.4	10.2	12.0	11.8	11.5	12.4	12.0	11.6	15.0	24.8	6.4	10.5	3.9	18.0	4.0	17.3	4.8	14.8	32.1	23.9	31.2	5.8	12.8	11.1	9.2	8.4	12.5	16.1	9.9	35.2	17.7	4.1	14.2	32.6	20.1	19.7	7.2	5.3	10.2	11.3	21.9	10.2	15.7	13.3	30.0	18.2	7.6	13.3	47.1	7.0	14.1	8.2	8.9	5.3	3.7	30.1	11.7	8.8	6.5	12.7	26.7	10.3	11.1	10.3	16.1	12.8	26.4	11.8	26.4	10.2	13.3	8.1	13.9	32.9	20.6	22.2	26.0	15.7	12.0	6.5	9.6	9.1	37.7	10.0	24.9
H2BC11	"H2B/r, H2BFR, HIST1H2BJ"	ENSG00000124635	"H2B clustered histone 11"	P06899	6	27125897-27132795	"Predicted intracellular proteins"		"Antibiotic, Antimicrobial, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 31.9"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 1.7;Cardiomyocytes: 3.0;Cytotrophoblasts: 1.5;Extravillous trophoblasts: 6.0;Hofbauer cells: 4.1;Syncytiotrophoblasts: 6.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	5	"neutrophil: 16.2"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 16.2"	"Cell line enhanced"	"Detected in many"		"K-562: 150.1;Karpas-707: 86.7;SiHa: 134.1;U-2 OS: 137.1;U-266/70: 129.2;U-266/84: 151.8"	"Low region specificity"	"Detected in all"							"HPA042205, HPA043013, HPA048671"	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 71: Testis - DNA repair"	"Cluster 16: U-266 - Nucleosome"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	Cytosol	"HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488"	"unprognostic (4.02e-2)"	"prognostic favorable (1.51e-4)"	"unprognostic (8.58e-2)"	"unprognostic (2.34e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.26e-2)"	"unprognostic (3.03e-1)"	"unprognostic (2.98e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.49e-2)"	"unprognostic (1.90e-3)"	"unprognostic (2.23e-1)"	"unprognostic (3.57e-4)"	"unprognostic (8.67e-2)"	"unprognostic (5.80e-2)"	"unprognostic (1.57e-2)"	"unprognostic (6.16e-2)"	4.3	1.4	3.4	2.3	3.9	9.1	1.9	3.8	5.9	15.0	3.8	5.0	1.4	1.5	3.0	9.5	3.7	1.9	4.1	3.0	4.3	2.4	4.2	9.1	3.1	5.3	4.4	1.3	0.6	0.3	1.0	1.7	6.1	6.9	2.4	0.3	3.2	2.3	6.2	2.9	2.5	2.0	5.3	12.7	4.0	31.9	5.9	7.2	2.7	3.7	2.6	2.5	10.8	8.4	13.4	17.1	5.3	4.6	26.3	1.4	7.0	7.1	3.9	29.7	12.6	14.1	7.7	2.4	22.7	7.8	12.9	9.3	6.5	6.3	15.5	16.2	14.3	4.3	18.2	0.8	2.5	1.7	10.2	11.0	0.7	6.6	2.2	4.2	1.3	6.8	150.1	86.7	8.5	6.9	5.9	8.1	5.8	15.1	15.5	3.1	3.5	16.5	2.8	4.7	35.3	3.5	134.1	8.7	4.2	6.9	0.3	6.4	4.1	7.2	137.1	5.6	3.3	129.2	151.8	35.6	1.9	42.3	3.7	2.3	0.7	1.1	0.5	0.8	0.9	1.9	0.9	0.4	0.5	2.4	0.5	0.6	16.2	1.3	0.3	1.2	3.0	15.9	3.4	3.9	3.8	5.9	3.0	4.3	5.3	4.4	6.1	5.3	5.9	8.4	1.7	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	1.5	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	6.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	6.2	0.3	0.0	0.0	0.0
H2AC11	"H2A.1b, H2A/p, H2AFP, HIST1H2AG, pH2A/f"	ENSG00000196787	"H2A clustered histone 11"	P0C0S8	6	27133042-27135291	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"breast: 2.8;testis: 3.1"	"Group enriched"	"Detected in some"	10	"Cardiomyocytes: 1.2;Cytotrophoblasts: 2.0;dendritic cells: 1.5;Extravillous trophoblasts: 3.1;Hofbauer cells: 2.6;Plasma cells: 1.3;Syncytiotrophoblasts: 3.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"basophil: 9.5"	"Group enriched"	"Detected in many"	5	"B-cells: 2.8;granulocytes: 9.5;T-cells: 2.9"	"Cell line enhanced"	"Detected in many"		"K-562: 15.5;SiHa: 17.3;U-266/84: 48.8"					"Low region specificity"	"Detected in many"			HPA041189	Supported		Approved	Nucleoplasm		NA	Yes			"Cluster 38: Basophils - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 16: U-266 - Nucleosome"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"HPA041189: AB_2677357"	"unprognostic (4.86e-2)"	"unprognostic (6.89e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.94e-1)"	"unprognostic (8.67e-2)"	"unprognostic (1.03e-3)"	"unprognostic (1.95e-1)"	"unprognostic (5.78e-2)"	"unprognostic (2.41e-1)"	"unprognostic (2.37e-1)"	"unprognostic (2.14e-3)"	"unprognostic (1.53e-2)"	"unprognostic (7.36e-2)"	"unprognostic (5.98e-2)"	"unprognostic (6.48e-2)"	"unprognostic (8.22e-3)"	"unprognostic (9.54e-2)"	0.3	0.3	0.7	0.3	0.9	2.4	2.8	0.5	0.7	0.5	0.7	0.9	1.3	0.1	0.6	0.6	0.2	0.3	0.2	0.6	1.0	0.2	0.5	0.3	1.0	1.5	1.4	0.1	0.2	0.0	0.1	0.4	1.4	0.7	0.7	0.1	0.1	0.4	0.2	0.2	1.1	0.2	1.2	0.9	0.5	3.1	1.7	1.9	0.3	0.3	0.4	0.4	0.4	1.7	2.1	2.8	2.3	2.0	7.1	1.5	1.5	0.7	1.1	2.4	0.3	1.2	2.1	0.7	3.0	0.9	2.3	4.2	2.8	1.2	1.6	3.7	1.6	1.1	5.2	0.0	1.5	1.1	2.2	2.7	0.5	0.7	0.8	1.2	0.8	2.0	15.5	6.9	0.1	2.7	2.9	1.8	1.3	3.1	1.9	1.9	2.3	8.0	0.4	0.5	9.0	2.1	17.3	2.7	1.0	1.1	0.0	0.7	0.9	2.6	5.8	2.1	1.1	12.4	48.8	4.9	0.5	1.7	1.6	9.5	0.3	0.6	0.4	0.2	0.9	2.3	1.7	1.1	0.5	2.8	1.4	1.3	2.3	0.9	0.6	1.0	2.9	5.3	0.7	0.9	0.5	0.7	0.6	1.0	1.5	1.4	1.4	1.2	1.7	1.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	2.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.0	0.2	0.0	0.0	0.0
H4C9	"H4/m, H4FM, HIST1H4I"	ENSG00000276180	"H4 clustered histone 9"	P62805	6	27138588-27139881	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"		DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"Cardiomyocytes: 2.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"K-562: 75.5;SiHa: 43.8;U-2 OS: 73.3;U-266/84: 78.9"									HPA042201	Approved					NA	NA		25000000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 16: U-266 - Nucleosome"	"Cluster 43: Cardiomyocytes - Nuclear processes"			"HPA042201: AB_2677898"	"unprognostic (2.49e-2)"	"prognostic favorable (9.70e-4)"	"unprognostic (1.97e-2)"	"unprognostic (2.51e-2)"	"unprognostic (2.26e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.16e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.29e-3)"	"unprognostic (1.86e-3)"	"unprognostic (1.95e-1)"	"prognostic unfavorable (1.32e-5)"	"unprognostic (6.28e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.80e-1)"	"unprognostic (2.02e-2)"	1.2	3.3	0.3	3.7	0.5	3.2	0.6	0.2	1.5	0.6	0.0	1.9	3.8	2.0	0.0	2.6	0.5	2.3	1.5	0.6	0.6	0.5	2.7	1.7	4.2	0.8	0.8	1.6	3.7	0.0	0.3	2.5	0.7	3.0	0.2	0.2	2.4	0.0	0.4	1.3	4.0	0.0	0.9	3.5	4.0	2.7	0.6	1.0	3.6	0.0	0.1	1.4	1.1	0.7	4.2	8.5	4.6	3.0	3.2	0.4	5.1	8.1	0.3	0.4	0.3	8.3	6.0	1.3	22.7	0.1	12.5	6.5	0.8	0.2	0.2	5.8	12.5	3.0	13.4	0.4	0.5	2.5	14.8	1.1	0.3	0.0	0.4	7.7	0.4	2.9	75.5	22.2	0.0	12.9	3.8	5.6	1.9	30.2	5.3	3.4	2.7	21.3	0.2	2.2	15.4	5.6	43.8	19.8	5.1	5.2	37.9	1.8	2.7	5.6	73.3	6.8	0.8	22.2	78.9	14.5	3.3	16.8	5.9	14.4	3.0	17.4	1.7	2.4	1.4	5.3	1.5	1.7	3.0	6.6	1.8	1.9	16.5	3.0	5.9	6.4	4.1	3.5	0.3	0.5	0.2	1.5	0.6	0.6	0.8	0.8	0.7	0.9	0.6	0.7	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0
H2BC12	"H2BFAiii, H2BFT, HIST1H2BK"	ENSG00000197903	"H2B clustered histone 12"	O60814	6	27146361-27146855	"Predicted intracellular proteins"		"Antibiotic, Antimicrobial, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 1.2;Extravillous trophoblasts: 3.4;Hofbauer cells: 1.1;Syncytiotrophoblasts: 3.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"K-562: 1269.7;SiHa: 771.0;U-2 OS: 949.9;U-266/84: 1355.8"									"HPA042205, HPA043013, HPA048671"	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 16: U-266 - Nucleosome"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	Cytosol	"HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488"	"unprognostic (1.78e-2)"	"unprognostic (4.70e-3)"	"unprognostic (9.00e-3)"	"unprognostic (1.30e-1)"	"unprognostic (3.81e-1)"	"unprognostic (4.50e-2)"	"unprognostic (6.50e-2)"	"unprognostic (4.27e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.29e-3)"	"unprognostic (3.46e-3)"	"unprognostic (9.49e-2)"	"prognostic unfavorable (5.77e-5)"	"unprognostic (3.93e-2)"	"unprognostic (1.49e-1)"	"unprognostic (7.59e-2)"	"unprognostic (2.37e-2)"	45.2	28.9	10.3	35.9	13.4	46.4	31.2	8.1	13.1	46.1	15.1	45.7	41.6	35.2	27.7	64.2	59.9	37.7	32.1	12.2	11.1	31.3	94.0	47.1	59.6	13.3	12.3	28.9	60.0	14.8	16.2	44.7	12.9	75.1	26.4	0.4	43.1	21.7	8.5	30.3	44.8	22.1	15.7	66.9	56.0	44.6	13.6	65.7	49.2	6.7	24.2	35.0	42.8	21.6	64.6	153.7	25.7	41.2	116.0	37.0	84.7	118.1	70.5	157.9	99.1	133.1	68.9	28.1	338.6	64.2	94.1	78.3	29.8	35.8	19.7	95.1	201.2	42.0	91.0	4.4	46.2	29.9	183.4	205.0	26.8	29.5	28.1	38.8	27.6	14.1	1269.7	194.4	66.5	166.3	49.1	52.6	20.2	204.6	98.8	27.9	24.2	265.9	55.2	23.4	124.1	74.2	771.0	178.6	56.9	18.9	473.7	29.8	41.6	57.6	949.9	54.0	18.8	293.6	1355.8	207.7	34.7	314.1	34.5	244.6	49.0	329.3	21.6	45.3	19.6	112.1	21.3	21.9	53.1	141.9	25.7	20.4	308.2	28.5	96.3	120.8	65.7	68.3	10.3	13.4	8.1	13.1	12.2	11.1	13.3	12.3	12.9	15.7	13.6	21.6	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	1.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	3.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.1	0.0	0.0	0.0
H2AC12	"dJ86C11.1, H2A/S, H2AFALii, HIST1H2AH"	ENSG00000274997	"H2A clustered histone 12"	Q96KK5	6	27147106-27147562	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 8.8;brain: 2.8"	"Cell type enhanced"	"Detected in some"		"dendritic cells: 1.6;Extravillous trophoblasts: 2.3;Hofbauer cells: 1.0"	"Cancer enhanced"	"Detected in some"		"colorectal cancer: 1.4"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"naive B-cell: 11.9"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEK 293: 5.4;MOLT-4: 6.2;NB-4: 6.9"									"CAB004030, HPA041189"	Supported		Approved	Nucleoplasm		NA	Yes			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 24: NB-4 - Immune response"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"CAB004030: AB_2118804, HPA041189: AB_2677357"	"unprognostic (4.07e-1)"	"unprognostic (2.73e-3)"	"unprognostic (4.04e-2)"	"unprognostic (4.01e-1)"	"unprognostic (2.02e-1)"	"unprognostic (5.35e-3)"	"unprognostic (3.90e-2)"	"unprognostic (3.20e-1)"	"unprognostic (2.36e-1)"	"unprognostic (2.38e-3)"	"unprognostic (2.91e-1)"	"unprognostic (2.32e-1)"		"unprognostic (9.74e-3)"	"unprognostic (1.87e-1)"		"unprognostic (1.26e-4)"	0.2	0.1	0.5	0.0	0.9	8.8	0.3	0.7	0.5	0.2	0.8	0.7	0.2	0.0	0.0	0.2	0.2	0.1	0.1	0.3	0.9	0.0	0.1	0.2	1.1	1.6	1.3	0.1	0.1	0.1	0.0	0.3	1.8	0.1	0.1	0.0	0.1	0.0	0.0	0.2	2.1	0.1	1.8	0.6	0.2	1.6	2.0	1.5	0.1	0.0	0.2	0.2	0.2	2.8	1.7	2.0	0.7	3.0	0.0	0.0	0.4	0.2	0.3	0.3	0.0	2.0	0.6	2.7	0.6	0.0	0.3	0.2	0.6	0.0	0.0	1.4	5.4	3.0	2.5	0.0	0.0	2.1	1.1	0.0	0.0	0.7	0.0	0.0	0.5	1.1	3.1	1.7	0.5	0.3	6.2	6.9	2.1	0.6	0.7	2.2	1.9	3.2	0.0	0.2	1.5	0.4	0.9	0.3	0.2	0.0	0.6	1.0	0.0	0.6	1.7	0.1	1.8	1.8	2.0	4.0	0.8	2.8	0.6	0.0	0.8	0.0	2.2	2.3	1.0	3.3	4.1	3.8	2.0	11.9	2.1	1.5	0.0	5.1	1.4	1.4	0.7	2.0	0.5	0.9	0.7	0.5	0.3	0.9	1.6	1.3	1.8	1.8	2.0	2.8	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.9	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0
PRSS16	TSSP	ENSG00000112812	"Serine protease 16"	Q9NQE7	6	27247701-27256624	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in many"	58	"lymphoid tissue: 826.7"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 42.1;Extravillous trophoblasts: 25.4;Syncytiotrophoblasts: 31.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"memory B-cell: 2.1"	"Lineage enhanced"	"Detected in single"		"B-cells: 2.1"	"Cell line enhanced"	"Detected in many"		"hTCEpi: 20.4;RPMI-8226: 11.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"								"Secreted in other tissues"	NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 47: Cytotrophoblasts - Unknown function"				"unprognostic (1.50e-1)"	"unprognostic (6.95e-2)"	"unprognostic (1.91e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.21e-2)"	"unprognostic (1.74e-2)"	"unprognostic (9.21e-3)"	"unprognostic (1.57e-1)"	"unprognostic (7.89e-2)"	"prognostic favorable (6.46e-5)"	"unprognostic (1.57e-1)"	"unprognostic (3.49e-2)"	"unprognostic (5.42e-2)"	"unprognostic (1.95e-1)"	"unprognostic (5.49e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.62e-2)"	0.2	0.4	0.0	0.3	0.0	0.0	6.0	0.1	0.3	3.6	0.0	5.7	4.4	0.7	13.5	2.9	5.6	4.0	0.0	0.1	0.0	1.8	0.0	3.8	0.1	0.0	0.0	2.5	14.1	7.8	1.4	4.1	0.1	3.2	6.7	0.1	7.5	4.2	0.0	5.1	3.3	0.2	0.0	0.3	4.8	1.0	0.0	826.7	13.1	0.0	1.4	2.5	1.0	0.0	3.2	0.2	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.1	3.8	4.7	0.0	0.7	0.0	0.0	1.5	2.7	3.2	0.0	0.1	0.5	0.0	0.0	0.0	0.0	2.1	0.5	0.0	20.4	0.0	4.1	0.5	0.0	1.7	2.5	1.9	0.0	1.2	0.5	0.0	0.7	2.1	0.5	0.0	0.0	11.5	2.4	3.6	0.0	0.0	1.4	3.2	0.0	4.5	2.0	0.9	0.0	0.0	0.7	0.0	0.0	0.7	1.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.7	2.1	0.9	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	9.6	7.7	0.0	2.6	6.4	10.8	4.6	8.6	0.0	16.6	9.5	0.4	15.7	4.6	14.7	0.0	42.1	0.2	22.9	1.9	10.0	0.6	2.5	0.8	0.4	4.2	0.0	0.7	17.6	25.4	0.7	12.8	8.0	5.7	0.1	0.0	0.0	4.0	0.0	0.2	20.0	14.2	0.3	0.4	0.5	0.6	0.3	5.4	0.0	0.2	1.2	0.0	0.0	0.1	9.4	18.7	0.0	13.7	6.9	16.5	0.7	3.4	0.0	0.0	0.0	1.2	2.0	6.1	8.6	6.5	31.7	1.1	0.0	14.9	8.5
POM121L2	POM121-L	ENSG00000158553	"POM121 transmembrane nucleoporin like 2"	Q96KW2	6	27285903-27312170	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	68	"testis: 8.3"	"Cell type enriched"	"Detected in single"	6	"Spermatocytes: 3.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA046150	Uncertain					NA	NA				"Cluster 74: Testis - Spermatogenesis"		"Cluster 66: Spermatocytes - Spermatogenesis"			"HPA046150: AB_10960993"		"unprognostic (2.45e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.22e-1)"				"unprognostic (1.43e-2)"		"unprognostic (5.88e-3)"				"unprognostic (3.48e-2)"	"unprognostic (1.93e-1)"	"unprognostic (3.51e-2)"	"unprognostic (2.03e-1)"	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.5	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ZNF391	dJ153G14.3	ENSG00000124613	"Zinc finger protein 391"	Q9UJN7	6	27374615-27403908	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	4	"Early spermatids: 52.5"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"amygdala: 2.1;basal ganglia: 3.1;cerebral cortex: 3.3;hippocampal formation: 2.8;white matter: 2.2"	"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA050886	Uncertain					NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 68: Epididymis - Unknown function"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 29: Early spermatids - Spermatogenesis"			"HPA050886: AB_2681262"	"unprognostic (1.59e-1)"	"unprognostic (4.97e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.88e-1)"	"unprognostic (4.68e-3)"	"unprognostic (6.27e-5)"	"unprognostic (2.18e-2)"	"unprognostic (2.50e-1)"	"prognostic favorable (1.89e-4)"	"unprognostic (5.62e-2)"	"unprognostic (3.02e-1)"	"unprognostic (3.73e-2)"	"unprognostic (2.39e-2)"	"unprognostic (3.40e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.82e-2)"	2.3	2.1	2.1	0.9	3.1	0.3	3.3	0.5	3.3	3.6	0.0	1.6	0.8	3.1	3.1	1.8	3.9	1.3	1.1	2.8	0.0	2.8	0.3	1.9	1.9	0.4	0.0	5.0	2.1	3.7	1.7	1.4	0.1	2.5	1.7	2.1	2.2	3.4	0.6	1.8	1.1	2.4	0.0	2.3	1.6	4.9	0.3	1.4	4.0	0.8	1.7	1.7	1.5	2.2	4.9	0.7	2.9	10.2	1.2	1.6	5.9	1.2	0.9	1.7	3.9	2.7	1.0	0.0	4.3	1.1	3.4	1.6	5.8	4.5	2.7	0.0	3.5	1.8	0.2	0.9	1.9	5.4	2.5	4.9	5.7	0.3	4.5	3.5	0.2	8.1	8.1	0.0	0.3	1.0	6.4	7.6	3.6	0.7	3.2	0.0	0.0	1.3	1.1	1.9	1.1	4.7	0.0	6.7	0.5	4.7	1.1	4.6	0.6	5.5	1.7	0.3	3.7	3.1	8.1	0.0	0.2	0.5	6.0	0.1	0.0	0.0	0.3	0.0	0.7	1.4	0.5	0.2	0.0	1.3	1.0	0.7	0.0	0.3	0.0	0.4	0.1	0.2	2.1	3.1	0.5	3.3	2.8	0.0	0.4	0.0	0.1	0.0	0.3	2.2	1.7	0.0	1.1	2.3	1.2	0.9	0.5	0.7	0.6	2.2	1.8	1.7	1.0	0.0	2.9	1.8	0.0	2.4	0.1	0.1	0.0	1.0	52.5	7.0	2.4	2.0	1.8	1.3	12.1	1.4	1.1	2.4	0.0	1.7	0.0	3.9	1.8	0.0	1.1	3.3	6.7	0.2	2.0	0.0	0.6	4.7	1.8	0.4	0.0	3.7	0.0	4.4	0.0	7.5	1.7	1.2	0.6	2.6	0.3	0.2	0.0	1.3	12.4	0.9	0.0	1.6	1.3	6.5	2.8	1.3	0.3	0.3	0.6	1.9	1.1	0.4
ZNF184		ENSG00000096654	"Zinc finger protein 184"	Q99676	6	27450743-27473118	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 36.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA003226, HPA064793"	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 13: T-cells - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 14: REH - Unknown function"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA003226: AB_2218705, HPA064793: AB_2732722"	"unprognostic (8.86e-2)"	"unprognostic (5.55e-2)"	"unprognostic (2.27e-3)"	"unprognostic (1.70e-1)"	"unprognostic (4.99e-3)"	"unprognostic (6.04e-2)"	"unprognostic (1.99e-2)"	"unprognostic (1.74e-2)"	"unprognostic (1.17e-2)"	"prognostic favorable (4.41e-5)"	"unprognostic (2.59e-1)"	"unprognostic (5.64e-2)"	"unprognostic (2.77e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.31e-2)"	"unprognostic (5.79e-3)"	2.8	3.1	2.4	4.3	4.6	8.8	5.4	1.2	8.4	6.1	0.0	4.4	3.4	5.4	4.1	3.8	4.5	4.0	2.8	6.4	0.6	7.0	3.6	4.1	6.3	0.4	0.3	6.0	2.7	5.9	4.1	3.0	0.3	4.3	4.5	4.4	3.5	4.3	2.9	5.7	3.6	4.3	0.6	4.6	4.4	8.3	0.3	10.2	5.6	5.0	6.6	4.5	2.9	2.7	6.4	2.0	10.8	19.7	7.6	5.6	3.6	6.2	8.3	7.1	10.9	3.6	3.7	11.7	10.3	4.0	4.8	3.9	9.7	4.0	10.3	11.4	6.0	14.0	7.3	5.1	4.0	16.9	9.7	4.1	6.0	5.2	5.4	8.4	7.8	17.8	10.9	21.1	11.9	3.2	27.3	14.3	6.3	3.5	4.5	35.4	15.2	17.5	4.9	5.9	18.4	8.9	7.0	6.0	9.2	5.3	7.0	14.4	5.3	10.8	7.1	4.9	7.2	9.6	17.4	21.8	2.4	19.4	10.9	2.1	2.7	8.0	7.9	3.7	10.9	7.4	8.3	7.7	4.1	6.9	6.3	7.9	1.4	7.0	2.9	2.5	10.4	3.9	2.4	4.6	1.2	8.4	6.4	0.6	0.4	0.3	0.3	0.6	0.3	2.7	5.4	6.4	8.1	2.0	9.8	4.1	3.8	2.5	6.8	2.5	5.1	5.5	3.5	2.8	6.4	1.8	2.1	4.3	17.5	2.1	7.9	2.7	36.9	7.9	3.7	5.1	7.1	3.4	10.3	3.0	3.0	4.5	2.0	5.0	5.1	7.4	3.9	1.5	2.8	10.1	3.4	5.1	2.0	3.8	3.8	12.6	3.4	3.6	1.8	5.6	3.0	3.3	9.2	4.0	4.2	2.5	2.1	3.8	6.5	4.6	1.6	4.5	6.3	4.8	0.0	5.2	6.8	12.8	5.9	4.3	4.4	2.9	12.5	4.6	4.4	4.5
H2BC13	"dJ97D16.4, H2B/c, H2BFC, HIST1H2BL"	ENSG00000185130	"H2B clustered histone 13"	Q99880	6	27807444-27807931	"Plasma proteins, Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 6.1;brain: 2.7"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"cerebellum: 2.7;cerebral cortex: 1.6"	"Immune cell enhanced"	"Detected in some"		"neutrophil: 4.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"MOLT-4: 12.3;U-266/84: 12.5"									"HPA042205, HPA043013, HPA048671"	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 16: U-266 - Nucleosome"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	Cytosol	"HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488"	"unprognostic (2.43e-1)"	"unprognostic (2.06e-2)"	"unprognostic (5.32e-3)"	"unprognostic (2.46e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.02e-3)"	"unprognostic (2.32e-3)"	"unprognostic (2.66e-1)"	"unprognostic (9.22e-2)"	"unprognostic (1.87e-2)"	"unprognostic (1.71e-2)"	"unprognostic (1.64e-1)"	"unprognostic (8.02e-3)"	"unprognostic (3.25e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.82e-1)"	"unprognostic (2.86e-2)"	0.1	0.2	0.3	0.0	0.3	6.1	0.1	2.7	1.6	0.3	0.1	0.3	0.1	0.1	0.0	0.2	0.2	0.1	0.0	0.5	0.1	0.1	0.1	0.2	0.5	0.0	0.1	0.3	0.3	0.3	0.0	0.0	0.4	0.2	0.3	0.0	0.0	0.0	0.0	0.2	0.4	0.1	0.0	0.4	0.2	0.2	0.3	1.2	0.3	0.0	0.4	0.1	0.2	0.3	2.2	2.0	0.6	2.1	0.0	0.0	0.1	1.3	0.3	1.1	2.8	0.9	1.5	0.8	0.5	0.2	0.6	1.4	0.0	0.2	0.4	1.0	2.9	1.6	2.7	3.5	0.0	2.6	2.1	0.9	0.0	0.0	0.0	0.2	0.6	1.8	2.1	5.2	0.0	5.6	12.3	4.5	1.9	1.5	3.0	2.8	0.0	1.3	0.0	2.0	2.7	1.0	3.5	1.4	0.2	0.2	1.2	0.9	0.5	0.1	1.4	1.1	0.9	2.9	12.5	3.9	0.3	4.7	0.5	0.5	0.3	2.3	0.5	0.1	0.7	1.0	0.3	0.6	0.7	0.6	0.2	0.3	4.1	0.2	0.3	0.4	1.1	0.5	0.3	0.3	2.7	1.6	0.5	0.1	0.0	0.1	0.4	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
H2AC13	"H2A/c, H2AFC, HIST1H2AI"	ENSG00000196747	"H2A clustered histone 13"	P0C0S8	6	27808199-27808701	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 5.2;brain: 4.2"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"K-562: 42.1;U-266/84: 118.9"									HPA041189	Supported		Approved	Nucleoplasm		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 16: U-266 - Nucleosome"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"HPA041189: AB_2677357"	"unprognostic (1.23e-1)"	"unprognostic (6.21e-3)"	"unprognostic (6.82e-2)"	"unprognostic (5.57e-3)"	"unprognostic (1.38e-1)"	"unprognostic (4.48e-2)"	"unprognostic (9.11e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.27e-1)"	"unprognostic (9.54e-5)"	"unprognostic (5.50e-2)"	"unprognostic (1.50e-5)"	"unprognostic (1.43e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.89e-1)"	"unprognostic (6.24e-2)"	0.3	0.1	1.0	0.2	0.5	5.2	0.1	0.6	0.6	0.3	2.8	2.5	0.9	0.0	0.1	0.7	0.4	0.3	0.1	0.4	1.2	0.1	0.2	0.5	1.5	1.7	1.8	0.4	0.0	0.7	0.0	0.7	1.6	0.2	2.2	0.0	0.1	0.0	0.0	0.2	1.1	0.1	1.6	1.1	0.9	0.5	2.5	2.5	0.1	0.0	0.6	0.4	0.5	4.2	2.4	8.5	2.0	1.4	0.9	0.5	0.8	1.6	0.3	2.7	2.0	2.8	1.5	2.4	5.1	0.7	1.5	1.8	0.0	1.5	1.2	8.6	11.0	3.7	12.6	8.0	0.9	0.9	1.9	3.7	0.6	0.8	0.2	2.3	0.6	3.0	42.1	9.9	0.0	11.8	6.5	7.0	2.2	7.2	3.2	3.4	0.0	16.6	3.0	1.6	11.7	2.3	23.6	3.4	0.8	0.7	14.2	1.1	0.4	1.2	4.6	1.0	1.0	9.1	118.9	5.0	1.1	9.8	0.7	0.0	0.2	1.5	0.3	0.3	0.3	0.8	1.4	0.3	1.1	1.1	0.3	0.2	2.1	1.0	0.3	1.0	1.8	1.0	1.0	0.5	0.6	0.6	0.4	1.2	1.7	1.8	1.6	1.6	2.5	4.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0
H3C10	"H3/k, H3F1K, H3FK, HIST1H3H"	ENSG00000278828	"H3 clustered histone 10"	P68431	6	27810064-27811300	"Disease related genes, Predicted intracellular proteins"		DNA-binding	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 6.4"	"Group enriched"	"Detected in some"	4	"Cytotrophoblasts: 4.4;Extravillous trophoblasts: 3.1;Hofbauer cells: 2.3;Syncytiotrophoblasts: 5.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in all"	8	"basophil: 101.9;neutrophil: 37.8"	"Lineage enriched"	"Detected in all"	12	"granulocytes: 101.9"	"Cell line enhanced"	"Detected in many"		"K-562: 33.7;SiHa: 28.3;U-266/70: 23.5;U-266/84: 61.3"									HPA042570	Approved					NA	Yes			"Cluster 34: Basophils - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 16: U-266 - Nucleosome"	"Cluster 24: Non-specific - Transcription regulation"			"HPA042570: AB_2678056"	"unprognostic (1.61e-1)"	"prognostic favorable (4.35e-4)"	"unprognostic (1.79e-1)"	"unprognostic (1.63e-2)"	"unprognostic (3.68e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.29e-1)"	"unprognostic (3.01e-1)"	"unprognostic (2.12e-1)"	"unprognostic (2.93e-1)"	"prognostic unfavorable (9.25e-6)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (5.73e-5)"	"unprognostic (4.09e-1)"	"unprognostic (4.94e-1)"	"unprognostic (3.70e-1)"	"unprognostic (2.82e-2)"	1.6	1.3	0.9	0.4	0.8	4.4	0.8	0.8	1.1	2.1	1.9	2.8	1.3	0.3	0.5	3.3	0.8	0.4	1.0	1.0	0.7	1.1	2.4	4.0	1.0	1.2	1.1	1.9	0.2	0.8	0.4	0.9	1.0	2.6	2.6	0.1	0.6	0.2	0.6	1.3	1.3	0.2	1.0	6.4	1.5	1.4	1.0	3.1	1.2	1.1	0.4	0.6	2.9	1.8	1.9	7.2	3.0	2.5	4.2	0.5	0.4	1.0	0.7	3.4	1.3	2.2	2.1	1.3	6.5	0.8	2.0	3.9	1.1	1.7	2.2	9.2	4.4	1.8	6.9	9.3	1.1	1.6	2.7	5.6	0.5	0.7	0.8	1.5	1.4	1.7	33.7	15.5	0.7	14.5	3.0	3.6	1.5	13.3	2.7	1.6	0.0	17.0	3.6	0.8	9.3	1.8	28.3	5.7	1.2	1.6	13.4	0.5	1.6	1.5	4.5	0.9	0.4	23.5	61.3	5.0	0.1	7.9	0.3	101.9	4.2	9.2	1.4	1.3	1.7	1.4	2.2	2.0	3.3	5.3	1.4	1.1	37.8	1.7	1.5	7.1	8.1	203.1	0.9	0.8	0.8	1.1	1.0	0.7	1.2	1.1	1.0	1.0	1.0	1.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	4.4	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	3.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	5.2	0.3	0.0	0.0	0.0
H2AC14	"H2A/E, H2AFE, HIST1H2AJ"	ENSG00000276368	"H2A clustered histone 14"	Q99878	6	27814302-27814777	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"bone marrow: 7.2"	"Cell type enhanced"	"Detected in single"		"Extravillous trophoblasts: 1.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in many"		"T-reg: 2.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Hep G2: 6.9;Karpas-707: 9.8;MCF7: 11.5"					"Low region specificity"	"Detected in many"			HPA041189	Supported		Approved	Nucleoplasm		NA	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"HPA041189: AB_2677357"	"unprognostic (8.95e-3)"	"unprognostic (4.08e-3)"	"unprognostic (3.28e-2)"	"unprognostic (5.72e-3)"	"unprognostic (2.29e-2)"	"unprognostic (2.69e-2)"	"unprognostic (6.06e-2)"	"unprognostic (1.97e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.18e-1)"	"unprognostic (9.39e-3)"	"unprognostic (3.43e-1)"		"unprognostic (9.35e-2)"	"unprognostic (1.51e-1)"		"unprognostic (1.88e-2)"	0.1	0.0	0.2	0.3	0.4	7.2	0.0	0.5	0.7	0.5	0.4	0.2	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.2	0.4	0.0	0.1	0.1	0.7	0.7	0.5	0.0	0.0	0.0	0.0	0.1	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.4	0.6	0.1	0.1	1.0	1.7	0.0	0.0	0.1	0.2	0.1	0.8	3.5	0.0	0.9	0.0	0.0	0.0	0.7	1.0	0.8	0.7	1.8	1.4	0.1	3.1	0.3	0.5	0.1	1.0	0.0	0.8	0.4	1.4	0.3	4.6	0.7	6.9	0.2	0.0	1.7	0.0	0.2	0.5	0.2	0.0	1.0	1.6	0.0	9.8	0.2	11.5	5.0	4.6	1.4	1.5	2.4	4.6	0.0	1.4	0.1	1.9	0.3	0.8	0.8	1.0	0.3	0.2	0.3	3.4	0.0	0.0	1.6	0.3	0.1	4.8	3.1	2.9	0.8	3.2	2.2	0.0	0.0	0.0	0.2	0.2	0.4	0.3	1.3	1.3	1.1	1.3	0.4	0.1	1.1	0.1	0.1	0.1	2.8	1.7	0.2	0.4	0.5	0.7	0.2	0.4	0.7	0.5	1.3	0.4	1.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.0
H2BC14	"dJ160A22.3, H2B/e, H2BFE, HIST1H2BM"	ENSG00000273703	"H2B clustered histone 14"	Q99879	6	27815022-27815489	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 3.5;lymphoid tissue: 3.1"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Karpas-707: 14.8;NB-4: 9.9;REH: 6.2;U-266/70: 12.3;U-698: 5.9"	"Not detected"	"Not detected"							"HPA042205, HPA043013, HPA048671"	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	Cytosol	"HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488"	"unprognostic (3.83e-1)"	"unprognostic (8.85e-4)"	"unprognostic (3.74e-1)"	"unprognostic (2.00e-1)"	"unprognostic (3.00e-1)"	"unprognostic (1.11e-1)"		"unprognostic (1.38e-1)"		"unprognostic (3.37e-1)"	"unprognostic (9.46e-3)"	"unprognostic (3.02e-1)"		"unprognostic (1.04e-1)"	"unprognostic (5.70e-1)"		"unprognostic (2.65e-1)"	0.5	0.0	0.1	0.3	0.5	3.5	0.0	1.2	0.6	1.1	0.2	0.3	0.0	0.1	0.0	0.4	0.0	0.3	0.1	0.4	0.4	0.3	0.2	0.5	1.5	0.4	0.7	0.2	0.0	0.0	0.0	0.1	0.7	0.5	0.2	0.0	0.1	0.0	0.0	0.2	0.2	0.0	0.6	1.0	0.2	0.4	0.8	3.1	0.2	0.0	1.1	0.0	1.0	1.1	1.5	0.0	0.2	0.0	0.0	0.0	1.0	0.3	0.2	0.3	1.5	0.3	0.2	1.9	0.0	0.0	0.4	0.9	0.0	0.0	0.0	1.1	0.0	0.7	0.2	0.6	0.0	0.0	1.6	0.0	0.0	0.6	0.0	0.0	0.0	0.5	0.1	14.8	0.0	0.4	4.0	9.9	2.8	0.9	0.6	6.2	0.0	0.3	0.0	0.0	0.2	1.7	0.6	0.9	0.0	0.1	0.8	3.0	0.0	0.0	1.6	1.0	0.1	12.3	0.5	5.9	0.9	1.0	0.7	0.0	0.0	0.0	0.2	0.0	0.4	0.3	0.4	0.3	0.1	0.4	0.0	0.2	0.0	0.3	0.0	0.0	0.1	0.0	0.1	0.5	1.2	0.6	0.4	0.4	0.4	0.7	0.7	0.6	0.8	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
H4C11	"H4/e, H4F2iv, H4FE, HIST1H4J"	ENSG00000197238	"H4 clustered histone 11"	P62805	6	27824092-27824480	"Disease related genes, Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 20.6"	"Cell type enhanced"	"Detected in some"		"dendritic cells: 2.5;Extravillous trophoblasts: 8.0;Hofbauer cells: 4.4;Syncytiotrophoblasts: 1.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in many"	6	"basophil: 80.9"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 80.9"	"Cell line enhanced"	"Detected in some"		"SK-MEL-30: 3.0;U-266/70: 2.4;U-266/84: 1.1;U-937: 6.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA042201	Supported					NA	NA		25000000	"Cluster 10: Basophils - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 32: U-937 - Innate immune response"	"Cluster 24: Non-specific - Transcription regulation"			"HPA042201: AB_2677898"	"unprognostic (3.79e-2)"	"unprognostic (2.05e-2)"	"unprognostic (7.65e-2)"	"unprognostic (8.35e-2)"	"unprognostic (1.12e-1)"	"unprognostic (5.85e-2)"	"unprognostic (2.99e-1)"	"unprognostic (7.30e-2)"	"unprognostic (3.77e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.53e-1)"	"unprognostic (4.18e-2)"	"unprognostic (1.79e-3)"	"unprognostic (3.50e-1)"	"unprognostic (2.77e-1)"	"unprognostic (2.08e-1)"	"unprognostic (4.24e-3)"	5.4	10.0	0.0	0.0	0.4	0.0	4.1	0.0	0.4	4.7	0.2	6.7	0.0	4.1	0.0	4.9	4.9	1.2	3.9	0.1	0.2	4.3	20.6	4.4	0.0	0.2	0.1	4.8	1.2	0.0	4.2	0.0	0.2	8.6	0.0	0.0	1.9	0.0	0.4	2.9	5.4	1.4	0.0	11.5	3.2	2.7	0.2	0.0	8.7	0.0	0.0	3.1	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	1.1	0.0	0.0	6.3	0.0	80.9	2.3	13.5	8.6	9.9	3.0	6.1	8.1	9.9	0.0	6.0	3.6	4.4	0.2	13.6	14.3	6.7	9.0	8.6	0.0	0.4	0.0	0.4	0.1	0.2	0.2	0.1	0.2	0.0	0.2	0.0	1.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.8	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	8.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.6	0.4	0.0	0.0	0.0
H4C12	"dJ160A22.1, H4/d, H4F2iii, H4FD, HIST1H4K"	ENSG00000273542	"H4 clustered histone 12"	P62805	6	27831174-27831560	"Disease related genes, Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 22.2;brain: 20.7"	"Cell type enriched"	"Detected in single"	6	"Cardiomyocytes: 2.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in all"		"basophil: 160.3"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 160.3"	"Cell line enhanced"	"Detected in many"		"Hep G2: 63.7;MCF7: 63.3"									HPA042201	Supported					NA	NA		25000000	"Cluster 41: Basophils - Cellular respiration"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 43: Cardiomyocytes - Nuclear processes"			"HPA042201: AB_2677898"	"unprognostic (3.19e-1)"	"unprognostic (9.09e-3)"	"unprognostic (1.16e-1)"	"unprognostic (4.84e-3)"	"unprognostic (9.63e-2)"	"unprognostic (9.13e-2)"	"unprognostic (1.48e-1)"	"unprognostic (4.80e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.58e-1)"	"unprognostic (7.39e-2)"	"unprognostic (5.79e-2)"	"unprognostic (3.13e-2)"	"unprognostic (2.79e-1)"	"unprognostic (3.45e-1)"	"unprognostic (4.16e-2)"	"unprognostic (1.02e-1)"	4.1	5.5	12.2	2.8	14.6	22.2	2.1	4.5	18.9	3.8	0.0	7.6	6.1	3.1	1.0	1.4	3.3	3.7	0.5	17.4	7.1	1.1	8.0	1.2	4.6	0.5	5.5	0.9	1.0	7.1	0.4	1.5	2.0	5.1	3.4	0.4	1.1	2.0	0.4	0.7	5.8	1.2	6.7	5.7	5.9	1.4	4.1	8.8	2.7	2.0	2.2	2.9	0.4	20.7	8.0	9.9	21.0	35.4	13.3	5.0	12.4	8.9	4.4	8.7	5.6	17.2	2.6	12.6	16.4	3.7	2.1	19.4	0.5	13.1	2.7	18.5	3.7	8.4	19.0	63.7	7.5	12.4	10.8	15.9	3.5	5.4	2.9	1.2	7.8	7.1	16.5	26.6	0.3	63.3	22.8	13.0	13.3	13.3	20.3	9.2	1.5	9.1	1.5	3.6	11.7	15.8	16.3	9.0	12.1	2.9	12.4	6.1	7.9	4.4	21.0	2.3	0.1	14.3	16.7	23.0	5.6	9.2	8.7	160.3	9.4	40.4	29.8	21.3	25.8	33.8	29.0	31.6	18.2	37.1	17.4	22.1	22.9	28.0	26.3	20.0	38.9	24.6	12.2	14.6	4.5	18.9	17.4	7.1	0.5	5.5	2.0	6.7	4.1	20.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
H2BC15	"H2B/d, H2BFD, HIST1H2BN"	ENSG00000233822	"H2B clustered histone 15"	Q99877	6	27837760-27855709	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 2.9;Cytotrophoblasts: 11.7;dendritic cells: 4.8;Extravillous trophoblasts: 5.3;Hofbauer cells: 11.3;Plasma cells: 4.4;Syncytiotrophoblasts: 5.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 8.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"K-562: 5.5;SCLC-21H: 6.4;U-266/84: 7.1"									"HPA042205, HPA043013, HPA048671"	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 21: Non-specific - Transcription"	"Cluster 16: U-266 - Nucleosome"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	Cytosol	"HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488"	"unprognostic (2.29e-1)"	"unprognostic (2.82e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.25e-2)"	"unprognostic (3.22e-2)"	"unprognostic (6.66e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.67e-1)"	"unprognostic (3.04e-1)"	"unprognostic (4.41e-2)"	"unprognostic (2.95e-3)"	"unprognostic (2.05e-3)"	"unprognostic (1.14e-4)"	"unprognostic (9.62e-2)"	"unprognostic (3.91e-1)"	"unprognostic (9.62e-2)"	"unprognostic (2.22e-2)"	0.2	1.5	0.3	0.5	0.5	1.0	0.6	2.1	0.5	0.7	0.6	0.4	0.4	0.6	0.8	0.3	0.7	0.3	1.5	0.4	0.3	0.6	0.9	0.5	0.6	0.3	0.2	1.0	1.4	0.6	1.0	0.3	0.4	0.8	0.3	1.7	0.5	0.1	0.9	0.3	0.5	0.2	0.5	0.6	0.4	1.5	0.2	0.6	1.2	0.1	0.2	0.3	0.4	1.7	0.7	0.1	1.1	0.8	0.9	0.2	0.6	0.5	0.3	0.2	0.2	0.2	0.6	0.5	1.8	0.2	0.5	1.1	1.0	0.3	0.2	0.9	2.1	0.6	2.4	0.6	1.0	0.7	1.8	0.9	0.2	0.1	0.4	0.8	0.1	1.0	5.5	3.8	0.6	0.5	1.6	1.9	0.6	0.5	0.5	0.9	0.7	4.1	0.3	0.2	6.4	1.0	2.2	1.0	0.8	0.5	1.7	0.6	1.2	1.3	1.4	0.7	0.3	3.4	7.1	1.5	0.5	0.4	0.5	0.5	1.4	1.0	1.9	1.2	1.1	4.8	1.3	1.3	2.9	3.3	0.9	0.8	8.8	0.8	0.8	4.0	1.8	0.7	0.3	0.5	2.1	0.5	0.4	0.3	0.3	0.2	0.4	0.5	0.2	1.7	0.5	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	11.7	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	5.3	1.6	0.0	0.0	0.0	0.0	0.0	0.0	11.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	5.1	1.2	0.0	0.0	0.0
H2AC15	"H2A/d, H2AFD, HIST1H2AK"	ENSG00000275221	"H2A clustered histone 15"	P0C0S8	6	27837880-27838375	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in single"		"dendritic cells: 1.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HeLa: 3.3;SCLC-21H: 3.5;U-266/84: 3.9"									HPA041189	Supported		Approved	Nucleoplasm		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 21: Non-specific - Transcription"	"Cluster 16: U-266 - Nucleosome"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"HPA041189: AB_2677357"																		0.4	1.0	0.9	0.4	0.9	1.0	0.4	2.7	1.3	0.9	2.5	0.4	0.1	0.5	1.7	0.3	1.2	1.0	1.7	0.9	1.8	0.9	0.6	0.8	1.2	1.9	1.5	2.0	0.6	0.4	1.3	0.3	2.0	1.2	0.4	0.2	0.4	0.3	0.8	0.2	0.6	0.0	2.2	0.8	0.4	2.6	2.2	1.2	1.3	0.4	0.2	0.4	0.7	3.9	0.0	1.3	0.1	1.7	0.3	0.0	0.0	0.1	0.0	0.3	0.0	1.1	0.0	0.6	0.1	0.2	0.1	1.4	0.5	0.0	0.3	0.4	0.1	0.4	3.3	0.6	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.8	0.0	0.2	0.3	0.4	0.0	0.2	0.0	1.1	0.6	0.2	0.1	0.3	0.0	3.5	0.3	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.6	0.4	0.1	0.0	1.2	3.9	0.3	0.0	0.0	0.1	0.0	0.1	0.0	1.4	0.0	1.3	4.1	1.7	1.5	0.0	3.2	2.5	1.8	0.0	0.9	0.4	0.7	1.3	2.6	0.9	0.9	2.7	1.3	0.9	1.8	1.9	1.5	2.0	2.2	2.2	3.9	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.5	0.0	0.0	0.0
H2AC16	"dJ193B12.9, H2A/i, H2AFI, HIST1H2AL"	ENSG00000276903	"H2A clustered histone 16"	P0C0S8	6	27865317-27865798	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"bone marrow: 7.6;brain: 2.5"	"Cell type enhanced"	"Detected in single"		"Extravillous trophoblasts: 1.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEK 293: 4.8;MOLT-4: 5.2"					"Low region specificity"	"Detected in single"			HPA041189	Supported		Approved	Nucleoplasm		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 24: NB-4 - Immune response"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"HPA041189: AB_2677357"	"unprognostic (2.45e-2)"	"unprognostic (2.94e-2)"	"unprognostic (5.88e-2)"	"unprognostic (2.46e-3)"	"unprognostic (3.17e-1)"	"unprognostic (1.82e-1)"	"unprognostic (3.86e-2)"	"unprognostic (2.08e-2)"	"unprognostic (4.18e-1)"	"unprognostic (2.38e-1)"	"unprognostic (4.01e-2)"	"unprognostic (4.29e-1)"		"unprognostic (2.41e-2)"	"unprognostic (2.12e-1)"		"unprognostic (6.21e-2)"	0.1	0.1	0.5	0.1	0.3	7.6	0.2	0.6	0.4	0.0	1.0	0.2	0.2	0.1	0.0	0.3	0.0	0.1	0.0	0.3	1.0	0.1	0.1	0.4	0.4	1.5	1.3	0.0	0.0	0.3	0.0	0.1	1.5	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.3	0.1	1.2	0.7	0.2	0.3	1.7	0.5	0.0	0.1	0.1	0.0	0.2	2.5	2.8	1.2	0.8	0.0	0.0	0.0	0.5	0.9	0.5	1.5	1.4	0.0	0.7	2.0	0.8	0.2	0.8	0.8	0.0	0.2	1.0	1.9	4.8	0.6	0.2	0.5	0.0	0.4	1.1	0.0	0.0	0.4	0.2	0.0	0.0	1.1	4.5	3.3	0.2	3.0	5.2	3.9	1.6	1.5	0.6	2.6	0.0	0.2	0.3	2.0	1.6	1.4	1.0	0.1	0.4	0.1	0.7	1.1	0.0	0.1	0.0	1.0	1.7	3.7	0.0	4.0	0.8	3.1	0.7	2.0	1.4	1.1	0.1	1.3	0.0	2.4	1.2	1.3	3.6	5.9	0.4	0.7	6.1	0.0	2.9	2.6	1.1	0.7	0.5	0.3	0.6	0.4	0.3	1.0	1.5	1.3	1.5	1.2	1.7	2.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0
H1-5	"H1b, H1F5, H1s-3, HIST1H1B"	ENSG00000184357	"H1.5 linker histone, cluster member"	P16401	6	27866792-27867588	"Plasma proteins, Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"bone marrow: 7.8;brain: 4.6;choroid plexus: 4.1;lymphoid tissue: 2.1"	"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 1.5;dendritic cells: 2.2;Extravillous trophoblasts: 4.7;Hofbauer cells: 3.3"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 4.6"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"B-cells: 10.3;dendritic cells: 12.1;T-cells: 3.3"	"Cell line enhanced"	"Detected in some"		"MOLT-4: 9.2;NB-4: 4.9;U-698: 3.9"	"Not detected"	"Not detected"							"CAB012241, HPA055907, HPA060331"	Supported		Supported	Nucleoplasm		NA	NA		2300000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"CAB012241: , HPA055907: AB_2682966, HPA060331: "	"unprognostic (2.34e-1)"	"unprognostic (3.75e-4)"	"unprognostic (2.12e-2)"	"unprognostic (3.63e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.37e-2)"	"unprognostic (1.91e-2)"	"unprognostic (4.93e-2)"	"unprognostic (1.20e-1)"	"unprognostic (8.47e-2)"	"unprognostic (6.23e-3)"	"unprognostic (5.85e-2)"		"unprognostic (5.68e-4)"	"unprognostic (2.10e-1)"	"unprognostic (9.79e-2)"	"unprognostic (1.35e-1)"	0.1	0.0	1.5	0.2	0.9	7.8	0.1	4.0	1.0	0.0	4.1	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.5	1.2	0.0	0.0	0.1	1.6	1.8	2.3	0.0	0.0	0.0	0.0	0.3	3.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.7	0.0	1.5	0.4	0.1	0.1	3.8	2.1	0.0	0.0	0.3	0.3	0.0	4.6	1.4	0.0	0.5	0.0	0.0	0.0	1.0	0.4	0.3	0.7	0.3	0.4	0.9	1.7	0.2	0.5	0.4	0.5	0.0	0.0	0.0	0.6	0.8	2.2	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.7	0.0	0.0	0.5	1.1	1.7	1.2	0.0	0.2	9.2	4.9	1.4	1.3	0.0	2.7	0.0	0.0	0.2	0.0	1.2	0.6	1.5	0.3	0.0	0.4	0.6	1.6	0.5	0.8	0.1	0.8	0.6	1.8	0.0	3.9	1.2	0.6	0.8	0.0	0.9	0.0	3.1	0.8	1.5	4.6	2.9	3.2	5.1	10.3	1.7	1.9	0.8	1.7	1.1	12.1	3.3	2.1	1.5	0.9	4.0	1.0	0.5	1.2	1.8	2.3	3.0	1.5	3.8	4.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.5	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.0
H3C11	"H3.f, H3/f, H3FF, HIST1H3I"	ENSG00000275379	"H3 clustered histone 11"	P68431	6	27871845-27872346	"Disease related genes, Predicted intracellular proteins"		DNA-binding	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 5.5;choroid plexus: 2.6"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"ovarian cancer: 2.0"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"NK-cell: 8.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HEL: 2.1;MOLT-4: 4.0;NB-4: 2.8;REH: 4.2"									HPA042570	Approved					NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"			"HPA042570: AB_2678056"		"unprognostic (1.60e-1)"	"unprognostic (5.58e-2)"	"unprognostic (8.16e-2)"	"unprognostic (1.06e-1)"	"unprognostic (6.48e-2)"		"unprognostic (2.39e-1)"		"unprognostic (1.18e-1)"				"unprognostic (1.13e-2)"	"unprognostic (1.25e-1)"		"unprognostic (1.29e-2)"	0.1	0.1	0.9	0.3	0.8	1.2	0.0	1.2	0.7	0.1	2.6	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	1.5	0.0	0.1	0.0	0.3	4.0	2.6	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.2	0.2	0.0	0.0	3.4	0.6	0.0	0.0	0.0	0.0	0.1	5.5	0.6	0.7	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.5	1.3	0.2	0.0	0.2	0.4	0.0	0.0	0.2	0.6	0.7	2.1	0.0	0.0	0.4	1.3	0.3	0.2	0.0	0.3	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	4.0	2.8	0.6	0.1	0.0	4.2	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.2	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.8	0.4	1.5	0.3	1.2	0.5	1.3	1.0	2.3	2.3	1.1	1.5	0.6	8.2	0.3	3.4	1.2	1.5	0.9	0.8	1.2	0.7	0.3	1.5	4.0	2.6	2.9	2.2	3.4	5.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0
H4C13	"H4.k, H4/k, H4FK, HIST1H4L"	ENSG00000275126	"H4 clustered histone 13"	P62805	6	27873148-27873534	"Disease related genes, Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"brain: 2.0"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"colorectal cancer: 1.2"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"naive B-cell: 2.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"MOLT-4: 4.1;NB-4: 2.3;REH: 1.0"	"Low region specificity"	"Detected in many"							HPA042201	Approved					NA	NA		25000000	"Cluster 21: B-cells - Adaptive immune response"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"				"HPA042201: AB_2677898"										"unprognostic (1.15e-1)"				"unprognostic (6.05e-4)"				0.0	0.0	0.5	0.0	0.3	0.4	0.0	0.3	0.4	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.1	1.7	1.1	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	1.3	0.3	0.0	0.0	0.0	0.0	0.0	2.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	4.1	2.3	0.0	0.4	0.0	1.0	0.2	0.0	0.0	0.0	0.0	0.5	0.6	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.3	0.0	0.5	0.3	0.1	0.8	0.4	0.7	1.1	2.7	0.2	0.6	0.0	0.8	0.7	1.7	0.5	0.1	0.5	0.3	0.3	0.4	0.3	0.4	1.7	1.1	1.4	1.0	1.3	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
H3C12	"H3/j, H3FJ, HIST1H3J"	ENSG00000197153	"H3 clustered histone 12"	P68431	6	27890315-27893106	"Disease related genes, Predicted intracellular proteins"		DNA-binding	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 1.2;brain: 2.1;choroid plexus: 1.3;lymphoid tissue: 1.1"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Daudi: 4.4;U-266/84: 11.7"									HPA042570	Approved					NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 16: U-266 - Nucleosome"				"HPA042570: AB_2678056"	"unprognostic (1.15e-1)"	"unprognostic (4.48e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.47e-2)"	"unprognostic (3.18e-1)"	"unprognostic (1.71e-4)"	"unprognostic (2.91e-2)"	"unprognostic (4.09e-3)"	"unprognostic (6.37e-3)"	"unprognostic (6.67e-2)"	"unprognostic (4.68e-3)"	"unprognostic (1.34e-1)"	"unprognostic (2.63e-8)"	"unprognostic (2.11e-1)"	"unprognostic (2.51e-1)"	"unprognostic (4.82e-3)"	"unprognostic (8.04e-2)"	0.0	0.0	0.2	0.0	0.4	1.2	0.1	0.6	0.6	0.1	1.3	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.4	0.0	0.1	0.1	1.0	0.9	2.1	0.0	0.0	0.0	0.0	0.2	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.6	0.4	0.0	0.3	0.9	1.1	0.0	0.0	0.2	0.1	0.1	1.3	0.9	0.3	1.3	0.6	0.5	0.2	0.6	0.3	0.0	0.7	0.1	0.0	0.2	4.4	0.7	0.2	0.5	0.1	0.9	0.5	0.0	0.2	0.4	0.8	1.8	0.0	0.2	0.1	0.1	0.0	0.0	0.3	0.0	0.0	0.3	0.5	1.9	1.0	0.0	0.5	2.0	2.5	1.7	0.8	0.2	1.0	0.3	0.4	0.0	0.0	2.3	1.0	1.5	1.4	0.0	0.2	0.4	0.5	0.0	0.5	0.0	0.1	0.2	3.1	11.7	1.1	0.5	0.4	1.4	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.7	0.9	0.7	0.5	0.1	0.2	0.0	0.3	0.2	0.1	0.7	0.1	0.2	0.4	0.6	0.6	0.3	0.4	0.9	2.1	1.5	0.6	0.9	1.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0
H2AC17	"H2A.1, H2A/n, H2AFN, HIST1H2AM"	ENSG00000278677	"H2A clustered histone 17"	P0C0S8	6	27892699-27893185	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 3.2;brain: 5.8"	"Cell type enhanced"	"Detected in some"		"dendritic cells: 1.2;Syncytiotrophoblasts: 1.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in all"		"basophil: 63.8"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-266/84: 28.9"									HPA041189	Supported		Approved	Nucleoplasm		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 16: U-266 - Nucleosome"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"HPA041189: AB_2677357"	"unprognostic (6.05e-2)"	"unprognostic (4.03e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.11e-2)"	"unprognostic (6.48e-2)"	"unprognostic (2.70e-1)"	"unprognostic (6.36e-2)"	"unprognostic (4.64e-3)"	"unprognostic (2.65e-3)"	"unprognostic (4.24e-1)"	"unprognostic (8.85e-6)"	"unprognostic (2.44e-1)"	"unprognostic (3.18e-1)"	"unprognostic (8.80e-2)"	"unprognostic (1.30e-1)"	0.4	0.4	1.3	0.2	0.9	3.2	0.3	1.2	1.1	0.5	2.5	0.8	0.7	0.3	0.2	0.9	0.0	0.0	0.2	0.5	1.5	0.2	0.5	0.6	1.5	3.3	3.2	0.0	0.3	0.3	0.0	0.9	3.2	0.6	0.6	0.0	0.3	0.0	0.2	0.4	0.8	0.0	2.7	1.2	0.4	0.9	2.4	2.1	0.7	0.0	0.4	0.3	0.7	5.8	3.7	2.6	2.3	5.4	0.3	0.2	4.8	1.2	0.6	2.4	3.1	0.9	1.6	5.8	4.3	0.7	2.9	2.2	2.3	1.6	1.9	4.6	1.3	2.9	3.5	3.9	0.0	2.1	2.4	1.8	0.0	1.7	0.0	0.2	2.3	4.2	12.5	8.0	0.4	6.8	12.6	8.9	4.2	2.1	1.2	7.7	3.6	11.9	1.2	0.9	8.9	1.6	6.5	0.6	0.9	1.2	5.4	1.7	0.0	1.1	0.2	1.2	2.0	9.0	28.9	14.2	1.5	9.7	1.0	63.8	5.0	21.1	10.0	6.0	5.9	13.5	8.8	8.6	18.3	15.3	3.5	4.2	16.7	8.5	10.5	22.5	13.4	9.7	1.3	0.9	1.2	1.1	0.5	1.5	3.3	3.2	3.2	2.7	2.4	5.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.2	0.0	0.0	0.0
H2BC17	"H2B.2, H2B/n, H2BFN, HIST1H2BO"	ENSG00000274641	"H2B clustered histone 17"	P23527	6	27893425-27893891	"Predicted intracellular proteins"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 2.4;brain: 2.3;lymphoid tissue: 2.6"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-266/84: 36.0"									"HPA042205, HPA043013, HPA048671"	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 16: U-266 - Nucleosome"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	Cytosol	"HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: AB_2680488"	"unprognostic (7.22e-2)"	"unprognostic (1.77e-3)"	"unprognostic (9.47e-2)"	"unprognostic (4.43e-2)"	"unprognostic (6.67e-2)"	"unprognostic (7.52e-2)"	"unprognostic (2.47e-2)"	"unprognostic (3.48e-2)"	"unprognostic (1.55e-2)"	"unprognostic (7.91e-2)"	"unprognostic (7.81e-3)"	"unprognostic (2.88e-3)"	"unprognostic (4.04e-7)"	"unprognostic (4.39e-2)"	"unprognostic (3.41e-1)"	"unprognostic (4.39e-2)"	"prognostic favorable (4.89e-4)"	0.3	0.1	0.7	0.2	0.3	2.4	0.1	1.1	0.8	0.6	1.3	0.3	0.2	0.1	0.0	0.5	0.0	0.1	0.2	0.2	0.7	0.2	0.4	1.0	0.7	1.2	2.3	0.0	0.0	0.0	0.0	0.6	1.9	0.5	0.3	0.0	0.2	0.0	0.1	0.4	0.2	0.0	0.8	1.3	0.2	0.2	1.8	2.6	0.2	0.0	0.6	0.3	0.8	2.0	2.8	3.0	1.6	5.1	0.7	0.0	3.0	0.9	0.1	5.3	5.1	1.1	1.5	3.2	2.3	0.2	1.3	2.6	2.9	0.5	1.4	2.4	2.0	1.9	4.7	2.1	0.0	0.3	1.4	0.3	0.0	0.4	0.5	0.1	1.4	2.3	7.6	9.1	0.2	1.3	12.9	10.9	1.8	1.8	2.2	7.4	1.7	5.5	1.1	0.4	7.3	1.4	5.8	1.3	0.8	0.6	2.3	0.2	0.0	1.7	0.3	1.8	2.4	9.1	36.0	8.8	1.0	10.2	0.8	0.6	0.1	1.7	0.3	0.2	0.4	0.5	0.3	0.6	1.0	0.9	0.1	0.2	2.6	0.5	0.3	0.7	0.6	2.0	0.7	0.3	1.1	0.8	0.2	0.7	1.2	2.3	1.9	0.8	1.8	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0
OR2B2	"hs6M1-10, OR2B2Q, OR2B9, OR6-1"	ENSG00000168131	"Olfactory receptor family 2 subfamily B member 2"	Q9GZK3	6	27911185-27912396	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																	NA	NA						"Cluster 53: Intestinal epithelial cells - Unknown function"																	"unprognostic (2.28e-1)"	"unprognostic (1.62e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR2B6	"dJ408B20.2, OR2B1, OR2B1P, OR2B5, OR2B6P, OR5-40, OR5-41, OR6-31"	ENSG00000124657	"Olfactory receptor family 2 subfamily B member 6"	P58173	6	27957241-27958182	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"Macrophages: 1.9;Squamous epithelial cells: 1.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HeLa: 1.6;K-562: 1.5;U-266/84: 4.0;U-937: 1.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA					"Cluster 16: U-266 - Nucleosome"	"Cluster 51: Myeloid cells - Hemostasis"				"unprognostic (7.98e-2)"	"unprognostic (3.10e-3)"	"unprognostic (7.02e-3)"	"unprognostic (1.58e-4)"	"unprognostic (3.07e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.58e-1)"	"unprognostic (3.95e-2)"	"unprognostic (4.29e-2)"	"unprognostic (6.54e-3)"	"unprognostic (1.75e-2)"	"unprognostic (1.89e-15)"	"unprognostic (1.23e-2)"	"unprognostic (5.26e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.47e-3)"	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.3	0.2	0.1	0.0	0.0	0.1	0.0	0.7	0.3	0.0	0.2	0.0	0.3	0.0	0.3	0.5	0.3	0.0	0.4	0.4	0.1	0.0	1.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.8	0.0	0.2	0.0	0.2	0.1	0.4	0.1	0.0	0.1	0.2	0.0	0.0	1.1	0.0	1.0	0.1	0.3	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	4.0	0.1	0.0	1.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.2	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.4	0.9	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.8	0.1	0.2	0.1	0.1
ZNF165	"CT53, ZSCAN7"	ENSG00000197279	"Zinc finger protein 165"	P49910	6	28080568-28089563	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 17.2"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 94.6;Early spermatids: 152.7;Glandular and luminal cells: 75.8;Paneth cells: 120.3;Syncytiotrophoblasts: 79.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A-431: 14.4;BEWO: 22.9;GAMG: 16.9"					"Low region specificity"	"Detected in all"			HPA007247			Approved	"Nuclear speckles,Microtubules"		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nuclear speckles, Microtubules"		"HPA007247: AB_2797217"	"unprognostic (1.85e-1)"	"unprognostic (2.01e-3)"	"unprognostic (1.12e-2)"	"unprognostic (2.43e-3)"	"unprognostic (1.45e-1)"	"unprognostic (4.32e-3)"	"unprognostic (3.42e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.93e-2)"	"prognostic favorable (2.10e-4)"	"unprognostic (1.18e-3)"	"unprognostic (1.29e-2)"	"prognostic favorable (1.19e-5)"	"unprognostic (1.10e-1)"	"unprognostic (2.40e-1)"	"unprognostic (2.18e-1)"	"prognostic favorable (9.82e-5)"	0.4	0.8	0.4	1.0	0.5	1.4	2.1	0.6	0.8	1.4	2.1	2.4	2.2	1.1	5.1	2.2	1.8	0.9	0.5	0.5	0.5	4.5	2.4	1.9	1.3	0.9	0.7	0.7	4.6	4.8	3.8	3.1	1.0	1.0	3.3	1.7	2.0	1.2	0.7	1.0	1.8	0.5	0.4	0.9	2.5	17.2	0.4	0.5	2.9	0.1	1.7	2.5	1.1	0.7	14.4	0.9	0.8	1.1	0.3	0.5	22.9	0.5	0.5	0.9	0.8	9.0	10.3	1.2	3.9	0.2	16.9	5.4	2.0	6.2	0.6	0.4	3.6	0.7	1.5	9.7	0.3	2.3	2.0	0.3	3.2	0.7	8.8	0.6	0.3	0.8	2.3	1.1	0.5	3.9	0.6	2.7	1.9	12.2	1.4	1.9	0.8	7.7	4.7	6.5	9.6	0.7	1.2	11.1	1.3	2.5	5.5	0.5	0.4	0.8	1.1	0.4	1.0	3.4	9.6	3.6	0.5	2.6	0.4	5.8	1.7	3.4	1.3	1.4	1.6	7.0	1.5	1.0	1.8	8.6	2.5	2.0	2.5	1.4	1.7	5.5	0.7	0.9	0.4	0.5	0.6	0.8	0.5	0.5	0.9	0.7	1.0	0.4	0.4	0.7	0.8	6.4	7.0	0.0	23.2	8.5	16.5	2.3	2.8	0.8	24.5	9.4	0.4	4.3	5.0	3.7	0.0	9.4	4.2	94.6	3.9	18.2	152.7	55.4	5.9	1.3	53.9	0.0	1.2	12.3	9.0	0.6	13.7	75.8	0.0	0.6	0.0	0.4	1.5	0.0	0.9	53.7	6.1	0.6	3.2	19.5	0.9	2.8	5.4	0.0	1.6	1.5	0.0	0.0	0.1	17.5	120.3	2.2	12.4	6.5	9.0	2.0	12.0	2.6	0.0	0.6	1.5	33.6	4.4	8.5	11.8	79.6	8.5	0.3	34.9	40.8
ZSCAN16	"dJ265C24.3, FLJ22191, ZNF392, ZNF435"	ENSG00000196812	"Zinc finger and SCAN domain containing 16"	Q9H4T2	6	28124609-28130082	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 69.0"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA007290	Supported		Approved	Nucleoplasm		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 45: Intestine - Brush border"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 63: NK-cells & T-cells - Immune response"	Nucleoplasm		"HPA007290: AB_1080721"	"unprognostic (1.50e-1)"	"prognostic favorable (5.73e-4)"	"unprognostic (3.29e-2)"	"unprognostic (8.93e-2)"	"unprognostic (3.05e-3)"	"unprognostic (1.00e-2)"	"unprognostic (3.07e-2)"	"prognostic favorable (3.19e-4)"	"unprognostic (1.23e-2)"	"prognostic favorable (1.14e-5)"	"unprognostic (2.50e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.55e-2)"	"unprognostic (2.14e-1)"	"unprognostic (3.37e-3)"	"prognostic favorable (3.41e-5)"	3.2	3.9	5.3	5.5	6.4	3.2	7.0	7.7	7.6	3.9	5.2	7.1	8.6	3.9	7.1	3.6	4.1	4.0	3.0	5.6	6.6	5.4	4.4	4.9	8.3	6.4	5.9	2.5	4.9	6.9	3.2	2.2	6.4	4.7	9.0	7.2	6.6	5.8	3.2	6.9	8.4	4.7	5.5	7.4	7.0	2.2	6.1	8.0	4.6	2.7	9.1	4.2	2.7	9.1	0.1	8.8	11.1	8.2	3.0	0.7	9.1	3.0	6.4	7.8	8.4	6.1	5.7	8.8	8.0	2.8	5.4	6.8	7.8	4.4	7.4	12.8	10.8	9.1	7.4	8.7	4.8	6.8	7.4	1.0	7.3	6.6	3.6	8.3	14.7	0.2	1.3	7.3	2.1	10.0	0.0	10.7	2.3	7.4	5.3	10.9	8.4	12.2	9.3	12.6	15.0	16.5	1.5	9.2	10.9	7.2	12.2	3.2	4.6	2.9	6.7	4.4	7.9	3.7	12.5	2.4	1.3	3.4	1.6	69.0	8.6	10.2	13.8	11.8	17.7	19.3	12.0	10.6	9.0	14.6	14.5	11.8	15.6	17.7	11.6	19.6	14.7	8.6	5.3	6.4	7.7	7.6	5.6	6.6	6.4	5.9	6.4	5.5	6.1	9.1	5.6	6.4	2.6	0.3	5.6	1.8	0.8	4.9	1.2	3.8	5.2	5.6	1.6	10.0	7.5	7.3	4.2	2.2	12.6	4.7	5.9	12.8	3.3	4.2	0.8	4.0	1.8	8.2	1.4	12.6	1.2	1.4	4.6	3.3	2.5	4.8	4.2	2.0	2.1	1.7	1.1	6.0	14.2	3.8	1.3	1.5	0.6	4.3	1.8	1.0	6.1	5.6	11.3	3.5	3.7	9.6	6.1	3.4	4.2	1.3	10.3	8.3	7.7	6.6	0.0	1.7	3.7	1.7	6.3	2.7	1.3	1.8	6.1	2.2	7.0	1.1
ZKSCAN8	"LD5-1, ZNF192, ZSCAN40"	ENSG00000198315	"Zinc finger with KRAB and SCAN domains 8"	Q15776	6	28141883-28159460	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003483	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 43: Cardiomyocytes - Nuclear processes"	Nucleoplasm	Cytosol	"HPA003483: AB_1080686"	"unprognostic (2.02e-1)"	"unprognostic (1.45e-1)"	"unprognostic (3.94e-1)"	"prognostic unfavorable (1.33e-4)"	"unprognostic (2.75e-3)"	"unprognostic (4.19e-2)"	"unprognostic (2.24e-3)"	"unprognostic (5.34e-2)"	"unprognostic (9.80e-3)"	"unprognostic (4.68e-3)"	"unprognostic (2.63e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.22e-2)"	"unprognostic (4.30e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.28e-1)"	"unprognostic (6.33e-3)"	11.0	7.7	4.5	8.1	6.2	14.8	11.5	8.9	7.2	11.2	7.4	11.8	6.6	15.9	13.3	5.6	11.1	7.6	7.6	4.5	5.6	7.7	7.3	9.2	10.5	5.5	5.1	17.6	9.9	12.9	8.4	9.4	6.1	10.3	8.4	17.6	9.0	11.6	8.1	7.9	10.7	10.7	5.0	10.8	9.2	9.1	5.2	13.1	10.6	8.9	10.9	10.2	7.9	9.2	9.0	5.6	26.1	25.4	15.8	14.9	8.2	9.7	18.3	12.6	15.7	6.3	5.3	19.4	15.7	9.4	10.5	7.4	16.7	6.2	17.9	11.2	14.1	17.7	11.7	13.6	14.4	21.8	12.7	15.4	10.4	12.9	19.2	21.5	12.5	16.9	27.9	7.1	12.9	4.4	15.5	18.2	9.5	2.1	6.4	17.0	16.5	15.2	8.6	10.9	19.5	24.7	11.6	5.3	11.9	14.3	5.9	11.7	10.9	18.1	10.5	6.1	13.2	17.3	13.2	15.6	5.1	14.8	9.9	2.2	0.5	0.6	1.0	1.2	1.1	0.5	0.6	0.4	0.4	1.7	1.0	0.8	0.1	1.1	2.1	0.7	0.6	0.6	4.5	6.2	8.9	7.2	4.5	5.6	5.5	5.1	6.1	5.0	5.2	9.2	6.9	3.2	9.3	11.8	9.8	4.8	2.6	3.8	14.8	9.5	8.5	5.1	8.0	7.2	5.0	7.3	6.2	4.2	11.0	2.0	0.0	3.1	3.7	5.9	10.0	8.8	7.2	9.4	11.1	2.9	2.0	9.5	4.6	7.4	5.1	12.7	8.6	10.2	4.1	6.7	12.5	4.6	4.1	11.1	6.8	5.2	9.0	6.0	1.8	15.9	5.9	6.5	4.1	26.7	17.1	3.0	2.4	9.1	9.0	4.3	2.3	3.5	6.1	9.2	0.0	9.9	7.3	11.9	8.6	8.5	2.8	2.3	7.1	7.4	3.7	1.9
ZSCAN9	"PRD51, ZNF193"	ENSG00000137185	"Zinc finger and SCAN domain containing 9"	O15535	6	28224886-28233487	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 23.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in many"			"HPA054512, HPA059951"	Uncertain		Approved	Nucleoplasm,Cytosol		No	No			"Cluster 48: NK-cells - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA054512: AB_2682511, HPA059951: AB_2684176"	"unprognostic (1.67e-1)"	"unprognostic (5.32e-2)"	"unprognostic (2.68e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.32e-2)"	"unprognostic (5.24e-3)"	"prognostic unfavorable (3.49e-4)"	"unprognostic (5.69e-2)"	"unprognostic (4.53e-2)"	"unprognostic (3.18e-2)"	"unprognostic (1.55e-2)"	"unprognostic (6.14e-3)"	"prognostic unfavorable (1.21e-6)"	"unprognostic (1.74e-2)"	"unprognostic (1.51e-2)"	"unprognostic (2.51e-1)"	"prognostic favorable (1.16e-5)"	9.7	11.2	11.3	8.9	12.6	10.7	13.9	15.0	13.8	14.5	14.4	13.4	9.2	14.2	13.4	7.9	11.4	9.4	11.8	11.1	12.6	15.2	9.3	10.1	8.6	12.4	12.5	14.3	12.1	11.5	14.2	11.2	12.9	14.6	14.8	17.4	11.6	11.8	9.1	6.4	12.9	11.7	12.2	16.3	11.8	20.9	12.6	4.4	13.2	7.9	10.3	12.0	10.3	13.4	11.2	7.7	25.7	30.9	9.8	10.6	8.9	13.5	11.3	12.9	14.4	7.1	5.5	0.1	19.9	8.5	12.5	7.7	12.3	12.5	14.6	7.5	10.6	17.1	16.8	13.1	12.4	20.4	13.1	9.1	19.1	10.9	16.6	19.5	16.9	0.0	25.8	9.3	19.2	6.5	0.1	33.4	9.5	5.0	8.6	10.5	17.9	11.7	16.3	15.4	22.3	30.0	11.8	8.8	16.3	19.1	10.9	13.8	13.9	26.2	18.0	6.3	23.2	20.8	22.5	4.5	5.4	24.6	15.4	4.3	3.5	5.1	3.5	1.8	2.9	4.7	1.2	2.7	5.0	4.0	0.4	0.7	1.3	11.7	0.9	2.6	0.9	2.2	11.3	12.6	15.0	13.8	11.1	12.6	12.4	12.5	12.9	12.2	12.6	13.4	6.1	9.6	3.6	5.9	4.4	0.9	5.3	8.0	0.6	7.3	5.5	4.3	5.1	12.8	10.2	3.7	0.0	5.1	5.3	3.8	1.9	8.5	21.5	2.5	4.9	6.5	5.4	4.0	4.5	6.4	3.1	5.3	2.0	3.6	5.7	7.3	5.7	2.4	5.4	6.7	4.7	6.9	4.1	5.3	4.6	5.1	3.7	5.0	3.6	10.3	3.1	4.8	4.1	8.0	10.0	6.1	6.1	4.9	3.6	3.5	4.9	3.8	4.8	6.6	6.6	5.0	5.3	23.7	15.8	3.1	1.1	12.0	2.3	5.8	6.7	2.5
ZKSCAN4	"FLJ32136, P1P373C6, p373c6.1, ZNF307, ZNF427, ZSCAN36"	ENSG00000187626	"Zinc finger with KRAB and SCAN domains 4"	Q969J2	6	28241697-28252269	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 27.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA009637	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 71: Testis - DNA repair"	"Cluster 32: U-937 - Innate immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm		"HPA009637: AB_2668244"	"unprognostic (4.29e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.04e-1)"	"unprognostic (5.01e-2)"	"unprognostic (4.23e-3)"	"unprognostic (3.77e-2)"	"prognostic unfavorable (1.90e-6)"	"prognostic favorable (5.04e-4)"	"unprognostic (8.73e-3)"	"unprognostic (1.80e-2)"	"unprognostic (7.20e-2)"	"unprognostic (5.13e-2)"	"unprognostic (2.13e-2)"	"unprognostic (1.62e-1)"	"unprognostic (6.07e-2)"	"unprognostic (9.70e-2)"	"unprognostic (7.36e-3)"	2.7	2.7	1.6	1.9	1.6	1.0	2.6	2.7	2.0	3.5	1.6	2.9	2.0	3.5	2.0	2.5	2.6	1.4	2.2	1.6	1.6	2.7	3.0	2.0	3.4	1.6	1.5	3.2	2.3	2.3	2.1	2.1	1.7	2.7	2.0	2.2	2.9	1.9	1.6	2.9	3.6	1.5	1.5	8.6	2.5	8.9	1.6	4.1	2.4	1.6	3.3	2.9	2.8	1.9	1.4	1.0	2.8	4.7	3.2	3.1	2.6	1.8	2.9	2.6	2.9	1.6	1.2	3.9	3.3	2.1	1.6	1.6	2.9	2.3	2.7	1.8	3.1	3.3	2.5	2.2	2.2	6.6	2.9	3.4	2.8	2.3	2.3	3.3	2.7	3.4	3.1	0.8	2.2	1.4	4.4	6.9	2.2	0.6	1.9	3.4	3.9	2.5	1.6	1.1	4.3	3.1	1.5	2.0	3.3	2.5	1.7	3.0	2.2	2.9	1.7	1.7	1.8	2.5	2.6	1.8	1.0	6.5	1.7	2.8	1.9	2.2	1.9	1.6	2.2	1.8	1.8	1.8	3.2	1.7	2.7	2.6	2.5	2.4	1.9	4.2	1.8	1.4	1.6	1.6	2.7	2.0	1.6	1.6	1.6	1.5	1.7	1.5	1.6	1.9	1.7	0.0	0.5	2.6	2.2	0.4	0.5	1.0	1.2	1.1	1.5	1.4	1.3	2.8	2.7	1.8	2.1	3.9	3.9	2.2	0.0	2.7	9.8	1.3	3.2	2.2	3.5	3.8	7.9	2.0	2.8	2.5	3.1	1.4	2.5	4.2	2.5	1.0	4.5	1.7	6.5	1.5	0.0	10.7	1.8	6.9	2.8	2.9	1.8	7.5	2.6	2.2	3.1	2.5	3.9	1.7	4.9	3.8	1.3	0.4	2.3	1.7	0.4	1.7	0.0	1.6	1.6	27.4	2.4	1.6	0.3	1.1	2.1	3.5	2.3	0.3
NKAPL	"bA424I5.1, C6orf194"	ENSG00000189134	"NFKB activating protein like"	Q5M9Q1	6	28259297-28260958	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 12.6;testis: 32.3"	"Group enriched"	"Detected in many"	4	"Early spermatids: 401.2;Spermatocytes: 307.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"ASC diff: 3.2;BJ: 1.4;fHDF/TERT166: 2.2;HHSteC: 4.6;HSkMC: 3.0;HUVEC TERT2: 1.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 77: Retina - Visual perception"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 66: Spermatocytes - Spermatogenesis"				"unprognostic (3.93e-2)"	"unprognostic (2.08e-2)"	"unprognostic (1.46e-2)"	"unprognostic (9.73e-2)"	"unprognostic (2.47e-1)"	"unprognostic (7.86e-2)"	"unprognostic (2.34e-2)"	"unprognostic (1.86e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.88e-2)"	"unprognostic (3.84e-3)"	"unprognostic (5.78e-2)"	"unprognostic (5.83e-5)"	"unprognostic (6.65e-3)"	"unprognostic (2.38e-1)"	"unprognostic (2.08e-2)"	"unprognostic (2.47e-2)"	1.9	1.3	5.9	0.7	5.9	0.2	1.5	6.4	9.0	0.8	5.0	2.2	0.2	1.1	1.1	0.9	0.7	0.7	5.0	5.6	6.1	2.0	0.8	0.7	0.7	6.8	6.3	2.0	1.5	0.3	2.1	0.8	6.7	1.4	0.4	12.6	1.6	2.5	5.6	0.7	0.7	1.4	6.1	1.3	1.1	32.3	6.4	0.5	1.0	4.0	0.5	2.0	0.5	6.6	0.0	0.0	0.0	0.0	3.2	0.9	0.0	1.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	3.0	0.0	0.2	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.0	1.6	0.1	1.3	0.3	1.2	0.0	0.2	0.9	0.1	0.2	0.2	2.2	0.3	1.0	2.5	0.0	0.2	5.9	5.9	6.4	9.0	5.6	6.1	6.8	6.3	6.7	6.1	6.4	6.6	4.2	0.0	0.0	2.6	1.1	1.0	1.6	2.5	0.0	29.5	1.8	3.7	13.0	1.5	2.6	1.8	43.8	0.1	4.7	0.0	9.8	2.1	401.2	0.4	2.5	4.8	0.0	0.0	3.3	0.7	0.0	4.1	0.0	0.2	0.0	1.4	3.9	3.5	3.2	33.7	3.3	0.1	10.2	5.1	3.1	49.2	5.6	2.7	5.4	1.9	3.6	15.7	2.1	1.0	2.1	1.4	0.0	6.4	0.4	1.6	0.1	4.1	1.3	77.4	0.0	3.1	5.7	307.1	28.1	1.1	0.9	0.3	1.9	3.2	0.1	0.6
ZSCAN26	"SRE-ZBP, ZNF187"	ENSG00000197062	"Zinc finger and SCAN domain containing 26"	Q16670	6	28267058-28278224	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocyte precursor cells: 30.7;Oligodendrocytes: 28.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027521			Enhanced	Nucleoplasm,Nucleoli		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 21: Non-specific - Transcription"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Nucleoli"		"HPA027521: AB_2672314"	"unprognostic (1.07e-1)"	"unprognostic (4.10e-1)"	"unprognostic (1.95e-1)"	"unprognostic (3.31e-2)"	"unprognostic (1.38e-3)"	"unprognostic (4.60e-3)"	"prognostic unfavorable (7.81e-5)"	"unprognostic (1.00e-2)"	"unprognostic (1.16e-2)"	"unprognostic (1.04e-2)"	"unprognostic (2.49e-3)"	"unprognostic (9.01e-2)"	"prognostic unfavorable (6.79e-5)"	"unprognostic (4.45e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.10e-1)"	"prognostic favorable (1.68e-4)"	9.9	11.1	18.5	10.3	19.1	6.8	15.1	24.3	23.0	20.2	14.4	16.2	8.9	18.9	13.5	9.6	14.3	12.7	13.0	19.5	20.4	12.1	9.9	10.3	11.0	19.0	17.9	30.2	11.9	14.0	16.4	9.3	18.6	17.1	10.0	26.6	10.2	18.1	11.9	9.9	11.6	16.3	17.3	17.5	10.9	7.8	18.7	11.4	14.4	10.4	12.2	13.6	12.2	22.4	8.1	6.6	18.8	16.2	19.0	18.5	4.2	16.2	15.0	19.9	19.8	4.9	5.7	4.6	22.9	10.1	15.1	5.7	8.6	11.3	21.5	9.8	9.6	12.2	10.6	9.9	13.2	10.1	7.1	15.5	10.7	15.4	14.0	25.8	20.5	7.0	10.2	9.2	16.0	6.7	10.9	13.3	5.6	4.3	10.5	10.7	16.1	7.8	17.2	7.9	13.6	10.3	9.6	4.0	13.2	15.2	6.5	6.9	13.7	16.3	11.7	5.8	19.2	9.9	14.5	8.7	5.8	11.0	14.3	17.9	7.9	14.0	16.1	6.4	19.0	16.3	16.0	17.6	12.5	19.9	19.4	16.0	5.8	22.5	5.5	6.0	15.6	12.5	18.5	19.1	24.3	23.0	19.5	20.4	19.0	17.9	18.6	17.3	18.7	22.4	8.8	0.0	5.6	15.3	9.2	0.0	2.7	0.0	4.0	8.9	4.7	8.3	10.4	2.8	6.2	0.0	4.2	4.9	9.2	1.8	3.9	5.6	5.9	3.8	7.8	7.0	6.7	7.8	23.5	5.0	2.8	8.1	2.0	3.1	6.3	11.1	4.6	1.8	5.9	1.7	26.1	2.6	0.0	5.1	0.0	2.5	9.0	4.3	0.0	8.4	2.3	12.8	14.4	30.7	28.8	3.6	4.0	13.2	3.5	2.2	4.9	4.6	1.5	9.6	19.7	7.7	7.5	7.5	8.7	2.9	0.0	1.4	7.2	8.1	3.4	0.8
AL021997.2		ENSG00000276302	"Novel protein"		6	28267121-28281580	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Low tissue specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEK 293: 2.0;U-266/84: 2.0"															NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 58: Brain - Synaptic function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"					"unprognostic (6.64e-2)"	"unprognostic (2.11e-1)"		"unprognostic (6.30e-2)"	"unprognostic (1.32e-1)"	"unprognostic (5.60e-2)"	"unprognostic (3.45e-2)"	"unprognostic (4.93e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.12e-1)"	"unprognostic (8.51e-3)"	"unprognostic (1.21e-1)"	"unprognostic (3.74e-4)"	"unprognostic (7.03e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.86e-2)"	"unprognostic (2.05e-1)"	0.5	0.7	0.3	0.5	0.4	0.2	0.3	0.5	0.9	0.2	0.0	0.2	0.7	0.4	0.4	0.1	0.2	0.1	0.1	0.5	0.6	0.4	0.1	0.2	0.2	0.5	0.2	0.4	0.1	0.4	0.2	0.2	0.3	0.1	0.0	1.0	0.5	0.0	0.4	0.2	0.8	0.0	0.0	0.3	0.5	0.4	0.3	0.0	0.2	0.0	0.2	0.1	0.1	0.9	0.2	0.0	0.1	0.9	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.3	0.0	0.4	0.4	0.1	0.7	2.0	0.0	0.2	0.0	0.2	0.6	0.8	0.0	0.0	0.0	0.0	0.3	0.0	0.5	0.4	0.3	0.0	0.0	0.9	0.5	0.0	0.0	0.0	0.3	0.2	0.0	0.1	0.4	0.4	1.3	0.0	0.1	0.5	0.2	0.1	0.0	0.0	0.1	0.1	0.7	0.5	1.3	2.0	0.0	0.1	1.2	0.3	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.3	0.4	0.5	0.9	0.5	0.6	0.5	0.2	0.3	0.0	0.3	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PGBD1	"dJ874C20.4, HUCEP-4, SCAND4"	ENSG00000137338	"PiggyBac transposable element derived 1"	Q96JS3	6	28281572-28302549	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 33.4;Inhibitory neurons: 26.7;Oligodendrocyte precursor cells: 20.6;Oligodendrocytes: 22.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 1.7;plasmacytoid DC: 1.5"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA007267	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 58: Brain - Synaptic function"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm	Cytosol	"HPA007267: AB_1079601"	"unprognostic (2.26e-1)"	"unprognostic (2.43e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.96e-3)"	"unprognostic (1.28e-2)"	"unprognostic (8.81e-2)"	"prognostic unfavorable (3.77e-4)"	"unprognostic (1.27e-1)"	"prognostic unfavorable (1.71e-4)"	"unprognostic (5.38e-3)"	"prognostic favorable (6.79e-4)"	"unprognostic (7.32e-3)"	"prognostic unfavorable (4.97e-4)"	"unprognostic (1.16e-2)"	"unprognostic (1.61e-1)"	"unprognostic (5.23e-2)"	"unprognostic (2.68e-1)"	2.9	2.9	5.8	1.9	6.2	1.6	2.9	5.9	7.3	3.8	2.9	5.9	1.4	4.4	2.6	2.1	3.4	1.9	3.2	6.8	4.5	3.2	2.6	2.5	1.6	4.1	4.2	3.1	2.1	2.4	3.1	2.0	4.5	3.5	2.1	6.2	2.1	3.2	2.1	1.4	2.7	5.4	4.0	3.2	3.2	3.1	4.4	2.3	2.5	1.6	1.6	3.3	2.8	6.7	6.4	3.5	10.9	15.5	8.6	6.1	3.6	8.2	5.6	10.2	11.5	3.9	2.6	4.2	5.1	5.7	11.6	2.8	11.9	6.7	13.2	4.7	6.8	7.8	6.9	4.9	4.0	9.7	0.9	5.0	3.1	10.1	3.5	5.8	12.7	8.1	10.2	0.5	11.5	2.0	8.2	12.1	4.1	0.1	6.9	14.0	13.9	0.1	5.1	3.4	7.5	14.3	5.6	1.0	6.5	10.8	3.1	5.9	9.1	15.2	10.2	1.0	13.2	4.0	4.3	5.5	3.4	5.5	7.3	1.7	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.4	0.2	0.3	0.0	0.1	0.0	0.5	0.0	1.5	0.1	0.1	5.8	6.2	5.9	7.3	6.8	4.5	4.1	4.2	4.5	4.0	4.4	6.7	6.1	6.4	1.1	12.7	1.4	0.3	3.0	0.7	1.8	6.2	2.3	2.9	7.5	0.0	0.2	0.0	2.1	0.8	3.6	0.5	0.0	1.1	1.4	1.1	4.4	4.6	1.2	5.2	33.4	2.5	3.7	4.1	0.5	1.0	3.8	4.7	3.6	0.2	1.7	5.0	26.7	0.7	2.0	4.0	1.4	1.0	1.8	1.2	3.6	7.5	2.1	4.4	0.0	20.6	22.3	1.1	0.3	3.4	1.5	0.8	0.6	3.9	4.2	4.4	0.0	6.2	4.3	5.0	9.7	1.8	0.3	0.4	1.3	3.1	1.1	0.5
ZSCAN31	"ZNF310P, ZNF323"	ENSG00000235109	"Zinc finger and SCAN domain containing 31"	Q96LW9	6	28324693-28356271	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 138.5;Late spermatids: 65.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	10	"basophil: 17.6"	"Lineage enriched"	"Detected in many"	10	"granulocytes: 17.6"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 29.5;EFO-21: 40.1;TIME: 31.0;U-2 OS: 47.6"					"Low region specificity"	"Detected in all"			HPA007124	Approved		Approved	Nucleoplasm,Cytosol		NA	Yes			"Cluster 18: Basophils - Vesicular transport"	"Cluster 21: Non-specific - Transcription"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Nucleoplasm	Cytosol	"HPA007124: AB_1080703"	"unprognostic (1.11e-1)"	"unprognostic (4.23e-2)"	"unprognostic (3.54e-3)"	"unprognostic (1.68e-1)"	"unprognostic (2.45e-3)"	"unprognostic (6.90e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.29e-2)"	"unprognostic (2.41e-2)"	"unprognostic (4.96e-2)"	"unprognostic (6.07e-2)"	"unprognostic (5.10e-2)"	"prognostic favorable (2.19e-5)"	"unprognostic (8.43e-3)"	"unprognostic (6.22e-2)"	"unprognostic (1.19e-1)"	"unprognostic (5.64e-2)"	5.3	3.4	10.5	2.5	12.9	4.7	13.0	24.1	18.3	8.1	4.4	9.9	4.1	19.2	9.5	11.3	7.9	18.7	7.9	15.5	8.7	6.2	5.6	10.7	2.5	14.0	10.8	19.7	7.2	4.4	6.2	3.0	14.6	8.3	6.1	8.2	6.4	9.3	9.6	13.4	4.4	12.6	11.7	2.7	16.9	20.9	12.7	4.6	13.5	8.0	4.1	5.7	6.3	21.2	2.0	2.7	4.1	19.1	0.7	0.9	6.0	0.9	1.2	0.9	0.8	2.5	29.5	0.5	40.1	1.4	5.9	6.2	2.1	1.8	0.6	3.6	1.7	6.5	16.0	4.5	1.7	14.0	8.3	0.7	16.2	1.1	1.7	1.9	28.0	5.4	7.7	4.9	4.3	2.9	2.4	3.4	1.3	1.4	12.1	6.2	3.7	3.7	2.8	2.5	13.6	3.7	26.3	16.6	3.9	3.0	8.4	4.7	31.0	6.1	47.6	1.2	2.2	2.1	3.3	0.5	0.7	6.7	1.4	17.6	0.3	0.6	1.3	0.2	1.2	1.2	1.1	1.0	0.3	1.0	0.8	1.2	0.2	1.3	0.3	1.8	0.2	0.3	10.5	12.9	24.1	18.3	15.5	8.7	14.0	10.8	14.6	11.7	12.7	21.2	7.0	28.9	3.3	15.7	0.5	0.8	2.4	7.5	14.8	8.9	3.3	2.8	7.6	2.8	11.6	3.7	0.0	1.9	1.8	4.9	7.9	2.9	138.5	6.6	1.5	7.4	6.0	0.8	27.9	8.1	0.9	4.1	10.2	5.8	2.5	2.2	1.8	4.8	0.7	1.7	11.7	2.5	16.2	0.8	1.2	65.0	3.7	0.7	1.8	4.7	0.7	7.2	1.0	4.0	18.5	4.8	2.6	5.3	2.0	1.4	1.2	8.1	3.9	5.9	6.6	2.7	3.4	11.2	4.5	6.8	2.3	0.8	1.1	2.3	3.3	1.5
ZKSCAN3	"ZF47, Zfp47, ZNF306, ZNF309, ZSCAN35"	ENSG00000189298	"Zinc finger with KRAB and SCAN domains 3"	Q9BRR0	6	28349947-28369172	"Predicted intracellular proteins, Transcription factors"	"Autophagy, Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 8.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"											"HPA009637, HPA060116"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 43: Cardiomyocytes - Nuclear processes"	Nucleoplasm		"HPA009637: AB_2668244, HPA060116: AB_2732641"	"unprognostic (2.71e-2)"	"unprognostic (1.94e-1)"	"unprognostic (8.12e-2)"	"unprognostic (2.67e-1)"	"prognostic favorable (4.93e-4)"	"unprognostic (6.42e-2)"	"unprognostic (4.63e-3)"	"unprognostic (2.50e-2)"	"unprognostic (8.65e-2)"	"unprognostic (4.37e-3)"	"unprognostic (7.09e-3)"	"unprognostic (1.29e-1)"	"unprognostic (8.20e-2)"	"unprognostic (2.73e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.41e-2)"	"unprognostic (3.10e-3)"	2.2	2.6	1.5	2.1	1.7	1.1	3.9	3.0	2.3	3.9	2.5	3.4	2.2	3.5	4.5	2.4	3.6	1.9	2.4	1.8	1.6	3.3	2.8	3.1	3.0	1.7	1.6	5.6	2.3	4.7	2.6	4.0	1.8	4.1	3.9	3.8	2.4	4.3	2.5	3.8	2.3	4.7	1.3	3.4	4.1	2.4	1.9	4.3	4.3	2.5	3.9	2.8	2.7	2.6	3.0	1.8	6.9	12.4	6.2	4.3	2.5	2.6	2.8	4.4	5.8	2.4	1.7	4.6	6.0	2.8	4.7	4.1	7.6	3.4	4.4	4.3	3.2	6.1	4.9	3.9	4.3	6.0	1.9	3.8	3.0	4.8	4.1	5.2	7.0	5.8	15.7	2.9	5.3	0.9	3.1	5.9	3.1	1.7	1.8	8.7	5.4	6.7	4.6	2.1	5.5	6.1	4.6	2.4	4.1	8.9	3.5	6.1	4.2	4.6	3.0	3.0	3.4	3.8	6.2	4.2	1.5	7.9	3.2	1.9	1.2	5.1	2.2	2.1	2.3	2.2	1.5	1.7	1.7	2.1	1.4	2.3	1.4	1.6	1.3	2.0	2.2	1.1	1.5	1.7	3.0	2.3	1.8	1.6	1.7	1.6	1.8	1.3	1.9	2.6	1.7	0.0	3.4	4.9	1.2	0.5	0.5	0.8	1.2	1.5	1.9	1.8	2.1	0.0	0.5	3.7	8.4	2.6	0.8	1.0	0.0	1.3	0.6	1.3	2.3	3.0	0.0	3.8	6.6	1.0	1.9	1.7	0.5	1.4	2.5	3.5	3.9	2.3	2.0	0.0	7.2	1.5	4.1	3.8	1.0	2.9	2.8	1.1	0.0	1.9	2.7	2.4	2.1	5.0	4.6	1.6	0.5	1.5	0.7	0.6	1.7	1.9	3.5	2.3	0.0	2.1	1.8	0.9	1.1	1.8	0.3	1.0	2.0	2.7	2.6	0.4
ZSCAN12	"dJ29K1.2, KIAA0426, ZFP96, ZNF29K1, ZNF305, ZNF96"	ENSG00000158691	"Zinc finger and SCAN domain containing 12"	O43309	6	28378955-28399734	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 31.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006637, HPA007018"	Approved		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 34: Non-specific - Transcription"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm	"Nuclear bodies, Cytosol"	"HPA006637: AB_1080646, HPA007018: "	"unprognostic (1.44e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.22e-1)"	"unprognostic (8.35e-4)"	"unprognostic (1.51e-2)"	"unprognostic (9.99e-2)"	"unprognostic (1.00e-3)"	"unprognostic (4.73e-2)"	"unprognostic (9.96e-2)"	"unprognostic (1.91e-2)"	"unprognostic (2.35e-1)"	"unprognostic (4.44e-2)"	"unprognostic (1.71e-1)"	"unprognostic (6.25e-3)"	"unprognostic (2.69e-1)"	"unprognostic (1.06e-1)"	"unprognostic (8.71e-2)"	2.4	2.3	1.8	2.6	2.0	2.2	5.6	3.6	2.5	3.6	1.6	2.9	2.5	4.3	3.6	1.8	3.0	2.3	2.4	1.8	2.2	2.9	1.6	2.9	4.7	1.7	2.1	5.5	3.2	4.0	2.0	3.6	1.6	4.3	2.9	6.8	3.1	3.7	0.9	1.8	2.7	3.6	1.6	3.9	2.9	4.1	2.2	5.1	5.1	1.7	4.1	3.1	2.9	2.0	5.5	1.8	8.1	0.1	4.1	3.2	5.7	3.7	5.1	5.5	7.6	1.2	2.0	5.3	6.8	2.6	2.8	2.4	0.0	4.6	5.6	0.0	6.6	7.6	5.6	3.8	3.8	2.7	1.8	4.2	4.3	5.5	9.9	6.0	1.5	0.0	11.4	1.1	3.5	0.6	0.0	6.1	5.1	0.5	0.9	9.2	7.3	1.4	4.1	3.5	9.8	10.0	1.9	4.3	6.4	8.0	1.7	6.7	1.5	2.2	4.6	1.7	3.0	3.1	3.4	1.0	1.9	0.7	3.4	2.4	0.7	1.5	1.5	0.4	1.4	1.8	1.1	1.8	1.0	2.7	1.8	1.6	0.2	1.8	0.8	0.9	0.9	0.8	1.8	2.0	3.6	2.5	1.8	2.2	1.7	2.1	1.6	1.6	2.2	2.0	2.1	6.4	5.1	4.6	4.0	0.4	1.1	0.9	0.6	6.1	2.6	2.5	3.2	1.5	6.5	0.0	4.2	1.5	3.6	0.3	1.9	1.7	31.8	0.6	2.4	1.9	1.2	2.1	6.9	2.6	1.0	2.7	1.5	0.9	1.3	5.5	3.3	1.0	1.0	6.7	7.0	1.2	0.0	1.3	1.1	9.7	1.8	1.1	1.8	1.0	1.8	4.9	2.1	10.1	6.2	1.3	0.3	3.4	2.4	1.5	1.5	1.2	0.6	6.0	6.6	1.7	2.4	12.6	3.9	1.2	0.3	0.5	1.5	4.2	2.1	0.7
ZSCAN23	"dJ29K1.3.1, ZNF390, ZNF453"	ENSG00000187987	"Zinc finger and SCAN domain containing 23"	Q3MJ62	6	28431930-28443502	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"Astrocytes: 13.7;Excitatory neurons: 20.2;Inhibitory neurons: 24.4;Oligodendrocyte precursor cells: 17.6;Oligodendrocytes: 10.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 1.5;SCLC-21H: 1.8"					"Low region specificity"	"Detected in all"			"HPA035959, HPA035960"	Uncertain					NA	NA				"Cluster 21: Non-specific - Transcription"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA035959: AB_10696647, HPA035960: AB_2674889"	"unprognostic (6.87e-2)"	"unprognostic (4.80e-3)"	"unprognostic (4.24e-1)"	"unprognostic (1.09e-3)"	"unprognostic (6.85e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.36e-1)"	"unprognostic (3.05e-1)"	"unprognostic (1.32e-2)"	"unprognostic (1.69e-1)"	"unprognostic (3.43e-1)"	"unprognostic (9.58e-2)"	"unprognostic (1.97e-3)"	"unprognostic (2.32e-3)"	"unprognostic (3.35e-1)"	"unprognostic (2.19e-2)"	"unprognostic (8.32e-3)"	0.1	0.3	0.2	0.1	0.3	0.0	0.7	0.8	0.2	0.4	0.3	0.2	0.1	0.8	1.2	0.1	0.4	0.3	0.2	0.1	0.1	0.2	0.0	0.2	0.2	0.1	0.1	1.1	0.3	0.7	0.3	0.3	0.1	0.8	0.3	1.3	0.6	0.6	0.0	0.1	0.2	0.4	0.0	0.3	0.1	0.5	0.1	0.2	0.8	0.1	0.2	0.2	0.2	0.2	0.1	0.0	1.5	0.0	0.7	1.4	0.2	0.4	0.1	0.4	0.7	0.0	0.0	0.0	0.2	0.2	0.2	0.1	0.6	0.4	0.5	0.0	1.0	0.0	0.0	0.1	0.2	0.4	0.0	0.5	0.3	0.3	0.5	0.8	0.1	0.2	0.6	0.0	0.3	0.0	0.0	0.4	0.7	0.0	0.3	0.3	0.4	0.0	0.2	0.5	1.8	1.1	0.0	0.4	0.0	1.1	0.0	0.1	0.0	1.0	0.8	0.3	0.0	0.0	0.2	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.8	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.2	0.5	0.0	0.0	13.7	0.2	0.0	0.2	0.2	1.2	2.1	0.2	0.1	0.4	0.0	0.0	0.0	4.2	0.3	0.0	0.1	0.0	0.2	4.8	0.3	0.8	0.3	1.8	0.0	20.2	0.6	0.1	0.3	0.0	0.1	0.0	2.3	0.0	0.0	0.0	0.0	24.4	0.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	5.6	0.0	0.6	0.0	17.6	10.0	0.2	0.1	0.0	0.3	0.1	0.0	0.1	0.0	2.3	0.0	0.5	0.7	1.9	0.6	0.1	0.0	0.1	0.1	1.1	0.1	0.0
GPX6	GPXP3	ENSG00000198704	"Glutathione peroxidase 6"	P59796	6	28503296-28528215	"Enzymes, Metabolic proteins, Predicted secreted proteins"		"Oxidoreductase, Peroxidase"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in single"	15	"epididymis: 3.3"	"Group enriched"	"Detected in some"	6	"Early spermatids: 3.3;Late spermatids: 2.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in some"	16	"basal ganglia: 23.8"	"Low region specificity"	"Detected in single"								"Secreted in male reproductive system"	NA	NA				"Cluster 68: Epididymis - Unknown function"		"Cluster 25: Spermatids - Spermatogenesis"																		"unprognostic (2.99e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GPX5		ENSG00000224586	"Glutathione peroxidase 5"	O75715	6	28525881-28534955	"Enzymes, Metabolic proteins, Predicted secreted proteins"		"Oxidoreductase, Peroxidase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"epididymis: 9.3"	"Group enriched"	"Detected in some"	46	"Early spermatids: 14.3;Late spermatids: 41.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																"Secreted in male reproductive system"	NA	NA				"Cluster 68: Epididymis - Unknown function"		"Cluster 25: Spermatids - Spermatogenesis"															"unprognostic (3.34e-2)"			"unprognostic (3.74e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	14.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	41.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ZBED9	"Buster4, FLJ31087, KIAA1925, SCAND3, ZFP38-L, ZNF305P2, ZNF452"	ENSG00000232040	"Zinc finger BED-type containing 9"	Q6R2W3	6	28570535-28616212	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"testis: 8.7"	"Group enriched"	"Detected in many"	4	"Early spermatids: 27.2;Spermatocytes: 24.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 4.7;hTCEpi: 4.4;K-562: 8.3;U-266/84: 3.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007246	Uncertain		Approved	"Nucleoplasm,Nucleoli,Golgi apparatus"		NA	NA				"Cluster 68: Epididymis - Unknown function"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoli	"Nucleoplasm, Golgi apparatus"	"HPA007246: AB_1080727"	"unprognostic (1.01e-1)"	"unprognostic (5.16e-5)"	"unprognostic (1.88e-1)"	"unprognostic (1.27e-4)"	"unprognostic (3.96e-2)"	"unprognostic (9.46e-3)"	"unprognostic (3.40e-1)"	"unprognostic (2.73e-2)"	"unprognostic (4.24e-2)"	"unprognostic (2.34e-3)"	"unprognostic (8.21e-3)"	"unprognostic (4.31e-1)"	"unprognostic (2.42e-2)"	"unprognostic (1.14e-2)"	"unprognostic (7.66e-3)"	"unprognostic (3.92e-2)"	"unprognostic (1.59e-1)"	0.1	0.5	0.8	0.1	0.6	0.1	0.9	1.6	0.8	0.8	0.1	0.4	0.2	0.6	3.1	0.2	1.2	0.2	0.3	0.6	0.6	0.8	1.2	0.5	0.1	0.2	0.3	1.6	0.8	0.9	0.7	0.6	0.3	1.4	0.5	1.5	0.7	1.9	0.0	0.2	0.2	0.3	0.1	0.0	0.3	8.7	0.4	0.4	1.7	0.0	0.1	0.2	0.3	0.4	1.1	1.2	1.2	0.0	0.0	0.0	1.3	0.2	0.0	0.2	0.7	0.0	0.7	0.0	4.7	0.1	2.4	0.6	0.0	1.3	0.2	0.0	3.0	0.2	0.8	1.1	0.7	0.0	0.0	0.6	4.4	0.1	2.1	0.7	0.0	0.0	8.3	0.0	0.0	0.9	0.0	0.0	1.1	0.0	0.6	0.4	0.5	0.0	1.3	1.3	1.2	2.8	0.0	1.2	0.0	1.6	0.0	0.3	0.0	0.0	1.3	0.0	0.8	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.8	0.6	1.6	0.8	0.6	0.6	0.2	0.3	0.3	0.1	0.4	0.4	0.0	0.0	3.2	0.3	0.2	0.0	0.9	0.0	2.2	1.6	1.5	0.8	1.9	2.8	0.6	0.0	2.1	2.8	0.0	1.0	1.9	1.7	27.2	1.1	0.3	0.3	1.2	0.0	5.2	1.3	1.5	0.3	0.0	1.1	0.0	1.7	0.0	1.9	0.4	0.0	5.7	1.4	0.0	0.0	0.0	5.4	2.5	0.1	0.0	0.0	0.1	1.1	0.0	1.0	0.2	0.4	0.8	0.0	0.0	0.9	0.5	0.6	0.7	1.5	0.0	0.2	0.2	24.9	3.5	1.3	0.0	1.0	0.0	0.2	1.2	0.6
TRIM27	"RFP, RNF76"	ENSG00000204713	"Tripartite motif containing 27"	P14373	6	28903002-28923988	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"Transcription, Transcription regulation, Transport, Ubl conjugation pathway"	"DNA-binding, Repressor, Transferase"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 49.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048684, HPA053408"	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoli	Nucleoplasm	"HPA048684: AB_2680493, HPA053408: AB_2682139"	"unprognostic (1.57e-1)"	"unprognostic (1.48e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.14e-2)"	"unprognostic (1.70e-2)"	"unprognostic (2.56e-1)"	"unprognostic (2.00e-3)"	"unprognostic (1.17e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.12e-3)"	"unprognostic (4.76e-3)"	"unprognostic (1.16e-2)"	"prognostic unfavorable (3.50e-6)"	"unprognostic (1.27e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.47e-1)"	"prognostic favorable (2.71e-4)"	23.8	28.1	1.8	7.2	1.7	1.1	23.3	1.1	2.6	33.0	2.2	23.0	8.7	24.5	0.0	20.5	31.0	0.5	24.3	1.6	1.3	32.7	59.5	26.8	2.2	2.2	2.1	30.8	53.0	0.6	33.8	4.5	1.8	35.1	0.6	0.1	25.8	6.5	21.2	17.6	26.8	2.3	1.5	45.8	27.3	14.4	2.0	0.9	26.3	0.0	1.0	28.7	22.6	2.0	2.4	8.2	1.2	21.7	2.8	6.2	0.3	16.1	0.8	5.1	6.2	6.1	1.7	1.6	1.1	4.8	1.3	17.5	4.0	9.2	0.5	1.3	2.6	20.3	2.5	9.3	4.3	2.0	5.7	0.1	1.0	4.1	1.3	0.6	4.5	5.8	2.1	12.1	1.3	4.9	11.1	0.9	0.0	3.4	13.5	20.1	4.6	49.7	3.9	2.3	4.9	18.7	19.9	11.6	4.1	0.6	11.6	12.2	13.1	6.3	9.3	14.7	5.1	31.7	2.7	17.9	6.8	24.8	20.0	5.2	4.4	2.5	7.0	12.5	11.3	7.0	10.6	5.5	8.5	1.8	4.1	7.6	2.7	6.4	7.0	5.6	5.2	9.9	1.8	1.7	1.1	2.6	1.6	1.3	2.2	2.1	1.8	1.5	2.0	2.0	21.4	16.0	24.8	11.8	32.2	28.4	41.9	27.4	33.6	11.7	32.2	24.6	18.3	24.3	24.0	29.5	16.7	46.4	25.4	15.9	21.5	39.5	12.9	27.1	27.0	32.0	27.6	24.6	13.5	43.4	55.5	25.5	26.5	27.2	21.5	36.9	27.8	42.1	41.1	8.4	13.4	38.5	26.4	28.3	23.5	6.8	23.9	29.0	8.8	16.9	46.5	10.4	29.9	19.1	19.7	48.9	18.7	18.4	51.2	53.3	19.3	27.6	23.9	13.6	19.7	14.8	31.0	8.0	16.1	25.8	19.6	45.6	28.9	43.7	28.3	30.9
ZNF311		ENSG00000197935	"Zinc finger protein 311"	Q5JNZ3	6	28994785-29005316	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"testis: 2.5"	"Cell type enhanced"	"Detected in some"		"Melanocytes: 3.6;Spermatocytes: 6.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HBEC3-KT: 1.0;HEL: 1.4;K-562: 2.0;SK-MEL-30: 1.1;WM-115: 1.0"					"Low region specificity"	"Detected in many"			HPA050541	Approved					NA	NA				"Cluster 71: Testis - DNA repair"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"			"HPA050541: AB_2681164"	"unprognostic (1.62e-1)"	"unprognostic (9.22e-2)"	"unprognostic (1.23e-1)"	"unprognostic (7.03e-4)"	"unprognostic (1.79e-1)"	"unprognostic (3.14e-1)"	"unprognostic (1.68e-1)"	"unprognostic (8.41e-2)"	"unprognostic (4.24e-3)"	"unprognostic (4.00e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.57e-1)"	"unprognostic (3.05e-4)"	"unprognostic (9.70e-2)"	"unprognostic (1.82e-1)"	"unprognostic (3.11e-1)"	"unprognostic (1.14e-1)"	0.5	0.5	0.0	0.1	0.0	0.0	0.8	0.0	0.1	0.9	0.0	0.7	0.0	0.7	0.7	0.6	0.9	0.2	0.3	0.1	0.0	1.0	0.7	0.4	0.1	0.0	0.2	1.1	0.6	0.0	0.3	0.0	0.0	1.1	0.2	0.0	0.6	0.1	0.1	0.6	0.5	0.0	0.0	0.6	0.5	2.5	0.0	0.0	1.2	0.0	0.1	0.7	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.8	0.0	0.0	0.2	0.0	1.0	0.0	0.0	0.0	1.4	0.3	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.4	0.0	0.0	2.0	0.3	0.0	0.6	0.0	0.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.5	0.0	0.0	1.3	0.0	0.4	0.6	0.5	1.2	0.7	1.1	1.0	0.4	1.5	0.1	1.8	0.0	0.4	0.0	0.7	1.9	0.8	0.1	1.1	1.0	0.6	0.0	1.3	0.2	0.7	0.3	0.5	0.0	0.5	0.0	1.8	2.5	0.8	0.5	0.0	0.3	1.7	0.0	0.8	0.0	1.3	0.6	0.2	3.6	1.0	0.8	1.4	0.0	0.0	1.8	1.0	1.7	0.0	0.0	0.6	0.6	0.1	0.1	0.8	0.0	0.4	0.6	6.5	2.8	0.6	0.1	0.0	0.1	0.7	1.1	0.3
OR2W1	hs6M1-15	ENSG00000204704	"Olfactory receptor family 2 subfamily W member 1"	Q9Y3N9	6	29044213-29045240	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"									NA	NA																											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR2B3	"OR2B3P, OR6-4"	ENSG00000204703	"Olfactory receptor family 2 subfamily B member 3"	O76000	6	29086208-29087313	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"No human protein/transcript evidence"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"									NA	NA																											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR2J1	"dJ80I19.2, hs6M1-4, OR2J1P, OR6-5"	ENSG00000204702	"Olfactory receptor family 2 subfamily J member 1"	Q9GZK6	6	29099657-29102701	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"No human protein/transcript evidence"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																	NA	NA																											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR2J3	OR6-6	ENSG00000204701	"Olfactory receptor family 2 subfamily J member 3"	O76001	6	29108058-29114770	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																	NA	NA																											0.0	0.0	0.2	0.0	0.2	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.9	0.9	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.1	0.2	0.1	0.9	0.9	0.6	0.5	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR2J2	"dJ80I19.4, hs6M1-6, OR6-8"	ENSG00000204700	"Olfactory receptor family 2 subfamily J member 2"	O76002	6	29170907-29175811	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in single"		"brain: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																	NA	NA				"Cluster 73: Brain - Neuropeptide signaling"		"Cluster 67: Proximal tubular cells - Tubular reabsorption"																					0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	1.0	1.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.2	0.2	1.0	1.1	0.6	0.6	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR14J1	"hs6M1-28, OR5U1"	ENSG00000204695	"Olfactory receptor family 14 subfamily J member 1"	Q9UGF5	6	29301701-29313017	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"brain: 5.2;retina: 2.0"	"Group enriched"	"Detected in some"	4	"Club cells: 1.3;granulocytes: 5.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.1"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA			"Cluster 42: Non-specific - Transcription"	"Cluster 6: Brain - Smell perception"	"Cluster 20: HeLa - Mitochondria"	"Cluster 60: Granulocytes - Receptor signaling"																					0.2	0.2	1.1	0.5	2.1	1.2	0.2	5.2	4.6	0.1	0.0	0.2	0.3	0.3	0.5	0.2	0.1	0.3	0.2	1.4	0.1	0.2	0.6	0.2	0.4	0.4	1.2	0.3	0.1	0.0	0.0	0.3	0.6	0.2	0.2	2.0	0.4	0.1	0.5	0.8	0.4	0.1	0.1	0.5	0.3	0.6	0.9	0.1	0.3	0.0	0.2	0.1	0.0	4.6	0.5	0.3	0.4	0.5	0.1	0.1	0.3	0.4	0.0	0.0	0.0	0.4	0.5	0.5	0.6	0.1	0.3	0.3	0.0	0.0	0.0	0.6	0.1	0.5	1.2	0.5	0.0	0.4	0.4	0.0	0.0	0.1	0.1	0.2	0.0	0.4	0.4	1.5	0.1	0.3	0.3	0.6	0.7	0.1	0.2	0.3	0.4	0.3	0.1	0.7	0.4	0.5	0.5	0.3	0.2	0.5	0.5	0.4	0.7	0.6	0.5	0.9	0.4	0.9	0.5	0.3	0.4	0.3	0.5	1.1	0.1	0.1	0.2	0.1	0.1	0.2	0.1	0.1	0.0	0.3	0.1	0.2	0.7	0.2	0.2	0.2	0.1	0.0	1.1	2.1	5.2	4.6	1.4	0.1	0.4	1.2	0.6	0.1	0.9	4.6	0.1	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0
OR5V1	hs6M1-21	ENSG00000243729	"Olfactory receptor family 5 subfamily V member 1"	Q9UGF6	6	29353749-29431967	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	28	"Early spermatids: 17.3;Late spermatids: 16.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	13	"olfactory bulb: 1.3"	"Not detected"	"Not detected"			HPA046707	Uncertain					NA	NA						"Cluster 23: Spermatids - Flagellum & Golgi organization"			"HPA046707: AB_2679763"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.7	0.8	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.7	0.8	0.5	0.4	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	16.8	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR12D3	hs6M1-27	ENSG00000112462	"Olfactory receptor family 12 subfamily D member 3"	Q9UGF7	6	29373423-29375291	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA																											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR12D2	hs6M1-20	ENSG00000280236	"Olfactory receptor family 12 subfamily D member 2"	P58182	6	29395631-29398008	"G-protein coupled receptors, Plasma proteins, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"									NA	NA																											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.5	0.5	0.0	0.0	0.0		0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.5	0.5	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR11A1	"hs6M1-18, OR11A2"	ENSG00000204694	"Olfactory receptor family 11 subfamily A member 1"	Q9GZK7	6	29425504-29457071	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	93	"Early spermatids: 33.7;Late spermatids: 41.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA						"Cluster 34: Spermatids - Unknown function"																					0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.1	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.3	0.3	0.0	0.5	0.5	0.4	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	33.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	41.2	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR10C1	"hs6M1-17, OR10C1P, OR10C2"	ENSG00000206474	"Olfactory receptor family 10 subfamily C member 1"	Q96KK4	6	29439306-29440977	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							HPA049336	Uncertain					NA	NA									"HPA049336: AB_2680718"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR2H1	"OR2H6, OR2H8, OR6-2"	ENSG00000204688	"Olfactory receptor family 2 subfamily H member 1"	Q9GZK4	6	29457181-29464328	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	127	"testis: 12.6"	"Cell type enriched"	"Detected in some"	4	"Early spermatids: 65.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in many"									NA	NA				"Cluster 74: Testis - Spermatogenesis"		"Cluster 29: Early spermatids - Spermatogenesis"																					0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	65.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MAS1L	"dJ994E9.2, MAS-L, MRG"	ENSG00000204687	"MAS1 proto-oncogene like, G protein-coupled receptor"	P35410	6	29486697-29487956	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"cervix: 3.1;epididymis: 1.9"	"Cell type enriched"	"Detected in single"	62	"granulocytes: 6.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA017983	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA				"Cluster 12: Smooth muscle tissue - Mixed function"		"Cluster 60: Granulocytes - Receptor signaling"	"Plasma membrane, Cytosol"	Nucleoplasm	"HPA017983: AB_1849332"	"unprognostic (3.66e-2)"										"unprognostic (2.51e-1)"	"unprognostic (2.30e-2)"	"unprognostic (5.22e-2)"	"unprognostic (1.65e-1)"				0.4	0.0	0.0	0.1	0.0	0.0	1.2	0.0	0.0	3.1	0.0	0.7	0.3	0.7	1.9	1.1	0.2	0.7	0.2	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.3	0.2	0.0	0.3	0.7	0.6	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.6	0.3	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR2I1P	"HS6M1-14, OR2I1, OR2I2, OR2I3P, OR2I4P"	ENSG00000237988	"Olfactory receptor family 2 subfamily I member 1 pseudogene"		6	29550407-29557721	"Predicted membrane proteins"				"No human protein/transcript evidence"	"No human protein/transcript evidence"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 3.2;Ductal cells: 1.0;granulocytes: 1.3;monocytes: 1.0"	"Cancer enhanced"	"Detected in all"		"liver cancer: 71.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA						"Cluster 3: Monocytes - Immune response regulation"				"unprognostic (7.45e-3)"	"unprognostic (1.69e-2)"	"unprognostic (6.00e-2)"	"prognostic favorable (3.29e-4)"	"unprognostic (1.60e-2)"	"unprognostic (1.07e-3)"	"unprognostic (3.29e-1)"	"unprognostic (2.23e-1)"	"unprognostic (5.34e-3)"	"prognostic favorable (5.58e-4)"	"unprognostic (1.32e-1)"	"unprognostic (3.17e-1)"	"prognostic unfavorable (4.00e-6)"	"unprognostic (8.46e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.32e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	1.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0
UBD	FAT10	ENSG00000213886	"Ubiquitin D"	O15205	6	29555515-29559732	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"lymphoid tissue: 151.3"	"Group enriched"	"Detected in many"	7	"Ductal cells: 534.8;Exocrine glandular cells: 273.8;monocytes: 151.9;Pancreatic endocrine cells: 510.6"	"Cancer enhanced"	"Detected in all"		"liver cancer: 75.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	16	"Hep G2: 63.9;RT4: 52.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA043710			Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 1: Pancreatic cells - Digestion"	Nucleoplasm	"Nucleoli fibrillar center"	"HPA043710: AB_2756303"	"unprognostic (2.99e-3)"	"unprognostic (4.16e-2)"	"unprognostic (6.37e-2)"	"unprognostic (2.61e-2)"	"unprognostic (3.93e-2)"	"unprognostic (3.53e-3)"	"unprognostic (1.60e-1)"	"unprognostic (9.47e-2)"	"unprognostic (1.44e-2)"	"prognostic favorable (7.35e-4)"	"unprognostic (1.28e-2)"	"unprognostic (6.43e-2)"	"prognostic unfavorable (2.40e-5)"	"unprognostic (4.04e-2)"	"unprognostic (6.02e-2)"	"unprognostic (8.40e-2)"	"unprognostic (1.21e-2)"	4.2	0.4	0.3	35.6	0.4	0.0	8.6	0.3	0.7	1.7	0.3	13.3	4.2	1.9	1.2	8.3	4.7	0.9	0.6	0.3	0.3	23.2	25.4	10.9	87.5	0.4	0.3	1.2	27.3	1.7	1.4	0.0	0.3	11.9	19.0	0.0	14.6	1.3	0.4	1.8	31.1	1.2	0.3	22.9	27.1	0.8	0.3	90.2	3.0	0.1	151.3	25.8	1.7	0.3	0.7	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.5	0.1	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	63.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	52.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.2	0.9	2.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.3	0.7	0.3	0.3	0.4	0.3	0.3	0.3	0.3	0.3	0.2	3.2	3.1	0.0	0.7	0.1	0.1	2.3	16.5	0.0	1.9	1.9	0.0	21.5	13.3	0.0	0.0	0.0	0.1	6.9	1.9	534.8	0.0	0.3	0.2	7.1	3.6	0.0	0.0	273.8	0.0	2.2	13.3	0.2	0.0	0.0	0.7	0.3	0.1	0.0	0.0	5.2	6.1	0.3	0.0	0.0	0.0	1.2	0.0	0.0	151.9	0.0	0.0	0.0	0.0	510.6	8.3	0.0	0.0	0.5	49.1	1.1	9.7	0.0	0.0	0.0	3.4	0.0	0.0	2.2	0.0	0.0	0.2	0.0	11.1	0.1
GABBR1	"GPRC3A, hGB1a"	ENSG00000204681	"Gamma-aminobutyric acid type B receptor subunit 1"	Q9UBS5	6	29555629-29633976	"FDA approved drug targets, G-protein coupled receptors, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 150.5;Excitatory neurons: 58.7;Inhibitory neurons: 68.1;Oligodendrocyte precursor cells: 72.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 6.3;HEL: 6.4;U-2 OS: 6.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050483, HPA058459"	Uncertain		Approved	Centrosome	"Intracellular and membrane"	NA	NA				"Cluster 72: Non-specific - Transcription"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 64: Astrocytes - Nervous system maintenance"	Centrosome		"HPA050483: AB_2681140, HPA058459: "	"unprognostic (1.01e-1)"	"unprognostic (2.07e-3)"	"unprognostic (3.22e-3)"	"unprognostic (2.93e-3)"	"unprognostic (3.37e-1)"	"unprognostic (2.65e-1)"	"unprognostic (7.95e-4)"	"unprognostic (5.44e-2)"	"unprognostic (4.24e-2)"	"unprognostic (1.14e-1)"	"prognostic favorable (2.54e-5)"	"unprognostic (1.23e-3)"	"prognostic unfavorable (3.77e-10)"	"unprognostic (3.82e-2)"	"unprognostic (2.26e-1)"	"unprognostic (3.87e-2)"	"unprognostic (2.55e-2)"	20.4	18.0	10.2	2.4	10.9	2.8	20.7	6.4	9.6	45.3	0.0	33.6	0.2	42.8	0.0	14.5	39.0	0.9	28.4	3.9	0.0	16.9	4.7	20.6	2.0	0.3	2.0	40.7	10.4	1.1	30.8	1.3	0.0	34.3	0.5	0.5	16.3	4.2	6.1	19.2	20.2	1.4	0.0	39.0	18.5	7.9	6.1	0.2	22.8	0.0	1.2	25.3	31.6	0.0	2.4	0.0	1.5	6.3	0.7	1.6	1.6	1.6	0.7	1.4	0.4	1.9	0.1	1.1	1.5	0.0	0.3	2.0	0.7	0.0	0.0	5.9	2.6	6.4	3.7	0.0	0.9	0.2	3.1	0.0	0.0	1.2	0.0	1.8	0.8	3.3	5.5	0.0	0.2	1.5	0.6	0.1	0.4	0.0	0.9	2.9	0.6	0.1	0.2	0.0	0.4	1.0	0.4	0.0	2.6	0.4	1.2	0.9	3.6	2.5	6.2	0.2	3.1	5.4	0.6	0.0	1.4	2.8	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	10.2	10.9	6.4	9.6	3.9	0.0	0.3	2.0	0.0	0.0	6.1	0.0	16.8	12.8	20.2	150.5	10.6	11.9	6.2	4.7	10.2	30.6	13.4	17.7	13.9	1.5	10.7	3.7	0.0	0.3	5.7	0.8	0.0	1.4	4.7	1.3	30.6	17.0	7.2	5.7	58.7	0.9	0.2	16.0	1.5	1.9	7.6	14.6	22.5	0.3	1.1	23.5	68.1	4.7	2.0	5.9	18.3	3.1	15.2	14.4	0.0	19.7	11.0	9.8	0.0	72.4	16.3	1.7	1.6	25.6	0.7	7.6	0.1	1.0	1.1	17.3	13.1	12.5	18.8	1.2	2.7	5.3	11.1	0.5	5.9	6.7	1.5	2.8
OR2H2	hs6M1-12	ENSG00000204657	"Olfactory receptor family 2 subfamily H member 2"	O95918	6	29585121-29590500	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"brain: 1.8;epididymis: 4.8;testis: 2.2"	"Cell type enriched"	"Detected in some"	5	"Early spermatids: 15.2"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"basal ganglia: 1.8"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"													NA	NA				"Cluster 68: Epididymis - Unknown function"		"Cluster 29: Early spermatids - Spermatogenesis"				"unprognostic (2.95e-1)"	"unprognostic (3.76e-1)"			"unprognostic (2.33e-2)"			"unprognostic (2.42e-1)"	"unprognostic (2.34e-1)"	"unprognostic (3.11e-1)"	"unprognostic (2.76e-1)"	"unprognostic (3.20e-1)"		"unprognostic (1.34e-1)"	"unprognostic (2.04e-1)"			0.1	0.0	0.5	0.1	1.8	0.7	0.0	0.8	0.6	0.3	0.0	0.1	0.0	0.1	4.8	0.1	0.2	0.0	0.3	0.5	0.0	0.0	0.0	0.1	0.2	0.0	0.2	0.3	0.0	0.0	0.5	0.0	0.0	0.3	0.0	1.5	0.0	0.3	0.0	0.1	0.1	0.0	0.0	0.1	0.1	2.2	0.2	0.0	0.1	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.8	0.8	0.6	0.5	0.0	0.0	0.2	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MOG	"BTN6, BTNL11"	ENSG00000204655	"Myelin oligodendrocyte glycoprotein"	Q16653	6	29657002-29672372	"Disease related genes, Human disease related genes, Predicted membrane proteins"	"Cell adhesion, Host-virus interaction"	"Host cell receptor for virus entry, Receptor"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	28	"brain: 73.8"	"Cell type enriched"	"Detected in some"	49	"Oligodendrocytes: 472.3"	"Cancer enriched"	"Detected in single"	45	"glioma: 15.1"	"Region enriched"	"Detected in all"	4	"cerebral cortex: 73.8"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in all"		"white matter: 1396.5"	"Low region specificity"	"Detected in all"			HPA021873	Enhanced					NA	NA				"Cluster 10: Brain - Neuronal signaling"		"Cluster 42: Oligodendrocytes - Myelin sheath organization"			"HPA021873: AB_1854055"	"unprognostic (1.33e-1)"				"unprognostic (1.32e-1)"				"unprognostic (1.03e-1)"	"unprognostic (1.05e-2)"		"unprognostic (7.87e-2)"	"unprognostic (3.00e-4)"	"unprognostic (4.89e-2)"	"unprognostic (4.90e-2)"			0.0	0.0	4.9	0.0	11.0	0.0	0.0	8.6	73.8	0.0	2.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.6	6.8	8.4	0.1	0.0	0.0	0.0	9.9	8.4	0.1	0.0	0.0	0.3	0.0	10.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	8.1	0.0	0.0	0.0	8.4	0.0	0.0	0.0	0.0	0.0	0.0	17.8	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	11.0	8.6	73.8	6.8	8.4	9.9	8.4	10.1	8.1	8.4	17.8	0.0	0.0	1.1	0.7	0.1	1.0	0.4	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.8	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.8	0.0	0.0	0.3	0.7	0.0	0.0	0.2	0.0	1.0	0.1	0.0	0.0	9.5	472.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.8	0.2	0.1	0.1	0.0	0.9	0.0	0.3	0.0	0.0	0.3
ZFP57	"bA145L22, bA145L22.2, C6orf40, ZNF698"	ENSG00000204644	"ZFP57 zinc finger protein"	Q9NU63	6	29672483-29681155	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"	"Diabetes mellitus, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"heart muscle: 8.9"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 4.8;Erythroid cells: 4.6;Extravillous trophoblasts: 4.4;Ionocytes: 8.2;Late spermatids: 5.9;Pancreatic endocrine cells: 4.0;Spermatogonia: 3.6"	"Cancer enriched"	"Detected in many"	10	"testis cancer: 18.1"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in many"	5	"basophil: 11.1"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 11.1"	"Group enriched"	"Detected in some"	13	"BEWO: 40.3;SuSa: 12.8"	"Low region specificity"	"Detected in all"													NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 31: Spermatids - Spermatogenesis"				"unprognostic (1.35e-1)"	"unprognostic (1.74e-1)"	"unprognostic (5.02e-2)"	"unprognostic (6.40e-2)"	"unprognostic (1.58e-1)"	"unprognostic (4.72e-3)"	"unprognostic (4.65e-2)"	"unprognostic (1.38e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.19e-4)"	"prognostic favorable (1.95e-4)"	"unprognostic (1.33e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.29e-2)"	"unprognostic (8.56e-2)"	"unprognostic (7.45e-2)"	"unprognostic (6.11e-2)"	0.3	0.3	0.2	0.0	0.3	1.8	1.6	0.2	0.3	0.1	0.0	0.1	0.0	0.2	0.0	0.3	0.4	0.2	8.9	0.0	0.0	0.2	0.0	0.6	0.9	0.5	0.2	0.0	0.0	0.0	0.1	1.4	0.3	0.5	0.2	0.0	0.7	2.1	0.0	0.8	0.4	0.2	0.2	1.0	0.0	0.7	0.2	0.3	0.1	0.0	0.0	0.1	0.2	0.8	0.0	0.0	0.0	0.0	0.0	0.0	40.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	11.1	1.4	0.0	1.7	0.9	0.7	0.8	1.0	1.1	2.1	0.2	0.3	1.0	0.0	1.3	0.3	0.1	1.5	1.2	0.2	0.3	0.2	0.3	0.0	0.0	0.5	0.2	0.3	0.2	0.2	0.8	1.1	0.0	0.6	0.0	0.7	0.3	0.2	0.4	2.8	0.0	0.6	1.8	4.8	0.0	0.2	0.0	0.0	0.2	0.7	0.0	0.0	0.9	2.1	0.0	0.0	0.1	0.0	4.6	0.0	1.1	4.4	0.6	1.1	0.0	2.5	2.0	0.0	0.0	1.2	0.0	0.1	0.0	8.2	0.0	1.3	5.9	0.0	1.3	0.0	0.0	0.6	0.0	0.0	0.0	2.1	4.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.8	3.6	0.3	0.1	0.3	1.7	0.2	0.1	0.1
HLA-F		ENSG00000204642	"Major histocompatibility complex, class I, F"	P30511	6	29722775-29738528	"Plasma proteins, Predicted membrane proteins"	Immunity			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 188.3"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 220.4;NK-cells: 339.8;Proximal enterocytes: 298.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"A-431: 36.3;GAMG: 13.5;HEK 293: 12.5;HEL: 8.9;HHSteC: 10.1;JURKAT: 7.6;U-266/70: 8.5;U-937: 13.6"															NA	NA		15000000	"Cluster 49: Eosinophils - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 63: NK-cells & T-cells - Immune response"				"unprognostic (3.07e-3)"	"unprognostic (5.16e-2)"	"unprognostic (3.05e-1)"	"unprognostic (9.32e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.82e-1)"	"unprognostic (4.99e-2)"	"unprognostic (2.68e-1)"	"unprognostic (4.21e-3)"	"unprognostic (2.43e-3)"	"unprognostic (3.21e-2)"	"unprognostic (2.57e-1)"	"prognostic unfavorable (2.67e-4)"	"unprognostic (1.26e-1)"	"unprognostic (2.95e-2)"	"unprognostic (4.13e-2)"	"unprognostic (1.30e-2)"	58.0	36.6	1.3	1.9	1.6	1.8	52.2	1.0	2.0	43.4	1.1	60.4	28.8	41.2	2.3	21.0	38.1	18.7	40.0	1.0	1.2	35.6	29.9	91.8	41.4	1.6	1.3	19.8	14.4	0.2	25.7	1.1	1.5	31.5	2.7	1.0	28.1	2.2	14.7	40.8	101.4	0.3	1.4	188.3	36.2	7.3	1.2	1.9	40.6	0.0	10.2	30.0	38.5	1.6	36.3	0.0	0.0	0.1	0.2	0.8	0.2	0.0	0.0	0.1	0.8	0.0	0.2	0.1	0.0	0.1	13.5	1.4	0.0	1.3	0.0	0.8	12.5	8.9	0.4	0.1	10.1	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	7.6	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.1	0.4	2.3	0.0	0.0	0.1	0.0	0.5	1.7	0.0	0.0	0.6	0.1	0.1	1.2	0.2	8.5	1.9	0.1	0.0	13.6	0.1	54.3	16.8	42.8	34.9	21.6	25.9	19.4	22.8	28.5	1.1	16.9	21.5	21.2	31.9	32.7	32.0	6.5	25.1	15.2	1.3	1.6	1.0	2.0	1.0	1.2	1.6	1.3	1.5	1.4	1.2	1.6	180.1	38.5	64.7	2.6	133.4	40.9	32.7	58.4	12.5	1.5	19.9	17.0	12.2	50.1	37.0	7.3	2.1	0.4	220.4	214.3	1.9	75.9	2.2	8.6	13.9	110.6	22.8	29.9	2.7	87.8	0.8	27.3	69.8	14.2	50.0	3.4	71.7	30.4	55.3	0.0	6.2	119.2	69.2	96.9	50.3	1.4	28.3	99.4	28.4	12.2	207.1	4.6	339.8	4.5	0.7	71.4	122.0	21.1	92.3	41.8	298.8	4.9	34.3	1.3	46.0	20.7	36.2	10.0	3.9	11.4	37.5	0.3	198.9	24.9	90.8	62.5
HLA-G		ENSG00000204632	"Major histocompatibility complex, class I, G"	P17693	6	29826967-29831125	"Cancer-related genes, Predicted membrane proteins, Predicted secreted proteins"	Immunity		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"pituitary gland: 13.8;placenta: 11.1"	"Cell type enriched"	"Detected in many"	45	"Extravillous trophoblasts: 1850.2"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"											CAB016158	Enhanced				"Secreted to blood"	NA	NA	32800000	67000000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 28: Placenta - Pregnancy"		"Cluster 38: Extravillous trophoblasts - Unknown function"			"CAB016158: AB_627938"	"unprognostic (1.13e-2)"	"unprognostic (9.95e-2)"	"unprognostic (1.30e-1)"	"unprognostic (3.40e-2)"	"unprognostic (8.35e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.18e-3)"	"unprognostic (2.51e-1)"	"prognostic favorable (3.91e-5)"	"unprognostic (6.34e-2)"	"unprognostic (8.31e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.03e-2)"	"unprognostic (6.56e-3)"	"unprognostic (1.40e-1)"	"unprognostic (1.52e-2)"	"unprognostic (3.19e-3)"	0.4	0.3	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.3	0.0	0.8	0.6	0.2	0.0	0.3	0.3	0.1	0.4	0.0	0.0	0.7	0.4	2.7	0.0	0.0	0.0	0.2	1.2	0.0	13.8	11.1	0.0	0.3	0.0	0.0	0.6	0.0	0.2	0.4	0.7	0.0	0.0	1.3	0.7	2.7	0.0	0.4	0.6	0.0	0.0	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.9	1.4	0.8	0.6	1.0	0.7	0.6	0.9	0.4	0.5	0.5	1.3	2.1	0.8	0.6	0.1	1.0	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.6	0.0	1.2	22.8	7.3	7.1	1.2	0.0	0.2	0.0	0.8	4.3	1.8	0.0	0.0	10.7	2.7	28.1	0.0	4.5	20.1	0.9	1.3	8.8	17.5	2.7	0.0	5.6	1850.2	5.5	1.5	2.6	0.0	0.7	6.4	1.2	25.5	0.0	0.0	34.3	2.0	8.1	27.3	13.0	2.5	4.8	12.4	0.0	1.4	0.0	3.1	0.0	0.0	24.9	19.9	2.6	0.9	14.3	0.2	0.3	0.6	0.0	0.0	4.8	3.8	5.9	2.8	0.1	35.2	40.5	6.8	1.9	18.2	15.0
HLA-A		ENSG00000206503	"Major histocompatibility complex, class I, A"	P04439	6	29941260-29945884	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Adaptive immunity, Host-virus interaction, Immunity, Innate immunity"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Ductal cells: 3747.8;Proximal enterocytes: 5267.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A-431: 1363.9;fHDF/TERT166: 360.3;HBEC3-KT: 366.7;RPMI-8226: 372.1;U-266/70: 344.6"									CAB078470			Supported	"Golgi apparatus,Plasma membrane"		NA	NA		170000000	"Cluster 49: Eosinophils - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 63: NK-cells & T-cells - Immune response"	"Plasma membrane"	"Golgi apparatus"	"CAB078470: AB_10985125"	"unprognostic (1.56e-2)"	"unprognostic (9.14e-2)"	"unprognostic (1.34e-2)"	"prognostic favorable (9.59e-4)"	"unprognostic (3.49e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.12e-1)"	"unprognostic (7.28e-2)"	"unprognostic (3.42e-2)"	"prognostic favorable (6.47e-4)"	"unprognostic (2.96e-1)"	"unprognostic (3.24e-1)"	"unprognostic (1.84e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.32e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.54e-2)"	635.4	714.2	15.0	34.8	15.5	137.7	566.7	14.7	36.5	504.9	18.0	737.5	278.3	476.1	181.1	366.8	390.3	239.9	473.4	14.6	17.0	687.0	392.0	1007.3	132.0	19.1	15.8	338.8	200.0	18.5	406.5	52.1	16.5	370.9	94.6	9.9	364.1	1.2	246.5	673.3	959.1	14.5	16.8	1413.1	442.2	132.6	18.0	138.9	531.9	14.5	178.3	412.3	466.8	18.3	1363.9	35.0	0.0	0.0	205.9	193.7	1.4	1.4	2.5	2.1	2.3	0.2	0.1	4.0	0.6	360.3	179.1	31.2	0.2	366.7	0.5	3.1	13.5	237.5	9.5	7.4	11.2	0.5	14.4	2.0	0.0	2.5	1.1	0.6	0.2	177.8	0.4	1.4	0.5	0.0	1.1	24.3	2.9	0.2	4.1	27.5	2.5	372.1	246.7	276.5	0.6	12.4	29.3	0.2	11.8	82.8	1.6	30.4	5.8	18.7	0.8	5.8	4.0	344.6	92.6	77.7	0.4	199.9	0.2	321.6	119.0	182.7	164.7	95.5	134.8	96.9	125.4	146.3	18.6	64.3	86.5	119.2	248.7	133.1	109.6	54.6	222.2	191.9	15.0	15.5	14.7	36.5	14.6	17.0	19.1	15.8	16.5	16.8	18.0	18.3	1622.4	371.8	478.6	22.9	1316.2	856.4	886.2	1417.5	228.8	30.8	289.6	188.5	147.4	936.5	952.5	503.9	6.2	18.3	1879.4	2631.8	88.0	3747.8	52.2	239.4	374.0	1717.8	955.2	499.4	3.6	1310.0	18.5	743.5	853.7	556.2	603.0	253.3	1266.2	276.4	1840.9	37.0	19.3	1755.3	1265.4	1575.0	1124.0	95.6	704.6	1419.1	635.0	67.5	3258.0	170.4	3201.9	49.3	16.1	1802.9	2452.4	484.1	1110.7	1026.6	5267.3	294.9	609.6	24.4	558.8	397.3	579.2	197.4	23.8	216.5	947.7	31.7	2234.9	1021.3	1225.4	1262.8
POLR1H	"A12.2, HTEX-6, hZR14, RPA12, tctex-6, ZNRD1"	ENSG00000066379	"RNA polymerase I subunit H"	Q9P1U0	6	30058899-30064909	"Metabolic proteins, Predicted intracellular proteins, RNA polymerase related proteins"	Transcription			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 14.6;B-cells: 17.6;Cardiomyocytes: 15.2;Cytotrophoblasts: 28.2;dendritic cells: 20.5;Extravillous trophoblasts: 43.0;Hofbauer cells: 35.3;Syncytiotrophoblasts: 17.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055074, HPA077979"	Supported		Supported	"Nucleoli fibrillar center"		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 72: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoli fibrillar center"		"HPA055074: AB_2682690, HPA077979: AB_2732366"	"unprognostic (4.94e-2)"	"unprognostic (2.93e-2)"	"unprognostic (2.54e-1)"	"unprognostic (3.81e-1)"	"unprognostic (3.88e-2)"	"unprognostic (8.55e-2)"	"unprognostic (5.36e-2)"	"unprognostic (2.82e-3)"	"unprognostic (1.96e-1)"	"unprognostic (9.52e-3)"	"unprognostic (5.18e-1)"	"unprognostic (3.28e-1)"	"prognostic unfavorable (2.17e-7)"	"unprognostic (2.57e-1)"	"unprognostic (1.51e-1)"	"unprognostic (9.97e-2)"	"prognostic favorable (2.75e-5)"	26.0	26.2	5.0	4.3	5.0	2.6	22.4	4.7	9.6	24.4	5.1	22.4	16.8	22.7	4.7	29.3	21.7	1.1	23.7	5.2	6.2	32.3	24.4	19.7	2.9	5.5	5.6	25.4	30.0	2.4	18.0	5.8	5.4	21.1	14.2	4.3	16.8	2.7	25.4	23.0	24.7	4.0	5.4	33.2	26.3	30.5	5.3	13.1	17.5	7.7	3.3	23.0	22.1	5.2	17.9	5.4	20.5	40.9	5.7	5.9	6.9	7.2	19.4	19.9	18.7	23.0	9.3	16.2	7.3	8.1	10.4	10.8	37.4	27.7	25.4	2.0	43.1	24.6	13.7	31.0	36.4	33.8	8.1	22.5	13.1	20.4	49.0	6.4	32.3	25.1	60.8	8.3	15.5	29.9	22.9	67.5	0.0	29.9	28.1	18.1	26.5	30.2	11.5	23.7	12.5	20.0	10.0	19.5	10.4	9.8	19.1	30.4	7.3	19.5	8.0	0.0	23.1	9.7	10.7	20.4	3.4	33.1	25.4	22.1	5.3	4.4	6.5	3.9	6.7	4.9	6.0	6.1	6.3	4.3	6.6	5.1	4.0	5.1	3.9	4.9	7.8	4.0	5.0	5.0	4.7	9.6	5.2	6.2	5.5	5.6	5.4	5.4	5.3	5.2	14.6	0.0	0.0	0.0	17.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.2	0.0	0.0	0.0	0.0	28.2	20.5	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	43.0	10.0	0.0	0.0	0.0	0.0	0.0	0.0	35.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	17.6	4.4	0.0	0.0	0.0
PPP1R11	"CFAP255, HCG-V, HCGV, TCTE5, Tctex5"	ENSG00000204619	"Protein phosphatase 1 regulatory inhibitor subunit 11"	O60927	6	30066709-30070333	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Protein phosphatase inhibitor, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 696.0"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in some"	8	"cerebral cortex: 8.8"	"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A-431: 51.5;AN3-CA: 65.6;fHDF/TERT166: 48.6;GAMG: 47.4;HBEC3-KT: 53.6;JURKAT: 76.7;RPTEC TERT1: 47.4;U-266/84: 64.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043266, HPA060174"	Approved		Approved	Vesicles		NA	NA		43000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 72: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 10: Non-specific - Unknown function"	Vesicles		"HPA043266: AB_2678400, HPA060174: AB_2684216"	"unprognostic (2.00e-2)"	"unprognostic (1.10e-1)"	"unprognostic (8.88e-2)"	"unprognostic (4.24e-2)"	"unprognostic (3.45e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.77e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.81e-1)"	"unprognostic (1.74e-3)"	"unprognostic (3.33e-2)"	"unprognostic (2.68e-1)"	"unprognostic (8.36e-3)"	"unprognostic (1.74e-1)"	"unprognostic (3.31e-1)"	"unprognostic (2.21e-1)"	"unprognostic (4.69e-3)"	44.5	41.1	0.7	0.0	0.7	1.9	41.4	0.6	8.8	44.4	0.6	55.5	11.6	49.6	33.1	52.1	37.3	11.8	51.0	0.7	0.7	62.3	47.5	43.7	5.4	0.9	0.7	41.8	45.1	2.2	29.2	5.8	0.8	46.3	0.7	7.9	42.8	0.0	50.4	42.9	50.7	0.0	0.6	39.8	59.5	41.5	0.7	9.7	42.3	0.0	11.8	51.6	42.7	1.1	51.5	0.0	0.0	65.6	29.4	26.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	48.6	47.4	0.0	0.0	53.6	0.0	1.0	34.5	42.6	0.0	0.0	0.0	3.0	3.9	0.0	0.0	0.0	0.7	0.0	0.0	76.7	0.5	2.7	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	1.4	47.4	29.0	0.0	0.0	0.7	35.5	4.8	26.8	0.0	0.0	0.0	0.0	0.3	4.1	1.5	30.7	64.9	26.7	0.7	0.0	0.0	11.5	4.1	12.4	4.7	9.3	4.5	6.8	5.3	6.5	2.2	7.2	4.9	7.0	2.8	3.9	7.9	3.2	8.4	6.8	0.7	0.7	0.6	8.8	0.7	0.7	0.9	0.7	0.8	0.6	0.7	1.1	38.2	19.2	20.2	2.6	57.8	52.8	80.0	77.2	29.0	29.3	47.7	32.8	18.8	52.9	49.7	40.5	6.2	56.0	39.2	111.5	95.9	142.2	242.1	19.8	24.2	44.3	53.7	32.4	10.1	136.3	119.9	27.0	53.5	31.8	78.6	21.4	45.7	28.0	65.7	13.5	9.0	83.8	77.3	49.7	53.8	696.0	32.3	43.5	62.2	3.7	75.4	58.4	92.7	6.0	7.6	136.5	114.1	40.3	42.2	66.6	139.6	93.3	38.7	33.1	39.5	27.2	89.4	61.9	23.2	39.0	66.5	75.2	52.4	16.5	51.8	94.9
RNF39	"FAP216, HZFw1, LIRF"	ENSG00000204618	"Ring finger protein 39"	Q9H2S5	6	30070266-30075887	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 24.5;skin 1: 63.3;vagina: 21.6"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 79.9;Basal respiratory cells: 96.2;Club cells: 55.7;Prostatic glandular cells: 57.2;Urothelial cells: 233.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"OE19: 4.5;U-266/84: 3.6"	"Region enhanced"	"Detected in many"		"cerebral cortex: 8.1"	"Group enriched"	"Detected in many"	4	"cerebellum: 9.0;cerebral cortex: 8.0;hippocampal formation: 4.4"	"CAB019278, HPA047115"	Uncertain		Approved	"Vesicles,Plasma membrane,Centrosome"		NA	NA				"Cluster 31: Skin - Epidermis development"	"Cluster 21: OE19 - Mitochondria"	"Cluster 22: Epithelial cell types - Mixed function"	"Vesicles, Plasma membrane, Centrosome"		"CAB019278: , HPA047115: AB_2679938"	"unprognostic (1.05e-2)"	"unprognostic (3.75e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.53e-2)"	"unprognostic (5.72e-3)"	"unprognostic (3.08e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.22e-2)"	"unprognostic (1.59e-2)"	"unprognostic (4.45e-3)"	"unprognostic (3.61e-2)"	"unprognostic (2.06e-4)"	"unprognostic (5.61e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.57e-2)"	1.1	0.8	0.0	0.0	0.1	0.0	8.6	0.1	0.3	16.8	0.0	0.6	0.2	0.6	0.0	24.5	1.4	0.1	0.3	0.1	0.1	0.4	0.2	1.9	0.0	0.2	0.0	1.3	1.7	0.1	1.4	0.0	0.2	7.2	0.0	0.5	15.8	0.1	0.4	63.3	0.5	0.0	0.0	0.2	8.3	1.6	0.1	0.0	0.4	0.0	0.4	3.9	21.6	0.1	1.2	0.0	0.3	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.6	0.0	0.2	1.1	0.5	0.1	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.7	0.0	0.9	0.3	0.2	0.0	0.4	0.0	0.5	0.0	4.5	0.0	0.1	0.1	0.0	0.8	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.2	0.2	0.0	0.1	0.8	3.6	0.3	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.1	0.1	0.2	0.0	0.2	0.0	0.1	0.1	0.3	3.2	2.7	0.0	0.0	17.8	79.9	96.2	42.1	0.5	23.7	28.6	0.3	7.2	55.7	0.0	0.0	0.0	0.8	1.8	0.0	6.4	0.6	3.6	2.4	1.1	0.0	0.0	0.0	3.3	0.0	1.2	17.3	20.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.5	14.2	0.0	2.1	0.0	1.2	0.4	3.6	0.0	0.6	0.0	0.0	0.0	0.0	24.2	2.2	1.2	0.0	57.2	0.1	0.0	13.0	0.4	0.0	0.0	3.0	0.1	0.4	11.3	23.9	0.7	0.6	0.0	0.9	233.1
TRIM31	"C6orf13, HCG1, HCGI, RNF"	ENSG00000204616	"Tripartite motif containing 31"	Q9BZY9	6	30102897-30113090	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 22.1;stomach 1: 6.0;urinary bladder: 8.6"	"Group enriched"	"Detected in some"	4	"Distal enterocytes: 409.1;Paneth cells: 404.9;Proximal enterocytes: 193.3;Urothelial cells: 227.9"	"Group enriched"	"Detected in many"	5	"cervical cancer: 6.7;colorectal cancer: 25.8;pancreatic cancer: 11.4;stomach cancer: 19.8;urothelial cancer: 12.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	726	"RT4: 294.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA074175	Enhanced					NA	NA				"Cluster 37: Intestine - Unknown function"	"Cluster 15: RT4 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA074175: "	"unprognostic (1.37e-1)"	"unprognostic (7.78e-3)"	"unprognostic (1.83e-1)"	"unprognostic (7.05e-3)"	"unprognostic (1.75e-1)"	"unprognostic (9.37e-2)"	"unprognostic (6.13e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.97e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.43e-3)"	"unprognostic (5.84e-3)"	"unprognostic (6.20e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.50e-3)"	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.1	0.0	22.1	0.9	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	1.2	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.0	0.2	0.0	0.0	0.0	0.0	0.4	12.1	0.1	0.0	0.0	6.0	3.3	0.0	0.0	0.0	0.0	0.0	8.6	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	294.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.0	0.6	0.1	12.3	2.5	0.0	0.0	0.4	0.3	5.7	4.3	3.0	0.0	0.0	0.0	0.2	409.1	0.0	2.7	0.2	25.7	0.2	0.4	5.4	2.7	0.0	1.7	0.0	0.3	73.9	1.1	4.5	0.0	0.0	0.0	0.1	0.0	0.0	52.3	0.0	0.0	0.0	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.1	404.9	0.0	0.2	2.7	193.3	0.6	14.2	0.0	0.0	0.2	0.5	1.8	0.2	0.0	0.0	0.0	0.8	0.0	25.6	227.9
TRIM40	RNF35	ENSG00000204614	"Tripartite motif containing 40"	Q6P9F5	6	30136124-30148735	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"intestine: 3.0;liver: 1.6;testis: 1.4"	"Group enriched"	"Detected in some"	5	"Distal enterocytes: 20.1;Paneth cells: 24.7"	"Cancer enhanced"	"Detected in some"		"colorectal cancer: 0.7;stomach cancer: 0.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	12	"HEL: 1.1"	"Region enriched"	"Detected in single"	18	"thalamus: 3.1"	"Low region specificity"	"Detected in many"			HPA043818	Uncertain		Approved	Cytosol		NA	NA				"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 36: HEL - Hemostasis"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol		"HPA043818: AB_10963090"		"unprognostic (2.88e-1)"	"unprognostic (5.20e-2)"			"unprognostic (4.11e-1)"	"unprognostic (1.13e-1)"				"unprognostic (1.77e-1)"			"unprognostic (4.84e-2)"				0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.1	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	20.1	0.0	0.0	0.2	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.7	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	24.7	0.0	0.0	0.0	3.8	0.5	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.3	0.0	0.0	0.7	0.0
TRIM10	"HERF1, RFB30, RNF9"	ENSG00000204613	"Tripartite motif containing 10"	Q9UDY6	6	30151943-30161211	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 7.8;kidney: 2.0;liver: 2.9"	"Cell type enriched"	"Detected in some"	21	"Erythroid cells: 126.9"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	16	"HEL: 22.5"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	11	"hippocampal formation: 3.4"	HPA043325	Uncertain					NA	NA				"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 36: HEL - Hemostasis"	"Cluster 6: Erythroid cells - Oxygen transport"			"HPA043325: AB_2678428"		"unprognostic (2.98e-1)"	"unprognostic (3.13e-2)"	"unprognostic (2.99e-2)"		"unprognostic (2.13e-1)"	"unprognostic (2.98e-1)"	"unprognostic (9.53e-3)"	"unprognostic (6.32e-2)"	"unprognostic (2.71e-1)"	"unprognostic (2.64e-2)"		"unprognostic (1.74e-3)"	"unprognostic (1.46e-2)"	"unprognostic (4.37e-2)"		"unprognostic (1.22e-2)"	0.0	0.0	0.0	0.1	0.0	7.8	0.0	0.0	0.0	0.1	0.0	1.6	1.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	2.0	2.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.5	1.5	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.5	0.1	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.5	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	1.2	126.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.1	0.0	0.0	1.9	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	5.9	0.0	0.0	0.0	3.1	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	1.3	0.0
TRIM15	"RNF93, ZNF178, ZNFB7"	ENSG00000204610	"Tripartite motif containing 15"	Q9C019	6	30163206-30172693	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"intestine: 17.1;kidney: 6.0;liver: 14.5"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 139.1;Intestinal goblet cells: 41.5;Paneth cells: 332.0;Proximal enterocytes: 80.0"	"Group enriched"	"Detected in many"	4	"colorectal cancer: 14.4;liver cancer: 5.6;pancreatic cancer: 7.7;renal cancer: 4.4;stomach cancer: 8.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	13	"HEL: 16.5;Hep G2: 7.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA047527			Approved	"Centriolar satellite,Cytosol"		NA	NA				"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 36: HEL - Hemostasis"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol	"Centriolar satellite"	"HPA047527: "	"unprognostic (2.61e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.71e-1)"		"unprognostic (5.36e-2)"	"unprognostic (1.92e-2)"	"unprognostic (7.57e-4)"	"unprognostic (5.27e-2)"	"unprognostic (1.11e-1)"	"unprognostic (4.00e-2)"		"unprognostic (2.16e-2)"	"unprognostic (2.19e-2)"	"unprognostic (3.83e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.41e-1)"	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	13.8	17.1	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	6.0	14.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.7	12.2	0.3	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.6	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.5	0.1	7.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	11.5	0.0	0.0	0.0	0.0	0.0	139.1	1.9	1.8	0.0	0.0	0.1	0.0	0.0	2.7	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	41.5	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.3	332.0	0.0	0.0	0.0	80.0	21.5	0.0	0.0	0.0	0.0	0.0	0.2	1.4	0.0	0.0	0.0	0.5	0.0	29.1	0.0
TRIM26	"RNF95, ZNF173"	ENSG00000234127	"Tripartite motif containing 26"	Q12899	6	30184455-30213427	"Enzymes, Predicted intracellular proteins"	"Immunity, Innate immunity"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Daudi: 38.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044975, HPA050456"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 16: U-266 - Nucleosome"	"Cluster 44: Endometrium - Transcription"	"Nucleoplasm, Cytosol"		"HPA044975: AB_2679162, HPA050456: AB_2681133"	"unprognostic (1.93e-1)"	"unprognostic (5.41e-2)"	"unprognostic (8.53e-2)"	"unprognostic (1.96e-3)"	"unprognostic (1.52e-1)"	"unprognostic (5.50e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.40e-2)"	"unprognostic (2.85e-1)"	"unprognostic (3.08e-2)"	"unprognostic (1.97e-1)"	"unprognostic (7.00e-3)"	"unprognostic (1.37e-2)"	"unprognostic (1.63e-3)"	"unprognostic (5.21e-2)"	"unprognostic (8.82e-2)"	"prognostic favorable (3.25e-5)"	15.6	16.5	3.6	6.9	4.4	4.5	16.3	4.5	7.1	15.8	3.7	17.9	5.6	16.8	2.9	28.9	16.4	4.9	12.5	3.3	4.9	18.1	26.1	16.8	6.6	4.7	4.0	12.5	15.5	4.2	14.1	2.9	4.3	18.2	2.3	4.2	21.0	3.2	14.5	20.8	19.8	1.1	3.6	18.0	17.6	11.5	4.8	3.9	17.6	1.3	6.6	17.8	17.4	4.9	15.7	8.3	0.0	23.8	8.1	4.6	7.8	9.7	5.4	11.4	11.6	0.0	0.9	38.2	13.0	12.4	17.0	17.6	0.0	16.8	3.5	0.0	13.0	6.1	2.5	16.7	7.1	13.3	5.4	4.6	5.7	11.9	7.1	0.0	7.6	18.4	2.8	0.0	0.0	0.0	19.1	17.8	0.0	0.0	6.7	16.9	15.1	5.3	9.8	14.5	0.5	11.0	18.5	0.9	5.2	5.0	8.0	2.3	16.5	8.7	5.8	0.0	0.2	15.1	31.2	18.1	0.0	21.3	15.0	0.5	1.5	0.1	1.8	1.9	1.2	1.0	1.2	1.5	1.2	1.4	0.7	1.0	0.5	0.7	1.6	0.5	1.6	1.3	3.6	4.4	4.5	7.1	3.3	4.9	4.7	4.0	4.3	3.6	4.8	4.9	13.5	28.9	21.7	18.3	23.8	30.1	22.4	13.1	34.7	20.1	22.0	18.0	13.5	18.6	15.7	12.9	16.7	18.6	31.1	21.8	11.7	16.1	0.5	25.7	15.1	16.2	22.3	1.7	16.5	15.9	14.4	12.7	17.9	34.7	5.1	12.2	9.3	52.9	13.8	13.5	25.1	15.4	6.1	17.3	25.7	1.6	7.5	21.0	17.8	18.7	24.0	12.1	21.6	18.1	26.9	13.6	15.7	12.0	26.3	20.2	17.1	15.8	24.4	19.7	6.6	10.7	12.1	5.0	13.4	42.0	34.0	17.6	28.7	9.4	17.2	22.3
TRIM39	RNF23	ENSG00000204599	"Tripartite motif containing 39"	Q9HCM9	6	30326479-30343729	"Enzymes, Predicted intracellular proteins"	"Apoptosis, Cell cycle, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051120, HPA059496"	Uncertain		Supported	Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 71: Testis - DNA repair"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 7: Non-specific - Mitochondria"	Cytosol		"HPA051120: AB_2681348, HPA059496: AB_2684040"	"unprognostic (2.90e-1)"	"unprognostic (1.61e-2)"	"unprognostic (2.79e-2)"	"unprognostic (2.86e-2)"	"unprognostic (6.38e-2)"	"unprognostic (4.55e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.15e-2)"	"unprognostic (3.47e-1)"	"unprognostic (9.44e-2)"	"prognostic favorable (2.50e-4)"	"unprognostic (1.30e-2)"	"unprognostic (4.69e-2)"	"unprognostic (6.35e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.39e-3)"	10.0	8.7	0.8	1.7	1.0	3.1	10.2	1.3	1.1	11.4	1.5	13.6	1.6	12.1	2.2	13.1	11.7	1.3	8.7	0.9	0.9	9.8	11.6	9.7	1.6	1.3	1.0	11.5	12.2	2.1	14.8	1.6	1.0	10.8	1.5	1.5	10.2	2.0	14.3	9.3	11.9	1.8	0.8	14.3	11.0	20.7	1.1	1.7	11.6	1.4	2.1	12.9	9.5	1.1	3.2	0.1	2.6	4.8	1.2	1.2	2.7	1.4	1.8	2.1	1.9	3.8	0.4	4.1	2.8	2.7	1.3	1.0	3.1	2.2	2.2	3.2	3.4	3.2	0.5	1.4	2.7	4.8	3.5	1.4	1.8	2.7	2.9	3.2	1.3	3.4	4.9	3.2	2.7	2.9	1.0	1.0	3.6	1.3	2.2	2.2	0.5	3.1	2.2	3.0	5.7	2.8	1.1	2.3	2.8	2.5	3.1	1.2	1.2	2.3	1.8	2.8	4.9	5.7	7.6	4.2	1.3	1.7	3.6	1.0	0.9	4.1	2.7	1.3	2.4	1.8	1.9	2.0	0.9	1.6	2.2	2.2	4.5	2.6	1.4	0.7	1.7	1.4	0.8	1.0	1.3	1.1	0.9	0.9	1.3	1.0	1.0	0.8	1.1	1.1	5.9	3.2	7.2	0.7	14.2	3.7	5.6	2.6	6.8	6.0	7.5	5.2	5.6	2.8	3.5	1.8	6.2	4.7	11.9	5.5	7.9	4.6	4.6	11.2	4.1	4.8	5.4	3.6	0.9	6.1	5.7	4.1	15.3	13.1	5.7	4.2	5.7	3.7	3.3	3.3	1.1	7.3	4.1	7.2	5.0	7.8	2.8	7.3	3.6	1.0	4.3	6.9	8.2	0.5	0.9	6.8	10.0	4.5	10.9	3.7	7.5	4.0	7.2	7.6	0.0	3.8	5.8	19.1	10.0	5.3	4.1	10.0	15.3	3.5	4.4	5.3
TRIM39-RPP21		ENSG00000248167	"TRIM39-RPP21 readthrough"		6	30328907-30346854	"Predicted intracellular proteins"				"No human protein/transcript evidence"	"No human protein/transcript evidence"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"Alveolar cells type 1: 3.2;Alveolar cells type 2: 2.0;Club cells: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA051120	Uncertain		Approved	Cytosol		NA	NA						"Cluster 11: Alveolar cells - Smell perception"	Cytosol		"HPA051120: AB_2681348"	"unprognostic (1.20e-1)"	"unprognostic (7.35e-2)"			"unprognostic (2.56e-1)"	"unprognostic (1.60e-1)"		"unprognostic (4.60e-1)"	"unprognostic (1.33e-1)"			"unprognostic (1.56e-1)"	"unprognostic (5.84e-4)"		"unprognostic (7.39e-2)"	"unprognostic (1.50e-1)"	"unprognostic (6.89e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0
RPP21	"C6orf135, Em:AB014085.3, FLJ22638"	ENSG00000241370	"Ribonuclease P/MRP subunit p21"	Q9H633	6	30345131-30346884	"Enzymes, Predicted intracellular proteins"	"tRNA processing"	"Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 97.3;Squamous epithelial cells: 122.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEK 293: 49.2;HHSteC: 46.3;JURKAT: 59.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 72: Non-specific - Transcription"	"Cluster 18: U-2197 - ECM organization"	"Cluster 59: Non-specific - Transcription"				"unprognostic (2.73e-1)"	"unprognostic (1.09e-3)"	"unprognostic (2.83e-1)"	"unprognostic (4.65e-2)"	"unprognostic (1.78e-1)"	"unprognostic (6.46e-2)"	"unprognostic (2.18e-2)"	"unprognostic (8.37e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.65e-2)"	"unprognostic (2.65e-2)"	"unprognostic (2.76e-2)"	"prognostic unfavorable (1.04e-5)"	"unprognostic (9.54e-2)"	"unprognostic (1.01e-2)"	"unprognostic (4.13e-2)"	"prognostic favorable (6.78e-5)"	34.8	39.6	4.9	0.7	4.4	2.7	36.4	5.0	12.9	46.8	4.1	73.1	0.8	60.2	4.1	62.7	41.6	2.6	38.9	4.6	6.2	35.5	37.7	27.0	2.3	5.4	4.1	42.0	62.1	0.1	35.3	2.5	5.2	42.1	0.0	0.4	36.2	6.8	56.5	46.6	38.8	11.8	5.2	31.8	52.1	34.5	4.6	4.2	31.3	11.0	1.4	56.7	48.2	6.0	34.0	0.0	0.0	14.8	21.8	1.6	18.7	11.7	6.8	26.3	17.6	0.9	0.0	20.4	31.0	7.1	32.1	2.1	0.0	24.4	7.9	26.0	49.2	5.7	0.0	1.0	46.3	0.0	0.0	0.7	5.3	4.1	1.5	5.8	0.1	59.8	5.4	14.4	8.1	2.4	0.0	4.7	16.9	0.0	0.0	4.9	0.0	7.3	12.2	26.9	29.1	11.0	0.0	11.6	34.3	4.6	0.1	0.6	0.8	0.0	0.0	36.0	0.0	12.7	31.1	11.7	0.0	5.3	0.0	60.4	45.4	41.8	25.9	51.8	30.4	86.6	41.2	29.6	35.3	85.2	51.9	33.1	14.4	25.4	53.8	15.9	70.1	41.9	4.9	4.4	5.0	12.9	4.6	6.2	5.4	4.1	5.2	5.2	4.6	6.0	10.6	6.4	18.4	0.0	53.3	35.7	11.4	23.5	97.3	3.2	30.3	27.6	1.2	17.2	28.9	25.8	0.0	12.9	16.7	27.1	7.9	37.0	4.5	17.1	15.1	16.2	42.6	28.8	0.0	60.1	19.3	18.5	68.8	15.8	13.3	5.8	13.6	16.5	10.4	1.7	0.0	29.9	26.4	11.0	20.0	2.1	13.7	17.0	24.9	0.0	14.4	3.0	12.3	0.0	0.0	41.8	42.6	10.5	44.1	8.7	42.7	22.2	13.0	3.3	6.6	9.2	18.5	19.1	25.4	122.9	40.5	11.4	42.3	3.3	33.7	10.2
HLA-E		ENSG00000204592	"Major histocompatibility complex, class I, E"	P13747	6	30489509-30494194	"Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	"Adaptive immunity, Host-virus interaction, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 2347.3;Hepatic stellate cells: 1647.8;NK-cells: 1874.4"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"cerebral cortex: 109.5"	"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 212.3;U-266/70: 284.8"									"CAB024589, HPA031454"	Enhanced		Approved	Vesicles	"Secreted to blood"	NA	NA		100000000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Vesicles		"CAB024589: AB_324025, HPA031454: AB_2673891"	"unprognostic (1.14e-2)"	"unprognostic (1.38e-2)"	"unprognostic (9.20e-2)"	"unprognostic (2.47e-3)"	"unprognostic (2.06e-1)"	"unprognostic (3.63e-1)"	"unprognostic (1.14e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.75e-2)"	"unprognostic (1.35e-2)"	"unprognostic (5.57e-2)"	"unprognostic (2.04e-2)"	"prognostic unfavorable (3.86e-4)"	"unprognostic (2.90e-1)"	"unprognostic (4.14e-2)"	"unprognostic (1.75e-3)"	"unprognostic (1.42e-3)"	724.7	217.2	9.6	173.7	10.0	410.3	578.9	10.9	109.5	360.1	7.3	329.4	0.6	313.5	119.3	330.9	336.5	186.1	356.0	7.7	13.1	375.2	332.8	1144.6	336.3	16.6	22.7	213.2	156.6	95.8	121.8	117.3	16.1	251.2	116.8	12.4	252.5	93.0	179.2	518.3	428.9	89.0	10.0	1007.2	259.5	41.1	11.7	86.0	381.9	0.0	137.5	295.0	366.3	14.2	100.7	16.7	6.8	57.0	212.3	166.4	0.9	0.0	0.0	0.1	0.3	40.0	189.1	65.6	98.7	92.7	148.3	121.6	12.8	53.1	0.0	67.6	32.7	78.6	18.7	0.0	0.0	0.2	38.3	135.4	94.4	67.7	0.0	0.0	0.2	34.6	9.8	0.9	54.5	0.2	0.3	0.8	0.5	32.0	0.0	20.6	0.2	97.4	82.7	58.4	0.3	4.8	63.3	56.9	0.3	1.2	0.0	132.7	102.0	60.7	0.1	0.5	14.7	284.8	171.6	29.4	0.3	62.1	149.2	1140.0	335.4	1153.0	723.3	550.2	602.2	449.1	539.9	709.2	158.5	450.3	531.5	547.8	1916.1	512.9	648.0	138.3	611.7	1441.6	9.6	10.0	10.9	109.5	7.7	13.1	16.6	22.7	16.1	10.0	11.7	14.2	2347.3	310.9	411.0	8.1	950.6	484.6	386.6	284.2	183.8	2.7	238.7	204.0	108.3	231.6	270.0	123.2	6.2	88.2	1304.6	603.0	17.6	484.9	5.0	157.7	157.9	1554.7	216.2	172.3	0.1	677.2	277.0	402.8	233.4	325.6	531.6	59.2	1647.8	120.1	700.6	5.0	0.1	545.3	248.2	1220.4	512.2	11.0	132.0	821.6	466.0	105.9	740.5	100.2	1874.4	2.0	0.5	682.2	559.1	76.3	716.6	436.9	473.9	79.9	214.7	9.5	177.5	535.1	350.1	10.6	7.0	170.0	426.5	359.0	1162.1	196.5	285.0	544.4
GNL1	HSR1	ENSG00000204590	"G protein nucleolar 1 (putative)"	P36915	6	30541377-30557174	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 193.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033575, HPA043338, HPA050455"	Uncertain		Supported	Vesicles		NA	NA		11000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 71: Testis - DNA repair"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 25: Spermatids - Spermatogenesis"	Vesicles		"CAB033575: AB_2109945, HPA043338: AB_2678437, HPA050455: AB_2681132"	"unprognostic (2.76e-2)"	"unprognostic (3.68e-2)"	"unprognostic (2.21e-1)"	"unprognostic (3.53e-2)"	"unprognostic (3.30e-2)"	"unprognostic (2.75e-1)"	"unprognostic (4.22e-2)"	"unprognostic (8.33e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.84e-2)"	"unprognostic (3.95e-3)"	"unprognostic (7.32e-2)"	"unprognostic (5.67e-3)"	"unprognostic (4.42e-2)"	"unprognostic (2.10e-1)"	"unprognostic (4.15e-1)"	"unprognostic (1.78e-1)"	22.6	19.6	3.3	3.5	3.5	2.0	21.7	2.0	4.0	30.5	1.7	19.3	0.6	27.3	3.9	17.0	26.2	2.4	15.2	2.3	4.8	21.2	13.1	27.8	2.3	3.3	3.0	37.5	24.3	7.8	23.8	2.8	3.5	19.9	3.4	4.1	16.6	3.9	15.0	23.3	17.4	4.5	2.7	18.7	20.0	38.0	4.7	5.0	23.3	1.6	4.6	21.1	22.9	5.4	10.5	2.2	5.9	16.9	10.9	12.8	0.4	3.2	6.4	2.6	4.0	15.1	6.5	4.8	6.2	10.4	25.8	6.9	15.4	12.7	4.4	1.8	9.0	7.8	7.9	1.4	0.0	1.3	5.0	11.0	9.9	20.4	6.7	0.0	1.1	18.6	14.2	0.3	6.5	2.4	3.8	0.2	3.4	8.4	1.6	7.3	3.6	5.3	8.7	4.5	5.2	4.9	4.2	3.1	1.6	2.0	3.0	4.9	6.2	10.5	3.0	2.0	3.7	7.9	9.3	9.9	0.1	6.6	13.1	0.2	0.2	0.2	0.7	0.2	1.0	0.4	0.8	0.9	0.0	0.3	0.1	0.3	0.2	0.4	0.2	0.1	0.5	0.5	3.3	3.5	2.0	4.0	2.3	4.8	3.3	3.0	3.5	2.7	4.7	5.4	48.2	44.8	41.8	17.3	45.0	59.3	104.0	44.1	56.3	40.6	35.4	40.6	14.3	34.3	28.8	25.8	41.7	72.6	36.3	22.6	23.5	38.4	113.1	30.0	40.2	50.8	46.0	13.3	26.2	35.3	65.5	46.4	27.5	47.5	31.7	40.9	50.7	16.9	28.5	16.8	27.0	25.8	26.4	19.8	32.5	193.5	36.4	24.6	28.4	9.4	14.8	30.9	18.6	11.1	10.8	29.9	22.1	32.0	42.6	56.2	32.4	30.3	20.7	34.6	39.5	47.9	58.1	108.4	51.8	36.1	40.6	160.1	46.0	40.9	27.0	66.7
PRR3	"CAT56, Em:AB014077.1, Em:AB023052.2"	ENSG00000204576	"Proline rich 3"	P79522	6	30557280-30563723	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Immune cell enhanced"	"Detected in single"		"plasmacytoid DC: 1.2"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 16.6;HAP1: 20.1;HEL: 15.1;JURKAT: 14.7;U-266/84: 13.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064061			Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 57: B-cells - Immune response"	Nucleoplasm	Cytosol	"HPA064061: AB_2685185"	"unprognostic (3.76e-2)"	"unprognostic (6.72e-3)"	"unprognostic (8.90e-2)"	"unprognostic (2.10e-3)"	"unprognostic (1.92e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.65e-3)"	"unprognostic (1.25e-2)"	"unprognostic (3.73e-2)"	"prognostic favorable (6.49e-6)"	"prognostic favorable (5.61e-5)"	"unprognostic (4.71e-2)"	"prognostic unfavorable (7.84e-7)"	"unprognostic (2.80e-1)"	"unprognostic (2.82e-1)"	"unprognostic (3.66e-1)"	"unprognostic (1.21e-3)"	3.9	5.3	0.7	0.1	0.7	0.0	3.5	0.7	3.0	6.5	0.6	3.4	0.0	6.9	1.1	2.5	5.9	0.0	3.6	0.7	0.7	3.5	3.1	3.3	0.3	0.7	0.9	10.6	3.2	0.1	5.8	0.0	0.8	4.3	0.2	0.6	2.6	0.2	1.5	3.1	3.6	0.0	0.6	5.0	3.1	4.8	0.7	0.8	3.9	0.0	0.6	4.5	4.1	0.7	0.1	3.9	7.7	16.6	5.2	1.3	0.0	0.0	0.0	0.0	0.0	6.6	0.1	7.0	8.6	2.1	4.4	0.6	20.1	1.5	0.0	4.1	3.7	15.1	0.0	0.0	0.0	0.0	0.0	2.1	0.0	5.6	0.0	0.0	0.0	14.7	7.8	0.0	3.6	0.0	0.1	0.4	0.0	0.1	0.0	0.2	0.0	0.0	1.7	0.3	0.1	10.6	4.8	0.5	0.0	0.0	0.0	4.3	0.5	6.4	0.1	0.0	0.0	9.2	13.1	8.8	0.0	5.8	3.6	0.3	0.1	0.0	0.1	0.0	0.0	0.0	0.4	0.1	0.2	0.5	0.0	0.1	0.0	0.2	0.0	1.2	0.0	0.1	0.7	0.7	0.7	3.0	0.7	0.7	0.7	0.9	0.8	0.6	0.7	0.7	10.6	9.6	19.1	11.4	18.2	5.7	6.4	8.6	12.5	11.3	11.0	22.9	3.6	11.5	10.7	3.7	14.6	14.2	11.2	14.0	7.9	5.8	0.6	8.7	14.2	8.0	7.8	7.6	18.8	9.5	8.7	10.9	24.5	8.4	12.0	16.3	9.3	5.9	7.9	6.7	16.4	10.2	14.2	6.0	7.9	2.6	10.2	8.8	10.6	9.4	12.7	6.4	12.3	17.1	12.2	5.7	5.7	10.1	14.5	5.7	9.9	9.4	11.3	19.2	6.6	11.9	9.8	10.3	6.6	9.1	5.7	9.9	12.0	15.9	8.3	3.9
ABCF1	"ABC50, EST123147"	ENSG00000204574	"ATP binding cassette subfamily F member 1"	Q8NE71	6	30571393-30597179	"Plasma proteins, Predicted intracellular proteins, Transporters"		Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 107.0"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017578	Approved		Enhanced	Cytosol		NA	NA		490000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Cytosol		"HPA017578: AB_1844438"	"unprognostic (5.85e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.41e-3)"	"unprognostic (4.31e-2)"	"unprognostic (7.03e-2)"	"prognostic unfavorable (9.47e-4)"	"unprognostic (5.50e-2)"	"unprognostic (3.45e-2)"	"unprognostic (1.70e-2)"	"unprognostic (2.35e-1)"	"unprognostic (2.77e-1)"	"unprognostic (3.50e-2)"	"unprognostic (1.65e-1)"	"unprognostic (3.65e-1)"	"unprognostic (1.68e-3)"	"unprognostic (7.16e-2)"	31.6	27.5	4.5	6.7	5.0	25.5	28.3	4.4	6.4	29.6	3.5	34.0	2.0	34.3	7.4	32.4	24.6	6.8	35.0	4.3	4.9	28.1	32.6	29.9	7.4	5.1	4.8	26.2	32.7	13.5	24.7	10.5	5.0	28.3	11.4	11.1	30.4	5.4	107.0	39.9	32.3	10.2	4.5	30.7	32.4	35.0	5.3	14.7	29.3	4.1	11.3	32.4	30.0	5.6	46.2	33.5	29.4	39.7	40.0	24.5	4.2	30.1	37.6	49.0	53.6	104.8	16.4	33.8	27.1	34.3	51.9	33.3	61.7	39.5	56.2	34.2	65.2	43.0	47.6	14.5	5.5	9.4	5.6	33.6	33.7	68.6	6.4	4.0	5.6	16.9	77.2	4.5	35.3	8.5	9.3	15.5	7.5	31.2	9.4	64.5	7.5	63.3	32.2	52.4	10.2	42.9	20.1	55.3	6.6	5.0	6.1	24.4	28.2	59.0	6.9	3.8	6.2	35.7	47.5	52.8	1.3	43.3	62.2	1.7	5.5	1.5	10.1	4.7	9.3	6.2	7.2	10.2	4.7	5.1	6.3	6.3	1.8	8.0	4.9	5.4	4.1	6.1	4.5	5.0	4.4	6.4	4.3	4.9	5.1	4.8	5.0	4.5	5.3	5.6	42.5	51.3	84.4	7.2	67.9	86.2	100.3	54.2	49.5	48.9	45.5	30.1	87.3	42.9	65.2	58.8	66.7	100.3	77.5	103.3	60.7	93.9	105.0	67.0	95.4	57.2	50.7	50.9	6.8	87.6	139.4	52.6	53.5	115.2	86.9	27.0	36.0	125.4	49.5	55.5	7.4	80.6	28.5	47.4	43.0	176.4	38.8	52.1	35.6	2.8	63.2	39.3	116.4	2.0	9.2	105.9	73.8	51.9	61.8	92.1	66.2	99.0	44.0	112.9	72.3	58.7	54.3	132.5	104.2	50.2	84.8	166.1	70.5	48.2	72.3	87.1
PPP1R10	"CAT53, FB19, p99, PNUTS"	ENSG00000204569	"Protein phosphatase 1 regulatory subunit 10"	Q96QC0	6	30600413-30618612	"Predicted intracellular proteins"		"DNA-binding, Protein phosphatase inhibitor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in many"		"basophil: 7.9"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025501, HPA047248, HPA056756"	Enhanced		Enhanced	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	"Nuclear bodies"	"CAB025501: , HPA047248: AB_2679996, HPA056756: AB_2683227"	"unprognostic (1.68e-1)"	"prognostic favorable (4.84e-4)"	"unprognostic (1.21e-1)"	"unprognostic (9.31e-3)"	"unprognostic (6.31e-2)"	"unprognostic (9.57e-3)"	"unprognostic (2.02e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.62e-2)"	"unprognostic (1.25e-1)"	"prognostic favorable (9.74e-5)"	"unprognostic (2.72e-1)"	"unprognostic (8.02e-3)"	"unprognostic (5.90e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.89e-1)"	"unprognostic (3.74e-2)"	20.9	27.5	0.2	12.0	0.1	1.0	15.8	0.2	1.3	23.3	0.1	21.8	8.9	21.2	1.1	23.1	22.0	10.7	14.6	0.5	0.4	22.8	33.6	17.4	5.0	1.2	1.3	22.8	28.0	4.8	26.3	5.0	0.6	22.8	6.4	5.2	20.1	7.9	23.0	21.1	21.0	7.0	0.3	25.1	25.2	21.7	0.3	10.1	22.9	1.2	5.6	22.5	21.8	0.2	9.1	20.0	30.9	16.8	17.0	2.2	8.9	15.9	7.0	5.6	23.3	5.0	9.7	11.5	9.6	16.0	10.5	23.6	24.3	35.7	9.7	13.1	0.0	19.8	14.1	0.2	7.6	16.3	27.3	14.2	4.0	28.0	30.9	13.2	9.7	3.9	18.4	3.7	14.4	5.4	5.5	2.4	9.1	1.9	2.3	25.4	39.3	19.8	1.4	8.0	19.3	9.1	29.5	28.3	8.8	13.0	13.8	21.8	2.6	12.7	9.0	18.5	10.7	26.9	5.1	11.3	15.8	19.9	15.8	7.9	1.2	2.0	0.9	2.1	1.6	2.9	0.4	1.7	3.3	0.7	0.5	1.1	1.0	1.0	0.8	1.2	1.9	0.4	0.2	0.1	0.2	1.3	0.5	0.4	1.2	1.3	0.6	0.3	0.3	0.2	243.9	32.1	40.3	20.5	152.7	69.8	64.9	41.1	167.9	72.7	165.1	163.8	59.1	28.6	34.2	27.6	131.3	44.0	178.9	120.5	35.2	27.2	32.0	138.2	103.8	102.6	71.3	30.5	26.1	23.0	21.8	103.2	107.0	151.4	44.9	143.0	38.2	33.6	33.1	35.3	27.0	102.2	54.9	35.5	70.6	11.3	46.3	123.4	37.4	30.0	46.4	59.0	72.1	21.1	29.7	29.8	58.3	30.1	140.1	51.9	88.1	40.3	46.9	102.2	32.9	211.5	114.9	45.9	23.4	125.7	77.9	88.5	144.1	99.9	77.0	34.5
MRPS18B	"C6orf14, HSPC183, MRPS18-2, PTD017"	ENSG00000204568	"Mitochondrial ribosomal protein S18B"	Q9Y676	6	30617840-30626395	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043485, HPA050334"	Supported		Supported	"Cell Junctions,Mitochondria"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria	"Cell Junctions"	"HPA043485: AB_2678506, HPA050334: AB_2681091"	"unprognostic (8.18e-3)"	"unprognostic (1.14e-1)"	"unprognostic (8.96e-2)"	"unprognostic (2.51e-2)"	"unprognostic (4.20e-2)"	"unprognostic (7.40e-2)"	"unprognostic (9.45e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.98e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.40e-2)"	"prognostic favorable (3.99e-5)"	"unprognostic (1.89e-1)"	"unprognostic (1.64e-1)"	"unprognostic (5.14e-2)"	"unprognostic (5.39e-2)"	37.2	52.0	43.6	27.6	45.7	20.3	61.0	46.8	44.3	41.1	43.2	52.3	49.8	31.3	57.6	39.3	62.5	27.4	108.1	40.5	44.1	77.9	99.8	39.4	43.6	46.0	45.2	63.0	47.0	74.0	29.2	38.4	46.2	32.0	62.3	41.6	58.0	42.4	180.2	45.1	39.4	38.1	45.2	39.3	44.4	22.0	46.1	43.7	54.1	229.0	63.6	33.0	29.4	48.2	112.7	68.3	51.1	73.5	72.9	101.8	92.6	39.8	92.6	122.8	75.5	117.7	51.8	112.6	91.5	61.7	91.3	86.1	115.0	109.9	122.0	68.7	122.9	107.9	45.1	124.2	67.2	105.7	45.4	88.8	139.4	99.5	273.8	82.7	72.4	104.7	171.3	107.7	112.2	83.1	70.6	111.4	40.6	86.1	81.8	91.2	69.8	220.7	114.8	49.5	111.3	38.4	34.7	147.1	163.0	46.0	190.6	58.4	39.6	79.2	80.8	47.3	70.8	89.5	114.1	99.2	38.3	154.6	121.7	79.2	72.4	42.5	77.0	94.4	104.7	153.5	104.3	86.3	79.8	140.3	129.6	103.5	7.2	120.3	101.4	74.3	108.1	108.4	43.6	45.7	46.8	44.3	40.5	44.1	46.0	45.2	46.2	45.2	46.1	48.2	59.4	60.9	56.1	7.2	58.4	36.8	65.9	114.0	58.6	47.4	56.6	73.0	175.5	117.2	75.0	47.8	64.6	121.2	43.7	39.1	193.7	103.8	54.2	37.5	42.8	59.4	31.3	45.4	6.0	92.1	124.9	47.4	39.3	30.8	37.4	53.1	61.8	121.6	81.4	43.7	7.9	59.5	75.3	53.2	30.4	37.4	70.2	39.7	60.5	1.9	80.0	46.9	70.0	4.5	14.4	69.5	49.9	44.8	56.8	53.2	89.6	201.6	60.4	69.4	52.6	50.0	53.0	29.6	57.4	61.7	44.9	96.5	43.9	144.4	85.3	50.1
ATAT1	"C6orf134, Em:AB023049.7, FLJ13158, MEC17"	ENSG00000137343	"Alpha tubulin acetyltransferase 1"	Q5SQI0	6	30626842-30646823	"Enzymes, Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 87.6;Late spermatids: 42.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 8.0;AN3-CA: 5.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046816, HPA050999"	Approved		Approved	"Golgi apparatus,Cytosol"	"Intracellular and membrane"	No	No			"Cluster 46: Basophils - DNA binding"	"Cluster 71: Testis - DNA repair"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	"Golgi apparatus, Cytosol"		"HPA046816: AB_2679822, HPA050999: AB_2681303"	"unprognostic (3.98e-1)"	"unprognostic (3.18e-1)"	"unprognostic (4.30e-2)"	"unprognostic (2.67e-2)"	"unprognostic (8.86e-2)"	"unprognostic (8.18e-3)"	"prognostic unfavorable (1.03e-5)"	"unprognostic (1.49e-2)"	"unprognostic (5.39e-2)"	"unprognostic (2.37e-2)"	"unprognostic (1.29e-3)"	"unprognostic (1.25e-2)"	"prognostic unfavorable (7.78e-5)"	"unprognostic (2.62e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.02e-1)"	"prognostic favorable (1.35e-4)"	5.3	6.0	2.3	0.6	2.9	0.6	7.6	1.8	3.3	12.4	0.9	8.6	0.5	9.7	3.6	7.6	9.8	0.7	5.5	2.6	3.3	11.3	7.6	5.8	0.6	2.3	2.7	13.4	6.0	0.2	21.3	0.4	2.5	13.5	0.6	2.5	7.7	0.3	4.9	6.6	7.8	0.7	1.9	5.6	7.4	13.5	2.5	0.7	9.3	0.0	0.7	9.2	8.4	3.1	1.4	0.7	8.0	5.3	0.9	0.7	0.6	0.3	0.0	0.2	0.4	2.3	1.4	0.1	1.1	1.1	2.2	1.5	2.5	0.9	0.0	1.0	4.2	0.1	0.1	2.6	0.4	0.5	1.1	1.4	0.5	0.3	0.0	1.0	0.5	3.8	1.5	0.0	1.3	1.5	1.0	0.3	0.4	2.2	0.0	1.0	0.1	0.4	1.3	2.4	0.3	3.2	0.6	0.6	0.4	0.0	2.9	0.4	1.0	3.0	1.3	0.0	0.5	0.9	2.5	0.8	1.6	3.4	2.1	0.5	0.4	0.3	0.1	0.3	0.1	0.5	0.2	0.1	0.4	0.2	0.4	0.4	0.3	0.1	0.2	0.5	0.1	0.1	2.3	2.9	1.8	3.3	2.6	3.3	2.3	2.7	2.5	1.9	2.5	3.1	6.2	0.0	1.5	14.7	6.4	5.6	14.0	16.9	14.2	9.0	9.4	11.4	1.9	5.7	8.6	14.7	10.4	11.9	4.1	7.6	7.9	11.9	87.6	9.0	7.7	7.9	18.0	3.0	7.8	4.5	6.3	6.9	8.2	8.0	1.3	16.0	3.3	2.9	6.1	1.7	11.4	8.9	14.2	1.6	3.1	42.4	4.1	3.1	0.0	5.6	9.1	12.5	6.2	16.6	13.1	9.3	10.8	8.6	4.1	11.6	9.7	5.4	10.8	10.7	6.6	8.0	7.8	12.4	11.8	8.0	5.4	8.9	4.7	6.1	11.1	15.3
C6orf136	Em:AB023049.8	ENSG00000204564	"Chromosome 6 open reading frame 136"	Q5SQH8	6	30647039-30653210	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Proximal enterocytes: 108.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046804	Uncertain					NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 16: U-266 - Nucleosome"	"Cluster 45: Enterocytes - Digestion"			"HPA046804: AB_2679815"	"unprognostic (1.94e-2)"	"unprognostic (1.71e-3)"	"unprognostic (1.26e-1)"	"unprognostic (8.01e-3)"	"unprognostic (1.65e-2)"	"unprognostic (2.76e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.13e-1)"	"unprognostic (2.62e-2)"	"unprognostic (4.72e-3)"	"unprognostic (3.43e-1)"	"prognostic favorable (9.16e-8)"	"unprognostic (2.33e-2)"	"unprognostic (4.54e-2)"	"unprognostic (6.03e-2)"	"prognostic favorable (7.51e-4)"	10.9	19.2	8.0	1.3	8.2	1.8	11.3	9.6	12.0	11.7	8.8	39.5	6.5	10.3	3.9	22.3	11.6	0.7	56.3	7.8	8.5	40.1	28.8	11.7	1.9	8.8	8.6	9.3	20.2	6.4	26.2	1.4	8.6	15.2	5.4	3.5	18.5	2.7	49.2	17.2	37.1	1.5	7.6	18.1	22.3	18.1	8.5	0.6	23.3	5.5	1.0	14.6	14.2	8.7	2.7	4.4	2.3	2.0	3.4	4.2	4.1	1.0	1.2	2.6	3.6	2.8	1.9	2.4	1.6	0.8	2.2	3.5	0.4	0.1	2.8	2.0	3.3	1.3	3.4	1.7	0.9	3.8	3.8	1.9	4.0	1.9	2.4	2.5	1.0	3.7	3.1	1.6	0.6	4.4	1.7	4.4	2.5	4.2	2.4	3.3	2.1	4.8	5.9	3.9	5.5	1.1	1.4	4.5	3.4	0.9	2.2	0.8	0.5	0.8	3.8	1.6	3.4	4.5	5.6	1.6	1.4	3.4	1.8	0.0	0.3	0.0	0.5	0.3	0.7	1.2	0.7	0.4	0.3	0.7	1.1	0.7	0.6	0.3	0.3	0.7	0.5	0.4	8.0	8.2	9.6	12.0	7.8	8.5	8.8	8.6	8.6	7.6	8.5	8.7	8.9	0.0	4.4	15.0	14.8	9.3	11.1	29.7	16.5	16.8	10.7	8.9	26.7	17.2	18.2	36.8	4.2	17.3	11.3	67.1	58.7	18.5	14.3	7.4	3.4	10.1	22.9	9.9	17.2	17.5	11.1	8.0	23.9	6.5	12.7	4.6	8.9	12.2	15.7	11.8	19.5	45.0	30.5	4.7	7.6	17.4	7.8	7.1	10.6	8.4	10.0	13.9	11.3	6.0	9.8	17.1	54.2	6.4	18.8	13.4	108.7	27.7	11.1	20.0	6.6	5.3	17.5	51.5	49.5	24.1	10.7	16.8	13.5	6.7	47.2	16.2
DHX16	"DBP2, DDX16, Prp2, PRPF2"	ENSG00000204560	"DEAH-box helicase 16"	O60231	6	30653119-30673006	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Helicase, Hydrolase"	"Disease variant, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 92.7;Spermatocytes: 86.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051455	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 71: Testis - DNA repair"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm		"HPA051455: AB_2681491"	"unprognostic (7.04e-2)"	"unprognostic (1.37e-1)"	"unprognostic (7.29e-2)"	"unprognostic (7.46e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.94e-1)"	"unprognostic (4.36e-3)"	"unprognostic (1.13e-1)"	"unprognostic (2.66e-2)"	"unprognostic (3.11e-1)"	"unprognostic (8.58e-2)"	"unprognostic (1.24e-2)"	"unprognostic (9.77e-3)"	"unprognostic (4.42e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.64e-1)"	"unprognostic (8.73e-3)"	24.3	28.2	5.4	13.8	6.3	11.3	26.0	6.3	6.8	27.7	8.3	29.5	18.8	25.5	8.6	27.2	26.6	11.3	26.6	5.3	6.0	34.9	36.5	25.4	18.1	6.3	5.9	26.2	35.0	16.0	28.6	10.5	6.4	30.1	10.3	14.4	32.0	12.8	45.0	28.8	37.5	12.5	5.2	40.3	28.3	46.8	6.6	17.1	38.2	17.6	12.7	24.8	26.8	6.4	31.9	17.9	20.3	38.7	26.8	15.7	27.0	33.0	30.7	47.6	44.3	35.8	15.9	25.5	24.2	31.1	39.6	34.0	47.0	24.1	35.5	35.4	15.5	27.2	25.5	17.9	21.4	65.9	40.4	17.6	22.7	47.3	30.1	16.5	16.9	36.9	44.4	29.3	26.7	29.0	22.4	20.8	21.4	20.9	12.1	38.5	17.4	28.2	18.4	24.0	27.9	19.7	30.8	37.4	32.0	20.3	29.5	24.7	11.8	31.2	21.3	27.4	46.3	29.9	49.9	20.2	15.7	36.8	40.4	10.5	11.2	18.6	7.4	14.7	9.5	7.7	9.1	7.9	11.1	5.9	7.4	5.8	11.4	14.8	16.4	9.8	7.4	7.5	5.4	6.3	6.3	6.8	5.3	6.0	6.3	5.9	6.4	5.2	6.6	6.4	13.0	22.4	20.9	4.6	16.9	10.8	11.7	11.3	16.5	13.9	10.0	9.9	14.6	10.0	20.2	5.5	39.6	19.2	14.4	18.3	9.8	15.7	92.7	25.2	18.0	11.8	6.0	14.9	4.3	18.6	20.1	11.6	26.5	15.8	42.3	11.1	8.6	9.7	13.9	5.0	4.1	14.6	8.2	12.6	12.8	49.3	14.3	14.4	5.4	5.6	20.3	11.6	15.5	2.5	5.2	22.9	23.1	12.4	22.1	9.3	18.0	9.8	31.4	51.1	19.7	16.2	19.2	86.9	32.6	14.7	10.7	19.2	19.5	11.4	12.8	9.5
PPP1R18	"KIAA1949, phostensin"	ENSG00000146112	"Protein phosphatase 1 regulatory subunit 18"	Q6NYC8	6	30676389-30687895	"Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 208.4;Kupffer cells: 164.4;Langerhans cells: 179.3;monocytes: 212.8;NK-cells: 332.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"eosinophil: 215.8;neutrophil: 169.6"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 215.8"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044745, HPA051000"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA		11000	"Cluster 52: Eosinophils - Transcription"	"Cluster 2: Immune cells - Immune response"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 63: NK-cells & T-cells - Immune response"	"Plasma membrane"	Nucleoplasm	"HPA044745: AB_2679070, HPA051000: AB_2681304"	"unprognostic (3.25e-2)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (4.71e-4)"	"unprognostic (1.01e-1)"	"unprognostic (2.11e-2)"	"unprognostic (1.59e-2)"	"unprognostic (2.90e-2)"	"unprognostic (3.37e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.61e-2)"	"unprognostic (2.40e-1)"	"prognostic unfavorable (1.11e-16)"	"unprognostic (1.73e-1)"	"unprognostic (4.42e-2)"	"unprognostic (9.33e-2)"	"unprognostic (4.76e-2)"	35.4	16.7	9.5	42.5	9.1	56.0	25.9	9.9	12.8	30.2	7.0	38.0	8.8	36.8	3.5	18.1	28.6	25.6	23.2	9.4	12.1	14.2	16.8	51.5	75.5	17.8	12.6	26.8	10.1	2.7	7.0	21.4	15.5	19.7	7.7	2.6	15.4	11.5	10.8	21.6	33.7	17.3	13.7	80.4	19.5	5.9	15.6	53.5	17.6	9.0	38.2	36.1	24.4	13.9	63.2	9.4	34.4	37.3	28.0	80.4	1.7	48.4	63.6	43.3	29.9	6.6	11.2	64.7	25.0	77.3	73.7	35.8	21.6	44.7	29.6	74.8	2.2	79.3	20.7	6.6	59.1	28.6	116.3	44.0	44.0	97.9	89.8	64.5	60.0	53.3	27.2	58.2	57.8	6.9	40.8	43.5	3.2	1.6	13.8	162.8	28.8	33.9	18.0	3.4	3.8	19.2	30.1	10.9	65.9	18.8	9.4	26.8	90.8	139.4	29.2	29.4	103.3	11.6	57.3	77.3	40.7	131.9	155.9	43.0	16.4	215.8	43.4	21.8	31.8	20.9	23.1	42.5	9.5	22.0	16.7	32.5	169.6	37.8	25.2	14.9	39.7	22.6	9.5	9.1	9.9	12.8	9.4	12.1	17.8	12.6	15.5	13.7	15.6	13.9	39.1	3.2	15.7	1.6	89.7	109.0	29.6	15.7	79.6	2.3	14.2	14.6	3.1	8.6	4.6	9.2	0.0	3.1	116.5	0.8	0.0	25.1	24.2	4.4	24.4	67.8	1.8	35.4	0.8	8.2	20.4	34.1	7.1	6.7	53.2	5.9	32.9	8.2	208.4	3.3	1.3	0.8	8.2	164.4	179.3	19.9	27.7	123.3	39.2	19.7	212.8	1.0	332.7	11.1	0.1	20.8	0.0	23.3	52.9	23.8	0.4	2.5	4.4	3.1	26.3	28.6	53.5	1.2	1.3	38.3	59.7	4.0	141.6	6.8	0.7	22.5
NRM	NRM29	ENSG00000137404	Nurim	Q8IXM6	6	30688047-30691420	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 60.1"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"HPA072545, HPA073982"			Enhanced	"Nuclear membrane"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 71: Testis - DNA repair"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nuclear membrane"		"HPA072545: AB_2686532, HPA073982: AB_2686649"	"unprognostic (2.09e-1)"	"unprognostic (6.35e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.32e-2)"	"unprognostic (3.13e-3)"	"unprognostic (1.30e-1)"	"unprognostic (8.44e-2)"	"unprognostic (1.32e-2)"	"unprognostic (2.87e-2)"	"unprognostic (2.44e-1)"	"prognostic unfavorable (3.52e-8)"	"unprognostic (3.95e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.51e-1)"	7.6	4.7	0.4	0.6	0.4	1.7	6.1	0.4	0.4	13.0	0.3	6.7	0.2	13.5	0.3	8.8	8.2	0.3	5.3	0.4	0.4	4.4	2.9	7.8	1.0	0.5	0.4	8.1	5.2	0.3	1.7	0.9	0.4	4.8	0.5	0.3	4.2	0.9	2.1	8.1	6.5	1.1	0.4	7.3	3.9	10.9	0.5	1.5	4.8	0.5	1.1	6.9	9.1	0.4	3.0	2.8	5.2	3.7	0.8	2.8	0.6	1.5	2.9	4.7	4.2	3.1	2.1	5.1	1.0	3.1	2.1	4.6	2.9	5.0	1.3	7.1	1.5	3.1	4.0	4.0	1.0	2.4	4.6	1.7	1.8	4.6	1.7	1.6	3.7	4.1	2.8	4.5	3.2	2.7	3.9	2.6	1.1	3.3	1.7	9.2	3.5	6.2	2.1	1.5	1.9	1.7	1.7	2.1	1.0	1.6	3.4	2.4	1.5	4.3	2.3	2.4	2.8	1.6	3.3	1.8	0.6	6.5	5.6	0.3	1.6	0.1	0.4	0.5	0.3	1.8	0.4	0.6	1.4	1.7	0.2	0.2	0.6	0.4	0.2	1.6	0.3	0.4	0.4	0.4	0.4	0.4	0.4	0.4	0.5	0.4	0.4	0.4	0.5	0.4	12.1	3.2	2.0	0.7	12.9	9.8	6.3	9.6	5.7	1.7	3.0	7.5	1.9	12.8	4.9	1.8	2.1	23.0	5.1	1.6	3.9	12.2	13.5	1.0	8.4	12.3	1.2	9.2	0.3	5.6	28.1	9.0	1.5	2.7	12.7	5.0	4.6	1.0	17.6	3.3	0.4	3.4	2.0	20.5	18.9	60.1	5.6	12.8	3.6	1.0	25.6	1.2	7.2	0.5	0.3	4.8	0.5	6.0	5.5	1.7	0.5	1.0	0.4	1.9	6.6	7.3	11.6	4.4	2.1	14.6	6.3	5.1	9.9	3.9	6.3	4.3
MDC1	"Em:AB023051.5, KIAA0170, NFBD1"	ENSG00000137337	"Mediator of DNA damage checkpoint 1"	Q14676	6	30699807-30717447	"Cancer-related genes, Predicted intracellular proteins"	"Cell cycle, DNA damage, DNA repair"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	4	"Spermatocytes: 74.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	4	"NK-cell: 3.2"	"Lineage enriched"	"Detected in single"	4	"NK-cells: 3.2"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006915	Enhanced		Supported	"Nucleoplasm,Nuclear bodies,Focal adhesion sites"		No	No			"Cluster 48: NK-cells - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Nucleoplasm, Nuclear bodies"	"Focal adhesion sites"	"HPA006915: AB_1853669"	"unprognostic (8.52e-2)"	"unprognostic (4.32e-1)"	"unprognostic (4.11e-2)"	"unprognostic (2.66e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.61e-1)"	"unprognostic (5.40e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.09e-2)"	"unprognostic (9.44e-2)"	"unprognostic (2.74e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.62e-2)"	"unprognostic (3.86e-2)"	"unprognostic (2.99e-1)"	"unprognostic (4.39e-3)"	"unprognostic (3.23e-1)"	11.3	7.0	2.7	8.6	3.2	13.0	10.9	4.1	5.2	12.4	3.3	11.0	4.9	13.7	8.5	6.2	12.3	4.6	9.5	2.4	4.1	8.2	9.7	9.5	10.2	4.5	3.3	16.8	10.8	8.6	12.8	7.4	3.5	10.1	6.9	14.1	9.1	8.2	11.0	9.4	10.9	8.9	2.0	11.3	8.4	28.2	3.4	14.5	16.4	5.8	11.3	10.7	9.3	3.6	36.7	11.1	47.4	34.8	6.3	10.0	23.0	14.8	10.0	25.2	21.3	22.7	8.5	37.7	17.5	17.0	23.5	20.2	63.0	28.6	34.9	29.9	65.6	43.4	28.7	12.5	4.1	27.1	16.9	7.9	9.2	48.6	27.3	9.0	11.5	25.7	61.0	36.7	19.1	14.7	14.6	20.0	20.6	8.4	7.8	33.2	24.7	37.4	11.0	10.7	39.9	23.2	11.5	26.2	13.5	29.1	21.8	16.8	13.8	24.8	26.4	19.2	26.3	19.3	21.6	34.5	7.8	63.9	34.3	0.1	0.1	0.1	0.6	0.1	0.3	0.4	0.4	0.5	0.1	0.7	0.5	0.5	0.0	3.2	0.1	0.7	0.0	0.3	2.7	3.2	4.1	5.2	2.4	4.1	4.5	3.3	3.5	2.0	3.4	3.6	9.7	16.0	13.0	10.1	13.4	4.5	5.5	5.6	15.9	11.5	6.8	8.6	7.6	7.2	5.7	5.5	8.4	7.9	11.0	2.5	3.9	5.3	4.7	8.0	8.7	9.7	6.7	14.5	8.3	6.2	11.4	11.2	4.1	13.7	17.1	12.8	6.1	12.0	6.7	5.0	8.1	3.3	12.2	6.0	5.7	3.9	7.8	7.3	1.8	11.2	5.9	10.6	14.4	12.5	9.9	5.2	1.1	6.0	16.9	2.9	1.2	3.0	8.0	17.1	13.1	16.2	8.3	74.5	18.0	8.7	3.7	1.9	12.1	7.7	6.0	1.9
TUBB	"M40, MGC16435, OK/SW-cl.56, Tubb5"	ENSG00000196230	"Tubulin beta class I"	P07437	6	30717435-30725538	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins"			"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Extravillous trophoblasts: 2296.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005417, CAB012406, HPA043640, HPA046280"	Enhanced		Supported	"Microtubules,Cytokinetic bridge,Mitotic spindle"		Yes	Yes		170000000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Microtubules	"Cytokinetic bridge, Mitotic spindle"	"CAB005417: AB_2241191, CAB012406: AB_2210370, HPA043640: AB_2678594, HPA046280: AB_2679612"	"unprognostic (1.01e-1)"	"unprognostic (2.33e-1)"	"unprognostic (2.17e-3)"	"unprognostic (1.92e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.16e-2)"	"prognostic unfavorable (5.97e-4)"	"unprognostic (2.57e-2)"	"unprognostic (2.52e-1)"	"unprognostic (2.18e-3)"	"unprognostic (1.27e-2)"	"unprognostic (2.47e-1)"	"prognostic unfavorable (2.62e-8)"	"unprognostic (8.63e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.49e-1)"	"unprognostic (2.50e-1)"	229.5	164.8	74.6	243.5	81.8	541.0	186.9	46.2	367.7	228.7	87.0	250.3	87.6	333.0	174.5	246.3	227.0	158.5	245.3	73.5	119.7	137.8	236.6	205.3	369.2	80.5	74.8	467.5	138.1	74.4	97.0	194.4	99.2	145.2	194.4	82.4	160.2	194.6	185.7	211.9	159.4	371.0	57.5	195.0	172.8	77.8	94.0	620.4	142.4	98.6	487.6	222.3	213.8	63.5	2281.7	1027.3	2650.0	1458.4	733.2	1265.2	568.2	396.9	469.5	943.3	863.5	1329.2	703.9	1494.1	1105.1	1408.1	1877.8	805.3	2160.6	1968.0	160.3	892.5	1321.1	461.4	207.3	1306.7	345.8	2550.0	1223.9	943.6	455.9	416.0	443.6	967.1	1493.3	2058.1	1270.4	294.1	1844.8	1398.2	2719.0	249.3	377.3	604.1	948.6	102.6	708.5	911.6	1564.5	1071.4	940.8	1516.7	969.0	911.2	354.7	1625.5	1148.3	422.4	880.6	2712.0	1526.0	614.5	917.7	835.3	1735.4	2101.3	538.8	2494.6	3548.7	119.8	115.6	122.8	187.3	182.5	218.8	166.1	152.3	188.8	111.7	113.0	143.2	163.3	46.8	165.1	222.4	227.7	180.8	342.5	74.6	81.8	46.2	367.7	73.5	119.7	80.5	74.8	99.2	57.5	94.0	63.5	215.8	131.4	47.3	21.5	214.9	576.2	358.4	698.6	434.2	72.7	234.2	312.8	114.9	244.5	238.7	171.0	39.6	811.9	198.7	133.4	311.0	1091.0	9.1	69.1	261.6	370.8	163.6	1322.1	28.2	1061.1	2296.1	471.5	95.3	140.2	207.3	643.6	298.4	267.8	955.2	109.4	25.0	185.3	376.4	454.5	689.6	24.4	402.6	295.8	321.9	30.9	774.0	192.6	246.1	20.1	23.0	1087.0	90.7	237.3	304.6	199.5	117.9	245.9	66.6	65.4	118.3	124.0	838.6	58.0	126.5	447.0	430.6	220.4	244.0	224.9	253.2	229.0
FLOT1		ENSG00000137312	"Flotillin 1"	O75955	6	30727709-30742732	"Plasma proteins, Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 314.3"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"GAMG: 423.3;hTERT-RPE1: 242.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001393, CAB007766"	Enhanced		Approved	"Golgi apparatus,Vesicles,Plasma membrane"		NA	NA		160000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 72: Non-specific - Transcription"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Golgi apparatus"	"Vesicles, Plasma membrane"	"CAB007766: AB_562116, HPA001393: AB_1078892"	"unprognostic (2.68e-1)"	"unprognostic (2.23e-1)"	"prognostic unfavorable (5.78e-4)"	"unprognostic (1.78e-2)"	"unprognostic (2.21e-1)"	"unprognostic (3.41e-3)"	"unprognostic (2.68e-3)"	"unprognostic (1.86e-1)"	"unprognostic (2.65e-1)"	"prognostic favorable (3.06e-4)"	"unprognostic (1.81e-2)"	"unprognostic (9.36e-2)"	"prognostic unfavorable (1.49e-4)"	"unprognostic (6.43e-3)"	"unprognostic (3.92e-1)"	"unprognostic (1.61e-2)"	"unprognostic (2.46e-2)"	141.7	239.5	49.3	27.9	54.6	41.7	129.8	49.4	60.9	111.1	56.8	150.3	28.7	108.9	8.4	81.8	95.8	23.1	234.5	55.1	57.9	146.1	127.3	136.8	22.1	50.9	51.5	84.1	88.5	41.4	102.5	35.0	57.4	109.6	17.7	6.3	99.1	45.8	190.0	51.7	87.1	33.0	45.8	129.6	96.9	65.0	53.6	24.9	111.7	83.1	17.0	134.5	96.9	48.8	54.3	18.3	46.4	62.0	49.1	71.0	1.3	59.7	67.5	82.8	79.3	19.4	30.0	13.0	29.0	101.3	423.3	41.8	35.0	20.1	28.6	36.1	1.3	41.1	17.5	19.1	119.2	12.2	67.0	75.4	30.6	40.9	71.3	242.7	65.9	37.9	21.7	52.7	77.9	22.9	38.0	14.5	15.1	29.4	15.7	20.2	48.4	38.0	30.3	13.0	16.4	17.2	33.7	28.7	164.6	30.4	43.8	10.1	44.0	199.5	37.6	20.6	120.6	18.6	19.7	28.8	26.2	42.6	122.7	179.3	76.9	132.0	35.0	38.9	24.1	28.0	21.3	30.4	58.9	23.0	23.7	27.4	314.3	79.9	26.3	59.2	3.9	58.3	49.3	54.6	49.4	60.9	55.1	57.9	50.9	51.5	57.4	45.8	53.6	48.8	175.4	89.8	77.0	26.1	38.1	28.7	111.5	44.9	80.2	14.7	72.1	73.4	90.6	62.9	59.2	84.6	6.2	82.2	57.7	103.2	123.3	77.6	60.2	73.9	50.1	141.6	68.8	41.7	41.3	85.9	70.7	67.6	55.5	75.2	143.3	41.4	154.9	59.7	130.6	20.2	40.2	66.6	57.0	61.3	84.9	144.1	61.8	89.4	71.2	28.1	99.2	64.7	68.0	27.2	22.7	65.7	112.0	38.0	60.4	69.5	89.0	172.1	80.7	18.1	52.6	58.1	65.9	80.2	26.7	63.7	26.9	61.6	51.2	29.1	83.2	99.4
IER3	"DIF-2, IEX-1, IEX-1L, PRG1"	ENSG00000137331	"Immediate early response 3"	P46695	6	30743199-30744548	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Glandular and luminal cells: 2626.8"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"A-431: 155.9;EFO-21: 55.6;HBEC3-KT: 189.9;RPTEC TERT1: 203.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA043847	Approved					NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 44: Endometrium - Transcription"			"HPA043847: AB_2678699"	"unprognostic (2.83e-3)"	"unprognostic (9.04e-3)"	"unprognostic (1.22e-1)"	"unprognostic (2.78e-2)"	"unprognostic (9.63e-3)"	"prognostic unfavorable (5.57e-4)"	"prognostic unfavorable (6.36e-5)"	"unprognostic (1.38e-3)"	"unprognostic (1.69e-1)"	"unprognostic (9.28e-2)"	"unprognostic (1.53e-3)"	"unprognostic (1.19e-2)"	"prognostic unfavorable (3.10e-7)"	"unprognostic (1.76e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.71e-2)"	"unprognostic (8.77e-2)"	153.6	102.5	0.0	14.4	0.0	0.0	48.2	0.0	0.4	176.4	0.0	81.3	0.0	40.5	3.4	257.9	56.5	0.0	167.9	0.0	0.0	257.1	101.1	158.3	0.0	0.0	0.0	32.5	98.5	0.0	32.3	0.0	0.0	59.4	0.0	1.1	90.2	0.0	12.9	88.8	40.8	0.0	0.0	67.4	157.7	6.3	0.0	0.0	32.3	0.0	1.0	50.9	199.7	0.0	155.9	0.0	0.0	18.0	4.4	5.8	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.4	55.6	9.9	16.2	0.0	0.0	189.9	0.0	0.6	7.1	0.0	0.0	0.7	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	203.4	24.3	0.0	0.5	0.0	0.4	0.7	0.0	0.0	0.4	0.0	0.0	0.5	0.0	0.1	1.3	0.7	1.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	307.4	208.3	142.4	2.6	47.9	457.7	865.5	557.8	905.5	1.8	735.2	929.2	8.5	175.8	321.4	101.2	0.0	40.3	179.1	634.3	82.2	1141.6	1.4	889.8	539.8	400.7	147.9	3.6	2.9	710.7	58.1	824.8	431.2	2626.8	124.9	5.8	69.7	19.6	329.5	3.3	2.0	656.2	105.8	110.1	711.5	3.6	9.9	914.8	236.5	35.6	295.3	16.0	10.3	1.0	0.6	802.4	671.0	6.8	52.7	658.9	85.3	18.4	85.0	3.3	26.3	331.4	552.5	0.3	2.2	1251.9	329.2	83.0	92.2	35.5	434.9	644.5
DDR1	"CAK, CD167, EDDR1, NEP, NTRK4, PTK3A, RTK6"	ENSG00000204580	"Discoidin domain receptor tyrosine kinase 1"	Q08345	6	30876421-30900156	"CD markers, Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Lactation, Pregnancy"	"Kinase, Receptor, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HaCaT: 90.9;HBEC3-KT: 70.1;RT4: 93.5;T-47d: 103.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010162, CAB025656, HPA057194"	Approved		Approved	"Nucleoplasm,Cell Junctions"	"Intracellular and membrane"	NA	NA		4400000	"Cluster 30: Non-specific - Translation"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 15: RT4 - Unknown function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Nucleoplasm, Cell Junctions"		"CAB010162: AB_2092090, CAB025656: , HPA057194: "	"unprognostic (2.11e-2)"	"unprognostic (9.31e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.07e-1)"	"unprognostic (7.75e-3)"	"unprognostic (6.43e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.50e-1)"	"unprognostic (4.41e-2)"	"prognostic favorable (3.31e-10)"	"unprognostic (1.42e-1)"	"unprognostic (2.53e-1)"	"unprognostic (5.49e-3)"	"unprognostic (4.09e-2)"	26.5	50.4	24.1	5.3	49.5	0.4	54.6	47.9	20.2	55.2	4.8	57.7	12.3	23.4	4.5	150.1	46.2	11.4	42.1	17.5	40.7	96.8	6.3	33.7	1.2	68.7	47.3	41.5	99.7	19.7	67.9	4.2	57.9	70.2	10.7	4.5	131.7	13.8	40.5	121.1	47.3	1.1	38.8	11.5	71.1	16.5	46.3	7.0	85.9	4.3	3.0	45.0	88.4	58.9	58.2	18.5	26.0	5.4	1.7	2.4	16.2	1.4	0.4	0.8	0.1	25.2	29.8	0.5	30.9	5.1	26.8	90.9	5.7	70.1	0.3	32.0	9.9	0.2	18.7	6.7	5.0	0.0	1.2	3.3	35.4	0.4	0.5	16.1	2.0	1.4	17.3	0.7	4.0	36.5	2.0	0.1	4.5	31.8	3.8	3.9	19.5	2.2	13.1	93.5	4.7	2.5	5.4	41.4	19.4	8.6	103.0	0.6	4.3	12.8	11.7	1.2	13.6	0.8	0.1	2.6	8.4	0.0	11.2	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.2	24.1	49.5	47.9	20.2	17.5	40.7	68.7	47.3	57.9	38.8	46.3	58.9	1.9	35.3	24.6	54.5	3.8	53.0	68.3	125.5	67.2	7.4	77.0	57.9	18.0	37.1	79.8	90.1	0.0	63.6	1.5	109.7	5.9	125.5	15.1	58.5	6.5	4.1	46.2	2.7	1.2	76.2	26.0	7.4	63.7	58.4	1.3	29.5	2.2	0.6	6.1	6.7	7.5	69.8	109.9	0.8	5.4	30.1	8.4	2.5	16.0	9.4	13.1	139.9	1.0	60.3	73.8	71.5	78.2	5.3	0.8	68.1	77.3	5.4	104.2	8.0	6.6	10.5	11.9	1.5	6.8	81.8	51.9	46.5	1.9	4.1	67.1	88.4
GTF2H4	"P52, TFB2, TFIIH"	ENSG00000213780	"General transcription factor IIH subunit 4"	Q92759	6	30908207-30914106	"Predicted intracellular proteins"	"DNA damage, DNA repair, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 12.5;Gastric mucus-secreting cells: 9.7;granulocytes: 7.0;Plasma cells: 9.2;Squamous epithelial cells: 13.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA074336			Supported	"Nuclear speckles"		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	"Nuclear speckles"		"HPA074336: AB_2686679"	"unprognostic (7.05e-2)"	"unprognostic (1.79e-1)"	"unprognostic (3.07e-1)"	"unprognostic (4.79e-4)"	"unprognostic (7.42e-2)"	"unprognostic (1.11e-1)"	"unprognostic (5.54e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.84e-1)"	"unprognostic (2.36e-2)"	"unprognostic (5.66e-4)"	"unprognostic (7.74e-3)"	"prognostic unfavorable (4.08e-4)"	"unprognostic (1.22e-1)"	"unprognostic (9.53e-2)"	"unprognostic (6.06e-2)"	"unprognostic (2.07e-2)"	12.6	11.1	5.4	6.6	6.6	4.7	11.4	6.2	7.0	12.8	4.8	12.0	1.8	12.8	1.9	14.4	10.6	2.2	9.3	5.6	6.3	14.6	21.5	10.1	5.6	5.2	5.8	12.2	11.0	6.8	13.4	3.5	4.9	10.5	4.0	1.1	8.6	3.5	13.2	9.7	10.4	1.9	6.0	11.9	12.4	11.9	6.3	8.7	13.5	3.8	3.7	11.7	11.7	8.1	20.5	15.0	15.9	16.5	16.0	11.6	17.7	3.3	5.3	5.8	9.6	14.9	9.1	12.3	8.0	21.1	11.1	16.6	10.7	21.4	10.6	18.6	2.5	10.0	11.5	13.8	10.1	0.0	17.0	18.5	20.5	9.8	0.0	10.3	6.1	9.1	35.2	11.3	11.4	25.0	22.5	16.9	18.5	10.4	6.1	28.5	0.0	11.8	20.7	11.4	9.2	4.5	0.8	11.5	8.8	9.8	16.2	13.7	6.8	15.5	21.5	16.4	28.6	11.1	13.1	9.3	8.9	16.8	7.0	1.8	1.1	0.9	0.8	1.2	0.3	1.3	1.2	1.3	2.5	0.6	1.2	2.2	0.0	1.1	0.6	1.2	2.1	0.3	5.4	6.6	6.2	7.0	5.6	6.3	5.2	5.8	4.9	6.0	6.3	8.1	0.6	0.0	0.0	4.2	4.0	0.4	0.1	0.4	12.5	0.7	1.1	0.8	0.0	1.5	0.1	0.0	2.1	0.4	0.5	0.4	1.9	0.6	0.1	1.1	1.0	1.8	0.0	4.2	4.6	0.6	0.4	1.4	9.7	1.0	7.0	0.8	0.7	1.1	0.3	0.0	3.3	0.0	0.0	1.2	1.2	0.0	0.9	1.5	1.8	1.9	0.3	0.5	0.0	3.5	2.8	0.0	1.2	0.7	9.2	0.1	0.1	0.9	0.8	0.3	0.0	0.4	1.9	1.4	0.4	13.8	1.0	0.3	3.5	0.4	0.6	0.1
VARS2	"DKFZP434L1435, G7a, KIAA1885, VARS2L, VARSL"	ENSG00000137411	"Valyl-tRNA synthetase 2, mitochondrial"	Q5ST30	6	30914205-30926459	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA062449, HPA070267"	Approved		Approved	Mitochondria		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 72: Non-specific - Transcription"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Mitochondria		"HPA062449: AB_2684766, HPA070267: AB_2686245"	"unprognostic (1.74e-1)"	"unprognostic (8.24e-2)"	"unprognostic (1.96e-3)"	"unprognostic (2.50e-1)"	"unprognostic (5.80e-2)"	"unprognostic (3.05e-2)"	"unprognostic (2.43e-2)"	"unprognostic (1.66e-2)"	"unprognostic (3.14e-1)"	"unprognostic (8.98e-2)"	"unprognostic (4.23e-2)"	"unprognostic (2.60e-2)"	"unprognostic (2.15e-3)"	"unprognostic (1.04e-2)"	"unprognostic (7.23e-2)"	"unprognostic (1.19e-2)"	"unprognostic (2.43e-2)"	10.2	14.4	1.3	2.1	1.5	1.9	9.7	1.5	1.6	12.5	0.4	10.5	1.2	10.4	1.5	22.5	10.1	0.2	11.1	1.4	1.3	12.5	18.9	10.5	3.1	1.3	1.6	15.3	14.0	2.3	17.1	0.9	1.4	10.2	2.2	1.4	10.9	1.1	20.9	10.1	12.8	0.7	1.2	13.4	11.7	11.8	1.3	4.1	15.0	0.2	2.3	10.5	13.2	1.3	13.8	9.6	5.5	23.1	4.9	4.4	0.7	2.2	1.9	2.5	1.6	12.6	8.9	11.9	7.5	3.0	9.4	0.0	21.3	0.0	2.4	4.6	15.7	13.2	10.2	0.9	6.7	2.3	0.3	6.2	8.1	5.9	1.3	0.9	1.3	19.5	0.1	10.5	5.4	0.0	4.6	0.0	1.7	0.0	1.2	9.1	0.0	10.3	18.3	0.0	8.5	0.2	0.2	6.6	5.4	5.0	16.3	7.4	2.2	14.2	1.4	1.0	0.1	10.0	17.1	18.8	0.0	0.6	8.7	0.0	0.0	0.0	0.3	0.1	0.4	0.3	0.1	0.3	0.2	0.1	0.1	0.1	0.0	0.0	0.2	0.3	0.2	0.1	1.3	1.5	1.5	1.6	1.4	1.3	1.3	1.6	1.4	1.2	1.3	1.3	3.0	6.4	12.5	14.7	8.0	4.0	4.9	4.7	4.0	6.6	6.4	3.7	11.6	8.6	5.5	9.2	0.0	8.7	4.1	10.1	1.9	6.7	1.5	7.7	5.2	3.9	13.1	3.4	8.3	7.1	9.6	4.8	11.7	8.6	12.7	12.9	7.5	22.5	9.2	8.4	9.1	8.4	2.0	6.9	3.5	1.6	4.1	5.1	1.8	3.7	7.9	2.8	4.1	8.0	7.2	8.9	4.7	4.1	12.3	2.3	12.4	12.5	8.9	6.0	0.0	2.9	3.7	10.4	8.0	9.0	4.1	3.4	4.8	6.9	10.9	3.8
SFTA2	SFTPG	ENSG00000196260	"Surfactant associated 2"	Q6UW10	6	30931353-30955636	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"esophagus: 49.1;lung: 179.1"	"Group enriched"	"Detected in many"	4	"Alveolar cells type 1: 535.2;Alveolar cells type 2: 806.4"	"Cancer enhanced"	"Detected in many"		"lung cancer: 121.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	20	"CACO-2: 12.0;CAPAN-2: 5.5"					"Not detected"	"Not detected"								"Secreted in other tissues"	NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 19: Lung - Lung function"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 11: Alveolar cells - Smell perception"				"unprognostic (5.82e-2)"	"unprognostic (1.16e-1)"	"unprognostic (7.20e-3)"	"unprognostic (6.64e-2)"	"unprognostic (3.12e-1)"	"unprognostic (1.34e-1)"		"unprognostic (6.37e-2)"		"unprognostic (2.27e-1)"	"prognostic unfavorable (1.26e-4)"	"unprognostic (1.16e-1)"	"unprognostic (3.96e-4)"	"unprognostic (8.84e-2)"	"unprognostic (2.36e-2)"	"unprognostic (5.39e-3)"	"unprognostic (7.95e-2)"	0.2	0.2	0.5	0.1	0.6	0.0	0.3	0.5	0.9	4.7	0.5	0.1	0.0	0.4	0.0	49.1	0.6	0.8	0.2	0.5	0.5	6.1	0.4	179.1	0.2	0.6	0.6	0.4	4.4	0.3	0.1	0.2	0.6	0.2	0.0	0.1	4.1	0.1	0.6	0.1	0.2	0.1	0.6	0.3	7.9	1.7	0.5	0.1	2.0	0.1	0.2	0.2	21.6	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.0	5.5	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.2	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.6	0.5	0.9	0.5	0.5	0.6	0.6	0.6	0.6	0.5	0.6	0.2	535.2	806.4	0.0	1.0	0.1	0.1	0.0	0.0	0.5	0.9	0.3	0.0	140.2	111.8	53.3	0.0	0.1	0.0	0.0	3.9	22.7	3.8	76.1	2.5	2.1	0.0	0.0	0.0	35.6	0.0	0.8	13.7	23.0	12.6	0.1	0.7	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.4	13.7	0.3	1.3	0.0	0.0	0.1	2.8	0.0	0.0	0.1	94.2	0.0	0.4	0.5	0.3	0.0	0.8	8.1	0.1	0.0	1.1	0.4	7.5	1.7	2.8	0.0	0.0	1.7	0.1	0.1	1.1
MUCL3	"bCX105N19.6, C6orf37, DPCR1, PBLT"	ENSG00000168631	"Mucin like 3"	Q3MIW9	6	30934523-30954221	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	19	"stomach 1: 202.8"	"Cell type enriched"	"Detected in some"	20	"Pancreatic endocrine cells: 239.5"	"Group enriched"	"Detected in some"	9	"pancreatic cancer: 56.8;stomach cancer: 55.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"OE19: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA014036	Enhanced					NA	NA				"Cluster 4: Stomach - Digestion"	"Cluster 21: OE19 - Mitochondria"	"Cluster 16: Pancreatic endocrine cells - Mixed function"			"HPA014036: AB_1847841"	"unprognostic (2.81e-1)"	"unprognostic (4.49e-2)"	"unprognostic (9.13e-4)"	"unprognostic (6.74e-2)"	"unprognostic (4.29e-2)"	"unprognostic (8.06e-2)"	"unprognostic (3.08e-1)"	"unprognostic (1.03e-1)"	"unprognostic (3.32e-3)"	"unprognostic (2.79e-1)"	"prognostic unfavorable (6.58e-4)"	"unprognostic (1.13e-1)"	"unprognostic (5.97e-2)"	"unprognostic (4.76e-2)"	"unprognostic (9.80e-2)"	"unprognostic (3.20e-2)"	"unprognostic (3.58e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	10.5	0.0	9.9	0.0	0.0	0.0	0.0	0.2	3.6	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	202.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	11.6	0.0	0.2	0.1	0.0	0.0	0.0	0.0	6.6	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	239.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0
MUC21	"bCX31G15.2, C6orf205"	ENSG00000204544	"Mucin 21, cell surface associated"	Q5SSG8	6	30983718-30989903	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"cervix: 135.8;esophagus: 696.3;vagina: 244.5"	"Group enriched"	"Detected in some"	5	"Club cells: 11.8;Squamous epithelial cells: 37.7;Urothelial cells: 32.0"	"Group enriched"	"Detected in many"	9	"cervical cancer: 6.8;head and neck cancer: 6.6;lung cancer: 13.9;stomach cancer: 7.0;thyroid cancer: 5.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							HPA052028	Enhanced					NA	NA				"Cluster 84: Esophagus - Epithelial cell function"		"Cluster 61: Squamous epithelial cells - Keratinization"			"HPA052028: AB_2681700"	"unprognostic (2.27e-2)"	"unprognostic (4.85e-3)"		"unprognostic (5.24e-3)"		"unprognostic (1.68e-2)"		"unprognostic (2.68e-2)"		"unprognostic (2.98e-3)"	"unprognostic (1.32e-4)"			"unprognostic (1.05e-1)"	"unprognostic (1.53e-1)"	"unprognostic (3.24e-2)"	"unprognostic (7.81e-2)"	0.2	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	135.8	0.0	0.1	0.0	0.1	0.0	696.3	0.2	0.0	0.1	0.0	0.0	0.1	0.3	1.3	0.0	0.0	0.0	0.2	0.4	0.0	0.6	0.0	0.0	0.3	0.0	0.0	106.8	0.0	0.3	0.2	0.1	0.0	0.0	0.1	1.7	0.1	0.1	0.0	0.1	0.0	13.4	0.2	244.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	5.4	0.0	0.0	0.0	1.2	1.6	0.0	0.0	0.0	0.0	0.2	0.0	11.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	37.7	0.0	0.0	0.3	0.1	0.0	32.0
MUC22	PBMUCL1	ENSG00000261272	"Mucin 22"	E2RYF6	6	31010474-31035402	"Human disease related genes, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"esophagus: 17.8"	"Cell type enriched"	"Detected in single"	6	"Microglial cells: 1.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																	NA	NA				"Cluster 84: Esophagus - Epithelial cell function"		"Cluster 44: Endometrium - Transcription"					"unprognostic (2.38e-1)"			"unprognostic (1.57e-1)"	"unprognostic (1.46e-1)"		"unprognostic (1.91e-1)"		"unprognostic (4.03e-1)"			"unprognostic (1.46e-2)"	"unprognostic (9.88e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.65e-1)"	"unprognostic (1.35e-3)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	17.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
C6orf15	STG	ENSG00000204542	"Chromosome 6 open reading frame 15"	Q6UXA7	6	31111223-31112575	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"cervix: 5.5;lymphoid tissue: 3.5;skin 1: 6.7"	"Cell type enriched"	"Detected in some"	14	"Breast glandular cells: 73.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	11	"RH-30: 13.4;U-2 OS: 5.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA001436	Uncertain				"Secreted to extracellular matrix"	NA	NA				"Cluster 31: Skin - Epidermis development"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 30: Mammary glandular cells - Lactation"			"HPA001436: AB_2243752"	"unprognostic (2.73e-2)"	"unprognostic (5.39e-2)"	"unprognostic (1.46e-2)"	"unprognostic (3.19e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.56e-1)"		"unprognostic (1.77e-1)"	"unprognostic (3.35e-1)"	"unprognostic (3.42e-2)"	"unprognostic (1.71e-2)"			"unprognostic (1.72e-1)"		"unprognostic (1.90e-1)"	"unprognostic (1.34e-3)"	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	6.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	3.5	0.0	0.6	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	13.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	73.3	2.8	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	2.3	0.0	1.3	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
PSORS1C1	"C6orf16, SEEK1"	ENSG00000204540	"Psoriasis susceptibility 1 candidate 1"	Q9UIG5	6	31114750-31140092	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	33	"testis: 109.9"	"Group enriched"	"Detected in many"	4	"Early spermatids: 358.6;Late spermatids: 1285.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"hTCEpi: 1.5"									HPA045049			Uncertain	Nucleoplasm		NA	NA				"Cluster 83: Testis - Spermatogenesis"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA045049: "	"unprognostic (1.15e-1)"	"unprognostic (4.25e-2)"	"unprognostic (2.28e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.72e-1)"	"unprognostic (9.23e-2)"	"unprognostic (4.77e-3)"	"unprognostic (8.48e-2)"	"unprognostic (3.05e-3)"	"unprognostic (1.66e-2)"	"unprognostic (4.17e-2)"	"unprognostic (9.56e-2)"	"unprognostic (5.72e-3)"	"unprognostic (4.80e-2)"	"unprognostic (1.59e-1)"	"unprognostic (6.33e-2)"	"unprognostic (1.30e-1)"	0.7	0.4	0.1	0.0	0.1	0.0	0.8	0.0	0.1	0.8	0.0	1.5	0.0	0.9	2.3	0.9	0.5	0.0	0.4	0.1	0.0	1.0	0.0	1.7	0.0	0.0	0.0	0.7	0.2	0.0	0.1	0.0	0.0	0.9	0.2	0.0	0.9	0.1	0.0	3.3	1.8	0.0	0.0	0.2	1.4	109.9	0.0	0.0	1.0	0.0	0.0	0.6	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	1.5	0.1	0.2	0.0	0.0	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	19.2	3.2	0.7	0.0	8.8	3.8	5.4	3.4	0.0	7.5	3.4	3.3	12.8	2.7	9.2	0.0	0.2	0.1	55.1	0.0	17.7	358.6	3.6	3.3	4.6	3.0	0.0	0.4	2.2	0.6	5.8	20.9	11.6	0.0	0.0	3.6	0.1	0.4	0.0	0.3	4.9	0.0	0.0	3.0	1285.1	9.3	0.4	3.6	0.0	0.6	0.7	0.0	2.0	2.4	12.2	131.7	6.8	0.0	2.7	26.0	1.0	0.6	0.0	6.6	0.9	1.3	170.3	31.8	3.5	10.5	0.1	0.4	0.2	6.9	2.4
CDSN	D6S586E	ENSG00000204539	Corneodesmosin		6	31115087-31120446	"Human disease related genes, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enriched"	"Detected in some"	104	"skin 1: 696.5"	"Cell type enhanced"	"Detected in some"		"Endometrial ciliated cells: 2.6;Gastric mucus-secreting cells: 2.0;Glandular and luminal cells: 7.1;granulocytes: 4.5;Suprabasal keratinocytes: 5.3"	"Group enriched"	"Detected in some"	8	"head and neck cancer: 2.4;melanoma: 2.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	7	"A-431: 1.6"	"Region enhanced"	"Detected in some"		"cerebral cortex: 1.5"	"Not detected"	"Not detected"			"HPA044730, HPA054184"	Enhanced				"Secreted in other tissues"	NA	NA				"Cluster 61: Skin - Cornification"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 44: Endometrium - Transcription"			"HPA044730: AB_10964923, HPA054184: AB_2682409"	"unprognostic (1.46e-1)"	"unprognostic (6.96e-2)"	"unprognostic (1.20e-1)"		"unprognostic (1.85e-1)"	"unprognostic (3.44e-2)"		"unprognostic (8.80e-2)"	"unprognostic (8.13e-2)"	"unprognostic (3.92e-4)"	"unprognostic (3.92e-3)"		"unprognostic (1.74e-4)"	"unprognostic (6.34e-2)"		"unprognostic (2.75e-1)"	"unprognostic (2.22e-1)"	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.9	0.0	0.1	0.0	0.1	3.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.7	696.5	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	6.6	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.9	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.9	0.4	2.6	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.1	2.0	7.1	4.5	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.2	1.2	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	5.3	0.0	0.0	0.0	0.0	0.2
PSORS1C2	"C6orf17, SPR1"	ENSG00000204538	"Psoriasis susceptibility 1 candidate 2"	Q9UIG4	6	31137534-31139066	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	53	"skin 1: 188.2"	"Group enriched"	"Detected in some"	8	"Endometrial ciliated cells: 3.3;Glandular and luminal cells: 9.0;Melanocytes: 8.8;Suprabasal keratinocytes: 7.0"	"Cancer enhanced"	"Detected in many"		"testis cancer: 14.6;urothelial cancer: 20.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA061228	Enhanced				"Secreted in other tissues"	NA	NA				"Cluster 61: Skin - Cornification"		"Cluster 44: Endometrium - Transcription"			"HPA061228: AB_2684455"	"unprognostic (8.86e-2)"	"unprognostic (7.73e-2)"	"unprognostic (1.52e-1)"	"unprognostic (5.67e-2)"	"unprognostic (5.20e-3)"	"unprognostic (1.67e-1)"		"unprognostic (1.75e-1)"	"unprognostic (2.03e-2)"	"unprognostic (3.78e-1)"	"unprognostic (1.64e-2)"	"unprognostic (1.06e-1)"	"unprognostic (9.40e-5)"	"unprognostic (2.09e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.66e-1)"	1.7	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.7	0.0	0.3	0.0	0.2	0.0	3.5	0.1	0.0	0.2	0.0	0.0	0.2	0.1	0.3	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.1	188.2	0.4	0.0	0.0	0.0	0.4	1.8	0.0	0.0	0.3	0.0	0.2	0.2	2.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.8	0.0	0.0	0.8	0.4	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	8.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	7.0	0.0	0.0	0.1	0.0	0.5
CCHCR1	"C6orf18, HCR"	ENSG00000204536	"Coiled-coil alpha-helical rod protein 1"	Q8TD31	6	31142439-31158238	"Predicted intracellular proteins"	Differentiation	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"testis: 138.9"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 89.7;Endometrial ciliated cells: 68.0;Glandular and luminal cells: 161.9;Late spermatids: 160.7;Spermatocytes: 68.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A-431: 38.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA054167			Supported	Cytosol		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 44: Endometrium - Transcription"	Cytosol		"HPA054167: AB_2682403"	"unprognostic (6.68e-2)"	"unprognostic (7.98e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.88e-1)"	"unprognostic (3.11e-3)"	"unprognostic (2.23e-3)"	"unprognostic (1.99e-1)"	"unprognostic (2.74e-1)"	"unprognostic (5.36e-3)"	"unprognostic (1.65e-1)"	"unprognostic (2.07e-1)"	"unprognostic (3.85e-3)"	"unprognostic (1.06e-1)"	"unprognostic (4.35e-2)"	"unprognostic (3.57e-1)"	"unprognostic (4.17e-2)"	10.4	7.6	1.4	2.8	1.4	1.3	11.8	1.6	2.3	18.1	1.5	16.2	10.1	12.4	5.7	15.1	18.7	1.7	11.7	1.5	1.6	19.7	12.2	9.0	6.9	1.6	1.4	19.0	14.5	1.3	9.3	0.9	1.9	19.9	3.3	1.2	11.4	4.0	19.3	17.4	14.7	1.6	1.0	13.3	13.9	138.9	2.2	2.1	16.1	1.1	1.7	13.4	15.4	1.5	38.9	3.0	9.8	1.6	6.1	7.4	8.8	3.3	1.1	0.5	1.2	14.9	0.7	5.1	17.6	8.5	23.1	1.6	0.6	15.4	1.5	5.8	23.9	18.1	13.2	11.7	3.7	0.4	11.5	9.7	1.8	6.9	1.5	7.2	8.1	27.2	7.3	10.3	4.1	2.8	6.7	19.9	0.6	1.4	0.2	12.0	13.8	9.6	9.6	3.8	29.2	4.9	11.7	0.0	2.8	6.0	4.2	9.3	1.0	14.5	4.8	0.3	9.4	23.7	14.7	20.7	3.1	4.4	1.5	0.2	0.6	0.5	0.9	0.3	0.8	0.3	0.8	1.4	0.5	0.6	1.3	1.3	0.0	1.0	0.4	1.2	1.5	0.6	1.4	1.4	1.6	2.3	1.5	1.6	1.6	1.4	1.9	1.0	2.2	1.5	8.0	3.2	5.1	10.4	7.7	9.7	13.0	12.8	8.6	9.6	8.2	10.9	8.7	11.5	11.0	3.7	0.0	3.1	5.4	41.9	11.7	8.9	89.7	68.0	19.0	6.7	29.3	6.3	5.2	10.5	7.5	7.7	28.5	161.9	0.0	15.0	5.7	7.5	6.8	15.2	4.3	27.6	0.0	5.0	3.7	160.7	9.9	5.4	7.2	1.9	8.4	5.1	9.2	0.5	1.8	8.4	17.3	11.7	6.7	9.0	36.2	7.6	15.9	2.3	6.6	9.2	8.6	68.6	21.1	7.3	5.8	1.4	6.0	14.7	35.9	8.3
TCF19	SC1	ENSG00000137310	"Transcription factor 19"	Q9Y242	6	31158547-31167159	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Erythroid cells: 37.0;Glandular and luminal cells: 17.6;Plasma cells: 21.1"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"A-431: 82.8;GAMG: 47.0;HEK 293: 43.3;JURKAT: 40.9;Karpas-707: 39.2;SCLC-21H: 48.5;U-138 MG: 49.0"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA065994			Approved	Nucleoplasm,Nucleoli		NA	Yes			"Cluster 35: T-regs - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	Nucleoli	"HPA065994: "	"unprognostic (1.41e-2)"	"unprognostic (4.92e-2)"	"unprognostic (4.00e-2)"	"unprognostic (5.16e-3)"	"unprognostic (1.99e-2)"	"unprognostic (6.04e-2)"	"prognostic unfavorable (5.66e-4)"	"unprognostic (7.04e-2)"	"unprognostic (1.35e-2)"	"unprognostic (5.92e-2)"	"unprognostic (1.74e-3)"	"unprognostic (1.56e-2)"	"prognostic unfavorable (3.54e-10)"	"unprognostic (3.11e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.36e-2)"	"unprognostic (1.21e-1)"	4.6	1.7	0.3	2.6	0.4	1.0	4.3	0.7	0.4	6.9	0.2	5.8	4.4	4.2	2.1	12.5	3.8	0.4	3.7	0.3	0.3	4.1	2.0	4.4	10.0	0.5	0.4	4.8	3.2	0.0	1.3	0.3	0.5	5.1	1.7	0.6	4.7	0.8	2.7	8.9	7.2	1.1	0.3	9.5	5.5	1.9	0.7	0.0	2.4	0.1	1.7	5.2	8.1	0.3	82.8	0.7	0.7	0.1	5.4	7.0	0.7	0.5	0.0	0.1	0.1	5.3	0.1	0.1	17.7	20.1	47.0	0.1	0.0	30.3	0.0	0.5	43.3	7.3	5.1	2.0	0.0	0.2	21.1	2.9	0.0	2.3	0.0	4.4	17.9	40.9	0.1	39.2	8.1	0.3	1.2	13.2	0.1	0.0	0.0	1.1	4.8	0.7	7.1	0.3	48.5	0.5	0.4	0.1	0.5	6.5	0.1	6.0	0.0	49.0	0.2	0.4	0.4	12.5	15.0	24.8	0.1	0.3	0.3	0.0	0.1	0.0	0.2	0.0	1.3	0.5	0.6	1.1	0.3	0.5	0.8	0.2	0.1	0.4	0.0	0.0	1.0	0.5	0.3	0.4	0.7	0.4	0.3	0.3	0.5	0.4	0.5	0.3	0.7	0.3	2.8	3.2	0.6	0.7	6.7	5.1	3.1	2.5	8.6	3.0	2.8	2.9	1.2	0.0	2.5	3.7	0.0	2.9	3.9	1.8	7.9	1.3	0.3	4.7	2.0	4.7	1.2	37.0	0.1	1.8	9.6	5.6	5.6	17.6	1.3	7.0	1.8	0.6	8.9	1.7	0.2	3.9	2.0	2.9	5.4	0.7	5.0	4.8	12.4	0.0	6.0	4.2	8.2	0.0	0.2	1.1	0.9	6.4	21.1	1.3	1.6	0.4	0.2	0.5	0.0	3.5	5.3	0.7	11.1	9.6	3.8	0.4	7.6	2.0	8.8	2.9
POU5F1	"MGC22487, OCT3, Oct4, OTF3"	ENSG00000204531	"POU class 5 homeobox 1"	Q01860	6	31164337-31180731	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 16.5"	"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 27.9;Glandular and luminal cells: 67.8"	"Cancer enriched"	"Detected in many"	34	"testis cancer: 355.9"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	51	"SuSa: 287.4"	"Not detected"	"Not detected"							"CAB025600, CAB026380, HPA058267, CAB079773"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 12: NES - Nervous system development"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	Cytosol	"CAB025600: , CAB026380: , CAB079773: AB_2687916, HPA058267: AB_2683659"	"unprognostic (3.25e-2)"	"unprognostic (3.12e-1)"	"unprognostic (2.87e-1)"	"unprognostic (1.06e-2)"	"unprognostic (3.02e-2)"	"unprognostic (2.11e-2)"	"unprognostic (2.62e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.59e-1)"	"unprognostic (9.27e-2)"	"unprognostic (2.27e-2)"	"unprognostic (4.79e-2)"	"unprognostic (1.19e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.35e-1)"	"unprognostic (3.86e-2)"	"prognostic favorable (2.04e-5)"	1.1	0.3	1.2	1.0	1.0	1.5	1.2	1.5	1.2	6.3	0.4	4.9	4.3	2.3	2.4	1.8	7.1	2.1	3.3	1.0	0.7	16.5	8.0	3.7	1.0	1.3	0.8	0.5	13.0	0.0	0.3	0.2	1.1	7.6	1.1	0.7	0.8	2.4	1.0	2.2	8.0	0.3	0.2	2.0	10.1	1.3	1.3	0.2	0.9	0.3	0.3	10.2	2.0	1.9	3.6	1.8	0.4	0.7	0.0	0.0	0.8	0.5	0.0	0.0	0.0	0.0	1.3	0.3	5.6	0.1	0.4	2.9	0.7	3.1	0.0	0.6	1.4	0.6	3.3	2.5	0.2	0.9	0.8	0.3	0.6	0.3	0.9	0.2	0.0	0.7	0.1	1.0	1.0	0.2	0.3	1.0	2.9	0.6	0.1	0.8	0.6	0.7	4.8	3.8	0.6	0.1	1.0	0.2	0.3	287.4	0.6	0.4	0.0	0.7	0.5	1.8	0.3	1.3	1.3	1.6	0.5	1.3	0.5	0.4	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.5	0.1	0.0	0.3	0.2	0.1	0.3	0.0	0.1	1.2	1.0	1.5	1.2	1.0	0.7	1.3	0.8	1.1	0.2	1.3	1.9	1.0	0.0	1.1	0.0	0.9	5.2	2.7	5.3	2.8	0.5	0.7	0.8	0.4	10.0	2.3	9.2	2.1	0.0	0.1	9.2	0.0	6.7	0.0	27.9	5.9	1.2	1.2	0.0	0.2	6.6	0.1	0.7	11.2	67.8	0.0	0.1	0.4	2.4	0.1	0.0	0.1	6.4	2.0	0.0	1.5	0.2	0.0	0.7	1.8	1.0	0.7	0.1	1.0	0.5	0.1	12.6	12.5	0.7	0.2	5.6	10.1	2.0	1.6	1.0	0.0	1.4	1.2	0.1	0.8	0.8	3.8	0.1	0.8	0.0	4.1	4.3
HLA-C	"D6S204, HLA-JY3, PSORS1"	ENSG00000204525	"Major histocompatibility complex, class I, C"	P10321	6	31268749-31272130	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Host-virus interaction, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 1445.7"	"Cell type enhanced"	"Detected in all"		"NK-cells: 3899.1;Proximal enterocytes: 3582.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A-431: 760.0;EFO-21: 795.5;RPTEC TERT1: 462.7;U-266/70: 481.6;U-266/84: 401.0;U-698: 289.3"														"Intracellular and membrane"	NA	NA		240000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 64: Macrophages - Immune response"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 63: NK-cells & T-cells - Immune response"				"unprognostic (2.17e-1)"	"unprognostic (3.38e-1)"	"unprognostic (3.05e-2)"	"unprognostic (4.42e-2)"	"unprognostic (1.56e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.90e-3)"	"unprognostic (3.23e-3)"	"unprognostic (1.17e-1)"	"unprognostic (2.39e-1)"	"unprognostic (2.34e-1)"	"unprognostic (2.00e-1)"	"unprognostic (8.12e-2)"	"unprognostic (1.87e-2)"	"unprognostic (7.16e-2)"	538.6	417.5	0.7	274.6	2.4	122.3	507.4	0.8	0.9	464.4	1.5	594.3	1.6	434.8	259.5	277.6	411.7	103.9	424.3	0.3	1.1	561.0	485.7	1078.3	334.0	1.6	0.9	266.3	245.3	0.2	269.6	34.5	0.9	344.2	27.7	13.7	389.5	0.4	190.6	449.6	750.0	51.0	1.3	1445.7	419.4	62.3	1.2	2.4	382.9	0.3	0.7	372.7	377.5	0.8	760.0	1.1	0.0	0.0	120.1	94.1	1.7	3.1	0.9	1.1	2.3	0.9	0.0	0.4	795.5	190.8	208.7	0.5	0.0	188.1	0.0	1.4	170.4	0.8	8.1	0.1	0.8	0.5	0.5	80.5	0.2	0.5	0.0	272.4	0.0	92.5	0.4	0.0	0.0	0.0	7.8	4.8	0.5	0.0	0.8	1.9	0.3	1.9	462.7	0.0	0.9	1.5	0.2	0.1	2.2	0.3	0.3	3.3	0.6	196.4	65.8	2.3	2.5	481.6	401.0	289.3	0.3	8.2	0.2	1.9	2.8	2.3	0.7	0.8	0.6	0.4	0.4	0.6	0.4	0.4	0.4	0.5	2.8	0.8	0.3	0.1	0.9	46.1	0.7	2.4	0.8	0.9	0.3	1.1	1.6	0.9	0.9	1.3	1.2	0.8	1903.4	227.6	328.1	13.1	1576.5	729.1	757.8	1082.3	236.8	33.4	457.0	342.8	61.2	807.8	662.7	483.7	10.4	39.5	2429.1	1994.0	84.1	1966.4	25.6	233.7	343.8	1466.2	482.2	301.2	3.9	1511.3	1010.7	608.5	648.8	557.2	344.1	256.3	1390.0	469.2	1579.0	99.3	5.8	1375.7	923.7	2050.7	1492.7	32.1	507.3	1595.9	836.0	76.8	2570.1	207.3	3899.1	18.6	3.8	1272.7	2195.7	333.6	2482.6	1038.0	3582.3	232.5	548.5	24.0	1203.0	336.7	558.8	142.0	43.5	192.6	651.7	121.6	2212.1	786.8	1003.1	1160.6
HLA-B	AS	ENSG00000234745	"Major histocompatibility complex, class I, B"	P01889	6	31353872-31357188	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Host-virus interaction, Immunity, Innate immunity"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 2493.7"	"Cell type enhanced"	"Detected in all"		"monocytes: 5683.6;NK-cells: 7881.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A-431: 638.3;EFO-21: 547.1;U-266/70: 1285.6;U-698: 377.2"									CAB015418	Enhanced					NA	NA		190000000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 64: Macrophages - Immune response"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"			"CAB015418: AB_831547"	"unprognostic (2.87e-2)"	"unprognostic (1.49e-1)"	"unprognostic (4.90e-2)"	"unprognostic (2.65e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.81e-1)"	"unprognostic (5.16e-3)"	"unprognostic (8.51e-2)"	"prognostic favorable (2.90e-4)"	"unprognostic (2.69e-3)"	"unprognostic (3.05e-2)"	"unprognostic (1.59e-1)"	"unprognostic (9.28e-3)"	"unprognostic (3.27e-1)"	"unprognostic (7.83e-2)"	"unprognostic (8.24e-3)"	"unprognostic (3.67e-2)"	944.9	581.6	5.5	429.4	8.1	53.5	850.0	5.5	14.4	552.0	6.0	912.0	4.7	567.1	222.1	434.4	488.6	461.2	563.1	4.6	6.7	731.7	488.9	1646.3	1061.9	9.6	10.4	296.9	268.7	24.2	288.3	106.6	7.5	439.2	238.5	8.1	485.9	3.8	237.9	936.4	1295.6	75.4	7.7	2493.7	540.1	132.6	6.7	4.4	593.2	3.8	414.9	476.2	582.0	7.9	638.3	0.0	0.0	0.1	13.5	98.9	3.8	0.5	1.2	0.5	1.1	0.0	1.9	22.7	547.1	111.0	203.2	231.9	116.4	112.4	0.0	2.3	29.9	8.3	0.8	0.0	79.8	0.2	2.4	200.2	0.5	0.0	13.9	183.3	0.4	39.8	1.3	30.2	0.0	0.3	1.5	161.4	0.6	0.0	0.1	19.7	3.4	4.7	163.5	0.6	0.9	3.7	5.5	1.4	1.4	0.2	32.6	6.2	134.7	21.4	4.8	4.9	2.3	1285.6	291.0	377.2	1.1	6.5	0.6	141.1	196.5	232.6	233.0	163.6	215.7	162.4	194.8	198.8	150.8	113.0	150.9	212.0	420.5	179.3	123.6	127.3	213.1	400.2	5.5	8.1	5.5	14.4	4.6	6.7	9.6	10.4	7.5	7.7	6.7	7.9	2836.3	913.5	1007.9	14.0	2936.9	1165.9	761.2	1139.6	396.1	27.7	533.2	550.2	168.5	1382.6	948.3	388.1	6.2	31.4	3876.2	3264.3	68.4	4206.8	63.9	311.6	349.2	2480.7	836.0	550.3	1.4	1771.3	182.3	777.7	1044.4	773.2	620.5	212.5	2189.2	701.5	2602.0	60.6	3.4	2121.8	1129.1	4229.7	2158.6	65.7	644.9	2674.7	891.2	126.5	5683.6	209.2	7881.6	25.1	3.9	2085.3	2327.5	306.9	2983.6	993.4	4541.4	183.9	829.4	27.3	1314.8	356.3	729.7	652.9	91.6	360.3	1004.3	50.9	3661.2	1219.5	1527.4	1161.2
MICA	PERB11.1	ENSG00000204520	"MHC class I polypeptide-related sequence A"		6	31399784-31415315	"Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"GAMG: 97.7;HSkMC: 65.6;hTERT-RPE1: 52.5;RPTEC TERT1: 44.6"															NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 16: Pancreatic endocrine cells - Mixed function"				"unprognostic (1.94e-1)"	"prognostic unfavorable (5.88e-4)"	"unprognostic (1.01e-1)"	"unprognostic (6.55e-2)"	"unprognostic (2.66e-2)"	"unprognostic (6.10e-2)"	"unprognostic (5.19e-2)"	"unprognostic (4.09e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.23e-1)"	"unprognostic (4.92e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.12e-2)"	30.8	35.3	1.5	5.2	2.4	6.1	29.3	3.6	5.6	53.4	2.7	36.8	3.7	29.1	10.9	20.3	34.0	10.6	28.9	2.1	2.3	34.5	28.6	43.1	7.2	2.6	2.4	49.9	21.6	2.9	10.7	3.4	2.3	32.1	6.6	2.3	20.0	1.2	10.5	20.5	23.0	4.3	2.0	28.5	23.1	17.3	2.3	2.2	29.5	4.2	2.5	32.4	39.1	4.2	44.5	0.3	2.4	3.5	32.3	41.3	0.7	2.0	1.4	1.4	1.3	2.0	0.1	1.8	25.8	38.3	97.7	26.0	31.1	38.4	4.4	1.7	17.1	0.0	39.4	0.7	11.9	0.0	1.4	65.6	0.1	0.3	0.5	52.5	0.9	5.4	4.5	5.5	2.7	0.4	0.7	6.0	1.4	0.2	0.0	1.3	0.0	4.6	44.6	0.6	0.8	0.1	3.3	0.3	2.2	1.0	0.7	2.2	32.9	1.8	8.7	2.5	1.2	7.0	26.4	3.5	1.3	0.4	2.6	1.0	0.4	1.7	0.6	1.0	0.8	0.5	0.7	0.8	0.8	0.8	0.9	0.7	1.4	0.2	0.3	0.3	1.0	1.0	1.5	2.4	3.6	5.6	2.1	2.3	2.6	2.4	2.3	2.0	2.3	4.2	22.9	32.1	12.2	20.5	8.3	40.0	26.9	54.4	19.4	0.8	12.4	10.7	7.2	12.8	22.3	18.4	0.0	0.2	11.6	26.0	0.0	29.6	1.8	7.1	8.2	22.7	2.4	4.2	3.8	45.4	0.5	24.1	13.3	11.6	9.5	6.7	24.7	9.4	14.6	0.0	1.2	22.0	42.7	14.5	36.8	1.5	14.9	11.6	33.8	19.7	17.7	10.0	17.5	1.5	0.1	51.2	20.1	15.8	8.6	32.7	40.1	7.0	17.1	0.8	19.7	10.7	24.1	15.3	6.6	14.8	34.4	0.8	15.2	11.3	12.2	21.1
MICB	PERB11.2	ENSG00000204516	"MHC class I polypeptide-related sequence B"	Q29980	6	31494881-31511124	"Disease related genes, Predicted membrane proteins"	"Adaptive immunity, Cytolysis, Host-virus interaction, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 9.9"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 10.3;Erythroid cells: 10.5;Hofbauer cells: 11.1;Kupffer cells: 17.8;monocytes: 13.2;T-cells: 11.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-266/70: 15.2;U-266/84: 36.5"									HPA064618			Approved	"Nucleoplasm,Golgi apparatus,Plasma membrane"		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 64: Macrophages - Immune response"	"Cluster 16: U-266 - Nucleosome"	"Cluster 63: NK-cells & T-cells - Immune response"	"Golgi apparatus, Plasma membrane"	Nucleoplasm	"HPA064618: AB_2685301"	"unprognostic (3.63e-3)"	"unprognostic (8.81e-2)"	"unprognostic (3.19e-1)"	"unprognostic (1.51e-2)"	"unprognostic (8.44e-2)"	"unprognostic (5.94e-2)"	"prognostic unfavorable (7.04e-5)"	"unprognostic (2.05e-1)"	"unprognostic (2.61e-1)"	"unprognostic (1.67e-3)"	"unprognostic (2.28e-2)"	"unprognostic (1.61e-1)"	"prognostic unfavorable (4.94e-9)"	"unprognostic (1.91e-3)"	"unprognostic (2.80e-2)"	"unprognostic (9.72e-2)"	"unprognostic (1.21e-2)"	2.6	1.2	0.1	1.4	0.2	2.2	2.2	0.2	0.4	1.4	0.2	1.9	0.2	1.7	0.3	1.4	1.2	0.4	2.5	0.2	0.1	1.8	1.2	6.2	2.8	0.2	0.1	0.7	0.8	0.1	0.6	0.2	0.2	1.1	0.5	0.0	1.3	0.0	0.5	1.0	4.5	0.4	0.1	9.9	1.4	1.3	0.3	0.7	1.6	0.7	1.6	1.4	1.5	0.2	3.4	1.3	0.0	0.0	1.9	3.2	0.1	2.3	2.2	2.9	3.7	0.0	0.4	3.9	5.9	4.3	8.1	0.8	1.0	4.1	1.0	3.4	2.3	4.6	0.6	1.3	0.7	1.4	3.5	4.1	0.8	5.0	3.5	3.1	1.9	6.0	4.2	7.8	3.5	0.0	1.3	5.9	0.4	0.0	0.5	4.7	0.0	8.2	3.8	0.2	0.0	0.0	1.5	0.0	0.7	1.2	2.0	1.6	1.9	2.2	0.0	1.9	0.1	15.2	36.5	8.3	0.5	12.0	4.9	1.8	0.9	1.2	0.8	1.1	1.0	0.6	0.8	1.1	0.6	0.5	0.4	0.9	0.9	0.6	1.6	0.4	1.4	0.7	0.1	0.2	0.2	0.4	0.2	0.1	0.2	0.1	0.2	0.1	0.3	0.2	3.0	3.2	1.5	0.0	8.2	2.9	0.5	0.3	0.0	0.0	3.1	1.9	0.5	1.5	0.8	0.0	0.0	0.1	10.3	0.8	1.9	1.6	0.0	3.1	1.6	3.0	0.0	10.5	0.6	0.7	0.3	1.5	2.0	5.2	0.0	0.1	3.9	0.1	11.1	0.0	0.1	0.6	0.0	17.8	8.2	0.4	0.3	8.0	1.8	3.7	13.2	0.0	7.2	0.0	0.1	1.9	1.9	0.4	8.7	2.1	0.5	0.3	0.9	0.0	0.0	0.6	2.2	4.6	5.2	0.1	1.1	0.1	11.3	0.5	2.1	1.1
MCCD1		ENSG00000204511	"Mitochondrial coiled-coil domain 1"	P59942	6	31528962-31530232	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	73	"kidney: 81.8"	"Group enriched"	"Detected in some"	44	"Distal tubular cells: 401.1;Proximal tubular cells: 414.8"	"Group enriched"	"Detected in some"	5	"breast cancer: 0.7;endometrial cancer: 0.8;liver cancer: 2.4;renal cancer: 2.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"								"Intracellular and membrane"	NA	NA				"Cluster 7: Kidney - Transmembrane transport"		"Cluster 67: Proximal tubular cells - Tubular reabsorption"				"unprognostic (1.34e-1)"			"unprognostic (2.39e-2)"			"unprognostic (2.71e-1)"			"unprognostic (3.22e-2)"			"prognostic favorable (1.73e-4)"					0.0	0.0	0.1	0.0	0.2	0.1	1.1	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	81.8	0.0	0.0	0.0	0.4	0.1	0.0	0.1	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.5	0.1	0.3	0.4	0.1	0.4	0.1	0.3	0.3	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	1.1	0.1	0.0	0.0	0.0	9.2	0.0	0.0	0.0	0.0	401.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	414.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.1
DDX39B	"BAT1, D6S81E, UAP56"	ENSG00000198563	"DExD-box helicase 39B"	Q13838	6	31530219-31542448	"Enzymes, Plasma proteins, Predicted intracellular proteins, Transporters"	"mRNA processing, mRNA splicing, mRNA transport, Transport"	"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEK 293: 352.9;hTERT-HME1: 244.9;K-562: 255.5;NB-4: 254.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034012, HPA055334, HPA058450"	Enhanced		Enhanced	"Nuclear speckles"		NA	NA		270000	"Cluster 32: T-cells - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	"Nuclear speckles"		"CAB034012: AB_2243237, HPA055334: AB_2682787, HPA058450: AB_2683721"	"unprognostic (2.78e-2)"	"unprognostic (1.30e-2)"	"unprognostic (6.86e-3)"	"unprognostic (3.44e-2)"	"unprognostic (3.22e-2)"	"unprognostic (5.13e-3)"	"unprognostic (2.89e-2)"	"unprognostic (1.19e-2)"	"unprognostic (4.89e-3)"	"unprognostic (1.25e-1)"	"unprognostic (2.81e-2)"	"unprognostic (3.53e-3)"	"prognostic unfavorable (1.11e-6)"	"unprognostic (2.85e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.90e-2)"	"prognostic favorable (1.43e-5)"	130.5	138.3	11.9	23.7	12.3	5.5	125.0	12.8	13.1	147.7	12.0	126.6	3.0	127.6	103.5	105.9	133.9	6.2	141.8	11.4	12.4	123.0	125.9	117.5	34.5	14.4	12.5	173.0	187.5	7.9	125.0	14.6	12.6	141.8	16.6	34.3	103.1	30.3	181.6	104.3	134.1	9.5	13.5	178.1	117.0	59.8	12.0	40.1	133.4	60.4	26.4	118.6	113.2	14.6	9.0	130.9	37.7	19.7	121.4	78.1	24.7	9.6	11.5	28.8	25.4	13.3	17.8	24.3	75.0	145.0	106.3	16.5	42.8	223.1	26.7	8.1	352.9	19.9	14.3	28.7	13.2	35.1	18.8	129.0	117.8	28.9	244.9	131.0	18.3	157.0	255.5	7.1	24.1	6.3	22.7	254.1	17.2	18.3	13.0	17.9	41.6	10.8	143.5	11.8	18.4	151.2	26.3	9.0	15.6	35.7	6.5	36.5	10.3	3.7	13.9	3.6	26.7	68.2	78.9	229.9	2.3	39.5	16.6	2.5	6.4	4.8	4.8	7.6	6.4	4.2	6.9	6.7	9.3	6.2	10.2	8.8	4.3	5.2	4.6	7.7	7.1	5.6	11.9	12.3	12.8	13.1	11.4	12.4	14.4	12.5	12.6	13.5	12.0	14.6	31.5	22.4	36.9	0.0	43.9	14.4	41.9	13.2	35.9	21.3	21.8	15.7	4.0	5.7	22.2	3.7	22.9	13.9	58.1	15.2	5.9	9.7	1.4	23.0	37.8	26.5	17.3	26.3	0.0	8.2	11.8	28.0	64.2	32.4	37.2	58.3	13.2	6.9	9.8	15.2	0.0	11.7	12.2	14.8	14.4	2.6	16.1	34.9	8.8	0.0	17.1	8.5	66.9	0.0	0.0	10.4	11.7	11.7	44.5	23.0	17.5	5.1	31.5	27.2	26.3	57.9	35.2	6.4	6.7	44.2	13.5	17.0	50.3	79.6	12.7	33.9
ATP6V1G2	"ATP6G, ATP6G2, Em:AC004181.3, NG38, Vma10"	ENSG00000213760	"ATPase H+ transporting V1 subunit G2"	O95670	6	31544444-31548427	"Metabolic proteins, Predicted intracellular proteins"	"Hydrogen ion transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 97.0"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 83.7;Cone photoreceptor cells: 14.6;Enteroendocrine cells: 14.3;Horizontal cells: 30.3;Muller glia cells: 25.1;Rod photoreceptor cells: 14.1"	"Cancer enriched"	"Detected in many"	11	"glioma: 15.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 3.2;HSkMC: 3.2;Karpas-707: 6.7;RPMI-8226: 4.9;SCLC-21H: 9.5"									"CAB004616, HPA068667"	Enhanced					NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 56: Bipolar cells - Visual perception"			"CAB004616: AB_667829, HPA068667: "	"unprognostic (9.95e-2)"	"unprognostic (8.75e-2)"	"unprognostic (9.21e-3)"	"unprognostic (2.11e-4)"	"unprognostic (2.40e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.65e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.78e-2)"	"unprognostic (1.41e-5)"	"unprognostic (1.36e-1)"	"unprognostic (7.22e-3)"	"unprognostic (3.94e-2)"	"unprognostic (1.77e-1)"	"unprognostic (3.86e-2)"	"unprognostic (1.02e-1)"	1.0	2.3	53.0	0.7	61.0	0.1	0.9	77.1	97.0	1.7	21.3	4.6	0.3	1.6	0.2	0.7	1.6	1.0	2.8	60.0	52.0	2.7	0.8	1.3	0.5	51.3	43.7	3.0	0.8	0.0	9.2	0.0	51.1	2.0	0.3	13.7	0.8	0.0	1.8	0.7	2.8	0.4	43.3	2.8	1.7	1.9	52.4	0.0	3.0	0.0	0.5	1.1	2.1	75.1	0.0	0.5	2.6	0.6	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.7	0.2	0.0	0.3	0.5	0.0	0.0	0.0	3.2	0.3	0.1	0.0	0.8	0.0	0.0	0.5	3.2	0.5	0.7	0.1	1.4	0.0	0.9	0.7	6.7	0.2	0.0	0.7	1.4	0.0	0.0	0.0	0.2	0.0	4.9	0.0	0.0	9.5	2.3	0.0	0.2	0.0	0.0	0.8	1.4	0.8	0.5	0.1	0.0	0.0	0.3	0.4	0.3	0.0	0.7	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.2	0.2	0.0	0.1	0.0	0.0	0.1	0.0	53.0	61.0	77.1	97.0	60.0	52.0	51.3	43.7	51.1	43.3	52.4	75.1	0.9	0.0	0.5	0.0	1.2	0.4	0.3	0.4	0.0	83.7	0.7	0.8	2.3	0.0	0.1	1.8	14.6	0.2	0.1	0.3	9.8	0.3	0.0	0.1	2.6	1.2	14.3	0.4	0.0	0.0	0.1	1.4	0.0	0.2	0.0	0.2	0.0	0.2	0.6	30.3	0.0	0.5	2.0	0.0	1.1	0.2	0.9	0.4	1.8	0.0	0.1	25.1	1.0	0.0	0.0	0.1	0.0	2.2	0.5	0.1	0.7	7.8	0.0	14.1	0.0	1.7	3.2	0.1	2.0	0.4	0.1	0.1	1.5	0.4	0.1	0.1
NFKBIL1	"IKBL, NFKBIL"	ENSG00000204498	"NFKB inhibitor like 1"	Q9UBC1	6	31546870-31558829	"Disease related genes, Predicted intracellular proteins, Transcription factors"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 5.8;HBEC3-KT: 5.0;HEK 293: 20.2;JURKAT: 9.8;U-266/70: 10.8;U-266/84: 9.6;U-698: 5.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006298			Supported	Nucleoplasm		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 50: Non-specific - Ribosome"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA006298: AB_1079480"	"unprognostic (1.11e-1)"	"unprognostic (3.18e-1)"	"unprognostic (2.01e-1)"	"prognostic unfavorable (3.38e-4)"	"unprognostic (1.21e-1)"	"unprognostic (3.63e-1)"	"unprognostic (2.51e-2)"	"unprognostic (6.29e-2)"	"unprognostic (5.41e-2)"	"unprognostic (5.97e-3)"	"unprognostic (5.54e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.16e-1)"	"unprognostic (8.73e-2)"	"unprognostic (9.92e-2)"	"unprognostic (3.15e-1)"	"unprognostic (7.50e-2)"	20.4	18.3	0.0	0.5	0.0	0.0	21.5	0.0	0.3	22.8	0.0	26.9	0.0	21.1	2.2	17.5	22.3	0.0	19.4	0.0	0.0	20.8	23.4	16.7	0.0	0.0	0.0	33.0	42.8	0.0	23.9	0.0	0.0	24.3	0.0	0.4	19.8	0.0	27.6	24.2	16.5	0.0	0.0	19.4	30.4	17.4	0.0	0.0	23.4	0.0	0.0	23.1	19.4	0.1	0.0	4.0	0.0	0.1	4.4	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	2.8	0.0	0.0	5.0	0.0	0.0	20.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.8	9.6	5.9	0.0	0.0	0.0	0.2	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.1	0.2	0.2	0.9	0.4	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	18.7	6.4	3.6	7.8	14.9	20.8	26.7	31.4	30.1	18.8	25.6	25.5	5.7	25.8	12.8	25.8	2.1	21.8	13.2	23.1	39.2	27.0	8.7	15.9	14.6	18.4	7.8	9.2	5.6	31.8	28.1	19.6	25.5	12.9	7.0	25.2	24.3	15.8	24.4	6.7	6.1	27.1	14.2	29.3	16.1	8.9	25.4	17.4	8.8	1.9	26.2	26.8	24.7	3.5	5.2	32.7	22.4	25.9	8.3	24.3	61.4	24.8	13.0	17.9	26.3	20.2	30.9	12.7	10.0	17.4	18.8	29.6	11.6	30.7	26.2	22.3
LTA	"LT, TNFB, TNFSF1"	ENSG00000226979	"Lymphotoxin alpha"	P01374	6	31572054-31574324	"Cancer-related genes, Disease related genes, FDA approved drug targets, Predicted secreted proteins"		Cytokine	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"intestine: 1.9;lymphoid tissue: 5.6;testis: 4.2"	"Group enriched"	"Detected in some"	4	"B-cells: 13.7;T-cells: 14.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"JURKAT: 1.2;MOLT-4: 2.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA007729	Uncertain				"Secreted to blood"	NA	NA	8150			"Cluster 16: Immune cells - Immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 58: T-cells - T-cell receptor"			"HPA007729: AB_1852906"	"unprognostic (3.76e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.36e-3)"	"unprognostic (8.99e-5)"	"unprognostic (3.22e-1)"	"unprognostic (5.13e-3)"	"unprognostic (2.07e-1)"	"unprognostic (4.71e-2)"	"unprognostic (3.10e-2)"	"unprognostic (3.39e-4)"	"unprognostic (2.68e-2)"	"unprognostic (6.77e-2)"	"unprognostic (8.72e-12)"	"unprognostic (2.59e-1)"	"unprognostic (5.49e-2)"	"unprognostic (4.30e-2)"	"unprognostic (3.03e-1)"	0.2	0.0	0.1	0.6	0.1	0.8	0.1	0.2	0.2	0.2	0.1	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.1	0.4	0.1	0.4	2.4	0.1	0.1	0.2	0.0	0.0	0.1	0.0	0.1	0.4	0.1	0.0	0.2	0.0	0.2	0.1	1.9	0.0	0.1	5.6	0.1	4.2	0.1	0.0	0.2	0.0	2.1	0.2	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	2.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	1.1	0.0	1.1	2.3	13.7	0.1	0.1	0.0	0.6	0.6	0.5	1.3	2.5	0.0	0.0	0.0	0.0	0.0	3.5	0.1	0.0	0.0	0.0	0.1	0.3	0.6	0.0	0.0	1.9	0.0	0.0	0.3	0.5	0.2	0.0	0.0	0.0	0.0	0.5	0.0	0.7	0.0	0.0	0.3	0.4	0.4	0.0	0.3	0.0	1.0	0.4	0.0	1.0	2.5	2.4	0.1	0.0	0.4	0.5	0.1	0.0	0.1	0.0	0.3	0.0	0.5	0.3	1.8	0.5	0.5	0.4	0.0	14.5	0.1	0.0	0.0
TNF	"DIF, TNF-alpha, TNFA, TNFSF2"	ENSG00000232810	"Tumor necrosis factor"	P01375	6	31575565-31578336	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		Cytokine	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 12.7;lymphoid tissue: 6.5"	"Cell type enhanced"	"Detected in many"		"B-cells: 90.7;dendritic cells: 60.8;Langerhans cells: 72.7;Macrophages: 108.3;T-cells: 100.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"non-classical monocyte: 68.0"	"Group enriched"	"Detected in all"	5	"granulocytes: 20.8;monocytes: 68.0;T-cells: 36.6"	"Group enriched"	"Detected in some"	8	"HDLM-2: 103.7;NB-4: 214.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			CAB078469	Supported				"Secreted to blood"	NA	NA	10100		"Cluster 51: Monocytes - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 24: NB-4 - Immune response"	"Cluster 57: B-cells - Immune response"			"CAB078469: AB_908070"	"unprognostic (1.93e-1)"	"unprognostic (1.07e-2)"	"unprognostic (3.85e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.19e-2)"	"unprognostic (1.67e-1)"	"unprognostic (3.46e-1)"	"unprognostic (1.19e-2)"	"unprognostic (1.94e-1)"	"unprognostic (3.07e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.46e-2)"	"unprognostic (1.82e-1)"	"unprognostic (9.85e-3)"	"unprognostic (1.09e-1)"	"unprognostic (2.04e-1)"	1.4	0.5	0.0	3.3	0.0	12.7	0.5	0.0	0.1	0.1	0.0	0.9	0.0	1.5	0.0	0.7	0.3	0.6	2.6	0.1	0.0	1.2	0.6	3.6	1.6	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.3	0.0	0.1	1.5	2.4	0.2	0.1	6.5	0.6	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.8	0.0	0.0	0.0	0.0	103.7	0.0	19.4	0.0	0.0	0.0	0.2	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	214.4	0.0	0.0	0.0	9.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.2	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	3.3	0.0	0.0	10.1	0.0	23.2	39.5	36.6	7.2	17.2	13.9	7.6	7.0	5.0	5.2	20.8	2.0	68.0	4.3	13.6	14.7	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	6.4	0.0	3.0	0.0	90.7	8.4	1.2	12.1	4.6	0.2	17.4	20.4	2.0	2.8	4.0	0.0	2.1	0.9	60.8	0.5	0.0	7.4	0.1	15.5	5.9	10.7	0.0	0.0	0.0	3.3	1.7	2.0	1.5	30.5	12.6	0.0	1.8	0.1	36.5	0.0	0.0	0.4	10.2	14.1	72.7	0.0	0.3	108.3	5.4	1.9	3.4	0.1	2.1	0.0	0.1	14.3	0.0	0.0	10.4	1.7	0.0	0.1	3.0	0.2	0.0	0.6	4.0	0.0	0.0	1.3	4.1	1.1	100.0	0.0	0.4	0.3
LTB	"p33, TNFC, TNFSF3"	ENSG00000227507	"Lymphotoxin beta"	Q06643	6	31580525-31582522	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"		Cytokine	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"intestine: 66.7;lymphoid tissue: 229.2"	"Cell type enhanced"	"Detected in many"		"B-cells: 1087.8;dendritic cells: 183.5;Ductal cells: 280.4;Pancreatic endocrine cells: 296.2;T-cells: 554.0"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 35.6;Daudi: 127.4;HDLM-2: 82.2;HMC-1: 38.1;NB-4: 62.3;REH: 58.6;U-698: 90.8"	"Not detected"	"Not detected"							HPA048884	Approved		Approved	Centrosome		NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Centrosome		"HPA048884: AB_2680543"	"unprognostic (1.43e-2)"	"unprognostic (3.89e-2)"	"unprognostic (7.29e-2)"	"prognostic favorable (2.36e-6)"	"unprognostic (2.91e-3)"	"prognostic favorable (1.74e-4)"	"unprognostic (1.45e-1)"	"unprognostic (9.49e-3)"	"unprognostic (1.42e-3)"	"unprognostic (4.26e-2)"	"unprognostic (4.52e-2)"	"unprognostic (1.49e-1)"	"prognostic unfavorable (3.31e-7)"	"unprognostic (8.91e-2)"	"unprognostic (4.92e-2)"	"unprognostic (6.56e-3)"	"unprognostic (1.99e-1)"	3.5	0.7	0.2	82.6	0.3	19.1	1.3	0.1	0.5	1.3	0.2	6.7	8.2	1.2	0.0	4.3	1.2	4.8	1.1	0.1	0.2	10.3	4.8	8.7	103.9	0.4	0.2	0.4	2.5	0.2	0.7	0.9	0.3	2.4	2.7	0.0	4.2	0.3	1.0	2.2	66.7	1.9	0.2	229.2	13.9	0.2	0.3	83.3	3.8	1.4	47.6	8.7	1.4	0.2	18.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.6	35.6	127.4	1.8	0.0	0.2	0.0	0.0	0.0	0.0	82.2	0.0	1.4	0.0	0.0	0.0	0.4	38.1	0.0	0.0	0.0	0.3	0.0	0.6	0.8	0.0	0.0	0.0	0.0	18.5	62.3	0.0	0.0	0.0	58.6	0.0	11.4	32.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	6.7	0.0	0.0	0.5	0.0	0.0	0.0	0.8	90.8	0.0	0.0	0.0	79.2	9.2	542.5	95.7	55.9	646.7	1027.3	924.3	419.4	14.5	1021.9	713.6	317.0	327.8	142.5	94.5	412.0	672.0	308.9	0.2	0.3	0.1	0.5	0.1	0.2	0.4	0.2	0.3	0.2	0.3	0.2	3.0	0.0	9.0	1.3	1087.8	16.3	0.5	45.7	2.2	0.7	2.9	3.7	0.5	2.8	4.7	90.1	0.0	0.9	183.5	0.9	1.9	280.4	3.5	2.2	2.0	8.4	0.0	11.2	0.9	113.1	0.3	6.3	3.1	1.5	14.0	0.1	10.8	3.5	10.1	0.0	0.9	0.4	160.7	31.0	112.1	0.2	0.6	49.8	42.7	0.0	72.3	1.8	99.9	0.0	0.3	296.2	1.6	0.0	13.6	3.0	0.0	11.6	0.9	0.2	6.6	1.3	4.3	0.4	1.2	1.2	12.4	0.3	554.0	0.3	3.6	0.3
LST1	"B144, D6S49E, LST-1"	ENSG00000204482	"Leukocyte specific transcript 1"	O00453	6	31586124-31588909	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell shape, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"bone marrow: 100.3;lung: 48.8;lymphoid tissue: 181.9"	"Group enriched"	"Detected in many"	11	"Hofbauer cells: 407.1;Kupffer cells: 1326.9;Langerhans cells: 1240.5;Macrophages: 871.6;monocytes: 1096.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"non-classical monocyte: 1746.7"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HEL: 39.3;HMC-1: 73.6;MOLT-4: 39.6;NB-4: 76.2;THP-1: 179.9;U-937: 92.9"	"Low region specificity"	"Detected in all"							HPA079451			Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 2: Immune cells - Immune response"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Plasma membrane, Cytosol"		"HPA079451: "	"unprognostic (1.08e-2)"	"prognostic favorable (7.89e-4)"	"unprognostic (6.99e-2)"	"unprognostic (4.16e-3)"	"unprognostic (3.13e-1)"	"unprognostic (3.92e-2)"	"unprognostic (3.65e-1)"	"unprognostic (7.06e-3)"	"unprognostic (2.81e-3)"	"unprognostic (2.12e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.28e-1)"	"prognostic unfavorable (5.97e-5)"	"unprognostic (1.47e-1)"	"prognostic unfavorable (7.62e-4)"	"unprognostic (1.03e-1)"	"unprognostic (1.95e-1)"	15.2	10.2	4.3	22.0	4.3	100.3	7.9	4.6	7.2	5.6	5.0	7.9	7.1	3.7	1.4	5.5	6.6	3.1	7.6	4.6	5.5	10.8	14.4	48.8	13.8	6.1	4.9	3.0	4.7	0.9	6.1	4.7	6.6	8.9	3.0	0.5	6.9	2.3	2.1	7.8	15.0	5.1	5.4	181.9	5.7	1.8	5.2	15.1	4.6	1.9	7.1	9.1	5.1	6.0	0.3	0.6	0.0	0.8	0.0	0.0	0.0	0.0	0.3	0.0	0.5	0.0	0.2	2.5	0.6	0.0	0.0	0.5	0.3	0.4	0.3	12.9	0.0	39.3	0.0	0.0	0.7	29.3	73.6	0.0	0.3	0.1	1.2	0.3	0.9	0.8	0.1	0.2	0.0	0.0	39.6	76.2	0.1	0.0	0.0	18.4	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	179.9	0.3	0.0	0.4	0.0	0.2	0.1	0.0	5.9	0.0	92.9	0.0	112.2	419.7	681.6	9.4	1273.9	80.7	32.8	15.9	20.2	392.9	21.9	10.9	9.0	1133.0	21.6	1746.7	69.9	12.0	541.6	4.3	4.3	4.6	7.2	4.6	5.5	6.1	4.9	6.6	5.4	5.2	6.0	5.4	35.3	86.7	0.7	43.7	35.2	0.3	0.2	0.0	0.3	3.2	12.2	1.9	7.2	13.0	11.0	0.0	2.9	42.8	1.0	0.0	0.6	1.5	0.4	1.9	12.9	0.0	15.1	0.2	0.2	3.8	9.2	1.5	0.4	70.3	0.1	22.9	5.8	407.1	0.0	0.3	0.0	2.0	1326.9	1240.5	5.4	3.7	871.6	44.4	24.4	1096.6	0.7	60.8	0.5	0.1	0.1	1.1	1.2	4.7	1.0	0.0	3.8	11.0	0.2	26.3	2.2	2.8	2.4	4.6	0.4	28.3	5.3	43.6	0.0	0.4	0.3
NCR3	"1C7, CD337, LY117, NKp30"	ENSG00000204475	"Natural cytotoxicity triggering receptor 3"	O14931	6	31588895-31593006	"CD markers, Predicted membrane proteins"	Immunity	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"bone marrow: 4.0;intestine: 5.6;lymphoid tissue: 16.1"	"Group enriched"	"Detected in some"	10	"B-cells: 43.6;dendritic cells: 110.4;NK-cells: 166.9;T-cells: 55.5"	"Cancer enhanced"	"Detected in many"		"testis cancer: 2.6"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"MAIT T-cell: 274.3"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"Daudi: 2.0;HEL: 2.7;NB-4: 10.9;U-698: 1.7"					"Low region specificity"	"Detected in many"									NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 24: NB-4 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"				"unprognostic (3.99e-3)"	"unprognostic (9.23e-4)"	"unprognostic (1.23e-3)"	"unprognostic (2.49e-4)"	"unprognostic (2.15e-1)"	"unprognostic (2.57e-4)"	"unprognostic (5.99e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.40e-2)"	"unprognostic (3.62e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.21e-4)"	"unprognostic (1.72e-1)"	"unprognostic (1.83e-1)"	"unprognostic (8.17e-2)"	"unprognostic (1.43e-1)"	0.5	0.0	0.0	2.9	0.0	4.0	0.2	0.0	0.1	0.1	0.0	0.4	0.3	0.2	0.0	0.2	0.2	0.0	0.2	0.0	0.0	0.3	1.0	1.8	5.4	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.4	0.0	0.1	0.2	5.6	0.0	0.0	16.1	0.4	0.7	0.1	2.0	0.3	0.0	4.9	0.5	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	10.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.1	0.0	0.2	0.5	0.0	98.8	0.1	274.3	65.2	12.1	53.9	0.3	51.8	5.7	30.1	0.9	76.6	0.6	0.6	20.3	31.6	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.7	0.0	1.9	0.0	43.6	3.4	0.0	0.0	0.6	0.0	0.3	0.4	0.1	0.0	1.3	0.0	0.0	0.1	110.4	0.1	0.0	0.0	0.5	0.1	0.2	0.5	0.0	2.7	0.0	0.0	0.2	0.3	0.5	0.1	8.9	0.0	1.4	0.4	0.4	0.0	0.0	0.0	0.0	2.5	2.9	0.2	0.3	1.2	3.6	0.0	1.6	0.0	166.9	0.0	0.1	0.0	0.1	0.0	2.9	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.6	0.7	0.1	1.7	0.1	55.5	0.0	0.1	0.0
AIF1	"AIF-1, Em:AF129756.17, IBA1, IRT-1"	ENSG00000204472	"Allograft inflammatory factor 1"	P55008	6	31615217-31617021	"Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 235.0;lymphoid tissue: 346.6"	"Group enriched"	"Detected in many"	22	"Hofbauer cells: 1777.1;Kupffer cells: 2140.2;Langerhans cells: 1359.1;Macrophages: 1494.0;monocytes: 1022.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	26	"classical monocyte: 3823.3;intermediate monocyte: 6550.1;myeloid DC: 2043.3;neutrophil: 2943.0;non-classical monocyte: 7744.5"	"Group enriched"	"Detected in all"	74	"dendritic cells: 2043.3;granulocytes: 2943.0;monocytes: 7744.5"	"Group enriched"	"Detected in some"	4	"HEL: 204.6;HMC-1: 329.6;NB-4: 264.7;THP-1: 184.2;U-937: 114.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049234, HPA062949"	Enhanced		Uncertain	Cytosol		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Cytosol		"HPA049234: AB_2680685, HPA062949: AB_2732694"	"unprognostic (3.20e-2)"	"unprognostic (7.21e-3)"	"unprognostic (6.11e-2)"	"unprognostic (2.33e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.13e-1)"	"unprognostic (6.98e-2)"	"unprognostic (4.83e-2)"	"unprognostic (2.72e-2)"	"unprognostic (7.56e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.94e-1)"	"prognostic unfavorable (2.30e-5)"	"unprognostic (1.29e-1)"	"unprognostic (1.02e-2)"	"unprognostic (9.59e-2)"	"unprognostic (4.89e-2)"	79.6	46.6	24.9	182.3	25.5	235.0	47.2	26.6	33.0	29.3	32.2	48.3	36.4	17.1	12.1	18.7	19.7	61.3	21.1	25.0	31.3	74.3	81.2	99.3	116.8	45.1	36.4	14.4	12.4	12.9	17.3	109.5	36.8	22.3	57.2	3.9	20.3	24.0	6.1	11.7	44.5	74.7	34.3	346.6	22.2	8.7	32.1	69.1	13.8	16.6	57.1	95.3	13.5	42.7	0.0	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	204.6	0.0	0.0	0.0	30.0	329.6	0.0	0.0	0.0	0.0	0.0	0.0	51.6	0.9	0.2	0.0	0.0	2.3	264.7	0.4	0.0	0.0	35.9	0.4	8.9	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.0	184.2	0.1	0.0	0.2	0.1	0.3	0.2	0.0	1.3	0.2	114.6	0.0	33.1	3823.3	177.9	10.2	6550.1	12.7	57.5	10.8	9.3	2043.3	6.3	33.1	26.2	2943.0	14.5	7744.5	144.2	10.7	4449.8	24.9	25.5	26.6	33.0	25.0	31.3	45.1	36.4	36.8	34.3	32.1	42.7	12.0	25.6	59.6	0.0	39.2	32.5	0.7	0.0	0.6	0.1	5.3	24.3	7.5	18.6	19.2	42.3	0.0	11.1	31.2	1.0	0.0	0.3	1.9	0.6	0.7	28.7	1.2	65.0	0.0	0.4	15.4	20.6	0.5	0.4	68.3	0.4	35.3	13.4	1777.1	0.0	0.0	0.1	0.0	2140.2	1359.1	4.9	7.5	1494.0	39.2	10.3	1022.6	0.0	32.0	0.5	0.1	0.2	11.1	0.7	7.2	0.4	0.3	4.2	10.2	0.1	52.6	4.7	6.5	0.5	1.5	2.1	28.3	22.7	46.1	1.9	0.6	0.3
PRRC2A	"BAT2, D6S51E, G2"	ENSG00000204469	"Proline rich coiled-coil 2A"	P48634	6	31620715-31637771	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 81.9;HEK 293: 148.3;U-266/70: 75.3;U-266/84: 86.8;U-698: 78.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB026383, HPA046791, HPA066501"	Uncertain		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		5600		"Cluster 71: Testis - DNA repair"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 59: Non-specific - Transcription"	Cytosol	"Nucleoplasm, Plasma membrane"	"CAB026383: , HPA046791: AB_2679809, HPA066501: AB_2732747"	"unprognostic (2.07e-1)"	"unprognostic (6.84e-2)"	"unprognostic (3.82e-1)"	"unprognostic (2.25e-3)"	"unprognostic (5.04e-2)"	"unprognostic (4.63e-1)"	"unprognostic (2.42e-3)"	"unprognostic (2.09e-1)"	"unprognostic (3.07e-1)"	"unprognostic (1.14e-1)"	"unprognostic (8.29e-3)"	"unprognostic (2.38e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.57e-1)"	"unprognostic (5.40e-2)"	"unprognostic (3.10e-1)"	37.2	36.5	0.2	6.8	0.2	0.1	36.3	0.2	0.4	48.8	0.0	47.9	0.5	53.7	12.2	42.0	47.3	0.0	41.5	0.6	0.2	37.4	23.0	36.4	3.4	0.6	1.0	55.7	35.1	0.0	50.4	0.8	0.1	47.5	0.6	2.9	31.8	0.3	54.9	37.6	37.3	0.1	0.2	41.7	37.1	84.3	0.2	4.3	41.9	0.0	0.0	44.1	40.3	0.2	4.4	19.3	0.2	0.7	35.5	33.6	3.3	2.0	0.0	0.0	0.2	0.9	0.2	4.2	24.5	41.8	0.0	1.8	0.0	81.9	0.0	8.1	148.3	4.6	0.2	0.3	0.1	2.0	1.4	14.9	0.0	0.2	0.0	0.0	0.0	30.7	2.0	0.0	0.2	0.7	0.9	0.2	0.4	0.1	1.7	2.2	0.6	0.9	6.9	0.5	2.6	1.3	1.5	0.1	0.7	0.0	0.3	1.5	0.7	0.5	17.6	1.3	0.9	75.3	86.8	78.7	25.7	2.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.4	0.6	0.2	0.6	1.0	0.1	0.2	0.2	0.2	39.3	0.0	5.5	25.5	39.2	32.9	28.4	26.1	67.7	36.1	41.6	39.0	6.7	18.6	14.5	40.5	60.5	26.9	38.0	48.4	5.9	24.8	58.7	33.3	37.1	33.4	38.9	47.9	19.2	25.6	22.2	32.9	52.0	35.9	10.8	55.5	33.5	22.5	34.6	37.0	19.7	39.1	26.4	28.2	30.9	23.7	49.0	31.4	19.6	15.9	28.7	20.9	39.1	23.1	15.3	34.5	37.8	44.8	47.2	39.1	27.0	16.0	20.1	35.9	19.7	57.0	44.8	58.0	43.2	64.1	28.4	18.3	38.2	45.3	48.0	28.4
BAG6	"BAT3, D6S52E, G3, Scythe"	ENSG00000204463	"BAG cochaperone 6"	P46379	6	31639028-31652705	"Predicted intracellular proteins"	"Apoptosis, Differentiation, Immunity, Spermatogenesis, Transport"	"Chaperone, Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 261.8;Late spermatids: 483.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020704, HPA045116, HPA053291"	Enhanced		Enhanced	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA		26000	"Cluster 52: Eosinophils - Transcription"	"Cluster 59: Non-specific - Translation"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 31: Spermatids - Spermatogenesis"	"Nucleoplasm, Cytosol"		"CAB020704: , HPA045116: AB_2679220, HPA053291: AB_2682103"	"unprognostic (7.32e-2)"	"unprognostic (2.96e-2)"	"unprognostic (3.43e-1)"	"unprognostic (7.67e-3)"	"unprognostic (2.61e-1)"	"unprognostic (6.00e-2)"	"unprognostic (1.07e-3)"	"unprognostic (2.14e-1)"	"unprognostic (4.46e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.88e-2)"	"unprognostic (9.98e-2)"	"unprognostic (1.08e-3)"	"unprognostic (2.04e-1)"	"unprognostic (1.82e-2)"	"unprognostic (6.05e-2)"	"unprognostic (8.16e-2)"	70.1	77.3	10.4	18.1	11.5	24.1	67.7	11.9	10.8	68.0	23.3	69.2	38.1	72.2	26.3	73.6	67.0	15.2	96.3	11.3	12.3	58.1	65.4	71.3	24.6	12.9	11.8	76.0	64.1	23.9	65.4	21.8	13.3	62.2	24.8	16.0	70.7	12.3	204.6	84.2	76.4	17.4	10.0	76.4	65.3	136.8	13.4	23.1	74.6	51.8	28.0	69.8	64.7	12.5	28.3	47.3	63.7	63.0	28.7	47.8	49.0	33.1	34.1	49.1	42.5	121.2	26.5	44.0	98.2	101.2	72.1	22.3	17.3	110.7	19.1	45.4	139.8	62.2	18.8	77.5	42.5	47.4	125.6	37.2	52.8	27.0	24.0	52.9	47.9	76.3	85.7	46.1	82.6	34.4	25.4	46.7	20.1	16.7	23.8	37.0	26.3	52.1	38.3	31.2	29.4	41.6	22.7	27.3	42.0	16.8	112.6	91.2	31.8	57.8	40.0	28.2	53.6	59.9	87.0	88.4	56.0	45.8	40.2	3.3	2.5	2.8	2.2	3.0	1.7	1.4	1.0	1.1	2.2	1.3	1.2	1.4	1.5	1.6	3.4	1.6	0.9	1.9	10.4	11.5	11.9	10.8	11.3	12.3	12.9	11.8	13.3	10.0	13.4	12.5	39.0	48.1	39.9	11.1	39.0	32.1	39.0	44.5	23.3	28.4	34.5	30.2	77.7	42.9	51.3	36.8	18.8	62.2	33.0	82.4	31.3	66.0	261.8	39.1	22.4	40.8	76.7	52.2	7.6	50.0	67.1	38.4	40.8	34.1	48.2	41.4	38.6	45.4	55.9	50.5	8.6	56.4	61.1	39.9	29.9	483.4	33.2	40.5	28.4	12.2	38.5	34.0	44.3	5.0	10.8	64.0	63.4	39.5	51.6	35.0	105.6	47.9	54.6	48.3	39.5	35.4	65.8	115.0	87.9	33.3	35.5	119.4	34.8	31.7	68.8	40.1
APOM	"G3a, NG20"	ENSG00000204444	"Apolipoprotein M"	O95445	6	31652416-31658210	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"liver: 390.7"	"Group enriched"	"Detected in many"	8	"Hepatocytes: 665.9;Proximal tubular cells: 681.1"	"Cancer enriched"	"Detected in all"	13	"liver cancer: 185.9"	"Low region specificity"	"Detected in single"			"Immune cell enhanced"	"Detected in some"		"basophil: 3.0"	"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	12	"Hep G2: 38.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB034086, HPA051006"	Approved		Approved	"Golgi apparatus"	"Secreted to blood"	NA	NA	7400000000	8200000000	"Cluster 34: Basophils - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Golgi apparatus"		"CAB034086: AB_1119033, HPA051006: AB_2681307"	"unprognostic (2.76e-3)"	"unprognostic (1.69e-2)"	"unprognostic (8.66e-2)"	"unprognostic (2.61e-2)"	"unprognostic (1.12e-1)"	"unprognostic (5.28e-2)"	"unprognostic (3.78e-1)"	"unprognostic (1.97e-2)"	"unprognostic (1.80e-1)"	"unprognostic (6.04e-3)"	"unprognostic (2.27e-2)"	"unprognostic (1.48e-1)"	"unprognostic (7.28e-2)"	"unprognostic (5.71e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.30e-1)"	"unprognostic (3.20e-2)"	4.9	5.3	0.6	0.1	0.6	2.5	5.2	1.0	0.9	3.7	0.5	3.8	0.6	3.9	1.0	4.1	4.1	0.5	3.5	0.6	0.7	93.7	390.7	2.6	0.6	0.7	0.7	6.2	6.0	0.7	4.7	0.1	0.7	3.8	0.4	0.4	3.5	0.5	7.2	6.4	9.0	0.4	0.7	4.1	5.3	16.0	0.6	1.2	5.5	0.6	1.1	3.3	3.3	0.8	0.5	0.3	0.6	0.7	0.6	0.8	0.0	0.4	1.1	0.4	0.9	3.2	1.0	1.4	0.2	1.1	0.2	0.6	0.4	0.6	0.8	0.8	0.7	0.8	0.3	38.2	1.3	1.7	0.1	1.2	0.4	0.3	1.0	0.5	0.3	0.9	1.2	0.4	1.1	1.1	1.1	0.9	0.5	0.6	0.2	0.8	0.4	1.5	1.1	0.6	0.5	0.2	0.4	0.0	0.5	0.2	1.5	1.2	0.4	0.2	0.1	0.3	0.3	1.1	1.2	1.5	0.2	1.8	0.1	3.0	0.6	0.6	0.3	0.3	0.5	1.1	0.4	0.3	0.5	0.5	0.5	0.6	0.4	0.3	0.7	0.3	0.7	0.3	0.6	0.6	1.0	0.9	0.6	0.7	0.7	0.7	0.7	0.7	0.6	0.8	1.5	0.0	7.4	2.3	9.0	6.4	6.7	6.7	9.1	1.5	6.6	12.4	1.6	12.8	3.0	14.7	4.2	2.0	1.6	4.1	76.3	4.3	60.2	5.2	3.1	2.0	4.2	11.4	0.3	6.9	0.9	4.3	5.1	1.6	5.1	1.8	8.9	665.9	5.4	0.0	0.4	4.9	2.0	14.5	4.2	38.4	9.3	6.1	5.4	0.0	2.5	14.6	1.0	0.5	1.3	6.4	4.9	6.4	7.4	4.2	81.4	681.1	4.6	2.5	0.0	6.2	3.1	33.1	6.6	5.3	6.5	1.2	5.6	4.6	6.5	6.1
C6orf47	"D6S53E, G4"	ENSG00000204439	"Chromosome 6 open reading frame 47"	O95873	6	31658298-31660778	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"A549: 4.5;HBEC3-KT: 7.6;HDLM-2: 4.7;HEK 293: 6.1;U-2 OS: 5.5;U-266/84: 5.5"	"Low region specificity"	"Detected in all"							HPA045281	Uncertain		Approved	Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 72: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 22: Epithelial cell types - Mixed function"	Cytosol		"HPA045281: AB_10961000"	"unprognostic (5.99e-2)"	"unprognostic (5.71e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.04e-1)"	"unprognostic (9.92e-2)"	"unprognostic (6.74e-2)"	"unprognostic (2.09e-1)"	"unprognostic (3.24e-2)"	"unprognostic (3.27e-1)"	"unprognostic (5.04e-2)"	"unprognostic (2.93e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.66e-3)"	"unprognostic (6.78e-3)"	"unprognostic (2.38e-1)"	"unprognostic (7.73e-2)"	"unprognostic (3.59e-3)"	11.2	12.9	0.4	0.4	0.5	0.2	10.8	1.1	0.7	11.9	0.2	18.0	0.0	15.1	3.2	21.4	12.1	1.0	17.2	0.4	0.5	15.0	10.9	12.0	1.4	0.7	0.5	11.2	13.1	0.6	11.6	0.8	0.7	12.4	1.0	0.6	13.5	0.0	18.9	17.9	17.6	0.0	0.5	18.1	15.5	4.8	0.6	0.7	11.5	0.0	0.0	16.6	13.1	0.8	0.1	4.5	0.0	0.3	3.2	0.1	0.5	0.0	0.0	0.1	0.0	0.3	0.6	3.0	2.4	3.8	0.0	0.0	0.0	7.6	0.0	4.7	6.1	0.0	0.0	0.4	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.1	0.3	0.0	0.3	0.0	1.2	3.8	0.9	2.6	0.3	0.0	0.1	0.0	0.0	0.0	1.1	0.4	5.5	0.0	0.2	3.7	5.5	0.9	1.9	0.0	0.2	0.6	1.5	2.8	2.6	1.0	1.3	1.9	0.7	1.6	1.0	1.4	2.0	0.8	1.8	0.7	0.9	0.6	1.4	1.9	0.4	0.5	1.1	0.7	0.4	0.5	0.7	0.5	0.7	0.5	0.6	0.8	8.7	6.4	10.9	0.0	16.6	25.1	29.1	14.6	18.2	16.0	12.2	6.5	1.5	25.8	11.5	12.9	8.4	20.0	17.7	42.2	25.4	24.2	0.0	4.3	7.8	10.9	6.7	6.1	0.0	28.9	15.1	11.2	11.7	6.1	11.4	12.8	15.4	8.5	18.2	6.7	0.0	21.6	4.1	17.4	18.7	0.0	16.1	17.1	8.8	0.0	19.4	12.5	32.0	0.0	0.0	29.9	29.0	21.8	5.1	25.6	40.9	18.1	5.0	13.5	32.9	13.0	14.2	1.0	5.5	20.9	26.9	23.8	16.1	15.8	26.2	47.0
GPANK1	"ANKRD59, BAT4, D6S54E, G5, GPATCH10"	ENSG00000204438	"G-patch domain and ankyrin repeats 1"	O95872	6	31661228-31666283	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 180.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006301	Approved		Approved	"Endoplasmic reticulum"		NA	Yes			"Cluster 2: Granulocytes - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Endoplasmic reticulum"		"HPA006301: AB_1078267"	"unprognostic (2.03e-1)"	"unprognostic (2.84e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.05e-1)"	"unprognostic (4.26e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.77e-2)"	"unprognostic (5.72e-2)"	"unprognostic (1.10e-1)"	"unprognostic (8.81e-2)"	"prognostic favorable (5.89e-4)"	"unprognostic (2.29e-1)"	"unprognostic (2.46e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.86e-1)"	"unprognostic (5.40e-2)"	"unprognostic (1.51e-1)"	14.5	11.8	1.5	2.7	1.9	3.9	14.7	3.6	2.8	14.9	1.4	15.9	1.6	15.9	2.5	11.4	14.9	2.1	21.5	1.5	1.8	14.7	16.0	13.2	3.8	2.0	1.7	17.3	15.1	3.3	13.5	1.8	2.2	14.0	2.4	2.3	13.8	2.0	28.4	15.8	15.6	1.1	1.4	16.7	15.4	36.4	1.8	6.7	12.8	2.8	2.3	15.0	13.3	2.6	3.3	3.3	1.7	5.6	8.3	6.6	4.4	3.2	5.2	3.1	4.2	0.2	4.8	10.8	5.2	3.4	4.2	3.9	0.0	8.1	2.3	6.4	5.6	11.3	0.0	3.7	5.7	3.7	4.3	3.2	4.3	10.4	6.9	6.1	3.8	10.9	3.0	8.8	4.2	2.6	13.1	4.4	0.0	5.1	1.2	5.4	7.5	7.9	5.1	2.6	12.6	8.4	4.3	1.9	5.4	4.6	5.1	9.2	4.8	7.3	7.0	0.5	0.0	6.5	10.8	4.1	8.6	7.9	4.2	11.8	3.1	9.9	4.1	2.5	4.1	2.0	3.2	2.5	3.1	2.9	3.7	3.3	9.5	4.5	2.6	3.8	4.6	2.7	1.5	1.9	3.6	2.8	1.5	1.8	2.0	1.7	2.2	1.4	1.8	2.6	22.6	38.5	21.7	5.9	30.5	25.0	24.2	27.6	23.3	29.1	25.0	23.4	35.9	30.0	21.6	18.4	35.5	30.1	28.3	26.4	45.0	31.6	55.4	21.9	21.4	29.1	27.1	33.0	3.2	23.6	39.7	23.8	13.3	22.9	35.4	21.9	27.8	30.3	27.7	11.8	3.5	29.9	22.4	27.0	18.5	51.5	34.5	21.0	19.6	3.7	43.5	37.8	47.4	5.0	7.3	21.9	43.3	24.8	29.2	32.3	90.5	74.5	20.1	47.3	19.7	21.6	29.7	180.8	87.2	16.2	34.2	47.1	26.9	17.3	26.9	19.9
CSNK2B	"Ckb1, Ckb2"	ENSG00000204435	"Casein kinase 2 beta"	P67870	6	31665227-31670343	"Cancer-related genes, Disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Wnt signaling pathway"		"Cancer-related genes, Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							"CAB004349, HPA005944, CAB013087, CAB016059"	Approved					NA	NA		83000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 72: Non-specific - Transcription"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 39: Non-specific - Basic cellular processes"			"CAB004349: AB_626791, CAB013087: AB_2533571, CAB016059: AB_626792, HPA005944: AB_1847290"	"unprognostic (1.61e-1)"	"unprognostic (3.21e-2)"	"unprognostic (8.88e-2)"	"unprognostic (1.55e-3)"	"unprognostic (9.51e-2)"	"unprognostic (1.38e-1)"	"unprognostic (3.03e-3)"	"unprognostic (1.60e-1)"	"unprognostic (7.52e-2)"	"unprognostic (1.62e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (1.06e-5)"	"unprognostic (5.88e-2)"	"unprognostic (1.72e-1)"	"unprognostic (9.67e-2)"	"unprognostic (3.72e-2)"	155.8	157.4	15.8	31.9	24.6	62.2	150.2	17.6	54.1	147.9	16.8	142.2	27.8	126.7	183.7	166.6	130.1	33.1	178.9	15.9	16.4	172.1	163.7	133.0	72.5	16.3	17.5	161.2	142.3	69.3	130.0	68.2	17.8	120.3	50.4	41.4	131.9	57.6	232.0	294.2	126.5	66.3	15.4	146.0	146.7	257.9	17.1	56.5	132.4	94.8	30.1	126.2	139.8	17.4	0.9	95.5	2.5	164.9	97.4	158.0	120.8	200.9	350.2	407.6	377.9	0.2	129.3	302.5	127.9	196.8	146.0	0.1	1.0	374.5	409.4	153.1	322.6	4.3	0.6	1.1	260.0	341.5	0.9	257.8	1.5	0.8	0.2	0.2	4.7	208.3	1.7	1.7	0.8	2.9	237.1	2.2	102.0	240.0	0.0	221.1	2.3	247.7	222.3	136.5	1.2	243.0	1.8	0.9	175.8	101.0	7.4	1.3	118.8	210.3	203.9	198.0	1.3	167.3	285.9	267.6	122.3	1.6	196.1	87.3	114.8	121.8	80.1	125.9	80.5	113.7	81.7	85.1	111.0	99.1	71.4	61.9	95.2	90.8	83.2	131.7	113.4	95.0	15.8	24.6	17.6	54.1	15.9	16.4	16.3	17.5	17.8	15.4	17.1	17.4	114.3	51.3	67.0	11.1	124.4	186.1	125.1	196.1	138.9	56.8	135.5	196.3	91.3	105.8	116.5	101.2	12.5	211.8	106.4	185.6	270.1	184.7	452.7	75.1	71.7	122.7	125.7	103.5	14.1	175.2	252.7	118.3	93.3	68.2	129.5	102.3	125.7	126.6	296.2	48.8	14.3	175.4	138.4	204.4	218.5	270.7	153.7	146.2	152.9	8.4	181.1	168.3	121.5	14.6	19.1	182.9	248.1	125.3	152.1	154.3	283.1	397.5	91.3	47.8	138.1	107.9	152.2	485.6	186.5	142.7	186.3	282.1	111.5	116.8	184.3	150.6
AL662899.2		ENSG00000263020	"Novel protein"		6	31666102-31673546	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 3.2;Club cells: 1.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in some"							"Low region specificity"	"Detected in all"			"HPA005944, HPA048307"	Uncertain					NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 11: Alveolar cells - Smell perception"			"HPA005944: AB_1847290, HPA048307: AB_2680348"	"unprognostic (7.19e-2)"	"unprognostic (4.75e-1)"	"unprognostic (2.65e-1)"	"unprognostic (7.07e-3)"	"unprognostic (1.09e-2)"	"unprognostic (6.32e-2)"	"unprognostic (1.37e-3)"	"unprognostic (2.55e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.16e-1)"	"unprognostic (3.95e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.28e-1)"	"unprognostic (3.00e-1)"	"unprognostic (1.56e-1)"	7.9	7.0	0.0	0.0	0.0	10.4	7.5	0.1	0.1	8.7	0.0	8.5	0.0	6.2	0.1	8.0	8.7	0.1	7.4	0.0	0.1	7.5	8.2	7.5	0.1	0.0	0.0	9.3	7.0	0.0	6.3	0.0	0.1	8.7	0.1	0.2	6.2	0.0	5.7	13.9	10.7	0.0	0.0	15.1	7.6	7.3	0.0	0.0	7.2	0.3	0.0	6.6	6.4	0.0	0.4	0.3	0.7	0.6	0.0	0.0	0.1	0.0	0.1	0.5	0.2	0.5	0.7	0.6	0.3	0.5	0.9	0.5	0.1	1.5	1.7	0.4	1.2	1.2	0.3	0.2	0.6	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.5	0.6	0.2	0.4	1.1	1.2	0.1	0.5	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.5	1.4	0.4	0.3	0.1	0.0	0.3	0.3	0.1	0.7	1.6	0.0	0.0	0.0	0.3	1.4	0.1	0.5	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.3	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
LY6G5B	"C6orf19, G5b"	ENSG00000240053	"Lymphocyte antigen 6 family member G5B"	Q8NDX9	6	31670167-31673776	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 3.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"							HPA048307	Approved				"Secreted to blood"	NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 72: Non-specific - Transcription"	"Cluster 20: HeLa - Mitochondria"	"Cluster 65: Plasmacytoid DCs - Unknown function"			"HPA048307: AB_2680348"	"unprognostic (2.69e-2)"	"unprognostic (1.52e-1)"	"unprognostic (8.53e-2)"	"unprognostic (1.44e-2)"	"unprognostic (5.80e-2)"	"unprognostic (9.85e-3)"	"unprognostic (5.04e-3)"	"unprognostic (8.34e-3)"	"unprognostic (5.45e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.58e-4)"	"unprognostic (7.27e-3)"	"unprognostic (1.98e-5)"	"unprognostic (2.12e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.00e-2)"	"unprognostic (3.98e-4)"	30.1	13.5	3.0	9.5	3.4	29.9	25.9	7.4	7.2	26.3	3.1	25.6	6.9	24.9	11.1	15.8	25.0	6.3	15.0	3.2	3.9	15.5	15.0	27.8	12.1	3.5	3.3	33.2	14.5	2.8	20.8	8.2	3.6	22.1	11.4	11.3	20.3	7.4	15.4	44.6	27.8	9.4	2.7	30.6	19.2	13.0	3.8	7.7	24.7	3.3	13.1	21.1	20.4	3.7	5.4	5.8	11.4	15.5	2.6	5.5	14.5	10.4	3.3	7.3	7.2	7.1	6.8	12.9	2.8	13.0	4.7	8.6	2.7	13.7	11.6	5.2	18.0	12.4	8.1	5.7	2.2	15.6	9.9	11.8	7.9	10.7	5.0	10.3	3.9	9.7	7.7	7.8	5.0	4.9	8.4	12.0	6.4	1.5	2.6	11.8	3.5	5.7	3.4	14.7	8.0	12.9	4.7	1.8	3.6	13.9	4.7	10.3	7.6	14.2	7.5	6.6	2.6	13.6	10.1	11.5	5.1	14.6	4.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	3.4	7.4	7.2	3.2	3.9	3.5	3.3	3.6	2.7	3.8	3.7	0.3	3.2	0.0	0.0	1.4	1.0	1.2	0.7	0.0	1.1	0.7	0.3	0.1	1.5	0.2	0.0	0.0	0.4	0.8	0.6	0.0	0.1	0.0	0.4	0.8	0.5	1.2	0.0	0.5	0.2	0.4	0.9	1.1	1.1	0.0	1.2	0.4	0.4	0.5	0.0	0.6	0.9	0.0	0.0	2.2	0.0	0.6	0.7	0.0	0.0	0.4	0.4	0.0	0.0	0.3	0.0	0.8	0.0	0.6	1.1	1.8	0.0	0.1	2.3	0.0	1.5	0.8	0.1	0.3	0.4	1.3	0.5	1.4	0.4	1.0	0.8
LY6G5C	"C6orf20, G5c, NG33"	ENSG00000204428	"Lymphocyte antigen 6 family member G5C"	Q5SRR4	6	31676684-31684040	"Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"testis: 1.7"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 21.4;Respiratory ciliated cells: 16.1;Spermatocytes: 15.9"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"cerebral cortex: 1.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA038690	Approved		Approved	Nucleoplasm,Cytosol	"Secreted - unknown location"	NA	NA				"Cluster 71: Testis - DNA repair"		"Cluster 51: Myeloid cells - Hemostasis"	Nucleoplasm	Cytosol	"HPA038690: AB_10673286"	"unprognostic (1.51e-2)"	"unprognostic (7.26e-2)"	"unprognostic (7.19e-2)"	"prognostic favorable (1.07e-4)"	"unprognostic (4.83e-1)"	"unprognostic (6.91e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.57e-2)"	"unprognostic (4.27e-2)"	"unprognostic (5.63e-2)"	"unprognostic (3.74e-5)"	"unprognostic (5.84e-2)"	"unprognostic (3.78e-4)"	"unprognostic (1.53e-1)"	"unprognostic (2.07e-1)"	"unprognostic (5.88e-2)"	"unprognostic (1.39e-2)"	0.3	0.2	0.0	0.6	0.4	0.3	0.2	0.2	1.0	0.2	0.0	0.2	0.1	0.1	0.1	0.1	0.5	0.5	0.3	0.0	0.0	0.5	0.3	0.5	0.3	0.0	0.0	0.2	0.6	0.0	0.9	0.1	0.3	0.4	0.0	0.6	0.1	0.0	0.8	0.2	0.3	0.0	0.0	0.6	0.3	1.7	0.0	0.1	0.3	0.0	0.0	0.2	0.2	0.2	0.0	0.0	0.1	0.6	0.8	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.7	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.8	0.4	0.3	0.0	0.1	0.0	0.1	0.3	0.0	0.0	0.2	0.4	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.2	0.1	0.2	0.0	0.1	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.3	0.5	0.0	0.1	0.1	0.1	0.6	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	1.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	7.8	3.2	1.5	0.3	1.4	1.7	1.8	2.0	0.0	2.8	7.7	8.0	1.2	1.5	2.1	1.8	2.1	0.5	4.2	3.8	3.9	2.1	21.4	6.9	1.4	5.6	3.5	3.0	0.8	4.9	0.2	1.6	3.1	1.8	5.1	1.4	10.4	2.2	6.2	0.0	1.2	2.0	8.2	5.5	3.1	7.5	1.2	11.6	1.8	0.0	3.7	6.0	2.1	1.0	0.6	3.4	3.1	1.5	3.2	2.1	3.0	4.6	16.1	1.1	0.0	2.6	1.7	15.9	13.9	2.0	0.9	0.3	5.2	1.3	3.1	1.9
ABHD16A	"BAT5, D6S82E, NG26"	ENSG00000204427	"Abhydrolase domain containing 16A, phospholipase"	O95870	6	31686955-31703356	"Enzymes, Predicted membrane proteins"	"Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 41.2;OE19: 42.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058606	Approved					NA	NA		37000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 72: Non-specific - Transcription"	"Cluster 21: OE19 - Mitochondria"	"Cluster 59: Non-specific - Transcription"			"HPA058606: AB_2683774"	"unprognostic (1.44e-1)"	"unprognostic (1.10e-1)"	"unprognostic (7.26e-2)"	"prognostic unfavorable (2.63e-4)"	"unprognostic (3.14e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.24e-1)"	"unprognostic (8.75e-2)"	"unprognostic (1.07e-1)"	"unprognostic (6.17e-3)"	"unprognostic (1.97e-3)"	"unprognostic (6.02e-2)"	"unprognostic (1.30e-2)"	"unprognostic (9.35e-2)"	"unprognostic (1.81e-1)"	"unprognostic (5.11e-3)"	"unprognostic (1.60e-3)"	16.2	22.1	1.1	11.7	1.3	6.7	13.3	1.2	4.1	20.5	0.9	20.9	0.0	21.5	19.0	21.1	18.9	9.9	17.4	1.2	1.2	17.0	30.0	16.0	13.0	1.6	2.0	15.0	18.7	5.8	40.0	7.9	1.4	19.6	7.3	6.7	17.4	4.2	35.0	12.9	17.6	0.0	1.5	18.5	21.5	31.6	1.5	4.5	21.3	0.0	0.0	20.7	15.0	1.5	0.0	15.7	0.0	41.2	29.0	11.7	0.0	14.5	16.2	16.5	15.6	0.0	26.1	16.5	33.7	21.2	0.0	0.0	0.0	19.7	9.0	16.0	12.7	0.0	0.0	0.0	34.7	0.0	0.0	12.1	0.0	0.0	0.0	0.0	0.0	13.3	0.0	0.3	0.0	0.0	0.0	0.5	0.0	42.4	0.0	0.7	0.0	29.3	21.0	0.0	0.2	20.0	0.9	0.5	0.4	0.0	0.0	0.0	14.9	19.6	14.5	0.0	0.0	10.5	21.1	8.5	13.6	0.1	16.1	2.5	6.8	8.4	4.1	8.9	1.9	2.8	1.2	4.2	6.2	2.8	3.5	2.7	13.3	5.9	0.5	4.1	4.1	6.3	1.1	1.3	1.2	4.1	1.2	1.2	1.6	2.0	1.4	1.5	1.5	1.5	1.2	0.0	8.2	11.4	10.7	0.4	0.3	1.7	15.4	1.2	1.5	1.0	0.5	0.0	1.6	0.0	0.0	3.9	2.2	12.0	3.9	18.3	1.3	1.4	1.7	2.7	12.5	14.9	13.4	13.3	1.5	5.3	12.2	1.2	1.3	0.5	0.7	0.8	3.3	0.0	14.6	9.7	2.0	2.2	2.1	0.4	0.9	8.8	3.6	13.1	8.1	1.0	5.2	15.6	21.1	12.7	16.0	0.4	16.4	0.4	16.5	0.7	1.7	1.4	0.0	0.7	4.9	2.5	1.6	16.8	1.0	5.3	7.6	0.2	12.1	0.3
LY6G6F	"C6orf21, G6f, LY6G6D, NG32"	ENSG00000204424	"Lymphocyte antigen 6 family member G6F"	Q5SQ64	6	31706866-31710679	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 3.7;lymphoid tissue: 1.2;skin 1: 1.3"	"Cell type enriched"	"Detected in some"	9	"Macrophages: 9.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	5	"neutrophil: 2.6"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 2.6"	"Cell line enriched"	"Detected in single"	379	"HEL: 37.8"	"Low region specificity"	"Detected in many"							HPA008053	Uncertain					NA	NA		380000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 36: HEL - Hemostasis"	"Cluster 51: Myeloid cells - Hemostasis"			"HPA008053: AB_1840160"			"unprognostic (3.77e-1)"							"unprognostic (7.01e-2)"						"unprognostic (2.66e-3)"		0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	1.2	0.0	0.3	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	37.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	2.6	0.0	0.0	0.5	0.0	17.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.3	0.0	9.1	0.0	0.0	0.2	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
LY6G6F-LY6G6D	"G6F-LY6G6D, MEGT-1, MEGT1"	ENSG00000250641	"LY6G6F-LY6G6D readthrough"		6	31706904-31717918	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Group enriched"	"Detected in some"	5	"skin 1: 5.4;testis: 2.9"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	23	"colorectal cancer: 9.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA008053	Uncertain					NA	NA				"Cluster 27: Brain & Skin - Unknown function"		"Cluster 33: Fibroblasts - ECM organization"			"HPA008053: AB_1840160"			"unprognostic (5.02e-2)"		"unprognostic (1.31e-1)"	"unprognostic (3.47e-1)"				"unprognostic (5.90e-2)"		"unprognostic (1.07e-2)"			"unprognostic (2.66e-1)"	"unprognostic (2.42e-1)"		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
LY6G6E	"C6orf22, G6e"	ENSG00000255552	"Lymphocyte antigen 6 family member G6E"		6	31711771-31714065	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in some"		"bone marrow: 1.4;skin 1: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	114	"HEL: 23.7"									HPA056234			Approved	Nucleoplasm	"Intracellular and membrane"	NA	NA				"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 36: HEL - Hemostasis"		Nucleoplasm		"HPA056234: AB_2732601"			"unprognostic (1.77e-1)"							"unprognostic (1.58e-2)"				"unprognostic (2.25e-1)"		"unprognostic (6.88e-2)"		0.1	0.0	0.2	0.0	0.2	1.4	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.0	0.1	0.1	0.0	0.1	0.8	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.3	0.0	0.1	0.2	0.0	0.5	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.1	0.4	0.1	0.1	0.2	0.1	0.2	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
LY6G6D	"C6orf23, G6D, Ly6-D, MEGT1, NG25"	ENSG00000244355	"Lymphocyte antigen 6 family member G6D"	O95868	6	31715356-31717804	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"skin 1: 24.7"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in some"	22	"colorectal cancer: 18.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"HEL: 1.7"	"Region enhanced"	"Detected in many"		"cerebellum: 6.1"					HPA054412	Uncertain				"Intracellular and membrane"	NA	NA				"Cluster 61: Skin - Cornification"	"Cluster 36: HEL - Hemostasis"	"Cluster 61: Squamous epithelial cells - Keratinization"			"HPA054412: AB_2682480"			"unprognostic (5.48e-2)"		"unprognostic (1.25e-1)"					"unprognostic (2.81e-2)"		"unprognostic (2.13e-1)"						0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.1	0.0	3.9	0.0	0.2	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	2.1	0.1	0.0	0.0	1.4	0.0	24.7	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.1	0.0	0.3	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.4	0.0	0.0	0.0	0.0	0.0
MPIG6B	"C6orf25, G6b, G6b-B, NG31"	ENSG00000204420	"Megakaryocyte and platelet inhibitory receptor G6b"	O95866	6	31718594-31726714	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		"Heparin-binding, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 4.8;skin 1: 8.3"	"Cell type enriched"	"Detected in single"	14	"granulocytes: 10.1"	"Low cancer specificity"	"Detected in single"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"NK-cell: 1.6"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in single"	14	"HEL: 6.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA054404, HPA073017"			Approved	"Nucleoplasm,Endoplasmic reticulum,Golgi apparatus,Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA		330000	"Cluster 15: NK-cells - Transcription"	"Cluster 31: Skin - Epidermis development"	"Cluster 36: HEL - Hemostasis"	"Cluster 60: Granulocytes - Receptor signaling"	"Golgi apparatus"	"Nucleoplasm, Endoplasmic reticulum, Plasma membrane, Cytosol"	"HPA054404: , HPA073017: AB_2686566"	"unprognostic (1.45e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.93e-1)"	"unprognostic (1.77e-2)"	"unprognostic (1.23e-1)"	"unprognostic (6.53e-2)"	"unprognostic (3.53e-2)"	"unprognostic (2.71e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.43e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.55e-2)"	"unprognostic (1.71e-2)"	0.5	0.0	0.0	0.1	0.0	1.1	0.4	0.1	0.2	1.0	0.1	0.3	0.1	0.4	0.0	1.6	0.5	0.2	0.8	0.1	0.1	0.1	0.3	3.5	0.0	0.1	0.2	0.2	0.1	0.0	0.2	0.0	0.1	0.3	0.0	0.0	0.6	0.0	0.2	8.3	0.4	0.0	0.0	4.8	0.3	2.3	0.1	0.0	0.5	0.0	0.0	0.5	1.3	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.1	0.3	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.2	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.6	0.0	0.8	0.0	2.2	0.0	0.0	0.1	0.2	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.0	0.1	0.0	0.5	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.2	10.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0
LY6G6C	"C6orf24, G6c, NG24"	ENSG00000204421	"Lymphocyte antigen 6 family member G6C"	O95867	6	31718648-31721746	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	11	"skin 1: 511.5"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 11.3;Late spermatids: 13.1;Suprabasal keratinocytes: 64.2;Syncytiotrophoblasts: 20.4"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 20.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 2.5;CACO-2: 1.0;HaCaT: 2.0;MCF7: 3.2;OE19: 1.5;SuSa: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA				"Cluster 61: Skin - Cornification"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 28: Keratinocytes - Keratinization"				"unprognostic (1.21e-1)"	"unprognostic (3.05e-2)"	"unprognostic (1.68e-1)"	"unprognostic (4.85e-3)"	"unprognostic (2.59e-3)"	"unprognostic (1.35e-1)"		"unprognostic (9.03e-2)"	"unprognostic (1.79e-1)"	"unprognostic (4.13e-1)"	"unprognostic (1.76e-3)"	"unprognostic (2.85e-1)"	"unprognostic (8.80e-7)"	"unprognostic (1.33e-2)"	"unprognostic (2.56e-1)"	"unprognostic (6.09e-2)"	"unprognostic (9.38e-2)"	1.1	0.1	0.1	0.2	0.4	0.0	15.8	0.1	0.4	13.0	0.1	0.3	0.0	0.4	0.2	47.6	1.5	0.0	0.5	0.2	0.1	0.2	0.4	0.6	0.0	0.1	0.1	0.6	0.2	0.1	0.3	7.6	0.1	0.5	0.1	0.1	12.0	0.0	1.6	511.5	0.2	0.1	0.1	0.6	0.5	1.9	0.1	1.2	0.6	0.0	12.1	0.3	31.0	0.2	0.4	0.1	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	1.0	0.3	0.1	0.0	0.1	0.0	2.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.2	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	1.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.1	0.4	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.6	0.0	0.0	0.3	0.1	4.7	0.7	0.5	0.6	0.0	3.5	2.0	0.1	0.0	0.1	0.0	0.0	7.5	0.0	2.3	0.0	0.1	11.3	1.3	1.3	0.6	0.0	0.0	0.0	0.0	1.2	0.7	0.0	3.0	0.0	0.3	0.0	0.0	0.7	0.0	0.0	2.0	0.0	0.0	0.7	13.1	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.5	0.0	0.0	2.1	0.2	0.0	0.9	0.0	0.0	0.4	0.5	0.0	0.1	6.1	64.2	20.4	0.2	0.1	2.0	3.2
DDAH2	G6A	ENSG00000213722	"Dimethylarginine dimethylaminohydrolase 2"	O95865	6	31727038-31730617	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 386.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MCF7: 63.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012389, HPA012509"	Uncertain		Supported	Mitochondria		NA	NA		1500000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Mitochondria		"HPA012389: , HPA012509: AB_1847533"	"unprognostic (2.29e-2)"	"unprognostic (1.38e-1)"	"unprognostic (4.49e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.44e-1)"	"unprognostic (7.67e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.62e-1)"	"unprognostic (8.78e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.02e-1)"	"unprognostic (9.42e-2)"	"unprognostic (2.32e-1)"	"unprognostic (2.24e-2)"	"unprognostic (2.72e-2)"	96.5	17.2	26.6	12.0	24.7	10.8	81.2	24.2	44.7	131.5	26.1	72.2	4.4	94.4	8.7	39.0	80.5	44.0	63.2	23.9	33.5	67.1	32.1	62.3	20.6	31.8	28.2	67.7	16.5	17.5	26.0	18.3	28.1	65.2	7.7	5.8	58.2	27.0	13.4	67.7	38.9	11.9	32.0	49.4	35.4	13.4	27.4	9.6	65.1	4.5	7.8	61.0	91.0	30.9	2.0	20.1	0.7	28.5	17.0	26.6	3.8	0.0	10.6	10.9	7.3	40.4	6.7	0.4	24.4	26.5	0.9	2.4	0.5	9.7	1.9	0.0	14.2	1.9	7.8	22.4	18.2	0.3	1.5	18.8	1.2	12.2	0.9	3.7	33.3	14.1	0.4	11.1	4.8	63.0	1.5	27.5	4.1	4.3	12.2	0.2	0.9	10.5	21.6	0.5	1.5	5.7	0.0	4.7	27.4	2.9	37.7	7.8	0.1	16.9	24.7	11.2	0.0	4.1	12.8	3.3	11.3	5.9	4.3	141.3	15.4	135.0	14.8	37.4	5.8	49.7	4.0	5.3	26.8	39.6	2.7	3.4	27.8	29.2	44.9	93.9	4.1	11.4	26.6	24.7	24.2	44.7	23.9	33.5	31.8	28.2	28.1	32.0	27.4	30.9	102.3	28.9	14.7	10.4	76.8	66.9	88.7	49.6	56.3	4.5	132.8	96.0	39.5	62.9	36.9	82.8	29.2	15.5	84.4	386.3	178.1	148.2	83.1	62.6	94.2	101.2	150.0	20.4	0.3	32.3	37.3	154.1	33.1	75.0	113.3	121.7	94.9	31.9	223.2	0.0	0.3	71.5	109.9	139.7	301.2	23.6	180.5	95.7	103.2	14.0	64.2	120.9	40.2	4.5	2.7	85.1	299.5	153.1	24.5	95.2	61.5	165.8	50.5	25.7	105.2	122.7	153.0	4.1	12.5	35.8	59.2	18.1	41.1	21.3	104.6	67.0
CLIC1	"CLCNL1, G6, NCC27, p64CLCP"	ENSG00000213719	"Chloride intracellular channel 1"	O00299	6	31730581-31739763	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel, Voltage-gated channel"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020825, CAB040557"	Enhanced		Supported	Cytosol		NA	NA		22000000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 72: Non-specific - Transcription"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Cytosol		"CAB020825: , CAB040557: "	"unprognostic (7.26e-2)"	"unprognostic (9.32e-2)"	"unprognostic (2.78e-3)"	"unprognostic (7.29e-2)"	"unprognostic (6.93e-2)"	"unprognostic (2.73e-2)"	"prognostic unfavorable (8.90e-7)"	"unprognostic (2.58e-2)"	"unprognostic (8.51e-2)"	"unprognostic (8.71e-3)"	"unprognostic (1.19e-3)"	"unprognostic (1.34e-1)"	"prognostic unfavorable (8.11e-5)"	"unprognostic (4.51e-2)"	"unprognostic (2.89e-1)"	"unprognostic (1.35e-2)"	"unprognostic (7.31e-2)"	292.8	156.5	6.9	43.4	6.8	64.0	256.7	7.1	11.0	222.2	8.7	291.6	37.0	197.9	20.9	395.9	190.5	43.7	183.7	6.7	10.2	318.5	102.6	330.4	44.1	9.4	7.7	149.8	148.1	20.1	111.5	45.5	8.9	217.0	64.0	2.6	251.3	22.3	47.3	324.8	231.6	32.7	8.9	332.6	247.8	41.0	9.6	35.2	180.8	11.1	58.1	257.7	246.8	8.9	119.5	54.1	87.0	45.6	56.6	118.6	43.3	52.8	105.4	92.6	77.9	125.2	87.2	48.7	73.6	186.0	116.9	70.2	65.8	154.9	124.4	38.9	34.4	93.0	43.4	109.3	73.0	164.3	125.9	74.3	80.5	157.0	148.4	101.7	157.9	44.6	109.4	149.5	181.0	79.2	77.2	213.2	7.7	128.9	78.4	13.5	47.5	115.3	210.2	73.0	16.5	19.5	43.1	49.1	71.5	60.4	33.7	228.3	105.0	128.6	91.2	39.0	166.8	48.3	98.3	66.0	62.4	122.0	136.6	244.3	179.4	239.3	165.6	194.3	135.8	186.1	98.0	155.5	143.8	150.3	30.5	92.3	341.1	176.3	174.3	80.5	149.2	414.2	6.9	6.8	7.1	11.0	6.7	10.2	9.4	7.7	8.9	8.9	9.6	8.9	514.8	70.5	67.0	0.7	382.5	960.8	589.1	869.7	331.2	0.4	274.3	300.5	18.6	296.0	457.7	237.3	0.0	545.5	472.2	730.7	602.6	1096.2	31.8	271.1	212.7	490.1	381.4	208.6	0.0	1008.9	912.5	296.6	370.5	301.3	554.1	431.2	300.9	54.2	1047.6	0.0	0.0	665.6	516.8	533.7	1529.8	17.3	233.9	685.7	524.7	13.1	426.4	86.8	706.5	0.5	0.0	1470.4	997.1	188.1	420.2	851.1	707.7	572.1	473.6	6.9	203.8	136.1	554.0	28.7	16.2	464.1	928.0	572.7	522.2	283.3	675.0	1005.9
MSH5	G7	ENSG00000204410	"MutS homolog 5"	O43196	6	31739677-31762676	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Meiosis"	DNA-binding	"Disease variant, Premature ovarian failure"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 14.0"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 18.8;Erythroid cells: 8.0;Gastric mucus-secreting cells: 10.7;Plasma cells: 10.7;Spermatocytes: 10.9;Spermatogonia: 8.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"basophil: 2.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"Daudi: 3.1;NB-4: 5.2"									HPA062688			Approved	"Endoplasmic reticulum,Vesicles"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 71: Testis - DNA repair"	"Cluster 24: NB-4 - Immune response"	"Cluster 59: Non-specific - Transcription"	Vesicles	"Endoplasmic reticulum"	"HPA062688: AB_2684835"	"unprognostic (3.21e-3)"	"unprognostic (2.32e-2)"	"unprognostic (2.05e-1)"	"unprognostic (4.37e-2)"	"unprognostic (4.51e-1)"	"unprognostic (9.20e-4)"	"unprognostic (7.67e-3)"	"unprognostic (2.57e-2)"	"unprognostic (1.45e-2)"	"unprognostic (2.05e-3)"	"unprognostic (4.59e-3)"	"unprognostic (2.28e-2)"	"unprognostic (5.19e-5)"	"unprognostic (3.75e-2)"	"unprognostic (8.83e-2)"	"unprognostic (9.21e-2)"	"unprognostic (9.34e-4)"	1.3	1.2	0.1	0.5	0.1	0.7	1.5	0.1	0.4	1.7	0.2	1.6	0.0	1.4	0.0	2.2	1.9	0.0	1.0	0.1	0.1	5.6	2.0	1.4	0.6	0.1	0.2	2.3	1.6	0.0	2.2	0.0	0.1	2.9	0.0	0.1	1.6	0.0	0.6	1.8	1.8	0.0	0.1	2.4	1.6	14.0	0.1	0.0	1.5	0.0	0.0	1.6	1.7	0.2	0.3	1.1	0.4	0.9	0.0	0.1	0.0	0.2	0.0	0.4	0.1	0.1	1.0	3.1	0.4	0.0	0.1	0.8	0.0	0.0	0.1	0.0	0.7	1.1	0.1	0.6	0.0	0.3	1.3	0.0	0.0	0.1	0.3	0.5	0.9	1.2	1.9	1.6	0.0	2.1	0.5	5.2	0.9	0.9	0.0	2.1	0.1	2.4	0.3	0.5	0.2	0.8	0.3	0.2	0.0	0.0	0.3	1.8	0.0	0.3	1.6	0.1	0.6	0.3	2.1	1.7	0.0	0.5	0.8	2.5	0.4	0.0	0.4	0.3	0.0	1.4	0.4	0.1	0.1	0.6	0.1	0.1	0.6	0.1	0.6	0.8	0.1	0.1	0.1	0.1	0.1	0.4	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.2	0.4	0.0	2.3	0.0	3.6	0.5	0.5	0.3	3.4	0.7	0.5	0.5	0.3	2.8	0.8	3.7	18.8	0.6	0.5	1.0	0.0	0.2	0.1	1.6	1.3	0.6	1.2	8.0	0.0	0.2	0.4	0.9	10.7	2.8	3.8	3.1	0.4	0.3	0.5	0.0	0.0	1.2	0.0	0.8	1.3	0.5	1.2	1.5	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.4	0.5	0.7	10.7	0.5	2.0	0.8	0.9	7.3	0.0	1.0	1.4	10.9	8.3	6.2	0.4	0.5	2.5	0.9	1.9	0.4
SAPCD1	"C6orf26, NG23"	ENSG00000228727	"Suppressor APC domain containing 1"	Q5SSQ6	6	31762996-31764851	"Metabolic proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 28.3"	"Cell type enriched"	"Detected in single"	15	"Respiratory ciliated cells: 1.5"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"NB-4: 1.4;U-2 OS: 1.1;U-937: 1.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA071699			Approved	"Vesicles,Cell Junctions"		NA	NA				"Cluster 31: Skin - Epidermis development"	"Cluster 24: NB-4 - Immune response"	"Cluster 49: Ciliated cells - Cilium organization"	Vesicles	"Cell Junctions"	"HPA071699: AB_2686433"	"unprognostic (9.25e-4)"	"unprognostic (1.32e-1)"	"unprognostic (3.41e-2)"	"unprognostic (3.28e-1)"	"unprognostic (9.34e-2)"	"unprognostic (8.02e-4)"	"unprognostic (1.63e-2)"	"unprognostic (3.80e-2)"	"unprognostic (2.01e-1)"	"unprognostic (8.16e-3)"	"unprognostic (1.56e-2)"	"unprognostic (2.25e-1)"	"unprognostic (8.15e-10)"	"unprognostic (2.65e-2)"	"unprognostic (4.45e-1)"	"unprognostic (3.57e-1)"	"unprognostic (7.98e-5)"	2.7	1.1	0.4	0.0	0.4	0.2	2.5	0.5	0.9	2.4	0.4	3.7	0.0	2.5	0.1	2.5	3.9	0.0	1.2	0.4	0.3	7.4	3.1	2.0	0.6	0.4	0.5	3.8	2.1	0.0	6.1	0.1	0.4	6.0	0.2	1.2	2.3	0.1	1.0	28.3	3.9	0.1	0.4	4.8	2.6	3.6	0.4	0.2	2.2	0.0	0.1	2.5	2.2	0.4	0.4	0.0	0.0	0.2	0.1	0.2	0.3	0.0	0.1	0.0	0.0	0.0	0.2	0.3	0.1	0.1	0.0	0.5	0.0	0.3	0.2	0.0	0.1	0.5	0.0	0.0	0.1	0.4	0.0	0.1	0.0	0.3	0.7	0.4	0.2	0.2	0.2	0.5	0.0	0.1	0.7	1.4	0.0	0.2	0.0	0.1	0.1	0.0	0.3	0.0	0.2	0.2	0.1	0.0	0.3	0.4	0.0	0.0	0.1	0.0	1.1	0.0	0.0	0.7	0.1	0.4	0.1	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.5	0.9	0.4	0.3	0.4	0.5	0.4	0.4	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
VWA7	"C6orf27, G7c, NG37"	ENSG00000204396	"Von Willebrand factor A domain containing 7"	Q9Y334	6	31765590-31777328	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pituitary gland: 21.3"	"Cell type enhanced"	"Detected in some"		"Enteroendocrine cells: 4.2;Gastric mucus-secreting cells: 8.2;Proximal enterocytes: 5.0;Proximal tubular cells: 2.4"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"cerebral cortex: 2.9;hypothalamus: 8.2;medulla oblongata: 5.9;pons: 5.5;thalamus: 7.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 1.2;HMC-1: 1.3;Karpas-707: 1.1;U-266/84: 1.6"	"Group enriched"	"Detected in some"	5	"cerebellum: 7.0;pons and medulla: 3.9"	"Low region specificity"	"Detected in many"			"HPA046954, HPA054262"	Approved		Approved	"Plasma membrane,Cytosol"	"Secreted - unknown location"	NA	NA		9200	"Cluster 10: Basophils - Unknown function"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 16: U-266 - Nucleosome"	"Cluster 45: Enterocytes - Digestion"	"Plasma membrane, Cytosol"		"HPA046954: AB_2679875, HPA054262: AB_2682430"	"unprognostic (9.13e-2)"	"unprognostic (8.60e-4)"	"unprognostic (9.99e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.85e-3)"	"unprognostic (4.96e-3)"	"unprognostic (6.38e-2)"	"unprognostic (4.40e-2)"	"unprognostic (2.68e-1)"	"unprognostic (5.84e-2)"	"unprognostic (1.65e-2)"	"unprognostic (9.25e-2)"	"prognostic favorable (4.35e-8)"	"unprognostic (3.75e-2)"	"unprognostic (2.37e-1)"	"unprognostic (9.48e-2)"	"unprognostic (7.66e-2)"	0.4	0.3	0.5	0.1	0.3	0.0	0.7	0.1	2.9	0.8	0.0	1.3	1.0	4.6	0.0	0.4	7.2	0.7	5.2	0.8	8.2	5.7	1.4	1.4	0.1	5.9	1.0	0.5	2.6	1.7	21.3	0.0	5.5	0.8	0.4	0.2	1.4	1.3	6.6	0.8	2.3	0.0	0.0	0.5	3.0	0.7	7.5	0.0	1.8	0.0	0.1	0.6	0.7	1.0	0.8	1.2	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.6	0.0	0.0	0.7	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.7	0.0	0.0	0.1	0.0	0.9	0.0	1.1	0.0	0.1	0.0	0.0	0.1	0.6	0.1	0.3	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.5	0.0	0.0	0.0	1.6	0.0	0.0	0.7	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.3	0.1	2.9	0.8	8.2	5.9	1.0	5.5	0.0	7.5	1.0	0.0	0.0	1.1	0.0	0.6	0.1	0.4	0.5	1.2	0.5	0.1	0.3	0.8	0.0	0.3	1.8	0.0	0.0	0.2	1.4	1.9	0.6	0.0	1.5	0.1	0.1	4.2	0.0	1.5	0.5	0.0	0.1	8.2	0.4	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.6	2.1	0.0	0.4	0.3	5.0	2.4	1.6	0.8	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.3	0.4	0.0	0.5	0.4
VARS1	"VARS, VARS2"	ENSG00000204394	"Valyl-tRNA synthetase 1"	P26640	6	31777518-31795752	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 10.1;Cytotrophoblasts: 23.2;Extravillous trophoblasts: 48.3;Hofbauer cells: 30.7;Syncytiotrophoblasts: 16.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in all"		"U-266/84: 140.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046710	Approved		Enhanced	Cytosol		NA	NA		110000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 71: Testis - DNA repair"	"Cluster 16: U-266 - Nucleosome"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol		"HPA046710: AB_2679765"	"unprognostic (1.86e-2)"	"prognostic unfavorable (7.25e-4)"	"unprognostic (2.19e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.49e-2)"	"unprognostic (3.43e-2)"	"prognostic unfavorable (1.86e-4)"	"prognostic unfavorable (6.90e-4)"	"unprognostic (3.20e-1)"	"unprognostic (2.76e-1)"	"unprognostic (4.72e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.09e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.85e-2)"	"unprognostic (2.59e-1)"	22.2	24.6	2.0	6.6	1.6	3.2	21.9	0.4	2.4	20.1	0.0	21.0	5.6	29.4	0.9	32.5	22.1	1.1	20.0	0.7	2.3	19.2	29.3	19.8	3.0	2.4	1.9	19.7	37.3	2.5	33.6	2.2	2.2	17.6	1.7	1.3	20.6	1.2	58.2	34.3	21.9	3.5	0.8	30.0	23.3	63.6	2.6	3.0	18.5	3.1	2.8	23.5	20.7	1.5	36.2	11.6	12.4	36.9	9.1	8.5	84.0	52.2	10.8	25.2	13.3	11.5	9.9	58.3	60.2	18.4	18.9	22.0	33.5	32.4	8.8	46.0	74.0	31.7	18.4	21.3	18.3	75.7	60.6	12.5	8.2	14.8	16.5	6.2	13.5	22.9	92.2	48.8	12.7	13.2	51.0	16.2	35.0	11.9	32.5	55.5	20.5	132.7	13.0	12.4	42.1	26.2	12.0	31.0	19.5	5.8	23.2	34.0	31.2	24.2	37.8	28.2	72.5	87.9	140.4	44.1	14.6	31.1	29.0	0.0	0.3	0.1	0.2	0.3	0.3	0.5	0.3	0.3	0.5	0.3	0.3	0.1	0.1	0.5	0.3	0.6	0.1	0.5	2.0	1.6	0.4	2.4	0.7	2.3	2.4	1.9	2.2	0.8	2.6	1.5	4.2	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.1	0.0	0.0	0.0	0.0	23.2	1.9	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	48.3	3.6	0.0	0.0	0.0	0.0	0.0	0.0	30.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	16.6	0.4	0.0	0.0	0.0
LSM2	"C6orf28, G7b, YBL026W"	ENSG00000204392	"LSM2 homolog, U6 small nuclear RNA and mRNA degradation associated"	Q9Y333	6	31797396-31806966	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052805, HPA066718"	Supported		Enhanced	Nucleoplasm		NA	NA		97000	"Cluster 32: T-cells - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"HPA052805: , HPA066718: AB_2685710"	"unprognostic (1.69e-1)"	"unprognostic (7.78e-2)"	"unprognostic (5.65e-2)"	"unprognostic (1.24e-1)"	"unprognostic (5.10e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.36e-3)"	"unprognostic (6.14e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.34e-3)"	"unprognostic (1.51e-1)"	"unprognostic (2.64e-1)"	"prognostic unfavorable (5.59e-9)"	"unprognostic (2.23e-1)"	"unprognostic (8.48e-2)"	"unprognostic (4.49e-2)"	"unprognostic (9.59e-2)"	38.6	34.3	19.0	19.3	21.8	32.7	37.9	20.6	21.4	44.8	17.4	43.0	23.6	45.0	19.3	39.0	36.9	18.1	32.3	19.4	19.1	43.8	27.6	31.6	36.6	22.8	19.6	37.6	37.2	20.5	30.1	22.5	21.7	29.7	27.8	7.2	25.2	16.3	43.9	37.0	33.6	27.7	24.5	43.5	34.6	26.7	22.9	45.1	30.1	20.9	39.3	39.9	35.6	23.7	91.1	42.5	84.9	103.7	43.8	61.9	58.4	50.1	38.5	85.2	75.1	56.9	37.6	50.3	66.8	50.1	79.8	36.2	109.3	101.1	76.9	72.4	85.0	83.6	27.3	60.1	55.7	80.6	39.7	47.1	47.3	78.6	80.4	40.6	90.3	102.0	127.5	63.0	60.7	73.3	132.3	168.4	56.8	75.0	77.6	73.4	40.5	123.4	69.5	31.6	66.6	55.6	56.0	58.8	101.7	44.7	61.6	68.7	20.1	47.6	74.5	54.1	85.1	53.2	109.9	88.2	26.8	123.3	76.7	29.1	31.3	15.9	36.9	37.7	45.2	3.7	51.6	33.6	35.4	4.1	45.6	30.1	8.7	13.8	25.1	30.9	29.9	57.5	19.0	21.8	20.6	21.4	19.4	19.1	22.8	19.6	21.7	24.5	22.9	23.7	82.9	22.4	23.6	4.6	95.2	58.2	63.7	104.9	56.3	30.9	108.2	177.2	14.9	60.1	48.5	55.2	6.2	143.5	58.5	36.5	113.5	104.5	20.1	38.8	61.2	90.2	54.0	121.8	5.9	137.1	218.8	58.0	46.9	49.2	82.6	119.9	72.8	59.7	143.2	30.3	6.0	93.9	73.2	67.9	76.8	26.0	49.7	56.6	92.5	3.7	99.3	53.3	109.2	9.5	19.8	94.0	55.7	49.2	91.5	78.2	40.8	113.3	24.2	28.3	46.0	70.7	71.4	66.9	176.5	90.8	64.2	69.0	77.8	101.3	113.6	58.6
HSPA1L	"HSP70-HOM, hum70t"	ENSG00000204390	"Heat shock protein family A (Hsp70) member 1 like"	P34931	6	31809619-31815283	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	16	"testis: 63.2"	"Group enriched"	"Detected in many"	22	"Early spermatids: 212.5;Late spermatids: 560.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 1.1;EFO-21: 1.5;HEK 293: 4.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA043285, HPA052504"	Enhanced		Approved	Nucleoplasm,Vesicles		NA	NA		53000000		"Cluster 83: Testis - Spermatogenesis"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 31: Spermatids - Spermatogenesis"	Vesicles	Nucleoplasm	"HPA043285: AB_10962482, HPA052504: AB_2681854"	"unprognostic (1.80e-1)"	"unprognostic (8.70e-2)"	"unprognostic (2.52e-3)"	"unprognostic (6.97e-4)"	"unprognostic (2.69e-2)"	"unprognostic (1.17e-2)"	"unprognostic (4.24e-2)"	"unprognostic (4.33e-2)"	"unprognostic (1.71e-1)"	"prognostic favorable (1.02e-4)"	"unprognostic (5.26e-3)"	"unprognostic (9.96e-2)"	"prognostic favorable (4.63e-4)"	"unprognostic (4.48e-2)"	"unprognostic (4.30e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.53e-3)"	1.2	1.4	0.0	0.0	0.2	0.1	0.9	1.4	0.3	1.5	0.0	1.8	0.1	1.8	0.0	0.6	2.4	0.0	1.4	0.1	0.2	1.5	1.2	1.3	0.0	0.2	0.2	2.2	0.9	0.0	1.7	0.0	0.3	1.1	0.0	0.1	1.0	0.0	3.9	1.0	1.5	0.0	0.2	2.4	1.3	63.2	0.4	0.0	1.5	0.1	0.0	1.6	1.1	0.6	0.1	1.1	0.1	0.4	0.3	0.3	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.0	1.5	0.0	0.4	0.4	0.1	0.0	0.1	0.3	4.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.2	0.3	0.4	0.0	0.0	0.0	0.0	0.6	0.3	0.0	0.1	0.3	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.4	0.3	0.1	0.2	0.2	0.2	0.3	0.2	0.4	0.6	4.2	0.0	1.1	2.9	3.5	0.9	1.3	0.4	2.2	2.6	1.9	2.0	4.5	0.0	0.9	0.0	8.4	0.6	1.4	1.4	0.0	0.7	212.5	2.0	0.7	2.2	1.8	3.2	0.6	0.2	0.6	1.3	0.0	1.3	0.0	0.9	1.8	1.1	1.3	3.3	0.8	1.4	0.0	4.4	2.5	560.9	5.0	2.1	5.4	2.8	4.1	3.6	1.0	0.5	2.0	0.4	1.4	2.2	1.9	0.9	0.9	0.6	2.2	2.8	0.0	0.8	2.9	17.0	8.7	1.7	0.1	0.4	3.8	0.9	1.5	0.3
HSPA1A	"HSP70-1, HSPA1"	ENSG00000204389	"Heat shock protein family A (Hsp70) member 1A"	P0DMV8	6	31815543-31817946	"Disease related genes, Predicted intracellular proteins"	"Host-virus interaction, Stress response"	"Chaperone, Host cell receptor for virus entry, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Basal prostatic cells: 7514.5;Langerhans cells: 2690.4;Urothelial cells: 3444.4"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	64	"cerebral cortex: 403.6"	"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"granulocytes: 6.8;monocytes: 3.6;T-cells: 3.0"	"Cell line enriched"	"Detected in some"	8	"HEK 293: 4450.4"									"CAB017451, CAB032815, HPA052504"	Supported		Approved	Nucleoplasm,Vesicles,Cytosol	"Intracellular and membrane"	NA	Yes		47000000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 22: Epithelial cell types - Mixed function"	"Nucleoplasm, Vesicles"	Cytosol	"CAB017451: AB_10013742, CAB032815: AB_627759, HPA052504: AB_2681854"	"unprognostic (2.44e-1)"	"unprognostic (2.27e-1)"	"prognostic unfavorable (1.54e-5)"	"unprognostic (6.86e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.18e-2)"	"unprognostic (6.17e-3)"	"unprognostic (2.47e-2)"	"unprognostic (1.74e-2)"	"unprognostic (8.43e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.38e-1)"	"unprognostic (6.48e-2)"	"unprognostic (4.12e-2)"	"unprognostic (1.51e-1)"	640.5	350.5	3.5	12.7	3.8	0.0	167.2	6.3	403.6	414.1	3.4	497.7	0.0	209.7	15.9	452.9	194.6	5.9	927.7	4.3	3.7	745.9	1116.2	1055.0	9.1	5.4	5.1	369.7	308.2	1.1	474.3	12.0	4.0	427.7	4.2	6.5	111.5	0.5	294.4	257.3	174.4	2.2	3.8	451.9	483.2	98.0	3.7	2.5	340.2	0.3	2.3	569.2	553.7	6.1	0.2	524.1	0.0	0.1	20.1	14.4	0.0	0.3	0.0	0.0	0.0	1.6	0.7	0.0	122.9	28.7	0.0	0.4	0.0	34.1	0.0	6.9	4450.4	0.0	1.7	3.1	0.0	1.1	0.0	8.8	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.4	0.0	1.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	33.4	0.0	0.5	0.7	0.0	0.0	16.6	5.3	0.0	0.1	4.1	0.0	49.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.3	2.3	3.2	1.1	3.6	0.7	0.6	1.6	1.4	0.3	0.2	0.7	0.6	6.8	0.8	2.0	0.3	3.0	0.4	3.5	3.8	6.3	403.6	4.3	3.7	5.4	5.1	4.0	3.8	3.7	6.1	1537.0	147.4	97.0	427.4	312.4	362.4	7514.5	125.5	968.7	305.3	782.0	844.3	1010.7	81.5	109.3	126.9	379.5	43.2	148.1	634.6	41.1	86.8	81.0	534.7	488.1	1049.0	469.2	64.0	9.7	21.6	154.1	1208.6	592.8	753.4	445.4	18.1	123.5	95.2	270.4	205.3	11.4	560.1	114.0	319.0	2690.4	49.5	603.0	1715.2	839.6	398.2	126.6	768.2	15.5	17.1	207.0	39.5	668.8	160.6	1173.3	1404.1	68.4	72.9	177.2	690.2	151.2	443.4	1802.0	65.4	148.8	1105.8	336.3	104.3	1382.2	285.6	454.9	3444.4
HSPA1B	HSP70-2	ENSG00000204388	"Heat shock protein family A (Hsp70) member 1B"	P0DMV9	6	31827738-31830254	"Predicted intracellular proteins"	"Host-virus interaction, Stress response"	"Chaperone, Host cell receptor for virus entry, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Basal prostatic cells: 3007.4;Urothelial cells: 1619.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"Karpas-707: 204.3"									"CAB008640, HPA052504"	Approved		Approved	Nucleoplasm,Vesicles,Cytosol		NA	Yes				"Cluster 18: Non-specific - Mitochondria"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 22: Epithelial cell types - Mixed function"	"Vesicles, Cytosol"	Nucleoplasm	"CAB008640: AB_1617331, HPA052504: AB_2681854"	"unprognostic (1.20e-1)"	"unprognostic (1.74e-1)"	"unprognostic (4.23e-3)"	"unprognostic (3.23e-2)"	"unprognostic (3.54e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.76e-3)"	"unprognostic (9.50e-2)"	"unprognostic (3.45e-1)"	"unprognostic (4.42e-2)"	"unprognostic (6.92e-2)"	"unprognostic (4.88e-2)"	"unprognostic (5.74e-2)"	"unprognostic (1.15e-1)"	"unprognostic (9.17e-3)"	"unprognostic (4.69e-2)"	"unprognostic (5.99e-2)"	526.3	340.1	0.7	0.4	1.3	0.0	126.0	1.6	5.6	475.3	0.6	361.2	0.0	154.0	9.1	375.2	231.5	2.3	718.3	1.1	1.9	555.5	685.4	845.3	0.0	0.8	1.0	682.2	336.5	3.3	438.2	0.0	1.2	303.6	0.5	2.6	94.8	0.3	159.9	299.0	139.1	0.0	0.4	274.7	372.0	93.8	1.5	0.0	289.9	0.0	0.0	415.3	503.3	1.2	0.4	24.1	0.4	0.2	1.1	0.0	0.3	0.2	0.0	0.0	0.0	1.0	0.1	0.0	8.4	0.0	0.0	3.3	0.0	0.0	0.0	0.0	15.4	0.0	0.5	2.2	0.0	0.0	0.9	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	204.3	0.0	3.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.5	0.0	1.7	0.0	1.6	0.0	0.0	0.3	3.2	0.0	0.4	41.5	0.4	0.4	0.4	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	1.3	1.6	5.6	1.1	1.9	0.8	1.0	1.2	0.4	1.5	1.2	563.2	112.2	75.0	140.7	242.7	239.2	3007.4	63.2	630.0	44.6	509.4	403.9	512.3	40.0	73.7	69.9	131.3	82.7	82.8	542.8	19.6	45.5	1.9	434.9	380.2	446.2	318.6	57.9	2.7	15.6	140.8	585.8	595.8	710.4	346.8	14.1	25.7	17.7	142.0	47.1	2.8	426.3	61.1	84.4	1140.4	9.8	220.6	627.1	642.1	126.5	17.7	192.4	1.0	5.5	61.8	21.4	524.1	54.9	967.0	584.2	159.1	38.3	75.0	144.2	105.2	226.4	846.5	15.2	46.4	904.0	221.9	259.7	604.6	116.7	400.5	1619.4
NEU1	NEU	ENSG00000204386	"Neuraminidase 1"	Q99519	6	31857659-31862905	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism, Lipid degradation, Lipid metabolism"	"Glycosidase, Hydrolase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Syncytiotrophoblasts: 197.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 3.0"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 3.0"	"Cell line enhanced"	"Detected in some"		"GAMG: 5.4;U-266/84: 9.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015634, HPA021506"	Approved		Supported	"Vesicles,Cell Junctions"		NA	NA		180000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 16: U-266 - Nucleosome"	"Cluster 7: Non-specific - Mitochondria"	Vesicles	"Cell Junctions"	"HPA015634: AB_1854386, HPA021506: AB_1854385"	"unprognostic (3.84e-2)"	"unprognostic (7.47e-2)"	"unprognostic (9.64e-2)"	"unprognostic (4.65e-2)"	"unprognostic (3.00e-1)"	"unprognostic (4.42e-3)"	"unprognostic (1.38e-3)"	"unprognostic (8.58e-3)"	"unprognostic (7.49e-2)"	"unprognostic (5.21e-2)"	"unprognostic (4.44e-3)"	"unprognostic (1.27e-1)"	"unprognostic (2.70e-2)"	"unprognostic (6.22e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.12e-1)"	"unprognostic (2.13e-3)"	23.9	57.2	0.7	0.4	0.8	0.0	22.4	2.5	1.2	21.2	1.2	25.1	0.7	19.5	0.0	14.9	16.8	1.0	22.5	0.7	0.6	43.7	29.9	28.9	0.3	0.8	0.5	20.3	35.9	0.3	33.0	0.2	0.8	26.5	0.0	1.6	38.6	0.0	21.3	20.1	24.3	0.1	0.3	25.3	29.8	8.2	1.0	0.0	31.8	0.0	0.0	23.2	16.2	1.7	0.3	0.2	0.8	1.4	1.8	0.4	0.7	0.2	0.2	0.3	0.3	1.5	0.6	0.7	0.4	0.1	5.4	0.3	2.2	0.0	0.4	2.5	0.3	0.6	0.9	1.2	1.4	0.9	1.8	1.0	0.2	1.4	0.7	0.2	0.6	0.9	1.1	1.2	0.5	0.3	0.6	0.0	0.6	0.5	0.4	0.9	0.4	0.9	1.0	0.4	0.7	0.4	0.2	0.3	0.7	0.9	0.9	0.5	0.7	1.1	0.8	0.7	0.6	3.7	9.6	0.9	1.7	0.4	0.4	1.3	0.3	0.4	0.2	0.3	0.1	0.2	0.2	0.1	0.2	0.6	0.2	0.3	3.0	0.3	0.2	0.3	0.2	0.1	0.7	0.8	2.5	1.2	0.7	0.6	0.8	0.5	0.8	0.3	1.0	1.7	65.7	25.6	46.3	5.2	57.0	34.3	48.5	45.0	39.9	26.4	87.7	55.8	29.0	51.5	54.8	47.8	25.0	62.8	100.5	83.7	9.8	114.2	0.8	29.3	53.5	42.8	113.5	4.6	6.3	59.6	57.8	73.8	32.6	60.8	67.9	17.4	30.7	34.5	170.9	10.1	7.6	39.9	79.3	63.0	65.9	1.4	27.7	93.0	71.2	9.4	25.8	48.8	9.2	5.0	4.0	34.4	88.1	23.3	81.7	89.0	115.0	59.9	29.2	32.7	26.3	60.8	43.7	5.4	10.0	29.3	41.6	197.0	81.7	40.3	41.1	34.6
SLC44A4	"C6orf29, CTL4, DFNA72, FLJ14491, NG22, TPPT"	ENSG00000204385	"Solute carrier family 44 member 4"	Q53GD3	6	31863192-31879046	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"			"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 132.0;prostate: 83.0;stomach 1: 83.4"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 546.0;Exocrine glandular cells: 213.4;Intestinal goblet cells: 327.8;Paneth cells: 299.3;Proximal enterocytes: 267.7;Respiratory ciliated cells: 406.7;Undifferentiated cells: 259.6"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 222.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	8	"OE19: 14.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA046977, HPA054176"	Enhanced					NA	NA				"Cluster 9: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA046977: AB_2679887, HPA054176: AB_2682404"	"unprognostic (5.84e-2)"	"unprognostic (4.90e-2)"	"unprognostic (3.86e-3)"	"unprognostic (4.85e-3)"	"unprognostic (2.75e-2)"	"prognostic favorable (3.54e-4)"	"unprognostic (2.65e-3)"	"unprognostic (2.44e-3)"	"unprognostic (3.08e-1)"	"unprognostic (2.45e-1)"	"unprognostic (2.89e-2)"	"unprognostic (1.89e-1)"	"prognostic favorable (1.06e-6)"	"unprognostic (1.37e-2)"	"unprognostic (2.48e-1)"	"unprognostic (4.54e-2)"	"prognostic favorable (6.06e-4)"	0.8	8.2	0.0	2.5	0.0	1.0	5.3	0.0	0.0	22.4	0.0	132.0	100.8	5.9	2.5	2.0	46.9	18.8	0.0	0.0	0.0	32.1	0.4	14.9	0.1	0.3	0.1	1.6	8.9	0.0	16.1	3.5	0.1	83.0	30.3	0.0	42.6	3.9	0.0	1.1	86.8	2.9	0.0	1.6	83.4	0.7	0.0	0.2	1.9	0.0	0.7	11.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	14.6	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.3	0.0	0.7	0.0	0.0	0.0	0.3	0.7	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.0	0.0	3.7	22.4	36.0	0.0	3.8	0.5	23.0	71.4	0.6	0.3	14.6	6.1	0.4	38.6	180.2	66.2	0.0	0.3	0.5	546.0	3.9	111.2	2.3	127.4	8.9	6.2	46.7	0.0	0.1	213.4	0.5	2.4	208.5	67.5	2.5	1.1	0.4	0.0	0.5	0.0	0.1	327.8	91.6	0.0	0.0	3.2	1.5	2.5	0.0	0.0	1.6	0.7	0.0	0.0	0.0	184.0	299.3	0.4	0.3	142.0	267.7	61.5	406.7	0.6	0.0	0.8	11.9	0.2	0.2	0.5	0.4	0.7	2.3	5.5	259.6	139.4
EHMT2	"BAT8, C6orf30, Em:AF134726.3, G9A, KMT1C, NG36/G9a"	ENSG00000204371	"Euchromatic histone lysine methyltransferase 2"	Q96KQ7	6	31879759-31897687	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Chromatin regulator, Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HL-60: 13.3;NTERA-2: 19.3;U-266/84: 16.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050550, HPA060259"	Supported		Supported	"Nucleoplasm,Nuclear speckles"	"Intracellular and membrane"	NA	NA				"Cluster 72: Non-specific - Transcription"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 52: Non-specific - Transcription"	"Nuclear speckles"	Nucleoplasm	"HPA050550: AB_2681170, HPA060259: AB_2684234"	"unprognostic (3.11e-2)"	"unprognostic (2.72e-1)"	"unprognostic (4.39e-2)"	"unprognostic (1.92e-2)"	"unprognostic (5.44e-2)"	"unprognostic (3.51e-2)"	"prognostic unfavorable (1.79e-4)"	"unprognostic (3.55e-2)"	"unprognostic (7.41e-2)"	"unprognostic (1.01e-1)"	"unprognostic (5.89e-2)"	"unprognostic (1.88e-1)"	"unprognostic (9.78e-3)"	"unprognostic (8.72e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.25e-1)"	"unprognostic (9.03e-2)"	8.6	9.6	0.5	0.3	0.4	1.0	8.7	0.4	0.5	15.1	0.2	12.9	2.4	19.8	1.7	10.1	12.8	0.0	5.7	0.4	0.4	7.1	4.6	7.3	1.0	0.4	0.5	16.1	7.8	0.6	12.8	0.7	0.4	10.3	0.3	0.6	9.5	1.3	5.5	9.3	10.5	1.4	0.4	11.5	9.4	12.6	0.5	1.5	10.3	0.4	1.0	13.1	11.3	0.4	0.0	4.5	7.8	0.0	3.4	1.8	5.0	3.5	2.8	3.9	3.2	0.0	0.0	0.0	7.6	5.7	4.0	0.0	0.0	8.6	1.8	5.4	11.8	0.0	0.0	0.1	0.0	13.3	0.0	4.6	1.4	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.0	0.0	9.4	0.0	19.3	0.0	0.0	8.8	0.0	0.0	1.5	0.0	0.0	0.0	0.0	2.3	6.5	3.1	0.0	0.0	3.8	4.1	3.1	6.9	0.0	11.0	16.1	3.8	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.5	0.4	0.4	0.5	0.4	0.4	0.4	0.5	0.4	0.4	0.5	0.4	16.9	16.0	12.0	22.9	20.3	8.4	6.3	11.9	26.2	60.6	15.9	17.8	6.6	17.2	18.9	25.8	41.7	24.6	13.4	9.2	7.9	15.7	41.5	10.1	19.1	16.1	22.6	19.3	16.6	12.2	15.0	16.0	13.3	11.8	14.5	33.8	22.1	7.5	16.3	38.7	24.4	16.4	12.2	12.9	7.3	60.0	27.4	12.1	19.6	9.4	19.9	26.8	25.7	20.1	23.9	10.8	9.1	23.0	16.5	6.2	12.5	10.1	10.8	48.2	26.3	16.3	15.0	20.8	33.7	23.5	11.1	5.6	18.3	19.9	19.0	5.2
C2		ENSG00000166278	"Complement C2"	P06681	6	31897785-31945672	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	"Complement pathway, Immunity, Innate immunity"	"Hydrolase, Protease, Serine protease"	"Age-related macular degeneration, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"liver: 477.9"	"Group enriched"	"Detected in many"	4	"Alveolar cells type 2: 142.4;Hepatocytes: 380.3;Hofbauer cells: 282.7;Kupffer cells: 99.3"	"Cancer enriched"	"Detected in all"	9	"liver cancer: 100.2"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"intermediate monocyte: 21.1;non-classical monocyte: 25.9"	"Lineage enriched"	"Detected in single"	35	"monocytes: 25.9"	"Cell line enriched"	"Detected in some"	5	"Karpas-707: 284.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			CAB016775	Supported				"Secreted to blood"	NA	NA		34000000000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 15: Hepatocytes - Hemostasis"			"CAB016775: "	"unprognostic (2.05e-1)"	"unprognostic (1.22e-1)"	"unprognostic (7.68e-2)"	"unprognostic (1.49e-3)"	"unprognostic (7.40e-2)"	"unprognostic (3.34e-2)"	"unprognostic (1.36e-2)"	"unprognostic (8.88e-3)"	"unprognostic (3.02e-1)"	"unprognostic (2.59e-3)"	"unprognostic (3.27e-2)"	"unprognostic (3.15e-3)"	"prognostic unfavorable (2.64e-7)"	"unprognostic (2.05e-1)"	"unprognostic (4.42e-2)"	"unprognostic (7.37e-2)"	"unprognostic (2.55e-2)"	42.6	12.1	0.8	27.6	1.0	3.2	11.7	0.9	1.4	8.1	1.7	14.3	16.7	7.0	1.3	7.6	12.0	23.0	8.5	0.7	1.1	23.2	477.9	80.0	27.8	3.0	2.6	5.3	1.9	0.9	3.8	48.4	3.0	5.4	13.0	0.4	9.1	0.9	2.1	5.8	30.2	23.6	2.1	46.3	12.0	4.1	3.7	5.5	3.3	2.7	12.5	23.6	5.3	2.1	0.3	0.1	0.1	0.6	0.1	0.0	6.8	0.5	0.3	0.4	0.3	0.4	0.3	0.6	3.5	1.0	0.6	0.5	0.1	0.0	0.3	0.2	0.4	0.3	0.4	52.8	1.1	0.1	0.7	2.7	0.3	0.6	0.1	0.6	0.0	0.7	0.5	284.0	0.0	0.0	0.4	0.5	0.3	0.1	0.0	0.2	16.5	3.0	0.0	0.1	0.3	0.3	2.6	0.3	0.2	0.3	0.2	9.5	0.2	0.2	0.7	0.5	0.1	0.9	31.6	2.7	0.8	0.9	0.1	0.1	5.6	0.0	0.1	21.1	0.1	0.0	0.0	0.0	0.7	0.1	0.1	0.1	0.5	0.1	25.9	0.0	0.0	2.2	0.8	1.0	0.9	1.4	0.7	1.1	3.0	2.6	3.0	2.1	3.7	2.1	2.1	25.6	142.4	2.6	1.9	3.3	1.1	2.0	0.6	1.4	1.3	1.3	0.6	25.8	11.2	1.8	0.0	2.1	0.1	1.8	0.0	0.6	0.3	1.5	18.7	1.9	2.4	10.7	6.6	2.7	2.7	19.8	3.1	1.3	3.8	0.2	21.0	380.3	282.7	1.7	6.3	11.3	0.0	99.3	5.0	1.3	6.8	32.6	3.6	7.5	7.3	0.1	0.0	1.0	1.7	4.5	33.1	1.2	0.4	4.0	55.2	35.7	9.4	0.9	0.0	5.6	3.5	0.8	1.4	0.7	2.8	4.0	2.0	0.5	15.8	4.5
ZBTB12	"C6orf46, D6S59E, G10, NG35"	ENSG00000204366	"Zinc finger and BTB domain containing 12"	Q9Y330	6	31899613-31902086	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 4.6;Erythroid cells: 2.5;Horizontal cells: 3.3;Oligodendrocytes: 2.2;Rod photoreceptor cells: 1.7;Squamous epithelial cells: 1.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 2.5;HEK 293: 3.1;NTERA-2: 2.5;REH: 4.6;U-266/84: 3.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047161, HPA070639"	Approved		Enhanced	Nucleoplasm		NA	NA				"Cluster 72: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA047161: AB_2679962, HPA070639: "	"unprognostic (2.05e-1)"	"unprognostic (3.15e-2)"	"unprognostic (3.77e-1)"	"unprognostic (2.93e-1)"	"unprognostic (1.24e-1)"	"unprognostic (8.92e-2)"	"unprognostic (1.26e-3)"	"unprognostic (1.55e-1)"	"unprognostic (5.22e-2)"	"unprognostic (8.16e-2)"	"unprognostic (2.58e-1)"	"unprognostic (5.41e-2)"	"prognostic unfavorable (1.52e-4)"	"unprognostic (1.87e-1)"	"unprognostic (2.11e-1)"	"unprognostic (6.39e-2)"	"unprognostic (8.98e-3)"	1.8	2.8	0.6	0.0	0.6	0.0	1.9	0.5	0.7	5.7	0.0	2.7	0.0	5.0	0.0	2.7	4.1	0.1	1.7	0.5	0.3	1.9	1.3	1.5	0.0	0.7	0.7	6.4	2.1	0.0	2.2	0.0	0.6	3.2	0.0	0.0	2.4	0.0	2.0	1.5	2.4	0.0	0.6	2.4	2.1	2.3	0.7	0.0	2.5	0.0	0.0	4.2	3.1	1.1	1.0	0.0	0.1	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.6	1.4	0.0	0.0	0.0	0.0	0.0	0.0	2.5	3.1	1.1	0.0	0.0	0.0	0.7	1.5	0.0	0.0	0.0	0.0	0.0	0.1	0.1	1.2	0.0	0.1	0.0	0.5	0.2	2.5	0.0	1.2	4.6	0.3	0.2	0.0	0.0	1.1	1.2	0.2	0.0	0.5	0.0	0.1	0.0	0.0	0.1	1.4	0.0	0.1	1.4	3.1	0.6	0.3	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.6	0.5	0.7	0.5	0.3	0.7	0.7	0.6	0.6	0.7	1.1	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.2	0.8	0.3	0.3	4.6	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.2	0.6	0.4	0.0	2.5	0.4	0.0	0.0	0.2	0.5	0.2	0.0	1.0	0.0	0.0	0.0	3.3	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.2	0.0	0.0	2.2	0.0	0.0	0.0	0.8	0.1	0.0	0.2	0.0	1.7	0.0	0.3	1.1	0.0	0.0	1.5	0.0	0.0	0.2	0.5	0.1	0.1
AL645922.1		ENSG00000244255	"Novel complement component 2 (C2) and complement factor B (CFB) protein"		6	31927698-31952048	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enhanced"	"Detected in single"		"liver: 2.9"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 1.5;Club cells: 3.1;Fibroblasts: 1.2;Respiratory ciliated cells: 5.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA000951, HPA001817, HPA001832"	Approved		Approved	"Endoplasmic reticulum,Vesicles,Cell Junctions"		NA	NA				"Cluster 60: Liver - Hemostasis & Lipid metabolism"		"Cluster 49: Ciliated cells - Cilium organization"	"Endoplasmic reticulum, Vesicles"	"Cell Junctions"	"HPA000951: AB_2797216, HPA001817: AB_1078779, HPA001832: AB_1078778"							"unprognostic (7.68e-2)"							"unprognostic (1.86e-2)"				0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.9	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CFB	"BF, BFD, H2-Bf"	ENSG00000243649	"Complement factor B"	P00751	6	31945650-31952084	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	"Complement alternate pathway, Immunity, Innate immunity"	"Hydrolase, Protease, Serine protease"	"Age-related macular degeneration, Disease variant, Hemolytic uremic syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	18	"liver: 2613.2"	"Cell type enhanced"	"Detected in many"		"Ductal cells: 873.6;Exocrine glandular cells: 197.3;Hepatocytes: 284.0;Pancreatic endocrine cells: 318.0;Proximal enterocytes: 139.7"	"Cancer enhanced"	"Detected in all"		"liver cancer: 78.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 15.0;ASC TERT1: 23.0;EFO-21: 25.1;fHDF/TERT166: 14.1;HSkMC: 19.1;U-87 MG: 10.1"					"Low region specificity"	"Detected in all"			"HPA000951, HPA001817, HPA001832, CAB016381"	Supported		Approved	"Endoplasmic reticulum,Vesicles,Cell Junctions"	"Secreted to blood"	NA	NA	879000000	120000000000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 62: Liver - Hemostasis"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 1: Pancreatic cells - Digestion"	"Endoplasmic reticulum, Vesicles"	"Cell Junctions"	"CAB016381: AB_627562, HPA000951: AB_2797216, HPA001817: AB_1078779, HPA001832: AB_1078778"	"prognostic favorable (2.76e-5)"	"unprognostic (1.02e-1)"	"unprognostic (1.44e-1)"	"unprognostic (7.94e-2)"	"unprognostic (1.82e-2)"	"unprognostic (8.56e-2)"	"unprognostic (8.08e-3)"	"unprognostic (8.81e-2)"	"unprognostic (3.51e-1)"	"unprognostic (2.26e-2)"	"unprognostic (1.32e-2)"	"unprognostic (6.57e-2)"	"prognostic unfavorable (1.53e-5)"	"unprognostic (1.36e-1)"	"unprognostic (5.13e-2)"	"unprognostic (1.05e-2)"	"unprognostic (3.68e-2)"	143.7	18.0	3.6	32.8	3.6	0.1	28.5	3.4	9.9	16.3	3.9	22.3	28.1	8.2	14.2	24.1	53.7	0.8	42.6	3.7	3.4	58.7	2613.2	39.2	4.2	4.1	3.7	9.9	51.8	0.2	17.7	5.0	3.8	60.3	14.5	1.4	43.3	0.0	3.0	7.7	73.1	48.3	3.4	12.9	54.5	2.1	3.7	1.9	15.5	0.7	6.7	17.8	9.2	3.6	0.5	1.9	0.1	0.0	15.0	23.0	0.1	0.0	0.2	1.1	0.0	0.1	8.6	0.1	25.1	14.1	0.6	6.0	0.0	1.8	1.2	1.0	0.3	0.7	0.4	0.5	0.0	1.0	0.4	19.1	0.4	0.6	0.5	1.3	0.2	0.1	0.3	0.7	0.1	0.2	0.1	0.3	0.4	0.0	0.4	0.3	0.3	1.3	1.7	0.5	0.0	0.1	0.0	1.3	0.0	0.0	0.0	0.2	0.0	3.4	1.2	0.4	0.4	0.7	2.1	1.0	10.1	0.6	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	3.6	3.6	3.4	9.9	3.7	3.4	4.1	3.7	3.8	3.4	3.7	3.6	1.0	0.0	16.9	0.0	2.6	0.8	0.9	64.8	11.4	0.3	4.9	0.9	0.4	44.3	127.3	5.5	0.0	0.1	0.0	3.7	3.9	873.6	0.0	1.9	0.4	3.9	2.4	16.0	0.2	197.3	0.2	34.6	20.9	1.2	0.0	0.0	11.7	284.0	1.0	0.0	0.2	8.5	18.3	19.7	1.0	0.0	2.8	1.1	0.0	5.6	18.1	0.4	0.0	0.0	0.0	318.0	10.6	0.0	0.1	8.6	139.7	17.1	75.4	0.7	0.0	1.0	12.6	0.1	0.1	3.9	1.8	1.6	1.6	0.0	12.4	4.5
NELFE	"D6S45, NELF-E, RD, RDBP, RDP"	ENSG00000204356	"Negative elongation factor complex member E"	P18615	6	31952087-31959038	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Repressor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"Early spermatids: 635.4;Late spermatids: 1699.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007187, HPA007594, HPA046502"	Enhanced		Enhanced	"Nucleoplasm,Nuclear bodies"		No	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 71: Testis - DNA repair"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 31: Spermatids - Spermatogenesis"	"Nucleoplasm, Nuclear bodies"		"HPA007187: AB_1856161, HPA007594: AB_2667867, HPA046502: AB_2679677"	"unprognostic (1.09e-1)"	"unprognostic (3.28e-1)"	"unprognostic (1.45e-1)"	"unprognostic (6.33e-3)"	"unprognostic (4.43e-2)"	"unprognostic (4.25e-2)"	"unprognostic (7.71e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.46e-2)"	"unprognostic (1.97e-1)"	"unprognostic (7.78e-2)"	"prognostic unfavorable (2.70e-4)"	"unprognostic (5.21e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.21e-1)"	"unprognostic (3.68e-2)"	51.9	48.5	37.4	15.2	38.2	23.5	49.4	38.6	40.3	47.9	36.6	45.9	12.7	50.1	26.9	51.7	46.9	11.9	57.1	35.8	39.2	50.0	24.5	43.6	16.9	39.1	38.3	47.4	52.4	41.1	42.5	20.5	37.4	35.4	24.2	6.3	40.5	26.7	58.2	51.3	37.2	27.7	38.7	38.7	46.6	166.2	39.2	36.8	39.6	30.8	25.4	44.1	43.5	39.6	51.8	59.9	55.5	48.4	54.7	59.9	50.9	40.3	73.8	90.1	74.6	69.5	35.7	49.0	41.3	79.0	117.1	44.0	47.4	85.7	64.5	39.4	63.2	35.9	41.9	80.5	110.6	43.4	29.0	63.2	119.2	96.2	113.5	75.6	84.2	87.6	51.6	56.6	90.2	89.6	77.1	44.6	22.9	79.6	68.1	63.0	49.1	95.2	61.0	49.8	42.3	52.8	30.4	44.4	80.1	48.4	66.0	89.6	37.1	39.7	63.5	34.5	67.8	65.9	77.8	47.6	26.0	36.4	69.8	44.9	60.4	58.7	49.4	68.8	46.2	50.9	45.4	47.2	56.9	49.9	41.9	41.0	31.4	48.8	67.8	45.4	49.0	55.4	37.4	38.2	38.6	40.3	35.8	39.2	39.1	38.3	37.4	38.7	39.2	39.6	49.0	16.0	27.9	4.6	42.8	47.2	69.0	61.5	40.5	15.5	55.1	62.5	47.2	72.9	43.1	33.1	12.5	98.4	37.7	84.6	133.1	93.3	635.4	68.4	40.8	49.8	34.2	52.2	6.2	136.5	112.1	47.7	31.1	45.6	45.6	46.7	45.3	34.8	82.8	11.8	6.2	71.1	46.8	55.3	42.6	1699.6	71.1	45.0	49.8	3.7	73.2	65.5	51.5	6.6	9.9	113.1	99.1	45.1	68.6	79.6	124.8	107.7	112.5	25.6	32.9	48.7	84.9	224.7	91.0	54.2	41.8	114.4	41.7	41.0	72.4	64.6
SKIV2L	"170A, DDX13, HLP, SKI2W, SKIV2, SKIV2L1"	ENSG00000204351	"Ski2 like RNA helicase"	Q15477	6	31959117-31969751	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"		"Helicase, Hydrolase, RNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-266/70: 42.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047122, HPA051959, HPA054419"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Mitotic spindle,Cytosol"		Yes	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Nuclear bodies"	"Mitotic spindle, Cytosol"	"HPA047122: , HPA051959: AB_2681672, HPA054419: AB_2682482"	"unprognostic (1.43e-1)"	"unprognostic (5.75e-2)"	"unprognostic (3.41e-2)"	"unprognostic (1.66e-2)"	"unprognostic (6.43e-2)"	"unprognostic (7.03e-2)"	"prognostic unfavorable (6.58e-4)"	"unprognostic (3.36e-2)"	"unprognostic (2.14e-2)"	"unprognostic (7.75e-2)"	"unprognostic (7.99e-3)"	"unprognostic (1.53e-3)"	"prognostic unfavorable (3.02e-7)"	"unprognostic (6.77e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.20e-1)"	"unprognostic (9.06e-2)"	21.9	33.1	0.0	5.2	0.3	4.1	21.6	0.0	0.4	26.5	0.0	25.1	10.5	22.6	9.4	23.0	25.0	0.0	22.0	0.0	0.1	24.0	54.7	22.2	3.4	0.0	0.5	24.6	25.7	2.4	39.7	2.6	0.0	31.9	2.4	2.1	22.4	3.2	20.4	20.2	31.2	5.7	0.0	40.6	27.6	16.6	0.1	4.3	27.7	5.3	2.7	23.6	20.9	0.0	0.2	12.7	13.3	0.0	16.5	11.8	27.1	10.9	11.7	13.6	13.2	0.4	0.0	0.0	26.0	25.5	13.2	11.9	0.0	30.8	9.9	14.8	15.7	0.0	0.0	0.2	0.0	0.1	0.2	28.3	17.9	0.1	0.0	12.7	0.0	19.3	0.0	13.6	0.0	0.0	0.0	0.3	20.6	0.0	0.0	0.3	0.0	0.0	11.2	0.0	0.0	0.0	23.6	0.0	17.6	11.5	0.0	15.7	12.8	16.0	7.2	18.7	0.2	42.2	35.7	12.0	20.4	0.1	0.0	0.3	0.5	0.2	1.5	1.4	1.1	0.2	0.7	0.3	1.1	0.9	0.8	0.8	0.1	0.0	2.2	0.5	0.2	0.4	0.0	0.3	0.0	0.4	0.0	0.1	0.0	0.5	0.0	0.0	0.1	0.0	6.4	16.0	11.3	10.1	13.3	2.8	5.0	7.9	11.4	5.0	9.3	5.1	8.5	10.0	8.8	7.3	8.4	12.6	12.7	19.7	1.9	9.5	3.1	7.7	7.9	7.9	12.6	6.5	7.2	8.6	7.9	7.4	28.1	6.3	8.2	10.8	8.6	19.4	9.2	0.0	5.0	13.2	8.2	6.3	4.1	1.5	9.3	7.8	7.2	2.8	10.2	4.9	18.6	3.0	4.8	9.4	16.0	6.0	20.2	5.9	25.5	6.9	16.5	8.3	0.0	4.1	10.2	4.7	7.5	6.6	3.7	12.4	14.4	12.3	11.0	5.2
DXO	DOM3Z	ENSG00000204348	"Decapping exoribonuclease"	O77932	6	31969810-31972290	"Predicted intracellular proteins"		"Exonuclease, Hydrolase, Nuclease, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"Early spermatids: 467.9;Late spermatids: 242.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046708	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 43: Testis - Unknown function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 34: Spermatids - Unknown function"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA046708: AB_2679764"	"unprognostic (4.56e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.80e-1)"	"unprognostic (4.07e-3)"	"unprognostic (1.93e-1)"	"unprognostic (2.00e-3)"	"unprognostic (3.43e-3)"	"unprognostic (4.18e-3)"	"unprognostic (3.10e-2)"	"unprognostic (2.64e-3)"	"prognostic favorable (5.87e-4)"	"unprognostic (4.29e-2)"	"prognostic unfavorable (4.77e-6)"	"unprognostic (9.17e-2)"	"unprognostic (7.24e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.23e-3)"	6.6	17.8	8.2	3.9	8.1	1.4	6.9	8.2	8.5	10.7	9.6	7.1	4.5	8.1	5.8	5.7	8.5	4.2	9.6	8.1	8.4	12.3	13.0	6.4	4.6	9.3	8.6	13.4	10.8	11.8	13.0	4.4	8.7	10.3	3.9	4.8	6.7	6.0	5.3	4.9	5.8	4.8	8.6	9.7	8.6	31.3	8.3	7.0	11.5	7.1	3.0	7.9	7.4	8.5	12.9	6.3	5.8	23.1	9.5	6.4	6.7	7.5	12.0	16.2	15.5	7.6	5.9	5.2	8.5	16.6	5.2	8.7	10.1	16.8	9.4	9.6	12.9	9.3	15.8	16.4	18.7	0.0	4.6	9.7	16.3	10.5	13.5	9.9	21.3	6.6	8.3	11.9	9.8	14.7	1.5	11.1	4.4	8.4	1.3	4.0	4.1	8.2	21.2	4.5	30.1	17.0	6.6	7.3	16.9	4.1	0.0	14.8	7.0	4.7	12.6	4.6	12.3	9.1	9.4	10.2	4.6	14.4	5.2	0.0	1.9	1.0	2.2	1.6	3.9	2.4	2.3	1.4	4.3	2.1	1.6	2.3	0.3	2.1	1.4	1.3	1.6	1.8	8.2	8.1	8.2	8.5	8.1	8.4	9.3	8.6	8.7	8.6	8.3	8.5	11.2	6.4	9.6	11.8	16.8	8.5	15.3	14.3	19.9	13.3	13.6	11.4	7.1	11.5	10.5	3.7	16.7	14.5	14.1	5.0	19.6	8.4	467.9	9.3	10.6	9.8	16.2	4.4	4.4	12.6	9.5	10.9	15.8	8.7	6.3	12.1	8.6	10.9	6.6	5.0	6.2	9.0	12.2	5.9	4.9	242.8	17.7	6.9	12.4	1.9	4.3	16.0	11.3	7.5	6.6	6.9	10.5	12.4	14.7	10.8	10.6	13.3	8.9	15.6	13.1	7.1	14.3	78.4	16.1	11.8	5.5	20.1	15.4	22.6	8.3	11.5
STK19	"D6S60, G11, RP1"	ENSG00000204344	"Serine/threonine kinase 19"	P49842	6	31971091-31982821	"Cancer-related genes, Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in all"	4	"Proximal tubular cells: 348.9"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 1.4;HEL: 1.5;HL-60: 1.6;REH: 1.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031511, HPA068559"	Uncertain		Supported	"Nuclear speckles"		NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 72: Non-specific - Transcription"	"Cluster 36: HEL - Hemostasis"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nuclear speckles"		"HPA031511: AB_2673915, HPA068559: AB_2686004"	"unprognostic (1.65e-1)"	"unprognostic (2.30e-1)"	"unprognostic (3.31e-1)"	"unprognostic (1.86e-1)"	"unprognostic (2.63e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.15e-2)"	"unprognostic (4.26e-2)"	"prognostic unfavorable (1.18e-4)"	"unprognostic (3.95e-2)"	"unprognostic (2.76e-3)"	"unprognostic (2.25e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.60e-1)"	"unprognostic (2.40e-1)"	"unprognostic (4.10e-1)"	1.5	3.6	0.1	0.2	0.1	0.0	1.3	0.4	0.9	2.1	0.0	2.5	0.0	1.4	0.3	1.9	1.0	0.1	1.2	0.0	0.0	1.5	2.2	1.3	0.0	0.0	0.0	1.1	1.1	0.2	1.4	0.4	0.1	2.1	0.0	0.2	0.9	0.1	1.3	2.5	0.7	0.0	0.0	1.2	1.3	1.5	0.1	0.1	1.2	0.0	0.1	2.0	1.5	0.4	0.0	0.1	0.0	0.4	1.1	0.7	0.0	0.3	0.1	0.2	0.4	0.0	0.7	0.6	0.3	0.5	0.0	0.6	0.0	0.2	0.3	1.4	0.4	1.5	0.3	0.0	0.5	1.6	0.0	0.6	0.0	0.3	0.1	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.7	1.1	0.4	0.0	0.0	0.1	0.3	0.1	0.3	0.0	0.0	0.7	0.0	0.0	0.0	0.4	0.4	0.0	0.0	0.9	0.0	0.7	0.2	0.0	0.0	1.1	0.0	0.1	0.3	0.2	0.6	0.2	0.0	0.8	0.2	0.3	0.1	0.1	0.3	0.4	0.4	0.0	0.1	0.1	0.1	0.4	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.4	21.2	9.6	21.5	13.7	16.4	13.0	14.0	23.0	13.6	11.8	26.6	27.6	8.1	18.6	24.6	22.0	20.9	37.2	22.4	13.8	39.2	26.3	85.8	27.8	31.8	20.6	19.3	4.6	8.7	28.3	20.0	23.3	19.4	20.7	9.5	20.1	14.3	21.1	19.3	10.1	8.0	17.3	18.3	8.8	10.0	76.0	20.2	18.3	17.8	11.2	12.5	30.2	13.4	4.5	6.5	23.6	16.4	18.4	11.9	13.2	15.0	348.9	41.8	21.9	32.9	19.6	21.1	39.5	21.0	17.9	18.2	49.7	19.8	45.1	13.1	11.8
C4A	"C4, C4A2, C4A3, C4A4, C4A6, C4B, C4S, CO4, CPAMD2, RG"	ENSG00000244731	"Complement C4A (Rodgers blood group)"	P0C0L4	6	31982057-32002681	"Blood group antigen proteins, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted secreted proteins"	"Complement pathway, Immunity, Inflammatory response, Innate immunity"	"Blood group antigen"	"Disease variant, FDA approved drug targets, Systemic lupus erythematosus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 115.8;liver: 336.8"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 9.6;Alveolar cells type 2: 46.4;Cardiomyocytes: 8.3;Club cells: 13.6;Fibroblasts: 19.1"	"Cancer enhanced"	"Detected in many"		"liver cancer: 27.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 58.5;HSkMC: 72.8;U-266/70: 17.1;U-266/84: 33.9"									"CAB009811, CAB032603, HPA046356, HPA048287, HPA050103"	Supported				"Secreted to blood"	NA	NA	342000000	120000000000		"Cluster 85: Liver - Metabolism"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 11: Alveolar cells - Smell perception"			"CAB009811: AB_2066891, CAB032603: AB_2290613, HPA046356: AB_2679635, HPA048287: AB_2680341, HPA050103: AB_2681016"	"unprognostic (2.13e-1)"	"unprognostic (3.02e-2)"	"unprognostic (3.74e-2)"	"unprognostic (3.10e-1)"	"unprognostic (5.29e-2)"	"unprognostic (3.09e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.70e-1)"	"unprognostic (3.15e-1)"	"unprognostic (4.47e-2)"	"unprognostic (3.20e-2)"	"unprognostic (5.20e-2)"	"unprognostic (3.97e-2)"	"unprognostic (8.63e-2)"	27.9	115.8	0.2	10.6	1.6	0.4	15.7	0.3	2.2	12.6	0.2	31.3	7.5	16.9	11.8	2.6	29.9	2.3	21.8	0.5	1.2	43.1	336.8	14.9	4.5	5.8	1.9	57.5	23.0	0.6	20.6	0.5	2.3	11.1	3.7	5.5	14.2	0.0	1.7	1.7	17.0	0.0	0.5	15.3	11.7	4.1	1.7	4.2	44.5	0.0	2.9	23.1	4.1	1.4	0.0	0.3	0.0	0.0	1.0	5.2	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.6	0.7	0.2	0.1	0.1	0.4	0.0	58.5	0.5	0.0	0.3	1.0	0.0	0.0	0.0	72.8	0.0	0.0	0.0	0.5	0.0	0.6	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	3.9	0.0	0.1	0.5	0.0	0.0	0.0	0.0	1.1	0.0	0.2	17.1	33.9	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.6	0.3	2.2	0.5	1.2	5.8	1.9	2.3	0.5	1.7	1.4	0.0	9.6	46.4	0.3	0.0	0.0	0.0	0.0	0.6	0.0	0.3	0.0	8.3	2.8	13.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	19.1	0.0	0.0	0.0	0.0	0.4	6.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.1	0.0	0.5	4.4	0.0	0.0	0.0	2.6	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0
C4B	"C4B1, C4B3, C4F, CH, CO4, CPAMD3"	ENSG00000224389	"Complement C4B (Chido blood group)"	P0C0L5	6	32014795-32035418	"Blood group antigen proteins, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Complement pathway, Immunity, Inflammatory response, Innate immunity"	"Blood group antigen"	"FDA approved drug targets, Systemic lupus erythematosus"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"adrenal gland: 221.5;liver: 385.2"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 103.9;Cardiomyocytes: 71.8;Club cells: 22.9;Fibroblasts: 53.9"	"Cancer enhanced"	"Detected in many"		"liver cancer: 33.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"Karpas-707: 129.8"									"HPA046356, HPA048287, HPA050103"	Approved				"Secreted to blood"	NA	NA		120000000000		"Cluster 85: Liver - Metabolism"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 11: Alveolar cells - Smell perception"			"HPA046356: AB_2679635, HPA048287: AB_2680341, HPA050103: AB_2681016"	"unprognostic (1.29e-1)"	"unprognostic (2.99e-2)"	"unprognostic (5.50e-3)"	"unprognostic (1.30e-1)"	"unprognostic (8.09e-2)"	"unprognostic (6.24e-2)"	"unprognostic (6.09e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.81e-2)"	"unprognostic (1.12e-1)"	"unprognostic (6.24e-2)"	"unprognostic (6.86e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.12e-2)"	"unprognostic (1.30e-1)"	"unprognostic (3.99e-3)"	"unprognostic (1.11e-2)"	29.7	221.5	4.0	0.4	2.5	0.6	15.9	2.5	2.3	10.3	2.4	27.3	2.0	16.6	0.0	2.2	24.0	5.9	22.7	3.2	13.3	39.8	385.2	13.6	2.7	7.1	12.4	56.5	25.1	1.1	20.1	1.6	7.7	10.2	6.0	2.5	21.0	1.2	1.3	1.1	16.6	9.7	9.9	16.3	10.3	3.1	11.8	7.5	49.1	0.2	4.3	18.5	3.7	11.6	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.8	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.2	0.0	21.0	7.8	0.5	0.0	26.2	0.1	0.0	0.0	2.6	0.0	0.0	0.0	129.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	2.5	2.5	2.3	3.2	13.3	7.1	12.4	7.7	9.9	11.8	11.6	0.0	3.2	103.9	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	71.8	1.5	22.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.5	0.6	0.0	0.0	0.0	0.2	0.0	53.9	0.0	0.0	1.3	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.6	0.1	0.0	0.5	8.0	0.0	0.0	0.0	7.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0
CYP21A2	"CA21H, CAH1, CPS1, CYP21, CYP21B, P450c21B"	ENSG00000231852	"Cytochrome P450 family 21 subfamily A member 2"	P08686	6	32038327-32041644	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	Steroidogenesis	"Monooxygenase, Oxidoreductase"	"Congenital adrenal hyperplasia, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	46	"adrenal gland: 2041.7"	"Cell type enriched"	"Detected in some"	6	"Hepatocytes: 15.9"	"Cancer enhanced"	"Detected in some"		"liver cancer: 2.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"HDLM-2: 3.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA048979, HPA053371"	Enhanced					NA	NA				"Cluster 17: Adrenal gland - Steroid metabolism"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 15: Hepatocytes - Hemostasis"			"HPA048979: AB_2680584, HPA053371: AB_2682131"	"unprognostic (1.03e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.02e-4)"	"unprognostic (2.58e-1)"	"unprognostic (2.97e-1)"	"unprognostic (2.93e-2)"	"unprognostic (2.76e-2)"	"unprognostic (8.75e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.93e-1)"	"unprognostic (6.67e-7)"	"unprognostic (7.39e-2)"	"unprognostic (5.24e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.82e-1)"	2.0	2041.7	0.0	0.0	0.0	0.0	1.5	0.0	0.6	1.9	0.0	2.5	0.0	1.5	0.6	0.6	2.4	0.0	2.9	0.0	0.0	7.0	44.8	0.8	0.0	0.0	0.0	4.3	0.9	0.0	1.9	0.0	0.0	1.9	0.0	0.0	4.0	0.0	0.3	0.7	1.1	0.0	0.0	5.5	0.8	0.8	0.0	0.0	2.3	0.0	0.0	2.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.4	2.4	0.5	0.3	1.5	0.8	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.1	0.1	0.8	0.9	1.8	0.0	0.1	0.0	0.0	1.6	0.0	0.2	1.3	0.4	0.0	15.9	0.0	0.0	0.1	0.0	0.0	0.3	0.3	0.1	0.6	0.1	1.8	0.0	0.0	0.3	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.2	0.0	2.0	1.2	0.6	0.0	0.3	0.6	0.6	0.4	0.0	0.0	0.0	0.3	1.0	0.0	0.0
TNXB	"TNXB1, TNXB2, TNXBS, XB, XBS"	ENSG00000168477	"Tenascin XB"	P22105	6	32041153-32115334	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"		"Disease variant, Ehlers-Danlos syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 274.8"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 54.7;Fibroblasts: 318.4;Granulosa cells: 94.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"ASC diff: 12.4;ASC TERT1: 20.1;U-2197: 15.8;U-87 MG: 8.2"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"								"Secreted to extracellular matrix"	NA	NA		1500000000		"Cluster 72: Non-specific - Transcription"	"Cluster 18: U-2197 - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"				"unprognostic (5.87e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.62e-3)"	"unprognostic (9.57e-2)"	"unprognostic (1.16e-1)"	"unprognostic (9.51e-4)"	"unprognostic (5.71e-2)"	"unprognostic (2.30e-1)"	"unprognostic (6.30e-3)"	"unprognostic (1.84e-1)"	"unprognostic (6.61e-2)"	"unprognostic (2.17e-1)"	"unprognostic (9.70e-2)"	"unprognostic (3.13e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.90e-2)"	"unprognostic (1.01e-1)"	68.0	274.8	2.0	0.9	3.1	3.4	40.0	4.4	1.8	45.1	3.5	35.9	3.0	66.7	3.2	18.1	37.4	4.7	73.8	0.7	0.8	13.0	17.6	51.1	0.8	1.5	1.1	67.0	3.7	0.4	6.8	3.8	1.5	15.6	1.7	0.3	19.5	1.0	14.2	27.4	29.0	3.1	2.2	30.7	18.8	11.4	3.0	0.7	27.7	7.2	0.4	34.5	35.2	0.4	0.1	0.3	0.3	0.2	12.4	20.1	0.2	0.0	0.4	0.1	0.1	0.2	0.0	0.0	0.4	1.2	0.0	0.1	0.0	0.0	0.1	1.3	1.1	0.2	0.6	0.0	2.8	0.0	0.3	0.2	0.2	0.5	0.0	0.5	0.0	0.5	0.7	0.4	0.0	0.2	0.0	0.1	0.3	0.0	3.5	0.3	0.1	0.2	0.0	0.1	0.1	0.2	1.3	0.0	0.1	0.1	0.0	0.3	0.2	0.1	0.4	15.8	0.0	0.4	0.4	0.2	8.2	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.0	3.1	4.4	1.8	0.7	0.8	1.5	1.1	1.5	2.2	3.0	0.4	54.7	3.2	2.4	2.6	0.5	32.9	0.2	0.3	0.6	1.3	1.3	1.8	2.5	4.3	0.2	0.0	0.0	0.5	1.0	0.0	0.0	0.2	3.0	1.3	39.7	38.8	0.0	25.0	7.1	0.0	2.6	318.4	6.1	1.1	0.0	94.8	12.8	0.9	0.7	0.0	4.2	0.1	0.0	0.6	39.1	2.8	27.1	4.7	32.0	17.8	0.0	1.2	0.0	1.0	1.2	0.0	0.1	4.5	2.5	0.5	0.0	0.3	0.9	0.6	0.0	21.7	20.8	4.1	2.1	1.6	26.6	1.0	4.8	5.6	0.2	0.4
ATF6B	"CREBL1, G13"	ENSG00000213676	"Activating transcription factor 6 beta"	Q99941	6	32115264-32128253	"Plasma proteins, Predicted membrane proteins, Transcription factors"	"Transcription, Transcription regulation, Unfolded protein response"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046871	Uncertain		Approved	Nucleoplasm,Nucleoli		NA	NA		46000000	"Cluster 34: Basophils - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 6: T47d - Mammary gland"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm	Nucleoli	"HPA046871: AB_10963542"	"unprognostic (2.93e-3)"	"unprognostic (1.56e-1)"	"unprognostic (5.50e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.37e-2)"	"unprognostic (9.80e-3)"	"unprognostic (1.55e-1)"	"unprognostic (3.15e-1)"	"unprognostic (3.68e-2)"	"unprognostic (9.03e-2)"	"unprognostic (3.66e-2)"	"unprognostic (4.04e-3)"	"unprognostic (1.75e-2)"	"unprognostic (1.76e-1)"	"unprognostic (3.86e-1)"	"unprognostic (1.10e-2)"	35.0	40.8	7.3	7.4	7.4	29.4	40.3	6.6	9.9	50.2	3.9	46.3	11.9	46.0	16.7	56.6	45.6	11.5	31.2	7.9	9.1	36.7	35.1	35.6	14.2	7.7	7.7	57.1	43.4	14.1	43.0	8.8	7.6	43.7	14.0	8.1	44.9	6.3	22.4	53.3	46.9	8.9	7.1	60.0	45.4	29.3	7.4	16.7	51.1	5.0	17.0	44.3	47.0	7.1	2.5	6.3	18.1	29.7	17.8	18.9	11.5	9.8	13.3	13.7	20.8	25.2	20.9	30.4	26.8	60.1	14.5	17.0	23.5	37.2	8.1	18.3	34.5	11.2	36.1	24.7	28.9	2.9	40.0	17.2	16.1	5.4	31.4	25.5	44.0	47.9	38.0	32.9	39.9	18.3	25.5	17.4	5.1	20.8	5.4	7.5	7.6	20.7	17.5	6.3	1.8	6.4	35.2	13.9	40.5	5.0	39.5	12.5	17.1	3.6	13.0	13.7	15.6	33.8	20.4	17.0	15.5	18.5	21.9	4.2	1.1	0.7	1.9	1.7	1.5	1.6	1.0	0.9	2.3	1.1	0.6	1.4	0.9	2.5	1.5	1.4	1.7	2.2	7.3	7.4	6.6	9.9	7.9	9.1	7.7	7.7	7.6	7.1	7.4	7.1	39.1	12.8	15.2	31.6	72.7	24.9	37.6	83.0	33.6	89.3	31.8	26.0	2.0	50.1	53.1	55.2	95.9	88.4	64.9	52.9	5.9	48.1	3.3	22.0	24.5	40.3	53.5	39.8	29.5	42.8	50.2	29.8	39.8	27.8	16.5	148.5	43.5	18.5	52.8	43.7	29.9	53.9	79.3	55.4	40.5	8.9	70.8	42.0	32.0	28.1	65.4	35.0	124.6	21.6	24.1	37.2	58.6	51.9	40.3	30.6	64.3	14.6	43.5	98.0	59.2	30.5	29.8	64.3	58.6	36.1	25.3	89.2	58.6	49.5	55.7	39.8
FKBPL	"DIR1, NG7, WISp39"	ENSG00000204315	"FKBP prolyl isomerase like"	Q9UIM3	6	32128707-32130288	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 51.2;Squamous epithelial cells: 34.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043478, HPA060158"	Approved		Approved	"Nucleoplasm,Mitotic spindle"		Yes	No			"Cluster 17: Basophils - Unknown function"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	"Mitotic spindle"	"HPA043478: AB_2678500, HPA060158: AB_2684213"	"unprognostic (1.80e-1)"	"unprognostic (6.80e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.03e-3)"	"unprognostic (1.02e-1)"	"unprognostic (7.67e-2)"	"unprognostic (8.22e-3)"	"unprognostic (2.25e-2)"	"unprognostic (1.22e-1)"	"prognostic favorable (8.46e-4)"	"unprognostic (1.30e-1)"	"unprognostic (8.96e-2)"	"unprognostic (5.79e-2)"	"unprognostic (7.32e-2)"	"unprognostic (4.39e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.13e-1)"	3.3	4.2	2.9	2.0	2.5	2.8	4.0	2.2	3.2	3.8	2.2	4.1	1.6	3.1	6.1	10.7	4.3	1.6	2.9	2.6	2.4	4.0	5.2	3.2	3.1	2.9	2.4	3.2	5.5	4.0	2.9	1.7	2.6	3.2	3.4	1.8	6.4	1.1	4.5	9.8	3.6	3.6	2.1	4.7	6.1	6.2	2.5	5.5	5.6	4.4	1.1	2.9	5.1	3.6	0.0	0.9	8.1	13.8	11.6	8.2	3.4	5.4	6.1	10.0	9.7	17.5	7.3	0.0	1.8	9.3	13.1	4.2	11.3	10.5	6.9	0.0	13.7	0.0	11.9	10.2	6.5	0.0	6.6	8.0	5.6	19.3	6.1	7.3	10.6	15.8	11.9	15.0	10.2	6.0	6.9	5.9	6.0	16.1	3.0	0.0	5.0	13.6	10.4	1.5	15.3	1.0	5.5	9.6	10.2	2.4	16.8	11.8	4.7	14.3	4.1	7.5	13.3	7.7	1.5	5.7	5.6	7.1	9.1	6.6	1.8	0.5	0.7	2.5	0.7	2.1	1.1	1.3	1.9	0.5	1.0	1.0	2.6	3.4	0.8	1.6	0.3	1.5	2.9	2.5	2.2	3.2	2.6	2.4	2.9	2.4	2.6	2.1	2.5	3.6	8.8	6.4	5.9	0.3	7.8	11.2	4.7	6.7	51.2	2.9	11.5	8.5	2.0	7.2	6.2	1.8	0.0	9.9	6.1	9.3	5.9	8.1	4.2	11.6	6.1	9.6	6.0	19.8	0.7	6.7	13.3	5.6	6.1	8.1	2.5	12.4	5.0	3.3	5.0	10.1	0.6	7.0	8.2	2.8	8.8	5.5	2.8	4.2	7.2	1.0	3.7	7.3	3.1	0.0	0.5	6.0	6.2	3.4	7.7	5.2	10.3	9.9	3.2	4.9	0.0	5.4	17.4	11.1	8.8	34.1	10.2	14.1	6.8	14.9	6.5	4.1
PRRT1	"C6orf31, DSPD1, IFITMD7, NG5"	ENSG00000204314	"Proline rich transmembrane protein 1"	Q99946	6	32148359-32153083	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 40.1;ovary: 11.9"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 67.5;Cardiomyocytes: 125.5;Granulosa cells: 181.6"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"amygdala: 38.4;cerebral cortex: 40.1;hippocampal formation: 37.0;white matter: 17.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEK 293: 1.0;SK-MEL-30: 1.6;U-2 OS: 1.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055149, HPA059099"	Enhanced					NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 40: Granulosa cells - Unknown function"			"HPA055149: AB_2682717, HPA059099: AB_2732632"	"unprognostic (1.40e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.10e-3)"	"unprognostic (3.87e-3)"	"unprognostic (2.89e-1)"	"unprognostic (4.74e-2)"	"unprognostic (5.51e-3)"	"unprognostic (5.93e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.58e-2)"	"unprognostic (8.08e-5)"	"unprognostic (2.99e-1)"	"unprognostic (2.22e-2)"	"unprognostic (8.59e-2)"	"unprognostic (9.40e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.78e-2)"	1.6	2.2	38.4	0.3	6.4	0.0	2.0	0.0	40.1	2.7	0.0	2.9	0.6	2.3	0.0	1.5	3.6	0.1	1.6	37.0	4.8	3.1	0.9	1.3	0.1	3.4	2.1	11.9	0.6	0.3	5.6	0.2	2.2	3.1	0.0	1.3	0.9	0.6	0.4	2.0	1.8	0.0	0.0	0.9	2.0	1.3	6.5	0.0	1.9	0.0	0.0	2.4	2.4	17.5	0.0	0.1	0.0	0.5	0.2	0.1	0.2	0.8	0.1	0.4	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.2	0.0	0.0	0.0	0.0	1.0	0.0	0.2	0.0	0.2	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.3	0.8	0.0	0.0	1.6	0.0	0.6	0.0	0.0	0.4	1.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	38.4	6.4	0.0	40.1	37.0	4.8	3.4	2.1	2.2	0.0	6.5	17.5	3.2	0.0	0.0	4.9	0.5	4.0	8.0	3.4	14.8	67.5	1.8	3.0	125.5	10.0	1.2	1.8	10.4	6.7	1.7	2.2	1.9	0.1	1.3	1.3	2.3	6.7	9.0	4.2	12.6	0.0	1.0	7.8	4.6	0.5	0.0	181.6	5.0	3.5	1.0	32.0	10.9	5.5	0.0	0.8	2.1	1.2	6.2	1.9	3.6	6.5	0.2	16.0	1.0	3.5	5.0	0.2	3.4	6.4	0.8	3.6	5.5	0.1	3.7	8.7	0.0	3.6	8.0	0.8	1.6	3.8	2.7	3.6	2.2	8.1	4.1	4.8
AL662884.4		ENSG00000285085	"Novel protein"		6	32150495-32154373	"Predicted intracellular proteins"				"No human protein/transcript evidence"	"No human protein/transcript evidence"			"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"Breast glandular cells: 4.4;Breast myoepithelial cells: 6.7;Collecting duct cells: 11.0;Distal tubular cells: 15.6;Endometrial ciliated cells: 4.6;Proximal tubular cells: 4.4"					"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																	NA	NA						"Cluster 39: Non-specific - Basic cellular processes"																					0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	6.7	0.0	0.0	0.0	11.0	0.0	0.0	1.1	0.0	15.6	0.2	0.0	4.6	1.8	0.8	0.0	0.0	0.0	0.2	0.0	0.7	0.0	0.8	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	4.4	2.2	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.3	2.7	0.0	0.0
PPT2		ENSG00000221988	"Palmitoyl-protein thioesterase 2"	Q9UMR5	6	32153441-32163678	"Metabolic proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Granulosa cells: 33.6;Smooth muscle cells: 27.8;Syncytiotrophoblasts: 23.3"	"Cancer enhanced"	"Detected in all"		"melanoma: 21.5"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"naive CD8 T-cell: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"ASC diff: 21.3;HEK 293: 27.9;SK-MEL-30: 29.4"									HPA000414			Supported	Vesicles	"Intracellular and membrane"	NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 10: Non-specific - Unknown function"	Vesicles		"HPA000414: "	"unprognostic (1.90e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.95e-1)"	"prognostic unfavorable (5.03e-5)"	"unprognostic (1.62e-1)"	"unprognostic (6.75e-3)"	"unprognostic (2.92e-3)"	"unprognostic (6.41e-3)"	"unprognostic (7.12e-2)"	"unprognostic (2.56e-3)"	"unprognostic (5.28e-3)"	"unprognostic (1.12e-2)"	"unprognostic (2.75e-3)"	"unprognostic (5.09e-2)"	"unprognostic (2.94e-1)"	"unprognostic (4.89e-2)"	"unprognostic (1.24e-3)"	19.0	18.0	1.1	2.1	1.1	0.1	18.7	1.1	4.8	26.5	1.0	23.7	1.6	22.0	2.6	28.2	21.7	0.0	24.5	1.1	1.1	22.1	13.9	14.3	1.7	1.1	1.2	46.2	14.3	0.0	13.7	3.9	1.1	17.2	1.5	6.2	14.9	0.0	19.0	29.4	14.9	1.3	1.1	13.3	21.0	8.3	1.1	1.9	14.6	0.2	1.0	18.1	24.2	1.3	0.0	0.0	0.0	0.4	21.3	7.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	16.2	1.6	0.7	5.3	2.6	5.0	0.0	0.0	27.9	4.0	0.0	0.0	0.0	3.5	1.8	4.0	1.6	0.0	7.3	3.8	0.0	14.9	0.0	1.8	1.7	13.0	4.6	0.0	0.0	0.9	0.0	6.3	5.8	0.0	14.3	0.0	1.6	5.4	8.7	5.2	29.4	15.2	0.0	3.7	0.8	0.0	11.4	0.0	0.0	0.8	12.6	3.0	5.8	2.2	3.5	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.0	0.0	0.1	1.0	0.0	0.1	0.0	0.7	0.0	0.1	1.1	1.1	1.1	4.8	1.1	1.1	1.1	1.2	1.1	1.1	1.1	1.3	9.4	0.0	0.5	0.0	0.7	3.3	2.9	2.6	5.7	12.4	4.2	2.9	6.8	2.8	2.8	3.7	16.7	14.5	4.4	2.4	1.9	1.8	0.3	4.5	4.3	7.6	4.9	17.4	0.0	3.0	9.2	6.3	1.5	5.0	0.0	33.6	6.4	4.4	3.0	3.3	0.0	2.6	2.0	1.3	1.3	1.1	4.1	1.1	7.2	0.0	0.2	9.5	3.1	0.0	0.0	1.8	3.8	3.0	1.7	1.4	1.4	3.1	0.6	6.1	0.0	3.6	27.8	4.0	6.7	4.4	2.3	23.3	1.4	5.0	3.0	1.5
EGFL8	"C6orf8, NG3"	ENSG00000241404	"EGF like domain multiple 8"	Q99944	6	32164595-32168281	"Metabolic proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 6.4;Granulosa cells: 10.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Hep G2: 3.2;SK-MEL-30: 3.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA061173	Uncertain		Approved	"Nuclear speckles,Vesicles"	"Secreted - unknown location"	NA	NA				"Cluster 72: Non-specific - Transcription"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 40: Granulosa cells - Unknown function"	Vesicles	"Nuclear speckles"	"HPA061173: AB_2684443"	"unprognostic (7.13e-2)"	"unprognostic (1.86e-1)"	"unprognostic (6.79e-3)"	"unprognostic (3.64e-1)"	"unprognostic (1.30e-1)"	"unprognostic (7.60e-4)"	"unprognostic (3.42e-2)"	"unprognostic (2.49e-1)"	"unprognostic (6.42e-3)"	"unprognostic (1.97e-1)"	"unprognostic (7.60e-3)"	"unprognostic (8.11e-3)"	"unprognostic (1.07e-4)"	"unprognostic (1.11e-1)"	"unprognostic (6.79e-2)"	"unprognostic (1.21e-1)"	"unprognostic (3.29e-2)"	13.3	7.2	3.8	0.5	3.5	1.1	13.6	3.6	5.7	23.4	4.1	19.8	0.6	10.0	0.8	12.3	16.3	3.0	14.2	3.9	3.9	16.3	7.4	9.4	0.3	3.8	3.9	31.2	5.1	0.4	8.2	2.9	3.7	16.9	0.5	0.0	7.9	1.4	3.8	12.8	8.8	0.3	3.8	7.9	10.2	4.4	4.1	0.6	8.7	2.5	0.2	13.5	17.2	3.8	0.2	0.1	0.4	1.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.3	0.0	0.0	1.1	0.4	0.0	0.0	0.0	0.5	0.0	0.3	3.2	0.0	0.0	0.3	0.0	0.4	0.2	0.1	0.0	0.2	0.7	0.5	0.0	0.0	0.6	1.0	1.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.2	0.1	0.6	0.0	0.0	3.4	0.0	1.0	0.7	0.0	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	3.5	3.6	5.7	3.9	3.9	3.8	3.9	3.7	3.8	4.1	3.8	1.2	6.4	4.1	0.0	0.3	1.5	0.6	0.3	4.6	1.5	0.5	0.3	0.1	0.0	1.6	1.8	2.1	0.8	0.6	0.2	0.0	0.4	0.1	1.0	1.9	1.7	0.0	1.7	0.0	0.2	0.4	1.5	4.6	1.3	0.0	10.4	3.3	0.3	0.2	0.0	0.0	1.1	0.0	0.6	1.6	0.2	3.7	0.7	0.0	0.0	0.0	0.9	3.1	0.0	0.0	0.3	0.2	1.2	2.1	0.7	0.4	0.1	1.6	1.5	0.0	2.0	1.5	0.5	0.4	4.0	2.3	0.8	0.9	1.5	1.3	0.5
AGPAT1	LPAAT-alpha	ENSG00000204310	"1-acylglycerol-3-phosphate O-acyltransferase 1"	Q99943	6	32168212-32178096	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 91.7"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebral cortex: 47.1"	"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048478, HPA073355"	Approved		Supported	"Endoplasmic reticulum,Rods & Rings"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 72: Non-specific - Transcription"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 45: Enterocytes - Digestion"	"Endoplasmic reticulum"	"Rods & Rings"	"HPA048478: AB_2680411, HPA073355: AB_2686596"	"prognostic unfavorable (1.93e-4)"	"unprognostic (9.35e-3)"	"unprognostic (1.87e-3)"	"prognostic unfavorable (5.21e-4)"	"unprognostic (4.79e-2)"	"unprognostic (7.05e-2)"	"unprognostic (7.16e-3)"	"unprognostic (1.55e-1)"	"unprognostic (3.79e-1)"	"unprognostic (4.24e-3)"	"unprognostic (1.84e-3)"	"unprognostic (1.77e-1)"	"unprognostic (6.58e-2)"	"unprognostic (1.97e-2)"	"unprognostic (2.16e-1)"	"unprognostic (9.92e-3)"	"unprognostic (7.00e-2)"	46.6	60.3	3.0	5.9	7.2	6.6	42.6	2.5	47.1	58.2	2.9	61.3	28.2	64.3	42.9	33.9	56.5	18.9	66.9	4.0	25.5	61.6	60.2	44.2	10.9	3.8	9.5	67.2	37.5	9.3	53.8	15.9	4.4	53.2	20.1	12.5	34.1	0.0	67.7	35.1	53.0	1.5	2.5	39.8	58.4	79.3	3.3	18.4	54.1	33.5	12.5	58.2	42.7	4.7	0.0	0.4	51.2	0.3	127.5	85.2	49.4	0.0	0.0	0.0	0.0	104.5	0.0	0.0	46.1	128.0	36.4	13.4	108.5	39.4	0.0	0.4	83.6	0.0	0.0	111.7	0.0	0.0	101.5	51.0	47.6	0.0	46.0	105.9	31.6	86.7	78.5	66.0	109.2	28.8	0.4	26.8	0.0	0.1	18.0	0.6	0.0	0.5	32.8	0.0	0.0	0.1	51.3	16.1	70.4	51.6	63.4	0.0	25.9	0.0	20.3	0.0	0.2	45.9	41.1	18.0	64.3	0.1	0.3	3.4	5.6	12.4	7.6	8.2	7.4	5.3	5.0	8.6	9.3	5.0	4.3	6.4	9.4	8.7	5.8	11.6	7.2	6.9	3.0	7.2	2.5	47.1	4.0	25.5	3.8	9.5	4.4	2.5	3.3	4.7	32.1	16.0	18.6	11.1	14.3	9.1	14.0	20.6	16.5	26.1	26.2	21.6	4.0	14.3	12.0	36.8	12.5	35.2	24.5	28.7	5.9	17.9	63.9	14.1	24.9	21.3	29.4	12.0	13.8	14.3	29.9	19.6	16.3	11.4	12.7	22.7	27.1	31.2	24.7	32.0	17.7	24.3	18.3	22.3	20.6	91.7	13.4	24.9	8.8	11.2	13.0	38.5	21.6	10.1	14.8	17.0	22.3	21.4	16.9	10.2	73.6	29.4	12.9	17.9	0.0	18.3	22.9	44.8	22.1	9.5	3.7	15.3	13.8	21.5	20.8	12.1
RNF5	"G16, NG2, RING5, RMA1"	ENSG00000204308	"Ring finger protein 5"	Q99942	6	32178405-32180793	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Proximal tubular cells: 371.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034107, HPA065032"	Uncertain		Supported	"Endoplasmic reticulum"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Endoplasmic reticulum"		"CAB034107: AB_2238618, HPA065032: AB_2685408"	"unprognostic (1.94e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.49e-1)"	"unprognostic (4.45e-3)"	"unprognostic (1.35e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.37e-2)"	"unprognostic (4.07e-1)"	"prognostic favorable (2.44e-4)"	"unprognostic (1.95e-1)"	"unprognostic (8.93e-3)"	"unprognostic (2.91e-3)"	"unprognostic (8.84e-2)"	"unprognostic (9.17e-2)"	"unprognostic (2.72e-1)"	"unprognostic (2.99e-2)"	38.2	75.9	60.4	29.2	63.4	40.4	44.5	64.6	66.0	44.9	59.4	59.5	61.6	44.8	45.8	37.5	54.1	46.1	81.7	59.2	60.6	115.6	126.2	38.7	43.1	65.0	60.6	60.4	41.6	55.5	17.2	30.1	62.6	44.0	62.4	42.9	43.9	31.7	89.6	44.6	76.5	30.5	62.8	38.8	55.3	29.5	61.8	60.7	48.6	76.5	43.4	45.1	38.8	67.0	51.2	66.1	43.7	167.5	46.9	31.3	34.0	20.6	26.5	44.4	48.7	89.1	42.1	65.2	70.8	47.9	62.5	41.7	80.3	45.1	45.2	41.8	107.5	53.9	69.5	184.4	55.0	0.2	101.2	32.3	60.3	73.3	53.6	77.2	89.1	115.0	136.6	67.8	63.8	71.9	66.5	151.5	0.3	71.8	28.7	44.4	48.2	88.2	124.0	32.6	44.8	92.1	39.9	42.4	46.7	39.9	87.0	183.0	40.3	48.1	44.7	0.5	79.1	38.6	63.5	79.3	33.2	116.4	29.6	64.8	45.7	75.8	64.8	65.9	55.6	64.6	52.5	57.6	64.7	56.2	57.5	58.3	22.1	79.6	46.7	264.6	58.2	75.0	60.4	63.4	64.6	66.0	59.2	60.6	65.0	60.6	62.6	62.8	61.8	67.0	38.3	19.2	41.1	2.9	52.7	95.7	70.0	146.6	52.3	23.6	61.8	56.5	62.9	87.2	79.5	92.0	0.0	78.1	70.3	151.9	283.7	110.8	21.6	47.2	31.7	50.9	73.2	126.3	3.4	91.3	101.7	44.6	28.5	31.7	56.3	41.5	47.8	131.5	68.9	33.7	3.5	83.0	132.2	51.1	171.7	22.6	59.4	43.3	85.4	1.0	69.5	91.3	65.9	1.5	10.0	78.5	173.0	72.6	45.5	58.4	270.6	371.6	73.4	27.6	65.7	50.6	63.0	55.7	37.7	44.4	84.4	84.1	53.8	42.8	100.3	56.5
AGER	"RAGE, SCARJ1"	ENSG00000204305	"Advanced glycosylation end-product specific receptor"	Q15109	6	32180968-32184322	"Cancer-related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"	"Inflammatory response"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	19	"lung: 728.3"	"Cell type enriched"	"Detected in many"	22	"Alveolar cells type 1: 2394.2"	"Cancer enhanced"	"Detected in all"		"lung cancer: 27.2;thyroid cancer: 20.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEK 293: 2.5;JURKAT: 3.0;RPTEC TERT1: 2.2;U-266/70: 2.4;U-266/84: 2.0"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"CAB011682, HPA064436, HPA069474"	Enhanced		Approved	"Nucleoli fibrillar center,Plasma membrane,Cell Junctions"	"Secreted in other tissues"	NA	NA	5360000	100000		"Cluster 19: Lung - Lung function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 11: Alveolar cells - Smell perception"	"Plasma membrane, Cell Junctions"	"Nucleoli fibrillar center"	"CAB011682: AB_2258049, HPA064436: AB_2685264, HPA069474: "	"unprognostic (9.37e-2)"	"unprognostic (3.70e-1)"	"unprognostic (2.37e-2)"	"unprognostic (1.14e-1)"	"unprognostic (4.55e-2)"	"unprognostic (1.59e-3)"	"unprognostic (4.36e-2)"	"unprognostic (1.00e-1)"	"unprognostic (4.38e-2)"	"unprognostic (1.27e-1)"	"prognostic favorable (3.41e-4)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (9.01e-7)"	"unprognostic (3.57e-1)"	"unprognostic (3.70e-2)"	"unprognostic (4.44e-2)"	"prognostic favorable (2.74e-6)"	2.2	1.7	0.1	1.1	0.1	0.5	1.6	0.1	0.4	4.4	0.2	3.9	0.6	2.5	1.9	2.1	4.5	0.1	2.7	0.2	0.1	6.4	2.7	728.3	0.6	0.2	0.1	4.8	1.7	0.0	5.0	0.4	0.2	4.9	0.8	0.4	1.6	0.0	1.0	2.0	3.2	0.1	0.1	7.0	2.0	2.2	0.2	0.8	39.2	0.1	0.5	2.9	3.2	0.3	0.1	0.0	0.0	0.3	0.1	0.9	1.5	0.0	0.1	0.0	0.1	0.0	0.2	0.1	1.0	0.2	0.0	1.0	0.1	0.3	0.2	0.2	2.5	0.7	0.0	0.0	0.0	0.3	1.1	0.0	0.1	0.0	0.1	0.2	0.1	3.0	0.0	0.3	0.1	1.3	0.1	0.9	0.0	0.1	0.0	0.0	0.1	0.1	2.2	0.0	0.0	0.2	0.0	0.0	1.1	0.0	0.5	0.0	0.1	0.0	0.6	0.8	0.1	2.4	2.0	0.9	1.1	0.3	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.4	0.2	0.1	0.2	0.1	0.2	0.1	0.2	0.3	5.4	2394.2	107.9	5.9	4.9	0.9	1.5	2.0	2.8	5.1	1.5	2.9	3.0	4.3	20.9	1.8	0.0	1.1	2.7	1.1	0.0	1.5	0.4	1.1	2.6	4.1	0.0	4.4	0.5	1.0	0.9	3.0	1.5	1.9	17.7	3.1	2.9	2.0	1.3	6.7	0.6	1.3	0.0	5.3	6.5	1.2	1.8	5.3	1.8	4.7	4.8	4.6	2.1	2.5	1.3	1.1	2.7	1.2	3.3	2.6	0.8	0.3	5.6	3.4	6.6	1.2	2.6	0.1	1.2	1.6	1.8	2.2	6.2	1.7	1.2	0.9
PBX2	"G17, HOX12, PBX2MHC"	ENSG00000204304	"PBX homeobox 2"	P40425	6	32184733-32190202	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA061478	Supported		Approved	Nucleoplasm		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 72: Non-specific - Transcription"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm		"HPA061478: AB_2684535"	"unprognostic (9.73e-3)"	"unprognostic (2.16e-2)"	"unprognostic (1.40e-2)"	"prognostic unfavorable (8.90e-5)"	"unprognostic (4.98e-1)"	"unprognostic (2.68e-2)"	"unprognostic (9.87e-2)"	"unprognostic (3.42e-2)"	"unprognostic (1.81e-2)"	"prognostic favorable (6.84e-4)"	"unprognostic (3.84e-2)"	"unprognostic (3.08e-1)"	"unprognostic (3.79e-3)"	"unprognostic (1.58e-1)"	"unprognostic (3.06e-1)"	"unprognostic (2.52e-2)"	"unprognostic (2.27e-1)"	30.3	39.6	4.9	14.2	4.5	9.0	27.6	3.9	5.5	47.4	5.0	51.2	10.6	47.8	30.4	33.5	47.1	4.9	32.1	4.5	4.7	37.9	31.0	43.9	16.7	5.1	4.6	52.3	28.2	4.5	52.0	25.2	4.8	39.3	12.2	8.5	27.6	12.3	29.8	34.1	39.8	13.0	4.3	64.5	36.7	23.9	5.0	23.9	55.2	2.3	17.8	42.4	39.2	4.6	4.8	7.9	32.3	17.7	23.5	29.4	13.9	3.7	8.9	9.7	10.0	6.5	7.8	21.9	23.5	13.7	3.8	13.4	8.1	26.8	10.6	19.5	30.3	20.5	7.1	3.8	20.7	13.2	18.7	43.2	14.9	7.4	24.8	16.6	19.1	38.8	26.5	11.1	3.7	18.1	13.6	29.7	0.6	2.9	2.2	18.8	5.0	26.1	21.2	7.7	9.4	12.6	3.0	6.8	26.5	18.3	16.9	25.0	6.5	8.5	19.8	3.4	4.2	54.1	36.9	27.2	17.3	9.9	14.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	4.9	4.5	3.9	5.5	4.5	4.7	5.1	4.6	4.8	4.3	5.0	4.6	27.7	6.4	11.0	14.4	18.5	18.2	18.5	11.8	15.4	19.2	17.0	12.2	3.7	31.5	10.1	16.5	8.4	32.2	29.4	9.6	3.9	17.1	1.0	12.3	24.5	24.8	30.5	19.1	7.8	14.0	25.6	16.0	12.2	16.6	15.2	21.8	28.9	23.0	19.0	26.9	7.0	15.5	10.2	34.5	55.5	4.2	20.2	25.3	8.8	9.4	23.9	21.0	35.0	6.0	9.1	13.9	12.5	19.5	17.7	19.4	12.5	10.2	9.6	4.9	6.6	19.7	19.8	1.6	6.1	19.7	19.5	47.2	16.7	22.8	13.2	18.1
GPSM3	"AGS4, C6orf9, G18, G18.1a, G18.1b, G18.2, NG1"	ENSG00000213654	"G protein signaling modulator 3"	Q9Y4H4	6	32190766-32195523	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 160.8;lymphoid tissue: 229.3"	"Cell type enhanced"	"Detected in many"		"B-cells: 261.0;dendritic cells: 238.9;Hofbauer cells: 278.3;Kupffer cells: 397.2;Langerhans cells: 209.3;Macrophages: 268.2;monocytes: 375.1;NK-cells: 352.2;T-cells: 256.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 226.9;NB-4: 115.8;THP-1: 107.1;U-937: 76.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA		73000	"Cluster 52: Eosinophils - Transcription"	"Cluster 2: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"				"unprognostic (2.93e-2)"	"unprognostic (2.51e-2)"	"unprognostic (2.02e-2)"	"prognostic favorable (5.98e-4)"	"unprognostic (3.55e-1)"	"unprognostic (3.07e-2)"	"unprognostic (3.66e-1)"	"unprognostic (6.61e-2)"	"unprognostic (4.48e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.34e-2)"	"unprognostic (1.12e-1)"	"prognostic unfavorable (6.92e-9)"	"unprognostic (2.01e-2)"	"unprognostic (1.69e-2)"	"unprognostic (5.47e-2)"	"unprognostic (5.87e-2)"	28.7	11.8	11.1	96.8	10.3	160.8	15.5	10.8	14.1	8.9	10.5	17.9	14.4	6.8	9.1	9.4	13.9	24.8	14.9	10.5	13.4	15.9	14.5	62.9	139.9	15.6	13.6	5.3	6.1	1.8	7.6	22.2	13.9	13.8	15.8	0.3	11.8	5.5	3.7	9.1	67.7	10.0	12.3	229.3	17.5	5.6	14.6	83.0	11.6	5.6	100.8	32.8	9.1	14.4	1.0	0.0	1.6	0.6	0.1	0.2	1.5	1.3	17.0	5.6	8.8	0.2	5.2	41.1	7.8	6.7	0.5	0.9	0.1	7.2	3.1	53.8	0.1	59.5	0.0	1.2	9.6	0.0	226.9	2.0	0.0	1.9	5.9	1.2	25.8	25.7	11.4	47.9	1.6	0.0	23.6	115.8	0.0	0.0	0.5	24.5	0.0	38.4	1.4	0.0	0.6	0.1	0.0	0.6	8.7	2.1	1.1	107.1	22.6	3.0	3.1	0.0	1.5	1.1	0.9	25.9	0.9	76.3	15.5	44.1	55.8	194.3	35.5	73.3	35.7	52.8	45.5	44.7	57.9	41.9	38.5	42.7	244.9	27.1	71.5	24.3	34.7	53.2	11.1	10.3	10.8	14.1	10.5	13.4	15.6	13.6	13.9	12.3	14.6	14.4	12.8	0.0	2.2	1.0	261.0	11.2	12.9	11.5	4.0	0.2	7.7	9.1	0.5	2.8	7.3	3.7	0.0	3.4	238.9	2.2	0.0	7.9	6.5	1.1	1.0	19.5	1.2	46.3	0.1	5.2	5.1	7.1	8.6	0.9	57.8	0.5	28.2	4.4	278.3	0.0	0.3	6.5	30.5	397.2	209.3	12.1	1.2	268.2	44.4	4.7	375.1	0.5	352.2	0.0	0.3	20.5	34.2	0.0	76.4	5.8	0.5	2.4	5.5	0.5	6.6	1.3	9.4	0.8	3.9	1.4	8.5	6.3	256.1	7.8	3.7	24.6
NOTCH4	INT3	ENSG00000204301	"Notch receptor 4"	Q99466	6	32194843-32224067	"Human disease related genes, Predicted membrane proteins"	"Differentiation, Notch signaling pathway, Transcription, Transcription regulation"	"Activator, Developmental protein, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 24.2;breast: 19.8"	"Group enriched"	"Detected in many"	4	"Adipocytes: 263.8;Endothelial cells: 121.0;Hepatic stellate cells: 188.8"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in all"									NA	NA		6400000		"Cluster 82: Adipose tissue - ECM organization"		"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"				"unprognostic (2.27e-1)"	"unprognostic (2.27e-1)"	"unprognostic (6.80e-3)"	"unprognostic (9.50e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.81e-2)"	"unprognostic (3.88e-2)"	"unprognostic (3.26e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.93e-3)"	"unprognostic (2.00e-1)"	"prognostic unfavorable (3.84e-4)"	"unprognostic (1.31e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.56e-1)"	"unprognostic (3.13e-1)"	24.2	4.0	0.0	0.5	0.0	0.0	19.8	0.0	0.0	5.8	0.0	3.6	0.5	7.2	3.2	2.7	5.8	0.0	15.8	0.0	0.0	8.5	2.5	18.5	0.4	0.0	0.1	2.8	2.6	0.0	3.0	1.4	0.0	6.0	0.1	0.0	2.6	0.0	5.6	2.8	3.9	0.0	0.0	2.6	3.9	0.9	0.0	0.0	9.6	0.0	0.1	5.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	263.8	0.0	6.1	0.0	6.0	5.2	32.1	9.9	13.6	2.7	2.6	6.6	8.7	0.0	4.2	5.5	4.2	0.4	11.9	0.6	0.0	2.6	46.0	2.6	3.1	121.0	6.0	12.0	0.2	1.1	0.3	4.7	0.0	1.0	0.0	1.8	188.8	2.3	1.7	6.7	0.2	0.8	4.1	9.3	5.2	35.6	7.2	6.8	3.6	10.3	1.6	21.0	0.0	0.0	0.5	0.4	0.3	5.3	0.7	18.0	1.0	0.9	3.1	3.6	0.0	7.8	9.3	5.5	1.9	1.9	1.6	0.3	3.6	3.7	0.9	5.6
TSBP1	"C6orf10, TSBP"	ENSG00000204296	"Testis expressed basic protein 1"	Q5SRN2	6	32288526-32371912	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	61	"testis: 35.0"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in single"		"testis cancer: 0.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA047479, HPA057426"	Approved		Approved	Cytosol		NA	NA				"Cluster 74: Testis - Spermatogenesis"			Cytosol		"HPA047479: , HPA057426: "	"unprognostic (1.00e-1)"	"unprognostic (2.24e-1)"				"unprognostic (1.05e-1)"		"unprognostic (5.63e-2)"	"unprognostic (2.86e-2)"	"unprognostic (2.14e-1)"		"unprognostic (1.55e-1)"	"unprognostic (4.32e-4)"	"unprognostic (2.42e-1)"	"unprognostic (8.19e-2)"	"unprognostic (6.56e-2)"		0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	35.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.3	0.2	0.0	0.1	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
BTNL2	"BTL-II, BTN7, HSBLMHC1"	ENSG00000204290	"Butyrophilin like 2"	Q9UIR0	6	32393963-32407128	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"									NA	NA						"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"				"unprognostic (4.04e-2)"	"unprognostic (1.54e-1)"			"unprognostic (1.50e-2)"	"unprognostic (8.13e-4)"		"unprognostic (3.74e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.21e-1)"	"unprognostic (3.04e-1)"	"unprognostic (9.36e-2)"	"unprognostic (2.41e-3)"	"unprognostic (2.07e-1)"	"unprognostic (3.67e-1)"	"unprognostic (8.03e-2)"		0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
HLA-DRA	HLA-DRA1	ENSG00000204287	"Major histocompatibility complex, class II, DR alpha"	P01903	6	32439878-32445046	"Plasma proteins, Predicted membrane proteins"	"Adaptive immunity, Host-virus interaction, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 940.2;lymphoid tissue: 1277.8"	"Cell type enhanced"	"Detected in many"		"B-cells: 4744.7;Kupffer cells: 4311.3;Langerhans cells: 24286.4;Macrophages: 6377.4;monocytes: 6924.4;Proximal enterocytes: 3639.5"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"cerebral cortex: 36.2"	"Group enriched"	"Detected in all"	4	"classical monocyte: 209.3;intermediate monocyte: 408.8;memory B-cell: 379.6;naive B-cell: 418.5;non-classical monocyte: 255.2;plasmacytoid DC: 229.8"	"Group enriched"	"Detected in all"	5	"B-cells: 418.5;dendritic cells: 229.8;monocytes: 408.8"	"Cell line enhanced"	"Detected in some"		"Daudi: 715.7;HDLM-2: 1623.6;REH: 277.1;U-266/70: 242.2;U-698: 730.2;U-87 MG: 258.0"					"Low region specificity"	"Detected in all"			"CAB002798, CAB015402, HPA050162, HPA053176"	Enhanced					NA	NA		950000	"Cluster 49: Eosinophils - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 41: Macrophages - Immune response"			"CAB002798: , CAB015402: AB_629980, HPA050162: AB_2681037, HPA053176: AB_2682070"	"unprognostic (1.20e-3)"	"unprognostic (4.70e-3)"	"prognostic favorable (5.30e-4)"	"unprognostic (3.13e-3)"	"unprognostic (1.30e-1)"	"unprognostic (2.72e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.11e-2)"	"unprognostic (2.77e-2)"	"unprognostic (3.05e-2)"	"unprognostic (3.92e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.98e-1)"	"unprognostic (4.42e-2)"	"unprognostic (5.67e-2)"	"unprognostic (2.52e-2)"	510.2	294.8	3.3	304.4	3.6	1.0	370.7	3.6	36.2	176.5	3.6	175.6	117.9	124.0	260.4	129.1	145.1	61.5	128.4	3.6	3.6	290.3	95.8	940.2	1277.8	7.8	7.5	58.5	73.9	0.1	125.6	23.5	5.9	141.5	151.1	8.3	156.0	8.5	79.4	195.5	713.3	1.4	3.5	1091.9	388.0	25.6	4.0	198.8	175.5	0.0	805.5	172.8	143.3	6.0	0.8	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.5	715.7	6.3	0.0	0.0	1.5	0.0	0.0	0.0	1623.6	0.0	17.7	0.0	0.0	0.0	1.1	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	3.1	0.1	0.0	0.0	277.1	0.4	0.9	0.0	0.1	0.6	0.7	1.3	0.3	22.8	0.0	0.0	0.8	0.0	8.9	1.4	2.7	1.6	242.2	6.1	730.2	258.0	0.5	0.5	5.9	209.3	74.1	2.1	408.8	1.1	379.6	2.4	10.8	4.6	418.5	1.2	2.2	17.9	15.0	255.2	229.8	19.8	137.8	3.3	3.6	3.6	36.2	3.6	3.6	7.8	7.5	5.9	3.5	4.0	6.0	935.5	291.7	1070.1	0.3	4744.7	748.4	18.1	160.7	84.2	4.1	101.2	172.6	22.5	115.8	458.0	150.8	0.0	12.7	983.5	79.5	29.4	329.2	8.7	26.9	5.2	803.1	64.9	228.5	0.2	59.8	18.3	128.0	159.6	27.1	174.8	80.9	167.4	19.8	2809.0	1.7	0.2	175.0	146.5	4311.3	24286.4	25.8	30.1	6377.4	773.7	59.0	6924.4	8.4	81.4	0.0	0.1	46.3	182.5	4.5	107.5	32.9	3639.5	303.5	487.1	19.7	72.3	27.8	78.0	3.5	5.2	35.3	576.1	25.9	218.8	0.8	245.4	273.3
HLA-DRB5		ENSG00000198502	"Major histocompatibility complex, class II, DR beta 5"	Q30154	6	32517353-32530287	"Human disease related genes, Predicted membrane proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 356.2;lymphoid tissue: 423.3"	"Cell type enriched"	"Detected in many"	4	"Langerhans cells: 4068.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"myeloid DC: 61.9"	"Group enriched"	"Detected in all"	10	"B-cells: 26.1;dendritic cells: 61.9;monocytes: 35.2"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 641.1;HMC-1: 154.2;U-698: 189.9;U-87 MG: 238.6"									HPA043151	Supported					NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 41: Macrophages - Immune response"			"HPA043151: AB_2678342"	"unprognostic (1.97e-3)"	"unprognostic (4.74e-2)"	"unprognostic (3.30e-2)"	"prognostic favorable (7.89e-4)"	"unprognostic (2.28e-2)"	"unprognostic (4.68e-3)"	"unprognostic (9.09e-3)"	"unprognostic (2.08e-3)"	"unprognostic (1.06e-2)"	"unprognostic (5.40e-2)"	"unprognostic (4.31e-2)"	"unprognostic (2.87e-1)"	"unprognostic (2.89e-2)"	"unprognostic (1.45e-1)"	"unprognostic (7.60e-3)"	"unprognostic (9.72e-2)"	"unprognostic (5.48e-2)"	110.0	63.0	1.0	138.9	1.4	23.0	82.6	0.9	4.2	53.8	2.9	70.1	13.1	39.7	109.8	48.6	61.0	2.5	48.0	0.9	1.9	66.6	42.6	356.2	423.3	1.2	1.3	25.4	27.9	0.0	27.2	6.6	0.9	32.6	52.9	3.0	27.6	0.0	22.3	47.9	184.7	0.2	2.3	228.4	214.2	11.8	3.2	165.8	46.1	0.0	162.8	56.2	28.9	2.0	0.2	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	3.4	0.0	0.0	0.7	0.0	0.0	0.0	641.1	6.2	0.0	0.0	0.0	0.0	0.6	154.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.6	0.0	0.2	0.2	1.3	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.1	0.3	0.4	0.0	6.6	0.0	0.0	56.0	0.1	3.3	0.8	1.9	0.4	41.4	0.8	189.9	238.6	1.8	0.1	0.2	28.6	3.8	0.9	35.2	0.1	23.0	0.8	2.4	61.9	26.1	0.1	1.1	0.7	2.1	20.3	13.3	4.1	51.9	1.0	1.4	0.9	4.2	0.9	1.9	1.2	1.3	0.9	2.3	3.2	2.0	467.2	16.0	84.9	0.0	632.7	104.3	3.1	9.3	23.9	0.6	9.9	15.2	9.5	88.6	35.6	14.7	4.2	1.4	140.9	17.5	1.9	2.8	2.7	1.5	1.1	285.3	1.8	72.3	0.1	8.1	2.9	30.3	75.4	2.0	60.1	1.5	88.5	3.4	475.2	0.0	0.1	35.4	12.2	516.2	4068.5	7.4	15.8	978.8	120.9	8.4	246.9	0.5	9.2	0.0	0.1	31.5	52.3	34.3	46.2	6.7	661.5	37.0	71.6	1.8	19.7	8.9	17.3	0.8	1.3	11.2	90.6	3.1	68.0	0.3	50.8	65.7
HLA-DRB1	HLA-DR1B	ENSG00000196126	"Major histocompatibility complex, class II, DR beta 1"	P01911	6	32578769-32589848	"Disease related genes, Human disease related genes, Plasma proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 581.3;lymphoid tissue: 651.4"	"Cell type enhanced"	"Detected in many"		"B-cells: 2149.9;Langerhans cells: 11630.1;Macrophages: 3622.3;monocytes: 3104.1;Proximal enterocytes: 1849.6"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebral cortex: 47.5"	"Immune cell enhanced"	"Detected in all"		"myeloid DC: 749.2"	"Group enriched"	"Detected in all"	9	"B-cells: 257.9;dendritic cells: 749.2;monocytes: 371.3"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 1181.9;HMC-1: 159.7;THP-1: 140.4;U-266/70: 150.3;U-698: 202.5;U-87 MG: 308.9"									"CAB015400, CAB034021, HPA043151"	Enhanced					NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 41: Macrophages - Immune response"			"CAB015400: AB_784538, CAB034021: AB_1124844, HPA043151: AB_2678342"	"unprognostic (3.69e-3)"	"unprognostic (3.66e-3)"	"unprognostic (1.80e-2)"	"unprognostic (2.40e-3)"	"unprognostic (2.21e-1)"	"unprognostic (5.45e-2)"	"unprognostic (5.28e-2)"	"unprognostic (1.22e-3)"	"unprognostic (8.56e-2)"	"unprognostic (3.00e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.08e-1)"	"unprognostic (2.28e-3)"	"unprognostic (6.16e-2)"	"unprognostic (1.19e-1)"	"unprognostic (5.10e-2)"	"unprognostic (1.53e-1)"	311.4	162.1	7.2	220.8	7.8	61.3	239.4	6.4	47.5	121.4	11.1	113.5	2.4	90.3	140.6	71.7	119.4	66.9	134.6	6.2	11.4	217.5	100.6	581.3	651.4	6.8	7.1	40.4	50.8	0.0	80.2	13.6	6.9	88.4	135.3	5.2	93.8	0.4	58.3	122.5	353.2	11.1	9.9	516.2	232.3	25.5	9.2	254.3	129.5	0.0	257.4	116.2	91.5	13.4	0.6	0.0	0.0	0.3	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.1	2.4	17.1	0.0	0.0	1.9	0.0	4.7	0.0	1181.9	12.9	0.1	0.5	0.0	0.0	0.4	159.7	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	12.3	0.0	28.5	0.4	2.3	0.4	0.0	0.0	4.4	0.4	0.1	0.0	0.0	0.1	0.2	6.5	0.0	26.7	1.5	4.8	140.4	0.1	0.0	0.9	2.1	0.7	150.3	4.4	202.5	308.9	5.8	0.5	2.5	323.0	53.7	12.2	371.3	2.2	225.4	9.0	27.2	749.2	257.9	1.1	12.2	8.9	21.0	223.8	147.6	35.4	411.8	7.2	7.8	6.4	47.5	6.2	11.4	6.8	7.1	6.9	9.9	9.2	13.4	1241.9	147.4	609.1	0.0	2149.9	173.6	14.1	78.2	51.8	2.0	96.0	150.9	30.5	90.1	277.5	141.6	0.0	3.7	484.0	92.2	25.4	272.8	4.6	23.9	4.0	721.5	36.0	120.8	0.0	73.8	7.0	77.9	131.0	21.6	124.0	47.9	179.9	5.0	1417.7	0.0	0.0	92.7	30.5	1755.3	11630.1	12.3	14.9	3622.3	217.1	0.0	3104.1	7.7	55.6	0.0	0.0	89.1	308.9	26.7	120.2	21.0	1849.6	218.2	357.1	10.7	26.3	16.6	47.9	2.4	3.6	27.2	147.9	6.8	245.6	52.5	152.2	125.5
HLA-DQA1	"CELIAC1, HLA-DQA"	ENSG00000196735	"Major histocompatibility complex, class II, DQ alpha 1"	P01909	6	32628179-32647062	"Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 333.9;lymphoid tissue: 335.8"	"Cell type enriched"	"Detected in many"	4	"Langerhans cells: 4114.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"myeloid DC: 666.6"	"Group enriched"	"Detected in all"	19	"B-cells: 287.6;dendritic cells: 666.6;monocytes: 257.6"	"Cell line enriched"	"Detected in some"	7	"HDLM-2: 1419.1"									HPA012315	Enhanced					NA	NA		200000	"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 16: Immune cells - Immune response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 41: Macrophages - Immune response"			"HPA012315: AB_1853930"	"unprognostic (4.24e-3)"	"unprognostic (1.47e-2)"	"unprognostic (1.43e-2)"	"unprognostic (7.94e-3)"	"unprognostic (1.72e-1)"	"unprognostic (6.07e-2)"	"unprognostic (3.26e-1)"	"unprognostic (5.81e-3)"	"unprognostic (2.84e-2)"	"unprognostic (1.17e-1)"	"unprognostic (4.65e-2)"	"unprognostic (1.15e-1)"	"unprognostic (5.36e-2)"	"unprognostic (6.74e-2)"	"unprognostic (2.27e-1)"	"unprognostic (7.43e-2)"	"unprognostic (1.57e-1)"	61.7	45.7	2.3	111.0	2.2	7.1	41.6	2.4	2.8	49.9	5.2	76.8	0.1	27.7	32.2	32.1	29.1	127.4	20.8	1.6	5.1	39.6	95.1	333.9	335.8	4.3	2.6	18.6	15.0	2.6	15.2	13.7	2.7	15.1	115.8	1.9	34.8	7.8	7.5	30.0	74.0	19.2	5.4	180.0	103.3	12.2	3.4	234.3	26.0	0.0	322.3	175.9	16.3	11.1	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	213.6	1.1	0.0	0.0	0.0	0.0	0.0	0.0	1419.1	0.9	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	4.1	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.1	0.0	2.4	0.4	0.0	0.1	0.6	0.6	63.2	1.5	156.1	24.4	0.0	0.0	1.9	105.8	0.5	2.4	257.6	1.0	287.6	3.3	16.5	666.6	274.1	0.4	4.3	3.0	8.2	68.3	162.7	21.6	129.0	2.3	2.2	2.4	2.8	1.6	5.1	4.3	2.6	2.7	5.4	3.4	11.1	67.9	12.8	86.3	0.0	972.8	50.2	0.4	4.3	4.6	0.1	9.8	28.6	2.1	7.2	19.4	0.0	2.1	0.8	179.8	0.9	1.9	4.6	0.6	0.5	0.4	97.4	0.0	38.3	0.1	4.6	2.4	14.7	10.7	0.9	50.4	0.8	12.8	0.6	381.0	0.0	0.1	0.4	2.0	518.6	4114.3	1.3	3.1	874.3	71.2	12.2	957.1	1.0	4.1	0.0	0.2	2.1	0.1	0.0	96.1	1.5	1.8	6.5	27.3	2.5	6.6	1.2	5.3	0.0	0.7	2.5	41.6	2.1	56.0	1.2	2.7	7.6
HLA-DQB1	"CELIAC1, HLA-DQB, IDDM1"	ENSG00000179344	"Major histocompatibility complex, class II, DQ beta 1"		6	32659467-32668383	"Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enhanced"	"Detected in many"		"lung: 179.1;lymphoid tissue: 301.8"	"Cell type enhanced"	"Detected in many"		"B-cells: 995.1;Langerhans cells: 4144.8;Macrophages: 1090.5;monocytes: 1038.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 153.5;intermediate monocyte: 142.9;memory B-cell: 159.2;myeloid DC: 386.3;naive B-cell: 169.1;plasmacytoid DC: 116.5"	"Group enriched"	"Detected in all"	6	"B-cells: 169.1;dendritic cells: 386.3;monocytes: 153.5"	"Cell line enriched"	"Detected in some"	6	"HDLM-2: 599.9"									HPA013667	Enhanced		Supported	"Golgi apparatus,Rods & Rings"		NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 16: Immune cells - Immune response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 41: Macrophages - Immune response"	"Rods & Rings"	"Golgi apparatus"	"HPA013667: AB_1853932"	"unprognostic (8.60e-3)"	"unprognostic (1.91e-2)"	"unprognostic (5.91e-2)"	"unprognostic (9.85e-3)"	"unprognostic (4.48e-1)"	"unprognostic (5.30e-2)"	"unprognostic (4.75e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.51e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.48e-2)"	"unprognostic (3.94e-1)"	"unprognostic (1.34e-2)"	"unprognostic (3.13e-1)"	"unprognostic (4.16e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.40e-1)"	56.6	23.9	2.2	77.8	2.2	40.0	45.3	2.7	3.1	19.9	3.0	45.8	0.2	18.9	126.9	21.3	22.2	43.6	21.6	2.0	3.6	34.3	37.1	179.1	301.8	4.7	3.8	7.4	14.3	10.6	21.3	10.1	2.9	17.1	39.0	1.7	24.2	11.9	9.6	31.8	78.0	11.2	4.6	139.3	128.0	7.0	3.1	108.2	26.3	0.0	122.3	89.9	16.9	5.5	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	93.9	2.2	0.0	0.0	19.2	0.0	19.2	0.0	599.9	13.4	0.0	0.0	0.0	0.0	0.2	7.8	0.0	3.0	0.0	0.0	0.0	0.0	2.9	0.0	1.8	0.0	7.2	0.1	0.9	0.1	0.0	0.0	0.0	0.1	0.2	0.0	1.3	0.0	0.1	1.6	1.1	1.4	0.0	3.3	10.9	0.2	0.0	0.6	0.8	0.4	68.7	2.1	66.0	47.1	0.1	0.0	0.3	153.5	27.9	12.8	142.9	6.6	159.2	6.9	20.0	386.3	169.1	0.4	6.3	11.8	10.4	41.1	116.5	41.1	217.0	2.2	2.2	2.7	3.1	2.0	3.6	4.7	3.8	2.9	4.6	3.1	5.5	162.9	41.7	181.1	0.0	995.1	89.9	8.7	23.1	31.3	5.1	16.8	32.1	3.2	27.1	40.7	18.4	10.4	1.4	188.2	10.3	7.9	38.8	16.5	4.1	1.0	135.3	22.8	37.2	0.2	20.0	3.0	18.8	41.8	5.2	38.5	7.9	25.0	2.3	422.1	0.0	0.8	24.7	12.2	487.3	4144.8	7.5	6.5	1090.5	97.8	8.4	1038.0	1.1	25.7	0.0	0.1	28.3	27.4	9.8	86.9	8.7	417.9	18.5	53.0	2.7	6.6	4.8	9.6	2.7	2.5	18.5	66.3	3.0	84.5	0.9	36.1	49.1
HLA-DQA2	HLA-DXA	ENSG00000237541	"Major histocompatibility complex, class II, DQ alpha 2"	P01906	6	32741391-32747198	"Human disease related genes, Predicted membrane proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 20.8;lymphoid tissue: 27.1"	"Cell type enriched"	"Detected in many"	4	"Langerhans cells: 1196.5"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																	NA	NA				"Cluster 64: Macrophages - Immune response"		"Cluster 41: Macrophages - Immune response"				"unprognostic (4.06e-3)"	"unprognostic (2.46e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.07e-2)"	"unprognostic (2.69e-1)"	"unprognostic (5.44e-2)"	"unprognostic (2.64e-1)"	"unprognostic (2.57e-2)"	"unprognostic (8.85e-2)"	"unprognostic (4.40e-1)"	"unprognostic (1.04e-1)"	"unprognostic (7.67e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.19e-2)"	"unprognostic (3.83e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.48e-2)"	10.9	4.5	0.0	0.0	0.0	0.0	7.2	0.0	0.0	3.1	0.0	3.9	0.0	2.1	0.0	3.0	2.8	0.1	2.3	0.0	0.0	5.8	1.7	20.8	0.0	0.0	0.0	0.9	1.2	0.0	2.5	0.0	0.0	2.5	0.0	0.0	3.4	0.0	1.4	8.4	11.6	0.0	0.0	27.1	2.9	0.6	0.0	0.3	3.7	0.0	0.3	3.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	46.1	3.2	3.6	0.0	179.2	23.5	0.3	1.8	1.2	0.0	2.5	1.3	0.5	0.0	7.5	3.7	0.0	0.2	144.1	0.1	0.0	0.2	0.7	0.1	0.2	20.6	2.4	0.4	0.0	0.0	0.8	1.6	0.0	0.3	0.0	0.8	2.2	0.3	110.0	0.0	0.0	0.0	0.0	78.9	1196.5	2.0	1.2	243.1	24.9	0.0	125.3	0.0	8.2	0.0	0.0	0.2	0.0	0.0	9.5	0.0	0.0	11.2	12.4	0.0	6.6	0.7	1.2	0.1	0.3	0.1	23.3	0.4	13.8	0.0	0.0	0.7
HLA-DQB2	HLA-DXB	ENSG00000232629	"Major histocompatibility complex, class II, DQ beta 2"	P05538	6	32756098-32763532	"Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 52.4"	"Cell type enriched"	"Detected in some"	33	"Langerhans cells: 1010.0"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"memory B-cell: 1.3"	"Low lineage specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA073187	Enhanced					NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 31: Skin - Epidermis development"		"Cluster 41: Macrophages - Immune response"			"HPA073187: "	"prognostic favorable (5.55e-4)"	"unprognostic (3.75e-3)"	"unprognostic (2.16e-1)"	"unprognostic (2.50e-2)"	"unprognostic (2.10e-1)"	"unprognostic (6.60e-2)"	"unprognostic (8.15e-2)"	"unprognostic (3.73e-3)"	"unprognostic (6.48e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.74e-1)"	"unprognostic (1.94e-1)"	"unprognostic (6.66e-2)"	"unprognostic (1.23e-1)"	"unprognostic (4.10e-2)"	"unprognostic (1.16e-1)"	"unprognostic (6.92e-2)"	4.6	1.9	0.0	0.0	0.0	0.1	3.8	0.0	0.0	3.3	0.2	1.8	0.3	0.9	0.1	7.3	1.4	0.5	1.4	0.0	0.0	2.3	0.6	14.6	0.7	0.1	0.0	0.4	0.6	0.0	1.9	0.0	0.0	1.5	1.0	0.0	2.5	0.0	0.8	52.4	6.5	0.0	0.0	12.8	1.3	0.6	0.0	0.2	2.4	0.0	0.4	1.4	4.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.5	0.0	1.3	0.0	0.0	1.1	0.8	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	1.1	3.2	13.0	0.0	5.9	28.4	0.0	0.1	0.0	0.0	0.4	1.7	0.4	0.0	1.3	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.3	0.2	0.0	6.5	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.1	2.5	0.1	0.0	0.0	2.4	0.0	0.1	0.0	0.0	6.2	1010.0	0.5	0.9	30.5	26.6	1.0	4.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.6	0.2	0.6	0.1	27.6	0.1	2.7	0.0	0.0	0.4
HLA-DOB		ENSG00000241106	"Major histocompatibility complex, class II, DO beta"	P13765	6	32812763-32820466	"Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"intestine: 19.5;lymphoid tissue: 41.0"	"Cell type enhanced"	"Detected in many"		"B-cells: 84.4;Langerhans cells: 35.6;monocytes: 44.7;Plasma cells: 35.0"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	18	"memory B-cell: 213.8;naive B-cell: 258.1"	"Lineage enriched"	"Detected in many"	20	"B-cells: 258.1"	"Cell line enhanced"	"Detected in some"		"Daudi: 38.1;U-698: 14.9;U-937: 7.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA013846	Enhanced					NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 57: B-cells - Immune response"			"HPA013846: AB_1853928"	"prognostic favorable (4.29e-4)"	"unprognostic (3.84e-2)"	"unprognostic (7.12e-3)"	"unprognostic (6.02e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.00e-2)"	"unprognostic (4.48e-2)"	"unprognostic (4.26e-3)"	"unprognostic (6.95e-2)"	"prognostic favorable (4.17e-5)"	"unprognostic (2.37e-1)"	"unprognostic (1.36e-1)"	"prognostic unfavorable (3.15e-5)"	"unprognostic (1.37e-1)"	"unprognostic (1.64e-1)"	"unprognostic (7.18e-2)"	"unprognostic (2.46e-1)"	1.0	0.6	0.1	0.8	0.2	3.3	1.5	0.1	0.5	0.9	0.0	2.7	1.9	0.7	0.0	2.0	0.7	1.2	0.5	0.1	0.2	2.1	0.9	2.9	21.6	0.3	0.1	0.6	0.3	0.0	2.7	0.0	0.2	1.1	1.9	1.1	4.2	0.8	0.2	1.7	19.5	0.4	0.2	41.0	2.0	1.2	0.2	8.3	1.9	1.3	28.2	3.7	1.3	0.2	0.2	0.0	0.0	0.1	0.4	1.3	0.1	0.1	0.0	0.0	0.8	0.4	2.2	38.1	0.3	0.5	0.0	0.5	2.6	2.3	0.0	1.0	0.6	0.1	1.1	0.0	0.0	0.1	0.3	0.6	0.7	0.0	1.0	0.0	0.0	0.4	2.0	1.4	0.0	0.0	0.3	2.4	0.0	0.0	0.0	0.7	0.2	2.6	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.2	1.1	0.2	0.0	0.0	0.3	0.9	0.5	14.9	0.0	7.0	0.0	0.1	0.2	0.1	0.1	0.0	0.1	213.8	0.3	0.1	13.2	258.1	0.0	0.2	0.5	0.2	0.3	0.6	0.8	6.8	0.1	0.2	0.1	0.5	0.1	0.2	0.3	0.1	0.2	0.2	0.2	0.2	1.7	0.0	4.8	5.9	84.4	1.0	0.3	2.2	1.2	0.9	1.2	0.9	0.0	0.0	1.0	0.0	0.0	0.0	4.7	0.1	0.0	0.9	1.3	4.3	2.4	0.9	0.0	2.7	1.0	0.2	0.4	0.3	0.0	14.8	1.3	0.2	0.0	0.0	0.6	0.0	1.8	0.1	0.0	1.0	35.6	0.9	0.0	4.6	14.2	1.9	44.7	0.7	2.1	2.0	1.3	0.4	0.0	0.0	35.0	0.3	0.4	0.3	0.4	0.6	6.6	0.4	1.2	0.1	0.3	0.7	1.6	0.0	2.3	0.1	0.3	0.4
AL669918.1		ENSG00000250264	"Novel protein, TAP2-HLA-DOB readthrough"		6	32813767-32838822	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 11.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 19.9;HDLM-2: 11.5;HEL: 9.8;U-698: 10.0"									HPA001312	Approved		Approved	"Nuclear speckles,Endoplasmic reticulum"		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"		"Nuclear speckles, Endoplasmic reticulum"		"HPA001312: AB_1080206"	"unprognostic (6.13e-2)"	"unprognostic (8.76e-3)"	"unprognostic (4.62e-1)"		"unprognostic (9.88e-2)"	"unprognostic (1.99e-1)"	"unprognostic (3.39e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.49e-1)"	"unprognostic (8.73e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.33e-1)"	1.7	1.0	0.4	11.8	0.4	1.4	1.0	0.7	0.5	1.5	0.1	1.6	2.0	1.4	0.0	1.4	1.1	0.6	0.6	0.5	0.5	0.6	0.5	1.9	5.9	0.6	0.4	0.6	0.4	0.4	1.5	0.2	0.6	0.7	1.0	0.0	2.8	0.0	0.4	1.0	5.0	0.4	0.8	7.0	4.4	0.6	0.6	0.7	1.1	0.0	1.3	1.1	1.2	0.9	2.4	2.9	0.0	0.8	1.6	1.8	0.6	0.7	0.3	0.0	0.7	0.0	3.3	19.9	1.7	0.4	0.2	6.2	2.1	2.8	0.7	11.5	0.4	9.8	2.8	0.3	0.5	0.0	1.3	0.0	0.9	0.6	0.2	0.0	0.0	2.1	3.8	2.4	0.1	0.7	1.6	1.1	0.3	0.0	3.8	4.0	0.6	6.3	0.1	0.0	0.3	0.4	2.2	6.1	1.6	0.0	4.6	1.0	0.0	1.4	2.0	0.5	1.0	1.8	4.7	10.0	1.0	4.2	0.4	0.7	1.8	3.7	1.5	1.7	1.9	4.5	1.6	2.2	3.4	4.5	1.2	2.6	4.1	1.3	3.0	3.1	2.5	3.3	0.4	0.4	0.7	0.5	0.5	0.5	0.6	0.4	0.6	0.8	0.6	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0
TAP2	"ABCB3, D6S217E, PSF2, RING11"	ENSG00000204267	"Transporter 2, ATP binding cassette subfamily B member"	Q03519	6	32821833-32838770	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Adaptive immunity, Host-virus interaction, Immunity, Peptide transport, Protein transport, Transport"	Translocase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"monocytes: 69.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 61.4;U-251 MG: 52.0"									HPA001312	Approved		Supported	"Nuclear speckles,Endoplasmic reticulum"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 64: Macrophages - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Endoplasmic reticulum"	"Nuclear speckles"	"HPA001312: AB_1080206"	"unprognostic (2.95e-3)"	"unprognostic (2.35e-1)"	"unprognostic (3.77e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.39e-1)"	"unprognostic (3.46e-1)"	"unprognostic (8.04e-2)"	"unprognostic (1.28e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.51e-2)"	"prognostic unfavorable (1.51e-4)"	"unprognostic (1.90e-1)"	"prognostic unfavorable (5.22e-8)"	"unprognostic (5.32e-1)"	"unprognostic (4.17e-2)"	"unprognostic (2.35e-1)"	"unprognostic (4.71e-2)"	17.1	11.7	1.0	4.3	1.0	8.8	14.7	0.8	1.2	16.3	0.5	14.6	10.2	13.7	1.1	26.0	11.9	1.1	14.4	1.2	2.0	12.4	11.5	25.7	7.9	1.6	1.1	9.2	9.0	3.7	8.2	3.1	1.5	9.9	5.5	2.5	11.2	2.1	8.6	14.5	25.2	4.1	0.8	29.8	11.4	2.5	1.8	9.7	12.3	5.8	8.1	10.6	17.2	1.7	4.4	2.0	0.5	5.0	6.1	6.5	0.0	2.3	3.3	13.1	17.7	3.9	41.0	36.5	7.5	9.1	37.1	38.8	15.8	61.4	6.9	43.8	1.9	20.3	11.6	1.3	8.5	0.0	29.5	0.6	2.6	10.3	24.8	0.0	12.1	0.0	20.0	12.2	0.4	1.6	5.8	2.4	0.5	0.0	11.7	25.8	0.0	12.8	10.9	1.1	0.0	0.0	16.0	37.3	4.1	1.0	7.4	1.9	5.7	25.7	6.9	3.9	52.0	17.9	31.4	33.3	19.5	25.7	10.9	1.8	1.3	1.6	3.0	3.2	1.7	0.4	0.8	1.7	0.8	0.3	0.6	0.7	3.8	1.9	2.8	1.3	1.2	0.8	1.0	1.0	0.8	1.2	1.2	2.0	1.6	1.1	1.5	0.8	1.8	1.7	48.2	0.0	7.5	7.5	20.7	0.0	15.6	0.0	3.4	5.0	9.2	8.0	3.5	4.3	3.7	14.7	2.1	1.9	37.9	21.0	1.9	34.1	0.1	18.0	19.4	32.0	3.6	4.0	6.6	33.4	45.8	8.0	10.7	41.9	5.1	8.7	16.4	8.3	23.9	18.5	14.6	14.9	0.0	18.9	0.0	0.0	5.6	20.3	0.0	14.0	69.3	17.7	47.4	10.6	6.5	35.1	12.6	6.0	18.0	29.7	55.9	4.8	1.5	5.8	0.0	8.6	10.3	0.7	2.5	11.1	0.0	1.6	24.0	20.3	14.3	16.7
PSMB8	"beta5i, D6S216E, LMP7, PSMB5i, RING10"	ENSG00000204264	"Proteasome 20S subunit beta 8"	P28062	6	32840717-32844679	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Differentiation, Host-virus interaction, Immunity"	"Hydrolase, Protease, Threonine protease"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046995, HPA050327"	Enhanced		Approved	"Vesicles,Cytokinetic bridge"		Yes	No		2700000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 64: Macrophages - Immune response"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Vesicles	"Cytokinetic bridge"	"HPA046995: AB_2679896, HPA050327: AB_2681088"	"prognostic favorable (5.08e-4)"	"unprognostic (4.22e-2)"	"unprognostic (2.39e-2)"	"prognostic favorable (7.16e-4)"	"unprognostic (1.92e-1)"	"unprognostic (1.68e-1)"	"unprognostic (7.78e-2)"	"unprognostic (1.09e-1)"	"unprognostic (5.71e-2)"	"unprognostic (1.17e-2)"	"unprognostic (2.79e-2)"	"unprognostic (1.47e-1)"	"unprognostic (4.14e-2)"	"unprognostic (1.24e-1)"	"unprognostic (4.35e-2)"	"unprognostic (1.97e-3)"	"unprognostic (7.11e-3)"	62.7	76.9	3.3	11.2	3.4	9.8	56.5	3.3	7.3	42.7	3.4	79.9	12.9	41.3	3.2	59.5	41.6	5.8	34.2	3.4	3.5	63.7	99.2	78.2	18.2	4.3	3.4	32.1	29.5	8.2	26.6	4.4	3.7	45.2	20.4	0.7	44.2	6.4	14.4	58.0	93.9	8.9	4.0	150.4	57.0	5.9	3.6	13.5	40.8	0.1	17.2	41.3	48.1	4.1	15.1	3.9	0.3	0.0	5.1	13.1	11.2	4.9	22.9	29.1	39.3	0.0	20.9	45.7	9.4	10.5	25.5	8.1	6.8	16.6	8.0	19.2	0.0	27.6	5.9	0.3	30.3	5.2	7.5	14.9	10.3	12.9	6.8	1.9	18.1	11.8	1.1	8.1	6.1	0.1	12.9	11.7	0.1	0.0	7.3	29.3	1.3	24.1	21.3	4.9	0.8	0.2	8.6	10.4	8.5	0.1	7.0	41.0	4.3	8.8	7.6	7.8	0.6	21.0	15.9	11.2	2.2	27.7	9.0	56.8	70.3	94.6	58.1	88.0	51.2	73.4	49.1	61.1	67.5	71.1	34.8	49.6	90.2	63.0	78.2	58.5	81.2	156.0	3.3	3.4	3.3	7.3	3.4	3.5	4.3	3.4	3.7	4.0	3.6	4.1	237.0	38.5	55.8	2.9	162.0	84.4	64.1	183.7	54.7	1.8	85.3	92.5	8.7	71.4	103.2	62.5	0.0	2.7	211.2	219.9	86.1	219.4	0.6	63.2	74.9	158.5	65.7	45.0	0.1	247.6	18.3	60.7	93.8	81.5	50.7	51.4	114.5	75.0	165.9	6.7	0.5	243.8	120.1	143.5	94.9	1.9	39.1	128.2	56.9	10.3	214.3	39.9	279.1	3.0	0.7	179.6	287.9	30.5	153.2	100.1	319.8	78.9	103.2	3.0	39.5	33.2	56.8	0.4	1.2	60.5	79.6	2.7	181.6	110.9	222.6	121.6
PSMB9	"beta1i, LMP2, PSMB6i, RING12"	ENSG00000240065	"Proteasome 20S subunit beta 9"	P28065	6	32844136-32859851	"Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, Immunity"	"Hydrolase, Protease, Threonine protease"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 160.9"	"Cell type enhanced"	"Detected in many"		"monocytes: 323.0;NK-cells: 495.4;Proximal enterocytes: 318.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+ RasG12V: 27.7;Daudi: 40.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015180, HPA042818, HPA053280"	Enhanced		Supported	Cytosol		NA	NA		340000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 64: Macrophages - Immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 63: NK-cells & T-cells - Immune response"	Cytosol		"CAB015180: AB_2172368, HPA042818: AB_2678186, HPA053280: AB_2682098"	"unprognostic (1.09e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.26e-2)"	"unprognostic (2.18e-3)"	"unprognostic (7.84e-2)"	"unprognostic (1.89e-1)"	"unprognostic (5.68e-2)"	"unprognostic (6.67e-2)"	"unprognostic (1.56e-2)"	"unprognostic (6.50e-3)"	"unprognostic (1.87e-3)"	"unprognostic (1.84e-1)"	"prognostic unfavorable (1.33e-4)"	"unprognostic (2.65e-1)"	"unprognostic (1.09e-1)"	"unprognostic (4.96e-3)"	"unprognostic (5.99e-2)"	47.0	31.1	4.8	18.4	4.9	6.9	41.4	4.3	5.5	28.8	2.6	38.4	10.2	26.8	2.3	25.7	25.9	4.7	31.6	4.8	5.6	36.3	37.4	60.2	26.2	7.6	4.9	18.1	12.1	1.5	14.0	3.4	5.9	26.5	8.7	1.3	20.3	5.0	11.9	27.7	78.1	5.7	5.7	160.9	26.5	4.9	5.1	15.0	28.7	3.8	22.2	23.6	30.8	5.8	5.5	0.3	0.0	0.2	3.4	8.5	3.0	0.7	11.5	17.3	27.7	0.0	3.1	40.8	1.3	2.9	14.3	10.0	0.2	5.8	2.6	9.3	0.1	17.6	0.7	0.8	17.3	1.8	2.2	2.1	0.3	7.0	1.0	3.3	2.7	10.1	1.4	12.8	1.9	1.0	16.1	8.0	0.0	0.0	0.8	19.0	1.2	7.4	2.1	2.5	0.0	0.0	1.0	2.1	10.7	0.0	4.4	10.3	0.0	2.5	1.6	14.7	1.2	11.3	23.9	9.3	7.5	6.8	4.0	92.7	30.3	75.6	56.1	55.8	45.9	59.7	45.1	55.9	26.6	45.3	41.0	49.6	96.3	61.5	60.9	20.5	61.0	46.2	4.8	4.9	4.3	5.5	4.8	5.6	7.6	4.9	5.9	5.7	5.1	5.8	258.6	41.7	51.1	1.3	197.2	72.5	37.4	155.6	30.1	2.4	25.3	47.0	7.3	50.1	64.8	25.8	0.0	1.5	216.2	88.0	19.6	116.6	1.3	28.9	47.5	146.5	33.5	29.9	0.0	115.6	6.6	45.1	34.1	42.6	77.3	20.0	119.6	26.6	117.2	0.0	0.1	148.0	99.7	126.8	155.7	2.1	29.2	145.2	35.6	8.4	323.0	22.7	495.4	0.5	8.3	67.8	150.3	15.8	136.1	40.4	318.5	40.5	133.7	1.7	32.9	23.1	50.8	1.5	7.4	21.0	58.7	1.4	241.8	45.3	110.6	39.1
TAP1	"ABCB2, D6S114E, PSF1, RING4"	ENSG00000168394	"Transporter 1, ATP binding cassette subfamily B member"	Q03518	6	32845209-32853816	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Adaptive immunity, Host-virus interaction, Immunity, Peptide transport, Protein transport, Transport"	Translocase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 126.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009516, HPA072354"	Approved		Approved	"Endoplasmic reticulum,Centriolar satellite"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 63: NK-cells & T-cells - Immune response"	"Endoplasmic reticulum, Centriolar satellite"		"CAB009516: AB_2303048, HPA072354: AB_2686513"	"unprognostic (3.59e-2)"	"unprognostic (1.06e-1)"	"prognostic favorable (9.01e-4)"	"unprognostic (1.33e-1)"	"unprognostic (1.84e-1)"	"unprognostic (3.22e-2)"	"unprognostic (4.92e-2)"	"unprognostic (6.16e-3)"	"unprognostic (2.56e-2)"	"prognostic favorable (4.07e-4)"	"unprognostic (3.02e-3)"	"unprognostic (2.37e-1)"	"prognostic unfavorable (6.58e-5)"	"unprognostic (2.07e-2)"	"unprognostic (4.69e-2)"	"unprognostic (2.42e-2)"	"unprognostic (2.21e-2)"	28.4	24.9	16.1	50.1	16.2	13.7	20.7	15.8	20.3	21.6	16.2	30.3	36.0	20.5	2.5	31.6	17.8	12.7	25.4	14.7	16.2	21.8	19.3	52.7	50.0	24.0	16.1	12.1	14.5	7.0	11.6	12.1	21.2	21.9	12.5	1.7	25.9	7.0	16.3	51.2	42.6	11.5	18.6	73.0	33.4	11.5	19.4	25.5	17.0	7.4	21.3	23.9	24.4	17.4	22.9	13.7	0.1	16.1	8.8	11.4	126.2	8.1	34.3	59.3	86.5	2.0	27.3	41.8	25.0	12.6	48.9	45.8	4.5	20.6	5.3	81.0	6.1	26.5	4.1	10.8	42.3	0.1	17.5	15.0	17.9	17.1	10.4	8.6	15.4	8.4	1.9	55.0	10.6	10.5	17.7	27.4	0.8	3.1	11.1	47.6	5.2	32.8	25.0	10.5	0.2	1.2	6.7	38.0	33.4	1.7	30.9	37.4	9.7	21.5	8.1	53.1	11.4	59.9	82.6	12.6	16.6	16.6	16.4	176.8	99.5	270.1	155.8	101.6	133.8	137.3	125.2	153.7	95.0	107.5	120.9	124.6	295.6	132.9	94.6	94.8	213.8	221.2	16.1	16.2	15.8	20.3	14.7	16.2	24.0	16.1	21.2	18.6	19.4	17.4	72.1	25.6	24.0	9.1	62.1	74.7	47.1	54.5	27.3	4.8	21.5	15.9	7.3	24.3	33.1	5.5	0.0	5.6	108.0	78.8	5.9	81.6	0.5	31.3	39.3	63.6	16.8	12.6	1.1	75.3	95.0	26.9	42.8	77.9	26.6	13.8	27.1	11.1	45.9	15.2	1.9	55.9	57.0	31.9	90.6	0.3	13.1	43.9	23.2	16.9	115.9	25.1	149.3	12.1	3.6	91.3	38.8	10.5	84.8	70.2	84.6	6.9	29.4	2.8	6.6	18.1	27.8	1.0	1.3	20.4	76.4	4.8	92.3	18.2	54.5	52.1
HLA-DMB	"D6S221E, RING7"	ENSG00000242574	"Major histocompatibility complex, class II, DM beta"	P28068	6	32934629-32941028	"Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 78.8;lymphoid tissue: 101.5"	"Group enriched"	"Detected in many"	4	"B-cells: 228.5;dendritic cells: 129.4;Hofbauer cells: 274.8;Kupffer cells: 201.9;Langerhans cells: 472.8;Macrophages: 272.4;monocytes: 187.1;Proximal enterocytes: 284.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in all"	6	"B-cells: 128.8;dendritic cells: 85.3;monocytes: 73.8"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 14.2;Daudi: 27.6;EFO-21: 12.4;U-266/70: 7.8;U-698: 31.9"					"Low region specificity"	"Detected in all"			"HPA012298, HPA077524"	Supported		Supported	Vesicles		NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 64: Macrophages - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 41: Macrophages - Immune response"	Vesicles		"HPA012298: AB_1853927, HPA077524: "	"unprognostic (5.34e-2)"	"unprognostic (1.63e-2)"	"unprognostic (2.45e-2)"	"prognostic favorable (3.89e-5)"	"unprognostic (3.07e-1)"	"unprognostic (7.64e-3)"	"unprognostic (4.00e-1)"	"unprognostic (3.46e-3)"	"unprognostic (6.99e-2)"	"unprognostic (8.76e-2)"	"unprognostic (8.93e-2)"	"unprognostic (2.73e-1)"	"unprognostic (6.82e-3)"	"unprognostic (2.03e-1)"	"unprognostic (4.14e-2)"	"unprognostic (8.35e-2)"	"unprognostic (5.60e-2)"	38.3	35.9	0.1	13.2	0.2	6.9	25.7	0.3	1.0	21.6	0.1	19.9	0.0	14.6	7.4	9.3	14.6	0.1	11.1	0.0	0.6	41.9	7.8	59.9	17.6	0.3	0.4	9.5	9.1	0.0	9.2	0.8	0.2	13.1	14.9	0.5	14.7	0.0	5.3	14.3	78.8	0.0	0.9	101.5	17.6	2.2	0.1	9.9	45.9	0.0	18.8	14.4	10.3	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.2	27.6	12.4	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.9	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	7.8	0.4	31.9	0.0	0.1	0.0	0.5	73.2	16.7	1.2	73.8	2.6	94.0	1.0	2.9	85.0	128.8	0.7	2.4	4.7	16.2	28.1	85.3	6.7	71.4	0.1	0.2	0.3	1.0	0.0	0.6	0.3	0.4	0.2	0.9	0.1	1.1	36.8	9.6	57.0	0.7	228.5	12.0	1.0	5.4	2.2	0.2	2.5	4.7	2.6	5.7	12.7	16.5	0.0	1.7	129.4	3.3	11.7	28.8	0.5	7.5	5.4	37.2	4.2	10.3	0.8	4.4	1.6	3.8	3.1	38.5	15.2	22.7	5.7	0.5	274.8	0.0	0.6	8.5	2.0	201.9	472.8	1.5	3.4	272.4	16.0	27.2	187.1	0.5	21.6	1.0	0.1	2.5	17.8	1.9	3.8	1.3	284.8	7.4	16.8	1.1	6.6	1.6	3.1	0.6	0.7	1.1	10.9	2.7	17.6	0.9	10.3	8.7
AL645941.2		ENSG00000248993	"Novel  protein"		6	32937364-32953122	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA012298	Uncertain					NA	NA			"Cluster 37: B-cells - Transcription"			"Cluster 11: Alveolar cells - Smell perception"			"HPA012298: AB_1853927"	"unprognostic (1.33e-1)"	"unprognostic (2.53e-1)"	"unprognostic (4.98e-1)"	"unprognostic (5.56e-4)"	"unprognostic (3.24e-2)"	"unprognostic (4.17e-2)"		"unprognostic (1.08e-1)"		"unprognostic (1.93e-1)"	"unprognostic (3.25e-2)"	"unprognostic (3.78e-1)"	"unprognostic (1.60e-1)"	"unprognostic (8.18e-2)"		"unprognostic (4.73e-2)"		0.3	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.7	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
HLA-DMA	"D6S222E, RING6"	ENSG00000204257	"Major histocompatibility complex, class II, DM alpha"	P28067	6	32948613-32969094	"Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 120.4"	"Cell type enhanced"	"Detected in many"		"B-cells: 400.4;Hofbauer cells: 354.3;Kupffer cells: 411.6;Langerhans cells: 1350.5;Macrophages: 591.4;monocytes: 332.4"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"classical monocyte: 3.8;intermediate monocyte: 3.8;memory B-cell: 6.3;myeloid DC: 7.2;naive B-cell: 6.4;plasmacytoid DC: 5.2"	"Group enriched"	"Detected in many"	12	"B-cells: 6.4;dendritic cells: 7.2;monocytes: 3.8"	"Group enriched"	"Detected in some"	5	"U-266/70: 30.5;U-698: 94.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012750, HPA017295"	Enhanced		Approved	Vesicles		NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 64: Macrophages - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 41: Macrophages - Immune response"	Vesicles		"HPA012750: AB_1853926, HPA017295: AB_2669575"	"unprognostic (1.69e-3)"	"unprognostic (3.52e-2)"	"unprognostic (8.03e-2)"	"prognostic favorable (4.64e-5)"	"unprognostic (3.99e-1)"	"unprognostic (3.90e-2)"	"unprognostic (1.60e-1)"	"prognostic favorable (4.59e-4)"	"unprognostic (7.01e-2)"	"unprognostic (9.69e-2)"	"unprognostic (6.66e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.12e-3)"	"unprognostic (1.41e-1)"	"unprognostic (4.95e-2)"	"unprognostic (3.80e-1)"	"unprognostic (2.14e-2)"	79.9	63.6	0.1	1.0	0.1	23.4	63.4	0.1	0.6	33.1	0.5	26.7	1.6	19.8	22.8	16.0	31.4	0.9	23.5	0.1	0.2	48.0	15.1	98.3	2.4	0.3	0.2	13.5	19.4	0.1	15.6	0.9	0.2	23.1	13.6	0.4	25.9	0.3	11.8	25.1	69.6	0.5	0.3	120.4	32.7	4.0	0.2	0.6	33.1	0.2	36.9	21.3	20.8	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	2.1	0.1	0.1	0.0	0.1	0.0	0.5	1.9	0.0	0.0	0.5	0.3	0.3	2.5	0.4	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.1	0.1	0.0	0.9	0.0	0.7	0.0	0.0	0.1	0.3	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.1	30.5	13.7	94.3	0.6	0.0	0.0	0.0	3.8	0.3	0.2	3.8	0.0	6.3	0.1	0.2	7.2	6.4	0.0	0.1	0.4	0.3	1.2	5.2	0.4	3.6	0.1	0.1	0.1	0.6	0.1	0.2	0.3	0.2	0.2	0.3	0.2	0.5	240.5	73.7	171.3	0.7	400.4	48.3	15.5	77.3	17.6	1.8	38.2	32.0	5.2	45.8	95.9	53.3	2.1	4.9	175.6	19.3	17.6	101.0	3.4	12.5	3.1	123.6	3.0	30.5	0.8	51.1	4.2	16.4	43.8	24.5	41.2	8.2	37.1	4.4	354.3	0.0	1.2	25.0	22.4	411.6	1350.5	5.3	16.1	591.4	80.0	14.0	332.4	4.3	33.0	1.5	1.3	26.6	46.2	18.8	68.9	19.1	267.0	47.1	77.6	1.3	19.7	5.4	15.6	4.1	4.8	7.0	41.9	4.0	44.7	4.3	42.6	60.9
BRD2	"BRD2-IT1, D6S113E, FSRG1, KIAA9001, NAT, RING3"	ENSG00000204256	"Bromodomain containing 2"	P25440	6	32968594-32981505	"Predicted intracellular proteins"	"Host-virus interaction, Transcription, Transcription regulation"	"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042816	Approved		Enhanced	"Nuclear speckles"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 72: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 7: Non-specific - Mitochondria"	"Nuclear speckles"		"HPA042816: AB_10794766"	"unprognostic (2.13e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.60e-2)"	"unprognostic (1.45e-1)"	"unprognostic (9.89e-2)"	"unprognostic (5.03e-2)"	"unprognostic (2.54e-1)"	"unprognostic (6.85e-3)"	"unprognostic (1.39e-2)"	"unprognostic (1.95e-2)"	"unprognostic (3.42e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.98e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.44e-2)"	64.2	61.8	0.8	22.1	2.1	66.5	62.4	4.7	3.8	67.7	0.2	62.1	19.8	71.3	1.8	67.9	66.6	17.4	51.7	3.0	2.8	68.3	61.9	65.3	22.1	1.5	2.4	81.7	80.4	26.3	71.4	19.4	2.1	60.8	11.6	10.1	66.1	18.2	71.4	69.5	60.8	11.7	1.4	71.2	66.0	82.9	2.3	26.9	77.0	10.4	21.2	61.6	65.0	4.0	45.7	19.5	41.6	41.8	31.8	28.5	38.3	44.6	44.4	48.5	35.8	22.7	22.5	37.3	44.6	37.2	32.4	28.1	39.3	33.2	27.7	49.5	147.7	41.2	18.3	14.6	23.5	60.6	39.2	29.2	28.7	38.2	44.9	27.6	21.3	35.2	44.4	76.0	21.7	12.1	77.0	8.5	24.0	28.9	20.4	76.2	18.7	53.8	13.8	26.6	85.6	28.9	54.5	63.7	52.7	27.8	37.4	39.0	27.5	58.6	32.0	21.5	50.0	61.1	69.5	77.9	23.1	19.7	47.8	9.6	7.6	11.6	14.5	8.8	13.0	9.2	9.4	9.9	10.6	8.7	6.6	10.4	9.7	10.3	9.5	8.5	13.3	11.7	0.8	2.1	4.7	3.8	3.0	2.8	1.5	2.4	2.1	1.4	2.3	4.0	325.8	76.9	121.5	38.2	327.1	212.1	232.7	70.0	478.1	78.6	295.5	383.9	171.7	94.4	80.1	60.7	104.3	91.7	395.7	210.7	21.5	69.2	302.4	201.9	149.3	191.2	259.1	97.6	16.1	91.4	145.0	224.2	249.8	256.6	115.2	103.1	113.2	85.3	79.9	55.5	19.9	247.5	77.3	92.6	209.2	177.9	86.9	194.5	124.5	26.2	94.7	62.8	107.1	15.1	22.1	81.2	137.3	77.1	313.0	211.5	133.7	39.5	84.4	65.1	39.5	240.0	251.3	88.4	137.9	365.0	226.9	205.1	356.7	71.2	179.5	248.4
HLA-DOA	"HLA-D0-alpha, HLA-DNA, HLA-DZA"	ENSG00000204252	"Major histocompatibility complex, class II, DO alpha"	P06340	6	33004182-33009591	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 28.7"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 30.3;B-cells: 61.5;dendritic cells: 20.3;Kupffer cells: 29.4;Langerhans cells: 59.0;Macrophages: 37.7;monocytes: 41.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"myeloid DC: 17.8;naive B-cell: 21.0"	"Group enriched"	"Detected in many"	11	"B-cells: 21.0;dendritic cells: 17.8;monocytes: 6.0"	"Cell line enhanced"	"Detected in some"		"Daudi: 12.9;HDLM-2: 9.1;REH: 40.5;U-698: 8.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA045038, HPA076922"	Enhanced					NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 64: Macrophages - Immune response"	"Cluster 14: REH - Unknown function"	"Cluster 41: Macrophages - Immune response"			"HPA045038: AB_10959457, HPA076922: "	"unprognostic (8.02e-2)"	"unprognostic (2.30e-2)"	"unprognostic (2.60e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.01e-1)"	"unprognostic (3.83e-2)"	"unprognostic (2.60e-1)"	"unprognostic (9.86e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.50e-1)"	"unprognostic (3.68e-1)"	"unprognostic (4.39e-2)"	"unprognostic (1.91e-1)"	"unprognostic (9.95e-2)"	"unprognostic (3.65e-2)"	"unprognostic (8.70e-2)"	"unprognostic (5.94e-2)"	7.1	6.1	0.2	7.8	0.4	1.5	6.5	0.4	0.4	4.9	0.3	3.2	5.0	3.0	1.2	2.3	5.0	2.1	2.2	0.3	1.0	8.0	2.8	12.7	15.1	1.8	0.8	2.8	2.4	0.9	3.5	0.0	1.5	5.0	4.2	0.4	3.2	2.1	0.8	2.8	15.2	1.1	0.8	28.7	4.0	0.4	0.7	7.0	4.5	1.0	19.8	3.0	3.7	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	12.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	9.1	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.2	0.1	0.0	0.0	0.0	40.5	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.1	1.4	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.8	0.1	8.2	0.0	0.2	0.0	0.0	1.0	0.0	0.0	6.0	0.0	14.6	0.1	0.3	17.8	21.0	0.3	1.3	0.7	0.2	4.7	5.0	1.0	2.4	0.2	0.4	0.4	0.4	0.3	1.0	1.8	0.8	1.5	0.8	0.7	1.2	7.5	3.2	30.3	0.0	61.5	1.9	0.6	0.1	0.6	0.0	0.5	2.4	1.6	1.5	2.0	3.7	0.0	0.1	20.3	0.3	0.0	6.6	0.1	0.3	0.2	8.5	0.0	2.5	0.0	0.2	0.1	1.2	0.5	0.3	5.1	3.5	1.1	0.0	13.4	0.0	0.0	0.1	2.0	29.4	59.0	0.2	0.3	37.7	0.0	6.5	41.9	0.6	4.1	0.0	0.1	0.3	0.0	0.0	0.9	0.6	0.0	2.9	1.4	0.2	0.0	0.7	0.6	0.0	0.2	0.5	1.1	0.1	4.1	1.0	0.3	1.2
HLA-DPA1	HLA-DP1A	ENSG00000231389	"Major histocompatibility complex, class II, DP alpha 1"	P20036	6	33064569-33080775	"Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lung: 319.9;lymphoid tissue: 359.6"	"Cell type enhanced"	"Detected in many"		"B-cells: 1387.3;Kupffer cells: 1794.6;Langerhans cells: 8122.8;Macrophages: 2736.9;monocytes: 2940.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"classical monocyte: 81.8;intermediate monocyte: 187.4;memory B-cell: 150.4;myeloid DC: 296.0;naive B-cell: 136.5;non-classical monocyte: 124.1;plasmacytoid DC: 82.6"	"Group enriched"	"Detected in all"	7	"B-cells: 150.4;dendritic cells: 296.0;monocytes: 187.4"	"Cell line enhanced"	"Detected in many"		"Daudi: 37.2;HDLM-2: 115.9;REH: 30.3;U-698: 26.1"									HPA017967	Enhanced		Supported	Vesicles		NA	NA		240000	"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 64: Macrophages - Immune response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 41: Macrophages - Immune response"	Vesicles		"HPA017967: AB_1853929"	"unprognostic (8.93e-3)"	"unprognostic (3.15e-2)"	"unprognostic (3.64e-2)"	"unprognostic (9.40e-3)"	"unprognostic (9.07e-2)"	"unprognostic (2.80e-2)"	"unprognostic (5.69e-2)"	"unprognostic (1.82e-2)"	"unprognostic (7.28e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.80e-1)"	"unprognostic (8.38e-2)"	"unprognostic (1.17e-1)"	"unprognostic (4.69e-2)"	"unprognostic (8.11e-2)"	"unprognostic (1.06e-1)"	180.8	108.0	2.2	33.4	2.0	12.8	138.4	2.7	3.3	76.7	2.5	72.1	20.2	55.3	8.3	43.1	63.0	13.0	62.0	2.0	3.4	99.0	36.8	319.9	51.3	4.9	2.8	24.9	28.6	5.9	58.0	3.4	4.3	64.0	16.1	2.0	59.5	16.2	29.5	66.3	174.4	14.6	4.3	359.6	52.1	13.4	3.1	30.2	76.6	7.3	51.5	58.6	60.0	4.4	0.1	0.0	0.0	0.0	0.8	1.3	1.1	0.4	0.4	0.5	0.0	0.0	4.9	37.2	5.0	0.9	7.1	0.0	0.0	0.0	0.1	115.9	2.5	6.2	0.0	0.0	0.1	0.0	11.6	1.7	0.0	2.2	0.0	0.0	0.6	0.0	0.0	3.3	0.0	0.0	0.1	0.1	0.6	0.0	0.0	30.3	0.0	4.9	0.1	0.0	0.1	0.0	0.0	0.0	2.9	0.0	0.0	1.3	2.6	7.8	0.1	0.1	0.0	5.6	0.9	26.1	12.2	0.2	4.4	2.2	81.8	6.6	21.6	187.4	5.7	150.4	9.6	23.9	296.0	136.5	3.4	15.7	3.0	20.9	124.1	82.6	29.2	136.0	2.2	2.0	2.7	3.3	2.0	3.4	4.9	2.8	4.3	4.3	3.1	4.4	621.8	83.3	404.3	0.3	1387.3	206.7	7.2	12.4	9.1	2.8	41.2	110.4	12.1	64.3	107.3	23.9	0.0	4.2	574.9	10.6	9.8	36.4	2.8	1.2	4.1	337.8	10.2	80.3	0.5	18.8	9.3	53.7	48.4	2.8	64.6	14.3	62.2	7.5	1153.8	5.0	0.9	18.2	12.2	1794.6	8122.8	11.7	18.0	2736.9	302.4	32.8	2940.3	5.1	94.7	0.0	0.1	4.7	5.4	27.4	100.2	10.6	114.0	42.7	129.2	5.0	52.6	14.7	29.8	1.3	4.8	6.0	175.2	6.8	157.8	11.5	28.6	34.4
HLA-DPB1	HLA-DP1B	ENSG00000223865	"Major histocompatibility complex, class II, DP beta 1"	P04440	6	33075990-33089696	"Human disease related genes, Predicted membrane proteins"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 278.7;lymphoid tissue: 409.4"	"Cell type enhanced"	"Detected in many"		"B-cells: 1569.6;Kupffer cells: 2374.2;Langerhans cells: 12627.8;Macrophages: 2453.8;monocytes: 3754.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"myeloid DC: 285.5"	"Group enriched"	"Detected in all"	10	"B-cells: 227.8;dendritic cells: 285.5;monocytes: 137.5"	"Group enriched"	"Detected in some"	6	"HDLM-2: 65.9;REH: 26.5"									"HPA011078, HPA058509"	Enhanced		Approved	"Nucleoplasm,Cell Junctions"		NA	NA		470000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 64: Macrophages - Immune response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 41: Macrophages - Immune response"	"Cell Junctions"	Nucleoplasm	"HPA011078: AB_1079378, HPA058509: AB_2683737"	"unprognostic (5.44e-3)"	"unprognostic (7.03e-3)"	"unprognostic (9.84e-2)"	"prognostic favorable (3.38e-4)"	"unprognostic (9.43e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.51e-3)"	"unprognostic (1.77e-2)"	"unprognostic (5.64e-2)"	"unprognostic (1.57e-1)"	"unprognostic (4.34e-1)"	"unprognostic (4.35e-2)"	"unprognostic (1.80e-1)"	"unprognostic (4.17e-2)"	"unprognostic (3.58e-2)"	"unprognostic (1.85e-1)"	151.6	101.3	1.0	42.0	1.0	5.8	112.8	3.3	1.3	68.2	0.9	69.4	12.4	50.2	2.9	43.9	55.7	17.2	51.1	0.8	1.8	96.1	38.6	278.7	66.7	1.8	1.3	26.2	32.4	1.0	51.5	0.8	1.8	70.3	2.5	1.5	57.2	6.4	25.1	72.3	176.5	4.7	2.1	409.4	54.1	12.8	1.0	10.9	69.5	1.3	42.2	49.2	56.5	3.0	0.0	0.0	0.1	0.0	0.0	0.3	3.6	0.0	0.0	0.0	0.0	0.0	0.0	1.3	6.2	0.2	0.0	0.1	0.0	0.0	0.0	65.9	1.9	1.5	0.0	0.0	0.0	0.0	0.5	1.4	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	4.9	0.0	0.0	26.5	0.1	0.3	0.3	0.0	0.9	0.0	0.0	0.3	0.1	0.4	0.0	0.1	1.8	0.1	0.2	0.0	0.0	7.2	0.3	4.4	1.1	0.0	0.0	0.5	59.6	4.0	14.8	137.5	1.8	226.6	5.1	22.2	285.5	227.8	2.3	11.9	1.6	8.2	60.3	77.5	22.7	107.8	1.0	1.0	3.3	1.3	0.8	1.8	1.8	1.3	1.8	2.1	1.0	3.0	354.8	67.3	330.7	1.3	1569.6	300.5	26.0	5.6	19.4	26.9	54.0	123.6	10.3	67.2	62.3	29.5	16.7	4.8	692.9	7.8	3.9	58.3	3.6	2.0	16.3	297.8	9.6	87.9	1.3	15.6	8.1	62.3	48.4	2.7	61.6	13.6	97.1	8.8	1099.4	8.4	1.6	13.0	10.2	2374.2	12627.8	10.1	27.4	2453.8	323.7	20.6	3754.7	43.3	203.9	2.5	0.2	7.4	10.0	21.1	50.9	28.2	154.7	60.2	54.4	21.9	46.0	21.4	47.5	1.3	7.8	6.4	233.3	9.0	200.7	3.9	23.0	51.7
COL11A2	"DFNA13, DFNB53, HKE5"	ENSG00000204248	"Collagen type XI alpha 2 chain"	P13942	6	33162681-33192499	"Disease related genes, Human disease related genes, Plasma proteins, Predicted secreted proteins"			"Deafness, Disease variant, Dwarfism, Non-syndromic deafness, Stickler syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"pituitary gland: 23.5;testis: 8.1"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 8.5;Early spermatids: 10.8;Muller glia cells: 5.2;Oligodendrocytes: 6.7"	"Cancer enriched"	"Detected in many"	8	"melanoma: 13.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Secreted to extracellular matrix"	NA	NA		2100000		"Cluster 26: Pituitary gland - Hormone signaling"		"Cluster 29: Early spermatids - Spermatogenesis"				"unprognostic (4.62e-1)"	"unprognostic (8.69e-2)"	"unprognostic (1.65e-4)"	"unprognostic (5.15e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.04e-2)"	"unprognostic (9.67e-2)"	"unprognostic (2.05e-2)"	"unprognostic (4.47e-2)"	"unprognostic (1.22e-1)"	"unprognostic (3.41e-3)"	"unprognostic (2.26e-6)"	"unprognostic (8.27e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.88e-1)"	"unprognostic (5.96e-2)"	1.0	0.3	0.3	0.0	0.6	0.0	0.9	0.5	0.6	1.6	0.0	0.7	0.2	1.2	0.2	0.5	0.9	0.1	1.8	0.3	0.3	1.3	0.8	1.0	0.0	0.5	0.4	1.1	0.6	0.1	23.5	0.0	0.5	1.3	0.0	0.1	0.8	0.1	1.3	0.6	0.7	0.1	0.5	1.2	0.7	8.1	0.5	0.3	3.5	0.7	0.0	0.6	0.9	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.2	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.3	0.1	0.0	0.2	0.2	0.0	0.0	0.6	0.5	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.6	0.5	0.6	0.3	0.3	0.5	0.4	0.5	0.5	0.5	0.8	2.6	0.0	0.0	8.5	0.1	1.5	0.2	0.1	1.8	2.8	1.2	1.8	2.3	0.0	0.1	0.0	4.2	0.0	0.6	0.3	0.0	0.1	10.8	0.2	0.6	1.5	0.0	0.0	4.2	0.0	0.0	0.3	0.0	0.5	0.0	0.6	4.6	0.2	0.2	0.0	3.7	0.1	0.0	0.6	0.4	1.9	0.0	0.3	1.8	1.0	0.0	5.2	0.0	3.5	6.7	0.1	0.6	0.4	0.8	0.2	0.0	0.1	0.0	1.1	0.0	0.7	1.8	0.9	2.1	0.7	1.1	0.0	0.4	0.2	0.5	0.1
RXRB	"H-2RIIBP, NR2B2, RCoR-1"	ENSG00000204231	"Retinoid X receptor beta"	P28702	6	33193588-33200665	"Cancer-related genes, FDA approved drug targets, Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Receptor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"GAMG: 11.0;RH-30: 14.4;RT4: 12.1;T-47d: 16.1;U-266/70: 11.1;U-266/84: 11.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002003, HPA063653"	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 72: Non-specific - Transcription"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"CAB002003: , HPA063653: AB_2685076"	"unprognostic (3.51e-1)"	"unprognostic (8.46e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.22e-2)"	"unprognostic (2.00e-2)"	"unprognostic (4.71e-3)"	"unprognostic (4.18e-2)"	"unprognostic (2.21e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.67e-3)"	"unprognostic (8.13e-3)"	"unprognostic (9.53e-3)"	"unprognostic (8.30e-2)"	"unprognostic (1.55e-1)"	"unprognostic (6.38e-2)"	"unprognostic (8.53e-3)"	26.8	29.1	1.5	2.0	1.5	2.3	27.1	1.6	5.7	33.9	1.4	34.4	3.9	31.9	7.4	27.0	31.4	3.3	31.4	1.5	2.6	29.5	34.4	27.2	1.4	1.5	1.7	32.9	32.3	0.0	33.0	2.5	1.5	32.8	1.6	3.2	27.0	3.3	42.5	26.3	28.6	9.6	1.6	38.3	28.3	20.0	1.6	2.8	37.7	12.3	9.1	30.6	29.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.0	0.0	10.0	0.0	10.4	7.1	0.0	11.0	4.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.0	9.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.2	0.0	8.9	0.0	0.0	0.5	3.2	0.0	0.0	0.1	14.4	0.0	8.0	12.1	0.0	7.4	0.0	0.0	0.0	0.0	16.1	0.0	0.0	0.0	4.8	0.0	0.0	11.1	11.8	9.2	0.0	0.0	0.0	2.3	0.4	1.7	1.1	0.3	0.8	1.0	1.3	1.3	0.6	0.3	1.1	0.8	0.7	0.8	0.6	0.6	1.1	0.3	1.5	1.5	1.6	5.7	1.5	2.6	1.5	1.7	1.5	1.6	1.6	1.7	21.2	41.7	13.3	14.4	19.2	17.3	14.9	8.9	18.2	25.2	22.4	18.9	16.1	15.7	14.7	5.5	20.9	23.6	26.3	21.8	25.4	19.9	2.7	10.6	14.7	18.2	22.0	8.6	14.9	16.2	17.9	18.3	23.0	11.9	10.2	22.5	14.3	15.9	15.8	18.5	12.9	21.8	16.2	14.7	9.2	8.6	16.1	12.2	16.0	10.3	18.8	16.6	33.0	14.1	15.2	13.6	20.2	16.1	12.0	16.3	23.2	14.1	10.8	20.4	26.3	19.3	20.0	17.7	12.5	16.8	18.8	28.7	19.4	18.7	24.5	12.7
SLC39A7	"D6S2244E, H2-KE4, HKE4, KE4, RING5, ZIP7"	ENSG00000112473	"Solute carrier family 39 member 7"	Q92504	6	33200445-33204439	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport, Zinc transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Syncytiotrophoblasts: 168.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053999	Approved		Supported	"Endoplasmic reticulum"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Endoplasmic reticulum"		"HPA053999: AB_2682338"	"unprognostic (3.63e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.21e-1)"	"unprognostic (3.24e-2)"	"unprognostic (8.95e-2)"	"unprognostic (2.51e-1)"	"prognostic unfavorable (3.62e-4)"	"unprognostic (4.87e-2)"	"unprognostic (9.92e-2)"	"unprognostic (7.20e-3)"	"unprognostic (3.29e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.99e-2)"	"unprognostic (4.80e-1)"	"unprognostic (1.50e-1)"	"unprognostic (8.22e-3)"	"unprognostic (1.12e-2)"	52.5	73.7	2.2	3.6	2.4	2.4	51.1	2.5	2.7	51.0	5.4	66.7	7.2	60.8	8.6	47.1	44.4	5.8	63.2	2.0	2.8	45.1	75.0	64.9	3.0	3.1	2.6	40.9	98.7	12.8	74.1	8.2	3.2	55.8	8.7	1.9	90.9	7.5	31.5	38.4	58.5	8.3	2.5	47.7	71.4	29.0	3.2	2.8	67.2	2.8	4.4	42.4	41.2	2.9	10.7	9.6	8.6	8.2	25.8	15.9	13.2	17.8	25.3	23.1	23.1	16.7	6.6	5.1	11.9	22.9	12.4	7.5	8.3	14.5	9.7	16.6	10.1	9.4	10.0	25.1	18.2	10.0	30.7	16.0	13.6	15.1	20.6	13.5	11.7	8.3	15.5	7.7	10.2	9.8	4.3	7.4	8.1	23.2	9.9	5.7	6.8	12.2	14.0	5.8	6.8	5.1	8.6	37.2	13.2	5.4	25.0	10.3	10.9	13.1	17.4	8.2	9.8	18.3	15.1	3.9	7.5	8.7	15.0	2.2	1.8	2.0	3.3	1.1	4.4	1.2	2.0	1.2	0.7	1.2	1.8	1.7	0.8	2.1	1.0	1.3	1.0	1.5	2.2	2.4	2.5	2.7	2.0	2.8	3.1	2.6	3.2	2.5	3.2	2.9	40.0	25.6	34.8	7.2	23.4	36.1	29.4	53.6	19.4	27.4	36.7	18.5	33.1	34.3	54.7	25.8	29.2	103.0	22.9	75.5	5.9	73.8	0.8	26.9	47.3	40.9	25.3	28.4	4.3	86.1	129.1	64.4	66.8	53.7	20.8	29.5	28.2	34.4	42.9	11.8	5.9	135.1	48.8	14.8	35.3	2.7	46.0	22.1	40.9	5.6	23.7	42.9	24.7	8.5	8.3	67.8	54.9	42.9	91.6	60.2	56.0	25.9	28.3	26.8	19.7	35.4	43.0	9.4	11.5	26.0	40.9	168.7	23.1	69.2	61.7	51.3
HSD17B8	"D6S2245E, FABGL, H2-KE6, HKE6, KE6, RING2, SDR30C1"	ENSG00000204228	"Hydroxysteroid 17-beta dehydrogenase 8"	Q92506	6	33204655-33206831	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 125.2;Proximal tubular cells: 137.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 79.5;T-47d: 62.0;U-266/70: 65.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042132	Enhanced					NA	NA		97000	"Cluster 35: T-regs - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA042132: AB_10793978"	"prognostic favorable (9.99e-4)"	"unprognostic (4.24e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.10e-1)"	"unprognostic (8.11e-2)"	"prognostic favorable (1.90e-5)"	"unprognostic (1.50e-3)"	"unprognostic (3.12e-1)"	"unprognostic (1.34e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.89e-1)"	"prognostic favorable (2.18e-12)"	"unprognostic (2.82e-2)"	"unprognostic (5.57e-1)"	"unprognostic (3.09e-1)"	"unprognostic (3.23e-2)"	9.6	24.6	10.1	6.5	10.5	9.7	17.0	9.9	11.3	13.7	10.9	18.0	19.7	7.2	29.4	25.5	23.6	7.9	20.3	9.6	10.8	30.7	67.4	11.2	10.5	11.3	11.9	8.6	55.3	42.2	14.1	5.6	12.3	11.3	16.2	11.8	25.1	16.5	20.8	25.9	18.8	7.3	11.4	12.1	15.1	5.9	10.8	13.3	32.9	25.0	15.1	9.8	12.8	11.3	7.0	15.0	6.8	9.3	2.3	4.4	1.3	0.8	4.7	0.1	0.1	5.8	17.5	45.4	11.2	1.2	2.2	29.1	7.2	11.7	1.0	8.6	0.0	2.6	14.0	27.1	20.0	0.0	3.8	5.0	28.9	0.2	49.4	0.4	2.1	13.6	0.3	46.2	4.1	9.4	31.2	1.3	2.1	23.3	2.9	11.0	1.2	79.5	27.8	1.3	12.1	7.6	2.9	34.3	7.6	4.6	62.0	1.8	1.3	0.7	7.3	0.6	0.4	65.5	42.4	16.6	3.1	1.0	1.7	0.1	5.8	2.0	18.7	13.4	30.0	16.6	24.0	29.2	11.6	13.1	26.4	28.5	0.7	16.8	14.6	20.8	21.8	26.7	10.1	10.5	9.9	11.3	9.6	10.8	11.3	11.9	12.3	11.4	10.8	11.3	12.5	19.2	21.6	3.3	18.6	29.7	28.3	55.0	21.6	12.4	31.3	34.8	31.8	48.6	25.9	22.0	6.2	29.9	9.7	21.2	125.2	27.9	6.3	20.0	6.0	10.1	18.0	12.8	0.3	32.4	12.9	9.1	16.3	13.7	7.0	9.8	10.0	83.2	17.4	1.7	0.5	26.6	20.3	10.3	16.4	18.1	7.5	7.9	49.8	1.0	8.1	32.6	6.2	1.0	0.7	21.9	21.1	6.0	47.6	15.4	74.8	137.2	33.3	14.8	0.0	11.3	9.8	8.1	8.5	40.0	37.2	17.4	18.0	29.8	44.4	31.5
RING1	RNF1	ENSG00000204227	"Ring finger protein 1"	Q06587	6	33208500-33212722	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation, Ubl conjugation pathway"	"Chromatin regulator, Repressor, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008701	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 35: Non-specific - Unknown function"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"	Nucleoplasm	Cytosol	"HPA008701: AB_1079814"	"unprognostic (2.12e-3)"	"unprognostic (7.98e-2)"	"unprognostic (3.77e-2)"	"unprognostic (1.37e-1)"	"unprognostic (3.91e-2)"	"unprognostic (3.21e-1)"	"unprognostic (1.53e-1)"	"unprognostic (4.75e-2)"	"unprognostic (7.76e-2)"	"unprognostic (1.26e-2)"	"unprognostic (3.70e-2)"	"unprognostic (1.62e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.13e-1)"	"unprognostic (9.88e-2)"	38.6	42.4	39.2	21.6	42.7	18.1	36.8	39.7	45.6	60.2	42.2	45.4	21.3	51.5	20.8	37.4	51.8	19.3	37.0	38.7	41.4	50.7	51.2	39.3	20.9	39.4	42.7	59.4	44.7	34.2	80.8	19.4	40.6	55.8	7.2	15.7	37.0	23.2	37.3	34.7	37.0	29.6	39.9	41.2	37.5	46.9	43.4	34.4	67.1	25.4	17.3	41.3	42.2	47.5	38.8	24.9	38.2	33.3	35.0	13.2	15.5	36.5	55.1	32.7	40.5	35.2	22.9	30.1	19.0	41.2	45.8	21.0	31.6	29.7	24.5	69.5	16.5	60.2	50.4	40.2	75.9	37.7	57.0	0.0	26.7	34.4	53.6	38.1	16.5	30.4	49.2	37.2	37.2	0.0	6.3	22.1	13.6	24.5	17.0	18.1	27.1	59.6	42.9	41.5	43.6	32.4	26.3	34.8	62.9	11.6	40.2	56.7	26.1	37.6	29.7	5.6	43.8	56.4	37.1	32.6	25.5	36.0	28.7	0.0	0.4	1.6	0.0	0.2	0.6	0.8	0.5	0.6	0.4	0.2	0.6	1.3	0.6	0.5	0.5	1.1	0.8	0.4	39.2	42.7	39.7	45.6	38.7	41.4	39.4	42.7	40.6	39.9	43.4	47.5	27.5	0.0	20.2	22.5	23.6	27.5	40.6	28.6	51.2	32.1	26.8	25.3	23.9	21.5	22.1	22.0	16.7	41.9	30.8	23.7	15.6	32.8	34.7	28.4	29.0	26.8	30.6	16.8	23.2	34.7	35.2	32.2	31.6	29.5	19.7	19.7	35.0	36.9	29.1	25.2	23.0	24.1	8.2	26.5	23.5	21.5	40.0	22.3	17.8	12.2	21.0	44.8	21.6	12.5	20.3	31.2	25.1	29.7	32.2	29.4	36.6	34.8	25.9	21.6	26.3	38.3	30.9	33.4	18.9	32.7	30.5	63.1	27.6	32.6	21.8	30.2
VPS52	"ARE1, SACM2L"	ENSG00000223501	"VPS52 subunit of GARP complex"	Q8N1B4	6	33250272-33272047	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SK-BR-3: 45.3;THP-1: 39.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042667, HPA048128"	Approved					NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 59: Non-specific - Transcription"			"HPA042667: AB_2678105, HPA048128: AB_2680278"	"unprognostic (2.65e-2)"	"unprognostic (2.13e-1)"	"unprognostic (9.44e-2)"	"unprognostic (1.03e-3)"	"unprognostic (6.07e-3)"	"unprognostic (3.13e-1)"	"unprognostic (2.28e-2)"	"unprognostic (4.38e-2)"	"unprognostic (1.49e-3)"	"unprognostic (2.38e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.21e-1)"	"unprognostic (4.24e-2)"	"unprognostic (1.02e-1)"	"unprognostic (4.17e-1)"	"unprognostic (3.33e-2)"	"unprognostic (7.63e-2)"	20.1	28.1	2.4	8.2	3.6	3.8	21.6	2.2	4.8	24.6	5.6	23.6	9.9	23.2	8.3	29.9	20.7	7.3	20.0	2.4	4.0	21.6	24.3	18.2	12.4	4.6	3.0	24.9	25.3	0.0	26.2	3.2	3.9	22.7	6.2	2.9	24.0	2.7	37.8	27.6	25.1	7.0	2.3	27.6	23.7	17.9	3.4	10.4	27.9	23.3	10.0	22.4	24.0	4.0	0.1	6.6	0.4	26.4	9.3	9.2	24.7	0.0	0.0	0.0	0.0	11.1	0.0	0.0	18.1	0.0	10.9	20.2	25.3	0.0	0.0	0.0	2.9	0.0	6.6	13.4	11.2	0.0	24.2	0.0	0.0	0.0	17.8	16.4	11.8	10.5	27.1	2.0	0.0	0.1	0.4	0.0	20.8	11.0	16.7	9.9	4.0	27.5	15.0	17.4	0.0	16.3	13.1	45.3	14.4	0.0	0.8	39.1	0.0	13.7	7.0	16.0	22.2	0.0	0.0	18.7	0.0	11.5	0.0	5.7	4.5	4.1	2.8	3.6	2.1	2.4	3.0	4.1	3.7	2.2	3.3	4.0	2.0	4.9	2.9	1.7	4.5	4.2	2.4	3.6	2.2	4.8	2.4	4.0	4.6	3.0	3.9	2.3	3.4	4.0	8.4	12.8	13.0	18.9	8.8	6.6	6.3	9.0	10.8	13.0	12.2	10.4	1.3	10.0	9.3	3.7	2.1	16.7	6.9	17.7	7.9	11.0	7.8	10.0	8.8	8.7	7.2	7.8	10.7	11.8	16.0	7.3	18.3	14.2	1.3	10.7	11.4	19.1	11.4	6.7	11.1	14.5	12.2	14.1	4.6	7.2	6.8	8.5	7.2	15.9	11.4	13.3	2.1	7.5	16.4	9.7	7.7	9.1	14.2	4.3	13.7	8.9	10.6	12.6	13.1	7.0	6.9	25.7	14.2	15.4	8.7	17.6	6.6	8.4	12.5	6.4
RPS18	"D6S218E, HKE3, KE-3, KE3, S18"	ENSG00000231500	"Ribosomal protein S18"	P62269	6	33272075-33276511	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein, RNA-binding, rRNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Breast myoepithelial cells: 26385.3;Suprabasal keratinocytes: 31942.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050159, HPA055007"	Approved		Supported	Cytosol		NA	NA		120000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"	Cytosol		"HPA050159: AB_2681035, HPA055007: AB_2682668"	"prognostic favorable (9.81e-4)"	"unprognostic (1.76e-1)"	"unprognostic (2.67e-1)"	"unprognostic (7.74e-2)"	"unprognostic (4.00e-2)"	"unprognostic (3.95e-2)"	"unprognostic (1.07e-2)"	"unprognostic (2.51e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.67e-1)"	"unprognostic (4.63e-3)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (1.15e-10)"	"unprognostic (7.00e-2)"	"unprognostic (4.00e-2)"	"unprognostic (2.85e-1)"	"unprognostic (9.19e-2)"	3268.2	2353.2	1862.8	2097.6	1883.3	6071.7	6110.7	1827.2	2345.5	3989.9	1782.7	3060.6	2024.5	2386.7	2877.9	4570.6	3069.7	1608.3	1778.5	1806.3	1863.3	2052.0	2248.2	2034.3	4842.9	1889.4	1840.1	6497.6	5554.4	1294.1	1412.1	1956.1	1895.2	2780.5	2977.4	697.1	3045.6	1415.3	2861.9	6539.3	2565.0	1891.5	1948.2	3087.2	2634.1	789.9	1920.2	3097.1	2084.7	2140.2	4485.9	3011.2	3685.5	1926.5	4603.2	2645.2	3377.1	8930.5	5769.4	11474.6	5486.7	4471.1	6678.3	5939.4	4461.0	6787.2	2617.5	15106.6	4694.9	4890.5	2759.3	3293.1	5472.9	7251.7	4665.1	4722.4	8590.2	5617.0	2868.6	9108.9	11226.3	9771.0	2849.3	12386.6	14318.8	4498.5	13349.4	5436.5	5770.2	4373.8	7686.7	4590.7	5362.0	7880.9	4994.9	10924.1	4652.3	5367.0	3798.3	5853.7	5446.7	10293.5	5524.1	6007.1	3902.3	5714.2	1754.6	8884.0	14781.0	2429.4	6105.7	16713.0	4642.3	2714.4	3129.5	2894.4	5978.6	5376.3	12310.7	11828.5	1512.3	10665.4	3350.2	578.7	1878.9	236.8	2362.1	1653.6	4023.7	5634.6	4545.5	3382.7	3273.4	4515.8	4968.4	4374.8	184.7	3177.0	1265.3	2962.7	3727.6	9405.4	1862.8	1883.3	1827.2	2345.5	1806.3	1863.3	1889.4	1840.1	1895.2	1948.2	1920.2	1926.5	4065.5	1480.8	2569.4	9.4	8276.1	20537.2	16151.5	18150.8	5757.2	343.9	19342.8	26385.3	596.5	4185.0	6755.1	1841.0	231.4	8761.7	5535.7	2348.6	5106.4	4750.1	1164.5	1985.2	7580.0	5826.2	3089.9	3782.1	7.5	12662.2	14558.3	4617.6	2073.4	3457.9	3051.1	5393.6	6329.9	4513.1	6281.1	159.9	8.1	7793.0	4418.8	6115.9	12428.1	3197.4	9895.8	4296.2	8448.8	13.1	6356.1	1521.4	4753.9	5.0	11.5	8283.0	5985.7	4056.9	3499.7	14221.0	5563.4	5974.5	1936.4	683.4	2005.0	7010.5	6802.2	773.3	1827.1	8678.7	31942.8	8778.2	6742.0	7987.5	9896.2	16152.8
B3GALT4	"beta3Gal-T4, GalT4"	ENSG00000235863	"Beta-1,3-galactosyltransferase 4"	O96024	6	33277123-33284832	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 27.9"	"Cell type enhanced"	"Detected in many"		"Late spermatids: 71.8;Spermatocytes: 81.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 4.0;MOLT-4: 1.1;SCLC-21H: 2.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043001	Approved					NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"			"HPA043001: AB_2678265"	"unprognostic (3.71e-2)"	"unprognostic (1.33e-2)"	"unprognostic (6.02e-2)"	"unprognostic (1.00e-1)"	"unprognostic (6.10e-3)"	"unprognostic (1.66e-2)"	"unprognostic (6.00e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.98e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.17e-3)"	"unprognostic (6.83e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.22e-2)"	"unprognostic (3.75e-2)"	9.3	8.8	0.4	0.0	0.8	0.0	8.0	1.8	1.2	8.5	0.5	11.7	0.0	8.1	0.0	19.5	6.5	0.0	8.5	0.2	0.4	7.0	1.5	7.6	0.0	1.5	0.9	3.5	3.4	0.0	5.6	0.0	1.2	9.0	0.0	0.0	12.4	0.0	2.5	15.2	10.8	0.0	0.8	12.8	9.5	27.9	0.8	0.0	7.3	0.0	0.0	9.7	11.2	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	7.7	4.6	2.4	1.8	1.8	1.8	3.1	2.5	8.8	1.8	2.4	2.8	5.0	5.7	4.7	4.5	2.0	0.4	0.8	1.8	1.2	0.2	0.4	1.5	0.9	1.2	0.8	0.8	1.3	12.6	12.8	4.8	1.3	12.0	3.2	6.3	18.9	4.0	14.5	7.6	4.2	3.8	15.7	18.9	14.7	4.2	18.4	20.2	38.2	5.9	17.7	36.8	12.1	3.1	11.1	12.6	5.2	1.0	18.4	12.9	8.2	13.3	11.0	10.2	5.0	15.0	0.4	20.3	11.8	1.4	15.8	16.2	22.3	8.6	71.8	7.8	15.2	8.8	4.7	27.2	9.8	54.6	1.5	2.1	20.0	32.6	6.0	6.2	9.1	35.5	6.1	26.0	15.0	6.6	3.3	5.9	81.2	2.7	13.2	4.8	32.0	14.2	5.1	11.2	17.0
WDR46	"BING4, C6orf11, UTP7"	ENSG00000227057	"WD repeat domain 46"	O15213	6	33279108-33289247	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA043004, HPA055425"	Uncertain		Supported	Nucleoli		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 72: Non-specific - Transcription"	"Cluster 16: U-266 - Nucleosome"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoli		"HPA043004: AB_10967417, HPA055425: "	"unprognostic (1.84e-1)"	"unprognostic (7.54e-2)"	"unprognostic (2.82e-1)"	"unprognostic (1.68e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.51e-3)"	"unprognostic (2.63e-3)"	"unprognostic (2.62e-1)"	"unprognostic (6.07e-2)"	"unprognostic (1.74e-1)"	"unprognostic (4.22e-2)"	"prognostic unfavorable (4.75e-4)"	"unprognostic (9.03e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.97e-1)"	"unprognostic (2.32e-1)"	19.4	19.0	2.2	14.1	2.4	12.6	18.9	1.8	3.8	21.2	2.5	16.4	13.5	23.6	13.6	19.1	17.4	3.2	12.8	2.7	2.7	15.6	17.1	14.7	10.6	2.2	2.4	17.3	19.2	3.0	19.7	5.5	2.6	16.8	11.2	3.0	18.7	2.7	26.1	23.9	15.6	9.6	2.2	20.4	16.7	14.8	2.5	6.3	16.4	12.6	18.8	19.6	17.8	3.5	0.9	21.1	15.3	61.2	11.4	1.6	56.2	42.3	4.9	0.2	7.0	27.8	15.5	49.4	35.5	22.5	60.2	23.4	3.9	31.0	19.3	31.6	32.2	65.6	20.3	54.0	10.4	56.6	74.2	12.5	5.2	18.4	9.5	15.6	0.0	26.6	37.5	13.8	6.8	23.3	32.1	46.8	45.1	8.5	18.3	47.1	28.1	40.3	9.3	20.7	30.9	40.3	20.4	44.4	46.9	18.3	17.2	37.8	30.9	37.9	42.8	31.6	64.3	56.5	104.3	83.5	16.4	55.9	35.3	12.1	17.3	6.2	24.9	28.7	21.4	16.1	18.2	22.4	27.9	18.9	17.0	21.7	1.2	28.1	33.9	13.7	18.6	20.1	2.2	2.4	1.8	3.8	2.7	2.7	2.2	2.4	2.6	2.2	2.5	3.5	21.0	0.0	11.7	2.9	30.4	43.7	30.8	40.7	28.5	14.4	23.8	20.2	7.2	17.2	25.7	23.9	6.2	44.0	33.9	20.4	11.7	43.5	65.0	19.0	30.9	22.9	13.8	13.7	11.1	43.0	48.7	27.7	20.4	24.3	21.6	35.1	14.6	26.4	28.9	13.5	6.5	21.5	22.4	19.0	24.1	23.3	25.7	22.0	17.8	5.6	29.0	17.9	36.0	2.5	2.8	33.1	15.6	23.0	25.0	38.0	18.2	37.8	14.7	10.1	13.1	35.7	28.3	42.3	37.2	23.6	42.6	38.2	26.1	46.8	31.9	30.0
PFDN6	"H2-KE2, HKE2, KE-2, PFD6"	ENSG00000204220	"Prefoldin subunit 6"	O15212	6	33289302-33298401	"Plasma proteins, Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-266/84: 220.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043032, HPA048123"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA		89000	"Cluster 49: Eosinophils - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 16: U-266 - Nucleosome"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Golgi apparatus"	Cytosol	"HPA043032: AB_2678278, HPA048123: AB_2680273"	"unprognostic (1.04e-1)"	"unprognostic (1.96e-2)"	"unprognostic (7.66e-2)"	"unprognostic (1.97e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.35e-2)"	"unprognostic (8.29e-2)"	"unprognostic (3.36e-1)"	"unprognostic (1.55e-1)"	"prognostic favorable (1.01e-4)"	"unprognostic (6.93e-2)"	"unprognostic (6.67e-2)"	"prognostic unfavorable (8.97e-4)"	"unprognostic (1.79e-1)"	"unprognostic (4.13e-2)"	"unprognostic (1.28e-1)"	"unprognostic (4.68e-3)"	45.3	78.2	23.7	13.7	24.4	12.9	45.4	24.2	27.3	49.2	22.6	55.9	9.3	54.8	14.2	70.2	46.2	6.7	85.1	24.4	24.4	78.8	98.1	41.7	15.9	24.6	24.6	45.3	51.7	14.4	62.7	13.6	24.7	51.0	11.6	8.6	47.6	8.0	129.3	49.6	45.3	9.9	23.7	49.9	58.4	91.4	24.0	17.1	45.6	14.7	17.0	55.6	46.7	25.2	49.4	36.0	34.9	56.7	22.7	17.3	43.4	37.2	20.6	48.0	48.7	42.6	24.0	102.8	43.1	20.5	83.5	42.2	69.5	47.6	58.3	49.3	52.9	89.8	39.4	78.3	33.2	56.3	49.3	20.7	50.9	64.8	41.6	28.5	40.2	61.2	107.2	29.6	36.7	36.0	73.9	58.7	47.7	33.0	37.6	71.9	38.0	65.2	58.9	23.4	61.3	83.9	32.1	83.3	61.3	35.0	44.4	65.0	22.5	24.7	36.0	26.0	68.7	71.2	220.3	89.4	20.5	71.9	38.1	1.8	2.6	1.8	1.9	3.2	2.1	3.3	2.3	3.1	2.4	3.2	1.8	2.5	1.1	2.1	3.5	3.5	3.5	1.9	23.7	24.4	24.2	27.3	24.4	24.4	24.6	24.6	24.7	23.7	24.0	25.2	17.4	25.6	8.7	5.2	49.1	55.7	45.2	92.6	43.9	24.5	30.2	17.1	20.7	60.1	51.6	55.2	10.4	127.5	37.6	90.0	121.3	87.6	94.2	106.5	64.7	30.6	50.4	48.4	4.3	103.8	126.1	32.6	44.4	66.9	61.6	32.9	19.2	74.0	79.2	18.5	4.1	75.7	87.5	35.4	45.2	42.7	61.8	37.2	71.2	2.8	66.3	51.0	50.4	1.5	7.1	88.0	71.3	49.2	55.3	53.9	76.4	210.0	53.0	29.0	39.5	43.6	96.3	208.2	60.4	64.3	63.9	110.8	36.9	47.4	82.7	46.7
RGL2	"HKE1.5, KE1.5, RAB2L"	ENSG00000237441	"Ral guanine nucleotide dissociation stimulator like 2"	O15211	6	33291654-33298942	"Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 19.0;SK-MEL-30: 20.4;TIME: 22.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047039, HPA053444"	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm		"HPA047039: AB_2732538, HPA053444: AB_2682153"	"unprognostic (4.12e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.07e-2)"	"unprognostic (6.31e-2)"	"unprognostic (1.18e-2)"	"unprognostic (2.74e-3)"	"unprognostic (2.64e-1)"	"unprognostic (1.04e-2)"	"unprognostic (3.30e-2)"	"unprognostic (2.35e-1)"	"prognostic favorable (6.16e-4)"	"unprognostic (1.27e-1)"	"unprognostic (5.00e-2)"	"unprognostic (4.84e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.62e-2)"	10.4	8.7	2.6	0.6	2.8	2.3	9.1	2.7	1.6	13.0	8.9	10.0	2.2	11.0	0.0	5.4	12.5	2.0	8.9	2.1	3.7	8.9	2.5	11.4	0.8	6.0	3.0	12.9	6.9	2.7	20.7	5.6	2.5	9.5	0.6	0.1	7.5	3.0	18.5	5.7	8.0	4.0	2.5	24.2	9.9	5.4	4.0	1.0	16.0	8.5	0.2	9.3	7.4	2.2	15.7	2.8	0.2	1.0	2.1	7.2	0.0	1.5	6.0	2.4	1.5	0.2	2.5	2.7	14.0	2.8	5.4	0.3	0.6	5.8	1.4	0.9	0.6	6.5	0.0	2.8	12.9	1.8	5.3	5.4	6.0	5.0	3.6	2.6	19.0	0.0	4.0	0.1	2.4	0.0	1.9	7.9	1.6	1.0	9.7	4.4	0.4	4.1	4.8	3.5	2.9	11.8	0.1	0.0	20.4	0.0	0.0	4.9	22.6	5.1	5.1	3.0	14.8	2.8	1.9	1.6	3.4	4.1	10.4	4.3	4.2	8.8	2.0	3.1	1.7	1.6	1.3	1.5	3.3	2.1	0.7	1.1	9.6	2.4	1.1	0.4	1.3	2.8	2.6	2.8	2.7	1.6	2.1	3.7	6.0	3.0	2.5	2.5	4.0	2.2	75.5	16.0	41.5	52.2	20.6	28.4	36.5	30.3	37.0	30.4	58.8	40.4	28.7	20.0	38.6	22.0	22.9	30.4	18.4	8.4	13.7	21.2	5.1	19.9	13.6	60.8	28.6	7.8	13.0	14.5	39.0	20.1	16.3	21.1	11.4	21.4	75.7	10.7	32.3	32.0	18.2	10.8	22.4	27.0	23.4	17.4	16.8	23.0	17.8	30.9	13.4	22.5	19.6	17.6	11.1	22.4	25.5	14.7	7.8	30.5	5.6	11.7	39.9	30.9	26.3	20.4	26.9	26.2	18.9	20.0	24.3	102.2	16.5	28.3	10.0	39.2
TAPBP	TAPA	ENSG00000231925	"TAP binding protein"	O15533	6	33299694-33314387	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 168.7;Karpas-707: 140.8;U-266/70: 140.5"	"Low region specificity"	"Detected in all"							HPA007066	Approved					NA	NA		20000	"Cluster 49: Eosinophils - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 1: Pancreatic cells - Digestion"			"HPA007066: AB_1857769"	"prognostic favorable (2.76e-4)"	"unprognostic (1.43e-2)"	"unprognostic (7.01e-2)"	"unprognostic (1.98e-2)"	"unprognostic (1.59e-3)"	"unprognostic (2.03e-1)"	"unprognostic (1.37e-1)"	"unprognostic (8.21e-2)"	"prognostic favorable (6.29e-4)"	"unprognostic (1.67e-2)"	"unprognostic (2.37e-1)"	"unprognostic (3.63e-1)"	"unprognostic (1.61e-2)"	"unprognostic (3.82e-1)"	"unprognostic (1.19e-2)"	"unprognostic (1.21e-1)"	"unprognostic (6.54e-3)"	47.3	73.1	2.4	28.5	4.8	25.0	43.1	1.9	2.8	40.1	1.2	66.7	52.3	38.2	13.3	57.3	43.8	10.5	63.7	2.9	1.8	67.4	107.5	82.1	21.2	2.7	3.2	33.3	48.2	14.9	38.8	18.7	2.0	64.3	19.6	4.1	61.9	17.2	26.7	54.0	81.9	23.1	1.9	129.0	52.1	16.2	2.0	24.4	59.1	6.5	36.7	45.0	43.4	2.4	3.3	1.2	6.3	26.1	20.3	25.6	92.9	18.5	88.1	42.5	57.1	0.1	168.7	48.1	38.1	41.3	92.2	2.9	0.3	30.3	15.8	125.5	4.1	19.1	9.9	24.8	0.2	20.4	63.0	51.7	20.6	0.8	8.2	37.8	0.4	16.0	1.5	140.8	14.7	19.6	51.9	44.1	0.5	0.0	6.3	2.8	0.4	1.3	35.5	1.2	8.6	0.6	0.6	2.4	23.7	3.7	1.4	0.9	45.5	89.4	18.6	1.3	2.0	140.5	117.4	46.2	58.6	38.8	58.8	159.7	87.9	172.1	137.3	121.6	117.0	97.1	99.7	114.3	90.0	86.0	76.2	109.9	151.3	159.6	139.0	102.9	85.9	150.5	2.4	4.8	1.9	2.8	2.9	1.8	2.7	3.2	2.0	1.9	2.0	2.4	116.8	125.0	102.1	22.5	186.6	77.0	93.3	148.2	66.6	34.7	82.0	64.1	73.9	84.4	105.8	71.7	33.3	46.9	223.7	259.6	13.7	256.4	1.9	64.0	52.4	99.1	84.6	58.0	25.9	282.9	85.9	63.9	105.5	78.4	91.9	65.9	75.0	143.7	119.7	20.2	15.0	174.6	83.4	124.3	128.0	9.2	33.2	131.9	119.2	30.9	229.3	34.7	195.7	23.6	8.7	215.5	172.4	32.0	194.9	130.4	283.2	33.1	113.3	30.4	32.9	39.3	57.6	1.2	0.6	53.6	56.3	49.1	163.7	66.4	162.3	141.0
ZBTB22	"BING1, fru, fruitless, ZBTB22A, ZNF297, ZNF297A"	ENSG00000236104	"Zinc finger and BTB domain containing 22"	O15209	6	33314406-33317942	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043848			Approved	Nucleoplasm		No	No			"Cluster 2: Granulocytes - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"HPA043848: AB_10961146"	"unprognostic (1.32e-1)"	"unprognostic (2.87e-1)"	"unprognostic (3.00e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.55e-2)"	"unprognostic (2.06e-1)"	"unprognostic (6.88e-2)"	"unprognostic (4.98e-2)"	"unprognostic (1.81e-1)"	"unprognostic (6.54e-3)"	"unprognostic (1.67e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.66e-2)"	"unprognostic (9.32e-3)"	10.2	15.1	1.2	2.6	1.2	2.1	11.3	1.1	3.5	15.6	0.7	10.4	4.7	15.6	8.5	13.3	12.6	1.7	10.6	1.2	0.9	11.9	10.1	12.0	1.1	2.1	1.3	14.9	12.2	11.6	10.5	2.3	1.4	12.1	4.2	5.7	12.0	3.8	8.6	19.2	11.6	3.0	1.5	13.7	11.8	6.1	1.0	5.3	15.1	3.9	3.9	12.0	13.2	1.4	0.3	0.3	8.5	4.4	8.3	3.3	3.5	7.5	7.3	7.1	4.6	0.1	1.9	1.9	5.6	12.5	9.1	0.6	0.3	4.6	5.2	11.7	2.8	7.5	4.4	4.1	0.0	0.0	2.8	10.8	10.0	0.3	2.6	9.8	0.7	6.3	2.9	7.8	2.6	4.7	4.6	6.7	0.0	0.4	2.2	0.5	0.1	4.2	6.3	0.4	9.7	0.6	0.7	0.4	4.3	5.0	0.7	0.4	10.7	3.9	4.5	0.2	0.2	4.3	4.5	1.9	5.6	1.1	4.3	0.8	0.2	0.8	0.3	0.3	0.1	0.5	0.4	0.2	0.2	0.3	0.7	0.1	0.3	0.1	0.2	0.4	0.1	0.2	1.2	1.2	1.1	3.5	1.2	0.9	2.1	1.3	1.4	1.5	1.0	1.4	9.4	0.0	5.0	2.6	7.3	6.4	16.3	6.0	8.6	20.1	9.9	7.6	4.3	4.3	4.9	7.3	8.4	6.3	3.3	9.8	23.5	11.0	1.6	8.3	5.2	7.7	7.7	4.0	2.8	7.1	4.6	6.7	5.6	6.9	3.8	6.5	7.9	2.0	5.3	20.2	2.8	8.7	12.2	4.4	4.0	1.8	9.3	5.3	1.8	3.7	12.1	18.2	8.2	3.5	2.6	6.5	8.6	6.4	4.0	10.9	7.6	8.3	6.0	21.2	13.1	10.0	7.6	2.2	2.0	8.1	7.4	10.1	4.9	8.0	5.8	11.8
DAXX	DAP6	ENSG00000204209	"Death domain associated protein"	Q9UER7	6	33318558-33323016	"Cancer-related genes, Human disease related genes, Predicted intracellular proteins"	"Apoptosis, Host-virus interaction, Transcription, Transcription regulation"	"Chaperone, Chromatin regulator, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Rod photoreceptor cells: 111.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002224, HPA008736, HPA008797, CAB025546, HPA065779"	Enhanced		Enhanced	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 72: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Nucleoplasm, Nuclear bodies"		"CAB002224: AB_563688, CAB025546: , HPA008736: AB_1078625, HPA008797: AB_2797218, HPA065779: AB_2685558"	"prognostic favorable (6.05e-4)"	"unprognostic (2.90e-1)"	"unprognostic (9.66e-2)"	"unprognostic (4.04e-2)"	"unprognostic (8.55e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.46e-3)"	"unprognostic (3.48e-1)"	"unprognostic (1.92e-1)"	"unprognostic (8.58e-3)"	"unprognostic (1.34e-1)"	"unprognostic (2.01e-2)"	"prognostic unfavorable (6.32e-7)"	"unprognostic (2.43e-1)"	"unprognostic (5.37e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.04e-1)"	27.5	33.6	6.4	4.0	6.2	8.1	25.3	5.0	12.0	28.4	2.9	27.9	8.1	27.8	18.9	30.8	28.6	7.2	22.3	6.8	5.8	23.2	25.0	24.0	8.7	6.9	5.9	23.8	23.1	19.3	22.1	7.9	5.5	25.1	10.8	5.2	24.2	9.3	35.4	28.8	30.4	10.6	4.8	44.3	25.0	36.7	6.7	23.5	24.2	12.5	27.3	27.2	25.9	9.0	20.8	0.1	38.0	15.6	16.0	16.0	30.1	27.4	76.7	61.5	43.6	1.6	11.8	58.5	14.8	33.3	65.5	11.8	0.3	46.1	62.5	29.9	39.6	52.0	29.9	39.9	26.5	37.0	17.0	27.0	32.5	25.8	31.0	22.7	15.5	16.2	39.1	21.2	32.1	23.2	29.7	54.1	1.2	0.2	9.1	35.2	5.6	41.8	11.7	1.6	49.7	20.2	0.0	0.9	22.7	14.8	17.5	0.5	22.9	26.3	29.1	0.5	0.3	35.4	58.3	66.4	23.3	23.0	27.7	24.1	22.5	47.3	55.6	28.9	54.9	58.8	48.3	61.3	28.2	56.8	44.5	49.6	22.9	62.9	35.1	27.0	59.0	70.5	6.4	6.2	5.0	12.0	6.8	5.8	6.9	5.9	5.5	4.8	6.7	9.0	18.4	6.4	22.8	5.2	45.3	58.5	23.5	36.2	48.3	19.2	25.8	19.4	7.9	18.6	27.6	12.9	18.8	25.2	41.3	23.3	23.5	38.5	15.7	14.5	54.8	23.9	21.0	27.1	3.7	38.3	35.9	25.2	16.8	23.6	37.9	12.9	16.4	14.5	24.3	15.2	3.8	21.2	12.2	17.2	42.5	7.6	17.7	19.7	24.9	6.5	48.8	29.9	52.5	5.0	4.6	45.4	21.8	23.3	38.7	31.8	20.3	14.4	15.6	111.1	13.1	18.7	19.9	63.8	41.5	45.9	60.9	24.8	42.8	24.1	22.0	35.7
SMIM40		ENSG00000286920	"Small integral membrane protein 40"		6	33323628-33329279	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enriched"	"Detected in single"	467	"retina: 46.7"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																	NA	NA																											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	46.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KIFC1	"HSET, KNSL2"	ENSG00000237649	"Kinesin family member C1"	Q9BW19	6	33391823-33409896	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 39.7;lymphoid tissue: 47.5"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 32.0;Erythroid cells: 62.3;Extravillous trophoblasts: 39.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Immune cell enhanced"	"Detected in some"		"T-reg: 1.6"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in many"			"HPA055997, HPA062674"	Enhanced		Approved	Centrosome		NA	Yes			"Cluster 40: NK-cells - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Centrosome		"HPA055997: AB_2683001, HPA062674: AB_2684829"	"unprognostic (7.33e-2)"	"unprognostic (1.28e-2)"	"unprognostic (2.17e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.30e-2)"	"prognostic unfavorable (7.07e-8)"	"unprognostic (6.34e-3)"	"unprognostic (9.36e-3)"	"unprognostic (8.58e-2)"	"prognostic unfavorable (4.21e-4)"	"unprognostic (1.83e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (5.17e-2)"	"unprognostic (6.66e-2)"	"unprognostic (1.48e-1)"	"unprognostic (4.52e-1)"	1.1	1.1	0.2	10.6	0.3	39.7	2.2	0.3	1.2	2.5	0.4	8.0	8.8	1.8	0.2	11.7	0.8	1.5	0.6	0.7	0.3	0.8	1.0	2.3	24.6	0.4	0.7	2.0	0.7	0.3	0.6	5.5	0.5	0.9	8.2	0.4	2.1	0.2	0.2	9.8	8.1	4.1	0.2	5.3	4.7	12.3	0.6	47.5	0.7	0.4	24.9	2.7	3.9	0.5	133.5	47.9	120.6	124.2	5.2	8.1	64.0	82.5	48.4	122.6	104.6	80.6	53.3	120.2	38.3	41.5	102.0	88.1	87.1	60.7	79.7	114.3	60.3	93.9	71.6	73.5	0.5	96.0	75.7	2.5	4.7	73.2	38.8	13.8	64.2	87.5	76.0	112.3	81.0	86.2	125.7	103.2	47.5	67.6	48.4	129.7	110.7	61.4	38.4	42.8	100.1	57.2	54.3	91.9	44.1	51.3	78.7	105.4	32.2	74.6	104.6	56.2	128.9	58.2	132.4	126.1	18.8	94.8	101.0	0.4	0.0	0.0	0.1	0.0	0.1	0.2	0.1	0.6	0.2	0.2	0.0	0.0	0.0	1.0	0.3	0.0	1.6	0.5	0.2	0.3	0.3	1.2	0.7	0.3	0.4	0.7	0.5	0.2	0.6	0.5	0.4	0.0	2.5	1.0	4.1	5.6	1.5	4.6	2.2	0.4	2.8	2.2	0.5	0.0	1.9	0.0	0.0	18.7	3.7	8.8	0.0	0.7	32.0	2.7	1.9	2.4	0.0	62.3	0.3	0.0	39.6	4.2	4.1	6.1	1.3	15.0	1.8	0.3	14.3	0.0	0.3	8.0	2.0	2.4	9.8	12.0	0.3	4.7	3.6	1.0	3.1	0.3	0.0	1.0	0.6	0.3	2.1	0.7	12.0	0.9	2.1	0.7	0.8	0.5	0.0	2.5	7.5	13.9	9.6	14.4	3.7	6.7	5.7	0.6	12.1	3.1
PHF1	"MTF2L2, PCL1, TDRD19C"	ENSG00000112511	"PHD finger protein 1"	O43189	6	33410399-33416453	"Disease related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, Transcription, Transcription regulation"	"Chromatin regulator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 153.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"GAMG: 25.9;HMC-1: 20.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031038	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 72: Non-specific - Transcription"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"HPA031038: AB_10671365"	"unprognostic (1.96e-3)"	"unprognostic (4.77e-2)"	"prognostic unfavorable (9.64e-5)"	"unprognostic (1.66e-1)"	"unprognostic (4.71e-2)"	"unprognostic (2.43e-3)"	"unprognostic (2.31e-2)"	"unprognostic (8.87e-3)"	"unprognostic (1.41e-1)"	"unprognostic (1.97e-1)"	"unprognostic (2.42e-3)"	"unprognostic (4.25e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.48e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.90e-1)"	"prognostic favorable (1.72e-4)"	35.0	31.9	0.3	4.6	0.2	11.2	37.6	0.2	1.1	65.8	0.4	49.6	5.9	51.8	18.1	19.4	57.8	4.2	41.6	0.3	0.2	38.2	22.8	41.1	6.3	0.6	0.2	89.6	41.5	2.1	76.6	1.8	0.3	49.9	2.3	6.1	32.8	4.2	42.2	25.5	38.6	2.6	0.3	47.3	39.7	70.2	0.3	5.5	58.4	13.1	10.3	49.1	40.6	0.6	1.4	2.0	4.5	2.8	1.9	1.1	10.3	3.1	4.8	2.5	2.6	2.8	1.3	0.5	2.0	7.4	25.9	0.4	0.9	1.6	0.6	1.8	0.9	4.3	3.6	1.2	0.3	2.5	20.0	2.2	2.0	4.6	4.0	3.3	1.5	1.4	1.7	3.6	1.9	1.1	0.8	1.5	1.9	0.4	1.4	1.8	0.6	1.5	0.3	1.9	2.9	3.3	1.6	1.6	2.6	1.0	1.2	3.0	3.0	4.5	1.2	2.7	3.4	2.9	4.5	8.3	3.3	2.6	2.7	0.2	0.2	1.0	0.7	0.2	2.1	0.6	1.6	1.9	0.3	0.9	1.6	0.9	1.5	0.7	0.2	0.1	0.6	0.7	0.3	0.2	0.2	1.1	0.3	0.2	0.6	0.2	0.3	0.3	0.3	0.6	32.9	19.2	24.8	19.2	70.5	33.9	89.0	26.8	34.1	74.4	36.0	37.1	19.6	15.7	20.5	23.9	37.5	16.9	53.3	16.7	35.2	13.1	153.8	14.9	15.3	29.9	12.0	3.8	19.1	17.9	16.3	32.6	15.3	20.3	69.2	21.4	33.2	7.6	11.8	45.4	30.3	16.0	34.6	14.1	43.1	88.6	43.2	20.9	37.4	13.1	11.4	34.7	27.8	26.2	18.0	17.9	14.5	41.0	54.8	59.0	29.6	22.9	22.1	73.6	78.9	28.9	42.3	80.9	51.2	15.9	24.0	37.5	71.4	19.1	10.1	75.1
CUTA	"ACHAP, C6orf82"	ENSG00000112514	"CutA divalent cation tolerance homolog"	O60888	6	33416442-33418317	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016787, HPA064369"	Uncertain		Approved	"Plasma membrane,Focal adhesion sites"	"Secreted to blood"	NA	NA		26000000	"Cluster 20: T-cells - T-cell receptor"	"Cluster 35: Non-specific - Unknown function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 32: Non-specific - Translation"	"Plasma membrane, Focal adhesion sites"		"CAB016787: , HPA064369: AB_2685248"	"unprognostic (7.03e-2)"	"unprognostic (5.44e-2)"	"unprognostic (4.56e-2)"	"unprognostic (8.91e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.98e-2)"	"prognostic favorable (8.50e-4)"	"unprognostic (1.87e-1)"	"unprognostic (2.78e-2)"	"unprognostic (1.27e-3)"	"unprognostic (1.91e-1)"	"unprognostic (5.55e-2)"	"unprognostic (9.90e-2)"	"unprognostic (1.54e-1)"	"unprognostic (7.94e-2)"	"unprognostic (2.74e-1)"	129.0	268.0	155.3	60.3	165.9	93.9	132.4	166.2	177.1	159.6	196.0	156.7	104.5	158.7	184.8	106.4	144.4	95.1	151.1	159.6	169.9	200.3	217.8	118.3	99.0	166.1	158.3	193.8	186.3	177.2	346.6	81.5	169.6	153.8	71.2	60.3	179.2	113.0	142.8	149.5	129.1	80.1	161.9	147.1	177.5	74.2	160.9	82.7	201.6	89.2	82.5	128.2	121.9	173.0	244.5	142.0	242.7	293.8	177.6	173.9	109.7	224.0	430.1	433.1	462.7	147.5	154.1	166.1	162.2	269.1	316.0	152.4	154.5	231.3	248.9	153.2	295.1	171.8	228.9	397.0	226.3	134.2	135.9	224.7	195.8	209.8	179.8	303.7	118.8	180.9	212.9	348.7	325.1	187.2	222.0	305.1	213.8	222.6	187.5	235.9	141.8	456.4	310.1	112.3	451.7	225.4	136.2	231.3	425.8	135.5	170.8	308.7	121.3	222.6	190.0	166.5	229.8	341.7	363.9	189.5	202.9	304.9	189.3	207.8	179.2	103.6	225.8	138.1	335.1	315.7	360.7	274.6	163.6	266.5	366.5	279.2	25.6	306.9	97.2	120.0	421.9	400.4	155.3	165.9	166.2	177.1	159.6	169.9	166.1	158.3	169.6	161.9	160.9	173.0	109.5	131.4	119.3	14.0	209.5	230.6	287.9	424.5	266.9	92.6	401.0	488.6	138.2	237.4	239.7	316.3	68.8	361.6	186.2	154.0	283.7	188.3	85.4	181.8	177.9	114.7	292.1	111.7	13.0	141.0	235.5	181.4	105.5	156.8	169.9	122.6	134.2	340.1	328.6	77.4	17.4	320.1	360.1	167.1	197.1	345.2	200.0	139.2	316.6	10.3	140.0	179.7	216.3	14.1	31.2	113.3	223.9	191.5	375.7	243.3	306.6	559.1	229.5	85.9	92.1	131.1	226.7	111.0	106.4	203.5	230.4	242.9	242.4	217.8	341.3	268.4
SYNGAP1	"KIAA1938, RASA5, SYNGAP"	ENSG00000197283	"Synaptic Ras GTPase activating protein 1"	Q96PV0	6	33419661-33453689	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"		"GTPase activation"	"Autism, Autism spectrum disorder, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pituitary gland: 40.1"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 34.5;Horizontal cells: 38.7"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	135	"amygdala: 11.4;basal ganglia: 11.3;cerebral cortex: 21.0;hippocampal formation: 26.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 26.1;HMC-1: 22.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038373	Enhanced		Approved	Nucleoplasm		NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 72: Non-specific - Transcription"	"Cluster 12: NES - Nervous system development"	"Cluster 62: Horizontal cells - Visual perception"	Nucleoplasm		"HPA038373: AB_10670779"	"unprognostic (3.72e-1)"	"unprognostic (3.13e-2)"	"unprognostic (4.74e-2)"	"unprognostic (2.23e-2)"	"unprognostic (4.35e-2)"	"prognostic favorable (2.80e-4)"	"unprognostic (3.66e-2)"	"unprognostic (8.65e-2)"	"unprognostic (4.02e-1)"	"unprognostic (1.68e-2)"	"unprognostic (1.17e-2)"	"unprognostic (9.81e-2)"	"prognostic unfavorable (1.34e-6)"	"unprognostic (9.48e-3)"	"unprognostic (1.73e-1)"	"unprognostic (1.83e-2)"	"unprognostic (2.47e-2)"	9.1	8.4	11.4	6.9	11.3	3.4	7.4	0.0	21.0	18.1	6.1	12.4	3.1	18.3	2.4	7.9	19.4	3.0	7.6	26.4	0.0	7.1	3.0	11.7	5.9	0.0	0.1	21.8	5.6	4.4	40.1	3.1	0.0	9.8	2.2	5.8	5.9	3.4	2.1	7.7	11.2	5.9	0.0	11.7	7.9	10.7	0.0	7.8	10.3	2.0	3.6	11.7	12.0	0.0	2.7	1.0	26.1	10.1	5.7	6.0	3.4	7.1	4.6	3.8	3.0	11.9	1.0	8.3	1.6	3.5	3.5	4.0	3.4	3.9	2.5	4.6	2.0	20.8	3.6	0.7	4.9	3.3	22.9	4.1	1.1	7.2	3.3	14.4	2.9	6.5	6.7	3.4	2.8	6.0	5.1	4.2	14.5	1.2	3.0	19.2	0.6	3.1	2.9	2.2	6.7	5.4	2.6	5.0	2.2	6.1	11.1	3.1	0.8	7.8	7.7	3.1	1.5	4.0	1.4	5.9	4.5	3.4	1.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.4	11.3	0.0	21.0	26.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	7.0	0.0	2.0	28.1	7.4	3.6	2.4	3.1	17.1	23.5	4.6	5.7	1.4	4.3	4.0	3.7	10.4	0.8	7.3	1.4	1.9	2.2	6.3	18.7	21.2	7.2	9.6	4.6	34.5	1.4	1.3	8.8	2.6	3.2	5.1	6.3	10.0	0.8	1.8	38.7	21.1	1.6	6.1	2.8	7.5	1.6	11.5	2.4	3.6	7.5	2.7	4.2	6.2	12.1	6.2	1.5	0.6	13.5	3.8	1.6	1.6	8.5	21.9	7.9	19.7	3.2	9.2	9.3	8.2	9.2	4.3	0.8	12.8	11.8	2.8	1.8
ZBTB9	"MGC23166, ZNF919"	ENSG00000213588	"Zinc finger and BTB domain containing 9"	Q96C00	6	33453970-33457544	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Basal keratinocytes: 4.5;Ionocytes: 6.1;Respiratory ciliated cells: 4.3;Suprabasal keratinocytes: 3.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 11.6;BEWO: 11.3;GAMG: 16.5;HMC-1: 14.2;U-698: 12.0"	"Low region specificity"	"Detected in all"							"HPA036767, HPA058171"	Uncertain		Approved	"Nucleoplasm,Nuclear membrane,Cytosol"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm	"Nuclear membrane, Cytosol"	"HPA036767: AB_10696787, HPA058171: "	"unprognostic (1.79e-2)"	"unprognostic (1.46e-1)"	"unprognostic (6.86e-2)"	"unprognostic (2.89e-1)"	"unprognostic (2.18e-1)"	"unprognostic (9.16e-2)"	"unprognostic (1.85e-4)"	"unprognostic (4.20e-1)"	"unprognostic (2.73e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.70e-2)"	"unprognostic (4.10e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.47e-1)"	"unprognostic (2.95e-1)"	2.8	3.9	0.9	1.5	1.0	1.7	2.3	0.8	1.6	2.5	8.6	2.4	2.3	2.6	1.7	3.8	2.5	0.6	3.0	1.9	0.7	4.4	3.2	2.4	1.9	1.2	0.9	3.0	2.9	0.6	10.0	0.5	0.6	2.4	1.4	1.9	2.9	0.1	1.8	3.8	2.7	0.8	0.2	3.5	2.7	7.4	0.4	0.2	2.2	1.0	3.3	2.5	2.2	0.9	1.0	0.3	11.6	2.9	2.1	0.1	11.3	0.6	0.2	0.2	0.1	3.0	0.8	2.7	1.8	0.3	16.5	1.2	4.8	2.4	1.3	3.1	2.0	9.0	2.3	0.0	0.0	2.3	14.2	0.5	0.9	3.3	2.6	0.6	0.1	1.5	3.2	1.8	2.6	1.6	0.6	0.9	4.3	0.5	0.7	5.6	3.0	2.7	2.2	2.3	1.8	1.1	3.3	0.3	1.1	1.1	1.6	0.4	1.9	0.9	1.3	1.3	1.2	0.7	3.5	12.0	0.9	2.9	0.3	5.2	1.1	0.4	2.8	0.8	1.2	0.4	1.2	2.6	1.5	0.8	2.5	1.9	0.8	1.3	1.7	0.3	2.2	0.6	0.9	1.0	0.8	1.6	1.9	0.7	1.2	0.9	0.6	0.2	0.4	0.9	0.1	0.0	0.0	1.3	2.1	4.5	0.0	1.9	1.8	0.0	0.2	0.1	0.0	0.0	1.1	0.0	0.0	0.1	0.0	0.5	0.0	1.5	0.3	0.4	0.1	0.6	1.8	1.3	1.2	1.3	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.7	6.1	0.0	1.2	1.1	0.0	0.2	1.8	1.0	0.0	0.0	0.0	0.0	0.6	1.0	0.1	0.0	0.6	0.0	0.2	0.1	4.3	0.0	0.0	0.0	0.7	0.1	0.1	0.8	3.7	0.0	0.7	0.1	1.0	0.0
BAK1	"BAK, BCL2L7, CDN1"	ENSG00000030110	"BCL2 antagonist/killer 1"	Q16611	6	33572547-33580293	"Predicted membrane proteins, Transporters"	"Apoptosis, Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 75.4;Proximal enterocytes: 79.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB005029	Enhanced					NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"CAB005029: AB_562051"	"unprognostic (3.52e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.26e-1)"	"prognostic unfavorable (1.71e-4)"	"unprognostic (5.67e-2)"	"unprognostic (6.58e-3)"	"prognostic unfavorable (4.52e-4)"	"prognostic unfavorable (5.64e-4)"	"unprognostic (2.36e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.80e-3)"	"unprognostic (2.09e-1)"	"prognostic unfavorable (1.64e-5)"	"unprognostic (6.07e-2)"	"unprognostic (3.36e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.46e-1)"	9.4	29.6	10.4	20.7	10.6	27.7	7.5	10.5	13.0	10.4	12.2	32.4	47.0	10.1	9.1	34.0	7.9	10.6	23.2	10.3	9.8	23.9	11.5	13.7	22.0	11.8	10.9	7.2	12.8	13.5	12.0	11.1	11.2	11.2	24.9	3.7	11.9	9.1	18.8	18.7	37.1	13.5	11.0	30.5	21.9	7.8	11.7	19.2	7.7	18.1	23.4	21.8	12.0	10.4	37.6	20.4	21.3	32.2	14.3	14.0	27.1	19.1	15.3	53.7	41.8	42.2	28.7	32.5	32.6	28.1	24.8	38.3	41.0	77.7	23.6	37.7	43.6	20.6	18.8	34.4	36.6	44.5	32.3	23.0	60.7	45.1	52.6	15.7	29.4	28.7	18.9	28.6	20.1	55.0	38.8	29.7	23.7	26.4	50.0	37.0	20.5	59.9	45.6	30.6	26.3	19.6	24.4	77.3	37.1	26.6	25.4	74.5	28.2	28.3	30.0	18.5	24.9	75.4	100.4	27.5	9.6	52.6	31.7	63.5	45.2	85.1	34.7	64.8	39.5	25.3	32.1	34.7	42.8	18.4	17.6	23.2	30.6	22.4	57.3	15.0	56.1	53.2	10.4	10.6	10.5	13.0	10.3	9.8	11.8	10.9	11.2	11.0	11.7	10.4	8.6	3.2	3.4	3.9	24.6	27.1	11.6	15.5	14.2	6.6	10.7	8.3	6.4	11.5	8.0	3.7	8.4	16.3	22.1	75.4	13.7	20.5	4.7	7.2	8.9	10.1	22.1	6.1	4.5	18.7	41.8	7.5	17.9	10.0	11.4	11.1	10.0	6.3	30.2	5.0	3.6	32.5	14.2	21.9	30.2	1.7	7.8	16.9	21.4	2.8	25.8	4.7	12.3	1.0	2.7	27.7	47.9	11.7	54.5	10.4	79.6	9.6	5.6	6.9	13.1	5.6	11.8	0.3	1.0	19.1	21.6	9.9	24.6	25.2	40.6	20.1
ITPR3	IP3R3	ENSG00000096433	"Inositol 1,4,5-trisphosphate receptor type 3"	Q14573	6	33620365-33696574	"Human disease related genes, Plasma proteins, Predicted membrane proteins"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Ligand-gated ion channel, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 123.0;Gastric mucus-secreting cells: 127.4;Late spermatids: 220.4;Pancreatic endocrine cells: 89.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 164.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA003915, HPA064704"	Approved		Uncertain	Vesicles		No	Yes			"Cluster 44: Non-specific - Transcription"	"Cluster 31: Skin - Epidermis development"	"Cluster 20: HeLa - Mitochondria"	"Cluster 34: Spermatids - Unknown function"	Vesicles		"HPA003915: AB_1851845, HPA064704: "	"unprognostic (2.57e-1)"	"unprognostic (2.81e-2)"	"unprognostic (1.52e-2)"	"unprognostic (2.30e-1)"	"unprognostic (5.40e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.08e-2)"	"unprognostic (6.14e-2)"	"unprognostic (3.35e-1)"	"unprognostic (3.08e-2)"	"unprognostic (4.14e-3)"	"unprognostic (1.88e-1)"	"unprognostic (6.44e-3)"	"unprognostic (5.01e-2)"	"unprognostic (1.74e-1)"	"unprognostic (8.89e-2)"	"unprognostic (2.43e-2)"	16.3	11.4	5.5	17.0	5.0	6.1	14.6	3.8	5.3	18.0	3.7	26.2	29.1	8.5	13.1	18.1	14.0	15.3	15.0	3.8	3.9	16.4	2.2	30.6	20.4	5.6	5.0	13.5	11.3	2.8	7.4	4.3	5.2	13.9	18.4	0.8	18.5	11.2	4.5	58.9	35.1	4.7	4.7	39.8	41.5	15.4	7.0	14.3	54.0	5.1	21.0	12.1	24.0	3.9	73.7	34.0	6.3	0.3	6.2	19.3	40.9	24.8	62.8	30.5	27.4	46.7	55.9	62.6	26.1	17.9	76.1	70.9	28.6	66.7	15.7	36.8	24.0	0.1	102.6	52.0	14.1	11.3	7.9	14.0	59.2	76.7	164.7	66.5	52.1	24.5	25.0	19.7	33.3	35.0	19.0	6.4	6.2	55.8	49.4	29.0	0.1	37.1	107.6	50.9	57.3	2.1	42.8	61.6	60.2	6.9	21.2	5.9	71.8	41.1	20.1	53.1	55.2	13.5	14.3	29.4	32.8	16.6	24.1	0.8	0.0	0.0	0.8	0.0	0.6	0.4	0.4	0.5	0.0	0.6	0.4	0.5	0.0	0.0	0.0	0.0	0.7	0.2	5.5	5.0	3.8	5.3	3.8	3.9	5.6	5.0	5.2	4.7	7.0	3.9	12.4	48.1	58.9	0.3	13.5	26.5	10.9	27.9	18.2	1.5	9.3	9.9	2.7	12.8	20.2	31.3	0.0	0.3	10.9	52.9	0.0	28.4	123.0	19.1	9.1	18.2	23.9	6.6	1.1	30.2	6.3	9.2	127.4	43.1	0.0	0.2	12.5	0.4	0.5	0.0	1.6	41.6	10.2	0.6	6.9	220.4	23.3	2.6	12.4	23.4	3.2	0.4	4.1	0.5	0.4	89.7	41.6	13.9	18.7	20.5	45.9	0.2	12.1	1.2	6.6	3.9	3.3	1.6	3.2	14.5	25.4	0.5	13.1	5.8	35.6	20.7
UQCC2	"bA6B20.2, C6orf125, Cbp6, M19, MGC14833, MNF1"	ENSG00000137288	"Ubiquinol-cytochrome c reductase complex assembly factor 2"	Q9BRT2	6	33694293-33711727	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 911.7;Late spermatids: 1207.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA039111	Uncertain		Supported	"Nuclear bodies,Mitochondria"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 38: Heart - Muscle contraction"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 10: Non-specific - Unknown function"	Mitochondria	"Nuclear bodies"	"HPA039111: AB_2676352"	"unprognostic (3.58e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.58e-2)"	"unprognostic (3.21e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.35e-3)"	"unprognostic (2.43e-2)"	"unprognostic (5.93e-2)"	"unprognostic (2.33e-2)"	"unprognostic (7.43e-2)"	"unprognostic (5.77e-2)"	"unprognostic (3.88e-1)"	"unprognostic (1.07e-1)"	38.9	69.6	100.5	37.3	102.8	45.3	45.3	103.3	140.9	48.4	97.6	43.3	34.3	61.5	58.4	59.2	40.0	20.8	267.2	100.1	106.6	66.9	83.3	33.9	35.6	102.5	102.2	33.4	61.2	46.8	78.0	29.3	102.9	55.4	44.0	104.3	53.0	28.6	228.8	42.9	28.5	52.4	102.4	43.2	49.5	104.1	104.4	45.7	42.9	197.9	40.8	46.1	42.8	107.9	207.7	144.2	162.8	139.4	130.9	129.8	125.5	116.4	117.3	167.7	162.6	233.9	84.5	84.4	180.3	143.5	244.1	109.0	111.7	164.5	138.6	108.0	187.7	163.3	87.3	327.6	215.9	153.8	127.2	136.2	257.4	131.7	204.7	91.0	120.4	158.9	178.4	165.9	190.4	220.9	149.0	315.9	97.3	158.4	167.6	106.5	130.7	279.9	116.2	191.5	273.1	97.1	127.9	191.7	165.6	84.1	168.3	382.2	110.5	178.0	151.1	115.9	242.0	126.8	193.1	146.6	53.7	229.7	211.0	32.7	88.5	18.2	76.1	141.6	93.6	152.4	95.0	87.6	108.6	116.1	98.7	88.0	8.4	81.6	120.9	133.2	110.7	123.8	100.5	102.8	103.3	140.9	100.1	106.6	102.5	102.2	102.9	102.4	104.4	107.9	18.5	28.9	29.3	8.1	54.2	58.5	96.8	193.0	61.5	108.7	96.0	100.3	911.7	74.4	119.8	77.3	50.1	134.7	34.0	112.4	391.3	103.4	342.3	46.6	78.7	54.1	99.7	105.0	8.9	179.7	124.4	88.5	90.7	39.1	59.5	90.0	41.4	166.1	218.8	70.7	10.2	94.5	154.6	67.8	55.6	1207.0	78.6	64.8	83.6	3.7	63.6	79.1	46.4	9.0	10.0	95.6	64.2	83.8	88.3	122.1	44.6	257.2	87.1	123.8	0.0	32.9	269.4	155.9	96.0	103.3	76.3	95.4	43.5	159.3	102.3	118.5
IP6K3	"IHPK3, INSP6K3"	ENSG00000161896	"Inositol hexakisphosphate kinase 3"	Q96PC2	6	33721662-33746905	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"skeletal muscle: 308.1;tongue: 83.3"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 8.5;Cardiomyocytes: 11.2;Hepatocytes: 8.9;Horizontal cells: 10.1;Oligodendrocytes: 15.3;Proximal tubular cells: 8.2;Skeletal myocytes: 51.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HHSteC: 21.9;HSkMC: 7.9;LHCN-M2: 36.2;RH-30: 15.7"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"HPA053644, HPA062531"	Enhanced		Approved	Nucleoplasm,Cytosol		Yes	NA				"Cluster 80: Striated muscle - Unknown function"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 37: Myocytes - Muscle contraction"	Nucleoplasm	Cytosol	"HPA053644: AB_2682214, HPA062531: "	"unprognostic (3.23e-2)"	"unprognostic (2.87e-1)"	"unprognostic (2.07e-5)"	"unprognostic (1.07e-3)"	"unprognostic (2.20e-1)"	"unprognostic (5.10e-3)"	"unprognostic (1.38e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.45e-1)"	"unprognostic (2.47e-2)"	"unprognostic (1.24e-2)"	"unprognostic (2.94e-3)"	"prognostic unfavorable (6.09e-4)"	"unprognostic (1.63e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.66e-3)"	"unprognostic (1.33e-1)"	1.4	0.7	4.8	0.4	15.5	0.0	1.3	12.2	9.5	1.9	5.7	6.8	0.4	3.8	0.1	6.5	1.2	0.1	29.6	5.9	8.8	6.0	18.8	5.2	0.1	14.7	13.1	0.5	0.6	0.0	0.5	4.7	15.0	5.3	0.6	0.9	2.7	1.6	308.1	0.7	2.3	1.8	7.0	3.3	1.6	0.2	12.4	0.5	12.9	83.3	0.0	2.4	1.9	27.1	0.1	0.0	0.5	0.0	0.0	0.1	3.6	0.1	0.4	0.3	2.6	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.1	21.9	0.0	0.1	7.9	1.2	0.1	0.6	0.1	0.0	0.0	0.0	0.0	36.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	15.7	0.0	0.0	0.0	0.4	0.1	0.0	0.7	0.5	5.3	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	15.5	12.2	9.5	5.9	8.8	14.7	13.1	15.0	7.0	12.4	27.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.2	0.0	8.5	0.4	0.4	11.2	0.0	1.4	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.4	5.0	0.2	0.0	0.0	0.2	0.0	0.1	0.9	0.0	0.2	0.0	0.0	0.0	8.9	0.3	10.1	0.1	0.0	0.0	0.0	0.0	0.1	0.9	0.1	0.0	0.0	0.0	1.1	0.0	0.0	15.3	0.0	0.0	0.0	0.0	0.0	0.0	8.2	1.0	0.4	6.6	51.7	1.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.2
LEMD2	"dJ482C21.1, LEM2, NET25"	ENSG00000161904	"LEM domain nuclear envelope protein 2"	Q8NC56	6	33771202-33789130	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"			"Cataract, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017340	Supported		Supported	"Nuclear membrane"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 31: Spermatids - Spermatogenesis"	"Nuclear membrane"		"HPA017340: AB_2296925"	"unprognostic (9.01e-2)"	"unprognostic (7.99e-2)"	"unprognostic (1.18e-1)"	"unprognostic (4.12e-2)"	"unprognostic (2.98e-1)"	"unprognostic (8.29e-3)"	"unprognostic (6.53e-2)"	"unprognostic (5.98e-2)"	"unprognostic (4.42e-2)"	"unprognostic (7.03e-2)"	"unprognostic (1.67e-3)"	"unprognostic (2.11e-2)"	"prognostic unfavorable (1.12e-5)"	"unprognostic (2.43e-1)"	"unprognostic (7.54e-2)"	"unprognostic (3.82e-2)"	"unprognostic (7.12e-2)"	40.5	45.8	46.0	35.0	47.9	63.3	39.6	53.1	50.8	52.6	44.6	45.3	31.9	44.1	29.7	50.2	45.9	30.0	46.7	43.9	44.0	51.5	49.9	51.2	45.4	52.0	47.0	53.7	54.5	39.3	56.5	38.5	47.9	51.9	30.0	29.7	43.3	31.3	37.4	51.8	50.1	30.4	46.3	70.1	44.9	45.5	47.2	46.1	53.0	28.1	41.6	43.8	44.9	54.4	36.6	40.5	67.3	66.1	37.6	40.3	50.9	39.1	59.7	48.5	50.9	30.6	37.8	33.8	53.5	55.6	136.7	62.0	39.4	52.1	34.0	35.9	36.6	12.7	45.8	40.3	78.4	26.1	42.6	44.3	96.5	51.6	88.1	80.0	52.8	43.9	36.3	38.3	42.8	30.8	48.6	64.1	39.2	53.5	23.2	31.8	27.8	28.3	52.0	50.5	47.8	37.8	23.4	74.0	52.6	68.0	49.5	70.7	24.6	67.8	26.3	36.6	46.5	49.8	43.0	24.0	26.7	40.3	83.0	1.6	1.7	3.2	2.3	1.5	2.9	2.2	2.5	2.3	1.7	2.3	2.0	2.3	1.4	1.5	2.1	2.9	2.8	1.2	46.0	47.9	53.1	50.8	43.9	44.0	52.0	47.0	47.9	46.3	47.2	54.4	19.8	3.2	9.0	16.0	17.4	10.8	13.4	7.9	14.2	18.6	10.0	7.1	10.0	8.6	5.2	9.2	18.8	24.9	18.6	24.3	1.9	9.4	24.9	7.5	10.1	18.5	5.4	8.6	14.5	6.8	36.6	12.2	15.3	10.6	12.7	16.6	12.5	7.7	17.5	43.7	17.4	17.7	6.1	14.5	12.4	44.2	10.5	13.5	12.4	14.0	9.4	14.0	13.4	14.6	18.2	13.2	20.1	16.1	11.9	14.6	14.8	6.6	7.2	13.1	19.7	12.7	15.2	24.6	7.4	8.9	10.2	29.8	15.2	12.5	15.9	13.2
MLN		ENSG00000096395	Motilin	P12872	6	33794673-33804003	"Predicted secreted proteins"		Hormone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	331	"intestine: 254.8"	"Cell type enriched"	"Detected in single"	11	"Enteroendocrine cells: 3.5"	"Cancer enriched"	"Detected in some"	6	"testis cancer: 5.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 3.0;SuSa: 1.1;TIME: 1.3"					"Low region specificity"	"Detected in many"			"HPA069392, HPA077622"	Enhanced				"Secreted to blood"	NA	NA	450000	200000		"Cluster 56: Intestine - Transmembrane transport"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 17: Intestinal endocrine cells - Hormone signaling"			"HPA069392: AB_2686136, HPA077622: "					"unprognostic (7.70e-2)"					"unprognostic (6.70e-2)"				"unprognostic (4.44e-2)"	"unprognostic (3.14e-1)"			0.0	0.2	0.0	0.6	0.2	0.0	0.0	0.1	0.3	0.0	0.0	0.5	254.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.3	0.7	0.4	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.2	0.0	0.0	0.1	0.3	43.3	0.0	0.2	0.0	0.1	0.3	0.4	0.2	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.6	0.6	0.0	0.0	0.7	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.4	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.2	0.3	0.0	0.0	0.0	1.1	0.0	0.0	1.3	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.3	0.0	0.5	0.7	0.4	0.7	0.2	0.4	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GRM4	"GPRC1D, mGlu4, MGLUR4"	ENSG00000124493	"Glutamate metabotropic receptor 4"	Q14833	6	34018643-34155622	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	93	"brain: 80.3"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 5.3;Early spermatids: 3.7;Enteroendocrine cells: 3.0;Excitatory neurons: 9.5;Inhibitory neurons: 10.8;Spermatogonia: 5.0"	"Cancer enhanced"	"Detected in some"		"testis cancer: 1.7"	"Region enriched"	"Detected in all"	7	"cerebellum: 80.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"BEWO: 7.6;SCLC-21H: 18.2"	"Region enhanced"	"Detected in all"		"cerebellum: 79.1"	"Region enriched"	"Detected in many"	5	"cerebellum: 138.8"	CAB022096	Enhanced					NA	NA				"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"CAB022096: "	"unprognostic (1.29e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.03e-1)"	"unprognostic (7.00e-2)"	"unprognostic (4.03e-2)"	"unprognostic (8.36e-2)"	"unprognostic (9.05e-3)"	"unprognostic (3.56e-1)"	"unprognostic (9.45e-2)"	"unprognostic (2.08e-2)"	"unprognostic (6.21e-3)"	"unprognostic (2.44e-1)"	"unprognostic (2.15e-11)"	"unprognostic (5.32e-2)"	"unprognostic (9.16e-2)"	"unprognostic (6.57e-2)"	"unprognostic (3.07e-1)"	0.0	0.2	3.1	0.0	10.7	0.0	0.0	80.3	5.2	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	2.2	1.7	0.0	0.0	0.0	0.0	2.6	3.5	0.1	0.7	0.0	0.5	0.0	5.0	0.1	0.0	0.8	0.0	0.0	0.0	0.1	0.2	0.1	1.1	0.0	0.0	0.8	6.5	0.0	0.0	0.0	0.1	0.0	0.1	2.0	0.0	0.0	0.0	0.0	0.0	0.0	7.6	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	18.2	0.1	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	10.7	80.3	5.2	2.2	1.7	2.6	3.5	5.0	1.1	6.5	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	5.3	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	3.7	0.4	0.1	0.2	3.0	0.0	9.5	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	10.8	1.1	0.0	0.3	0.3	2.4	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.5	0.0	0.1	0.0	0.0	0.3	0.0	0.1	0.1	0.7	0.0	0.0	0.1	0.9	5.0	0.0	0.0	0.1	0.4	0.0	0.3	0.1
HMGA1	HMGIY	ENSG00000137309	"High mobility group AT-hook 1"	P17096	6	34236873-34246231	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 275.1"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 947.5;Cytotrophoblasts: 894.3;Pancreatic endocrine cells: 1838.5;Prostatic glandular cells: 1483.3;Syncytiotrophoblasts: 822.8;Urothelial cells: 1681.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB032200, HPA065612, HPA068442"	Enhanced		Supported	Nucleoplasm,Nucleoli		NA	NA		72000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Nucleoplasm	Nucleoli	"CAB032200: AB_2117771, HPA065612: , HPA068442: "	"unprognostic (1.81e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.08e-1)"	"prognostic unfavorable (7.13e-4)"	"unprognostic (1.57e-1)"	"unprognostic (1.20e-3)"	"prognostic unfavorable (1.29e-6)"	"prognostic unfavorable (3.36e-4)"	"unprognostic (8.54e-2)"	"unprognostic (1.84e-2)"	"prognostic unfavorable (8.71e-4)"	"unprognostic (1.55e-1)"	"unprognostic (8.22e-2)"	"unprognostic (4.52e-3)"	"unprognostic (1.19e-1)"	"unprognostic (4.37e-1)"	"unprognostic (2.65e-2)"	28.1	9.0	22.1	79.6	20.9	184.0	27.4	17.8	27.3	93.3	2.6	59.9	118.7	22.8	16.7	275.1	41.0	39.2	35.8	24.1	23.3	89.2	20.0	46.5	139.3	24.3	19.1	4.7	31.9	15.0	15.4	82.4	21.1	27.7	57.2	32.2	69.7	12.6	119.7	141.6	103.6	9.7	15.4	68.7	73.3	80.1	22.9	156.0	31.5	35.1	154.7	100.1	109.6	25.2	1418.7	547.0	274.2	192.9	124.8	916.6	1193.8	556.0	628.8	421.5	233.4	361.3	960.0	658.9	273.1	229.1	264.0	294.7	326.2	991.8	332.3	146.0	228.2	202.6	177.1	488.2	263.7	732.1	227.3	396.1	109.4	765.1	395.8	1083.8	1290.0	369.3	832.0	32.9	596.0	143.0	650.0	898.8	1340.9	697.5	950.3	947.6	6.2	728.0	286.6	128.4	477.0	202.5	59.3	278.3	533.3	430.2	112.2	775.8	1132.1	218.5	691.2	321.3	528.0	260.5	444.5	867.4	461.2	301.7	1115.0	18.7	26.6	35.5	24.4	26.8	32.2	63.5	45.0	39.0	79.6	39.5	52.0	42.9	6.7	20.1	26.5	86.6	55.8	30.7	22.1	20.9	17.8	27.3	24.1	23.3	24.3	19.1	21.1	15.4	22.9	25.2	11.0	28.9	21.7	2.3	117.8	432.3	947.5	181.3	109.8	29.0	88.8	47.4	30.8	28.6	106.1	40.5	4.2	894.3	70.3	173.5	46.9	755.3	7.2	50.5	14.6	113.9	117.0	268.3	5.4	277.5	799.8	72.0	79.5	115.3	66.7	8.3	18.2	12.3	377.2	11.8	5.7	226.4	97.6	74.0	149.9	24.5	5.6	94.3	90.7	1.0	74.3	44.1	33.0	4.5	2.7	1838.5	249.1	2.6	198.2	1483.3	174.5	15.8	21.7	41.9	0.0	18.6	77.7	40.2	417.6	224.7	361.4	822.8	66.6	0.9	364.3	1681.0
SMIM29	"C6orf1, LBH, MGC57858"	ENSG00000186577	"Small integral membrane protein 29"	Q86T20	6	34246381-34249108	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 175.9"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 72.4;Ductal cells: 50.9;Hofbauer cells: 104.0;monocytes: 44.5;Proximal tubular cells: 43.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 412.8"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA037659, HPA037660"	Uncertain					NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 7: Non-specific - Mitochondria"			"HPA037659: AB_2675591, HPA037660: AB_10671881"	"unprognostic (2.63e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.35e-2)"	"unprognostic (2.10e-1)"	"unprognostic (3.23e-1)"	"unprognostic (1.93e-3)"	"unprognostic (1.36e-2)"	"unprognostic (2.62e-1)"	"unprognostic (4.12e-2)"	"prognostic favorable (7.98e-4)"	"unprognostic (9.32e-2)"	"prognostic unfavorable (4.38e-4)"	"unprognostic (3.83e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.16e-2)"	"unprognostic (3.66e-1)"	19.4	29.7	133.7	14.4	129.9	14.7	19.5	131.5	175.9	26.5	98.3	24.2	8.4	19.8	34.5	26.9	17.0	17.1	29.8	131.3	135.5	22.5	18.7	27.8	21.3	138.0	136.0	16.4	15.4	18.6	33.4	13.2	142.4	22.8	6.1	16.1	16.2	16.3	24.5	48.8	17.9	12.2	133.5	30.8	16.9	11.7	139.1	14.6	25.7	23.5	15.5	24.0	26.0	128.0	25.1	31.1	6.2	33.3	79.2	62.2	6.7	24.6	58.4	27.4	34.4	7.6	12.3	14.1	19.8	28.6	56.6	15.6	12.7	31.3	8.9	36.0	17.3	10.5	6.1	19.9	45.4	12.0	62.0	33.7	28.4	38.5	37.6	38.4	40.9	11.6	13.5	81.8	64.0	17.9	13.5	24.2	1.9	42.8	21.5	5.5	3.8	25.1	33.1	32.4	26.0	12.1	2.6	23.8	70.9	5.3	14.1	19.1	26.4	62.1	14.4	65.1	21.6	42.9	66.1	4.7	35.4	25.7	82.9	99.1	83.8	412.8	78.7	62.7	52.6	133.3	62.4	69.1	59.7	126.4	41.8	61.8	231.6	57.1	48.3	50.1	90.3	64.0	133.7	129.9	131.5	175.9	131.3	135.5	138.0	136.0	142.4	133.5	139.1	128.0	18.1	9.6	13.6	0.0	5.6	0.0	0.0	0.0	0.0	0.0	28.5	20.8	0.0	0.0	6.8	31.3	0.0	37.8	13.6	0.0	72.4	50.9	0.0	9.9	8.6	15.5	0.0	0.0	0.0	24.0	11.8	8.0	0.0	15.0	12.6	10.8	0.0	0.0	104.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.6	0.0	0.0	44.5	0.0	0.0	0.0	0.0	25.3	0.0	0.0	1.9	0.0	0.0	43.8	10.2	0.0	0.0	0.0	9.2	0.0	0.0	0.0	0.0	35.4	9.4	17.8	0.0	0.0
NUDT3	DIPP	ENSG00000272325	"Nudix hydrolase 3"	O95989	6	34279679-34392669	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA047027, HPA055953"	Uncertain		Approved	Cytosol		NA	NA		87000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 5: Muller glia cells - Visual perception"	Cytosol		"HPA047027: AB_2679907, HPA055953: AB_2682984"	"unprognostic (2.42e-1)"	"prognostic favorable (5.29e-4)"	"unprognostic (9.63e-3)"	"unprognostic (4.74e-3)"	"unprognostic (3.60e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.41e-3)"	"unprognostic (4.21e-2)"	"unprognostic (4.93e-3)"	"unprognostic (1.08e-1)"	"unprognostic (3.16e-1)"	"unprognostic (4.63e-1)"	"unprognostic (1.24e-2)"	"unprognostic (3.28e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.54e-1)"	"unprognostic (6.24e-2)"	12.8	12.9	72.7	11.4	65.3	12.0	14.7	41.2	73.1	17.2	33.8	10.4	9.0	13.2	30.1	12.3	17.3	9.2	20.7	64.9	55.9	18.0	12.1	13.3	13.7	60.8	59.6	19.7	10.5	29.9	5.7	10.4	59.0	12.8	10.9	43.1	11.4	17.5	70.8	13.4	9.4	13.0	64.5	16.5	9.8	7.6	73.7	11.4	25.3	51.8	14.9	9.4	7.4	59.5	11.0	8.0	20.9	41.2	13.7	22.9	8.7	7.9	13.2	8.0	5.7	9.7	7.2	37.3	10.5	14.3	5.1	9.2	11.0	21.3	14.7	14.5	15.2	42.9	10.4	20.7	13.0	41.5	21.7	20.8	18.8	9.0	16.8	9.9	23.2	20.1	42.5	14.0	12.6	11.4	28.7	48.1	13.4	32.5	7.3	24.7	17.4	39.2	18.2	22.7	29.3	32.4	17.5	24.4	32.1	6.0	23.6	28.2	25.7	15.6	5.7	14.1	17.4	11.7	28.7	27.9	9.7	40.1	25.4	1.4	3.9	9.2	2.1	4.1	2.4	2.2	2.1	1.9	4.4	3.0	1.9	2.2	2.8	1.4	4.2	2.1	1.6	1.8	72.7	65.3	41.2	73.1	64.9	55.9	60.8	59.6	59.0	64.5	73.7	59.5	36.6	16.0	26.7	0.0	41.4	59.9	72.2	32.4	51.8	117.0	30.5	27.9	47.5	62.9	25.0	42.3	118.9	34.7	28.2	16.1	13.7	19.2	4.1	25.0	38.6	67.0	49.1	40.8	0.0	28.5	32.0	36.4	19.4	37.2	13.9	30.3	109.6	56.1	76.0	169.9	0.0	29.0	22.4	107.1	79.2	8.1	37.6	65.2	53.4	0.0	90.1	137.4	42.2	0.0	0.0	27.9	16.0	63.2	22.8	90.1	25.3	24.4	46.4	126.6	59.2	68.1	35.0	45.6	83.9	58.4	60.2	19.6	26.5	32.8	31.8	64.7
RPS10-NUDT3		ENSG00000270800	"RPS10-NUDT3 readthrough"		6	34284887-34426071	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 35.3;Alveolar cells type 2: 58.7;Club cells: 19.2;granulocytes: 10.1;Respiratory ciliated cells: 11.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 27.3"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA047027, HPA047268, HPA048084, HPA055953"	Uncertain		Approved	Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 11: Alveolar cells - Smell perception"	Cytosol		"HPA047027: AB_2679907, HPA047268: AB_2680007, HPA048084: AB_2680255, HPA055953: AB_2682984"	"unprognostic (1.37e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.85e-2)"	"unprognostic (7.54e-3)"	"unprognostic (1.28e-2)"	"unprognostic (6.85e-2)"		"unprognostic (8.95e-2)"	"unprognostic (2.67e-1)"	"unprognostic (5.07e-2)"	"unprognostic (1.36e-1)"	"unprognostic (3.63e-1)"	"unprognostic (5.17e-8)"	"unprognostic (5.80e-2)"	"unprognostic (9.49e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.42e-1)"	7.7	6.6	5.9	6.3	5.2	9.5	5.5	3.3	9.0	7.2	0.0	5.0	1.4	4.1	0.1	9.6	4.3	1.5	17.0	6.0	6.3	8.6	10.2	6.3	3.2	7.1	6.7	6.3	7.7	2.0	6.1	4.5	7.3	5.7	1.3	1.4	5.6	0.6	18.6	4.9	4.4	2.9	6.8	6.8	5.1	8.9	7.3	3.8	5.8	8.6	2.3	5.8	7.2	4.8	17.6	6.0	16.0	27.3	11.6	8.0	16.2	13.0	7.0	10.3	10.3	6.7	9.2	22.9	22.2	8.7	23.4	11.5	23.7	7.1	12.5	15.1	9.9	35.1	11.3	19.4	4.2	33.2	38.4	3.2	14.9	15.2	31.6	14.2	10.1	20.7	35.9	22.7	13.2	17.8	33.9	16.4	7.9	38.5	5.8	18.7	13.5	15.0	10.5	19.1	24.6	8.7	9.6	10.0	34.1	10.1	15.1	59.6	7.9	15.3	22.9	7.0	18.2	11.3	18.3	28.8	2.1	20.2	23.7	11.2	5.9	27.3	3.2	6.8	3.3	6.0	3.7	3.6	7.5	5.9	3.6	3.4	4.3	5.0	6.9	5.3	3.7	5.4	5.9	5.2	3.3	9.0	6.0	6.3	7.1	6.7	7.3	6.8	7.3	4.8	0.0	35.3	58.7	2.6	0.0	0.8	0.1	0.0	0.0	0.0	0.4	0.3	0.0	0.0	19.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.2	2.1	0.0	0.0	8.3	0.4	0.1	3.8	0.0	0.3	10.1	0.1	0.0	0.0	0.0	0.0	6.8	0.0	0.0	0.0	0.5	0.0	0.0	4.1	0.0	1.0	0.0	0.0	0.0	0.5	4.8	0.0	0.0	0.0	0.0	0.2	0.0	0.1	11.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	2.3	0.0	0.0	0.2
RPS10	"MGC88819, S10"	ENSG00000124614	"Ribosomal protein S10"	P46783	6	34417454-34426069	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"	"Diamond-Blackfan anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Squamous epithelial cells: 4571.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA047268, HPA048084"	Approved		Approved	Cytosol		NA	NA		130000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"	Cytosol		"HPA047268: AB_2680007, HPA048084: AB_2680255"	"unprognostic (1.92e-1)"	"unprognostic (1.54e-1)"	"unprognostic (8.21e-2)"	"unprognostic (1.78e-1)"	"unprognostic (8.92e-3)"	"unprognostic (3.79e-2)"	"unprognostic (9.72e-3)"	"unprognostic (1.93e-2)"	"unprognostic (4.30e-3)"	"unprognostic (2.04e-1)"	"unprognostic (3.59e-1)"	"unprognostic (3.82e-1)"	"prognostic unfavorable (2.57e-6)"	"unprognostic (4.98e-2)"	"unprognostic (7.66e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.45e-1)"	1437.4	1373.5	1054.1	937.6	1054.4	2688.5	2003.3	1013.6	1284.2	1984.1	1022.8	1472.3	919.9	1332.0	1064.3	1995.2	1606.9	756.7	1024.5	1010.7	1034.1	1114.4	1161.4	1006.5	2137.6	1058.2	1024.2	2878.3	2424.5	633.4	929.2	829.4	1051.3	1432.9	916.2	273.2	1532.7	895.2	1419.3	2399.7	1342.9	909.8	1088.6	1538.6	1455.3	558.6	1091.1	1486.2	1090.6	774.4	1696.6	1470.6	1716.1	1069.7	2314.3	1481.2	1486.9	3397.3	2550.1	3757.4	2454.7	1847.4	2604.3	3061.1	2200.4	3633.8	1140.6	4393.3	1873.0	2105.8	1522.9	1688.8	2814.8	3224.9	1840.0	1869.0	5082.5	1974.1	1475.4	3504.8	3492.4	3158.5	2028.2	4156.0	5548.7	2111.2	3977.8	2642.2	2725.4	2459.5	3452.0	2175.2	2327.1	3633.7	2591.3	4761.0	2242.3	5664.1	2144.7	2409.8	1736.7	4221.2	2314.1	2558.9	2492.6	1515.7	1328.4	2213.1	5332.3	1391.5	2878.1	7936.5	1837.0	1338.8	1699.0	1543.5	3072.5	1764.4	4423.0	3815.8	732.4	4092.2	2465.9	746.2	1242.2	378.2	1406.3	996.8	2067.1	2824.8	2408.2	1994.5	1679.6	2732.8	3083.6	2462.3	251.9	1676.0	963.1	1983.5	1767.5	5386.9	1054.1	1054.4	1013.6	1284.2	1010.7	1034.1	1058.2	1024.2	1051.3	1088.6	1091.1	1069.7	597.4	359.0	714.8	0.0	2967.8	1351.9	563.2	354.6	3754.5	62.0	1279.7	1271.1	65.3	1096.6	494.1	263.0	29.2	1497.5	1221.5	911.7	598.7	1451.9	447.1	169.2	282.1	670.4	1232.9	1778.0	0.0	2404.1	1918.4	612.0	1241.6	181.4	589.1	215.5	1258.9	970.6	1034.5	52.2	0.0	2462.2	130.2	1695.5	1330.7	1537.7	849.0	1006.5	633.3	0.0	1923.1	488.6	1562.3	0.0	0.0	1813.3	1843.4	472.4	2267.5	640.3	2166.8	1066.8	284.9	103.5	263.0	652.5	649.4	268.8	270.0	4571.8	1657.0	1454.1	1851.6	284.8	2985.5	573.4
PACSIN1	SDPI	ENSG00000124507	"Protein kinase C and casein kinase substrate in neurons 1"	Q9BY11	6	34466061-34535229	"Plasma proteins, Predicted intracellular proteins"	Endocytosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	17	"brain: 149.3;retina: 64.3"	"Group enriched"	"Detected in some"	4	"Bipolar cells: 76.1;Cone photoreceptor cells: 81.3;dendritic cells: 24.9;Excitatory neurons: 49.9;Horizontal cells: 69.0;Inhibitory neurons: 47.6;Rod photoreceptor cells: 89.4"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 4.9"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in some"	4	"plasmacytoid DC: 15.8"	"Lineage enriched"	"Detected in many"	4	"dendritic cells: 15.8"	"Cell line enhanced"	"Detected in some"		"MCF7: 12.1;RPMI-8226: 14.0;T-47d: 21.5;U-266/84: 16.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009929, HPA028852, HPA055491"	Enhanced		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 58: Brain - Synaptic function"	"Cluster 6: T47d - Mammary gland"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Nucleoplasm, Vesicles"		"CAB009929: AB_2268057, HPA028852: AB_10602812, HPA055491: AB_2682834"	"unprognostic (3.33e-1)"	"unprognostic (1.21e-1)"	"unprognostic (6.33e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.72e-2)"	"unprognostic (2.47e-3)"	"unprognostic (2.14e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.74e-1)"	"unprognostic (6.63e-2)"	"unprognostic (3.95e-4)"	"unprognostic (9.12e-2)"	"unprognostic (3.02e-2)"	"unprognostic (4.18e-2)"	"unprognostic (9.90e-2)"	"unprognostic (5.50e-2)"	"unprognostic (9.33e-2)"	0.2	0.7	40.9	1.2	72.9	0.8	0.2	0.0	149.3	0.3	0.0	0.8	0.5	0.5	0.1	0.1	0.6	0.3	5.4	64.4	0.0	1.4	0.2	0.2	3.6	58.8	10.0	0.6	5.1	1.7	6.3	0.0	55.4	0.7	0.2	64.3	1.0	0.4	0.2	0.3	1.4	0.1	0.0	1.3	1.3	0.8	3.9	1.3	0.2	0.1	2.2	0.4	0.3	59.5	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	4.5	0.8	0.0	0.0	0.1	1.4	0.0	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	4.4	1.1	0.1	0.0	12.1	0.7	0.0	2.8	0.1	0.1	0.1	0.0	14.0	0.0	0.4	4.2	0.3	0.0	2.2	0.0	0.4	21.5	2.4	0.0	0.0	0.3	0.0	0.0	3.5	16.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	3.6	0.0	15.8	0.0	0.1	40.9	72.9	0.0	149.3	64.4	0.0	58.8	10.0	55.4	0.0	3.9	59.5	0.2	0.0	0.0	2.3	0.3	0.0	0.1	0.0	0.0	76.1	0.2	0.1	4.5	0.0	0.0	0.0	81.3	0.1	24.9	0.1	0.0	0.3	0.2	1.3	0.2	0.6	0.0	0.0	49.9	0.7	0.0	0.1	0.5	2.0	0.0	0.2	0.0	0.0	0.0	69.0	47.6	0.0	0.0	0.0	0.0	0.2	0.0	1.0	0.0	6.5	0.0	12.7	1.0	1.0	2.0	0.1	0.0	0.0	0.2	0.1	0.0	2.3	0.0	89.4	0.0	0.2	0.2	0.4	1.7	0.0	0.0	0.0	0.6	0.1	0.1	0.1
SPDEF	"bA375E1.3, PDEF"	ENSG00000124664	"SAM pointed domain containing ETS transcription factor"	O95238	6	34537802-34556333	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"prostate: 140.7;salivary gland: 114.8"	"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 94.2;Breast myoepithelial cells: 61.1;Intestinal goblet cells: 315.1;Prostatic glandular cells: 72.7"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 388.1"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"MCF7: 288.4;OE19: 118.0;SK-BR-3: 192.2;T-47d: 154.0"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	7	"midbrain: 2.9"	HPA055707			Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA				"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Nucleoplasm, Nucleoli"	Cytosol	"HPA055707: AB_2682894"	"unprognostic (2.98e-1)"	"unprognostic (9.68e-2)"	"unprognostic (2.84e-1)"	"prognostic favorable (9.26e-9)"	"unprognostic (1.57e-1)"	"unprognostic (7.10e-3)"	"unprognostic (2.56e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.63e-1)"	"unprognostic (7.39e-3)"	"unprognostic (3.48e-3)"	"unprognostic (2.92e-1)"	"unprognostic (6.16e-11)"	"unprognostic (8.04e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.12e-2)"	0.4	0.1	0.5	1.4	0.5	0.1	36.6	0.8	1.1	28.0	0.0	18.4	11.6	9.0	0.5	2.2	6.3	2.4	0.4	0.5	0.2	0.1	0.1	1.1	0.0	0.3	0.4	0.1	0.6	0.0	0.2	0.0	0.2	140.7	10.2	0.0	114.8	0.1	0.3	9.3	14.3	0.6	0.1	0.1	35.4	0.3	0.5	0.0	0.1	0.0	0.0	1.0	0.3	0.5	0.0	30.9	0.1	0.2	0.0	0.0	0.5	0.0	0.0	0.1	0.2	0.3	0.3	0.0	0.1	0.0	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	288.4	0.3	0.4	0.0	118.0	38.6	0.1	0.0	0.3	0.3	0.3	2.1	0.2	0.0	192.2	0.0	0.0	154.0	0.0	0.0	0.0	0.5	0.4	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.8	1.1	0.5	0.2	0.3	0.4	0.2	0.1	0.5	0.5	0.8	0.0	2.2	0.7	0.3	0.1	13.3	20.7	0.0	0.0	94.2	61.1	0.3	5.7	31.7	0.0	0.0	0.0	1.4	27.1	0.0	2.6	1.1	6.2	0.7	0.6	5.4	0.0	0.8	1.2	0.0	0.4	28.1	18.7	0.0	0.2	0.4	0.0	0.0	0.0	0.6	315.1	12.2	0.0	0.2	5.5	0.0	0.9	3.6	0.0	0.0	0.0	0.0	0.0	0.2	20.2	12.3	0.0	0.1	72.7	5.7	0.0	2.9	0.0	0.0	0.0	1.2	0.1	0.2	0.0	0.0	0.3	0.8	0.0	30.0	11.5
ILRUN	"C6orf106, dJ391O22.4, FLJ22195"	ENSG00000196821	"Inflammation and lipid regulator with UBA-like and NBR1-like domains"	Q9H6K1	6	34587288-34696859	"Predicted intracellular proteins"	"Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 211.7"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 9.9;Cardiomyocytes: 73.7;Cytotrophoblasts: 13.7;dendritic cells: 11.8;Hofbauer cells: 15.6;Syncytiotrophoblasts: 21.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034489, HPA034490"	Approved		Supported	"Nuclear speckles,Centrosome,Cytosol"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Nuclear speckles"	"Centrosome, Cytosol"	"HPA034489: AB_10669991, HPA034490: AB_2674186"	"unprognostic (3.76e-2)"	"unprognostic (2.51e-1)"	"unprognostic (7.71e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.32e-1)"	"unprognostic (8.40e-2)"	"unprognostic (9.94e-2)"	"unprognostic (7.57e-2)"	"unprognostic (5.68e-2)"	"unprognostic (3.55e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.08e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.53e-1)"	57.0	35.3	38.4	31.4	39.3	28.6	35.2	48.8	51.6	26.6	36.2	43.4	30.1	29.5	29.0	42.1	27.2	29.3	76.8	39.8	39.8	43.1	77.1	42.5	34.0	41.6	49.9	25.8	30.3	47.3	24.5	30.4	41.5	30.7	29.8	46.7	33.9	32.4	211.7	37.0	35.7	39.4	39.6	31.6	35.0	67.8	43.7	32.9	37.4	187.4	44.8	40.2	28.1	41.4	94.0	41.8	40.3	59.8	95.7	51.9	48.5	63.5	72.3	72.1	89.4	83.0	42.1	107.0	46.1	62.3	99.5	90.7	120.0	52.6	90.3	151.4	47.0	89.2	47.3	80.0	93.4	76.0	96.2	35.4	108.0	73.3	66.4	49.5	58.6	43.9	103.0	43.6	41.7	56.3	52.7	52.7	37.7	152.0	37.3	40.6	52.2	57.0	57.0	91.2	48.6	38.0	93.3	44.9	91.8	82.1	56.5	63.3	60.1	59.1	45.6	63.0	62.7	63.2	154.3	81.8	21.3	66.7	70.1	23.9	3.7	8.1	8.9	6.6	4.7	6.7	6.4	7.1	4.4	8.1	3.5	5.5	4.6	6.2	8.3	2.2	10.0	5.7	38.4	39.3	48.8	51.6	39.8	39.8	41.6	49.9	41.5	39.6	43.7	41.4	9.9	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	73.7	0.0	0.0	0.0	0.0	13.7	11.8	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	8.6	7.0	0.0	0.0	0.0	0.0	0.0	0.0	15.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	21.6	1.6	0.0	0.0	0.0
SNRPC	"U1-C, Yhc1"	ENSG00000124562	"Small nuclear ribonucleoprotein polypeptide C"	P09234	6	34757505-34773857	"Plasma proteins, Predicted intracellular proteins"		"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 384.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034338, HPA042419, HPA055490"	Supported		Enhanced	Nucleoplasm		NA	NA		320000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm		"CAB034338: AB_2295245, HPA042419: AB_2677989, HPA055490: AB_2682833"	"unprognostic (1.84e-1)"	"unprognostic (3.73e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.32e-3)"	"unprognostic (1.45e-1)"	"unprognostic (3.93e-2)"	"prognostic unfavorable (5.65e-4)"	"unprognostic (1.48e-2)"	"unprognostic (6.16e-2)"	"unprognostic (1.16e-3)"	"unprognostic (7.71e-2)"	"unprognostic (1.21e-1)"	"prognostic unfavorable (8.20e-5)"	"unprognostic (4.39e-2)"	"unprognostic (8.64e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.62e-2)"	71.7	73.9	68.4	67.7	73.7	176.7	74.2	73.1	84.5	67.0	75.3	78.5	73.1	83.5	63.1	85.5	84.8	48.9	195.7	70.5	71.8	91.7	92.0	62.6	101.6	72.2	70.5	75.0	87.0	78.2	57.6	73.5	73.1	65.8	65.6	39.7	75.2	55.3	162.0	67.4	75.6	65.3	75.4	84.7	81.8	124.4	72.6	115.5	75.3	125.0	95.3	73.9	66.6	78.4	332.8	203.2	260.7	331.6	137.7	134.7	199.0	186.6	204.9	367.9	308.6	349.6	128.4	373.9	239.1	235.0	255.6	156.0	398.7	279.1	297.8	247.6	420.0	287.7	158.7	493.4	240.1	371.2	171.0	167.3	266.4	372.5	264.1	144.9	237.0	354.4	471.2	205.0	270.4	280.8	443.8	592.0	282.4	493.9	245.8	295.2	219.4	350.5	242.0	140.9	316.9	229.9	167.3	167.0	422.3	167.7	256.0	541.5	157.4	219.8	258.3	181.0	460.4	228.5	645.6	522.4	101.2	629.7	381.1	122.8	165.7	133.4	127.2	200.4	149.4	233.5	156.2	148.4	196.1	210.7	168.3	153.9	30.3	163.3	238.6	207.6	235.7	245.6	68.4	73.7	73.1	84.5	70.5	71.8	72.2	70.5	73.1	75.4	72.6	78.4	43.6	121.8	107.9	5.2	70.5	44.0	76.0	178.6	72.8	25.9	47.4	64.4	229.3	82.9	131.3	68.0	25.0	239.8	69.0	49.1	189.8	148.4	185.6	74.2	58.0	74.3	90.7	73.2	11.1	156.8	213.9	72.3	51.5	63.7	80.4	83.6	71.4	101.1	232.2	28.6	10.1	92.6	118.0	77.3	55.1	83.8	55.3	75.4	64.0	1.9	158.2	96.6	123.6	8.5	14.6	149.3	66.7	41.8	116.6	70.0	96.0	214.6	127.4	41.4	65.7	49.0	82.8	384.6	99.7	83.8	44.8	113.3	70.7	86.3	109.6	67.8
UHRF1BP1	"C6orf107, dJ349A12.1, FLJ20302, ICBP90"	ENSG00000065060	"UHRF1 binding protein 1"	Q6BDS2	6	34792015-34883138	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Inhibitory neurons: 39.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA032099, HPA032100"	Uncertain		Approved	"Nucleoplasm,Nuclear membrane,Cytosol"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Nuclear membrane"	Cytosol	"HPA032099: AB_10696057, HPA032100: AB_10671087"	"unprognostic (2.30e-2)"	"unprognostic (9.52e-2)"	"unprognostic (4.58e-3)"	"unprognostic (1.28e-2)"	"unprognostic (3.42e-2)"	"unprognostic (7.01e-2)"	"prognostic unfavorable (3.86e-4)"	"unprognostic (3.58e-2)"	"unprognostic (4.39e-3)"	"unprognostic (9.82e-2)"	"unprognostic (4.68e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.90e-1)"	"unprognostic (4.24e-2)"	4.3	4.4	2.8	4.3	2.8	14.2	3.6	7.1	3.2	2.7	4.6	3.1	3.2	3.3	2.4	3.2	2.8	2.5	6.8	2.4	3.4	3.7	3.9	4.2	4.9	3.5	3.7	3.3	8.0	8.5	3.0	5.3	3.9	3.6	3.9	7.5	5.9	2.9	14.3	3.1	3.6	3.9	3.5	4.4	4.0	12.0	3.5	5.8	6.0	7.5	4.2	3.5	2.4	3.8	12.9	9.1	7.9	25.9	4.1	3.0	14.3	7.4	5.0	7.1	10.0	18.2	3.4	19.4	7.9	7.7	12.3	9.6	29.2	4.2	9.6	10.0	9.4	17.2	8.7	15.2	16.7	15.7	10.3	6.8	12.0	5.7	12.0	6.6	9.1	16.6	29.3	7.5	3.1	12.3	12.2	10.2	3.6	9.3	6.3	7.3	12.7	11.8	9.6	11.8	9.5	9.7	18.7	9.7	24.7	8.1	18.5	20.3	5.6	3.5	12.7	5.5	8.2	11.1	18.6	12.0	1.9	21.5	8.8	0.1	0.3	0.3	0.3	0.4	0.3	0.3	0.3	0.3	0.3	0.3	0.1	0.2	0.1	0.4	1.3	0.1	0.1	0.2	2.8	2.8	7.1	3.2	2.4	3.4	3.5	3.7	3.9	3.5	3.5	3.8	5.1	16.0	6.3	16.0	5.0	1.0	3.0	3.9	5.7	10.1	5.2	2.9	16.8	4.3	9.1	0.0	20.9	6.9	3.7	3.0	1.9	5.4	10.0	5.8	4.9	6.3	9.5	6.7	20.8	5.8	3.8	4.9	10.2	11.5	1.3	14.3	15.0	6.0	15.6	5.0	39.3	4.9	10.2	19.0	6.0	18.2	5.6	11.9	0.0	22.5	9.4	4.6	4.1	25.6	14.1	7.2	3.3	2.6	11.4	9.9	4.1	3.9	5.1	10.8	13.1	7.5	5.4	16.4	10.8	8.3	2.8	4.9	3.9	4.0	3.8	8.5
TAF11	"TAF2I, TAFII28"	ENSG00000064995	"TATA-box binding protein associated factor 11"	Q15544	6	34877462-34888071	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029326, HPA049127"			Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoplasm	"Golgi apparatus"	"HPA029326: AB_2672999, HPA049127: AB_2680645"	"unprognostic (4.02e-2)"	"unprognostic (5.36e-3)"	"unprognostic (7.41e-2)"	"unprognostic (5.18e-3)"	"unprognostic (6.65e-3)"	"unprognostic (1.70e-1)"	"unprognostic (2.56e-3)"	"unprognostic (1.45e-2)"	"unprognostic (1.68e-3)"	"prognostic favorable (5.87e-4)"	"unprognostic (2.91e-1)"	"unprognostic (6.77e-3)"	"unprognostic (1.89e-2)"	"unprognostic (3.24e-1)"	"unprognostic (1.87e-2)"	"unprognostic (4.92e-1)"	"unprognostic (3.32e-1)"	23.2	27.9	21.3	19.5	22.4	47.1	23.0	24.8	26.5	23.9	22.0	27.8	19.3	22.6	18.4	25.8	25.1	15.5	29.5	21.4	21.0	27.5	28.5	25.5	27.1	22.0	21.7	27.9	27.2	16.7	19.8	22.6	22.0	26.2	20.6	24.8	20.9	16.9	32.6	29.0	26.5	20.7	21.1	33.8	25.1	33.4	22.3	23.7	24.4	21.6	25.4	24.9	23.1	25.6	37.2	15.4	50.2	91.4	29.5	30.8	44.5	29.5	23.1	47.2	44.8	35.9	23.0	49.5	37.8	27.3	23.1	23.4	61.5	25.1	37.7	30.3	49.6	55.7	30.7	58.8	41.3	74.9	38.6	35.8	41.2	32.2	25.2	28.8	57.6	55.0	89.0	38.1	22.6	65.6	48.1	63.4	45.9	74.3	26.0	51.6	44.9	39.7	34.4	23.0	60.6	55.3	33.9	37.9	68.6	41.5	59.4	88.6	34.6	33.3	44.6	20.1	36.9	35.2	90.5	72.4	12.2	86.3	49.9	43.6	27.8	24.5	14.3	25.8	13.8	13.8	14.9	15.4	24.1	17.1	17.4	15.6	17.5	17.6	21.7	21.5	21.4	15.9	21.3	22.4	24.8	26.5	21.4	21.0	22.0	21.7	22.0	21.1	22.3	25.6	49.9	28.9	19.5	18.3	44.9	46.0	31.4	36.1	24.5	29.0	55.1	44.3	24.0	25.8	31.3	42.3	12.5	71.9	50.4	33.5	64.6	47.9	6.6	37.4	49.7	43.8	39.5	39.5	20.8	63.2	68.9	33.5	29.6	47.7	22.2	57.8	61.1	58.8	44.2	32.0	23.7	38.4	50.8	52.2	32.2	10.6	33.8	36.5	24.9	13.1	48.5	37.8	48.4	16.6	33.6	50.8	51.2	37.2	44.0	32.9	43.5	48.9	17.1	32.9	32.9	34.0	35.5	130.9	71.2	36.3	58.4	76.8	44.3	38.2	40.6	31.2
ANKS1A	"ANKS1, KIAA0229"	ENSG00000064999	"Ankyrin repeat and sterile alpha motif domain containing 1A"	Q92625	6	34889255-35091406	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 94.0;Inhibitory neurons: 160.5;Microglial cells: 168.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"SCLC-21H: 58.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036768, HPA036769"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		17000	"Cluster 14: Monocytes - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	Cytosol	"HPA036768: AB_10670923, HPA036769: AB_10672473"	"unprognostic (3.75e-2)"	"unprognostic (2.67e-1)"	"unprognostic (2.59e-2)"	"unprognostic (7.79e-3)"	"unprognostic (5.73e-2)"	"prognostic favorable (7.48e-4)"	"unprognostic (1.18e-3)"	"unprognostic (3.51e-3)"	"unprognostic (1.62e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.38e-2)"	"prognostic favorable (8.05e-5)"	"unprognostic (1.76e-1)"	"unprognostic (9.71e-2)"	"unprognostic (2.23e-2)"	"unprognostic (7.80e-2)"	15.0	19.1	15.2	8.0	13.9	5.7	15.0	16.4	15.8	10.9	13.8	29.0	10.5	10.7	7.4	15.4	20.1	10.0	18.6	12.7	13.4	13.1	10.7	18.8	9.3	15.6	17.0	17.4	9.4	16.4	8.4	27.8	17.4	11.7	9.0	22.9	9.2	15.4	20.1	15.6	14.3	14.3	14.0	23.0	14.8	16.5	22.1	7.6	13.8	9.5	5.7	27.2	13.1	11.9	15.4	7.3	14.8	14.2	6.5	6.4	22.3	6.0	6.7	7.2	8.7	18.4	9.7	10.4	10.0	6.4	13.1	15.7	17.4	17.6	8.3	8.0	21.9	7.3	9.2	13.7	4.0	11.8	6.7	7.4	14.9	9.3	12.3	7.7	15.9	10.7	12.6	4.4	6.4	10.0	7.4	12.8	10.7	20.3	8.4	8.9	8.3	10.6	14.5	27.9	58.5	14.8	10.3	14.1	43.7	18.1	11.1	13.0	13.9	7.3	9.2	7.6	8.9	6.7	10.9	5.5	5.6	16.8	20.3	0.0	0.6	0.5	0.2	0.9	0.4	0.4	0.2	0.4	0.5	0.1	0.3	0.2	1.1	0.2	1.5	1.1	0.3	0.4	15.2	13.9	16.4	15.8	12.7	13.4	15.6	17.0	17.4	14.0	22.1	11.9	48.2	80.1	11.4	54.2	4.4	12.1	9.1	4.2	4.0	28.8	11.3	14.4	25.3	11.5	8.3	12.9	64.6	8.9	5.5	17.2	0.0	7.3	12.7	32.1	7.4	31.7	13.2	5.7	94.0	5.9	7.5	10.0	13.3	35.6	2.5	17.2	47.5	6.6	11.9	8.4	160.5	11.0	18.3	29.2	10.9	11.3	12.8	18.9	5.4	168.6	8.1	21.7	10.3	90.5	75.9	10.2	7.6	30.1	6.4	13.3	10.0	7.0	29.0	45.4	19.7	10.3	13.5	6.9	5.9	8.5	20.5	12.4	4.8	5.9	9.2	14.9
TCP11	"D6S230E, FPPR, KIAA0229"	ENSG00000124678	"T-complex 11"	Q8WWU5	6	35118071-35148610	"Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	338	"testis: 340.8"	"Group enriched"	"Detected in some"	11	"Early spermatids: 1921.3;Late spermatids: 6899.4"	"Cancer enhanced"	"Detected in some"		"cervical cancer: 1.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"hTEC/SVTERT24-B: 1.6;WM-115: 2.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA048311	Supported					NA	NA				"Cluster 36: Testis - Spermatogenesis"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 25: Spermatids - Spermatogenesis"			"HPA048311: AB_2680351"	"unprognostic (1.35e-1)"	"prognostic favorable (5.02e-4)"	"unprognostic (2.78e-1)"	"unprognostic (1.16e-1)"	"unprognostic (6.43e-4)"	"unprognostic (8.09e-7)"	"unprognostic (4.06e-3)"	"unprognostic (1.25e-1)"	"unprognostic (9.98e-2)"	"unprognostic (9.53e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.61e-1)"	"unprognostic (5.54e-4)"	"unprognostic (9.41e-2)"	"unprognostic (4.56e-2)"	"unprognostic (2.77e-2)"	"unprognostic (2.49e-1)"	0.2	0.1	0.1	0.1	0.1	0.1	0.4	0.0	0.3	0.3	0.0	0.1	0.0	0.1	0.7	0.1	1.0	0.1	0.2	0.0	0.1	0.6	0.2	0.2	0.1	0.0	0.0	0.8	0.1	0.0	0.3	0.0	0.0	0.5	0.0	0.1	0.4	0.1	0.2	0.4	0.1	0.1	0.0	0.0	0.2	340.8	0.0	0.1	0.2	0.3	0.1	0.1	0.2	0.1	0.0	0.0	0.1	0.1	0.1	0.5	0.1	0.3	0.4	0.0	0.1	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	1.6	0.1	0.2	0.1	0.1	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.2	0.0	0.3	0.4	0.0	0.1	0.1	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.5	0.1	0.3	0.0	0.0	0.1	0.1	0.4	0.0	1.3	0.0	0.0	0.0	0.1	0.0	1.9	0.0	1921.3	0.3	0.1	1.7	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	6899.4	30.1	2.2	1.8	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	29.0	0.0	0.1	0.0	0.1	3.6	0.0	13.1	0.0	0.1	375.1	26.2	0.0	0.1	0.0	0.0	0.2	0.0	0.2
SCUBE3	"CEGF3, FLJ34743"	ENSG00000146197	"Signal peptide, CUB domain and EGF like domain containing 3"	Q8IX30	6	35213956-35253079	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"thyroid gland: 28.9"	"Cell type enhanced"	"Detected in some"		"Enteroendocrine cells: 10.8;Horizontal cells: 10.1;Rod photoreceptor cells: 7.1"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 9.2"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 26.0;ASC diff: 76.7;ASC TERT1: 102.2;HSkMC: 48.1;hTEC/SVTERT24-B: 30.1;U-138 MG: 29.1;WM-115: 25.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA040606	Uncertain		Approved	"Plasma membrane"	"Secreted to blood"	NA	NA	1890000	490000		"Cluster 1: Thyroid gland - Transcription"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 62: Horizontal cells - Visual perception"	"Plasma membrane"		"HPA040606: AB_10795383"	"unprognostic (1.45e-1)"	"unprognostic (1.79e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.41e-3)"	"unprognostic (1.52e-1)"	"unprognostic (1.27e-1)"	"unprognostic (4.43e-2)"	"unprognostic (5.01e-2)"	"unprognostic (2.00e-2)"	"unprognostic (7.41e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.64e-2)"	"unprognostic (4.83e-8)"	"unprognostic (1.54e-2)"	"unprognostic (2.12e-1)"	"prognostic unfavorable (1.38e-4)"	"unprognostic (3.06e-3)"	1.7	2.4	0.7	0.9	1.1	0.1	0.4	2.0	1.0	0.5	2.9	4.2	0.1	0.6	0.9	0.7	0.8	0.5	3.4	0.5	0.6	2.9	0.1	0.7	0.1	0.8	1.0	0.5	0.1	0.1	1.7	0.7	0.3	2.2	0.9	1.4	0.2	4.5	0.3	0.8	0.7	0.9	0.1	0.2	1.4	1.1	0.7	0.1	28.9	0.0	0.2	5.1	0.9	0.8	0.0	0.1	26.0	0.2	76.7	102.2	0.3	6.7	3.3	0.1	0.1	0.5	0.1	0.0	0.9	15.5	0.0	0.0	5.3	0.0	0.4	0.0	0.1	0.0	0.7	0.1	0.1	0.0	0.0	48.1	0.0	30.1	0.0	0.5	0.0	0.0	0.1	0.2	0.2	0.3	0.0	0.0	1.2	0.0	0.4	0.1	0.0	0.0	0.1	2.9	0.5	0.0	0.1	0.7	1.9	10.2	0.7	0.1	1.5	29.1	1.3	0.0	0.2	0.1	0.0	0.0	4.6	0.0	25.2	0.3	0.1	0.2	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.4	0.1	0.1	0.2	0.1	0.0	0.7	1.1	2.0	1.0	0.5	0.6	0.8	1.0	0.3	0.1	0.7	0.8	0.2	0.0	0.6	0.7	0.5	0.0	0.2	0.4	0.0	2.6	0.3	0.0	3.5	0.0	2.0	1.8	2.1	1.2	0.5	0.0	0.0	0.0	2.1	1.2	0.4	0.6	10.8	0.0	2.2	0.0	2.1	1.3	0.0	0.4	1.3	0.5	0.0	0.1	0.3	10.1	3.2	0.1	0.0	0.6	0.4	3.3	0.9	0.2	1.8	0.0	0.1	3.0	0.0	4.0	3.5	0.1	0.0	3.8	0.4	0.1	0.0	0.1	0.9	7.1	0.0	0.6	3.2	0.5	2.1	0.0	0.0	0.7	0.2	0.1	0.0	0.2
ZNF76	"D6S229E, Zfp523, ZNF523"	ENSG00000065029	"Zinc finger protein 76"	P36508	6	35258909-35295985	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030090, HPA030091"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	Cytosol	"HPA030090: AB_10603334, HPA030091: AB_10602593"	"unprognostic (8.29e-3)"	"unprognostic (3.61e-2)"	"unprognostic (7.71e-2)"	"unprognostic (8.70e-3)"	"unprognostic (2.76e-1)"	"unprognostic (6.51e-2)"	"unprognostic (1.40e-3)"	"unprognostic (5.78e-2)"	"unprognostic (1.23e-2)"	"prognostic favorable (1.18e-4)"	"prognostic favorable (5.09e-4)"	"unprognostic (3.66e-3)"	"unprognostic (1.20e-3)"	"unprognostic (5.31e-3)"	"unprognostic (1.14e-1)"	"unprognostic (3.76e-1)"	"unprognostic (1.20e-3)"	15.7	33.0	17.9	11.7	18.3	10.0	18.2	17.5	18.6	22.4	20.7	21.2	12.6	17.4	18.5	15.5	20.9	9.9	30.3	17.4	17.7	27.5	25.6	17.7	17.5	18.8	18.2	30.9	23.4	21.5	45.2	11.0	18.2	27.8	10.4	22.9	21.3	14.5	54.7	13.1	23.1	10.7	17.2	33.7	20.3	24.7	18.6	15.3	39.1	31.7	14.6	20.2	18.0	18.3	10.7	9.6	20.7	23.0	8.6	13.2	14.8	9.0	15.1	14.9	11.9	7.3	14.0	23.1	13.1	13.5	14.2	5.9	17.5	13.6	8.6	34.5	26.7	22.2	15.7	11.6	17.1	11.2	12.6	16.2	8.5	17.2	16.0	9.1	13.7	23.1	16.6	23.7	13.7	23.5	19.1	13.1	10.2	8.5	9.2	18.1	10.7	21.4	13.5	14.7	32.5	11.9	11.0	13.9	27.3	6.8	20.8	36.1	10.6	10.4	8.9	7.2	13.2	23.8	17.8	21.6	9.0	17.4	28.0	5.2	7.2	6.3	16.8	9.5	13.2	10.9	12.1	12.0	8.2	10.4	12.6	13.2	2.2	10.8	10.9	4.1	10.3	10.3	17.9	18.3	17.5	18.6	17.4	17.7	18.8	18.2	18.2	17.2	18.6	18.3	9.6	16.0	9.6	16.3	19.3	5.7	8.3	10.2	15.9	28.5	14.0	10.2	20.3	8.6	9.7	9.2	50.1	23.7	11.6	13.4	21.5	12.5	20.6	9.2	7.7	10.5	12.1	6.9	19.7	15.5	12.4	10.0	7.7	10.1	12.7	19.5	10.0	8.7	11.3	30.3	22.0	13.9	8.2	7.2	6.9	13.4	11.1	7.6	5.4	21.5	6.1	15.3	16.5	24.1	23.9	7.6	13.1	6.0	16.1	6.8	12.1	12.5	9.2	31.2	19.7	8.8	10.2	21.9	10.4	8.7	6.3	22.7	12.6	14.8	10.1	7.9
DEF6	"IBP, SLAT, SWAP70L"	ENSG00000023892	"DEF6 guanine nucleotide exchange factor"	Q9H4E7	6	35297818-35321771	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 63.2;lymphoid tissue: 62.9"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 94.0;Late spermatids: 151.4;NK-cells: 88.6;T-cells: 78.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"JURKAT: 83.3;MOLT-4: 75.5;NB-4: 99.3;REH: 68.8;THP-1: 78.9;U-937: 117.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"HPA038975, HPA038976"	Enhanced		Enhanced	Nucleoplasm		Yes	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 32: U-937 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Nucleoplasm		"HPA038975: AB_10697544, HPA038976: AB_10673409"	"prognostic favorable (3.02e-6)"	"prognostic favorable (1.08e-4)"	"prognostic unfavorable (1.71e-4)"	"prognostic favorable (2.37e-4)"	"unprognostic (1.93e-1)"	"unprognostic (3.63e-3)"	"unprognostic (2.24e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.12e-1)"	"unprognostic (2.14e-1)"	"unprognostic (6.21e-3)"	"prognostic unfavorable (1.02e-8)"	"unprognostic (1.78e-1)"	"unprognostic (2.91e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.45e-3)"	5.8	3.6	5.9	33.5	5.9	63.2	6.0	6.3	7.2	8.0	7.3	9.8	10.2	2.8	8.5	28.2	4.4	7.2	2.6	5.9	6.6	4.7	5.2	14.7	48.6	8.7	7.0	3.1	21.6	1.3	8.3	7.7	8.0	21.0	7.4	2.2	15.8	4.8	1.7	28.5	30.7	3.5	7.7	62.9	16.3	26.7	8.1	50.2	8.3	1.1	38.1	10.2	16.5	8.8	24.0	0.0	0.8	0.6	0.1	0.3	29.0	2.6	3.6	0.6	0.7	1.5	10.0	28.1	8.3	1.3	0.1	15.5	0.0	19.6	0.4	1.0	1.1	31.7	0.4	12.6	0.7	57.5	40.0	4.5	24.6	0.3	22.0	0.1	0.0	83.3	14.3	65.7	0.1	12.3	75.5	99.3	1.3	3.0	2.8	68.8	0.6	38.4	2.5	17.8	0.4	0.2	2.1	5.8	5.5	1.1	15.9	78.9	3.8	0.3	0.6	0.1	0.3	37.2	37.1	23.3	0.0	117.7	0.2	49.2	39.5	119.7	78.6	29.7	62.4	34.2	63.3	76.8	55.2	31.3	65.1	65.2	69.3	72.9	27.8	36.6	73.1	64.3	5.9	5.9	6.3	7.2	5.9	6.6	8.7	7.0	8.0	7.7	8.1	8.8	1.7	6.4	8.0	1.3	49.2	11.9	16.9	15.0	20.5	2.5	5.4	7.2	0.8	2.8	8.2	5.5	0.0	25.0	52.3	4.2	0.0	0.9	56.3	2.2	0.8	3.1	4.2	6.7	2.0	10.0	17.2	2.2	26.0	3.0	17.7	1.5	2.9	0.9	94.0	3.3	1.0	9.9	2.0	28.0	26.4	151.4	2.8	31.7	7.2	17.8	30.0	0.8	88.6	0.5	0.5	8.0	8.9	1.9	57.9	6.0	3.1	0.3	5.8	1.7	0.0	0.6	1.2	40.0	0.9	20.0	11.8	12.6	78.3	1.0	9.1	13.0
PPARD	"FAAR, NR1C2, NUC1, NUCII"	ENSG00000112033	"Peroxisome proliferator activated receptor delta"	Q03181	6	35342558-35428191	"FDA approved drug targets, Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 67.7;Pancreatic endocrine cells: 102.5;Syncytiotrophoblasts: 98.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB017635	Approved					NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"CAB017635: AB_1128605"	"unprognostic (3.70e-2)"	"unprognostic (8.75e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.57e-1)"	"unprognostic (8.68e-2)"	"prognostic unfavorable (4.57e-4)"	"unprognostic (4.59e-3)"	"unprognostic (4.34e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.51e-3)"	"unprognostic (7.27e-3)"	"unprognostic (1.43e-1)"	"unprognostic (9.42e-2)"	"unprognostic (5.95e-2)"	"unprognostic (2.00e-2)"	21.0	20.6	31.9	18.7	30.2	9.1	18.4	27.4	35.3	25.3	22.2	24.2	11.6	19.1	18.4	45.9	19.7	14.9	23.0	35.9	26.5	29.9	31.8	31.5	15.5	31.3	31.5	32.0	12.2	14.2	24.6	28.3	31.2	28.2	12.3	10.9	20.5	17.2	29.4	28.9	27.4	11.3	29.1	30.7	29.8	14.1	36.1	7.6	40.9	13.4	13.8	23.5	33.7	27.8	51.0	8.9	13.7	29.3	20.0	34.9	74.3	40.6	36.1	34.2	28.4	12.0	9.4	8.1	11.6	29.1	19.4	17.8	13.0	39.4	23.8	11.8	11.8	7.7	12.2	17.9	35.0	1.9	8.3	59.7	13.0	50.7	25.9	39.0	16.2	9.9	8.1	8.9	29.1	16.1	5.6	8.2	6.7	19.1	23.9	7.9	23.5	8.2	8.5	44.7	7.7	21.4	16.3	27.9	34.5	9.4	10.4	28.1	35.1	46.3	17.5	28.1	49.1	7.5	11.2	8.7	15.2	16.3	21.2	0.5	1.5	3.3	1.2	1.3	0.9	1.3	1.3	1.2	1.3	1.7	2.2	2.1	2.3	1.0	0.9	0.8	1.4	1.1	31.9	30.2	27.4	35.3	35.9	26.5	31.3	31.5	31.2	29.1	36.1	27.8	14.8	9.6	7.8	11.8	8.8	18.7	19.5	7.5	5.7	7.6	6.6	6.2	11.0	10.0	11.6	1.8	2.1	35.6	3.2	67.7	3.9	30.9	3.0	9.7	8.5	11.9	6.6	1.7	24.4	24.1	32.1	8.0	31.6	18.3	22.9	5.5	6.1	5.6	14.9	5.0	18.7	9.2	10.2	6.6	18.3	3.6	5.9	17.0	12.4	59.0	4.3	8.0	6.2	23.1	42.8	102.5	38.6	8.2	6.1	18.5	22.6	6.3	5.1	7.5	13.1	9.6	10.2	6.2	7.7	7.2	12.8	98.1	7.1	18.8	8.1	51.4
FANCE	"FACE, FAE"	ENSG00000112039	"FA complementation group E"	Q9HB96	6	35452338-35467102	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair"		"Cancer-related genes, Disease variant, Fanconi anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 22.1;Extravillous trophoblasts: 104.8;Syncytiotrophoblasts: 46.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB014893	Enhanced		Supported	Nucleoplasm		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 32: U-937 - Innate immune response"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Nucleoplasm		"CAB014893: "	"unprognostic (2.66e-1)"	"unprognostic (8.01e-3)"	"unprognostic (7.73e-2)"	"prognostic unfavorable (6.25e-4)"	"unprognostic (1.99e-1)"	"unprognostic (2.80e-3)"	"prognostic unfavorable (2.08e-9)"	"unprognostic (8.90e-2)"	"unprognostic (5.70e-3)"	"unprognostic (8.41e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.91e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.70e-1)"	"unprognostic (3.05e-1)"	"unprognostic (2.44e-2)"	"unprognostic (5.14e-2)"	4.6	1.5	2.6	3.2	2.5	5.8	5.0	2.8	3.1	7.1	2.0	3.1	2.1	3.7	3.4	8.6	4.8	1.5	3.3	2.3	2.9	2.1	1.3	4.1	4.5	2.7	2.6	7.8	3.5	4.0	3.1	9.3	2.6	3.8	3.0	1.8	4.3	2.7	11.0	13.8	3.5	3.1	2.4	3.8	3.4	8.7	2.7	2.6	3.0	3.1	5.7	4.0	7.7	2.7	9.9	4.2	12.8	27.6	9.2	15.9	34.6	11.4	9.6	14.8	12.1	11.1	5.3	33.0	7.5	6.7	11.2	7.2	13.7	9.8	13.9	11.0	11.9	23.8	11.7	6.8	4.8	12.6	8.2	10.1	28.6	17.7	27.7	3.9	8.7	12.6	21.3	11.6	12.2	11.4	5.8	16.6	4.7	10.6	7.0	18.8	12.3	12.1	3.1	10.0	12.1	11.4	6.4	9.1	10.0	11.9	8.8	43.7	5.6	16.7	14.5	10.9	18.1	7.4	29.3	11.6	3.9	24.3	16.8	0.0	0.2	0.2	0.4	0.1	0.7	0.1	0.6	0.9	0.1	0.5	0.3	0.3	0.0	0.5	0.1	0.4	0.3	0.2	2.6	2.5	2.8	3.1	2.3	2.9	2.7	2.6	2.6	2.4	2.7	2.7	7.0	6.4	0.0	1.0	2.4	8.8	4.1	4.7	1.8	1.1	2.0	2.8	2.7	0.0	1.6	0.0	0.0	22.1	2.0	1.6	0.0	1.7	0.3	1.9	2.4	3.7	1.2	2.5	0.4	0.8	104.8	2.8	1.1	3.4	0.0	5.2	1.4	0.7	6.0	0.0	0.9	3.6	0.0	0.8	1.3	0.6	1.5	1.4	1.8	2.8	0.5	1.9	1.0	0.5	1.0	1.1	0.4	0.7	3.1	5.8	1.1	0.3	0.1	2.0	0.0	4.0	3.4	8.2	13.2	4.6	7.1	46.7	2.2	3.4	4.4	3.5
RPL10A	"Csa-19, L10A, NEDD6"	ENSG00000198755	"Ribosomal protein L10a"	P62906	6	35468401-35470785	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA053803	Approved		Supported	"Nucleoli,Endoplasmic reticulum,Cytosol"		NA	NA		740000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"	"Endoplasmic reticulum, Cytosol"	Nucleoli	"HPA053803: AB_2682268"	"unprognostic (5.47e-2)"	"unprognostic (8.02e-2)"	"unprognostic (1.45e-1)"	"unprognostic (3.37e-1)"	"unprognostic (3.40e-2)"	"unprognostic (1.36e-1)"	"unprognostic (3.34e-2)"	"unprognostic (4.74e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.37e-2)"	"unprognostic (9.66e-2)"	"prognostic unfavorable (3.77e-4)"	"unprognostic (2.21e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.16e-1)"	"unprognostic (9.72e-2)"	1323.4	939.9	613.7	824.8	622.4	2051.4	2092.0	591.3	764.2	1803.2	604.3	1445.1	776.4	1350.0	1255.9	1583.0	1911.2	720.6	845.6	594.7	625.1	957.2	840.9	835.2	1625.6	619.7	603.1	3180.4	1894.4	682.3	731.1	747.7	627.8	1322.3	1178.3	255.2	1271.7	1007.2	1411.5	2166.4	1075.0	1114.2	654.0	1063.9	1188.8	230.5	628.8	1585.0	1084.1	1009.5	1733.0	1434.0	1506.3	642.7	1205.5	1211.3	1349.6	1275.9	1967.9	3560.6	1522.8	1213.7	2475.5	1671.2	1320.9	1765.5	1126.2	3571.4	1089.8	1650.2	819.4	1036.0	1832.7	2764.1	1374.0	1249.1	1618.0	1375.9	1007.0	2501.0	2909.6	2031.3	1096.1	4179.2	3172.8	1225.0	4066.4	2689.3	2481.9	1760.1	1652.9	1712.2	1920.0	2112.5	2158.4	2452.2	1421.3	1879.5	1057.5	1681.9	1298.7	2801.6	2124.0	1949.5	945.6	1384.7	747.8	1688.0	3632.5	1076.1	1831.0	3628.9	1450.9	541.4	975.4	729.4	1559.5	1073.4	1889.4	2381.8	681.1	2322.7	992.7	215.5	1232.7	120.6	1478.3	1210.1	2629.7	3176.9	2436.2	1905.6	1990.0	2806.5	3252.5	2601.9	113.1	2069.4	1077.8	1875.3	2059.9	5496.8	613.7	622.4	591.3	764.2	594.7	625.1	619.7	603.1	627.8	654.0	628.8	642.7	973.2	535.2	1036.5	19.2	3101.2	5399.7	5910.9	3550.3	2636.7	221.4	4627.1	4144.2	270.8	1742.9	1828.0	597.7	73.0	4048.8	1980.0	867.3	2983.7	1701.7	243.5	992.0	2446.8	1604.3	1512.3	1533.0	23.1	3272.4	5396.6	1667.3	884.8	1150.5	917.2	2228.2	1601.0	1519.3	2201.2	109.4	23.8	2834.0	1084.4	1989.9	3307.5	430.7	2517.0	1457.1	2406.5	17.8	2486.8	530.4	1845.5	31.7	32.4	2092.1	2269.8	1479.8	1382.6	4479.8	1447.6	2791.4	790.8	252.3	769.2	3139.6	1955.7	236.4	357.1	3510.2	6623.0	4105.6	2341.0	2848.1	3482.8	5438.5
TEAD3	"ETFR-1, TEAD5, TEF-5"	ENSG00000007866	"TEA domain transcription factor 3"	Q99594	6	35473597-35497079	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 66.7;Cytotrophoblasts: 56.4;Extravillous trophoblasts: 70.3;Syncytiotrophoblasts: 159.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 93.7"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA028906	Uncertain					NA	NA				"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"			"HPA028906: AB_10603347"	"unprognostic (1.77e-3)"	"unprognostic (2.40e-2)"	"unprognostic (3.11e-2)"	"prognostic unfavorable (5.09e-4)"	"unprognostic (2.03e-1)"	"unprognostic (4.17e-2)"	"unprognostic (1.76e-2)"	"unprognostic (1.83e-2)"	"unprognostic (9.58e-3)"	"unprognostic (1.68e-1)"	"unprognostic (9.27e-3)"	"unprognostic (4.06e-1)"	"prognostic unfavorable (1.01e-7)"	"unprognostic (2.58e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.22e-1)"	"unprognostic (5.92e-2)"	17.8	6.3	2.4	12.8	2.3	0.2	17.6	2.0	2.6	41.4	4.4	85.8	18.6	79.3	8.5	37.4	50.8	19.9	22.9	2.1	2.0	14.6	12.4	24.2	2.5	4.2	3.0	28.4	10.7	19.5	7.2	34.5	2.4	36.3	16.6	8.2	24.5	42.4	33.2	45.5	26.5	50.3	2.3	9.2	33.4	5.8	2.7	3.6	14.0	11.3	6.6	59.6	38.3	1.7	22.9	3.8	32.4	16.6	14.3	28.2	93.7	30.6	69.2	30.5	31.4	52.6	12.9	0.0	14.6	32.2	12.5	24.6	5.3	17.6	18.6	0.4	5.2	0.1	14.3	36.4	29.7	3.0	0.7	35.7	27.6	27.1	18.7	27.2	1.8	2.2	8.1	0.5	32.3	52.3	1.2	7.7	7.5	21.3	3.7	0.5	12.0	2.1	8.6	42.8	0.6	6.6	9.3	19.9	7.3	39.8	30.6	13.0	2.2	25.8	24.4	9.7	2.4	4.0	4.2	0.1	4.6	0.8	7.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	2.3	2.0	2.6	2.1	2.0	4.2	3.0	2.4	2.3	2.7	1.7	2.1	22.4	10.2	7.8	0.3	18.9	27.6	7.8	18.8	3.1	18.2	16.8	14.9	10.0	12.6	7.3	66.7	56.4	0.3	23.6	3.9	5.7	0.4	8.2	16.9	2.2	3.6	0.0	0.1	7.0	70.3	14.6	9.7	7.9	0.0	5.4	2.2	10.8	5.9	1.7	0.1	13.4	10.2	0.0	2.2	0.7	23.0	1.1	0.0	2.8	1.0	4.0	0.0	5.0	0.2	13.3	12.3	30.5	0.3	26.6	17.7	4.3	10.6	14.5	32.9	17.2	26.8	2.3	4.3	12.6	24.9	159.5	0.9	1.6	15.8	34.3
TULP1	"LCA15, RP14, TUBL1"	ENSG00000112041	"TUB like protein 1"	O00294	6	35497874-35512896	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Phagocytosis, Sensory transduction, Vision"		"Disease variant, Leber congenital amaurosis, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	286	"retina: 209.1"	"Group enriched"	"Detected in some"	5	"Cone photoreceptor cells: 266.9;Rod photoreceptor cells: 393.2"	"Low cancer specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 2.7;MCF7: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Intracellular and membrane"	NA	NA				"Cluster 79: Retina - Phototransduction"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 46: Photoreceptor cells - Phototransduction"				"unprognostic (7.98e-2)"	"unprognostic (2.33e-2)"	"unprognostic (4.38e-2)"	"unprognostic (4.60e-5)"	"unprognostic (2.28e-2)"	"unprognostic (3.12e-3)"		"unprognostic (3.30e-1)"	"unprognostic (5.49e-3)"	"unprognostic (1.85e-1)"	"unprognostic (2.66e-2)"	"unprognostic (7.42e-2)"	"unprognostic (1.66e-6)"	"unprognostic (1.72e-1)"	"unprognostic (1.30e-1)"	"unprognostic (5.42e-2)"	"unprognostic (4.11e-2)"	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.3	0.4	0.3	0.1	0.0	0.3	0.4	0.2	0.5	0.0	0.1	0.2	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.2	0.1	0.0	0.7	0.0	209.1	0.2	0.3	0.0	0.5	0.1	0.0	0.1	0.1	0.1	0.3	0.0	0.0	0.1	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	64.2	0.0	0.0	0.7	0.0	0.0	0.0	266.9	0.2	0.0	0.0	0.0	0.0	0.2	0.1	0.3	2.6	0.0	0.0	0.1	0.0	2.4	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.1	18.5	0.1	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	55.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	393.2	0.0	0.4	0.2	0.1	0.7	0.0	0.0	2.2	0.0	0.0	0.0	0.4
FKBP5	"FKBP51, FKBP54, P54, PPIase, Ptg-10"	ENSG00000096060	"FKBP prolyl isomerase 5"	Q13451	6	35573585-35728583	"Cancer-related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Chaperone, Isomerase, Rotamase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 892.7;tongue: 925.1"	"Cell type enhanced"	"Detected in many"		"Kupffer cells: 384.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 759.3;ASC TERT1: 468.5;HHSteC: 593.0;HSkMC: 718.3;hTCEpi: 368.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009315, HPA031092, HPA031093, HPA031095"	Enhanced		Enhanced	Nucleoplasm		No	No		39000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm		"CAB009315: AB_2278350, HPA031092: AB_10600195, HPA031093: AB_10601748, HPA031095: AB_2673734"	"unprognostic (2.09e-3)"	"unprognostic (1.70e-1)"	"unprognostic (1.44e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.93e-1)"	"unprognostic (4.72e-1)"	"unprognostic (6.30e-3)"	"unprognostic (3.70e-3)"	"unprognostic (1.47e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.73e-1)"	"unprognostic (7.48e-3)"	"unprognostic (2.18e-3)"	"unprognostic (8.31e-2)"	"unprognostic (4.22e-2)"	"unprognostic (6.90e-3)"	400.1	92.3	18.2	70.1	26.8	26.6	160.4	19.7	32.1	86.4	20.2	110.9	11.3	97.5	63.0	130.6	104.6	78.9	93.7	16.8	20.7	108.8	144.5	92.7	166.7	22.7	23.8	122.1	200.4	227.0	52.9	28.5	23.5	85.0	37.1	25.6	61.0	49.8	892.7	114.0	135.7	81.8	17.0	105.6	129.0	41.4	22.1	229.4	97.2	925.1	80.3	108.9	109.1	26.2	40.0	17.1	73.1	109.7	759.3	468.5	1.2	21.2	1.0	13.6	31.0	29.7	6.9	195.3	19.5	4.1	11.8	0.6	44.1	93.2	32.0	77.7	41.6	84.0	14.1	41.7	593.0	53.3	8.3	718.3	368.6	23.7	220.5	14.8	80.1	38.8	91.3	77.1	144.3	25.3	222.5	99.6	18.9	8.7	12.3	97.7	19.1	95.4	60.2	23.7	27.7	16.8	17.3	19.8	4.2	15.9	108.4	62.2	178.7	19.3	17.3	2.8	29.7	34.9	42.9	243.5	6.6	102.3	7.6	57.6	105.0	70.0	64.4	92.3	78.0	9.7	90.6	68.5	107.5	12.5	133.4	96.7	85.1	45.2	46.8	32.0	37.2	158.5	18.2	26.8	19.7	32.1	16.8	20.7	22.7	23.8	23.5	17.0	22.1	26.2	180.2	12.8	11.3	23.2	42.9	17.6	59.2	20.1	37.0	1.9	32.0	20.8	131.8	74.4	14.2	5.5	0.0	1.2	102.0	14.3	23.5	0.6	9.8	55.7	76.1	57.9	20.9	102.2	25.9	7.9	0.8	97.5	18.8	79.2	38.5	54.7	117.1	225.6	35.1	0.0	2.8	35.5	34.6	384.2	44.8	22.0	160.9	192.2	7.2	66.5	110.3	4.6	44.3	16.6	26.3	2.9	19.3	218.6	66.4	49.9	157.0	27.4	18.2	22.6	144.7	188.1	106.8	14.9	19.1	37.5	21.3	0.4	128.7	2.8	39.5	22.2
ARMC12	"C6orf81, FLJ25390"	ENSG00000157343	"Armadillo repeat containing 12"	Q5T9G4	6	35737032-35749079	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"testis: 64.2"	"Group enriched"	"Detected in some"	96	"Early spermatids: 503.3;Late spermatids: 1116.3"	"Cancer enhanced"	"Detected in some"		"glioma: 1.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 4.9;HSkMC: 6.1;MOLT-4: 4.8;U-698: 5.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA030895, HPA075457, HPA075777"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 34: Spermatids - Unknown function"	"Nucleoplasm, Plasma membrane"		"HPA030895: AB_10602114, HPA075457: , HPA075777: "	"unprognostic (1.94e-4)"	"unprognostic (2.21e-1)"	"unprognostic (3.24e-1)"	"unprognostic (1.32e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.52e-1)"	"unprognostic (2.12e-1)"	"unprognostic (4.48e-1)"	"unprognostic (3.52e-2)"	"unprognostic (6.36e-4)"	"unprognostic (8.99e-2)"	"unprognostic (1.17e-12)"	"unprognostic (6.53e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.09e-1)"	1.6	1.7	4.4	0.6	4.4	0.9	1.5	4.0	5.3	2.5	5.1	1.5	0.0	1.7	5.8	0.8	2.8	0.7	0.7	4.3	4.5	1.5	4.5	1.2	1.3	4.6	5.1	3.0	1.3	0.5	11.2	0.2	4.6	3.6	0.3	1.3	0.6	0.8	1.9	1.1	1.7	0.7	4.3	2.8	1.2	64.2	4.3	3.0	2.4	0.5	0.7	1.1	1.7	4.5	0.0	0.3	2.1	2.7	4.9	2.3	0.0	0.1	0.1	0.2	0.2	0.0	0.1	0.5	0.1	0.1	0.8	0.1	0.6	0.1	0.1	1.2	0.6	0.3	0.1	0.0	2.4	0.0	0.0	6.1	1.5	0.1	0.9	2.5	0.5	2.0	0.0	3.2	0.8	0.3	4.8	0.6	0.4	0.0	0.1	2.2	0.0	0.0	0.5	0.0	0.6	2.0	0.0	0.0	0.4	1.0	1.4	0.2	0.0	0.4	0.2	0.1	0.0	0.7	0.2	5.4	0.2	2.8	0.2	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.3	0.1	0.2	0.0	0.2	0.9	0.0	0.0	0.0	0.8	0.0	0.1	4.4	4.4	4.0	5.3	4.3	4.5	4.6	5.1	4.6	4.3	4.3	4.5	0.8	0.0	0.0	4.6	0.1	0.9	1.9	0.2	1.2	0.0	0.3	0.4	0.2	1.5	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	503.3	0.4	0.4	0.8	0.0	0.4	0.3	0.0	0.0	0.6	0.0	0.3	0.0	2.4	0.4	2.8	0.0	0.0	0.5	0.2	0.0	1.2	0.8	1116.3	8.4	1.3	0.0	0.0	0.1	0.8	0.0	0.5	0.3	0.0	0.0	4.1	0.0	0.7	0.2	0.3	0.2	0.2	0.0	0.5	0.4	8.1	6.0	0.7	0.1	0.0	0.3	0.2	0.2	0.4
CLPSL2	"C6orf126, dJ510O8.5, UNQ3045"	ENSG00000196748	"Colipase like 2"	Q6UWE3	6	35776594-35779552	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	102	"epididymis: 532.1"	"Group enriched"	"Detected in some"	4	"Breast glandular cells: 3.4;Breast myoepithelial cells: 2.2;Enteroendocrine cells: 1.8;Exocrine glandular cells: 4.0;Pancreatic endocrine cells: 2.1;Spermatogonia: 2.2"	"Cancer enhanced"	"Detected in some"		"breast cancer: 2.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"T-47d: 6.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA051655	Approved				"Secreted in male reproductive system"	NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 30: Epididymis - Antimicrobial activity"	"Cluster 6: T47d - Mammary gland"	"Cluster 1: Pancreatic cells - Digestion"			"HPA051655: "	"unprognostic (2.38e-1)"	"unprognostic (3.65e-1)"	"unprognostic (6.39e-3)"	"unprognostic (9.38e-2)"	"unprognostic (4.03e-2)"			"unprognostic (2.47e-1)"		"unprognostic (4.85e-3)"	"unprognostic (8.69e-2)"	"unprognostic (3.17e-2)"		"unprognostic (3.95e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.37e-1)"	0.0	0.0	0.3	0.0	0.4	0.1	0.4	0.2	0.8	0.0	0.2	0.0	0.0	0.0	532.1	0.0	0.0	0.0	0.0	0.6	0.4	0.0	0.0	0.0	0.0	0.2	0.4	0.0	5.2	0.0	0.1	0.0	0.2	0.0	0.0	0.0	1.7	0.7	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.3	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.1	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	1.4	0.2	0.2	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.7	0.0	0.6	0.2	0.0	0.0	0.0	0.0	0.5	0.4	0.0	0.3	0.0	0.1	6.3	0.7	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.3	0.4	0.2	0.8	0.6	0.4	0.2	0.4	0.2	0.2	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	2.2	0.1	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.1	0.3	0.1	0.0	0.0	1.8	0.0	0.2	4.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1
CLPSL1	"C6orf127, dJ510O8.6"	ENSG00000204140	"Colipase like 1"	A2RUU4	6	35781019-35793675	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Group enriched"	"Detected in some"	90	"epididymis: 607.6;pancreas: 178.4"	"Cell type enriched"	"Detected in some"	4	"Exocrine glandular cells: 39.0"	"Group enriched"	"Detected in some"	6	"breast cancer: 3.6;cervical cancer: 1.0;endometrial cancer: 2.8;ovarian cancer: 1.8;pancreatic cancer: 3.4"	"Group enriched"	"Detected in many"	4	"amygdala: 1.1;basal ganglia: 2.5;cerebral cortex: 2.3;hippocampal formation: 2.9;white matter: 1.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	17	"T-47d: 8.4"									HPA073155	Enhanced				"Secreted in male reproductive system"	NA	NA				"Cluster 30: Epididymis - Antimicrobial activity"	"Cluster 6: T47d - Mammary gland"	"Cluster 1: Pancreatic cells - Digestion"			"HPA073155: AB_2686576"	"unprognostic (7.97e-2)"	"unprognostic (1.58e-1)"		"unprognostic (4.75e-1)"				"unprognostic (2.54e-1)"		"unprognostic (3.10e-2)"	"unprognostic (2.13e-1)"			"unprognostic (1.97e-1)"	"unprognostic (6.60e-2)"		"unprognostic (7.06e-3)"	0.1	0.3	1.1	0.0	2.5	0.0	4.3	0.3	2.3	0.0	0.2	0.0	0.0	0.0	607.6	0.0	0.0	0.0	0.0	2.9	0.3	0.0	0.0	0.0	0.0	0.3	0.4	0.1	178.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.5	2.3	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	8.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	2.5	0.3	2.3	2.9	0.3	0.3	0.4	0.3	0.3	0.4	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	1.8	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	39.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	8.9	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0
CLPS		ENSG00000137392	Colipase	P04118	6	35794982-35797344	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Digestion, Lipid degradation, Lipid metabolism"		"Diabetes mellitus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	1696	"pancreas: 262086.0"	"Cell type enriched"	"Detected in some"	17	"Exocrine glandular cells: 23175.0"	"Cancer enriched"	"Detected in many"	188	"pancreatic cancer: 1726.0"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA010512	Enhanced				"Secreted to digestive system"	NA	NA		1600000	"Cluster 15: NK-cells - Transcription"	"Cluster 25: Pancreas - Digestion"		"Cluster 1: Pancreatic cells - Digestion"			"HPA010512: AB_1846979"	"unprognostic (2.00e-1)"			"unprognostic (1.11e-1)"						"unprognostic (8.12e-3)"	"unprognostic (2.47e-1)"			"unprognostic (1.33e-1)"	"unprognostic (1.61e-1)"			30.4	6.1	0.9	5.8	1.8	9.0	17.8	0.1	0.7	13.4	0.2	6.8	40.2	6.0	5.6	9.9	3.8	0.0	46.3	1.2	0.1	5.5	17.7	4.1	10.5	0.2	0.2	154.4	262086.0	0.0	6.3	11.9	0.3	7.9	0.0	0.0	41.7	0.0	5.8	8.1	24.0	0.0	0.1	7.9	27.7	4.0	0.6	0.0	3.8	0.0	0.0	3.3	5.1	0.6	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.8	0.0	0.2	0.0	0.6	0.3	0.0	0.2	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.9	1.8	0.1	0.7	1.2	0.1	0.2	0.2	0.3	0.1	0.6	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	28.6	0.0	0.0	0.0	1.1	11.9	0.0	0.0	23175.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.7	0.0	0.0	130.8	0.0	0.0	0.0	0.0	1331.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0
LHFPL5	"DFNB67, dJ510O8.8, MGC33835, Tmhs"	ENSG00000197753	"LHFPL tetraspan subfamily member 5"	Q8TAF8	6	35797206-35845397	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport"		"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 18.8;epididymis: 12.4"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 13.5;Excitatory neurons: 8.0;Glandular and luminal cells: 2.8;Inhibitory neurons: 3.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 3.3"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029421, HPA055110"	Uncertain		Approved	Vesicles		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 6: Brain - Smell perception"	"Cluster 20: HeLa - Mitochondria"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Vesicles		"HPA029421: , HPA055110: AB_2682697"	"unprognostic (2.35e-1)"	"unprognostic (6.45e-2)"	"unprognostic (2.41e-2)"	"unprognostic (1.22e-3)"	"unprognostic (1.96e-1)"	"unprognostic (1.78e-1)"		"unprognostic (4.89e-3)"		"unprognostic (2.96e-3)"	"unprognostic (2.46e-2)"		"unprognostic (1.47e-8)"	"unprognostic (5.53e-2)"	"unprognostic (1.70e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.41e-1)"	0.9	1.1	4.1	2.7	4.6	18.8	0.8	4.8	5.6	0.3	0.3	0.9	3.0	1.5	12.4	1.3	0.6	1.7	0.7	3.6	2.6	0.6	0.8	1.0	2.8	0.0	0.3	1.1	5.6	0.3	0.5	1.3	0.2	1.0	0.7	8.2	2.4	0.4	1.4	7.6	2.5	0.3	0.0	2.2	1.7	1.5	1.9	0.5	1.4	0.2	0.6	0.6	0.0	2.7	2.3	1.5	3.0	3.1	0.2	0.6	4.6	1.6	0.3	0.1	0.4	2.7	2.0	3.6	1.2	0.6	1.9	2.9	0.2	0.8	0.3	1.6	2.6	3.2	5.3	4.0	0.0	3.4	2.2	0.5	0.3	0.3	0.4	2.1	0.2	3.6	3.1	5.1	0.9	1.9	2.5	6.2	2.6	0.7	1.5	2.2	1.1	2.0	0.7	5.6	3.4	1.9	1.6	2.3	1.0	2.9	2.4	1.9	2.6	3.1	1.7	2.5	2.4	3.2	3.0	3.1	1.1	3.6	1.6	2.9	0.6	0.5	0.3	0.3	0.3	0.5	0.3	0.3	0.1	0.9	0.4	0.5	3.3	0.6	0.4	0.7	0.4	0.1	4.1	4.6	4.8	5.6	3.6	2.6	0.0	0.3	0.2	0.0	1.9	2.7	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	13.5	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	1.3	0.7	0.3	0.0	0.4	8.0	0.2	0.0	0.2	0.0	2.8	0.0	0.0	0.0	0.0	0.1	0.0	3.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.8	0.0	0.3	0.3	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0
SRPK1	SFRSK1	ENSG00000096063	"SRSF protein kinase 1"	Q96SB4	6	35832966-35921342	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Chromosome partition, Differentiation, Host-virus interaction, mRNA processing, mRNA splicing"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 379.9;Late spermatids: 599.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 61.0"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 61.0"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016431, HPA056486"	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 31: Spermatids - Spermatogenesis"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA016431: AB_1857478, HPA056486: AB_2683148"	"unprognostic (4.65e-3)"	"unprognostic (6.82e-3)"	"unprognostic (2.54e-3)"	"unprognostic (1.01e-3)"	"unprognostic (7.74e-2)"	"unprognostic (3.31e-2)"	"prognostic unfavorable (7.90e-6)"	"unprognostic (1.23e-2)"	"unprognostic (2.54e-3)"	"unprognostic (2.36e-2)"	"prognostic unfavorable (6.53e-5)"	"unprognostic (7.28e-2)"	"unprognostic (2.21e-3)"	"unprognostic (9.24e-2)"	"unprognostic (4.43e-1)"	"unprognostic (1.01e-1)"	"unprognostic (7.55e-3)"	8.7	6.0	6.4	18.1	8.2	41.7	14.5	10.0	14.8	12.5	6.8	31.2	25.2	12.7	9.3	23.9	8.6	11.9	8.3	8.9	3.7	16.7	16.0	12.9	19.7	4.0	4.1	8.7	23.3	14.5	9.0	14.5	4.3	9.6	35.6	25.8	16.1	10.9	20.0	26.7	23.6	14.2	2.4	17.8	18.0	44.7	5.2	19.9	8.7	12.6	24.3	31.0	16.2	11.6	104.1	39.2	54.9	82.4	30.2	39.3	69.0	62.1	60.1	57.3	60.2	109.0	34.1	139.0	51.8	39.1	65.5	51.3	110.3	74.2	100.6	96.2	79.9	73.5	42.6	93.8	26.7	111.3	34.0	25.6	39.3	66.0	84.7	44.6	72.3	76.4	157.7	55.6	48.2	36.8	111.1	80.8	45.9	62.9	42.7	77.8	67.3	84.1	56.8	169.5	117.5	42.9	65.4	59.3	42.5	55.2	33.3	70.3	54.8	52.4	41.3	37.2	78.6	33.1	78.6	128.5	20.9	124.3	48.1	61.0	4.4	30.6	8.5	5.3	12.1	8.6	11.2	11.5	5.9	6.9	9.2	10.0	50.9	11.2	7.6	3.3	14.9	6.3	6.4	8.2	10.0	14.8	8.9	3.7	4.0	4.1	4.3	2.4	5.2	11.6	26.6	9.6	25.8	18.6	40.0	42.3	119.3	91.0	67.7	36.8	25.8	22.7	28.7	14.3	51.4	22.0	37.5	54.3	33.1	51.6	29.4	55.4	379.9	29.9	40.2	29.2	46.2	46.7	74.2	68.2	53.2	25.1	46.9	54.0	7.6	44.1	13.2	41.8	21.6	10.1	50.0	50.8	32.6	16.3	19.9	599.1	22.1	20.0	16.0	24.4	31.5	16.8	32.0	30.2	29.7	100.4	47.9	24.8	68.0	117.9	50.8	59.4	33.8	92.9	6.6	17.8	48.9	197.3	100.4	126.8	41.8	39.7	43.6	33.7	90.7	162.6
SLC26A8		ENSG00000112053	"Solute carrier family 26 member 8"	Q96RN1	6	35943516-36024868	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Anion exchange, Differentiation, Ion transport, Meiosis, Spermatogenesis, Transport"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"testis: 44.0"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 54.1;Excitatory neurons: 15.8;Inhibitory neurons: 12.1;Late spermatids: 12.0;Spermatocytes: 64.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Immune cell enriched"	"Detected in single"	11	"neutrophil: 2.3"	"Lineage enriched"	"Detected in single"	11	"granulocytes: 2.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA038081	Enhanced					NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 78: Testis - Spermatogenesis"		"Cluster 66: Spermatocytes - Spermatogenesis"			"HPA038081: AB_10670653"	"unprognostic (8.18e-2)"	"unprognostic (1.74e-1)"	"unprognostic (6.71e-2)"	"unprognostic (1.31e-2)"	"unprognostic (2.46e-1)"	"unprognostic (7.07e-3)"	"unprognostic (2.93e-1)"	"unprognostic (6.31e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.85e-1)"	"unprognostic (3.78e-1)"	"unprognostic (4.63e-6)"	"unprognostic (7.14e-2)"	"unprognostic (4.24e-1)"	"unprognostic (2.31e-1)"	"unprognostic (5.24e-8)"	0.2	0.1	0.6	0.3	0.5	4.8	0.1	0.8	0.8	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.4	1.1	0.0	0.1	0.3	0.0	0.9	0.6	0.0	0.1	0.0	0.2	0.1	1.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.3	1.0	0.0	44.0	0.9	0.0	0.2	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.1	0.6	0.5	0.8	0.8	0.4	1.1	0.9	0.6	1.1	0.3	0.9	0.2	0.1	3.2	1.1	2.0	0.0	0.4	0.4	0.1	0.0	0.3	0.1	0.1	0.6	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	54.1	0.4	0.2	0.3	0.0	0.0	15.8	0.0	0.0	0.3	0.0	0.8	0.0	0.1	0.4	0.8	0.1	0.0	12.1	0.0	0.0	1.2	0.4	12.0	0.9	0.5	1.8	1.0	0.9	0.0	0.0	0.5	1.0	0.1	0.0	0.4	0.1	0.4	0.3	0.1	0.3	0.3	0.0	0.7	0.1	64.8	0.8	0.0	0.1	0.3	0.3	0.0	0.0	0.2
MAPK14	"CSBP1, CSBP2, CSPB1, Mxi2, p38, PRKM14, PRKM15"	ENSG00000112062	"Mitogen-activated protein kinase 14"	Q16539	6	36027677-36111236	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Apoptosis, Stress response, Transcription, Transcription regulation"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 104.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"basophil: 79.0;neutrophil: 24.9"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 79.0"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010285, CAB040578, HPA051825"	Approved		Supported	"Nuclear speckles,Cytosol"		NA	NA		970000	"Cluster 38: Basophils - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 32: U-937 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Nuclear speckles"	Cytosol	"CAB010285: AB_632140, CAB040578: , HPA051825: "	"unprognostic (6.76e-3)"	"unprognostic (6.28e-2)"	"unprognostic (6.30e-3)"	"unprognostic (3.30e-3)"	"unprognostic (6.98e-2)"	"unprognostic (4.04e-2)"	"unprognostic (8.10e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.20e-3)"	"unprognostic (8.39e-2)"	"unprognostic (6.27e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.47e-2)"	"unprognostic (3.66e-3)"	"unprognostic (6.66e-2)"	"unprognostic (3.25e-1)"	"unprognostic (1.58e-1)"	29.9	26.1	15.2	31.5	16.5	89.3	23.8	19.2	17.1	30.8	19.3	26.6	27.9	37.2	15.8	32.3	25.7	23.5	25.7	17.2	18.2	23.9	41.4	28.3	28.0	11.5	11.7	22.2	18.3	20.6	19.3	44.6	12.1	19.6	29.0	14.8	21.0	24.4	33.5	34.4	26.2	39.0	13.0	44.9	22.5	9.1	18.1	38.6	31.1	31.9	33.3	32.3	29.2	13.8	49.7	26.7	28.3	44.9	60.0	59.8	62.2	50.2	64.8	58.7	60.3	67.3	24.8	40.4	49.6	54.9	28.0	34.8	47.2	43.7	60.9	47.3	37.6	94.9	37.2	53.1	33.2	60.3	54.9	43.1	40.5	42.2	40.9	47.6	67.1	67.2	52.4	49.1	40.3	21.1	62.2	62.5	17.0	29.9	26.2	71.7	45.5	37.5	38.5	67.6	21.8	17.2	46.0	33.5	50.3	34.1	40.8	99.9	47.9	52.5	29.8	33.6	47.7	24.3	59.8	39.5	23.2	112.1	43.9	79.0	10.3	6.3	4.5	7.2	5.5	3.1	4.4	5.1	8.2	5.3	4.6	4.7	24.9	6.1	10.8	4.0	5.8	5.1	15.2	16.5	19.2	17.1	17.2	18.2	11.5	11.7	12.1	13.0	18.1	13.8	24.4	32.1	13.9	37.2	22.6	15.9	11.0	13.9	28.5	18.9	14.0	11.7	25.0	14.3	18.5	18.4	31.3	45.4	26.8	29.0	1.9	13.9	3.6	18.7	25.8	22.6	16.8	47.1	104.9	11.3	18.7	25.9	21.9	30.7	21.0	17.7	28.9	52.9	25.3	11.8	79.2	25.4	10.2	51.7	24.9	5.2	24.5	38.5	10.6	52.5	58.7	10.9	39.1	46.8	69.6	22.8	16.2	26.7	27.7	10.3	33.7	17.2	20.9	22.5	13.1	20.4	15.7	9.9	8.5	27.1	19.0	23.9	28.0	12.3	18.8	10.7
MAPK13	"p38delta, PRKM13, SAPK4"	ENSG00000156711	"Mitogen-activated protein kinase 13"	O15264	6	36127809-36144524	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Cell cycle, Stress response, Transcription, Transcription regulation"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 102.4"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 146.2;Late spermatids: 282.5;Proximal enterocytes: 178.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 63.8;RPMI-8226: 40.2;RT4: 47.0"	"Low region specificity"	"Detected in single"			"Region enriched"	"Detected in all"	14	"cerebellum: 37.5"	"HPA007667, CAB025854"	Enhanced		Approved	"Nucleoplasm,Nucleoli,Nucleoli rim,Cytosol"		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 30: Mammary glandular cells - Lactation"	"Nucleoplasm, Nucleoli, Nucleoli rim, Cytosol"		"CAB025854: , HPA007667: AB_1079867"	"unprognostic (6.36e-2)"	"unprognostic (6.88e-2)"	"unprognostic (2.93e-1)"	"unprognostic (6.64e-3)"	"unprognostic (1.13e-2)"	"unprognostic (4.80e-2)"	"unprognostic (4.30e-3)"	"unprognostic (5.28e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.14e-2)"	"unprognostic (1.57e-1)"	"unprognostic (7.21e-2)"	"prognostic favorable (9.00e-4)"	"unprognostic (3.12e-2)"	"unprognostic (1.70e-1)"	"unprognostic (2.21e-2)"	"unprognostic (1.41e-1)"	8.7	55.9	3.1	8.8	3.0	9.4	14.2	0.5	4.4	18.6	0.0	44.6	30.9	3.4	11.5	102.4	7.6	7.5	2.5	2.9	2.2	17.3	6.7	23.8	7.9	0.6	0.0	5.4	47.7	38.9	33.3	5.6	0.2	16.7	24.4	2.7	49.5	15.5	1.2	74.1	40.1	1.9	0.1	16.1	24.1	40.0	4.2	6.9	18.9	1.0	12.4	12.2	39.3	2.7	31.4	0.3	0.7	0.5	2.4	11.2	4.3	3.3	0.4	0.3	0.8	22.3	28.4	7.0	2.0	2.5	4.6	24.4	0.3	63.8	0.7	20.0	7.9	0.2	1.2	22.8	4.0	0.4	2.2	9.2	25.9	4.3	1.0	4.5	4.1	1.2	0.6	9.4	0.9	12.7	0.4	2.6	0.4	30.9	0.4	21.0	0.5	40.2	11.6	47.0	30.5	0.7	2.5	0.5	0.2	1.3	33.0	4.1	6.3	2.4	0.4	1.0	0.7	0.8	12.7	2.3	0.1	1.3	0.2	7.6	0.4	6.5	18.3	0.1	12.3	13.9	14.5	15.4	0.1	22.0	12.8	14.4	4.6	3.8	0.1	0.2	38.0	8.6	3.1	3.0	0.5	4.4	2.9	2.2	0.6	0.0	0.2	0.1	4.2	2.7	1.5	28.9	33.0	1.0	16.4	27.3	43.5	24.9	15.4	0.7	58.8	17.7	1.7	25.8	27.3	29.5	6.2	55.3	14.9	146.2	15.6	56.9	110.3	9.1	2.8	2.1	65.5	0.0	10.0	115.9	11.8	5.0	32.1	26.2	2.5	21.1	1.1	1.7	40.3	0.0	6.7	83.2	34.6	6.8	3.3	282.5	7.2	8.8	17.8	3.7	14.2	2.1	21.6	1.5	1.2	103.6	102.2	9.8	11.4	37.1	178.4	11.5	3.7	2.4	0.0	2.2	3.4	56.6	2.9	62.6	53.3	32.3	18.5	2.5	93.0	59.9
BRPF3	KIAA1286	ENSG00000096070	"Bromodomain and PHD finger containing 3"	Q9ULD4	6	36196744-36232790	"Plasma proteins, Predicted intracellular proteins"		"Chromatin regulator"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA022787	Uncertain		Approved	Nucleoplasm,Mitochondria		No	No			"Cluster 46: Basophils - DNA binding"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	Mitochondria	"HPA022787: AB_1845454"	"unprognostic (1.44e-1)"	"unprognostic (2.24e-1)"	"unprognostic (5.52e-2)"	"unprognostic (2.15e-2)"	"unprognostic (2.98e-1)"	"unprognostic (9.51e-2)"	"unprognostic (5.33e-2)"	"unprognostic (3.78e-1)"	"unprognostic (3.02e-2)"	"unprognostic (1.07e-1)"	"unprognostic (7.98e-2)"	"unprognostic (3.74e-1)"	"unprognostic (3.59e-2)"	"unprognostic (3.29e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.28e-1)"	6.6	11.9	3.5	7.6	4.3	12.1	8.4	9.0	5.4	8.4	0.1	13.1	11.7	11.9	6.1	7.9	8.8	8.6	7.3	5.5	1.9	11.8	6.9	7.4	6.2	0.6	1.4	11.9	18.0	14.5	4.4	7.5	0.7	9.6	12.9	6.4	15.7	10.9	12.1	12.6	13.8	10.2	0.3	9.0	10.7	19.9	2.1	9.4	12.1	12.2	6.2	7.4	4.7	4.0	10.6	10.0	24.6	19.4	13.3	11.2	21.0	15.6	16.3	21.5	16.9	29.4	9.8	16.3	16.4	15.4	27.0	10.0	21.8	11.2	18.8	15.6	13.5	11.5	9.3	17.6	14.0	9.1	15.5	14.4	9.4	25.6	12.8	15.6	16.3	7.7	24.5	14.6	11.9	15.0	10.4	3.9	12.4	12.9	8.5	29.9	10.1	5.1	6.9	21.4	35.0	11.0	12.7	13.8	12.9	15.1	15.4	24.6	17.2	22.3	18.9	6.1	18.3	12.0	16.8	12.1	3.7	14.1	26.9	0.7	0.0	0.3	0.4	0.0	0.4	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.4	0.0	0.0	0.1	0.2	0.1	3.5	4.3	9.0	5.4	5.5	1.9	0.6	1.4	0.7	0.3	2.1	4.0	5.7	6.4	12.7	8.8	5.6	9.6	7.2	4.6	9.6	9.0	21.1	11.7	13.7	10.0	7.3	5.5	6.2	4.8	9.7	28.1	0.0	6.6	15.3	7.3	10.9	7.2	19.7	5.7	16.6	10.8	4.1	9.8	10.2	12.7	2.5	16.6	9.7	18.2	4.5	0.0	11.4	27.5	6.1	5.7	6.6	14.0	11.1	4.9	7.2	6.5	5.4	6.1	9.2	13.6	11.0	11.2	13.6	9.4	10.5	11.3	21.5	13.5	4.5	7.2	0.0	11.1	8.0	25.7	17.5	7.3	11.4	8.2	6.3	14.2	16.2	10.2
PNPLA1	"dJ50J22.1, FLJ38755"	ENSG00000180316	"Patatin like phospholipase domain containing 1"	Q8N8W4	6	36243203-36313955	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Lipid biosynthesis, Lipid metabolism"	Transferase	"Disease variant, Ichthyosis"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"skin 1: 23.9"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 1.9;granulocytes: 4.5;Oligodendrocyte precursor cells: 1.5;Proximal enterocytes: 1.5;Proximal tubular cells: 3.8;Suprabasal keratinocytes: 3.7"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 1.0"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	7	"basophil: 69.8;eosinophil: 18.9"	"Lineage enriched"	"Detected in many"	17	"granulocytes: 69.8"	"Cell line enriched"	"Detected in some"	4	"U-937: 17.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 61: Skin - Cornification"	"Cluster 32: U-937 - Innate immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"				"unprognostic (3.57e-2)"	"unprognostic (2.04e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.95e-4)"	"unprognostic (1.69e-1)"	"unprognostic (1.47e-1)"	"unprognostic (7.37e-2)"	"unprognostic (2.49e-1)"	"unprognostic (8.89e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.95e-1)"	"unprognostic (2.76e-2)"	"unprognostic (2.70e-2)"	"unprognostic (9.85e-2)"	"unprognostic (2.06e-1)"	"unprognostic (2.04e-2)"	"unprognostic (1.65e-2)"	0.1	0.2	0.1	0.6	0.2	4.3	0.6	0.3	0.4	0.3	0.0	0.1	0.7	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.1	4.7	0.1	0.2	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.1	0.0	0.0	0.2	23.9	0.9	0.2	0.1	0.7	1.7	1.0	0.2	0.1	0.1	0.0	0.1	0.2	0.6	0.3	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.7	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	3.9	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.0	17.6	0.0	69.8	4.0	18.9	0.0	2.2	0.0	0.0	0.0	0.0	1.8	0.1	0.0	0.2	6.2	0.1	1.1	0.0	0.0	1.1	0.1	0.2	0.3	0.4	0.1	0.1	0.2	0.0	0.2	0.1	0.2	0.3	0.0	0.0	0.0	1.0	0.0	0.9	0.5	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.1	0.1	0.0	0.0	1.9	0.0	0.0	0.1	0.0	0.2	4.5	0.7	0.0	0.0	0.2	0.0	1.2	0.4	0.0	0.0	0.3	1.3	0.0	0.1	0.0	0.0	0.7	0.0	0.0	1.5	0.7	0.1	0.0	0.0	0.0	0.1	1.5	3.8	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	3.7	0.1	0.0	0.4	0.2	0.2
BNIP5	"C6orf222, DKFZp779B1540"	ENSG00000189325	"BCL2 interacting protein 5"	P0C671	6	36315761-36336888	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"intestine: 24.7"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	19	"colorectal cancer: 8.7;pancreatic cancer: 5.1;stomach cancer: 8.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Daudi: 1.0;OE19: 2.3;REH: 1.0;U-937: 1.1"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA038407, HPA058189"	Uncertain		Approved	Cytosol		NA	NA				"Cluster 56: Intestine - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"		Cytosol		"HPA038407: AB_10669644, HPA058189: AB_2683634"	"unprognostic (1.97e-5)"	"unprognostic (5.46e-3)"	"unprognostic (3.93e-1)"	"unprognostic (1.49e-1)"	"unprognostic (7.52e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.81e-1)"	"unprognostic (4.13e-1)"		"unprognostic (1.22e-1)"	"unprognostic (1.03e-1)"	"unprognostic (6.75e-2)"	"unprognostic (3.04e-2)"	"unprognostic (4.55e-2)"	"unprognostic (3.16e-2)"	"unprognostic (3.98e-1)"	"unprognostic (1.66e-4)"	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.7	24.7	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.1	0.0	0.1	0.0	5.7	0.0	0.0	0.0	0.0	0.2	23.5	0.1	0.0	0.0	4.2	1.1	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	1.0	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ETV7	"TEL-2, TEL2"	ENSG00000010030	"ETS variant transcription factor 7"	Q9Y603	6	36354091-36387800	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 16.0;skin 1: 15.4"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 19.2;Cytotrophoblasts: 28.8;Exocrine glandular cells: 23.8;Proximal enterocytes: 21.5;Spermatogonia: 26.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 18.9;T-reg: 16.3"	"Group enriched"	"Detected in many"	4	"granulocytes: 18.9;monocytes: 5.7;T-cells: 16.3"	"Cell line enhanced"	"Detected in some"		"BEWO: 27.1;BJ hTERT+ SV40 Large T+: 14.7;BJ hTERT+ SV40 Large T+ RasG12V: 27.8;HDLM-2: 59.7"					"Low region specificity"	"Detected in all"			HPA029033	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 31: Skin - Epidermis development"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm		"HPA029033: AB_10601375"	"unprognostic (1.67e-2)"	"prognostic favorable (5.16e-4)"	"unprognostic (9.48e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.62e-3)"	"unprognostic (9.08e-2)"	"unprognostic (4.11e-2)"	"unprognostic (2.08e-2)"	"prognostic favorable (5.32e-4)"	"unprognostic (6.81e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.69e-3)"	"unprognostic (5.54e-2)"	"unprognostic (4.93e-1)"	"unprognostic (1.27e-2)"	"prognostic favorable (2.95e-6)"	1.9	2.1	1.5	6.9	1.5	0.9	2.1	1.0	1.7	2.1	1.4	3.3	16.0	1.0	1.3	3.6	2.2	3.4	0.4	1.5	1.4	2.3	2.9	4.9	5.3	2.2	1.2	1.5	1.6	2.2	3.8	3.6	2.1	2.9	2.6	0.4	8.6	1.5	0.2	15.4	12.7	1.0	2.1	3.1	6.2	1.1	1.4	4.0	1.2	0.3	3.9	5.5	2.5	1.4	3.2	0.0	0.2	0.1	0.0	0.2	27.1	0.0	9.2	14.7	27.8	0.5	6.2	0.1	0.7	0.2	2.3	3.3	0.4	1.7	0.7	59.7	0.5	0.5	0.0	0.0	1.8	0.0	0.3	1.2	2.4	0.7	0.2	0.0	0.4	0.0	0.1	0.2	0.3	0.1	0.2	0.3	0.2	0.3	0.1	6.1	0.1	0.2	0.2	1.1	0.8	0.0	0.6	2.1	0.5	0.0	3.1	0.6	0.2	0.3	0.7	0.3	0.1	0.1	0.1	0.2	0.0	2.7	0.4	0.0	3.7	0.3	1.6	5.7	3.9	3.3	5.4	2.2	0.9	2.4	1.0	1.4	18.9	0.6	1.9	0.0	16.3	2.5	1.5	1.5	1.0	1.7	1.5	1.4	2.2	1.2	2.1	2.1	1.4	1.4	1.4	19.2	14.8	0.3	1.2	2.0	2.2	8.0	6.2	0.2	2.5	2.7	0.5	7.2	7.1	0.0	0.0	28.8	0.7	6.6	0.0	12.4	0.4	0.4	1.4	1.1	3.6	0.0	0.5	23.8	6.6	2.7	8.2	0.7	2.5	1.7	0.0	0.4	2.9	0.0	0.3	6.5	6.1	1.3	1.6	0.5	1.5	1.0	3.6	0.0	6.5	3.1	1.0	0.0	0.3	13.4	7.8	1.2	5.6	4.8	21.5	1.3	3.0	0.6	0.0	1.0	5.5	0.9	26.8	6.4	3.7	8.5	3.6	0.7	7.6	4.8
PXT1	STEPP	ENSG00000179165	"Peroxisomal testis enriched protein 1"	Q8NFP0	6	36390551-36442854	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	6	"testis: 2.3"	"Group enriched"	"Detected in some"	4	"Spermatocytes: 10.6;Spermatogonia: 4.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	4	"HDLM-2: 2.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA044042			Approved	Vesicles		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Vesicles		"HPA044042: AB_10963537"	"unprognostic (1.85e-2)"	"unprognostic (1.12e-3)"	"unprognostic (9.92e-2)"	"unprognostic (5.49e-2)"	"unprognostic (4.43e-1)"	"unprognostic (9.38e-2)"	"unprognostic (2.28e-2)"	"unprognostic (2.92e-3)"	"unprognostic (4.64e-2)"	"unprognostic (1.92e-1)"	"unprognostic (5.86e-2)"	"unprognostic (3.15e-1)"	"unprognostic (4.94e-5)"	"unprognostic (2.98e-1)"	"unprognostic (2.16e-1)"	"unprognostic (7.21e-3)"	"unprognostic (2.61e-3)"	0.1	0.0	0.2	0.3	0.1	0.2	0.1	0.2	0.3	0.0	0.1	0.0	0.3	0.1	0.2	0.0	0.1	0.2	0.1	0.2	0.1	0.0	0.0	0.2	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.3	0.1	0.1	0.0	0.1	0.1	0.0	2.3	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.1	0.0	0.3	0.0	0.4	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.2	0.3	0.2	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.3	0.0	0.0	1.0	0.3	0.0	0.2	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.1	0.0	0.0	0.9	0.2	0.4	0.1	0.0	0.0	0.7	0.2	0.1	0.2	1.1	0.4	0.0	0.2	0.0	0.0	0.1	0.0	0.7	0.2	0.0	1.8	0.0	0.7	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.0	0.0	1.2	0.1	0.3	0.1	0.0	0.0	0.0	0.1	0.2	10.6	4.9	0.0	0.0	0.3	0.5	0.1	0.2	0.2
KCTD20	"C6orf69, dJ108K11.3, MGC14254"	ENSG00000112078	"Potassium channel tetramerization domain containing 20"	Q7Z5Y7	6	36442767-36491143	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Langerhans cells: 126.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030092	Approved		Approved	"Nuclear speckles,Endoplasmic reticulum"		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 41: Macrophages - Immune response"	"Endoplasmic reticulum"	"Nuclear speckles"	"HPA030092: AB_10601437"	"unprognostic (2.17e-1)"	"unprognostic (2.02e-1)"	"unprognostic (5.20e-3)"	"unprognostic (2.43e-2)"	"unprognostic (1.00e-3)"	"unprognostic (5.03e-3)"	"prognostic unfavorable (8.32e-4)"	"unprognostic (3.63e-1)"	"unprognostic (1.80e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.22e-1)"	"unprognostic (8.05e-2)"	"prognostic unfavorable (8.02e-4)"	"unprognostic (1.18e-1)"	"unprognostic (1.31e-1)"	"prognostic unfavorable (9.31e-4)"	"unprognostic (2.94e-2)"	41.6	25.9	15.3	28.1	16.7	27.7	21.3	16.0	16.4	23.7	14.8	21.5	14.3	25.7	15.4	28.1	19.5	28.9	18.0	15.6	19.5	16.0	31.2	22.0	27.6	18.6	19.4	22.8	12.8	14.6	11.9	26.0	18.6	19.3	18.1	10.9	14.6	21.0	20.7	29.6	15.7	31.5	16.3	25.3	14.7	10.3	17.0	34.8	14.3	18.9	29.5	28.6	17.6	17.5	36.7	16.9	47.0	90.4	62.8	41.3	23.4	43.7	60.4	46.9	52.2	43.6	20.8	124.3	38.2	72.4	26.8	33.3	62.3	31.4	77.3	90.3	34.9	70.3	26.0	46.5	29.9	68.9	46.8	41.1	32.5	36.1	23.0	31.2	48.7	64.1	112.8	68.2	44.9	33.1	78.5	26.6	17.5	29.1	15.3	78.0	53.4	68.8	25.5	40.6	11.4	65.9	38.4	38.6	116.6	46.6	53.5	68.1	56.4	126.2	43.4	37.5	55.0	53.0	132.9	87.8	21.7	93.7	131.4	29.7	17.4	11.4	8.1	15.1	9.4	6.8	6.5	6.8	16.3	5.6	6.5	6.6	12.5	7.8	8.9	9.0	8.6	13.9	15.3	16.7	16.0	16.4	15.6	19.5	18.6	19.4	18.6	16.3	17.0	17.5	38.3	38.5	23.7	21.9	28.6	50.1	19.6	15.2	24.5	22.4	23.7	23.9	15.9	28.6	22.2	16.5	10.4	26.3	45.4	14.0	1.9	18.2	0.7	20.0	33.8	38.3	15.1	64.6	23.3	14.2	18.9	38.9	23.9	24.6	53.8	40.8	44.6	45.6	26.7	15.2	23.3	15.5	12.2	51.3	126.3	2.3	31.7	61.4	33.8	27.2	58.4	18.1	30.9	22.6	26.5	19.5	16.3	53.4	48.7	18.9	18.8	19.0	22.5	10.5	19.7	35.8	42.7	8.1	27.2	27.6	63.4	23.0	39.6	23.8	16.1	32.2
STK38	"NDR, NDR1"	ENSG00000112079	"Serine/threonine kinase 38"	Q15208	6	36493892-36547479	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"NK-cells: 101.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004673, HPA038623, HPA051324"	Uncertain		Approved	Cytosol		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 63: NK-cells & T-cells - Immune response"	Cytosol		"CAB004673: AB_425892, HPA038623: AB_10967059, HPA051324: AB_2681442"	"unprognostic (3.58e-3)"	"unprognostic (1.80e-2)"	"unprognostic (3.07e-2)"	"unprognostic (6.76e-3)"	"unprognostic (8.25e-2)"	"unprognostic (1.47e-2)"	"unprognostic (2.88e-3)"	"unprognostic (2.08e-1)"	"prognostic unfavorable (9.44e-5)"	"unprognostic (3.78e-2)"	"unprognostic (2.18e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.98e-2)"	"unprognostic (3.80e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.13e-3)"	27.6	11.5	13.2	28.9	13.6	30.6	23.2	15.8	18.1	23.5	15.2	40.4	24.0	21.3	12.5	39.6	21.4	20.7	24.2	14.2	13.4	23.1	24.7	24.9	34.5	14.4	13.4	16.0	12.5	8.3	14.4	21.7	13.6	23.8	36.5	11.3	33.6	16.0	16.1	30.6	41.6	27.4	13.0	34.6	23.2	13.8	14.8	28.0	14.0	16.2	33.8	30.0	28.4	14.2	43.0	31.1	32.1	34.8	63.4	47.9	27.9	46.7	37.6	47.6	47.4	24.0	28.7	57.3	35.3	70.0	39.5	44.7	26.9	19.6	55.7	23.6	23.0	41.1	40.8	21.9	31.2	15.8	21.7	31.9	50.0	36.9	23.6	54.5	30.1	28.7	34.0	32.4	68.5	25.7	25.5	40.8	13.4	50.5	27.3	97.7	38.9	15.3	45.0	52.9	37.4	17.7	57.0	25.9	34.0	35.7	27.8	40.8	29.4	38.4	33.6	30.9	30.7	27.1	51.4	39.9	8.7	60.1	37.8	91.2	45.2	34.6	57.0	49.5	44.1	22.4	46.9	50.4	29.1	16.2	41.1	45.8	59.4	59.3	73.3	14.4	48.7	58.3	13.2	13.6	15.8	18.1	14.2	13.4	14.4	13.4	13.6	13.0	14.8	14.2	29.7	19.2	16.0	27.4	25.7	13.5	9.6	21.5	21.1	3.0	16.0	14.5	15.5	18.6	47.9	7.3	0.0	13.8	59.5	47.1	1.9	18.9	9.0	15.3	16.0	18.4	14.4	16.6	46.5	12.7	17.8	22.2	34.7	20.4	13.3	13.5	12.1	15.0	13.2	5.0	34.2	25.4	22.4	38.2	20.3	5.3	27.1	40.1	17.8	57.1	48.7	7.6	101.0	38.2	36.8	27.8	30.8	30.1	39.6	12.8	32.8	16.6	40.4	7.7	13.1	8.3	14.0	26.5	10.3	31.5	21.2	15.3	45.5	10.1	28.4	27.9
SRSF3	"SFRS3, SRp20"	ENSG00000112081	"Serine and arginine rich splicing factor 3"	P84103	6	36594353-36605600	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing, mRNA transport, Transport"	RNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012986, HPA056981"	Supported		Supported	Nucleoplasm		NA	NA		1600000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"CAB012986: AB_2533150, HPA056981: AB_2683299"	"unprognostic (3.25e-1)"	"unprognostic (1.08e-3)"	"prognostic favorable (2.56e-4)"	"unprognostic (8.19e-2)"	"unprognostic (2.06e-2)"	"unprognostic (2.77e-2)"	"prognostic unfavorable (6.22e-5)"	"unprognostic (2.92e-2)"	"prognostic unfavorable (1.95e-4)"	"prognostic favorable (1.37e-4)"	"unprognostic (9.61e-2)"	"unprognostic (1.21e-1)"	"prognostic unfavorable (2.02e-4)"	"unprognostic (9.88e-2)"	"unprognostic (3.33e-2)"	"unprognostic (8.33e-2)"	"unprognostic (1.06e-2)"	97.2	62.5	39.2	93.5	40.9	172.3	90.2	43.6	44.0	72.6	42.4	89.6	54.0	76.1	62.5	97.8	78.0	40.5	70.2	40.1	43.8	83.3	75.3	68.8	118.9	40.0	40.6	84.0	58.0	62.3	49.2	74.6	41.6	58.6	95.2	45.2	57.8	64.6	76.0	66.4	73.2	89.9	43.1	67.2	74.9	59.9	44.0	164.3	60.7	48.5	147.9	97.7	72.0	45.5	357.2	232.3	401.4	308.9	151.9	117.9	247.2	248.4	206.5	408.6	312.2	275.1	248.2	593.4	174.3	273.3	266.8	275.1	533.1	395.4	433.2	279.3	327.3	357.0	175.5	312.3	184.9	485.2	289.6	105.8	131.6	267.4	295.6	130.3	315.2	354.4	438.7	244.1	300.8	277.4	601.0	457.0	424.5	414.5	241.5	527.3	384.2	355.9	292.2	291.1	308.7	291.8	276.1	267.4	385.4	284.9	271.2	513.1	207.9	208.1	303.9	211.0	380.1	238.6	381.4	822.9	178.4	443.7	295.5	85.6	179.0	57.9	145.8	176.6	166.0	129.0	136.8	154.7	350.7	113.5	136.1	140.8	17.1	190.5	125.1	206.8	184.2	305.6	39.2	40.9	43.6	44.0	40.1	43.8	40.0	40.6	41.6	43.1	44.0	45.5	648.3	201.9	238.6	47.3	337.6	469.6	425.1	308.4	225.9	146.2	371.3	388.4	227.9	198.8	258.0	125.0	54.2	495.6	574.3	245.3	363.9	357.3	176.1	216.0	295.7	346.9	332.9	345.9	24.0	324.9	816.9	373.6	226.8	251.1	396.8	275.2	243.8	182.7	359.3	99.3	23.8	409.9	191.2	262.9	559.3	321.2	211.9	356.5	334.4	45.9	366.3	368.8	334.8	38.2	51.1	290.1	301.9	172.3	256.3	401.7	259.2	274.7	164.8	154.5	203.8	497.3	448.2	374.2	290.8	312.2	445.8	526.1	415.2	184.1	427.4	285.1
CDKN1A	"CAP20, CDKN1, CIP1, P21, p21CIP1, p21Cip1/Waf1, SDI1, WAF1"	ENSG00000124762	"Cyclin dependent kinase inhibitor 1A"	P38936	6	36676460-36687337	"Cancer-related genes, Human disease related genes, Predicted intracellular proteins"	"Cell cycle"	"Protein kinase inhibitor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"non-classical monocyte: 74.5"	"Group enriched"	"Detected in many"	9	"B-cells: 20.7;dendritic cells: 21.5;monocytes: 74.5"	"Cell line enhanced"	"Detected in many"		"HHSteC: 798.5;HSkMC: 586.5;hTCEpi: 775.8;LHCN-M2: 604.2"	"Region enhanced"	"Detected in all"		"olfactory bulb: 76.0"	"Low region specificity"	"Detected in all"			"CAB000064, HPA005946, CAB069401"	Supported		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 7: Non-specific - Mitochondria"	"Nucleoplasm, Nuclear bodies"		"CAB000064: , CAB069401: AB_1620493, HPA005946: AB_2667477"	"unprognostic (7.99e-3)"	"unprognostic (4.01e-2)"	"unprognostic (1.58e-1)"	"prognostic favorable (3.14e-5)"	"unprognostic (1.57e-2)"	"unprognostic (2.19e-2)"	"unprognostic (1.39e-2)"	"prognostic unfavorable (7.05e-4)"	"unprognostic (1.30e-1)"	"unprognostic (7.27e-2)"	"unprognostic (2.79e-2)"	"unprognostic (7.55e-3)"	"prognostic favorable (4.95e-5)"	"unprognostic (8.32e-2)"	"unprognostic (6.52e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.21e-2)"	322.1	98.1	47.0	62.1	48.1	72.7	144.2	47.3	60.9	123.3	85.9	119.0	115.2	74.4	41.0	203.2	213.9	132.6	170.6	47.2	49.5	149.9	173.4	182.2	17.3	63.7	54.6	184.9	130.5	70.1	104.4	44.7	53.4	91.4	108.2	29.2	79.1	29.4	241.6	224.4	130.0	114.3	55.0	34.4	121.3	47.0	50.3	59.7	77.5	26.9	21.8	212.7	142.3	53.6	27.0	108.1	80.1	2.0	273.3	490.3	149.5	435.6	344.8	52.3	203.7	9.6	25.3	18.3	15.5	267.9	48.0	60.2	3.7	477.7	82.4	36.2	22.0	3.0	85.8	137.0	798.5	0.5	127.7	586.5	775.8	476.2	147.1	309.3	275.3	1.4	5.1	120.8	604.2	57.4	3.9	11.3	10.2	112.8	15.5	54.4	67.1	31.9	91.2	201.5	36.7	35.6	101.3	8.4	21.3	185.2	32.7	111.2	155.8	91.5	86.9	6.2	36.4	202.0	42.9	54.5	118.7	9.9	261.0	0.0	22.8	0.5	0.5	52.2	0.8	20.7	1.1	0.6	20.0	16.2	0.3	0.4	4.2	0.7	74.5	21.5	2.9	34.2	47.0	48.1	47.3	60.9	47.2	49.5	63.7	54.6	53.4	55.0	50.3	53.6	571.2	83.3	45.1	1.0	126.9	440.5	340.1	293.1	512.8	0.8	203.9	187.6	151.6	41.5	214.4	68.0	0.0	42.1	56.4	505.3	46.9	217.6	0.9	227.9	57.3	327.1	175.5	5.7	0.5	264.7	52.8	302.4	150.9	199.2	104.4	20.4	71.7	68.9	72.9	0.0	0.4	197.1	156.6	62.0	556.0	3.9	34.5	277.6	218.7	5.6	280.6	58.4	2.1	0.0	0.5	429.9	466.1	16.6	376.4	201.7	383.2	17.2	215.1	3.1	26.3	303.6	471.6	1.2	1.7	620.9	672.0	155.3	106.0	10.7	75.8	478.0
RAB44	"dJ431A14.3, RASD3, RASL13"	ENSG00000255587	"RAB44, member RAS oncogene family"	Q7Z6P3	6	36697826-36733184	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	63	"bone marrow: 58.9"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 3.2;Alveolar cells type 2: 4.4;granulocytes: 14.5;monocytes: 2.3;Squamous epithelial cells: 2.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	10	"basophil: 10.6;eosinophil: 7.2"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 10.6"	"Cell line enhanced"	"Detected in some"		"HEL: 21.9;HL-60: 30.9;HMC-1: 88.9;NB-4: 76.7;THP-1: 30.1;U-937: 60.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA079390			Approved	Vesicles		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 60: Granulocytes - Receptor signaling"	Vesicles		"HPA079390: "	"unprognostic (8.86e-2)"	"unprognostic (5.58e-3)"	"unprognostic (5.09e-2)"	"unprognostic (4.66e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.28e-3)"	"unprognostic (9.56e-2)"	"unprognostic (6.35e-4)"	"unprognostic (1.45e-1)"	"unprognostic (1.13e-1)"	"unprognostic (7.13e-3)"	"unprognostic (2.57e-1)"	"unprognostic (3.02e-2)"	"unprognostic (3.13e-3)"	"unprognostic (3.03e-2)"	"unprognostic (9.67e-3)"	"unprognostic (5.79e-2)"	0.5	0.0	0.0	0.6	0.1	58.9	0.4	0.0	0.1	0.4	0.0	0.4	0.6	0.3	0.2	0.5	0.5	0.8	0.0	0.0	0.0	0.0	0.2	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.2	0.1	0.1	0.5	0.9	0.4	0.0	0.5	0.7	0.0	0.0	0.1	0.0	0.1	0.1	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	21.9	0.0	0.0	0.0	30.9	88.9	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	76.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	30.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	60.7	0.0	10.6	0.8	7.2	0.0	0.5	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	3.2	4.4	0.7	0.0	0.0	0.1	0.0	1.2	0.0	0.1	0.3	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.2	0.3	0.0	1.3	0.3	0.2	0.0	0.3	0.0	0.5	14.5	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	2.3	0.0	1.0	0.0	0.0	0.1	0.0	0.0	1.9	0.0	0.0	0.0	0.7	0.0	0.0	0.6	0.3	0.0	0.0	2.2	0.0	0.0	0.4	0.1	0.0	0.1
CPNE5	"COPN5, CPN5, KIAA1599"	ENSG00000124772	"Copine 5"	Q9HCH3	6	36740775-36839444	"Plasma proteins, Predicted intracellular proteins"	Differentiation			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 62.4;heart muscle: 92.7"	"Cell type enhanced"	"Detected in many"		"B-cells: 50.6;Cardiomyocytes: 30.0;Excitatory neurons: 35.1;Oligodendrocyte precursor cells: 36.7;Plasma cells: 89.6"	"Cancer enhanced"	"Detected in all"		"glioma: 11.3"	"Region enhanced"	"Detected in many"		"basal ganglia: 62.4"	"Group enriched"	"Detected in some"	80	"memory B-cell: 51.6;naive B-cell: 26.8"	"Lineage enriched"	"Detected in single"	105	"B-cells: 51.6"	"Group enriched"	"Detected in some"	5	"Daudi: 59.4;HUVEC TERT2: 25.7;U-266/70: 19.7;U-266/84: 17.1;U-698: 28.1"	"Region enhanced"	"Detected in many"		"basal ganglia: 103.3"	"Region enhanced"	"Detected in many"		"basal ganglia: 135.5"	HPA031369	Enhanced		Approved	Cytosol		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"	Cytosol		"HPA031369: AB_10601801"	"unprognostic (5.71e-3)"	"unprognostic (1.07e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.73e-2)"	"unprognostic (1.04e-1)"	"prognostic favorable (2.87e-5)"	"unprognostic (1.07e-1)"	"unprognostic (3.07e-2)"	"unprognostic (9.57e-2)"	"unprognostic (1.21e-3)"	"unprognostic (2.45e-1)"	"unprognostic (4.10e-2)"	"prognostic unfavorable (6.00e-5)"	"unprognostic (1.68e-2)"	"unprognostic (3.80e-1)"	"unprognostic (2.00e-1)"	"unprognostic (3.57e-1)"	6.4	0.9	16.6	10.7	62.4	1.4	2.3	0.0	29.5	3.9	0.0	6.2	5.6	5.8	1.0	2.4	19.9	2.0	92.7	23.0	2.7	4.5	0.8	2.6	23.6	0.0	4.6	6.6	1.0	0.4	11.0	1.4	0.0	5.8	5.0	2.8	3.5	2.5	0.5	1.8	8.6	4.7	1.1	20.0	5.1	25.3	0.8	2.3	3.3	0.2	28.1	4.9	5.7	13.3	0.9	0.0	0.5	0.1	0.1	0.0	0.3	0.2	0.2	0.3	0.5	0.0	0.2	59.4	0.5	0.8	2.7	0.4	0.1	0.4	0.2	0.0	0.0	2.6	0.0	0.0	0.0	0.1	1.1	0.0	0.0	0.7	0.0	4.1	25.7	0.2	0.2	1.7	0.5	0.0	0.0	0.4	0.1	0.8	0.0	0.3	0.5	0.0	0.0	0.1	0.5	0.1	0.0	0.0	5.3	0.3	0.0	0.8	5.9	0.4	0.7	0.0	2.1	19.7	17.1	28.1	0.3	6.5	0.1	0.0	0.1	0.0	0.0	0.2	0.2	51.6	0.2	0.0	0.1	26.8	0.0	0.0	0.4	0.0	0.2	0.3	0.0	4.5	16.6	62.4	0.0	29.5	23.0	2.7	0.0	4.6	0.0	1.1	0.8	13.3	2.8	0.0	3.6	1.3	50.6	0.6	0.2	0.2	0.0	13.4	0.3	0.5	30.0	0.0	0.0	0.0	0.0	0.0	1.5	15.1	1.9	0.0	3.3	0.4	0.8	7.4	4.2	0.0	35.1	0.2	0.0	2.8	1.5	1.4	12.6	0.3	5.0	1.0	0.4	0.0	8.6	1.8	0.0	1.9	0.6	4.8	0.0	6.2	3.6	2.8	0.2	1.3	2.1	36.7	0.8	0.5	12.5	0.4	89.6	0.2	2.3	0.1	0.0	1.6	0.0	2.3	1.0	0.8	1.5	1.1	0.1	0.0	2.0	0.2	1.7	0.4
PPIL1	CYPL1	ENSG00000137168	"Peptidylprolyl isomerase like 1"	Q9Y3C6	6	36854827-36874803	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	"Isomerase, Rotamase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 58.7;Extravillous trophoblasts: 72.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062916			Supported	Nucleoli		NA	NA		21000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Nucleoli		"HPA062916: AB_2684904"	"unprognostic (3.51e-2)"	"unprognostic (2.33e-1)"	"unprognostic (2.64e-3)"	"unprognostic (1.11e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.81e-2)"	"prognostic unfavorable (1.28e-5)"	"unprognostic (2.01e-1)"	"unprognostic (3.37e-2)"	"prognostic favorable (4.90e-4)"	"unprognostic (6.58e-2)"	"unprognostic (5.49e-2)"	"unprognostic (8.99e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.30e-1)"	"unprognostic (3.39e-2)"	"unprognostic (2.15e-2)"	12.4	21.7	20.3	19.1	21.9	11.4	18.4	22.6	27.3	15.0	23.8	14.7	13.2	15.7	19.1	17.0	23.0	10.7	42.8	20.0	25.2	18.9	21.5	10.5	21.9	22.0	22.0	17.7	14.3	21.7	12.0	22.3	23.3	16.8	17.6	29.1	19.5	17.6	18.5	9.5	11.3	22.9	24.1	9.5	12.9	23.2	22.2	18.6	33.2	20.7	24.6	20.5	8.0	22.8	69.2	50.0	111.2	78.5	19.7	31.5	77.5	60.9	41.0	82.7	70.0	89.7	39.7	87.7	75.5	41.9	105.5	55.4	135.1	92.7	96.2	81.3	114.6	102.7	33.6	147.7	53.5	89.3	40.8	24.7	48.7	62.3	118.9	31.8	75.5	79.1	202.4	48.0	63.3	71.2	101.9	69.8	92.3	108.5	57.9	79.4	100.2	92.0	63.2	53.5	140.0	68.5	41.8	51.4	102.5	83.5	76.3	100.2	44.0	66.7	69.0	58.5	98.8	57.0	145.2	153.0	23.7	183.7	139.4	1.6	4.8	1.3	14.7	6.2	19.7	10.3	12.1	13.9	9.2	7.4	13.4	15.9	1.2	7.3	3.4	7.8	10.2	9.8	20.3	21.9	22.6	27.3	20.0	25.2	22.0	22.0	23.3	24.1	22.2	22.8	5.7	6.4	7.5	2.9	10.8	3.1	18.6	12.2	5.7	16.9	9.0	10.5	45.8	8.6	8.3	5.5	4.2	58.7	6.6	3.3	23.5	25.7	32.0	10.3	14.2	12.3	3.6	22.7	6.5	20.3	72.3	12.2	7.7	7.7	10.8	16.3	5.0	8.2	30.1	16.8	8.6	11.4	4.1	3.3	3.6	11.7	6.8	6.4	7.2	1.9	9.2	41.0	11.3	7.5	5.4	22.1	5.5	12.4	15.0	13.5	3.3	17.1	13.5	15.5	6.6	6.1	12.8	25.7	51.0	10.6	4.5	25.3	9.2	21.1	11.9	8.6
C6orf89	"BRAP, FLJ25357"	ENSG00000198663	"Chromosome 6 open reading frame 89"	Q6UWU4	6	36871870-36928964	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	7	"Early spermatids: 340.1;Late spermatids: 699.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 351.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012548	Uncertain					NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 34: Spermatids - Unknown function"			"HPA012548: AB_1845748"	"unprognostic (2.26e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.32e-1)"	"unprognostic (3.01e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.52e-1)"	"unprognostic (2.94e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.69e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.44e-1)"	"prognostic favorable (5.77e-5)"	"unprognostic (3.75e-3)"	"unprognostic (3.85e-1)"	"unprognostic (9.94e-3)"	"unprognostic (8.42e-3)"	37.4	37.5	24.6	27.3	28.8	37.6	32.0	26.1	24.6	45.8	22.7	33.8	28.1	36.8	50.0	35.4	38.5	33.1	49.7	26.7	31.2	32.9	34.1	32.8	24.7	29.0	29.4	44.9	46.2	54.3	28.2	33.3	29.1	37.0	37.1	13.4	42.3	47.6	36.6	24.2	27.5	45.0	29.9	24.9	33.4	47.5	30.2	30.2	58.2	44.3	31.4	31.7	26.5	35.3	37.9	22.9	31.1	44.8	111.0	76.2	18.3	73.1	91.6	50.5	55.2	23.7	39.2	33.6	55.5	150.6	54.1	40.3	38.3	46.0	72.9	60.4	33.2	48.8	23.3	26.8	55.5	39.6	48.3	66.0	56.2	62.0	58.9	60.4	44.5	60.1	93.8	90.1	79.0	37.7	43.5	15.0	11.6	43.1	25.7	21.1	30.9	61.1	33.7	33.2	54.9	39.5	48.8	23.5	50.8	25.8	56.0	53.3	52.7	72.3	41.2	57.6	57.4	48.4	63.8	351.0	32.6	55.8	77.3	28.1	16.7	20.9	18.1	16.4	17.9	9.8	14.8	16.8	14.7	9.1	10.2	11.2	27.2	11.2	22.5	9.2	16.4	14.4	24.6	28.8	26.1	24.6	26.7	31.2	29.0	29.4	29.1	29.9	30.2	35.3	31.2	38.5	56.8	22.9	24.6	6.8	23.9	28.8	19.4	15.5	24.6	19.0	67.1	41.5	31.6	38.6	10.4	34.0	26.6	39.2	19.6	41.2	340.1	24.9	36.1	36.1	17.4	56.0	38.4	58.1	41.6	37.7	27.5	33.7	30.4	52.6	25.0	45.5	40.0	23.5	35.3	27.9	32.6	29.8	12.5	699.2	45.1	27.2	10.6	29.0	24.9	53.9	28.8	31.7	54.5	56.3	27.9	50.8	44.1	26.6	30.5	20.1	28.3	12.8	19.7	35.8	36.9	33.7	38.5	23.5	8.9	46.0	28.5	50.8	25.9	26.1
PI16	"CD364, dJ90K10.5, MGC45378, MSMBBP"	ENSG00000164530	"Peptidase inhibitor 16"	Q6UXB8	6	36948263-36964837	"CD markers, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"		"Protease inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 140.6;heart muscle: 127.7;vagina: 127.6"	"Cell type enhanced"	"Detected in many"		"Fibroblasts: 204.8;Leydig cells: 205.9;Oligodendrocytes: 67.3;Peritubular cells: 149.7"	"Cancer enhanced"	"Detected in many"		"glioma: 15.5"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"T-reg: 66.1"	"Lineage enriched"	"Detected in many"	5	"T-cells: 66.1"	"Cell line enriched"	"Detected in some"	6	"JURKAT: 29.5"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in all"	7	"spinal cord: 33.2"	HPA076574	Approved				"Secreted to blood"	NA	NA		2900000000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 50: Fibroblasts - ECM organization"			"HPA076574: AB_2732314"	"unprognostic (6.24e-3)"	"unprognostic (6.00e-3)"	"unprognostic (7.34e-2)"	"unprognostic (9.53e-2)"	"unprognostic (3.38e-2)"	"unprognostic (2.42e-1)"	"unprognostic (2.71e-2)"	"unprognostic (5.06e-2)"	"unprognostic (6.48e-2)"	"unprognostic (1.88e-1)"	"unprognostic (3.25e-2)"	"unprognostic (4.46e-2)"	"unprognostic (1.59e-3)"	"unprognostic (5.82e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.28e-1)"	"unprognostic (8.76e-2)"	57.8	3.5	12.2	3.1	17.7	0.2	66.1	14.3	15.1	140.6	7.9	11.6	1.5	5.7	29.0	10.6	15.0	46.4	127.7	10.1	16.1	1.5	0.7	11.4	2.2	15.3	14.2	3.4	5.6	0.9	8.4	2.4	15.8	31.3	7.9	0.0	14.0	34.2	15.1	51.7	4.5	8.4	13.4	1.3	22.1	14.7	16.4	2.4	23.2	33.6	6.0	116.1	127.6	19.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	4.9	0.3	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.1	29.5	0.1	0.0	0.0	0.0	0.5	0.0	0.0	1.1	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	1.0	0.0	1.8	0.6	19.7	5.7	0.0	1.3	6.4	2.2	0.5	13.5	0.0	0.5	66.1	3.3	12.2	17.7	14.3	15.1	10.1	16.1	15.3	14.2	15.8	13.4	16.4	19.3	10.9	0.0	1.5	3.3	0.7	21.5	0.1	0.0	0.6	0.0	0.4	0.4	4.5	0.0	0.6	1.8	0.0	0.0	0.4	0.0	1.9	0.1	10.8	0.1	0.2	11.0	0.0	0.0	0.1	0.0	0.0	204.8	4.1	0.1	0.0	0.0	10.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	39.6	19.0	205.9	1.9	10.6	3.7	0.0	0.0	0.0	0.0	67.3	0.1	0.0	149.7	0.6	0.1	0.0	0.2	0.0	0.0	0.0	7.7	4.2	2.4	1.3	0.4	18.5	0.1	3.5	0.3	0.0	0.2
MTCH1	"CGI-64, PSAP, SLC25A49"	ENSG00000137409	"Mitochondrial carrier 1"	Q9NZJ7	6	36968141-36986298	"Predicted membrane proteins, Transporters"	"Apoptosis, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 1002.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015971	Approved					NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 68: Epididymis - Unknown function"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 54: Cardiomyocytes - Muscle contraction"			"HPA015971: AB_1854171"	"unprognostic (3.17e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.71e-1)"	"prognostic unfavorable (2.06e-4)"	"unprognostic (1.40e-1)"	"unprognostic (1.87e-1)"	"prognostic unfavorable (1.17e-4)"	"unprognostic (1.29e-1)"	"unprognostic (2.88e-2)"	"unprognostic (1.54e-1)"	"unprognostic (7.49e-2)"	"unprognostic (1.35e-3)"	"prognostic favorable (1.16e-7)"	"unprognostic (1.32e-2)"	"unprognostic (3.11e-1)"	"unprognostic (6.68e-2)"	"unprognostic (4.70e-2)"	151.0	279.7	314.7	97.4	331.9	194.1	140.2	290.1	341.2	194.5	257.9	151.7	93.7	136.3	312.1	130.8	154.2	99.6	259.7	326.1	333.3	168.1	117.2	202.5	95.4	306.1	310.3	177.3	165.4	142.1	284.8	106.0	333.1	183.1	96.4	92.0	144.2	196.5	133.7	176.6	125.2	114.7	305.1	148.7	156.2	81.1	349.0	88.2	364.1	89.0	88.6	156.4	166.2	340.8	196.3	130.8	173.3	214.0	254.7	171.9	99.0	225.3	208.2	312.1	322.1	218.0	118.3	97.1	197.7	379.8	301.8	167.1	189.2	181.8	360.2	104.5	183.9	101.3	223.4	165.4	184.1	65.7	92.1	194.5	140.5	289.7	140.5	271.8	269.3	133.0	186.1	97.5	199.8	221.4	134.3	149.8	170.1	175.2	147.5	122.9	135.4	102.6	169.1	160.5	278.8	119.9	163.9	141.2	206.8	173.6	182.5	181.9	299.6	311.5	246.1	241.3	247.3	85.3	92.5	1002.9	112.1	179.4	250.1	11.0	34.7	45.4	14.5	34.9	13.5	18.8	27.5	29.2	31.1	31.2	26.2	15.4	37.8	18.4	44.7	17.3	22.4	17.3	314.7	331.9	290.1	341.2	326.1	333.3	306.1	310.3	333.1	305.1	349.0	340.8	133.7	48.1	99.1	47.3	79.1	113.7	177.1	138.6	71.7	0.0	152.7	125.2	162.5	117.2	101.2	69.9	0.0	183.5	91.8	149.9	168.3	213.0	8.2	99.0	139.4	112.3	149.3	67.6	54.1	170.0	224.0	163.4	94.3	177.3	29.2	193.6	85.6	50.9	189.2	0.0	52.8	133.0	105.8	97.2	150.6	16.3	138.2	109.5	136.9	44.0	173.2	0.0	55.6	28.1	106.4	181.7	162.3	132.4	57.6	255.0	144.3	129.4	68.0	0.0	52.6	108.8	133.5	18.5	46.4	86.2	123.5	248.3	85.8	118.5	145.1	208.5
FGD2	ZFYVE4	ENSG00000146192	"FYVE, RhoGEF and PH domain containing 2"	Q7Z6J4	6	37005646-37029069	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 39.7"	"Cell type enhanced"	"Detected in many"		"B-cells: 53.7;dendritic cells: 29.7;Kupffer cells: 118.2;Langerhans cells: 49.3;Macrophages: 52.0;Microglial cells: 43.1;monocytes: 51.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	16	"classical monocyte: 22.3;intermediate monocyte: 64.8;memory B-cell: 23.2;myeloid DC: 35.0;naive B-cell: 18.6;non-classical monocyte: 70.5;plasmacytoid DC: 27.4"	"Group enriched"	"Detected in many"	18	"B-cells: 23.2;dendritic cells: 35.0;monocytes: 70.5"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 2.7;Daudi: 11.5;HDLM-2: 11.3;U-698: 9.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA029145, HPA049692"	Approved					NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 57: B-cells - Immune response"			"HPA029145: AB_10601321, HPA049692: AB_2680852"	"unprognostic (3.54e-2)"	"unprognostic (1.40e-4)"	"unprognostic (5.69e-3)"	"unprognostic (2.29e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.67e-4)"	"unprognostic (7.97e-2)"	"unprognostic (1.58e-2)"	"unprognostic (2.47e-2)"	"unprognostic (2.78e-1)"	"unprognostic (3.39e-2)"	"unprognostic (2.82e-1)"	"unprognostic (1.15e-2)"	"unprognostic (3.91e-1)"	"unprognostic (1.02e-2)"	"unprognostic (3.88e-1)"	"unprognostic (7.10e-2)"	6.1	3.3	1.0	14.8	1.3	6.0	2.6	1.2	1.3	1.5	2.3	3.4	3.7	1.3	1.5	2.4	2.8	4.1	1.6	1.0	1.6	1.4	2.5	8.0	22.5	3.2	1.7	1.0	1.3	0.3	1.1	2.7	1.9	1.5	2.7	0.1	2.3	1.8	0.6	2.1	11.1	4.7	2.1	39.7	3.8	0.6	2.1	5.5	2.7	0.9	9.8	4.5	1.6	2.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	11.5	0.0	0.0	0.0	0.4	0.0	0.0	0.3	11.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.4	0.0	1.7	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.3	0.0	0.0	0.0	0.1	22.3	2.3	0.1	64.8	0.1	23.2	0.0	0.0	35.0	18.6	0.0	0.0	0.3	0.4	70.5	27.4	0.1	7.5	1.0	1.3	1.2	1.3	1.0	1.6	3.2	1.7	1.9	2.1	2.1	2.0	0.3	6.4	7.4	0.0	53.7	2.0	3.0	1.0	0.6	0.3	0.7	0.6	3.2	2.8	0.5	0.0	0.0	0.3	29.7	0.3	0.0	2.8	11.9	0.5	0.2	1.2	0.0	1.3	0.1	0.9	0.4	1.0	1.5	1.2	7.6	0.0	2.5	0.6	17.7	0.0	0.2	0.1	4.1	118.2	49.3	2.1	1.5	52.0	1.8	43.1	51.8	0.4	2.1	0.5	0.2	1.0	3.9	0.0	14.2	1.6	0.1	0.2	3.2	0.2	0.0	2.3	0.5	0.0	0.1	3.3	2.3	0.4	3.0	0.1	0.4	5.6
PIM1	PIM	ENSG00000137193	"Pim-1 proto-oncogene, serine/threonine kinase"	P11309	6	37170152-37175428	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Apoptosis, Cell cycle"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 219.0"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 368.2;Suprabasal keratinocytes: 228.6;Urothelial cells: 455.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 321.3"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 321.3"	"Cell line enhanced"	"Detected in all"		"HEL: 219.9;HMC-1: 391.5;K-562: 192.7;U-698: 735.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003941, CAB017040"	Uncertain		Supported	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"	Cytosol	"Nucleoplasm, Nucleoli"	"CAB017040: , HPA003941: AB_1079618"	"unprognostic (1.25e-2)"	"unprognostic (4.77e-1)"	"unprognostic (3.61e-2)"	"prognostic unfavorable (9.73e-4)"	"unprognostic (1.91e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.75e-1)"	"unprognostic (4.64e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.65e-2)"	"unprognostic (7.32e-2)"	"unprognostic (2.14e-3)"	"unprognostic (8.16e-3)"	"unprognostic (1.04e-1)"	"unprognostic (5.26e-3)"	"unprognostic (2.90e-1)"	152.8	14.4	8.5	42.3	8.6	219.0	46.2	10.5	10.7	82.9	10.0	45.8	39.2	46.3	2.6	201.5	66.4	52.6	65.4	7.9	11.6	27.0	58.0	49.8	38.5	15.1	12.2	60.4	20.4	3.4	14.8	28.9	12.8	22.5	17.8	8.2	41.1	7.5	36.3	109.8	44.4	38.1	12.3	61.7	40.3	10.7	11.6	26.6	22.7	5.8	26.8	101.6	113.3	12.1	19.1	7.9	12.1	6.7	27.2	14.5	141.9	6.7	20.3	13.5	21.5	28.3	26.2	38.3	10.4	8.0	30.2	21.7	12.7	20.1	12.3	174.4	8.4	219.9	8.7	37.0	27.9	3.8	391.5	49.0	24.5	12.4	8.3	14.9	4.0	9.2	192.7	59.7	2.2	5.0	12.3	19.9	22.7	35.4	12.1	29.7	22.0	45.7	3.9	114.4	58.8	11.9	14.7	1.7	3.8	27.9	3.2	6.5	7.4	7.8	23.3	35.6	8.5	28.0	15.9	735.7	3.4	55.3	8.1	321.3	8.0	113.5	60.3	7.3	77.7	7.1	53.4	53.8	6.3	5.2	47.1	36.9	61.7	39.8	4.2	1.9	41.3	42.1	8.5	8.6	10.5	10.7	7.9	11.6	15.1	12.2	12.8	12.3	11.6	12.1	41.1	22.4	16.0	2.9	35.1	127.8	166.5	63.3	26.7	4.9	9.6	5.3	36.0	18.6	37.6	9.2	0.0	36.5	55.0	50.4	5.9	40.6	4.8	40.3	125.8	33.3	37.1	368.2	2.4	17.2	121.8	67.4	26.0	92.0	49.3	27.5	11.0	33.8	53.6	15.2	2.2	12.4	44.7	44.3	47.4	12.4	8.1	53.9	44.4	4.7	72.3	7.6	112.3	1.0	0.9	60.7	34.2	3.0	190.1	109.6	51.1	17.2	12.9	1.7	0.0	34.2	41.3	14.5	33.9	92.8	228.6	80.7	118.0	1.1	7.8	455.2
TMEM217	"C6orf128, dJ355M6.2"	ENSG00000172738	"Transmembrane protein 217"	Q8N7C4	6	37212178-37258155	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 9.1"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 20.5;Exocrine glandular cells: 16.0;Pancreatic endocrine cells: 15.9;Spermatocytes: 55.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HEL: 7.7;HUVEC TERT2: 6.4;TIME: 17.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA045432, HPA071187"			Approved	Nucleoli,Cytosol		NA	NA				"Cluster 43: Testis - Unknown function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoli	Cytosol	"HPA045432: AB_2732519, HPA071187: AB_2732174"	"unprognostic (7.78e-2)"	"unprognostic (5.49e-2)"	"unprognostic (2.22e-2)"	"unprognostic (1.29e-2)"	"unprognostic (7.79e-2)"	"unprognostic (2.02e-1)"	"unprognostic (6.77e-3)"	"unprognostic (1.40e-2)"	"unprognostic (3.51e-2)"	"unprognostic (4.23e-4)"	"unprognostic (8.22e-2)"	"unprognostic (2.18e-1)"	"unprognostic (5.62e-2)"	"unprognostic (7.26e-2)"	"unprognostic (1.33e-2)"	"unprognostic (6.99e-2)"	"unprognostic (1.59e-1)"	0.7	3.1	0.9	0.7	1.0	2.8	0.5	1.0	1.6	0.3	0.9	0.3	1.1	0.3	1.5	1.6	0.7	1.2	0.3	0.9	0.9	0.6	0.9	0.7	0.4	0.9	0.9	0.3	2.7	1.3	0.1	0.3	1.0	0.3	0.3	0.7	1.2	0.1	0.1	1.0	0.4	0.4	0.8	0.2	0.2	9.1	1.0	0.7	0.7	0.0	0.3	2.2	0.1	1.1	0.7	0.0	0.5	0.4	0.3	2.1	0.3	2.2	3.9	1.9	5.5	1.7	1.3	0.1	0.8	0.5	2.4	1.2	0.7	0.6	2.0	0.7	1.1	7.7	1.7	0.9	0.9	0.2	3.7	1.4	1.7	5.0	0.5	1.0	6.4	0.8	2.5	0.0	0.9	0.9	0.5	3.2	0.6	0.0	0.3	1.0	0.2	0.2	2.1	0.8	0.6	0.3	0.4	0.4	1.0	0.9	0.1	0.4	17.6	1.8	0.5	0.2	0.4	0.5	0.7	1.9	0.3	1.7	0.4	0.3	0.1	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.1	0.2	0.1	0.2	0.2	0.1	0.0	0.1	0.1	0.1	0.9	1.0	1.0	1.6	0.9	0.9	0.9	0.9	1.0	0.8	1.0	1.1	2.6	0.0	0.6	2.9	0.7	2.5	8.9	2.6	0.6	0.8	3.9	1.8	0.2	1.5	3.9	1.8	0.0	0.8	1.3	3.4	3.9	15.0	20.5	8.3	1.3	3.3	1.8	0.0	2.9	16.0	0.6	3.8	2.0	5.6	5.7	1.4	0.4	0.1	0.9	3.3	2.1	0.4	2.0	0.6	6.3	14.9	0.6	2.8	1.8	0.0	0.0	6.4	0.0	1.5	3.0	15.9	1.1	0.0	0.5	6.9	0.8	1.1	5.0	0.5	0.0	4.1	1.8	55.0	0.8	3.4	3.0	1.1	1.1	1.5	1.0	13.9
AL353579.1		ENSG00000286105	"Transmembrane protein 217"		6	37212181-37257637	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enriched"	"Detected in single"	6	"testis: 4.6"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+ SV40 Large T+ RasG12V: 1.1;HBF TERT88: 1.2;HEL: 1.2;hTEC/SVTERT24-B: 1.2;TIME: 2.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA					"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"																						0.1	0.0	0.2	0.0	0.2	0.6	0.0	0.1	0.7	0.0	0.1	0.0	0.0	0.0	0.6	0.2	0.0	0.1	0.0	0.2	0.2	0.0	0.3	0.0	0.1	0.2	0.2	0.0	0.0	0.0		0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	4.6	0.3	0.0	0.0	0.0	0.0	0.2		0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.5	1.1	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.2	0.2	0.0	1.2	0.8	0.1	0.4	0.0	0.4	0.5	0.0	1.2	0.0	0.0	0.6	0.0	0.3	0.0	0.1	0.3	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.0	0.0	2.4	0.5	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.7	0.2	0.2	0.2	0.2	0.2	0.2	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TBC1D22B	"C6orf197, dJ744I24.2, FLJ20337"	ENSG00000065491	"TBC1 domain family member 22B"	Q9NU19	6	37257772-37332970	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 80.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027908, HPA027909, HPA027910"	Uncertain		Uncertain	Nucleoplasm,Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 1: Pancreatic cells - Digestion"	"Nucleoplasm, Cytosol"		"HPA027908: AB_10602073, HPA027909: AB_10601857, HPA027910: AB_10602203"	"unprognostic (9.83e-2)"	"unprognostic (5.36e-2)"	"unprognostic (2.17e-2)"	"prognostic unfavorable (8.15e-5)"	"unprognostic (2.70e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.29e-2)"	"unprognostic (1.44e-1)"	"unprognostic (9.48e-2)"	"unprognostic (6.06e-3)"	"unprognostic (3.10e-2)"	"unprognostic (1.46e-1)"	"unprognostic (3.53e-3)"	"unprognostic (9.87e-2)"	"unprognostic (2.71e-1)"	"unprognostic (3.19e-1)"	"unprognostic (9.73e-2)"	5.8	12.1	8.3	5.1	8.4	18.3	5.7	8.3	8.2	7.9	8.8	6.5	7.9	6.4	7.4	14.1	8.2	5.9	7.4	8.3	8.0	8.6	6.1	8.0	5.8	7.7	8.1	9.4	12.8	10.7	6.7	6.0	7.9	8.2	7.7	7.7	11.8	5.5	15.0	15.2	8.5	6.7	7.1	7.2	7.5	10.0	8.5	13.5	7.7	7.8	7.1	7.5	9.3	8.1	13.2	5.5	9.9	10.9	9.1	9.1	14.2	7.2	15.0	13.2	16.2	12.6	8.5	12.3	7.4	9.2	17.9	8.9	12.7	11.6	14.8	19.9	10.4	19.5	9.0	17.2	13.0	11.1	15.9	7.8	16.6	13.0	15.4	12.6	18.9	20.4	22.5	3.1	9.6	11.9	16.6	8.4	13.0	15.0	5.1	10.7	9.1	9.6	13.6	9.5	13.0	8.4	7.9	11.2	14.3	13.3	8.2	19.7	18.4	8.0	12.2	5.5	9.6	11.1	12.4	80.8	5.5	16.5	12.6	1.4	2.6	4.4	2.3	3.5	2.7	1.7	2.6	2.3	4.0	2.0	2.8	2.4	1.1	3.0	1.5	1.1	1.9	2.6	8.3	8.4	8.3	8.2	8.3	8.0	7.7	8.1	7.9	7.1	8.5	8.1	4.1	3.2	5.6	17.9	6.3	8.2	8.5	7.5	8.0	5.0	6.0	3.7	5.8	7.2	10.1	1.8	4.2	6.3	4.6	15.1	3.9	12.3	5.6	10.6	3.6	4.9	1.8	10.5	20.3	15.4	9.2	4.2	3.1	8.1	5.7	5.0	3.6	3.9	5.8	0.0	22.0	4.9	10.2	4.4	7.8	5.0	3.1	4.1	1.8	6.5	6.0	3.6	6.2	14.1	24.1	15.0	6.8	1.2	5.6	10.0	11.2	9.0	15.8	4.5	0.0	4.2	3.6	6.5	6.4	10.8	15.9	6.7	6.6	3.2	6.3	11.2
RNF8	KIAA0646	ENSG00000112130	"Ring finger protein 8"	O76064	6	37353979-37394734	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, DNA damage, DNA repair, Host-virus interaction, Mitosis, Ubl conjugation pathway"	"Chromatin regulator, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 76.0"	"Not detected"	"Not detected"							"HPA050731, HPA064925"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 51: Myeloid cells - Hemostasis"	Nucleoplasm	Cytosol	"HPA050731: AB_2681222, HPA064925: AB_2685385"	"unprognostic (1.80e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.39e-2)"	"unprognostic (8.20e-2)"	"unprognostic (5.17e-2)"	"unprognostic (3.99e-2)"	"prognostic unfavorable (3.33e-5)"	"unprognostic (2.36e-2)"	"prognostic unfavorable (1.91e-4)"	"unprognostic (2.26e-3)"	"unprognostic (3.38e-1)"	"prognostic unfavorable (4.99e-5)"	"unprognostic (7.95e-3)"	"unprognostic (1.78e-1)"	"unprognostic (3.41e-2)"	"unprognostic (3.66e-3)"	"unprognostic (1.09e-1)"	5.0	7.8	10.0	3.5	10.1	4.6	5.2	11.8	14.3	7.7	9.3	6.3	3.1	7.0	2.1	10.6	6.0	4.0	8.6	10.1	10.5	8.8	4.8	5.9	4.2	10.2	10.6	7.6	4.5	7.4	6.6	4.8	10.3	6.0	3.6	9.0	6.2	5.2	8.1	7.6	5.0	4.9	9.4	4.7	5.2	11.2	11.2	5.8	4.5	10.6	6.6	6.5	7.8	9.9	12.5	7.3	17.3	20.7	13.7	19.6	4.9	12.6	15.5	23.4	25.6	11.0	6.8	15.3	7.5	12.4	20.1	11.4	24.4	16.0	24.4	16.2	23.7	26.5	12.0	16.6	7.8	14.3	18.7	9.8	15.2	14.0	16.2	14.3	22.9	17.9	18.1	5.2	13.6	8.3	17.4	17.5	12.1	6.3	9.4	13.5	16.0	10.6	12.1	8.7	34.0	11.4	9.5	10.6	18.0	11.3	9.5	13.6	10.4	15.4	13.5	14.7	18.8	15.2	21.8	76.0	7.5	20.1	18.0	1.0	4.3	2.5	9.5	5.8	8.8	8.1	7.0	9.2	7.8	4.9	6.1	8.1	0.5	7.9	8.8	3.3	9.1	5.2	10.0	10.1	11.8	14.3	10.1	10.5	10.2	10.6	10.3	9.4	11.2	9.9	21.0	19.2	25.9	13.4	15.0	18.2	22.2	26.0	26.2	26.7	16.5	20.4	31.1	12.8	18.5	25.8	39.6	24.8	18.2	10.3	15.6	24.7	41.1	68.5	32.2	19.2	22.2	18.7	17.0	18.9	25.8	28.0	16.3	52.3	28.5	37.0	27.8	16.5	17.5	50.5	15.9	16.5	14.2	13.9	17.7	30.2	26.8	24.0	10.6	11.2	19.6	25.4	37.0	12.5	20.5	28.8	18.1	30.9	13.7	31.8	11.8	20.6	23.8	32.3	13.1	23.2	20.8	46.5	34.5	34.2	22.0	5.9	19.3	22.0	18.0	21.9
CMTR1	"FTSJD2, ISG95, KIAA0082, MTr1"	ENSG00000137200	"Cap methyltransferase 1"	Q8N1G2	6	37433219-37482827	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"mRNA capping, mRNA processing"	"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 253.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029954, HPA029979, HPA029980"	Enhanced		Enhanced	Nucleoplasm,Vesicles		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 71: Testis - DNA repair"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm	Vesicles	"HPA029954: AB_10670558, HPA029979: AB_10671363, HPA029980: AB_10671094"	"unprognostic (1.33e-1)"	"unprognostic (2.12e-2)"	"unprognostic (6.43e-2)"	"prognostic unfavorable (1.73e-5)"	"unprognostic (1.00e-1)"	"unprognostic (3.72e-1)"	"unprognostic (1.68e-2)"	"unprognostic (6.43e-3)"	"unprognostic (2.95e-2)"	"unprognostic (9.17e-2)"	"unprognostic (5.24e-3)"	"unprognostic (1.50e-3)"	"unprognostic (3.00e-3)"	"unprognostic (3.27e-2)"	"unprognostic (9.72e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.14e-2)"	20.1	22.1	21.0	19.2	21.2	30.9	19.5	20.3	22.9	23.6	18.6	26.8	18.1	23.1	17.4	16.9	22.4	15.1	25.1	20.7	22.0	19.4	21.8	20.4	25.3	21.5	21.0	28.0	22.1	27.5	26.0	24.9	20.3	21.9	15.2	28.5	21.7	18.4	30.1	23.2	23.2	20.4	20.2	28.8	21.9	62.9	23.5	30.9	20.3	23.4	25.6	21.6	20.0	20.2	23.5	21.9	31.0	50.7	34.2	31.1	37.4	27.5	37.7	68.1	75.9	33.3	15.3	48.6	30.5	40.7	63.8	25.7	39.7	28.4	51.7	33.8	35.2	26.8	26.8	37.2	26.3	38.9	17.6	27.1	20.9	37.6	26.7	35.7	32.2	44.3	60.6	34.5	36.3	38.5	49.8	34.6	15.6	15.7	20.7	39.0	36.7	28.1	22.0	28.2	34.2	25.6	30.8	23.4	40.2	22.1	39.8	29.7	30.0	40.7	30.3	16.3	31.1	39.3	21.8	253.0	16.0	40.1	45.6	4.2	5.4	3.5	4.9	7.1	4.1	5.5	4.3	5.2	5.1	3.8	4.7	3.9	3.3	5.6	5.5	4.2	6.1	4.6	21.0	21.2	20.3	22.9	20.7	22.0	21.5	21.0	20.3	20.2	23.5	20.2	11.3	9.6	9.2	5.9	12.0	3.6	3.9	4.0	8.6	14.2	6.3	5.5	10.4	8.6	11.5	7.3	33.3	18.0	15.4	5.3	0.0	4.5	20.2	7.7	15.4	9.6	8.4	6.5	15.1	8.5	8.0	8.8	11.7	8.9	3.8	24.9	7.9	10.1	7.5	11.8	13.9	8.4	4.1	7.5	2.3	11.3	7.8	9.5	3.6	14.0	11.5	8.8	7.2	10.6	14.2	8.5	3.3	6.8	12.4	4.3	4.7	4.0	11.2	11.9	6.6	8.5	13.5	16.8	10.6	5.8	4.7	20.8	11.5	22.0	6.9	3.6
CCDC167	"C6orf129, dJ153P14.2"	ENSG00000198937	"Coiled-coil domain containing 167"	Q9P0B6	6	37482938-37499893	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 281.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"B-cells: 145.2;granulocytes: 140.2;T-cells: 423.5"	"Cell line enriched"	"Detected in all"	9	"U-698: 1553.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045215	Uncertain		Approved	Cytosol		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 12: Non-specific - Cell cycle regulation"	Cytosol		"HPA045215: AB_10962866"	"unprognostic (1.82e-1)"	"prognostic favorable (7.59e-4)"	"unprognostic (6.99e-2)"	"unprognostic (3.66e-1)"	"unprognostic (2.86e-1)"	"unprognostic (2.07e-1)"	"prognostic unfavorable (2.94e-4)"	"unprognostic (2.73e-1)"	"unprognostic (7.67e-2)"	"unprognostic (3.41e-3)"	"unprognostic (2.71e-1)"	"unprognostic (2.79e-1)"	"prognostic unfavorable (1.71e-7)"	"unprognostic (1.57e-1)"	"unprognostic (4.06e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.95e-1)"	13.2	19.2	49.8	22.8	52.1	28.3	18.5	52.7	54.2	22.1	49.0	19.9	11.6	15.8	45.1	26.6	21.3	11.9	34.9	49.0	51.0	22.0	56.4	13.3	49.5	53.4	51.1	8.5	19.1	27.2	15.0	15.4	52.9	22.8	23.5	14.4	22.6	13.5	21.4	13.4	14.4	31.6	53.0	28.3	15.0	37.7	51.9	90.7	15.1	26.2	70.3	16.8	17.1	57.7	27.2	61.9	137.1	95.4	37.4	65.5	50.4	31.6	25.8	48.8	54.5	66.1	39.5	146.9	69.4	54.8	92.1	20.7	90.4	74.1	49.7	122.9	166.9	69.7	25.3	168.7	39.1	68.4	26.4	30.7	153.4	52.1	47.4	34.2	154.0	150.2	44.1	123.1	85.1	90.2	129.1	56.6	8.0	76.7	39.3	79.0	48.4	108.9	66.3	53.6	93.3	109.6	47.1	46.0	74.3	119.3	50.1	70.3	38.5	31.8	61.6	17.8	32.5	89.3	97.1	1553.2	30.8	147.9	90.8	34.9	32.6	140.2	140.0	35.6	169.2	145.2	230.0	177.9	56.3	122.6	105.5	99.7	10.0	55.8	29.5	35.8	423.5	165.8	49.8	52.1	52.7	54.2	49.0	51.0	53.4	51.1	52.9	53.0	51.9	57.7	18.6	6.4	10.3	5.2	50.6	14.1	26.5	62.1	10.8	9.4	22.4	30.4	50.0	24.3	36.0	14.7	8.4	67.1	33.4	31.8	31.3	69.3	108.2	19.1	31.8	23.4	25.2	86.7	2.2	50.4	108.7	26.4	16.3	31.7	15.2	61.9	25.0	141.9	89.8	15.2	3.2	56.2	48.8	18.8	31.4	281.6	13.1	23.8	55.2	1.9	25.2	56.5	29.9	2.0	7.3	57.9	13.6	18.8	100.2	35.9	10.8	89.0	30.3	11.8	6.6	14.0	28.7	96.8	118.9	26.2	15.2	29.7	59.7	38.1	36.6	31.9
MDGA1	"GPIM, MAMDC3"	ENSG00000112139	"MAM domain containing glycosylphosphatidylinositol anchor 1"	Q8NFP4	6	37630679-37699306	"Predicted intracellular proteins"	"Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	12	"brain: 79.9"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 34.0;Cone photoreceptor cells: 50.1;Horizontal cells: 57.2"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in all"	9	"cerebellum: 79.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 12.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA031235, HPA050382"	Enhanced		Supported	"Golgi apparatus,Plasma membrane"	"Intracellular and membrane"	NA	NA		1200000	"Cluster 32: T-cells - Unknown function"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 62: Horizontal cells - Visual perception"	"Plasma membrane"	"Golgi apparatus"	"HPA031235: AB_10603017, HPA050382: AB_2681108"	"unprognostic (4.67e-2)"	"unprognostic (6.97e-3)"	"unprognostic (3.24e-1)"	"unprognostic (5.69e-4)"	"unprognostic (2.75e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.45e-2)"	"unprognostic (2.00e-1)"	"unprognostic (2.02e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.16e-2)"	"unprognostic (3.00e-1)"	"unprognostic (1.52e-5)"	"unprognostic (9.19e-3)"	"unprognostic (5.28e-3)"	"unprognostic (3.80e-3)"	"unprognostic (4.60e-2)"	2.6	2.9	4.2	2.6	3.9	0.3	1.6	79.9	5.3	5.4	0.0	2.6	0.5	3.4	1.8	3.7	2.7	3.2	2.3	8.8	4.9	1.2	0.6	3.1	2.6	4.3	4.7	6.5	2.4	4.1	4.8	0.3	7.4	2.1	1.1	4.0	1.1	1.3	1.1	4.9	2.8	2.5	1.0	3.1	2.0	1.5	2.1	0.8	1.4	1.7	2.1	1.9	4.4	3.2	0.2	3.5	4.8	2.4	12.3	4.3	2.2	2.8	2.2	3.5	3.2	0.0	0.0	0.7	0.5	1.7	3.0	5.4	0.5	0.0	1.0	4.9	3.4	0.0	0.3	0.0	0.5	0.0	1.1	1.0	0.0	1.4	0.0	6.8	0.0	0.1	0.0	0.0	1.2	0.0	0.0	0.4	0.0	0.1	0.4	5.9	1.7	0.0	0.8	3.7	4.3	0.0	1.5	0.3	2.6	0.2	3.1	0.6	0.3	3.4	1.4	1.2	4.3	0.0	0.1	0.0	4.2	1.0	2.0	0.0	0.0	0.0	0.3	0.0	0.1	0.2	0.2	0.1	0.0	0.2	0.6	0.1	0.0	0.0	0.0	0.0	0.3	0.1	4.2	3.9	79.9	5.3	8.8	4.9	4.3	4.7	7.4	1.0	2.1	3.2	3.0	9.6	0.5	12.7	2.0	2.3	2.4	0.7	1.2	34.0	0.4	0.6	5.7	1.5	0.8	3.7	50.1	0.2	3.1	0.0	0.0	0.5	2.6	0.6	1.8	1.6	1.8	0.0	4.9	0.0	1.4	4.4	0.5	0.5	0.0	1.1	1.4	0.0	0.1	57.2	4.9	0.0	0.0	0.3	1.1	0.2	10.2	0.3	1.8	1.9	0.0	2.6	4.1	4.0	2.1	0.6	0.0	4.9	1.7	2.0	0.0	0.5	1.9	2.0	0.0	2.6	3.0	2.1	1.3	2.8	3.0	0.7	2.9	0.2	0.0	5.1
ZFAND3	"FLJ13222, TEX27"	ENSG00000156639	"Zinc finger AN1-type containing 3"	Q9H8U3	6	37819727-38154624	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"Early spermatids: 821.8;Late spermatids: 3021.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016755	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 25: Spermatids - Spermatogenesis"	"Nucleoplasm, Vesicles"		"HPA016755: AB_1859011"	"unprognostic (3.32e-1)"	"unprognostic (3.04e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.89e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.14e-1)"	"unprognostic (9.24e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.36e-2)"	"unprognostic (9.30e-2)"	"unprognostic (1.48e-2)"	"unprognostic (9.60e-3)"	"unprognostic (1.01e-1)"	"unprognostic (2.94e-1)"	"unprognostic (7.41e-2)"	"unprognostic (4.33e-1)"	44.2	42.3	36.6	31.7	38.0	42.6	36.4	36.8	36.4	42.6	33.2	50.3	39.3	41.2	35.3	37.4	33.4	36.3	51.1	37.0	41.4	47.7	53.3	37.8	28.1	46.2	40.8	32.3	39.0	56.6	33.8	48.8	41.5	35.3	32.1	39.4	32.8	46.1	137.8	33.8	39.5	46.9	39.2	31.6	42.0	113.0	38.2	39.7	52.0	67.3	29.3	49.3	31.2	42.9	59.1	33.8	116.8	82.8	72.4	75.9	42.5	88.6	115.6	87.3	92.8	68.4	33.4	24.6	71.8	106.8	96.2	39.5	48.3	73.4	122.3	102.2	30.6	75.6	17.3	65.3	171.0	29.5	59.4	96.1	93.7	91.7	157.0	101.6	76.8	56.9	37.3	48.1	68.4	50.6	50.2	27.0	33.4	84.5	38.4	52.4	48.4	29.6	79.5	94.0	74.2	63.2	54.6	43.6	151.5	98.1	70.2	61.5	81.5	87.2	66.2	47.5	58.8	47.3	47.7	74.2	32.4	47.1	91.9	0.5	1.7	6.1	1.5	1.7	1.1	1.3	1.1	1.2	0.9	1.9	0.9	1.5	6.0	1.6	1.3	2.9	1.5	0.9	36.6	38.0	36.8	36.4	37.0	41.4	46.2	40.8	41.5	39.2	38.2	42.9	25.4	22.4	11.5	241.0	27.0	27.3	30.9	20.0	52.9	25.8	19.8	19.4	23.0	25.8	11.6	47.8	22.9	35.0	23.2	55.2	74.3	27.3	821.8	25.4	26.6	28.1	16.2	22.5	332.7	29.3	33.1	27.2	31.6	33.2	5.1	33.9	27.5	48.8	33.8	30.3	262.9	30.5	6.1	43.7	44.3	3021.1	38.8	49.2	14.2	283.9	32.9	47.4	34.0	276.0	316.4	38.9	29.1	55.3	28.3	52.3	57.6	38.2	17.2	21.6	32.9	32.9	31.2	63.5	54.1	41.3	30.1	86.1	31.2	21.1	21.5	61.2
BTBD9	"dJ322I12.1, KIAA1880"	ENSG00000183826	"BTB domain containing 9"	Q96Q07	6	38168451-38640148	"Disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	9	"Astrocytes: 191.3;Excitatory neurons: 390.4;Inhibitory neurons: 257.0;Microglial cells: 142.4;Oligodendrocyte precursor cells: 193.5;Oligodendrocytes: 218.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041930	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 42: Non-specific - Transcription"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm		"HPA041930: AB_10795270"	"unprognostic (4.40e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.75e-3)"	"unprognostic (1.64e-2)"	"unprognostic (6.59e-2)"	"unprognostic (3.94e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.76e-3)"	"unprognostic (5.44e-2)"	"unprognostic (6.13e-2)"	"unprognostic (1.92e-2)"	"unprognostic (2.74e-1)"	"prognostic favorable (4.20e-13)"	"unprognostic (1.35e-1)"	"unprognostic (6.56e-2)"	"unprognostic (8.67e-2)"	"unprognostic (1.15e-2)"	4.2	4.7	13.1	4.3	13.2	8.3	3.8	1.8	22.6	3.8	10.1	5.1	5.2	5.2	4.4	5.6	8.7	5.8	8.3	18.8	4.2	6.2	3.2	9.2	4.7	3.0	7.8	8.1	3.5	13.7	4.3	4.3	4.1	5.2	5.6	7.1	4.5	4.1	7.8	5.2	7.2	5.0	0.7	4.8	4.7	8.1	7.5	3.7	6.7	6.7	4.4	4.7	3.5	10.7	5.4	4.7	6.8	8.5	4.6	6.7	5.4	5.3	7.4	5.4	6.3	6.2	3.1	3.1	3.7	8.2	7.3	3.5	3.2	6.7	5.9	7.4	7.0	6.9	5.1	2.5	4.0	6.5	13.4	5.2	6.0	7.4	7.9	4.9	9.3	4.8	3.2	5.2	5.6	3.4	4.6	2.7	2.0	4.9	3.6	3.0	4.7	6.1	5.1	12.3	10.2	5.8	4.5	5.7	5.2	4.6	5.8	5.3	7.0	5.6	3.7	6.6	5.5	3.3	2.5	3.7	4.9	4.4	6.6	12.3	1.8	3.2	2.4	2.6	3.3	2.6	2.4	2.2	1.7	3.7	3.0	2.7	4.5	3.3	4.0	2.6	4.1	1.9	13.1	13.2	1.8	22.6	18.8	4.2	3.0	7.8	4.1	0.7	7.5	10.7	3.9	3.2	17.9	191.3	14.2	4.6	2.2	2.9	4.6	11.5	3.6	2.9	11.8	8.6	6.7	9.2	8.4	2.7	7.3	15.5	5.9	4.6	17.5	12.8	5.3	4.1	4.9	1.3	390.4	5.8	1.5	4.6	10.2	8.1	0.0	5.5	7.5	3.0	2.6	5.0	257.0	3.9	6.1	3.5	3.0	24.6	3.1	5.6	1.8	142.4	1.5	5.9	2.1	193.5	218.3	5.5	5.0	3.4	10.4	2.1	13.1	6.8	8.7	5.6	0.0	5.4	6.1	3.1	2.9	4.4	5.8	4.7	11.1	3.7	6.0	3.2
GLO1	GLOD1	ENSG00000124767	"Glyoxalase I"	Q04760	6	38675925-38703145	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Lyase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	4	"HMC-1: 2571.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB040541, CAB040542, HPA059791"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		No	No		1500000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Nucleoplasm, Plasma membrane, Cytosol"		"CAB040541: , CAB040542: , HPA059791: AB_2684126"	"unprognostic (4.33e-2)"	"unprognostic (1.09e-1)"	"unprognostic (4.37e-2)"	"unprognostic (1.08e-2)"	"unprognostic (3.96e-3)"	"unprognostic (2.51e-1)"	"prognostic unfavorable (5.21e-4)"	"unprognostic (5.09e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.28e-2)"	"unprognostic (2.61e-2)"	"unprognostic (8.71e-2)"	"unprognostic (1.20e-2)"	"unprognostic (9.29e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.54e-1)"	"unprognostic (6.21e-2)"	55.4	62.3	69.4	38.9	74.1	31.6	74.2	74.6	83.4	55.9	77.2	51.8	116.3	57.8	110.9	60.0	72.3	41.4	88.9	72.6	76.2	87.2	157.7	66.6	48.4	73.7	72.8	82.8	42.1	106.1	23.2	64.1	75.1	171.4	52.3	100.3	43.2	62.1	154.2	66.6	67.7	61.8	77.9	48.2	48.5	27.9	72.9	50.0	54.8	128.8	60.3	52.4	51.6	77.1	201.6	92.0	257.4	256.7	119.2	213.9	227.0	171.1	161.4	235.4	243.0	224.4	75.3	222.5	132.2	137.5	280.1	129.5	222.5	221.1	295.8	203.8	343.0	329.4	105.7	211.3	178.5	126.7	2571.5	183.9	133.5	223.7	159.0	153.2	258.5	154.9	264.7	143.6	223.3	170.6	199.5	160.5	185.5	179.2	176.7	171.0	311.1	145.8	217.8	149.9	199.3	201.3	120.6	165.4	329.8	175.9	192.4	628.3	107.6	182.0	167.1	159.8	275.9	112.7	227.0	608.6	66.1	322.7	299.6	23.7	20.7	15.3	35.5	33.4	48.0	51.9	35.3	36.7	39.0	51.4	32.7	34.9	2.7	23.5	26.9	60.4	34.1	33.3	69.4	74.1	74.6	83.4	72.6	76.2	73.7	72.8	75.1	77.9	72.9	77.1	69.2	131.4	174.4	26.1	86.3	64.6	112.6	88.2	37.0	56.1	67.7	55.8	133.2	58.6	84.5	90.1	20.9	102.7	68.3	34.1	248.4	132.1	4.5	76.2	58.8	74.3	36.5	83.5	23.9	73.3	323.0	86.0	53.0	67.5	71.4	78.7	161.0	114.0	78.8	69.0	21.9	39.3	99.7	125.7	72.8	6.5	83.9	70.0	104.9	17.8	92.6	190.3	49.4	25.1	24.8	77.3	36.0	109.9	86.4	178.8	103.2	132.2	80.7	65.5	46.0	62.0	70.9	15.0	16.1	77.2	88.2	73.2	62.4	123.7	63.4	130.2
DNAH8	hdhc9	ENSG00000124721	"Dynein axonemal heavy chain 8"	Q96JB1	6	38715311-39030792	"Plasma proteins, Predicted intracellular proteins"		"Motor protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"epididymis: 2.6;prostate: 2.1;testis: 7.8"	"Group enriched"	"Detected in some"	4	"Early spermatids: 35.4;Late spermatids: 13.2;Spermatocytes: 33.3"	"Cancer enriched"	"Detected in single"	7	"prostate cancer: 2.5"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	8	"basophil: 2.5"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 2.5"	"Cell line enriched"	"Detected in some"	8	"HMC-1: 47.1"	"Not detected"	"Not detected"							HPA028447	Uncertain					NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 68: Epididymis - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"			"HPA028447: AB_10599600"	"unprognostic (2.83e-1)"	"unprognostic (4.46e-4)"	"unprognostic (1.27e-1)"	"unprognostic (5.24e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.00e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.22e-2)"	"unprognostic (1.41e-1)"	"unprognostic (3.47e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.17e-9)"	"unprognostic (1.46e-3)"	"unprognostic (1.56e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.48e-3)"	0.0	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.1	2.1	0.0	0.0	0.0	0.1	0.0	1.6	0.1	0.0	0.0	0.9	0.1	7.8	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	47.1	0.0	0.0	0.0	0.0	0.0	5.9	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.7	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.9	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	35.4	0.0	0.0	0.2	0.0	0.0	2.7	0.0	0.1	0.2	1.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	13.2	1.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	1.7	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.1	33.3	5.7	0.0	0.0	0.0	0.6	0.0	0.0	0.0
GLP1R	GLP-1R	ENSG00000112164	"Glucagon like peptide 1 receptor"	P43220	6	39048781-39091303	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 3.7;heart muscle: 2.7;pancreas: 7.0"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 2.2;Early spermatids: 1.0;Inhibitory neurons: 1.2"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"NTERA-2: 1.1;SCLC-21H: 2.7"	"Region enriched"	"Detected in many"	4	"basal ganglia: 20.7"	"Low region specificity"	"Detected in some"									NA	NA				"Cluster 22: Non-specific - Unknown function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"				"unprognostic (4.06e-3)"			"unprognostic (5.38e-6)"	"unprognostic (1.80e-2)"	"unprognostic (4.16e-2)"	"unprognostic (4.98e-2)"	"unprognostic (3.55e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.38e-1)"	"unprognostic (9.76e-2)"	"unprognostic (3.29e-1)"	"unprognostic (1.73e-1)"	"unprognostic (8.60e-3)"	"unprognostic (2.47e-1)"	"unprognostic (1.15e-2)"	"unprognostic (1.42e-2)"	0.1	0.0	0.4	0.0	0.9	0.0	0.6	0.3	0.5	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	2.7	0.6	3.7	0.1	0.0	0.3	0.1	1.1	0.5	0.0	7.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	2.2	0.0	0.0	0.1	0.1	0.0	1.1	0.0	0.9	0.2	1.6	0.1	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.9	0.3	0.5	0.6	3.7	1.1	0.5	1.2	1.1	1.6	0.3	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SAYSD1	"C6orf64, FLJ11101"	ENSG00000112167	"SAYSVFN motif domain containing 1"	Q9NPB0	6	39104063-39115186	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 55.5"	"Group enriched"	"Detected in many"	4	"Early spermatids: 136.1;Late spermatids: 63.2;Spermatocytes: 223.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007959		Approved	Supported	Vesicles		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 66: Spermatocytes - Spermatogenesis"	Vesicles		"HPA007959: AB_1078359"	"unprognostic (2.65e-1)"	"unprognostic (1.49e-2)"	"unprognostic (2.03e-2)"	"unprognostic (2.58e-1)"	"unprognostic (3.70e-1)"	"unprognostic (2.56e-1)"	"unprognostic (9.90e-3)"	"unprognostic (1.96e-2)"	"unprognostic (6.50e-2)"	"unprognostic (1.82e-3)"	"unprognostic (5.08e-2)"	"unprognostic (9.90e-2)"	"unprognostic (2.54e-2)"	"unprognostic (1.79e-1)"	"unprognostic (9.78e-3)"	"unprognostic (2.27e-1)"	"unprognostic (2.00e-3)"	8.8	7.9	7.8	6.5	8.4	7.6	10.5	8.3	10.3	8.6	8.0	8.7	9.9	8.4	11.1	7.5	8.6	6.9	8.3	8.2	8.3	9.6	10.1	7.0	10.3	8.0	8.1	8.8	11.1	7.7	6.3	6.7	8.1	9.2	7.8	6.8	12.6	8.2	7.0	7.4	9.4	6.8	8.1	7.5	7.8	55.5	8.1	17.0	8.7	7.0	9.4	7.2	6.9	9.6	14.8	9.4	8.3	9.9	13.4	17.7	8.6	6.7	7.3	7.9	8.3	13.6	10.2	13.4	9.4	8.8	11.2	9.9	7.3	6.3	8.3	8.5	13.2	8.8	5.5	11.9	10.9	10.1	12.7	12.3	15.4	3.1	7.8	5.6	7.4	19.9	15.1	7.9	9.0	20.4	16.1	16.6	7.2	9.7	4.8	2.3	10.1	5.4	16.7	10.3	23.3	9.4	11.6	10.0	10.9	6.6	16.4	13.1	9.7	10.4	7.5	3.2	8.8	0.2	4.3	16.2	6.0	14.4	7.8	10.6	10.8	24.9	14.0	15.1	16.0	16.4	15.2	12.8	11.4	18.5	21.0	17.9	5.2	15.8	15.8	9.0	22.2	12.1	7.8	8.4	8.3	10.3	8.2	8.3	8.0	8.1	8.1	8.1	8.1	9.6	19.3	3.2	6.0	4.6	11.4	15.4	13.2	29.1	8.6	6.4	26.4	21.8	18.8	21.5	17.0	18.4	8.4	33.1	8.3	10.5	17.6	22.9	136.1	22.8	14.0	11.2	8.4	13.5	3.2	21.8	32.7	16.8	4.6	19.0	8.2	13.8	6.4	23.3	26.8	6.7	4.2	16.5	2.0	13.9	15.7	63.2	20.5	13.2	12.4	0.0	11.9	15.5	12.3	9.0	6.3	15.9	9.7	19.2	5.3	22.6	21.8	28.3	19.2	4.1	6.6	13.1	17.3	223.6	14.5	11.6	16.6	12.3	12.8	10.2	20.1	14.9
KCNK5	"K2p5.1, TASK-2, TASK2"	ENSG00000164626	"Potassium two pore domain channel subfamily K member 5"	O95279	6	39188971-39229475	"Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 35.4;kidney: 37.2"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 48.6;Distal enterocytes: 55.6;Gastric mucus-secreting cells: 31.6;Proximal enterocytes: 66.5;Proximal tubular cells: 45.4;Syncytiotrophoblasts: 45.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CACO-2: 34.9;HEL: 36.1;HMC-1: 31.8;K-562: 34.3;OE19: 27.4;T-47d: 25.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA059148	Uncertain		Approved	Nucleoplasm		NA	NA				"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm		"HPA059148: AB_2683929"	"unprognostic (1.46e-1)"	"prognostic favorable (3.29e-4)"	"unprognostic (1.08e-1)"	"unprognostic (2.92e-3)"	"unprognostic (8.09e-4)"	"unprognostic (3.97e-2)"	"unprognostic (2.33e-1)"	"unprognostic (9.57e-3)"	"unprognostic (7.14e-2)"	"unprognostic (3.43e-1)"	"prognostic unfavorable (5.85e-4)"	"unprognostic (2.98e-1)"	"prognostic favorable (4.98e-7)"	"unprognostic (2.34e-1)"	"unprognostic (7.13e-2)"	"unprognostic (1.03e-2)"	"prognostic favorable (4.45e-4)"	4.0	3.7	0.1	2.2	0.1	9.6	5.3	0.0	0.1	4.4	0.1	14.2	28.4	2.1	0.2	6.1	2.3	18.8	1.7	0.0	0.2	37.2	23.5	6.1	2.7	0.2	0.2	6.4	20.4	1.9	1.2	8.6	0.1	3.5	8.5	0.1	27.1	2.4	0.2	29.4	35.4	1.3	0.1	2.2	16.7	0.7	0.3	1.8	10.0	0.1	1.9	3.2	6.7	0.0	6.6	5.9	7.7	2.9	0.0	0.0	6.6	0.0	0.0	0.0	0.0	34.9	14.3	0.0	10.2	0.0	0.8	13.2	6.0	0.2	0.0	0.0	4.5	36.1	3.1	0.2	0.0	7.5	31.8	0.0	0.1	0.2	0.0	0.0	0.0	7.8	34.3	0.1	0.0	11.4	16.7	8.1	14.4	27.4	0.0	0.0	1.4	13.6	5.3	5.4	1.9	1.5	5.7	7.3	0.0	2.9	25.9	12.1	0.2	0.0	6.4	0.0	0.0	0.0	0.0	0.0	0.0	19.5	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.2	0.2	0.2	0.1	0.1	0.3	0.0	2.3	0.0	19.2	0.0	0.1	3.7	2.5	1.5	5.7	0.0	4.2	3.2	0.6	48.6	7.7	1.8	0.0	28.8	0.8	55.6	5.9	14.5	0.1	2.6	0.3	6.9	0.0	6.1	0.0	11.8	5.3	3.2	31.6	5.3	0.0	2.2	0.0	27.5	2.1	0.0	0.0	15.3	8.2	0.6	3.5	0.7	0.6	0.8	1.8	0.0	0.6	0.0	0.0	0.0	0.0	12.1	25.1	0.0	0.4	2.6	66.5	45.4	1.0	0.0	0.0	2.4	0.6	0.0	1.1	8.2	2.7	45.6	3.5	1.4	11.1	10.4
KCNK17	"K2p17.1, TALK-2, TALK2, TASK-4, TASK4"	ENSG00000124780	"Potassium two pore domain channel subfamily K member 17"	Q96T54	6	39299001-39314461	"Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 7.7;thyroid gland: 6.5"	"Cell type enhanced"	"Detected in some"		"dendritic cells: 11.0;Exocrine glandular cells: 7.9;granulocytes: 6.3;Microglial cells: 17.8;Smooth muscle cells: 5.4"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in some"	34	"plasmacytoid DC: 63.8"	"Lineage enriched"	"Detected in many"	34	"dendritic cells: 63.8"	"Cell line enriched"	"Detected in some"	7	"SCLC-21H: 83.8"					"Not detected"	"Not detected"			HPA043892	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 65: Plasmacytoid DCs - Unknown function"	"Plasma membrane, Cytosol"	Nucleoplasm	"HPA043892: AB_10962838"	"unprognostic (5.33e-3)"	"unprognostic (6.42e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.54e-1)"	"unprognostic (3.70e-2)"	"unprognostic (3.85e-2)"	"unprognostic (4.09e-2)"	"unprognostic (4.95e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.71e-2)"	"unprognostic (2.54e-1)"	"unprognostic (3.77e-11)"	"unprognostic (5.89e-2)"	"unprognostic (5.36e-1)"	"unprognostic (2.82e-1)"	"unprognostic (3.86e-3)"	0.5	0.3	0.3	0.4	0.4	1.2	0.8	0.3	0.6	0.7	0.2	0.6	1.9	1.2	0.0	0.3	0.8	2.5	5.8	0.2	0.3	0.1	4.0	7.7	0.7	0.4	0.5	0.2	3.9	0.1	1.8	4.0	0.3	0.6	0.5	0.0	0.7	0.2	0.1	0.1	1.1	1.0	0.2	0.7	2.9	0.2	0.5	1.3	6.5	0.5	1.1	0.7	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	83.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.8	0.0	63.8	0.0	0.3	0.3	0.4	0.3	0.6	0.2	0.3	0.4	0.5	0.3	0.2	0.5	0.3	0.0	0.0	2.6	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.1	1.9	0.3	0.0	0.0	0.0	0.0	0.0	11.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.1	7.9	0.0	1.8	1.1	0.1	6.3	0.0	0.7	0.2	0.1	0.0	0.1	0.4	0.0	0.6	0.0	0.0	0.0	0.9	0.0	17.8	0.2	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	2.3	5.4	0.0	0.2	0.0	0.0	0.0	0.7	0.1	0.0	0.0
KCNK16	"K2p16.1, TALK-1, TALK1"	ENSG00000095981	"Potassium two pore domain channel subfamily K member 16"	Q96T55	6	39314698-39322968	"Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"pancreas: 23.7;stomach 1: 10.3"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in some"	17	"pancreatic cancer: 13.3"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	10	"basophil: 2.1"	"Lineage enriched"	"Detected in single"	10	"granulocytes: 2.1"	"Cell line enriched"	"Detected in single"	390	"SCLC-21H: 127.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 25: Pancreas - Digestion"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 1: Pancreatic cells - Digestion"														"unprognostic (3.29e-2)"					"unprognostic (3.48e-1)"		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	23.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.0	0.0	0.0	10.3	0.1	0.1	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	127.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KIF6	"C6orf102, dJ1043E3.1, dJ137F1.4, dJ188D3.1, DKFZp451I2418, MGC33317"	ENSG00000164627	"Kinesin family member 6"	Q6ZMV9	6	39329990-39725408	"Predicted intracellular proteins"		"Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 18.3;testis: 5.3"	"Cell type enriched"	"Detected in many"	5	"Oligodendrocytes: 220.3"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"GAMG: 22.1;RPMI-8226: 9.2;SCLC-21H: 12.2;SK-MEL-30: 5.0"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"midbrain: 1.7"	"HPA038811, HPA058624"	Enhanced		Approved	Centrosome		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Centrosome		"HPA038811: AB_10795140, HPA058624: AB_2683781"	"unprognostic (4.94e-2)"	"unprognostic (3.38e-2)"	"unprognostic (3.68e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.55e-1)"	"unprognostic (8.25e-4)"	"unprognostic (3.12e-3)"	"unprognostic (1.00e-1)"	"unprognostic (3.06e-1)"	"unprognostic (3.48e-2)"	"unprognostic (9.12e-4)"	"unprognostic (1.08e-1)"	"unprognostic (3.07e-2)"	"unprognostic (3.10e-2)"	"unprognostic (5.09e-2)"	"unprognostic (3.92e-2)"	"unprognostic (1.99e-1)"	0.3	0.3	8.0	0.1	15.5	0.1	0.5	10.5	9.3	0.3	1.5	0.2	0.5	0.2	0.5	0.3	3.8	0.4	0.3	7.2	8.6	0.3	0.3	0.8	0.3	12.3	9.8	0.2	0.4	0.3	1.2	0.3	11.1	0.2	0.1	3.0	0.1	0.1	0.4	0.2	0.2	0.1	8.0	0.2	0.2	5.3	10.0	0.1	0.6	0.2	0.1	0.0	0.0	18.3	0.0	0.2	0.2	0.0	0.0	0.0	0.1	0.1	1.0	0.3	0.5	0.1	0.0	0.0	0.1	1.0	22.1	0.2	0.1	0.0	0.2	0.0	0.3	0.1	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.3	0.0	0.6	0.0	0.2	0.0	0.0	0.1	0.1	0.1	0.6	0.0	0.0	0.5	9.2	0.2	0.0	12.2	0.1	0.0	0.1	5.0	0.3	0.1	0.1	0.1	0.0	0.1	2.9	0.7	0.2	0.0	0.0	0.7	0.0	1.5	0.5	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.1	0.1	0.5	0.2	0.1	0.6	0.0	0.0	8.0	15.5	10.5	9.3	7.2	8.6	12.3	9.8	11.1	8.0	10.0	18.3	0.2	0.0	0.6	31.3	0.1	0.1	0.7	1.0	0.0	3.9	0.5	0.5	1.3	0.0	2.2	0.0	10.4	0.3	0.0	0.0	1.9	1.5	9.1	23.9	1.0	0.8	2.4	0.0	8.6	0.9	0.5	2.7	0.0	1.0	0.0	0.4	0.0	0.0	0.3	3.3	15.6	0.0	0.0	0.0	1.5	10.3	0.3	0.3	0.0	1.9	0.1	12.9	0.0	5.0	220.3	0.1	0.1	0.0	0.1	0.3	0.0	3.5	40.0	16.3	0.0	3.1	0.8	17.0	3.1	0.1	0.4	0.3	0.2	2.2	0.0	0.4
DAAM2	KIAA0381	ENSG00000146122	"Dishevelled associated activator of morphogenesis 2"	Q86T65	6	39792298-39904877	"Predicted intracellular proteins"	"Wnt signaling pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 245.9"	"Group enriched"	"Detected in many"	5	"Astrocytes: 275.6;Oligodendrocytes: 449.8;Sertoli cells: 151.2"	"Group enriched"	"Detected in all"	5	"glioma: 15.0;melanoma: 21.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HSkMC: 54.9;JURKAT: 30.4;LHCN-M2: 55.8;SK-MEL-30: 68.7;WM-115: 26.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051300, HPA054630"	Approved		Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 70: Brain - Nervous system development"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm	"Vesicles, Cytosol"	"HPA051300: AB_2681430, HPA054630: AB_2682549"	"unprognostic (7.53e-2)"	"unprognostic (6.02e-3)"	"unprognostic (4.49e-2)"	"unprognostic (7.93e-2)"	"unprognostic (8.24e-2)"	"unprognostic (4.28e-2)"	"unprognostic (2.43e-2)"	"unprognostic (1.05e-3)"	"unprognostic (1.33e-1)"	"unprognostic (5.89e-2)"	"unprognostic (2.17e-1)"	"unprognostic (5.24e-2)"	"prognostic unfavorable (2.79e-4)"	"unprognostic (2.67e-2)"	"unprognostic (8.54e-2)"	"unprognostic (7.94e-2)"	"unprognostic (8.54e-4)"	33.7	22.5	179.4	9.0	229.4	1.8	23.3	175.8	159.3	15.7	65.1	18.9	9.8	14.0	10.4	36.6	18.5	7.4	13.5	144.0	170.5	9.3	4.8	12.4	3.6	234.8	195.8	10.0	7.5	4.1	5.1	12.2	205.0	11.0	8.7	1.6	7.6	21.7	38.3	8.5	20.9	18.3	194.3	40.2	18.9	12.3	187.7	2.5	13.1	38.1	2.3	9.9	11.3	245.9	0.1	0.0	5.8	0.1	12.2	0.3	0.2	9.8	13.1	2.2	1.2	0.9	0.0	0.1	0.5	14.7	4.5	0.1	0.0	0.0	0.8	0.0	2.4	0.0	0.0	0.1	8.8	0.0	0.1	54.9	0.0	0.3	0.0	15.6	0.0	30.4	0.0	0.1	55.8	0.2	1.5	0.1	1.6	3.1	0.1	0.0	10.0	8.1	0.0	0.0	2.0	2.3	0.0	0.7	68.7	11.7	0.0	0.1	0.6	20.8	6.0	0.2	0.3	0.0	0.0	0.0	0.2	0.0	26.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	179.4	229.4	175.8	159.3	144.0	170.5	234.8	195.8	205.0	194.3	187.7	245.9	11.2	9.6	12.2	275.6	0.1	1.8	0.9	0.0	0.0	1.3	1.5	1.5	2.5	1.5	3.8	0.0	0.0	0.5	0.1	0.0	0.0	0.5	3.8	1.2	10.4	9.0	0.0	2.7	1.4	3.3	0.5	11.8	0.5	2.3	0.0	1.9	2.5	1.2	0.2	0.0	5.8	0.0	0.0	31.5	2.4	6.4	23.6	6.2	8.8	21.5	0.0	5.8	1.0	8.5	449.8	0.3	0.0	22.2	0.0	0.8	0.0	0.1	1.5	1.6	151.2	12.7	48.8	1.0	1.9	0.4	1.1	0.3	0.7	55.9	0.0	1.2
MOCS1	MOCOD	ENSG00000124615	"Molybdenum cofactor synthesis 1"	Q9NZB8	6	39899578-39934551	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Molybdenum cofactor biosynthesis"	Lyase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 33.7;Hepatocytes: 36.2;Sertoli cells: 78.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CACO-2: 40.4;JURKAT: 51.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045783, HPA058177, HPA075505"	Uncertain		Enhanced	Cytosol		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 15: Liver - Metabolism"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 47: Cytotrophoblasts - Unknown function"	Cytosol		"HPA045783: AB_10960058, HPA058177: AB_2683629, HPA075505: AB_2686751"	"unprognostic (1.22e-1)"	"prognostic unfavorable (1.07e-5)"	"unprognostic (3.26e-2)"	"unprognostic (1.44e-1)"	"unprognostic (9.03e-2)"	"unprognostic (1.99e-1)"	"unprognostic (2.61e-2)"	"unprognostic (4.85e-2)"	"unprognostic (3.14e-2)"	"unprognostic (1.08e-1)"	"prognostic favorable (6.07e-5)"	"unprognostic (5.34e-3)"	"unprognostic (1.21e-1)"	"unprognostic (3.97e-3)"	"unprognostic (2.78e-1)"	"unprognostic (2.93e-1)"	"unprognostic (6.21e-2)"	33.7	9.5	14.6	3.2	17.9	0.0	26.8	16.8	14.7	8.8	11.2	11.7	16.2	10.0	10.1	6.7	10.3	5.5	22.0	12.7	16.0	20.4	40.3	22.9	4.5	17.4	18.8	9.0	11.9	9.6	5.3	35.6	16.2	5.3	5.6	3.0	6.1	7.5	25.7	7.3	12.7	9.2	15.6	2.6	7.6	3.2	17.3	3.3	16.0	45.0	3.4	10.0	6.6	16.4	0.0	2.1	7.0	11.4	19.3	7.2	15.2	8.7	15.0	12.1	10.0	40.4	0.1	0.0	8.4	7.4	7.0	0.4	8.2	9.8	8.7	0.0	8.6	0.0	0.0	13.7	12.2	0.0	3.1	12.0	3.7	7.9	4.2	7.2	10.1	51.1	8.4	0.7	11.7	5.0	16.0	0.0	7.9	0.1	4.6	0.0	6.3	1.1	7.6	8.2	6.1	8.5	0.0	4.2	7.0	6.3	5.2	1.4	16.2	12.2	9.8	7.7	4.1	0.0	1.7	0.0	1.3	0.0	4.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.6	0.5	0.0	0.3	0.0	0.0	0.0	0.2	14.6	17.9	16.8	14.7	12.7	16.0	17.4	18.8	16.2	15.6	17.3	16.4	5.7	6.4	1.5	6.2	0.1	0.6	0.6	0.7	1.2	1.6	9.3	6.5	11.6	8.6	0.3	9.2	12.5	33.7	0.5	3.6	5.9	4.4	0.8	0.9	1.6	3.3	0.0	0.0	3.2	4.1	2.3	4.3	1.1	1.4	1.3	6.3	3.3	36.2	2.9	3.3	2.6	3.5	0.0	2.8	1.0	1.8	3.7	0.4	1.8	2.8	0.0	4.6	0.0	1.0	4.4	1.0	9.1	3.0	1.3	0.2	13.2	17.8	0.0	2.2	78.9	3.9	20.3	1.6	1.9	1.2	1.1	6.2	0.3	0.8	5.5	0.6
LRFN2	"FIGLER2, KIAA1246, SALM1"	ENSG00000156564	"Leucine rich repeat and fibronectin type III domain containing 2"	Q9ULH4	6	40391591-40587364	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 6.4;retina: 3.2"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 24.2;Cone photoreceptor cells: 62.6;Excitatory neurons: 111.5;Inhibitory neurons: 62.8;Oligodendrocyte precursor cells: 49.8"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"basal ganglia: 6.4;cerebral cortex: 5.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"REH: 1.7;SH-SY5Y: 4.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA076660	Enhanced		Supported	"Plasma membrane"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 58: Brain - Synaptic function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane"		"HPA076660: AB_2686812"	"unprognostic (1.93e-2)"	"unprognostic (2.04e-1)"	"unprognostic (3.61e-2)"	"unprognostic (4.58e-4)"	"unprognostic (3.10e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.69e-1)"	"unprognostic (5.75e-3)"	"unprognostic (4.94e-2)"	"unprognostic (1.80e-1)"	"unprognostic (9.05e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.98e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.66e-4)"	0.0	0.3	1.6	0.0	6.4	0.3	0.0	0.0	5.9	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.7	0.2	0.0	0.0	0.0	0.0	3.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	1.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	1.7	0.0	0.0	0.0	0.1	0.7	4.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.6	6.4	0.0	5.9	1.3	0.0	0.0	0.0	0.0	0.0	0.4	1.3	0.0	0.0	0.0	24.2	0.0	0.0	0.0	0.0	0.0	10.8	0.1	0.3	0.6	0.0	0.1	0.0	62.6	0.4	0.3	0.1	0.0	0.0	1.5	0.0	0.0	0.1	4.2	0.0	111.5	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	62.8	1.0	0.0	0.0	0.0	1.5	0.3	0.0	0.0	3.7	0.0	0.8	0.0	49.8	2.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	9.6	0.0	0.0	0.0	1.9	0.0	1.0	0.0	0.3	0.2	0.0	0.1	0.1
UNC5CL	"MGC34763, ZUD"	ENSG00000124602	"Unc-5 family C-terminal like"	Q8IV45	6	41026895-41039221	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"intestine: 37.1;kidney: 58.6;liver: 52.8;pancreas: 36.2;stomach 1: 23.6"	"Group enriched"	"Detected in many"	6	"Cholangiocytes: 30.0;Collecting duct cells: 22.0;Ductal cells: 25.7;Exocrine glandular cells: 68.6;Gastric mucus-secreting cells: 36.7;Hepatocytes: 30.0;Pancreatic endocrine cells: 19.8;Proximal enterocytes: 37.3;Proximal tubular cells: 41.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"OE19: 44.8;RPTEC TERT1: 13.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA015725	Enhanced		Approved	Centrosome		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 1: Pancreatic cells - Digestion"	Centrosome		"HPA015725: AB_2669283"	"unprognostic (1.10e-2)"	"unprognostic (3.59e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.57e-1)"	"unprognostic (7.87e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.16e-1)"	"unprognostic (8.55e-3)"	"unprognostic (3.58e-1)"	"unprognostic (2.02e-2)"	"unprognostic (1.20e-1)"	"unprognostic (6.67e-2)"	"unprognostic (9.30e-2)"	"unprognostic (2.35e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.60e-6)"	1.2	1.0	1.3	1.0	1.6	0.9	1.6	1.3	1.7	1.5	1.2	3.1	37.1	1.1	0.3	1.3	1.9	9.2	1.2	1.3	1.3	58.6	52.8	2.1	1.0	1.7	1.4	1.5	36.2	0.3	0.8	0.4	1.6	1.5	1.3	0.8	1.7	0.6	0.7	1.9	29.4	0.4	1.4	3.3	23.6	2.2	1.5	2.7	1.6	0.2	0.7	1.1	1.1	2.3	0.5	0.2	0.6	0.9	0.2	0.1	0.6	0.0	0.1	0.0	0.0	7.0	0.1	0.1	2.5	0.0	0.0	0.2	0.1	0.2	0.1	1.1	1.3	0.6	0.0	3.8	0.1	0.3	0.2	0.1	0.6	0.0	0.4	0.1	0.0	2.8	0.5	0.4	0.0	0.1	0.9	2.3	0.2	44.8	0.2	0.9	0.1	0.5	13.0	0.0	0.6	0.6	0.0	0.0	1.3	0.7	0.1	0.2	0.2	0.0	0.4	0.3	0.1	4.3	2.3	0.6	0.0	1.5	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	1.3	1.6	1.3	1.7	1.3	1.3	1.7	1.4	1.6	1.4	1.5	2.3	0.3	3.2	1.1	4.2	1.3	0.8	0.6	0.4	0.6	0.6	1.0	1.0	0.8	30.0	0.3	22.0	4.2	0.4	1.8	2.3	3.9	25.7	2.4	0.6	0.3	0.4	1.2	0.4	0.3	68.6	0.8	0.5	36.7	1.6	0.0	0.3	1.4	30.0	0.3	1.7	0.2	5.0	0.0	0.8	0.3	0.4	0.3	0.8	1.8	0.0	0.8	0.2	2.1	0.0	3.5	19.8	3.1	0.7	0.3	0.6	37.3	41.8	0.9	0.3	0.0	0.3	0.4	0.9	0.8	0.5	0.1	0.8	1.0	0.1	5.4	0.4
OARD1	"C6orf130, dJ34B21.3, MGC19570, TARG1"	ENSG00000124596	"O-acyl-ADP-ribose deacylase 1"	Q9Y530	6	41033627-41097787	"Disease related genes, Metabolic proteins, Predicted intracellular proteins"		Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 193.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"OE19: 294.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029036	Approved		Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 21: OE19 - Mitochondria"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	"Nucleoplasm, Nucleoli"		"HPA029036: AB_10602336"	"unprognostic (2.33e-2)"	"unprognostic (5.23e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.92e-1)"	"unprognostic (6.50e-2)"	"unprognostic (1.45e-1)"	"unprognostic (3.62e-2)"	"unprognostic (7.06e-2)"	"unprognostic (5.54e-2)"	"unprognostic (3.99e-3)"	"unprognostic (3.46e-2)"	"unprognostic (2.15e-1)"	"prognostic favorable (1.13e-4)"	"unprognostic (4.78e-1)"	"unprognostic (7.85e-2)"	"unprognostic (1.70e-1)"	"unprognostic (2.15e-1)"	20.9	25.5	26.4	20.3	30.5	26.3	30.1	28.5	32.3	19.5	26.5	28.8	31.4	17.6	38.3	23.3	30.1	19.3	22.0	26.0	28.4	44.3	59.2	17.3	28.5	29.7	28.3	35.7	40.6	34.9	22.6	20.0	30.4	25.0	31.1	43.8	25.6	22.0	25.5	21.6	30.2	15.0	28.8	23.0	39.5	58.6	28.2	39.7	30.9	37.1	33.4	20.0	20.1	35.6	44.2	25.0	55.8	40.6	32.1	37.6	36.9	28.0	36.5	29.1	31.4	39.7	33.1	61.7	29.3	15.4	32.1	33.4	38.1	33.1	41.0	53.2	18.6	73.8	28.0	75.4	29.1	50.1	47.6	28.7	45.6	28.1	102.2	26.5	20.3	77.4	95.4	48.8	32.2	59.0	88.1	55.1	51.4	294.4	17.3	36.8	52.4	54.7	58.0	21.4	60.5	38.7	25.5	25.2	88.6	43.2	41.9	42.3	21.9	32.0	39.3	20.0	43.6	65.8	72.7	140.1	25.2	48.5	27.1	49.1	21.8	42.4	26.2	23.3	34.3	45.7	30.6	26.6	26.8	43.2	37.2	36.9	20.8	45.0	28.2	26.0	37.2	22.7	26.4	30.5	28.5	32.3	26.0	28.4	29.7	28.3	30.4	28.8	28.2	35.6	30.5	16.0	40.9	7.8	49.8	28.6	40.3	51.8	38.7	63.2	47.5	41.1	43.4	52.9	40.6	60.7	45.9	89.5	44.1	28.5	86.1	42.9	164.2	43.3	19.6	34.2	22.1	56.4	2.9	48.0	60.2	23.5	37.8	29.8	48.2	21.7	35.0	69.5	45.6	42.1	3.9	52.2	50.8	53.4	37.0	153.8	28.3	33.4	35.6	3.7	42.1	75.9	59.8	4.0	13.1	34.6	44.0	25.9	29.3	37.1	63.0	112.9	56.6	70.5	26.3	23.9	26.7	193.0	148.0	43.4	29.3	45.6	47.5	34.2	61.7	32.4
TSPO2	"BZRPL1, dJ34B21.2"	ENSG00000112212	"Translocator protein 2"	Q5TGU0	6	41042467-41044337	"Predicted membrane proteins, Transporters"	Transport	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	30	"bone marrow: 50.1"	"Cell type enriched"	"Detected in some"	115	"Erythroid cells: 253.9"	"Cancer enhanced"	"Detected in some"		"liver cancer: 0.8"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"OE19: 11.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA060691, HPA066996"			Enhanced	"Plasma membrane"		NA	NA				"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 21: OE19 - Mitochondria"	"Cluster 6: Erythroid cells - Oxygen transport"	"Plasma membrane"		"HPA060691: , HPA066996: AB_2685761"	"unprognostic (1.89e-3)"	"unprognostic (8.35e-3)"	"unprognostic (2.57e-3)"	"unprognostic (2.29e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.66e-2)"	"unprognostic (6.61e-3)"	"unprognostic (2.29e-1)"	"unprognostic (3.37e-1)"	"unprognostic (2.89e-1)"	"unprognostic (2.71e-1)"	"unprognostic (4.92e-2)"	"unprognostic (1.86e-2)"	"unprognostic (2.70e-2)"	"unprognostic (1.16e-1)"	"unprognostic (5.37e-2)"	"unprognostic (1.76e-2)"	0.0	0.0	0.1	0.1	0.6	50.1	0.0	0.1	0.7	0.0	0.0	0.1	1.1	0.0	0.0	0.0	0.0	0.6	0.1	0.1	0.4	0.5	0.6	0.2	0.1	0.8	0.4	0.1	0.1	0.0	0.0	1.2	0.9	0.0	0.0	0.3	0.0	0.0	0.1	0.5	0.7	0.0	0.2	1.3	0.5	0.2	0.8	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.2	0.1	0.4	0.0	11.0	0.0	0.3	0.0	0.0	0.2	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.5	0.1	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.1	0.7	0.1	0.4	0.8	0.4	0.9	0.2	0.8	1.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.9	0.3	0.1	0.0	0.0	0.0	253.9	0.2	0.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	2.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.3	0.0
APOBEC2	"ARCD1, ARP1"	ENSG00000124701	"Apolipoprotein B mRNA editing enzyme catalytic subunit 2"	Q9Y235	6	41053202-41064891	"Enzymes, Predicted intracellular proteins"	"mRNA processing"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 203.7;skeletal muscle: 853.2;tongue: 288.0"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 15.8;Cardiomyocytes: 103.5;Early spermatids: 25.7;Exocrine glandular cells: 21.8;Extravillous trophoblasts: 18.1;Late spermatids: 25.1;Skeletal myocytes: 36.7"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 3.7;pancreatic cancer: 4.9"	"Low region specificity"	"Detected in some"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in single"		"CACO-2: 2.8"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"HPA014252, HPA017957"	Enhanced					NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 37: Myocytes - Muscle contraction"			"HPA014252: AB_1844932, HPA017957: AB_1844933"	"unprognostic (5.05e-2)"	"unprognostic (5.55e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.77e-1)"	"unprognostic (2.51e-2)"	"unprognostic (8.16e-3)"	"unprognostic (1.43e-1)"	"unprognostic (7.22e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.50e-2)"	"unprognostic (1.21e-1)"	"unprognostic (3.87e-1)"	"unprognostic (2.01e-2)"	"unprognostic (7.02e-2)"	"unprognostic (3.69e-1)"	"unprognostic (1.31e-3)"	"unprognostic (2.19e-2)"	0.2	0.8	0.3	0.3	0.9	1.1	0.3	0.4	0.7	0.0	0.2	0.8	1.4	0.1	0.0	12.0	0.1	0.1	203.7	0.2	0.4	0.4	0.1	0.5	0.3	1.0	0.6	0.1	12.7	0.0	0.1	0.7	0.8	7.7	0.1	5.7	12.7	0.0	853.2	1.1	1.2	2.1	0.5	0.2	12.6	2.7	0.7	10.9	0.3	288.0	0.0	0.3	0.1	1.7	0.0	0.0	0.1	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	2.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.2	0.0	0.3	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.1	0.0	0.0	0.1	0.4	0.0	0.4	0.0	0.2	0.2	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.1	0.7	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.7	0.1	0.3	0.1	0.1	0.0	0.8	0.6	1.3	1.6	0.5	1.4	2.1	1.5	1.7	0.4	1.9	1.6	1.8	0.6	0.6	0.9	2.2	1.6	0.1	0.3	0.9	0.4	0.7	0.2	0.4	1.0	0.6	0.8	0.5	0.7	1.7	0.0	0.0	0.0	1.0	0.0	0.3	0.7	1.0	0.0	15.8	0.0	0.0	103.5	0.0	0.0	0.0	2.1	1.6	0.1	0.0	0.0	8.0	25.7	0.0	0.0	1.2	0.0	0.0	0.5	21.8	18.1	2.3	8.6	0.1	0.0	0.0	0.0	0.0	0.4	1.7	0.5	0.1	0.0	0.3	0.3	25.1	0.3	0.1	1.8	0.0	0.0	0.9	0.0	2.0	3.7	2.2	0.0	0.0	0.0	0.0	0.5	2.0	0.0	3.1	0.0	36.7	2.0	1.1	0.2	0.0	0.0	1.4	0.1	0.0	0.0	0.0
NFYA	"CBF-B, HAP2, NF-YA"	ENSG00000001167	"Nuclear transcription factor Y subunit alpha"	P23511	6	41072945-41099976	"Predicted intracellular proteins, Transcription factors"	"Biological rhythms, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 41.4;Late spermatids: 44.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009250, HPA050779"	Enhanced		Supported	Nucleoplasm		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 21: OE19 - Mitochondria"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm		"CAB009250: AB_2152107, HPA050779: AB_2681234"	"unprognostic (2.56e-1)"	"unprognostic (4.48e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.95e-2)"	"unprognostic (4.57e-1)"	"unprognostic (1.94e-2)"	"prognostic unfavorable (8.74e-4)"	"unprognostic (1.97e-2)"	"unprognostic (2.24e-2)"	"unprognostic (5.23e-3)"	"unprognostic (5.62e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.92e-3)"	"unprognostic (3.11e-1)"	"unprognostic (5.98e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.92e-3)"	10.8	8.9	13.3	14.0	18.1	40.7	15.6	14.3	13.2	11.3	9.6	11.9	9.9	14.9	14.7	10.8	11.6	12.5	8.8	12.5	13.4	10.1	14.3	11.8	19.5	15.8	16.6	18.7	11.5	15.3	9.0	13.8	15.5	13.6	14.6	21.5	9.4	8.0	9.3	10.6	11.2	10.8	13.6	14.5	12.6	38.5	14.8	41.5	18.4	12.4	20.5	14.6	9.4	24.3	32.8	26.3	49.2	82.7	19.9	19.3	20.9	24.2	22.4	37.2	31.4	34.6	23.3	39.4	19.7	16.0	19.6	21.0	30.1	29.1	40.9	28.4	38.0	51.7	23.2	49.4	14.1	55.0	43.3	12.3	24.4	29.8	40.0	18.1	32.6	64.5	51.4	46.4	36.9	32.4	62.5	22.1	22.1	95.8	25.9	50.3	27.1	29.6	27.2	43.8	49.8	34.3	21.1	18.9	37.5	31.2	17.7	55.1	32.2	65.7	35.6	13.2	46.9	18.2	19.8	64.2	13.0	46.2	26.5	2.7	2.9	4.8	5.8	3.9	7.6	3.7	5.4	6.4	3.3	4.1	5.7	6.3	8.0	6.5	3.5	4.3	6.7	3.2	13.3	18.1	14.3	13.2	12.5	13.4	15.8	16.6	15.5	13.6	14.8	24.3	7.6	9.6	3.9	6.2	11.1	14.5	9.9	4.2	2.8	4.1	13.2	7.1	4.7	11.5	5.3	11.0	4.2	7.7	11.7	9.3	1.9	11.3	41.4	7.4	7.7	7.5	4.8	12.2	4.4	7.4	12.5	6.8	5.1	8.1	2.5	11.9	7.5	7.0	10.0	0.0	5.1	4.2	4.1	9.3	14.0	44.4	3.7	6.4	7.2	10.3	7.2	3.3	7.2	5.0	13.8	9.6	9.6	3.0	5.6	12.8	5.1	2.6	6.9	5.0	0.0	4.3	8.3	20.0	8.2	6.3	15.9	10.8	10.1	5.6	7.6	18.7
TREML1	"dJ238O23.3, TLT1"	ENSG00000161911	"Triggering receptor expressed on myeloid cells like 1"	Q86YW5	6	41149342-41154337	"Plasma proteins, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 8.7;brain: 4.5;lymphoid tissue: 7.3"	"Group enriched"	"Detected in some"	7	"Macrophages: 75.6;monocytes: 28.3"	"Cancer enhanced"	"Detected in some"		"glioma: 1.6"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	9	"basophil: 92.4"	"Lineage enriched"	"Detected in many"	49	"granulocytes: 92.4"	"Cell line enriched"	"Detected in single"	170	"HEL: 66.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA016700, HPA017860"	Enhanced		Uncertain	"Nuclear speckles,Golgi apparatus,Plasma membrane,Cytosol"		NA	NA		43000000	"Cluster 34: Basophils - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 36: HEL - Hemostasis"	"Cluster 51: Myeloid cells - Hemostasis"	"Nuclear speckles, Cytosol"	"Golgi apparatus, Plasma membrane"	"HPA016700: AB_1858262, HPA017860: AB_1858261"	"unprognostic (6.70e-2)"	"unprognostic (3.50e-3)"	"unprognostic (1.15e-3)"	"unprognostic (1.62e-1)"	"unprognostic (3.48e-2)"	"unprognostic (4.53e-5)"	"unprognostic (1.10e-2)"	"unprognostic (2.55e-3)"	"unprognostic (4.50e-1)"	"unprognostic (2.12e-3)"	"unprognostic (2.34e-2)"	"unprognostic (7.04e-2)"	"unprognostic (1.11e-4)"	"unprognostic (1.36e-1)"	"unprognostic (8.38e-2)"	"unprognostic (7.51e-2)"	"unprognostic (3.41e-2)"	0.9	1.0	1.7	2.7	2.1	8.7	0.5	2.2	4.5	0.3	1.3	0.3	0.0	0.1	0.4	0.1	0.4	0.9	0.3	1.9	2.5	0.2	0.3	2.1	5.4	3.3	2.4	0.1	0.4	0.2	0.4	0.5	2.8	0.2	0.9	0.2	0.4	0.3	0.1	0.3	0.4	0.2	2.5	7.3	0.2	0.1	3.6	4.1	0.3	0.5	4.8	0.4	0.1	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	66.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	92.4	1.7	2.8	0.2	1.8	0.4	0.2	0.1	0.0	0.7	0.3	0.5	0.0	10.7	0.0	0.3	0.9	0.0	110.6	1.7	2.1	2.2	4.5	1.9	2.5	3.3	2.4	2.8	2.5	3.6	3.3	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.8	0.0	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.3	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	3.9	0.0	3.9	0.0	0.0	0.0	0.0	1.6	2.7	0.0	0.0	75.6	0.0	6.5	28.3	0.0	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0
TREM2	"TREM-2, Trem2a, Trem2b, Trem2c"	ENSG00000095970	"Triggering receptor expressed on myeloid cells 2"	Q9NZC2	6	41158506-41163186	"Disease related genes, Human disease related genes, Predicted membrane proteins, Predicted secreted proteins"		Receptor	"Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 69.8;lung: 30.1"	"Cell type enriched"	"Detected in many"	8	"Hofbauer cells: 1014.1"	"Cancer enhanced"	"Detected in all"		"glioma: 93.5"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"plasmacytoid DC: 2.0"	"Lineage enhanced"	"Detected in single"		"dendritic cells: 2.0"	"Group enriched"	"Detected in some"	4	"hTCEpi: 74.6;THP-1: 42.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010917, HPA012571"	Approved				"Secreted in brain"	NA	NA		50000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 4: Macrophages - Innate immune response"			"HPA010917: AB_1080365, HPA012571: AB_1858260"	"unprognostic (3.89e-1)"	"unprognostic (4.44e-3)"	"unprognostic (2.77e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.53e-1)"	"prognostic unfavorable (4.24e-4)"	"unprognostic (4.83e-2)"	"unprognostic (1.07e-1)"	"unprognostic (8.57e-3)"	"unprognostic (1.33e-1)"	"unprognostic (2.09e-1)"	"unprognostic (3.58e-3)"	"unprognostic (8.04e-2)"	"unprognostic (1.04e-2)"	"unprognostic (3.16e-3)"	"unprognostic (1.85e-2)"	10.7	13.2	28.1	3.5	31.1	0.2	9.8	33.7	61.5	6.5	29.1	3.5	0.9	1.6	2.3	0.6	7.4	9.7	2.1	27.5	32.3	1.3	2.3	30.1	2.6	44.5	34.4	2.4	3.9	7.4	3.9	10.7	42.7	2.0	4.3	1.9	6.0	3.1	0.4	0.5	1.4	4.5	46.7	0.5	2.5	0.7	43.5	1.8	1.7	0.0	0.4	4.5	0.6	69.8	0.0	0.3	0.0	0.0	0.1	0.3	0.8	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.5	0.0	0.0	0.0	0.4	0.0	0.8	0.0	0.0	0.0	1.2	74.6	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	42.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	28.1	31.1	33.7	61.5	27.5	32.3	44.5	34.4	42.7	46.7	43.5	69.8	1.8	6.4	7.5	0.0	0.7	0.8	0.2	79.8	0.0	0.3	1.8	58.8	0.1	1.5	9.6	0.0	0.0	5.0	0.4	0.0	0.0	0.0	0.6	0.0	0.1	10.4	0.0	0.0	0.0	0.0	4.9	1.2	0.0	0.0	2.5	0.0	2.2	0.2	1014.1	0.0	0.0	0.0	2.0	34.7	5.2	1.0	0.6	120.5	0.0	12.2	8.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	3.3	1.0	6.6	0.1	1.0	0.0	0.0	0.0	0.1	7.3	0.8	0.0	0.0	0.1
TREML2	"C6orf76, dJ238O23.1, FLJ13693, TLT2"	ENSG00000112195	"Triggering receptor expressed on myeloid cells like 2"	Q5T2D2	6	41189749-41201149	"Plasma proteins, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"bone marrow: 14.4;lymphoid tissue: 9.5"	"Cell type enhanced"	"Detected in some"		"B-cells: 5.3;Early spermatids: 19.1;Late spermatids: 37.3;Syncytiotrophoblasts: 8.8"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"naive B-cell: 23.3;neutrophil: 33.3"	"Group enriched"	"Detected in many"	15	"B-cells: 23.3;dendritic cells: 9.3;granulocytes: 33.3"	"Cell line enhanced"	"Detected in some"		"HEL: 27.9;HL-60: 6.9;JURKAT: 7.9;SuSa: 4.5;U-698: 8.0;U-937: 5.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA		3400000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 36: HEL - Hemostasis"	"Cluster 31: Spermatids - Spermatogenesis"				"unprognostic (3.76e-3)"	"unprognostic (2.39e-1)"	"unprognostic (9.05e-3)"	"unprognostic (1.30e-3)"	"unprognostic (3.22e-3)"	"unprognostic (2.02e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.83e-1)"	"unprognostic (7.46e-2)"	"unprognostic (2.51e-1)"	"unprognostic (2.40e-3)"	"unprognostic (2.46e-1)"	"unprognostic (2.02e-2)"	"unprognostic (7.45e-2)"	"unprognostic (1.54e-2)"	"unprognostic (6.23e-2)"	"unprognostic (6.71e-2)"	1.7	0.0	0.1	6.4	0.1	14.4	0.1	0.2	0.3	0.0	0.0	0.3	0.3	0.0	0.0	0.2	0.3	0.5	0.1	0.1	0.5	0.0	0.1	0.7	9.5	0.1	0.1	0.0	0.2	0.4	0.0	3.0	0.2	0.0	0.3	0.1	0.3	0.0	0.8	0.1	1.1	0.3	0.0	6.6	0.3	3.7	0.1	6.9	0.1	0.8	7.5	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	27.9	0.0	0.0	0.0	6.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.9	0.1	0.4	0.0	0.0	1.5	2.2	0.0	0.0	0.0	0.2	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.0	0.0	5.2	0.0	2.6	0.6	13.4	0.4	1.2	0.5	6.0	1.0	0.2	2.2	23.3	1.3	0.4	33.3	0.7	1.4	9.3	0.7	2.0	0.1	0.1	0.2	0.3	0.1	0.5	0.1	0.1	0.2	0.0	0.1	0.1	0.0	0.0	1.1	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	2.7	0.0	0.0	0.0	19.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.6	0.4	37.3	0.0	0.9	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	8.8	0.2	0.0	0.0	0.0
TREML4	TLT4	ENSG00000188056	"Triggering receptor expressed on myeloid cells like 4"	Q6UXN2	6	41228339-41238882	"Predicted membrane proteins, Predicted secreted proteins"	"Immunity, Innate immunity"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in single"		"choroid plexus: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"eosinophil: 4.5;neutrophil: 8.1"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 8.1"	"Cell line enriched"	"Detected in single"	6	"HEL: 1.1"	"Not detected"	"Not detected"							HPA065044	Uncertain		Approved	"Plasma membrane"	"Secreted - unknown location"	NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 36: HEL - Hemostasis"	"Cluster 41: Macrophages - Immune response"	"Plasma membrane"		"HPA065044: AB_2685411"	"unprognostic (1.49e-1)"	"unprognostic (1.51e-1)"	"unprognostic (5.58e-2)"		"unprognostic (2.07e-1)"	"unprognostic (2.12e-1)"		"unprognostic (1.03e-1)"		"unprognostic (5.50e-2)"	"unprognostic (9.50e-3)"		"unprognostic (1.18e-4)"	"unprognostic (1.05e-3)"	"unprognostic (1.32e-1)"	"unprognostic (5.26e-2)"	"unprognostic (1.21e-2)"	0.0	0.0	0.0	0.3	0.2	0.7	0.0	0.0	0.4	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	4.5	0.0	0.4	0.0	0.1	0.0	0.0	0.5	0.9	0.0	0.0	8.1	0.0	0.4	0.7	0.0	0.4	0.0	0.2	0.0	0.4	0.1	0.2	0.2	0.1	0.1	0.2	0.2	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TREM1	"CD354, TREM-1"	ENSG00000124731	"Triggering receptor expressed on myeloid cells 1"	Q9NP99	6	41267926-41286682	"CD markers, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	"Adaptive immunity, Immunity, Innate immunity"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 96.0;lung: 65.3;lymphoid tissue: 44.1"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 26.1;Hofbauer cells: 25.1;Kupffer cells: 35.5;Langerhans cells: 21.5;Late spermatids: 20.6;Macrophages: 104.2;monocytes: 19.9"	"Cancer enhanced"	"Detected in many"		"lung cancer: 9.6"	"Region enhanced"	"Detected in some"		"cerebral cortex: 8.5"	"Immune cell enriched"	"Detected in many"	7	"neutrophil: 615.1"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 615.1"	"Group enriched"	"Detected in some"	4	"SuSa: 6.2;U-87 MG: 24.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA005563, HPA053612"	Approved		Approved	"Golgi apparatus"	"Secreted to blood"	NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 41: Macrophages - Immune response"	"Golgi apparatus"		"HPA005563: AB_1858259, HPA053612: "	"unprognostic (6.41e-2)"	"unprognostic (1.47e-3)"	"unprognostic (1.22e-1)"	"unprognostic (3.39e-2)"	"unprognostic (6.07e-3)"	"unprognostic (2.97e-2)"	"unprognostic (5.73e-5)"	"unprognostic (1.29e-1)"	"unprognostic (1.24e-2)"	"unprognostic (4.13e-3)"	"unprognostic (2.24e-3)"	"unprognostic (7.65e-2)"	"unprognostic (3.18e-7)"	"unprognostic (6.32e-3)"	"unprognostic (4.95e-2)"	"unprognostic (1.08e-1)"	"unprognostic (7.26e-2)"	20.4	1.4	0.4	44.1	0.4	96.0	1.2	0.4	8.5	0.8	2.3	0.9	0.4	2.2	0.0	1.5	3.9	9.9	3.8	0.4	0.6	1.1	6.9	65.3	0.4	0.9	0.7	0.5	3.9	1.1	2.4	7.7	1.9	0.7	0.3	0.6	1.2	0.5	0.5	0.2	1.0	8.4	0.6	11.1	0.8	0.3	2.6	3.1	0.7	2.6	1.3	12.6	0.4	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.5	0.3	0.6	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	6.2	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.1	1.6	0.0	0.1	82.7	2.3	0.0	20.7	0.1	0.6	0.1	0.0	32.8	1.5	0.2	0.0	615.1	0.2	10.1	0.7	0.0	32.5	0.4	0.4	0.4	8.5	0.4	0.6	0.9	0.7	1.9	0.6	2.6	0.9	0.0	6.4	26.1	0.0	1.8	0.4	0.4	5.4	0.0	0.0	0.1	0.1	0.3	2.8	12.4	0.0	0.0	0.4	0.3	0.1	0.0	0.3	12.1	0.3	1.8	3.8	0.0	0.0	0.0	0.2	1.1	2.5	1.1	0.1	6.3	0.0	0.7	0.5	25.1	0.0	0.0	0.0	2.0	35.5	21.5	20.6	0.0	104.2	0.0	0.0	19.9	0.0	0.0	0.0	0.0	0.9	0.0	0.0	1.2	0.2	0.0	0.3	13.3	0.1	0.0	0.8	2.8	0.0	0.1	0.0	0.1	14.6	2.0	0.0	0.0	0.1
NCR2	"CD336, LY95, NK-p44"	ENSG00000096264	"Natural cytotoxicity triggering receptor 2"	O95944	6	41335608-41350889	"CD markers, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	17	"NK-cell: 1.7;plasmacytoid DC: 4.8"	"Group enriched"	"Detected in many"	17	"dendritic cells: 4.8;NK-cells: 1.7"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			HPA067249	Uncertain					NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"			"Cluster 63: NK-cells & T-cells - Immune response"			"HPA067249: AB_2685811"		"unprognostic (5.81e-2)"				"unprognostic (3.39e-1)"		"unprognostic (1.95e-1)"		"unprognostic (2.12e-2)"				"unprognostic (1.65e-1)"				0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	4.8	0.0	0.0	0.0	0.2	0.0	0.5	0.1	0.1	0.3	0.1	0.2	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0
FOXP4	FLJ40908	ENSG00000137166	"Forkhead box P4"	Q8IVH2	6	41546381-41602384	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Enteroendocrine cells: 40.2;Gastric mucus-secreting cells: 56.6;Intestinal goblet cells: 41.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in all"		"CACO-2: 113.9;OE19: 118.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007176	Approved		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 50: Non-specific - Ribosome"	"Cluster 21: OE19 - Mitochondria"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Nucleoplasm, Cytosol"		"HPA007176: AB_1078911"	"unprognostic (8.28e-2)"	"unprognostic (2.90e-2)"	"unprognostic (1.12e-1)"	"prognostic unfavorable (1.17e-6)"	"unprognostic (3.20e-2)"	"unprognostic (2.96e-3)"	"prognostic unfavorable (9.72e-4)"	"unprognostic (2.13e-2)"	"unprognostic (7.86e-3)"	"unprognostic (4.36e-2)"	"unprognostic (2.22e-3)"	"unprognostic (9.31e-2)"	"unprognostic (1.65e-1)"	"unprognostic (2.41e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.95e-2)"	15.9	10.6	7.7	11.0	6.6	4.9	18.6	3.6	10.4	33.0	1.9	22.7	19.9	32.5	2.0	15.3	16.3	9.1	21.3	10.1	12.0	19.9	28.5	17.3	9.5	13.1	8.6	16.7	34.8	6.3	19.9	5.1	11.8	33.5	6.0	2.9	31.6	10.3	14.3	12.5	18.7	9.1	3.4	8.0	50.1	27.9	12.8	6.8	32.0	4.3	5.9	16.8	15.6	11.4	25.8	36.2	41.2	45.7	7.1	2.5	44.0	14.5	6.8	11.2	7.8	113.9	8.0	29.9	25.7	7.8	33.3	19.3	11.4	13.2	4.1	25.1	20.7	24.2	20.1	74.9	14.1	15.1	19.3	6.6	14.1	10.4	5.6	15.8	10.9	17.6	30.2	11.6	5.0	70.5	17.5	22.4	10.8	118.6	11.7	19.3	13.8	20.9	8.6	22.2	11.9	17.0	15.2	35.4	23.3	10.5	20.0	35.3	17.0	15.1	37.3	24.0	24.0	9.1	6.2	40.9	12.3	25.8	14.3	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	7.7	6.6	3.6	10.4	10.1	12.0	13.1	8.6	11.8	3.4	12.8	11.4	1.1	0.0	11.7	4.6	6.2	9.2	5.8	5.1	2.8	5.2	19.2	15.2	21.0	7.2	4.8	5.5	2.1	2.6	4.3	22.0	0.0	8.7	26.9	6.3	1.9	3.4	40.2	0.8	2.5	16.1	3.4	4.6	56.6	9.5	3.8	15.0	13.6	21.0	4.1	0.0	1.9	41.7	8.2	4.2	7.0	21.0	4.1	4.4	1.8	1.0	5.4	1.2	7.2	6.6	3.5	20.9	20.3	8.6	3.6	14.7	15.8	8.8	3.4	2.7	13.1	4.8	8.4	2.2	13.1	7.6	7.7	4.4	4.0	0.6	17.4	10.2
MDFI	I-mfa	ENSG00000112559	"MyoD family inhibitor"	Q99750	6	41636882-41654244	"Predicted intracellular proteins"	Differentiation	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 44.7"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 221.7;Extravillous trophoblasts: 113.7;Pancreatic endocrine cells: 134.9;Syncytiotrophoblasts: 138.7;Urothelial cells: 73.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 80.5;HBEC3-KT: 117.2;OE19: 100.0;REH: 315.3"	"Region enriched"	"Detected in many"	7	"cerebellum: 17.0"	"Low region specificity"	"Detected in all"			HPA049973	Approved		Approved	Nucleoplasm		NA	NA				"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 14: REH - Unknown function"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm		"HPA049973: AB_2680975"	"unprognostic (9.74e-3)"	"unprognostic (4.25e-2)"	"unprognostic (6.82e-2)"	"unprognostic (6.26e-3)"	"unprognostic (9.18e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.69e-1)"	"prognostic unfavorable (1.32e-5)"	"prognostic unfavorable (9.11e-4)"	"unprognostic (1.66e-1)"	"unprognostic (3.27e-2)"	"unprognostic (4.04e-2)"	"prognostic unfavorable (2.85e-6)"	"unprognostic (2.66e-2)"	"unprognostic (6.06e-2)"	"unprognostic (1.57e-1)"	"unprognostic (8.22e-2)"	33.0	4.3	3.9	5.7	4.2	0.2	23.1	4.1	5.8	23.2	4.3	2.5	1.7	5.8	1.2	44.7	10.0	12.8	8.8	3.5	4.3	5.5	1.5	18.6	1.7	8.2	5.8	15.6	3.2	1.6	9.1	11.0	6.3	14.3	0.4	0.1	22.4	2.2	0.9	15.4	3.2	2.5	3.6	0.3	4.6	5.0	4.6	1.5	4.6	1.1	2.5	13.6	27.1	4.2	60.1	0.2	50.4	0.1	0.1	0.0	80.5	0.0	0.0	0.0	0.0	0.0	28.2	0.1	18.2	0.0	0.3	48.4	13.8	117.2	0.0	0.0	0.0	0.4	0.0	2.5	2.2	0.0	0.3	3.6	53.3	0.6	24.6	0.0	38.4	16.1	0.2	0.3	0.0	0.0	41.8	0.4	34.4	100.0	1.6	315.3	29.6	0.5	3.3	9.2	9.4	23.2	0.6	43.1	0.0	34.5	0.2	4.0	40.3	0.1	44.1	0.5	1.7	0.1	0.3	0.1	0.3	2.8	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	4.2	4.1	5.8	3.5	4.3	8.2	5.8	6.3	3.6	4.6	4.2	1.8	0.0	0.0	0.0	0.0	24.5	48.6	36.8	12.0	0.5	18.9	16.9	0.9	0.0	8.2	5.5	0.0	221.7	0.2	0.4	0.0	33.8	0.5	0.5	1.7	12.7	0.0	0.0	0.1	51.2	113.7	12.8	0.0	0.7	0.0	10.0	7.9	0.1	19.6	0.0	0.3	1.2	6.1	0.0	4.5	0.5	39.1	0.4	0.0	2.8	0.6	0.0	0.0	4.5	0.2	134.9	0.0	6.0	0.0	55.6	0.0	0.0	3.5	0.0	0.0	19.7	9.1	0.1	7.9	10.7	9.1	138.7	0.6	2.7	0.3	73.5
TFEB	"bHLHe35, TCFEB"	ENSG00000112561	"Transcription factor EB"	P19484	6	41683978-41736259	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Adaptive immunity, Autophagy, Immunity, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 89.9"	"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 97.4;Syncytiotrophoblasts: 120.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"classical monocyte: 16.1;eosinophil: 16.9;intermediate monocyte: 16.3;memory B-cell: 34.2;myeloid DC: 14.7;naive B-cell: 22.6;neutrophil: 47.4;non-classical monocyte: 14.1"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 60.3;Daudi: 35.8;OE19: 53.1;U-698: 42.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067082			Supported	Cytosol		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 57: B-cells - Immune response"	Cytosol		"HPA067082: "	"unprognostic (3.63e-3)"	"unprognostic (1.51e-3)"	"unprognostic (1.75e-2)"	"unprognostic (4.48e-3)"	"unprognostic (1.95e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.64e-1)"	"unprognostic (4.22e-3)"	"unprognostic (1.39e-2)"	"unprognostic (4.13e-2)"	"prognostic favorable (4.77e-4)"	"unprognostic (2.12e-2)"	"prognostic favorable (1.06e-5)"	"unprognostic (1.44e-1)"	"unprognostic (3.51e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.31e-2)"	14.3	10.7	18.3	16.7	29.9	8.3	15.0	24.0	23.5	13.4	9.6	25.7	5.8	11.1	1.5	14.8	12.8	7.7	37.1	18.1	19.7	26.7	11.6	18.2	26.1	30.9	27.7	6.5	12.9	17.8	31.3	14.5	25.8	23.4	4.3	2.2	21.2	7.0	89.9	17.9	34.6	5.7	22.5	57.2	14.4	2.6	25.4	5.0	22.9	41.5	17.2	19.6	15.6	39.9	3.5	3.2	0.6	12.3	3.8	2.5	60.3	5.3	6.9	3.4	2.7	6.9	2.7	35.8	6.8	3.5	2.9	8.7	2.4	4.9	1.0	28.3	4.1	0.1	8.8	12.8	6.8	1.0	4.3	0.7	9.8	4.9	2.6	6.9	4.1	3.3	4.1	7.4	1.0	1.8	2.3	1.2	0.1	53.1	1.6	24.3	0.1	5.0	7.5	2.6	12.8	4.3	4.7	10.5	1.0	3.4	2.3	19.5	7.1	1.5	3.1	0.1	3.0	15.7	2.3	42.1	2.6	15.3	0.9	0.3	16.1	16.9	3.8	16.3	0.9	34.2	1.5	1.8	14.7	22.6	0.4	1.5	47.4	1.7	14.1	2.9	0.6	8.7	18.3	29.9	24.0	23.5	18.1	19.7	30.9	27.7	25.8	22.5	25.4	39.9	14.5	9.6	9.3	10.1	36.7	14.1	8.2	14.8	5.2	6.1	5.7	5.6	19.2	10.0	6.0	12.9	12.5	50.7	13.8	16.3	21.5	3.7	1.1	11.4	2.6	12.2	13.2	3.2	6.3	6.9	8.3	6.9	6.1	8.0	1.3	0.5	6.4	4.2	26.8	26.9	7.9	10.2	26.4	22.8	13.3	4.2	3.4	19.6	0.0	17.8	20.0	18.4	22.6	11.1	97.4	10.6	18.0	10.9	16.0	7.1	14.1	3.7	7.4	5.2	6.6	13.1	7.8	0.9	1.0	6.4	14.5	120.4	9.1	0.8	8.8	6.3
PGC		ENSG00000096088	Progastricsin	P20142	6	41736711-41754109	"Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted secreted proteins, Transporters"	Digestion	"Aspartyl protease, Hydrolase, Protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	45	"stomach 1: 59821.1"	"Group enriched"	"Detected in some"	10	"Gastric mucus-secreting cells: 5737.5;Pancreatic endocrine cells: 1449.1"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 1050.3"	"Region enhanced"	"Detected in single"		"cerebellum: 1.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	11	"Hep G2: 253.1;OE19: 152.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA031717, HPA031718"	Enhanced		Approved	Nucleoplasm	"Secreted to digestive system"	NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 4: Stomach - Digestion"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Nucleoplasm		"HPA031717: AB_10670130, HPA031718: AB_10610148"	"unprognostic (9.18e-2)"	"unprognostic (1.87e-1)"	"unprognostic (9.83e-2)"	"unprognostic (2.27e-1)"	"unprognostic (7.18e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.47e-1)"	"unprognostic (8.50e-2)"		"unprognostic (1.86e-1)"	"unprognostic (9.23e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.33e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.65e-1)"		"unprognostic (8.74e-2)"	19.4	7.0	0.0	0.3	0.1	0.2	6.6	1.2	0.5	6.7	0.0	26.4	1327.3	2.8	0.9	85.5	9.2	2.3	6.2	0.1	0.0	4.9	11.0	378.8	0.3	0.0	0.0	3.9	136.3	0.0	7.4	2.8	0.0	83.9	0.3	0.1	4.6	437.7	2.5	3.4	3.2	0.0	0.0	7.7	59821.1	4.2	0.0	0.1	2.2	0.0	0.3	3.8	4.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	15.5	0.0	0.1	0.0	0.0	18.4	0.0	0.0	0.6	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	253.1	0.0	0.3	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.5	0.9	5.7	152.2	0.0	2.9	0.0	6.2	0.0	0.2	0.0	0.7	0.0	0.0	0.0	0.3	0.0	2.8	0.0	0.0	3.7	0.1	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.2	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	25.6	335.2	0.0	4.4	0.4	2.8	0.0	0.0	0.0	0.3	0.8	0.3	87.2	5.0	0.0	0.0	1.2	0.0	0.3	0.0	4.6	0.0	0.4	0.0	1.1	0.0	0.0	0.3	131.2	1.5	0.9	5737.5	0.1	10.1	0.0	0.0	0.2	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.3	1.7	0.0	0.0	2.0	0.0	0.0	0.0	0.1	1449.1	2.1	0.0	2.4	85.2	0.1	0.2	3.0	0.0	0.0	0.0	0.6	0.0	0.5	0.0	0.0	4.1	2.6	0.0	0.2	4.2
FRS3	"FRS2B, FRS2beta, SNT-2"	ENSG00000137218	"Fibroblast growth factor receptor substrate 3"	O43559	6	41770176-41786542	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 12.5;Spermatogonia: 12.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030162, HPA030174"	Enhanced		Uncertain	Nucleoplasm		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Nucleoplasm		"HPA030162: AB_10599976, HPA030174: AB_10602093"	"unprognostic (2.52e-2)"	"unprognostic (1.31e-1)"	"unprognostic (4.30e-2)"	"unprognostic (8.91e-2)"	"unprognostic (8.13e-2)"	"unprognostic (1.67e-2)"	"unprognostic (3.79e-2)"	"unprognostic (8.47e-3)"	"unprognostic (2.96e-1)"	"unprognostic (1.83e-1)"	"prognostic favorable (3.87e-4)"	"unprognostic (4.23e-2)"	"unprognostic (3.29e-3)"	"unprognostic (2.96e-2)"	"unprognostic (8.48e-2)"	"unprognostic (5.10e-2)"	"unprognostic (3.29e-3)"	5.9	6.0	13.7	2.9	15.5	2.8	5.9	11.3	21.7	7.6	3.7	8.8	3.3	8.1	2.0	3.3	8.2	3.0	8.1	15.1	12.8	6.4	5.4	5.1	4.1	14.9	12.2	7.3	6.2	3.1	7.2	3.1	14.8	7.0	1.9	4.5	5.0	5.1	9.1	2.8	5.5	2.9	8.4	6.8	6.0	17.5	12.9	3.0	9.7	5.0	2.1	7.8	5.7	17.2	2.4	2.0	3.4	4.7	2.6	2.8	7.0	2.5	3.6	3.0	3.0	2.8	1.4	4.1	2.8	2.2	3.9	1.6	2.2	2.7	2.5	4.3	2.2	2.5	4.6	4.5	3.3	2.1	3.6	2.8	3.2	2.9	2.6	3.9	3.1	9.9	2.9	3.3	2.7	3.9	6.2	4.6	1.7	5.3	2.1	5.8	3.0	3.0	2.6	4.6	4.8	7.3	1.8	2.5	5.6	2.5	3.2	4.2	2.7	5.2	5.5	3.4	2.6	5.9	5.3	7.3	1.4	3.5	1.6	0.0	0.3	0.4	0.1	0.1	0.1	0.0	0.2	0.1	0.2	0.1	0.1	0.0	0.0	0.3	0.0	0.3	0.1	0.0	13.7	15.5	11.3	21.7	15.1	12.8	14.9	12.2	14.8	8.4	12.9	17.2	4.0	0.0	3.7	4.9	1.7	1.0	1.3	1.0	2.8	5.6	2.1	1.9	3.1	7.2	1.2	0.0	0.0	1.9	1.1	0.3	0.0	1.6	0.9	1.9	2.8	3.2	1.8	0.4	7.8	1.4	1.0	3.0	0.5	2.4	0.0	2.2	1.4	1.7	1.9	5.0	8.2	1.5	0.0	2.9	3.7	1.0	2.5	1.9	3.6	4.7	0.7	2.9	0.0	7.5	5.4	1.3	1.6	4.5	0.4	0.9	1.7	1.0	1.3	4.3	0.0	2.8	2.9	12.5	12.4	0.8	0.6	0.5	1.4	1.7	1.6	1.6
PRICKLE4	"C6orf49, DKFZp761H221, OEBT"	ENSG00000278224	"Prickle planar cell polarity protein 4"	Q2TBC4	6	41780782-41787452	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"B-cells: 15.0;Basal squamous epithelial cells: 30.7;Erythroid cells: 17.7;Gastric mucus-secreting cells: 17.3;Plasma cells: 36.8;Squamous epithelial cells: 49.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 4.0;HeLa: 4.6;hTERT-RPE1: 9.7"									"HPA031240, HPA055593"	Approved		Approved	"Mitotic spindle,Centriolar satellite"		Yes	NA				"Cluster 72: Non-specific - Transcription"	"Cluster 20: HeLa - Mitochondria"	"Cluster 59: Non-specific - Transcription"	"Centriolar satellite"	"Mitotic spindle"	"HPA031240: AB_10600929, HPA055593: "	"unprognostic (1.16e-2)"	"unprognostic (2.08e-2)"	"unprognostic (2.56e-2)"	"unprognostic (6.86e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.15e-2)"	"unprognostic (6.41e-2)"	"unprognostic (1.93e-2)"	"unprognostic (3.47e-4)"	"unprognostic (4.25e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.56e-5)"	"unprognostic (3.64e-3)"	"unprognostic (5.74e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.17e-3)"	1.8	1.2	1.3	0.3	1.2	0.1	1.9	1.3	1.2	2.2	0.0	1.6	1.1	2.4	0.0	3.8	2.3	1.0	1.9	0.7	1.0	1.3	2.0	2.1	0.1	1.1	0.7	1.3	1.2	0.4	1.0	0.6	1.0	2.3	0.5	0.6	1.7	0.4	1.6	0.8	1.2	1.5	0.3	4.5	2.6	0.8	1.0	0.0	2.5	1.5	0.3	2.6	2.9	1.3	0.2	0.6	1.3	1.2	0.0	0.0	4.0	0.1	0.1	0.0	0.0	0.7	0.9	0.4	1.5	0.0	0.1	2.1	0.0	0.1	0.0	0.3	0.3	0.2	4.6	0.8	0.0	0.0	0.0	0.0	0.2	0.0	0.0	9.7	0.0	0.5	1.2	0.2	0.0	0.6	0.0	0.7	0.2	1.8	0.2	1.3	0.3	0.0	0.2	1.4	0.1	0.4	0.0	2.4	0.2	1.2	0.6	0.7	0.6	0.4	0.8	0.2	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	1.2	1.3	1.2	0.7	1.0	1.1	0.7	1.0	0.3	1.0	1.3	0.0	0.0	0.0	1.6	15.0	1.5	1.4	2.4	30.7	2.3	0.0	0.0	0.6	0.0	1.0	0.0	0.0	0.0	2.7	2.6	0.0	0.0	0.3	0.0	0.0	2.8	3.5	17.7	0.2	0.0	0.0	4.8	17.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.5	0.0	0.0	1.5	0.6	1.2	8.4	0.0	0.0	1.0	1.9	0.0	0.0	0.0	0.0	0.5	2.6	36.8	1.7	2.2	0.0	0.7	4.1	0.0	1.9	3.7	1.9	1.4	49.4	2.0	0.0	10.9	0.0	3.0	1.4
TOMM6	"OBTP, Tom6"	ENSG00000214736	"Translocase of outer mitochondrial membrane 6"	Q96B49	6	41787662-41789898	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"Alveolar cells type 2: 18.7;Astrocytes: 31.0;Club cells: 10.5;Excitatory neurons: 16.5;granulocytes: 8.8;Inhibitory neurons: 15.5;Microglial cells: 10.3;Oligodendrocyte precursor cells: 12.1;Oligodendrocytes: 26.3;Respiratory ciliated cells: 16.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"OE19: 2247.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004801	Approved		Supported	Mitochondria		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 11: Alveolar cells - Smell perception"	Mitochondria		"HPA004801: AB_1859553"																		176.9	267.7	240.1	136.8	246.2	228.0	219.9	246.7	320.8	158.4	254.4	158.2	101.8	139.7	270.3	234.0	162.9	96.2	285.9	245.2	248.1	271.8	232.2	143.6	207.5	243.9	242.9	179.0	208.3	193.3	143.2	141.2	245.5	177.6	177.1	128.8	166.1	120.3	272.4	196.4	134.8	132.3	250.1	200.3	170.2	133.9	245.5	192.6	161.4	232.8	260.9	166.5	153.9	254.2	647.0	319.0	372.7	382.2	337.6	398.5	391.6	312.2	324.8	390.3	380.4	559.4	295.3	289.3	373.3	370.1	445.4	201.2	597.3	523.3	505.9	409.8	619.8	525.5	382.4	928.6	264.9	708.7	328.6	362.0	529.4	431.8	366.2	277.1	480.4	407.1	1335.5	350.4	481.7	766.0	519.4	1124.8	329.7	2247.1	312.6	373.3	234.1	865.3	540.1	329.3	327.6	458.7	213.0	369.5	548.5	389.7	451.6	1411.8	342.8	272.0	340.9	274.2	478.8	318.6	751.6	1314.8	155.9	586.7	362.7	119.3	439.5	259.3	291.7	448.3	283.7	419.2	294.4	291.2	454.1	380.7	329.3	324.1	55.9	230.6	475.3	474.6	303.3	674.5	240.1	246.2	246.7	320.8	245.2	248.1	243.9	242.9	245.5	250.1	245.5	254.2	0.0	3.2	18.7	31.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.5	0.0	0.0	0.5	0.0	0.0	8.8	0.0	0.0	0.0	0.0	0.0	15.5	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	10.3	0.0	0.0	0.0	12.1	26.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0
USP49	MGC20741	ENSG00000164663	"Ubiquitin specific peptidase 49"	Q70CQ1	6	41789896-41895361	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing, Ubl conjugation pathway"	"Chromatin regulator, Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 43.8;Excitatory neurons: 42.8;Inhibitory neurons: 48.6;Oligodendrocyte precursor cells: 56.3;Oligodendrocytes: 31.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in some"	5	"basophil: 5.1"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 5.1"	"Cell line enhanced"	"Detected in all"		"REH: 46.7;U-698: 63.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030254, HPA030255"	Uncertain					NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 6: Brain - Smell perception"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 56: Bipolar cells - Visual perception"			"HPA030254: AB_10600198, HPA030255: AB_10601218"	"unprognostic (1.71e-1)"	"unprognostic (4.86e-3)"	"unprognostic (1.93e-1)"	"unprognostic (2.57e-4)"	"unprognostic (4.46e-2)"	"unprognostic (2.84e-4)"	"unprognostic (7.17e-3)"	"unprognostic (5.06e-2)"	"unprognostic (1.19e-2)"	"unprognostic (3.22e-1)"	"unprognostic (5.59e-3)"	"unprognostic (8.28e-2)"	"unprognostic (1.26e-5)"	"unprognostic (5.39e-2)"	"unprognostic (4.58e-2)"	"unprognostic (4.37e-3)"	"unprognostic (3.24e-3)"	2.9	2.8	4.3	2.6	3.2	5.3	2.6	6.0	3.8	3.4	0.4	2.6	1.7	2.9	1.6	1.9	2.6	1.6	2.0	3.3	3.7	2.0	1.6	2.7	2.6	2.7	3.9	3.1	2.0	1.5	2.7	1.4	2.5	2.3	1.5	9.3	2.0	1.6	2.9	3.0	1.7	1.6	0.7	2.5	1.8	4.8	4.1	6.7	7.0	1.0	2.5	2.5	2.6	3.8	6.0	1.8	23.6	11.6	2.8	3.0	9.7	2.3	2.2	3.4	4.3	7.5	1.4	24.5	2.5	2.9	4.9	2.6	14.7	2.2	5.1	6.1	11.0	8.8	10.3	2.7	2.0	6.9	5.2	3.1	1.7	5.0	3.1	3.1	2.2	24.9	18.7	6.4	2.6	3.5	26.7	10.5	6.5	6.4	2.2	46.7	11.3	5.4	1.4	4.1	15.8	6.5	3.1	1.1	1.3	5.5	3.5	6.1	6.1	8.1	8.0	2.6	3.1	12.2	11.4	63.9	1.0	6.9	1.5	5.1	0.4	0.6	0.3	0.4	0.2	0.6	0.2	0.3	0.1	0.4	0.4	0.3	1.0	0.4	0.5	0.3	0.2	0.2	4.3	3.2	6.0	3.8	3.3	3.7	2.7	3.9	2.5	0.7	4.1	3.8	2.4	0.0	9.7	20.2	2.0	5.0	3.0	3.9	1.2	27.5	3.6	3.3	4.6	4.3	6.5	5.5	43.8	2.9	4.5	1.4	1.9	1.9	6.5	4.1	5.0	2.8	0.0	8.2	42.8	2.0	1.6	4.3	3.1	4.6	1.3	4.8	1.4	2.1	2.0	15.2	48.6	1.9	4.1	3.1	4.6	7.2	3.7	3.1	3.6	14.0	5.0	2.8	2.1	56.3	31.8	2.6	1.9	6.0	3.0	4.5	2.1	1.1	7.1	10.9	6.6	6.2	3.4	13.3	14.3	2.7	6.3	5.7	2.4	5.1	2.2	4.6
MED20	"DKFZp586D2223, PRO0213, SRB2, TRFP"	ENSG00000124641	"Mediator complex subunit 20"	Q9H944	6	41905354-41921139	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Syncytiotrophoblasts: 24.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040717	Uncertain		Approved	Nucleoplasm,Centrosome		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 52: Non-specific - Ribosome"	"Cluster 21: OE19 - Mitochondria"	"Cluster 47: Cytotrophoblasts - Unknown function"	Centrosome	Nucleoplasm	"HPA040717: AB_10794146"	"unprognostic (1.45e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.58e-3)"	"unprognostic (8.32e-2)"	"unprognostic (9.86e-3)"	"unprognostic (1.72e-1)"	"unprognostic (1.16e-3)"	"unprognostic (1.22e-1)"	"prognostic unfavorable (1.48e-5)"	"unprognostic (1.58e-3)"	"unprognostic (4.23e-2)"	"unprognostic (5.10e-2)"	"prognostic favorable (1.17e-4)"	"unprognostic (1.71e-2)"	"unprognostic (4.63e-1)"	"unprognostic (4.13e-3)"	"unprognostic (2.31e-1)"	8.1	11.8	6.3	7.7	7.3	6.1	10.9	9.1	8.0	10.6	7.9	10.6	10.5	9.7	13.5	9.8	9.9	7.7	11.6	6.5	7.1	12.8	10.4	7.4	10.0	6.6	6.6	8.2	9.3	10.6	6.4	13.6	7.0	11.2	11.8	5.9	8.7	10.2	14.5	9.7	8.7	12.0	5.8	9.2	9.7	7.4	7.2	12.7	11.9	16.6	13.3	10.2	7.6	9.0	28.5	23.0	25.7	32.1	23.1	24.8	31.7	18.2	17.1	25.9	20.5	29.5	20.3	41.4	34.3	23.0	15.5	22.0	39.7	26.4	31.2	22.2	14.7	37.5	19.6	28.6	23.9	30.5	22.2	18.6	36.8	22.5	33.3	19.6	33.9	36.4	49.0	19.3	32.7	25.7	36.3	22.3	35.1	93.5	19.3	48.0	29.4	15.1	34.9	19.9	23.7	18.6	25.3	12.6	26.5	28.7	24.7	32.4	33.2	18.2	38.9	11.4	22.5	19.3	27.1	85.7	9.9	33.3	26.3	18.7	24.9	18.4	10.7	29.4	14.0	19.0	7.3	12.2	26.1	23.6	9.4	11.3	9.3	17.4	20.7	23.5	14.4	16.7	6.3	7.3	9.1	8.0	6.5	7.1	6.6	6.6	7.0	5.8	7.2	9.0	4.4	9.6	3.9	2.3	6.6	3.7	4.2	7.2	6.8	2.4	7.0	5.1	5.2	2.8	6.8	7.3	0.0	22.7	7.3	6.6	7.9	6.9	0.6	5.1	7.1	4.2	9.6	8.0	2.8	3.3	18.6	5.0	6.1	6.7	7.0	8.3	8.6	8.3	8.7	1.7	2.8	5.6	14.2	6.3	2.6	0.7	3.4	3.7	1.8	4.7	6.3	3.7	7.2	5.5	3.0	4.9	3.1	6.8	5.7	4.7	5.8	10.1	4.6	4.2	0.0	3.6	4.9	8.3	13.6	5.8	5.7	24.9	3.0	7.1	7.2	5.4
BYSL	Enp1	ENSG00000112578	"Bystin like"	Q13895	6	41921499-41933046	"Predicted intracellular proteins"	"Ribosome biogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031217, HPA031219"	Enhanced		Enhanced	"Nucleoplasm,Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	No			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 52: Non-specific - Ribosome"	"Cluster 21: OE19 - Mitochondria"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoli, Nucleoli rim, Mitotic chromosome"	Nucleoplasm	"HPA031217: AB_10599488, HPA031219: AB_10601989"	"unprognostic (6.12e-3)"	"unprognostic (6.97e-2)"	"unprognostic (2.90e-1)"	"unprognostic (2.33e-3)"	"unprognostic (4.38e-2)"	"unprognostic (2.73e-3)"	"prognostic unfavorable (6.43e-4)"	"unprognostic (2.09e-2)"	"unprognostic (2.51e-1)"	"unprognostic (6.38e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.03e-1)"	"prognostic unfavorable (2.15e-8)"	"unprognostic (4.39e-2)"	"unprognostic (2.18e-1)"	"unprognostic (2.79e-3)"	"unprognostic (5.99e-2)"	10.7	10.1	6.0	8.2	6.1	7.4	8.8	5.7	6.2	6.4	5.8	6.8	4.7	8.2	5.4	9.2	8.5	5.4	7.2	6.1	6.7	6.5	10.7	5.1	8.4	6.0	6.7	8.1	11.6	6.5	3.6	10.0	6.9	6.8	7.0	2.5	4.8	6.5	20.1	8.0	4.0	11.9	5.9	5.8	5.5	7.9	6.6	12.2	5.2	10.8	13.2	15.4	5.9	6.2	50.6	52.1	30.2	54.2	21.8	25.5	59.7	44.0	21.6	66.7	48.9	72.1	15.7	78.2	43.9	32.9	51.9	34.3	91.6	61.0	58.0	30.1	89.2	72.7	37.3	81.5	38.6	58.8	36.0	30.1	39.5	67.2	62.1	16.9	50.5	47.3	96.1	26.0	48.7	70.8	74.2	68.3	29.0	162.4	50.9	77.9	38.2	57.3	45.2	37.9	65.6	37.4	30.0	37.8	58.2	26.3	38.0	58.6	39.3	49.0	53.5	31.4	77.2	24.6	33.0	185.8	14.5	57.9	49.9	0.0	3.8	0.7	4.3	3.9	5.9	3.8	2.5	3.5	6.0	5.5	1.6	3.3	0.5	6.1	3.0	9.2	3.3	2.3	6.0	6.1	5.7	6.2	6.1	6.7	6.0	6.7	6.9	5.9	6.6	6.2	6.4	0.0	3.9	0.7	6.7	31.0	34.5	19.2	8.6	2.8	8.6	8.5	2.8	5.7	9.5	1.8	4.2	22.1	4.8	4.6	3.9	21.4	10.4	7.9	12.1	10.9	5.4	6.3	2.8	17.5	24.4	11.4	4.6	9.8	2.5	11.4	3.9	6.8	12.0	0.0	2.5	6.5	12.2	1.0	7.3	6.8	8.1	5.1	8.8	1.9	6.6	4.4	9.2	4.0	2.8	23.5	2.9	7.2	4.9	26.2	2.2	10.5	5.1	3.4	6.6	16.1	13.8	10.8	25.7	14.0	25.3	29.1	4.1	18.2	11.4	32.2
CCND3		ENSG00000112576	"Cyclin D3"	P30281	6	41934934-42050357	"Cancer-related genes, Human disease related genes, Predicted intracellular proteins"	"Cell cycle, Cell division"	Cyclin	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 256.6"	"Cell type enhanced"	"Detected in all"		"NK-cells: 555.1;Syncytiotrophoblasts: 236.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MOLT-4: 696.3;REH: 651.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000116, HPA042871"	Approved		Supported	Nucleoplasm		NA	Yes			"Cluster 10: Basophils - Unknown function"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 51: Myeloid cells - Hemostasis"	Nucleoplasm		"CAB000116: , HPA042871: "	"unprognostic (4.53e-2)"	"unprognostic (4.45e-2)"	"unprognostic (2.45e-1)"	"unprognostic (4.40e-3)"	"unprognostic (1.01e-1)"	"unprognostic (9.80e-2)"	"unprognostic (3.40e-2)"	"unprognostic (5.25e-2)"	"unprognostic (7.76e-2)"	"unprognostic (3.45e-1)"	"unprognostic (9.17e-2)"	"unprognostic (6.39e-2)"	"unprognostic (2.45e-3)"	"unprognostic (9.12e-2)"	"unprognostic (1.71e-1)"	"prognostic favorable (8.08e-6)"	"unprognostic (2.11e-1)"	74.3	137.6	84.8	63.1	84.6	220.2	64.8	80.0	94.5	36.9	78.4	45.6	40.6	35.4	15.3	39.6	43.2	34.4	68.1	86.2	88.6	42.4	22.1	102.5	143.3	87.4	82.5	36.0	31.6	23.7	33.3	55.4	84.0	50.4	27.0	10.3	50.4	25.6	18.2	52.3	78.5	28.6	79.7	170.4	66.1	11.1	86.4	256.6	58.7	32.5	83.6	45.4	44.3	80.8	67.7	242.2	24.6	54.8	43.7	88.6	286.1	77.1	43.7	77.7	57.1	45.9	29.7	288.9	127.8	51.9	68.9	40.5	65.8	93.4	39.2	49.2	43.4	458.8	106.6	37.3	94.9	75.9	385.2	84.7	59.8	76.0	27.9	23.5	96.6	188.3	236.7	27.2	111.6	92.0	696.3	354.6	10.9	202.8	51.5	651.8	96.3	32.2	179.1	44.9	83.8	21.8	65.8	83.3	38.6	30.6	51.5	288.4	162.9	86.2	47.9	74.7	88.1	17.9	15.2	458.5	50.4	157.6	53.3	1281.3	246.3	725.1	390.4	294.4	276.5	127.1	266.4	318.1	343.3	180.8	306.4	328.3	339.3	333.2	405.6	221.4	193.0	635.4	84.8	84.6	80.0	94.5	86.2	88.6	87.4	82.5	84.0	79.7	86.4	80.8	102.2	60.9	67.9	31.0	102.9	27.0	95.8	52.3	48.9	19.6	49.9	45.1	26.2	64.3	27.8	20.2	6.2	201.0	227.3	66.4	29.4	20.3	12.8	12.1	10.8	68.3	9.6	133.6	37.1	24.3	82.4	32.3	19.9	11.2	26.6	7.7	70.6	7.2	45.3	11.8	23.7	19.5	50.8	115.7	51.7	9.4	41.3	152.2	37.4	47.8	79.0	40.8	555.1	18.1	9.3	29.9	30.5	51.9	48.7	40.3	18.6	19.8	22.5	16.2	46.0	19.2	31.9	4.3	6.3	21.7	22.6	236.6	195.0	141.6	32.7	52.8
TAF8	"FLJ32821, TAF(II)43, TBN"	ENSG00000137413	"TATA-box binding protein associated factor 8"	Q7Z7C8	6	42050513-42087461	"Predicted intracellular proteins"	"Differentiation, Transcription, Transcription regulation"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031730, HPA031731, HPA031734"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 21: OE19 - Mitochondria"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA031730: AB_2674016, HPA031731: AB_2674017, HPA031734: AB_10603994"	"unprognostic (7.41e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.98e-1)"	"unprognostic (3.46e-3)"	"unprognostic (3.08e-1)"	"unprognostic (2.23e-2)"	"unprognostic (2.46e-1)"	"unprognostic (3.53e-1)"	"unprognostic (2.01e-3)"	"unprognostic (6.74e-2)"	"unprognostic (8.22e-2)"	"unprognostic (1.44e-1)"	"unprognostic (8.49e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.42e-2)"	"unprognostic (2.26e-2)"	13.7	9.8	5.9	12.8	6.4	21.1	10.8	4.2	6.8	8.5	7.8	9.8	10.5	8.8	6.8	10.1	7.5	8.4	18.0	5.3	5.3	11.3	8.6	9.5	15.6	6.4	5.5	8.0	7.4	16.0	6.6	12.7	5.3	9.0	9.2	8.7	9.5	8.9	16.9	8.5	8.5	10.1	4.4	11.6	10.8	7.9	6.4	23.6	13.9	15.4	15.0	9.8	8.6	7.1	17.2	18.4	14.9	16.7	16.5	15.1	13.6	7.9	13.7	20.4	20.9	31.8	10.0	26.2	16.4	11.5	20.9	12.5	24.5	16.7	15.7	22.6	23.6	33.4	23.3	15.7	20.2	19.5	23.4	20.6	13.0	14.6	18.4	10.0	23.0	31.8	41.7	26.6	11.5	22.7	17.9	29.2	9.3	45.5	8.4	36.1	17.7	20.2	18.0	13.9	15.4	13.7	14.3	11.0	15.7	12.2	16.5	23.6	21.2	18.1	18.8	8.2	16.3	23.0	24.4	55.5	8.3	21.2	10.4	23.0	17.0	27.0	16.0	18.2	11.1	18.2	14.4	12.6	17.8	18.3	14.7	14.4	19.9	10.8	37.4	26.5	13.4	11.0	5.9	6.4	4.2	6.8	5.3	5.3	6.4	5.5	5.3	4.4	6.4	7.1	16.8	19.2	21.1	14.0	17.2	7.0	13.1	14.8	14.2	16.0	14.1	10.4	28.6	10.0	17.4	11.0	31.3	22.1	21.0	12.3	31.3	9.5	12.0	26.5	12.8	16.9	9.0	21.9	7.6	9.9	8.6	11.7	6.6	47.4	19.0	14.2	9.7	9.6	13.5	21.9	8.2	13.3	14.2	21.6	9.5	17.5	14.9	13.1	7.2	13.1	19.3	10.7	33.0	18.6	14.2	8.8	8.3	11.7	19.0	14.4	10.5	16.5	9.8	23.2	13.1	10.6	13.3	15.3	12.9	12.0	8.4	21.5	19.8	19.4	11.1	15.0
C6orf132	bA7K24.2	ENSG00000188112	"Chromosome 6 open reading frame 132"	Q5T0Z8	6	42101119-42142620	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 157.0;skin 1: 73.6"	"Cell type enhanced"	"Detected in many"		"Late spermatids: 163.8;Pancreatic endocrine cells: 219.9;Prostatic glandular cells: 144.6;Urothelial cells: 226.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 57.8;CACO-2: 52.0;CAPAN-2: 44.0;OE19: 181.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA044588	Enhanced		Approved	"Golgi apparatus,Cytosol"		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	"Golgi apparatus, Cytosol"		"HPA044588: AB_10794293"	"unprognostic (7.09e-2)"	"unprognostic (8.88e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.24e-3)"	"unprognostic (1.60e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.15e-1)"	"unprognostic (6.78e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.30e-2)"	"prognostic unfavorable (4.90e-4)"	"unprognostic (1.31e-1)"	"unprognostic (4.26e-3)"	"unprognostic (1.04e-2)"	"unprognostic (5.53e-2)"	"unprognostic (2.47e-2)"	"unprognostic (1.30e-1)"	3.7	1.0	0.4	2.2	0.4	1.0	8.7	0.6	0.7	31.7	0.3	14.1	33.4	1.0	0.1	157.0	5.8	6.6	1.8	0.4	0.1	14.9	0.5	5.8	0.3	0.4	0.1	0.2	18.0	2.5	1.7	1.5	0.4	12.1	11.7	0.9	47.1	2.3	0.9	73.6	20.7	0.5	0.0	0.1	36.2	0.7	0.3	0.7	10.7	0.3	13.9	9.9	54.9	0.6	57.8	0.5	0.0	0.1	0.3	6.1	29.0	2.9	4.4	7.6	7.6	52.0	44.0	0.0	5.4	5.4	0.1	37.5	0.1	17.3	5.2	5.1	7.2	2.8	5.0	12.1	2.0	0.0	0.2	4.0	30.4	5.9	8.8	3.1	0.0	0.3	1.7	0.5	1.7	20.4	0.4	0.3	3.6	181.7	1.5	0.1	0.0	0.3	6.2	25.5	3.0	0.1	4.7	35.2	0.1	4.1	25.2	0.3	0.8	0.4	3.5	13.5	0.2	0.1	0.1	0.2	0.1	0.2	0.1	0.5	0.2	0.3	0.0	0.1	0.0	0.1	0.1	0.1	0.3	0.2	0.1	0.1	0.5	0.1	0.0	0.3	0.0	0.1	0.4	0.4	0.6	0.7	0.4	0.1	0.4	0.1	0.4	0.0	0.3	0.6	0.8	44.8	16.6	0.3	0.2	52.5	88.6	31.8	19.4	0.8	41.7	19.8	5.1	45.8	63.1	51.5	20.9	12.4	1.2	89.9	0.0	57.9	22.2	91.9	9.4	2.8	7.3	0.0	0.5	134.7	1.0	9.2	57.1	135.8	1.3	18.3	1.4	0.0	0.8	5.0	0.5	41.3	38.7	1.2	6.8	163.8	0.6	1.5	12.4	0.0	3.8	0.5	4.1	0.5	0.2	219.9	66.8	1.5	0.3	144.6	102.7	7.7	92.1	7.9	0.0	7.9	4.9	4.9	9.1	81.4	82.0	4.1	1.5	45.4	43.7	226.0
GUCA1A	"C6orf131, COD3, CORD14, dJ139D8.6, GCAP, GCAP1, GUCA, GUCA1"	ENSG00000048545	"Guanylate cyclase activator 1A"	P43080	6	42155406-42181338	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Sensory transduction, Vision"		"Cone-rod dystrophy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	91	"retina: 804.8"	"Cell type enhanced"	"Detected in some"		"Cone photoreceptor cells: 667.2;Late spermatids: 432.4;Muller glia cells: 219.9;Rod photoreceptor cells: 1191.6"	"Cancer enriched"	"Detected in single"	9	"testis cancer: 3.5"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	10	"plasmacytoid DC: 4.9"	"Lineage enriched"	"Detected in single"	10	"dendritic cells: 4.9"	"Group enriched"	"Detected in some"	8	"NTERA-2: 3.8;SH-SY5Y: 4.5"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"HPA005561, HPA075056"	Enhanced		Approved	"Plasma membrane"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 79: Retina - Phototransduction"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Plasma membrane"		"HPA005561: AB_2667361, HPA075056: "	"unprognostic (1.91e-2)"	"unprognostic (3.92e-3)"	"unprognostic (2.49e-2)"	"unprognostic (9.16e-2)"	"unprognostic (1.04e-4)"	"unprognostic (9.70e-2)"		"unprognostic (6.71e-3)"	"unprognostic (1.89e-1)"	"unprognostic (1.59e-2)"	"unprognostic (3.08e-3)"	"unprognostic (2.79e-1)"		"unprognostic (1.51e-1)"	"unprognostic (1.54e-1)"		"unprognostic (1.16e-1)"	0.0	0.0	1.5	0.1	3.5	0.1	0.0	0.9	1.8	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	5.4	0.0	0.0	0.0	0.1	1.5	1.4	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	804.8	0.0	0.0	0.1	0.1	0.1	0.1	0.8	0.0	0.0	8.8	6.2	0.0	0.0	0.0	0.2	0.0	0.1	1.2	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.1	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.2	0.1	0.5	0.0	0.0	4.9	0.0	0.0	1.5	3.5	0.9	1.8	1.3	5.4	1.5	1.4	1.4	0.8	6.2	1.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	140.7	0.0	0.0	0.3	0.0	0.0	0.0	667.2	0.6	1.3	0.0	0.0	0.0	106.5	0.0	0.0	8.2	0.0	0.0	0.3	0.0	0.3	0.9	0.0	0.0	0.0	0.5	0.0	0.0	0.2	65.6	1.0	0.0	4.1	0.0	0.0	432.4	1.8	0.1	0.0	0.0	5.2	219.9	0.0	0.0	0.1	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.1	1191.6	0.0	0.0	1.2	3.2	3.9	0.0	0.0	0.3	0.0	0.1	0.0	0.1
GUCA1ANB		ENSG00000287363	"GUCA1A neighbor"		6	42155406-42180056	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enriched"	"Detected in single"	226	"testis: 37.9"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"													NA	NA																											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	37.9	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GUCA1B	"GCAP2, RP48"	ENSG00000112599	"Guanylate cyclase activator 1B"	Q9UMX6	6	42183284-42194956	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Sensory transduction, Vision"		"Disease variant, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	99	"retina: 466.0"	"Group enriched"	"Detected in some"	4	"Astrocytes: 23.2;Cone photoreceptor cells: 83.4;Oligodendrocytes: 28.2;Rod photoreceptor cells: 53.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"hTCEpi: 4.3;U-698: 3.9"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA055479	Enhanced					NA	NA				"Cluster 79: Retina - Phototransduction"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 9: Photoreceptor cells - Phototransduction"			"HPA055479: AB_2732598"	"unprognostic (1.61e-1)"	"unprognostic (3.28e-1)"	"unprognostic (1.14e-6)"	"unprognostic (5.39e-2)"	"unprognostic (1.73e-2)"	"unprognostic (2.87e-3)"	"unprognostic (6.06e-3)"	"unprognostic (1.12e-1)"	"unprognostic (1.34e-1)"	"unprognostic (5.57e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.72e-2)"	"unprognostic (3.28e-7)"	"unprognostic (4.50e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.76e-2)"	"unprognostic (2.59e-3)"	1.5	0.9	3.5	0.8	3.6	1.3	1.4	3.8	4.1	2.3	2.2	1.3	0.3	1.9	1.0	0.8	2.3	0.2	1.6	3.2	3.2	1.0	1.9	1.1	0.7	3.3	3.2	2.7	0.9	0.2	1.0	0.4	3.6	1.5	0.5	466.0	1.1	0.5	2.6	2.8	1.4	1.0	3.0	2.1	0.8	2.6	3.5	1.0	1.0	0.9	0.9	1.1	1.4	4.6	0.1	0.6	1.3	0.5	1.0	0.9	0.3	0.5	0.8	0.8	0.7	1.1	0.4	1.6	0.8	0.1	0.2	0.4	1.4	0.2	1.4	1.3	0.6	0.4	0.1	0.2	0.4	1.5	0.5	0.3	4.3	0.8	1.1	0.4	0.1	1.2	1.0	1.5	0.2	1.3	0.6	1.0	0.0	0.3	0.3	0.2	0.8	0.1	0.8	0.5	0.6	0.9	0.0	0.2	0.1	0.2	0.1	0.9	0.0	0.2	1.7	0.6	0.7	2.7	1.3	3.9	0.2	0.6	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	3.5	3.6	3.8	4.1	3.2	3.2	3.3	3.2	3.6	3.0	3.5	4.6	0.2	0.0	0.0	23.2	0.0	0.3	0.1	0.0	0.0	4.0	0.2	0.1	0.3	0.0	0.0	0.0	83.4	0.1	0.1	0.1	0.0	0.0	0.1	0.3	0.3	0.3	0.0	0.0	8.1	0.0	0.0	0.2	0.0	0.1	0.0	0.2	0.0	0.0	0.0	6.7	11.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	1.8	2.8	0.1	8.1	0.0	11.6	28.2	0.1	0.0	0.0	0.0	0.3	0.0	0.1	0.0	53.0	0.0	0.5	0.4	0.5	0.3	0.0	0.1	0.0	0.2	0.0	0.0	0.2
MRPS10	FLJ10567	ENSG00000048544	"Mitochondrial ribosomal protein S10"	P82664	6	42206807-42217861	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"OE19: 295.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029133, HPA029134"	Supported		Approved	"Actin filaments,Mitochondria"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 59: Non-specific - Translation"	"Cluster 21: OE19 - Mitochondria"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria	"Actin filaments"	"HPA029133: AB_10600084, HPA029134: AB_10600058"	"unprognostic (1.06e-1)"	"unprognostic (3.90e-2)"	"unprognostic (5.55e-2)"	"unprognostic (3.77e-3)"	"unprognostic (1.70e-1)"	"unprognostic (1.78e-3)"	"unprognostic (2.37e-2)"	"unprognostic (8.65e-2)"	"unprognostic (1.50e-3)"	"unprognostic (5.13e-3)"	"unprognostic (2.78e-3)"	"unprognostic (6.29e-2)"	"unprognostic (3.17e-2)"	"unprognostic (8.54e-2)"	"unprognostic (3.45e-1)"	"unprognostic (3.36e-2)"	"unprognostic (5.04e-2)"	24.7	24.0	16.3	20.3	17.1	24.1	21.6	16.8	18.4	19.4	16.1	20.3	19.1	18.3	18.1	43.3	14.5	15.9	46.6	17.3	17.7	29.1	37.5	15.7	24.3	16.5	16.8	14.6	17.2	22.9	13.2	21.6	16.7	18.4	23.6	18.3	19.9	17.0	73.6	18.4	17.7	22.1	16.1	18.8	18.3	16.2	17.5	24.9	24.1	61.8	27.7	24.2	23.7	18.0	99.4	35.1	36.1	61.8	49.4	47.6	32.2	64.3	63.3	61.0	53.3	40.3	38.2	70.2	41.7	60.2	68.3	35.3	60.3	87.5	81.6	64.5	49.3	62.5	30.9	67.2	51.4	93.1	38.8	41.3	65.9	57.2	121.1	41.4	62.8	73.5	110.5	53.4	74.7	63.5	61.0	67.1	30.7	295.3	57.1	51.7	54.3	66.8	105.1	44.2	55.0	40.6	36.9	49.9	122.0	33.5	83.0	125.2	40.7	51.7	51.0	50.3	96.9	39.6	64.4	149.1	35.3	91.7	52.6	22.4	26.0	20.1	23.9	30.4	28.2	30.1	29.2	28.7	29.4	27.1	29.6	28.9	13.1	29.8	28.8	37.7	35.1	28.0	16.3	17.1	16.8	18.4	17.3	17.7	16.5	16.8	16.7	16.1	17.5	18.0	40.4	22.4	21.6	6.8	41.8	40.5	53.6	61.5	22.8	26.8	35.3	33.4	131.8	20.0	39.6	38.6	31.3	102.0	48.0	25.2	92.0	66.5	7.6	35.3	52.4	41.3	14.9	74.5	7.6	47.0	67.5	42.9	23.4	26.8	32.9	46.1	24.7	58.9	52.8	32.0	9.0	27.6	67.1	24.4	28.0	8.8	28.9	34.8	30.2	2.8	110.6	47.8	60.8	7.5	9.5	61.1	30.5	36.5	41.9	64.9	30.0	86.9	60.5	57.3	19.7	35.2	43.0	75.5	83.8	62.2	40.6	75.4	33.8	65.7	35.3	69.4
TRERF1	"BCAR2, dJ139D8.5, HSA277276, RAPA, TReP-132"	ENSG00000124496	"Transcriptional regulating factor 1"	Q96PN7	6	42224931-42452051	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 96.9;Inhibitory neurons: 111.4;Microglial cells: 52.5;Oligodendrocyte precursor cells: 80.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 144.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA027771, HPA051273, HPA059943"	Enhanced		Enhanced	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"		No	No			"Cluster 49: Eosinophils - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	"Nucleoli fibrillar center, Cytosol"	"HPA027771: AB_2672381, HPA051273: AB_2681416, HPA059943: AB_2684173"	"unprognostic (5.85e-3)"	"unprognostic (4.38e-2)"	"unprognostic (2.39e-1)"	"unprognostic (3.28e-3)"	"unprognostic (6.64e-2)"	"unprognostic (3.92e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.58e-2)"	"unprognostic (2.05e-4)"	"unprognostic (2.67e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.97e-2)"	"prognostic unfavorable (3.67e-5)"	"unprognostic (8.60e-2)"	"unprognostic (5.39e-2)"	"unprognostic (6.05e-2)"	"unprognostic (2.78e-2)"	3.4	5.7	1.3	5.8	2.2	13.9	2.6	1.1	3.8	7.7	0.0	3.7	3.2	6.0	2.9	8.8	5.1	3.9	1.8	0.8	0.6	2.9	1.0	2.9	7.7	0.3	0.7	7.1	1.6	3.9	3.5	2.6	0.0	5.4	3.4	2.0	2.3	3.6	1.1	6.4	4.7	3.9	0.2	7.2	4.2	6.0	1.6	10.3	2.0	1.2	5.0	7.0	8.0	0.8	13.7	9.4	10.3	13.2	4.7	10.4	14.5	10.2	16.2	11.4	9.4	0.1	7.1	12.7	2.2	15.5	15.6	16.2	13.2	12.6	9.1	144.3	1.0	13.7	8.0	0.0	3.2	25.4	42.1	4.3	17.3	10.2	4.1	10.3	0.0	8.5	0.1	4.1	5.0	3.0	6.6	42.9	11.3	10.1	9.6	11.8	0.8	4.7	6.7	16.7	8.3	4.4	6.1	0.2	1.0	5.6	5.9	34.1	4.5	6.5	7.5	10.7	2.9	1.7	9.5	13.7	4.4	22.7	0.1	1.1	0.6	4.6	1.5	0.2	1.4	0.2	1.1	1.3	0.7	0.0	0.9	1.0	2.0	1.5	0.1	0.6	1.2	0.7	1.3	2.2	1.1	3.8	0.8	0.6	0.3	0.7	0.0	0.2	1.6	0.8	2.7	3.2	1.3	37.9	3.6	8.3	2.9	3.2	6.2	9.9	4.1	2.5	1.9	1.5	5.9	5.5	0.0	3.4	20.9	8.4	0.0	1.8	2.7	3.3	16.2	5.4	3.0	0.4	96.9	1.0	0.9	11.8	11.2	1.7	12.0	14.7	6.4	0.3	2.6	8.4	111.4	2.1	4.1	4.7	10.4	3.2	14.0	8.0	3.6	52.5	7.9	4.2	12.3	80.4	3.8	1.2	2.5	22.2	7.2	1.6	1.0	0.2	8.5	0.5	26.3	4.4	7.9	10.0	7.4	23.5	7.4	1.2	18.0	4.2	3.8	4.3
UBR2	"bA49A4.1, C6orf133, dJ392M17.3, KIAA0349"	ENSG00000024048	"Ubiquitin protein ligase E3 component n-recognin 2"	Q8IWV8	6	42564029-42693505	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 138.5;Inhibitory neurons: 142.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 38.5"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027869, HPA027880"	Approved		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 21: OE19 - Mitochondria"	"Cluster 6: Erythroid cells - Oxygen transport"	Nucleoplasm	"Plasma membrane"	"HPA027869: AB_10600416, HPA027880: AB_10601217"	"unprognostic (3.26e-1)"	"unprognostic (1.29e-1)"	"unprognostic (8.33e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.08e-2)"	"unprognostic (4.23e-2)"	"unprognostic (1.32e-1)"	"unprognostic (7.24e-2)"	"unprognostic (5.05e-2)"	"prognostic favorable (1.65e-4)"	"unprognostic (1.12e-1)"	"unprognostic (7.53e-2)"	"unprognostic (1.30e-2)"	"unprognostic (3.88e-1)"	"unprognostic (1.81e-1)"	"unprognostic (5.78e-2)"	"unprognostic (7.77e-3)"	11.0	10.7	8.5	12.7	10.1	17.9	12.9	14.1	11.1	10.3	11.3	12.7	14.4	10.9	11.2	9.5	9.4	8.6	11.2	9.0	8.8	12.1	17.2	11.9	12.7	9.0	8.7	12.2	15.6	15.0	8.8	11.7	9.3	10.5	13.8	29.7	12.0	10.0	22.8	12.2	13.8	10.6	8.6	15.3	12.2	6.2	9.1	13.5	13.3	22.3	11.5	10.8	10.4	14.2	18.5	9.0	10.4	16.4	20.9	20.0	14.0	13.8	14.9	12.0	12.4	13.2	7.4	12.5	10.7	15.0	13.9	18.1	15.1	11.8	15.2	17.1	10.6	20.0	13.3	17.3	17.0	19.6	13.1	14.1	12.7	12.0	12.9	14.8	13.7	17.9	23.7	15.4	11.7	14.9	15.4	17.1	9.5	36.2	8.7	13.6	15.5	19.0	13.8	15.7	12.4	9.8	14.0	13.3	13.9	15.7	13.0	18.7	19.8	10.8	8.4	13.5	10.1	14.1	13.4	18.9	5.7	14.5	6.8	17.7	7.1	15.2	6.5	7.3	5.4	5.2	4.2	5.1	5.5	5.2	4.3	4.8	38.5	5.9	9.8	4.1	5.3	3.4	8.5	10.1	14.1	11.1	9.0	8.8	9.0	8.7	9.3	8.6	9.1	14.2	33.5	16.0	24.6	82.6	33.9	16.6	18.1	14.9	28.5	43.0	20.4	15.9	39.3	30.0	22.1	20.2	60.5	17.4	46.6	51.6	17.6	18.5	12.4	27.5	30.8	24.8	12.6	75.1	138.5	15.3	13.4	26.5	34.1	32.9	20.3	31.3	21.8	35.0	13.2	63.9	142.7	22.5	14.2	26.7	28.6	3.9	25.4	26.1	19.6	87.1	43.0	23.5	32.0	123.1	131.4	15.0	29.1	24.0	50.6	22.8	37.2	11.7	27.9	53.5	39.5	30.0	27.2	11.2	10.9	28.1	16.2	17.2	44.0	24.0	21.5	22.7
PRPH2	"CACD2, rd2, RDS, RP7, TSPAN22"	ENSG00000112619	"Peripherin 2"	P23942	6	42696598-42722597	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Cell adhesion, Sensory transduction, Vision"		"Cone-rod dystrophy, Disease variant, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	48	"retina: 641.4"	"Group enriched"	"Detected in some"	8	"Cone photoreceptor cells: 260.6;Rod photoreceptor cells: 482.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 3.0;ASC TERT1: 3.4;fHDF/TERT166: 5.3;HHSteC: 7.8;HSkMC: 6.0;LHCN-M2: 3.5"	"Region enriched"	"Detected in single"	7	"hippocampal formation: 2.4"	"Not detected"	"Not detected"			HPA029458	Enhanced					NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 79: Retina - Phototransduction"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 46: Photoreceptor cells - Phototransduction"			"HPA029458: AB_10602193"	"unprognostic (2.37e-1)"	"unprognostic (4.88e-2)"	"unprognostic (6.67e-2)"	"unprognostic (8.43e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.87e-3)"	"unprognostic (4.73e-1)"	"unprognostic (1.85e-1)"	"unprognostic (6.87e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.18e-2)"	"unprognostic (7.07e-4)"	"unprognostic (1.13e-3)"	"unprognostic (1.59e-1)"	"unprognostic (8.42e-2)"	"unprognostic (8.96e-3)"	1.1	0.8	2.1	0.5	1.5	0.0	0.5	0.4	1.8	2.0	0.1	2.2	0.4	2.1	1.8	0.7	1.3	1.1	1.5	3.1	2.1	1.4	0.2	1.5	0.1	0.9	1.0	3.1	2.3	4.3	2.5	0.9	1.2	1.5	0.8	641.4	0.7	1.1	13.2	0.3	1.4	1.9	0.4	0.8	1.2	3.7	2.7	0.2	4.1	2.9	0.1	1.2	1.1	1.2	0.0	0.0	0.0	0.0	3.0	3.4	0.7	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	7.8	0.0	0.0	6.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.7	0.0	0.2	0.0	0.1	0.0	2.1	1.5	0.4	1.8	3.1	2.1	0.9	1.0	1.2	0.4	2.7	1.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	39.3	0.1	0.0	0.9	0.0	0.1	0.0	260.6	0.1	0.0	0.0	3.9	0.3	0.2	0.1	0.9	2.3	0.0	0.0	2.3	0.2	0.0	1.3	0.0	0.1	0.0	0.2	0.4	0.2	0.0	11.8	1.7	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.9	0.0	42.6	1.0	0.5	0.6	0.5	0.0	1.9	0.0	0.2	0.0	0.2	0.0	482.7	0.0	0.9	0.8	2.3	0.5	0.1	0.3	0.1	0.0	1.3	0.0	0.1
TBCC	CFC	ENSG00000124659	"Tubulin folding cofactor C"	Q15814	6	42744498-42746103	"Plasma proteins, Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA035073, HPA035074"	Approved		Supported	Cytosol		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 21: OE19 - Mitochondria"	"Cluster 7: Non-specific - Mitochondria"	Cytosol		"HPA035073: AB_10602897, HPA035074: AB_2674448"	"unprognostic (7.16e-2)"	"unprognostic (9.88e-2)"	"unprognostic (2.17e-1)"	"unprognostic (4.23e-2)"	"unprognostic (8.20e-2)"	"unprognostic (6.79e-2)"	"unprognostic (5.80e-3)"	"unprognostic (1.41e-2)"	"unprognostic (2.47e-1)"	"unprognostic (3.96e-3)"	"unprognostic (1.84e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.29e-1)"	"unprognostic (6.31e-2)"	"unprognostic (3.76e-3)"	10.4	15.0	15.9	17.8	15.8	39.6	9.9	15.4	18.3	9.9	12.3	17.0	14.5	14.4	12.9	16.1	15.6	10.1	16.0	16.4	16.3	11.9	13.1	11.6	29.1	18.0	14.1	12.2	14.9	11.3	11.1	7.6	18.8	11.3	9.9	15.4	14.5	11.8	26.7	16.8	23.5	10.7	15.2	30.1	15.5	18.0	14.7	21.9	14.0	14.4	19.5	13.1	10.0	16.6	34.5	11.2	16.9	31.7	23.9	16.0	22.3	23.2	26.1	25.3	27.4	17.4	13.3	31.0	18.3	22.7	21.0	29.5	22.9	23.2	14.0	17.0	25.0	16.3	16.7	29.7	27.2	17.9	25.5	26.2	27.8	19.7	16.1	22.7	20.1	17.1	37.8	27.4	22.9	42.4	14.8	34.3	15.8	93.5	30.4	14.8	20.3	20.3	24.5	18.6	64.7	28.1	15.1	25.8	41.1	15.4	28.3	59.7	21.9	24.1	21.6	19.6	32.3	36.1	43.7	53.0	11.8	24.2	23.7	139.1	91.4	174.5	105.5	79.2	108.9	101.7	111.9	116.7	83.5	90.9	129.6	119.9	162.1	170.8	74.1	142.3	154.8	170.4	15.9	15.8	15.4	18.3	16.4	16.3	18.0	14.1	18.8	15.2	14.7	16.6	19.3	3.2	24.0	2.6	50.8	25.1	25.9	49.3	51.2	55.0	25.4	29.1	6.8	24.3	25.7	11.0	41.7	21.4	83.8	25.1	33.2	38.6	30.3	23.0	21.2	20.9	45.3	13.0	7.0	30.9	23.5	17.1	18.3	22.9	31.0	21.0	19.6	10.0	18.8	18.5	7.8	21.2	71.2	16.2	27.8	10.2	17.7	15.9	28.4	8.4	33.6	46.3	77.2	5.0	12.8	28.5	27.0	20.7	37.1	15.9	29.8	23.9	22.0	51.7	19.7	13.0	46.1	50.1	22.7	30.7	24.9	21.1	80.2	26.6	22.3	22.1
BICRAL	"GLTSCR1L, KIAA0240"	ENSG00000112624	"BRD4 interacting chromatin remodeling complex associated protein like"	Q6AI39	6	42746958-42868560	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 10.3;Alveolar cells type 1: 9.6;Alveolar cells type 2: 9.4;Breast glandular cells: 10.2;Breast myoepithelial cells: 9.1;dendritic cells: 11.6;Endometrial stromal cells: 9.6;Glandular and luminal cells: 9.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029390, HPA029391"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 21: OE19 - Mitochondria"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA029390: AB_10599730, HPA029391: AB_10599949"	"unprognostic (2.30e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.15e-2)"	"unprognostic (3.46e-2)"	"unprognostic (9.25e-2)"	"prognostic favorable (5.47e-4)"	"unprognostic (2.74e-1)"	"unprognostic (6.17e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.04e-2)"	"unprognostic (1.55e-1)"	"unprognostic (7.24e-2)"	"unprognostic (1.54e-3)"	"unprognostic (4.71e-2)"	"unprognostic (2.60e-1)"	"unprognostic (1.29e-1)"	"unprognostic (6.54e-2)"	8.5	5.7	4.5	8.3	4.4	7.7	9.5	15.9	6.9	9.4	1.1	7.6	6.1	11.3	7.7	6.5	10.2	7.2	7.0	4.2	5.0	6.1	5.7	7.8	12.2	4.8	4.0	16.2	7.0	10.4	5.8	5.2	5.1	9.2	9.5	14.3	8.3	8.1	8.0	8.7	6.7	9.6	2.9	9.8	7.5	5.0	4.0	11.6	11.3	9.4	12.2	7.7	7.3	7.4	6.2	4.9	4.3	6.9	8.7	10.0	3.7	5.4	5.6	4.7	3.6	2.2	4.4	14.4	4.8	9.1	7.2	4.8	4.2	5.6	7.7	10.8	2.7	10.1	4.9	6.3	4.6	8.6	8.8	6.2	10.6	4.6	8.4	8.9	4.9	8.4	9.8	12.5	5.6	7.4	1.4	4.9	4.8	24.3	3.0	8.9	2.5	14.3	4.8	4.0	14.6	7.8	6.1	8.7	6.1	4.1	7.6	10.0	5.7	6.5	6.4	4.3	5.4	11.3	7.0	21.6	3.9	10.8	4.7	2.3	0.5	2.8	2.2	0.4	1.9	1.2	1.3	2.1	0.4	1.3	1.2	1.6	3.7	1.6	0.8	0.7	1.6	0.6	4.5	4.4	15.9	6.9	4.2	5.0	4.8	4.0	5.1	2.9	4.0	7.4	10.3	9.6	9.4	0.0	4.2	0.0	0.0	0.0	0.0	0.0	10.2	9.1	0.0	0.0	4.3	3.7	0.0	2.3	11.6	0.0	0.0	3.8	0.0	6.2	9.6	3.1	0.0	0.0	0.0	3.8	2.1	3.9	0.0	9.8	1.3	8.4	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	1.6	0.0	0.0	0.0	0.0	3.6	0.0	0.0	3.5	0.0	0.0	4.3	2.9	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	1.4	5.0	5.2	0.0	0.0
RPL7L1	dJ475N16.4	ENSG00000146223	"Ribosomal protein L7 like 1"	Q6DKI1	6	42879616-42889925	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046049, HPA050478"			Approved	Nucleoli,Mitochondria		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 52: Non-specific - Transcription"	"Nucleoli, Mitochondria"		"HPA046049: AB_10964167, HPA050478: AB_2681138"	"unprognostic (1.03e-3)"	"unprognostic (4.37e-2)"	"unprognostic (3.37e-1)"	"unprognostic (7.97e-2)"	"unprognostic (7.73e-3)"	"unprognostic (4.26e-2)"	"prognostic unfavorable (8.53e-5)"	"unprognostic (2.56e-1)"	"unprognostic (2.98e-2)"	"unprognostic (3.78e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.94e-2)"	"unprognostic (7.53e-2)"	"unprognostic (1.06e-1)"	"unprognostic (7.31e-3)"	"unprognostic (4.58e-2)"	37.2	39.5	26.1	31.7	28.0	22.6	40.2	27.2	33.5	28.2	20.6	30.4	25.4	30.0	34.0	35.4	34.2	21.5	30.8	28.7	27.3	37.7	48.4	25.2	34.4	23.7	24.1	33.6	32.2	45.4	29.1	31.7	24.2	33.7	34.1	20.0	28.0	27.7	45.5	33.9	23.4	33.4	24.0	27.1	28.6	16.1	26.6	37.1	35.9	44.4	42.8	35.6	27.0	25.9	155.6	48.4	84.2	135.5	77.5	99.5	57.1	121.3	87.8	115.0	94.6	120.4	57.6	231.4	107.0	102.6	93.4	72.5	193.4	147.6	189.4	121.9	144.6	123.7	64.5	109.9	85.2	192.5	91.6	102.5	110.6	151.0	144.7	77.5	114.7	100.2	243.1	77.6	106.2	113.3	110.5	124.2	85.1	472.2	70.3	124.9	94.3	147.1	89.7	96.6	160.1	97.8	103.7	78.2	131.3	66.1	105.0	183.1	110.1	110.5	91.9	88.4	211.3	96.7	163.8	343.2	61.7	178.7	117.7	7.3	13.1	12.4	16.0	15.8	20.3	14.9	15.7	17.0	12.5	17.4	16.5	16.0	2.8	19.7	14.9	14.5	14.3	13.6	26.1	28.0	27.2	33.5	28.7	27.3	23.7	24.1	24.2	24.0	26.6	25.9	56.2	76.9	103.0	12.7	69.3	57.1	89.3	70.6	67.7	62.6	49.2	61.8	42.2	61.5	71.2	42.3	33.3	88.2	77.7	23.9	86.1	92.2	12.6	68.4	96.6	71.6	94.4	73.0	25.9	66.9	84.1	67.5	42.8	44.9	51.2	120.6	51.8	65.0	53.0	72.3	23.3	44.4	54.9	45.0	34.4	12.5	79.2	44.5	30.2	8.4	75.8	78.6	64.9	12.5	15.6	81.3	30.8	71.5	56.1	83.8	25.1	79.8	71.3	69.7	52.6	89.9	64.0	54.9	75.6	65.8	60.2	80.0	65.6	117.8	52.5	58.9
C6orf226	LOC441150	ENSG00000221821	"Chromosome 6 open reading frame 226"	Q5I0X4	6	42890265-42890821	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA045350	Approved		Approved	"Nuclear speckles"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 35: Non-specific - Unknown function"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 39: Non-specific - Basic cellular processes"	"Nuclear speckles"		"HPA045350: AB_10964640"	"prognostic favorable (1.93e-5)"	"unprognostic (2.21e-3)"	"unprognostic (2.91e-1)"	"unprognostic (2.77e-3)"	"unprognostic (1.71e-1)"	"unprognostic (4.17e-2)"	"unprognostic (5.40e-2)"	"unprognostic (2.00e-3)"	"unprognostic (8.82e-2)"	"unprognostic (3.50e-3)"	"prognostic favorable (5.13e-4)"	"unprognostic (2.24e-2)"	"prognostic favorable (3.35e-4)"	"unprognostic (4.63e-1)"	"unprognostic (3.97e-2)"	"unprognostic (6.13e-2)"	"unprognostic (5.82e-3)"	19.3	31.9	12.9	5.9	12.6	13.2	15.7	13.0	19.6	14.5	11.4	19.3	7.8	18.5	6.2	11.7	13.6	2.2	14.9	11.9	14.5	20.0	14.9	14.4	5.4	13.3	12.8	12.6	13.5	4.1	25.5	2.2	12.9	17.5	1.5	5.6	12.8	7.0	19.7	25.8	15.0	2.5	14.0	18.8	15.4	11.3	13.7	6.3	15.6	3.6	3.0	18.5	12.4	14.2	9.9	7.5	6.7	13.6	7.2	6.3	8.1	6.0	3.2	7.2	9.4	2.8	3.3	2.1	12.2	2.9	4.6	7.8	1.8	3.8	2.1	9.3	13.9	7.8	6.6	19.7	7.4	2.1	5.5	7.1	4.9	3.6	1.7	2.0	5.6	8.1	0.5	11.1	4.5	19.9	16.0	13.4	2.4	9.6	6.3	7.0	4.8	10.4	4.0	7.6	13.1	15.9	11.4	5.0	16.3	2.4	12.1	6.1	7.5	5.7	17.0	10.7	5.7	26.9	22.1	32.9	3.5	4.2	4.0	7.5	21.8	21.8	17.4	17.3	13.1	16.8	22.1	18.0	25.4	15.7	17.1	21.0	9.6	23.8	24.6	23.7	19.3	15.1	12.9	12.6	13.0	19.6	11.9	14.5	13.3	12.8	12.9	14.0	13.7	14.2	18.7	12.8	10.4	7.5	12.9	14.4	19.3	26.8	24.5	29.9	15.2	18.2	13.9	15.7	16.9	22.0	6.2	22.8	24.9	11.1	66.5	21.9	1.5	31.6	10.2	15.7	9.7	7.4	2.5	32.7	9.7	16.0	14.8	18.1	7.0	28.8	12.1	18.2	21.6	30.3	3.9	10.6	16.2	20.4	14.8	2.3	14.6	19.8	30.2	7.5	18.2	54.2	36.0	1.5	10.8	22.3	13.8	13.5	17.2	12.6	11.0	38.6	33.2	29.3	0.0	12.3	15.4	2.9	5.4	18.3	17.0	16.7	20.3	17.0	9.1	20.0
PTCRA	"PT-ALPHA, PTA"	ENSG00000171611	"Pre T cell antigen receptor alpha"	Q6ISU1	6	42915989-42925838	"Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	38	"lymphoid tissue: 128.6"	"Group enriched"	"Detected in some"	6	"dendritic cells: 110.6;Macrophages: 152.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in some"	46	"plasmacytoid DC: 410.7"	"Lineage enriched"	"Detected in many"	46	"dendritic cells: 410.7"	"Group enriched"	"Detected in some"	9	"MOLT-4: 42.8;SK-MEL-30: 13.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 51: Myeloid cells - Hemostasis"				"unprognostic (5.50e-2)"	"unprognostic (3.37e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.83e-2)"	"unprognostic (6.57e-4)"	"unprognostic (7.18e-2)"	"unprognostic (4.24e-2)"	"unprognostic (8.16e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.73e-1)"	"unprognostic (2.84e-4)"	"unprognostic (1.16e-1)"	"unprognostic (4.89e-1)"	"unprognostic (3.22e-2)"	"unprognostic (3.09e-2)"	"unprognostic (1.45e-1)"	0.3	0.1	0.0	0.3	0.7	1.7	0.1	0.1	1.3	0.1	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.4	0.0	0.2	2.6	2.8	1.1	0.7	0.0	0.0	0.0	0.0	0.6	0.8	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.4	5.0	0.1	0.0	3.3	128.6	0.1	0.0	2.2	0.2	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	42.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.4	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.4	8.7	0.4	1.7	0.1	1.1	0.1	0.0	0.0	0.3	0.4	0.1	0.4	0.0	8.9	0.1	0.7	410.7	0.0	32.8	0.0	0.7	0.1	1.3	0.3	0.4	1.1	0.7	0.8	0.4	3.3	1.8	0.1	0.0	0.5	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.1	110.6	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.0	6.5	0.1	0.0	0.0	0.0	0.0	2.2	0.0	19.4	0.0	0.2	0.0	0.0	15.1	0.0	0.0	0.0	152.8	5.4	0.0	2.7	0.0	2.1	0.0	0.1	0.0	0.0	0.0	0.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.9	0.0	0.0	0.0
CNPY3	"CAG4A, TNRC5"	ENSG00000137161	"Canopy FGF signaling regulator 3"	Q9BT09	6	42929192-42939294	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Immunity, Innate immunity"	Chaperone	"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hofbauer cells: 248.5;Kupffer cells: 233.3;monocytes: 207.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016560	Uncertain				"Intracellular and membrane"	NA	NA		4100000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 57: B-cells - Immune response"			"HPA016560: AB_1858173"	"unprognostic (5.26e-3)"	"unprognostic (6.63e-2)"	"prognostic unfavorable (3.03e-5)"	"unprognostic (8.15e-2)"	"unprognostic (3.12e-1)"	"unprognostic (1.79e-1)"	"unprognostic (5.70e-3)"	"unprognostic (5.11e-2)"	"unprognostic (4.77e-2)"	"unprognostic (1.94e-2)"	"unprognostic (2.26e-3)"	"unprognostic (4.54e-2)"	"prognostic unfavorable (9.85e-6)"	"unprognostic (2.34e-1)"	"unprognostic (1.93e-2)"	"unprognostic (2.21e-2)"	"unprognostic (2.98e-3)"	35.3	31.4	58.2	64.3	59.1	144.6	32.7	59.0	72.8	40.0	70.0	30.9	30.9	37.5	32.3	23.4	49.8	37.8	28.8	59.7	64.2	31.8	64.7	45.4	78.6	70.0	63.1	48.5	90.0	29.0	41.7	47.6	67.0	45.1	29.7	23.9	32.5	33.8	10.9	22.2	50.1	42.0	62.8	105.2	36.7	46.7	65.8	115.8	34.1	16.7	69.2	43.3	30.0	75.8	78.2	75.6	72.8	157.0	118.4	44.8	73.5	60.3	78.9	79.1	91.0	85.2	57.0	82.1	91.0	102.9	170.8	63.7	54.7	68.7	48.2	82.7	61.6	88.6	65.2	134.0	70.0	155.7	173.3	54.3	41.7	61.2	67.4	113.9	72.4	77.6	73.3	157.3	51.9	147.9	141.4	188.8	59.1	367.3	42.1	97.2	50.6	123.2	79.6	58.6	78.5	68.9	37.7	38.6	134.4	93.4	49.8	334.6	54.6	82.7	82.9	30.9	66.0	107.0	78.9	115.0	34.2	178.6	70.9	212.7	483.3	249.0	115.2	336.3	110.9	267.3	101.1	126.1	407.0	258.7	112.6	115.1	852.8	132.3	327.2	696.4	102.2	404.5	58.2	59.1	59.0	72.8	59.7	64.2	70.0	63.1	67.0	62.8	65.8	75.8	32.3	12.8	11.1	4.2	132.1	22.8	32.1	41.1	31.9	41.6	25.6	29.7	16.9	22.8	26.2	23.9	14.6	51.1	176.5	16.7	7.9	47.4	61.0	25.9	24.2	36.7	55.3	47.9	5.1	34.1	180.8	33.9	20.9	31.8	46.3	81.5	42.1	58.9	248.5	1.7	6.7	31.1	34.6	233.3	61.7	81.7	33.5	184.3	30.2	18.7	207.0	20.8	62.8	4.5	6.6	27.9	34.9	30.1	70.7	50.8	38.4	18.1	32.8	11.1	19.7	12.6	28.0	72.3	39.9	23.9	17.0	36.1	64.1	39.8	36.5	37.9
GNMT		ENSG00000124713	"Glycine N-methyltransferase"	Q14749	6	42960754-42963880	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		"Methyltransferase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	9	"liver: 296.5;pancreas: 600.1"	"Cell type enriched"	"Detected in many"	10	"Hepatocytes: 842.9"	"Group enriched"	"Detected in many"	20	"liver cancer: 69.6;prostate cancer: 49.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"Hep G2: 8.5;SCLC-21H: 9.5;T-47d: 6.1"	"Region enriched"	"Detected in some"	4	"cerebellum: 15.7"	"Low region specificity"	"Detected in many"			HPA027501	Enhanced		Approved	Cytosol		NA	NA		390000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 25: Pancreas - Digestion"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"	Cytosol		"HPA027501: AB_1849879"	"unprognostic (1.53e-2)"	"unprognostic (8.02e-4)"	"unprognostic (3.11e-2)"	"unprognostic (4.24e-3)"	"unprognostic (3.91e-2)"	"unprognostic (6.40e-4)"	"prognostic favorable (1.86e-4)"	"unprognostic (4.08e-6)"	"unprognostic (1.01e-1)"	"unprognostic (2.67e-2)"	"unprognostic (1.63e-3)"	"unprognostic (2.52e-1)"	"unprognostic (3.50e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.49e-2)"	"unprognostic (4.92e-2)"	0.9	0.9	2.3	1.3	2.5	3.8	7.1	2.8	2.4	0.8	2.0	0.7	0.2	0.8	2.2	0.6	1.3	0.5	4.7	2.2	2.2	0.9	296.5	2.0	1.0	1.1	1.0	1.9	600.1	0.2	8.4	0.4	1.1	20.3	0.3	2.2	9.8	1.2	1.8	0.9	1.6	0.5	0.9	2.9	50.8	0.7	1.9	1.8	1.9	0.4	1.2	0.8	0.7	2.1	0.4	0.3	1.4	3.9	0.4	0.1	0.2	0.3	1.6	0.6	0.9	0.0	0.1	1.3	0.1	0.3	0.7	0.4	0.2	0.2	0.2	1.6	1.2	1.0	0.9	8.5	0.0	0.9	1.8	0.3	0.0	0.3	0.1	0.9	0.0	3.0	1.2	1.5	0.2	1.8	1.6	3.0	0.1	0.4	0.4	1.4	1.3	0.8	0.6	0.2	9.5	1.3	0.1	1.3	0.6	0.4	6.1	2.8	0.3	0.7	0.7	0.4	0.8	1.0	1.0	1.1	0.1	1.6	0.8	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.2	0.5	0.0	0.0	0.7	0.0	0.1	2.3	2.5	2.8	2.4	2.2	2.2	1.1	1.0	1.1	0.9	1.9	2.1	0.3	0.0	2.2	5.5	2.8	0.3	5.2	0.7	0.0	1.7	10.2	14.7	5.4	24.3	0.2	1.8	0.0	0.1	1.7	0.0	3.9	0.5	0.2	1.6	0.2	2.2	0.0	77.9	18.4	0.9	0.1	0.3	0.5	0.8	0.0	2.6	24.3	842.9	0.7	1.7	18.2	0.0	6.1	28.9	0.7	0.1	0.9	1.1	0.0	11.2	0.3	0.2	0.0	7.1	4.7	0.6	0.0	2.6	0.5	17.9	0.3	3.4	4.6	0.3	0.0	0.2	0.6	0.6	0.7	0.0	0.1	0.1	3.0	0.0	0.2	1.9
PEX6	"PAF-2, PXAAA1"	ENSG00000124587	"Peroxisomal biogenesis factor 6"	Q13608	6	42963865-42979181	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Peroxisome biogenesis"		"Amelogenesis imperfecta, Deafness, Disease variant, Peroxisome biogenesis disorder, Zellweger syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 76.2"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"OE19: 78.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025924, HPA074179"	Supported		Supported	"Nucleoplasm,Nuclear bodies,Vesicles"		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Vesicles"	"Nuclear bodies"	"HPA025924: AB_1855230, HPA074179: "	"unprognostic (7.32e-3)"	"unprognostic (2.43e-1)"	"unprognostic (1.38e-1)"	"unprognostic (9.16e-2)"	"unprognostic (9.18e-2)"	"unprognostic (3.27e-1)"	"unprognostic (8.88e-2)"	"unprognostic (5.92e-2)"	"unprognostic (3.36e-1)"	"unprognostic (7.12e-2)"	"unprognostic (7.24e-3)"	"unprognostic (5.31e-2)"	"unprognostic (3.79e-3)"	"unprognostic (1.86e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.55e-1)"	11.6	20.5	24.9	9.2	25.2	9.5	12.1	23.9	27.7	19.1	25.5	16.3	9.3	15.5	7.7	16.4	22.7	9.6	18.7	25.1	25.5	16.5	27.7	10.0	14.5	27.2	25.5	26.1	76.2	15.2	24.3	9.6	24.2	21.6	7.8	9.9	14.8	11.4	23.4	14.0	16.3	9.6	23.9	17.5	16.3	16.2	25.1	14.7	19.8	15.0	10.4	17.3	15.7	25.2	35.0	16.4	8.1	30.6	29.6	28.3	8.4	6.0	9.4	4.8	10.0	10.5	10.1	14.1	8.2	14.3	20.5	32.2	28.7	31.1	5.0	27.6	15.2	4.7	24.4	6.2	20.0	4.8	9.4	35.5	35.5	19.9	5.5	39.1	24.7	18.9	25.2	14.1	10.7	3.9	12.7	15.8	10.0	78.8	14.3	26.8	14.3	5.8	12.3	10.0	25.4	11.1	5.6	21.9	32.7	13.1	43.2	21.2	14.0	15.2	2.9	7.5	14.0	21.0	19.8	19.7	5.2	24.6	12.4	1.3	1.3	2.1	1.2	1.1	2.1	1.0	1.8	2.5	1.9	1.9	2.2	2.1	0.8	2.0	0.7	1.0	0.9	1.1	24.9	25.2	23.9	27.7	25.1	25.5	27.2	25.5	24.2	23.9	25.1	25.2	5.6	6.4	2.6	19.9	5.6	5.0	10.2	6.2	10.8	15.2	11.8	12.7	4.1	10.0	5.6	7.3	2.1	11.4	5.4	10.2	13.7	2.8	2.5	17.6	10.6	5.8	5.4	1.7	24.6	1.5	6.7	9.2	11.2	9.1	0.0	19.8	8.6	14.1	5.8	21.9	22.4	8.5	6.1	9.7	3.2	3.6	14.6	5.4	8.8	9.4	4.5	11.8	9.2	13.0	16.6	1.9	10.4	9.4	3.1	6.3	15.1	13.9	14.3	7.0	0.0	13.0	6.6	7.3	2.6	6.3	5.5	7.4	7.8	26.1	10.5	6.6
PPP2R5D	"B56D, B56delta"	ENSG00000112640	"Protein phosphatase 2 regulatory subunit B'delta"	Q14738	6	42984553-43012342	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal enterocytes: 35.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029045, HPA029046"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA		29000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 45: Enterocytes - Digestion"	"Nucleoplasm, Cytosol"		"HPA029045: AB_10598912, HPA029046: AB_10600988"	"unprognostic (2.25e-1)"	"unprognostic (7.14e-2)"	"unprognostic (4.73e-2)"	"unprognostic (6.89e-2)"	"unprognostic (1.74e-2)"	"unprognostic (1.70e-1)"	"prognostic unfavorable (3.89e-4)"	"unprognostic (4.08e-2)"	"unprognostic (1.24e-1)"	"unprognostic (9.44e-2)"	"unprognostic (2.59e-1)"	"unprognostic (2.71e-1)"	"unprognostic (1.21e-1)"	"unprognostic (9.96e-2)"	"unprognostic (2.70e-1)"	"unprognostic (7.95e-2)"	"unprognostic (6.05e-2)"	23.2	20.2	29.9	17.5	32.5	18.3	20.2	25.7	38.1	30.9	17.2	27.2	29.7	28.7	4.3	24.3	28.5	15.2	30.3	33.1	26.8	18.2	20.8	18.7	19.9	31.0	26.6	28.6	19.1	24.5	15.9	18.1	30.8	24.8	23.5	29.7	19.8	21.2	40.6	27.8	35.8	30.6	21.1	18.7	22.3	28.6	29.6	44.4	18.3	41.2	24.0	24.7	27.4	31.2	71.3	38.0	72.6	88.2	61.0	63.6	32.6	38.3	39.9	108.5	86.6	58.7	24.9	55.8	36.3	71.8	67.3	38.6	108.6	66.4	94.6	45.3	67.5	62.9	51.2	81.8	33.5	51.4	43.6	45.6	47.3	88.5	35.1	54.1	87.2	68.7	67.4	41.1	63.0	44.0	114.9	40.0	26.2	228.1	36.3	86.3	73.8	37.3	45.3	39.0	77.9	45.7	56.2	38.7	47.3	63.2	47.9	55.5	57.1	57.2	50.9	55.8	61.4	39.6	54.6	109.0	21.2	48.0	51.6	18.4	13.8	21.9	18.4	11.6	19.2	10.1	16.9	21.2	13.7	9.2	12.8	15.6	8.1	14.3	8.9	14.4	23.9	20.1	29.9	32.5	25.7	38.1	33.1	26.8	31.0	26.6	30.8	21.1	29.6	31.2	6.2	9.6	6.7	6.8	7.6	8.4	2.9	5.1	13.1	12.9	6.9	6.6	4.9	4.3	6.3	7.3	10.4	7.5	10.1	15.7	5.9	6.9	6.4	7.7	19.9	7.4	9.0	12.4	10.5	7.8	11.0	9.7	7.1	9.5	8.2	10.8	6.4	11.3	9.2	3.3	10.3	8.3	8.2	6.2	5.2	7.0	9.6	6.9	10.6	3.7	6.8	8.1	3.1	3.0	5.3	9.8	9.0	14.7	7.7	3.7	35.7	5.2	5.1	7.5	6.6	8.7	10.8	8.3	10.2	13.3	9.5	4.5	11.1	6.1	13.0	2.5
MEA1	MEA	ENSG00000124733	"Male-enhanced antigen 1"	Q16626	6	43011143-43016868	"Plasma proteins, Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"Early spermatids: 804.1;Late spermatids: 2062.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017921, HPA073087"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 21: OE19 - Mitochondria"	"Cluster 31: Spermatids - Spermatogenesis"	"Nucleoplasm, Cytosol"		"HPA017921: AB_1853708, HPA073087: "	"unprognostic (1.30e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.15e-1)"	"unprognostic (2.45e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.10e-2)"	"unprognostic (2.74e-2)"	"prognostic favorable (3.37e-4)"	"unprognostic (8.56e-2)"	"unprognostic (2.12e-2)"	"prognostic unfavorable (1.29e-6)"	"unprognostic (2.07e-1)"	"unprognostic (8.62e-2)"	"unprognostic (1.89e-2)"	"unprognostic (5.58e-2)"	48.6	56.1	96.7	41.3	99.3	39.6	48.4	96.0	114.3	58.3	91.5	54.4	36.5	49.9	65.9	51.0	55.1	33.1	42.6	100.3	110.1	62.4	52.7	38.4	45.1	98.9	98.6	59.4	46.1	69.3	59.0	43.6	101.2	53.0	46.3	55.6	45.8	52.4	30.4	55.4	39.7	53.4	95.5	43.8	46.0	222.9	102.1	70.9	45.6	33.8	61.5	58.9	49.4	96.8	200.9	113.7	166.9	133.0	147.6	97.7	66.3	130.6	137.9	156.8	172.3	169.9	51.6	103.6	133.9	159.9	232.8	99.7	128.8	177.7	147.0	119.8	176.3	192.7	121.8	188.1	76.4	142.7	97.8	79.0	87.5	211.3	137.3	162.0	96.8	166.7	132.9	113.4	176.0	384.7	193.0	165.5	78.3	569.8	99.1	93.3	98.6	104.2	112.4	186.9	160.3	112.0	100.5	86.2	155.3	134.2	130.8	154.9	73.1	175.8	141.2	115.3	229.4	128.0	113.4	174.1	88.3	105.4	146.3	229.1	112.3	214.8	128.9	136.0	118.7	190.3	116.3	126.8	119.8	180.7	115.6	122.7	104.7	145.5	161.6	117.3	158.3	201.2	96.7	99.3	96.0	114.3	100.3	110.1	98.9	98.6	101.2	95.5	102.1	96.8	45.1	25.6	16.7	10.1	46.9	66.3	73.6	129.3	85.4	19.6	56.9	69.8	28.2	42.9	78.1	55.2	4.2	111.8	32.8	56.7	168.3	89.4	804.1	36.2	27.1	51.1	29.9	42.7	11.5	92.4	101.5	52.0	36.7	29.3	46.9	38.9	45.3	54.0	108.1	16.8	11.6	48.7	89.5	39.2	55.3	2062.6	63.3	51.6	67.6	5.6	70.1	98.5	68.0	7.5	11.9	80.5	61.4	59.8	55.0	84.7	82.8	142.2	73.0	23.4	118.3	26.8	102.8	285.9	98.1	73.6	69.6	85.0	51.1	35.0	49.9	86.3
KLHDC3	"dJ20C7.3, hPeas, PEAS"	ENSG00000124702	"Kelch domain containing 3"	Q9BQ90	6	43014103-43021298	"Predicted intracellular proteins"	Meiosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 395.9"	"Group enriched"	"Detected in all"	5	"Early spermatids: 552.0;Late spermatids: 1588.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030131, HPA030132, HPA030133, HPA030134"	Uncertain		Enhanced	Nucleoplasm		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA030131: AB_10599712, HPA030132: AB_10600880, HPA030133: AB_10611532, HPA030134: AB_10601350"	"unprognostic (3.85e-2)"	"prognostic favorable (9.15e-4)"	"unprognostic (5.31e-2)"	"prognostic unfavorable (4.52e-4)"	"unprognostic (9.97e-3)"	"unprognostic (2.80e-1)"	"unprognostic (2.09e-3)"	"unprognostic (1.05e-2)"	"unprognostic (5.09e-2)"	"unprognostic (1.58e-3)"	"prognostic favorable (9.08e-4)"	"unprognostic (6.34e-2)"	"unprognostic (2.88e-2)"	"unprognostic (8.73e-2)"	"unprognostic (9.78e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.52e-1)"	52.5	64.9	161.4	33.9	170.8	48.6	52.7	144.2	203.3	48.5	139.0	75.0	40.1	44.5	56.3	49.5	53.0	37.4	105.7	178.2	143.8	53.2	73.0	43.2	45.4	150.6	153.9	55.6	51.1	54.6	68.8	59.2	156.5	56.8	40.7	48.2	60.6	47.8	395.9	51.4	48.6	43.3	140.5	54.0	64.8	192.2	158.6	67.1	49.7	203.9	44.8	49.8	46.2	157.1	119.1	36.0	117.1	197.3	79.0	59.4	83.8	52.6	67.7	100.7	109.4	104.5	60.6	117.0	58.7	77.3	37.8	61.6	126.1	67.8	68.5	62.8	171.3	146.0	102.1	109.7	77.4	86.5	99.7	95.8	67.1	77.6	45.2	77.9	98.7	131.1	180.7	80.9	38.4	147.3	142.3	148.9	153.4	297.3	38.0	137.2	86.0	141.4	62.3	67.9	216.1	168.8	55.8	63.2	93.1	75.7	109.8	247.6	58.8	45.7	83.9	50.8	52.9	88.0	118.8	170.9	19.9	122.7	39.4	42.3	83.5	100.3	62.0	78.9	51.9	41.6	50.8	56.0	90.7	39.6	65.6	51.8	40.4	54.7	63.3	49.8	59.5	76.5	161.4	170.8	144.2	203.3	178.2	143.8	150.6	153.9	156.5	140.5	158.6	157.1	21.3	12.8	17.0	10.4	26.7	18.7	32.9	33.5	14.8	31.9	37.8	33.7	40.3	37.1	19.1	18.4	14.6	99.6	32.7	34.8	86.1	61.7	552.0	19.2	19.0	30.4	52.3	59.3	29.1	54.7	115.1	36.2	20.9	18.8	13.4	50.7	32.5	28.4	63.8	32.0	22.0	43.7	34.6	47.0	22.7	1588.3	44.7	31.8	33.8	11.2	54.7	55.4	55.6	11.6	14.8	46.3	44.3	59.0	31.7	44.4	72.6	55.3	16.9	25.9	52.6	30.4	32.2	180.8	35.6	22.8	20.6	107.0	28.3	71.4	53.7	36.7
RRP36	"C6orf153, dJ20C7.4"	ENSG00000124541	"Ribosomal RNA processing 36"	Q96EU6	6	43021623-43034156	"Predicted intracellular proteins"	"Ribosome biogenesis, rRNA processing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029904, HPA029905"	Uncertain		Enhanced	Nucleoplasm,Nucleoli		Yes	No			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 21: OE19 - Mitochondria"	"Cluster 7: Non-specific - Mitochondria"	"Nucleoplasm, Nucleoli"		"HPA029904: AB_10611817, HPA029905: AB_2673244"	"unprognostic (1.76e-1)"	"unprognostic (4.47e-1)"	"unprognostic (3.78e-2)"	"unprognostic (1.46e-2)"	"unprognostic (3.25e-1)"	"unprognostic (1.33e-1)"	"prognostic unfavorable (5.95e-4)"	"unprognostic (2.61e-1)"	"unprognostic (6.83e-2)"	"unprognostic (1.32e-3)"	"unprognostic (1.39e-1)"	"unprognostic (3.38e-1)"	"prognostic unfavorable (2.48e-5)"	"unprognostic (3.53e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.09e-2)"	30.0	34.6	19.4	27.4	19.7	28.7	28.7	21.5	23.2	26.0	19.8	29.0	20.8	25.5	22.9	37.8	23.2	19.0	30.1	20.3	22.3	35.1	37.3	25.5	32.3	21.3	20.9	18.4	35.8	34.7	31.9	24.2	22.0	28.5	24.3	16.6	27.1	25.0	51.3	34.3	25.9	29.7	20.8	33.3	30.6	17.7	21.0	31.1	23.4	34.8	35.2	30.0	26.4	20.8	141.5	77.9	75.8	111.3	79.7	74.0	63.6	108.9	97.7	136.1	132.6	141.9	59.8	64.7	86.3	113.8	100.1	73.5	127.7	131.8	149.3	82.5	129.9	104.1	82.7	153.2	92.3	87.5	77.7	75.6	79.0	163.0	69.1	48.7	112.2	57.6	128.2	68.4	127.8	148.1	106.0	95.6	84.3	249.7	79.6	98.7	74.7	74.9	83.2	130.5	96.4	84.5	80.1	72.8	129.1	70.6	100.1	106.0	91.2	125.1	95.1	83.4	173.8	63.8	103.9	172.0	54.5	108.6	119.1	2.4	2.2	2.0	3.3	3.0	2.7	4.5	2.4	4.2	2.3	1.4	2.2	4.5	2.5	2.0	2.4	6.0	1.4	0.8	19.4	19.7	21.5	23.2	20.3	22.3	21.3	20.9	22.0	20.8	21.0	20.8	26.8	0.0	15.6	4.6	14.7	13.4	11.2	13.5	5.7	16.1	19.7	22.1	15.1	20.0	14.1	20.2	16.7	29.3	33.1	12.7	13.7	33.7	10.1	18.3	26.5	18.5	13.9	4.6	8.1	44.8	41.8	18.0	12.8	18.0	6.3	27.3	21.0	36.0	29.1	18.5	8.1	12.6	12.2	16.6	11.7	23.0	11.8	20.0	14.2	2.8	26.1	36.9	20.6	6.6	9.6	44.0	7.4	18.8	18.8	17.7	12.4	20.5	10.0	20.3	6.6	19.3	24.7	9.5	10.6	16.5	18.6	33.7	16.5	61.5	14.2	14.3
CUL7	"dJ20C7.5, KIAA0076"	ENSG00000044090	"Cullin 7"	Q14999	6	43037617-43053943	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Host-virus interaction, Ubl conjugation pathway"		"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015449, HPA030095, HPA030096"	Approved					NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 51: Non-specific - Unknown function"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 52: Non-specific - Transcription"			"CAB015449: AB_629341, HPA030095: AB_10600659, HPA030096: AB_10600997"	"unprognostic (2.32e-2)"	"unprognostic (4.79e-2)"	"unprognostic (1.01e-3)"	"unprognostic (6.06e-2)"	"unprognostic (5.41e-3)"	"unprognostic (4.95e-2)"	"unprognostic (3.72e-2)"	"unprognostic (1.94e-2)"	"unprognostic (1.01e-1)"	"unprognostic (9.81e-2)"	"unprognostic (2.13e-3)"	"unprognostic (4.81e-1)"	"prognostic unfavorable (2.19e-4)"	"unprognostic (8.92e-2)"	"unprognostic (6.78e-2)"	"unprognostic (2.23e-1)"	"unprognostic (3.35e-1)"	7.5	13.7	5.0	6.6	5.0	4.4	8.8	5.7	5.3	14.4	7.9	7.6	7.7	11.7	9.0	6.9	14.2	7.6	5.9	5.4	7.0	11.0	9.7	7.4	6.2	3.8	4.4	15.9	15.7	6.9	26.0	10.2	4.9	11.0	5.4	5.5	8.5	8.7	13.2	7.5	8.0	9.2	3.5	9.7	9.4	5.7	6.9	6.1	12.9	10.7	5.4	8.9	9.6	4.0	10.6	8.2	27.1	32.0	27.9	40.7	2.2	15.7	21.0	18.8	19.0	18.0	7.9	4.9	35.2	27.0	19.1	3.9	9.9	13.9	8.8	12.4	10.5	12.2	9.1	25.5	23.2	4.4	14.2	42.5	13.1	16.2	17.4	33.7	18.0	5.6	10.7	12.3	24.1	21.8	5.6	10.9	4.5	32.2	6.7	9.1	6.5	12.7	16.6	14.4	14.6	18.2	12.2	11.3	11.1	12.4	16.6	8.3	18.9	28.1	12.0	9.1	6.9	25.6	7.0	12.9	11.2	4.8	16.5	0.0	0.7	0.4	0.6	0.6	0.4	0.5	0.4	0.2	0.7	0.7	0.2	0.4	0.2	0.6	0.5	0.9	0.3	0.6	5.0	5.0	5.7	5.3	5.4	7.0	3.8	4.4	4.9	3.5	6.9	4.0	3.9	6.4	10.5	6.5	4.5	2.5	1.7	5.2	4.0	6.0	7.2	6.0	4.6	1.5	4.6	3.7	6.2	4.8	1.7	3.8	0.0	6.4	0.6	8.4	7.7	5.8	7.2	2.1	6.0	4.8	3.7	6.9	10.7	6.3	4.5	15.9	5.7	2.2	5.0	1.7	5.9	8.2	6.1	2.2	1.8	0.2	9.3	2.7	1.8	5.6	1.2	4.1	1.0	3.0	3.1	4.6	2.6	7.5	3.9	2.2	6.4	4.9	12.9	7.8	0.0	7.5	4.9	0.8	2.5	4.2	1.7	4.4	2.8	17.3	4.6	1.5
KLC4	"bA387M24.3, KNSL8"	ENSG00000137171	"Kinesin light chain 4"	Q9NSK0	6	43040777-43075095	"Predicted intracellular proteins"		"Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 89.9"	"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 81.9;Hepatocytes: 67.8;Paneth cells: 70.4;Proximal enterocytes: 143.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"OE19: 65.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030168, HPA030169"	Enhanced		Approved	Mitochondria,Cytosol		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 21: OE19 - Mitochondria"	"Cluster 45: Enterocytes - Digestion"	Mitochondria	Cytosol	"HPA030168: AB_10599285, HPA030169: AB_10601105"	"unprognostic (2.96e-2)"	"unprognostic (6.29e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.08e-2)"	"unprognostic (3.67e-2)"	"unprognostic (5.63e-3)"	"unprognostic (6.36e-3)"	"unprognostic (1.19e-2)"	"unprognostic (4.67e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.47e-2)"	"unprognostic (9.22e-2)"	"prognostic favorable (6.99e-6)"	"unprognostic (2.08e-1)"	"unprognostic (3.93e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.06e-2)"	12.3	17.2	18.8	11.2	19.6	12.4	13.4	21.8	22.8	16.6	18.6	41.1	72.5	15.1	23.0	10.9	17.7	17.9	25.1	18.7	19.0	24.2	89.9	16.5	13.5	21.2	19.2	19.7	17.8	28.7	24.1	12.2	21.2	17.0	34.2	23.8	19.9	15.8	22.9	17.5	63.7	14.0	17.5	12.5	31.8	24.8	19.6	17.1	19.7	22.8	11.1	17.3	12.9	20.9	7.5	6.0	15.9	18.9	15.0	14.7	13.7	5.5	8.5	9.5	15.6	9.8	11.5	9.9	19.7	13.4	12.6	12.3	15.8	14.9	7.2	10.0	19.1	11.4	18.2	44.0	14.5	5.4	9.1	19.3	18.2	11.8	10.8	29.8	12.1	20.5	7.9	12.8	8.0	13.0	16.2	12.2	6.1	65.4	7.9	12.6	9.0	19.3	14.3	6.5	26.7	12.8	10.3	9.6	20.3	14.9	16.4	15.0	10.2	10.6	12.8	5.4	5.9	25.8	9.9	24.1	5.8	8.5	3.9	2.6	2.6	3.2	2.6	2.6	3.4	3.7	3.7	2.5	3.0	3.2	4.5	3.3	6.5	4.9	2.6	8.7	4.5	2.3	18.8	19.6	21.8	22.8	18.7	19.0	21.2	19.2	21.2	17.5	19.6	20.9	4.1	16.0	14.4	23.5	4.3	3.7	9.2	12.5	15.9	21.8	8.0	8.8	10.6	20.0	10.8	14.7	29.2	11.8	11.4	81.9	19.6	8.7	13.4	8.9	3.8	5.8	22.3	9.3	17.2	9.8	4.9	5.9	33.6	7.9	7.0	12.2	7.5	67.8	6.5	11.8	24.2	35.3	10.2	5.7	2.9	6.5	10.2	3.6	3.6	6.5	5.3	16.3	4.1	10.6	9.7	7.6	70.4	6.8	7.4	5.0	143.4	23.5	19.0	28.0	13.1	6.0	5.5	27.3	15.6	9.4	4.5	13.5	5.3	6.2	44.0	6.6
MRPL2	"CGI-22, MRP-L14, RPML14"	ENSG00000112651	"Mitochondrial ribosomal protein L2"	Q5T653	6	43054029-43059438	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 185.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007455, HPA064814"	Approved		Supported	Nucleoplasm,Mitochondria	"Intracellular and membrane"	NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 10: Non-specific - Unknown function"	Mitochondria	Nucleoplasm	"HPA007455: AB_1079410, HPA064814: AB_2685358"	"unprognostic (2.31e-1)"	"unprognostic (1.49e-2)"	"unprognostic (3.06e-1)"	"unprognostic (1.48e-2)"	"unprognostic (3.34e-1)"	"unprognostic (1.62e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.01e-1)"	"unprognostic (3.17e-1)"	"prognostic favorable (6.01e-4)"	"unprognostic (3.07e-1)"	"unprognostic (1.79e-1)"	"unprognostic (3.24e-2)"	"unprognostic (6.42e-2)"	"unprognostic (2.33e-2)"	"unprognostic (3.13e-1)"	"unprognostic (2.78e-1)"	26.5	32.4	27.9	12.6	28.8	20.0	26.0	31.0	37.6	23.2	27.9	27.5	25.6	23.5	13.7	24.6	22.2	10.1	48.2	28.3	31.7	33.7	51.2	18.6	13.4	29.8	28.9	24.5	27.1	29.6	29.5	13.3	30.1	22.0	16.8	10.9	22.6	17.6	75.1	25.1	20.3	12.0	27.4	19.9	23.6	19.7	29.0	17.7	26.7	56.7	14.4	22.6	21.4	28.9	47.9	43.1	20.3	39.3	28.4	20.7	38.9	20.4	24.8	47.3	41.3	109.0	15.4	61.8	42.3	24.6	36.2	49.9	50.5	48.7	27.8	30.4	90.9	46.8	34.9	109.5	57.2	43.5	21.0	27.6	51.4	52.5	82.8	22.6	32.6	68.7	84.6	36.6	23.6	84.0	48.1	127.1	22.7	175.7	49.5	59.0	25.1	77.3	38.2	26.3	51.3	27.4	18.2	39.4	73.4	18.6	41.4	73.9	27.3	27.6	40.0	35.7	58.7	47.7	44.9	115.2	21.5	65.2	27.8	17.5	37.8	30.2	28.4	40.9	36.5	46.5	31.8	33.6	54.3	48.6	32.7	32.3	9.8	38.5	33.7	56.1	39.2	31.3	27.9	28.8	31.0	37.6	28.3	31.7	29.8	28.9	30.1	27.4	29.0	28.9	36.8	22.4	18.6	5.5	27.5	24.3	32.0	86.5	19.4	22.7	25.9	30.0	37.5	38.6	48.9	60.7	27.1	74.0	21.3	43.1	185.9	59.1	94.0	30.6	34.1	32.1	30.6	35.3	5.3	53.7	53.1	31.1	30.1	32.5	28.5	43.1	33.2	75.9	49.3	5.0	5.8	44.2	69.2	23.7	26.6	37.0	55.0	22.9	53.4	2.8	41.3	44.7	43.3	2.0	5.5	44.2	51.3	51.6	35.6	31.6	77.6	159.4	40.4	23.4	26.3	32.5	82.7	53.1	41.7	35.7	27.1	63.5	27.2	59.0	65.7	28.7
PTK7	CCK4	ENSG00000112655	"Protein tyrosine kinase 7 (inactive)"	Q13308	6	43076307-43161719	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Cell adhesion, Wnt signaling pathway"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 317.3;Endometrial stromal cells: 84.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	10	"plasmacytoid DC: 13.5"	"Lineage enriched"	"Detected in many"	10	"dendritic cells: 13.5"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003222	Approved				"Secreted to blood"	NA	NA		12000000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 29: Early spermatids - Spermatogenesis"			"HPA003222: AB_1079713"	"unprognostic (1.80e-1)"	"unprognostic (7.49e-3)"	"unprognostic (6.22e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.15e-2)"	"unprognostic (5.85e-3)"	"unprognostic (9.81e-3)"	"unprognostic (1.47e-3)"	"unprognostic (7.15e-2)"	"unprognostic (5.11e-3)"	"unprognostic (8.17e-2)"	"unprognostic (3.37e-2)"	"unprognostic (1.73e-1)"	"unprognostic (3.61e-1)"	"unprognostic (9.12e-2)"	"unprognostic (5.70e-3)"	15.0	5.0	9.6	6.7	8.4	2.8	17.5	8.5	8.9	69.5	36.0	9.4	6.5	87.4	87.1	30.1	38.2	24.7	8.8	8.7	10.8	29.3	1.6	33.9	3.9	10.2	11.4	85.3	16.4	13.0	21.1	48.8	8.7	37.9	8.5	6.0	36.7	25.4	0.6	34.6	9.5	38.7	9.0	27.8	12.2	41.7	11.2	30.4	23.0	1.5	6.4	22.3	43.6	8.2	9.1	2.5	83.6	141.6	88.0	89.9	119.4	94.2	145.5	77.0	99.4	77.0	31.0	0.2	74.0	107.3	56.4	99.5	38.0	87.5	49.3	0.7	52.0	8.5	17.1	105.2	132.5	0.3	0.4	129.1	77.4	103.2	32.6	135.8	10.1	35.0	6.2	0.2	36.4	7.0	32.5	12.6	39.1	0.8	7.0	33.3	119.0	0.3	61.0	42.4	48.3	91.6	14.8	1.5	50.0	87.8	51.9	19.5	6.8	84.1	53.1	0.4	51.0	0.5	0.9	3.2	19.1	0.3	14.1	0.4	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.4	0.0	0.0	1.4	0.2	0.7	0.0	13.5	0.0	0.8	9.6	8.4	8.5	8.9	8.7	10.8	10.2	11.4	8.7	9.0	11.2	8.2	3.0	16.0	13.1	10.7	0.8	17.3	19.9	40.4	27.9	4.3	23.5	32.5	1.6	5.7	14.6	12.9	56.3	19.1	6.3	1.7	1.9	21.0	317.3	23.5	84.7	8.7	21.6	4.0	8.7	6.9	2.2	30.0	8.6	25.2	1.3	25.3	2.2	0.0	3.5	0.0	5.3	3.9	42.7	0.0	9.8	48.9	18.3	4.1	16.0	1.0	1.0	20.1	0.0	3.5	1.4	10.5	4.1	18.4	1.4	11.8	0.6	0.6	15.4	2.2	13.1	8.7	27.9	2.8	21.2	13.7	10.4	8.2	3.0	17.7	6.3	11.8
SRF	MCM1	ENSG00000112658	"Serum response factor"	P11831	6	43171269-43181506	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 89.6;Enteroendocrine cells: 102.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001819, CAB005416"	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 17: Intestinal endocrine cells - Hormone signaling"	Nucleoplasm		"CAB005416: AB_2255249, HPA001819: AB_1079928"	"unprognostic (1.44e-3)"	"unprognostic (1.09e-1)"	"unprognostic (5.39e-3)"	"unprognostic (2.66e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.47e-2)"	"unprognostic (4.60e-2)"	"unprognostic (9.84e-2)"	"unprognostic (4.28e-2)"	"unprognostic (2.21e-2)"	"unprognostic (6.72e-2)"	"unprognostic (1.78e-1)"	"prognostic unfavorable (2.01e-5)"	"unprognostic (5.31e-2)"	"unprognostic (1.59e-1)"	"unprognostic (5.10e-2)"	"unprognostic (1.97e-2)"	29.7	16.7	16.0	27.0	15.3	27.3	24.7	12.4	18.7	31.2	12.4	82.6	13.4	69.3	12.4	33.3	49.2	26.5	61.2	17.6	11.6	17.0	20.2	28.6	21.4	14.1	12.7	27.6	21.8	18.5	18.8	17.4	11.8	38.7	14.9	8.8	16.8	45.5	55.4	21.2	29.3	48.2	12.1	22.3	37.0	12.6	13.4	21.4	23.9	32.7	16.5	54.5	25.7	16.7	38.4	15.0	34.2	22.6	19.8	16.2	50.2	34.2	28.0	29.0	17.9	40.4	11.1	48.1	30.5	36.7	36.7	30.4	35.0	30.2	25.5	53.5	34.4	43.6	30.7	40.2	37.7	41.2	50.9	27.8	32.3	44.8	32.7	27.4	24.5	41.0	31.6	36.8	22.2	41.1	51.2	35.9	23.8	85.7	18.3	38.7	34.9	17.3	21.3	24.5	20.0	18.1	28.0	21.1	34.2	26.2	21.7	75.6	29.9	34.2	26.4	33.4	59.5	25.4	22.6	80.6	21.4	29.2	23.5	0.4	0.4	0.8	0.8	0.8	0.6	0.5	0.4	0.6	0.5	0.5	0.3	0.6	1.2	0.3	0.6	1.0	0.6	0.3	16.0	15.3	12.4	18.7	17.6	11.6	14.1	12.7	11.8	12.1	13.4	16.7	17.1	38.5	22.5	3.9	8.8	78.0	64.3	22.6	38.1	5.7	64.0	52.1	89.6	18.6	21.7	11.0	20.9	9.7	9.4	29.8	0.0	13.6	4.7	23.8	24.6	17.5	102.2	20.2	4.9	20.0	22.6	17.0	18.3	29.5	7.6	20.6	17.2	50.6	12.7	10.1	3.5	39.1	8.2	11.3	18.8	1.1	12.5	11.6	24.9	0.0	8.0	12.5	5.2	1.5	2.8	21.5	19.6	29.0	6.5	17.8	11.1	3.8	20.3	7.5	13.1	23.6	21.8	5.2	3.3	28.7	66.9	12.2	10.5	8.9	25.6	30.2
CUL9	"H7AP1, KIAA0708, PARC"	ENSG00000112659	"Cullin 9"	Q8IWT3	6	43182184-43224587	"Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	53	"Early spermatids: 513.7;Late spermatids: 1508.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016434, HPA052004"	Approved		Approved	Cytosol		No	No			"Cluster 39: Non-specific - mRNA processing"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 21: OE19 - Mitochondria"	"Cluster 25: Spermatids - Spermatogenesis"	Cytosol		"HPA016434: AB_1848125, HPA052004: AB_2681690"	"prognostic favorable (5.28e-4)"	"unprognostic (1.47e-2)"	"prognostic unfavorable (2.48e-4)"	"unprognostic (5.20e-3)"	"unprognostic (1.56e-1)"	"prognostic favorable (2.37e-5)"	"unprognostic (3.05e-3)"	"unprognostic (1.83e-2)"	"unprognostic (2.53e-2)"	"unprognostic (1.29e-1)"	"prognostic favorable (8.07e-4)"	"unprognostic (8.22e-3)"	"unprognostic (2.03e-1)"	"unprognostic (2.68e-1)"	"unprognostic (2.31e-1)"	"unprognostic (9.94e-2)"	"prognostic favorable (4.87e-4)"	2.9	3.0	3.1	4.9	4.5	6.9	2.9	1.3	3.4	3.2	3.5	3.6	4.0	3.3	1.7	5.5	4.9	3.6	2.6	3.2	2.0	3.1	2.1	3.6	6.3	2.4	2.8	4.3	4.2	5.5	2.9	2.4	2.7	3.4	2.3	3.2	3.9	4.0	2.8	8.0	4.2	2.8	1.5	4.9	4.2	5.2	2.5	7.6	5.2	2.9	4.7	3.8	2.7	2.7	8.2	6.0	3.2	7.7	8.8	5.2	4.4	3.2	5.6	5.0	4.6	1.9	3.4	6.8	6.0	5.1	4.5	5.8	2.7	6.7	2.3	8.3	2.5	7.4	6.8	3.0	5.8	4.7	11.6	7.1	13.8	4.1	3.7	4.4	7.4	11.5	3.9	8.7	4.5	7.2	9.6	6.8	0.6	15.7	3.6	13.9	2.2	6.6	3.8	8.4	5.5	7.8	4.2	5.0	7.2	2.7	8.6	10.4	6.9	12.5	8.6	3.7	6.1	8.3	8.3	5.5	3.2	8.2	5.7	0.0	0.2	0.0	0.2	0.1	0.2	0.1	0.1	0.5	0.2	0.1	0.1	0.2	0.0	0.0	0.0	0.1	0.4	0.2	3.1	4.5	1.3	3.4	3.2	2.0	2.4	2.8	2.7	1.5	2.5	2.7	6.6	0.0	8.2	16.3	7.5	6.4	2.7	9.3	16.5	10.2	8.0	6.1	6.9	8.6	5.9	3.7	12.5	3.4	6.5	8.8	3.9	4.2	513.7	7.5	5.5	6.8	6.0	3.4	15.8	6.2	1.7	5.3	18.8	6.4	2.5	14.6	9.3	6.4	11.6	11.8	11.9	7.9	6.1	9.6	5.0	1508.3	11.1	8.5	3.6	9.4	6.3	9.6	5.2	11.6	11.2	6.5	2.1	8.2	4.1	2.3	8.5	6.7	8.5	10.0	13.1	6.4	3.6	14.5	10.1	14.2	5.5	2.6	7.1	5.6	7.2	2.9
DNPH1	"C6orf108, dJ330M21.3, rcl"	ENSG00000112667	"2'-deoxynucleoside 5'-phosphate N-hydrolase 1"	O43598	6	43225629-43229481	"Predicted intracellular proteins"	"Nucleotide metabolism"	"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 450.0;Proximal enterocytes: 818.0;Proximal tubular cells: 1091.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"OE19: 547.1;RPMI-8226: 347.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029675, HPA029676"	Enhanced		Approved	Nucleoplasm,Cytosol		No	No		540000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm	Cytosol	"HPA029675: AB_10599998, HPA029676: AB_10599424"	"unprognostic (1.12e-2)"	"unprognostic (1.38e-1)"	"unprognostic (4.03e-3)"	"unprognostic (8.24e-3)"	"unprognostic (1.69e-1)"	"unprognostic (3.53e-2)"	"unprognostic (2.61e-1)"	"unprognostic (7.72e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.33e-3)"	"unprognostic (2.25e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.74e-1)"	"unprognostic (5.52e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.77e-2)"	"unprognostic (5.10e-2)"	46.1	103.3	42.7	29.1	45.1	23.2	37.2	40.2	66.2	45.2	66.7	68.7	104.0	50.2	8.3	62.3	57.8	13.2	46.5	41.7	45.7	172.4	136.8	31.8	33.0	39.9	42.5	40.3	100.7	75.8	37.2	9.2	41.5	42.0	17.9	6.0	45.8	18.7	89.5	42.2	88.3	11.4	43.2	61.6	57.5	10.2	46.1	17.0	35.8	44.7	18.8	39.1	39.8	42.3	189.4	135.3	20.7	86.2	14.4	44.5	64.1	44.9	16.1	29.8	38.9	55.8	67.2	134.9	69.4	15.3	1.5	95.1	16.2	35.7	8.6	72.4	318.7	63.7	127.4	161.2	34.1	54.3	40.3	28.1	44.3	9.0	26.7	12.0	39.6	96.8	147.1	232.0	24.5	311.8	52.3	135.3	41.5	547.1	81.5	87.0	27.7	347.3	52.1	63.6	79.8	96.2	41.4	108.5	95.7	6.6	149.2	177.9	49.7	22.6	39.2	51.6	90.2	160.7	79.6	109.5	14.3	71.6	36.0	1.2	109.7	4.8	42.4	237.9	78.5	219.8	138.8	74.6	178.2	194.6	122.2	83.8	4.1	42.0	176.6	135.3	269.7	92.3	42.7	45.1	40.2	66.2	41.7	45.7	39.9	42.5	41.5	43.2	46.1	42.3	16.4	28.9	38.2	5.5	73.9	61.3	91.3	147.6	68.3	11.9	138.4	181.0	91.0	163.0	80.9	115.8	2.1	53.4	12.9	164.0	450.0	201.6	0.6	159.5	66.4	30.8	64.8	78.8	4.1	107.2	66.5	60.1	88.7	39.1	33.7	108.4	28.5	231.2	308.3	6.7	4.9	216.6	93.6	75.8	62.3	3.1	67.1	63.4	110.3	1.0	36.7	78.4	10.3	5.5	5.1	157.2	155.3	59.8	81.8	112.6	818.0	1091.6	260.3	23.5	0.0	39.4	57.9	8.9	38.1	131.5	73.6	32.3	44.5	82.2	288.9	101.4
TTBK1	KIAA1855	ENSG00000146216	"Tau tubulin kinase 1"	Q5TCY1	6	43243481-43288258	"Enzymes, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 20.7;pituitary gland: 9.2"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 10.7;Bipolar cells: 6.6;Excitatory neurons: 12.1;Inhibitory neurons: 13.0;Oligodendrocyte precursor cells: 12.1;Oligodendrocytes: 12.4"	"Group enriched"	"Detected in some"	4	"glioma: 3.0;liver cancer: 0.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"SCLC-21H: 20.3;SH-SY5Y: 7.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031735, HPA031736"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol	Nucleoplasm	"HPA031735: AB_2674019, HPA031736: AB_10670294"	"unprognostic (1.68e-1)"	"unprognostic (7.88e-3)"	"unprognostic (7.01e-2)"	"unprognostic (1.62e-3)"	"unprognostic (2.18e-1)"	"unprognostic (2.24e-4)"	"unprognostic (2.46e-3)"	"unprognostic (3.01e-2)"	"unprognostic (3.09e-1)"	"unprognostic (1.85e-1)"	"unprognostic (3.01e-2)"	"unprognostic (2.12e-4)"	"unprognostic (7.42e-2)"	"unprognostic (3.68e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.64e-3)"	"unprognostic (3.04e-4)"	0.0	1.3	11.8	0.2	10.6	0.0	0.0	3.8	20.7	0.0	0.0	0.2	1.7	0.0	0.0	0.0	0.0	0.2	0.1	12.0	1.1	0.4	1.9	0.0	0.1	5.0	2.2	0.0	0.2	0.3	9.2	0.0	3.5	0.1	0.1	3.0	0.0	0.1	0.0	0.0	2.8	0.0	0.5	0.1	0.1	0.9	6.0	0.0	0.0	0.0	0.2	0.0	0.0	11.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	1.1	0.0	0.3	0.0	0.0	0.7	0.0	0.2	0.1	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.3	0.6	0.0	0.1	0.0	0.0	0.0	0.0	20.3	7.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	1.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.8	10.6	3.8	20.7	12.0	1.1	5.0	2.2	3.5	0.5	6.0	11.0	0.0	0.0	0.0	10.7	0.0	0.0	0.1	0.0	0.0	6.6	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.2	0.1	0.1	0.1	0.0	0.0	12.1	0.2	0.0	0.1	0.0	0.0	0.0	2.2	0.4	2.5	0.1	5.0	13.0	0.2	0.0	0.0	0.4	0.5	0.0	0.0	0.0	2.8	0.0	1.4	0.0	12.1	12.4	0.0	1.1	0.0	0.0	0.0	3.8	3.5	0.0	0.5	0.0	0.0	0.1	0.3	0.5	0.0	0.0	0.0	0.1	0.0	0.6	0.0
SLC22A7	"NLT, OAT2"	ENSG00000137204	"Solute carrier family 22 member 7"	Q9Y694	6	43295694-43305538	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"liver: 427.9"	"Group enriched"	"Detected in some"	17	"Hepatocytes: 254.5;Proximal tubular cells: 91.8"	"Cancer enriched"	"Detected in some"	37	"liver cancer: 81.5"	"Region enhanced"	"Detected in single"		"cerebellum: 1.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	20	"Hep G2: 9.9"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA030220	Approved					NA	NA				"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA030220: AB_10603027"	"unprognostic (9.17e-2)"			"unprognostic (9.73e-4)"	"unprognostic (2.13e-1)"		"prognostic favorable (5.48e-6)"			"unprognostic (1.45e-1)"	"unprognostic (1.54e-3)"	"unprognostic (1.74e-2)"	"prognostic favorable (8.98e-4)"	"unprognostic (1.29e-1)"	"unprognostic (1.07e-1)"			0.0	0.0	0.3	0.0	0.4	0.0	0.0	1.5	0.6	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	47.6	427.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.2	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.9	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.3	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	1.5	0.6	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.3	1.5	0.0	0.0	0.0	0.0	0.0	0.1	9.8	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	254.5	0.0	0.0	0.7	0.0	0.0	4.6	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	1.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	91.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0
CRIP3	"bA480N24.2, TLP, TLP-A"	ENSG00000146215	"Cysteine rich protein 3"	Q6Q6R5	6	43299710-43308826	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 24.3;testis: 25.7"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 9.4;Distal tubular cells: 9.8;Granulosa cells: 12.5;Late spermatids: 7.9;Oligodendrocyte precursor cells: 6.6"	"Cancer enhanced"	"Detected in some"		"liver cancer: 3.3"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	16	"myeloid DC: 44.6"	"Lineage enriched"	"Detected in many"	16	"dendritic cells: 44.6"	"Cell line enhanced"	"Detected in some"		"HAP1: 2.8;HEK 293: 3.3;HeLa: 3.5;Hep G2: 6.5;NTERA-2: 5.7;RPMI-8226: 4.6;THP-1: 2.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA036198	Uncertain		Approved	"Nuclear speckles"		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 43: Testis - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 40: Granulosa cells - Unknown function"	"Nuclear speckles"		"HPA036198: AB_10670791"	"unprognostic (8.35e-3)"	"unprognostic (4.14e-3)"	"unprognostic (6.37e-2)"	"unprognostic (5.34e-3)"	"unprognostic (1.71e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.30e-2)"	"unprognostic (4.34e-2)"	"unprognostic (1.46e-2)"	"unprognostic (8.49e-4)"	"unprognostic (1.86e-2)"	"unprognostic (7.30e-3)"	"unprognostic (5.02e-2)"	"unprognostic (4.89e-2)"	"unprognostic (4.46e-2)"	"unprognostic (2.80e-4)"	0.8	0.6	10.1	1.7	10.2	2.6	0.9	11.3	16.5	2.4	8.1	1.1	2.0	1.3	1.6	0.7	2.0	0.6	24.3	10.1	10.4	5.3	10.4	0.6	5.4	9.4	9.4	2.1	1.6	2.1	2.3	0.2	9.4	5.7	0.4	2.5	0.8	8.0	0.4	1.8	3.5	0.6	9.0	7.9	0.8	25.7	10.0	1.6	2.0	0.0	5.9	1.1	1.4	10.4	0.0	0.8	0.2	0.1	0.2	0.3	0.2	0.0	0.0	0.0	0.1	0.0	0.4	0.1	0.2	0.0	0.1	0.6	2.8	0.1	0.0	0.0	3.3	0.0	3.5	6.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	5.7	0.0	0.0	0.0	0.0	4.6	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.4	0.6	2.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.0	2.7	0.9	0.0	1.7	0.0	2.3	0.0	0.0	44.6	2.6	0.0	0.0	0.8	0.3	2.3	0.4	0.0	1.8	10.1	10.2	11.3	16.5	10.1	10.4	9.4	9.4	9.4	9.0	10.0	10.4	0.2	0.0	0.0	9.4	2.8	0.6	0.3	0.0	0.0	0.9	0.1	0.8	3.2	5.7	0.1	0.0	0.0	0.0	0.1	0.3	9.8	1.1	3.9	1.1	0.2	0.2	0.0	0.8	4.7	0.2	0.0	0.2	0.0	0.1	0.0	12.5	0.0	2.9	0.2	0.0	3.5	0.1	0.0	0.9	3.4	7.9	1.2	0.7	0.0	1.0	1.4	0.5	1.0	6.6	3.4	0.3	0.1	0.0	0.1	0.1	0.7	4.5	0.3	0.8	0.0	0.3	0.4	5.3	1.6	0.0	0.0	0.0	0.3	1.0	0.4	0.1
ZNF318	"HRIHFB2436, ZFP318"	ENSG00000171467	"Zinc finger protein 318"	Q5VUA4	6	43307134-43369647	"Predicted intracellular proteins"	"Meiosis, Transcription, Transcription regulation"	"Activator, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 82.9;Spermatogonia: 46.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"naive B-cell: 2.1"	"Lineage enriched"	"Detected in single"	4	"B-cells: 2.1"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027022, HPA027031"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 34: Non-specific - Transcription"	"Cluster 21: OE19 - Mitochondria"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA027022: AB_1859189, HPA027031: AB_1859190"	"unprognostic (1.64e-1)"	"unprognostic (3.80e-1)"	"unprognostic (1.13e-1)"	"unprognostic (4.11e-3)"	"unprognostic (1.97e-2)"	"unprognostic (3.02e-2)"	"unprognostic (2.53e-3)"	"unprognostic (1.93e-1)"	"unprognostic (1.80e-2)"	"unprognostic (3.37e-2)"	"unprognostic (8.24e-2)"	"unprognostic (3.47e-1)"	"unprognostic (4.61e-3)"	"unprognostic (3.61e-1)"	"unprognostic (3.00e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.54e-2)"	8.1	6.4	6.4	12.4	5.5	11.4	7.9	11.7	8.8	14.2	1.9	9.3	7.2	11.5	10.6	6.4	9.7	7.0	7.0	6.3	5.3	6.4	8.1	7.5	25.6	3.7	4.6	11.9	8.2	10.8	7.3	8.0	3.6	9.7	8.0	21.2	7.5	8.1	8.5	12.0	9.7	9.0	3.1	14.4	6.3	26.2	4.8	13.3	12.5	6.3	25.0	8.9	10.0	6.9	26.4	6.2	18.0	29.9	15.4	13.7	9.3	11.6	14.3	12.8	11.1	6.6	3.2	41.5	6.4	14.4	15.0	11.4	20.0	9.5	16.6	11.8	10.7	11.4	8.1	10.7	7.7	20.2	9.2	8.8	9.8	10.8	9.6	10.8	10.2	11.3	15.6	19.3	13.8	9.0	6.4	12.8	8.1	42.9	5.9	7.6	17.9	6.4	7.1	5.9	16.6	10.2	8.6	7.2	9.0	13.8	9.1	27.6	10.6	17.9	9.2	12.2	11.4	12.4	10.9	28.2	5.6	15.1	10.2	0.0	0.3	0.0	0.5	0.2	0.1	0.6	0.4	0.3	0.3	2.1	0.3	0.3	0.1	0.3	0.1	0.3	0.5	0.2	6.4	5.5	11.7	8.8	6.3	5.3	3.7	4.6	3.6	3.1	4.8	6.9	7.8	9.6	14.5	10.7	29.9	9.7	4.4	5.6	12.0	18.1	6.5	6.9	9.5	8.6	6.4	9.2	8.4	5.8	6.8	5.2	3.9	5.2	30.7	9.2	13.3	7.8	5.4	8.2	19.9	4.7	4.4	10.4	5.1	6.3	6.3	20.6	11.7	19.4	6.6	25.2	18.9	5.1	6.1	11.1	7.2	16.5	6.2	10.7	3.6	4.7	9.7	9.4	16.5	15.6	17.5	4.2	8.2	9.8	5.1	3.0	11.4	3.9	6.8	11.8	26.3	13.6	8.7	82.9	46.3	9.0	5.1	1.8	8.8	8.9	8.3	2.0
ABCC10	"EST182763, MRP7, SIMRP7"	ENSG00000124574	"ATP binding cassette subfamily C member 10"	Q5T3U5	6	43427366-43450427	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport	Translocase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA041607, HPA045464"	Approved					NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 35: Non-specific - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 52: Non-specific - Transcription"			"HPA041607: AB_2677579, HPA045464: AB_2679336"	"unprognostic (2.41e-1)"	"unprognostic (2.76e-1)"	"unprognostic (1.85e-2)"	"unprognostic (2.64e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.69e-2)"	"unprognostic (3.01e-3)"	"unprognostic (1.85e-2)"	"unprognostic (8.88e-2)"	"unprognostic (2.64e-1)"	"unprognostic (8.35e-2)"	"unprognostic (1.29e-1)"	"prognostic unfavorable (1.90e-4)"	"unprognostic (2.75e-1)"	"unprognostic (3.85e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.80e-2)"	9.2	17.7	18.0	8.2	17.9	7.5	8.9	19.6	24.2	14.4	16.6	12.7	9.4	13.2	8.3	16.3	11.8	6.8	12.4	17.5	17.0	15.5	10.1	10.8	8.7	17.0	17.0	17.6	19.5	5.0	19.6	7.7	17.3	17.3	7.6	4.5	12.7	7.6	7.8	11.0	13.0	8.6	15.7	15.5	13.5	9.2	17.6	8.3	12.8	3.4	7.4	16.2	13.8	17.3	13.3	6.7	8.7	19.9	18.8	12.0	9.0	13.7	9.6	10.1	8.6	14.9	5.6	2.8	15.9	16.7	7.9	16.5	5.8	10.6	7.2	17.1	11.7	9.5	8.4	29.8	11.5	13.2	13.7	20.9	13.9	13.5	7.4	10.0	13.8	8.9	11.3	14.9	12.1	13.1	7.8	20.3	5.6	32.1	8.0	3.9	2.3	9.8	11.7	21.6	12.1	9.8	8.1	11.5	10.2	7.6	11.3	12.8	14.4	12.4	4.2	11.6	16.6	13.3	6.2	6.9	5.8	9.4	5.9	5.0	1.9	2.2	2.9	0.6	1.3	1.0	2.2	2.6	1.1	0.9	1.2	1.8	0.7	1.3	1.5	0.8	2.8	1.8	18.0	17.9	19.6	24.2	17.5	17.0	17.0	17.0	17.3	15.7	17.6	17.3	4.6	3.2	5.6	15.7	5.6	1.1	5.9	6.7	10.2	9.3	3.2	3.8	2.5	4.3	3.4	0.0	10.4	7.1	6.6	5.4	1.9	4.5	1.3	4.9	5.5	5.1	7.8	1.7	16.0	3.3	6.0	4.1	15.3	4.9	6.3	11.8	6.1	2.0	6.9	11.8	14.9	3.6	4.1	4.1	3.3	0.8	7.5	5.2	3.6	9.4	3.4	2.1	13.4	13.6	11.1	4.7	6.1	6.0	7.1	2.1	5.4	3.4	9.9	5.6	0.0	3.3	3.7	2.2	4.5	4.7	1.8	4.4	7.9	14.4	5.4	2.8
DLK2	"EGFL9, MGC2487"	ENSG00000171462	"Delta like non-canonical Notch ligand 2"	Q6UY11	6	43450352-43456632	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 12.3;prostate: 12.9;skin 1: 12.7"	"Group enriched"	"Detected in many"	4	"Basal prostatic cells: 96.9;Basal respiratory cells: 56.8;Basal squamous epithelial cells: 64.3;Breast myoepithelial cells: 26.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HaCaT: 24.1;HBEC3-KT: 13.1;hTCEpi: 38.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA061223, HPA068672, HPA070955"	Uncertain		Approved	Nucleoplasm,Nucleoli,Vesicles		No	No			"Cluster 40: NK-cells - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoplasm	"Nucleoli, Vesicles"	"HPA061223: AB_2684454, HPA068672: AB_2686017, HPA070955: "	"unprognostic (4.65e-5)"	"unprognostic (1.27e-1)"	"unprognostic (1.69e-1)"	"unprognostic (9.68e-4)"	"unprognostic (2.87e-1)"	"unprognostic (3.80e-1)"	"unprognostic (4.19e-3)"	"unprognostic (1.65e-1)"	"unprognostic (2.65e-3)"	"unprognostic (4.04e-1)"	"unprognostic (1.88e-2)"	"unprognostic (1.88e-1)"	"unprognostic (9.27e-12)"	"unprognostic (7.71e-4)"	"unprognostic (8.92e-2)"	"unprognostic (1.55e-1)"	"unprognostic (6.43e-2)"	0.8	0.5	3.8	0.7	4.5	0.9	2.9	6.9	7.0	2.9	1.8	0.4	0.4	0.6	2.0	12.3	0.6	0.3	1.7	4.4	4.2	0.5	0.7	0.5	0.9	2.7	2.6	1.1	0.8	0.1	0.8	0.6	2.7	12.9	0.0	0.6	8.1	5.2	0.2	12.7	0.6	0.1	2.6	0.7	0.4	1.0	3.5	2.3	0.7	0.0	0.9	0.8	6.7	3.2	7.9	2.8	0.8	11.3	0.0	0.6	2.5	2.8	3.0	3.1	1.4	2.7	0.4	1.5	1.7	0.5	3.8	24.1	8.0	13.1	0.7	1.5	3.0	0.6	1.5	4.2	0.8	0.5	1.6	1.3	38.5	0.9	7.1	1.0	0.0	4.5	0.7	1.1	1.2	3.0	0.6	0.6	1.0	3.0	2.9	1.6	1.4	0.7	0.4	2.6	8.3	0.8	0.9	0.3	0.4	0.6	0.7	2.4	0.8	1.1	3.6	0.8	5.6	1.8	0.4	2.5	0.1	1.1	0.8	0.3	0.1	0.1	0.1	0.0	0.8	0.1	0.5	0.5	0.0	0.2	0.2	0.1	0.2	0.8	0.1	0.5	0.0	0.1	3.8	4.5	6.9	7.0	4.4	4.2	2.7	2.6	2.7	2.6	3.5	3.2	0.3	0.0	0.5	0.3	0.4	10.1	96.9	56.8	64.3	1.3	0.6	26.7	0.6	0.0	6.0	0.0	0.0	1.3	0.5	0.0	0.0	0.1	0.3	0.1	3.0	0.7	1.2	0.0	6.1	0.0	2.7	0.4	0.0	0.2	0.0	4.7	0.0	0.0	0.1	11.8	2.8	0.0	2.0	0.0	0.4	0.5	0.3	0.6	1.8	2.8	0.0	0.6	0.0	3.0	0.9	0.1	0.0	0.0	0.1	12.9	0.0	0.0	1.1	1.2	0.0	0.5	1.1	1.7	7.0	6.7	2.6	0.3	1.3	0.4	0.0	8.3
TJAP1	"PILT, TJP4"	ENSG00000137221	"Tight junction associated protein 1"	Q5JTD0	6	43477523-43506556	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	4	"Oligodendrocytes: 117.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030164, HPA030165, HPA030166"	Supported		Enhanced	"Golgi apparatus"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 35: Non-specific - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Golgi apparatus"		"HPA030164: AB_10599849, HPA030165: AB_2673350, HPA030166: AB_10601858"	"unprognostic (5.05e-3)"	"unprognostic (2.82e-2)"	"unprognostic (6.89e-3)"	"unprognostic (1.03e-3)"	"unprognostic (3.09e-2)"	"unprognostic (4.50e-3)"	"prognostic unfavorable (9.02e-6)"	"unprognostic (4.27e-2)"	"unprognostic (4.76e-2)"	"unprognostic (1.43e-1)"	"unprognostic (5.53e-3)"	"unprognostic (1.61e-3)"	"prognostic unfavorable (1.13e-4)"	"unprognostic (2.29e-1)"	"unprognostic (2.95e-1)"	"unprognostic (5.15e-3)"	"unprognostic (7.51e-3)"	24.4	32.1	25.5	17.3	36.6	18.5	24.4	28.2	32.8	31.8	23.5	30.1	20.3	31.1	10.1	16.7	28.8	13.4	24.8	26.3	29.3	21.8	25.9	21.7	20.6	34.0	33.3	37.2	33.2	13.2	24.5	14.9	31.2	31.3	9.2	11.3	24.0	14.5	44.1	19.7	25.9	15.1	25.7	32.2	26.0	20.3	35.1	17.1	30.4	16.7	14.9	28.7	23.5	49.4	40.6	15.7	27.1	40.7	21.5	20.1	30.0	25.1	26.8	26.2	28.4	23.8	17.2	22.4	18.6	23.3	25.0	35.0	22.9	30.0	16.8	38.7	35.2	28.5	30.8	26.3	25.8	29.2	39.6	23.0	39.7	32.6	28.6	20.7	17.4	28.6	24.9	41.2	23.5	22.5	28.7	48.3	23.7	69.0	23.9	34.2	17.8	24.0	16.3	22.1	17.8	24.7	21.4	13.0	33.5	16.7	23.2	56.7	15.3	34.9	26.9	29.3	37.9	30.0	26.9	40.0	15.3	33.1	30.2	13.6	7.1	5.7	7.1	8.2	9.2	6.3	5.8	6.2	5.4	6.7	6.5	7.2	4.0	5.5	7.5	5.7	3.5	7.1	25.5	36.6	28.2	32.8	26.3	29.3	34.0	33.3	31.2	25.7	35.1	49.4	10.9	12.8	10.3	12.1	10.3	7.5	14.7	9.3	13.6	11.1	9.9	13.0	7.7	10.0	6.3	12.9	29.2	21.3	7.3	7.2	3.9	10.0	1.4	7.3	10.6	10.5	11.4	7.8	11.6	8.4	18.6	10.6	8.6	9.8	14.7	21.9	8.2	8.3	9.8	8.4	9.4	8.5	14.2	7.7	8.7	2.2	10.5	9.1	5.4	14.0	8.3	10.0	6.2	19.6	117.1	9.5	7.2	12.8	10.2	14.9	7.9	6.2	5.9	15.2	6.6	9.5	10.0	14.1	14.8	4.9	3.7	18.7	9.8	10.6	7.0	9.0
LRRC73	"C6orf154, dJ337H4.2"	ENSG00000204052	"Leucine rich repeat containing 73"	Q5JTD7	6	43506969-43510686	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"testis: 44.2"	"Group enriched"	"Detected in many"	4	"Early spermatids: 411.0;Spermatocytes: 121.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 3.1;MCF7: 3.2;OE19: 4.5;T-47d: 3.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046698	Enhanced		Approved	Cytosol		NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 21: OE19 - Mitochondria"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Cytosol		"HPA046698: AB_10959526"	"unprognostic (3.23e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.13e-1)"	"unprognostic (4.42e-3)"	"unprognostic (1.04e-2)"	"unprognostic (3.52e-1)"	"unprognostic (6.08e-3)"	"unprognostic (1.19e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.24e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.72e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.76e-3)"	"unprognostic (1.89e-2)"	0.2	6.4	4.6	0.0	4.8	0.0	0.3	0.0	8.9	0.9	0.6	0.4	0.6	0.6	0.3	0.2	5.1	0.5	1.5	5.6	2.4	2.6	0.5	0.9	0.0	1.3	1.4	0.9	1.2	2.9	4.7	0.2	1.5	1.0	0.1	1.3	0.6	0.6	0.0	0.3	0.2	0.3	0.2	0.5	1.0	44.2	3.5	0.0	1.1	0.0	0.0	0.4	0.3	3.7	0.3	0.7	0.4	3.1	0.5	1.5	0.1	0.1	0.9	0.2	0.1	0.0	0.1	0.1	0.0	0.5	0.4	1.2	0.3	0.4	0.0	0.0	0.5	0.0	0.2	0.1	0.4	0.0	0.0	0.2	0.6	1.0	0.1	1.5	0.1	0.1	0.2	0.3	0.6	3.2	0.0	0.0	0.0	4.5	0.4	0.0	0.0	0.0	0.8	0.0	1.1	1.3	0.3	0.2	0.1	0.0	3.2	0.0	0.1	0.2	0.3	1.1	0.1	0.3	0.2	0.1	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	4.8	0.0	8.9	5.6	2.4	1.3	1.4	1.5	0.2	3.5	3.7	0.3	0.0	0.0	1.0	0.0	0.4	3.1	0.7	0.0	5.6	0.8	1.3	1.0	1.5	1.6	3.7	0.0	0.1	0.0	1.0	7.9	0.6	411.0	27.1	4.0	0.6	5.4	0.0	3.3	0.9	0.1	0.8	1.5	1.3	0.0	0.6	0.0	0.8	0.1	28.6	3.3	2.2	0.0	0.0	0.0	58.3	4.4	0.4	1.8	0.0	0.0	8.7	0.0	0.0	0.3	0.2	0.1	4.1	0.0	2.8	2.2	9.4	12.6	8.4	6.6	0.3	0.9	121.6	12.4	0.0	0.0	0.3	0.1	7.1	0.8	0.6
POLR1C	"AC40, RPA39, RPA40, RPA5, RPAC1, RPC40"	ENSG00000171453	"RNA polymerase I and III subunit C"	O15160	6	43509702-43562419	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, RNA polymerase related proteins"	Transcription		"Disease variant, Leukodystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"OE19: 306.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031010			Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Nucleoli fibrillar center"		"HPA031010: AB_10603131"	"unprognostic (2.84e-1)"	"unprognostic (1.67e-1)"	"unprognostic (3.15e-1)"	"unprognostic (6.57e-2)"	"unprognostic (7.01e-2)"	"unprognostic (3.59e-1)"	"unprognostic (6.69e-3)"	"unprognostic (1.09e-3)"	"unprognostic (2.00e-3)"	"unprognostic (1.90e-2)"	"unprognostic (2.05e-1)"	"unprognostic (7.32e-2)"	"prognostic unfavorable (4.17e-4)"	"unprognostic (1.20e-2)"	"unprognostic (4.69e-2)"	"unprognostic (3.01e-1)"	"unprognostic (6.41e-2)"	15.5	19.2	16.0	12.3	16.0	7.7	20.3	15.7	20.9	15.3	19.8	18.4	13.1	15.1	15.7	21.3	21.0	9.5	13.3	16.0	16.4	17.6	17.7	11.0	13.9	15.9	15.9	14.4	15.5	17.1	13.8	12.2	16.2	14.4	15.5	6.6	15.8	12.0	15.3	20.5	10.9	14.8	16.0	12.7	14.6	20.1	16.3	12.5	16.1	13.4	20.8	23.4	15.5	17.1	76.0	61.7	26.6	72.3	40.0	43.0	42.1	45.3	33.5	49.7	42.2	82.5	25.2	85.2	48.3	44.2	42.5	45.2	64.7	57.6	57.6	45.4	67.7	58.3	57.2	115.7	50.1	90.0	39.1	38.7	54.8	67.9	85.4	29.4	39.6	35.4	136.9	24.5	44.0	106.4	47.4	65.0	49.2	306.8	52.9	31.9	41.8	57.6	60.7	104.1	49.0	32.8	39.6	34.1	62.2	19.4	36.9	77.9	47.6	35.3	48.1	38.4	72.3	35.1	85.0	146.0	24.1	60.9	40.0	5.7	30.0	4.6	34.1	24.0	46.5	51.1	40.4	34.1	42.4	55.0	55.1	49.6	2.7	41.7	20.5	38.6	32.7	34.0	16.0	16.0	15.7	20.9	16.0	16.4	15.9	15.9	16.2	16.0	16.3	17.1	13.0	12.8	17.7	9.8	24.9	61.8	50.6	34.3	42.1	8.2	24.0	23.6	5.2	17.2	30.4	5.5	6.2	29.7	15.3	11.3	15.6	26.7	13.5	23.4	15.9	18.6	13.1	12.8	13.6	24.4	18.9	21.5	25.0	14.2	14.0	14.4	15.7	11.9	13.3	5.0	12.3	17.4	28.5	5.2	17.0	8.3	11.5	8.5	21.4	11.2	8.3	7.1	14.4	14.1	10.2	21.0	11.5	11.7	13.1	29.2	5.0	27.5	48.5	15.4	6.6	29.1	45.6	34.4	43.3	26.4	40.9	13.5	17.4	21.5	19.9	37.0
YIPF3	"C6orf109, dJ337H4.3, DKFZp566C243, FinGER3, KLIP1"	ENSG00000137207	"Yip1 domain family member 3"	Q9GZM5	6	43511832-43516985	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Differentiation			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"OE19: 494.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014859, HPA063699"	Supported		Enhanced	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 22: Non-specific - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 55: Plasma cells - Humoral immune response"	"Golgi apparatus"	Nucleoplasm	"HPA014859: AB_1845729, HPA063699: AB_2685095"	"unprognostic (2.82e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.29e-2)"	"unprognostic (4.71e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.05e-1)"	"unprognostic (2.15e-3)"	"unprognostic (3.77e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.70e-3)"	"unprognostic (1.70e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.94e-2)"	"unprognostic (3.55e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.10e-1)"	72.3	120.2	78.9	43.3	79.9	46.4	70.0	79.5	92.0	74.0	102.6	74.3	65.2	72.1	100.5	80.3	69.7	63.3	87.6	80.2	78.9	78.2	105.4	68.9	42.6	80.5	79.2	75.6	152.0	110.0	91.9	77.8	81.2	76.3	62.1	49.8	118.6	61.1	82.8	70.0	66.1	57.5	78.3	67.2	106.1	48.0	81.6	46.0	74.3	83.4	46.5	69.1	67.3	80.8	95.0	66.2	95.3	185.4	208.3	168.5	56.1	111.9	174.6	91.8	115.7	79.1	67.6	37.8	84.4	208.6	78.4	93.4	71.0	110.2	59.4	69.9	95.7	61.2	91.8	153.2	163.2	64.7	85.9	169.0	141.2	77.9	78.3	154.4	141.1	61.1	67.8	88.2	111.5	146.9	47.5	82.3	49.7	494.4	71.1	42.6	43.0	103.2	164.3	101.4	76.7	109.0	50.3	66.9	122.2	72.8	111.4	133.5	133.5	103.1	53.4	57.0	78.8	102.5	88.8	74.3	73.2	53.5	71.5	147.2	84.8	128.7	60.0	82.2	52.3	46.1	53.7	54.1	78.7	48.5	42.7	48.5	316.0	65.5	83.2	70.3	79.8	78.2	78.9	79.9	79.5	92.0	80.2	78.9	80.5	79.2	81.2	78.3	81.6	80.8	77.8	35.3	33.6	12.7	41.4	40.7	63.8	121.7	63.2	54.6	62.8	49.4	31.7	82.9	86.5	55.2	37.5	192.2	41.1	109.7	49.0	149.6	38.1	63.5	60.5	78.9	107.1	42.1	12.1	101.8	209.5	78.2	59.7	67.9	40.6	77.9	74.6	71.0	99.3	58.9	14.7	117.6	101.7	49.1	31.2	79.0	69.9	49.6	65.8	14.0	72.4	115.0	42.2	15.1	17.7	117.5	108.8	67.0	111.6	71.4	129.1	74.9	51.2	63.5	32.9	45.5	64.4	44.0	40.8	52.8	35.5	264.1	34.9	101.9	80.0	81.6
XPO5	KIAA1291	ENSG00000124571	"Exportin 5"	Q9HAV4	6	43522334-43576038	"Predicted intracellular proteins, Transporters"	"Host-virus interaction, Protein transport, RNA-mediated gene silencing, Transport"	"RNA-binding, tRNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012357, HPA018402, HPA023959, HPA029909"	Enhanced		Enhanced	Nucleoplasm		NA	NA		13000	"Cluster 27: Non-specific - Gene expression"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 21: OE19 - Mitochondria"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"CAB012357: , HPA018402: AB_1848330, HPA023959: AB_1848331, HPA029909: AB_10611245"	"unprognostic (6.98e-2)"	"unprognostic (4.34e-2)"	"unprognostic (5.13e-2)"	"prognostic unfavorable (4.94e-7)"	"unprognostic (6.16e-2)"	"unprognostic (2.43e-2)"	"prognostic unfavorable (3.98e-8)"	"unprognostic (4.78e-1)"	"unprognostic (4.72e-3)"	"unprognostic (1.72e-1)"	"unprognostic (4.86e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.45e-1)"	"unprognostic (9.48e-2)"	"unprognostic (5.66e-3)"	7.3	8.0	4.6	9.1	5.3	8.3	8.5	5.1	5.8	7.6	4.1	7.2	6.3	8.0	9.1	12.0	6.9	5.8	7.0	4.7	4.7	7.4	6.7	6.5	8.7	4.8	4.6	6.3	14.0	11.1	6.5	7.6	4.5	7.9	8.8	11.7	8.1	7.1	11.2	12.3	6.4	9.7	4.2	6.9	8.3	23.7	5.2	12.0	13.1	6.0	11.2	11.2	7.9	4.7	48.8	28.5	46.7	94.4	23.7	19.9	43.3	24.8	17.3	47.9	34.4	79.1	16.5	65.6	31.4	23.7	45.1	40.8	78.4	36.2	53.5	48.0	61.9	63.6	34.5	57.8	34.0	71.0	32.6	14.5	36.8	50.4	78.0	17.2	34.6	46.0	138.5	50.2	32.6	59.5	53.9	35.1	50.1	132.3	28.7	57.9	49.5	49.2	27.6	37.6	95.7	39.7	34.5	31.5	44.7	40.6	36.3	56.1	29.2	35.2	41.9	34.0	52.8	31.8	37.1	126.3	12.6	60.7	38.4	0.0	4.3	3.1	4.8	5.4	4.4	2.8	4.3	5.3	4.9	2.4	3.4	4.6	0.4	7.1	10.8	1.4	4.7	4.0	4.6	5.3	5.1	5.8	4.7	4.7	4.8	4.6	4.5	4.2	5.2	4.7	4.7	6.4	3.3	21.2	6.0	8.9	6.8	4.6	5.2	11.3	7.0	7.4	6.5	2.8	3.5	11.0	8.4	5.5	8.4	3.6	1.9	6.7	12.3	7.1	10.9	6.6	14.4	9.4	31.7	7.7	6.5	7.5	10.2	7.5	11.4	13.4	2.5	4.6	6.2	21.9	35.2	5.9	2.0	5.3	2.5	13.5	4.1	4.9	1.8	25.3	5.1	4.5	13.4	26.7	32.0	6.6	2.2	8.2	10.8	13.0	4.1	4.7	5.5	14.3	0.0	10.0	7.3	26.9	23.5	10.2	7.1	4.4	5.4	11.5	7.2	5.8
POLH	"RAD30A, XP-V"	ENSG00000170734	"DNA polymerase eta"	Q9Y253	6	43576185-43620523	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, DNA replication, DNA synthesis"	"DNA-binding, DNA-directed DNA polymerase, Mutator protein, Nucleotidyltransferase, Transferase"	"Disease variant, Xeroderma pigmentosum"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 25.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 91.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006721, HPA026762"	Approved		Enhanced	Nucleoplasm		NA	Yes			"Cluster 15: NK-cells - Transcription"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 57: B-cells - Immune response"	Nucleoplasm		"HPA006721: AB_1847785, HPA026762: AB_10601248"	"unprognostic (1.79e-1)"	"unprognostic (7.29e-2)"	"unprognostic (2.25e-1)"	"unprognostic (7.28e-2)"	"unprognostic (3.61e-1)"	"unprognostic (5.11e-3)"	"unprognostic (9.68e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.18e-1)"	"unprognostic (7.75e-2)"	"unprognostic (4.11e-3)"	"unprognostic (2.24e-1)"	"unprognostic (9.50e-2)"	"unprognostic (6.73e-2)"	"unprognostic (8.77e-2)"	"unprognostic (7.91e-2)"	"unprognostic (6.02e-2)"	5.0	3.8	2.3	6.9	2.7	4.2	4.8	5.1	2.9	5.9	5.3	7.0	4.6	4.2	3.6	5.5	5.5	4.3	3.7	2.2	2.2	4.7	5.6	5.7	12.9	2.7	2.2	4.7	5.4	3.7	3.2	4.0	2.7	4.7	7.2	7.4	4.0	3.8	8.5	8.5	4.4	6.3	1.8	5.6	4.6	10.6	2.5	12.9	6.8	4.7	14.2	4.8	4.3	3.6	46.7	9.7	13.5	19.9	17.6	29.1	33.0	48.6	13.9	26.2	29.2	12.0	7.9	48.9	12.0	17.6	7.6	11.4	13.1	28.6	31.5	25.9	10.0	15.3	31.6	35.5	13.4	26.8	19.2	19.5	33.4	21.5	11.3	10.6	24.3	14.5	24.0	29.6	33.0	15.0	23.9	6.4	4.2	33.2	7.2	25.1	14.3	11.8	9.9	34.6	15.1	5.4	14.5	12.9	7.3	15.4	17.9	10.8	36.2	23.6	24.4	12.2	25.2	28.0	21.3	91.1	11.8	14.5	27.3	4.1	1.7	2.7	4.2	1.6	3.8	5.0	3.5	3.1	1.3	4.9	2.8	3.0	1.7	4.2	1.6	2.6	4.6	2.0	2.3	2.7	5.1	2.9	2.2	2.2	2.7	2.2	2.7	1.8	2.5	3.6	3.1	12.8	8.2	12.1	15.1	4.7	3.2	4.8	19.4	6.3	3.4	3.3	2.3	5.7	6.5	3.7	10.4	2.4	5.2	6.3	5.9	2.1	11.4	10.2	4.8	2.8	5.4	5.7	14.8	0.9	2.8	5.3	8.2	9.0	0.0	6.1	1.4	2.4	1.7	0.0	15.3	2.2	4.1	2.2	2.2	7.3	3.4	3.0	1.8	6.5	3.2	2.6	2.1	10.1	13.4	1.9	4.5	3.0	12.7	2.2	3.1	2.3	5.4	9.4	0.0	7.0	5.0	25.9	6.7	13.0	3.0	1.9	8.8	5.6	3.0	2.3
GTPBP2		ENSG00000172432	"GTP binding protein 2"	Q9BX10	6	43605316-43629264	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 47.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 5.4"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 5.4"	"Cell line enhanced"	"Detected in all"		"hTERT-HME1: 181.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031418, HPA031419"	Approved		Approved	Vesicles		NA	Yes			"Cluster 34: Basophils - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 51: Myeloid cells - Hemostasis"	Vesicles		"HPA031418: AB_2673872, HPA031419: AB_10600709"	"unprognostic (1.35e-1)"	"unprognostic (1.01e-1)"	"unprognostic (8.94e-2)"	"unprognostic (1.08e-3)"	"unprognostic (2.56e-1)"	"unprognostic (1.37e-1)"	"prognostic unfavorable (1.08e-6)"	"unprognostic (4.71e-2)"	"unprognostic (2.58e-3)"	"unprognostic (6.47e-2)"	"unprognostic (8.31e-2)"	"unprognostic (6.15e-3)"	"prognostic unfavorable (1.44e-15)"	"unprognostic (1.13e-1)"	"unprognostic (3.36e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.89e-3)"	38.5	29.8	14.5	15.3	15.3	28.7	37.4	16.5	17.9	39.5	16.0	34.0	19.9	26.8	15.5	61.3	25.1	12.5	35.4	14.4	15.0	36.1	33.3	46.7	16.9	17.5	16.7	29.0	40.0	24.1	40.0	18.0	15.6	31.5	17.0	18.9	42.6	11.6	31.6	26.5	34.7	15.4	14.3	44.5	35.9	27.2	17.0	16.8	44.2	10.4	17.0	33.9	40.4	16.2	59.2	10.9	37.7	24.0	28.3	30.6	45.6	56.3	55.2	52.6	70.1	12.0	19.9	18.8	23.5	26.9	53.8	31.6	9.8	14.5	45.6	60.9	31.6	44.1	33.0	13.9	126.0	35.6	50.1	35.1	160.5	72.5	181.4	35.1	20.5	25.7	77.1	107.8	26.2	13.9	23.4	45.1	10.6	41.2	14.8	19.4	29.5	17.5	24.0	25.8	33.1	32.4	19.5	14.0	72.5	19.0	30.3	37.3	34.8	27.2	33.2	20.5	38.3	70.8	38.2	26.7	45.4	26.0	27.5	5.4	0.8	2.1	1.2	0.7	0.9	0.6	0.2	1.1	0.4	1.0	0.7	1.0	1.3	0.6	0.9	1.1	0.6	1.2	14.5	15.3	16.5	17.9	14.4	15.0	17.5	16.7	15.6	14.3	17.0	16.2	19.6	3.2	5.5	6.8	5.1	5.2	2.3	4.3	1.2	5.9	7.5	5.0	11.4	5.7	5.7	1.8	8.4	2.8	5.3	24.0	0.0	10.1	17.0	8.5	8.2	9.7	1.2	14.3	7.2	10.1	9.8	6.8	11.7	13.3	1.3	5.7	6.8	5.5	8.2	1.7	6.3	8.8	2.0	12.6	6.5	47.6	5.3	16.0	7.2	5.6	10.1	3.4	1.0	5.5	9.1	20.7	13.4	4.1	2.4	5.8	6.8	1.8	4.1	9.2	13.1	5.3	7.8	7.1	8.1	4.4	5.3	2.5	3.8	4.7	6.0	12.6
MAD2L1BP	"CMT2, dJ261G23.1, KIAA0110"	ENSG00000124688	"MAD2L1 binding protein"	Q15013	6	43629540-43640941	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"OE19: 221.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028729			Supported	"Nucleoplasm,Nuclear membrane,Nucleoli"		Yes	No			"Cluster 44: Non-specific - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 21: OE19 - Mitochondria"	"Cluster 51: Myeloid cells - Hemostasis"	Nucleoplasm	"Nuclear membrane, Nucleoli"	"HPA028729: AB_2672752"	"unprognostic (2.60e-1)"	"unprognostic (2.06e-1)"	"unprognostic (3.92e-2)"	"unprognostic (6.97e-2)"	"unprognostic (6.91e-2)"	"unprognostic (6.92e-2)"	"unprognostic (5.74e-3)"	"unprognostic (2.67e-3)"	"unprognostic (3.60e-1)"	"unprognostic (7.18e-2)"	"unprognostic (1.71e-1)"	"unprognostic (6.64e-2)"	"unprognostic (4.61e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.34e-1)"	"unprognostic (1.16e-1)"	"unprognostic (3.25e-3)"	13.3	16.2	13.6	14.1	13.8	53.5	17.3	14.1	15.8	14.6	15.4	25.9	23.6	12.4	17.3	17.6	16.7	14.4	25.4	14.3	14.9	17.5	21.9	14.9	21.7	13.8	13.2	13.0	16.7	21.1	12.6	14.0	14.2	14.4	27.7	15.2	22.8	13.5	28.5	13.2	18.8	14.5	13.6	17.4	19.3	20.4	14.3	29.3	15.6	44.6	26.6	21.4	10.6	13.8	53.9	24.4	37.7	42.2	32.1	34.7	22.7	31.7	50.9	68.5	63.8	50.3	21.4	41.6	17.6	37.3	62.2	34.4	59.2	43.9	52.6	38.5	46.0	51.5	26.1	43.8	34.6	30.6	29.9	35.3	53.0	51.1	31.0	34.5	52.2	32.8	67.2	21.8	48.4	50.6	27.4	56.5	23.3	221.1	31.3	31.3	29.3	39.4	48.9	42.5	44.7	45.3	22.8	34.5	152.2	28.6	40.6	80.3	28.7	36.5	30.7	24.4	51.3	27.7	25.8	99.0	33.2	51.3	41.0	105.4	41.4	49.4	46.3	42.8	46.5	52.6	54.7	51.4	52.7	47.9	56.5	51.2	35.2	55.6	41.3	34.9	78.9	43.6	13.6	13.8	14.1	15.8	14.3	14.9	13.8	13.2	14.2	13.6	14.3	13.8	11.6	25.6	12.7	3.3	18.2	14.4	20.5	44.9	17.6	12.8	11.6	9.3	10.8	15.7	32.5	3.7	12.5	21.1	11.1	30.7	27.4	28.0	47.0	13.2	8.6	12.5	17.4	20.6	3.0	21.2	21.5	12.0	14.3	10.8	31.6	7.8	11.4	12.7	17.6	10.1	3.2	17.1	32.6	10.4	8.6	36.5	12.2	19.6	28.4	1.9	17.3	13.9	11.3	3.0	5.0	24.7	29.5	12.0	11.1	11.5	28.2	21.2	21.1	15.1	26.3	8.3	13.4	26.4	18.3	12.6	9.7	6.2	14.8	11.9	23.4	27.2
RSPH9	"C6orf206, CILD12, FLJ30845, MRPS18AL1"	ENSG00000172426	"Radial spoke head component 9"	Q9H1X1	6	43645036-43672600	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"		"Ciliopathy, Disease variant, Kartagener syndrome, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"fallopian tube: 8.3;testis: 15.2"	"Group enriched"	"Detected in many"	4	"Early spermatids: 195.6;Endometrial ciliated cells: 96.3;Respiratory ciliated cells: 327.5;Spermatocytes: 89.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"U-87 MG: 2.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031703	Enhanced					NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 49: Ciliated cells - Cilium organization"			"HPA031703: AB_10602126"	"unprognostic (2.54e-2)"	"unprognostic (1.85e-3)"	"unprognostic (3.57e-3)"	"unprognostic (4.06e-2)"	"unprognostic (7.28e-2)"	"unprognostic (6.62e-2)"	"unprognostic (1.81e-3)"	"unprognostic (2.78e-3)"	"unprognostic (6.42e-2)"	"unprognostic (7.27e-2)"	"unprognostic (6.89e-3)"	"unprognostic (1.33e-1)"	"unprognostic (2.62e-4)"	"unprognostic (1.48e-1)"	"unprognostic (2.42e-2)"	"unprognostic (1.16e-2)"	"unprognostic (3.73e-2)"	0.6	0.7	1.0	0.3	0.9	0.6	0.6	1.9	1.0	1.5	3.8	0.7	0.2	1.3	0.2	0.6	8.3	0.3	0.7	0.8	1.6	0.8	0.5	2.1	0.2	1.7	2.1	0.7	0.4	0.2	3.3	0.4	0.9	1.1	0.1	1.0	0.5	0.3	0.6	0.5	0.5	0.4	0.8	0.7	0.8	15.2	1.9	0.1	0.5	0.1	0.1	0.7	0.8	0.5	0.3	0.1	0.5	0.5	0.1	1.6	0.5	0.7	0.2	0.0	0.0	0.8	0.1	0.1	0.2	0.3	0.3	0.3	0.1	0.0	0.0	0.2	0.4	0.4	0.2	0.2	1.3	0.5	0.2	0.5	0.0	0.5	0.0	0.2	0.1	0.3	0.5	0.5	0.0	0.4	0.3	0.6	0.2	1.7	0.4	0.2	0.4	0.4	0.0	0.5	0.6	0.8	0.0	0.4	0.5	0.6	0.2	0.5	0.2	0.3	0.3	0.3	0.2	0.6	1.0	0.5	2.0	0.4	0.6	0.1	0.6	0.3	0.6	0.2	0.5	0.7	0.4	0.3	0.5	1.5	0.5	0.4	1.0	0.6	0.1	0.3	0.5	0.8	1.0	0.9	1.9	1.0	0.8	1.6	1.7	2.1	0.9	0.8	1.9	0.5	0.4	0.0	4.8	0.3	0.4	0.5	0.6	24.0	0.0	0.4	0.3	2.7	1.0	2.8	28.9	0.0	2.1	0.5	0.0	0.3	0.0	0.6	195.6	96.3	2.3	1.9	1.2	0.0	1.4	0.0	3.0	3.4	0.0	1.5	3.8	0.6	0.4	0.2	0.6	1.7	1.5	0.2	38.7	0.3	0.3	26.4	2.8	4.2	7.2	1.0	1.2	6.4	0.0	0.5	0.5	0.4	0.1	1.5	0.0	0.4	0.4	0.3	327.5	1.7	0.0	1.8	8.4	89.9	2.3	0.0	0.3	0.5	0.4	1.1	0.3	0.1
MRPS18A	"FLJ10548, MRPS18-3"	ENSG00000096080	"Mitochondrial ribosomal protein S18A"	Q9NVS2	6	43671202-43687791	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"OE19: 370.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035450, HPA035451"	Approved					NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 59: Non-specific - Translation"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA035450: AB_10670701, HPA035451: AB_10602029"	"unprognostic (9.85e-2)"	"unprognostic (3.08e-1)"	"unprognostic (2.04e-1)"	"unprognostic (7.35e-3)"	"unprognostic (2.00e-1)"	"unprognostic (1.15e-2)"	"unprognostic (4.81e-2)"	"unprognostic (1.25e-1)"	"unprognostic (5.16e-2)"	"unprognostic (1.41e-2)"	"unprognostic (3.86e-2)"	"unprognostic (9.15e-2)"	"unprognostic (2.14e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.96e-1)"	"prognostic favorable (4.03e-5)"	"unprognostic (9.35e-2)"	34.5	44.1	37.0	21.0	37.9	21.5	33.3	37.8	43.4	31.5	53.8	42.6	36.3	32.4	20.9	58.3	30.1	20.4	66.7	39.2	37.7	46.9	63.3	25.6	22.7	38.8	38.1	21.9	32.3	39.1	19.5	22.7	37.7	39.5	45.4	15.0	35.1	26.8	149.4	41.7	31.3	27.1	38.2	32.1	56.1	17.5	39.4	26.4	28.4	103.4	33.1	34.8	33.9	38.1	71.0	57.7	45.2	63.9	45.2	30.4	51.4	32.9	50.2	78.6	77.3	118.7	28.4	29.6	55.4	46.0	64.1	56.6	64.3	92.5	40.9	45.6	76.5	55.7	44.3	104.5	78.1	76.1	32.4	41.4	73.5	66.6	100.6	40.2	59.9	73.0	97.9	61.4	47.0	115.2	58.3	63.4	33.6	370.3	46.2	48.8	35.9	95.9	59.1	79.9	72.5	38.9	34.7	64.5	121.8	32.1	65.5	106.7	32.6	49.4	56.4	40.2	60.2	67.1	60.2	110.3	66.2	52.8	134.8	106.6	69.8	76.8	79.1	60.9	74.8	135.4	73.6	76.0	82.3	98.3	73.0	67.9	32.5	93.3	45.2	91.2	86.9	84.1	37.0	37.9	37.8	43.4	39.2	37.7	38.8	38.1	37.7	38.2	39.4	38.1	27.1	32.1	24.5	5.2	31.8	33.4	44.6	97.7	12.0	13.6	29.1	26.4	1.3	30.0	61.2	33.1	2.1	72.7	15.6	96.0	99.7	78.2	16.5	26.2	26.2	25.3	32.3	23.5	5.1	67.4	64.0	24.6	56.6	43.7	26.6	28.8	30.4	51.8	51.1	8.4	4.5	73.4	73.2	17.5	19.8	35.2	22.7	16.5	40.9	7.5	51.7	23.4	29.9	9.0	5.2	69.3	94.2	21.1	42.9	45.0	73.4	115.4	34.7	15.5	32.9	24.7	25.8	27.3	36.2	31.0	27.3	67.5	19.5	61.7	97.2	77.9
VEGFA	"VEGF, VEGF-A, VPF"	ENSG00000112715	"Vascular endothelial growth factor A"	P15692	6	43770184-43786487	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins"	"Angiogenesis, Differentiation"	"Developmental protein, Growth factor, Heparin-binding, Mitogen"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 349.4;Muller glia cells: 265.8"	"Cancer enhanced"	"Detected in all"		"renal cancer: 79.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in all"		"hTERT-RPE1: 398.9;U-87 MG: 628.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005429, CAB039240, HPA069116, CAB069907"	Supported				"Secreted to blood"	NA	NA	562000	57000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 41: Macrophages - Immune response"			"CAB005429: AB_2212984, CAB039240: , CAB069907: AB_10001947, HPA069116: AB_2686089"	"unprognostic (1.12e-1)"	"prognostic unfavorable (4.50e-4)"	"unprognostic (2.42e-2)"	"prognostic unfavorable (2.10e-4)"	"unprognostic (4.35e-2)"	"unprognostic (1.49e-1)"	"prognostic unfavorable (2.34e-5)"	"unprognostic (5.10e-2)"	"unprognostic (5.27e-3)"	"unprognostic (2.30e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.00e-2)"	"prognostic unfavorable (1.76e-5)"	"unprognostic (2.20e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.43e-1)"	"prognostic favorable (2.73e-4)"	155.8	52.7	17.6	36.5	20.3	45.5	92.4	34.2	28.2	45.2	46.8	32.6	50.9	104.0	10.5	61.3	40.9	80.1	208.3	22.8	25.1	116.9	217.3	94.1	9.3	27.0	38.5	25.0	68.1	105.0	22.3	46.2	26.8	120.3	21.4	229.1	32.1	17.8	221.2	44.2	44.6	57.1	19.6	70.1	63.9	5.3	32.0	5.6	270.9	150.9	9.5	122.3	61.7	24.9	76.5	13.4	12.5	71.8	21.0	32.9	84.2	45.6	81.1	29.7	58.4	43.1	9.9	24.9	35.5	27.7	305.4	30.6	34.0	92.0	52.0	27.4	10.4	19.0	17.8	29.2	220.3	20.8	40.4	58.0	178.6	290.6	286.2	398.9	7.7	21.0	35.7	121.7	109.4	31.3	2.3	28.3	7.9	221.2	19.2	2.3	12.0	60.5	114.8	62.9	22.3	46.8	65.6	44.4	162.0	16.1	17.3	75.1	10.4	122.6	32.9	179.2	76.1	68.8	43.6	49.1	628.6	47.9	43.8	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.6	20.3	34.2	28.2	22.8	25.1	27.0	38.5	26.8	19.6	32.0	24.9	63.6	349.4	84.7	121.5	9.8	70.5	51.2	76.8	60.3	37.8	67.0	57.1	164.7	77.2	85.7	22.0	31.3	1.3	11.6	92.9	1.9	54.7	0.0	38.4	59.1	29.0	27.4	21.3	12.1	40.8	6.3	69.7	124.4	121.2	112.0	111.7	17.5	116.0	13.9	180.0	17.0	71.8	12.2	16.2	199.0	0.3	1.8	144.1	28.4	10.3	11.3	265.8	0.0	124.1	1.8	86.0	47.1	3.4	15.9	119.4	61.9	20.5	11.4	43.9	0.0	42.1	79.1	1.1	1.9	82.0	78.3	7.9	11.4	17.4	51.0	137.5
MRPL14	"MRP-L32, RPML32"	ENSG00000180992	"Mitochondrial ribosomal protein L14"	Q6P1L8	6	44113451-44127452	"Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 182.1"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"OE19: 622.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038769, HPA076790"	Uncertain		Supported	Mitochondria		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 21: OE19 - Mitochondria"	"Cluster 10: Non-specific - Unknown function"	Mitochondria		"HPA038769: AB_10673288, HPA076790: AB_2686815"	"unprognostic (4.58e-1)"	"unprognostic (8.39e-2)"	"unprognostic (1.84e-1)"	"unprognostic (7.25e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.19e-2)"	"unprognostic (3.21e-2)"	"unprognostic (7.20e-2)"	"prognostic favorable (4.81e-4)"	"unprognostic (1.74e-2)"	"unprognostic (3.75e-1)"	"prognostic unfavorable (7.46e-5)"	"unprognostic (7.13e-2)"	"unprognostic (1.65e-1)"	"prognostic favorable (1.08e-4)"	"unprognostic (3.27e-2)"	26.5	41.0	25.7	22.4	26.1	20.7	25.0	25.2	28.5	23.7	24.7	38.0	36.1	29.4	25.5	41.9	22.9	16.2	48.8	25.8	25.3	34.7	80.3	57.8	26.0	25.5	24.7	16.2	24.9	20.6	23.2	26.3	25.5	25.0	34.8	23.6	30.0	19.2	182.1	43.4	29.5	27.7	25.8	26.0	30.1	51.4	26.2	35.3	24.3	109.4	28.6	35.9	27.6	26.5	216.0	90.2	62.5	87.1	53.0	51.4	79.6	78.5	77.8	102.6	101.6	189.1	73.8	93.1	86.7	67.4	98.2	85.9	71.2	127.9	80.8	111.2	193.8	96.1	77.2	235.1	65.3	92.1	64.8	48.2	68.5	96.7	57.1	78.7	85.9	78.8	205.9	58.3	91.7	216.3	111.4	144.6	54.8	622.6	85.8	78.8	70.2	126.7	170.8	104.9	138.8	54.2	50.4	97.5	101.7	53.9	89.5	93.1	69.1	90.4	135.6	65.6	137.9	71.9	68.3	221.8	102.3	90.5	67.4	45.3	115.6	26.3	79.0	113.7	95.1	111.9	100.3	90.5	108.3	105.3	79.2	81.1	6.7	171.4	78.4	122.2	76.1	107.1	25.7	26.1	25.2	28.5	25.8	25.3	25.5	24.7	25.5	25.8	26.2	26.5	48.2	375.0	250.0	3.6	64.5	231.1	200.5	362.7	65.4	29.8	126.6	146.3	136.9	112.9	217.2	57.0	31.3	179.5	51.1	257.9	203.5	205.3	293.1	94.9	66.0	82.0	93.4	78.4	5.0	220.2	206.2	76.4	82.0	101.5	44.4	83.4	50.3	341.2	279.8	33.7	5.3	158.3	219.7	52.0	164.6	122.9	74.6	66.1	69.4	3.7	152.9	66.0	85.5	4.5	7.3	333.0	278.5	53.4	73.7	376.8	203.7	258.7	157.5	70.0	46.0	63.3	149.4	199.2	122.3	116.6	281.3	160.1	56.3	100.5	199.5	376.3
TMEM63B	"C6orf110, dJ421H19.2, DKFZp434P0531"	ENSG00000137216	"Transmembrane protein 63B"	Q5T3F8	6	44126914-44155519	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 87.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in all"		"OE19: 163.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029249, HPA029250, HPA029251"	Uncertain		Enhanced	"Plasma membrane,Actin filaments"		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 34: Spermatids - Unknown function"	"Plasma membrane, Actin filaments"		"HPA029249: AB_2672965, HPA029250: AB_2672966, HPA029251: AB_2672967"	"unprognostic (8.83e-3)"	"unprognostic (2.16e-2)"	"unprognostic (2.42e-3)"	"unprognostic (3.61e-1)"	"unprognostic (2.89e-1)"	"unprognostic (1.85e-1)"	"unprognostic (6.97e-3)"	"unprognostic (1.25e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.75e-1)"	"unprognostic (8.60e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.67e-2)"	"unprognostic (6.12e-3)"	"unprognostic (3.15e-1)"	12.4	19.6	18.1	9.5	18.9	17.9	12.6	18.9	24.7	17.8	15.1	24.6	17.1	11.4	12.1	34.6	10.7	12.8	26.5	25.1	21.0	17.1	39.2	38.3	5.8	19.9	17.5	12.1	12.6	20.2	15.6	13.6	20.4	17.4	19.4	31.6	20.9	8.6	51.6	41.4	18.5	9.9	15.7	9.8	25.4	31.0	19.8	8.6	16.2	21.2	8.6	18.8	23.2	18.3	41.7	23.1	21.1	34.6	32.3	18.6	34.6	17.0	22.8	18.7	17.7	16.1	15.7	7.2	25.5	25.3	30.1	37.8	25.6	62.6	12.3	20.6	19.5	20.8	17.2	49.1	22.2	4.6	19.2	24.8	55.5	26.2	16.7	37.8	18.9	15.3	67.7	11.2	22.0	42.7	4.6	10.3	11.4	163.7	11.2	5.8	14.0	13.2	52.2	44.5	24.3	18.8	15.2	35.5	35.8	26.0	40.1	11.6	21.8	23.8	27.0	17.9	20.7	14.0	11.1	8.8	35.9	6.6	30.7	0.2	0.4	0.2	0.2	0.1	0.4	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.3	0.0	0.2	0.2	0.4	0.2	18.1	18.9	18.9	24.7	25.1	21.0	19.9	17.5	20.4	15.7	19.8	18.3	7.2	16.0	19.7	17.6	3.3	13.6	14.9	41.3	21.1	18.4	11.2	9.3	3.8	10.0	25.1	11.0	16.7	14.1	4.2	75.1	1.9	17.0	72.9	10.6	8.9	6.9	18.6	28.4	26.3	15.2	16.6	11.0	45.9	25.1	0.0	11.0	11.7	43.4	26.4	16.8	28.4	32.4	30.5	11.7	11.4	87.6	11.8	9.1	7.2	15.0	8.5	9.4	5.2	21.6	12.1	32.5	45.7	9.1	6.4	21.9	32.7	10.8	15.7	27.6	6.6	10.4	12.0	2.1	14.7	19.4	18.3	20.0	5.5	7.1	24.3	29.4
CAPN11		ENSG00000137225	"Calpain 11"	Q9UMQ6	6	44158811-44184401	"Enzymes, Predicted intracellular proteins"		"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	13	"testis: 30.3"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 14.0;Breast myoepithelial cells: 11.8;Early spermatids: 24.7;Late spermatids: 9.8;Spermatocytes: 50.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"NTERA-2: 2.2;TIME: 5.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB018070, HPA030955"	Enhanced					NA	NA				"Cluster 83: Testis - Spermatogenesis"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 66: Spermatocytes - Spermatogenesis"			"CAB018070: AB_2069481, HPA030955: AB_2673672"	"unprognostic (2.20e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.64e-2)"	"unprognostic (2.75e-1)"	"unprognostic (6.22e-2)"	"unprognostic (3.34e-2)"	"unprognostic (3.99e-2)"	"unprognostic (4.57e-2)"	"unprognostic (1.29e-1)"	"unprognostic (8.96e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.13e-1)"	"unprognostic (3.62e-6)"	"unprognostic (2.38e-2)"	"unprognostic (3.51e-1)"	"unprognostic (2.27e-2)"	"unprognostic (8.89e-2)"	1.6	0.4	0.2	0.3	0.2	0.5	2.3	0.4	0.5	0.8	0.1	0.2	0.0	0.3	0.5	0.2	0.3	0.3	0.3	0.3	0.3	0.2	0.1	0.2	0.4	0.2	0.1	0.0	0.1	0.1	0.0	0.5	0.2	0.3	0.1	0.1	0.4	0.0	0.1	0.8	0.4	0.3	0.1	0.1	0.2	30.3	0.3	2.2	0.3	0.2	0.3	0.4	0.5	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.0	0.2	0.2	0.0	0.0	0.0	0.1	2.2	0.0	0.0	0.3	0.1	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.1	5.8	0.2	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.2	0.2	0.4	0.5	0.3	0.3	0.2	0.1	0.2	0.1	0.3	0.5	14.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.5	11.8	0.5	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	24.7	0.0	0.0	3.9	0.0	2.7	0.5	0.0	0.0	0.7	0.0	0.2	0.0	0.1	1.1	0.0	1.3	0.0	0.3	0.1	0.0	0.3	0.3	9.8	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.7	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.2	50.0	0.9	0.1	0.0	0.0	0.1	0.1	0.1	0.1
MYMX	MINION	ENSG00000262179	"Myomixer, myoblast fusion factor"	A0A1B0GTQ4	6	44216926-44218234	"Predicted intracellular proteins"	Myogenesis			"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Group enriched"	"Detected in some"	5	"adipose tissue: 7.7;breast: 6.9;pancreas: 5.6;stomach 1: 2.3"	"Group enriched"	"Detected in some"	4	"Adipocytes: 5.5;Distal tubular cells: 3.9;Exocrine glandular cells: 2.2;Extravillous trophoblasts: 1.6"	"Cancer enhanced"	"Detected in some"		"testis cancer: 2.5"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	106	"plasmacytoid DC: 10.6"	"Lineage enriched"	"Detected in single"	106	"dendritic cells: 10.6"	"Cell line enriched"	"Detected in some"	31	"RH-30: 134.6"	"Not detected"	"Not detected"							HPA051451	Supported		Approved	Vesicles,Mitochondria,Cytosol		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Vesicles	"Mitochondria, Cytosol"	"HPA051451: "	"unprognostic (1.24e-1)"	"unprognostic (8.55e-2)"	"unprognostic (6.86e-2)"	"unprognostic (6.51e-3)"	"unprognostic (2.78e-1)"	"unprognostic (1.26e-1)"	"unprognostic (5.27e-2)"	"unprognostic (2.10e-3)"	"unprognostic (4.32e-1)"	"unprognostic (1.77e-1)"	"unprognostic (8.71e-2)"	"unprognostic (2.70e-2)"	"unprognostic (2.01e-4)"	"unprognostic (1.63e-2)"	"unprognostic (1.33e-2)"	"unprognostic (1.77e-2)"	"unprognostic (2.67e-1)"	7.7	0.1	0.0	0.2	0.0	0.0	6.9	0.1	0.1	0.2	0.0	0.3	0.0	0.1	0.2	0.2	0.1	0.5	1.0	0.0	0.0	0.7	0.1	0.4	0.6	0.1	0.0	0.1	5.6	0.0	0.0	0.0	0.1	0.1	0.1	0.0	1.1	0.0	0.4	0.9	0.5	0.1	0.0	0.8	2.3	0.4	0.0	0.8	0.4	0.2	0.3	0.5	0.2	0.1	0.0	0.0	0.2	0.0	0.1	0.0	4.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	3.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.6	0.0	0.0	0.0	1.0	0.0	0.0	0.0	134.6	0.0	0.2	0.0	0.2	0.0	0.1	0.0	0.0	1.7	0.2	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.6	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.9	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	2.2	1.6	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0
SLC29A1	ENT1	ENSG00000112759	"Solute carrier family 29 member 1 (Augustine blood group)"	Q99808	6	44219553-44234142	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 216.6;Extravillous trophoblasts: 224.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	26	"eosinophil: 1046.6"	"Lineage enriched"	"Detected in all"	26	"granulocytes: 1046.6"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012384	Approved					NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 38: Heart - Muscle contraction"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 38: Extravillous trophoblasts - Unknown function"			"HPA012384: AB_1857073"	"unprognostic (1.82e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.49e-3)"	"unprognostic (2.76e-1)"	"unprognostic (5.13e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.76e-1)"	"prognostic unfavorable (2.96e-4)"	"unprognostic (1.38e-2)"	"unprognostic (4.60e-2)"	"unprognostic (9.02e-2)"	"unprognostic (1.34e-1)"	76.4	95.8	10.2	22.3	10.2	53.4	50.4	13.0	14.8	25.4	4.5	59.7	13.1	37.3	15.9	25.3	34.5	44.2	119.7	10.1	12.2	17.8	57.9	33.1	25.9	13.2	10.2	12.9	91.2	22.8	22.6	58.8	15.3	16.5	17.8	21.1	35.6	19.3	144.5	53.0	17.2	46.2	9.5	14.5	53.7	14.9	10.7	81.3	30.7	100.7	17.0	32.8	17.7	10.8	85.3	84.2	58.5	95.1	87.8	8.1	347.1	61.2	24.0	83.6	57.4	91.8	34.8	171.2	60.8	18.5	51.7	103.8	105.2	72.8	51.9	97.6	97.2	150.5	57.8	122.5	14.1	170.3	139.7	10.9	18.4	123.0	42.7	171.6	216.0	137.2	205.4	100.1	46.9	94.0	142.0	114.4	89.0	218.4	55.4	94.0	117.8	208.9	49.1	49.5	75.0	97.0	18.4	58.9	43.9	61.5	80.7	107.1	333.1	46.4	74.8	62.6	117.7	67.0	93.8	221.9	28.8	136.8	57.1	21.9	12.1	1046.6	5.1	38.8	4.2	4.4	2.7	3.9	6.8	2.4	1.1	2.4	1.8	3.1	32.5	40.0	8.2	6.6	10.2	10.2	13.0	14.8	10.1	12.2	13.2	10.2	15.3	9.5	10.7	10.8	64.2	0.0	10.5	1.3	4.0	10.7	9.0	4.1	2.2	10.9	20.2	30.1	46.4	17.2	6.0	7.3	14.6	216.6	5.7	3.0	3.9	24.2	0.5	4.3	3.5	31.7	31.2	49.2	18.4	56.7	224.6	40.0	26.5	11.2	8.2	25.4	25.7	16.7	63.6	5.0	25.4	2.9	79.3	37.0	13.3	2.8	32.9	19.2	35.6	16.9	8.3	4.3	0.0	5.0	2.6	61.9	3.4	53.8	14.2	18.2	0.7	0.9	6.9	11.9	92.1	21.0	22.5	0.4	11.0	4.6	15.6	42.0	3.2	4.1	6.2	9.8
HSP90AB1	"HSPC2, HSPCB"	ENSG00000096384	"Heat shock protein 90 alpha family class B member 1"	P08238	6	44246166-44253888	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters"	"Stress response"	Chaperone	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Basal prostatic cells: 4755.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005230, HPA055729, HPA072606, HPA074351"	Enhanced		Supported	Cytosol	"Intracellular and membrane"	NA	Yes		63000000	"Cluster 27: Non-specific - Gene expression"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 22: Epithelial cell types - Mixed function"	Cytosol		"CAB005230: AB_2121392, HPA055729: AB_2682899, HPA072606: AB_2732203, HPA074351: AB_2732252"	"unprognostic (6.12e-3)"	"unprognostic (2.96e-3)"	"unprognostic (4.72e-2)"	"unprognostic (9.24e-2)"	"unprognostic (4.20e-1)"	"unprognostic (1.15e-3)"	"unprognostic (1.76e-3)"	"unprognostic (2.74e-1)"	"unprognostic (7.97e-2)"	"prognostic favorable (4.03e-4)"	"unprognostic (1.31e-1)"	"unprognostic (1.60e-1)"	"prognostic unfavorable (9.94e-4)"	"unprognostic (3.02e-1)"	"unprognostic (9.53e-2)"	"unprognostic (2.63e-1)"	"unprognostic (1.06e-1)"	584.8	719.5	647.1	368.9	700.4	466.4	507.6	675.2	1529.5	581.3	651.0	425.3	215.8	594.2	540.1	463.8	708.5	332.5	783.8	699.9	811.5	494.6	396.5	526.9	427.7	707.0	738.2	1204.8	722.9	606.0	574.8	451.9	764.3	471.2	389.8	339.5	410.2	491.9	1379.0	483.7	332.6	526.8	655.1	346.0	538.8	251.6	745.8	362.1	456.8	998.8	571.4	525.0	509.4	818.8	2393.2	1495.7	1298.1	1606.0	871.2	904.4	1355.3	1049.1	1021.8	1898.3	1325.5	2254.5	708.0	3029.2	1106.3	1099.8	1928.1	1349.9	3197.5	1563.4	2326.7	1010.5	1292.5	2359.3	793.9	2978.8	628.9	2386.2	1563.2	842.6	1034.9	1495.5	1277.7	1658.4	1847.6	1533.9	3210.4	1095.1	1309.8	2404.3	2003.1	1432.6	1519.7	4378.9	1129.7	1900.7	1325.9	1658.7	1287.7	1422.1	1891.1	1154.8	816.3	1164.8	1526.2	1751.5	1518.6	1178.2	1169.0	1124.0	1875.7	931.1	2440.0	1255.6	2125.8	5370.7	1221.7	1720.8	1312.1	65.9	231.7	52.8	343.7	341.0	577.8	544.0	380.3	395.0	375.1	473.1	509.3	494.0	27.3	434.9	349.0	232.1	326.8	678.5	647.1	700.4	675.2	1529.5	699.9	811.5	707.0	738.2	764.3	655.1	745.8	818.8	1165.2	897.4	678.2	70.5	906.4	1059.3	4755.7	862.6	1331.1	329.3	938.9	1418.3	1407.0	519.0	942.6	366.0	227.2	1104.3	629.3	538.6	729.8	1011.1	185.5	1385.8	1359.6	1070.6	567.4	775.9	103.5	688.9	1107.1	1247.3	616.2	1444.8	1003.4	761.3	360.5	360.3	807.5	339.9	151.0	578.2	518.8	314.5	1262.5	198.4	686.0	896.7	736.4	76.8	573.3	326.1	200.8	69.9	127.4	811.7	504.8	611.2	725.0	1810.6	361.5	664.8	1219.1	262.1	348.4	1512.7	1437.2	266.1	694.1	1232.8	923.5	1123.3	1265.6	1350.0	739.6	2408.7
SLC35B2	UGTrel4	ENSG00000157593	"Solute carrier family 35 member B2"	Q8TB61	6	44254096-44257890	"Metabolic proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029638	Approved		Approved	Vesicles		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 55: Plasma cells - Humoral immune response"	Vesicles		"HPA029638: AB_10602402"	"prognostic unfavorable (7.90e-4)"	"unprognostic (2.47e-3)"	"unprognostic (2.30e-1)"	"unprognostic (1.39e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.65e-2)"	"prognostic unfavorable (8.59e-5)"	"unprognostic (3.84e-1)"	"unprognostic (2.51e-1)"	"unprognostic (7.03e-3)"	"unprognostic (4.27e-2)"	"prognostic favorable (6.07e-4)"	"unprognostic (3.60e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.07e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.06e-1)"	20.1	36.7	21.2	19.6	25.7	18.4	25.2	27.0	42.3	23.3	24.1	27.1	19.6	28.5	29.5	17.5	26.2	30.0	26.4	19.5	23.3	30.3	30.6	21.7	21.5	25.8	25.1	21.3	41.8	42.5	14.6	25.0	25.6	24.0	28.8	14.6	46.4	27.4	22.4	21.9	23.9	29.7	26.1	24.7	30.6	14.7	26.1	18.5	24.4	23.7	22.3	28.1	19.5	30.9	87.2	48.8	61.4	117.6	106.4	102.3	44.1	95.1	152.3	89.3	109.4	43.3	79.3	19.2	81.9	117.3	97.7	81.1	42.5	106.3	64.4	57.4	53.3	39.8	37.9	59.5	94.1	85.2	61.5	107.0	112.1	85.5	43.1	129.1	67.4	43.2	56.8	81.4	112.5	106.9	32.5	71.0	27.2	271.3	58.9	30.9	38.3	100.2	100.3	65.5	75.4	71.4	45.9	52.2	109.6	37.6	93.3	75.7	65.8	71.0	46.2	71.3	83.3	62.4	75.7	45.6	95.6	67.6	147.5	51.9	14.5	23.5	33.1	11.4	28.3	19.7	18.6	25.2	12.9	13.2	16.6	22.0	1.3	20.3	3.9	23.5	16.4	17.7	21.2	25.7	27.0	42.3	19.5	23.3	25.8	25.1	25.6	26.1	26.1	30.9	8.0	6.4	11.5	8.5	19.2	13.5	32.0	58.3	23.9	9.7	31.6	30.1	7.8	37.1	34.8	27.6	2.1	59.2	15.3	15.2	13.7	84.0	0.6	16.0	17.8	11.1	19.7	10.5	3.5	73.8	52.1	27.5	14.3	19.5	34.9	11.9	13.6	18.7	38.4	10.1	4.3	21.6	57.0	11.4	10.8	2.3	23.3	22.0	53.4	4.7	22.0	38.8	23.7	9.5	13.8	67.4	25.9	19.9	23.3	36.3	18.8	13.5	18.4	12.5	0.0	18.3	24.5	21.0	60.8	17.4	13.9	35.2	14.0	14.8	31.5	24.2
NFKBIE	IKBE	ENSG00000146232	"NFKB inhibitor epsilon"	O00221	6	44258166-44265788	"Cancer-related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Langerhans cells: 151.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002692, HPA005941, CAB010272"	Supported		Supported	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"		NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 2: Immune cells - Immune response"	"Cluster 24: NB-4 - Immune response"	"Cluster 41: Macrophages - Immune response"	"Nucleoli fibrillar center"	"Nucleoplasm, Cytosol"	"CAB010272: AB_2235977, HPA002692: AB_1079479, HPA005941: AB_1079478"	"prognostic favorable (1.72e-5)"	"unprognostic (1.43e-1)"	"unprognostic (1.39e-2)"	"unprognostic (2.37e-2)"	"unprognostic (6.32e-3)"	"unprognostic (1.28e-1)"	"prognostic unfavorable (3.50e-4)"	"unprognostic (4.88e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.43e-2)"	"unprognostic (3.36e-1)"	"unprognostic (2.60e-1)"	"prognostic unfavorable (1.37e-6)"	"unprognostic (2.61e-2)"	"unprognostic (8.83e-2)"	"unprognostic (1.37e-2)"	"prognostic favorable (8.07e-4)"	6.8	5.8	10.9	19.1	10.8	31.5	5.9	12.1	17.6	4.1	10.7	7.2	7.4	3.7	4.7	5.9	3.3	8.3	5.3	11.3	10.6	16.1	10.5	13.6	19.9	11.5	11.4	2.7	8.3	5.3	4.5	5.5	11.2	8.3	5.9	3.7	7.4	3.3	3.5	9.9	12.1	3.6	11.7	35.0	7.0	10.7	11.8	9.9	5.3	3.9	25.1	16.3	5.0	12.3	28.4	7.9	9.5	15.1	3.7	2.8	5.3	4.9	23.8	14.9	15.4	15.0	12.9	15.7	17.0	5.1	39.7	6.2	10.3	15.4	16.6	26.1	6.0	7.9	3.0	17.0	11.4	26.1	23.0	7.1	6.7	13.8	8.8	12.5	10.7	7.2	7.7	39.2	3.9	14.4	5.2	52.7	5.0	44.1	4.0	9.9	8.5	14.0	34.7	30.3	6.1	7.8	3.4	12.5	20.9	8.0	8.6	29.9	18.1	8.4	9.8	5.3	15.4	25.0	11.4	28.7	7.4	28.4	16.1	8.8	7.5	4.0	1.6	9.4	3.2	8.6	2.2	1.5	6.6	6.5	1.0	1.6	3.0	0.8	11.1	8.1	3.1	1.7	10.9	10.8	12.1	17.6	11.3	10.6	11.5	11.4	11.2	11.7	11.8	12.3	7.5	0.0	9.7	1.0	26.0	38.2	28.7	11.6	14.8	3.4	15.3	9.9	5.4	22.8	9.2	3.7	2.1	5.2	12.5	12.2	17.6	49.5	17.3	10.0	6.2	15.9	14.9	1.7	1.1	21.0	8.0	17.3	10.7	12.8	32.5	2.5	6.1	2.0	57.2	3.3	2.0	11.9	6.1	22.6	151.2	34.1	1.8	48.6	48.0	3.7	55.2	3.3	1.0	0.5	0.9	58.9	33.3	2.6	18.7	32.6	14.3	14.4	6.1	4.1	6.6	11.8	11.0	25.9	12.3	11.6	39.2	5.3	13.8	7.0	8.5	34.7
TMEM151B	"bA444E17.5, C6orf137, TMEM193"	ENSG00000178233	"Transmembrane protein 151B"	Q8IW70	6	44270450-44307506	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"brain: 53.7"	"Group enriched"	"Detected in some"	5	"Excitatory neurons: 27.0;Inhibitory neurons: 31.4"	"Cancer enhanced"	"Detected in single"		"glioma: 1.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"SCLC-21H: 28.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055167	Uncertain					NA	NA				"Cluster 6: Brain - Smell perception"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA055167: AB_2682723"	"unprognostic (1.28e-3)"	"unprognostic (6.25e-2)"	"unprognostic (5.06e-2)"	"unprognostic (7.02e-3)"	"unprognostic (6.61e-2)"	"unprognostic (1.22e-3)"	"unprognostic (2.41e-2)"	"unprognostic (3.01e-2)"	"unprognostic (6.92e-2)"	"unprognostic (1.10e-1)"	"unprognostic (3.65e-4)"	"unprognostic (1.48e-1)"	"unprognostic (4.56e-3)"	"unprognostic (1.85e-1)"	"unprognostic (9.15e-2)"	"unprognostic (3.86e-2)"	"unprognostic (1.66e-1)"	0.1	2.9	12.4	0.4	20.9	0.2	0.2	47.4	53.7	0.3	0.0	0.9	0.5	0.2	0.0	0.2	0.3	0.0	0.6	34.8	2.9	0.2	0.2	0.1	0.2	8.4	4.3	0.3	0.4	0.0	3.9	0.0	11.3	0.3	0.3	2.8	0.3	0.0	0.2	0.2	0.7	0.1	1.5	0.3	0.5	0.8	12.9	0.1	0.3	0.0	0.0	0.1	0.4	15.7	0.0	0.1	6.3	0.5	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.6	0.2	0.0	0.1	0.0	0.7	0.1	0.2	0.0	0.0	0.1	0.2	0.4	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.8	0.0	0.4	0.0	0.0	0.1	0.7	4.9	0.1	0.2	0.5	0.0	0.1	0.0	0.1	28.6	5.9	0.1	0.0	0.0	0.2	0.2	0.1	0.1	0.1	0.2	0.1	0.2	0.4	0.3	0.1	0.1	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.4	20.9	47.4	53.7	34.8	2.9	8.4	4.3	11.3	1.5	12.9	15.7	0.0	0.0	0.0	2.9	0.0	0.0	0.1	0.0	0.0	5.3	0.1	0.1	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	27.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	5.0	31.4	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	2.8	0.0	0.4	0.0	4.5	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.1	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TCTE1	"D6S46, DRC5, FAP155, MGC33600"	ENSG00000146221	"T-complex-associated-testis-expressed 1"	Q5JU00	6	44278734-44297698	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"fallopian tube: 14.4;testis: 30.0"	"Group enriched"	"Detected in some"	10	"Early spermatids: 161.8;Late spermatids: 359.0"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 1.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Karpas-707: 1.0;U-266/84: 1.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA031739			Uncertain	Vesicles		NA	NA				"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 31: Spermatids - Spermatogenesis"	Vesicles		"HPA031739: AB_10601269"	"unprognostic (3.27e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.04e-2)"	"unprognostic (5.27e-3)"	"unprognostic (1.55e-1)"	"unprognostic (1.57e-2)"	"unprognostic (7.06e-2)"	"unprognostic (1.42e-2)"	"unprognostic (3.46e-1)"	"unprognostic (3.49e-2)"	"unprognostic (1.17e-2)"	"unprognostic (7.05e-2)"	"unprognostic (2.23e-5)"	"unprognostic (7.68e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.37e-3)"	"unprognostic (2.68e-1)"	0.2	0.2	1.4	0.0	1.3	0.9	0.2	6.2	1.3	0.9	1.3	0.2	0.0	0.4	0.2	0.1	14.4	0.1	0.1	1.4	1.0	0.1	0.1	1.4	0.0	3.0	3.3	0.5	0.1	0.0	0.5	1.9	1.5	0.2	0.1	1.0	0.2	0.1	0.1	0.5	0.2	0.1	2.6	0.2	0.1	30.0	1.2	0.1	0.1	0.2	0.0	0.1	0.2	1.0	0.0	0.0	0.0	0.0	0.2	0.3	0.3	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.1	0.0	0.1	0.0	0.2	0.4	0.0	0.0	0.7	0.1	0.1	0.1	0.0	1.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.9	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.5	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	1.3	6.2	1.3	1.4	1.0	3.0	3.3	1.5	2.6	1.2	1.0	0.1	0.0	0.0	1.0	0.0	0.1	0.1	0.7	0.0	1.1	0.1	0.1	0.5	0.0	1.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	161.8	7.3	0.3	0.1	0.0	0.0	1.3	0.0	0.0	0.2	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.3	359.0	1.2	0.2	0.0	0.0	0.0	0.0	0.0	1.0	0.3	0.0	0.0	0.7	0.0	0.0	0.1	0.0	16.0	0.2	0.0	0.4	0.3	23.9	2.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0
AARS2	"AARSL, bA444E17.1, KIAA1270"	ENSG00000124608	"Alanyl-tRNA synthetase 2, mitochondrial"	Q5JTZ9	6	44298731-44313347	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase, RNA-binding, tRNA-binding"	"Cancer-related genes, Cardiomyopathy, Disease variant, Neurodegeneration, Premature ovarian failure, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035636, HPA061396"	Approved		Enhanced	Mitochondria		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 35: Non-specific - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Mitochondria		"HPA035636: AB_10670837, HPA061396: AB_2684502"	"unprognostic (1.56e-1)"	"unprognostic (3.24e-2)"	"unprognostic (2.58e-2)"	"unprognostic (2.04e-3)"	"unprognostic (2.83e-1)"	"unprognostic (1.69e-1)"	"unprognostic (8.83e-3)"	"unprognostic (5.12e-2)"	"unprognostic (3.64e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.19e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.02e-1)"	4.7	5.2	6.5	5.6	6.2	5.4	4.9	9.4	6.7	7.6	6.7	5.8	6.5	6.1	3.2	9.2	6.4	4.6	6.0	6.8	5.1	5.7	6.9	4.3	6.0	6.1	5.8	8.3	6.5	5.9	6.3	4.1	6.4	7.0	4.1	5.4	6.2	4.3	4.8	7.2	7.9	4.1	5.4	7.2	5.4	3.7	6.0	6.2	6.2	3.3	5.3	5.6	7.4	6.7	14.6	9.9	13.9	23.8	8.1	7.2	18.3	10.9	5.7	11.2	10.6	11.4	7.1	16.3	16.2	4.8	12.2	10.0	14.7	16.0	4.7	10.9	23.7	18.9	10.6	14.5	4.8	17.9	16.0	5.9	9.8	9.0	10.2	7.3	9.5	21.8	21.0	15.4	6.2	16.0	14.2	15.9	9.9	40.3	9.8	16.4	8.7	10.4	6.7	12.7	32.0	11.4	9.4	10.9	15.5	9.7	9.9	21.6	8.4	12.1	13.5	7.6	13.9	8.8	8.7	16.5	6.8	15.9	22.1	2.2	1.1	0.1	1.3	1.3	2.1	1.5	1.9	1.7	1.0	2.9	1.8	1.7	0.2	1.9	1.4	1.3	1.2	1.3	6.5	6.2	9.4	6.7	6.8	5.1	6.1	5.8	6.4	5.4	6.0	6.7	2.6	6.4	3.3	5.2	3.7	0.6	2.1	1.9	4.0	6.6	2.8	2.7	3.5	5.7	2.8	0.0	12.5	5.0	4.9	3.0	0.0	2.3	10.1	3.5	5.4	3.0	0.0	8.2	5.5	0.4	5.0	3.4	5.1	6.2	0.0	5.9	3.9	2.5	3.3	0.0	9.0	2.2	2.0	2.8	1.8	1.0	4.7	2.5	0.0	1.9	3.9	2.0	4.1	3.0	3.6	1.4	0.7	4.5	6.9	1.6	6.3	1.0	3.0	7.1	0.0	4.7	2.8	4.3	6.1	4.4	0.4	5.3	4.1	4.5	3.7	1.6
SPATS1	"FLJ25442, SPATA8, SRSP1"	ENSG00000249481	"Spermatogenesis associated serine rich 1"	Q496A3	6	44342650-44380179	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"epididymis: 5.9;fallopian tube: 7.6;testis: 22.1"	"Group enriched"	"Detected in some"	13	"Early spermatids: 30.9;Late spermatids: 12.1;Respiratory ciliated cells: 9.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	9	"SK-MEL-30: 7.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030897, HPA049722"	Approved		Approved	Nucleoplasm		NA	NA				"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Nucleoplasm		"HPA030897: AB_2673647, HPA049722: AB_2680861"				"unprognostic (2.30e-3)"														0.0	0.1	0.7	0.0	0.7	0.2	0.0	0.6	0.8	0.2	0.7	0.0	0.0	0.2	5.9	0.0	7.6	0.0	0.1	0.8	0.8	0.0	0.0	0.6	0.1	1.4	2.1	0.0	0.1	0.1	0.0	0.0	1.2	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	1.3	0.0	0.1	22.1	0.7	0.1	0.1	0.0	0.0	0.0	0.0	1.4	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.3	0.2	0.2	0.3	0.1	0.1	0.0	0.1	0.3	0.0	0.1	0.4	0.1	0.0	0.1	7.9	0.1	0.1	0.1	0.1	0.2	0.0	0.0	0.1	0.2	0.1	0.3	0.1	0.1	0.1	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.1	0.7	0.7	0.6	0.8	0.8	0.8	1.4	2.1	1.2	1.3	0.7	1.4	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.9	0.2	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	12.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.5	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CDC5L	"CDC5, CEF1, hCDC5, PCDC5RP"	ENSG00000096401	"Cell division cycle 5 like"	Q99459	6	44387706-44450425	"Disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Cell cycle, DNA damage, DNA repair, mRNA processing, mRNA splicing, Transcription, Transcription regulation"	"Activator, DNA-binding, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 291.8;Late spermatids: 285.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006302, HPA011361, CAB012275"	Supported		Supported	Nucleoplasm		NA	NA		22000	"Cluster 42: Non-specific - Transcription"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm		"CAB012275: , HPA006302: AB_1078488, HPA011361: AB_1846379"	"unprognostic (2.67e-1)"	"unprognostic (9.31e-2)"	"unprognostic (8.26e-3)"	"unprognostic (4.17e-3)"	"unprognostic (2.01e-2)"	"unprognostic (2.17e-1)"	"unprognostic (7.96e-2)"	"unprognostic (1.61e-1)"	"prognostic unfavorable (7.02e-5)"	"unprognostic (1.01e-2)"	"unprognostic (6.31e-2)"	"unprognostic (1.63e-1)"	"unprognostic (4.33e-2)"	"unprognostic (3.08e-2)"	"unprognostic (3.37e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.46e-1)"	11.5	11.9	6.7	10.7	7.1	21.3	13.5	10.1	9.4	10.3	7.0	10.5	9.4	12.0	13.2	10.9	9.7	8.7	13.8	7.3	7.0	10.5	18.7	9.6	13.4	6.7	6.8	14.0	10.1	19.8	5.7	12.0	7.1	11.8	11.3	13.2	9.7	9.4	17.8	8.5	9.4	11.7	6.9	10.5	9.7	13.2	6.9	15.3	10.8	22.5	14.1	12.1	8.1	8.7	43.0	16.5	39.8	32.5	16.0	20.7	22.5	30.6	23.8	37.9	41.5	21.7	14.4	40.8	24.8	24.7	30.8	26.6	41.8	24.2	56.4	34.5	37.6	54.5	15.4	28.1	14.6	41.3	28.2	15.9	20.9	37.0	31.9	21.7	25.0	20.7	42.6	23.3	34.7	29.0	38.4	28.1	28.0	103.5	15.1	29.6	45.7	26.4	21.5	25.2	43.8	38.0	24.7	16.5	33.3	25.4	23.2	39.6	23.0	32.4	32.8	25.5	43.7	19.9	25.8	73.8	20.9	35.3	33.2	20.2	13.1	17.5	10.4	15.7	11.8	9.9	10.0	11.7	13.0	11.3	10.7	10.4	19.9	14.8	18.1	11.2	14.6	8.5	6.7	7.1	10.1	9.4	7.3	7.0	6.7	6.8	7.1	6.9	6.9	8.7	57.3	73.7	50.3	14.7	48.5	44.2	69.2	58.0	55.8	36.4	26.7	29.5	82.2	30.0	80.5	23.9	31.3	57.5	58.2	26.8	39.2	53.4	291.8	63.7	64.2	51.5	36.1	48.1	20.6	55.2	49.4	52.2	28.5	72.1	71.0	58.8	26.7	44.7	45.3	32.0	34.7	40.7	52.9	38.6	29.8	285.9	61.5	53.1	19.6	18.7	74.3	65.8	45.3	14.1	33.0	47.8	34.5	55.3	37.7	49.0	18.6	28.6	78.6	38.1	65.7	67.9	76.2	48.2	98.7	35.6	38.4	71.7	46.8	59.8	40.8	62.5
SUPT3H	"SPT3, SPT3L"	ENSG00000196284	"SPT3 homolog, SAGA and STAGA complex component"	O75486	6	44809317-45377953	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in all"	6	"Astrocytes: 110.7;Early spermatids: 142.2;Excitatory neurons: 286.4;Inhibitory neurons: 405.2;Late spermatids: 183.4;Microglial cells: 124.6;Oligodendrocyte precursor cells: 182.9;Oligodendrocytes: 192.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024371	Enhanced		Supported	Nucleoplasm		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 12: NES - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"HPA024371: AB_1857660"	"unprognostic (5.72e-3)"	"unprognostic (7.92e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.34e-1)"	"prognostic favorable (3.55e-4)"	"unprognostic (1.07e-2)"	"unprognostic (6.15e-5)"	"unprognostic (7.46e-2)"	"unprognostic (1.75e-1)"	"prognostic favorable (1.72e-4)"	"unprognostic (1.49e-1)"	"unprognostic (2.30e-1)"	"unprognostic (2.05e-2)"	"unprognostic (3.08e-2)"	"unprognostic (1.23e-1)"	"unprognostic (8.13e-3)"	"unprognostic (4.31e-2)"	2.4	5.1	3.6	1.2	4.1	1.2	2.4	4.8	5.7	4.4	0.0	3.6	2.2	3.5	4.2	2.9	4.1	2.0	1.8	3.9	4.7	4.3	1.6	2.4	1.7	4.5	3.3	5.2	3.8	3.8	3.2	3.4	3.6	4.4	2.3	4.2	7.2	2.1	1.6	1.4	2.4	2.5	1.8	1.8	2.2	8.9	5.7	2.7	4.4	0.5	1.9	3.2	2.4	5.7	5.2	2.4	12.9	6.8	2.7	7.8	4.3	3.2	4.0	7.2	8.9	4.0	4.0	2.0	3.0	1.5	6.2	2.2	9.0	7.1	13.2	5.0	3.6	1.4	1.9	10.4	6.4	3.9	1.5	4.2	5.7	3.7	10.0	20.5	3.7	7.2	4.7	3.7	6.6	1.5	4.0	8.2	4.6	11.2	1.1	8.8	5.7	2.2	10.2	4.2	6.4	3.1	0.7	0.8	10.2	16.7	3.3	3.8	1.3	6.4	0.1	4.6	7.3	7.2	2.2	12.3	5.0	7.9	6.0	0.1	0.3	0.1	2.9	0.5	5.1	1.2	4.4	3.4	1.4	1.6	5.1	4.3	0.2	2.3	0.7	3.9	1.9	1.6	3.6	4.1	4.8	5.7	3.9	4.7	4.5	3.3	3.6	1.8	5.7	5.7	4.5	3.2	4.8	110.7	11.5	1.8	14.5	10.0	8.6	7.4	5.1	6.7	3.0	2.8	7.2	7.3	6.2	11.7	19.7	1.2	11.7	8.4	142.2	5.4	4.5	5.7	8.4	5.9	286.4	3.2	12.3	7.2	6.6	6.3	3.8	16.0	7.1	3.0	8.7	3.3	405.2	2.3	2.0	2.9	5.0	183.4	7.8	4.5	5.4	124.6	10.5	2.8	20.6	182.9	192.9	4.0	2.1	5.3	14.7	11.3	1.9	10.7	8.3	13.5	13.1	6.8	16.0	26.8	22.0	6.2	1.3	8.2	30.7	7.8	3.7	9.3
RUNX2	"AML3, CBFA1, CCD, CCD1, PEBP2A1, PEBP2aA1"	ENSG00000124813	"RUNX family transcription factor 2"	Q13950	6	45328157-45664349	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	DNA-binding	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 10.7"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 55.8;Early spermatids: 128.3;Inhibitory neurons: 95.2;Microglial cells: 128.4;Plasma cells: 44.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"NK-cell: 22.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 39.3;Karpas-707: 62.3;RH-30: 51.8;U-698: 55.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB008374, HPA022040, CAB062561, CAB068226, HPA070715"	Enhanced		Enhanced	Nucleoplasm		No	No			"Cluster 48: NK-cells - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"CAB008374: AB_590789, CAB062561: AB_2665599, CAB068226: AB_2665598, HPA022040: AB_1846086, HPA070715: "	"unprognostic (1.49e-1)"	"unprognostic (8.90e-3)"	"unprognostic (3.99e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.06e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.70e-2)"	"unprognostic (3.18e-1)"	"prognostic unfavorable (3.97e-9)"	"prognostic unfavorable (2.24e-4)"	"unprognostic (5.52e-2)"	"unprognostic (5.35e-2)"	"prognostic unfavorable (6.66e-5)"	1.7	0.7	1.1	4.3	1.0	9.7	2.8	1.2	1.4	6.7	0.9	3.7	2.0	1.5	0.8	1.4	0.9	3.4	0.7	1.3	1.5	1.5	0.7	2.7	4.5	1.9	1.8	2.2	0.6	0.6	1.6	1.5	1.9	4.8	3.9	0.1	10.7	2.6	0.8	2.4	6.0	1.6	1.6	3.6	3.2	0.5	2.0	4.5	1.8	0.9	5.6	3.6	4.9	1.9	3.6	1.1	0.8	0.0	3.2	8.3	0.0	3.3	7.9	10.9	15.2	0.0	1.9	0.0	3.8	4.7	4.9	4.3	0.0	3.1	19.7	13.7	1.5	0.0	2.4	0.0	16.7	14.2	0.1	22.5	2.5	9.7	10.9	39.3	0.2	5.6	0.0	62.3	19.7	1.0	0.4	24.7	0.7	3.2	0.5	0.1	51.8	0.0	10.7	7.0	0.0	0.0	2.4	0.1	4.1	9.2	3.6	1.2	0.5	11.1	8.8	17.2	12.1	19.6	0.0	55.2	12.5	5.3	5.0	8.6	0.9	4.5	1.5	0.2	12.9	0.2	3.5	4.0	2.4	0.2	0.6	1.8	6.5	22.1	0.1	15.4	3.2	1.0	1.1	1.0	1.2	1.4	1.3	1.5	1.9	1.8	1.9	1.6	2.0	1.9	0.9	0.0	2.7	4.6	5.7	2.8	16.6	5.3	1.2	0.0	2.0	1.4	2.7	0.0	4.9	3.7	0.0	0.0	55.8	0.3	0.0	0.6	128.3	0.7	3.5	0.8	0.0	3.8	17.4	0.2	0.0	7.0	4.1	0.5	2.5	0.1	1.1	0.8	3.7	0.0	95.2	1.0	20.3	6.7	20.8	20.0	1.2	16.3	7.2	128.4	18.6	0.0	7.2	6.6	5.2	0.4	0.1	2.2	44.4	16.5	0.0	3.3	5.1	0.0	6.6	1.5	6.2	0.8	0.5	1.2	1.6	0.1	21.4	0.2	0.2	28.0
CLIC5	DFNB102	ENSG00000112782	"Chloride intracellular channel 5"	Q9NZA1	6	45880827-46080348	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Hearing, Ion transport, Sensory transduction, Transport, Vision"	"Chloride channel, Ion channel, Voltage-gated channel"	"Deafness, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 102.7;skeletal muscle: 289.7;tongue: 98.3"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 509.6;Cardiomyocytes: 285.7;Distal enterocytes: 164.2;Late spermatids: 93.8;Proximal enterocytes: 126.0"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 11.6"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"MAIT T-cell: 5.1"	"Lineage enriched"	"Detected in single"	17	"T-cells: 5.1"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 13.5;EFO-21: 9.2;HDLM-2: 4.7;REH: 11.9;U-266/70: 12.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA074371			Supported	"Nuclear speckles,Plasma membrane"		NA	NA		400000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane"	"Nuclear speckles"	"HPA074371: "	"unprognostic (4.95e-2)"	"unprognostic (1.59e-2)"	"unprognostic (8.84e-2)"	"unprognostic (5.05e-2)"	"unprognostic (2.44e-1)"	"unprognostic (6.73e-2)"	"unprognostic (3.37e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.79e-1)"	"unprognostic (6.46e-2)"	"unprognostic (5.50e-2)"	"unprognostic (3.65e-1)"	"unprognostic (6.77e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.99e-1)"	"unprognostic (8.26e-2)"	"unprognostic (1.01e-1)"	18.9	1.5	3.2	4.3	4.4	0.2	6.5	1.5	2.9	19.0	0.5	28.6	20.9	2.1	0.9	2.9	4.5	3.0	102.7	2.1	5.0	54.7	0.3	70.8	1.7	2.1	3.8	0.5	1.1	1.7	3.0	16.5	2.2	2.6	25.8	16.9	2.7	1.4	289.7	1.2	36.6	2.3	1.8	44.5	1.6	1.4	5.5	1.0	7.3	98.3	1.9	2.0	2.6	1.9	0.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.6	13.5	0.0	9.2	0.0	0.0	0.3	0.0	0.1	0.0	4.7	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.8	0.0	0.0	0.0	0.1	0.4	1.6	0.0	11.9	0.3	0.1	0.1	0.4	0.1	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.4	0.1	0.0	12.8	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	1.5	0.0	5.1	0.1	2.0	1.3	0.0	0.0	0.3	0.2	0.0	0.3	0.0	0.0	1.0	0.5	3.2	4.4	1.5	2.9	2.1	5.0	2.1	3.8	2.2	1.8	5.5	1.9	59.6	509.6	30.0	4.6	1.4	0.1	0.1	0.0	1.2	0.3	0.5	0.4	285.7	5.7	26.9	14.7	0.0	0.2	0.7	164.2	0.0	1.7	52.9	4.6	0.5	29.8	13.1	0.4	8.6	0.2	0.1	7.9	0.5	5.7	1.3	0.0	0.7	0.0	0.0	0.0	5.4	23.5	0.0	0.0	0.0	93.8	0.9	0.7	0.0	34.7	0.6	53.8	0.0	0.5	2.9	2.9	51.1	0.7	3.4	3.2	126.0	2.9	11.4	1.8	0.0	6.1	4.3	1.0	0.1	0.1	0.1	2.2	5.8	0.1	13.5	4.3
ENPP4	"AP3Aase, KIAA0879, NPP4"	ENSG00000001561	"Ectonucleotide pyrophosphatase/phosphodiesterase 4"	Q9Y6X5	6	46129989-46146688	"Enzymes, Predicted membrane proteins"	"Blood coagulation, Hemostasis"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 76.9;Oligodendrocytes: 125.3;Respiratory ciliated cells: 70.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-266/70: 21.9;U-266/84: 26.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016594	Approved					NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"			"HPA016594: AB_1848171"	"unprognostic (9.87e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.75e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.92e-1)"	"unprognostic (1.90e-1)"	"unprognostic (8.13e-2)"	"unprognostic (5.51e-3)"	"unprognostic (1.98e-1)"	"unprognostic (1.26e-1)"	"unprognostic (8.51e-2)"	"unprognostic (4.36e-1)"	"prognostic favorable (6.95e-7)"	"unprognostic (1.82e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.62e-2)"	"unprognostic (2.56e-1)"	15.1	13.6	11.7	7.3	20.9	38.0	7.8	19.5	19.5	10.3	6.4	12.1	10.9	4.0	11.6	5.1	10.8	8.0	15.1	10.8	16.0	18.4	8.2	20.7	7.7	20.5	19.3	2.1	11.9	22.3	9.0	3.5	19.9	16.4	12.8	12.2	21.3	19.7	22.1	2.3	10.1	7.0	18.5	13.9	14.8	8.3	17.5	8.5	12.5	25.3	6.5	6.8	2.1	30.2	0.1	1.1	0.7	1.5	0.0	0.0	0.1	1.7	1.6	4.0	0.3	1.9	13.4	15.2	12.7	2.1	9.9	0.2	4.1	0.6	0.8	18.5	11.1	8.5	0.0	0.0	0.5	10.5	14.9	2.1	0.0	0.1	0.0	1.1	1.4	10.5	0.0	0.0	1.5	1.8	7.8	1.0	2.7	16.9	0.5	5.9	2.7	5.7	8.3	1.7	18.0	0.0	0.0	2.8	0.0	4.1	7.6	4.3	0.0	0.0	6.7	0.3	11.2	21.9	26.6	5.2	10.3	0.0	1.4	0.0	0.4	0.9	9.2	1.1	5.4	2.8	3.4	6.8	1.5	1.2	3.2	5.8	0.3	4.4	2.6	1.6	1.2	3.0	11.7	20.9	19.5	19.5	10.8	16.0	20.5	19.3	19.9	18.5	17.5	30.2	43.5	76.9	27.0	23.5	11.6	0.9	3.2	2.3	0.6	9.3	11.0	2.4	23.1	14.3	25.4	29.5	14.6	0.5	23.5	27.2	0.0	12.9	18.3	28.8	2.0	16.0	15.7	3.0	26.4	12.2	0.3	8.5	10.7	17.3	15.8	4.5	6.1	8.6	5.8	26.9	19.2	13.8	4.1	24.8	11.0	26.0	1.2	19.0	3.6	6.5	15.2	21.6	34.0	32.2	125.3	9.7	16.1	11.3	10.3	12.6	16.3	12.6	70.6	6.2	0.0	22.1	5.4	9.1	9.8	0.3	0.6	0.3	14.7	3.7	11.3	14.8
ENPP5		ENSG00000112796	"Ectonucleotide pyrophosphatase/phosphodiesterase family member 5"	Q9UJA9	6	46159185-46170980	"Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"epididymis: 243.6"	"Cell type enhanced"	"Detected in many"		"Muller glia cells: 100.1;Respiratory ciliated cells: 47.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"gdT-cell: 14.9"	"Lineage enriched"	"Detected in many"	5	"T-cells: 14.9"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 11.1;HSkMC: 7.1;SuSa: 6.2;T-47d: 8.7;U-266/84: 7.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016902	Enhanced		Approved	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA		620000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 68: Epididymis - Unknown function"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 5: Muller glia cells - Visual perception"	Cytosol	Nucleoplasm	"HPA016902: AB_1848172"	"unprognostic (1.12e-1)"	"unprognostic (5.19e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.32e-1)"	"unprognostic (7.61e-2)"	"unprognostic (1.63e-1)"	"unprognostic (5.01e-2)"	"prognostic favorable (4.57e-4)"	"unprognostic (1.96e-1)"	"unprognostic (9.89e-2)"	"prognostic favorable (4.04e-4)"	"unprognostic (7.00e-2)"	"prognostic favorable (4.44e-13)"	"unprognostic (4.40e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.60e-1)"	1.8	8.6	6.2	1.1	7.6	0.2	13.4	6.9	12.6	12.8	4.0	2.6	1.5	1.8	243.6	1.8	15.4	7.0	4.4	7.0	9.7	24.3	0.5	8.8	1.2	5.8	13.0	9.7	9.7	46.3	19.8	1.7	6.2	29.4	3.2	30.6	14.4	31.0	10.7	1.6	1.9	0.9	4.5	5.7	6.7	35.5	14.0	8.2	51.0	10.3	1.4	5.6	1.8	6.3	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.5	0.1	0.3	11.1	1.8	3.6	0.2	3.7	0.0	0.6	1.5	0.1	0.0	2.4	0.7	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.4	1.9	0.0	0.5	2.3	5.4	0.0	0.0	0.2	0.2	4.5	0.6	4.7	0.2	0.0	4.6	0.0	6.2	8.7	0.0	0.0	0.0	1.2	0.0	0.1	5.3	7.9	0.0	2.8	0.0	0.1	0.0	0.0	0.0	14.9	0.1	8.0	0.5	3.0	9.7	0.0	0.8	0.9	8.7	1.1	2.8	0.0	0.0	0.0	3.2	6.2	7.6	6.9	12.6	7.0	9.7	5.8	13.0	6.2	4.5	14.0	6.3	0.4	12.8	12.2	16.3	1.6	0.9	4.8	0.5	1.2	10.6	18.1	10.8	7.5	8.6	6.1	23.9	4.2	4.9	4.2	1.9	1.9	11.6	0.7	15.3	0.8	0.4	8.3	0.0	24.6	7.5	2.9	4.2	2.0	5.4	4.5	4.0	0.4	0.1	0.4	10.1	14.5	2.8	2.0	0.0	0.4	3.8	2.8	0.5	0.0	1.9	0.6	100.1	23.7	9.0	10.5	2.2	2.3	12.0	0.1	12.0	1.7	16.3	47.3	3.4	6.6	25.7	1.8	0.5	2.4	1.1	0.6	0.3	3.2	21.2	2.9	3.3
RCAN2	"DSCR1L1, ZAKI-4"	ENSG00000172348	"Regulator of calcineurin 2"	Q14206	6	46220736-46491972	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 199.5;tongue: 180.1"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 255.4;Excitatory neurons: 261.4;Inhibitory neurons: 254.4;Muller glia cells: 183.1;Oligodendrocytes: 294.6;Smooth muscle cells: 138.4"	"Cancer enhanced"	"Detected in all"		"renal cancer: 25.2"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	17	"gdT-cell: 1.8;memory CD4 T-cell: 1.1;memory CD8 T-cell: 2.2;naive CD8 T-cell: 1.5"	"Lineage enriched"	"Detected in single"	23	"T-cells: 2.2"	"Group enriched"	"Detected in some"	6	"fHDF/TERT166: 63.3;HDLM-2: 129.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053880	Uncertain		Approved	Nucleoplasm,Mitochondria		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 48: Smooth muscle cells - ECM organization"	Mitochondria	Nucleoplasm	"HPA053880: AB_2682290"	"unprognostic (2.82e-1)"	"unprognostic (7.76e-2)"	"unprognostic (4.13e-2)"	"unprognostic (1.14e-1)"	"unprognostic (5.55e-3)"	"unprognostic (4.52e-2)"	"unprognostic (1.29e-3)"	"unprognostic (1.86e-3)"	"unprognostic (2.26e-1)"	"unprognostic (4.33e-1)"	"prognostic favorable (2.48e-4)"	"unprognostic (1.37e-1)"	"prognostic favorable (1.12e-6)"	"unprognostic (3.83e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.02e-1)"	"unprognostic (2.11e-2)"	38.1	12.6	35.7	7.7	41.2	0.0	17.1	31.7	106.3	20.3	0.0	20.1	9.8	17.5	51.5	25.9	17.0	35.1	199.5	34.0	65.0	32.4	4.9	16.3	4.1	69.6	76.0	24.0	11.1	85.5	17.5	0.6	68.8	25.3	22.6	61.6	9.6	27.0	73.3	17.2	19.1	14.0	20.6	7.1	36.5	5.7	65.5	4.7	20.1	180.1	7.0	44.0	21.4	62.3	0.0	0.0	1.6	0.0	0.7	0.2	0.1	1.1	15.1	1.1	0.1	0.0	0.0	0.0	0.8	63.3	0.0	0.1	0.0	0.0	0.3	129.7	0.8	0.0	0.0	0.0	1.0	0.0	0.0	1.2	0.0	0.1	0.1	0.0	0.3	0.3	0.0	0.1	5.1	0.0	0.0	0.2	2.7	0.4	0.4	0.4	13.6	0.1	0.2	0.3	4.9	0.0	0.0	0.0	0.0	3.0	0.0	0.1	0.0	0.1	1.8	0.1	0.2	6.8	0.1	0.0	0.2	0.0	0.4	0.0	0.0	0.0	1.8	0.0	0.0	0.0	1.1	2.2	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.4	35.7	41.2	31.7	106.3	34.0	65.0	69.6	76.0	68.8	20.6	65.5	62.3	7.6	6.4	5.8	13.7	0.6	6.2	4.6	0.0	0.0	24.8	1.8	1.4	255.4	8.6	0.0	3.7	4.2	0.1	0.8	1.0	70.5	5.5	40.2	0.8	0.4	17.1	25.1	0.0	261.4	2.5	0.0	22.2	1.5	0.8	0.0	0.3	0.4	1.2	0.1	30.3	254.4	1.5	34.6	0.3	8.0	14.2	29.2	0.9	32.0	46.9	0.0	183.1	0.0	76.9	294.6	2.9	0.3	50.4	0.4	3.3	0.0	1.9	0.0	9.7	98.6	16.4	138.4	1.5	1.4	0.5	7.4	0.0	4.0	0.8	0.3	1.4
CYP39A1		ENSG00000146233	"Cytochrome P450 family 39 subfamily A member 1"	Q9NYL5	6	46549580-46652830	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism"	"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"liver: 99.2"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 62.9;Late spermatids: 20.1"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 11.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Daudi: 6.5;hTCEpi: 13.6;OE19: 6.1;SiHa: 8.4;U-698: 10.4"	"Region enhanced"	"Detected in all"		"olfactory bulb: 22.9"	"Low region specificity"	"Detected in all"									NA	NA				"Cluster 85: Liver - Metabolism"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 2: Hepatocytes - Metabolism"				"unprognostic (1.33e-1)"	"unprognostic (1.62e-2)"	"unprognostic (8.46e-3)"	"unprognostic (5.89e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.03e-1)"	"unprognostic (5.78e-2)"	"unprognostic (1.61e-1)"	"unprognostic (4.99e-2)"	"unprognostic (7.33e-2)"	"unprognostic (6.11e-2)"	"prognostic favorable (1.86e-4)"	"unprognostic (1.54e-1)"	"unprognostic (5.48e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.20e-1)"	3.0	2.5	2.1	1.0	2.7	0.0	5.4	3.5	2.9	3.7	5.3	2.7	0.8	3.6	21.0	3.3	4.1	6.3	3.9	2.0	2.1	5.7	99.2	3.3	0.5	2.3	2.3	11.5	5.7	15.3	2.9	0.4	2.1	14.8	3.6	4.1	23.5	2.6	0.6	15.9	1.6	2.4	2.4	0.7	2.8	4.2	2.4	0.4	6.1	1.2	1.4	2.7	3.0	2.9	0.2	0.4	0.3	1.8	0.3	0.0	0.0	0.0	1.1	0.3	0.1	0.0	0.5	6.5	4.4	0.0	0.9	1.7	0.8	1.4	0.0	0.0	2.8	0.0	1.7	1.8	4.0	0.0	0.0	0.5	13.6	0.0	1.6	1.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	6.1	1.5	0.5	1.1	0.1	2.9	4.0	0.7	0.0	8.4	0.0	0.2	0.4	1.5	0.0	0.0	0.2	0.9	0.0	0.1	0.0	0.0	10.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	2.7	3.5	2.9	2.0	2.1	2.3	2.3	2.1	2.4	2.4	2.9	3.3	16.0	1.5	3.9	0.2	4.0	8.8	2.7	2.8	1.4	4.6	6.5	5.8	10.0	4.3	3.7	2.1	0.0	0.0	1.1	5.9	2.9	12.7	4.4	1.0	3.5	0.0	5.3	3.2	0.4	0.9	4.5	1.5	3.1	0.0	2.7	1.1	62.9	0.2	0.0	2.0	4.0	10.2	2.5	0.9	20.1	6.2	0.3	3.6	8.4	0.0	8.6	0.0	1.0	7.2	0.5	2.7	9.4	0.0	7.9	0.3	5.3	7.2	1.5	0.0	1.9	2.3	0.7	0.8	2.6	15.3	0.0	0.2	6.3	2.5	8.1
SLC25A27	"FLJ33552, UCP4"	ENSG00000153291	"Solute carrier family 25 member 27"	O95847	6	46652915-46678190	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 53.2;Excitatory neurons: 78.1;Inhibitory neurons: 78.1;Oligodendrocyte precursor cells: 127.2;Oligodendrocytes: 88.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HeLa: 53.6;hTCEpi: 24.2;U-698: 27.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA069732			Supported	Mitochondria		NA	NA				"Cluster 21: Non-specific - Transcription"	"Cluster 20: HeLa - Mitochondria"	"Cluster 68: Oligodendrocytes - Mixed function"	Mitochondria		"HPA069732: AB_2686185"	"unprognostic (2.16e-2)"	"unprognostic (2.19e-1)"	"unprognostic (9.86e-3)"	"unprognostic (4.93e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.03e-1)"	"unprognostic (2.81e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.35e-1)"	"prognostic favorable (6.16e-4)"	"unprognostic (3.82e-3)"	"unprognostic (1.01e-1)"	"unprognostic (7.53e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.74e-1)"	"unprognostic (7.47e-3)"	33.7	23.7	34.7	5.9	46.5	1.5	31.6	76.5	45.5	57.9	42.1	50.4	6.7	41.4	69.9	18.6	52.9	19.8	36.0	41.3	34.0	52.2	43.8	25.2	5.7	35.9	36.7	94.3	34.1	21.1	114.7	3.0	36.5	72.2	15.5	118.8	28.4	24.4	21.2	41.1	24.4	22.2	28.5	15.8	31.7	32.5	44.9	1.2	70.8	10.9	4.8	43.0	40.9	57.1	3.5	2.3	3.9	13.1	14.6	10.0	0.1	2.0	6.2	1.8	0.4	0.0	4.9	1.4	8.9	3.3	4.3	6.9	1.8	5.8	1.2	0.0	19.7	0.0	53.6	5.0	7.7	0.1	0.6	15.7	24.2	0.1	15.2	9.4	0.4	13.5	0.2	0.1	1.6	1.4	0.0	0.2	2.0	3.5	5.2	0.0	5.0	0.2	9.7	12.5	11.8	1.3	9.2	0.6	5.4	5.7	9.8	0.0	1.4	8.1	5.3	0.8	1.7	5.3	0.0	27.4	1.3	0.1	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	34.7	46.5	76.5	45.5	41.3	34.0	35.9	36.7	36.5	28.5	44.9	57.1	3.6	3.2	4.6	53.2	0.2	0.9	4.4	0.5	9.1	32.0	3.6	7.5	9.5	2.8	1.7	5.5	29.2	0.0	0.0	0.7	0.0	1.2	29.0	5.7	6.1	4.5	6.0	2.5	78.1	0.7	0.1	7.2	1.1	5.1	1.3	7.3	1.8	2.2	0.2	20.2	78.1	1.3	2.0	0.3	0.3	22.7	3.1	0.8	1.8	27.2	0.0	7.0	0.0	127.2	88.5	0.2	0.7	5.3	0.2	4.5	0.5	1.0	5.0	36.2	0.0	8.8	7.5	0.5	1.8	4.4	2.4	0.0	0.2	8.8	1.5	2.8
TDRD6	"bA446F17.4, CT41.2, NY-CO-45, SPATA36"	ENSG00000180113	"Tudor domain containing 6"	O60522	6	46687875-46704319	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Differentiation, Spermatogenesis"	"Developmental protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 30.3"	"Group enriched"	"Detected in many"	4	"Early spermatids: 224.8;Spermatocytes: 82.7"	"Cancer enhanced"	"Detected in some"		"prostate cancer: 2.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"HeLa: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA075923, HPA077353"	Enhanced		Approved	"Vesicles,Microtubules,Cytokinetic bridge,Mitotic spindle"		Yes	NA				"Cluster 21: Non-specific - Transcription"	"Cluster 20: HeLa - Mitochondria"	"Cluster 29: Early spermatids - Spermatogenesis"	"Microtubules, Cytokinetic bridge, Mitotic spindle"	Vesicles	"HPA075923: , HPA077353: "	"unprognostic (2.01e-1)"	"unprognostic (7.41e-3)"	"unprognostic (7.25e-3)"	"unprognostic (3.88e-2)"	"unprognostic (3.54e-1)"	"unprognostic (4.10e-2)"	"unprognostic (1.03e-1)"	"unprognostic (4.32e-2)"	"unprognostic (7.97e-2)"	"unprognostic (2.50e-1)"	"unprognostic (2.20e-3)"	"unprognostic (2.20e-1)"	"unprognostic (2.79e-1)"	"unprognostic (2.86e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.16e-2)"	"unprognostic (4.38e-3)"	0.7	1.7	3.3	3.0	5.1	0.2	0.8	7.8	5.4	1.2	1.8	1.0	0.7	0.9	3.4	0.6	0.8	2.2	1.6	4.1	2.6	2.1	2.5	0.7	4.0	3.9	3.2	1.1	1.1	0.4	3.0	1.6	4.1	2.0	0.3	8.9	1.3	0.6	2.3	3.5	0.7	0.4	2.7	2.5	0.8	30.3	3.7	0.0	5.6	0.1	0.1	1.1	0.8	4.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.3	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.8	0.0	0.0	0.0	0.2	0.2	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	5.1	7.8	5.4	4.1	2.6	3.9	3.2	4.1	2.7	3.7	4.0	0.8	9.6	0.5	3.9	0.0	0.5	0.4	0.1	1.2	11.3	0.4	0.8	3.4	0.0	3.8	7.3	6.2	0.0	0.0	0.0	1.9	0.3	224.8	1.0	2.2	1.2	4.2	0.0	13.6	0.2	0.0	1.0	0.0	0.7	0.0	0.4	0.7	3.0	0.1	5.0	14.7	0.3	0.0	0.3	0.0	33.8	4.1	0.5	3.6	6.5	0.0	1.1	0.0	14.6	17.8	0.1	0.0	4.5	0.0	0.6	0.4	0.4	0.2	7.5	13.1	3.0	0.5	82.7	34.7	0.0	1.6	0.0	0.0	1.4	0.5	0.2
PLA2G7	"LDL-PLA2, PAFAH"	ENSG00000146070	"Phospholipase A2 group VII"	Q13093	6	46704201-46735693	"Candidate cardiovascular disease genes, Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted secreted proteins"	"Lipid degradation, Lipid metabolism, Phospholipid degradation, Phospholipid metabolism"	Hydrolase	"Asthma, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 27.2;placenta: 23.3"	"Group enriched"	"Detected in many"	5	"Hofbauer cells: 372.2;Macrophages: 140.9"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 37.2"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"classical monocyte: 43.4"	"Group enriched"	"Detected in many"	49	"dendritic cells: 14.1;monocytes: 43.4"	"Cell line enhanced"	"Detected in some"		"NTERA-2: 1.7;PC-3: 3.4;RT4: 1.6;U-2 OS: 1.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Secreted to blood"	NA	NA	7380000	290000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 16: Immune cells - Immune response"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 4: Macrophages - Innate immune response"				"unprognostic (3.63e-3)"	"unprognostic (2.82e-3)"	"unprognostic (8.69e-2)"	"unprognostic (3.00e-1)"	"unprognostic (1.47e-1)"	"unprognostic (6.26e-2)"	"unprognostic (9.45e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.06e-2)"	"unprognostic (5.33e-2)"	"unprognostic (2.35e-2)"	"unprognostic (2.47e-1)"	"unprognostic (9.20e-2)"	"unprognostic (1.93e-1)"	"unprognostic (7.08e-2)"	4.5	3.1	1.6	22.9	3.6	2.8	2.6	2.7	4.5	2.5	0.4	7.5	4.1	4.8	1.1	0.6	1.9	6.0	0.6	2.6	1.4	0.3	6.9	7.2	26.8	3.9	2.6	1.1	0.8	21.0	2.1	23.3	4.2	13.1	10.3	0.6	1.4	2.6	0.4	3.6	3.3	2.8	2.6	27.2	2.9	0.9	8.9	4.9	20.2	0.0	10.0	11.1	0.3	7.4	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.9	0.7	0.0	0.0	0.0	0.1	0.8	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.7	0.0	3.4	0.0	0.0	0.0	0.0	1.6	0.0	0.2	0.0	0.0	0.0	0.4	0.4	0.4	0.0	0.0	1.6	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.6	0.3	43.4	0.3	0.1	9.2	0.3	0.3	0.0	0.0	14.1	0.0	0.0	0.1	0.5	0.0	0.5	0.3	0.0	11.9	1.6	3.6	2.7	4.5	2.6	1.4	3.9	2.6	4.2	2.6	8.9	7.4	0.5	0.0	1.3	0.3	3.6	0.8	4.4	0.0	0.0	0.2	0.3	4.3	0.3	0.0	0.0	0.0	0.0	1.6	0.0	0.2	0.0	0.6	0.1	1.6	50.3	0.6	3.5	0.0	7.1	0.0	5.1	1.8	0.0	1.5	0.0	0.0	0.0	0.0	372.2	1.7	4.8	0.3	0.0	24.6	4.9	0.1	0.0	140.9	10.6	11.2	29.3	0.3	0.0	6.0	0.3	0.3	0.0	0.0	0.1	6.9	0.0	0.1	0.0	0.1	0.0	0.9	0.6	0.1	0.0	0.1	0.1	3.1	0.8	8.9	0.2	3.8
ANKRD66		ENSG00000230062	"Ankyrin repeat domain 66"	B4E2M5	6	46746917-46759506	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"fallopian tube: 40.2"	"Group enriched"	"Detected in some"	8	"Endometrial ciliated cells: 104.2;Respiratory ciliated cells: 184.4"	"Cancer enriched"	"Detected in single"	5	"endometrial cancer: 1.0"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"									NA	NA				"Cluster 42: Ciliated cells - Cilium & Cell projection"		"Cluster 49: Ciliated cells - Cilium organization"							"unprognostic (1.67e-3)"	"unprognostic (2.52e-1)"			"unprognostic (2.44e-2)"		"unprognostic (2.03e-2)"		"unprognostic (9.36e-2)"		"unprognostic (4.30e-3)"	"unprognostic (2.19e-1)"			0.0	0.0	0.8	0.0	0.9	0.0	0.0	0.4	0.2	0.8	0.8	0.0	0.0	0.7	0.0	0.0	40.2	0.0	0.0	0.8	1.4	0.0	0.0	3.2	0.0	4.5	5.1	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.9	0.4	0.2	0.8	1.4	4.5	5.1	3.4	3.1	0.9	1.5	0.0	0.0	0.5	0.0	0.0	0.0	0.1	8.5	0.0	0.0	0.0	0.0	0.1	0.0	17.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	104.2	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	184.4	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1
MEP1A	PPHA	ENSG00000112818	"Meprin A subunit alpha"	Q16819	6	46793389-46839778	"Enzymes, Plasma proteins, Predicted membrane proteins"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	101	"intestine: 467.7"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 309.4;Intestinal goblet cells: 87.0;Paneth cells: 156.9;Proximal enterocytes: 902.8"	"Cancer enriched"	"Detected in many"	5	"colorectal cancer: 38.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 1.3;CACO-2: 2.9;RPMI-8226: 1.2"									"CAB025163, HPA029416"	Enhanced					NA	NA		2100000		"Cluster 56: Intestine - Transmembrane transport"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 45: Enterocytes - Digestion"			"CAB025163: , HPA029416: AB_10600823"	"unprognostic (1.83e-1)"	"unprognostic (2.81e-4)"	"unprognostic (2.03e-1)"	"unprognostic (8.53e-2)"	"unprognostic (8.73e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.43e-2)"	"unprognostic (5.27e-4)"	"unprognostic (2.05e-1)"	"unprognostic (2.35e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.11e-3)"	"unprognostic (1.45e-1)"	"unprognostic (1.91e-2)"	"unprognostic (4.70e-3)"	"unprognostic (1.68e-1)"	0.2	0.0	0.0	4.6	0.0	0.0	0.1	0.0	0.1	0.0	0.0	115.6	269.9	0.3	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.1	0.0	4.2	0.0	0.0	0.5	0.1	0.1	102.5	0.0	0.0	0.2	0.0	0.0	467.7	2.6	0.0	0.1	0.5	0.7	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	309.4	0.0	0.0	7.7	0.1	0.0	0.0	15.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	87.0	0.0	0.0	0.0	6.9	0.0	0.2	0.0	3.7	0.0	0.0	0.0	0.5	0.3	0.0	156.9	0.4	0.0	0.0	902.8	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	45.8	0.0
ADGRF5	"DKFZp564O1923, GPR116, KIAA0758"	ENSG00000069122	"Adhesion G protein-coupled receptor F5"	Q8IZF2	6	46852522-46954943	"G-protein coupled receptors, Plasma proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 104.5"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 428.1;Alveolar cells type 1: 291.7;Alveolar cells type 2: 539.9;Endothelial cells: 222.6;Hepatic stellate cells: 251.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"HUVEC TERT2: 25.0;TIME: 74.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA		55000000		"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"				"unprognostic (8.45e-2)"	"unprognostic (3.00e-3)"	"unprognostic (1.13e-1)"	"unprognostic (3.26e-1)"	"unprognostic (6.51e-2)"	"unprognostic (1.89e-2)"	"unprognostic (5.76e-2)"	"unprognostic (9.00e-3)"	"unprognostic (7.80e-2)"	"unprognostic (3.32e-1)"	"unprognostic (1.42e-1)"	"unprognostic (4.56e-2)"	"prognostic favorable (8.84e-5)"	"unprognostic (1.43e-2)"	"unprognostic (5.91e-2)"	"unprognostic (2.82e-2)"	"unprognostic (3.78e-2)"	69.8	22.8	15.1	6.9	15.0	0.0	46.0	15.0	18.0	10.4	8.6	9.9	5.7	16.0	7.7	7.0	15.0	16.9	51.6	12.8	15.1	58.9	13.0	104.5	8.5	16.6	15.6	6.5	6.4	13.2	6.7	50.6	18.2	8.9	5.7	1.8	5.9	9.2	30.4	7.7	8.5	21.8	13.8	40.5	8.4	3.1	21.6	3.7	32.2	70.2	3.2	11.4	10.0	15.3	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	74.1	0.0	0.2	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.1	15.0	15.0	18.0	12.8	15.1	16.6	15.6	18.2	13.8	21.6	15.3	428.1	291.7	539.9	2.0	2.9	0.0	0.2	0.0	2.2	0.0	1.5	2.9	16.2	8.6	89.7	1.8	0.0	0.2	1.1	0.6	11.7	0.2	10.6	0.8	1.2	222.6	0.0	0.0	8.4	0.0	1.1	9.0	2.6	0.4	12.6	0.0	251.3	4.0	0.2	0.0	1.0	0.5	0.0	13.7	0.0	4.8	3.1	2.7	0.0	104.0	0.0	0.0	0.0	1.0	0.4	0.0	0.0	0.0	1.2	0.6	0.5	0.2	48.1	0.7	98.6	9.6	80.1	0.2	0.9	0.6	0.0	0.3	1.8	15.5	0.1	0.8
ADGRF1	"GPR110, hGPCR36, PGR19"	ENSG00000153292	"Adhesion G protein-coupled receptor F1"	Q5T601	6	46997708-47042350	"G-protein coupled receptors, Predicted membrane proteins, Predicted secreted proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"esophagus: 17.5;kidney: 20.3;urinary bladder: 42.6"	"Group enriched"	"Detected in some"	4	"Collecting duct cells: 108.5;Pancreatic endocrine cells: 98.9;Urothelial cells: 363.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 31.2;CAPAN-2: 113.3;HaCaT: 25.3;PC-3: 36.6;RPTEC TERT1: 50.9;RT4: 132.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA038438	Approved				"Secreted - unknown location"	NA	NA				"Cluster 37: Intestine - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 22: Epithelial cell types - Mixed function"			"HPA038438: AB_10672645"	"unprognostic (4.83e-4)"	"unprognostic (1.38e-1)"	"unprognostic (1.64e-1)"	"unprognostic (6.71e-3)"	"unprognostic (1.95e-3)"	"unprognostic (3.02e-3)"	"unprognostic (7.76e-2)"	"unprognostic (2.63e-2)"	"unprognostic (2.90e-1)"	"unprognostic (4.20e-2)"	"unprognostic (3.64e-3)"	"unprognostic (1.99e-1)"	"prognostic favorable (1.35e-5)"	"unprognostic (7.41e-2)"	"unprognostic (8.39e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.08e-2)"	0.1	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	3.4	0.0	0.3	0.0	0.2	0.1	17.5	0.8	6.1	0.0	0.0	0.0	20.3	0.0	3.6	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	3.0	0.1	0.0	3.2	1.7	0.0	0.0	3.2	0.0	0.0	0.0	1.4	0.6	0.0	0.1	6.2	0.0	5.9	42.6	6.4	0.0	31.2	0.1	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	113.3	0.0	2.0	0.0	0.0	25.3	0.0	7.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	20.5	36.6	0.0	0.0	0.0	50.9	132.6	0.0	0.0	0.0	4.2	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	21.8	0.0	0.1	0.0	25.4	0.0	0.6	0.0	5.5	1.9	0.7	12.8	13.6	108.5	0.0	0.0	0.0	1.5	23.5	30.8	0.0	7.0	5.0	0.7	0.0	0.0	0.1	18.9	0.1	0.8	3.6	46.9	1.3	0.0	0.0	0.0	0.1	0.0	0.1	0.6	0.0	0.0	0.0	0.2	0.3	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	98.9	0.0	0.0	0.0	39.1	1.2	0.7	14.6	0.0	0.0	0.2	1.1	0.0	0.2	2.6	0.0	0.1	1.0	0.1	0.2	363.7
TNFRSF21	"CD358, DR6"	ENSG00000146072	"TNF receptor superfamily member 21"	O75509	6	47231532-47309905	"CD markers, Metabolic proteins, Plasma proteins, Predicted membrane proteins"	"Adaptive immunity, Apoptosis, Host-virus interaction, Immunity"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"urinary bladder: 148.1"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 179.9;Prostatic glandular cells: 180.8;Syncytiotrophoblasts: 178.7;Urothelial cells: 387.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	35	"plasmacytoid DC: 69.2"	"Lineage enriched"	"Detected in single"	303	"dendritic cells: 69.2"	"Cell line enhanced"	"Detected in many"		"OE19: 208.0;RT4: 523.8;SuSa: 213.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006746, CAB009805"	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA		2300000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 15: RT4 - Unknown function"	"Cluster 22: Epithelial cell types - Mixed function"	"Plasma membrane, Cytosol"		"CAB009805: AB_2206956, HPA006746: AB_1078701"	"unprognostic (1.19e-2)"	"unprognostic (2.70e-1)"	"unprognostic (3.26e-1)"	"unprognostic (7.85e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.41e-2)"	"unprognostic (9.80e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.46e-2)"	"unprognostic (7.53e-2)"	"unprognostic (1.38e-3)"	"unprognostic (1.74e-1)"	"prognostic favorable (7.23e-6)"	"unprognostic (1.48e-1)"	"unprognostic (1.34e-1)"	"unprognostic (9.78e-2)"	"unprognostic (1.45e-2)"	55.7	6.6	17.6	17.7	31.0	13.4	13.4	48.9	31.4	17.5	1.1	38.1	12.3	17.1	2.5	41.3	16.4	35.7	9.8	21.8	27.4	49.6	8.9	16.9	17.2	76.8	43.8	6.5	20.0	58.8	6.5	33.2	56.9	13.7	34.8	4.1	25.6	4.0	6.0	4.0	19.2	15.7	43.7	14.9	60.8	8.1	49.0	26.8	4.0	14.1	32.9	148.1	17.1	100.1	156.6	50.0	47.7	15.3	127.4	37.5	53.9	17.9	34.9	5.5	2.1	86.7	107.7	11.6	70.3	13.1	101.8	92.2	7.2	66.1	3.1	0.2	15.1	0.1	6.4	88.2	74.6	2.5	0.6	67.1	77.2	3.3	58.1	4.2	25.8	10.1	3.8	0.1	1.9	30.8	13.9	1.4	37.5	208.0	50.8	29.1	14.7	17.1	90.8	523.8	34.1	7.5	15.6	14.4	12.9	213.0	11.1	11.0	5.2	14.1	12.9	0.5	16.5	0.1	0.2	16.1	23.1	11.1	40.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.1	0.0	0.0	0.1	0.1	0.1	69.2	0.0	0.6	17.6	31.0	48.9	31.4	21.8	27.4	76.8	43.8	56.9	43.7	49.0	100.1	5.5	0.0	9.8	1.6	3.1	23.7	179.9	140.5	64.9	1.1	8.0	10.8	10.2	35.8	59.9	1.8	0.0	31.0	77.3	100.7	15.6	86.8	55.0	12.0	17.3	8.6	12.0	3.0	46.6	29.6	21.4	32.9	80.5	13.8	19.7	2.1	1.1	0.3	22.4	0.0	29.6	42.9	107.8	53.6	12.5	40.3	2.8	22.6	12.4	13.1	0.6	5.4	0.0	53.3	44.7	89.1	54.5	1.2	2.0	180.8	14.7	51.3	54.7	1.4	78.9	21.5	24.2	1.0	3.7	40.4	9.9	178.7	2.8	13.1	19.9	387.3
CD2AP	CMS	ENSG00000198087	"CD2 associated protein"	Q9Y5K6	6	47477789-47627263	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 204.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 9.9"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003267, HPA003326, CAB004352"	Enhanced		Supported	"Plasma membrane,Centriolar satellite"		NA	NA		58000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane"	"Centriolar satellite"	"CAB004352: AB_627009, HPA003267: AB_1078458, HPA003326: AB_1078457"	"unprognostic (5.98e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.75e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.77e-2)"	"unprognostic (1.74e-3)"	"unprognostic (1.19e-1)"	"unprognostic (6.71e-2)"	"unprognostic (2.69e-2)"	"prognostic unfavorable (5.53e-5)"	"unprognostic (2.21e-1)"	"unprognostic (3.09e-3)"	"unprognostic (6.12e-3)"	"unprognostic (1.74e-1)"	"unprognostic (1.84e-1)"	"prognostic favorable (7.57e-5)"	14.0	10.5	3.4	15.0	3.4	14.3	17.8	6.3	4.6	18.1	8.8	40.0	56.9	12.0	13.2	19.2	14.1	15.0	7.7	2.7	3.8	34.1	20.2	17.1	15.9	4.3	3.9	6.4	20.2	35.6	6.0	21.6	4.7	19.7	36.9	6.9	17.0	13.5	6.9	18.0	59.5	10.9	4.3	13.7	40.4	9.4	3.9	34.0	18.2	10.3	17.4	30.1	10.1	4.6	58.0	22.5	6.9	14.3	9.4	13.6	54.8	13.9	16.9	18.5	23.3	37.3	39.9	74.5	56.9	18.2	24.0	21.2	23.0	34.7	29.9	29.9	37.2	41.3	18.4	33.6	12.5	23.3	15.4	9.7	32.1	17.7	25.5	35.7	30.1	24.4	73.5	23.2	16.9	18.2	44.6	8.7	20.3	69.6	8.1	23.6	17.6	34.1	115.6	101.7	20.9	8.1	27.9	36.9	27.7	31.1	35.0	14.8	36.2	36.9	30.8	12.0	39.9	17.5	31.3	52.6	39.4	12.4	19.2	1.8	0.5	3.2	1.2	0.4	1.8	0.9	1.0	1.1	1.2	1.0	0.9	1.5	0.1	3.1	0.4	9.9	0.9	0.5	3.4	3.4	6.3	4.6	2.7	3.8	4.3	3.9	4.7	4.3	3.9	4.6	81.7	96.1	67.1	32.0	40.5	32.2	52.1	26.5	39.9	10.0	40.4	26.4	17.2	35.8	68.9	71.7	16.7	53.0	96.1	204.1	21.5	84.6	10.4	97.9	25.0	56.6	55.8	42.9	40.7	98.0	17.1	20.6	101.4	136.7	24.1	28.5	37.5	24.2	17.4	15.2	45.3	97.3	40.7	26.2	12.6	10.5	16.8	30.6	14.2	83.4	18.0	12.5	22.6	28.6	30.8	151.3	114.0	10.9	27.7	89.0	182.3	67.4	60.0	13.0	26.3	34.9	27.8	38.9	27.2	44.2	41.1	40.9	29.4	48.0	68.8	143.6
ADGRF2	"GPR111, hGPCR35, PGR20"	ENSG00000164393	"Adhesion G protein-coupled receptor F2"	Q8IZF7	6	47656436-47697797	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"fallopian tube: 1.0;skin 1: 2.1"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 1.1;Early spermatids: 1.0;Endometrial ciliated cells: 1.6;Excitatory neurons: 1.2;Glandular and luminal cells: 1.3;Squamous epithelial cells: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							HPA035507	Uncertain					NA	NA				"Cluster 31: Skin - Epidermis development"		"Cluster 44: Endometrium - Transcription"			"HPA035507: AB_10601809"	"unprognostic (1.79e-2)"	"unprognostic (1.10e-1)"	"unprognostic (5.16e-2)"	"unprognostic (3.74e-2)"	"unprognostic (5.95e-1)"	"unprognostic (1.59e-1)"		"unprognostic (1.53e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.51e-4)"		"unprognostic (3.05e-2)"	"unprognostic (3.86e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.24e-1)"	"unprognostic (7.99e-2)"	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	2.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	1.6	0.1	0.4	0.0	0.0	1.2	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.1
ADGRF4	"FLJ38076, GPR115, PGR18"	ENSG00000153294	"Adhesion G protein-coupled receptor F4"	Q8IZF3	6	47685864-47722021	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 18.3;skin 1: 38.8"	"Cell type enhanced"	"Detected in some"		"Extravillous trophoblasts: 15.1;Pancreatic endocrine cells: 20.5;Prostatic glandular cells: 6.0;Squamous epithelial cells: 14.4;Syncytiotrophoblasts: 7.3;Urothelial cells: 20.5"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 8.2"	"Region enriched"	"Detected in single"	5	"hypothalamus: 1.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 13.2;HBEC3-KT: 21.0;hTCEpi: 31.8;OE19: 18.4;U-87 MG: 26.5"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"HPA007131, HPA007158"	Enhanced		Uncertain	Mitochondria		NA	NA				"Cluster 31: Skin - Epidermis development"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 22: Epithelial cell types - Mixed function"	Mitochondria		"HPA007131: AB_2667756, HPA007158: AB_1849254"	"unprognostic (1.40e-2)"	"unprognostic (7.06e-3)"	"unprognostic (2.11e-1)"	"unprognostic (4.68e-2)"	"unprognostic (3.79e-2)"	"unprognostic (3.77e-2)"		"unprognostic (2.04e-3)"	"unprognostic (2.64e-1)"	"unprognostic (3.47e-1)"	"prognostic unfavorable (5.52e-4)"	"unprognostic (2.86e-1)"	"unprognostic (1.66e-8)"	"unprognostic (1.62e-3)"	"unprognostic (2.01e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.25e-1)"	0.2	0.7	0.0	0.2	0.0	0.0	2.2	0.4	0.1	4.7	0.0	1.2	0.0	0.3	0.0	18.3	1.1	0.7	0.6	0.0	1.9	0.7	0.0	0.1	0.0	0.0	0.2	0.2	0.0	0.0	0.1	2.0	0.0	0.2	1.5	0.0	2.4	0.0	0.6	38.8	0.2	0.1	0.0	0.0	0.0	0.5	0.1	0.2	0.0	0.9	4.1	4.3	9.6	0.0	8.9	1.2	0.0	0.0	0.0	0.0	1.0	0.0	5.1	0.1	0.0	2.4	0.0	0.0	0.0	0.0	8.2	13.2	0.0	21.0	0.2	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.0	0.0	31.8	0.4	0.7	1.6	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	18.4	1.2	0.0	0.0	0.0	0.0	8.2	0.0	0.0	0.4	1.8	0.1	0.2	0.0	0.0	0.0	0.8	0.1	1.0	0.0	0.0	0.0	0.0	26.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	1.9	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.6	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	1.2	0.0	4.4	0.0	3.5	0.7	1.6	0.3	0.2	0.0	0.0	0.6	3.4	15.1	0.4	0.0	3.8	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.5	0.5	0.0	0.0	6.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	14.4	0.0	7.3	0.0	0.0	0.1	20.5
OPN5	"dJ402H5.1, neuropsin, TMEM13"	ENSG00000124818	"Opsin 5"	Q6U736	6	47781982-47832780	"G-protein coupled receptors, Predicted membrane proteins"	"Sensory transduction, Vision"	"G-protein coupled receptor, Photoreceptor protein, Receptor, Retinal protein, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	6	"testis: 2.6"	"Group enriched"	"Detected in some"	11	"Early spermatids: 27.1;Late spermatids: 25.6;Spermatocytes: 13.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA026084	Supported					NA	NA				"Cluster 78: Testis - Spermatogenesis"		"Cluster 25: Spermatids - Spermatogenesis"			"HPA026084: AB_2671807"					"unprognostic (1.95e-1)"								"unprognostic (6.18e-2)"		"unprognostic (4.84e-1)"	"unprognostic (1.07e-1)"		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.1	0.2	0.0	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	25.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.0	0.0	13.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PTCHD4	"C6orf138, dJ402H5.2, FLJ41841, PTCH53"	ENSG00000244694	"Patched domain containing 4"	Q6ZW05	6	47856673-48111197	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in some"			"Cell type enriched"	"Detected in some"	5	"Inhibitory neurons: 479.8"	"Group enriched"	"Detected in some"	6	"melanoma: 1.1;renal cancer: 1.6;thyroid cancer: 4.0"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 9.4;BEWO: 12.4;Hep G2: 21.8;LHCN-M2: 9.6;SuSa: 20.1;TIME: 9.9;WM-115: 11.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA041276	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA				"Cluster 68: Epididymis - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane, Cytosol"		"HPA041276: AB_10796570"	"unprognostic (1.35e-4)"	"unprognostic (1.66e-2)"	"unprognostic (3.25e-1)"	"unprognostic (3.11e-3)"	"unprognostic (1.07e-2)"	"unprognostic (1.57e-3)"	"unprognostic (7.94e-2)"	"unprognostic (3.59e-3)"	"unprognostic (2.80e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.55e-1)"	"unprognostic (1.92e-1)"	"prognostic favorable (1.49e-6)"	"unprognostic (5.03e-4)"	"unprognostic (9.84e-2)"	"unprognostic (1.57e-2)"	"unprognostic (5.56e-3)"	0.5	0.1	0.6	0.0	0.6	0.0	0.3	0.0	1.5	0.6	0.1	0.3	0.1	0.3	0.6	0.3	0.5	0.2	0.5	0.8	0.5	0.4	0.3	0.5	0.0	0.2	1.0	0.2	0.2	0.0	0.9	0.3	0.0	0.5	0.1	0.8	0.5	1.0	0.1	0.0	0.1	0.3	0.5	0.0	0.1	0.2	0.3	0.0	0.8	0.1	0.0	0.3	0.3	0.4	0.0	0.0	9.4	0.0	1.3	3.9	12.4	1.2	2.8	0.0	0.4	0.0	0.5	0.0	0.0	0.9	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.2	21.8	0.5	0.0	0.0	6.2	5.4	0.0	0.1	4.4	1.8	2.5	0.0	0.0	9.6	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.8	0.5	0.1	0.0	0.0	20.1	0.0	0.0	9.9	2.3	1.9	0.0	0.2	0.0	0.0	0.0	3.3	0.0	11.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.6	0.0	1.5	0.8	0.5	0.2	1.0	0.0	0.5	0.3	0.4	0.5	0.0	1.1	6.5	0.0	0.1	0.0	1.0	0.0	1.0	0.4	0.3	0.2	0.0	1.3	1.8	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.6	0.0	0.0	90.6	0.0	0.1	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	479.8	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	89.9	0.0	0.6	0.0	2.5	2.8	0.1	0.0	0.4	0.0	0.2	0.0	0.0	1.1	0.9	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1
MMUT	"MCM, MUT"	ENSG00000146085	"Methylmalonyl-CoA mutase"	P22033	6	49430360-49463253	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Isomerase	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 199.0"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 62.5;Cytotrophoblasts: 26.5;Extravillous trophoblasts: 13.3;Hofbauer cells: 12.4;Syncytiotrophoblasts: 33.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035971, HPA035972"	Enhanced		Approved	Mitochondria,Cytosol		NA	NA		150000	"Cluster 27: Non-specific - Gene expression"	"Cluster 85: Liver - Metabolism"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol	Mitochondria	"HPA035971: AB_10696648, HPA035972: AB_2674895"	"unprognostic (1.34e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.17e-2)"	"unprognostic (3.72e-2)"	"unprognostic (3.18e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.16e-2)"	"unprognostic (3.62e-2)"	"unprognostic (1.89e-2)"	"unprognostic (6.57e-2)"	"unprognostic (9.89e-2)"	"prognostic favorable (8.71e-13)"	"unprognostic (5.38e-2)"	"unprognostic (3.78e-1)"	"unprognostic (6.01e-3)"	"unprognostic (1.91e-1)"	19.8	23.3	12.1	11.5	13.2	8.6	18.4	14.2	16.2	14.0	19.3	22.6	27.1	15.2	15.6	17.9	13.9	14.2	31.0	12.1	13.5	50.6	199.0	12.5	11.8	13.0	12.7	24.2	24.6	31.1	11.7	13.2	13.2	20.8	21.5	17.2	18.7	15.8	23.6	15.0	20.1	14.9	14.1	9.4	20.1	14.6	13.3	12.2	19.2	36.1	11.2	13.0	11.9	16.3	23.9	8.3	24.6	28.8	47.8	45.1	13.6	20.9	27.3	21.6	31.7	9.7	12.1	21.9	16.3	22.4	32.6	13.3	27.6	14.8	30.2	18.9	20.0	11.7	17.5	25.4	34.8	15.1	10.8	27.4	21.6	22.0	25.4	19.3	21.1	23.4	21.6	25.6	25.7	15.0	17.9	14.9	10.5	25.0	6.0	15.8	30.8	30.7	24.9	22.6	22.7	15.8	23.0	16.3	35.7	25.6	14.2	23.9	15.4	20.0	14.6	27.4	28.7	10.0	12.2	18.8	28.1	17.6	17.9	16.0	6.5	11.4	6.4	8.8	8.2	7.6	7.7	8.1	7.8	6.9	9.6	7.2	3.8	12.5	14.7	5.5	10.9	5.8	12.1	13.2	14.2	16.2	12.1	13.5	13.0	12.7	13.2	14.1	13.3	16.3	6.6	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	62.5	0.0	0.0	0.0	0.0	26.5	2.2	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	13.3	5.3	0.0	0.0	0.0	0.0	0.0	0.0	12.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	33.4	0.6	0.0	0.0	0.0
CENPQ	"C6orf139, CENP-Q, FLJ10545"	ENSG00000031691	"Centromere protein Q"	Q7L2Z9	6	49463370-49493107	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatogonia: 34.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029043, HPA046634, HPA054965"	Approved		Supported	Nucleoplasm		NA	Yes			"Cluster 37: B-cells - Transcription"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"HPA029043: AB_2672881, HPA046634: AB_2679728, HPA054965: AB_2682653"	"unprognostic (7.39e-2)"	"unprognostic (7.33e-2)"	"unprognostic (1.37e-2)"	"prognostic unfavorable (4.64e-4)"	"unprognostic (2.49e-2)"	"unprognostic (1.40e-1)"	"prognostic unfavorable (2.21e-5)"	"unprognostic (1.36e-1)"	"unprognostic (1.76e-2)"	"prognostic favorable (6.26e-4)"	"unprognostic (2.89e-1)"	"unprognostic (8.19e-2)"	"unprognostic (1.48e-3)"	"unprognostic (8.93e-2)"	"unprognostic (7.47e-2)"	"unprognostic (2.74e-3)"	"unprognostic (2.56e-1)"	4.8	4.7	4.7	5.4	5.8	4.9	5.4	5.8	6.9	3.1	3.8	3.9	2.8	4.7	3.0	4.3	4.0	3.5	6.4	4.2	5.1	3.8	4.4	3.8	7.0	5.8	5.2	6.2	2.5	3.6	2.3	5.9	6.0	4.5	4.7	4.2	2.8	3.3	5.0	4.0	3.3	4.4	5.3	4.7	3.8	6.0	4.8	9.4	3.7	8.4	8.4	3.7	3.3	7.6	35.3	9.7	30.1	18.9	8.0	12.4	26.4	44.6	25.5	41.9	58.4	11.9	13.8	23.7	21.7	12.7	32.8	12.5	15.8	16.2	61.6	25.9	22.0	17.5	14.6	19.2	3.4	37.4	21.2	5.7	8.7	51.5	17.9	10.7	15.5	20.4	27.3	22.9	31.4	10.2	26.4	17.6	18.8	30.6	8.7	18.8	35.6	25.8	12.3	14.3	16.2	16.0	21.0	12.4	23.9	29.6	15.9	33.8	9.2	32.3	25.2	25.7	40.4	10.4	28.9	21.4	21.9	27.8	32.0	2.2	1.2	4.1	2.0	1.4	2.0	4.4	2.1	2.3	1.3	4.5	2.3	2.3	0.9	2.4	1.8	2.7	3.2	1.2	4.7	5.8	5.8	6.9	4.2	5.1	5.8	5.2	6.0	5.3	4.8	7.6	8.6	0.0	2.7	7.2	9.5	8.7	9.9	10.4	8.6	6.3	4.1	4.7	6.2	4.3	5.2	7.3	2.1	17.3	8.7	4.2	7.9	7.8	1.3	8.8	5.6	8.0	2.4	5.9	3.0	7.9	30.8	9.3	6.6	5.4	4.5	6.3	14.3	3.4	10.1	6.7	3.1	3.7	2.0	11.4	6.0	2.3	8.7	5.9	3.6	11.2	7.6	14.5	13.4	6.6	13.5	7.8	8.0	10.9	7.5	5.4	1.7	4.4	9.4	5.1	6.6	15.2	6.5	17.7	34.6	6.5	7.0	12.4	5.9	4.2	5.9	6.2
GLYATL3	"bA28H17.2, C6orf140"	ENSG00000203972	"Glycine-N-acyltransferase like 3"	Q5SZD4	6	49499923-49528078	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"liver: 1.2"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in single"		"endometrial cancer: 0.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	67	"T-47d: 13.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA044044	Uncertain					NA	NA				"Cluster 85: Liver - Metabolism"	"Cluster 6: T47d - Mammary gland"				"HPA044044: AB_10960855"				"unprognostic (3.57e-1)"			"unprognostic (6.85e-2)"											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
C6orf141	MGC46457	ENSG00000197261	"Chromosome 6 open reading frame 141"	Q5SZD1	6	49550646-49561907	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 41.3;Basal prostatic cells: 38.8;Distal enterocytes: 41.0;Ductal cells: 39.2;Enteroendocrine cells: 106.3;Gastric mucus-secreting cells: 50.4;Glandular and luminal cells: 61.7;Paneth cells: 39.6"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"basal ganglia: 5.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"GAMG: 7.6;HaCaT: 8.7;HeLa: 8.4;PC-3: 11.7;T-47d: 7.3"	"Not detected"	"Not detected"							HPA036199	Uncertain		Approved	"Nuclear membrane"		NA	NA				"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 44: Endometrium - Transcription"	"Nuclear membrane"		"HPA036199: AB_2675002"	"prognostic favorable (3.92e-6)"	"unprognostic (1.58e-1)"	"unprognostic (9.87e-2)"	"prognostic favorable (1.15e-4)"	"unprognostic (4.95e-2)"	"unprognostic (2.15e-2)"	"unprognostic (1.39e-3)"	"unprognostic (8.13e-2)"	"unprognostic (7.02e-2)"	"unprognostic (2.85e-2)"	"unprognostic (6.37e-3)"	"unprognostic (1.41e-1)"	"unprognostic (1.89e-8)"	"unprognostic (2.33e-2)"	"unprognostic (5.81e-1)"	"unprognostic (3.77e-1)"	"unprognostic (4.43e-1)"	4.0	0.1	0.0	0.5	5.4	0.0	4.2	1.1	1.8	3.0	0.0	1.8	6.4	1.8	0.5	2.8	2.2	6.0	0.3	0.4	0.1	0.2	1.1	0.5	0.3	2.4	0.4	0.5	3.1	0.0	1.6	0.1	2.4	0.4	0.7	0.0	4.2	0.3	0.7	2.8	1.0	0.4	0.0	0.0	5.5	1.8	1.2	0.0	1.3	0.4	0.4	0.9	3.5	0.0	4.8	3.1	0.0	0.0	0.0	0.0	1.6	0.9	0.9	0.0	0.0	0.2	3.2	0.0	0.5	1.5	7.6	8.7	0.9	2.3	0.0	0.0	5.5	0.0	8.4	0.0	0.2	0.0	0.0	0.3	6.6	0.0	4.7	2.6	1.7	0.0	0.2	0.0	0.0	0.1	0.0	0.0	3.2	1.2	11.7	0.0	0.0	0.0	1.5	5.3	0.3	0.0	2.1	0.0	0.0	0.4	7.3	0.0	2.7	0.4	0.0	0.0	5.8	0.0	0.0	0.0	4.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	1.1	1.8	0.4	0.1	2.4	0.4	2.4	0.0	1.2	0.0	19.9	0.0	3.1	0.0	0.0	41.3	38.8	2.9	13.1	0.0	8.1	3.7	2.1	8.6	7.6	0.0	0.0	3.9	0.4	41.0	0.0	39.2	0.3	36.9	3.8	11.9	106.3	0.0	1.9	9.0	18.5	2.3	50.4	61.7	0.0	0.8	0.4	0.3	0.9	0.0	0.4	3.1	4.1	0.0	2.1	0.7	0.6	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	12.2	39.6	0.4	0.1	8.2	0.7	0.1	3.9	0.0	0.0	0.4	0.9	0.5	1.1	25.7	35.9	2.1	0.4	0.1	7.6	19.3
RHAG	"CD241, RH50A, SLC42A1"	ENSG00000112077	"Rh associated glycoprotein"	Q02094	6	49605175-49636839	"CD markers, Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Ammonia transport, Transport"		"Disease variant, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	54	"bone marrow: 119.6"	"Cell type enriched"	"Detected in some"	170	"Erythroid cells: 494.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	202	"HEL: 506.0;K-562: 491.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA046051, HPA055331"	Approved		Approved	"Endoplasmic reticulum"		NA	NA				"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 6: Erythroid cells - Oxygen transport"	"Endoplasmic reticulum"		"HPA046051: , HPA055331: AB_2682785"					"unprognostic (8.16e-2)"						"unprognostic (6.86e-2)"	"unprognostic (1.25e-3)"		"unprognostic (1.65e-1)"				0.2	0.0	0.0	0.0	0.0	119.6	0.0	0.0	0.0	0.7	0.0	0.5	0.1	0.1	0.0	0.1	0.2	0.0	2.1	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.2	0.0	0.2	0.2	0.0	0.2	0.6	0.0	0.1	0.4	0.0	0.0	1.7	0.2	0.1	0.0	0.1	0.1	0.1	0.0	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	506.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	491.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	1.4	0.4	0.1	0.3	0.0	494.2	0.2	0.2	0.6	0.3	0.0	0.6	2.5	0.0	1.1	0.1	0.5	0.0	0.1	0.0	0.0	0.6	0.3	2.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.4	0.1	0.0	0.0
CRISP2	"CRISP-2, CT36, GAPDL5, TPX1"	ENSG00000124490	"Cysteine rich secretory protein 2"	P16562	6	49692358-49713590	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	29	"testis: 505.0"	"Group enriched"	"Detected in some"	33	"Early spermatids: 5765.5;Late spermatids: 21517.6"	"Cancer enhanced"	"Detected in some"		"pancreatic cancer: 1.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA031248	Enhanced				"Secreted in male reproductive system"	NA	NA		820000		"Cluster 83: Testis - Spermatogenesis"		"Cluster 25: Spermatids - Spermatogenesis"			"HPA031248: AB_10602211"	"unprognostic (1.10e-1)"							"unprognostic (1.51e-1)"		"unprognostic (1.72e-2)"	"unprognostic (7.38e-2)"	"unprognostic (2.35e-2)"		"unprognostic (9.23e-3)"	"unprognostic (4.05e-2)"			0.1	0.0	0.0	0.0	0.0	16.6	0.5	0.0	0.0	1.9	0.7	0.0	0.1	0.2	0.9	3.6	17.6	7.7	0.1	0.0	0.2	0.8	0.2	1.2	0.0	0.1	0.1	0.1	0.6	0.0	2.0	0.0	0.0	1.2	0.0	0.1	15.6	2.5	0.2	0.5	0.3	0.0	0.0	0.5	0.1	505.0	0.1	0.0	0.2	0.0	0.0	0.1	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.6	0.3	0.1	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.4	5765.5	17.8	0.5	6.3	0.0	0.0	0.0	0.2	0.0	0.1	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	21517.6	133.9	6.1	5.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	83.8	0.0	2.8	0.2	0.1	24.1	0.0	65.7	0.0	0.0	409.8	65.1	0.0	0.0	0.0	0.0	0.0	0.3	2.3
CRISP3	"Aeg2, CRISP-3, CRS3, dJ442L6.3, SGP28"	ENSG00000096006	"Cysteine rich secretory protein 3"	P54108	6	49727376-49744437	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"fallopian tube: 1203.8;salivary gland: 2310.0"	"Group enriched"	"Detected in some"	7	"Endometrial ciliated cells: 182.2;Glandular and luminal cells: 551.5"	"Group enriched"	"Detected in many"	7	"breast cancer: 31.9;pancreatic cancer: 59.8;prostate cancer: 85.6"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	19	"neutrophil: 2.5;non-classical monocyte: 1.2"	"Group enriched"	"Detected in many"	19	"granulocytes: 2.5;monocytes: 1.2"	"Group enriched"	"Detected in some"	20	"HEL: 12.3;RT4: 4.1;SK-BR-3: 9.3;T-47d: 4.4"					"Not detected"	"Not detected"			HPA054392	Supported				"Secreted in other tissues"	NA	NA		420000000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 36: HEL - Hemostasis"	"Cluster 44: Endometrium - Transcription"			"HPA054392: AB_2682472"	"unprognostic (1.28e-2)"	"unprognostic (7.01e-2)"		"unprognostic (8.93e-2)"		"unprognostic (5.56e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.22e-4)"	"unprognostic (5.30e-2)"	"unprognostic (6.70e-2)"	"unprognostic (9.16e-2)"	"unprognostic (4.34e-3)"		"unprognostic (1.91e-1)"			"unprognostic (1.93e-1)"	0.3	0.6	0.0	0.0	0.0	381.8	3.9	0.0	0.0	61.0	0.0	0.1	0.4	1.7	0.1	266.8	1203.8	23.1	0.8	0.0	0.0	0.1	0.9	1.3	0.0	0.0	0.0	0.5	5.5	0.0	0.5	0.6	0.0	2.9	0.0	0.0	2310.0	111.9	0.3	3.9	0.2	0.0	0.0	2.5	0.3	0.2	0.0	0.3	0.2	0.0	4.0	4.7	140.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	9.3	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	1.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	1.0	0.0	0.0	0.0	2.1	5.6	0.0	21.5	13.1	3.7	0.0	0.0	0.0	0.0	0.0	1.5	0.0	182.2	47.2	0.8	0.0	0.4	0.0	3.7	0.0	0.2	0.0	551.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	23.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.1	1.5	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	1.7	0.1	0.0	26.8
PGK2	"PGK-2, PGKPS"	ENSG00000170950	"Phosphoglycerate kinase 2"	P07205	6	49785660-49787285	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	Glycolysis	"Kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	531	"testis: 199.9"	"Group enriched"	"Detected in some"	9	"Early spermatids: 1143.9;Late spermatids: 2784.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA045385, HPA073644, HPA073656"	Supported					NA	NA				"Cluster 36: Testis - Spermatogenesis"		"Cluster 31: Spermatids - Spermatogenesis"			"HPA045385: AB_2679306, HPA073644: AB_2732231, HPA073656: AB_2732235"					"unprognostic (8.87e-3)"					"unprognostic (5.02e-1)"				"unprognostic (1.24e-1)"				0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	199.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1143.9	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2784.5	14.6	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.7	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	204.0	8.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CRISP1	"AEGL1, ARP, CRISP-1, HSCRISP1D, HSCRISP1G, HUMARP"	ENSG00000124812	"Cysteine rich secretory protein 1"	P54107	6	49834257-49877096	"Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	24	"epididymis: 1573.9"	"Group enriched"	"Detected in some"	29	"Early spermatids: 45.5;Late spermatids: 71.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 1.0;NB-4: 2.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA028445, HPA030534"	Enhanced				"Secreted in male reproductive system"	NA	NA		35000		"Cluster 30: Epididymis - Antimicrobial activity"	"Cluster 24: NB-4 - Immune response"	"Cluster 25: Spermatids - Spermatogenesis"			"HPA028445: AB_10670428, HPA030534: AB_2732459"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1573.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	66.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	45.5	0.0	0.2	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	71.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1
DEFB133		ENSG00000214643	"Defensin beta 133"	Q30KQ1	6	49946021-49950265	"Predicted secreted proteins"		"Antibiotic, Antimicrobial, Defensin"		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enriched"	"Detected in single"	130	"epididymis: 12.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"								"Secreted in male reproductive system"	NA	NA				"Cluster 30: Epididymis - Antimicrobial activity"																							0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DEFB114	DEFB-14	ENSG00000177684	"Defensin beta 114"	Q30KQ6	6	49960249-49964164	"Predicted secreted proteins"		"Antibiotic, Antimicrobial, Defensin"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	496	"epididymis: 49.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"								"Secreted in male reproductive system"	NA	NA				"Cluster 30: Epididymis - Antimicrobial activity"																							0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	49.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DEFB113	DEFB-13	ENSG00000214642	"Defensin beta 113"	Q30KQ7	6	49968677-49969625	"Predicted secreted proteins"		"Antibiotic, Antimicrobial, Defensin"		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enriched"	"Detected in single"	465	"epididymis: 46.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted in male reproductive system"	NA	NA				"Cluster 30: Epididymis - Antimicrobial activity"																							0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	46.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DEFB110	"DEFB-10, DEFB-11, DEFB111"	ENSG00000203970	"Defensin beta 110"	Q30KQ9	6	50009138-50021994	"Predicted secreted proteins"		"Antibiotic, Antimicrobial, Defensin"		"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enriched"	"Detected in single"	4674	"epididymis: 871.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	6	"NB-4: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted in male reproductive system"	NA	NA				"Cluster 30: Epididymis - Antimicrobial activity"	"Cluster 24: NB-4 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"																					0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	871.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DEFB112	DEFB-12	ENSG00000180872	"Defensin beta 112"		6	50042099-50049929	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enriched"	"Detected in single"	56	"epididymis: 24.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"									NA	NA						"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"																					0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TFAP2D	TFAP2BL1	ENSG00000008197	"Transcription factor AP-2 delta"	Q7Z6R9	6	50713526-50773033	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	18	"brain: 6.3"	"Cell type enhanced"	"Detected in single"		"Horizontal cells: 1.7"	"Cancer enriched"	"Detected in single"	10	"lung cancer: 0.5"	"Region enriched"	"Detected in some"	5	"midbrain: 6.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"HAP1: 1.0"	"Region enriched"	"Detected in many"	4	"midbrain: 11.8"	"Region enriched"	"Detected in some"	6	"midbrain: 9.4"	HPA048962			Uncertain	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 62: Horizontal cells - Visual perception"	Nucleoplasm	"Golgi apparatus, Vesicles"	"HPA048962: AB_2680573"																		0.0	0.0	0.6	0.0	1.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	1.1	0.0	0.3	0.2	0.0	0.0	6.3	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TFAP2B	AP2-B	ENSG00000008196	"Transcription factor AP-2 beta"	Q92481	6	50818723-50847619	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"epididymis: 33.3;retina: 14.8"	"Cell type enhanced"	"Detected in some"		"Basal squamous epithelial cells: 145.7;Bipolar cells: 76.4;Horizontal cells: 437.4;Melanocytes: 106.7"	"Cancer enriched"	"Detected in some"	8	"breast cancer: 12.1"	"Group enriched"	"Detected in many"	6	"cerebellum: 3.5;medulla oblongata: 3.9;midbrain: 9.0;pons: 10.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"AF22: 109.6;SH-SY5Y: 208.1"	"Region enhanced"	"Detected in many"		"cerebellum: 10.0"	"Low region specificity"	"Detected in many"			"HPA034683, HPA062942"	Enhanced		Approved	Nucleoplasm		NA	NA				"Cluster 68: Epididymis - Unknown function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 62: Horizontal cells - Visual perception"	Nucleoplasm		"HPA034683: AB_10670966, HPA062942: AB_2684909"	"unprognostic (2.02e-1)"	"unprognostic (2.29e-2)"		"unprognostic (4.27e-2)"	"unprognostic (5.88e-4)"	"unprognostic (9.76e-2)"		"unprognostic (2.10e-1)"	"unprognostic (1.00e-1)"			"unprognostic (4.57e-1)"	"unprognostic (6.58e-6)"	"unprognostic (1.13e-2)"	"unprognostic (1.88e-1)"		"unprognostic (7.17e-3)"	0.1	3.4	0.0	0.0	0.0	0.0	8.2	3.5	0.1	0.1	0.0	0.1	0.0	0.0	33.3	3.9	0.0	0.0	0.0	0.0	0.1	9.8	0.0	0.0	0.0	3.9	9.0	0.0	0.0	0.0	0.6	0.2	10.2	0.0	0.0	14.8	6.4	0.7	0.0	8.6	0.0	0.0	0.6	0.0	0.0	0.4	1.1	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	109.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	35.5	0.1	0.2	208.1	0.0	0.8	0.0	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.1	0.0	0.1	3.9	9.0	10.2	0.6	1.1	0.2	0.2	0.0	0.0	0.0	0.0	11.7	0.0	0.0	145.7	76.4	43.0	29.7	0.9	0.0	0.0	51.5	8.4	14.9	0.1	0.0	54.8	0.0	17.4	0.0	0.0	0.7	0.0	0.0	0.0	0.0	4.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.1	437.4	0.0	0.0	0.0	0.0	1.5	2.0	0.0	0.5	106.7	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.4	1.2	0.0	0.0	0.7	0.0	11.8	0.0	0.0	0.3	1.9	0.6	31.1	4.3	4.9	0.2	0.0	0.0	0.0
PKHD1	"ARPKD, FCYT, FPC, TIGM1"	ENSG00000170927	"PKHD1 ciliary IPT domain containing fibrocystin/polyductin"	P08F94	6	51615299-52087613	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		Receptor	"Ciliopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"epididymis: 4.7;kidney: 13.6;pancreas: 9.4"	"Cell type enhanced"	"Detected in some"		"Cholangiocytes: 60.1;Collecting duct cells: 46.0;Early spermatids: 293.6;Late spermatids: 83.1"	"Group enriched"	"Detected in some"	5	"pancreatic cancer: 1.4;renal cancer: 5.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"RPTEC TERT1: 10.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA031227	Enhanced				"Intracellular and membrane"	NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 29: Early spermatids - Spermatogenesis"			"HPA031227: AB_10602068"	"unprognostic (6.34e-3)"	"unprognostic (5.51e-2)"	"unprognostic (8.80e-3)"	"unprognostic (1.35e-1)"	"unprognostic (3.80e-2)"	"unprognostic (1.29e-2)"	"unprognostic (4.03e-2)"	"unprognostic (6.42e-2)"	"unprognostic (7.08e-2)"	"unprognostic (2.44e-2)"	"unprognostic (1.02e-2)"	"unprognostic (2.62e-2)"	"prognostic favorable (9.74e-8)"	"unprognostic (2.33e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.48e-2)"	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	4.7	0.0	0.1	1.1	0.0	0.0	0.0	13.6	1.5	0.0	0.0	0.1	0.1	0.0	9.4	0.0	0.0	0.0	0.0	0.1	0.0	1.5	0.0	1.0	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.8	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.6	0.5	0.0	0.0	0.3	10.7	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	1.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.3	0.3	1.4	60.1	0.0	46.0	0.0	0.1	0.0	0.1	1.9	18.2	293.6	0.2	0.0	0.3	0.0	0.0	3.2	0.9	0.1	0.1	2.6	0.4	0.0	0.0	0.0	3.7	0.1	0.0	2.8	0.0	0.0	0.0	0.0	83.1	2.1	0.5	5.4	0.0	0.0	3.1	0.0	0.5	0.7	2.6	0.0	0.4	0.0	0.4	0.0	23.3	0.0	0.1	0.0	0.0	0.1	15.0	1.7	0.0	0.0	0.0	0.3	0.0	0.1	0.8
IL17A	"CTLA8, IL-17, IL-17A, IL17"	ENSG00000112115	"Interleukin 17A"	Q16552	6	52186375-52190638	"Cancer-related genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins"	"Adaptive immunity, Immunity, Inflammatory response, Innate immunity"	Cytokine	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"lymphoid tissue: 1.4"	"Cell type enriched"	"Detected in single"	14	"T-cells: 8.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	23	"Karpas-707: 2.7;U-266/84: 1.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA052258	Uncertain				"Secreted to blood"	NA	NA	9920			"Cluster 16: Immune cells - Immune response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 24: Non-specific - Transcription regulation"			"HPA052258: "		"unprognostic (5.55e-1)"	"unprognostic (2.18e-4)"			"unprognostic (3.05e-4)"		"unprognostic (1.41e-2)"						"unprognostic (2.22e-2)"				0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	8.7	0.0	0.0	0.2
IL17F	"IL-17F, ML-1, ML1"	ENSG00000112116	"Interleukin 17F"	Q96PD4	6	52236681-52244500	"Disease related genes, Human disease related genes, Predicted secreted proteins"	"Adaptive immunity, Immunity, Inflammatory response, Innate immunity"	Cytokine	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"lymphoid tissue: 2.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted to blood"	NA	NA	30000			"Cluster 14: B-cells - Humoral immune response"		"Cluster 58: T-cells - T-cell receptor"					"unprognostic (1.40e-1)"	"unprognostic (1.20e-1)"											"unprognostic (3.02e-1)"	"unprognostic (2.52e-1)"			0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	2.3	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0
MCM3		ENSG00000112118	"Minichromosome maintenance complex component 3"	P25205	6	52264014-52284881	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, DNA replication"	"DNA-binding, Helicase, Hydrolase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 122.7;Erythroid cells: 92.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002162, HPA004789, HPA004790"	Supported		Supported	Nucleoplasm		NA	Yes		150000	"Cluster 35: T-regs - Unknown function"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"CAB002162: AB_564115, HPA004789: AB_1079336, HPA004790: AB_1079335"	"unprognostic (9.14e-2)"	"prognostic favorable (1.89e-4)"	"unprognostic (2.37e-1)"	"unprognostic (1.53e-2)"	"unprognostic (2.14e-1)"	"unprognostic (5.48e-3)"	"prognostic unfavorable (1.40e-4)"	"unprognostic (1.36e-1)"	"prognostic unfavorable (4.40e-5)"	"unprognostic (1.01e-3)"	"unprognostic (2.96e-2)"	"unprognostic (1.15e-1)"	"unprognostic (8.35e-2)"	"unprognostic (1.16e-2)"	"unprognostic (1.00e-1)"	"prognostic favorable (3.13e-5)"	"unprognostic (1.34e-2)"	24.3	15.9	12.8	41.5	13.6	55.5	29.1	13.7	13.7	27.5	13.4	32.9	19.6	30.8	23.8	33.4	29.2	16.4	25.4	11.9	12.7	27.5	18.8	21.4	68.8	14.1	13.6	31.9	17.0	28.9	10.8	40.0	14.1	19.7	39.3	19.3	19.2	30.7	16.0	32.2	29.3	37.0	14.5	31.3	24.1	21.1	14.0	81.1	18.3	17.7	78.5	28.1	24.5	13.9	187.9	121.7	208.0	196.9	43.9	39.4	136.1	135.8	103.7	226.6	230.3	251.6	99.2	202.8	132.5	79.7	147.8	145.4	277.4	165.9	226.9	230.0	261.4	383.6	233.2	358.2	11.8	381.7	150.8	23.7	38.1	166.6	46.2	55.6	117.3	240.4	318.1	452.9	118.3	123.8	386.9	293.5	173.1	369.8	84.8	338.3	317.0	271.2	101.1	195.8	210.3	160.5	142.2	81.1	125.3	289.4	159.7	266.9	60.5	153.5	163.6	160.8	206.4	132.9	163.5	356.4	132.2	323.8	184.0	30.5	18.3	27.3	50.0	31.3	42.8	47.7	49.9	50.3	30.0	41.2	47.6	51.2	2.6	55.0	18.3	19.0	71.6	46.9	12.8	13.6	13.7	13.7	11.9	12.7	14.1	13.6	14.1	14.5	14.0	13.9	24.3	22.4	12.3	3.3	26.4	19.2	20.0	24.9	12.5	16.1	14.1	17.1	19.9	7.2	19.2	22.0	4.2	122.7	18.6	10.9	13.7	30.9	1.1	9.6	16.7	30.9	7.3	92.6	2.5	20.2	63.6	22.3	15.8	15.1	37.4	48.3	15.0	10.5	36.0	0.0	2.1	20.4	8.2	10.1	7.5	3.6	27.1	12.1	7.2	8.4	12.5	17.8	34.0	2.5	6.1	17.3	10.5	21.1	37.6	10.9	7.3	7.5	17.0	16.0	6.6	16.8	27.9	22.5	64.0	24.5	10.1	27.4	26.0	19.0	37.1	13.9
PAQR8	"C6orf33, LMPB1, MPRB"	ENSG00000170915	"Progestin and adipoQ receptor family member 8"	Q8TEZ7	6	52361421-52407777	"Predicted membrane proteins, Transporters"	"Differentiation, Oogenesis"	"Developmental protein, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 144.9"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 168.5;Distal enterocytes: 154.3;Microglial cells: 74.0;Oligodendrocytes: 298.2;Paneth cells: 80.7;Proximal enterocytes: 100.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Hep G2: 41.8;OE19: 87.9;SuSa: 34.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064625			Supported	"Golgi apparatus,Plasma membrane"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane"	"Golgi apparatus"	"HPA064625: AB_2685304"	"prognostic favorable (4.61e-4)"	"unprognostic (7.39e-3)"	"unprognostic (2.77e-3)"	"unprognostic (8.23e-2)"	"unprognostic (4.33e-1)"	"unprognostic (4.08e-3)"	"unprognostic (2.66e-2)"	"unprognostic (5.67e-2)"	"unprognostic (6.37e-2)"	"unprognostic (4.30e-3)"	"unprognostic (2.10e-1)"	"unprognostic (5.55e-2)"	"unprognostic (8.82e-3)"	"unprognostic (1.04e-1)"	"unprognostic (2.12e-1)"	"unprognostic (3.14e-2)"	"prognostic favorable (6.40e-4)"	2.7	4.0	83.7	9.2	113.9	1.2	2.3	122.9	86.7	4.7	42.0	38.9	19.3	5.1	8.0	17.6	6.3	6.0	3.5	74.4	89.7	8.0	1.5	7.3	10.3	133.8	110.7	24.3	2.8	5.2	2.2	7.0	123.1	4.3	36.7	2.9	2.2	23.3	0.9	3.1	33.7	6.3	102.8	6.2	32.3	3.7	106.4	9.2	2.8	1.5	7.6	9.7	5.5	144.9	0.9	1.0	10.7	4.6	6.3	10.2	7.3	3.2	12.1	2.0	4.4	4.1	3.8	1.1	1.2	2.2	4.7	0.4	1.4	5.3	3.2	14.8	1.7	6.6	1.0	41.8	1.7	1.8	0.9	2.9	0.7	1.4	7.5	7.4	11.5	12.9	1.5	6.4	8.3	1.5	4.4	6.1	5.4	87.9	0.5	11.5	1.7	2.8	12.4	3.1	4.0	8.7	0.8	0.3	12.4	34.4	0.3	14.7	4.8	4.0	1.6	1.2	1.9	1.9	2.6	1.6	3.7	16.9	21.5	3.0	3.2	1.4	2.8	0.6	4.2	1.1	8.3	5.7	7.0	1.0	17.8	8.3	0.6	8.5	0.6	3.5	6.2	4.2	83.7	113.9	122.9	86.7	74.4	89.7	133.8	110.7	123.1	102.8	106.4	144.9	4.9	3.2	10.6	168.5	3.6	2.0	3.7	3.1	0.6	2.1	0.7	1.3	4.4	14.3	3.5	3.7	8.4	1.7	7.6	154.3	0.0	4.4	0.5	12.2	3.9	7.4	22.9	4.2	21.1	1.1	3.1	6.8	18.8	7.5	4.5	23.7	4.2	0.2	8.8	0.0	19.4	45.5	6.1	19.8	3.5	1.6	5.6	7.3	14.2	74.0	11.4	4.2	3.1	19.1	298.2	4.9	80.7	10.1	0.6	6.6	100.5	0.1	8.9	3.3	0.0	1.0	3.6	12.1	3.3	5.3	1.0	0.8	9.2	10.0	42.5	7.3
EFHC1	"EJM, EJM1, FLJ10466, POC9, RIB72"	ENSG00000096093	"EF-hand domain containing 1"	Q5JVL4	6	52362123-52529886	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"fallopian tube: 34.6"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 242.0;Endometrial ciliated cells: 227.5;Respiratory ciliated cells: 529.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 6.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 25.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035307	Approved					NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 49: Ciliated cells - Cilium organization"			"HPA035307: AB_2674561"	"unprognostic (2.11e-1)"	"unprognostic (5.22e-2)"	"unprognostic (3.31e-1)"	"unprognostic (3.43e-2)"	"unprognostic (2.51e-1)"	"unprognostic (4.03e-3)"	"unprognostic (1.60e-4)"	"unprognostic (2.53e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.44e-1)"	"prognostic favorable (2.33e-4)"	"unprognostic (3.04e-1)"	"prognostic unfavorable (3.29e-4)"	"unprognostic (5.83e-2)"	"unprognostic (3.14e-1)"	"unprognostic (6.53e-2)"	"unprognostic (3.27e-1)"	4.4	3.9	4.4	1.9	6.6	3.6	5.4	4.9	5.8	8.8	24.6	5.4	2.1	6.8	6.7	3.3	34.6	3.6	3.8	4.4	4.5	5.6	2.5	6.5	2.4	8.1	8.3	7.3	4.5	5.6	15.5	3.6	5.2	5.6	3.3	21.7	5.1	3.8	2.1	5.7	3.9	3.4	5.6	3.4	4.2	17.6	5.2	2.0	9.3	1.3	2.0	4.7	5.4	6.7	3.5	3.9	9.3	6.4	9.0	15.3	1.8	4.1	10.6	5.5	8.6	2.4	4.1	1.5	9.0	6.8	10.5	3.6	2.7	7.6	7.1	0.8	3.3	1.4	11.0	3.3	6.2	1.5	1.6	7.3	4.2	7.8	7.2	25.9	11.7	1.7	3.1	2.4	8.4	3.1	1.7	2.3	2.8	2.7	1.5	2.3	5.1	1.9	7.4	1.3	18.5	5.2	1.0	1.8	8.4	11.8	6.5	1.6	3.8	4.0	5.3	1.5	3.2	2.1	2.8	2.7	11.2	0.5	7.3	0.7	0.6	1.5	0.7	0.2	0.3	3.8	0.3	0.6	1.4	3.9	0.3	0.6	2.0	1.5	0.3	6.1	0.2	0.4	4.4	6.6	4.9	5.8	4.4	4.5	8.1	8.3	5.2	5.6	5.2	6.7	14.5	6.4	14.9	32.7	24.2	18.1	36.0	49.5	53.5	23.1	31.3	19.2	4.5	17.2	44.7	42.3	60.5	12.6	10.2	9.9	0.0	18.8	242.0	227.5	19.0	15.0	25.0	6.5	25.6	8.0	17.8	27.1	14.3	15.3	8.2	22.6	17.5	5.6	7.8	13.5	26.3	14.9	69.2	10.6	14.5	73.8	28.3	6.9	16.0	14.0	8.8	10.9	20.6	22.1	23.8	11.0	15.9	22.2	13.8	17.4	24.8	6.9	529.7	47.5	32.9	29.3	21.3	93.5	22.8	13.2	12.1	4.5	9.0	28.8	10.1	27.8
TRAM2	KIAA0057	ENSG00000065308	"Translocation associated membrane protein 2"	Q15035	6	52497408-52577060	"Predicted membrane proteins, Transporters"	"Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 122.0;Plasma cells: 69.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"ASC diff: 250.1;ASC TERT1: 265.8;fHDF/TERT166: 253.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA035092, HPA057925"	Approved		Approved	Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 28: Placenta - Pregnancy"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 55: Plasma cells - Humoral immune response"	Cytosol		"HPA035092: AB_10610562, HPA057925: AB_2683557"	"unprognostic (2.32e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.72e-1)"	"prognostic unfavorable (1.88e-4)"	"unprognostic (1.12e-1)"	"unprognostic (4.07e-2)"	"unprognostic (8.90e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.65e-1)"	"unprognostic (3.03e-1)"	"unprognostic (3.01e-1)"	"unprognostic (5.05e-1)"	"prognostic unfavorable (1.41e-9)"	"unprognostic (1.37e-2)"	"unprognostic (1.60e-1)"	"unprognostic (6.64e-2)"	"unprognostic (1.19e-2)"	19.5	4.9	3.4	14.8	4.7	5.3	13.8	3.0	4.3	14.9	7.8	12.5	14.0	13.1	11.5	5.6	13.5	17.3	10.4	3.0	3.3	7.4	16.2	14.1	7.5	4.3	3.5	12.4	7.0	2.8	3.9	35.8	3.6	6.0	14.7	3.9	6.4	5.8	3.6	11.5	12.6	17.5	3.3	19.2	9.5	13.3	4.4	4.5	12.4	5.9	13.3	13.3	9.6	3.3	45.4	19.8	22.7	22.6	250.1	265.8	39.8	130.0	130.8	106.7	98.2	43.2	9.2	11.0	21.4	253.4	76.0	10.0	14.9	81.3	133.6	24.8	8.0	24.1	20.5	54.9	71.3	6.2	13.1	97.4	8.0	93.5	41.2	155.1	124.1	9.1	15.1	78.4	154.5	16.2	8.9	17.7	10.4	17.9	8.8	10.9	59.8	91.0	25.3	7.5	5.5	8.7	29.9	13.2	31.6	47.7	20.6	12.9	198.8	177.6	38.4	65.0	72.1	53.4	97.7	31.1	64.7	16.1	110.8	0.1	1.0	1.0	0.9	1.1	0.5	1.2	0.7	0.5	1.1	0.8	0.3	0.6	0.2	0.7	2.1	0.5	0.2	0.7	3.4	4.7	3.0	4.3	3.0	3.3	4.3	3.5	3.6	3.3	4.4	3.3	12.8	6.4	3.2	6.8	15.9	8.2	2.8	8.5	3.4	3.1	4.0	5.1	9.9	4.3	4.1	7.3	25.0	36.2	6.6	7.8	3.9	3.6	38.3	4.0	28.9	17.9	9.0	8.6	12.0	3.2	30.8	26.2	6.1	5.0	2.5	34.0	19.6	36.1	15.7	5.0	9.2	19.6	6.1	12.0	6.9	122.0	20.8	5.7	26.6	13.1	4.3	1.8	8.2	3.5	3.1	6.2	1.7	23.3	69.5	2.8	7.0	3.1	4.9	12.7	13.1	16.2	15.7	23.4	8.6	1.2	4.1	20.7	6.0	14.3	5.7	1.5
TMEM14A	"C6orf73, PTD011"	ENSG00000096092	"Transmembrane protein 14A"	Q9Y6G1	6	52671113-52686588	"Predicted membrane proteins"	Apoptosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"A-431: 253.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA072536	Approved		Approved	"Nucleoplasm,Endoplasmic reticulum"		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 15: Liver - Metabolism"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 1: Pancreatic cells - Digestion"	"Nucleoplasm, Endoplasmic reticulum"		"HPA072536: AB_2686531"	"unprognostic (6.75e-2)"	"unprognostic (3.65e-2)"	"unprognostic (2.04e-1)"	"unprognostic (8.10e-3)"	"unprognostic (3.55e-2)"	"unprognostic (1.06e-1)"	"unprognostic (8.05e-2)"	"unprognostic (4.10e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.56e-3)"	"unprognostic (8.88e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.52e-2)"	"unprognostic (9.60e-2)"	"unprognostic (5.44e-2)"	"unprognostic (3.37e-1)"	"unprognostic (2.64e-1)"	20.7	46.8	51.9	13.6	52.7	10.3	24.9	52.7	78.4	25.8	72.6	25.3	38.3	27.7	36.4	36.2	31.3	25.0	16.5	53.3	62.6	51.5	106.4	18.0	19.7	55.1	50.5	39.8	36.2	22.2	24.2	16.1	55.8	36.4	25.9	31.4	21.7	21.6	4.4	13.9	35.4	26.4	52.5	13.7	40.8	17.2	55.0	15.5	28.6	8.5	23.9	24.4	26.2	55.4	253.4	37.5	27.3	77.6	73.1	56.0	23.1	50.0	68.0	45.2	69.5	57.8	63.5	30.8	54.2	63.1	94.9	93.9	61.3	83.7	75.3	125.0	50.1	45.6	57.4	95.7	24.0	23.6	54.7	50.5	57.8	49.5	11.1	59.5	61.7	38.9	9.8	85.4	54.1	51.3	46.4	26.9	16.2	165.9	64.7	36.0	38.8	24.5	88.5	48.1	141.4	68.5	55.6	44.2	97.1	33.9	68.0	44.8	45.8	62.0	83.3	24.5	81.3	40.9	37.1	46.6	87.4	14.8	50.7	23.3	0.5	16.4	38.4	0.1	24.8	54.6	48.7	40.4	19.4	36.0	36.9	39.4	2.1	11.0	0.1	35.2	66.5	30.3	51.9	52.7	52.7	78.4	53.3	62.6	55.1	50.5	55.8	52.5	55.0	55.4	28.6	25.6	17.6	13.1	23.4	48.4	61.9	183.5	56.9	20.4	71.3	72.4	17.4	54.3	90.1	51.5	8.4	56.1	27.5	22.6	64.6	108.1	1.4	31.2	33.3	37.3	33.5	32.8	50.3	140.9	150.8	62.4	50.0	26.3	25.4	46.5	38.6	138.7	47.0	5.0	45.7	53.1	77.3	7.0	56.6	2.5	43.5	10.9	88.9	16.9	4.9	27.1	16.5	15.1	15.5	74.7	25.2	50.0	18.6	48.5	77.4	152.7	85.5	13.2	6.6	38.6	60.7	4.3	41.2	139.5	38.2	15.5	30.9	22.0	51.7	69.3
GSTA2	GST2	ENSG00000244067	"Glutathione S-transferase alpha 2"	P09210	6	52750087-52763475	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"kidney: 696.0;liver: 2058.5"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 201.6;Distal tubular cells: 213.2;Exocrine glandular cells: 239.6;Pancreatic endocrine cells: 334.7;Proximal enterocytes: 367.0;Proximal tubular cells: 1186.6;Respiratory ciliated cells: 435.5"	"Group enriched"	"Detected in many"	16	"liver cancer: 124.6;renal cancer: 48.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	13	"CACO-2: 25.9;Hep G2: 20.0"									"HPA004342, HPA048934, HPA053817"	Supported		Supported	Cytosol		NA	NA				"Cluster 85: Liver - Metabolism"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol		"HPA004342: AB_1078987, HPA048934: AB_2680563, HPA053817: AB_2630367"	"unprognostic (1.14e-1)"		"unprognostic (1.20e-1)"	"unprognostic (2.72e-2)"			"unprognostic (1.15e-1)"	"unprognostic (6.43e-3)"		"unprognostic (2.41e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.15e-1)"	"prognostic unfavorable (1.17e-4)"	"unprognostic (4.34e-2)"	"unprognostic (1.91e-1)"		"unprognostic (6.54e-2)"	0.4	4.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.6	149.5	0.0	0.7	0.1	2.5	109.4	0.0	0.0	0.0	696.0	2058.5	4.8	0.1	0.0	0.0	0.2	299.2	0.0	0.0	0.1	0.0	3.8	0.1	0.0	0.5	0.0	0.0	0.0	115.5	0.0	0.0	0.0	11.7	44.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	25.9	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	1.2	0.0	20.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.2	0.0	1.7	0.0	0.0	0.6	0.4	0.0	0.0	0.0	0.2	0.7	0.0	0.0	0.6	0.0	0.0	0.3	0.6	0.5	0.5	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.4	0.0	1.7	0.0	0.2	1.5	0.0	0.0	0.1	0.1	0.0	201.6	31.1	16.5	0.0	0.0	0.0	0.1	213.2	8.1	6.9	0.0	0.0	0.6	0.0	0.0	0.0	239.6	0.2	0.5	7.7	0.0	0.0	37.2	0.7	124.2	0.1	0.0	0.0	13.7	2.0	2.2	0.0	14.6	1.2	5.1	0.0	0.0	5.2	0.0	0.0	0.0	0.1	334.7	18.8	0.4	0.0	3.9	367.0	1186.6	435.5	0.0	0.0	0.0	1.5	1.9	0.7	0.0	0.0	0.0	2.6	10.4	30.1	1.3
GSTA1		ENSG00000243955	"Glutathione S-transferase alpha 1"	P08263	6	52791371-52803860	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Isomerase, Oxidoreductase, Peroxidase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 916.5;kidney: 943.1;liver: 2610.5"	"Cell type enhanced"	"Detected in many"		"Exocrine glandular cells: 1652.6;Granulosa cells: 3177.1;Proximal enterocytes: 4294.8;Proximal tubular cells: 3190.6;Theca cells: 4578.2"	"Cancer enriched"	"Detected in many"	4	"liver cancer: 555.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	14	"Hep G2: 263.9"									"HPA004342, HPA048934, HPA053817"	Supported		Supported	Cytosol		NA	NA	27800000			"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 40: Granulosa cells - Unknown function"	Cytosol		"HPA004342: AB_1078987, HPA048934: AB_2680563, HPA053817: AB_2630367"	"unprognostic (4.84e-3)"	"unprognostic (2.40e-2)"	"unprognostic (3.40e-1)"	"unprognostic (4.78e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.00e-2)"	"prognostic favorable (8.66e-4)"	"unprognostic (5.75e-2)"	"unprognostic (6.90e-3)"	"unprognostic (3.00e-1)"	"unprognostic (8.27e-2)"	"prognostic unfavorable (3.71e-4)"	"unprognostic (1.21e-1)"	"unprognostic (4.26e-3)"	"unprognostic (1.02e-1)"	"unprognostic (2.16e-2)"	0.5	916.5	0.0	2.5	0.0	0.0	4.2	0.0	0.2	2.0	0.0	7.3	672.0	0.4	7.0	5.3	86.1	119.5	0.2	0.0	0.0	943.1	2610.5	12.2	0.5	0.0	0.0	78.9	148.6	0.0	0.2	0.5	0.0	18.7	8.1	0.0	21.5	0.6	0.1	1.2	674.6	0.3	0.0	0.2	135.5	336.8	0.3	0.1	0.1	0.0	11.5	2.2	5.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	1.1	0.1	0.0	0.0	0.0	19.4	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.5	0.1	263.9	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.1	0.0	0.0	0.4	2.1	0.0	0.2	1.5	2.1	0.3	0.0	0.0	1.1	0.0	0.2	0.5	0.5	0.1	0.6	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	6.4	7.7	0.0	13.5	0.0	5.0	35.7	0.0	0.0	7.0	1.5	0.0	453.2	159.9	73.5	0.0	0.1	0.1	5.8	536.1	71.3	11.8	0.4	0.1	3.1	3.0	45.5	0.0	1652.6	0.2	7.3	116.7	0.5	2.5	3177.1	26.4	1013.9	0.1	0.0	0.0	165.6	42.7	31.5	0.0	43.0	65.6	25.3	0.0	0.0	13.3	0.0	1.0	0.0	0.1	629.1	187.4	4.5	0.2	27.6	4294.8	3190.6	533.5	0.0	0.0	0.0	98.6	36.8	3.4	6.8	0.0	0.5	10.4	4578.2	295.3	58.7
GSTA5		ENSG00000182793	"Glutathione S-transferase alpha 5"	Q7RTV2	6	52831655-52840843	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	10	"Smooth muscle cells: 23.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"							"HPA004342, HPA048934, HPA053817"	Uncertain		Approved	Cytosol		NA	NA						"Cluster 10: Non-specific - Unknown function"	Cytosol		"HPA004342: AB_1078987, HPA048934: AB_2680563, HPA053817: AB_2630367"							"unprognostic (1.97e-2)"			"unprognostic (2.83e-1)"								0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	2.2	0.4	0.0	0.0	0.0	23.6	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.1
GSTA3		ENSG00000174156	"Glutathione S-transferase alpha 3"	Q16772	6	52896639-52909698	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"adrenal gland: 67.3;fallopian tube: 65.4;placenta: 22.7;skin 1: 26.0"	"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 194.9;Syncytiotrophoblasts: 515.3;Theca cells: 91.3"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 1.5;testis cancer: 1.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"SuSa: 1.4"									"HPA004342, HPA048934, HPA053817"	Approved		Supported	Cytosol		NA	NA				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 12: NES - Nervous system development"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Cytosol		"HPA004342: AB_1078987, HPA048934: AB_2680563, HPA053817: AB_2630367"	"unprognostic (7.51e-2)"			"unprognostic (7.06e-3)"		"unprognostic (3.10e-1)"	"unprognostic (5.53e-2)"	"unprognostic (4.38e-3)"	"unprognostic (2.86e-3)"	"unprognostic (1.81e-1)"		"unprognostic (1.41e-1)"		"unprognostic (1.93e-1)"	"unprognostic (9.35e-2)"			0.0	67.3	0.0	0.1	0.1	0.0	1.8	0.0	0.0	1.1	0.5	0.0	0.3	0.8	0.8	0.0	65.4	0.0	0.0	0.0	0.2	0.0	0.0	1.4	0.0	0.1	0.5	0.9	0.1	2.9	0.0	22.7	0.0	0.1	0.0	0.0	0.3	0.2	0.0	26.0	0.4	0.1	0.0	0.0	2.4	11.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.5	0.0	0.0	0.3	0.1	0.0	0.0	1.1	0.0	0.0	1.0	0.0	0.9	0.0	0.0	0.4	0.0	0.0	0.0	6.2	0.0	0.0	194.9	0.0	0.0	0.0	0.0	1.3	47.0	0.5	0.5	0.0	0.0	0.0	0.0	7.5	1.1	0.0	0.7	1.3	7.4	0.0	0.4	15.7	0.0	0.0	0.0	2.0	0.0	0.4	2.1	1.5	0.0	24.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.4	24.8	0.0	0.0	0.0	0.8	0.5	0.5	0.0	9.8	515.3	0.1	91.3	0.0	0.0
GSTA4		ENSG00000170899	"Glutathione S-transferase alpha 4"	O15217	6	52977948-52995304	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 295.7"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 280.0;Granulosa cells: 335.6;Syncytiotrophoblasts: 450.3;Theca cells: 415.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	6	"non-classical monocyte: 20.0"	"Lineage enriched"	"Detected in many"	6	"monocytes: 20.0"	"Cell line enhanced"	"Detected in many"		"AF22: 95.4;ASC TERT1: 93.1"					"Low region specificity"	"Detected in all"			HPA048934	Approved					NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 35: Non-specific - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 40: Granulosa cells - Unknown function"			"HPA048934: AB_2680563"	"unprognostic (5.13e-3)"	"unprognostic (2.75e-1)"	"unprognostic (5.04e-2)"	"unprognostic (1.38e-1)"	"unprognostic (5.24e-2)"	"unprognostic (3.63e-3)"	"unprognostic (1.81e-1)"	"unprognostic (1.63e-2)"	"unprognostic (5.05e-3)"	"unprognostic (9.26e-2)"	"unprognostic (3.31e-3)"	"unprognostic (2.29e-2)"	"unprognostic (1.34e-2)"	"unprognostic (2.21e-1)"	"unprognostic (4.07e-3)"	"unprognostic (1.53e-1)"	"unprognostic (1.13e-1)"	19.2	295.7	51.2	6.9	52.6	1.7	36.0	55.6	61.0	37.0	37.7	19.2	20.4	27.5	61.2	53.4	24.7	22.9	20.4	53.8	55.5	32.1	34.8	38.7	7.3	44.1	43.5	51.9	31.3	74.4	43.1	48.0	45.2	40.7	24.5	31.2	32.8	28.5	35.9	136.0	19.0	26.2	43.0	13.6	37.2	37.3	48.7	9.9	25.0	36.7	21.4	15.6	40.3	53.8	1.3	10.3	95.4	80.3	56.1	93.1	8.9	13.6	33.7	9.4	16.0	15.6	0.3	1.0	9.1	25.8	10.1	3.9	69.7	13.5	11.8	2.3	29.2	3.3	8.2	54.4	39.8	0.0	2.3	80.1	20.6	12.0	10.1	28.5	59.1	14.1	12.9	15.0	31.9	0.0	1.2	0.3	36.4	58.5	17.3	2.4	41.2	18.6	34.3	1.7	42.2	62.1	0.4	9.9	24.9	48.9	2.5	2.8	28.5	10.0	22.6	9.3	11.6	18.4	2.5	0.5	15.2	1.5	11.0	0.0	0.0	0.0	2.6	0.9	2.0	0.8	0.7	1.2	0.9	2.9	0.5	0.7	0.0	3.2	20.0	1.7	0.8	0.9	51.2	52.6	55.6	61.0	53.8	55.5	44.1	43.5	45.2	43.0	48.7	53.8	15.4	51.3	84.3	22.9	2.2	44.9	22.0	79.0	35.3	39.7	26.1	31.2	10.0	15.7	44.4	27.6	0.0	280.0	3.6	5.6	54.8	14.0	1.4	3.5	24.1	20.0	23.9	9.5	63.4	9.0	108.8	40.5	23.0	4.1	5.7	335.6	31.4	21.1	69.8	37.0	88.2	41.8	57.0	2.5	14.6	9.6	41.7	3.5	96.0	13.1	2.8	70.1	4.1	75.9	62.7	10.8	9.6	39.1	0.8	25.8	12.7	47.7	15.6	11.3	19.7	28.5	36.3	4.7	10.5	96.3	135.5	450.3	3.9	415.9	18.0	21.1
CILK1	"ICK, KIAA0936, LCK2, MGC46090, MRK"	ENSG00000112144	"Ciliogenesis associated kinase 1"	Q9UPZ9	6	53001279-53061824	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Cilium biogenesis/degradation"	"Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"	"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 11.0;Cytotrophoblasts: 20.6;Extravillous trophoblasts: 33.9;Syncytiotrophoblasts: 58.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000791, HPA001113"	Approved		Supported	"Nucleoli fibrillar center"		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoli fibrillar center"		"HPA000791: AB_2732392, HPA001113: AB_1851385"	"unprognostic (1.75e-2)"	"unprognostic (1.02e-1)"	"unprognostic (5.47e-2)"	"unprognostic (2.95e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.00e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.82e-2)"	"unprognostic (1.17e-3)"	"unprognostic (5.11e-2)"	"unprognostic (1.18e-1)"	"unprognostic (8.28e-2)"	"unprognostic (8.12e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.26e-1)"	7.9	17.9	10.2	4.9	11.0	2.7	10.7	8.4	9.7	8.9	5.1	8.7	9.8	8.0	5.5	8.6	7.4	6.9	8.5	6.8	7.8	4.5	7.5	6.3	5.2	9.4	11.6	9.5	5.0	7.3	1.7	12.1	8.8	9.9	10.7	17.4	17.9	7.3	4.0	8.7	10.4	7.4	8.8	5.6	12.9	4.5	14.9	10.1	6.3	5.0	6.2	6.5	5.8	12.8	7.8	2.9	14.6	10.0	8.9	14.0	17.0	6.9	12.4	10.8	12.3	4.1	2.4	5.7	4.0	21.0	3.5	5.0	17.6	7.1	14.2	19.9	7.0	4.2	3.3	22.3	4.5	5.2	5.4	12.5	7.6	4.6	5.3	7.7	10.2	12.1	8.1	22.6	24.9	6.7	5.6	6.4	5.6	27.0	6.3	8.8	6.5	7.5	4.5	5.6	23.6	10.6	6.7	16.3	9.6	14.2	9.5	10.9	8.5	17.2	8.0	6.5	17.1	6.3	4.8	2.2	3.5	5.0	8.5	2.8	1.0	2.2	1.7	0.8	1.5	1.2	1.2	1.4	1.0	1.5	1.4	1.2	0.5	1.1	0.9	1.4	1.7	0.8	10.2	11.0	8.4	9.7	6.8	7.8	9.4	11.6	8.8	8.8	14.9	12.8	6.3	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.0	0.0	0.0	0.0	0.0	20.6	5.7	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	33.9	5.3	0.0	0.0	0.0	0.0	0.0	0.0	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	58.1	0.8	0.0	0.0	0.0
AL031178.1		ENSG00000288614	"Novel protein"		6	53041266-53041385	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enriched"	"Detected in some"	4	"brain: 4.5"	"Not detected"	"Not detected"							"Group enriched"	"Detected in some"	7	"cerebral cortex: 4.5;medulla oblongata: 1.6;pons: 1.6"	"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HL-60: 1.2;RH-30: 1.5;RPMI-8226: 1.6"															NA	NA			"Cluster 6: Non-specific - Transcription"		"Cluster 25: RPMI-8226 - Immune response"																						0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.1	4.5	0.0	0.0	0.1	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.2	0.1	0.0	1.6	0.3	0.0	0.0	0.0		0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.5	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.5	0.0	6.8	3.1	3.9	2.8	1.9	3.7	4.0	2.1	2.1	1.9	4.4	2.2	2.7	1.3	2.4	1.8	8.4	1.6	1.4	0.0	0.3	0.1	4.5	0.2	0.3	1.6	0.3	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FBXO9	"FBX9, NY-REN-57"	ENSG00000112146	"F-box protein 9"	Q9UK97	6	53051991-53100873	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064246			Approved	Centrosome		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 6: Erythroid cells - Oxygen transport"	Centrosome		"HPA064246: AB_2685225"	"unprognostic (6.23e-2)"	"unprognostic (9.19e-2)"	"unprognostic (1.71e-1)"	"unprognostic (9.38e-2)"	"unprognostic (3.38e-2)"	"unprognostic (3.06e-3)"	"unprognostic (6.73e-2)"	"unprognostic (1.40e-3)"	"unprognostic (2.89e-3)"	"prognostic favorable (1.51e-4)"	"prognostic favorable (1.82e-4)"	"unprognostic (2.50e-1)"	"unprognostic (3.41e-1)"	"unprognostic (2.29e-1)"	"unprognostic (8.73e-2)"	"unprognostic (1.56e-2)"	"unprognostic (6.64e-3)"	45.8	126.4	25.2	30.5	25.0	102.9	38.4	29.8	39.8	34.5	36.9	42.6	34.4	38.7	41.8	45.4	37.6	30.0	56.2	23.8	24.8	51.6	64.1	35.2	33.2	25.4	27.6	37.3	56.7	64.7	36.5	34.7	25.7	39.2	33.3	61.0	49.4	44.8	71.9	40.8	34.6	50.5	20.0	37.6	47.9	36.3	27.2	26.9	46.2	48.6	36.4	34.5	30.7	28.6	74.2	29.4	26.6	81.2	53.4	42.9	61.7	68.2	68.8	61.4	61.0	56.6	31.6	36.6	46.3	67.7	39.2	44.8	58.2	54.5	78.4	45.7	57.9	87.8	56.5	83.4	44.4	84.6	53.2	56.1	58.9	42.5	43.5	61.9	52.9	37.6	88.5	56.4	65.4	47.4	36.9	57.3	24.1	70.1	41.5	43.8	71.0	44.9	68.4	54.3	94.9	36.5	69.2	50.0	96.5	53.6	76.8	83.6	45.2	87.6	60.8	97.3	80.8	59.9	80.6	57.3	43.0	58.1	50.3	14.5	21.8	13.2	10.9	11.7	12.6	13.5	11.3	11.2	14.5	13.7	12.5	9.6	13.5	14.6	11.6	11.6	13.1	8.2	25.2	25.0	29.8	39.8	23.8	24.8	25.4	27.6	25.7	20.0	27.2	28.6	36.4	76.9	91.5	44.1	34.0	14.1	20.7	35.2	54.1	82.1	43.6	42.2	42.2	40.0	47.0	20.2	66.7	41.0	47.7	26.2	39.2	68.7	135.1	23.8	40.5	32.6	29.9	166.1	57.8	76.3	44.1	31.7	50.4	21.5	32.2	43.9	28.9	60.6	24.9	77.4	48.9	28.0	28.5	41.2	15.7	116.8	38.5	36.9	19.6	30.0	52.8	71.6	63.8	53.3	58.6	57.4	18.8	32.4	41.5	33.2	28.5	66.9	31.7	81.9	19.7	43.2	39.1	40.7	24.1	60.4	16.2	75.4	38.1	60.5	23.9	18.2
AL031178.2		ENSG00000288646	"Novel protein"		6	53065602-53065673	"Predicted intracellular proteins"				"No human protein/transcript evidence"	"No human protein/transcript evidence"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																	NA	NA			"Cluster 21: B-cells - Adaptive immune response"																								0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GCM1	"GCMA, hGCMa"	ENSG00000137270	"Glial cells missing transcription factor 1"	Q9NP62	6	53126961-53148841	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"placenta: 20.2"	"Group enriched"	"Detected in some"	7	"Extravillous trophoblasts: 230.3;Syncytiotrophoblasts: 266.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 1.4"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	5	"BEWO: 39.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA011343, HPA073469"	Enhanced		Approved	Vesicles		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 28: Placenta - Pregnancy"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Vesicles		"HPA011343: AB_2668489, HPA073469: "	"unprognostic (2.81e-2)"	"unprognostic (4.09e-2)"	"unprognostic (1.89e-2)"	"unprognostic (1.53e-1)"	"unprognostic (3.17e-1)"	"unprognostic (7.68e-2)"	"unprognostic (8.47e-3)"	"unprognostic (2.83e-2)"	"unprognostic (2.81e-1)"	"unprognostic (4.04e-2)"	"unprognostic (1.42e-1)"	"unprognostic (5.98e-2)"	"unprognostic (1.29e-4)"	"unprognostic (1.86e-1)"	"unprognostic (7.42e-2)"		"unprognostic (2.96e-2)"	0.1	0.1	0.4	0.1	0.2	0.4	0.1	0.3	0.7	0.0	0.2	0.0	0.0	0.1	0.1	0.2	0.0	0.2	0.1	0.3	0.1	1.3	0.0	0.1	0.3	0.1	0.1	0.1	0.1	0.0	0.0	20.2	0.2	0.0	0.0	0.4	0.1	0.0	3.6	0.1	0.1	0.0	0.0	0.4	0.1	0.6	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.3	0.1	0.1	0.2	0.2	0.0	0.0	39.2	0.0	0.0	0.0	0.0	1.8	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.2	0.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.1	0.2	0.0	0.1	0.0	8.2	0.1	0.2	0.0	0.1	0.2	0.1	0.1	0.4	0.3	0.2	0.0	0.1	0.1	0.2	0.0	0.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.5	0.0	0.0	1.4	0.1	0.1	0.0	0.0	0.0	0.4	0.2	0.3	0.7	0.3	0.1	0.1	0.1	0.2	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.7	0.1	0.3	0.0	0.0	0.0	0.0	33.8	0.0	0.0	0.0	0.3	2.0	0.4	0.0	0.4	0.0	0.0	0.1	0.2	230.3	0.5	0.0	0.6	0.0	0.0	0.0	0.0	6.6	0.0	0.1	0.0	0.0	0.0	0.7	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.1	0.0	11.7	0.0	0.0	0.0	0.5	0.1	0.1	0.1	0.0	0.0	266.1	0.1	0.0	0.0	0.1
ELOVL5	"dJ483K16.1, HELO1, SCA38"	ENSG00000012660	"ELOVL fatty acid elongase 5"	Q9NYP7	6	53267398-53349179	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"	Transferase	"Disease variant, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017042, HPA047752, HPA054197"	Enhanced		Enhanced	"Endoplasmic reticulum"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 35: Glandular cells - Unknown function"	"Endoplasmic reticulum"		"CAB017042: , HPA047752: AB_2680147, HPA054197: AB_2682413"	"unprognostic (7.33e-2)"	"unprognostic (5.80e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.16e-1)"	"unprognostic (5.01e-2)"	"unprognostic (3.06e-1)"	"unprognostic (2.19e-1)"	"unprognostic (4.38e-2)"	"unprognostic (1.43e-2)"	"unprognostic (3.23e-1)"	"unprognostic (6.40e-2)"	"prognostic unfavorable (1.94e-6)"	"unprognostic (1.58e-1)"	"unprognostic (5.12e-2)"	"prognostic unfavorable (6.80e-4)"	"unprognostic (2.76e-2)"	242.4	134.7	51.3	74.9	67.0	114.6	199.2	74.6	79.2	48.9	49.4	40.0	28.3	39.8	49.7	28.4	46.0	51.3	37.8	50.8	65.3	38.9	108.9	68.4	106.7	80.7	69.0	32.3	15.4	24.3	28.5	40.2	74.5	128.0	18.3	36.5	24.8	103.0	9.9	32.9	47.5	52.4	67.7	56.1	22.8	82.5	65.8	107.3	45.1	19.5	102.4	67.1	27.0	98.9	137.2	98.1	168.0	309.0	436.0	250.8	71.3	155.8	174.2	123.2	171.5	87.4	154.5	154.4	110.3	163.3	193.1	78.9	168.0	142.6	183.7	131.2	117.5	153.1	85.0	122.9	239.0	122.2	107.2	233.6	109.8	123.6	153.9	124.5	139.1	301.4	194.2	87.3	90.3	14.9	364.4	107.9	91.2	5.2	73.6	139.9	115.3	54.3	232.7	80.6	155.7	107.1	129.3	66.9	135.2	108.7	152.3	112.9	133.0	134.7	118.5	242.2	208.8	72.8	72.1	116.2	70.2	173.6	97.8	47.6	49.2	183.7	34.9	34.9	56.5	88.4	58.1	42.7	77.9	101.5	27.8	26.3	261.5	36.7	45.0	20.4	110.0	50.6	51.3	67.0	74.6	79.2	50.8	65.3	80.7	69.0	74.5	67.7	65.8	98.9	48.6	80.1	50.7	75.4	118.3	52.4	108.2	36.8	44.3	11.6	177.3	70.9	23.3	21.5	40.2	12.9	2.1	25.3	55.5	2.1	15.6	34.9	94.2	37.4	53.2	54.4	25.0	77.0	25.8	36.1	58.2	54.8	3.1	66.4	99.0	28.4	39.3	88.7	35.5	8.4	29.8	1.6	16.2	57.3	114.6	181.0	20.8	55.5	48.0	39.4	53.5	83.2	39.1	49.3	111.2	27.8	1.4	32.0	45.2	169.2	21.9	48.4	58.5	6.0	65.7	27.3	77.5	27.0	18.9	35.7	60.9	31.2	97.2	60.0	4.4	73.4
GCLC	"GCS, GLCL, GLCLC"	ENSG00000001084	"Glutamate-cysteine ligase catalytic subunit"	P48506	6	53497341-53616970	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Glutathione biosynthesis"	Ligase	"Disease variant, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 152.1"	"Cell type enhanced"	"Detected in many"		"Enteroendocrine cells: 220.7;Urothelial cells: 144.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"NK-cell: 4.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"A549: 205.4;Hep G2: 178.2;OE19: 287.5;RT4: 189.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009569, HPA036359, HPA036360"	Approved		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA		5800000	"Cluster 15: NK-cells - Transcription"	"Cluster 85: Liver - Metabolism"	"Cluster 21: OE19 - Mitochondria"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoplasm	"Nucleoli, Cytosol"	"CAB009569: AB_675582, HPA036359: AB_10672243, HPA036360: AB_10669789"	"unprognostic (8.41e-2)"	"unprognostic (1.27e-2)"	"unprognostic (5.65e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.76e-1)"	"unprognostic (2.60e-1)"	"unprognostic (7.50e-2)"	"unprognostic (9.94e-3)"	"unprognostic (4.67e-3)"	"unprognostic (1.30e-1)"	"unprognostic (5.23e-2)"	"prognostic favorable (3.83e-6)"	"unprognostic (3.78e-2)"	"unprognostic (8.91e-2)"	"prognostic unfavorable (8.24e-4)"	"unprognostic (2.30e-2)"	26.7	18.3	18.5	16.6	24.9	37.8	27.2	18.1	23.3	9.5	14.1	22.8	41.9	19.2	10.8	37.0	62.9	32.1	16.4	16.8	18.9	34.1	152.1	10.9	26.2	18.4	19.7	8.5	15.9	18.3	4.8	9.1	20.4	26.9	26.0	14.4	13.1	15.8	11.4	18.8	32.2	16.0	18.2	39.1	32.9	11.3	22.5	13.7	30.0	14.5	24.0	63.7	14.5	36.0	31.3	205.4	16.5	39.1	19.4	8.6	22.1	15.5	24.9	11.4	13.3	30.5	70.7	59.1	28.7	14.1	86.9	43.3	50.7	112.5	15.3	46.9	31.4	39.6	38.3	178.2	22.1	52.8	23.5	13.5	46.6	12.8	56.8	15.0	17.7	50.9	22.4	18.2	5.6	32.9	45.5	20.9	30.6	287.5	19.2	14.9	10.2	52.1	37.0	189.8	47.5	23.3	25.9	40.9	27.8	23.8	28.2	24.6	24.6	10.2	35.5	26.0	23.4	24.1	39.9	34.0	25.6	37.0	17.5	1.2	0.5	0.3	0.5	0.9	0.4	0.8	0.5	1.1	2.3	0.5	0.3	0.6	0.2	4.2	1.0	1.6	0.9	0.3	18.5	24.9	18.1	23.3	16.8	18.9	18.4	19.7	20.4	18.2	22.5	36.0	17.1	0.0	2.4	36.9	12.7	34.8	61.6	56.6	47.3	14.4	23.7	13.6	20.9	38.6	47.4	0.0	25.0	6.4	22.9	22.1	11.7	14.6	2.2	34.8	14.9	14.1	220.7	113.2	22.4	12.8	8.6	13.6	43.8	69.8	2.5	50.9	10.4	118.5	22.7	8.4	30.4	19.4	40.7	87.2	10.9	1.5	6.5	32.1	8.8	24.4	10.6	12.5	17.5	30.2	84.1	15.9	13.2	9.4	10.4	88.3	18.2	27.1	66.5	5.0	13.1	14.0	13.5	3.1	9.2	72.6	24.9	7.8	14.9	26.6	14.8	144.8
KLHL31	"bA345L23.2, BKLHD6, KBTBD1"	ENSG00000124743	"Kelch like family member 31"	Q9H511	6	53647916-53665756	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"heart muscle: 51.3;skeletal muscle: 146.1;tongue: 34.8"	"Cell type enriched"	"Detected in some"	33	"Cardiomyocytes: 248.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"SCLC-21H: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA				"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 54: Cardiomyocytes - Muscle contraction"				"unprognostic (7.27e-2)"	"unprognostic (6.18e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.67e-1)"	"unprognostic (7.67e-4)"	"unprognostic (2.23e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.55e-1)"	"unprognostic (3.98e-2)"	"unprognostic (5.50e-2)"	"unprognostic (4.24e-1)"	"unprognostic (1.09e-4)"	"unprognostic (8.73e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.40e-1)"	8.6	0.8	0.2	0.2	0.5	0.0	3.1	0.2	0.3	0.2	0.7	0.2	0.4	0.2	0.8	0.7	0.8	0.2	51.3	0.1	0.3	0.2	0.4	0.2	0.1	0.3	0.2	0.3	0.4	0.0	0.4	0.1	0.3	1.3	0.2	0.4	1.2	0.1	146.1	1.3	0.3	0.0	0.3	0.1	0.3	0.3	0.3	0.1	0.9	34.8	0.2	0.3	0.4	0.3	0.3	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.7	0.0	0.0	0.0	0.2	0.5	0.2	0.1	0.0	0.0	0.3	0.1	0.6	0.4	0.0	0.1	0.0	0.5	0.7	0.0	0.1	0.1	0.0	0.4	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.4	0.2	0.0	0.8	0.0	0.2	0.2	1.0	0.1	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.2	0.3	0.1	0.3	0.3	0.2	0.3	0.3	0.3	0.3	0.2	0.0	0.0	0.7	0.0	0.6	0.8	0.7	0.0	0.5	0.9	0.9	248.9	0.0	0.5	0.0	0.0	1.0	0.1	0.6	0.0	0.1	0.4	2.0	0.3	1.7	0.0	3.2	0.2	0.4	0.2	7.5	0.5	3.1	0.0	0.9	0.0	0.2	0.2	0.0	0.2	0.1	2.0	0.3	0.0	0.2	0.3	0.1	0.0	0.0	0.0	0.2	1.0	0.0	0.5	0.0	0.2	0.0	0.1	0.6	0.0	0.2	0.2	0.1	0.0	3.7	2.2	0.0	0.2	0.0	0.4	0.8	0.3	0.4	0.3	0.4
LRRC1	"dJ523E19.1, FLJ10775, FLJ11834, LANO"	ENSG00000137269	"Leucine rich repeat containing 1"	Q9BTT6	6	53794497-53924125	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 115.1;Late spermatids: 117.0;Oligodendrocytes: 138.8;Syncytiotrophoblasts: 107.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"RT4: 57.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031603, HPA031604"	Enhanced		Supported	Cytosol		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 37: Intestine - Unknown function"	"Cluster 15: RT4 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol		"HPA031603: AB_10601753, HPA031604: AB_10601224"	"unprognostic (2.90e-1)"	"unprognostic (8.01e-2)"	"unprognostic (9.59e-3)"	"unprognostic (2.46e-2)"	"unprognostic (7.04e-3)"	"unprognostic (1.55e-2)"	"unprognostic (2.19e-3)"	"unprognostic (6.37e-2)"	"unprognostic (7.02e-2)"	"unprognostic (7.12e-3)"	"prognostic unfavorable (1.18e-4)"	"unprognostic (3.97e-1)"	"prognostic favorable (2.21e-7)"	"unprognostic (1.74e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.09e-1)"	"unprognostic (9.84e-3)"	14.0	2.2	8.7	5.1	13.8	2.9	13.3	10.1	11.2	13.2	13.7	25.5	17.3	5.1	7.5	18.2	8.5	7.8	4.2	9.2	10.4	7.7	0.8	7.6	2.7	13.9	10.8	4.8	8.8	22.6	7.9	11.1	14.2	8.7	25.4	7.1	16.7	6.7	1.5	22.5	18.1	5.1	10.9	1.5	14.8	14.5	11.1	13.9	15.3	1.4	10.7	14.5	18.0	24.1	45.2	5.7	6.1	10.9	1.6	0.8	42.8	6.1	12.3	5.2	7.1	49.4	21.7	6.4	4.9	3.9	9.7	21.7	47.9	19.4	6.6	7.9	13.8	3.9	4.5	33.5	15.2	4.9	2.9	1.6	15.8	0.4	11.5	8.1	9.4	23.1	0.9	5.8	2.9	19.7	33.6	0.6	4.8	33.5	4.2	6.8	10.2	3.3	14.1	57.4	15.7	1.5	7.3	31.7	9.9	15.2	20.6	5.0	4.3	3.9	12.6	0.2	5.6	5.8	4.9	4.6	4.4	6.7	4.8	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.2	0.2	0.3	0.5	0.1	0.1	0.0	0.7	0.0	0.3	0.0	0.0	8.7	13.8	10.1	11.2	9.2	10.4	13.9	10.8	14.2	10.9	11.1	24.1	19.8	41.7	3.9	53.2	2.9	52.6	25.5	16.3	12.0	43.0	16.0	8.1	3.5	11.5	20.6	16.5	4.2	54.5	2.3	115.1	7.9	20.5	88.5	38.8	9.4	18.8	18.0	1.7	11.9	15.6	62.0	5.9	26.0	74.3	5.7	10.5	8.6	0.3	5.1	8.4	21.9	23.6	12.2	0.6	7.1	117.0	9.3	1.3	10.6	26.2	2.5	32.7	6.2	35.2	138.8	29.5	62.5	10.1	4.2	18.5	32.5	12.3	14.1	3.0	6.6	3.5	3.7	27.3	7.3	19.9	52.7	107.4	3.1	1.6	24.5	32.5
MLIP	"C6orf142, CIP, MGC18257"	ENSG00000146147	"Muscular LMNA interacting protein"	Q5VWP3	6	53929982-54266280	"Disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	11	"heart muscle: 209.2;liver: 131.3;skeletal muscle: 246.6;tongue: 149.5"	"Group enriched"	"Detected in some"	11	"Cardiomyocytes: 224.9;Excitatory neurons: 244.1"	"Group enriched"	"Detected in some"	4	"glioma: 0.8;head and neck cancer: 0.5;liver cancer: 1.9;melanoma: 1.4"	"Group enriched"	"Detected in some"	5	"cerebral cortex: 15.4;hippocampal formation: 6.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"HUVEC TERT2: 19.6;SK-MEL-30: 19.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029252, HPA046654"	Approved		Approved	Nucleoplasm		NA	NA				"Cluster 8: Non-specific - Mitochondria"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm		"HPA029252: AB_2732446, HPA046654: "	"unprognostic (7.95e-3)"	"unprognostic (4.39e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.06e-4)"	"unprognostic (2.38e-2)"	"unprognostic (1.26e-2)"	"unprognostic (5.60e-2)"	"unprognostic (2.74e-2)"	"unprognostic (1.89e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.91e-5)"	"unprognostic (7.49e-2)"	"unprognostic (2.65e-2)"	"unprognostic (5.27e-2)"	"unprognostic (3.29e-3)"	3.7	4.3	0.1	0.1	2.2	0.0	3.5	0.0	15.4	1.7	0.0	0.9	0.3	0.2	0.9	12.6	0.7	1.6	209.2	6.0	0.0	0.9	131.3	0.4	0.2	0.0	0.0	0.2	0.8	0.3	0.5	0.1	0.0	1.6	0.7	0.9	6.9	0.3	246.6	17.4	2.6	0.5	0.0	0.1	0.3	1.0	0.0	0.3	6.9	149.5	5.2	1.3	2.5	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.4	2.2	0.2	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.7	2.4	0.0	0.0	0.0	19.6	0.1	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	1.2	0.0	0.1	0.6	1.4	0.0	0.0	0.5	19.6	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	1.6	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.2	0.0	15.4	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	4.9	0.0	0.4	0.1	0.5	0.6	0.1	0.2	0.0	224.9	0.0	0.4	0.0	0.0	0.0	0.0	0.0	1.9	0.0	15.7	0.5	0.5	2.6	0.0	2.7	244.1	0.0	0.0	4.9	0.0	0.4	0.0	0.1	0.7	20.0	0.0	13.5	4.6	3.7	0.0	0.8	0.6	12.9	0.3	0.2	7.2	16.9	0.0	0.0	0.0	5.0	4.2	0.0	0.0	0.0	0.0	0.1	1.0	1.9	0.6	0.1	0.0	17.8	1.9	1.5	0.4	4.1	2.0	0.0	0.1	0.1	0.1	0.1
TINAG		ENSG00000137251	"Tubulointerstitial nephritis antigen"	Q9UJW2	6	54307859-54390142	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"kidney: 110.4"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 48.6;Distal tubular cells: 23.5;Proximal enterocytes: 72.5;Proximal tubular cells: 207.1"	"Cancer enriched"	"Detected in some"	4	"renal cancer: 15.8"	"Group enriched"	"Detected in some"	6	"medulla oblongata: 1.7;pons: 1.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	33	"RPTEC TERT1: 91.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA035427, HPA073753"	Approved				"Secreted to extracellular matrix"	NA	NA		40000		"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA035427: AB_10601822, HPA073753: "			"unprognostic (7.62e-3)"			"unprognostic (1.12e-2)"	"prognostic unfavorable (2.05e-5)"	"unprognostic (7.27e-2)"			"unprognostic (5.99e-3)"		"prognostic favorable (8.75e-5)"	"unprognostic (7.10e-2)"				0.0	0.0	0.1	0.8	0.1	0.0	0.0	0.0	0.2	0.0	0.0	14.0	11.7	0.0	0.0	0.0	0.0	1.7	0.1	0.2	0.0	110.4	0.0	0.0	0.0	1.7	0.1	0.0	0.0	0.0	0.0	0.0	1.6	0.0	13.8	0.0	0.0	0.0	0.2	0.0	14.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	91.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.2	0.0	1.7	0.1	1.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	7.3	0.0	0.0	0.0	48.6	23.5	0.0	1.0	0.1	0.0	0.0	9.7	0.0	2.8	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	6.6	0.0	0.0	0.0	0.1	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	15.3	0.0	0.0	0.0	72.5	207.1	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.3	0.0	18.4	0.0
FAM83B	"C6orf143, FLJ30642"	ENSG00000168143	"Family with sequence similarity 83 member B"	Q5T0W9	6	54846771-54945099	"Predicted intracellular proteins"			Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 14.5;skin 1: 25.9"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 33.8;Basal prostatic cells: 32.5;Basal squamous epithelial cells: 43.3;Squamous epithelial cells: 31.9;Suprabasal keratinocytes: 41.1;Urothelial cells: 25.4"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 15.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 13.3;HaCaT: 18.1;HBEC3-KT: 9.8;hTCEpi: 19.7;hTERT-HME1: 23.8;RT4: 19.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA031464, HPA031465"	Enhanced					NA	NA				"Cluster 31: Skin - Epidermis development"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 22: Epithelial cell types - Mixed function"			"HPA031464: AB_10599973, HPA031465: AB_10601566"	"unprognostic (2.29e-1)"	"unprognostic (3.93e-2)"	"unprognostic (3.71e-2)"	"unprognostic (1.03e-2)"		"unprognostic (1.71e-2)"		"prognostic unfavorable (1.48e-4)"	"unprognostic (7.27e-2)"	"unprognostic (5.77e-3)"	"prognostic unfavorable (7.60e-4)"	"unprognostic (1.62e-1)"	"unprognostic (3.19e-2)"	"unprognostic (1.85e-1)"	"unprognostic (4.35e-1)"	"unprognostic (2.16e-1)"	"prognostic unfavorable (1.86e-5)"	0.0	0.0	0.1	1.0	0.1	0.1	2.2	0.1	0.1	3.8	0.0	8.0	7.4	0.3	1.2	14.5	1.6	2.1	1.1	0.0	0.0	2.5	0.1	0.1	0.0	0.0	0.7	0.0	1.5	0.0	0.0	4.3	0.1	1.8	8.2	0.1	4.7	1.1	0.7	25.9	7.4	0.2	0.0	0.0	3.9	0.6	0.0	2.3	3.6	0.1	3.6	4.3	9.8	0.2	13.3	0.2	0.0	0.0	0.0	0.0	7.3	0.0	0.0	0.0	0.0	6.5	3.6	0.0	0.0	0.0	0.1	18.1	0.0	9.8	0.1	0.0	2.2	0.0	2.5	0.0	0.0	0.0	0.0	0.0	19.7	0.0	23.8	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.6	4.1	0.0	0.0	0.0	0.0	9.1	19.2	0.2	0.0	2.9	0.6	0.0	3.3	4.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	33.8	32.5	6.6	43.3	0.0	1.5	3.0	3.1	5.7	6.5	7.3	0.0	11.2	0.1	9.0	0.0	6.1	6.3	8.8	0.8	0.3	1.2	0.0	0.2	3.5	11.9	0.4	9.2	8.1	0.0	0.0	0.4	0.0	0.6	0.0	0.1	5.4	6.1	0.0	1.5	2.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	17.4	0.0	0.1	9.1	12.6	0.0	1.8	0.0	0.0	0.0	0.1	0.1	0.6	31.9	41.1	18.7	0.1	0.0	8.8	25.4
HCRTR2	OX2R	ENSG00000137252	"Hypocretin receptor 2"	O43614	6	55106460-55282617	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	10	"brain: 7.0"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 11.7;Inhibitory neurons: 18.3;Peritubular cells: 3.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	5	"AF22: 1.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA054516	Enhanced					NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 12: NES - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA054516: AB_2682513"						"unprognostic (4.86e-1)"		"unprognostic (2.69e-2)"		"unprognostic (1.86e-2)"	"unprognostic (2.32e-1)"			"unprognostic (7.45e-2)"	"unprognostic (7.39e-2)"			0.0	0.0	1.5	0.0	0.9	0.0	0.0	1.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.5	1.6	0.6	0.0	0.0	0.0	2.4	7.0	0.3	0.0	0.0	0.0	0.4	4.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.3	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.9	1.2	0.7	1.5	1.6	2.4	7.0	4.5	0.7	1.6	0.7	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.2	0.0	0.1	0.0	0.0	0.0	11.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	18.3	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GFRAL	"bA360D14.1, C6orf144, GRAL, UNQ9356"	ENSG00000187871	"GDNF family receptor alpha like"	Q6UXV0	6	55327469-55402493	"Predicted membrane proteins"		Receptor		"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA047372	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Actin filaments,Focal adhesion sites"		NA	NA						"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nucleoplasm, Plasma membrane"	"Actin filaments, Focal adhesion sites"	"HPA047372: AB_2680017"															"unprognostic (2.31e-1)"			0.2	0.0	0.2	0.0	0.3	0.0	0.0	0.3	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.3	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.2	0.3	0.3	0.3	0.2	0.1	0.1	0.1	0.1	0.1	0.2	0.2	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
HMGCLL1	"bA418P12.1, DKFZP434G1411"	ENSG00000146151	"3-hydroxymethyl-3-methylglutaryl-CoA lyase like 1"	Q8TB92	6	55434373-55579197	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Lyase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 10.6"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 49.9;Excitatory neurons: 80.7;Inhibitory neurons: 76.2;Oligodendrocytes: 23.5"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"SCLC-21H: 5.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"				"unprognostic (2.74e-3)"		"unprognostic (1.54e-2)"	"unprognostic (4.08e-3)"	"unprognostic (6.11e-2)"	"unprognostic (1.41e-1)"	"unprognostic (9.54e-3)"	"unprognostic (8.97e-3)"		"unprognostic (2.12e-2)"	"unprognostic (9.27e-3)"	"unprognostic (4.11e-2)"	"unprognostic (1.18e-4)"	"unprognostic (3.13e-3)"	"unprognostic (7.57e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.52e-1)"	1.4	3.6	6.1	0.2	5.9	0.0	1.4	5.9	5.2	0.8	0.0	0.8	0.2	0.2	0.0	1.0	0.4	0.6	1.8	5.5	10.6	0.9	0.7	2.6	0.3	5.6	6.3	0.4	1.6	0.1	4.7	6.2	6.6	3.0	0.8	4.5	0.8	1.0	1.1	0.1	0.9	0.5	9.2	0.0	1.0	2.6	8.3	0.6	0.4	2.8	0.2	0.9	0.7	9.4	0.0	0.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.2	0.0	0.0	0.0	1.1	0.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	5.9	5.9	5.2	5.5	10.6	5.6	6.3	6.6	9.2	8.3	9.4	0.6	0.0	1.3	49.9	0.0	0.0	0.0	0.0	1.2	15.1	3.7	2.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.1	0.5	0.0	0.0	80.7	0.0	0.0	5.8	0.0	0.0	0.0	3.5	3.9	0.0	0.1	0.0	76.2	0.0	0.0	0.3	0.0	1.3	0.3	0.1	0.0	15.0	0.0	1.5	0.0	5.5	23.5	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.3	0.0	0.9	5.6	1.3	1.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0
BMP5		ENSG00000112175	"Bone morphogenetic protein 5"	P22003	6	55753653-55875590	"Predicted intracellular proteins, Predicted secreted proteins"	"Chondrogenesis, Differentiation, Osteogenesis"	"Cytokine, Developmental protein, Growth factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"placenta: 71.3"	"Group enriched"	"Detected in some"	8	"Cardiomyocytes: 17.7;Fibroblasts: 28.9;Microglial cells: 26.2;Smooth muscle cells: 26.3"	"Cancer enhanced"	"Detected in many"		"lung cancer: 2.8"	"Group enriched"	"Detected in some"	4	"medulla oblongata: 2.3;pons: 2.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	11	"AF22: 27.6;U-2 OS: 20.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Secreted - unknown location"	NA	NA				"Cluster 28: Placenta - Pregnancy"	"Cluster 12: NES - Nervous system development"	"Cluster 33: Fibroblasts - ECM organization"				"unprognostic (2.84e-4)"		"unprognostic (9.07e-4)"	"unprognostic (3.50e-1)"	"unprognostic (1.27e-1)"	"unprognostic (6.21e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.39e-3)"		"unprognostic (1.29e-1)"	"unprognostic (1.20e-1)"	"unprognostic (6.76e-2)"	"unprognostic (4.43e-3)"	"unprognostic (3.15e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.76e-2)"	1.5	1.0	0.1	1.0	0.3	0.2	1.0	0.6	0.5	0.0	2.0	6.2	8.3	0.0	0.0	0.9	0.0	2.3	3.8	0.1	0.0	2.4	3.2	12.9	0.4	2.3	0.3	0.0	1.6	1.1	3.5	71.3	2.9	14.1	7.4	0.0	1.2	0.0	4.4	0.1	9.7	0.3	0.1	0.0	3.3	0.0	0.1	0.2	1.0	12.3	0.2	9.3	0.3	0.0	0.0	0.0	27.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	2.2	0.0	0.4	0.0	0.0	1.1	0.0	0.0	0.0	0.0	20.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.6	0.5	0.1	0.0	2.3	0.3	2.9	0.1	0.1	0.0	1.8	0.0	3.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	1.0	17.7	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	1.2	0.0	2.7	0.4	0.0	0.8	28.9	0.0	0.0	0.0	0.0	2.2	0.0	2.4	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	26.2	0.0	0.0	0.0	0.0	0.1	1.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	2.6	26.3	0.0	0.1	0.3	0.0	1.9	0.6	0.0	0.0	0.1
COL21A1		ENSG00000124749	"Collagen type XXI alpha 1 chain"	Q96P44	6	56056590-56394094	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 24.1;placenta: 28.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 66.6;Cardiomyocytes: 36.9;Extravillous trophoblasts: 75.3;Inhibitory neurons: 63.3;Respiratory ciliated cells: 51.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"ASC TERT1: 23.4;BEWO: 7.6;HSkMC: 24.0;SuSa: 11.1"					"Low region specificity"	"Detected in all"			HPA031212			Supported	Cytosol	"Secreted to extracellular matrix"	NA	NA		290000		"Cluster 46: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"	Cytosol		"HPA031212: AB_10599941"	"unprognostic (1.69e-1)"	"unprognostic (4.53e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.21e-1)"	"unprognostic (9.32e-3)"	"unprognostic (6.84e-2)"	"unprognostic (9.04e-3)"	"unprognostic (1.54e-3)"	"unprognostic (2.17e-1)"	"unprognostic (5.29e-2)"	"unprognostic (3.10e-1)"	"unprognostic (1.26e-3)"	"unprognostic (3.27e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.27e-3)"	2.6	1.4	2.6	0.6	3.2	0.0	1.4	3.3	1.9	24.1	11.4	7.8	0.5	12.4	2.8	2.4	7.4	3.8	4.2	2.4	5.6	1.1	1.2	7.6	0.5	2.7	6.3	3.7	1.9	0.6	1.9	28.3	3.1	3.5	2.0	0.0	5.0	10.7	1.3	6.6	1.3	7.9	1.5	0.5	2.7	2.7	4.0	0.7	1.0	6.6	0.5	6.1	6.0	2.7	0.0	3.4	0.2	0.0	1.3	23.4	7.6	0.0	1.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	3.2	0.1	0.0	24.0	0.9	0.0	0.3	0.5	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.1	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	11.1	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	3.2	3.3	1.9	2.4	5.6	2.7	6.3	3.1	1.5	4.0	2.7	6.4	0.0	1.5	66.6	0.0	5.9	2.2	2.8	2.2	0.0	0.3	0.4	36.9	0.0	8.2	0.0	0.0	27.5	0.1	0.0	0.0	0.0	7.4	24.8	10.6	6.6	0.0	0.0	16.0	0.0	75.3	28.2	0.5	1.2	0.0	0.2	2.9	0.0	6.1	0.0	63.3	0.0	16.2	0.3	3.0	1.7	15.2	0.3	5.4	0.0	0.0	0.0	0.0	3.5	1.6	0.0	0.0	12.4	0.0	0.1	0.1	0.1	51.3	0.0	0.0	7.3	15.0	1.2	2.5	1.0	4.1	23.3	0.4	2.1	0.2	1.3
DST	"BP240, BPA, BPAG1, CATX-15, FLJ13425, FLJ21489, FLJ30627, FLJ32235, KIAA0728, MACF2"	ENSG00000151914	Dystonin	Q03001	6	56457987-56954830	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell adhesion"	"Actin-binding, Muscle protein"	"Cancer-related genes, Epidermolysis bullosa, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Basal keratinocytes: 2368.6;Basal prostatic cells: 1651.4;Basal squamous epithelial cells: 3008.4;Cone photoreceptor cells: 1401.1;Oligodendrocytes: 1410.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"plasmacytoid DC: 1.3"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"hTCEpi: 488.1;hTERT-HME1: 371.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030200	Uncertain		Approved	Nucleoplasm,Microtubules,Cytosol		NA	NA		16000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 22: Epithelial cell types - Mixed function"	"Nucleoplasm, Microtubules"	Cytosol	"HPA030200: AB_10601901"	"unprognostic (4.87e-3)"	"unprognostic (1.29e-1)"	"unprognostic (3.40e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.25e-2)"	"unprognostic (3.60e-2)"	"unprognostic (5.78e-2)"	"unprognostic (2.35e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.75e-2)"	"unprognostic (1.13e-1)"	"unprognostic (3.69e-1)"	"unprognostic (4.39e-2)"	"unprognostic (5.13e-3)"	"unprognostic (1.46e-1)"	"unprognostic (2.66e-1)"	"unprognostic (7.62e-2)"	60.9	86.2	206.5	16.2	275.8	3.3	117.3	240.6	221.9	158.8	143.3	173.2	25.4	167.1	38.2	66.1	103.9	32.6	166.0	194.6	230.7	52.2	80.8	108.0	11.3	258.1	250.4	78.2	39.8	36.7	78.8	28.7	263.4	84.5	32.4	87.4	100.3	48.7	143.1	166.2	64.2	106.0	209.1	36.7	68.9	28.4	243.3	31.4	29.8	104.1	15.2	90.4	113.2	325.4	62.4	26.6	41.2	20.8	79.5	103.5	24.6	82.2	89.7	37.8	42.1	17.1	15.5	10.4	32.2	220.7	35.6	46.7	34.4	161.2	73.0	52.3	45.2	17.8	49.5	31.4	65.9	15.0	0.4	58.3	488.1	92.5	371.6	69.1	73.3	9.5	12.6	38.2	113.9	20.2	5.1	6.8	27.7	35.6	21.9	0.1	28.8	16.5	118.8	83.0	47.2	37.8	32.7	11.7	64.1	67.7	18.6	27.2	176.5	77.3	55.9	37.0	68.9	39.6	28.6	5.0	55.8	8.8	40.3	0.0	0.7	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.9	0.2	0.0	0.0	0.0	0.9	0.3	1.3	0.0	0.1	206.5	275.8	240.6	221.9	194.6	230.7	258.1	250.4	263.4	209.1	243.3	325.4	193.2	336.5	11.8	1048.7	5.6	2368.6	1651.4	250.1	3008.4	673.1	81.0	301.5	862.8	77.2	161.7	55.2	1401.1	61.5	7.8	357.8	7.9	204.3	53.6	133.8	218.4	122.7	44.9	12.4	550.4	66.3	11.6	212.5	71.9	166.8	17.1	478.7	60.7	80.3	21.8	307.9	591.7	100.3	118.0	74.2	124.6	15.5	133.3	56.6	215.3	215.5	46.6	200.8	2.1	630.3	1410.3	194.1	283.0	152.4	27.2	229.8	124.2	10.3	52.0	122.6	65.7	381.8	196.6	20.0	13.7	298.2	857.2	26.5	19.7	30.5	48.1	142.8
BEND6	"bA203B9.1, C6orf65, FLJ30162"	ENSG00000151917	"BEN domain containing 6"	Q5SZJ8	6	56955107-57027346	"Predicted intracellular proteins"	"Neurogenesis, Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 30.9;retina: 11.8"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 82.6;Excitatory neurons: 87.3;Horizontal cells: 42.1;Inhibitory neurons: 118.6;Oligodendrocyte precursor cells: 49.8"	"Cancer enriched"	"Detected in many"	6	"glioma: 4.1"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	5	"plasmacytoid DC: 8.8"	"Lineage enriched"	"Detected in many"	6	"dendritic cells: 8.8"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 28.8;fHDF/TERT166: 28.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031605, HPA052973"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Plasma membrane"		"HPA031605: AB_10602395, HPA052973: AB_2682002"	"unprognostic (4.27e-1)"	"unprognostic (7.05e-2)"	"unprognostic (4.42e-2)"	"unprognostic (1.18e-6)"	"unprognostic (2.44e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.77e-2)"	"unprognostic (9.41e-3)"	"unprognostic (1.57e-1)"	"unprognostic (8.82e-2)"	"unprognostic (1.94e-2)"	"unprognostic (9.84e-6)"	"unprognostic (9.27e-3)"	"unprognostic (1.51e-1)"	"unprognostic (4.79e-2)"	"unprognostic (2.98e-3)"	1.2	2.1	12.1	1.5	14.2	0.7	0.6	30.5	30.9	4.0	2.9	1.4	0.5	2.8	0.7	1.2	1.0	3.8	2.4	12.6	16.0	0.6	0.2	0.6	0.9	19.5	16.0	2.0	0.4	0.7	1.7	2.0	20.4	2.4	1.5	11.8	0.5	2.4	3.9	1.0	0.7	3.6	12.1	0.8	0.8	1.0	15.7	1.1	0.8	0.6	0.8	2.8	1.7	21.7	5.4	2.2	1.3	0.6	17.6	28.8	4.9	16.1	15.6	7.1	8.2	0.2	2.4	0.1	5.2	28.7	9.9	0.7	1.8	0.8	8.7	2.4	1.0	3.6	7.5	0.4	4.7	10.3	0.2	12.7	4.5	9.8	4.3	11.9	4.7	13.3	4.6	9.2	14.3	5.5	6.2	2.5	4.4	0.3	1.3	0.1	0.2	2.6	2.6	5.4	6.1	6.2	10.8	1.3	1.4	6.1	0.3	5.9	6.1	21.5	0.7	14.5	3.6	12.6	15.2	4.3	12.6	6.5	19.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	1.5	0.0	8.8	0.0	0.1	12.1	14.2	30.5	30.9	12.6	16.0	19.5	16.0	20.4	12.1	15.7	21.7	0.4	0.0	0.0	16.6	0.3	0.9	0.2	0.2	0.0	82.6	0.2	1.1	3.6	0.0	0.7	0.0	4.2	0.5	10.8	0.0	0.0	0.2	0.6	0.5	11.9	0.2	0.0	0.0	87.3	0.4	1.6	5.6	0.0	0.5	0.0	13.5	1.1	0.0	0.1	42.1	118.6	0.0	0.0	0.0	4.0	0.8	1.8	1.1	3.6	13.1	0.3	4.9	0.0	49.8	22.9	0.6	0.0	3.0	0.0	0.4	0.0	1.0	0.0	4.8	0.0	8.7	2.7	0.7	5.8	0.2	1.0	0.0	0.1	4.4	0.0	0.1
KIAA1586		ENSG00000168116	KIAA1586	Q9HCI6	6	57046532-57055239	"Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 87.0;Erythroid cells: 74.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA036370	Approved		Approved	"Nucleoplasm,Nuclear membrane"		No	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nucleoplasm, Nuclear membrane"		"HPA036370: AB_10672219"	"unprognostic (7.17e-2)"	"unprognostic (3.05e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.29e-2)"	"unprognostic (2.50e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.51e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.46e-2)"	"unprognostic (4.96e-3)"	"unprognostic (2.62e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.36e-3)"	"unprognostic (5.64e-2)"	"unprognostic (8.25e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.07e-1)"	4.1	4.8	2.0	3.6	2.4	8.6	5.4	9.4	3.7	4.6	0.0	2.9	2.1	6.1	3.7	3.3	2.8	4.6	3.5	2.3	3.0	3.6	4.9	2.7	4.6	2.9	2.4	7.6	2.8	5.2	3.7	9.4	2.8	5.2	2.6	4.0	2.7	3.6	1.6	2.5	2.4	4.4	1.4	4.5	2.1	8.0	2.8	5.9	5.7	3.4	3.9	4.8	2.6	2.6	8.6	3.5	21.9	25.1	8.5	13.7	12.0	14.1	11.6	12.0	14.4	5.9	2.7	3.4	11.4	10.4	10.6	4.2	16.7	8.3	16.4	10.7	12.7	35.9	8.0	13.3	11.1	29.0	12.7	10.1	5.9	10.6	11.7	8.5	11.5	9.1	49.9	2.7	14.4	6.8	14.0	17.5	14.2	3.0	5.0	12.8	16.0	8.4	8.0	17.6	18.5	16.8	9.3	3.0	10.6	15.1	7.2	26.0	9.4	18.6	7.7	17.9	10.2	10.9	15.4	16.8	11.5	21.0	7.7	0.2	2.5	2.0	2.3	2.0	2.7	3.7	3.4	3.0	3.9	3.1	4.2	3.6	0.1	5.3	2.0	4.0	4.4	1.9	2.0	2.4	9.4	3.7	2.3	3.0	2.9	2.4	2.8	1.4	2.8	2.6	15.4	9.6	6.3	10.4	8.8	10.5	4.5	13.0	13.1	15.4	7.4	11.7	23.1	1.5	7.8	7.3	2.1	43.3	11.7	1.0	11.7	7.0	87.0	4.6	29.6	12.5	5.4	74.9	32.4	5.4	33.2	21.4	3.1	3.2	13.3	30.5	8.2	4.0	12.5	10.1	32.7	2.4	6.1	6.6	7.1	21.9	12.8	8.9	3.6	12.2	9.7	9.6	15.5	23.6	24.4	2.8	0.9	14.7	13.0	2.3	0.7	14.6	8.4	8.2	19.7	19.5	17.6	23.4	17.9	8.7	4.4	10.7	10.6	29.5	3.2	1.6
ZNF451	"COASTER, dJ417I1.1, KIAA0576, KIAA1702"	ENSG00000112200	"Zinc finger protein 451"	Q9Y4E5	6	57086844-57170305	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 70.3"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 247.3;Late spermatids: 412.7;Oligodendrocytes: 212.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028838			Approved	Nucleoplasm		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm		"HPA028838: AB_10603330"	"unprognostic (5.95e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.81e-1)"	"unprognostic (9.00e-3)"	"unprognostic (1.06e-2)"	"unprognostic (1.02e-1)"	"unprognostic (6.87e-3)"	"unprognostic (1.38e-2)"	"unprognostic (1.27e-3)"	"unprognostic (9.09e-2)"	"unprognostic (6.42e-2)"	"unprognostic (1.11e-3)"	"unprognostic (2.11e-1)"	"unprognostic (2.50e-1)"	"unprognostic (2.13e-3)"	"unprognostic (6.17e-2)"	12.2	15.0	11.1	10.8	17.9	70.3	13.4	28.7	15.8	11.9	5.4	10.7	8.2	12.9	14.8	10.7	9.7	10.3	9.2	10.4	11.8	11.1	12.9	12.6	16.0	13.9	12.2	12.3	8.9	14.2	10.0	15.0	13.8	13.7	9.8	17.2	10.6	10.2	8.9	11.7	9.4	11.5	10.3	14.7	11.8	29.0	13.7	16.3	15.6	11.3	13.9	10.7	9.4	24.4	17.8	10.6	23.0	14.4	21.6	27.3	22.1	19.5	23.8	22.3	24.0	20.9	8.5	19.1	12.7	20.8	26.4	16.6	22.6	21.9	36.3	15.5	16.7	50.5	17.6	20.3	16.5	28.3	20.7	19.3	21.0	24.7	31.1	16.7	22.6	26.8	69.6	17.9	19.4	12.5	34.5	24.1	12.6	13.3	10.6	23.5	29.1	17.9	15.1	29.0	27.3	18.4	20.7	13.6	22.7	27.1	16.4	26.4	14.7	22.5	23.2	29.5	22.5	17.7	32.2	39.1	19.7	34.1	11.4	33.5	10.1	10.5	11.0	8.9	11.1	10.7	9.1	6.8	11.1	14.8	12.3	9.6	5.0	8.8	9.7	14.6	7.9	7.8	11.1	17.9	28.7	15.8	10.4	11.8	13.9	12.2	13.8	10.3	13.7	24.4	47.6	25.6	34.5	67.6	40.6	56.3	14.9	19.3	40.5	55.7	31.7	25.1	25.1	25.8	24.5	31.3	75.0	40.8	62.0	21.1	9.8	15.1	247.3	33.4	51.3	37.0	36.7	124.6	87.6	14.0	30.5	44.5	34.1	35.1	43.0	71.3	45.0	32.6	18.3	48.8	84.8	23.4	14.2	36.0	43.4	412.7	37.6	33.4	33.8	47.8	28.7	26.5	24.7	82.0	212.2	18.9	13.0	41.3	38.2	25.9	19.8	14.6	35.2	68.6	6.6	37.6	36.8	48.0	32.0	32.7	42.8	13.1	40.6	44.9	23.1	22.8
BAG2		ENSG00000112208	"BAG cochaperone 2"	O95816	6	57172326-57189833	"Plasma proteins, Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 32.6"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 73.3;Early spermatids: 152.3;Spermatocytes: 93.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018862, HPA019918"	Enhanced		Supported	"Intermediate filaments,Cytosol"		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"	Cytosol	"Intermediate filaments"	"HPA018862: AB_2669957, HPA019918: AB_2670317"	"unprognostic (3.93e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.60e-1)"	"unprognostic (1.33e-1)"	"unprognostic (5.63e-2)"	"unprognostic (8.32e-3)"	"prognostic unfavorable (6.72e-6)"	"unprognostic (1.10e-1)"	"unprognostic (7.79e-5)"	"unprognostic (6.20e-3)"	"unprognostic (4.71e-2)"	"unprognostic (6.56e-2)"	"unprognostic (6.07e-3)"	"unprognostic (5.97e-3)"	"unprognostic (8.77e-2)"	"prognostic unfavorable (1.26e-4)"	"unprognostic (6.24e-3)"	3.7	4.4	2.5	6.6	2.7	1.5	1.7	2.8	4.0	11.4	3.0	32.6	2.1	25.1	3.9	7.2	9.1	7.3	9.1	2.5	2.7	2.8	4.1	5.0	2.7	2.3	2.7	8.5	1.6	0.4	2.0	7.6	2.4	11.2	4.5	4.9	1.0	15.9	9.2	1.3	6.5	29.0	2.3	1.1	7.8	6.4	2.6	1.3	4.6	6.5	2.1	22.5	5.9	3.0	17.2	9.3	3.9	13.8	9.4	26.9	10.9	27.2	25.8	19.2	18.2	12.1	8.6	5.7	25.3	43.2	15.7	3.1	22.5	2.4	18.3	18.3	16.4	16.7	13.3	27.5	14.5	14.8	3.7	13.1	1.2	15.8	14.6	11.4	15.2	13.0	34.1	7.9	19.1	1.3	10.5	12.4	14.8	0.3	9.6	9.5	10.9	11.4	23.2	2.8	4.9	4.4	12.2	0.9	10.1	17.8	2.1	12.7	20.8	10.9	17.9	23.2	27.4	5.3	5.5	12.5	9.7	5.8	1.0	0.1	0.2	0.5	1.9	0.2	2.2	3.5	1.7	1.9	0.9	3.0	3.4	2.9	0.1	2.1	0.0	0.3	2.0	1.1	2.5	2.7	2.8	4.0	2.5	2.7	2.3	2.7	2.4	2.3	2.6	3.0	2.4	3.2	3.7	4.6	16.7	2.4	4.6	5.0	1.8	6.9	4.1	2.7	40.0	0.0	3.8	3.7	12.5	73.3	8.0	0.6	1.9	11.6	152.3	11.0	35.5	3.1	1.8	12.2	8.1	3.7	18.2	46.2	3.1	4.2	4.5	25.6	2.2	15.8	15.8	10.1	10.0	0.3	14.2	2.6	6.6	35.9	31.1	5.1	7.2	5.6	9.1	8.2	3.1	10.6	10.6	5.4	1.3	38.7	13.0	6.2	0.4	33.9	9.1	16.9	6.6	32.1	31.0	93.5	9.8	1.3	3.8	18.9	12.2	30.6	1.3	2.1
RAB23		ENSG00000112210	"RAB23, member RAS oncogene family"	Q9ULC3	6	57186992-57222307	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Protein transport, Transport"	"Developmental protein"	"Craniosynostosis, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Fibroblasts: 22.3;Peritubular cells: 30.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in all"		"ASC TERT1: 97.2;U-2197: 177.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029135, HPA029136"	Enhanced		Enhanced	"Plasma membrane,Cytosol"		NA	NA			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 18: U-2197 - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"	"Plasma membrane, Cytosol"		"HPA029135: AB_10602070, HPA029136: AB_10601794"	"unprognostic (8.78e-2)"	"unprognostic (6.55e-2)"	"unprognostic (7.17e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.14e-2)"	"unprognostic (2.28e-2)"	"unprognostic (2.55e-2)"	"unprognostic (5.33e-3)"	"unprognostic (6.41e-2)"	"unprognostic (6.55e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.97e-2)"	"unprognostic (9.12e-3)"	"unprognostic (1.36e-2)"	"unprognostic (2.38e-1)"	"unprognostic (6.37e-2)"	"unprognostic (1.46e-3)"	9.6	6.1	8.6	13.2	9.0	0.8	7.8	10.9	9.6	45.9	6.1	59.7	7.0	52.6	14.1	19.9	14.5	26.9	12.3	8.5	15.2	7.3	4.1	10.6	4.5	8.7	8.7	10.8	2.9	5.7	3.4	27.6	9.5	38.7	15.9	3.9	3.9	55.7	6.1	4.8	10.8	75.0	9.2	2.2	11.6	5.1	9.7	3.2	32.6	10.4	4.1	46.7	14.7	11.5	15.6	6.1	21.6	15.3	32.3	97.2	19.8	44.9	77.4	38.6	39.7	13.4	7.3	3.1	13.6	72.3	19.3	5.5	22.7	16.4	45.6	11.6	10.5	11.3	9.4	10.6	19.8	5.9	1.6	36.5	18.6	48.1	44.7	18.7	20.3	6.6	17.6	9.3	43.4	13.2	5.2	6.3	8.1	10.3	8.2	5.7	31.7	4.7	26.8	10.7	11.2	7.6	22.5	10.6	11.6	26.8	9.7	6.8	27.4	59.6	18.5	177.4	26.6	8.0	9.3	7.6	33.5	12.5	30.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.0	0.1	0.1	0.2	0.0	0.0	8.6	9.0	10.9	9.6	8.5	15.2	8.7	8.7	9.5	9.2	9.7	11.5	2.9	12.8	5.0	6.8	0.7	4.1	1.6	2.0	5.7	2.5	4.0	3.0	3.4	1.5	1.6	0.0	2.1	11.5	1.7	2.4	0.0	3.4	2.4	6.5	15.5	2.6	1.2	4.8	13.0	2.9	10.7	22.3	1.1	6.2	0.0	3.7	4.6	3.4	4.2	1.7	12.3	1.4	2.0	0.8	3.1	2.5	19.9	1.4	5.4	11.2	7.7	4.4	0.0	8.0	5.3	2.6	0.1	30.5	0.5	3.5	0.6	6.1	5.3	0.9	0.0	17.2	14.5	6.6	7.8	4.1	5.1	13.7	0.8	4.0	1.6	1.8
PRIM2	PRIM2A	ENSG00000146143	"DNA primase subunit 2"	P49643	6	57314805-57646850	"Plasma proteins, Predicted intracellular proteins"	"DNA replication"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"prostate: 30.6"	"Cell type enhanced"	"Detected in many"		"Microglial cells: 70.3;Oligodendrocyte precursor cells: 56.8;Oligodendrocytes: 54.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046566			Supported	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 18: U-2197 - ECM organization"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm		"HPA046566: AB_2679701"	"unprognostic (1.24e-1)"	"unprognostic (1.55e-2)"	"unprognostic (2.66e-2)"	"prognostic unfavorable (6.98e-4)"	"unprognostic (3.08e-1)"	"unprognostic (6.24e-2)"	"prognostic unfavorable (3.44e-5)"	"unprognostic (2.31e-1)"	"unprognostic (1.00e-2)"	"prognostic favorable (3.00e-5)"	"prognostic unfavorable (5.25e-4)"	"unprognostic (3.89e-1)"	"prognostic unfavorable (7.34e-6)"	"unprognostic (2.04e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.08e-1)"	4.3	3.3	3.9	6.6	4.6	15.0	6.9	6.0	4.3	5.6	6.9	6.9	6.0	7.2	6.9	4.3	6.2	4.3	3.3	3.9	5.6	3.9	5.0	4.8	10.6	4.2	4.7	7.2	4.0	3.9	1.9	7.5	4.4	30.6	8.4	4.0	4.2	5.6	2.3	5.8	5.2	8.0	2.8	5.5	4.8	6.5	4.5	15.3	4.4	2.4	11.8	5.8	4.1	7.1	44.8	17.7	34.1	37.6	16.8	29.5	27.3	53.1	48.8	57.0	74.7	26.6	21.1	39.4	27.7	66.6	39.6	27.9	30.2	29.2	71.6	35.1	24.2	47.6	22.7	43.0	7.3	43.5	27.4	12.1	12.0	61.0	20.3	14.2	26.9	44.1	46.2	38.9	48.3	28.2	49.8	37.6	22.0	37.1	17.2	34.7	46.9	31.2	21.0	20.7	24.5	19.2	31.5	15.9	21.3	38.9	33.3	47.4	17.9	54.7	55.5	106.2	44.2	14.4	29.3	47.2	26.6	50.5	30.4	0.7	1.9	1.8	4.1	3.7	4.3	3.5	3.5	5.4	3.0	4.0	2.8	5.7	1.4	5.2	4.2	5.1	4.7	2.1	3.9	4.6	6.0	4.3	3.9	5.6	4.2	4.7	4.4	2.8	4.5	7.1	5.9	0.0	2.7	30.0	11.2	4.0	6.7	4.1	11.4	5.6	6.2	4.2	1.1	2.8	4.6	3.7	12.5	17.0	15.1	4.3	3.9	5.1	10.3	4.9	7.1	5.0	1.2	26.5	38.0	5.2	22.0	6.9	4.1	6.0	12.0	13.7	4.2	3.5	9.3	6.7	32.6	6.5	10.2	6.6	6.4	3.7	6.5	7.0	0.0	70.3	7.3	4.8	17.5	56.8	54.5	4.9	5.3	6.8	12.7	7.1	4.4	1.8	4.1	5.6	19.7	4.9	6.8	10.1	11.2	8.7	3.0	5.7	13.6	8.0	8.6	5.3
KHDRBS2	"MGC26664, SLM-1, SLM1"	ENSG00000112232	"KH RNA binding domain containing, signal transduction associated 2"	Q5VWX1	6	61679961-62286225	"Predicted intracellular proteins"	"mRNA processing, Transcription, Transcription regulation"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 5.8;retina: 4.0;thyroid gland: 4.1"	"Group enriched"	"Detected in some"	4	"Excitatory neurons: 1423.1;Inhibitory neurons: 720.1"	"Cancer enhanced"	"Detected in some"		"thyroid cancer: 1.6"	"Region enhanced"	"Detected in many"		"cerebral cortex: 5.8"	"Group enriched"	"Detected in some"	13	"memory B-cell: 5.9;naive B-cell: 6.9;plasmacytoid DC: 1.9"	"Group enriched"	"Detected in many"	12	"B-cells: 6.9;dendritic cells: 1.9"	"Group enriched"	"Detected in some"	7	"AF22: 4.7;NTERA-2: 1.6;THP-1: 1.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000500, HPA029392"	Supported					NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 58: Brain - Synaptic function"	"Cluster 12: NES - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA000500: AB_1079184, HPA029392: AB_10600816"	"unprognostic (6.98e-2)"			"unprognostic (1.21e-1)"	"unprognostic (3.06e-2)"		"unprognostic (1.37e-1)"	"unprognostic (1.80e-3)"	"unprognostic (4.35e-1)"	"unprognostic (2.80e-1)"	"unprognostic (1.25e-4)"	"unprognostic (1.45e-2)"	"unprognostic (2.19e-5)"	"unprognostic (5.52e-2)"	"unprognostic (4.54e-2)"	"unprognostic (6.24e-3)"	"unprognostic (1.15e-1)"	0.1	0.9	1.0	0.3	2.0	0.1	0.0	0.0	5.8	0.0	0.0	0.3	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.3	0.0	2.3	0.3	0.0	0.0	0.1	0.0	0.0	1.2	0.4	0.0	0.1	0.1	4.0	0.0	0.1	0.2	0.0	0.7	0.0	0.0	1.0	0.1	0.1	0.5	0.6	4.1	0.0	0.5	0.2	0.0	2.1	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	1.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.1	0.0	5.9	0.0	0.0	0.1	6.9	0.0	0.0	0.0	0.1	0.3	1.9	0.0	0.3	1.0	2.0	0.0	5.8	0.9	0.0	0.0	0.0	0.0	0.0	0.5	2.1	0.0	38.5	3.3	17.6	24.3	0.0	0.0	0.0	0.6	41.4	0.0	0.0	0.4	0.0	6.2	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.3	0.8	0.0	1.7	1423.1	0.0	0.0	0.4	0.0	0.3	0.0	0.6	0.4	0.0	0.1	35.3	720.1	0.0	0.0	0.3	0.0	0.0	0.3	1.4	0.0	117.1	0.3	30.5	0.0	238.8	99.4	0.0	0.0	0.0	1.6	0.0	0.0	2.1	0.0	3.1	0.0	0.3	0.3	0.1	1.2	0.0	0.0	0.0	0.7	0.1	0.0	0.0
FKBP1C	bA184C23.2	ENSG00000198225	"FKBP prolyl isomerase 1C"		6	63211446-63213024	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Low tissue specificity"	"Detected in some"			"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 9.9;Cardiomyocytes: 11.7;Langerhans cells: 12.0;Melanocytes: 8.8;Suprabasal keratinocytes: 15.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"dendritic cells: 3.0;granulocytes: 4.4;monocytes: 5.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"							HPA051798	Uncertain					NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 72: Non-specific - Transcription"		"Cluster 48: Smooth muscle cells - ECM organization"			"HPA051798: AB_2681615"	"unprognostic (6.64e-2)"	"unprognostic (1.25e-3)"	"unprognostic (2.58e-1)"	"unprognostic (1.08e-1)"	"unprognostic (3.90e-2)"	"unprognostic (1.19e-1)"	"unprognostic (4.91e-5)"	"unprognostic (4.78e-2)"	"unprognostic (3.58e-1)"	"unprognostic (1.98e-1)"	"unprognostic (9.79e-2)"	"unprognostic (8.54e-2)"	"unprognostic (9.95e-2)"	"unprognostic (9.46e-2)"	"unprognostic (3.48e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.73e-1)"	1.5	0.9	0.0	0.2	0.0	0.0	1.0	0.0	0.1	0.4	0.0	0.7	0.0	0.8	0.0	0.8	0.5	0.0	0.9	0.0	0.0	0.8	0.4	1.3	0.0	0.0	0.0	0.6	0.5	0.0	0.3	0.0	0.0	0.6	0.0	0.0	0.5	0.0	0.7	0.6	0.5	0.0	0.0	0.8	0.6	0.2	0.0	0.0	1.0	0.0	0.0	0.5	0.6	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.7	0.1	0.4	0.0	0.2	0.0	0.0	0.1	0.2	0.2	0.3	0.0	0.2	0.8	0.0	0.1	0.1	0.4	0.4	0.1	0.1	0.4	0.1	0.1	0.1	0.0	0.1	0.1	1.3	3.3	4.4	0.4	5.1	0.4	0.6	0.5	0.5	3.0	0.6	0.6	0.7	2.7	0.7	4.7	1.2	1.0	4.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.5	0.0	0.3	9.9	3.1	3.4	0.0	0.0	0.1	0.0	11.7	1.5	0.9	1.8	0.0	1.5	0.0	1.0	0.0	0.1	1.2	0.2	0.5	6.1	0.0	0.0	0.0	0.0	3.3	3.3	0.0	0.3	1.3	0.1	3.3	0.6	3.9	0.0	0.0	0.0	6.1	3.1	12.0	1.8	0.9	1.5	8.8	0.0	1.4	0.0	1.0	0.0	0.0	0.2	2.4	0.4	0.0	2.0	0.5	0.6	2.5	0.0	0.0	1.0	3.9	3.0	2.1	0.0	15.9	0.8	0.6	0.3	0.4	2.0
LGSN	"GLULD1, LGS"	ENSG00000146166	"Lengsin, lens protein with glutamine synthetase domain"	Q5TDP6	6	63275951-63319983	"Metabolic proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"kidney: 2.0;liver: 3.8;placenta: 1.1"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 3.5;Inhibitory neurons: 3.7;Late spermatids: 4.4;Oligodendrocytes: 5.9;Proximal tubular cells: 5.6;Respiratory ciliated cells: 3.0"	"Cancer enriched"	"Detected in some"	4	"lung cancer: 2.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 6.2;BEWO: 3.3;CACO-2: 1.6;HeLa: 1.8;Karpas-707: 1.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA030957, HPA039983"	Enhanced		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nucleoplasm, Vesicles"		"HPA030957: AB_10670149, HPA039983: AB_2676784"	"unprognostic (1.94e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.12e-1)"	"unprognostic (9.03e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.01e-1)"	"unprognostic (5.05e-4)"	"unprognostic (1.26e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.13e-1)"	"unprognostic (2.53e-2)"	"unprognostic (4.51e-3)"	"unprognostic (1.64e-3)"	"unprognostic (1.31e-1)"		"unprognostic (2.19e-1)"	0.0	0.1	0.1	0.0	0.1	0.2	0.0	0.4	0.2	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.1	2.0	3.8	0.2	0.0	0.3	0.1	0.0	0.3	0.0	0.0	1.1	0.2	0.2	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.3	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	6.2	0.0	0.0	0.0	0.0	3.3	0.0	0.1	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.2	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.3	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.4	0.2	0.1	0.1	0.3	0.1	0.2	0.1	0.1	0.4	0.0	0.0	0.5	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.5	0.0	2.0	0.0	0.0	2.2	0.0	1.1	1.9	0.1	1.2	2.0	0.0	0.1	0.0	0.0	3.5	0.2	0.5	0.1	0.0	0.0	0.0	0.3	0.0	1.1	0.3	0.0	3.7	0.7	0.0	0.3	0.0	4.4	0.3	0.1	0.0	1.9	0.0	0.0	0.0	1.5	5.9	0.0	0.3	0.0	0.1	0.2	0.1	5.6	3.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	1.4	0.1	0.1	0.8	0.2
PTP4A1	"PRL-1, PRL1, PTPCAAX1"	ENSG00000112245	"Protein tyrosine phosphatase 4A1"	Q93096	6	63521746-63583436	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Cell cycle"	"Developmental protein, Hydrolase, Protein phosphatase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 493.7"	"Cell type enriched"	"Detected in all"	4	"Late spermatids: 3071.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Hep G2: 533.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA003281	Approved					NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 25: Spermatids - Spermatogenesis"			"HPA003281: AB_1855903"	"unprognostic (8.63e-2)"	"prognostic unfavorable (5.53e-4)"	"unprognostic (9.05e-2)"	"unprognostic (7.96e-2)"	"unprognostic (2.79e-2)"	"unprognostic (2.71e-2)"	"unprognostic (6.12e-2)"	"unprognostic (1.96e-1)"	"unprognostic (5.28e-2)"	"unprognostic (2.33e-2)"	"unprognostic (6.62e-3)"	"unprognostic (1.23e-2)"	"unprognostic (1.07e-2)"	"unprognostic (6.64e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.10e-2)"	"unprognostic (1.11e-2)"	39.4	140.5	24.1	37.4	29.5	227.4	31.5	30.9	35.9	41.5	28.3	107.9	55.1	43.8	15.3	53.5	34.6	58.9	31.7	24.7	37.5	50.5	493.7	54.8	24.4	32.5	28.0	54.7	69.5	16.1	41.1	72.5	32.1	44.2	110.1	22.5	68.2	21.0	300.0	66.0	50.8	56.6	34.9	19.4	55.2	62.5	27.9	26.2	39.2	113.0	24.6	51.6	33.6	44.8	71.5	122.9	106.2	128.3	85.8	77.2	239.1	113.9	97.6	58.4	79.2	103.5	45.4	65.1	50.6	88.7	95.7	41.8	97.0	197.9	94.3	61.0	51.6	43.8	320.2	533.9	175.7	118.6	57.7	91.3	383.6	124.7	320.5	63.5	80.3	65.0	106.1	148.7	151.5	140.9	52.4	69.1	50.6	91.0	53.7	70.9	53.4	60.5	132.4	120.6	44.7	62.5	278.5	71.8	140.1	156.9	59.8	122.0	77.5	132.9	130.6	89.5	122.3	90.7	94.9	121.7	60.9	72.5	154.1	45.4	20.4	15.1	12.8	21.3	20.1	12.9	14.5	14.3	17.2	10.7	12.8	12.9	48.4	16.3	16.6	9.1	18.8	15.4	24.1	29.5	30.9	35.9	24.7	37.5	32.5	28.0	32.1	34.9	27.9	44.8	33.3	22.4	90.3	4.6	105.4	681.3	268.7	94.1	261.8	22.3	98.4	55.4	78.5	207.3	83.0	75.4	16.7	248.7	99.8	336.5	80.3	186.9	716.1	189.8	68.8	47.0	129.6	30.9	11.7	193.9	215.1	90.8	178.4	279.5	63.0	41.2	41.4	528.8	98.6	11.8	9.9	253.4	63.1	71.6	236.5	3071.4	28.6	99.7	170.7	5.6	47.4	22.0	15.5	9.5	20.4	151.8	196.9	24.0	110.6	166.4	181.3	112.1	61.2	24.6	6.6	44.4	110.2	47.2	26.3	181.8	641.0	459.6	123.4	79.1	214.6	164.1
AL135905.2		ENSG00000285976	"Novel protein"		6	63572472-63583587	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in all"		"liver: 177.9;skeletal muscle: 173.8"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 16.0;Alveolar cells type 2: 64.6;Club cells: 27.2;Respiratory ciliated cells: 10.2"					"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"																	NA	NA			"Cluster 9: Neutrophils - Innate immune response"		"Cluster 30: Epithelial cell lines - Translation"	"Cluster 11: Alveolar cells - Smell perception"																					15.1	46.5	6.5	12.3	8.9	41.2	9.0	9.0	8.8	16.1	4.2	43.1	20.7	15.8	3.0	13.7	14.2	14.7	8.3	6.8	17.6	17.9	177.9	22.8	8.3	10.8	11.5	10.6	30.0	5.1		20.1	10.5	14.3	39.3	6.5	12.6	10.5	173.8	5.0	19.9	22.9	9.3	8.1	18.5	9.6	8.5	11.4	10.9	40.6	9.5	15.4		13.6	25.3	26.0	36.6	45.1	36.2	35.9	54.2	49.0	42.8	17.0	25.2	21.6	11.3	36.2	19.5	37.1	20.3	9.0	29.4	68.0	25.6	16.9	33.5	21.6	62.9	71.0	66.8	57.1	21.8	47.5	119.4	38.4	112.0	25.7	38.0	25.9	31.9	32.1	59.7	25.8	19.4	20.1	14.1	33.3	26.6	32.6	25.0	19.1	35.6	22.0	16.7	30.5	144.8	22.3	48.8	38.4	22.8	38.3	39.1	49.8	29.4	29.9	40.5	43.5	30.2	36.8	28.1	29.9	42.2	13.6	6.1	4.3	3.9	6.1	5.4	4.1	4.1	3.8	5.2	4.0	4.7	4.8	11.4	5.1	5.0	3.4	5.2	4.0	6.5	8.9	9.0	8.8	6.8	17.6	10.8	11.5	10.5	9.3	8.5	13.6	0.0	16.0	64.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0
PHF3		ENSG00000118482	"PHD finger protein 3"	Q92576	6	63635802-63779336	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024676, HPA025763"	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 34: Non-specific - Transcription"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA024676: AB_10599736, HPA025763: AB_10600987"	"unprognostic (4.33e-1)"	"unprognostic (2.16e-1)"	"unprognostic (2.76e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.23e-2)"	"unprognostic (2.89e-1)"	"unprognostic (6.17e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.19e-2)"	"unprognostic (1.76e-2)"	"unprognostic (1.84e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.04e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.65e-1)"	"unprognostic (3.37e-1)"	19.6	18.2	12.5	16.9	18.9	39.5	21.4	32.2	15.3	20.6	11.7	16.7	16.0	22.8	17.5	12.8	16.7	16.1	13.7	11.0	15.4	19.7	28.0	16.0	21.6	17.4	13.7	32.2	18.4	23.8	12.2	24.3	19.4	18.2	17.6	27.7	15.2	15.9	20.3	16.5	16.1	15.5	14.5	21.3	18.3	14.3	14.7	30.6	26.1	22.9	18.1	15.4	16.8	30.5	35.8	17.5	28.1	17.0	27.3	29.6	28.6	23.0	32.5	16.9	22.3	24.0	16.6	44.0	19.3	20.7	24.4	15.3	27.7	23.9	27.8	35.2	23.3	52.5	21.7	38.2	24.7	45.3	20.7	21.4	21.2	24.0	34.1	29.1	19.8	23.0	58.4	39.9	17.4	21.2	19.5	23.9	16.3	22.9	10.4	33.7	25.6	21.2	20.5	21.0	30.8	22.7	27.7	12.5	20.1	30.7	21.3	41.2	28.2	25.9	30.4	20.0	27.6	33.9	37.6	41.0	11.9	35.6	20.3	15.5	6.2	7.1	7.6	8.0	7.4	7.3	7.1	6.1	5.5	8.9	10.0	7.6	14.4	5.0	11.5	6.7	5.5	4.4	12.5	18.9	32.2	15.3	11.0	15.4	17.4	13.7	19.4	14.5	14.7	30.5	87.9	157.0	133.2	76.0	108.0	54.9	62.1	42.2	71.7	67.9	49.4	56.8	95.2	34.3	88.6	46.0	47.9	47.6	91.2	50.1	15.6	48.4	40.5	68.8	93.7	61.1	43.1	63.1	71.1	37.6	31.5	77.2	60.6	84.3	103.0	85.5	41.7	47.1	28.8	50.5	80.5	46.1	28.5	46.2	33.2	26.5	81.1	65.3	23.2	70.3	69.6	47.4	74.2	76.9	129.8	29.8	40.5	56.8	92.4	64.1	55.5	36.4	72.9	66.8	59.2	103.7	58.5	103.0	69.3	48.4	42.9	31.2	97.1	114.2	49.4	51.0
EYS	"bA166P24.2, bA307F22.3, bA74E24.1, C6orf178, C6orf179, C6orf180, dJ1018A4.2, dJ303F19.1, EGFL10, EGFL11, RP25, SPAM"	ENSG00000188107	"Eyes shut homolog"	Q5T1H1	6	63719980-65707226	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins"	"Sensory transduction, Vision"		"Disease variant, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	36	"retina: 24.8"	"Cell type enhanced"	"Detected in some"		"Cone photoreceptor cells: 316.9;Early spermatids: 87.3;Inhibitory neurons: 83.8;Late spermatids: 45.7;Rod photoreceptor cells: 140.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.1"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 1.1"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 1.5;SCLC-21H: 1.1"														"Secreted in other tissues"	NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 9: Photoreceptor cells - Phototransduction"				"unprognostic (2.92e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.47e-2)"	"unprognostic (2.16e-3)"	"unprognostic (1.96e-1)"	"unprognostic (1.82e-1)"	"unprognostic (6.38e-2)"	"unprognostic (3.67e-1)"	"unprognostic (1.97e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.61e-4)"	"unprognostic (1.89e-1)"	"unprognostic (8.41e-2)"	"unprognostic (6.38e-3)"	"unprognostic (1.11e-1)"	0.6	0.0	0.3	0.0	0.4	0.3	0.2	0.6	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.2	0.1	0.1	0.4	0.1	0.0	0.1	0.0	0.1	0.1	0.5	0.1	0.6	24.8	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.1	1.5	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.3	0.0	1.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.3	0.0	0.0	0.1	0.2	0.0	1.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.9	0.1	0.1	0.0	0.0	0.3	0.3	0.4	0.6	0.6	0.4	0.0	0.4	0.1	0.5	0.0	0.1	0.3	0.1	0.0	1.8	3.9	0.5	0.3	0.7	0.1	0.6	8.3	0.1	0.0	2.1	0.0	0.7	1.8	316.9	0.8	0.2	0.0	0.0	0.4	87.3	1.0	1.0	0.7	20.3	0.0	22.0	0.4	0.4	0.7	0.0	2.1	2.5	0.0	0.0	0.3	0.1	10.1	83.8	0.4	0.0	0.0	0.6	45.7	0.9	0.2	0.0	3.7	0.1	4.0	0.0	5.5	12.9	0.3	0.0	0.7	0.1	0.2	0.1	0.3	0.1	140.2	0.0	1.5	0.3	2.6	1.3	0.4	0.1	1.1	0.6	0.3	0.2	0.2
ADGRB3	"BAI3, KIAA0550"	ENSG00000135298	"Adhesion G protein-coupled receptor B3"	O60242	6	68635282-69389506	"G-protein coupled receptors, Plasma proteins, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 49.6;pituitary gland: 23.7"	"Group enriched"	"Detected in some"	10	"Astrocytes: 1795.3;Excitatory neurons: 3843.1;Inhibitory neurons: 2738.1;Oligodendrocyte precursor cells: 2036.3;Oligodendrocytes: 1210.5"	"Cancer enriched"	"Detected in single"	10	"glioma: 3.7"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"SCLC-21H: 8.8;SH-SY5Y: 19.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA		8600		"Cluster 6: Brain - Smell perception"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"				"unprognostic (1.71e-1)"	"unprognostic (9.01e-2)"	"unprognostic (2.69e-1)"	"unprognostic (3.72e-3)"	"unprognostic (3.27e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.73e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.36e-2)"	"unprognostic (5.08e-5)"	"unprognostic (4.93e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.55e-3)"	"unprognostic (2.43e-1)"	"unprognostic (1.01e-1)"	"unprognostic (8.16e-3)"	0.8	3.9	21.1	0.8	25.5	0.0	0.6	49.6	29.7	1.3	0.0	4.3	0.4	2.2	0.9	0.7	0.9	0.9	1.9	31.1	12.1	1.0	0.5	1.7	0.0	0.0	0.6	1.6	0.3	0.1	23.7	0.1	1.1	1.0	1.3	7.1	1.2	1.4	0.3	0.4	1.4	3.3	0.0	0.6	1.3	1.9	18.2	0.1	0.8	1.4	0.0	2.6	1.4	19.1	0.0	0.0	2.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.4	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	1.0	0.0	1.2	1.0	0.0	0.0	8.8	19.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.2	0.0	0.0	1.1	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	21.1	25.5	49.6	29.7	31.1	12.1	0.0	0.6	1.1	0.0	18.2	19.1	3.1	0.0	0.0	1795.3	0.3	0.0	0.1	0.0	0.0	47.3	0.0	0.3	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.7	0.2	4.8	0.6	0.0	0.0	3843.1	0.0	0.0	2.1	0.0	0.0	0.0	0.8	3.6	0.0	0.0	0.0	2738.1	0.0	0.0	0.6	0.0	3.1	5.0	1.3	0.0	216.4	1.0	0.8	0.0	2036.3	1210.5	0.1	0.0	8.6	0.0	0.1	0.0	0.0	0.0	2.8	0.0	0.6	7.4	11.8	3.2	0.2	0.0	0.0	0.0	0.5	0.0	0.1
LMBRD1	"bA810I22.1, C6orf209, cblF, FLJ11240"	ENSG00000168216	"LMBR1 domain containing 1"	Q9NUN5	6	69672757-69867236	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Endocytosis, Gastrulation, Host-virus interaction, Transport"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"naive B-cell: 21.0"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 37.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016491, HPA019547"	Uncertain		Supported	Vesicles		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 59: Non-specific - Transcription"	Vesicles		"HPA016491: , HPA019547: AB_2281256"	"unprognostic (1.44e-1)"	"unprognostic (3.84e-2)"	"unprognostic (7.67e-2)"	"unprognostic (7.64e-2)"	"unprognostic (2.41e-1)"	"unprognostic (5.37e-2)"	"unprognostic (2.26e-1)"	"unprognostic (4.39e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.97e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.47e-1)"	"prognostic favorable (1.07e-7)"	"unprognostic (7.99e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.60e-2)"	"unprognostic (2.68e-2)"	33.3	49.4	10.3	11.5	10.8	4.2	31.4	20.7	17.0	28.9	13.3	26.4	13.5	22.5	27.7	25.7	26.3	16.0	27.7	11.1	11.5	53.0	42.9	27.9	12.1	13.6	11.9	34.5	36.5	31.7	26.5	17.2	12.3	19.1	20.5	10.7	33.2	20.0	28.8	28.1	28.6	12.7	11.4	21.8	29.6	10.4	10.2	9.1	35.1	13.1	16.8	30.1	29.4	16.1	3.8	3.8	6.0	10.2	16.5	23.7	17.9	2.2	7.1	2.6	5.6	4.8	8.2	6.5	9.2	8.8	5.8	7.5	3.8	9.8	2.4	16.3	11.9	6.2	4.9	7.8	13.7	3.4	8.7	7.6	9.6	0.8	5.7	19.1	7.4	5.5	9.4	6.1	6.0	8.1	2.5	4.7	4.6	8.5	4.8	0.3	15.4	37.8	17.0	13.8	5.5	8.5	0.9	7.0	13.3	3.0	4.6	25.3	1.1	3.9	4.6	4.3	2.8	8.8	5.5	2.8	2.3	4.0	12.3	6.5	2.2	3.9	2.0	2.5	2.5	12.1	2.9	1.9	1.7	21.0	3.1	2.3	11.4	2.6	4.8	2.2	3.7	2.1	10.3	10.8	20.7	17.0	11.1	11.5	13.6	11.9	12.3	11.4	10.2	16.1	49.7	64.1	38.3	82.3	93.4	29.1	41.9	45.2	71.2	73.7	39.2	25.4	40.6	50.1	56.0	58.8	110.5	69.6	36.2	79.0	19.6	49.0	28.8	48.3	22.7	41.1	18.7	18.5	119.2	49.6	59.2	56.1	36.7	61.7	40.5	15.7	44.6	60.5	42.1	55.5	144.6	37.6	44.7	66.9	36.3	9.3	35.4	52.0	32.0	79.6	49.3	56.3	28.8	122.2	156.6	42.0	51.0	33.8	82.7	19.6	78.7	64.1	65.5	90.8	26.3	36.4	33.9	22.5	16.9	43.4	38.1	77.4	43.2	26.9	31.7	34.2
COL19A1		ENSG00000082293	"Collagen type XIX alpha 1 chain"	Q14993	6	69866556-70212468	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion, Differentiation, Myogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 9.1;lymphoid tissue: 3.2"	"Cell type enhanced"	"Detected in some"		"B-cells: 33.5;Excitatory neurons: 66.6;Inhibitory neurons: 164.2;Oligodendrocyte precursor cells: 39.7"	"Cancer enhanced"	"Detected in single"		"melanoma: 0.7"	"Region enhanced"	"Detected in many"		"cerebellum: 9.1"	"Group enriched"	"Detected in some"	218	"memory B-cell: 14.6;naive B-cell: 31.9"	"Lineage enriched"	"Detected in single"	299	"B-cells: 31.9"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 5.3;RH-30: 11.4;SCLC-21H: 3.7;SH-SY5Y: 2.9;SK-MEL-30: 9.6;WM-115: 9.2"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA042422	Uncertain				"Secreted to extracellular matrix"	NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA042422: AB_10794798"	"unprognostic (2.65e-2)"	"unprognostic (2.55e-1)"	"unprognostic (2.71e-1)"	"unprognostic (9.24e-2)"	"unprognostic (2.26e-2)"	"unprognostic (6.20e-2)"	"unprognostic (3.17e-1)"	"unprognostic (1.10e-3)"	"unprognostic (3.41e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.76e-1)"	"unprognostic (1.62e-2)"	"unprognostic (1.31e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.20e-1)"	"unprognostic (3.35e-1)"	"unprognostic (8.91e-2)"	0.0	0.1	1.2	1.5	1.6	0.3	0.0	9.1	1.9	0.0	0.0	0.5	0.2	0.0	0.0	0.1	0.1	0.1	0.7	2.3	0.1	1.4	0.1	0.0	2.6	0.2	0.2	0.0	0.2	0.0	0.6	0.0	0.3	0.7	0.7	0.6	0.1	0.0	0.7	0.0	0.7	0.0	0.0	1.6	1.1	0.4	0.0	1.1	0.0	0.2	3.2	2.2	0.2	2.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	5.3	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	11.4	0.0	0.0	0.0	3.7	2.9	0.0	0.0	9.6	0.1	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	9.2	0.0	0.0	0.0	0.0	0.0	0.0	14.6	0.0	0.0	0.0	31.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	1.2	1.6	9.1	1.9	2.3	0.1	0.2	0.2	0.3	0.0	0.0	2.1	0.0	0.0	0.0	11.1	33.5	0.1	0.2	0.0	0.0	4.4	0.1	0.0	2.5	0.0	1.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.2	0.2	0.0	0.0	66.6	0.0	0.0	0.1	0.0	0.0	0.0	1.1	0.7	0.1	0.0	0.0	164.2	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.8	8.4	0.3	0.1	1.0	39.7	10.6	0.0	0.0	0.0	0.9	0.0	0.0	3.8	0.7	0.1	0.0	11.2	0.4	1.8	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.1
COL9A1		ENSG00000112280	"Collagen type IX alpha 1 chain"	P20849	6	70216040-70303084	"Disease related genes, Human disease related genes, Predicted secreted proteins"			"Deafness, Stickler syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"choroid plexus: 68.8"	"Cell type enriched"	"Detected in some"	4	"Oligodendrocyte precursor cells: 310.1"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 3.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"AF22: 25.7;NTERA-2: 8.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA074749	Enhanced				"Secreted to extracellular matrix"	NA	NA		120000		"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 12: NES - Nervous system development"	"Cluster 68: Oligodendrocytes - Mixed function"			"HPA074749: AB_2732266"	"unprognostic (2.18e-2)"	"unprognostic (2.16e-1)"	"unprognostic (2.25e-2)"	"unprognostic (3.48e-3)"	"unprognostic (5.72e-2)"	"unprognostic (5.32e-4)"	"unprognostic (3.24e-3)"	"unprognostic (8.79e-2)"	"unprognostic (1.25e-1)"	"unprognostic (8.68e-2)"	"unprognostic (8.27e-2)"	"unprognostic (2.52e-1)"	"unprognostic (5.69e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.09e-1)"	"unprognostic (2.78e-1)"	"unprognostic (3.62e-2)"	0.2	0.0	5.1	0.1	5.3	0.0	0.1	4.5	5.6	0.8	68.8	1.3	0.8	0.3	0.1	0.1	0.2	0.3	9.1	5.6	5.7	1.2	0.0	0.0	0.0	7.1	5.8	0.0	0.3	0.1	5.1	0.0	6.0	15.2	0.5	9.5	1.5	0.3	0.0	0.1	0.9	0.2	5.1	0.0	1.5	4.1	5.3	0.1	0.4	0.3	0.0	1.3	2.9	6.3	0.0	0.0	25.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	8.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	5.3	4.5	5.6	5.6	5.7	7.1	5.8	6.0	5.1	5.3	6.3	0.6	0.0	0.0	2.3	0.1	0.0	0.1	0.0	0.0	0.4	0.0	0.1	3.7	0.0	0.0	0.0	4.2	0.0	0.0	1.0	1.9	0.0	21.4	1.2	0.1	0.8	1.2	0.0	1.4	0.2	0.0	0.5	0.0	1.7	0.0	1.0	0.0	0.0	0.1	35.3	6.7	0.5	0.0	0.0	0.0	11.6	0.0	0.1	0.0	2.8	0.1	68.5	0.0	310.1	0.6	0.0	0.8	0.4	0.0	2.3	0.0	0.1	0.0	3.2	0.0	0.3	4.2	0.6	2.3	0.1	0.0	0.0	0.0	0.1	0.8	0.1
FAM135A	"FLJ20176, KIAA1411"	ENSG00000082269	"Family with sequence similarity 135 member A"	Q9P2D6	6	70412941-70561174	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 29.8"	"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 170.1;Horizontal cells: 238.9;Inhibitory neurons: 172.8;Microglial cells: 132.1;Oligodendrocyte precursor cells: 219.2;Oligodendrocytes: 121.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RH-30: 31.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031743, HPA031744"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 37: Intestine - Unknown function"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 62: Horizontal cells - Visual perception"	Nucleoplasm	Cytosol	"HPA031743: AB_10600767, HPA031744: AB_10601101"	"unprognostic (5.79e-2)"	"unprognostic (1.64e-1)"	"prognostic favorable (8.00e-4)"	"unprognostic (1.59e-1)"	"unprognostic (1.66e-2)"	"unprognostic (1.08e-1)"	"unprognostic (6.69e-4)"	"unprognostic (4.08e-2)"	"unprognostic (3.87e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.41e-1)"	"prognostic favorable (3.46e-4)"	"unprognostic (3.99e-1)"	"unprognostic (2.75e-1)"	"unprognostic (6.26e-2)"	"unprognostic (2.65e-2)"	2.6	2.8	2.5	4.8	3.6	1.3	2.5	8.1	3.3	4.9	0.6	10.7	13.6	6.3	2.5	29.8	4.1	7.0	4.1	3.2	2.1	4.9	2.4	4.2	3.8	2.4	2.3	6.3	6.0	9.7	1.9	4.0	2.4	16.1	11.1	8.2	4.5	3.5	2.6	9.6	11.5	3.7	1.2	3.5	10.7	10.1	2.2	2.9	3.8	6.5	6.4	4.9	7.1	3.7	7.9	4.8	9.5	6.1	4.5	3.2	8.9	2.5	5.0	2.6	4.3	8.9	6.2	14.3	18.1	1.9	12.6	7.3	9.6	5.6	4.6	6.8	8.2	6.2	4.6	8.0	5.5	12.3	6.4	2.9	13.8	5.0	13.4	3.1	7.2	4.4	10.6	6.8	3.1	0.8	2.2	5.5	6.4	9.2	3.9	6.8	31.3	6.8	9.8	4.0	10.1	3.1	2.9	2.6	3.0	6.3	1.8	5.2	3.6	2.2	5.7	2.2	5.8	8.5	10.3	5.5	1.6	10.4	4.2	1.8	2.3	0.1	0.8	2.0	0.9	1.6	0.7	0.3	3.5	2.0	1.1	0.7	0.6	2.7	3.3	0.5	0.9	0.9	2.5	3.6	8.1	3.3	3.2	2.1	2.4	2.3	2.4	1.2	2.2	3.7	12.0	28.9	12.5	85.8	10.8	15.9	12.9	8.3	31.3	20.8	4.5	4.1	11.5	17.2	8.9	20.2	29.2	2.9	4.7	49.9	5.9	6.7	30.4	13.9	15.6	13.0	23.4	1.7	170.1	12.4	1.5	10.2	45.9	21.4	8.8	13.5	9.7	6.5	5.6	238.9	172.8	29.2	16.2	10.6	15.5	23.8	15.5	11.9	5.4	132.1	11.9	13.8	4.1	219.2	121.3	18.4	31.7	13.2	6.4	35.4	24.0	10.0	9.9	26.4	6.6	11.6	9.3	33.2	10.5	71.4	33.5	8.2	4.6	10.9	25.5	15.8
SDHAF4	"C6orf57, Sdh8"	ENSG00000154079	"Succinate dehydrogenase complex assembly factor 4"	Q5VUM1	6	70566917-70589569	"Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA031824	Supported		Approved	Nucleoplasm,Mitochondria	"Intracellular and membrane"	No	No			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 7: Non-specific - Mitochondria"	Mitochondria	Nucleoplasm	"HPA031824: AB_10602113"	"unprognostic (8.72e-2)"	"unprognostic (1.64e-1)"	"unprognostic (4.95e-2)"	"unprognostic (9.96e-2)"	"unprognostic (4.58e-1)"	"unprognostic (2.02e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.42e-3)"	"unprognostic (3.18e-2)"	"unprognostic (3.17e-1)"	"prognostic favorable (1.95e-5)"	"unprognostic (2.45e-2)"	"unprognostic (9.37e-2)"	"unprognostic (3.05e-1)"	"unprognostic (9.94e-2)"	11.2	12.3	7.1	4.2	7.5	4.3	10.5	6.8	10.5	6.6	7.3	6.8	5.0	5.8	9.3	7.5	10.3	4.2	14.5	7.6	9.4	12.5	8.5	5.4	6.0	6.9	6.3	6.4	6.6	14.4	12.7	6.8	7.3	7.6	6.7	10.0	8.7	5.4	23.6	8.6	5.4	4.2	5.8	5.6	7.0	5.3	7.8	6.4	7.3	10.6	5.2	6.8	6.7	7.6	13.3	4.2	18.8	11.6	9.0	13.6	3.5	7.1	5.1	3.4	5.0	3.8	11.3	9.1	12.7	3.8	8.0	2.3	6.2	5.9	5.2	18.3	4.3	6.6	1.8	3.9	15.3	6.3	5.1	9.6	19.3	2.6	14.8	11.6	8.0	14.8	4.2	13.9	11.0	9.0	5.9	15.7	8.8	6.5	4.5	6.4	12.6	10.8	14.9	4.4	16.8	12.1	4.3	2.1	9.6	8.0	9.6	16.5	6.3	3.5	2.7	2.8	7.7	6.2	4.5	3.1	3.9	15.1	8.5	4.0	4.6	4.4	3.4	4.3	3.3	3.7	3.7	4.1	5.1	4.7	3.9	3.8	3.3	4.7	4.6	6.2	4.2	3.0	7.1	7.5	6.8	10.5	7.6	9.4	6.9	6.3	7.3	5.8	7.8	7.6	5.4	12.8	13.9	4.9	3.3	0.0	7.9	0.0	3.4	7.4	6.5	7.5	21.3	10.0	5.6	7.3	8.4	10.5	5.0	2.9	23.5	9.1	5.5	20.2	8.2	5.0	3.6	2.5	7.7	11.6	8.5	6.6	2.6	6.0	5.1	6.1	4.2	11.8	10.0	18.5	7.5	5.8	0.0	5.3	0.0	2.5	12.5	6.2	0.0	2.8	10.1	10.1	3.1	12.1	7.7	13.2	5.3	6.8	2.2	9.5	6.2	16.8	13.8	6.4	13.1	5.1	4.9	10.0	6.1	5.7	0.0	5.1	3.9	6.1	5.3	8.0
SMAP1	"FLJ13159, SMAP-1"	ENSG00000112305	"Small ArfGAP 1"	Q8IYB5	6	70667776-70862011	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 325.7;Late spermatids: 281.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030574	Approved		Approved	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 22: Non-specific - Unknown function"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 34: Spermatids - Unknown function"	"Plasma membrane, Cytosol"	"Golgi apparatus"	"HPA030574: AB_10601589"	"unprognostic (1.55e-1)"	"unprognostic (2.66e-3)"	"unprognostic (1.01e-3)"	"unprognostic (2.98e-3)"	"unprognostic (7.06e-2)"	"unprognostic (2.90e-2)"	"unprognostic (1.66e-3)"	"unprognostic (3.46e-1)"	"unprognostic (6.50e-2)"	"unprognostic (3.75e-2)"	"unprognostic (7.80e-2)"	"unprognostic (2.40e-2)"	"unprognostic (1.32e-1)"	"unprognostic (4.73e-2)"	"unprognostic (6.08e-2)"	"unprognostic (2.85e-1)"	"unprognostic (1.22e-1)"	17.0	12.8	24.4	16.1	27.8	18.6	13.6	19.5	44.8	15.2	13.3	27.5	26.8	14.1	18.0	28.4	10.2	17.4	23.1	27.6	24.3	14.1	16.6	14.9	15.4	22.7	25.3	11.1	37.2	28.5	8.6	16.1	23.7	17.6	28.3	24.8	18.0	15.2	32.9	20.4	26.7	19.7	20.1	13.7	20.9	30.9	24.4	24.8	21.1	20.1	22.4	18.1	16.1	29.2	60.3	18.6	28.5	35.3	26.0	33.9	46.4	26.6	29.5	21.4	20.9	27.9	17.4	31.4	28.1	32.0	30.5	18.5	27.4	28.1	35.5	36.3	39.4	34.7	16.5	23.6	17.2	25.5	28.0	22.3	31.3	24.2	29.2	39.6	34.2	16.1	33.8	36.9	33.8	35.0	19.2	31.4	21.3	30.9	21.9	36.0	107.9	51.8	38.1	36.0	40.7	28.7	16.9	23.3	17.1	24.2	31.0	37.3	33.6	17.2	29.7	11.4	23.5	34.3	32.9	16.0	13.0	29.4	24.2	35.0	16.4	18.4	18.2	18.3	20.7	14.8	24.3	21.0	14.0	12.7	12.1	15.7	22.6	25.6	20.0	13.7	25.3	23.4	24.4	27.8	19.5	44.8	27.6	24.3	22.7	25.3	23.7	20.1	24.4	29.2	45.0	38.5	39.4	58.1	39.3	66.9	37.7	66.9	33.0	51.8	39.6	47.2	38.8	52.9	46.0	38.6	37.5	26.2	47.6	111.3	54.8	78.9	325.7	26.1	46.8	43.2	41.9	28.8	120.1	151.0	48.8	40.3	64.7	52.1	48.2	42.9	58.5	41.3	56.6	55.5	104.3	82.3	61.1	61.2	59.8	281.1	50.7	53.0	32.0	60.0	64.1	69.7	64.9	115.6	72.7	108.2	99.5	67.0	51.8	76.3	92.6	69.6	21.1	38.6	65.7	36.3	53.3	105.2	84.2	89.3	77.3	31.7	64.9	44.1	75.8	51.6
B3GAT2	GlcAT-S	ENSG00000112309	"Beta-1,3-glucuronyltransferase 2"	Q9NPZ5	6	70856679-70957060	"Enzymes, Metabolic proteins, Predicted membrane proteins"		Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 29.8;retina: 18.4"	"Cell type enriched"	"Detected in many"	8	"Horizontal cells: 319.7"	"Group enriched"	"Detected in some"	20	"glioma: 4.7;testis cancer: 1.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	19	"SCLC-21H: 21.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012059	Uncertain					NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 62: Horizontal cells - Visual perception"			"HPA012059: AB_2061050"	"unprognostic (7.10e-3)"	"unprognostic (7.81e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.10e-3)"	"unprognostic (2.21e-1)"	"unprognostic (1.22e-2)"	"unprognostic (1.96e-2)"	"unprognostic (4.88e-2)"	"unprognostic (4.22e-2)"	"unprognostic (9.16e-4)"	"unprognostic (8.09e-2)"	"unprognostic (7.43e-3)"	"unprognostic (6.88e-7)"	"unprognostic (2.72e-2)"	"unprognostic (3.35e-2)"	"unprognostic (2.53e-2)"	"unprognostic (3.45e-3)"	1.4	0.4	13.9	0.5	20.9	0.4	1.1	12.5	14.5	1.4	6.9	0.9	0.6	0.7	0.1	1.0	0.7	0.2	1.0	25.9	16.2	0.6	0.9	1.0	0.5	20.9	19.1	0.8	1.4	0.0	0.8	0.1	23.7	0.9	0.0	18.4	1.2	0.0	0.8	1.5	1.0	0.1	23.8	0.7	1.1	0.9	16.9	0.5	1.0	0.0	0.0	1.1	1.4	29.8	0.3	0.0	0.6	0.3	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.1	0.2	0.1	0.0	0.0	0.2	1.1	0.1	0.3	0.2	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.1	0.5	0.0	0.2	0.0	0.5	0.7	0.1	0.1	0.1	0.2	0.2	0.0	0.2	21.8	0.2	0.0	0.1	0.0	0.3	0.1	0.0	0.1	0.1	0.2	0.1	0.3	0.5	0.0	0.1	0.1	0.1	0.1	0.2	0.1	0.2	0.1	0.1	0.1	0.1	0.2	0.3	0.0	0.1	0.2	0.2	0.3	0.1	0.1	0.1	0.3	0.0	13.9	20.9	12.5	14.5	25.9	16.2	20.9	19.1	23.7	23.8	16.9	29.8	4.5	0.0	2.2	23.8	9.7	25.5	11.9	19.4	0.0	16.5	7.2	1.7	1.0	11.5	9.0	16.5	22.9	6.0	10.0	13.0	0.0	5.6	9.7	3.6	5.4	7.7	0.0	3.2	2.5	3.9	3.9	6.9	2.0	6.0	0.0	2.5	9.3	10.7	7.5	319.7	8.2	4.9	16.2	10.0	27.0	6.0	19.9	5.1	14.2	0.0	11.6	15.2	30.9	32.2	0.2	9.1	15.5	13.5	3.7	16.9	23.3	1.4	3.4	22.5	13.1	5.8	5.8	18.7	36.7	1.2	19.9	7.1	15.1	2.1	6.2	12.2
OGFRL1	dJ331H24.1	ENSG00000119900	"Opioid growth factor receptor like 1"	Q5TC84	6	71288811-71309059	"Predicted intracellular proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 69.6"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 175.3;Langerhans cells: 144.0;Macrophages: 155.7;monocytes: 133.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 11.1"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 11.1"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027122			Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 70: Brain - Nervous system development"	"Cluster 32: U-937 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"	"Golgi apparatus"	Nucleoplasm	"HPA027122: AB_2156775"	"unprognostic (8.44e-3)"	"unprognostic (1.41e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.52e-1)"	"unprognostic (4.24e-3)"	"prognostic unfavorable (3.62e-4)"	"unprognostic (9.62e-3)"	"unprognostic (2.30e-2)"	"unprognostic (2.49e-1)"	"unprognostic (4.22e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.39e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.37e-1)"	"unprognostic (3.25e-2)"	"unprognostic (5.58e-3)"	25.2	11.2	32.9	16.1	28.1	26.7	51.0	40.5	26.3	7.9	7.8	9.3	3.6	10.4	13.7	33.2	6.5	10.8	6.8	40.9	47.7	7.1	6.4	11.5	14.5	50.8	60.5	6.6	8.0	6.2	7.6	13.5	51.5	8.4	5.3	13.2	46.3	12.8	5.1	20.1	6.8	33.4	55.3	16.8	6.3	2.8	47.9	11.4	5.3	12.1	25.5	7.4	12.5	69.6	9.7	2.9	10.0	0.0	26.5	24.1	3.6	42.2	26.5	16.9	17.0	3.7	1.8	59.1	56.3	18.5	15.6	4.7	7.8	29.4	59.5	12.5	6.1	13.0	10.0	1.5	21.4	6.2	4.4	24.4	24.7	12.5	38.8	14.2	13.7	0.0	0.8	4.5	58.8	8.1	0.0	9.7	4.0	3.8	2.3	4.2	30.4	13.8	38.8	0.7	33.8	15.3	12.6	7.8	2.8	14.3	13.4	48.0	21.1	41.3	20.5	4.3	14.1	6.0	0.4	7.6	13.8	41.0	7.2	3.4	2.6	0.1	0.4	1.7	0.4	0.3	0.3	0.4	2.1	0.5	0.0	0.3	11.1	0.5	1.3	0.8	0.1	0.6	32.9	28.1	40.5	26.3	40.9	47.7	50.8	60.5	51.5	55.3	47.9	69.6	40.3	6.4	18.6	175.3	17.4	38.9	22.3	18.4	22.8	42.8	79.4	86.4	8.7	11.5	14.1	11.0	25.0	23.2	31.7	1.4	1.9	17.0	0.5	8.0	14.2	30.2	14.4	11.1	29.1	32.9	11.0	50.8	5.6	19.1	6.3	6.6	8.9	5.1	61.7	38.7	28.0	2.2	8.2	95.5	144.0	1.2	16.4	155.7	32.0	71.2	133.5	87.0	18.6	13.0	4.0	19.3	2.4	33.1	11.6	16.2	0.1	4.9	3.2	6.0	26.3	26.8	31.3	0.6	1.2	57.9	46.5	19.0	19.3	3.4	4.4	19.3
RIMS1	"CORD7, KIAA0340, RAB3IP2, RIM, RIM1"	ENSG00000079841	"Regulating synaptic membrane exocytosis 1"	Q86UR5	6	71886703-72403143	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Differentiation, Exocytosis, Neurotransmitter transport, Sensory transduction, Transport, Vision"		"Cone-rod dystrophy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	49	"brain: 365.0"	"Group enriched"	"Detected in many"	4	"Excitatory neurons: 653.2;Inhibitory neurons: 572.7;Oligodendrocyte precursor cells: 323.2"	"Cancer enhanced"	"Detected in single"		"prostate cancer: 0.7"	"Region enriched"	"Detected in many"	16	"cerebellum: 365.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Daudi: 5.2;EFO-21: 8.8;LHCN-M2: 10.0;RPTEC TERT1: 15.0;SH-SY5Y: 10.7;TIME: 5.4;U-138 MG: 5.1"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebellum: 352.9"	HPA076565	Enhanced					NA	NA				"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA076565: "	"unprognostic (1.34e-3)"	"unprognostic (3.47e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.63e-3)"	"unprognostic (6.62e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.73e-2)"	"unprognostic (8.57e-2)"		"unprognostic (2.85e-1)"	"unprognostic (7.76e-4)"	"unprognostic (2.42e-2)"	"unprognostic (2.29e-1)"	"unprognostic (7.91e-2)"	"unprognostic (2.76e-1)"	"unprognostic (5.74e-2)"	"unprognostic (1.07e-2)"	0.2	1.2	5.5	0.8	14.1	0.0	0.5	365.0	22.5	0.3	0.0	0.3	0.7	0.2	0.0	2.1	0.0	3.9	0.1	16.3	8.4	0.0	0.0	0.2	0.0	0.3	9.0	0.0	0.4	1.6	2.4	0.0	20.8	3.0	0.1	7.4	1.1	0.3	0.2	0.2	0.4	0.7	0.0	0.0	1.4	4.1	5.4	0.0	0.0	0.9	0.0	0.1	0.0	13.2	0.0	0.0	1.0	0.0	0.0	0.5	0.0	0.2	1.4	0.0	0.2	0.0	0.0	5.2	8.8	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.4	1.6	0.0	0.0	0.0	0.0	10.0	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.0	0.5	15.0	0.0	0.4	10.7	0.0	0.0	0.0	0.3	0.7	0.0	5.4	5.1	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	14.1	365.0	22.5	16.3	8.4	0.3	9.0	20.8	0.0	5.4	13.2	0.2	0.0	0.5	120.2	0.0	0.0	0.2	2.1	0.0	69.1	3.0	3.2	1.4	0.0	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	15.2	0.0	0.9	2.5	0.0	0.0	653.2	0.8	0.0	1.8	0.0	0.0	1.3	0.3	3.6	0.0	0.0	62.2	572.7	0.0	2.0	0.0	0.0	10.2	0.3	0.3	3.6	16.9	0.0	109.7	0.0	323.2	76.5	0.5	0.0	1.5	0.0	1.0	0.0	0.4	3.6	9.9	0.0	1.3	2.7	21.3	13.6	0.0	0.1	0.0	0.1	0.3	0.0	0.5
KCNQ5	Kv7.5	ENSG00000185760	"Potassium voltage-gated channel subfamily Q member 5"	Q9NR82	6	72621792-73198853	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 28.3;skeletal muscle: 21.1;tongue: 12.2"	"Group enriched"	"Detected in some"	30	"Excitatory neurons: 2136.7;Inhibitory neurons: 862.4"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebral cortex: 28.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 34.9;HEL: 23.2;HL-60: 31.5;U-251 MG: 23.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA016655	Approved		Approved	Vesicles		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 47: Non-specific - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Vesicles		"HPA016655: AB_1855557"	"unprognostic (4.91e-2)"	"unprognostic (1.42e-1)"	"unprognostic (4.96e-2)"	"unprognostic (3.78e-2)"	"unprognostic (2.69e-1)"	"unprognostic (2.18e-2)"	"unprognostic (3.57e-2)"	"unprognostic (1.43e-1)"	"unprognostic (6.09e-2)"	"unprognostic (8.55e-2)"	"unprognostic (7.96e-2)"	"unprognostic (1.05e-1)"	"unprognostic (6.77e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.62e-1)"	"unprognostic (8.16e-2)"	"unprognostic (1.39e-3)"	0.1	1.6	1.2	1.3	7.5	5.1	0.4	0.0	28.3	0.4	0.0	0.4	0.2	0.1	0.0	0.9	0.3	0.3	0.2	4.3	0.0	0.1	0.2	0.3	2.2	17.4	1.0	0.1	0.1	0.0	0.2	0.4	19.4	1.3	0.3	0.2	1.2	0.9	21.1	0.1	0.7	0.3	0.0	1.1	0.3	1.2	0.0	1.7	4.7	12.2	2.0	0.9	0.6	4.6	4.4	1.1	0.0	0.2	0.0	1.5	0.0	34.9	5.2	5.1	4.3	0.0	0.0	21.2	0.0	11.9	0.4	0.7	0.1	2.1	6.1	0.3	7.2	23.2	0.1	0.0	0.9	31.5	0.0	0.3	0.8	14.5	14.9	3.3	0.0	0.0	1.4	14.2	10.2	0.1	0.0	13.5	1.3	0.0	7.1	0.0	1.1	14.4	1.9	0.0	5.8	2.7	0.0	0.1	13.7	0.2	4.3	2.3	0.0	21.0	9.2	0.1	23.4	14.8	0.4	9.3	0.2	14.9	1.2	0.3	0.0	0.0	0.0	0.0	0.2	0.9	0.1	0.4	0.1	0.3	0.3	0.3	0.0	0.6	0.0	0.0	0.0	0.0	1.2	7.5	0.0	28.3	4.3	0.0	17.4	1.0	19.4	0.0	0.0	4.6	0.0	0.0	0.0	38.8	7.6	0.3	3.6	0.7	5.2	0.3	0.4	0.5	3.6	0.0	0.1	0.0	0.0	0.1	2.6	0.0	0.0	0.0	0.7	0.0	0.0	0.4	0.0	5.5	2136.7	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.7	862.4	0.0	0.0	0.0	1.5	1.6	0.0	0.2	1.8	49.6	0.0	0.1	1.0	30.2	26.7	0.0	0.0	0.0	7.6	5.7	0.0	0.0	0.0	0.2	0.0	6.0	0.8	0.5	0.5	0.8	0.3	0.3	2.8	0.0	0.0	0.7
KHDC1L	RP11-257K9.7	ENSG00000256980	"KH domain containing 1 like"	Q5JSQ8	6	73223544-73225770	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Group enriched"	"Detected in some"	4	"brain: 1.7;pituitary gland: 1.5;testis: 5.5"	"Group enriched"	"Detected in some"	10	"Early spermatids: 31.8;Late spermatids: 96.9"	"Cancer enriched"	"Detected in some"	9	"testis cancer: 33.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"BEWO: 51.5"															NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 31: Spermatids - Spermatogenesis"				"unprognostic (1.18e-1)"	"unprognostic (6.11e-5)"		"unprognostic (3.06e-2)"	"unprognostic (1.93e-1)"	"unprognostic (3.07e-2)"		"unprognostic (9.32e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.48e-1)"	"unprognostic (4.01e-2)"		"unprognostic (1.31e-2)"	"unprognostic (4.13e-1)"	"unprognostic (6.63e-2)"	"unprognostic (3.17e-3)"	0.0	0.0	1.1	0.0	1.7	0.2	0.0	1.3	1.7	0.1	0.7	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.8	0.9	0.0	0.0	0.6	0.0	0.8	0.9	0.2	0.1	0.1	1.5	0.5	0.8	0.2	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.1	5.5	0.8	0.4	0.1	0.0	0.4	0.1	0.1	1.0	10.7	0.2	0.0	0.4	0.0	0.0	51.5	0.2	0.3	0.3	0.2	0.4	0.2	0.4	0.4	0.0	0.0	0.1	0.2	0.1	0.1	0.2	0.0	0.1	0.1	0.0	0.1	0.3	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.3	0.2	0.2	0.5	0.0	0.1	0.1	0.0	3.4	0.0	0.0	0.1	0.0	0.0	0.3	0.1	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	1.8	0.0	0.3	0.0	0.2	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	1.7	1.3	1.7	0.8	0.9	0.8	0.9	0.8	0.8	0.8	1.0	0.0	0.0	0.0	1.0	0.4	0.0	0.0	0.2	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	31.8	0.1	0.0	0.0	0.0	0.0	0.3	0.4	1.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	96.9	0.3	0.2	0.0	0.0	0.6	0.1	0.0	1.0	0.2	0.3	0.0	0.7	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	2.3	5.9	0.0	0.0	0.1	0.0	0.2	0.1	0.1
KHDC1	"bA257K9.4, C6orf147, C6orf148, Em:AC019205.8, MGC10818, NDG1"	ENSG00000135314	"KH domain containing 1"	Q4VXA5	6	73241314-73310365	"Predicted intracellular proteins, Predicted membrane proteins"		RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 13.6"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 32.9;Inhibitory neurons: 30.7;Oligodendrocyte precursor cells: 29.1;Spermatocytes: 38.8;Spermatogonia: 20.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											HPA029032			Approved	Mitochondria,Cytosol		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Mitochondria, Cytosol"		"HPA029032: AB_10602914"	"unprognostic (3.46e-1)"	"unprognostic (2.20e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.73e-4)"	"unprognostic (1.95e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.20e-1)"	"unprognostic (7.54e-2)"	"unprognostic (5.76e-2)"	"unprognostic (6.27e-2)"	"unprognostic (1.16e-1)"	"unprognostic (4.97e-3)"	"unprognostic (1.83e-4)"	"unprognostic (8.18e-2)"	"unprognostic (2.97e-1)"	"unprognostic (2.14e-1)"	"unprognostic (5.17e-3)"	1.2	1.0	11.0	0.6	11.6	0.2	0.9	11.4	13.6	2.1	8.8	1.6	0.1	1.7	1.2	1.0	2.5	1.0	3.9	11.2	11.2	1.0	0.1	0.8	1.3	10.8	11.2	3.0	2.7	2.2	7.5	0.5	11.3	2.0	0.4	3.8	0.6	1.3	1.1	0.4	0.8	0.9	11.3	0.7	1.6	8.3	11.6	2.1	2.4	1.4	1.4	1.4	1.6	11.4	3.2	4.6	0.9	2.4	4.2	4.8	2.2	6.1	6.0	9.3	13.7	4.4	2.5	6.9	2.3	2.7	4.8	3.1	6.4	1.3	7.1	6.5	4.6	4.6	4.2	0.0	5.4	2.3	0.1	6.2	2.7	9.3	2.6	3.9	2.1	7.1	3.4	8.0	3.8	7.7	0.5	2.1	4.2	0.6	9.1	1.0	0.0	5.5	1.5	0.1	11.1	2.4	3.6	0.2	0.3	3.0	0.1	6.8	0.1	2.0	4.2	1.2	6.6	13.5	8.8	4.9	0.1	1.9	0.7	1.9	0.1	0.0	2.1	0.0	1.3	1.2	1.3	2.4	0.4	0.8	1.0	1.6	0.0	1.4	0.0	1.3	2.8	1.1	11.0	11.6	11.4	13.6	11.2	11.2	10.8	11.2	11.3	11.3	11.6	11.4	0.3	0.0	1.5	8.5	2.8	0.8	3.4	5.4	2.8	9.6	2.0	6.5	2.8	0.0	2.1	3.7	2.1	1.7	4.7	0.3	1.9	0.9	12.0	4.6	2.8	0.4	0.0	1.3	32.9	3.7	0.4	3.6	8.2	0.8	0.0	5.8	0.0	0.0	0.5	13.5	30.7	0.7	2.0	0.0	0.4	15.2	2.1	0.3	3.6	2.8	0.7	16.1	3.1	29.1	11.2	3.2	0.2	3.4	6.8	2.0	0.1	0.2	1.4	7.2	19.7	1.9	2.0	38.8	20.9	1.0	0.6	0.1	2.5	2.7	1.1	0.8
DPPA5	Esg1	ENSG00000203909	"Developmental pluripotency associated 5"	A6NC42	6	73353063-73354276	"Predicted intracellular proteins"		"Developmental protein, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"testis: 2.1"	"Group enriched"	"Detected in some"	4	"Spermatocytes: 2.4;Spermatogonia: 1.4"	"Cancer enriched"	"Detected in single"	2209	"testis cancer: 347.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	43	"SuSa: 6.9"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"HPA055016, HPA064505"	Uncertain		Uncertain	"Cell Junctions"		NA	NA				"Cluster 83: Testis - Spermatogenesis"	"Cluster 12: NES - Nervous system development"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	"Cell Junctions"		"HPA055016: , HPA064505: AB_2685275"															"unprognostic (1.85e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1
KHDC3L	"C6orf221, ECAT1"	ENSG00000203908	"KH domain containing 3 like, subcortical maternal complex member"	Q587J8	6	73362658-73364171	"Disease related genes, Human disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"testis: 1.1"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	3156	"testis cancer: 254.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			HPA043699	Uncertain					NA	NA				"Cluster 78: Testis - Spermatogenesis"		"Cluster 33: Fibroblasts - ECM organization"			"HPA043699: AB_10960564"					"unprognostic (1.39e-2)"					"unprognostic (1.37e-1)"					"unprognostic (1.67e-1)"	"unprognostic (4.36e-1)"		0.0	0.1	0.2	0.0	0.2	0.0	0.0	0.2	0.4	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.4	0.1	0.0	0.0	0.6	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	1.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.4	0.4	0.1	0.2	0.1	0.1	0.1	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OOEP	"C6orf156, Em:AC019205.2, KHDC2"	ENSG00000203907	"Oocyte expressed protein"	A6NGQ2	6	73368555-73395133	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"testis: 14.2"	"Group enriched"	"Detected in some"	6	"Early spermatids: 29.4;Spermatocytes: 74.1;Spermatogonia: 56.8"	"Cancer enriched"	"Detected in single"	26	"testis cancer: 10.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 2.8;CAPAN-2: 8.3;MCF7: 2.9;U-2 OS: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA055165	Approved					NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 66: Spermatocytes - Spermatogenesis"			"HPA055165: AB_2682722"	"unprognostic (7.95e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.63e-1)"	"unprognostic (4.50e-1)"	"unprognostic (4.68e-1)"	"unprognostic (2.20e-3)"	"unprognostic (6.86e-2)"	"unprognostic (3.99e-2)"	"unprognostic (7.22e-2)"	"unprognostic (2.52e-1)"	"unprognostic (6.04e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.86e-2)"	"unprognostic (8.66e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.16e-1)"	"unprognostic (4.98e-2)"	0.2	0.2	0.1	0.1	0.1	0.0	0.3	0.1	0.7	0.1	0.1	0.1	0.1	0.1	0.0	0.3	0.0	0.1	0.2	0.1	0.1	0.4	0.3	0.2	0.1	0.2	0.1	0.2	0.9	0.0	0.1	1.4	0.2	0.2	0.0	0.0	1.8	0.4	0.0	0.9	0.1	0.0	0.1	0.2	0.5	14.2	0.1	0.0	0.4	0.2	0.1	0.2	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.1	0.0	0.1	0.2	0.0	8.3	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.7	0.0	0.3	0.5	0.2	0.1	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.1	0.1	0.7	0.1	0.1	0.2	0.1	0.2	0.1	0.1	0.3	0.3	0.0	0.0	0.0	0.3	1.1	0.3	3.8	0.0	0.0	0.4	0.6	0.0	1.5	0.5	0.0	0.0	8.6	0.2	0.2	0.0	0.1	29.4	1.8	0.1	0.7	0.0	2.7	0.0	0.6	2.4	0.5	0.0	0.8	0.0	0.0	0.0	0.7	1.2	0.0	0.0	0.5	2.0	0.3	0.7	7.2	0.6	0.3	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.7	0.0	1.2	0.4	0.3	0.2	1.2	0.5	0.6	0.0	0.5	0.2	74.1	56.8	0.0	1.0	4.5	0.4	0.0	0.0	0.3
DDX43	"CT13, DKFZp434H2114, HAGE"	ENSG00000080007	"DEAD-box helicase 43"	Q9NXZ2	6	73394828-73417566	"Enzymes, Predicted intracellular proteins"		"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"placenta: 4.9;testis: 19.5"	"Group enriched"	"Detected in many"	6	"Spermatocytes: 50.6;Spermatogonia: 41.5"	"Cancer enriched"	"Detected in many"	15	"testis cancer: 13.0"	"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BEWO: 8.0;CAPAN-2: 13.8;HHSteC: 3.7;MCF7: 2.6;U-2 OS: 8.7"									HPA031381	Enhanced					NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"			"HPA031381: AB_10601885"	"unprognostic (4.03e-3)"	"unprognostic (8.20e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.19e-1)"	"unprognostic (3.59e-4)"	"unprognostic (1.64e-2)"	"unprognostic (3.11e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.15e-1)"	"unprognostic (3.12e-1)"	"unprognostic (3.08e-1)"	"unprognostic (1.19e-3)"	"unprognostic (1.02e-1)"	"unprognostic (2.68e-1)"	"unprognostic (1.58e-1)"	"unprognostic (8.78e-2)"	1.0	0.4	0.3	0.5	0.4	0.7	0.9	0.4	0.4	0.6	0.3	0.9	1.2	0.8	0.0	0.9	0.4	1.2	0.7	0.2	0.4	0.8	0.3	1.0	0.8	0.7	0.5	1.1	1.3	0.0	0.4	4.9	0.8	1.4	0.5	0.4	1.8	1.8	0.2	1.2	0.8	0.8	0.4	0.8	1.7	19.5	0.5	0.2	1.4	0.3	0.6	1.0	0.4	0.8	0.0	0.0	0.0	0.0	0.0	0.0	8.0	0.5	0.0	0.0	0.0	0.1	13.8	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.7	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	8.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.9	1.0	0.3	0.7	0.8	0.7	0.9	0.2	1.0	0.4	0.1	0.2	0.6	0.2	0.0	0.4	0.2	0.3	0.4	0.4	0.4	0.2	0.4	0.7	0.5	0.8	0.4	0.5	0.8	2.1	3.2	5.4	0.3	1.0	2.7	0.9	3.4	0.0	0.3	0.8	0.9	0.8	1.5	2.5	0.0	0.0	7.2	2.6	0.5	0.0	0.4	5.1	2.1	0.5	2.4	0.0	0.0	0.3	1.0	3.2	1.7	0.0	2.4	0.0	0.1	0.4	0.1	2.7	0.0	0.3	0.3	4.1	0.8	1.5	5.0	2.1	1.5	3.6	0.0	0.6	0.5	6.2	0.0	2.0	1.5	0.0	1.2	0.7	0.3	0.3	1.5	1.4	1.1	0.0	1.7	1.3	50.6	41.5	0.0	1.4	6.0	2.1	0.2	0.3	0.8
CGAS	"C6orf150, MB21D1"	ENSG00000164430	"Cyclic GMP-AMP synthase"	Q8N884	6	73413515-73452297	"Enzymes, Predicted intracellular proteins"	"Antiviral defense, DNA damage, DNA repair, Host-virus interaction, Immunity, Innate immunity"	"DNA-binding, Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 14.0"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 10.2;dendritic cells: 12.0;Glandular and luminal cells: 12.5;Hofbauer cells: 12.4;Macrophages: 10.0;monocytes: 27.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 37.1;RH-30: 43.8;RPMI-8226: 45.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA031700, HPA031702"	Enhanced		Supported	Nucleoplasm		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA031700: AB_10601693, HPA031702: AB_2673999"	"unprognostic (2.49e-1)"	"unprognostic (2.36e-1)"	"unprognostic (4.61e-2)"	"unprognostic (4.95e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.81e-1)"	"unprognostic (4.84e-3)"	"unprognostic (1.01e-2)"	"unprognostic (9.80e-2)"	"unprognostic (4.25e-2)"	"unprognostic (2.20e-2)"	"unprognostic (2.77e-1)"	"prognostic unfavorable (2.27e-7)"	"unprognostic (1.93e-3)"	"unprognostic (1.17e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.78e-1)"	2.9	1.1	1.7	6.4	2.1	14.0	1.7	2.2	3.0	2.4	1.7	1.9	2.7	1.9	0.6	2.3	1.8	2.6	1.5	1.9	2.0	1.1	0.8	3.5	7.4	2.6	2.2	1.2	1.2	0.6	0.6	3.1	2.6	1.9	1.8	0.2	1.8	1.8	0.5	1.1	2.5	2.0	2.4	5.2	2.3	1.0	3.0	2.3	1.6	0.9	4.7	4.3	2.1	3.4	19.9	5.8	0.1	0.2	1.2	2.7	0.1	10.1	3.7	11.3	12.6	20.7	14.2	0.2	20.9	4.3	6.3	10.1	9.8	0.2	12.0	31.9	0.0	16.9	8.2	0.1	4.0	12.3	11.5	1.6	3.2	11.8	0.1	0.0	3.5	0.1	0.0	37.1	8.7	8.0	0.0	27.1	6.2	2.4	11.2	23.4	43.8	45.2	0.0	7.3	0.3	0.1	17.3	0.4	10.2	0.2	0.0	33.9	5.0	0.0	9.1	8.5	0.2	8.1	19.8	0.2	0.1	17.5	11.4	26.3	12.7	19.0	6.0	17.5	4.7	8.4	7.9	5.9	7.5	6.7	1.8	3.4	8.5	4.2	11.6	17.6	8.0	6.0	1.7	2.1	2.2	3.0	1.9	2.0	2.6	2.2	2.6	2.4	3.0	3.4	10.2	3.2	4.8	0.0	4.7	0.0	0.0	0.0	0.0	0.0	2.6	1.8	0.0	0.0	0.6	0.0	0.0	0.2	12.0	0.0	0.0	2.0	0.0	8.4	8.5	6.0	0.0	0.0	0.0	3.9	0.7	2.3	0.0	12.5	5.1	1.0	0.0	0.0	12.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.0	0.0	0.0	27.4	0.0	0.0	0.0	0.0	5.9	0.0	0.0	3.0	0.0	0.0	0.2	2.9	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.3	8.0	0.7	0.0	0.0
MTO1		ENSG00000135297	"Mitochondrial tRNA translation optimization 1"	Q9Y2Z2	6	73461578-73509236	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"tRNA processing"		"Cardiomyopathy, Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 127.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030230, HPA030232"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA030230: AB_10598910, HPA030232: AB_10600891"	"unprognostic (2.17e-2)"	"unprognostic (5.29e-2)"	"unprognostic (1.05e-2)"	"unprognostic (3.22e-2)"	"unprognostic (6.47e-2)"	"unprognostic (8.58e-2)"	"unprognostic (6.28e-2)"	"unprognostic (5.48e-2)"	"unprognostic (2.97e-1)"	"unprognostic (2.12e-3)"	"unprognostic (9.01e-3)"	"unprognostic (1.55e-1)"	"unprognostic (9.17e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.67e-1)"	"unprognostic (8.08e-3)"	"unprognostic (1.64e-1)"	5.8	5.6	3.3	5.5	3.4	4.1	6.0	5.6	4.9	6.6	3.1	6.7	6.1	5.6	4.4	6.3	6.4	3.5	8.3	3.3	3.2	11.6	17.6	5.0	7.8	3.3	2.9	7.3	6.2	9.3	5.7	4.1	3.4	6.2	6.6	6.7	5.6	4.6	9.3	5.3	7.5	5.2	2.7	9.8	6.5	9.9	3.4	7.2	6.3	9.8	9.3	6.8	6.7	4.6	6.5	6.0	8.0	5.9	12.4	13.7	4.3	13.5	14.7	15.7	15.7	13.2	4.1	13.7	9.4	13.9	9.5	10.1	18.6	12.5	24.9	7.6	9.6	15.7	12.0	13.5	16.3	27.0	7.1	9.2	17.4	16.0	16.7	7.8	11.3	14.6	22.5	16.8	14.4	10.9	6.4	9.0	6.5	9.4	5.8	11.3	27.8	25.8	9.2	12.0	5.5	3.9	5.5	14.2	12.2	7.1	7.6	24.1	6.9	7.9	6.6	5.1	13.0	8.5	15.1	6.6	4.7	17.8	11.6	1.3	4.5	3.8	5.9	6.1	9.2	6.2	7.1	5.7	4.7	5.4	7.9	5.9	1.6	8.2	6.0	4.5	12.0	7.0	3.3	3.4	5.6	4.9	3.3	3.2	3.3	2.9	3.4	2.7	3.4	4.6	9.4	16.0	17.9	11.1	22.7	7.8	14.5	13.2	4.6	0.0	5.7	5.0	15.7	11.5	12.1	11.0	0.0	12.1	19.9	6.7	21.5	7.3	127.7	12.0	13.7	11.7	8.4	5.0	14.3	7.5	8.6	10.9	10.2	22.7	6.3	8.4	10.0	22.6	8.7	0.0	15.8	9.0	6.1	8.2	7.2	20.1	11.1	10.6	0.0	11.2	15.1	0.0	18.6	11.1	21.9	7.0	6.9	9.8	20.1	14.4	16.0	17.4	7.5	0.0	6.6	19.7	10.4	42.9	11.6	7.2	10.1	10.3	21.2	11.5	11.7	10.8
EEF1A1	"EE1A1, EEF1A, EF1A, LENG7"	ENSG00000156508	"Eukaryotic translation elongation factor 1 alpha 1"	P68104	6	73489308-73525587	"Cancer-related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Protein biosynthesis, Transcription, Transcription regulation"	"Elongation factor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051759, HPA053862, HPA056990"	Supported		Supported	Cytosol		NA	NA		82000000	"Cluster 30: Non-specific - Translation"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"	Cytosol		"HPA051759: AB_2681595, HPA053862: AB_2797248, HPA056990: AB_2683302"	"unprognostic (6.47e-2)"	"unprognostic (7.86e-3)"	"unprognostic (2.53e-2)"	"unprognostic (9.64e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.08e-1)"	"prognostic unfavorable (5.57e-4)"	"unprognostic (3.13e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.77e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.47e-1)"	"unprognostic (8.61e-2)"	"unprognostic (1.65e-1)"	"unprognostic (8.00e-2)"	"unprognostic (2.04e-1)"	"unprognostic (7.73e-2)"	7265.1	5743.3	2531.3	4576.8	2717.1	10489.1	10504.6	2524.2	2783.1	7953.2	2902.2	6991.5	4783.5	7397.5	7203.8	6302.2	9034.9	4902.1	4074.6	2309.3	2687.4	7520.3	6459.1	4891.3	8813.5	2792.2	2572.6	12627.2	10370.0	6942.9	3776.4	5545.3	2828.4	5639.5	6936.4	2200.9	8381.0	6045.9	1682.1	7151.8	5076.6	7695.8	2980.6	5912.7	5776.4	1701.2	2687.7	8091.2	8348.4	1938.8	11294.9	6993.4	6470.3	2900.2	5218.1	8235.8	8697.0	13940.8	18183.0	32963.3	7874.7	7061.7	21384.2	10632.9	10044.2	12591.7	8020.5	20786.6	9976.7	13824.2	6089.1	5849.1	11729.0	15249.9	9969.0	3868.8	7099.6	7824.7	6142.2	13619.5	14708.8	15773.6	9201.9	26454.1	27514.4	7357.6	24803.6	17437.1	14783.4	8434.8	15242.2	7357.1	13131.5	8385.7	7184.5	17411.3	10348.2	6259.3	4400.0	14212.5	15389.7	26105.5	12201.5	14719.8	8337.9	8853.1	3931.6	10026.7	17535.8	9067.6	6928.7	24671.0	11535.0	4637.5	6195.9	3343.0	9206.4	7296.2	6913.1	5011.8	4780.9	12625.1	7404.1	2888.1	8472.3	895.8	7474.9	7600.7	14243.9	10580.7	12006.0	10174.3	8618.3	8426.8	13912.6	12049.7	681.7	9555.0	7680.9	6461.2	9278.5	26796.5	2531.3	2717.1	2524.2	2783.1	2309.3	2687.4	2792.2	2572.6	2828.4	2980.6	2687.7	2900.2	4915.6	3169.9	6059.2	107.4	11291.6	9829.9	12187.6	10417.5	11667.5	978.9	10528.4	9476.3	160.6	6258.2	5739.8	2637.3	546.3	9401.2	8653.6	2189.4	10344.0	5796.3	1373.9	4535.2	6754.2	5952.7	3862.8	6396.8	84.5	10404.1	12700.2	5756.1	4472.5	5831.2	3736.3	5732.4	6124.7	3323.0	6415.2	494.6	109.3	6969.3	3289.7	7779.7	8970.1	2325.8	8931.5	6705.0	5112.0	175.2	18016.6	3733.0	8468.7	76.9	162.0	7231.8	5821.6	7213.5	6811.7	11638.2	7494.7	14215.0	2974.6	1469.9	3536.8	7040.7	7075.1	1092.8	703.6	12784.4	10055.1	11086.8	9616.5	6982.9	8574.9	16180.0
SLC17A5	"AST, ISSD, NSD, SD, SIALIN, SIASD, SLD"	ENSG00000119899	"Solute carrier family 17 member 5"	Q9NRA2	6	73593379-73653992	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Amino-acid transport, Symport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	7	"parathyroid gland: 310.5"	"Low cell type specificity"	"Detected in many"			"Cancer enhanced"	"Detected in all"		"thyroid cancer: 47.0"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 99.9;ASC TERT1: 74.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044479			Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Plasma membrane, Cytosol"		"HPA044479: "	"unprognostic (6.48e-3)"	"unprognostic (7.95e-3)"	"unprognostic (9.23e-2)"	"unprognostic (1.45e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.59e-3)"	"unprognostic (4.44e-2)"	"unprognostic (4.18e-2)"	"unprognostic (2.60e-1)"	"unprognostic (3.14e-2)"	"unprognostic (8.29e-2)"	"unprognostic (4.59e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.40e-1)"	"prognostic favorable (3.52e-4)"	"unprognostic (1.09e-1)"	10.4	10.5	5.9	6.4	6.0	6.8	13.8	6.2	7.0	10.7	5.9	20.4	16.4	9.4	44.6	8.4	5.3	10.4	8.5	6.5	8.5	31.9	17.6	13.2	5.3	6.5	7.0	4.0	11.6	310.5	9.9	21.7	7.8	16.8	22.1	18.3	30.3	14.7	5.4	7.1	21.1	10.6	5.7	7.0	14.4	6.1	7.1	4.5	43.5	6.2	5.6	12.6	6.3	7.6	7.4	9.9	9.7	15.6	99.9	74.2	12.8	23.8	59.4	6.3	22.0	6.6	17.6	6.8	11.2	32.9	14.8	12.6	13.7	5.9	11.2	4.8	15.5	2.8	5.1	15.4	19.4	5.6	10.8	34.2	8.8	14.2	9.7	26.4	16.2	9.0	7.1	7.2	22.3	4.9	2.3	3.3	7.1	30.9	5.7	5.0	12.1	28.5	16.0	20.2	3.8	6.7	4.8	14.0	14.4	14.0	6.3	34.1	23.5	3.0	2.8	12.1	5.7	20.4	30.6	1.9	10.5	11.6	9.0	13.3	7.9	3.3	6.0	7.4	5.8	3.9	6.6	5.8	7.6	2.4	5.4	6.0	5.7	8.9	4.8	5.5	6.6	4.9	5.9	6.0	6.2	7.0	6.5	8.5	6.5	7.0	7.8	5.7	7.1	7.6	8.8	22.4	20.7	16.3	8.2	9.6	13.2	13.7	5.7	8.2	22.6	5.5	6.8	18.6	17.4	51.5	29.2	19.4	11.0	46.4	3.9	14.2	36.6	16.6	7.8	13.8	12.1	3.8	47.7	13.7	13.5	25.8	14.8	19.6	14.5	3.2	23.9	32.9	64.6	0.0	46.8	47.7	20.3	24.8	22.7	48.3	7.5	25.4	10.6	14.0	11.2	8.3	13.4	17.6	16.3	19.2	17.5	11.3	20.6	29.1	23.9	36.3	21.5	28.9	0.0	10.5	9.1	8.4	3.6	10.2	11.2	22.8	11.0	2.9	19.2	30.7
CD109	"CPAMD7, DKFZp762L1111, FLJ38569"	ENSG00000156535	"CD109 molecule"	Q6YHK3	6	73695785-73828316	"CD markers, Plasma proteins, Predicted membrane proteins"		"Protease inhibitor, Serine protease inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	17	"parathyroid gland: 330.4"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 65.3;Basal respiratory cells: 62.8;Hofbauer cells: 45.0;Squamous epithelial cells: 51.4;Suprabasal keratinocytes: 43.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 206.4;BJ hTERT+: 126.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA008992, HPA015723"	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA		180000000		"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane"	Cytosol	"HPA008992: , HPA015723: AB_2732415"	"unprognostic (2.28e-1)"	"unprognostic (1.03e-1)"	"unprognostic (7.76e-2)"	"unprognostic (1.52e-2)"	"unprognostic (9.17e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.03e-3)"	"unprognostic (1.23e-3)"	"unprognostic (7.49e-2)"	"unprognostic (2.47e-1)"	"unprognostic (1.15e-3)"	"unprognostic (8.81e-2)"	"prognostic unfavorable (2.65e-4)"	"prognostic unfavorable (7.96e-5)"	"unprognostic (9.50e-2)"	"unprognostic (2.02e-1)"	"prognostic unfavorable (4.68e-4)"	8.6	1.1	2.3	2.4	2.5	2.8	5.5	2.1	2.1	9.9	0.7	6.9	1.3	12.5	5.6	10.2	3.2	4.1	5.8	2.0	4.0	7.0	1.1	6.6	1.0	3.2	3.6	0.7	0.5	330.4	0.4	6.5	3.5	3.6	2.9	0.2	3.4	2.5	1.2	18.9	2.2	12.6	3.7	2.1	1.1	1.8	2.5	3.1	1.3	3.3	2.2	4.5	7.4	3.1	35.6	29.4	1.5	0.1	48.2	206.4	0.0	30.5	126.0	9.0	18.4	0.1	20.2	0.0	19.7	63.5	19.5	96.5	3.5	60.9	12.1	8.5	5.5	11.5	21.0	5.8	10.1	0.0	0.3	60.7	52.4	18.6	68.7	34.2	71.6	3.9	0.0	0.2	45.0	0.8	0.8	0.0	2.4	0.3	18.9	2.6	8.4	40.6	4.8	3.6	0.0	0.1	68.6	0.7	30.8	1.3	0.8	5.8	68.7	96.8	10.1	17.2	28.5	0.7	17.9	0.1	40.3	0.1	89.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.1	0.0	0.2	0.0	0.0	2.3	2.5	2.1	2.1	2.0	4.0	3.2	3.6	3.5	3.7	2.5	3.1	65.3	3.2	1.7	39.8	1.1	41.4	8.4	62.8	35.9	0.3	2.2	2.2	13.0	0.0	16.3	0.0	0.0	0.4	1.2	0.1	1.9	0.1	23.4	10.8	10.5	38.0	0.0	7.6	4.0	0.0	0.5	25.0	0.5	15.0	2.5	0.0	21.0	0.6	45.0	0.0	3.3	0.1	4.1	2.7	28.5	21.0	0.6	13.5	23.2	19.7	3.3	0.0	0.0	1.5	1.0	0.4	0.0	0.0	1.7	10.8	0.0	23.5	16.0	0.2	0.0	7.4	13.2	1.0	3.5	51.4	43.8	1.4	4.6	1.4	0.2	7.2
COL12A1	COL12A1L	ENSG00000111799	"Collagen type XII alpha 1 chain"	Q99715	6	75084326-75206267	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"		"Congenital muscular dystrophy, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 76.9;Endometrial stromal cells: 44.3;Excitatory neurons: 52.9;Fibroblasts: 99.7;Leydig cells: 60.3;Sertoli cells: 46.0;Smooth muscle cells: 48.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"fHDF/TERT166: 1432.1;SiHa: 846.1"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"spinal cord: 29.1"	"HPA009143, HPA010021"	Uncertain		Approved	Vesicles,Cytosol	"Secreted to extracellular matrix"	NA	NA		9100000		"Cluster 89: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Vesicles	Cytosol	"HPA009143: AB_1847095, HPA010021: "	"unprognostic (2.60e-2)"	"unprognostic (2.80e-3)"	"unprognostic (7.92e-2)"	"unprognostic (8.27e-3)"	"unprognostic (1.13e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.47e-3)"	"unprognostic (1.38e-1)"	"unprognostic (4.30e-1)"	"unprognostic (1.18e-3)"	"unprognostic (3.04e-1)"	"prognostic unfavorable (1.69e-9)"	"unprognostic (1.03e-3)"	"unprognostic (1.81e-1)"	"unprognostic (3.16e-3)"	"unprognostic (1.92e-2)"	105.1	15.7	2.2	16.0	1.9	0.0	65.4	0.8	2.7	112.8	0.4	74.9	8.7	124.5	5.5	36.2	42.2	20.9	25.5	1.0	1.2	25.9	3.5	24.6	7.2	1.8	4.8	123.2	5.9	5.0	4.8	1.8	0.6	20.8	17.2	0.4	16.1	42.4	14.4	48.9	40.6	72.1	0.6	11.4	18.1	4.6	2.0	5.5	19.3	12.5	4.2	26.3	45.8	0.8	0.2	2.2	11.5	0.2	270.2	162.0	28.3	275.4	229.3	186.2	257.3	27.5	0.7	0.0	27.7	1432.1	3.9	59.2	0.5	28.7	174.6	0.2	1.4	0.2	101.1	0.1	97.9	0.3	0.2	234.9	5.0	42.2	50.6	173.6	32.0	0.1	0.0	0.0	29.4	0.2	0.1	0.2	6.4	0.0	15.3	0.1	23.1	0.2	8.9	14.4	0.0	0.0	846.1	21.2	0.3	15.5	131.8	0.5	0.2	78.5	97.0	41.5	91.4	0.1	0.1	0.4	26.4	0.3	40.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	1.9	0.8	2.7	1.0	1.2	1.8	4.8	0.6	0.6	2.0	0.8	14.2	76.9	5.1	2.3	0.0	20.6	0.6	12.7	5.2	0.4	4.7	7.1	4.1	0.0	4.7	3.7	0.0	0.6	0.0	0.0	0.0	1.4	24.1	6.3	44.3	11.0	0.0	0.0	52.9	4.6	1.3	99.7	2.6	14.1	1.3	0.1	3.3	0.0	0.8	0.0	32.4	0.0	0.0	0.3	18.4	14.7	60.3	1.8	21.4	38.4	0.0	0.0	0.0	19.6	1.2	6.7	0.0	13.2	0.1	1.7	0.0	0.9	1.7	0.0	46.0	20.0	48.6	0.3	0.6	0.6	13.1	0.7	2.5	1.4	0.1	0.3
COX7A2	"COX7AL, COXVIIa-L"	ENSG00000112695	"Cytochrome c oxidase subunit 7A2"		6	75237675-75250323	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 4705.1;Late spermatids: 3873.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"				"unprognostic (8.49e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.98e-2)"	"unprognostic (2.15e-2)"	"unprognostic (1.34e-1)"	"unprognostic (5.67e-3)"	"unprognostic (1.00e-1)"	"unprognostic (1.65e-1)"	"unprognostic (7.70e-2)"	"unprognostic (2.73e-3)"	"unprognostic (7.44e-2)"	"unprognostic (1.74e-1)"	"prognostic favorable (3.43e-5)"	"unprognostic (1.80e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.26e-1)"	180.5	204.2	346.7	94.5	356.4	171.8	166.2	374.6	579.3	133.0	382.9	314.4	196.3	128.4	215.0	253.0	135.7	105.5	601.8	357.5	401.2	374.6	307.6	146.1	117.3	344.1	349.7	103.8	154.1	407.8	232.6	92.4	355.2	163.4	327.9	332.2	160.4	124.0	185.3	163.6	200.9	158.5	358.6	138.6	286.4	497.7	353.5	166.6	146.8	293.8	156.6	160.5	154.1	378.4	116.5	260.5	334.6	276.7	195.9	220.0	242.3	276.9	252.7	270.3	291.3	471.1	172.9	188.1	239.0	251.9	363.1	247.1	236.1	299.9	336.8	347.8	482.6	283.6	842.1	630.6	200.8	305.6	319.9	240.7	392.7	250.9	163.2	283.4	318.7	420.8	255.2	266.0	370.4	536.6	130.7	329.7	210.9	569.4	472.5	210.2	169.0	500.7	436.3	745.0	228.2	275.3	172.4	312.0	301.7	273.2	190.9	843.6	156.4	118.8	218.2	95.9	319.5	373.2	444.7	221.4	135.7	342.5	237.3	693.0	582.0	585.0	435.6	663.4	468.5	659.6	563.3	527.9	619.7	559.7	551.1	511.9	437.7	496.6	696.0	781.4	680.8	1055.8	346.7	356.4	374.6	579.3	357.5	401.2	344.1	349.7	355.2	358.6	353.5	378.4	370.9	304.5	371.3	15.0	391.8	553.7	624.1	2000.6	268.6	251.0	584.8	693.0	2518.6	630.5	1019.4	503.9	120.9	686.3	348.5	1504.8	2602.2	800.4	4705.1	460.2	288.0	382.5	663.0	354.3	18.9	1007.3	787.6	367.5	414.9	451.7	300.1	269.4	385.8	1485.8	870.3	154.8	22.4	1283.5	1468.9	484.8	499.6	3873.2	355.7	420.2	846.6	10.3	715.3	390.3	396.5	14.1	20.9	1157.5	1498.6	339.3	593.7	848.5	1790.7	2008.3	772.8	359.9	407.6	303.7	587.8	2905.4	230.0	627.9	626.4	818.3	381.9	336.4	1242.8	994.8
TMEM30A	"C6orf67, CDC50A, FLJ10856"	ENSG00000112697	"Transmembrane protein 30A"	Q9NV96	6	75252924-75284948	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014561	Approved					NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 68: Epididymis - Unknown function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"			"HPA014561: AB_10601823"	"unprognostic (2.00e-1)"	"unprognostic (2.00e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.27e-2)"	"unprognostic (3.48e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.02e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.15e-1)"	"unprognostic (4.80e-2)"	"unprognostic (1.88e-1)"	"unprognostic (5.06e-2)"	"unprognostic (7.12e-2)"	"unprognostic (8.96e-2)"	"unprognostic (1.00e-1)"	62.9	57.0	60.3	59.1	70.2	53.7	54.0	65.2	67.5	61.3	72.8	64.7	43.9	62.0	50.2	58.1	47.4	60.0	45.3	67.2	73.5	77.3	99.6	91.7	53.5	63.3	64.5	47.6	70.8	96.2	47.6	48.5	64.6	64.7	70.8	57.0	55.2	58.6	29.2	38.3	46.4	79.1	73.5	62.1	59.4	28.8	69.5	47.6	84.5	40.4	60.9	66.4	34.8	82.1	54.2	60.6	91.5	77.6	228.2	212.0	76.3	217.9	171.3	82.3	128.2	56.3	129.1	61.9	148.3	194.8	82.7	62.4	41.5	120.4	211.5	84.9	63.8	60.4	55.1	56.7	129.2	73.7	104.6	197.2	116.5	116.9	63.7	175.2	262.4	59.1	59.4	107.8	158.4	37.2	27.1	54.2	32.7	46.1	46.7	44.4	65.6	78.5	315.3	131.1	64.9	62.9	111.9	52.8	74.9	105.8	58.6	224.8	234.5	103.8	116.9	65.6	153.3	90.3	136.1	27.9	81.7	137.2	165.7	44.5	85.8	59.0	37.1	84.7	44.8	27.1	37.3	36.7	78.6	22.6	34.8	34.5	138.3	42.5	87.5	33.2	53.0	61.5	60.3	70.2	65.2	67.5	67.2	73.5	63.3	64.5	64.6	73.5	69.5	82.1	73.2	163.5	132.5	7.5	38.8	71.2	33.7	67.6	42.1	24.5	53.1	27.6	43.8	40.0	96.1	66.2	45.9	39.6	51.0	67.6	11.7	51.0	11.1	46.7	57.0	68.0	36.2	20.8	15.8	111.2	52.1	65.7	43.3	76.0	39.8	31.4	66.0	79.1	54.3	20.2	14.5	44.3	54.9	89.3	79.1	9.5	45.4	57.8	48.0	10.3	62.4	40.7	35.0	17.1	15.6	101.6	38.5	62.4	55.8	80.9	31.1	33.2	95.2	24.0	32.9	56.1	77.2	45.0	21.2	41.8	78.3	94.4	43.3	62.5	28.8	65.9
FILIP1	"FILIP, KIAA1275"	ENSG00000118407	"Filamin A interacting protein 1"	Q7Z7B0	6	75291859-75493800	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 53.8;skeletal muscle: 35.8;tongue: 48.9"	"Cell type enriched"	"Detected in many"	4	"Cardiomyocytes: 582.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 6.9;HUVEC TERT2: 1.7;RPTEC TERT1: 1.9;U-266/70: 6.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA053564	Enhanced		Approved	"Plasma membrane,Actin filaments"		No	NA				"Cluster 38: Heart - Muscle contraction"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Plasma membrane, Actin filaments"		"HPA053564: AB_2682192"	"unprognostic (4.90e-2)"	"unprognostic (3.77e-2)"	"unprognostic (9.77e-3)"	"unprognostic (3.83e-1)"	"unprognostic (1.52e-1)"	"unprognostic (4.98e-1)"	"unprognostic (2.27e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.06e-1)"	"unprognostic (5.17e-3)"	"unprognostic (3.29e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.30e-3)"	"unprognostic (3.97e-3)"	"unprognostic (2.34e-1)"	"unprognostic (4.65e-2)"	"unprognostic (7.66e-3)"	6.8	1.5	1.5	2.9	1.8	0.2	2.4	0.1	2.5	1.8	0.7	11.7	1.8	8.5	0.9	9.5	4.8	5.7	53.8	4.1	0.5	1.8	3.2	7.6	1.2	0.2	0.5	1.3	1.4	12.4	1.4	5.1	0.3	3.9	3.3	0.4	1.2	3.4	35.8	0.6	2.6	13.2	0.5	0.3	3.2	2.1	0.8	1.1	2.3	48.9	0.9	10.9	1.6	1.5	0.0	1.3	0.2	0.1	0.0	0.2	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.1	6.9	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.2	0.1	0.2	0.0	0.0	0.1	0.1	0.9	0.0	0.1	0.0	0.0	1.7	0.2	0.0	0.2	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	1.9	0.4	0.1	0.1	0.0	0.1	0.0	1.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	6.9	0.7	0.0	0.0	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.1	0.1	0.0	0.0	1.5	1.8	0.1	2.5	4.1	0.5	0.2	0.5	0.3	0.5	0.8	1.5	82.1	128.2	82.6	5.9	0.5	0.6	0.5	2.8	0.0	3.5	0.5	0.8	582.5	0.0	9.1	0.0	0.0	0.8	0.5	0.1	1.9	0.1	54.2	18.2	1.7	45.9	0.0	2.7	9.7	0.4	0.3	60.3	0.0	19.2	1.3	1.7	72.1	0.7	1.3	0.0	12.8	0.1	8.2	1.9	1.2	17.6	2.5	1.8	1.8	5.6	0.0	2.5	1.0	6.0	10.0	0.0	0.0	4.5	0.0	0.8	0.4	0.1	62.4	3.5	92.1	70.2	114.2	7.1	7.9	0.7	0.9	0.8	1.8	11.9	0.1	0.4
SENP6	"KIAA0797, SUSP1"	ENSG00000112701	"SUMO specific peptidase 6"	Q9GZR1	6	75601509-75718281	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024376	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 34: Non-specific - Transcription"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	Cytosol	"HPA024376: AB_1856678"	"unprognostic (9.86e-2)"	"unprognostic (1.20e-2)"	"unprognostic (4.84e-2)"	"unprognostic (1.87e-2)"	"unprognostic (6.38e-3)"	"unprognostic (7.33e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.97e-1)"	"unprognostic (3.93e-2)"	"unprognostic (5.32e-3)"	"unprognostic (7.81e-2)"	"unprognostic (9.24e-2)"	"prognostic unfavorable (6.09e-4)"	"unprognostic (1.78e-1)"	"unprognostic (1.74e-1)"	"prognostic unfavorable (2.83e-5)"	"unprognostic (1.72e-1)"	25.1	22.6	12.8	24.6	16.8	37.9	31.4	47.6	15.5	28.6	7.5	26.6	20.9	33.0	22.1	25.3	26.8	26.0	22.6	9.6	14.3	28.5	28.0	26.4	28.5	11.9	11.9	40.5	27.0	39.4	22.3	33.4	12.8	29.3	26.0	31.4	21.8	28.9	25.5	25.2	20.5	31.9	12.3	28.9	24.9	33.8	12.0	32.4	41.9	30.1	30.4	29.7	21.2	22.3	23.8	24.5	54.3	39.1	41.3	54.6	40.3	41.9	46.5	34.6	43.1	33.9	22.4	40.1	38.6	48.7	40.9	29.8	51.6	28.0	53.1	59.2	44.2	60.8	28.9	31.7	57.3	53.5	42.8	42.6	45.6	32.6	71.8	41.9	58.2	32.8	74.9	43.2	43.0	29.0	21.4	28.6	33.1	31.9	20.4	39.7	28.7	59.0	36.7	35.0	47.2	48.7	35.8	31.3	36.4	43.5	28.2	50.1	49.0	30.8	33.4	15.9	43.8	48.9	52.4	31.4	15.4	49.8	33.1	7.5	8.0	20.8	7.3	8.4	10.5	9.1	7.4	9.9	8.9	10.5	10.5	9.6	14.9	10.1	14.7	11.0	6.9	6.3	12.8	16.8	47.6	15.5	9.6	14.3	11.9	11.9	12.8	12.3	12.0	22.3	76.7	67.3	128.3	158.0	74.0	46.5	65.0	27.6	78.6	58.8	53.0	59.6	76.7	31.5	70.9	29.5	91.8	33.0	73.8	43.2	17.6	33.7	40.4	62.9	78.1	57.9	27.6	50.5	152.6	33.7	29.4	69.3	51.0	62.9	65.1	74.2	42.1	32.0	29.5	60.6	177.3	35.6	24.4	43.2	41.5	35.6	70.8	57.7	35.6	149.9	68.4	56.6	50.4	218.1	228.9	32.1	29.9	63.2	62.8	63.4	32.6	26.8	47.2	65.7	26.3	98.9	73.7	107.7	61.7	61.4	48.4	41.2	67.2	66.0	46.3	66.8
MYO6	"DFNA22, DFNB37, KIAA0389"	ENSG00000196586	"Myosin VI"	Q9UM54	6	75749192-75919537	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Endocytosis, Hearing, Protein transport, Transport"	"Actin-binding, Calmodulin-binding, Motor protein, Myosin"	"Cardiomyopathy, Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 409.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"gdT-cell: 5.5;MAIT T-cell: 3.0;memory CD4 T-cell: 1.8;memory CD8 T-cell: 3.1;naive CD8 T-cell: 3.0;NK-cell: 2.9"	"Group enriched"	"Detected in many"	7	"NK-cells: 2.9;T-cells: 5.5"	"Cell line enhanced"	"Detected in many"		"RT4: 103.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010762, HPA035482, HPA035483"	Enhanced		Supported	Nucleoplasm		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 15: RT4 - Unknown function"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoplasm		"CAB010762: AB_477166, HPA035482: , HPA035483: AB_2674647"	"unprognostic (6.29e-2)"	"unprognostic (6.34e-2)"	"unprognostic (3.63e-3)"	"unprognostic (1.30e-1)"	"unprognostic (8.98e-2)"	"unprognostic (2.73e-2)"	"unprognostic (3.41e-3)"	"unprognostic (1.23e-2)"	"unprognostic (1.23e-2)"	"unprognostic (2.66e-2)"	"unprognostic (7.78e-2)"	"unprognostic (2.78e-2)"	"prognostic favorable (1.27e-12)"	"unprognostic (1.57e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.49e-2)"	9.9	9.5	18.6	7.1	29.3	0.3	28.3	22.6	32.0	18.5	32.6	22.1	33.0	7.6	22.9	32.0	11.5	27.0	5.3	19.6	19.5	51.4	15.2	23.2	4.7	23.7	24.4	4.7	21.6	40.4	14.5	7.6	24.3	17.2	19.2	49.0	25.9	19.9	3.4	16.8	33.9	5.7	16.0	7.6	27.6	14.6	23.9	5.1	15.9	3.1	12.8	24.0	15.8	34.6	52.2	13.0	12.3	8.9	29.7	23.7	42.6	20.7	23.6	12.3	18.3	22.2	44.2	0.1	16.1	25.7	14.0	40.0	15.3	29.2	18.6	17.0	30.3	17.4	5.6	14.1	25.0	0.0	22.2	17.5	21.6	19.3	14.5	24.0	43.3	7.9	22.4	7.2	15.4	48.3	0.2	0.8	7.7	44.1	3.8	0.7	29.1	1.6	51.1	103.6	26.8	14.8	5.6	46.6	6.8	28.3	16.5	35.8	59.4	13.7	9.3	0.6	20.0	13.2	16.1	0.3	10.9	0.2	5.3	0.2	0.1	0.1	5.5	0.0	3.0	0.2	1.8	3.1	0.0	0.1	0.4	3.0	0.6	2.9	0.1	0.1	0.2	0.8	18.6	29.3	22.6	32.0	19.6	19.5	23.7	24.4	24.3	16.0	23.9	34.6	74.8	141.1	207.0	286.3	4.7	30.1	87.5	49.2	18.2	83.6	99.6	35.9	8.1	38.6	91.3	150.8	120.9	32.0	14.7	112.2	54.8	128.9	7.0	86.9	26.9	57.2	85.0	0.0	147.8	120.3	23.8	30.5	91.7	169.2	26.0	81.0	37.9	33.8	6.3	95.9	167.2	76.4	116.0	2.9	6.1	9.6	30.1	6.7	30.2	105.9	2.7	307.3	12.3	179.4	409.1	197.0	99.7	43.2	11.4	165.9	105.7	97.6	109.5	188.4	13.1	26.5	32.7	14.4	32.1	28.3	34.1	78.4	13.4	191.8	77.5	199.7
IMPG1	"GP147, IPM150, SPACR"	ENSG00000112706	"Interphotoreceptor matrix proteoglycan 1"	Q17R60	6	75921114-76072678	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins"		"Heparin-binding, Receptor"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	267	"retina: 670.7"	"Group enriched"	"Detected in some"	8	"Cone photoreceptor cells: 673.5;Rod photoreceptor cells: 694.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"HaCaT: 1.2"	"Region enriched"	"Detected in single"	4	"basal ganglia: 3.3"	"Not detected"	"Not detected"			"HPA027142, HPA030332, HPA030333"	Enhanced				"Secreted in other tissues"	NA	NA				"Cluster 79: Retina - Phototransduction"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 46: Photoreceptor cells - Phototransduction"			"HPA027142: AB_2672132, HPA030332: AB_2673432, HPA030333: AB_2673433"	"unprognostic (6.65e-2)"	"unprognostic (4.13e-2)"	"unprognostic (1.20e-1)"	"unprognostic (8.69e-2)"	"unprognostic (1.22e-1)"	"unprognostic (5.49e-3)"	"unprognostic (5.97e-2)"	"unprognostic (3.56e-3)"	"unprognostic (1.89e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.12e-3)"	"unprognostic (2.84e-1)"	"unprognostic (1.73e-2)"	"unprognostic (2.09e-1)"	"unprognostic (6.01e-2)"	"unprognostic (1.96e-2)"	0.3	0.1	0.5	0.0	2.5	0.0	0.5	1.0	1.4	0.3	0.8	0.3	1.0	0.2	0.0	0.2	0.1	0.4	0.2	0.5	0.4	0.6	0.2	0.6	0.1	0.6	0.6	0.1	1.8	0.0	0.3	0.2	0.6	0.2	0.0	670.7	0.5	0.0	0.2	1.4	0.8	0.0	0.1	0.2	0.3	0.3	0.6	0.1	0.4	0.0	0.0	0.2	0.3	1.6	0.6	0.0	0.8	0.0	0.0	0.1	0.4	0.2	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.3	0.0	0.5	0.1	0.1	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	2.5	1.0	1.4	0.5	0.4	0.6	0.6	0.6	0.1	0.6	1.6	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	53.2	0.0	0.0	0.2	0.0	0.0	0.0	673.5	0.2	0.0	0.0	3.9	0.0	1.9	0.2	0.0	3.0	0.0	0.0	1.6	0.0	9.4	0.1	0.0	1.1	0.0	0.0	0.0	0.0	0.2	30.3	0.9	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	85.0	0.0	0.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	694.9	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0
HTR1B	"5-HT1B, 5-HT1DB, HTR1D2, S12"	ENSG00000135312	"5-hydroxytryptamine receptor 1B"	P28222	6	77460924-77463491	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters"	Behavior	"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 9.6;placenta: 6.7;stomach 1: 5.0"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"pancreatic cancer: 0.7;stomach cancer: 0.8;testis cancer: 1.0"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	16	"HUVEC TERT2: 79.4;TIME: 35.1"	"Region enriched"	"Detected in all"	4	"basal ganglia: 38.6"	"Region enhanced"	"Detected in many"		"basal ganglia: 11.7"	HPA028808	Enhanced		Supported	"Endoplasmic reticulum,Plasma membrane"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"		"Plasma membrane"	"Endoplasmic reticulum"	"HPA028808: AB_2672782"	"unprognostic (3.86e-2)"	"unprognostic (3.56e-1)"	"unprognostic (7.68e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.18e-2)"	"unprognostic (2.67e-1)"	"unprognostic (2.11e-1)"	"unprognostic (8.96e-2)"	"unprognostic (4.03e-1)"	"unprognostic (1.77e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.10e-3)"	"unprognostic (3.08e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.02e-1)"	0.8	0.6	2.1	0.4	6.0	0.0	0.2	0.0	3.8	0.8	0.0	0.1	0.1	0.5	0.0	0.0	0.5	0.5	0.0	1.2	2.1	0.5	0.0	0.4	0.0	0.6	4.3	0.3	0.1	0.0	0.2	6.7	1.2	0.2	0.1	0.3	0.2	0.5	0.1	0.2	0.1	0.1	0.1	0.0	5.0	0.5	9.6	0.0	0.2	0.3	0.0	1.3	0.5	1.4	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.4	3.5	1.7	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.6	0.0	0.0	0.1	0.0	0.0	1.2	0.0	0.0	0.4	0.2	0.6	2.2	1.4	79.4	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.2	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	35.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	6.0	0.0	3.8	1.2	2.1	0.6	4.3	1.2	0.1	9.6	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MEI4		ENSG00000269964	"Meiotic double-stranded break formation protein 4"	A8MW99	6	77650274-77927028	"Predicted intracellular proteins"	"DNA recombination, Meiosis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"kidney: 4.0;testis: 3.7;thyroid gland: 2.1"	"Cell type enriched"	"Detected in some"	4	"Early spermatids: 86.1"	"Cancer enhanced"	"Detected in some"		"renal cancer: 0.9;testis cancer: 1.3"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"									NA	NA				"Cluster 43: Testis - Unknown function"		"Cluster 23: Spermatids - Flagellum & Golgi organization"				"unprognostic (3.47e-1)"				"unprognostic (9.76e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.88e-1)"	"unprognostic (4.62e-2)"	"unprognostic (9.70e-4)"	"unprognostic (3.16e-1)"	"unprognostic (2.86e-4)"	"unprognostic (3.35e-2)"	"unprognostic (4.17e-2)"	"unprognostic (4.85e-2)"	0.1	0.7	0.4	0.0	0.4	0.0	0.0	0.3	0.2	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.5	0.2	0.6	4.0	0.8	0.0	0.0	1.0	0.5	0.0	2.0	0.1	1.0	0.0	1.2	0.0	0.0	0.4	0.1	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.1	3.7	0.6	0.0	2.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.3	0.2	0.2	0.6	1.0	0.5	1.2	0.5	0.6	0.6	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	86.1	0.0	0.0	0.1	0.0	0.0	4.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	3.0	0.0	0.0	0.0	0.0	21.3	0.3	0.0	0.0	9.4	0.0	0.6	0.0	2.0	2.5	0.1	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.1	0.0	0.0	0.0	3.6	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IRAK1BP1	"AIP70, SIMPL"	ENSG00000146243	"Interleukin 1 receptor associated kinase 1 binding protein 1"	Q5VVH5	6	78867551-78946440	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 65.4;Excitatory neurons: 73.1;Inhibitory neurons: 57.2;Late spermatids: 52.0;Oligodendrocyte precursor cells: 56.3"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebellum: 5.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035742, HPA035743"	Uncertain		Approved	Vesicles		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 34: Non-specific - Transcription"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 49: Ciliated cells - Cilium organization"	Vesicles		"HPA035742: AB_10670119, HPA035743: AB_2674764"	"unprognostic (2.62e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.82e-2)"	"unprognostic (2.12e-1)"	"unprognostic (2.38e-3)"	"unprognostic (3.93e-2)"	"unprognostic (6.55e-2)"	"unprognostic (2.34e-2)"	"unprognostic (1.32e-2)"	"unprognostic (9.88e-2)"	"unprognostic (2.81e-2)"	"unprognostic (4.64e-2)"	"unprognostic (1.82e-1)"	"unprognostic (3.39e-2)"	"unprognostic (2.58e-1)"	1.5	1.8	0.4	1.0	1.0	5.3	2.4	5.3	2.8	1.8	1.7	1.7	1.1	2.8	4.4	1.2	3.2	1.4	1.7	1.0	0.5	2.9	0.9	2.2	1.8	0.3	0.1	3.1	3.2	3.6	3.4	1.1	0.6	1.8	1.4	5.6	2.6	2.4	1.2	2.3	1.4	2.1	0.0	2.0	3.5	3.9	0.5	3.0	3.3	1.1	1.0	1.5	1.5	1.4	1.1	2.0	3.7	3.5	1.6	3.5	2.1	0.8	2.1	0.8	1.4	1.8	0.9	1.6	0.9	1.9	2.0	2.3	7.1	3.4	1.4	3.7	2.8	1.3	2.4	0.9	2.1	7.6	1.3	2.9	3.3	1.5	1.8	2.7	2.7	4.9	4.0	2.1	1.3	0.6	2.2	3.8	1.8	0.5	2.0	0.4	2.2	1.2	3.6	1.9	5.1	6.0	1.1	1.2	0.9	2.4	2.8	5.1	1.9	1.8	1.3	0.6	2.4	2.5	3.3	2.2	0.6	0.3	2.3	0.9	0.0	0.0	0.3	0.0	0.2	0.3	0.3	0.1	0.1	0.2	0.4	0.4	0.4	0.2	0.1	0.4	0.4	0.1	0.4	1.0	5.3	2.8	1.0	0.5	0.3	0.1	0.6	0.0	0.5	1.4	6.1	19.2	7.8	39.2	3.3	2.5	5.3	3.9	10.8	10.3	5.2	8.5	13.6	8.6	9.3	3.7	33.3	3.6	3.5	1.0	9.8	5.5	65.4	20.5	11.5	5.5	6.6	7.8	73.1	6.0	0.8	5.8	5.1	3.6	0.0	11.6	5.0	2.4	1.6	5.0	57.2	2.7	0.0	1.3	0.9	52.0	10.5	1.6	0.0	22.5	0.8	12.9	2.1	56.3	33.6	3.3	1.0	8.2	3.1	1.2	0.6	11.8	21.5	17.9	13.1	8.2	8.1	42.3	15.2	6.3	2.6	0.8	2.5	11.1	3.2	2.8
PHIP	"BRWD2, DCAF14, FLJ20705, ndrp, WDR11"	ENSG00000146247	"Pleckstrin homology domain interacting protein"	Q8WWQ0	6	78934419-79078254	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019140, HPA019838"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 34: Non-specific - Transcription"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA019140: AB_2670073, HPA019838: AB_2670287"	"unprognostic (1.58e-1)"	"unprognostic (1.60e-1)"	"unprognostic (9.43e-2)"	"unprognostic (8.47e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.01e-3)"	"unprognostic (3.50e-3)"	"unprognostic (5.03e-2)"	"unprognostic (4.03e-2)"	"unprognostic (6.40e-3)"	"unprognostic (1.72e-1)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (1.71e-5)"	"unprognostic (2.76e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.55e-2)"	8.5	5.7	7.6	8.4	9.9	29.4	12.0	18.8	9.3	11.0	6.0	8.5	5.8	11.1	8.4	6.2	9.8	6.3	6.6	6.6	9.0	6.1	4.8	8.8	11.0	8.8	8.7	11.7	8.4	8.5	9.4	7.9	9.2	8.7	7.7	20.5	8.5	7.0	9.7	8.9	7.9	7.1	8.3	9.9	8.1	6.4	8.5	13.1	7.8	8.4	9.1	8.4	9.2	14.0	13.6	10.8	25.2	24.6	9.6	13.7	14.6	14.3	11.3	12.0	15.1	13.4	8.2	22.3	11.1	9.0	10.1	12.2	19.1	9.1	20.1	32.2	13.9	25.0	20.7	10.0	4.4	28.2	15.4	8.4	7.9	14.4	14.3	10.1	12.9	14.0	25.5	20.8	11.7	9.1	11.0	21.0	15.9	7.0	11.8	18.9	32.3	9.7	12.9	18.0	24.7	15.8	19.0	14.4	9.2	16.0	11.2	37.6	15.2	13.9	9.8	6.8	23.8	14.2	14.9	12.3	5.9	17.9	21.2	10.0	4.2	7.7	4.4	3.0	4.7	6.1	5.3	5.0	2.9	6.6	5.8	4.6	14.4	4.6	5.7	5.3	4.8	2.1	7.6	9.9	18.8	9.3	6.6	9.0	8.8	8.7	9.2	8.3	8.5	14.0	64.4	70.5	109.9	181.8	92.5	63.2	88.9	56.7	48.9	183.4	53.7	52.2	58.6	54.3	95.9	55.2	152.2	85.4	95.3	52.1	1.9	71.6	33.8	94.6	75.1	74.5	72.7	80.4	168.9	47.2	91.0	77.3	59.7	58.4	115.2	76.6	71.0	21.3	51.0	181.7	196.4	58.2	71.2	83.8	75.6	17.2	101.2	83.3	49.8	154.6	134.7	84.4	83.4	154.3	346.1	58.1	49.1	87.6	124.8	81.5	46.7	19.0	148.4	174.1	52.6	97.9	87.4	127.3	53.6	50.1	56.4	102.1	92.9	50.5	62.1	104.5
HMGN3	TRIP7	ENSG00000118418	"High mobility group nucleosomal binding domain 3"	Q15651	6	79201245-79234738	"Predicted intracellular proteins"		"Chromatin regulator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB018370, HPA027971, HPA063572"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 24: NB-4 - Immune response"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm	Cytosol	"CAB018370: , HPA027971: AB_1850808, HPA063572: AB_2732703"	"unprognostic (1.02e-1)"	"unprognostic (2.04e-2)"	"unprognostic (5.92e-2)"	"unprognostic (5.26e-2)"	"unprognostic (3.48e-1)"	"unprognostic (3.88e-2)"	"unprognostic (5.24e-2)"	"prognostic favorable (2.76e-4)"	"unprognostic (8.78e-2)"	"unprognostic (5.31e-3)"	"unprognostic (1.47e-3)"	"unprognostic (5.81e-2)"	"prognostic unfavorable (1.02e-7)"	"unprognostic (1.70e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.69e-1)"	"unprognostic (6.43e-3)"	92.4	174.4	132.9	69.5	136.2	72.8	116.1	141.8	190.4	82.2	153.6	100.6	90.4	93.6	168.6	95.1	209.3	82.8	227.2	132.9	135.8	168.4	147.5	111.5	127.1	139.5	135.2	105.5	90.3	116.7	152.0	114.6	140.8	84.7	73.4	164.6	154.3	68.0	151.4	81.1	74.1	76.1	136.6	91.5	106.9	83.2	133.7	112.7	113.2	130.1	109.9	77.1	81.9	145.6	101.7	90.3	309.7	135.0	121.9	99.6	70.1	69.0	73.7	75.6	110.3	508.3	83.9	1.2	124.2	56.5	101.0	63.4	203.6	78.3	74.2	298.7	170.9	355.9	292.3	268.9	78.0	294.9	52.3	121.5	85.4	50.3	27.7	72.9	170.9	74.3	212.3	275.0	123.8	92.9	136.3	564.7	227.8	87.7	224.5	229.7	472.6	103.8	525.3	145.3	126.0	168.5	131.3	149.4	102.4	271.1	85.1	488.6	75.0	20.9	91.7	73.5	155.3	235.3	375.2	1.9	11.8	1.1	103.0	38.3	147.3	13.6	107.8	148.0	95.9	112.9	75.7	92.8	179.2	99.8	88.7	106.8	7.2	142.3	143.9	208.6	90.4	169.3	132.9	136.2	141.8	190.4	132.9	135.8	139.5	135.2	140.8	136.6	133.7	145.6	140.6	96.1	167.9	129.9	110.1	171.1	193.7	516.8	234.5	261.8	301.4	376.3	424.5	231.6	373.7	242.8	75.0	940.6	169.9	35.3	602.6	229.3	72.5	775.8	108.1	166.0	272.9	95.4	115.8	198.6	823.7	165.3	116.2	199.2	109.6	80.9	261.3	256.3	309.7	195.2	105.3	131.1	435.4	186.0	206.5	60.9	187.0	148.4	257.9	58.1	403.3	320.2	198.8	66.9	159.7	107.2	52.4	167.0	211.3	85.3	36.5	852.5	900.3	134.3	144.7	102.4	233.9	26.8	52.0	260.0	149.9	555.3	109.9	232.4	121.5	173.2
LCA5	C6orf152	ENSG00000135338	"Lebercilin LCA5"	Q86VQ0	6	79484991-79537458	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Protein transport, Transport"		"Disease variant, Leber congenital amaurosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 52.6;Respiratory ciliated cells: 89.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HEL: 14.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029053, HPA029055"	Supported					NA	NA				"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 36: HEL - Hemostasis"	"Cluster 49: Ciliated cells - Cilium organization"			"HPA029053: AB_10602020, HPA029055: AB_2672889"	"unprognostic (8.96e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.06e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.45e-1)"	"unprognostic (6.58e-2)"	"unprognostic (1.34e-3)"	"unprognostic (6.83e-2)"	"unprognostic (2.73e-2)"	"unprognostic (4.11e-1)"	"unprognostic (1.51e-1)"	"prognostic unfavorable (4.69e-4)"	"unprognostic (7.09e-3)"	"unprognostic (1.39e-1)"	"unprognostic (5.39e-2)"	"unprognostic (3.21e-2)"	3.2	1.9	4.4	1.6	3.9	3.6	4.9	4.0	5.0	4.2	16.9	2.5	1.0	5.4	3.7	3.0	9.6	3.0	2.4	6.0	4.6	2.8	1.2	4.0	1.5	4.5	5.8	7.3	2.5	17.2	3.6	3.3	5.1	3.9	1.6	13.7	5.5	4.7	1.1	1.0	1.3	4.2	5.3	1.7	1.6	6.9	2.8	1.1	6.3	2.0	1.0	3.5	2.8	6.1	1.7	1.3	3.9	2.2	4.8	5.3	1.7	3.0	3.6	1.8	3.7	9.9	1.9	0.4	3.9	2.4	3.4	1.8	2.9	1.8	3.3	0.0	2.2	14.6	1.9	1.4	5.0	0.3	1.2	5.0	2.0	3.1	4.0	7.0	5.6	0.1	2.3	0.9	3.0	0.0	0.0	0.0	1.1	1.0	1.5	0.0	6.8	0.7	3.9	0.5	2.9	3.5	2.7	0.4	1.9	4.8	0.3	0.8	3.9	1.9	2.2	0.6	2.6	3.7	1.4	0.0	0.9	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	3.9	4.0	5.0	6.0	4.6	4.5	5.8	5.1	5.3	2.8	6.1	6.7	16.0	11.5	17.0	1.1	1.0	12.5	5.9	11.4	12.4	6.5	15.2	5.1	11.5	17.5	11.0	22.9	8.0	0.1	0.1	0.0	15.9	17.3	52.6	8.6	14.4	2.4	4.6	32.8	4.9	3.6	12.0	0.5	3.7	1.3	6.3	9.3	0.1	1.1	10.1	16.2	0.3	8.2	1.3	0.9	5.3	18.0	1.0	3.6	4.7	0.2	13.4	0.0	24.6	21.9	7.1	0.1	15.8	1.6	6.2	0.1	3.3	89.7	30.4	6.6	14.0	12.1	18.0	11.4	5.5	1.0	12.3	1.2	8.4	0.6	9.5
SH3BGRL2		ENSG00000198478	"SH3 domain binding glutamate rich protein like 2"	Q9UJC5	6	79631329-79703655	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"salivary gland: 161.7"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 156.3;Excitatory neurons: 86.5;Intestinal goblet cells: 87.8"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 50.8"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	5	"basophil: 11.1"	"Lineage enriched"	"Detected in many"	10	"granulocytes: 11.1"	"Cell line enhanced"	"Detected in many"		"CACO-2: 81.6;HEL: 41.8;OE19: 99.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047486	Approved		Supported	Nucleoplasm		NA	NA		2000000	"Cluster 34: Basophils - Unknown function"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"HPA047486: AB_2680065"	"unprognostic (3.48e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.75e-2)"	"unprognostic (2.28e-2)"	"unprognostic (4.21e-1)"	"unprognostic (7.77e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.60e-2)"	"unprognostic (6.92e-2)"	"unprognostic (6.53e-3)"	"unprognostic (2.78e-1)"	"unprognostic (7.94e-2)"	"prognostic favorable (2.24e-4)"	"unprognostic (1.60e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.11e-2)"	"unprognostic (1.33e-1)"	26.4	6.9	18.8	7.5	18.6	1.7	21.6	15.6	27.5	22.3	15.1	50.5	35.2	9.9	24.7	55.1	17.8	23.2	6.8	21.4	21.8	15.7	53.1	12.7	5.5	26.7	22.0	4.1	23.3	31.5	16.6	24.0	28.1	26.2	47.9	26.0	161.7	11.4	4.8	11.3	35.6	15.8	24.1	6.6	68.9	2.1	24.2	4.8	59.1	10.1	10.7	12.7	19.7	22.5	8.5	1.5	7.6	1.6	6.7	5.6	18.0	0.5	5.6	1.9	4.0	81.6	16.3	0.1	11.4	0.5	1.6	3.9	7.0	9.2	6.7	0.0	10.2	41.8	1.8	15.8	2.8	1.7	1.1	3.1	7.3	5.8	3.3	2.7	23.8	0.0	16.8	0.0	0.7	1.3	0.0	0.2	6.5	99.7	2.8	0.0	2.2	0.2	2.0	27.3	20.3	22.3	0.5	2.4	0.6	10.3	0.4	3.5	13.6	5.2	3.4	0.1	4.9	12.0	6.0	0.0	0.9	0.0	1.6	11.1	0.2	0.4	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.2	1.0	2.2	0.0	0.0	0.1	0.0	8.8	18.8	18.6	15.6	27.5	21.4	21.8	26.7	22.0	28.1	24.1	24.2	22.5	83.2	6.4	24.8	20.9	0.9	2.2	4.6	3.3	2.2	13.5	14.8	9.9	6.1	52.9	21.4	22.0	8.4	40.4	1.7	156.3	0.0	14.8	18.1	14.3	3.7	33.8	12.6	7.4	86.5	13.0	3.7	4.6	81.1	21.0	0.0	2.0	44.6	69.6	4.1	13.5	38.1	87.8	4.1	2.9	2.1	20.3	0.6	21.6	16.0	11.2	4.6	8.6	0.0	33.7	24.9	15.0	76.0	4.5	1.3	19.7	48.7	11.3	24.6	12.2	0.0	3.7	4.7	2.5	1.2	21.5	0.9	52.7	1.0	1.8	67.2	29.9
ELOVL4	"CT118, SCA34, STGD2, STGD3"	ENSG00000118402	"ELOVL fatty acid elongase 4"	Q9GZR5	6	79914814-79947553	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted membrane proteins"	"Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism"	Transferase	"Disease variant, FDA approved drug targets, Ichthyosis, Mental retardation, Neurodegeneration, Spinocerebellar ataxia, Stargardt disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 105.5;retina: 176.7"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 63.8;Cone photoreceptor cells: 148.0;Excitatory neurons: 55.3;Rod photoreceptor cells: 355.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	6	"MAIT T-cell: 23.7"	"Lineage enriched"	"Detected in single"	238	"T-cells: 23.7"	"Cell line enhanced"	"Detected in many"		"JURKAT: 41.2;MOLT-4: 32.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 46: Photoreceptor cells - Phototransduction"				"unprognostic (1.67e-2)"	"unprognostic (8.58e-3)"	"unprognostic (2.38e-2)"	"unprognostic (3.08e-6)"	"unprognostic (1.49e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.85e-1)"	"unprognostic (3.46e-1)"	"unprognostic (6.91e-3)"	"unprognostic (3.39e-1)"	"unprognostic (1.38e-2)"	"unprognostic (3.45e-3)"	"unprognostic (1.66e-1)"	"unprognostic (1.77e-1)"	"prognostic unfavorable (6.27e-4)"	0.7	2.0	7.1	1.1	7.0	0.1	4.1	10.0	15.4	3.5	9.7	1.8	0.6	2.2	1.0	10.6	0.7	1.6	0.9	7.8	9.9	1.5	0.1	0.3	0.4	14.4	5.3	1.7	0.5	10.8	6.4	1.7	15.0	4.0	1.0	176.7	2.8	1.7	0.2	43.1	0.8	2.7	4.3	0.5	0.9	5.7	7.4	105.5	1.5	0.5	1.7	1.2	4.0	7.2	0.0	0.8	10.8	12.0	8.8	8.5	1.6	5.6	6.1	4.7	10.2	1.5	0.0	0.0	1.0	7.7	19.3	1.1	14.1	7.9	3.5	0.0	18.2	0.4	2.2	0.0	8.1	4.4	1.7	6.9	2.9	4.8	4.9	6.8	7.8	41.2	0.0	0.0	10.0	1.9	32.8	0.0	10.4	0.0	5.6	0.0	15.5	0.0	0.1	0.0	14.2	4.2	6.0	9.6	1.7	7.4	3.8	0.3	0.8	2.1	4.1	3.2	4.3	7.2	15.3	0.0	5.0	0.0	3.3	0.0	0.0	0.0	2.3	0.0	23.7	0.0	3.3	3.9	0.0	0.0	0.6	1.6	0.0	0.0	0.0	0.0	0.2	0.9	7.1	7.0	10.0	15.4	7.8	9.9	14.4	5.3	15.0	4.3	7.4	7.2	0.7	0.0	0.0	7.5	0.2	11.3	2.3	7.5	15.4	63.8	0.7	1.7	0.9	0.0	3.9	0.0	148.0	0.9	1.7	0.0	0.0	0.1	6.3	0.3	7.0	2.2	8.9	0.0	55.3	0.0	1.5	6.5	0.0	0.1	0.0	1.5	0.0	0.0	0.2	42.1	53.0	0.5	6.1	0.3	1.5	2.1	1.2	0.2	3.6	8.4	0.1	50.7	0.0	20.1	8.6	0.0	1.1	3.4	0.3	3.1	0.0	2.3	0.5	355.3	0.0	2.0	4.3	15.4	15.4	14.8	37.8	1.0	2.6	1.3	0.2	0.7
TTK	"CT96, MPH1, MPS1, MPS1L1"	ENSG00000112742	"TTK protein kinase"	P33981	6	80003887-80042527	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase, Tyrosine-protein kinase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"bone marrow: 25.3;lymphoid tissue: 46.6;testis: 34.3"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 43.3;Erythroid cells: 23.1;Late spermatids: 21.4;Spermatocytes: 130.5;Spermatogonia: 33.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"T-reg: 1.2"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"CAB010166, CAB013229"	Enhanced		Approved	Nucleoli,Cytosol		NA	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoli, Cytosol"		"CAB010166: AB_632567, CAB013229: AB_2533230"	"unprognostic (4.27e-2)"	"unprognostic (8.71e-2)"	"unprognostic (1.04e-2)"	"prognostic unfavorable (1.44e-5)"	"unprognostic (7.97e-2)"	"unprognostic (4.78e-2)"	"prognostic unfavorable (3.84e-10)"	"unprognostic (1.56e-3)"	"unprognostic (7.95e-2)"	"unprognostic (2.02e-3)"	"prognostic unfavorable (2.54e-4)"	"unprognostic (1.54e-1)"	"unprognostic (0.00e+0)"	"unprognostic (3.51e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.66e-1)"	0.7	0.8	0.0	4.2	0.1	25.3	2.2	0.1	0.3	0.7	0.0	4.8	4.0	1.0	0.1	4.8	0.6	0.5	0.1	0.1	0.1	0.2	0.5	0.8	8.1	0.2	0.1	0.2	0.2	0.3	0.0	3.9	0.2	0.8	5.9	1.8	0.7	0.1	0.0	3.6	4.1	1.7	0.1	1.4	3.3	34.3	0.2	46.6	0.4	0.1	9.0	1.2	1.4	0.2	39.9	23.4	68.2	56.4	3.1	9.5	38.5	44.9	27.4	64.2	77.8	32.1	29.6	58.5	34.1	19.5	66.9	50.0	60.7	27.6	88.6	53.4	49.3	54.1	29.4	26.5	0.2	64.4	33.9	1.2	2.8	45.0	28.6	9.6	36.9	80.6	60.2	58.5	55.2	29.5	37.0	46.4	40.4	35.4	27.9	32.7	124.4	24.4	16.3	25.2	46.8	27.4	26.6	28.3	16.3	36.6	26.6	48.3	15.4	28.8	28.5	18.8	72.9	13.1	47.1	32.4	10.3	58.9	25.1	0.0	0.0	0.3	0.1	0.0	0.1	0.2	0.2	0.4	0.0	0.7	0.0	0.1	0.0	0.3	0.0	0.0	1.2	0.2	0.0	0.1	0.1	0.3	0.1	0.1	0.2	0.1	0.2	0.1	0.2	0.2	0.3	3.2	1.1	0.0	1.4	1.3	0.6	2.6	0.0	0.2	0.9	0.5	0.6	0.0	2.3	0.0	2.1	9.8	0.8	2.2	3.9	0.4	43.3	3.1	1.6	1.1	1.8	23.1	0.2	0.2	15.0	2.1	2.6	2.3	1.3	13.9	0.7	0.2	6.5	0.0	0.2	3.0	4.1	2.6	1.2	21.4	0.9	1.9	0.0	0.0	5.2	0.2	1.0	0.0	0.1	0.6	0.2	0.7	5.1	0.4	0.3	0.1	3.0	1.6	6.6	0.1	1.7	130.5	33.0	8.5	0.3	3.7	1.1	0.5	5.6	1.6
BCKDHB		ENSG00000083123	"Branched chain keto acid dehydrogenase E1 subunit beta"	P21953	6	80106647-80346270	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Disease variant, Maple syrup urine disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 78.4"	"Cell type enhanced"	"Detected in all"		"Astrocytes: 296.5;Early spermatids: 110.9;Inhibitory neurons: 94.9;Oligodendrocyte precursor cells: 98.5;Oligodendrocytes: 101.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031580, HPA031956"	Approved		Supported	Nucleoplasm,Nucleoli,Mitochondria	"Intracellular and membrane"	Yes	No			"Cluster 15: NK-cells - Transcription"	"Cluster 85: Liver - Metabolism"	"Cluster 32: U-937 - Innate immune response"	"Cluster 64: Astrocytes - Nervous system maintenance"	Mitochondria	"Nucleoplasm, Nucleoli"	"HPA031580: AB_10696054, HPA031956: "	"unprognostic (4.23e-1)"	"unprognostic (1.61e-1)"	"unprognostic (9.50e-3)"	"unprognostic (9.37e-3)"	"unprognostic (1.66e-1)"	"unprognostic (6.03e-2)"	"unprognostic (6.84e-3)"	"unprognostic (2.30e-2)"	"unprognostic (1.94e-1)"	"unprognostic (7.32e-3)"	"unprognostic (2.67e-1)"	"unprognostic (4.65e-2)"	"prognostic favorable (5.54e-9)"	"unprognostic (2.67e-1)"	"unprognostic (1.12e-1)"	"unprognostic (8.02e-2)"	"unprognostic (1.49e-2)"	19.7	10.7	7.3	7.6	8.3	8.2	22.3	11.5	7.8	11.7	11.6	22.5	11.5	9.2	7.1	10.3	11.5	7.8	18.8	8.8	7.0	31.8	78.4	7.3	8.8	10.7	9.2	14.6	12.9	19.7	7.2	4.8	13.1	15.9	20.7	7.9	26.6	11.3	10.9	8.5	12.4	9.4	11.8	6.3	17.6	13.1	8.7	9.1	15.5	15.3	9.1	11.2	7.6	16.0	13.8	5.1	18.8	25.3	18.6	16.1	14.9	9.7	19.8	15.4	21.0	8.3	18.5	38.9	10.1	23.1	18.0	13.6	10.6	12.7	21.5	48.8	15.6	19.4	12.6	11.3	20.7	27.7	8.3	15.6	12.8	10.7	13.3	13.8	18.6	29.8	16.6	33.8	35.0	7.6	10.3	16.3	14.0	30.1	6.5	25.5	58.3	33.8	43.2	20.7	12.6	17.8	16.2	13.4	9.9	20.6	17.3	21.1	8.0	9.2	6.3	8.5	13.0	24.0	25.2	12.9	11.3	20.4	14.2	3.4	4.2	1.0	10.1	5.1	13.3	10.6	8.3	8.5	8.3	12.7	11.0	11.6	0.8	17.4	5.9	12.9	20.3	6.1	7.3	8.3	11.5	7.8	8.8	7.0	10.7	9.2	13.1	11.8	8.7	16.0	8.4	9.6	21.0	296.5	11.5	8.5	12.5	21.1	15.9	7.8	19.6	14.7	29.3	8.6	18.0	5.5	2.1	17.0	9.1	17.5	27.4	8.2	110.9	8.3	10.3	8.0	12.0	10.3	72.0	10.4	8.3	13.7	15.3	17.6	16.5	19.2	11.0	66.5	12.2	3.3	94.9	31.3	10.2	9.1	9.0	13.7	8.7	5.4	16.0	59.0	7.3	15.5	10.3	98.5	101.7	5.4	10.4	8.6	8.4	6.2	11.5	33.1	13.5	8.7	6.6	11.1	9.4	15.2	5.6	20.1	12.4	10.4	9.9	15.5	17.4	10.9
TENT5A	"C6orf37, FAM46A, FLJ20037"	ENSG00000112773	"Terminal nucleotidyltransferase 5A"	Q96IP4	6	81491439-81752774	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Nucleotidyltransferase, Transferase"	"Disease variant, Osteogenesis imperfecta"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"bone marrow: 225.9;salivary gland: 104.4"	"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 73.1;Endometrial stromal cells: 70.6;Extravillous trophoblasts: 115.4;Glandular and luminal cells: 176.7;Syncytiotrophoblasts: 162.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 81.9;HeLa: 86.1;HL-60: 95.6;THP-1: 162.0;U-937: 72.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA051067, HPA067140"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	Cytosol	"HPA051067: , HPA067140: AB_2685788"	"unprognostic (2.02e-1)"	"unprognostic (3.02e-2)"	"unprognostic (5.39e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.86e-2)"	"unprognostic (2.62e-3)"	"unprognostic (5.93e-2)"	"unprognostic (2.48e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.40e-3)"	"unprognostic (1.26e-1)"	"prognostic unfavorable (3.07e-5)"	"unprognostic (7.18e-2)"	"unprognostic (6.38e-2)"	"unprognostic (9.25e-2)"	"unprognostic (9.66e-2)"	13.5	21.3	4.3	7.9	4.6	225.9	12.2	9.0	5.8	21.3	9.9	17.2	16.4	10.2	19.7	4.4	12.0	32.3	21.7	4.0	14.0	6.4	35.9	9.1	5.2	7.8	7.1	23.6	8.3	9.4	17.4	18.7	6.1	9.9	16.9	8.7	104.4	24.8	2.1	18.7	22.2	11.1	5.0	9.9	37.8	3.7	6.7	2.9	8.8	5.1	4.3	16.6	8.8	5.3	3.5	5.0	3.3	0.2	67.9	29.8	6.2	27.0	19.2	15.7	23.5	51.0	2.6	0.3	1.0	81.9	10.0	2.9	2.4	4.2	11.5	0.0	6.2	0.1	86.1	8.0	21.2	95.6	7.1	13.2	2.4	12.3	2.1	51.2	2.0	0.8	1.4	0.0	10.6	14.7	0.0	67.2	0.9	29.2	3.8	0.0	28.8	0.1	2.1	6.2	3.3	4.4	12.1	5.2	8.3	9.9	1.2	162.0	4.5	17.9	3.8	7.6	7.6	0.4	0.3	0.3	25.3	72.7	7.8	37.3	29.9	46.3	11.5	29.6	6.8	18.2	4.3	5.7	24.2	21.0	8.1	8.0	13.8	16.9	47.3	8.5	5.6	14.0	4.3	4.6	9.0	5.8	4.0	14.0	7.8	7.1	6.1	5.0	6.7	5.3	22.0	0.0	0.0	0.0	7.0	0.0	0.0	0.0	0.0	0.0	40.8	44.2	0.0	0.0	0.0	5.5	0.0	39.9	43.1	0.0	3.9	30.5	0.0	73.1	70.6	2.9	0.0	0.0	0.0	23.4	115.4	32.7	0.0	176.7	0.0	40.9	0.0	0.0	28.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.1	0.0	0.0	9.8	0.0	0.0	0.0	0.0	26.7	0.0	0.0	5.9	0.0	0.0	3.6	0.0	0.0	0.0	0.0	26.2	0.0	0.0	0.0	0.0	162.0	9.4	12.6	0.0	0.0
IBTK	"BTBD26, BTKI, DKFZP564B116"	ENSG00000005700	"Inhibitor of Bruton tyrosine kinase"	Q9P2D0	6	82169986-82247754	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 190.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023826, HPA048438"	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoplasm		"HPA023826: AB_1851378, HPA048438: AB_2680392"	"unprognostic (3.13e-2)"	"prognostic unfavorable (3.86e-4)"	"unprognostic (2.72e-2)"	"unprognostic (1.75e-2)"	"unprognostic (2.48e-1)"	"unprognostic (2.78e-1)"	"unprognostic (5.93e-2)"	"unprognostic (1.97e-2)"	"unprognostic (6.18e-2)"	"unprognostic (1.90e-2)"	"unprognostic (8.81e-2)"	"unprognostic (3.02e-2)"	"unprognostic (1.08e-2)"	"unprognostic (7.33e-2)"	"unprognostic (1.09e-1)"	"unprognostic (7.27e-2)"	"unprognostic (9.78e-2)"	7.3	14.3	2.5	8.1	3.3	3.7	7.9	3.2	2.6	8.9	3.1	8.6	8.4	8.0	4.8	8.3	7.6	6.0	10.0	2.0	2.7	10.3	22.2	7.0	6.7	2.8	3.4	8.8	11.0	12.3	4.8	6.3	3.0	7.7	10.4	8.5	8.9	7.4	21.4	4.1	8.4	7.4	3.5	6.5	11.5	4.0	3.1	7.2	10.3	20.9	7.2	8.6	5.9	3.5	8.3	17.0	12.2	10.3	14.4	19.8	5.5	19.3	21.1	15.5	16.6	9.0	9.6	16.4	11.9	22.8	20.5	8.8	9.8	10.8	18.5	22.5	7.3	17.6	8.8	14.1	20.2	20.7	10.3	17.1	17.6	14.8	36.8	14.5	15.7	11.4	16.4	10.0	16.7	12.7	7.2	6.7	5.5	13.0	9.1	10.2	25.7	6.5	23.2	18.9	8.2	9.0	13.0	16.1	10.3	10.8	15.1	12.5	12.6	9.0	6.7	11.3	15.6	10.3	17.1	7.5	9.9	13.4	11.9	1.3	1.2	1.0	1.8	1.1	2.4	1.6	1.8	1.6	1.9	1.0	1.7	1.6	0.0	1.0	2.3	1.4	2.7	0.8	2.5	3.3	3.2	2.6	2.0	2.7	2.8	3.4	3.0	3.5	3.1	3.5	26.1	41.7	47.6	46.4	33.5	13.6	42.8	19.4	15.4	55.6	27.4	19.0	64.9	40.0	41.2	38.6	54.2	23.9	25.9	62.2	15.6	37.5	4.2	37.4	28.1	27.3	38.9	37.4	102.6	51.6	16.4	34.1	117.8	57.0	36.8	38.1	21.8	77.0	26.7	52.2	97.9	49.3	6.1	33.4	26.1	4.1	25.7	36.1	23.2	44.0	43.6	32.7	25.7	80.9	190.0	52.1	55.5	21.1	68.2	53.4	31.1	28.3	42.1	39.2	26.3	42.0	29.1	21.2	22.9	41.1	11.6	9.4	29.8	67.0	41.9	64.4
TPBG	"5T4, 5T4-AG"	ENSG00000146242	"Trophoblast glycoprotein"	Q13641	6	82363206-82367420	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 120.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	8	"MAIT T-cell: 1.4"	"Lineage enriched"	"Detected in single"	14	"T-cells: 1.4"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 94.6;hTCEpi: 115.2;hTEC/SVTERT24-B: 98.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA010554	Enhanced		Approved	Nucleoplasm		NA	NA		310000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Nucleoplasm		"HPA010554: AB_1858206"	"unprognostic (3.03e-1)"	"unprognostic (1.46e-2)"	"prognostic unfavorable (6.68e-4)"	"unprognostic (1.06e-1)"	"unprognostic (4.52e-3)"	"unprognostic (7.47e-3)"	"unprognostic (8.55e-2)"	"unprognostic (3.55e-3)"	"unprognostic (8.39e-2)"	"unprognostic (3.42e-2)"	"unprognostic (8.02e-2)"	"unprognostic (4.94e-1)"	"unprognostic (3.77e-1)"	"unprognostic (7.46e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.54e-1)"	"unprognostic (5.57e-2)"	19.9	2.5	1.6	3.3	20.6	0.5	17.3	0.4	5.7	24.2	0.6	8.5	3.5	15.8	2.6	26.3	14.9	6.9	9.1	0.2	4.2	10.7	1.5	7.5	1.9	8.2	11.4	6.0	8.3	4.2	14.2	6.2	9.3	15.3	3.0	0.2	20.1	7.0	2.9	15.9	8.0	6.7	3.1	9.9	9.0	3.6	3.6	4.2	15.7	1.9	3.0	35.1	20.2	3.6	17.1	27.6	8.7	21.2	35.2	40.4	17.6	84.9	94.6	16.7	22.0	3.9	26.9	0.0	9.6	39.5	51.9	37.3	10.3	44.6	13.9	0.0	14.5	11.9	13.1	0.8	29.1	0.9	9.2	25.8	115.2	98.5	34.1	12.9	4.5	0.7	2.3	0.2	3.9	37.8	0.0	0.0	12.5	8.8	22.3	0.0	19.4	0.2	24.4	25.8	4.4	16.9	20.9	28.3	0.0	16.2	49.4	3.5	10.8	15.1	15.8	33.5	19.2	0.1	0.0	0.0	71.3	1.3	17.8	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	20.6	0.4	5.7	0.2	4.2	8.2	11.4	9.3	3.1	3.6	3.6	16.4	12.8	6.5	2.3	0.2	67.9	78.2	120.3	68.3	1.1	44.6	24.0	2.1	21.5	62.4	55.2	0.0	42.7	0.4	9.0	0.0	35.8	8.6	29.2	38.7	25.4	1.2	0.0	21.3	45.4	82.5	48.0	14.8	68.0	0.0	3.8	11.0	0.2	3.6	1.7	0.9	20.2	75.3	0.6	11.5	6.5	12.8	2.3	17.8	7.5	0.1	2.1	0.0	2.0	3.2	38.2	17.8	6.0	0.0	51.9	1.9	0.7	29.9	0.3	32.9	55.6	47.0	13.7	11.8	25.2	31.3	65.9	3.5	9.7	10.8	78.8
UBE3D	"C6orf157, DKFZp434A1520, H10BH, UBE2CBP, YJR141W"	ENSG00000118420	"Ubiquitin protein ligase E3D"	Q7Z6J8	6	82892390-83065841	"Enzymes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 95.7;Inhibitory neurons: 74.5;Oligodendrocyte precursor cells: 78.9;Oligodendrocytes: 70.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027231	Approved		Approved	"Rods & Rings"		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 52: Non-specific - Ribosome"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Rods & Rings"		"HPA027231: AB_2256689"	"unprognostic (1.91e-1)"	"unprognostic (3.60e-2)"	"unprognostic (5.05e-2)"	"unprognostic (6.17e-3)"	"unprognostic (2.91e-3)"	"unprognostic (5.03e-2)"	"unprognostic (2.39e-5)"	"unprognostic (6.93e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.70e-2)"	"unprognostic (3.48e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.47e-1)"	"unprognostic (4.26e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.58e-2)"	"unprognostic (3.18e-1)"	1.6	2.4	0.8	1.4	1.4	0.8	1.5	0.4	2.1	1.7	0.2	1.7	2.1	1.7	1.2	1.7	5.0	1.3	1.4	1.0	1.4	2.1	1.2	1.1	1.6	0.8	1.9	2.1	2.3	1.9	2.4	1.1	1.2	1.2	1.7	3.3	1.9	1.4	2.7	1.3	1.4	1.6	1.6	1.6	1.7	1.1	1.3	2.1	2.7	2.5	1.8	2.1	1.9	1.3	2.9	4.0	3.8	3.5	3.0	4.9	3.0	3.0	3.7	3.8	6.5	5.7	1.5	13.2	4.6	1.8	6.6	3.0	7.5	3.7	6.0	5.6	17.0	7.6	2.0	6.2	4.1	6.5	3.6	3.9	5.2	4.2	5.0	2.8	5.0	7.0	11.1	5.8	3.3	3.3	4.1	8.3	4.8	10.4	6.3	6.1	8.6	5.2	7.2	3.8	6.8	4.2	1.7	4.4	2.8	5.1	2.8	4.7	1.5	1.6	4.6	3.6	7.5	6.4	13.8	4.4	2.8	12.0	3.5	0.0	0.7	0.2	3.3	2.0	4.3	4.7	3.5	2.6	2.2	3.2	3.7	5.5	0.0	1.0	0.9	1.7	4.0	2.2	0.8	1.4	0.4	2.1	1.0	1.4	0.8	1.9	1.2	1.6	1.3	1.3	4.7	6.4	6.4	35.9	8.1	6.2	5.2	6.7	6.2	11.0	2.7	2.7	3.1	2.8	5.1	7.3	35.5	7.4	10.0	1.5	1.9	5.4	2.1	15.7	6.2	5.8	7.7	2.1	95.7	4.7	4.7	5.1	2.0	2.8	1.3	6.8	4.2	2.7	5.2	6.7	74.5	5.2	8.2	4.6	3.4	1.1	6.8	3.1	7.2	36.5	2.7	3.9	3.1	78.9	70.9	3.6	5.9	4.1	4.8	3.6	3.6	5.5	31.9	14.9	6.6	11.1	4.3	7.3	14.7	4.8	6.8	3.0	5.8	8.4	6.7	3.7
DOP1A	"dJ202D23.2, DOPEY1, KIAA1117"	ENSG00000083097	"DOP1 leucine zipper like protein A"	Q5JWR5	6	83067666-83171350	"Predicted intracellular proteins, Predicted membrane proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 5.7;Cardiomyocytes: 9.8;Cytotrophoblasts: 4.8;dendritic cells: 5.9;Hofbauer cells: 4.1;Plasma cells: 3.8;Syncytiotrophoblasts: 3.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027902, HPA027904"	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	Vesicles	"HPA027902: AB_10600003, HPA027904: AB_10600877"	"unprognostic (7.18e-2)"	"unprognostic (3.91e-1)"	"unprognostic (6.11e-2)"	"unprognostic (6.05e-3)"	"unprognostic (8.21e-3)"	"unprognostic (1.36e-2)"	"unprognostic (3.32e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.84e-1)"	"unprognostic (2.47e-1)"	"prognostic favorable (7.36e-4)"	"unprognostic (2.13e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.17e-1)"	5.2	4.9	5.0	6.2	5.7	4.9	10.9	8.7	6.4	8.9	3.5	8.0	7.9	10.4	7.4	7.1	9.4	7.2	9.0	5.1	4.2	6.9	6.2	6.8	7.2	3.8	3.7	13.8	9.1	11.6	7.7	6.0	3.7	9.6	8.8	24.0	9.5	10.7	6.3	13.6	8.9	7.5	5.0	8.2	7.2	12.7	4.1	10.6	13.6	9.4	7.5	6.2	5.0	11.0	4.2	3.0	9.8	8.9	8.7	9.1	4.6	7.0	5.9	4.7	6.8	6.4	1.0	8.2	4.9	7.7	5.9	5.5	10.0	7.6	5.9	7.2	11.3	6.8	4.2	2.4	4.7	10.1	6.9	7.3	10.4	6.6	17.0	6.2	7.0	12.6	14.4	5.9	5.1	3.9	3.0	4.5	2.0	3.1	6.1	8.2	7.4	3.0	6.1	11.7	17.6	3.2	5.2	3.3	1.3	7.0	5.3	5.7	11.8	5.9	2.1	6.0	5.5	7.3	5.7	4.6	3.2	4.6	4.7	0.0	0.3	0.4	0.5	0.4	0.4	0.6	0.4	1.1	0.7	0.4	0.8	0.4	0.0	0.4	0.3	0.3	0.4	0.4	5.0	5.7	8.7	6.4	5.1	4.2	3.8	3.7	3.7	5.0	4.1	11.0	5.7	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.8	0.0	0.0	0.0	0.0	4.8	5.9	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	1.1	2.3	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	3.4	0.8	0.0	0.0	0.0
PGM3	"AGM1, DKFZP434B187, PAGM"	ENSG00000013375	"Phosphoglucomutase 3"	O95394	6	83161150-83193936	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Carbohydrate metabolism"	Isomerase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004998, HPA029759, HPA029760"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA		220000	"Cluster 34: Basophils - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 55: Plasma cells - Humoral immune response"	"Nucleoplasm, Cytosol"		"CAB004998: AB_425591, HPA029759: AB_10600305, HPA029760: AB_10601109"	"prognostic unfavorable (8.78e-4)"	"prognostic unfavorable (5.67e-4)"	"unprognostic (1.45e-2)"	"unprognostic (3.03e-2)"	"unprognostic (1.51e-2)"	"unprognostic (4.04e-2)"	"unprognostic (1.09e-3)"	"unprognostic (6.72e-3)"	"unprognostic (3.11e-1)"	"prognostic favorable (9.96e-4)"	"unprognostic (4.00e-1)"	"unprognostic (1.30e-1)"	"prognostic unfavorable (2.39e-7)"	"unprognostic (2.21e-1)"	"unprognostic (7.98e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.22e-3)"	23.6	21.0	12.0	18.1	12.9	9.3	18.0	20.2	15.2	24.4	19.6	18.0	15.8	17.1	34.5	12.3	13.4	24.6	14.3	9.7	10.5	13.6	38.3	16.8	11.2	10.9	10.2	22.7	46.1	13.3	28.2	47.5	13.1	51.0	23.4	26.8	35.8	20.3	6.7	10.9	18.2	18.5	6.6	11.5	24.9	32.3	11.1	8.2	25.6	8.6	15.2	19.0	12.3	15.9	35.1	23.4	41.8	51.0	68.9	72.9	48.9	118.1	82.9	55.2	83.3	60.1	16.1	18.3	24.7	112.3	53.0	20.1	38.4	49.5	104.6	14.6	37.8	22.7	41.9	105.0	77.6	22.6	11.2	46.2	40.1	96.6	120.0	55.5	64.6	12.1	74.9	19.6	61.0	39.1	3.7	14.7	18.8	31.8	31.6	16.2	92.5	11.3	42.0	36.0	16.9	26.3	34.8	28.5	20.9	61.8	27.0	25.5	94.2	38.3	21.2	74.9	60.5	36.5	16.1	13.0	29.7	17.7	58.4	10.8	4.1	2.7	2.6	3.5	3.9	4.6	2.8	3.4	3.6	2.5	4.5	4.7	1.8	3.5	4.5	4.2	2.1	2.3	12.0	12.9	20.2	15.2	9.7	10.5	10.9	10.2	13.1	6.6	11.1	15.9	14.3	28.9	27.7	14.4	13.0	15.8	29.2	28.5	5.7	16.4	19.9	15.0	6.8	15.7	36.1	11.0	10.4	32.4	12.7	15.9	7.9	31.7	67.7	17.0	35.1	13.8	16.1	6.9	25.1	49.6	71.1	46.1	23.9	36.4	5.1	25.4	14.3	32.6	17.6	8.4	29.4	35.5	18.3	6.0	8.7	20.9	33.5	8.6	10.6	15.9	10.1	25.9	2.1	41.2	36.8	37.9	19.7	18.4	44.1	56.5	16.1	23.2	22.2	21.1	6.6	22.1	26.6	75.5	34.2	11.6	15.6	64.4	10.1	12.2	17.6	25.6
RWDD2A	"dJ747H23.2, MGC13523, RWDD2"	ENSG00000013392	"RWD domain containing 2A"	Q9UIY3	6	83193357-83198935	"Metabolic proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 52.3;Spermatocytes: 65.2"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 11.6"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030105, HPA030106, HPA030107"	Uncertain		Approved	Vesicles		NA	NA			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Vesicles		"HPA030105: AB_10599826, HPA030106: AB_10600896, HPA030107: AB_10601009"	"unprognostic (2.51e-3)"	"unprognostic (1.25e-1)"	"unprognostic (2.48e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.19e-3)"	"unprognostic (3.99e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.60e-1)"	"prognostic favorable (3.82e-5)"	"prognostic favorable (1.38e-4)"	"unprognostic (1.26e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.91e-2)"	"unprognostic (2.57e-2)"	"unprognostic (1.85e-3)"	"unprognostic (2.59e-2)"	2.9	6.9	7.1	2.1	7.0	0.5	3.2	6.1	8.1	3.4	6.3	2.9	2.5	3.3	9.4	1.7	3.8	4.6	4.4	6.9	7.9	4.5	5.9	2.8	2.5	5.6	6.0	4.0	9.6	4.0	5.6	2.5	5.9	11.5	2.5	4.7	6.0	4.7	2.3	1.9	2.7	3.2	5.7	2.9	3.9	8.9	8.4	1.8	6.2	4.0	2.6	2.6	1.8	6.1	2.1	1.9	4.4	8.3	5.2	3.7	3.0	4.8	10.1	3.5	4.2	2.8	1.1	1.6	3.8	5.8	8.0	2.1	3.7	2.8	5.4	2.0	3.8	1.9	3.0	6.2	8.0	0.5	1.5	4.9	4.6	4.4	9.2	11.5	6.6	4.5	3.1	2.8	4.3	3.1	0.7	1.5	1.5	1.9	1.9	2.4	9.1	1.0	7.4	2.4	1.5	5.3	2.9	4.5	4.4	6.3	2.8	2.9	7.1	2.4	1.5	3.5	2.1	6.2	2.7	0.9	2.8	0.8	2.9	0.3	0.9	0.0	1.2	0.8	1.8	1.9	1.7	1.7	1.0	1.0	2.2	2.1	0.3	0.4	2.2	3.5	2.2	1.0	7.1	7.0	6.1	8.1	6.9	7.9	5.6	6.0	5.9	5.7	8.4	6.1	2.4	0.0	6.7	9.8	4.2	3.7	3.6	5.3	3.4	5.6	3.7	3.2	5.4	2.8	3.3	1.8	0.0	7.7	3.9	2.4	5.9	8.9	52.3	4.8	4.5	3.5	5.4	0.4	10.8	9.1	3.3	6.5	3.6	4.0	0.0	7.0	5.0	6.8	5.0	1.7	11.2	6.1	8.2	1.6	2.5	14.8	9.0	2.2	8.8	3.7	3.8	11.0	0.0	13.6	4.5	5.8	2.5	6.0	11.2	8.7	4.1	13.3	4.9	5.0	6.6	7.0	5.2	65.2	10.5	1.2	2.4	5.7	2.9	6.3	3.4	2.8
ME1		ENSG00000065833	"Malic enzyme 1"	P48163	6	83210402-83431051	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 71.8;Excitatory neurons: 117.1;Inhibitory neurons: 70.6;Kupffer cells: 74.4;Muller glia cells: 100.6;Oligodendrocyte precursor cells: 123.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	7	"MAIT T-cell: 16.0"	"Lineage enriched"	"Detected in many"	10	"T-cells: 16.0"	"Cell line enhanced"	"Detected in many"		"CACO-2: 139.4;OE19: 158.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006493	Enhanced		Uncertain	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		3600000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 21: OE19 - Mitochondria"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoplasm, Plasma membrane"	Cytosol	"HPA006493: AB_1078272"	"unprognostic (7.21e-2)"	"unprognostic (3.99e-2)"	"unprognostic (2.24e-1)"	"unprognostic (3.12e-3)"	"prognostic unfavorable (7.73e-4)"	"unprognostic (7.98e-3)"	"prognostic unfavorable (4.57e-5)"	"unprognostic (3.24e-1)"	"unprognostic (4.44e-3)"	"unprognostic (1.41e-3)"	"unprognostic (7.10e-3)"	"unprognostic (2.43e-1)"	"prognostic unfavorable (1.81e-7)"	"unprognostic (4.07e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.85e-2)"	"unprognostic (4.51e-2)"	41.4	44.4	13.4	5.2	15.4	0.4	29.9	14.5	18.1	8.0	8.5	7.7	21.7	4.2	6.5	28.6	4.2	15.5	18.6	13.1	17.4	3.6	9.8	8.8	4.2	15.0	19.1	10.8	3.4	19.9	12.5	2.9	18.3	8.4	11.0	30.0	10.3	17.2	34.7	14.4	10.4	7.8	13.4	7.3	23.8	16.1	16.8	5.6	6.7	30.5	4.5	15.3	12.0	13.5	29.0	59.1	1.4	0.0	48.0	44.4	0.1	18.4	47.0	19.2	37.1	139.4	24.9	0.0	46.8	43.4	38.2	29.8	43.4	16.4	20.9	0.0	24.4	0.0	33.8	0.0	61.4	14.3	50.3	49.0	32.3	38.7	26.3	32.1	30.4	0.0	20.4	0.1	26.4	32.7	0.0	16.2	0.0	158.3	23.0	0.0	48.5	27.9	56.8	13.7	5.8	14.9	31.2	45.7	1.0	25.0	0.0	34.5	32.4	11.9	14.1	3.9	0.1	10.9	13.3	0.1	0.0	0.0	35.9	0.0	1.6	0.0	0.8	0.3	16.0	0.0	0.2	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	13.4	15.4	14.5	18.1	13.1	17.4	15.0	19.1	18.3	13.4	16.8	13.5	0.9	19.2	12.1	71.8	0.6	1.9	5.1	12.5	6.8	17.1	2.5	0.9	41.0	7.2	12.7	5.5	2.1	0.6	0.5	12.7	1.9	12.3	5.5	0.7	6.8	2.3	0.0	0.0	117.1	9.5	0.9	8.5	62.7	0.2	0.0	11.2	4.2	12.1	7.1	13.5	70.6	4.1	8.2	74.4	25.6	6.5	25.7	16.7	0.0	23.4	5.5	100.6	0.0	123.6	38.6	15.0	4.5	37.2	0.5	5.2	15.2	3.1	7.2	7.5	0.0	4.5	8.3	7.5	2.3	22.3	3.4	0.8	1.8	33.6	8.9	3.3
PRSS35	"C6orf158, dJ223E3.1, MGC46520"	ENSG00000146250	"Serine protease 35"	Q8N3Z0	6	83512534-83525704	"Enzymes, Predicted secreted proteins"		"Serine protease homolog"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"retina: 50.5"	"Cell type enriched"	"Detected in some"	36	"Muller glia cells: 410.9"	"Group enriched"	"Detected in some"	4	"glioma: 2.8;testis cancer: 4.7"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	9	"MAIT T-cell: 19.5"	"Lineage enriched"	"Detected in single"	195	"T-cells: 19.5"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 10.4;CACO-2: 86.3;HAP1: 12.8;RPTEC TERT1: 24.6;SuSa: 17.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"amygdala: 2.9;cerebellum: 3.6;cerebral cortex: 5.8;hippocampal formation: 5.3;olfactory bulb: 2.7"	"HPA038787, HPA038788"	Uncertain				"Secreted in female reproductive system"	NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 5: Muller glia cells - Visual perception"			"HPA038787: AB_10675951, HPA038788: AB_2676208"	"unprognostic (6.17e-2)"	"unprognostic (8.75e-2)"	"unprognostic (1.19e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.16e-1)"	"unprognostic (4.03e-2)"	"unprognostic (3.70e-4)"	"unprognostic (6.08e-2)"	"unprognostic (1.18e-3)"	"unprognostic (2.33e-2)"	"unprognostic (7.01e-2)"	"unprognostic (9.07e-2)"	"unprognostic (3.88e-6)"	"unprognostic (7.15e-3)"	"unprognostic (5.81e-2)"	"unprognostic (2.82e-2)"	"unprognostic (3.54e-4)"	1.3	2.4	2.9	0.1	3.8	0.0	0.3	1.7	6.8	2.9	1.5	0.1	0.3	1.3	1.1	0.3	1.4	4.2	4.4	3.2	2.1	3.1	0.4	1.3	0.7	1.8	1.9	10.2	0.3	0.3	1.1	3.6	1.8	1.1	0.3	50.5	0.3	0.4	0.1	0.2	0.1	1.5	1.8	0.7	0.3	3.1	2.6	0.1	0.4	0.1	0.1	1.3	0.5	2.2	0.0	0.5	1.9	0.0	0.1	0.0	0.0	0.3	10.4	1.0	2.0	86.3	0.0	0.0	0.1	0.4	0.0	0.0	12.8	0.0	0.6	0.0	0.5	0.0	0.0	0.0	0.2	0.0	0.0	3.1	0.0	1.2	0.0	0.2	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.1	1.6	0.4	8.2	0.0	0.0	0.0	24.6	0.0	0.0	1.0	0.0	0.0	0.0	17.9	0.0	0.0	0.0	0.3	0.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.2	0.0	19.5	0.0	0.3	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.9	3.8	1.7	6.8	3.2	2.1	1.8	1.9	1.8	1.8	2.6	2.2	0.3	3.2	0.5	8.1	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.1	1.5	0.0	0.0	1.8	0.0	0.3	0.0	0.1	9.8	0.1	0.1	0.0	0.3	0.8	1.8	0.0	0.2	0.0	0.0	4.4	0.0	0.0	0.0	0.9	0.0	0.3	0.4	6.7	0.2	0.0	0.0	0.0	0.0	0.2	1.2	0.1	0.0	1.0	0.0	410.9	0.0	1.0	0.1	0.0	0.0	8.6	0.0	0.0	0.0	0.0	0.0	11.4	6.6	0.1	3.7	0.1	0.5	0.0	0.0	0.1	0.7	5.1	0.0	0.0
SNAP91	"AP180, CALM, KIAA0656"	ENSG00000065609	"Synaptosome associated protein 91"	O60641	6	83552880-83709691	"Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 80.8;pituitary gland: 25.8;retina: 91.8"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 91.1;Excitatory neurons: 336.6;Inhibitory neurons: 296.9;Oligodendrocyte precursor cells: 209.1;Oligodendrocytes: 89.0"	"Cancer enhanced"	"Detected in some"		"glioma: 2.5;prostate cancer: 2.0"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	25	"plasmacytoid DC: 2.8"	"Lineage enriched"	"Detected in single"	25	"dendritic cells: 2.8"	"Group enriched"	"Detected in some"	10	"GAMG: 7.4;SCLC-21H: 23.7;SH-SY5Y: 14.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009745, HPA029632, HPA029633"	Enhanced		Uncertain	Centrosome,Cytosol		NA	NA		28000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 58: Brain - Synaptic function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Centrosome, Cytosol"		"CAB009745: AB_2302221, HPA029632: AB_10794614, HPA029633: AB_10794615"	"unprognostic (1.07e-2)"	"unprognostic (1.74e-1)"	"unprognostic (7.55e-3)"	"unprognostic (3.68e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.42e-1)"		"unprognostic (2.56e-2)"		"unprognostic (1.17e-1)"	"unprognostic (4.54e-4)"	"unprognostic (6.99e-2)"	"unprognostic (1.75e-2)"	"unprognostic (4.82e-2)"	"unprognostic (2.15e-2)"	"unprognostic (1.51e-2)"	"unprognostic (3.14e-2)"	0.3	7.9	42.1	1.0	52.0	0.0	0.6	61.2	80.8	1.1	0.0	1.2	0.3	0.7	0.1	0.1	0.7	1.0	0.7	51.3	31.6	0.1	0.0	0.3	3.0	40.9	11.1	2.1	1.5	1.1	25.8	0.5	41.1	3.1	0.6	91.8	0.5	0.6	0.2	0.1	0.8	0.7	7.2	1.4	0.9	12.1	23.0	0.3	0.9	1.5	1.9	0.4	0.4	40.8	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.8	0.0	0.0	0.0	0.0	0.0	7.4	0.3	1.0	0.0	0.0	0.4	1.4	0.6	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.4	0.0	0.0	0.1	0.2	0.3	23.7	14.7	0.0	0.1	0.0	0.2	0.0	0.6	0.0	0.0	0.5	0.0	0.0	1.3	0.0	0.0	0.2	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	42.1	52.0	61.2	80.8	51.3	31.6	40.9	11.1	41.1	7.2	23.0	40.8	0.0	0.0	0.0	91.1	0.0	0.0	0.0	0.0	0.0	49.8	0.1	0.0	1.3	0.0	0.0	0.0	62.6	1.5	0.1	0.1	0.0	0.0	23.9	0.2	1.4	0.3	0.0	0.0	336.6	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	32.0	296.9	0.0	0.0	0.0	0.0	12.8	0.9	0.0	0.0	31.9	0.0	10.9	0.0	209.1	89.0	0.4	0.0	1.2	0.0	0.5	0.0	0.0	0.0	59.8	0.0	0.0	0.1	29.6	4.8	0.0	0.0	4.4	0.0	0.1	0.0	0.0
RIPPLY2	"C6orf159, dJ237I15.1"	ENSG00000203877	"Ripply transcriptional repressor 2"	Q5TAB7	6	83853266-83857515	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Developmental protein"	Dwarfism	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 21.2;choroid plexus: 9.6;pituitary gland: 11.2"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 12.0;Excitatory neurons: 10.0;Horizontal cells: 11.8;Inhibitory neurons: 10.5;Oligodendrocyte precursor cells: 13.0;Rod photoreceptor cells: 8.5"	"Cancer enhanced"	"Detected in some"		"glioma: 2.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"GAMG: 19.1;HEL: 6.2;SCLC-21H: 26.0;SH-SY5Y: 17.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047454	Uncertain					NA	NA				"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 62: Horizontal cells - Visual perception"			"HPA047454: AB_2680053"		"unprognostic (2.09e-1)"			"unprognostic (7.43e-2)"	"unprognostic (2.51e-1)"		"unprognostic (1.20e-3)"			"unprognostic (2.69e-3)"	"unprognostic (3.66e-1)"		"unprognostic (6.94e-3)"	"unprognostic (2.30e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.74e-1)"	0.3	1.4	13.8	0.2	14.4	0.0	0.2	17.9	21.2	0.9	9.6	1.3	0.2	0.8	0.0	0.2	0.5	0.3	0.2	14.6	14.6	0.2	0.0	0.1	0.0	13.9	12.7	0.4	1.1	0.0	11.2	0.0	13.8	0.7	0.2	4.2	0.1	0.4	0.3	0.1	0.4	0.3	13.3	0.0	0.7	0.8	13.5	0.0	0.2	0.0	0.0	1.4	0.5	14.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.7	19.1	0.0	0.0	0.0	0.0	0.0	0.0	6.2	0.0	0.0	0.2	0.0	0.0	1.6	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	3.6	0.1	0.0	0.0	1.5	0.0	0.0	1.1	26.0	17.7	1.3	0.1	0.1	0.0	0.1	0.1	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.7	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.8	14.4	17.9	21.2	14.6	14.6	13.9	12.7	13.8	13.3	13.5	14.2	0.2	0.0	0.0	2.0	0.0	0.0	0.4	0.3	1.8	12.0	0.0	0.1	3.5	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.3	1.8	0.0	10.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.8	10.5	0.0	4.1	0.0	0.3	0.5	0.3	0.0	0.0	1.0	0.0	1.4	0.0	13.0	4.6	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.1	8.5	0.0	2.9	1.0	0.8	4.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1
CYB5R4	"b5+b5R, dJ676J13.1, NCB5OR"	ENSG00000065615	"Cytochrome b5 reductase 4"	Q7L1T6	6	83859656-83967423	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 179.2;Late spermatids: 364.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 199.1"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 75.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018992	Approved					NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 25: Spermatids - Spermatogenesis"			"HPA018992: AB_1847371"	"unprognostic (4.86e-3)"	"unprognostic (1.16e-1)"	"unprognostic (1.80e-3)"	"unprognostic (1.21e-2)"	"unprognostic (1.72e-1)"	"unprognostic (3.25e-2)"	"unprognostic (1.72e-2)"	"unprognostic (7.94e-2)"	"unprognostic (4.77e-1)"	"unprognostic (6.77e-2)"	"unprognostic (1.39e-2)"	"unprognostic (5.44e-1)"	"unprognostic (6.36e-2)"	"unprognostic (1.95e-1)"	"unprognostic (4.11e-2)"	"unprognostic (2.15e-1)"	"unprognostic (8.15e-2)"	5.1	3.1	4.0	12.0	4.4	17.0	3.6	9.8	6.0	2.4	1.0	7.1	6.5	3.0	3.2	4.5	2.3	3.2	4.2	3.7	4.0	4.0	3.9	5.1	9.8	4.0	2.9	2.5	5.6	2.6	1.9	3.4	4.7	3.0	5.0	5.4	3.6	2.5	6.3	3.1	7.3	3.5	2.6	8.8	7.0	12.1	4.1	6.6	2.3	4.4	7.1	5.3	3.1	8.2	10.6	9.2	6.5	8.1	3.4	4.6	12.0	7.0	10.9	10.4	14.8	12.7	6.8	19.9	10.8	4.7	27.7	8.8	6.1	10.1	7.5	75.1	14.2	47.0	5.2	7.0	6.4	28.5	40.0	6.1	2.8	7.3	7.1	4.2	5.8	17.2	17.1	14.1	7.7	4.5	7.4	9.6	3.6	8.5	8.9	12.3	23.3	6.9	5.6	10.9	17.4	9.6	8.7	8.2	9.5	3.9	5.0	16.3	7.2	10.2	8.5	21.2	22.4	16.4	27.0	10.7	11.8	19.2	11.7	104.0	59.0	177.3	16.6	50.4	13.6	27.4	14.6	15.0	46.6	26.9	9.4	14.7	199.1	14.2	58.1	19.7	23.9	29.3	4.0	4.4	9.8	6.0	3.7	4.0	4.0	2.9	4.7	2.6	4.1	8.2	9.9	6.4	13.9	31.3	46.5	11.1	14.4	17.5	8.0	15.5	8.5	5.8	15.4	11.5	18.3	7.3	16.7	5.9	31.3	22.0	11.7	25.7	179.2	8.4	9.2	9.7	16.2	10.1	46.6	25.1	20.5	9.2	21.9	13.5	25.3	6.0	4.2	11.3	45.1	13.5	51.0	14.8	28.5	56.6	49.7	364.5	8.4	59.4	16.0	37.5	74.4	5.8	47.4	48.7	85.8	28.4	17.3	7.5	27.1	13.6	15.7	21.6	14.8	18.7	6.6	16.9	13.1	25.7	27.3	12.5	14.8	11.5	28.2	8.3	13.3	23.6
MRAP2	"bA51G5.2, C6orf117"	ENSG00000135324	"Melanocortin 2 receptor accessory protein 2"	Q96G30	6	84033772-84090881	"Disease related genes, Human disease related genes, Predicted membrane proteins"			Obesity	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 20.0"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 56.5;Inhibitory neurons: 33.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"K-562: 91.7;SCLC-21H: 30.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"									NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 65: Brain - Ion transport"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"				"unprognostic (3.82e-4)"	"unprognostic (7.11e-2)"	"unprognostic (2.35e-1)"	"prognostic favorable (1.66e-4)"	"unprognostic (8.80e-3)"	"unprognostic (3.15e-1)"	"unprognostic (9.85e-2)"	"unprognostic (7.43e-2)"	"unprognostic (2.76e-1)"	"unprognostic (2.05e-3)"	"unprognostic (1.41e-2)"	"unprognostic (4.47e-1)"	"unprognostic (6.02e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.01e-2)"	"unprognostic (4.50e-3)"	"unprognostic (9.12e-2)"	1.0	7.3	10.5	1.3	9.5	0.1	1.6	4.9	20.0	2.6	3.6	5.3	3.7	2.5	1.1	1.4	8.6	1.9	1.1	8.3	11.3	3.4	0.2	0.9	0.5	8.4	8.5	4.6	4.3	0.1	3.6	0.2	8.7	6.1	5.1	2.1	6.9	7.8	1.3	1.9	3.9	1.1	3.8	8.6	7.6	2.8	18.6	0.9	0.6	0.5	1.7	0.8	2.2	13.0	0.0	2.5	0.9	0.0	0.3	1.4	0.1	0.9	0.0	1.5	0.2	1.2	0.1	0.2	0.1	9.6	3.2	0.0	1.7	0.4	0.1	0.8	0.8	3.1	0.2	0.4	0.0	0.7	0.2	0.4	1.3	0.1	0.0	0.1	5.7	0.1	91.7	0.1	0.4	0.0	0.0	0.0	2.1	0.0	0.4	0.1	5.0	0.0	5.3	1.6	30.1	10.2	0.2	0.0	1.5	1.1	0.2	2.6	0.4	0.5	0.4	5.0	1.2	0.0	0.0	0.0	0.0	0.1	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	10.5	9.5	4.9	20.0	8.3	11.3	8.4	8.5	8.7	3.8	18.6	13.0	0.8	0.0	0.5	3.3	0.0	1.8	7.8	1.7	0.6	1.2	0.8	1.0	0.2	1.5	2.1	12.9	0.0	0.1	0.1	6.4	1.9	4.3	2.8	5.1	0.5	2.3	0.0	0.0	56.5	5.3	0.0	1.1	13.7	2.4	0.0	1.8	4.2	0.0	0.0	0.0	33.5	11.3	0.0	0.0	0.4	4.8	4.1	0.2	0.0	2.8	0.0	0.4	0.0	3.5	4.0	0.6	6.4	5.3	0.0	2.8	2.3	0.0	4.5	0.5	0.0	8.1	2.4	0.2	4.7	2.7	1.0	0.0	0.1	1.8	6.8	4.7
CEP162	"C6orf84, KIAA1009, QN1"	ENSG00000135315	"Centrosomal protein 162"	Q5TB80	6	84124241-84227643	"Plasma proteins, Predicted intracellular proteins"	"Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 141.3;Oligodendrocytes: 64.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030170, HPA030171, HPA030172, HPA030173"	Supported		Approved	"Nucleoplasm,Centriolar satellite,Cytosol"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 49: Ciliated cells - Cilium organization"	"Nucleoplasm, Centriolar satellite, Cytosol"		"HPA030170: AB_10611113, HPA030171: AB_10601567, HPA030172: AB_10602414, HPA030173: AB_10602206"	"unprognostic (1.75e-1)"	"unprognostic (1.46e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.63e-3)"	"unprognostic (2.95e-4)"	"unprognostic (1.03e-1)"	"unprognostic (6.73e-2)"	"unprognostic (1.21e-3)"	"unprognostic (1.57e-3)"	"unprognostic (3.98e-2)"	"unprognostic (2.87e-3)"	"unprognostic (3.27e-2)"	"unprognostic (6.32e-2)"	"unprognostic (3.58e-1)"	"unprognostic (1.44e-3)"	2.0	1.5	1.1	2.3	1.9	2.4	2.6	1.8	1.6	2.4	3.2	1.9	1.2	3.7	2.2	1.8	3.7	2.8	1.6	0.8	1.3	2.5	1.4	2.7	2.2	1.4	1.6	4.1	2.1	4.2	1.2	2.5	1.5	2.4	2.6	2.8	1.9	2.3	1.0	2.3	1.7	2.6	1.3	2.3	2.7	8.6	1.6	3.9	3.5	1.6	2.3	2.1	1.4	3.0	2.5	1.1	7.1	7.8	4.2	6.1	4.6	2.8	2.7	3.9	4.6	3.2	3.4	2.7	2.6	2.2	6.7	3.8	4.2	2.6	6.2	7.0	2.8	5.0	5.1	2.4	2.1	5.5	4.6	2.9	1.9	3.9	1.5	5.0	4.4	3.7	10.2	3.1	2.8	1.3	1.4	3.3	4.8	1.7	1.6	7.6	9.3	1.5	2.9	2.3	4.6	5.7	2.0	1.1	2.1	5.1	2.5	3.7	3.5	3.8	3.4	3.4	3.1	2.3	3.3	1.6	2.4	2.9	4.8	0.0	0.2	0.3	0.4	0.2	0.5	0.5	0.3	0.3	0.1	0.3	0.2	0.4	0.5	0.0	0.2	0.4	0.0	0.2	1.1	1.9	1.8	1.6	0.8	1.3	1.4	1.6	1.5	1.3	1.6	3.0	13.6	32.1	17.6	42.7	9.6	0.0	6.7	0.0	4.6	5.9	6.1	7.1	11.2	4.3	6.8	9.2	12.5	6.5	7.0	7.0	5.9	12.6	141.3	43.2	18.3	11.3	11.4	10.8	35.0	7.1	5.9	13.3	8.6	11.3	18.3	18.0	7.9	4.2	5.5	28.6	29.2	4.7	0.0	7.9	0.0	57.9	11.8	9.9	0.0	36.5	7.6	9.2	6.2	54.3	64.0	6.8	12.7	12.0	3.7	2.5	5.6	6.8	39.4	14.3	13.1	13.8	10.9	58.7	20.0	3.6	0.0	3.8	8.5	13.4	5.0	4.1
TBX18		ENSG00000112837	"T-box transcription factor 18"	O95935	6	84687351-84764598	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 10.3"	"Cell type enriched"	"Detected in some"	5	"Microglial cells: 91.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A549: 57.4;ASC diff: 39.0;ASC TERT1: 40.4;RH-30: 37.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA006807			Supported	Nucleoplasm		NA	NA				"Cluster 82: Adipose tissue - ECM organization"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoplasm		"HPA006807: "	"unprognostic (8.04e-2)"	"unprognostic (7.06e-3)"	"unprognostic (9.71e-2)"	"unprognostic (2.31e-1)"	"unprognostic (4.00e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.19e-1)"	"unprognostic (3.24e-1)"	"unprognostic (2.57e-1)"	"unprognostic (7.92e-2)"	"unprognostic (3.50e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.88e-14)"	"unprognostic (4.81e-5)"	"unprognostic (1.86e-1)"	"unprognostic (3.07e-3)"	"unprognostic (1.78e-1)"	10.3	2.0	1.6	0.9	3.1	0.0	6.1	1.1	3.4	1.9	4.6	0.7	0.1	1.4	0.4	3.1	1.8	1.5	6.6	1.3	1.3	0.4	0.2	0.3	1.8	1.7	1.2	2.7	0.5	0.4	1.6	1.8	1.6	0.6	0.4	0.1	1.6	1.1	1.3	4.7	1.1	0.5	1.5	0.0	0.4	1.0	2.1	0.6	1.7	1.4	0.2	4.5	2.9	1.7	0.0	57.4	0.0	0.0	39.0	40.4	0.0	23.5	11.5	17.4	16.5	0.4	0.0	0.1	0.0	9.8	0.0	3.0	0.0	13.8	14.0	0.0	23.2	0.0	0.0	0.0	5.0	0.0	23.1	17.1	1.3	12.1	25.8	0.0	20.2	0.0	30.7	0.2	12.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	37.3	0.0	0.3	0.0	0.2	1.2	0.0	1.0	9.0	1.4	0.0	31.0	18.2	0.0	4.8	17.6	0.0	0.3	0.0	0.0	10.9	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	3.1	1.1	3.4	1.3	1.3	1.7	1.2	1.6	1.5	2.1	1.7	1.6	0.0	0.0	0.3	0.0	5.5	0.0	0.4	0.0	0.0	0.2	0.3	2.3	0.0	0.3	0.0	0.0	0.1	0.1	0.2	0.0	0.0	6.9	0.0	0.1	1.6	0.0	0.0	0.1	0.0	0.0	14.9	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.1	0.4	0.0	2.1	6.1	2.3	1.2	0.1	8.8	91.8	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.4	0.0	0.0	1.0	0.1	0.2	0.1	0.0	1.6	16.9	0.4	3.1	0.1	4.4	0.1	0.8	0.8	0.3	0.0
NT5E	"CALJA, CD73, eN, eNT, NT5"	ENSG00000135318	"5'-nucleotidase ecto"	P21589	6	85449584-85495791	"CD markers, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 112.6;retina: 94.4"	"Cell type enhanced"	"Detected in many"		"Glandular and luminal cells: 58.0;Oligodendrocyte precursor cells: 61.3;Pancreatic endocrine cells: 124.8;Rod photoreceptor cells: 81.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"naive B-cell: 33.0;naive CD8 T-cell: 30.7"	"Group enriched"	"Detected in many"	41	"B-cells: 33.0;T-cells: 30.7"	"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 807.8;LHCN-M2: 934.3;TIME: 546.2;U-87 MG: 821.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017357	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA		3000000	"Cluster 21: B-cells - Adaptive immune response"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA017357: AB_1846330"	"unprognostic (1.92e-2)"	"unprognostic (4.44e-3)"	"unprognostic (1.54e-1)"	"unprognostic (1.57e-3)"	"unprognostic (9.33e-2)"	"unprognostic (1.82e-3)"	"unprognostic (1.20e-2)"	"prognostic unfavorable (6.66e-4)"	"unprognostic (5.45e-2)"	"unprognostic (1.80e-1)"	"prognostic unfavorable (1.32e-5)"	"unprognostic (1.39e-1)"	"unprognostic (3.11e-2)"	"prognostic unfavorable (1.02e-4)"	"unprognostic (3.49e-2)"	"unprognostic (2.26e-1)"	"unprognostic (2.78e-1)"	20.7	6.0	9.8	11.9	11.9	0.6	14.1	11.2	10.7	112.6	14.9	29.4	40.1	49.4	6.3	8.6	20.7	17.2	8.7	8.5	11.3	17.2	54.8	6.8	9.6	11.7	14.1	39.3	1.8	1.8	11.8	25.3	13.0	13.3	31.9	94.4	6.6	34.2	2.1	6.4	20.9	73.9	14.7	13.0	8.1	10.4	12.7	5.2	23.7	9.8	11.3	15.8	28.5	12.1	48.9	26.0	42.9	0.8	95.1	302.4	0.4	306.1	332.7	147.5	275.2	0.4	469.6	0.0	107.3	270.2	379.0	24.5	0.1	308.0	348.8	0.8	0.1	0.1	7.3	6.0	47.5	0.2	0.7	77.4	3.7	302.0	191.3	807.8	124.9	0.3	0.3	1.4	934.3	8.3	0.0	0.2	0.8	8.2	34.6	1.5	9.5	1.3	323.1	21.8	0.3	5.5	3.8	18.8	104.9	2.2	0.4	8.3	546.2	120.6	0.9	152.9	506.8	22.7	15.3	0.5	821.7	0.4	385.3	0.0	0.0	0.5	3.7	0.0	6.4	23.7	4.2	11.7	0.0	33.0	4.1	30.7	0.5	0.7	0.0	0.1	1.7	6.4	9.8	11.9	11.2	10.7	8.5	11.3	11.7	14.1	13.0	14.7	12.7	12.1	6.4	0.0	5.8	36.9	21.6	5.2	1.7	6.1	2.8	4.4	1.2	0.3	1.7	27.1	4.8	1.8	10.4	0.6	2.2	49.2	3.9	3.8	0.6	19.3	20.8	20.5	0.0	0.0	1.6	4.1	2.5	39.4	11.2	58.0	0.0	0.1	49.6	33.7	1.3	0.0	2.1	27.7	0.0	3.5	8.2	1.3	13.1	2.1	7.2	11.2	0.5	9.1	0.0	61.3	0.7	124.8	46.0	25.6	3.6	1.5	8.3	27.6	4.8	81.6	0.0	3.3	9.6	0.0	0.3	0.6	4.8	15.2	5.0	0.1	18.0	9.6
SNX14	RGS-PX2	ENSG00000135317	"Sorting nexin 14"	Q9Y5W7	6	85505496-85594156	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Protein transport, Transport"		"Disease variant, Mental retardation, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 173.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017639	Approved		Supported	Vesicles,Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 68: Epididymis - Unknown function"	"Cluster 32: U-937 - Innate immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Vesicles, Cytosol"		"HPA017639: AB_1857345"	"unprognostic (1.16e-2)"	"unprognostic (3.29e-2)"	"unprognostic (2.19e-2)"	"unprognostic (1.52e-2)"	"unprognostic (5.23e-2)"	"prognostic unfavorable (2.78e-4)"	"unprognostic (1.92e-2)"	"unprognostic (3.45e-2)"	"unprognostic (4.60e-1)"	"unprognostic (1.57e-2)"	"unprognostic (3.14e-2)"	"unprognostic (2.37e-2)"	"unprognostic (1.10e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.87e-3)"	"unprognostic (4.72e-3)"	27.3	39.9	39.0	23.0	40.5	31.4	41.7	44.4	61.0	30.8	49.7	39.7	29.8	23.5	57.3	24.3	28.2	28.3	24.8	40.7	47.0	54.4	69.6	39.6	32.6	40.1	40.7	26.8	43.6	47.1	36.3	36.2	43.1	33.2	35.1	47.2	27.8	30.8	16.4	28.6	31.7	22.4	40.9	37.4	45.3	87.0	42.5	18.9	40.5	12.9	28.8	35.1	24.7	44.2	46.1	27.3	44.5	64.9	98.3	71.6	46.0	58.0	78.5	44.2	67.5	49.0	75.4	60.3	69.8	74.4	85.9	60.7	30.5	58.8	69.4	53.3	18.0	66.1	36.4	75.1	80.9	62.4	65.0	63.0	43.7	52.0	51.6	81.1	79.4	23.2	67.7	50.4	96.9	52.1	4.4	117.0	18.3	72.1	31.1	26.2	90.6	29.1	107.1	82.7	19.8	44.5	35.0	76.6	56.3	57.9	47.9	108.9	71.6	35.4	21.8	44.1	60.3	50.4	87.0	22.8	71.3	72.2	71.8	36.7	21.5	33.0	19.9	33.6	14.7	13.3	13.4	18.1	26.2	14.7	12.0	15.0	9.9	22.9	40.9	7.9	16.7	15.7	39.0	40.5	44.4	61.0	40.7	47.0	40.1	40.7	43.1	40.9	42.5	44.2	28.5	93.0	47.2	76.4	25.3	14.7	18.7	32.8	15.9	36.4	23.3	15.1	16.9	15.7	39.1	22.0	56.3	50.4	32.6	30.7	5.9	31.7	87.1	37.3	22.2	26.9	31.8	13.2	115.2	41.6	31.9	23.1	37.8	32.5	31.6	36.0	26.0	28.7	35.4	15.2	124.4	26.1	65.1	37.7	22.3	21.6	19.6	33.4	28.4	63.7	43.1	26.1	41.2	85.5	91.0	34.4	22.0	29.3	23.8	15.7	31.9	25.1	58.9	40.7	19.7	26.2	33.0	173.0	14.9	15.9	14.8	56.5	26.4	26.5	28.6	17.7
SYNCRIP	"dJ3J17.2, GRY-RBP, hnRNP-Q, HNRNPQ, HNRPQ1, NSAP1"	ENSG00000135316	"Synaptotagmin binding cytoplasmic RNA interacting protein"	O60506	6	85607779-85644063	"Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, mRNA processing, mRNA splicing, Translation regulation"	"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010895, HPA041275, HPA069241"	Supported		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA		1300000	"Cluster 27: Non-specific - Gene expression"	"Cluster 16: Immune cells - Immune response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	"Vesicles, Cytosol"	"CAB010895: AB_261964, HPA041275: AB_2677389, HPA069241: "	"unprognostic (1.01e-1)"	"unprognostic (3.49e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.49e-2)"	"unprognostic (6.22e-2)"	"prognostic unfavorable (6.28e-5)"	"unprognostic (6.84e-2)"	"unprognostic (6.48e-2)"	"prognostic favorable (5.59e-4)"	"unprognostic (1.58e-2)"	"unprognostic (1.43e-1)"	"unprognostic (4.86e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.00e-1)"	"unprognostic (4.11e-1)"	60.5	43.2	25.1	80.2	28.0	67.3	55.6	28.1	24.8	51.4	26.0	54.1	48.0	46.1	41.7	75.8	34.0	47.8	45.6	22.8	29.9	53.1	66.7	49.4	88.1	28.9	27.4	36.2	51.9	56.9	19.5	68.5	31.0	44.9	62.7	36.0	41.4	46.5	55.9	43.5	44.0	62.1	27.7	51.3	50.0	38.7	27.6	91.0	87.3	56.0	101.9	81.5	40.8	29.0	209.5	147.5	239.9	157.1	150.8	165.3	162.8	258.6	218.1	244.4	239.9	250.4	132.6	480.0	200.0	262.8	203.1	197.4	331.1	269.0	405.4	175.9	163.9	405.4	152.8	165.2	130.3	497.6	177.7	141.8	179.6	276.4	272.1	138.4	254.9	133.2	451.5	210.0	295.1	243.5	255.2	218.9	231.5	209.4	153.2	364.7	345.5	209.9	236.2	307.1	239.5	184.6	188.5	180.8	128.6	137.2	150.8	360.9	247.4	165.8	142.7	189.8	374.2	138.0	260.5	275.4	165.4	328.7	251.4	1.8	24.7	8.8	30.6	36.2	30.0	21.9	27.1	27.5	37.7	21.2	23.4	27.7	3.0	36.1	41.1	29.0	31.6	24.6	25.1	28.0	28.1	24.8	22.8	29.9	28.9	27.4	31.0	27.7	27.6	29.0	106.9	115.4	119.5	26.4	73.0	148.2	160.9	124.4	83.6	44.5	89.0	82.8	88.9	52.9	126.7	46.0	16.7	101.3	97.2	50.4	54.8	120.7	117.6	105.1	156.2	100.7	56.7	65.6	24.0	99.6	133.3	101.8	79.5	152.1	61.4	81.6	57.5	81.4	96.9	62.2	24.3	78.0	79.3	71.1	67.1	28.7	73.7	92.9	53.4	31.9	90.7	45.1	57.7	32.2	40.9	130.0	45.7	64.3	97.4	133.0	47.7	80.7	84.6	42.2	19.7	158.6	131.8	93.7	65.8	142.4	141.6	118.1	81.6	85.8	106.7	159.8
HTR1E	5-HT1E	ENSG00000168830	"5-hydroxytryptamine receptor 1E"	P28566	6	86937528-87016679	"FDA approved drug targets, G-protein coupled receptors, Plasma proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 4.2;ovary: 4.2"	"Group enriched"	"Detected in some"	15	"Excitatory neurons: 125.4;Inhibitory neurons: 104.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	11	"PC-3: 1.7;SH-SY5Y: 6.6"					"Low region specificity"	"Detected in many"			HPA004931	Approved					NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA004931: AB_1856706"					"unprognostic (2.25e-2)"					"unprognostic (1.32e-1)"		"unprognostic (6.29e-2)"			"unprognostic (4.52e-2)"	"unprognostic (1.25e-1)"		0.0	0.0	1.7	0.0	3.0	0.0	0.0	0.0	4.2	0.3	0.0	0.0	0.0	1.5	0.2	0.0	0.0	0.1	0.0	2.6	1.3	0.0	0.0	0.0	0.0	0.2	0.3	4.2	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.8	0.0	0.0	1.3	0.3	1.2	0.0	0.8	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.1	6.6	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	3.0	0.0	4.2	2.6	1.3	0.2	0.3	0.1	0.0	1.2	2.5	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.0	1.1	0.0	0.0	0.0	125.4	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	104.7	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	1.0	0.0	0.0	0.0	1.5	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	1.7	0.0	0.0
CGA	"FSHA, GPA1, GPHa, GPHA1, HCG, LHA, TSHA"	ENSG00000135346	"Glycoprotein hormones, alpha polypeptide"	P01215	6	87085498-87095106	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"		Hormone	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"pituitary gland: 4389.4"	"Cell type enriched"	"Detected in some"	15	"Syncytiotrophoblasts: 85317.2"	"Cancer enhanced"	"Detected in many"		"breast cancer: 10.9;testis cancer: 13.0"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	28	"BEWO: 776.1;SuSa: 1437.9"	"Region enriched"	"Detected in many"	6	"hypothalamus: 22.2"	"Region enriched"	"Detected in many"	40	"hypothalamus: 82.2"	"CAB023350, HPA029698"	Enhanced				"Secreted to blood"	NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 12: NES - Nervous system development"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"			"CAB023350: AB_617281, HPA029698: AB_2673153"	"unprognostic (1.66e-1)"	"unprognostic (2.10e-1)"		"unprognostic (3.22e-5)"	"unprognostic (1.46e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.69e-2)"	"unprognostic (3.17e-1)"			"unprognostic (7.04e-3)"	"unprognostic (1.51e-1)"		"unprognostic (2.85e-1)"	"unprognostic (4.32e-2)"	"unprognostic (8.32e-2)"	"unprognostic (9.15e-3)"	0.8	4.1	0.2	0.1	0.4	1.9	0.1	0.7	0.7	0.0	0.3	0.3	0.5	1.0	1.2	1.2	0.1	0.2	1.5	0.3	0.3	2.7	2.0	0.7	0.3	2.1	1.6	0.5	1.3	18.9	4389.4	725.8	0.9	2.7	0.3	0.3	0.5	1.1	3.3	2.1	0.3	3.4	0.1	1.1	38.1	0.5	1.0	0.8	0.5	0.0	0.3	0.4	0.2	1.5	0.0	1.0	0.0	0.1	0.0	0.0	776.1	0.7	0.6	0.5	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.9	4.2	1.8	0.3	40.2	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.2	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.9	0.0	0.3	0.2	0.1	0.0	0.3	0.0	0.1	1.0	0.6	0.1	22.6	0.0	1437.9	0.1	0.0	0.0	0.9	0.2	0.4	0.3	3.1	0.4	0.5	0.2	0.0	0.1	0.7	0.2	0.1	0.3	0.0	0.1	0.2	0.1	0.3	0.1	0.4	0.2	0.4	0.6	0.2	0.3	0.4	0.1	0.0	0.2	0.4	0.7	0.7	0.3	0.3	2.1	1.6	0.9	0.1	1.0	1.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.9	1.9	0.0	0.0	7.3	0.0	1414.2	0.1	0.0	0.0	0.0	0.2	20.2	1.1	22.9	1.8	0.0	0.2	0.0	5400.7	65.5	0.0	28.4	0.0	0.0	0.0	0.0	625.7	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.4	0.0	0.0	85317.2	6.0	0.0	0.2	9.9
ZNF292	"bA393I2.3, KIAA0530, ZFP292, Zn-15, Zn-16"	ENSG00000188994	"Zinc finger protein 292"	O60281	6	87152833-87265943	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA032154, HPA050618"	Uncertain		Approved	"Nucleoplasm,Nuclear membrane"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 44: Endometrium - Transcription"	"Nucleoplasm, Nuclear membrane"		"HPA032154: AB_10601930, HPA050618: AB_2681190"	"unprognostic (6.26e-2)"	"unprognostic (1.32e-2)"	"unprognostic (2.97e-1)"	"unprognostic (3.66e-2)"	"unprognostic (1.02e-2)"	"unprognostic (2.07e-2)"	"unprognostic (2.08e-3)"	"unprognostic (2.28e-2)"	"unprognostic (2.81e-2)"	"unprognostic (4.03e-2)"	"unprognostic (8.43e-2)"	"unprognostic (7.46e-2)"	"unprognostic (9.06e-2)"	"unprognostic (2.80e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.02e-1)"	"unprognostic (7.36e-2)"	6.8	6.3	4.4	7.8	4.6	25.4	9.6	17.8	8.7	8.7	1.8	7.3	7.9	10.3	9.5	6.6	6.2	6.7	6.2	3.9	3.1	6.3	6.4	5.7	10.9	3.2	2.5	13.7	6.9	13.8	8.5	8.8	3.8	8.2	6.8	26.4	8.3	7.2	5.5	8.6	8.8	6.4	2.2	8.0	8.1	6.2	3.7	14.3	9.6	5.6	9.1	7.1	7.3	10.3	8.3	4.7	16.1	14.2	9.0	8.1	16.8	6.4	8.1	7.4	10.1	8.2	5.7	12.8	9.0	8.4	10.4	8.4	10.1	9.6	15.9	29.3	7.6	17.3	6.4	6.8	6.7	14.0	7.6	8.1	9.2	7.3	9.4	11.8	6.9	13.6	12.8	19.1	8.1	4.6	8.1	12.0	8.1	2.9	4.4	16.9	15.9	4.9	6.2	17.8	11.9	16.8	8.0	5.3	6.1	9.2	5.4	16.0	7.8	9.8	6.8	7.2	10.1	17.5	12.3	8.6	10.8	11.8	7.2	60.3	16.9	20.0	15.7	5.4	14.8	46.6	16.8	17.3	8.0	42.8	18.7	16.1	83.6	11.2	5.7	25.0	18.3	8.3	4.4	4.6	17.8	8.7	3.9	3.1	3.2	2.5	3.8	2.2	3.7	10.3	64.2	60.9	72.4	147.2	99.0	66.2	31.2	46.1	70.0	167.7	48.0	47.9	76.8	48.6	51.8	25.8	123.0	27.0	89.9	64.9	9.8	122.3	44.4	119.3	89.6	55.6	47.3	43.5	176.6	38.5	36.6	52.3	66.3	203.1	29.1	135.6	40.0	19.0	26.8	186.7	225.7	52.7	40.7	29.2	53.1	12.4	60.0	46.3	32.0	124.6	53.0	62.5	65.9	210.6	209.8	52.2	49.5	66.2	90.8	49.4	72.5	14.5	50.1	99.4	32.9	84.6	59.5	56.3	34.1	36.7	51.4	211.8	90.8	66.8	44.5	58.5
GJB7	"bA136M9.1, CX25"	ENSG00000164411	"Gap junction protein beta 7"	Q6PEY0	6	87282980-87329278	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Group enriched"	"Detected in some"	5	"fallopian tube: 7.0;pituitary gland: 5.5;placenta: 2.6"	"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 10.4;Endometrial ciliated cells: 12.8;Ionocytes: 22.4;Respiratory ciliated cells: 18.4;Syncytiotrophoblasts: 7.3"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 4.5;HDLM-2: 7.6;MCF7: 4.1;OE19: 4.8;RT4: 3.6;SuSa: 2.4"					"Not detected"	"Not detected"			HPA014392			Approved	"Plasma membrane,Cytosol"		NA	NA				"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 49: Ciliated cells - Cilium organization"	"Plasma membrane, Cytosol"		"HPA014392: "	"unprognostic (8.30e-2)"	"unprognostic (2.45e-1)"	"unprognostic (3.06e-1)"	"unprognostic (4.20e-1)"	"unprognostic (2.84e-1)"	"unprognostic (4.07e-3)"		"unprognostic (2.61e-1)"	"unprognostic (5.13e-3)"	"unprognostic (6.69e-3)"	"unprognostic (1.59e-1)"	"unprognostic (3.82e-2)"	"unprognostic (4.15e-2)"	"unprognostic (3.24e-1)"	"unprognostic (5.64e-2)"	"unprognostic (2.09e-2)"	"unprognostic (3.10e-2)"	0.0	0.0	0.2	0.0	0.1	0.3	0.0	1.0	0.6	0.2	0.0	0.0	0.0	0.1	0.0	0.0	7.0	0.0	0.1	0.1	0.1	0.0	0.0	0.7	0.0	0.4	0.1	0.0	0.0	0.1	5.5	2.6	0.5	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	1.0	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.2	1.5	0.0	0.1	0.1	0.0	0.0	4.5	0.0	0.0	0.0	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.6	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	4.1	0.0	0.1	1.2	4.8	0.0	0.1	0.0	0.0	0.0	3.6	0.1	0.0	0.8	0.0	0.0	2.4	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	1.0	0.6	0.1	0.1	0.4	0.1	0.5	0.0	0.1	0.2	0.2	0.0	0.0	0.7	0.1	0.0	0.0	1.3	0.0	2.5	0.6	0.3	0.2	0.0	0.5	0.0	0.0	10.4	0.5	0.1	0.0	0.2	1.1	12.8	0.8	0.3	0.0	0.0	0.7	0.2	4.4	0.6	0.0	3.0	0.0	0.1	0.4	0.0	0.5	0.0	1.1	0.0	22.4	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.1	0.4	0.0	0.0	0.0	0.0	18.4	0.6	0.0	1.7	0.3	0.3	0.3	0.0	0.0	7.3	0.5	0.2	0.3	0.2
SMIM8	"C6orf162, dJ102H19.2, DKFZP586E1923"	ENSG00000111850	"Small integral membrane protein 8"	Q96KF7	6	87322583-87399749	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007401, HPA067453"	Approved		Approved	Vesicles		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 39: Non-specific - Basic cellular processes"	Vesicles		"HPA007401: AB_1078357, HPA067453: AB_2685844"	"unprognostic (2.54e-1)"	"unprognostic (5.24e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.56e-2)"	"unprognostic (3.16e-2)"	"unprognostic (3.09e-2)"	"unprognostic (6.17e-2)"	"unprognostic (5.31e-2)"	"unprognostic (6.12e-3)"	"unprognostic (1.86e-5)"	"unprognostic (1.98e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.01e-1)"	"unprognostic (3.06e-2)"	"unprognostic (2.86e-2)"	"unprognostic (4.01e-1)"	5.0	5.0	8.0	3.8	8.0	6.0	5.2	8.5	9.5	6.4	8.1	6.0	5.2	6.5	6.7	4.1	5.5	2.7	7.7	8.1	8.3	7.3	7.0	3.9	5.0	7.8	8.0	6.5	4.7	6.2	7.2	3.4	7.8	4.7	4.6	8.7	4.0	3.9	10.6	4.3	4.8	4.1	8.1	4.1	4.1	4.9	8.5	6.7	4.8	8.7	4.0	5.3	5.5	8.0	5.3	4.6	9.3	16.2	5.3	6.0	4.1	5.8	4.5	4.8	9.2	3.2	4.8	10.8	6.8	5.8	8.4	6.5	7.6	4.4	9.1	9.6	8.2	15.9	5.2	6.4	5.0	16.8	5.5	5.7	5.9	4.9	5.2	5.4	7.0	13.8	18.1	17.7	5.5	4.0	10.1	13.3	5.7	7.9	7.1	16.1	13.8	6.2	6.2	5.2	15.9	6.5	8.5	5.0	10.1	8.4	4.6	16.5	6.8	2.5	7.2	10.8	5.7	7.8	13.6	7.2	8.1	7.9	7.6	5.8	8.8	15.7	11.2	8.6	11.4	18.5	13.2	13.6	10.1	11.4	19.3	16.9	14.7	9.7	10.3	8.5	18.4	9.1	8.0	8.0	8.5	9.5	8.1	8.3	7.8	8.0	7.8	8.1	8.5	8.0	19.4	12.8	5.8	18.9	17.6	13.8	20.6	29.7	8.6	24.4	12.8	16.0	47.3	17.2	16.6	23.9	37.5	17.7	8.7	8.0	45.0	10.7	18.7	32.1	19.0	15.0	8.5	17.1	21.7	10.3	12.3	17.8	12.8	9.6	5.1	31.4	22.5	13.8	14.9	37.0	19.8	9.4	36.7	12.3	11.5	14.5	15.8	11.1	8.8	8.4	11.0	28.4	13.4	8.0	13.3	8.1	11.6	20.7	14.0	10.1	15.5	23.0	17.5	22.9	26.3	21.1	17.9	23.9	28.4	10.7	14.8	14.9	14.8	30.7	16.5	13.4
C6orf163		ENSG00000203872	"Chromosome 6 open reading frame 163"	Q5TEZ5	6	87344813-87365463	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 7.7"	"Group enriched"	"Detected in some"	7	"Early spermatids: 180.7;Late spermatids: 267.1"	"Cancer enhanced"	"Detected in single"		"testis cancer: 1.2"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in some"			"Region enriched"	"Detected in single"	4	"basal ganglia: 1.5"	"Low region specificity"	"Detected in all"			"HPA044797, HPA052927"	Uncertain		Uncertain	Nucleoplasm		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA044797: AB_10962365, HPA052927: AB_2681990"	"unprognostic (4.98e-2)"	"unprognostic (6.42e-2)"	"unprognostic (1.65e-1)"	"unprognostic (2.33e-2)"	"unprognostic (4.18e-2)"	"unprognostic (3.49e-2)"	"unprognostic (7.55e-3)"	"unprognostic (3.96e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.95e-2)"	"unprognostic (5.60e-4)"	"unprognostic (6.66e-2)"	"unprognostic (3.77e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.93e-2)"	"unprognostic (3.19e-1)"	"unprognostic (1.42e-2)"	0.6	0.6	1.1	0.3	0.7	2.3	0.9	0.5	1.6	1.0	1.4	0.8	0.1	0.9	1.4	0.4	1.5	0.4	0.8	1.1	0.3	0.8	0.7	0.4	0.7	0.7	0.4	1.1	0.8	0.7	1.2	0.4	0.7	0.9	0.8	1.2	0.9	0.3	1.2	1.6	0.8	0.4	0.0	1.2	0.6	7.7	0.8	0.5	0.8	0.6	0.6	0.5	0.5	1.4	0.0	0.2	1.0	1.6	0.1	1.1	1.3	0.0	0.0	0.2	0.3	0.4	0.3	0.6	0.1	0.1	0.6	0.3	0.4	0.9	0.0	0.6	0.7	0.8	0.4	0.3	0.0	0.4	0.2	0.5	0.5	0.3	0.3	0.4	0.2	0.6	1.3	0.5	0.1	0.2	0.1	0.5	0.2	0.0	0.0	1.4	0.3	0.0	0.7	1.0	0.8	0.4	0.1	0.2	0.5	1.0	0.2	0.4	0.3	0.6	0.5	0.3	0.5	0.2	0.3	0.1	0.0	0.8	0.4	0.2	0.1	0.0	0.4	0.1	0.2	0.2	0.3	0.2	0.1	0.2	0.3	0.3	0.8	0.2	0.2	0.0	0.2	0.1	1.1	0.7	0.5	1.6	1.1	0.3	0.7	0.4	0.7	0.0	0.8	1.4	0.7	0.0	0.5	28.4	0.4	0.4	0.5	0.5	0.0	0.6	0.5	0.3	2.5	1.5	0.2	0.0	0.0	0.6	0.3	0.6	0.0	0.3	180.7	1.8	1.2	1.3	0.0	1.3	31.4	0.0	0.4	0.5	1.5	0.4	0.0	1.6	0.4	0.5	0.2	0.0	25.1	0.4	0.0	0.8	0.0	267.1	2.5	0.4	1.8	12.2	0.2	0.2	0.0	14.1	16.0	0.1	0.2	1.9	0.5	0.4	0.4	0.5	1.1	0.5	6.6	1.4	0.9	2.3	1.8	0.2	0.1	0.8	0.7	1.6	0.2	0.4
CFAP206	"C6orf165, dJ382I10.1, FLJ25974"	ENSG00000272514	"Cilia and flagella associated protein 206"	Q8IYR0	6	87407972-87464465	"Predicted intracellular proteins"	"Cilium biogenesis/degradation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"fallopian tube: 22.3;testis: 59.1"	"Group enriched"	"Detected in some"	4	"Early spermatids: 300.7;Spermatocytes: 128.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"MCF7: 2.3;RPTEC TERT1: 2.6;T-47d: 4.5"									"HPA044891, HPA072261"	Approved		Approved	"Nucleoplasm,Cell Junctions"		NA	NA				"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 6: T47d - Mammary gland"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Nucleoplasm	"Cell Junctions"	"HPA044891: AB_10960832, HPA072261: AB_2686501"	"unprognostic (4.31e-1)"	"unprognostic (8.75e-3)"		"unprognostic (2.40e-1)"	"unprognostic (2.31e-1)"	"unprognostic (5.51e-2)"		"unprognostic (1.68e-1)"	"unprognostic (1.17e-1)"	"unprognostic (4.68e-3)"	"unprognostic (3.13e-2)"	"unprognostic (3.99e-3)"	"unprognostic (9.08e-3)"	"unprognostic (4.22e-2)"	"unprognostic (1.46e-1)"	"unprognostic (8.54e-2)"	"unprognostic (2.26e-2)"	0.1	0.4	1.0	0.0	0.9	0.0	0.3	0.5	0.9	0.7	4.3	0.0	0.0	0.5	0.6	0.0	22.3	0.1	0.2	0.8	1.4	0.9	0.1	1.5	0.0	2.3	2.6	0.1	0.1	0.7	1.2	0.1	1.6	0.5	0.0	0.5	0.1	0.3	0.0	0.1	0.0	0.1	1.5	0.0	0.0	59.1	1.7	0.0	1.4	0.1	0.0	0.2	0.0	0.9	0.0	0.5	0.2	1.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.1	0.5	0.0	0.0	0.0	1.0	0.4	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.4	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.6	0.6	0.5	0.3	0.2	0.2	0.1	0.0	4.5	0.1	0.0	0.2	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.0	0.9	0.5	0.9	0.8	1.4	2.3	2.6	1.6	1.5	1.7	0.9	0.0	0.0	0.5	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.3	0.3	0.0	0.0	7.4	0.0	0.0	0.1	0.0	0.0	1.9	0.3	300.7	15.8	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	32.5	2.1	0.4	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.1	0.0	1.2	0.0	0.1	0.0	1.4	43.7	0.4	0.0	0.0	0.1	128.8	4.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0
SLC35A1	"CMPST, hCST"	ENSG00000164414	"Solute carrier family 35 member A1"	P78382	6	87470623-87512336	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Sugar transport, Transport"		"Congenital disorder of glycosylation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 103.0;Inhibitory neurons: 87.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 45: Intestine - Brush border"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 27: Mucus-secreting cells - Mucin production"				"unprognostic (3.04e-2)"	"unprognostic (1.93e-1)"	"unprognostic (6.33e-2)"	"unprognostic (2.55e-2)"	"unprognostic (2.82e-1)"	"unprognostic (4.07e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.58e-2)"	"unprognostic (3.01e-3)"	"unprognostic (7.26e-2)"	"unprognostic (3.85e-1)"	"prognostic unfavorable (2.70e-6)"	"unprognostic (2.85e-1)"	"unprognostic (8.51e-2)"	"unprognostic (5.48e-2)"	"unprognostic (1.04e-1)"	16.4	24.0	24.6	15.6	25.4	11.2	30.9	28.3	31.6	27.8	28.5	39.6	18.8	24.9	22.1	13.9	20.2	19.5	16.0	26.0	25.5	21.2	32.9	37.6	17.9	24.3	24.1	23.1	15.8	23.7	18.9	19.7	24.4	36.8	47.6	14.4	31.6	16.5	13.8	24.9	21.5	22.0	24.5	19.0	29.2	13.2	24.9	16.3	16.9	15.7	16.3	21.5	16.7	25.4	4.8	11.5	20.4	24.1	54.4	49.3	16.4	13.9	12.2	11.4	15.6	9.9	86.0	17.6	16.8	17.3	31.7	18.5	24.8	11.3	14.6	25.3	18.4	20.0	14.7	17.8	35.7	26.3	13.3	25.3	26.6	13.5	26.1	26.8	27.5	25.5	26.1	28.4	17.0	44.6	7.3	39.6	11.0	60.4	18.6	22.4	19.9	19.0	35.6	20.4	13.3	14.6	25.7	47.4	23.2	23.3	42.2	53.0	26.0	16.4	11.1	18.2	11.3	21.1	32.7	6.5	13.7	46.2	23.7	52.1	54.1	22.8	17.5	42.8	27.1	17.8	18.7	21.5	46.9	16.7	23.7	22.3	13.2	17.5	44.2	17.3	26.8	36.9	24.6	25.4	28.3	31.6	26.0	25.5	24.3	24.1	24.4	24.5	24.9	25.4	14.7	44.8	33.6	19.2	11.7	14.8	18.1	37.1	18.8	6.2	23.6	16.6	6.2	20.0	25.5	16.5	12.5	25.0	16.1	27.1	7.9	10.1	10.6	6.3	9.9	15.8	15.0	8.2	103.0	8.9	19.7	19.2	13.3	6.8	21.6	14.2	42.8	20.7	15.6	11.8	87.2	73.5	48.8	28.2	11.1	7.1	16.4	15.8	21.4	24.4	27.4	17.3	16.5	42.3	26.9	11.5	19.0	19.2	9.4	17.5	14.5	11.3	25.4	7.0	19.7	8.9	16.9	9.6	14.2	9.0	14.8	27.5	14.9	12.5	32.7	8.9
RARS2	"DALRD2, dJ382I10.6, MGC14993, MGC23778, PRO1992, RARSL"	ENSG00000146282	"Arginyl-tRNA synthetase 2, mitochondrial"	Q5T160	6	87513938-87589987	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	"Aminoacyl-tRNA synthetase, Ligase"	"Neurodegeneration, Pontocerebellar hypoplasia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039987, HPA042645"	Uncertain		Approved	Mitochondria		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 77: Retina - Visual perception"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 66: Spermatocytes - Spermatogenesis"	Mitochondria		"HPA039987: AB_2676786, HPA042645: AB_2678097"	"unprognostic (1.49e-2)"	"unprognostic (1.08e-1)"	"unprognostic (5.03e-2)"	"unprognostic (6.98e-2)"	"unprognostic (9.27e-2)"	"unprognostic (5.41e-2)"	"unprognostic (6.61e-2)"	"unprognostic (4.30e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.08e-3)"	"unprognostic (8.28e-2)"	"unprognostic (2.20e-1)"	"unprognostic (7.56e-3)"	"unprognostic (1.62e-1)"	"unprognostic (1.89e-2)"	"unprognostic (5.73e-2)"	"unprognostic (7.16e-3)"	24.0	39.6	10.8	15.8	11.8	19.3	21.3	14.7	11.6	21.5	19.2	20.8	17.8	21.8	18.6	17.7	19.7	19.0	22.7	10.4	11.4	20.5	27.9	18.3	16.8	11.5	11.6	18.5	24.0	21.4	17.5	22.2	11.8	18.8	22.7	25.9	20.8	13.6	22.5	18.5	22.6	21.5	11.0	18.5	19.2	25.3	12.5	18.5	20.6	19.3	19.0	20.6	18.2	15.5	19.8	19.1	45.1	49.8	44.6	47.5	31.9	46.6	54.2	30.8	38.6	36.6	21.6	25.0	26.9	47.4	32.0	26.7	37.9	25.8	43.2	18.0	36.0	25.7	24.4	58.7	56.1	30.7	21.3	48.9	24.6	26.4	33.1	44.5	41.0	25.7	59.6	24.4	46.8	35.2	10.0	32.8	29.2	42.3	20.0	19.9	45.9	22.2	38.5	40.1	40.8	54.7	24.8	12.1	33.1	38.2	22.5	45.8	28.1	21.2	16.8	22.8	38.4	25.6	45.1	21.1	32.2	31.8	36.6	18.8	17.8	22.7	16.1	18.6	19.0	15.1	20.4	15.1	15.6	16.2	19.9	16.9	11.9	18.6	20.7	17.9	27.9	15.4	10.8	11.8	14.7	11.6	10.4	11.4	11.5	11.6	11.8	11.0	12.5	15.5	34.4	19.2	15.6	30.0	21.2	17.3	35.4	51.3	12.5	13.9	17.3	16.8	19.9	10.0	37.8	11.0	20.9	31.0	18.1	14.6	45.0	32.9	95.3	23.5	29.3	22.8	9.0	7.4	46.8	46.9	45.5	28.3	12.8	20.3	18.3	27.9	23.6	15.5	20.5	6.7	59.0	23.5	44.7	13.5	14.1	50.6	25.4	15.0	19.6	38.4	22.6	13.6	19.6	56.3	63.9	37.6	21.2	24.0	20.7	30.8	57.2	32.9	24.2	20.3	26.3	18.9	30.0	61.8	33.7	14.1	18.0	39.5	20.6	51.4	27.0	33.9
ORC3	"IMAGE50150, LATHEO, ORC3L"	ENSG00000135336	"Origin recognition complex subunit 3"	Q9UBD5	6	87590067-87667453	"Predicted intracellular proteins, Predicted membrane proteins"	"DNA replication"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039553, HPA053748"	Enhanced		Supported	Nucleoplasm		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 21: Non-specific - Transcription"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 45: Enterocytes - Digestion"	Nucleoplasm		"HPA039553: AB_2676566, HPA053748: AB_2682247"	"unprognostic (9.38e-3)"	"unprognostic (2.38e-1)"	"unprognostic (3.74e-2)"	"prognostic unfavorable (2.89e-5)"	"unprognostic (8.63e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.39e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.26e-3)"	"unprognostic (1.21e-1)"	"unprognostic (9.07e-2)"	"prognostic unfavorable (7.23e-4)"	"unprognostic (1.33e-1)"	"unprognostic (2.92e-2)"	"unprognostic (3.38e-3)"	"unprognostic (1.09e-1)"	11.8	17.9	13.5	9.8	14.0	8.8	15.8	18.3	17.9	11.1	11.1	10.0	6.8	13.6	16.3	9.0	15.3	9.5	20.3	14.0	13.6	14.5	15.8	10.8	13.8	14.2	12.7	20.1	9.6	19.4	13.2	12.7	13.9	12.3	10.6	33.8	9.0	11.5	21.7	10.6	8.8	10.9	14.3	10.8	8.4	25.8	13.5	20.5	16.1	20.5	13.2	10.8	9.5	17.0	16.5	22.9	39.1	30.6	31.0	32.2	29.4	32.9	30.4	38.5	53.0	31.6	20.0	32.3	44.6	22.9	33.0	28.5	45.1	27.3	52.4	40.6	31.3	30.8	30.5	33.3	16.9	34.6	9.7	29.6	20.1	43.5	38.6	21.4	23.7	34.2	71.5	33.8	37.5	22.2	13.7	18.4	28.5	24.3	24.3	33.5	53.5	20.4	30.8	24.6	27.8	20.4	25.9	15.7	26.2	41.4	20.9	29.9	19.6	19.1	18.5	39.1	39.7	16.1	38.0	22.4	25.3	34.7	29.9	22.5	10.1	11.5	12.6	17.1	18.7	17.7	17.7	15.7	8.6	15.2	21.9	18.5	7.0	19.4	22.4	11.0	18.8	12.7	13.5	14.0	18.3	17.9	14.0	13.6	14.2	12.7	13.9	14.3	13.5	17.0	17.8	12.8	13.4	36.2	21.6	5.0	11.0	16.0	5.7	18.7	9.2	11.0	36.3	11.5	15.7	7.3	12.5	23.4	13.6	14.2	21.5	10.8	61.2	21.2	19.8	10.9	10.3	12.0	56.2	10.3	24.5	17.5	11.7	15.1	12.0	23.7	12.1	9.5	20.0	6.7	68.0	12.5	10.2	8.8	3.9	26.7	18.6	13.1	8.8	37.5	12.4	20.2	10.3	41.7	44.8	10.5	12.1	15.4	23.9	10.0	58.3	31.4	21.4	28.1	13.1	21.6	17.1	67.8	34.6	8.7	4.4	14.6	17.0	20.0	14.2	8.3
AKIRIN2	"C6orf166, dJ486L4.2, FLJ10342"	ENSG00000135334	"Akirin 2"	Q53H80	6	87674860-87702233	"Predicted intracellular proteins"	"Immunity, Innate immunity, Transcription, Transcription regulation"	"Developmental protein, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA064239			Supported	Nucleoplasm		No	Yes			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm		"HPA064239: AB_2685222"	"unprognostic (9.65e-2)"	"unprognostic (2.56e-1)"	"unprognostic (8.25e-2)"	"unprognostic (8.09e-2)"	"unprognostic (3.58e-1)"	"unprognostic (1.87e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.38e-2)"	"unprognostic (6.17e-2)"	"unprognostic (6.60e-3)"	"unprognostic (1.62e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.48e-2)"	"unprognostic (9.62e-2)"	"unprognostic (9.55e-2)"	"unprognostic (2.23e-3)"	"unprognostic (1.02e-1)"	32.9	37.1	29.0	23.8	32.5	70.5	26.0	26.5	37.6	22.7	27.8	19.8	12.7	24.6	23.7	33.2	22.6	15.3	30.9	34.0	34.0	20.8	31.2	33.2	28.4	26.9	28.8	25.6	13.2	17.8	23.4	18.5	26.4	17.0	12.5	29.7	24.5	11.7	97.4	22.9	22.9	16.4	29.5	49.0	16.8	24.1	35.7	31.2	17.2	42.6	30.3	23.2	25.0	30.9	23.9	24.7	71.0	40.1	43.1	29.6	41.4	41.1	25.7	33.2	32.3	39.7	18.0	62.2	44.1	42.1	55.1	36.2	39.1	29.6	37.9	79.2	48.5	36.3	21.8	89.7	47.1	31.4	30.2	34.6	29.9	41.0	40.2	32.5	36.6	24.3	71.2	42.2	43.5	30.7	9.9	64.9	51.0	20.3	38.1	38.7	50.2	25.7	41.7	20.8	53.0	50.3	24.9	14.8	44.2	40.1	17.9	73.9	47.6	27.5	18.8	23.5	54.6	40.9	48.4	38.8	30.4	40.2	45.1	76.1	57.8	64.8	28.1	73.2	29.2	41.6	27.4	27.6	55.0	32.6	21.4	23.1	144.4	36.6	75.6	75.1	39.1	35.0	29.0	32.5	26.5	37.6	34.0	34.0	26.9	28.8	26.4	29.5	35.7	30.9	49.9	25.6	19.8	10.4	88.2	96.5	192.2	101.9	80.8	13.0	31.8	28.8	22.5	35.8	43.7	18.4	8.4	45.1	94.4	17.1	45.0	30.9	58.0	44.9	34.3	45.6	12.1	45.4	15.6	14.7	71.0	51.1	16.3	39.9	33.6	47.2	44.6	29.9	77.0	11.8	14.8	10.9	69.2	104.4	167.0	100.9	35.8	142.8	74.7	19.7	46.7	80.5	33.0	17.6	15.1	29.6	21.7	28.2	69.4	119.7	19.0	53.5	17.9	17.0	6.6	62.2	39.9	70.6	63.0	92.6	92.9	136.5	99.5	54.2	12.6	191.0
SPACA1	SAMP32	ENSG00000118434	"Sperm acrosome associated 1"	Q9HBV2	6	88047841-88066838	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	371	"testis: 41.9"	"Cell type enriched"	"Detected in some"	11	"Early spermatids: 910.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA026744, HPA043297"	Enhanced					NA	NA				"Cluster 36: Testis - Spermatogenesis"		"Cluster 23: Spermatids - Flagellum & Golgi organization"			"HPA026744: AB_2194642, HPA043297: AB_2678413"															"unprognostic (4.15e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	41.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	910.1	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	80.5	5.6	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	61.3	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CNR1	"CANN6, CB-R, CB1, CB1A, CB1K5, CNR"	ENSG00000118432	"Cannabinoid receptor 1"	P21554	6	88139864-88166359	"Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 23.0;brain: 25.1"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 44.6;Inhibitory neurons: 200.3;Sertoli cells: 98.6"	"Cancer enriched"	"Detected in many"	13	"glioma: 12.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"ASC diff: 81.4;HSkMC: 53.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042256, HPA069945"	Enhanced	Supported	Supported	"Plasma membrane,Actin filaments"		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane"	"Actin filaments"	"HPA042256: AB_2677917, HPA069945: "	"unprognostic (1.28e-1)"	"unprognostic (7.04e-2)"	"unprognostic (4.61e-2)"	"unprognostic (4.08e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.07e-3)"	"unprognostic (1.37e-1)"	"unprognostic (2.07e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.16e-2)"	"unprognostic (2.74e-2)"	"unprognostic (2.68e-1)"	"unprognostic (1.70e-1)"	"unprognostic (5.59e-3)"	"unprognostic (2.68e-3)"	"unprognostic (5.88e-2)"	"unprognostic (7.00e-2)"	23.0	5.4	10.4	3.5	25.1	0.7	16.9	7.5	22.8	5.7	0.0	12.3	1.1	6.9	2.6	2.4	11.2	2.0	1.0	19.5	11.8	0.9	0.1	4.0	4.4	9.9	1.1	3.8	1.5	0.5	20.7	3.1	0.5	2.9	2.9	1.5	2.6	2.1	2.4	3.8	10.5	3.6	0.0	1.7	4.3	1.2	18.0	1.3	5.1	1.2	6.6	4.1	5.1	3.0	0.0	0.1	3.8	0.0	81.4	9.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	6.0	0.0	0.0	0.0	0.2	1.9	2.9	0.0	5.3	0.0	0.0	53.8	0.0	0.0	0.1	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.4	0.5	0.0	6.8	0.0	1.7	0.1	0.0	0.0	0.0	0.3	0.0	1.4	4.9	0.0	0.0	0.1	0.0	0.0	1.6	7.1	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	10.4	25.1	7.5	22.8	19.5	11.8	9.9	1.1	0.5	0.0	18.0	3.0	3.4	0.0	10.4	3.6	7.1	0.6	0.5	0.0	0.0	1.7	0.1	0.4	0.9	1.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.2	0.0	0.4	3.8	0.0	0.0	44.6	0.0	0.0	0.9	1.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	200.3	0.0	0.0	0.3	0.8	0.0	1.5	0.2	0.0	5.6	0.0	0.0	0.0	9.0	3.2	0.0	0.1	0.4	4.2	0.0	0.0	0.0	0.0	0.2	98.6	6.4	12.4	0.0	0.5	0.2	0.1	0.1	0.5	0.0	0.0	0.8
RNGTT	"hCAP, HCE, HCE1"	ENSG00000111880	"RNA guanylyltransferase and 5'-phosphatase"	O60942	6	88609897-88963618	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction, mRNA capping, mRNA processing"	"Hydrolase, Multifunctional enzyme, Nucleotidyltransferase, Protein phosphatase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 108.6;Inhibitory neurons: 110.2;Oligodendrocyte precursor cells: 96.5;Oligodendrocytes: 94.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003750	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 34: Non-specific - Transcription"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 57: B-cells - Immune response"	Nucleoplasm		"HPA003750: AB_1856383"	"unprognostic (5.19e-3)"	"unprognostic (1.00e-1)"	"unprognostic (2.82e-2)"	"unprognostic (3.45e-3)"	"unprognostic (4.82e-2)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (1.37e-4)"	"unprognostic (4.48e-3)"	"unprognostic (1.28e-1)"	"unprognostic (4.05e-3)"	"unprognostic (3.76e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.23e-3)"	"unprognostic (9.83e-2)"	"unprognostic (6.55e-2)"	"unprognostic (1.67e-1)"	"unprognostic (8.08e-3)"	5.3	6.7	4.9	8.2	4.9	9.5	5.6	9.1	5.7	5.2	2.6	4.6	4.2	5.2	3.6	7.2	4.1	3.7	5.3	5.1	7.0	5.3	6.9	4.4	17.2	4.6	5.2	4.8	2.9	6.4	4.9	5.0	5.1	5.3	5.4	10.6	3.5	4.9	5.2	4.4	5.2	6.1	4.6	7.6	4.2	9.3	7.3	14.7	5.6	6.4	17.3	6.2	4.8	5.3	9.2	14.0	21.1	26.2	12.0	12.6	12.4	20.2	13.4	16.4	20.4	15.9	6.8	23.1	16.2	14.9	21.5	11.1	24.7	16.5	29.7	31.8	19.0	30.5	11.4	12.2	9.5	33.2	16.6	7.7	13.8	16.8	15.9	13.6	14.7	12.7	30.9	18.1	23.8	12.0	14.6	22.8	12.5	15.0	11.7	28.6	32.0	13.3	14.0	14.2	12.3	17.3	16.8	9.8	11.1	19.7	10.8	31.8	11.5	13.0	12.0	14.7	27.9	16.1	31.6	13.2	18.9	23.8	24.1	5.2	4.1	7.6	7.8	5.9	7.8	22.9	8.6	9.7	5.8	22.8	9.7	10.1	3.4	10.9	5.5	4.0	9.0	5.4	4.9	4.9	9.1	5.7	5.1	7.0	4.6	5.2	5.1	4.6	7.3	5.3	8.9	0.0	16.2	54.5	60.4	8.3	10.7	6.0	10.8	22.4	6.5	6.1	10.7	7.2	12.9	12.9	39.6	10.4	19.7	8.0	0.0	6.3	17.9	7.9	12.1	7.0	9.1	7.6	108.6	4.9	9.9	9.7	15.8	12.4	8.8	11.0	7.5	10.3	7.8	15.2	110.2	7.0	4.1	9.1	7.3	5.2	5.9	13.6	3.6	69.3	9.8	7.2	18.6	96.5	94.3	7.2	5.1	7.9	42.3	8.6	4.6	6.3	10.1	43.4	6.6	15.8	9.5	23.3	20.1	10.7	8.7	11.8	24.6	8.0	6.7	7.4
PNRC1	"B4-2, PROL2, PRR2"	ENSG00000146278	"Proline rich nuclear receptor coactivator 1"	Q12796	6	89080751-89085160	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Langerhans cells: 1848.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HHSteC: 212.8;hTCEpi: 234.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029839, HPA066513"	Approved		Approved	Nucleoplasm,Nucleoli		NA	Yes			"Cluster 52: Eosinophils - Transcription"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 41: Macrophages - Immune response"	"Nucleoplasm, Nucleoli"		"HPA029839: AB_10601247, HPA066513: AB_2685684"	"unprognostic (9.02e-3)"	"unprognostic (7.65e-2)"	"unprognostic (3.01e-2)"	"unprognostic (2.31e-2)"	"unprognostic (6.10e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.78e-1)"	"unprognostic (5.20e-2)"	"unprognostic (5.28e-3)"	"unprognostic (1.96e-2)"	"unprognostic (6.29e-2)"	"prognostic unfavorable (6.88e-6)"	"unprognostic (8.63e-3)"	"unprognostic (2.05e-1)"	"unprognostic (1.03e-1)"	"unprognostic (5.09e-2)"	232.7	171.7	61.6	145.9	66.3	368.1	135.4	84.0	67.5	93.8	47.9	158.4	70.2	100.6	80.4	91.4	204.4	139.3	132.5	58.3	74.2	103.5	318.1	159.6	134.1	87.7	65.7	222.5	89.2	86.8	78.5	122.6	73.0	95.0	77.5	129.8	91.9	84.3	460.6	147.5	94.3	130.3	69.5	139.6	104.6	50.1	57.4	165.9	105.6	163.4	111.2	141.4	98.5	80.4	12.1	12.0	25.3	42.4	96.7	166.6	16.9	16.0	110.6	29.5	69.0	10.2	34.5	25.9	71.2	19.4	116.3	40.5	13.3	23.9	45.6	31.8	36.3	4.7	69.8	31.9	212.8	25.0	57.9	117.6	234.4	19.6	90.1	107.9	49.4	30.3	4.1	81.0	33.3	11.5	6.8	124.7	7.0	13.9	23.1	29.1	30.0	21.5	70.2	21.1	15.7	42.2	40.3	56.3	44.0	73.6	27.9	119.4	44.8	23.1	13.2	16.2	5.9	118.3	64.0	9.0	46.3	20.6	14.9	32.8	17.3	103.8	18.3	19.0	19.0	20.7	22.1	19.7	11.3	23.0	24.9	25.9	100.9	19.2	17.9	18.7	19.0	10.5	61.6	66.3	84.0	67.5	58.3	74.2	87.7	65.7	73.0	69.5	57.4	80.4	405.7	141.1	149.8	36.2	747.6	968.9	776.8	98.9	1286.2	130.6	412.5	381.5	188.6	230.2	65.2	90.1	50.1	235.8	662.8	158.1	234.8	203.5	103.4	528.4	655.3	356.1	248.0	284.1	10.0	238.2	78.6	720.1	225.8	955.1	164.6	153.2	238.5	207.6	229.4	72.3	15.5	200.7	34.6	452.6	1848.0	41.5	481.9	898.3	439.4	39.4	763.5	403.3	440.8	20.1	41.5	143.0	184.6	377.3	530.6	738.5	211.1	319.2	61.5	134.8	420.7	731.3	725.6	51.9	64.6	840.2	1250.8	274.5	735.8	214.3	136.9	472.8
SRSF12	"SFRS13B, SFRS19, SRrp35"	ENSG00000154548	"Serine and arginine rich splicing factor 12"	Q8WXF0	6	89095959-89118071	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"testis: 11.4"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 162.1;Late spermatids: 214.0;Spermatocytes: 65.7;Spermatogonia: 42.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 9.3;AN3-CA: 9.5;HAP1: 7.5;HEK 293: 7.6;REH: 7.6;SCLC-21H: 8.1;SH-SY5Y: 7.9;SuSa: 5.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049782	Approved					NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 12: NES - Nervous system development"	"Cluster 25: Spermatids - Spermatogenesis"			"HPA049782: AB_2680880"	"unprognostic (6.18e-2)"	"unprognostic (1.23e-1)"	"unprognostic (7.66e-3)"	"unprognostic (1.58e-4)"	"unprognostic (4.19e-1)"	"unprognostic (5.21e-2)"	"unprognostic (1.11e-3)"	"unprognostic (4.17e-2)"	"unprognostic (9.53e-2)"	"unprognostic (2.69e-2)"	"unprognostic (1.09e-4)"	"unprognostic (2.83e-1)"	"unprognostic (9.34e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.78e-2)"	"unprognostic (2.04e-1)"	"unprognostic (9.96e-3)"	0.4	0.4	3.1	0.6	3.7	0.4	0.5	4.4	3.3	1.0	0.3	0.6	0.1	0.8	0.6	0.2	0.8	0.9	0.4	3.7	4.3	1.7	0.3	0.4	0.2	2.0	2.6	1.6	0.6	1.5	2.5	0.3	2.3	1.0	0.1	2.4	0.3	0.7	0.2	0.3	0.2	0.9	2.2	0.1	0.4	11.4	4.3	0.4	1.3	0.1	0.2	0.7	0.5	2.3	0.0	0.8	9.3	9.5	0.0	0.0	0.0	0.0	0.1	0.5	1.0	0.2	0.1	0.0	0.8	0.0	0.3	0.0	7.5	0.2	1.0	0.1	7.6	0.0	0.1	0.6	1.0	0.0	0.0	0.1	0.4	0.2	0.5	0.0	0.0	0.7	0.1	0.2	0.2	0.1	0.0	0.3	2.1	0.0	0.2	7.6	0.5	0.1	4.6	0.0	8.1	7.9	0.2	0.1	1.4	5.5	0.0	2.3	0.0	0.1	0.2	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.4	0.2	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.1	0.5	0.0	0.1	0.0	0.0	3.1	3.7	4.4	3.3	3.7	4.3	2.0	2.6	2.3	2.2	4.3	2.3	0.6	0.0	1.1	9.1	0.8	1.0	3.9	1.0	0.6	9.7	1.4	1.5	3.3	0.0	0.2	0.0	8.4	0.8	1.5	0.1	1.9	5.4	162.1	1.9	4.3	1.2	0.0	0.0	20.1	3.2	0.5	2.5	2.6	3.9	0.0	2.9	0.0	0.2	0.3	0.0	18.9	0.0	0.0	0.0	0.4	214.0	3.4	1.0	3.6	1.9	6.2	6.6	0.0	14.6	3.4	3.3	0.0	2.6	0.7	4.7	0.0	3.6	0.0	1.3	6.6	4.5	2.7	65.7	42.6	1.1	0.6	0.3	1.5	0.3	0.0	1.6
PM20D2	"ACY1L2, bA63L7.3"	ENSG00000146281	"Peptidase M20 domain containing 2"	Q8IYS1	6	89146055-89165565	"Enzymes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Daudi: 88.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030325, HPA030326, HPA030327"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 52: Non-specific - Ribosome"	"Cluster 32: U-937 - Innate immune response"	"Cluster 37: Myocytes - Muscle contraction"	Nucleoplasm		"HPA030325: , HPA030326: AB_2673429, HPA030327: AB_10603129"	"unprognostic (3.60e-2)"	"unprognostic (1.40e-1)"	"unprognostic (6.36e-2)"	"unprognostic (3.18e-3)"	"unprognostic (3.22e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.13e-3)"	"unprognostic (8.60e-2)"	"unprognostic (1.04e-1)"	"unprognostic (5.86e-2)"	"unprognostic (2.27e-2)"	"unprognostic (1.04e-1)"	"unprognostic (9.99e-2)"	"unprognostic (6.84e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.31e-1)"	5.4	6.0	4.5	8.6	4.8	9.2	9.4	7.3	5.2	9.4	10.1	13.6	8.8	11.8	8.2	8.9	12.9	6.5	8.2	4.5	6.1	9.2	4.8	4.9	11.2	4.6	4.0	22.3	10.7	9.2	8.2	4.8	3.3	25.4	10.1	14.1	7.8	8.5	29.1	12.6	8.9	10.4	3.4	6.1	8.5	3.0	5.9	13.6	12.5	16.3	10.8	10.9	8.1	3.9	30.7	13.4	11.8	18.3	3.8	2.3	0.8	15.1	15.0	22.1	28.2	15.7	14.6	88.3	18.0	3.3	18.8	11.5	24.3	12.1	49.9	27.8	30.8	18.0	8.0	14.9	4.2	52.4	13.9	3.8	8.8	8.4	17.7	18.0	5.4	26.2	7.0	46.3	6.9	4.7	33.3	41.3	4.8	26.4	13.2	54.5	58.5	65.1	24.8	5.7	33.1	23.0	9.1	14.5	15.1	15.3	0.1	45.5	8.8	0.4	13.3	4.6	32.0	24.5	38.3	19.0	6.1	44.3	2.1	0.8	0.3	1.2	0.7	0.2	1.2	1.5	0.9	1.3	0.6	1.0	1.4	1.2	1.0	1.9	0.2	0.9	0.1	0.6	4.5	4.8	7.3	5.2	4.5	6.1	4.6	4.0	3.3	3.4	5.9	3.9	7.3	9.6	10.3	21.5	14.3	30.2	23.8	7.4	17.1	28.5	21.6	16.5	23.4	27.1	11.5	16.5	31.3	2.8	7.1	6.8	5.9	11.9	5.5	15.1	13.6	8.8	10.8	18.3	29.5	10.4	2.4	12.0	15.3	20.6	6.3	17.3	8.9	9.2	3.4	8.4	38.9	21.4	6.1	6.7	17.9	9.0	24.5	6.8	17.8	26.2	14.6	11.1	4.1	32.2	27.3	18.1	7.9	19.2	15.5	44.4	5.2	15.6	12.2	24.3	6.6	26.9	20.3	5.3	6.6	24.4	31.7	1.2	10.5	5.3	28.4	17.4
GABRR1		ENSG00000146276	"Gamma-aminobutyric acid type A receptor subunit rho1"	P24046	6	89177504-89231278	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in single"	25	"retina: 24.6"	"Cell type enriched"	"Detected in some"	12	"Bipolar cells: 63.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"NTERA-2: 1.2;OE19: 2.6;SuSa: 1.6"	"Region enhanced"	"Detected in single"		"midbrain: 1.3"											NA	NA				"Cluster 79: Retina - Phototransduction"	"Cluster 21: OE19 - Mitochondria"	"Cluster 56: Bipolar cells - Visual perception"				"unprognostic (5.75e-2)"	"unprognostic (3.92e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.90e-2)"	"unprognostic (5.78e-2)"	"unprognostic (4.90e-2)"		"unprognostic (8.32e-3)"	"unprognostic (2.52e-3)"	"unprognostic (1.74e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.62e-5)"	"unprognostic (1.18e-1)"	"unprognostic (9.90e-2)"	"unprognostic (2.12e-2)"	"unprognostic (2.29e-1)"	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	24.6	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.6	0.0	0.3	0.1	0.0	0.0	63.1	0.0	0.0	0.3	0.0	0.0	0.0	4.2	0.4	0.0	0.0	0.0	0.0	2.3	0.0	0.1	0.1	0.0	0.0	4.7	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	5.0	4.2	0.0	0.0	0.0	0.3	1.1	0.0	0.0	0.0	1.9	0.0	0.6	0.0	3.5	3.5	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	4.5	0.0	0.0	0.4	0.0	1.8	0.0	0.0	0.3	0.0	0.0	0.0	0.2
GABRR2		ENSG00000111886	"Gamma-aminobutyric acid type A receptor subunit rho2"	P28476	6	89254464-89315299	"Predicted membrane proteins"	"Ion transport, Transport"	"Chloride channel, Ion channel"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	25	"retina: 31.4"	"Cell type enriched"	"Detected in some"	18	"Bipolar cells: 30.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Karpas-707: 2.2;U-266/70: 5.1;U-266/84: 1.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"									NA	NA				"Cluster 79: Retina - Phototransduction"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 56: Bipolar cells - Visual perception"				"unprognostic (2.05e-2)"	"unprognostic (1.47e-4)"	"unprognostic (1.56e-1)"	"unprognostic (1.88e-4)"	"unprognostic (4.19e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.24e-2)"	"unprognostic (9.13e-2)"	"unprognostic (2.87e-1)"	"unprognostic (1.10e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.54e-6)"	"unprognostic (3.69e-2)"	"unprognostic (7.81e-2)"	"unprognostic (5.79e-2)"	"unprognostic (7.15e-3)"	0.4	0.3	0.5	1.2	0.4	0.7	0.2	0.7	0.6	0.2	0.3	0.3	0.7	0.5	0.4	0.1	0.1	0.3	0.2	0.4	0.3	0.4	0.1	0.3	0.8	0.5	0.6	0.2	0.1	0.0	0.0	0.3	0.5	0.3	0.4	31.4	0.3	0.2	0.8	0.3	0.7	0.3	0.3	0.8	0.3	0.2	0.6	1.2	0.3	0.2	0.6	0.2	0.0	0.8	0.0	0.0	0.2	0.3	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.4	1.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.5	0.5	0.0	0.2	0.1	0.3	0.0	0.0	0.0	0.0	0.6	0.1	0.2	0.0	2.2	0.0	0.0	0.1	0.4	0.0	0.1	0.0	0.3	0.1	0.8	0.1	0.0	0.2	0.1	0.0	0.0	0.3	0.6	0.0	0.7	0.1	0.2	0.1	0.0	0.3	5.1	1.4	0.2	0.2	0.1	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.3	0.1	0.0	0.1	0.0	0.0	0.5	0.4	0.7	0.6	0.4	0.3	0.5	0.6	0.5	0.3	0.6	0.8	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	30.9	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.1	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.7	0.7	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	1.0	0.0	0.3	0.0	1.0	0.4	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.8	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
UBE2J1	"CGI-76, HSPC153, NCUBE1, UBC6"	ENSG00000198833	"Ubiquitin conjugating enzyme E2 J1"	Q9Y385	6	89326625-89352722	"Enzymes, Metabolic proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"Early spermatids: 498.7;Late spermatids: 1426.6;Plasma cells: 1003.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 294.1;Karpas-707: 247.4;U-266/70: 274.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003509, CAB073419"	Enhanced					NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"			"CAB073419: , HPA003509: AB_1858531"	"unprognostic (1.82e-1)"	"unprognostic (3.20e-2)"	"unprognostic (1.55e-3)"	"prognostic favorable (2.87e-4)"	"unprognostic (3.41e-1)"	"unprognostic (7.93e-3)"	"prognostic unfavorable (6.90e-5)"	"unprognostic (1.19e-1)"	"unprognostic (9.36e-2)"	"prognostic favorable (7.43e-4)"	"unprognostic (1.74e-1)"	"unprognostic (9.33e-2)"	"prognostic unfavorable (1.11e-4)"	"unprognostic (5.11e-2)"	"unprognostic (2.83e-1)"	"unprognostic (3.87e-2)"	"unprognostic (9.38e-2)"	25.9	23.2	14.9	52.3	15.9	119.3	31.4	16.8	18.8	33.3	15.0	48.9	55.0	27.8	28.6	23.2	20.9	26.6	14.7	15.2	16.5	22.0	26.9	29.9	90.5	16.9	17.8	23.7	32.0	21.8	12.9	33.3	17.1	42.3	49.6	19.4	44.7	21.2	12.0	14.3	45.9	30.2	16.9	43.7	49.1	24.6	16.2	57.8	31.9	15.6	97.1	36.7	14.5	18.3	38.8	13.4	36.3	46.5	37.0	47.8	0.2	60.4	53.4	36.7	40.0	21.9	23.7	294.1	32.9	63.0	30.6	15.3	23.9	35.1	59.4	41.6	37.0	53.6	16.1	36.0	98.2	68.2	33.4	36.7	34.4	30.8	52.1	48.9	83.1	34.7	43.9	247.4	43.4	23.8	28.5	52.1	12.5	27.3	19.0	110.1	46.5	143.6	46.2	26.9	18.3	36.7	25.6	55.7	56.9	52.2	22.0	149.3	56.1	20.2	19.1	36.3	47.0	274.1	146.1	80.0	40.3	48.3	34.4	24.6	13.5	24.7	6.2	22.0	7.2	37.5	8.2	7.6	12.4	29.6	7.6	7.0	30.7	12.8	37.4	45.5	13.0	13.3	14.9	15.9	16.8	18.8	15.2	16.5	16.9	17.8	17.1	16.9	16.2	18.3	65.3	16.0	33.9	18.6	185.6	24.9	60.0	39.1	31.3	34.6	39.5	29.5	9.7	30.0	38.5	20.2	29.2	89.7	136.8	71.0	50.9	60.5	498.7	35.6	50.3	104.6	77.3	34.7	26.9	101.4	91.8	60.0	72.9	50.2	25.3	27.1	99.2	45.5	75.8	23.5	28.9	80.3	42.7	107.7	53.0	1426.6	54.7	105.5	72.9	23.4	65.4	18.6	30.9	26.2	31.0	112.0	74.3	47.8	1003.3	99.5	72.4	49.2	33.4	16.0	32.9	54.3	61.1	22.5	20.5	54.4	34.7	129.4	52.3	32.6	65.0	123.7
RRAGD	"bA11D8.2.1, DKFZP761H171"	ENSG00000025039	"Ras related GTP binding D"	Q9NQL2	6	89364616-89412273	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 84.5"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 129.1;Distal tubular cells: 117.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 3.3"	"Group enriched"	"Detected in many"	7	"granulocytes: 3.3;monocytes: 2.4"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 63.9;SCLC-21H: 33.1;U-266/70: 80.0;U-266/84: 39.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA068664	Approved		Approved	Nucleoplasm,Vesicles,Centrosome		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm	"Vesicles, Centrosome"	"HPA068664: AB_2686016"	"unprognostic (3.06e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.53e-3)"	"unprognostic (1.09e-1)"	"unprognostic (2.03e-1)"	"unprognostic (2.09e-1)"	"prognostic unfavorable (7.80e-4)"	"unprognostic (3.75e-2)"	"unprognostic (1.66e-2)"	"unprognostic (4.33e-2)"	"unprognostic (1.11e-2)"	"unprognostic (1.00e-1)"	"prognostic favorable (8.47e-8)"	"unprognostic (8.41e-3)"	"unprognostic (1.23e-1)"	"unprognostic (9.46e-2)"	"unprognostic (4.40e-2)"	9.8	9.1	14.0	2.3	18.9	11.6	8.2	31.8	16.1	9.4	17.9	4.0	1.7	1.5	6.9	13.8	13.7	3.6	38.4	15.9	13.9	26.5	4.4	7.0	2.8	16.4	12.2	1.6	6.4	22.7	11.4	3.2	17.2	6.1	1.8	21.8	52.2	2.8	84.5	6.7	2.0	2.1	21.5	4.8	1.7	6.9	14.8	5.5	28.1	60.3	2.5	5.8	6.2	23.8	0.1	1.7	4.4	3.3	0.4	0.0	0.3	0.0	0.0	0.5	0.9	0.1	0.1	0.0	1.5	0.0	22.6	0.1	24.5	0.1	0.0	0.0	12.1	5.8	0.1	0.1	1.8	16.9	19.0	0.4	1.5	0.0	0.1	0.0	0.0	16.9	0.5	63.9	0.1	1.8	8.2	8.4	3.6	0.0	1.8	16.8	23.1	0.2	5.8	0.6	33.1	1.8	0.6	2.2	28.8	1.3	0.7	13.2	0.0	1.8	2.8	11.5	3.0	80.0	39.8	0.0	6.1	12.5	1.9	2.6	0.6	1.4	0.0	0.5	0.0	0.0	0.2	0.0	0.4	0.0	0.1	0.3	3.3	0.1	2.4	0.3	0.0	0.1	14.0	18.9	31.8	16.1	15.9	13.9	16.4	12.2	17.2	21.5	14.8	23.8	1.4	9.6	16.7	5.2	3.7	16.2	17.0	5.8	4.0	21.7	17.4	9.7	129.1	17.2	13.9	14.7	31.3	0.6	4.7	0.1	117.4	20.2	25.6	10.4	2.5	4.8	1.2	5.0	17.6	16.9	1.5	10.0	1.1	15.0	4.5	2.9	2.5	9.7	51.9	47.1	20.6	0.5	42.7	25.8	9.2	15.5	3.1	23.2	39.2	3.7	10.4	29.6	0.0	13.0	17.2	8.1	0.0	4.1	8.0	28.4	0.0	18.6	19.4	16.3	0.0	11.8	7.0	21.7	30.3	32.4	22.6	0.7	3.9	0.2	0.2	30.2
ANKRD6	KIAA0957	ENSG00000135299	"Ankyrin repeat domain 6"	Q9Y2G4	6	89433152-89633834	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 26.7"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 35.3;Granulosa cells: 53.9;Inhibitory neurons: 54.3;Oligodendrocyte precursor cells: 32.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 15.1;BEWO: 44.9;HAP1: 15.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020693, HPA035694, HPA064642"	Approved		Enhanced	Vesicles		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 40: Granulosa cells - Unknown function"	Vesicles		"CAB020693: , HPA035694: AB_2674739, HPA064642: AB_2685310"	"unprognostic (3.80e-1)"	"unprognostic (3.16e-2)"	"unprognostic (2.39e-3)"	"unprognostic (2.03e-1)"	"unprognostic (1.36e-1)"	"unprognostic (3.06e-2)"	"unprognostic (2.91e-2)"	"unprognostic (3.29e-2)"	"unprognostic (4.95e-2)"	"unprognostic (2.09e-1)"	"unprognostic (7.84e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.43e-3)"	"unprognostic (2.28e-1)"	"unprognostic (3.01e-1)"	"unprognostic (2.10e-1)"	3.5	1.8	15.3	2.6	16.5	1.4	3.6	24.7	14.8	5.0	10.5	2.8	0.7	5.2	1.8	4.1	9.1	4.7	7.8	13.6	17.6	4.9	4.1	4.9	2.3	11.2	9.7	12.8	3.8	6.5	3.4	3.7	9.5	2.6	0.9	3.0	5.1	1.7	3.8	1.6	1.5	4.0	8.8	1.8	2.2	5.3	26.7	3.8	4.7	3.1	1.7	3.5	2.8	6.7	0.0	2.0	15.1	6.6	0.1	0.7	44.9	0.2	0.2	0.1	1.0	0.5	1.2	0.0	1.5	0.0	7.0	0.0	15.2	8.2	0.6	0.1	10.0	5.5	0.0	0.5	0.2	0.0	2.0	1.0	2.3	0.0	0.0	0.0	1.6	1.4	0.4	3.6	0.0	1.9	0.2	0.6	4.4	0.6	1.5	5.7	0.0	0.0	2.9	8.0	9.5	3.6	1.2	10.7	4.6	9.0	3.1	3.5	0.0	2.3	0.9	0.2	1.3	0.5	0.1	0.0	0.4	0.0	1.8	0.0	0.1	0.9	0.2	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.0	15.3	16.5	24.7	14.8	13.6	17.6	11.2	9.7	9.5	8.8	26.7	6.7	6.8	16.0	19.4	35.3	1.6	0.9	5.6	4.7	10.2	0.9	4.4	4.6	5.7	11.5	6.4	1.8	12.5	3.6	1.3	0.1	11.7	5.9	2.6	12.0	2.9	5.7	1.8	1.7	23.8	11.2	10.8	7.2	5.6	3.9	10.8	53.9	5.0	2.8	2.6	0.0	54.3	0.0	8.2	2.6	2.1	6.1	9.6	2.5	3.6	25.3	2.9	7.2	3.1	32.6	6.6	5.1	0.1	27.8	4.0	2.5	0.0	4.1	8.2	1.7	6.6	3.4	5.2	5.3	5.3	4.3	1.1	1.9	1.5	4.3	0.0	4.9
LYRM2	DJ122O8.2	ENSG00000083099	"LYR motif containing 2"	Q9NU23	6	89568144-89638749	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA063932	Uncertain		Approved	Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 39: Non-specific - Basic cellular processes"	Cytosol		"HPA063932: AB_2685155"	"unprognostic (3.23e-2)"	"unprognostic (1.47e-1)"	"unprognostic (8.52e-3)"	"unprognostic (8.49e-2)"	"unprognostic (4.27e-2)"	"unprognostic (6.26e-2)"	"prognostic unfavorable (2.58e-8)"	"unprognostic (1.46e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.29e-3)"	"unprognostic (8.07e-3)"	"unprognostic (3.63e-2)"	"unprognostic (7.98e-2)"	"unprognostic (3.70e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.23e-2)"	"unprognostic (5.64e-2)"	10.7	15.9	11.6	10.3	12.3	14.8	14.1	11.2	12.3	9.4	9.1	13.7	8.6	11.1	14.3	12.3	13.4	10.2	17.4	12.5	12.4	17.4	12.4	10.1	12.8	11.2	11.9	9.9	10.5	22.5	10.7	13.9	11.1	13.2	16.1	9.0	9.8	8.6	21.3	6.2	9.5	11.9	12.5	9.0	13.0	8.7	12.5	9.2	25.2	16.9	10.9	10.7	6.6	12.7	18.4	9.6	32.1	19.7	16.0	24.0	12.8	31.3	22.2	24.0	23.8	8.6	9.6	25.1	29.5	29.6	35.7	16.5	20.6	29.7	30.8	32.0	36.5	39.8	9.9	7.3	24.0	42.6	29.7	29.7	28.2	27.2	36.5	19.4	18.8	27.0	41.8	32.0	27.9	16.5	10.0	15.3	7.6	14.9	12.5	20.7	40.1	18.9	27.2	18.1	35.7	24.2	18.3	11.1	31.1	14.6	15.8	43.0	30.2	15.0	13.2	27.4	44.0	22.9	35.1	13.0	31.6	30.3	28.9	16.4	21.0	14.3	21.5	24.8	23.1	32.6	24.0	28.4	19.7	30.9	26.8	25.1	6.0	27.3	33.9	26.1	24.2	14.8	11.6	12.3	11.2	12.3	12.5	12.4	11.2	11.9	11.1	12.5	12.5	12.7	37.1	41.7	50.3	11.8	47.6	11.9	29.0	43.1	29.0	27.0	37.6	45.7	87.5	27.1	48.3	27.6	16.7	87.6	33.9	31.3	93.9	40.1	66.0	86.2	56.6	30.7	40.7	35.3	17.6	49.4	32.9	35.6	37.2	55.8	32.9	33.9	24.7	27.1	57.8	25.2	19.7	43.4	44.7	35.1	12.9	18.7	30.7	39.9	30.2	15.9	44.8	100.6	44.3	13.0	26.4	40.1	32.8	27.1	30.9	25.9	29.3	68.8	70.6	45.3	52.6	39.2	41.1	57.0	31.6	43.3	16.2	72.4	37.5	81.8	39.8	26.2
MDN1	"KIAA0301, Rea1"	ENSG00000112159	"Midasin AAA ATPase 1"	Q9NU22	6	89642498-89819794	"Plasma proteins, Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 82.5;Inhibitory neurons: 79.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"K-562: 24.7;NTERA-2: 22.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029666, HPA029667, HPA029668, HPA029669"	Uncertain		Approved	"Nucleoplasm,Nucleoli,Intermediate filaments,Cytosol"		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	"Nucleoli, Cytosol"	"Nucleoplasm, Intermediate filaments"	"HPA029666: AB_10600888, HPA029667: AB_10696207, HPA029668: AB_10669868, HPA029669: AB_10670429"	"unprognostic (2.00e-1)"	"unprognostic (4.46e-2)"	"unprognostic (7.62e-2)"	"unprognostic (2.26e-2)"	"unprognostic (6.14e-3)"	"unprognostic (3.46e-1)"	"unprognostic (6.68e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.51e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.77e-2)"	"unprognostic (9.07e-2)"	"unprognostic (2.54e-3)"	"unprognostic (6.28e-3)"	"unprognostic (9.22e-2)"	"unprognostic (2.02e-1)"	"unprognostic (6.09e-2)"	4.2	4.6	3.4	1.9	3.6	4.2	4.3	4.4	3.3	4.5	1.7	4.4	1.2	5.6	2.1	4.9	5.0	1.2	4.9	3.1	3.3	4.4	9.1	3.9	2.6	3.3	3.1	7.6	5.9	3.0	4.6	1.2	3.7	3.6	1.8	3.0	3.9	1.5	8.3	7.1	5.0	1.7	2.2	4.5	4.6	6.5	3.3	2.8	6.0	3.4	2.5	4.2	4.3	5.7	4.2	4.1	4.1	3.8	6.6	6.3	4.1	2.8	2.1	3.1	3.8	9.4	1.5	12.5	3.1	2.9	3.3	3.6	10.7	3.8	5.5	4.9	7.1	13.5	5.6	6.1	2.5	17.7	3.2	3.9	3.1	8.3	7.6	1.9	5.6	5.6	24.7	2.9	3.1	5.0	2.8	6.6	22.7	3.4	3.5	5.5	7.8	3.1	2.7	5.8	7.5	3.3	3.9	2.3	2.5	5.4	1.6	7.7	7.2	2.1	3.8	2.8	6.5	3.3	3.9	5.9	2.8	9.8	3.7	3.2	0.3	0.6	0.7	0.2	0.6	1.0	1.0	0.8	0.2	1.3	1.3	1.0	0.0	1.1	0.3	3.0	0.4	0.1	3.4	3.6	4.4	3.3	3.1	3.3	3.3	3.1	3.7	2.2	3.3	5.7	13.2	28.9	19.1	55.2	19.2	29.3	8.2	6.0	30.7	24.4	14.0	11.0	39.2	11.5	16.9	14.7	25.0	5.5	25.2	6.6	0.0	6.3	7.5	20.1	21.9	15.0	7.7	58.5	82.5	8.1	7.2	13.3	19.4	25.2	6.3	26.4	6.4	48.5	6.6	18.5	79.5	7.7	6.1	6.3	9.5	4.3	7.2	8.6	12.4	33.7	6.6	8.0	9.2	35.7	74.8	6.9	3.7	8.6	26.0	18.1	4.7	2.5	12.9	18.7	0.0	33.1	12.7	37.5	50.1	26.1	30.1	3.4	19.4	17.4	10.3	8.5
CASP8AP2	"CED-4, FLASH, FLJ11208, KIAA1315, RIP25"	ENSG00000118412	"Caspase 8 associated protein 2"		6	89829894-89874436	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in single"		"brain: 2.6"	"Cell type enhanced"	"Detected in many"		"Spermatogonia: 74.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053573			Approved	"Nucleoli,Nuclear bodies"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	"Nucleoli, Nuclear bodies"		"HPA053573: AB_2682194"	"unprognostic (7.80e-2)"	"unprognostic (1.47e-1)"	"unprognostic (6.05e-2)"	"unprognostic (1.84e-2)"	"unprognostic (2.64e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.75e-4)"	"unprognostic (4.58e-1)"	"unprognostic (4.36e-3)"	"unprognostic (2.20e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.91e-1)"	"prognostic unfavorable (1.88e-5)"	"unprognostic (2.35e-1)"	"unprognostic (1.63e-1)"	"unprognostic (4.16e-2)"	"unprognostic (3.53e-1)"	0.6	0.3	0.4	0.4	1.0	0.2	0.5	2.6	1.2	0.7	0.3	0.9	0.0	0.7	0.0	0.4	0.6	0.1	0.4	0.6	0.4	0.4	0.2	0.5	0.4	0.5	0.5	0.5	0.5	0.1	0.4	0.1	0.8	0.5	0.1	0.0	0.4	0.0	0.8	0.4	0.5	0.2	0.8	0.4	0.3	0.3	0.7	0.6	0.6	0.7	0.2	0.6	0.5	1.9	0.4	1.0	1.3	1.0	0.1	0.4	0.3	2.1	0.2	0.7	0.5	0.8	0.5	2.4	0.7	1.0	0.8	0.7	2.5	0.6	0.7	3.7	3.5	4.0	3.0	0.0	0.0	2.6	1.1	0.2	0.2	1.6	0.6	0.2	0.8	1.4	4.4	1.3	0.6	0.7	1.6	0.0	0.2	0.2	1.3	3.3	3.8	0.9	0.0	3.2	1.4	0.8	1.8	0.0	0.5	0.5	0.4	1.2	1.6	0.3	0.5	1.6	1.6	0.2	2.8	1.3	0.5	1.4	1.4	14.4	1.5	5.6	6.2	2.6	5.9	5.5	7.1	6.5	1.9	6.3	5.4	5.6	3.1	12.6	2.3	4.9	6.6	2.3	0.4	1.0	2.6	1.2	0.6	0.4	0.5	0.5	0.8	0.8	0.7	1.9	27.3	32.1	14.5	26.1	26.8	0.0	9.1	0.0	13.6	19.5	13.3	16.4	47.5	7.2	11.8	7.3	6.2	20.5	21.4	12.7	3.9	15.1	5.9	9.6	22.1	21.1	2.4	35.7	32.3	12.3	15.8	21.4	11.7	13.7	15.8	31.8	9.7	6.9	12.4	35.3	33.5	11.7	0.0	11.5	0.0	4.7	23.0	16.1	0.0	33.7	26.9	18.1	34.0	23.6	38.2	9.3	10.3	25.9	14.4	13.2	11.8	7.2	13.8	25.5	19.7	30.6	25.1	47.2	74.2	15.7	0.0	10.9	24.7	16.7	14.6	9.1
GJA10	CX62	ENSG00000135355	"Gap junction protein alpha 10"	Q969M2	6	89894469-89921760	"Predicted membrane proteins"				"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	92	"Horizontal cells: 18.5"	"Cancer enriched"	"Detected in single"	7	"testis cancer: 1.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA021145	Uncertain					NA	NA						"Cluster 62: Horizontal cells - Visual perception"			"HPA021145: AB_2670600"															"unprognostic (1.09e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
BACH2	BTBD25	ENSG00000112182	"BTB domain and CNC homolog 2"	Q9BYV9	6	89926528-90296908	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 11.7;lymphoid tissue: 17.0"	"Group enriched"	"Detected in many"	4	"Astrocytes: 81.3;B-cells: 93.1;Excitatory neurons: 95.2;Horizontal cells: 198.5;Inhibitory neurons: 293.9;Oligodendrocyte precursor cells: 169.9;Oligodendrocytes: 253.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"naive B-cell: 14.1"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"Daudi: 139.5;U-698: 78.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA051384, HPA058384"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	Cytosol	"HPA051384: AB_2681462, HPA058384: AB_2683700"	"unprognostic (4.00e-3)"	"unprognostic (3.17e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.47e-4)"	"unprognostic (1.49e-1)"	"unprognostic (2.29e-1)"	"unprognostic (3.42e-2)"	"unprognostic (8.92e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.06e-2)"	"unprognostic (3.12e-3)"	"unprognostic (4.22e-1)"	"unprognostic (9.87e-3)"	"unprognostic (2.10e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.03e-1)"	"unprognostic (3.87e-4)"	1.3	0.8	2.0	4.9	3.7	11.7	1.7	3.2	4.0	1.9	0.1	0.9	0.3	2.6	0.6	0.6	1.1	0.9	1.2	2.3	3.3	0.6	2.5	2.4	17.0	4.9	2.9	3.3	1.6	1.6	0.6	1.0	3.2	1.3	0.5	1.3	1.3	0.8	3.2	2.2	2.7	1.1	1.9	4.4	0.6	1.7	2.7	12.3	0.6	2.3	12.8	1.4	1.3	7.7	1.0	0.1	5.1	0.5	0.2	0.0	0.8	0.0	0.2	0.1	0.6	0.0	0.2	139.5	0.2	0.0	0.1	0.1	0.8	1.7	0.4	0.0	1.7	0.0	0.1	0.0	0.0	0.2	0.4	1.1	0.4	0.1	3.0	0.0	0.1	8.6	5.8	11.6	0.0	0.4	3.0	0.0	1.4	0.0	1.1	19.3	3.6	2.5	0.0	0.3	4.5	12.8	0.5	0.1	0.9	1.7	0.2	0.1	0.4	0.0	1.9	0.0	0.1	8.9	0.4	78.8	0.6	1.4	1.0	2.4	0.0	0.8	0.3	0.0	0.8	2.5	0.8	0.7	0.2	14.1	3.6	2.5	0.0	1.7	0.0	0.2	0.1	0.5	2.0	3.7	3.2	4.0	2.3	3.3	4.9	2.9	3.2	1.9	2.7	7.7	4.0	0.0	0.5	81.3	93.1	7.5	11.4	1.7	15.9	5.9	5.4	7.7	2.2	0.0	2.2	3.7	41.7	0.2	10.2	0.1	0.0	6.2	19.9	2.9	7.2	2.9	0.0	2.5	95.2	2.8	0.3	8.4	1.5	11.4	0.0	0.7	2.2	3.1	0.5	198.5	293.9	0.2	0.0	0.3	11.8	10.6	5.9	3.0	3.6	38.4	2.5	0.7	20.6	169.9	253.9	3.4	0.0	4.5	7.6	20.0	0.0	0.3	0.7	1.8	0.0	13.5	4.2	0.1	2.4	3.8	7.7	0.0	23.6	0.5	0.1	3.5
MAP3K7	"MEKK7, TAK1"	ENSG00000135341	"Mitogen-activated protein kinase kinase kinase 7"	O43318	6	90513573-90587072	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Apoptosis, Host-virus interaction, Stress response, Transcription, Transcription regulation"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 137.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007633, HPA075335"	Approved		Supported	"Nuclear speckles,Plasma membrane,Cytosol"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 21: Non-specific - Transcription"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Cytosol	"Nuclear speckles, Plasma membrane"	"HPA007633: AB_1079359, HPA075335: "	"unprognostic (1.48e-1)"	"unprognostic (3.45e-2)"	"unprognostic (1.35e-1)"	"unprognostic (6.48e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.84e-1)"	"prognostic unfavorable (3.51e-4)"	"unprognostic (9.77e-2)"	"unprognostic (6.51e-2)"	"unprognostic (1.98e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.79e-1)"	"unprognostic (2.56e-3)"	"unprognostic (4.76e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.17e-1)"	11.8	12.5	13.1	12.5	15.1	8.7	14.3	15.6	17.3	14.3	11.7	11.6	9.2	16.6	16.5	10.6	11.0	12.7	16.9	14.7	14.9	11.4	11.6	10.4	16.4	15.3	13.7	15.8	9.7	16.3	13.0	17.4	15.8	14.9	10.9	23.5	12.1	13.3	16.9	13.9	9.8	14.0	15.3	17.6	10.8	9.9	13.8	20.8	14.7	18.4	16.8	14.3	12.2	22.4	16.7	14.4	41.3	35.6	29.5	39.1	29.0	32.7	37.7	28.8	36.1	18.6	15.5	36.9	20.4	35.6	25.6	17.3	26.3	25.5	48.7	19.0	27.7	32.9	19.9	24.9	30.8	36.9	24.4	32.5	30.5	28.2	34.2	33.1	27.4	31.8	67.0	29.3	41.8	20.3	17.2	31.2	34.0	25.7	18.0	29.3	73.9	18.0	24.2	18.4	20.8	29.5	22.9	15.6	24.8	32.2	15.5	64.7	26.5	23.3	14.7	21.6	30.9	25.9	24.7	15.8	35.7	39.7	35.0	18.2	11.5	18.4	12.8	15.9	14.5	13.0	12.3	12.5	14.6	9.9	13.7	13.4	11.5	17.9	17.6	8.9	20.8	13.4	13.1	15.1	15.6	17.3	14.7	14.9	15.3	13.7	15.8	15.3	13.8	22.4	16.1	16.0	26.9	47.0	24.3	36.3	20.8	19.5	21.6	23.3	17.9	12.3	31.0	14.3	16.9	16.5	27.1	31.8	17.8	12.4	7.9	17.6	3.6	10.9	19.8	21.2	12.1	14.1	85.7	20.9	34.6	23.2	16.3	14.8	13.9	25.9	25.7	20.7	24.3	28.6	63.8	13.7	20.3	27.3	24.6	3.2	26.8	21.7	21.4	36.5	35.2	19.6	16.5	50.8	137.2	20.1	9.1	41.0	18.8	30.1	11.1	16.6	21.4	21.5	19.7	28.0	18.5	25.9	24.9	21.3	37.2	48.4	22.7	18.1	15.1	24.8
EPHA7	Hek11	ENSG00000135333	"EPH receptor A7"	Q15375	6	93240020-93419687	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Apoptosis, Neurogenesis"	"Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"intestine: 24.6;parathyroid gland: 69.9"	"Group enriched"	"Detected in some"	8	"Excitatory neurons: 138.6;Inhibitory neurons: 172.0"	"Cancer enhanced"	"Detected in many"		"renal cancer: 6.4"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"AF22: 12.0;HEK 293: 35.1;RH-30: 31.7;THP-1: 32.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB010496	Approved				"Intracellular and membrane"	NA	NA		660000		"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"CAB010496: AB_2099673"	"unprognostic (3.34e-1)"	"unprognostic (7.82e-2)"	"unprognostic (1.41e-1)"	"unprognostic (9.32e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.56e-2)"		"unprognostic (1.62e-2)"	"unprognostic (4.07e-1)"	"unprognostic (4.16e-2)"	"unprognostic (3.19e-2)"	"unprognostic (5.69e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.74e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.56e-2)"	"unprognostic (4.82e-2)"	0.3	0.0	1.2	0.4	3.4	0.0	1.2	3.4	5.1	1.4	0.0	24.6	1.5	0.9	0.2	0.2	0.5	2.2	3.6	4.9	2.6	5.9	0.0	0.2	0.0	1.2	2.2	1.9	0.1	69.9	1.2	0.4	1.5	9.7	2.5	1.8	5.4	0.9	0.1	0.2	4.4	2.1	0.4	3.9	10.3	0.9	0.6	0.0	0.1	0.1	0.0	8.2	1.8	1.2	0.0	0.5	12.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	35.1	0.0	3.0	0.0	0.0	0.0	0.0	0.5	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.6	0.0	1.0	5.4	31.7	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.1	0.0	32.6	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	3.4	3.4	5.1	4.9	2.6	1.2	2.2	1.5	0.4	0.6	1.2	0.2	0.0	0.0	4.2	0.0	0.4	0.4	0.0	0.6	18.5	3.1	1.8	17.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	13.1	1.3	1.4	1.8	0.0	0.0	138.6	0.0	0.0	5.9	0.0	3.8	0.0	3.7	0.0	0.0	0.1	11.8	172.0	0.0	0.0	0.0	0.4	3.3	0.9	0.1	0.0	11.2	0.0	0.4	0.0	4.5	8.3	0.1	0.0	0.0	0.0	0.4	0.0	11.8	0.0	1.0	0.0	0.2	0.5	0.2	1.1	0.2	1.0	0.0	0.2	0.9	0.0	0.1
MANEA	"FLJ12838, mandaselin"	ENSG00000172469	"Mannosidase endo-alpha"	Q5SRI9	6	95577535-95609452	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Hepatocytes: 59.8;Plasma cells: 113.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011046, HPA011069"	Enhanced		Supported	"Golgi apparatus"		NA	NA		140000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 55: Plasma cells - Humoral immune response"	"Golgi apparatus"		"HPA011046: AB_1079303, HPA011069: AB_1079304"	"unprognostic (6.00e-2)"	"unprognostic (7.81e-2)"	"prognostic favorable (3.04e-4)"	"unprognostic (1.17e-2)"	"unprognostic (1.11e-1)"	"unprognostic (5.03e-2)"	"unprognostic (2.98e-3)"	"unprognostic (2.74e-1)"	"unprognostic (5.71e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.44e-1)"	"unprognostic (9.07e-2)"	"unprognostic (2.86e-3)"	"unprognostic (5.18e-2)"	"unprognostic (3.08e-1)"	"unprognostic (9.68e-2)"	"unprognostic (7.47e-2)"	11.9	6.9	3.1	7.9	3.6	3.3	8.9	3.7	3.7	8.4	4.2	8.1	8.8	6.8	6.3	8.0	6.4	7.9	5.6	2.5	3.7	12.0	24.0	7.3	9.2	4.3	3.3	9.7	8.4	11.1	2.1	6.3	4.4	7.0	8.7	6.1	5.6	7.9	1.4	6.8	8.8	6.7	3.6	9.6	12.1	6.1	3.7	9.1	11.6	3.4	11.2	9.0	3.5	5.6	6.5	5.3	20.4	16.6	33.1	38.5	7.7	17.7	16.2	10.1	14.8	6.1	16.0	12.3	21.7	11.7	14.9	10.4	14.1	12.0	23.2	20.9	12.6	16.6	4.7	10.2	11.5	22.3	14.4	38.4	13.7	12.0	8.5	14.6	24.3	12.1	26.2	28.1	22.0	4.5	13.1	9.5	3.0	17.1	5.5	15.4	19.9	18.8	15.5	11.2	16.3	8.8	10.0	7.2	6.5	14.3	11.4	20.7	22.0	10.1	7.1	18.4	17.8	20.9	12.9	15.2	18.2	19.1	23.6	8.5	2.3	1.3	3.2	4.1	4.6	4.5	3.9	3.8	2.5	2.3	4.5	3.1	0.5	2.9	3.7	1.0	7.7	2.4	3.1	3.6	3.7	3.7	2.5	3.7	4.3	3.3	4.4	3.6	3.7	5.6	11.6	12.8	8.4	7.8	15.5	7.4	4.4	6.4	8.6	8.1	8.4	7.4	4.5	10.0	7.4	12.9	4.2	5.4	5.4	1.8	5.9	4.1	16.7	7.3	14.4	10.7	1.8	8.2	6.0	7.3	5.6	12.0	8.2	8.1	2.5	17.8	28.2	59.8	11.0	11.8	7.3	4.6	0.0	12.0	5.8	11.7	5.9	7.9	8.8	8.4	6.8	10.5	3.1	16.1	18.7	3.4	2.8	15.8	113.4	3.4	4.8	8.5	8.5	5.3	13.1	9.8	17.1	7.1	12.1	11.8	7.0	1.4	9.2	13.5	5.0	3.5
FUT9	Fuc-TIX	ENSG00000172461	"Fucosyltransferase 9"	Q9Y231	6	96015974-96215612	"Enzymes, Metabolic proteins, Predicted membrane proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 18.9;stomach 1: 23.2"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 776.4;Excitatory neurons: 333.5;Inhibitory neurons: 238.2;Oligodendrocyte precursor cells: 168.9;Oligodendrocytes: 224.7"	"Cancer enhanced"	"Detected in some"		"glioma: 1.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"MCF7: 2.9;OE19: 2.8;RT4: 6.5;SCLC-21H: 6.3;SK-BR-3: 3.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA070923			Approved	"Nucleoplasm,Microtubules,Cytokinetic bridge,Cytosol"		Yes	No				"Cluster 22: Non-specific - Unknown function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 64: Astrocytes - Nervous system maintenance"	Nucleoplasm	"Microtubules, Cytokinetic bridge, Cytosol"	"HPA070923: AB_2686323"	"unprognostic (1.60e-1)"	"unprognostic (2.48e-1)"		"unprognostic (5.99e-3)"	"unprognostic (1.33e-1)"	"unprognostic (2.40e-1)"		"unprognostic (2.97e-1)"		"unprognostic (1.35e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.12e-1)"	"unprognostic (6.43e-3)"	"unprognostic (5.60e-2)"	"unprognostic (1.65e-2)"	"unprognostic (3.03e-2)"	0.0	0.4	10.5	0.0	12.6	0.0	0.6	14.5	11.7	0.0	0.0	0.1	2.1	0.2	0.0	0.0	0.2	0.0	0.0	11.8	13.6	0.2	0.0	0.0	0.0	3.4	18.9	0.0	4.8	0.0	0.4	0.4	3.2	0.2	0.0	0.5	0.0	0.2	0.1	0.1	0.0	0.0	5.5	0.0	23.2	0.0	15.3	0.0	0.1	0.0	0.0	0.9	0.0	6.4	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	1.4	2.8	0.0	0.0	0.0	0.0	0.0	6.5	6.3	0.1	0.0	3.6	0.0	0.1	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.5	12.6	14.5	11.7	11.8	13.6	3.4	18.9	3.2	5.5	15.3	6.4	0.0	0.0	0.0	776.4	0.2	0.0	0.6	0.0	0.0	4.2	1.4	1.7	0.8	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.3	0.5	0.1	1.3	0.0	0.0	333.5	2.0	0.0	0.1	56.1	1.4	0.0	0.4	0.0	0.0	0.1	0.0	238.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.1	0.0	0.2	0.0	168.9	224.7	0.5	0.0	0.0	0.1	1.1	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.2	0.2	0.0	0.0	0.3	0.1	0.0	0.0	0.2
UFL1	"KIAA0776, Maxer, NLBP, RCAD"	ENSG00000014123	"UFM1 specific ligase 1"	O94874	6	96521595-96555276	"Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030558, HPA030559, HPA030560"	Enhanced		Supported	"Endoplasmic reticulum"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 55: Plasma cells - Humoral immune response"	"Endoplasmic reticulum"		"HPA030558: AB_10600663, HPA030559: AB_10600537, HPA030560: AB_10602000"	"unprognostic (5.40e-2)"	"unprognostic (7.48e-3)"	"unprognostic (1.06e-2)"	"unprognostic (1.99e-1)"	"unprognostic (8.12e-2)"	"unprognostic (9.04e-2)"	"unprognostic (9.99e-2)"	"unprognostic (4.67e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.50e-1)"	"unprognostic (4.46e-2)"	"unprognostic (4.10e-2)"	"unprognostic (5.92e-2)"	"unprognostic (8.65e-2)"	"unprognostic (4.46e-1)"	17.0	20.6	9.8	18.9	13.1	17.9	21.4	11.9	15.4	20.8	7.8	18.7	22.7	19.0	23.4	20.7	16.8	18.0	23.7	9.2	12.1	21.3	29.7	15.4	22.1	13.8	11.4	22.4	25.2	24.9	10.0	18.1	15.3	24.4	19.5	31.6	23.5	17.9	21.1	20.3	22.8	17.1	12.4	17.9	21.8	14.2	10.8	20.8	28.1	21.4	21.8	20.1	11.2	19.5	16.9	8.8	18.3	30.7	25.8	39.2	27.2	23.3	23.6	14.6	13.6	11.0	19.2	40.7	28.9	23.5	16.2	32.0	15.0	22.0	21.3	21.9	13.6	17.9	13.3	20.2	34.3	34.0	25.6	28.2	20.1	17.4	47.9	27.1	24.2	25.7	24.1	43.7	27.9	16.3	12.5	21.0	6.6	14.5	9.9	15.6	21.4	32.6	26.5	30.5	12.9	12.5	19.2	22.4	21.5	16.2	54.4	28.7	24.0	20.3	11.0	20.8	24.7	25.7	14.2	30.9	31.2	22.5	19.0	8.7	7.9	8.9	8.7	10.1	10.0	9.6	9.2	9.4	10.2	8.6	11.4	9.3	1.6	13.1	10.4	10.7	11.1	7.2	9.8	13.1	11.9	15.4	9.2	12.1	13.8	11.4	15.3	12.4	10.8	19.5	42.8	57.7	50.2	54.2	53.9	19.5	34.4	52.2	36.5	48.8	33.3	33.8	60.4	31.5	64.9	46.0	45.9	64.1	57.2	31.6	19.6	42.0	61.0	64.3	60.8	35.1	19.8	30.7	26.5	50.7	34.3	45.2	32.1	62.2	30.9	43.0	32.5	69.5	35.4	43.7	33.0	48.9	36.7	33.2	13.9	44.1	50.1	37.5	14.2	30.9	42.5	34.9	39.1	58.3	103.1	40.4	29.9	50.4	72.7	29.8	46.1	30.7	76.1	74.9	19.7	49.0	44.2	85.3	37.8	37.6	19.2	91.0	46.5	59.5	35.9	29.8
FHL5	"ACT, dJ393D12.2, FLJ33049"	ENSG00000112214	"Four and a half LIM domains 5"	Q5TD97	6	96562548-96616636	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 65.5"	"Group enriched"	"Detected in some"	20	"Early spermatids: 1160.3;Late spermatids: 1540.1"	"Cancer enhanced"	"Detected in many"		"renal cancer: 4.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	10	"ASC diff: 4.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"									NA	NA				"Cluster 71: Testis - DNA repair"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 34: Spermatids - Unknown function"				"unprognostic (6.56e-2)"	"unprognostic (9.97e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.22e-1)"	"prognostic favorable (4.81e-4)"	"unprognostic (4.93e-2)"	"unprognostic (1.91e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.46e-2)"	"unprognostic (6.56e-2)"	"unprognostic (1.84e-1)"	"unprognostic (9.30e-2)"	"unprognostic (1.71e-3)"	"unprognostic (1.11e-3)"	"unprognostic (1.18e-1)"	"unprognostic (2.22e-1)"	"unprognostic (3.48e-3)"	35.7	10.3	5.4	4.4	8.5	0.0	16.0	5.8	7.5	27.8	6.2	5.8	2.5	15.0	17.6	9.6	21.5	12.9	5.6	4.9	5.3	6.4	0.4	14.0	1.8	6.3	5.8	11.4	4.6	3.3	1.2	0.6	7.1	4.9	5.0	0.4	2.1	11.1	8.9	5.5	5.1	9.6	5.4	3.5	4.0	65.5	7.2	1.2	8.9	14.6	0.8	6.8	10.3	5.5	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	8.5	5.8	7.5	4.9	5.3	6.3	5.8	7.1	5.4	7.2	5.5	5.5	0.0	0.0	0.0	0.1	0.8	0.1	0.0	0.0	0.0	0.1	0.3	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1160.3	0.0	0.1	3.8	0.0	0.0	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.9	1540.1	52.5	1.1	5.4	8.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.9	0.0	0.2	0.0	0.0	0.0	0.0	52.6	1.9	67.4	13.2	4.4	0.0	0.3	0.0	0.6	0.1	0.0	0.2
GPR63	"PSP24(beta), PSP24B"	ENSG00000112218	"G protein-coupled receptor 63"	Q9BZJ6	6	96794125-96837477	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in some"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 31.4;Excitatory neurons: 46.2;Granulosa cells: 31.2;Inhibitory neurons: 20.3;Late spermatids: 35.2;Spermatocytes: 24.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 8.8;HHSteC: 13.5;Karpas-707: 20.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039103	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 65: Brain - Ion transport"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoplasm, Plasma membrane, Cytosol"		"HPA039103: AB_10672841"	"unprognostic (8.22e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.15e-1)"	"unprognostic (3.39e-1)"	"unprognostic (2.53e-2)"	"unprognostic (7.29e-3)"	"unprognostic (3.00e-1)"	"unprognostic (2.03e-3)"	"unprognostic (1.67e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.34e-1)"	"unprognostic (2.30e-2)"	0.5	0.9	1.4	0.7	3.5	0.1	0.4	0.7	2.7	1.5	2.7	1.2	1.5	0.5	0.3	0.5	0.7	0.7	0.5	1.5	0.1	0.3	0.0	0.3	0.1	1.6	0.6	1.0	1.4	1.0	0.9	0.7	2.0	0.9	1.8	0.2	0.4	0.5	0.2	0.4	1.1	0.6	0.0	0.3	1.1	2.4	0.9	0.6	0.6	0.1	0.2	0.8	1.4	1.8	0.0	0.1	1.6	0.4	2.3	0.8	0.4	1.0	0.0	0.0	0.2	0.2	1.2	0.1	0.0	0.1	1.3	1.2	5.4	2.5	0.0	8.8	4.1	5.2	0.4	0.0	13.5	3.3	0.6	2.5	0.4	0.0	3.7	0.3	0.0	7.6	3.8	20.8	0.5	0.4	2.5	0.0	5.4	0.0	0.7	0.0	1.9	4.3	0.3	0.2	2.4	1.5	0.3	3.3	0.6	1.7	1.3	0.7	0.0	1.4	2.1	0.2	2.0	1.6	0.9	0.1	0.8	2.0	1.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.4	0.2	0.0	0.1	0.0	0.0	1.4	3.5	0.7	2.7	1.5	0.1	1.6	0.6	2.0	0.0	0.9	1.8	0.6	0.0	0.0	2.3	0.2	1.9	0.7	0.3	4.0	1.5	0.6	0.9	0.7	2.8	0.1	1.8	0.0	0.2	0.3	0.1	0.0	0.4	31.4	0.1	0.5	0.7	3.0	0.4	46.2	0.9	0.7	2.5	1.1	0.1	0.0	31.2	1.1	0.0	0.2	0.0	20.3	0.5	0.0	0.0	8.9	35.2	3.4	0.4	1.8	9.4	0.1	0.2	0.0	11.6	4.8	0.4	0.1	4.9	1.0	1.1	0.1	0.2	0.0	0.2	0.0	0.4	2.2	24.6	10.5	1.9	0.3	0.1	0.4	2.1	0.5	0.3
NDUFAF4	"bA22L21.1, C6orf66, HRPAP20, HSPC125, My013"	ENSG00000123545	"NADH:ubiquinone oxidoreductase complex assembly factor 4"	Q9P032	6	96889315-96897891	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Host-virus interaction"	Calmodulin-binding	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 168.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046560	Uncertain		Supported	Mitochondria		NA	Yes			"Cluster 30: Non-specific - Translation"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA046560: AB_10966700"	"prognostic unfavorable (1.31e-4)"	"unprognostic (1.32e-1)"	"unprognostic (1.09e-2)"	"unprognostic (1.14e-3)"	"unprognostic (2.89e-1)"	"unprognostic (7.53e-3)"	"unprognostic (6.89e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.57e-2)"	"unprognostic (2.78e-2)"	"unprognostic (2.03e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.20e-3)"	"unprognostic (6.32e-2)"	"unprognostic (1.11e-1)"	"unprognostic (4.87e-2)"	"unprognostic (1.31e-1)"	5.7	7.9	13.3	3.4	14.7	2.2	7.0	16.8	21.4	6.4	10.4	7.4	4.9	5.5	4.7	5.4	4.4	4.5	25.6	14.7	15.6	12.6	9.3	3.2	4.7	14.9	14.5	7.8	5.5	10.1	2.5	4.8	15.6	7.2	7.5	9.8	6.2	9.6	23.2	4.8	4.4	5.6	12.3	4.9	4.7	4.6	16.6	5.3	7.4	31.1	4.7	7.8	3.7	13.7	2.2	6.1	10.5	14.3	10.3	5.9	5.6	6.0	5.6	8.8	6.6	8.4	3.7	20.6	10.7	5.6	8.4	4.4	24.7	9.3	8.5	14.5	19.5	23.0	3.2	7.4	11.2	24.4	9.2	5.7	14.2	7.6	7.7	4.4	6.9	14.3	21.0	13.6	13.9	7.0	15.7	13.1	20.1	11.3	10.0	7.4	5.9	10.7	14.6	6.0	17.9	8.4	3.1	10.7	17.5	10.2	3.3	16.1	5.8	4.6	3.5	16.2	9.9	3.1	5.4	20.0	6.2	18.1	6.9	0.2	1.8	0.5	4.0	3.6	5.3	5.1	5.2	5.4	3.3	5.4	7.6	6.9	0.3	3.0	2.3	3.8	5.9	3.2	13.3	14.7	16.8	21.4	14.7	15.6	14.9	14.5	15.6	12.3	16.6	13.7	31.9	9.6	19.8	9.8	43.2	108.8	74.4	82.6	60.9	15.1	28.5	48.1	126.9	25.8	37.3	23.9	0.0	49.6	27.9	23.5	168.3	37.7	3.3	19.2	18.3	30.7	39.3	23.3	18.5	27.6	47.6	34.4	33.6	15.9	20.3	42.5	26.0	51.8	53.9	26.9	17.8	44.3	67.1	18.3	33.7	6.2	26.1	20.2	55.2	11.2	19.7	20.7	24.7	8.0	13.1	21.4	19.7	24.8	40.6	63.7	24.2	118.0	16.6	16.6	26.3	57.8	49.1	42.3	63.7	63.1	96.7	32.8	34.3	43.4	58.1	46.4
KLHL32	"BKLHD5, KIAA1900"	ENSG00000186231	"Kelch like family member 32"	Q96NJ5	6	96924620-97140754	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"brain: 65.2"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 143.7;Excitatory neurons: 168.8;Inhibitory neurons: 143.9;Oligodendrocyte precursor cells: 197.5;Oligodendrocytes: 724.3"	"Cancer enhanced"	"Detected in some"		"glioma: 2.0"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Group enriched"	"Detected in many"	4	"B-cells: 1.0;T-cells: 2.6"	"Cell line enhanced"	"Detected in some"		"Daudi: 3.3;HDLM-2: 4.5;RPMI-8226: 2.1;SCLC-21H: 1.8;U-266/70: 2.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039150	Enhanced					NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"			"HPA039150: AB_2676367"	"unprognostic (1.75e-1)"	"unprognostic (7.99e-2)"	"unprognostic (6.66e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.67e-1)"	"unprognostic (5.22e-2)"	"unprognostic (5.00e-1)"	"unprognostic (3.12e-3)"	"unprognostic (5.88e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.51e-5)"	"unprognostic (5.82e-2)"	"unprognostic (6.04e-2)"	"unprognostic (7.01e-2)"	"unprognostic (1.86e-2)"	"unprognostic (7.48e-2)"	"unprognostic (4.49e-4)"	0.2	0.9	19.6	0.4	40.7	0.1	0.3	24.7	33.3	0.3	1.7	0.6	0.8	0.2	0.4	0.0	6.4	0.3	0.7	21.6	25.9	1.9	0.6	0.7	0.4	31.2	28.2	0.9	1.3	0.7	1.2	0.0	29.9	0.2	0.9	2.5	0.5	0.2	1.2	0.1	1.1	0.1	25.3	0.3	0.5	1.6	29.1	0.7	0.7	0.3	0.4	0.1	0.1	65.2	0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.3	3.3	0.1	0.0	0.0	0.1	0.3	0.1	0.0	4.5	0.7	0.2	0.0	0.1	0.1	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.5	1.6	0.0	0.0	0.8	0.2	0.2	0.1	0.1	0.1	0.0	2.1	0.0	0.0	1.8	0.6	0.0	0.0	0.4	0.1	0.1	0.1	0.2	0.0	0.0	0.0	0.0	2.3	0.4	1.3	0.1	0.1	0.2	0.0	0.0	0.0	0.4	0.0	0.9	1.0	1.7	0.6	0.0	0.7	1.9	2.6	0.0	0.4	0.0	0.0	1.2	0.8	19.6	40.7	24.7	33.3	21.6	25.9	31.2	28.2	29.9	25.3	29.1	65.2	0.2	3.2	0.0	143.7	1.1	0.0	0.3	0.1	0.0	2.5	0.4	0.5	2.6	0.0	0.1	5.5	0.0	0.1	0.2	0.3	3.9	0.2	6.9	7.5	0.1	0.0	11.3	0.0	168.8	0.2	0.0	0.3	1.5	0.2	0.0	3.2	0.4	1.3	0.1	18.5	143.9	4.1	0.0	0.0	0.0	3.3	0.0	0.1	0.0	13.1	0.0	1.1	0.0	197.5	724.3	0.0	0.1	0.0	0.5	0.2	0.5	2.4	15.3	1.1	0.0	0.2	0.1	0.8	1.8	0.0	0.0	0.0	0.7	1.1	0.5	0.0
MMS22L	"C6orf167, dJ39B17.2"	ENSG00000146263	"MMS22 like, DNA repair protein"	Q6ZRQ5	6	97142161-97283217	"Predicted intracellular proteins"	"DNA damage, DNA repair"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 67.8;Oligodendrocytes: 52.3;Spermatocytes: 56.9;Spermatogonia: 45.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			HPA067042			Supported	Nucleoplasm		NA	Yes			"Cluster 27: Non-specific - Gene expression"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"HPA067042: AB_2685768"	"unprognostic (3.61e-2)"	"unprognostic (2.80e-1)"	"unprognostic (2.26e-2)"	"unprognostic (1.97e-3)"	"unprognostic (1.70e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.00e-5)"	"unprognostic (9.63e-2)"	"unprognostic (5.81e-3)"	"unprognostic (8.21e-3)"	"unprognostic (9.39e-2)"	"unprognostic (6.58e-2)"	"unprognostic (1.34e-6)"	"unprognostic (3.48e-2)"	"unprognostic (2.00e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.29e-1)"	1.1	1.1	0.7	2.0	1.8	7.0	2.3	1.3	1.2	1.6	0.7	1.6	1.2	1.5	0.5	1.7	1.4	1.0	0.7	0.7	1.0	0.8	0.9	1.1	3.4	2.1	1.4	1.4	1.3	1.4	0.5	2.0	1.8	1.3	2.3	2.4	1.0	0.8	0.6	2.9	1.6	1.5	1.2	1.4	1.1	6.8	1.5	5.2	1.1	0.5	3.4	1.3	1.1	2.4	7.5	8.2	13.5	14.8	2.2	4.0	10.6	15.0	6.9	13.8	20.1	11.4	8.6	16.4	9.0	5.7	16.0	13.4	17.1	8.3	27.4	14.1	12.7	16.7	11.3	7.2	1.3	25.8	11.3	2.2	4.3	19.5	9.0	2.8	6.0	15.2	23.1	25.6	13.1	8.9	9.5	10.4	5.2	12.1	6.1	15.8	12.8	5.8	5.9	9.7	7.7	6.6	9.8	4.9	4.0	7.6	7.6	15.7	4.5	14.0	13.3	11.8	20.8	3.2	10.3	18.3	8.0	16.0	15.7	0.5	0.4	0.9	0.6	0.7	1.0	0.5	0.9	1.0	1.1	0.7	0.8	1.1	0.4	0.6	1.6	1.2	0.9	0.4	0.7	1.8	1.3	1.2	0.7	1.0	2.1	1.4	1.8	1.2	1.5	2.4	5.9	3.2	8.6	16.6	9.7	9.2	5.8	4.0	4.0	11.6	6.1	6.2	4.2	5.7	6.9	3.7	41.7	12.5	14.6	3.3	1.9	2.9	67.8	4.4	6.1	6.5	1.2	26.3	11.3	4.1	11.2	6.1	7.7	2.8	7.6	24.0	10.8	3.1	6.4	3.3	7.7	8.4	8.2	7.5	6.0	17.2	9.9	6.8	7.2	36.5	6.4	6.1	6.2	22.6	52.3	3.0	2.0	5.7	13.1	2.9	5.4	0.8	6.1	31.9	6.6	7.9	5.1	56.9	45.8	7.1	8.2	3.6	9.6	5.2	10.3	3.0
POU3F2	"BRN2, OCT7, OTF7, POUF3"	ENSG00000184486	"POU class 3 homeobox 2"	P20265	6	98834574-98839458	"Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	15	"brain: 17.3"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 77.4;Excitatory neurons: 8.8;Muller glia cells: 11.1;Oligodendrocyte precursor cells: 27.2;Oligodendrocytes: 13.4"	"Cancer enriched"	"Detected in some"	11	"glioma: 16.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 125.4;SK-MEL-30: 18.3;U-251 MG: 39.9;WM-115: 33.8"	"Low region specificity"	"Detected in all"							"HPA047081, HPA056261"		Approved	Supported	Nucleoplasm		NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 12: NES - Nervous system development"	"Cluster 64: Astrocytes - Nervous system maintenance"	Nucleoplasm		"HPA047081: , HPA056261: AB_2683081"	"unprognostic (5.94e-4)"	"unprognostic (7.80e-2)"	"unprognostic (3.07e-3)"	"unprognostic (1.83e-1)"	"unprognostic (3.57e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.17e-3)"	"unprognostic (1.84e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.63e-3)"	"unprognostic (4.77e-1)"	"unprognostic (9.38e-11)"	"unprognostic (4.77e-2)"	"unprognostic (2.84e-2)"	"unprognostic (8.47e-3)"	"unprognostic (4.04e-1)"	0.0	0.0	9.7	0.0	9.6	0.0	0.0	11.4	15.5	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.6	13.0	0.0	0.0	0.0	0.0	9.8	17.3	0.0	0.0	0.0	0.0	0.0	9.3	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	10.5	0.0	0.0	0.1	10.6	0.0	0.0	0.0	0.0	0.0	0.0	12.2	0.0	0.0	125.4	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	5.6	0.0	0.0	0.2	7.6	0.1	0.1	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	1.6	5.0	0.0	0.1	0.0	1.0	0.0	0.6	0.0	5.5	4.3	1.0	0.0	0.0	0.0	6.9	3.6	0.0	0.0	18.3	0.1	1.0	0.1	0.0	0.7	0.0	0.2	39.9	0.1	0.0	0.0	0.2	0.0	33.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.7	9.6	11.4	15.5	7.6	13.0	9.8	17.3	9.3	10.5	10.6	12.2	0.1	0.0	0.0	77.4	0.0	0.1	0.4	0.0	0.0	0.2	0.1	0.3	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.2	0.0	0.0	8.8	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	2.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	2.8	0.0	11.1	0.0	27.2	13.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.8	0.4	0.3	1.4	0.0	0.1	0.0	0.4	0.0	0.1	0.3
FBXL4	"FBL4, FBL5"	ENSG00000112234	"F-box and leucine rich repeat protein 4"	Q9UKA2	6	98868535-98948006	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Ubl conjugation pathway"		"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocyte precursor cells: 97.0;Oligodendrocytes: 94.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029140, CAB033362"	Approved		Supported	"Nuclear speckles"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 68: Oligodendrocytes - Mixed function"	"Nuclear speckles"		"CAB033362: AB_2103974, HPA029140: AB_10611967"	"unprognostic (1.24e-1)"	"unprognostic (5.10e-2)"	"unprognostic (1.10e-2)"	"unprognostic (1.42e-1)"	"unprognostic (3.34e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.03e-1)"	"unprognostic (3.10e-1)"	"unprognostic (2.79e-1)"	"unprognostic (2.68e-1)"	"unprognostic (4.53e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.05e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.62e-1)"	5.8	8.0	5.9	5.3	8.4	5.1	7.7	7.6	5.5	7.0	5.5	6.2	5.9	6.9	11.2	5.3	7.7	6.6	5.9	4.6	7.1	13.1	15.7	5.9	6.1	8.0	8.3	8.2	9.4	12.7	4.8	6.8	8.4	8.0	6.9	5.1	9.9	6.6	9.4	5.7	5.8	6.2	7.2	5.3	7.4	4.1	7.4	9.0	12.2	7.2	6.4	5.7	5.3	11.0	5.7	9.0	7.6	10.2	12.5	22.8	8.2	12.7	10.7	7.3	10.3	4.1	10.7	13.1	11.5	10.6	12.8	8.1	8.8	9.2	11.1	21.4	7.2	9.3	6.2	9.4	9.7	11.5	8.9	13.0	16.4	6.6	18.4	20.4	9.5	10.2	12.6	10.1	13.4	5.6	4.3	5.5	4.0	7.5	5.5	14.6	5.2	10.7	13.9	8.2	9.5	7.7	6.7	8.9	12.2	9.2	6.6	8.2	13.3	8.4	3.7	11.9	9.3	3.4	3.4	5.5	10.5	10.4	10.2	18.4	4.7	13.0	4.6	4.5	6.1	7.1	4.6	4.6	3.8	5.7	5.9	5.6	5.9	4.3	6.0	2.5	6.1	3.9	5.9	8.4	7.6	5.5	4.6	7.1	8.0	8.3	8.4	7.2	7.4	11.0	12.2	19.2	11.9	42.7	14.2	9.7	8.2	9.0	12.0	14.9	9.1	8.3	16.2	5.7	8.8	36.8	22.9	10.1	9.5	9.8	19.6	9.7	5.4	10.6	14.5	10.8	7.2	20.2	46.9	11.0	10.7	13.7	14.3	7.9	8.9	20.8	11.4	19.4	8.9	10.1	58.3	13.7	8.2	12.3	6.4	2.1	19.0	11.8	5.4	41.2	14.9	10.6	12.3	97.0	94.4	7.5	9.8	12.8	8.8	13.9	12.5	11.8	11.3	13.3	13.1	12.7	10.0	4.1	6.4	12.4	8.5	9.9	9.3	16.9	10.4	8.2
FAXC	"C6orf168, dJ273F20, MGC2817"	ENSG00000146267	"Failed axon connections homolog, metaxin like GST domain containing"	Q5TGI0	6	99271168-99350062	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 22.7"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 25.6;Excitatory neurons: 57.1;Inhibitory neurons: 60.1;Oligodendrocyte precursor cells: 43.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"GAMG: 26.0;HAP1: 23.8;SCLC-21H: 34.2;SH-SY5Y: 23.7;SK-MEL-30: 22.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039106	Uncertain		Approved	Nucleoplasm		NA	NA				"Cluster 68: Epididymis - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"HPA039106: AB_10697546"	"unprognostic (8.03e-2)"	"unprognostic (4.91e-2)"	"unprognostic (5.04e-3)"	"unprognostic (6.44e-2)"	"unprognostic (3.80e-1)"	"unprognostic (5.00e-3)"	"unprognostic (7.56e-2)"	"unprognostic (7.29e-2)"	"unprognostic (7.08e-2)"	"unprognostic (1.34e-2)"	"unprognostic (2.79e-3)"	"unprognostic (2.47e-3)"	"unprognostic (6.70e-4)"	"unprognostic (1.13e-2)"	"unprognostic (1.71e-1)"	"unprognostic (4.86e-2)"	"unprognostic (3.49e-3)"	0.7	2.2	11.0	1.5	12.7	0.0	3.2	9.3	19.0	2.5	2.0	22.7	1.5	6.5	11.0	6.2	3.7	2.4	0.8	14.1	7.6	2.7	0.0	1.7	0.1	7.2	5.6	2.2	2.5	6.5	15.9	0.8	6.3	8.2	2.9	10.4	7.4	10.6	0.5	0.9	3.3	7.8	4.4	0.4	7.1	2.1	8.5	2.2	1.7	0.6	0.1	14.3	2.9	11.4	4.0	3.2	10.3	14.3	0.0	0.0	3.8	5.0	3.2	8.1	7.0	1.9	1.3	0.0	0.6	1.0	26.0	0.1	23.8	4.7	7.0	0.0	11.8	0.1	1.9	0.7	0.6	0.0	0.0	0.5	7.5	0.2	3.8	5.9	0.0	2.0	0.5	0.0	2.7	7.0	0.0	0.0	12.2	0.0	4.8	0.0	1.0	0.0	4.3	0.3	34.2	23.7	4.5	3.2	22.6	4.2	10.0	0.0	1.0	2.5	4.7	0.0	15.5	0.0	0.0	0.0	0.1	0.0	19.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.0	12.7	9.3	19.0	14.1	7.6	7.2	5.6	6.3	4.4	8.5	11.4	0.2	25.6	15.2	5.5	0.5	0.4	4.2	4.2	5.7	14.4	5.3	9.0	1.1	0.0	8.1	1.8	10.4	1.2	0.4	0.2	9.8	2.3	2.6	0.6	1.0	1.7	0.0	0.0	57.1	0.7	0.2	1.4	0.0	0.4	3.8	0.4	1.4	0.1	0.2	3.3	60.1	0.2	4.1	0.6	1.1	5.0	0.0	1.2	1.8	2.8	0.1	3.6	2.1	43.7	4.4	1.0	0.1	1.9	0.1	4.8	0.0	1.0	2.1	13.6	0.0	0.2	1.3	1.3	8.9	1.2	0.3	0.3	1.2	0.2	0.4	1.2
COQ3	bA9819.1	ENSG00000132423	"Coenzyme Q3, methyltransferase"	Q9NZJ6	6	99369401-99394195	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Ubiquinone biosynthesis"	"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"tongue: 51.1"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 42.8;Distal tubular cells: 33.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA031273, HPA031274"	Enhanced		Approved	Nucleoplasm,Mitochondria		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm	Mitochondria	"HPA031273: AB_10611107, HPA031274: AB_10602176"	"unprognostic (1.81e-2)"	"unprognostic (2.69e-2)"	"unprognostic (1.45e-2)"	"unprognostic (4.62e-2)"	"unprognostic (2.41e-2)"	"unprognostic (2.16e-2)"	"unprognostic (1.48e-3)"	"unprognostic (1.76e-1)"	"unprognostic (3.40e-1)"	"unprognostic (8.77e-2)"	"unprognostic (9.78e-2)"	"unprognostic (1.09e-1)"	"prognostic favorable (6.86e-5)"	"unprognostic (4.61e-2)"	"unprognostic (1.81e-1)"	"unprognostic (5.45e-2)"	"unprognostic (1.08e-1)"	6.4	10.1	13.4	5.2	14.3	4.6	8.6	14.7	18.0	5.6	13.7	10.7	8.2	5.2	7.6	9.3	5.1	3.5	30.9	13.8	13.9	12.7	15.1	3.5	5.6	13.8	14.0	6.8	6.6	14.2	8.5	3.0	13.9	7.7	12.5	11.9	9.6	8.4	37.3	6.9	6.6	6.3	13.7	6.4	7.4	3.0	13.8	7.9	5.2	51.1	7.1	6.8	6.5	13.7	20.2	11.4	13.5	19.2	8.6	9.6	18.4	17.0	10.5	25.2	29.0	15.9	8.5	19.6	11.1	12.8	16.3	18.3	22.7	26.6	30.6	21.0	29.1	24.1	15.5	17.1	11.3	35.0	9.0	6.1	16.0	14.9	14.9	5.5	15.6	23.8	37.2	14.5	13.6	19.8	15.5	29.0	16.4	19.7	21.7	7.5	13.8	26.1	19.9	17.3	21.0	11.2	11.8	18.0	22.9	9.0	22.1	22.8	5.6	10.9	16.0	17.0	26.4	5.1	10.0	30.9	14.0	33.6	16.4	14.1	2.9	2.4	5.0	6.9	5.8	5.6	6.4	8.1	7.3	2.5	10.5	7.8	0.4	10.1	6.1	4.9	5.2	4.7	13.4	14.3	14.7	18.0	13.8	13.9	13.8	14.0	13.9	13.7	13.8	13.7	4.7	3.2	3.7	6.5	3.9	4.5	6.8	26.1	7.4	8.1	5.0	6.3	42.8	5.7	11.2	3.7	0.0	14.0	2.2	3.7	33.2	11.5	0.5	3.5	4.9	5.5	0.0	8.2	10.6	10.5	13.3	5.9	3.6	2.6	1.3	6.6	3.3	8.6	6.8	6.7	13.2	7.3	24.4	1.3	3.5	0.3	8.1	2.4	5.4	1.0	2.0	13.2	4.1	4.5	7.6	9.2	5.8	6.0	4.7	2.4	5.2	12.0	4.9	8.7	6.6	6.5	10.6	3.6	10.9	8.0	4.3	6.3	3.7	11.1	9.8	4.7
PNISR	"bA98I9.2, C6orf111, DKFZp564B0769, FLJ14752, SFRS18, SRrp130"	ENSG00000132424	"PNN interacting serine and arginine rich protein"	Q8TF01	6	99397629-99425331	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038796, HPA075076"	Approved		Supported	"Nuclear speckles,Plasma membrane,Cytosol"		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 51: Non-specific - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 52: Non-specific - Transcription"	"Nuclear speckles"	"Plasma membrane, Cytosol"	"HPA038796: AB_10672652, HPA075076: "	"unprognostic (2.95e-1)"	"unprognostic (2.29e-1)"	"unprognostic (2.11e-1)"	"unprognostic (9.72e-3)"	"unprognostic (1.68e-2)"	"unprognostic (8.55e-3)"	"unprognostic (4.41e-2)"	"unprognostic (1.58e-3)"	"unprognostic (5.82e-2)"	"unprognostic (4.32e-3)"	"prognostic favorable (5.27e-4)"	"unprognostic (1.47e-2)"	"prognostic unfavorable (1.41e-4)"	"unprognostic (3.43e-2)"	"unprognostic (2.59e-1)"	"unprognostic (8.89e-2)"	"prognostic favorable (1.09e-4)"	68.2	68.8	56.9	52.0	55.4	106.8	75.3	78.4	89.8	103.1	67.5	114.5	51.4	79.7	93.6	51.8	93.2	38.2	84.6	54.3	56.4	67.1	62.2	74.4	78.7	56.7	54.7	123.0	66.0	38.4	112.0	36.4	52.9	91.2	49.4	102.1	76.6	48.1	89.4	64.1	94.1	49.4	49.3	90.6	77.1	39.4	56.9	51.4	114.5	31.2	54.9	81.6	80.3	60.1	26.7	19.5	98.8	72.0	35.3	46.8	45.8	44.1	22.8	25.6	29.9	33.3	49.2	85.8	26.6	25.3	28.7	41.9	49.3	33.3	45.2	75.0	48.8	52.6	105.0	30.6	22.2	73.0	67.9	51.8	50.0	27.4	37.5	95.7	34.2	44.8	59.3	52.5	31.3	25.2	31.8	71.2	55.2	24.5	15.3	62.1	29.6	32.4	47.1	47.1	43.4	51.9	21.7	23.6	35.3	75.4	32.8	58.6	45.0	25.2	28.9	25.7	37.2	35.9	24.3	70.5	37.5	68.3	27.0	12.3	10.8	11.9	12.5	6.4	13.0	19.3	12.0	10.4	5.0	25.8	17.9	16.6	30.0	23.5	7.7	19.6	12.4	3.7	56.9	55.4	78.4	89.8	54.3	56.4	56.7	54.7	52.9	49.3	56.9	60.1	175.8	185.9	237.6	356.2	375.8	195.3	357.3	250.5	165.6	546.2	143.9	192.5	121.2	137.2	215.7	178.4	446.2	158.3	336.4	152.4	74.3	130.8	17.0	132.2	185.7	210.7	247.8	194.4	241.5	104.5	102.1	240.1	100.9	140.5	190.5	344.5	135.7	109.4	99.7	498.0	257.4	129.6	199.4	128.0	236.8	47.9	593.3	152.1	167.2	193.9	261.6	223.6	375.9	270.4	252.6	133.1	176.2	441.2	209.8	293.6	205.8	58.6	179.6	419.9	249.8	288.7	236.3	342.6	181.3	115.5	173.6	180.9	283.8	363.3	151.3	352.4
USP45	MGC14793	ENSG00000123552	"Ubiquitin specific peptidase 45"	Q70EL2	6	99432325-99521728	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"	"Disease variant, Leber congenital amaurosis"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	7	"brain: 53.5"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 47.1;Inhibitory neurons: 44.4;Oligodendrocytes: 39.4"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	6	"cerebellum: 53.5"	"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029602, HPA029604"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoplasm, Cytosol"		"HPA029602: AB_10600418, HPA029604: AB_10602283"	"unprognostic (7.81e-3)"	"unprognostic (3.10e-3)"	"unprognostic (1.63e-2)"	"unprognostic (6.62e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.15e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.77e-2)"	"unprognostic (8.65e-2)"	"unprognostic (2.95e-3)"	"unprognostic (1.10e-1)"	"unprognostic (3.43e-3)"	"unprognostic (1.13e-1)"	"unprognostic (3.53e-1)"	"unprognostic (1.43e-1)"	"unprognostic (6.91e-2)"	6.1	4.4	5.2	4.9	5.8	4.4	4.6	53.5	9.4	4.3	3.8	5.3	7.3	5.1	4.8	5.3	4.0	6.2	6.2	5.8	6.3	6.3	4.2	3.7	7.4	6.0	7.7	4.5	4.0	4.5	3.6	5.2	8.2	5.1	6.7	6.7	4.0	4.2	6.0	6.3	5.8	4.5	5.3	4.6	4.4	3.3	6.2	3.1	5.3	5.5	5.2	4.3	3.8	9.0	5.9	4.0	8.1	11.2	14.3	13.5	8.7	10.3	11.1	10.1	14.7	8.2	6.4	15.2	7.3	10.3	11.9	7.7	12.1	9.8	13.9	12.2	12.0	15.2	8.4	6.7	11.4	14.2	8.3	15.3	7.6	9.2	15.5	10.7	15.4	13.8	37.2	14.8	9.6	5.5	4.5	13.3	12.8	9.1	8.9	6.8	5.9	8.9	13.8	6.8	11.3	9.2	7.0	9.1	7.8	10.0	4.9	6.8	15.5	5.5	7.1	8.1	15.5	6.3	6.2	29.1	9.8	13.1	10.1	2.9	1.4	0.4	3.2	0.8	4.2	5.3	2.7	4.0	2.4	6.7	1.9	1.9	0.3	1.9	2.0	3.6	2.6	1.0	5.2	5.8	53.5	9.4	5.8	6.3	6.0	7.7	8.2	5.3	6.2	9.0	13.3	3.2	5.8	22.5	13.3	2.3	9.6	6.8	4.6	10.3	4.4	4.6	9.4	4.3	4.7	3.7	18.8	6.4	7.3	5.9	5.9	4.3	15.7	10.1	10.3	7.6	2.4	4.2	47.1	2.5	6.6	7.1	9.7	4.3	2.5	5.8	6.8	4.5	4.0	10.1	44.4	2.9	10.2	4.8	2.6	10.2	13.1	4.6	3.6	22.5	10.0	5.4	2.1	32.6	39.4	5.0	3.1	8.6	6.5	8.6	8.3	15.8	10.4	7.4	0.0	6.3	6.7	1.9	7.5	5.2	2.8	7.4	7.1	5.8	7.3	6.9
TSTD3		ENSG00000279170	"Thiosulfate sulfurtransferase like domain containing 3"	H0UI37	6	99520976-99589899	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 81.9;Excitatory neurons: 41.7;Inhibitory neurons: 49.4;Oligodendrocyte precursor cells: 62.8;Oligodendrocytes: 93.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 6.1"															NA	NA			"Cluster 24: B-cells - Unknown function"		"Cluster 2: Karpas-707 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"				"unprognostic (2.43e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.70e-2)"	"unprognostic (6.01e-2)"	"unprognostic (9.22e-2)"	"unprognostic (5.74e-2)"	"unprognostic (6.38e-2)"	"unprognostic (9.44e-3)"	"unprognostic (4.70e-2)"	"unprognostic (3.56e-2)"	"unprognostic (7.83e-3)"	"unprognostic (3.13e-1)"	"unprognostic (2.00e-1)"	"unprognostic (3.62e-2)"	"unprognostic (2.88e-3)"	3.9	1.0	0.6	0.8	1.2	1.3	1.2	3.5	2.2	0.5	0.8	1.0	1.2	0.5	1.0	0.4	1.2	1.6	1.5	0.7	0.9	1.4	0.7	1.0	0.6	1.3	0.8	0.6	1.1	3.2		0.7	1.1	2.6	0.9	1.2	1.1	0.8	2.0	1.1	0.7	0.5	0.7	0.6	1.4	0.4	1.1	0.7	2.0	1.1	0.4	0.7		2.5	0.8	1.5	0.8	2.5	4.7	2.2	1.0	0.6	0.8	0.6	0.5	0.9	2.2	0.2	1.1	0.9	3.3	0.8	0.7	1.0	0.5	0.7	0.4	0.2	4.0	1.5	3.1	1.1	1.4	1.3	2.2	0.3	3.5	3.2	1.0	1.2	1.3	6.1	1.4	1.4	0.5	1.2	0.8	3.8	1.3	0.0	1.0	1.9	3.4	0.5	1.1	0.3	1.0	0.7	1.2	4.7	1.6	0.2	0.7	1.1	0.9	0.5	0.6	0.5	0.4	1.8	2.7	0.8	1.6	1.6	0.4	1.1	0.4	0.1	0.6	0.8	0.4	0.3	0.2	1.6	0.3	0.4	1.1	1.4	0.1	0.5	0.1	0.1	0.6	1.2	3.5	2.2	0.7	0.9	1.3	0.8	1.1	0.7	1.1	2.5	1.5	3.2	5.4	81.9	5.5	1.9	4.1	5.8	4.6	1.4	6.2	5.2	0.0	11.5	6.4	12.9	0.0	0.0	2.2	5.2	23.5	4.5	0.3	5.4	4.0	4.1	3.6	9.9	41.7	7.8	0.0	3.6	5.6	3.1	1.3	1.9	7.9	3.4	0.0	0.0	49.4	5.6	14.2	3.2	0.8	1.0	6.5	1.7	5.4	26.2	2.5	7.9	2.1	62.8	93.3	6.5	4.2	9.8	1.4	4.8	5.7	16.3	6.7	2.8	13.1	3.8	4.7	0.8	1.9	4.9	2.0	0.0	3.5	3.0	5.7	4.2
CCNC	CycC	ENSG00000112237	"Cyclin C"	P24863	6	99542387-99568825	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Activator, Cyclin, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010499, HPA069322"	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoplasm	Cytosol	"CAB010499: AB_2244021, HPA069322: AB_2686120"	"unprognostic (1.48e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.85e-3)"	"unprognostic (6.34e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.95e-3)"	"unprognostic (2.09e-1)"	"unprognostic (3.86e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.64e-2)"	"unprognostic (1.92e-1)"	"unprognostic (7.10e-2)"	"prognostic favorable (8.12e-4)"	"unprognostic (1.91e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.83e-2)"	31.3	32.5	15.9	27.4	17.0	33.0	47.4	26.1	19.3	29.8	26.8	30.9	42.8	21.9	58.7	41.3	18.9	42.1	23.6	17.3	17.9	54.3	74.6	25.1	39.6	17.0	16.9	16.7	62.6	47.3	22.2	35.7	17.0	34.6	30.3	27.0	70.4	23.2	22.1	32.5	35.0	21.9	17.0	24.1	41.6	17.1	18.1	32.1	60.6	17.7	43.3	34.6	19.7	18.0	86.9	29.8	45.8	99.2	39.3	53.7	126.9	61.4	78.3	75.9	97.9	118.2	53.2	177.2	69.1	51.5	69.8	60.5	72.2	91.1	109.7	45.1	91.2	101.6	44.4	97.7	67.6	118.6	35.3	51.5	55.4	55.9	67.3	52.0	82.2	102.3	151.6	62.9	68.3	53.8	43.7	98.5	64.1	53.5	47.4	75.8	76.7	71.2	105.3	101.2	72.5	43.8	35.6	67.1	69.5	65.5	46.5	117.8	60.6	38.4	51.2	47.0	92.8	42.9	69.7	134.1	69.0	87.9	55.8	40.9	20.7	16.2	21.2	22.1	39.8	29.7	25.5	20.9	23.4	25.3	27.4	21.7	3.3	28.2	16.7	23.0	29.6	30.7	15.9	17.0	26.1	19.3	17.3	17.9	17.0	16.9	17.0	17.0	18.1	18.0	37.1	44.8	32.8	25.5	58.3	75.1	99.3	58.0	50.7	42.8	60.0	31.0	16.1	81.5	57.5	23.9	22.9	110.3	45.0	32.2	84.1	127.2	45.1	36.7	27.3	46.3	43.6	23.3	64.2	186.9	93.3	33.2	38.2	43.1	32.4	31.1	36.4	53.0	41.1	25.2	56.6	38.2	67.1	37.0	52.8	45.5	22.4	32.8	58.7	24.4	41.2	64.6	40.2	52.8	40.5	133.7	27.1	25.2	120.5	158.8	37.8	128.4	37.4	42.2	19.7	26.9	40.2	62.3	21.4	60.0	67.5	176.4	38.7	42.8	46.3	147.0
PRDM13	PFM10	ENSG00000112238	"PR/SET domain 13"	Q9H4Q3	6	99606774-99615578	"Cancer-related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"DNA-binding, Methyltransferase, Transferase"	"Cancer-related genes"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"Bipolar cells: 4.8;Horizontal cells: 1.7;Spermatogonia: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEK 293: 1.8;HMC-1: 1.1;JURKAT: 2.7;RPMI-8226: 2.0;SCLC-21H: 2.3;U-266/70: 2.7;U-266/84: 1.4;WM-115: 1.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA070592	Uncertain					NA	NA					"Cluster 29: U-266 - Adaptive immune response"	"Cluster 62: Horizontal cells - Visual perception"			"HPA070592: AB_2686283"		"unprognostic (4.09e-1)"	"unprognostic (1.68e-2)"	"unprognostic (4.30e-1)"	"unprognostic (3.65e-1)"	"unprognostic (1.55e-1)"		"unprognostic (3.16e-2)"	"unprognostic (1.24e-2)"	"unprognostic (2.93e-1)"				"unprognostic (1.86e-2)"	"unprognostic (7.54e-2)"		"unprognostic (1.29e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.2	0.0	0.0	0.5	1.1	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.0	0.0	0.0	2.3	0.0	1.1	0.0	0.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	2.7	1.4	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.9	0.0	0.0	0.6	0.5	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MCHR2	"GPR145, MCH2, MCH2R, SLT"	ENSG00000152034	"Melanin concentrating hormone receptor 2"	Q969V1	6	99918519-99994247	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	12	"brain: 3.5;testis: 1.5"	"Cell type enriched"	"Detected in some"	27	"Excitatory neurons: 44.0"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"cerebral cortex: 3.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"									NA	NA				"Cluster 10: Brain - Neuronal signaling"		"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"								"unprognostic (5.76e-2)"													0.0	0.0	0.9	0.0	2.1	0.1	0.0	0.0	3.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.1	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.9	2.1	0.0	3.5	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	44.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.5	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SIM1	bHLHe14	ENSG00000112246	"SIM bHLH transcription factor 1"	P81133	6	100385009-100464921	"Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Differentiation, Neurogenesis, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 4.4;kidney: 9.9;skeletal muscle: 3.5"	"Cell type enhanced"	"Detected in some"		"Collecting duct cells: 20.2;Distal tubular cells: 7.9;Ductal cells: 4.5;Skeletal myocytes: 7.6"	"Cancer enhanced"	"Detected in single"		"renal cancer: 1.8"	"Group enriched"	"Detected in some"	5	"hypothalamus: 4.4;midbrain: 1.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 9.7;BJ: 16.4;BJ hTERT+: 23.7;BJ hTERT+ SV40 Large T+: 7.2;HDLM-2: 7.3;RPTEC TERT1: 18.4"	"Region enriched"	"Detected in single"	8	"hypothalamus: 5.2"	"Region enhanced"	"Detected in some"		"hypothalamus: 3.1"	HPA024385			Approved	"Nuclear speckles"		NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 37: Myocytes - Muscle contraction"	"Nuclear speckles"		"HPA024385: AB_1856879"	"unprognostic (1.04e-1)"			"unprognostic (4.34e-3)"	"unprognostic (2.24e-1)"	"unprognostic (1.51e-1)"	"unprognostic (4.34e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.85e-1)"	"unprognostic (4.64e-2)"	"unprognostic (3.76e-2)"		"prognostic favorable (5.32e-7)"	"unprognostic (1.00e-1)"	"unprognostic (1.19e-1)"			1.7	0.0	0.5	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	4.4	9.9	0.3	0.0	0.0	0.0	1.2	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	3.5	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	6.5	9.7	0.0	16.4	23.7	7.2	6.7	0.0	0.0	0.0	0.0	5.2	1.5	0.0	0.0	0.0	6.1	7.3	2.2	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	18.4	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.6	0.0	0.0	0.0	0.3	0.2	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	4.4	0.0	1.2	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	20.2	0.0	0.1	0.0	0.0	7.9	4.5	1.8	0.1	0.1	0.1	1.8	0.0	0.1	1.2	0.1	1.5	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.4	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.2	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	7.6	0.3	1.5	0.1	0.0	0.4	0.0	0.1	0.0	0.0	0.1
ASCC3	"ASC1p200, dJ121G13.4, dJ467N11.1, HELIC1, RNAH"	ENSG00000112249	"Activating signal cointegrator 1 complex subunit 3"	Q8N3C0	6	100508194-100881372	"Enzymes, Predicted intracellular proteins"	"DNA damage, DNA repair, Transcription, Transcription regulation"	"Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 166.0;Inhibitory neurons: 166.2;Oligodendrocyte precursor cells: 150.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031608, HPA031609, HPA031610"	Enhanced		Supported	"Golgi apparatus,Cytosol"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol	"Golgi apparatus"	"HPA031608: AB_10599970, HPA031609: AB_10600777, HPA031610: AB_10611526"	"unprognostic (6.79e-2)"	"unprognostic (1.46e-2)"	"unprognostic (2.96e-3)"	"unprognostic (1.12e-1)"	"unprognostic (9.70e-3)"	"unprognostic (4.56e-2)"	"unprognostic (1.50e-1)"	"unprognostic (5.14e-2)"	"unprognostic (4.02e-1)"	"unprognostic (3.34e-1)"	"unprognostic (5.08e-3)"	"unprognostic (1.16e-1)"	"unprognostic (9.91e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.55e-2)"	6.0	6.6	4.1	10.0	5.3	11.2	9.2	6.6	4.2	10.2	7.7	9.3	8.2	7.9	8.5	8.4	5.8	7.5	6.5	3.9	5.2	5.0	12.5	7.1	10.1	4.7	4.3	5.9	6.4	10.7	6.2	12.9	5.1	9.2	11.3	5.7	6.3	8.1	6.0	7.2	8.5	8.5	4.7	8.3	8.6	8.6	4.6	12.7	7.2	5.4	11.0	14.8	7.4	6.0	16.8	21.1	30.1	18.6	32.9	41.7	48.0	71.5	45.5	24.1	27.6	43.3	13.0	52.1	14.4	48.3	19.0	37.6	26.2	63.5	38.7	35.2	23.2	38.7	36.0	27.8	30.1	41.0	28.5	38.1	31.7	35.4	44.2	22.6	45.1	20.5	47.1	23.0	67.3	16.5	21.1	12.7	15.9	31.8	16.4	24.7	23.3	18.7	23.7	46.6	20.2	15.3	30.1	26.7	12.5	53.3	14.7	23.2	64.2	26.9	20.6	23.3	30.4	9.9	11.3	46.4	19.4	30.6	29.0	6.2	2.7	1.8	4.3	4.3	5.2	4.2	3.8	4.0	2.9	5.7	4.3	4.2	0.2	4.4	3.8	6.4	3.1	1.4	4.1	5.3	6.6	4.2	3.9	5.2	4.7	4.3	5.1	4.7	4.6	6.0	32.7	32.1	24.9	58.1	45.4	25.5	41.3	33.3	19.4	27.0	24.1	24.0	32.0	20.0	37.7	3.7	22.9	24.4	49.0	17.3	11.7	23.1	11.3	30.1	77.3	25.2	13.8	20.8	166.0	25.1	66.3	32.2	46.9	35.0	22.1	29.9	10.4	30.3	17.7	28.6	166.2	22.8	22.4	17.2	12.5	3.7	23.0	27.5	5.4	103.0	26.2	14.6	29.9	150.8	132.3	28.6	14.4	17.3	66.4	66.9	17.5	10.6	32.0	31.1	6.6	39.6	30.0	50.2	30.3	38.2	27.4	38.0	43.7	42.6	23.5	65.4
GRIK2	"GluK2, GLUR6, MRT6"	ENSG00000164418	"Glutamate ionotropic receptor kainate type subunit 2"	Q13002	6	101181257-102070083	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"Disease variant, FDA approved drug targets, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	20	"brain: 93.3"	"Group enriched"	"Detected in some"	26	"Excitatory neurons: 724.6;Inhibitory neurons: 2376.0;Oligodendrocyte precursor cells: 1234.0"	"Cancer enriched"	"Detected in some"	5	"glioma: 3.9"	"Region enhanced"	"Detected in all"		"cerebellum: 93.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ: 16.4;BJ hTERT+: 26.6;fHDF/TERT166: 20.8;HAP1: 10.2;SiHa: 11.1;WM-115: 24.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014395, HPA014623, CAB022463"	Approved				"Intracellular and membrane"	NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"CAB022463: , HPA014395: AB_1850303, HPA014623: AB_1850305"	"unprognostic (1.43e-3)"	"unprognostic (1.26e-2)"	"unprognostic (3.99e-2)"	"unprognostic (3.20e-1)"	"unprognostic (1.92e-1)"	"unprognostic (3.48e-2)"	"unprognostic (2.57e-1)"	"unprognostic (4.32e-2)"	"unprognostic (8.46e-2)"	"unprognostic (9.19e-2)"	"unprognostic (4.01e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.34e-5)"	"unprognostic (1.94e-3)"	"unprognostic (7.78e-2)"	"unprognostic (1.09e-2)"	"unprognostic (8.68e-4)"	0.2	1.8	18.7	0.4	20.3	0.3	0.2	93.3	25.2	1.4	0.0	0.5	0.6	0.4	1.1	0.4	0.3	0.5	4.5	20.7	28.4	0.8	0.1	0.1	0.1	1.0	6.8	0.4	2.6	0.0	1.6	2.4	7.9	0.9	0.4	4.2	0.7	1.2	0.9	1.6	0.6	0.3	1.6	0.4	0.3	0.7	19.8	0.0	3.4	0.1	0.0	0.5	0.4	7.6	0.1	0.1	3.1	0.2	3.6	0.1	0.0	16.4	26.6	0.8	0.5	0.0	0.3	0.1	0.0	20.8	0.0	5.1	10.2	0.0	0.3	0.0	0.0	1.7	8.5	0.0	0.9	0.0	0.2	0.3	0.0	0.0	1.0	2.3	0.0	0.0	0.0	0.4	6.2	0.0	0.0	0.2	2.7	0.0	0.2	0.1	0.4	0.1	0.7	0.0	3.3	7.0	11.1	0.0	0.5	0.5	0.0	0.8	0.0	2.1	0.5	0.1	1.3	0.1	0.0	0.1	1.5	0.0	24.6	0.5	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.3	0.2	0.1	0.1	0.0	0.0	18.7	20.3	93.3	25.2	20.7	28.4	1.0	6.8	7.9	1.6	19.8	7.6	0.2	0.0	0.5	54.9	0.0	0.6	1.0	0.1	0.6	11.4	0.1	0.0	5.9	0.0	1.3	0.0	0.0	0.1	0.0	0.1	0.0	0.0	3.8	3.4	1.9	0.4	1.8	0.0	724.6	0.6	0.0	1.8	0.0	0.5	0.0	13.0	0.0	0.0	0.1	0.0	2376.0	0.0	0.0	0.0	0.0	7.7	0.3	0.1	1.8	38.4	0.0	0.5	0.0	1234.0	40.5	0.1	1.1	0.4	0.0	0.8	0.1	0.0	2.2	1.1	0.0	0.7	4.6	0.0	0.5	0.1	0.6	0.0	0.0	4.3	0.1	0.9
HACE1	KIAA1320	ENSG00000085382	"HECT domain and ankyrin repeat containing E3 ubiquitin protein ligase 1"	Q8IYU2	6	104728094-104859919	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Cell cycle, Transcription, Transcription regulation, Ubl conjugation pathway"	Transferase	"Disease variant, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 30.6"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 45.9;Excitatory neurons: 118.8;Inhibitory neurons: 84.2;Microglial cells: 45.9;Oligodendrocyte precursor cells: 64.3;Oligodendrocytes: 74.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046071			Supported	"Nuclear bodies,Endoplasmic reticulum"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 28: Placenta - Pregnancy"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Endoplasmic reticulum"	"Nuclear bodies"	"HPA046071: AB_2679524"	"unprognostic (6.32e-2)"	"unprognostic (3.77e-2)"	"unprognostic (2.93e-2)"	"unprognostic (1.12e-2)"	"unprognostic (3.75e-2)"	"unprognostic (3.75e-3)"	"unprognostic (1.22e-3)"	"unprognostic (4.63e-2)"	"unprognostic (7.41e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.56e-2)"	"unprognostic (2.25e-1)"	"prognostic unfavorable (1.17e-5)"	"unprognostic (1.12e-2)"	"unprognostic (2.06e-1)"	"prognostic unfavorable (7.50e-4)"	"unprognostic (1.75e-1)"	3.7	3.2	2.7	2.2	4.4	2.9	3.1	5.0	4.8	3.9	0.4	2.6	2.1	3.9	1.1	5.3	3.3	3.1	3.3	3.1	2.5	6.2	1.6	3.6	2.2	1.9	2.6	3.8	1.9	7.2	1.5	30.6	2.3	3.7	1.8	11.5	2.9	4.1	2.2	2.5	2.1	4.0	1.4	2.5	2.4	10.4	3.1	3.9	4.5	4.1	2.4	3.3	2.9	5.8	3.9	2.7	11.3	14.3	6.6	8.8	13.3	7.7	11.9	4.8	7.2	2.5	2.3	2.2	3.4	5.9	8.1	2.6	2.8	5.3	10.0	9.1	7.2	7.7	2.5	3.4	6.6	6.8	2.5	5.9	4.7	6.2	5.2	6.3	8.0	9.2	7.6	2.4	9.6	2.8	5.1	4.1	5.0	2.9	2.6	8.0	12.8	0.9	3.8	6.6	6.1	9.1	4.2	4.3	2.3	7.3	2.7	9.2	8.5	3.9	3.2	10.5	7.4	3.5	4.1	7.6	4.0	6.4	7.1	0.0	0.6	0.7	1.2	1.0	1.3	0.9	1.1	1.1	0.6	0.8	1.2	0.9	0.1	0.8	0.5	0.8	0.4	0.5	2.7	4.4	5.0	4.8	3.1	2.5	1.9	2.6	2.3	1.4	3.1	5.8	11.6	3.2	1.1	42.4	5.1	4.7	2.3	2.3	5.2	11.6	5.3	3.7	6.7	1.5	3.9	5.5	45.9	10.6	4.1	1.5	1.9	1.6	6.2	2.7	6.2	12.9	1.8	3.0	118.8	1.5	5.4	7.1	5.6	3.4	1.3	7.1	4.2	2.6	5.7	16.8	84.2	2.0	0.0	4.1	2.4	4.6	6.2	3.5	1.8	45.9	4.3	6.1	8.2	64.3	74.6	1.4	2.9	3.8	3.7	1.6	3.8	5.7	2.6	31.7	6.6	6.4	6.6	13.2	3.5	5.3	4.7	6.3	6.2	2.9	1.9	1.9
LIN28B	"CSDD2, FLJ16517"	ENSG00000187772	"Lin-28 homolog B"	Q6ZN17	6	104936616-105083332	"Predicted intracellular proteins"	"RNA-mediated gene silencing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	16	"placenta: 65.4"	"Group enriched"	"Detected in some"	5	"Cytotrophoblasts: 75.4;Early spermatids: 27.5;Excitatory neurons: 40.2;Extravillous trophoblasts: 83.0;Late spermatids: 25.2;Syncytiotrophoblasts: 55.8"	"Cancer enriched"	"Detected in single"	25	"testis cancer: 12.6"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 49.1;BEWO: 252.1;Hep G2: 44.0;K-562: 86.9;NTERA-2: 44.8;SuSa: 44.5"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in single"			"HPA036630, HPA061745"	Enhanced		Supported	Nucleoplasm,Nucleoli,Cytosol		NA	NA				"Cluster 28: Placenta - Pregnancy"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Nucleoplasm, Nucleoli"	Cytosol	"HPA036630: AB_10669911, HPA061745: AB_2684601"				"unprognostic (2.00e-4)"	"unprognostic (6.75e-2)"					"unprognostic (2.02e-1)"				"unprognostic (2.57e-2)"	"unprognostic (1.59e-2)"		"unprognostic (4.10e-2)"	0.1	0.1	0.4	0.0	0.8	0.5	0.0	0.0	1.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.7	0.0	0.0	0.0	0.1	0.4	0.2	0.0	0.0	0.0	0.3	65.4	0.1	0.0	0.0	1.5	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.1	4.2	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.1	3.2	49.1	10.0	0.0	0.0	252.1	0.1	0.0	0.0	0.0	16.6	0.1	0.1	0.0	0.1	3.0	0.1	31.2	0.0	0.0	0.0	24.1	36.6	0.0	44.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	86.9	1.2	0.0	0.0	5.6	6.2	44.8	0.0	0.0	0.0	0.0	2.2	0.0	0.1	0.1	11.6	0.1	0.3	4.0	44.5	0.0	10.6	1.0	0.1	5.3	0.2	0.1	14.8	22.6	0.1	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.4	0.8	0.0	1.3	0.6	0.7	0.4	0.2	0.1	0.0	0.3	0.3	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.2	0.0	0.0	0.0	6.2	75.4	0.0	0.0	0.0	0.0	27.5	0.0	0.0	8.3	0.0	0.0	40.2	0.0	83.0	3.7	0.0	0.1	0.0	0.0	0.0	0.0	9.7	1.7	5.7	0.0	0.0	0.0	0.0	25.2	0.3	0.0	0.0	1.0	0.0	0.5	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	6.6	0.0	0.0	6.3	9.9	0.0	0.0	55.8	0.0	0.0	0.0	0.0
BVES	"HBVES, POP1, POPDC1"	ENSG00000112276	"Blood vessel epicardial substance"	Q8NE79	6	105096822-105137157	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Cell adhesion"	"Developmental protein"	"Limb-girdle muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 27.8;skeletal muscle: 43.9;tongue: 29.3"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 34.2;Early spermatids: 36.1;Late spermatids: 55.3;Oligodendrocytes: 17.8;Spermatocytes: 24.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"RH-30: 29.7;WM-115: 30.2"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA014788, HPA018176"	Enhanced		Supported	"Plasma membrane,Cell Junctions"		Yes	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 25: Spermatids - Spermatogenesis"	"Plasma membrane, Cell Junctions"		"HPA014788: AB_1845504, HPA018176: AB_1845503"	"unprognostic (2.91e-1)"	"unprognostic (2.45e-1)"	"unprognostic (2.79e-2)"	"unprognostic (1.73e-2)"	"unprognostic (5.46e-2)"	"unprognostic (3.66e-2)"	"unprognostic (5.21e-2)"	"unprognostic (2.22e-2)"	"unprognostic (8.37e-2)"	"unprognostic (4.49e-2)"	"unprognostic (2.29e-2)"	"unprognostic (8.92e-2)"	"unprognostic (5.84e-3)"	"unprognostic (3.77e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.02e-2)"	"unprognostic (3.24e-4)"	2.9	0.7	2.6	2.3	7.1	0.2	1.5	5.8	3.6	2.5	4.6	14.9	1.4	5.8	1.7	5.3	2.8	1.8	27.8	2.7	4.3	1.6	0.3	1.9	0.6	7.3	5.6	1.0	0.6	0.7	2.4	3.5	7.4	5.2	3.3	0.2	1.4	10.0	43.9	0.7	3.0	17.7	5.2	0.3	6.9	11.5	5.2	0.2	1.3	29.3	0.4	9.3	2.2	10.8	1.3	2.0	7.6	1.3	10.9	14.9	3.3	5.8	4.1	8.8	11.6	0.5	0.0	0.0	0.0	10.9	14.7	0.1	3.3	2.0	8.1	0.0	2.8	0.0	1.0	0.3	2.4	0.0	0.6	8.7	6.9	13.6	1.1	6.6	4.0	3.3	0.1	19.3	19.7	0.1	0.2	1.0	1.6	0.0	0.0	5.7	29.7	0.0	0.0	0.0	9.9	17.1	3.7	0.1	7.7	5.5	0.0	20.0	8.9	14.0	0.0	0.0	15.3	1.8	0.8	0.0	8.3	0.0	30.2	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	2.6	7.1	5.8	3.6	2.7	4.3	7.3	5.6	7.4	5.2	5.2	10.8	2.1	0.0	0.0	1.6	0.0	0.3	0.4	0.1	0.6	0.0	0.4	1.0	34.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	36.1	1.9	4.4	3.1	0.0	0.0	3.3	0.0	0.2	2.6	0.0	6.0	0.0	0.9	2.2	0.1	2.3	0.0	0.6	0.0	0.0	0.0	1.9	55.3	1.2	0.5	0.0	3.7	1.0	0.0	0.0	5.0	17.8	0.1	0.0	3.4	0.0	0.5	0.1	0.1	0.1	0.0	13.1	11.8	4.4	24.4	5.4	0.1	0.9	0.1	0.2	1.3	0.0	0.3
POPDC3	"bA355M14.1, MGC22671, POP3"	ENSG00000132429	"Popeye domain containing 3"	Q9HBV1	6	105157900-105180014	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"			"Limb-girdle muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 23.0;skeletal muscle: 96.3;tongue: 29.6"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 42.8;Early spermatids: 88.0;Excitatory neurons: 16.6;Late spermatids: 18.2;Oligodendrocytes: 15.0;Skeletal myocytes: 32.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"GAMG: 25.9;RH-30: 15.8;SH-SY5Y: 15.4;U-87 MG: 14.2;WM-115: 14.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA012514			Approved	Nucleoli,Cytosol		NA	NA				"Cluster 80: Striated muscle - Unknown function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nucleoli, Cytosol"		"HPA012514: "	"unprognostic (2.17e-1)"	"unprognostic (2.15e-2)"	"unprognostic (3.65e-1)"	"unprognostic (1.14e-3)"	"unprognostic (7.74e-2)"	"prognostic unfavorable (4.43e-4)"	"unprognostic (2.24e-3)"	"prognostic unfavorable (5.79e-4)"	"unprognostic (2.81e-1)"	"unprognostic (1.69e-1)"	"unprognostic (5.12e-3)"	"unprognostic (2.37e-1)"	"unprognostic (2.83e-9)"	"unprognostic (6.25e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.75e-3)"	"unprognostic (1.33e-2)"	0.5	0.3	5.1	0.3	6.8	0.0	0.2	5.8	10.0	0.5	4.8	2.5	0.1	0.9	1.5	1.8	0.4	0.7	23.0	6.2	6.2	0.2	0.0	0.1	0.1	6.3	6.4	0.2	0.1	0.1	4.4	0.7	6.2	0.8	0.0	0.5	1.3	0.3	96.3	0.2	0.5	0.0	6.3	0.0	3.2	3.9	6.0	0.0	0.2	29.6	0.0	1.3	0.4	9.7	1.3	1.6	0.5	0.2	2.7	6.8	0.6	2.9	2.5	4.5	5.2	0.0	1.6	0.1	1.1	5.5	25.9	0.0	1.7	1.5	3.6	0.0	4.1	0.0	1.1	0.0	0.1	0.0	0.0	2.3	0.3	7.5	1.0	1.4	0.3	0.1	3.4	7.0	12.8	0.0	0.0	1.5	3.0	0.0	6.3	0.5	15.8	0.0	0.0	0.0	7.5	15.4	0.0	0.1	11.5	1.4	0.0	6.2	6.5	3.4	0.0	2.1	10.7	0.0	0.0	0.0	14.2	0.0	14.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	6.8	5.8	10.0	6.2	6.2	6.3	6.4	6.2	6.3	6.0	9.7	0.0	0.0	0.0	1.6	0.0	0.0	0.1	0.3	0.0	0.0	0.3	0.0	42.8	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.1	88.0	1.5	1.0	0.4	0.0	0.0	16.6	0.0	1.2	2.0	0.0	5.6	0.0	0.1	0.0	0.0	0.3	0.0	4.9	0.0	2.0	0.0	0.0	18.2	0.6	0.7	0.0	2.8	2.0	0.0	0.0	0.5	15.0	0.2	0.0	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	32.0	3.5	2.9	5.1	0.0	0.0	0.1	0.1	0.0	0.0	0.7
PREP		ENSG00000085377	"Prolyl endopeptidase"	P48147	6	105273218-105454062	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 84.8"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 79.7;Syncytiotrophoblasts: 67.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025414, HPA031388, HPA031389, HPA031390"	Supported		Supported	Cytosol		NA	NA		1700000	"Cluster 27: Non-specific - Gene expression"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Cytosol		"CAB025414: , HPA031388: AB_2673855, HPA031389: AB_2673856, HPA031390: AB_2673857"	"unprognostic (3.05e-2)"	"unprognostic (9.09e-3)"	"unprognostic (2.85e-2)"	"unprognostic (5.46e-2)"	"unprognostic (3.36e-1)"	"prognostic unfavorable (3.33e-4)"	"unprognostic (2.63e-3)"	"unprognostic (2.39e-1)"	"unprognostic (6.78e-2)"	"unprognostic (5.81e-2)"	"unprognostic (2.66e-2)"	"unprognostic (1.15e-1)"	"unprognostic (4.47e-3)"	"unprognostic (2.74e-2)"	"unprognostic (8.98e-2)"	"unprognostic (6.59e-2)"	"unprognostic (2.33e-1)"	17.3	17.4	7.2	14.6	8.1	14.3	17.7	7.4	12.0	15.2	7.8	32.1	23.6	15.8	12.1	21.1	13.0	8.7	22.5	8.8	7.3	11.3	19.0	16.2	13.6	6.7	7.7	16.0	19.2	20.5	13.0	17.8	6.8	11.6	37.5	15.4	18.6	9.0	84.8	33.4	25.6	15.3	6.6	14.3	18.7	21.4	8.8	16.4	12.3	46.9	16.2	21.4	17.5	8.5	22.3	26.9	27.9	32.1	63.1	37.1	27.7	28.6	27.0	37.2	39.0	35.9	14.2	28.5	26.8	33.9	35.0	33.3	41.8	86.5	42.7	41.8	37.4	38.1	21.7	40.0	25.3	40.5	26.2	35.8	53.4	27.6	71.7	28.0	35.4	50.1	67.4	49.8	45.5	38.8	25.8	41.4	27.9	44.2	25.0	41.1	48.4	18.3	28.2	53.8	36.0	51.8	25.3	42.0	21.7	35.3	17.9	61.9	36.1	17.3	23.9	21.6	36.2	14.2	9.7	38.5	30.4	42.6	56.6	5.5	15.2	8.4	16.3	16.8	16.8	9.3	14.2	17.1	16.5	6.9	12.9	15.5	0.8	19.9	22.7	7.0	13.6	13.5	7.2	8.1	7.4	12.0	8.8	7.3	6.7	7.7	6.8	6.6	8.8	8.5	6.3	3.2	6.7	22.9	10.1	10.8	6.8	12.0	5.7	5.1	6.0	5.5	14.8	7.2	13.6	7.3	14.6	28.2	14.5	19.3	5.9	10.4	1.4	6.6	15.1	10.1	19.3	11.2	79.7	11.7	35.9	10.6	24.5	11.6	13.4	11.2	7.5	15.1	15.0	13.5	48.3	29.4	10.2	14.2	10.8	3.2	10.8	13.3	5.4	27.2	19.1	3.3	5.2	28.6	18.7	18.0	29.1	9.1	11.0	5.3	18.5	8.8	4.8	10.4	0.0	8.3	10.3	3.9	18.8	12.9	8.5	67.9	16.1	14.4	38.2	8.5
PRDM1	"BLIMP1, PRDI-BF1"	ENSG00000057657	"PR/SET domain 1"	O75626	6	105993463-106109939	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Adaptive immunity, Immunity, Innate immunity, Transcription, Transcription regulation"	"DNA-binding, Methyltransferase, Repressor, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 55.2"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 199.8;Langerhans cells: 199.2;Plasma cells: 786.9;T-cells: 184.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"eosinophil: 11.1;gdT-cell: 22.1;MAIT T-cell: 34.0;memory CD4 T-cell: 20.5;memory CD8 T-cell: 20.2;naive CD8 T-cell: 11.3;neutrophil: 12.5;T-reg: 29.4"	"Group enriched"	"Detected in many"	5	"granulocytes: 12.5;T-cells: 34.0"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 212.1;RPMI-8226: 42.4;U-266/70: 81.5;U-266/84: 57.0"	"Region enriched"	"Detected in single"	6	"olfactory bulb: 3.6"	"Low region specificity"	"Detected in many"			"HPA030033, HPA075427"	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"	Nucleoli	Nucleoplasm	"HPA030033: AB_10601050, HPA075427: "	"unprognostic (9.60e-2)"	"unprognostic (3.28e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.98e-2)"	"unprognostic (4.03e-1)"	"unprognostic (3.77e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.81e-1)"	"unprognostic (3.50e-2)"	"unprognostic (7.56e-2)"	"prognostic unfavorable (9.81e-5)"	"unprognostic (1.52e-1)"	"unprognostic (3.51e-1)"	"unprognostic (2.45e-3)"	"unprognostic (7.90e-2)"	6.6	2.1	1.6	20.0	1.6	20.3	6.8	5.5	1.8	15.7	3.1	15.2	9.2	17.2	1.3	55.2	5.5	12.7	1.7	1.5	2.8	2.5	4.5	10.1	15.9	3.2	1.8	4.9	1.9	2.5	1.4	5.1	2.7	3.4	17.2	1.3	9.3	2.4	4.3	9.1	12.6	5.5	2.4	13.6	15.2	1.2	2.9	4.2	9.0	2.2	27.8	19.6	20.2	3.4	1.4	0.5	1.1	0.0	1.6	2.1	0.2	7.2	23.3	2.3	3.7	1.4	9.2	2.0	0.4	13.8	0.3	0.5	0.0	3.6	2.5	21.7	0.1	0.4	4.9	0.0	3.6	0.8	1.6	2.3	11.6	3.3	9.7	0.7	2.9	1.0	1.4	212.1	0.4	0.0	0.1	0.5	0.8	1.4	0.0	0.5	0.0	42.4	2.1	0.3	0.0	0.3	1.0	0.9	0.0	1.6	1.0	2.4	1.5	3.1	1.8	2.1	7.2	81.5	57.0	4.9	5.1	1.3	2.1	2.4	0.8	11.1	22.1	1.2	34.0	2.5	20.5	20.2	0.5	1.0	1.8	11.3	12.5	4.7	0.3	0.4	29.4	2.6	1.6	1.6	5.5	1.8	1.5	2.8	3.2	1.8	2.7	2.4	2.9	3.4	93.1	0.0	5.1	0.3	42.1	19.5	8.6	15.0	3.4	0.6	2.8	3.4	1.5	0.0	19.1	3.7	52.1	0.7	199.8	129.8	0.0	0.3	0.9	15.9	101.0	41.1	1.8	6.1	1.8	0.2	0.7	18.5	19.4	62.6	3.8	9.9	6.4	2.5	19.8	0.0	19.2	15.0	10.2	38.0	199.2	0.3	0.0	64.5	37.4	23.4	30.4	0.5	89.6	0.5	0.1	7.8	103.7	1.2	786.9	4.0	3.2	0.3	13.0	1.1	0.0	5.3	30.1	0.5	2.3	43.9	41.5	0.7	184.3	1.6	8.7	91.9
ATG5	"APG5, APG5L, ASP, hAPG5"	ENSG00000057663	"Autophagy related 5"	Q9H1Y0	6	106045423-106325791	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Apoptosis, Autophagy, Host-virus interaction, Immunity"		"Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034432, CAB037309, HPA042973"	Approved		Approved	Centrosome	"Intracellular and membrane"	NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Centrosome		"CAB034432: AB_2243288, CAB037309: AB_796188, HPA042973: AB_2678246"	"unprognostic (1.21e-3)"	"unprognostic (6.53e-3)"	"unprognostic (2.68e-3)"	"unprognostic (4.14e-1)"	"unprognostic (1.13e-1)"	"unprognostic (6.35e-3)"	"prognostic unfavorable (8.84e-4)"	"unprognostic (1.60e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.34e-1)"	"unprognostic (9.60e-2)"	"unprognostic (2.12e-1)"	"prognostic unfavorable (8.73e-4)"	"unprognostic (1.86e-1)"	"unprognostic (2.37e-1)"	"unprognostic (2.51e-1)"	"unprognostic (6.42e-2)"	12.5	19.2	9.9	6.7	10.2	8.1	15.4	10.5	13.2	15.3	10.7	15.8	12.8	14.9	16.6	12.3	14.7	9.5	9.7	10.3	10.7	14.4	17.7	10.8	8.5	10.0	10.3	14.3	12.1	11.8	7.9	13.2	9.9	15.3	15.2	10.5	11.8	13.1	15.7	8.0	13.1	14.2	9.5	10.6	12.0	8.3	10.2	9.4	17.5	15.2	9.8	13.4	11.9	10.5	14.6	6.0	10.3	14.0	23.2	24.0	10.7	15.4	24.6	22.2	27.2	6.2	8.6	10.2	12.0	23.7	25.0	10.2	15.2	22.2	39.2	4.6	7.3	11.8	6.8	7.8	25.0	14.6	6.0	19.3	24.8	16.1	20.0	29.7	23.9	9.4	17.6	10.0	25.7	6.4	6.0	17.5	11.9	19.4	8.3	6.0	23.7	7.9	24.0	10.3	7.1	6.9	9.4	17.8	14.6	18.6	8.5	27.5	19.8	8.6	4.8	10.1	26.7	4.1	4.2	9.3	31.7	19.6	16.1	4.7	4.8	9.6	2.9	6.1	8.4	5.1	5.6	4.6	5.3	3.3	6.0	5.0	4.1	4.8	8.8	1.9	6.9	3.3	9.9	10.2	10.5	13.2	10.3	10.7	10.0	10.3	9.9	9.5	10.2	10.5	35.8	22.4	18.9	24.2	41.3	26.3	28.5	45.2	25.6	14.8	25.5	26.5	18.1	25.8	36.7	25.8	16.7	47.3	46.5	48.3	29.4	39.6	35.7	33.0	27.4	25.9	19.2	27.0	79.2	44.9	63.8	25.8	42.3	34.5	20.3	20.4	21.8	20.7	38.1	20.2	71.5	38.4	36.7	26.9	32.3	13.7	20.5	33.6	23.2	43.1	44.6	18.3	44.3	43.7	49.1	40.5	59.8	18.0	85.9	40.8	49.2	43.2	30.0	17.9	26.3	23.6	32.1	36.5	39.6	28.5	27.1	66.5	47.3	21.9	36.6	43.0
CRYBG1	"AIM1, ST4"	ENSG00000112297	"Crystallin beta-gamma domain containing 1"		6	106360717-106572017	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enhanced"	"Detected in many"		"esophagus: 61.9;placenta: 72.0"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 219.4;dendritic cells: 153.6;Plasma cells: 89.9;Syncytiotrophoblasts: 600.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 93.7;HBEC3-KT: 124.1;hTERT-HME1: 95.8"	"Region enriched"	"Detected in single"	5	"olfactory bulb: 4.2"	"Low region specificity"	"Detected in many"			"CAB026378, HPA030948, HPA030949"	Approved		Approved	Nucleoplasm,Microtubules,Cytosol		NA	NA			"Cluster 13: T-cells - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Microtubules, Cytosol"		"CAB026378: , HPA030948: AB_2673670, HPA030949: AB_2673671"	"unprognostic (1.66e-1)"	"unprognostic (3.44e-2)"	"unprognostic (9.02e-3)"	"unprognostic (1.13e-1)"	"unprognostic (3.80e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.27e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.69e-3)"	"unprognostic (5.61e-2)"	"unprognostic (8.97e-2)"	"unprognostic (3.53e-2)"	"unprognostic (8.89e-2)"	"unprognostic (8.60e-2)"	"unprognostic (3.25e-2)"	17.0	1.2	0.6	21.9	0.5	24.1	17.3	0.7	0.8	6.8	40.3	25.0	25.4	2.4	6.2	61.9	6.7	8.1	1.0	1.9	0.4	15.3	11.8	9.8	20.4	0.8	0.7	2.3	4.9	5.8	0.4	72.0	0.6	25.2	19.2	0.8	9.3	5.4	1.1	42.1	23.7	4.8	0.5	12.6	10.3	5.1	1.5	9.7	2.6	1.2	33.5	19.0	14.0	0.4	34.7	0.2	0.0	0.1	25.5	93.7	9.9	4.9	33.5	10.8	10.0	2.4	11.5	54.0	2.3	21.7	14.6	54.5	0.2	124.1	5.3	74.0	2.3	0.0	1.5	16.9	12.1	33.4	0.2	44.9	66.7	19.7	95.8	0.1	46.5	41.9	1.7	7.3	28.5	3.5	9.7	10.7	0.4	0.2	21.2	16.4	0.4	0.4	14.9	80.0	2.2	0.2	20.3	31.9	0.3	3.0	16.4	24.3	13.5	11.6	1.5	0.2	34.4	5.7	4.7	57.7	56.0	39.3	26.3	0.3	3.4	0.4	7.4	3.6	10.1	6.6	9.8	8.5	8.6	2.9	5.8	5.7	2.4	4.8	4.1	1.0	9.9	4.0	0.6	0.5	0.7	0.8	1.9	0.4	0.8	0.7	0.6	0.5	1.5	0.4	13.4	12.8	11.9	0.0	24.2	0.0	0.0	0.0	0.0	0.0	31.2	14.1	0.0	0.0	13.0	33.1	0.0	219.4	153.6	0.0	3.9	10.9	0.0	20.2	2.7	4.4	0.0	0.0	0.0	12.5	15.3	2.5	0.0	31.6	1.3	0.1	0.0	0.0	36.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	34.8	0.0	0.0	5.7	0.0	0.0	0.0	0.0	26.4	0.0	0.0	89.9	0.0	0.0	15.0	8.7	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	600.1	76.7	0.1	0.0	0.0
RTN4IP1	NIMP	ENSG00000130347	"Reticulon 4 interacting protein 1"	Q8WWV3	6	106570771-106629498	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	Neurogenesis		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 27.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036357	Approved					NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA036357: AB_10673128"	"prognostic unfavorable (9.18e-6)"	"unprognostic (5.87e-2)"	"unprognostic (2.20e-3)"	"unprognostic (2.88e-1)"	"unprognostic (3.51e-2)"	"unprognostic (3.71e-2)"	"unprognostic (7.37e-3)"	"unprognostic (1.57e-1)"	"unprognostic (7.77e-2)"	"unprognostic (3.35e-1)"	"unprognostic (2.51e-2)"	"unprognostic (1.72e-2)"	"prognostic favorable (8.55e-6)"	"unprognostic (1.62e-1)"	"unprognostic (9.82e-2)"	"unprognostic (3.71e-1)"	"unprognostic (5.76e-2)"	2.5	6.8	2.8	3.1	3.0	1.8	3.2	3.3	3.9	2.6	3.3	6.3	4.8	2.7	5.5	4.2	2.7	1.6	14.7	2.7	2.7	6.4	7.4	2.0	4.6	2.5	2.5	2.2	3.2	5.2	4.5	2.2	2.8	2.7	6.0	6.0	4.6	2.7	15.6	2.9	4.5	2.9	2.5	4.2	5.9	5.5	2.8	3.0	4.0	15.4	6.1	2.9	2.8	3.4	7.6	10.8	7.3	12.6	5.9	3.5	8.6	5.0	7.0	7.7	7.4	17.4	4.1	11.6	7.6	6.5	15.1	10.8	13.0	10.7	12.1	8.1	7.4	12.1	8.4	14.0	6.1	12.5	8.1	5.2	8.3	10.3	6.7	4.7	6.9	16.3	21.7	4.7	8.5	11.3	4.7	14.4	9.1	10.7	7.9	16.1	13.3	8.8	12.4	8.1	7.1	5.7	4.7	12.3	11.2	7.5	15.5	8.0	3.6	4.4	6.1	8.8	8.9	3.5	5.7	24.8	11.5	18.1	9.6	0.1	4.6	2.2	3.2	5.1	3.3	11.4	4.4	3.4	10.7	16.0	4.0	3.9	0.8	6.5	3.7	5.6	8.2	3.3	2.8	3.0	3.3	3.9	2.7	2.7	2.5	2.5	2.8	2.5	2.8	3.4	1.6	0.0	2.8	7.8	8.1	0.8	1.9	6.4	0.6	5.5	2.8	1.7	18.4	4.3	3.1	1.8	8.4	12.5	1.3	5.2	27.4	6.7	8.5	7.6	2.0	2.1	4.2	1.3	15.6	8.6	15.0	2.1	4.1	4.2	2.5	3.6	2.5	5.5	7.3	0.0	17.2	3.0	10.2	5.4	1.8	3.4	0.6	3.6	0.0	8.4	0.9	3.7	1.0	6.6	17.5	4.9	3.0	1.9	4.2	1.2	3.3	14.5	5.4	6.2	13.1	2.1	2.5	11.9	16.7	4.1	1.0	5.6	2.8	5.6	6.4	2.0
QRSL1	"DKFZP564C1278, FLJ10989, FLJ12189, FLJ13447, GatA"	ENSG00000130348	"Glutaminyl-tRNA amidotransferase subunit QRSL1"	Q9H0R6	6	106629578-106668417	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Protein biosynthesis"	Ligase	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"B-cells: 64.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	6	"memory B-cell: 86.4;naive B-cell: 71.0"	"Lineage enriched"	"Detected in all"	7	"B-cells: 86.4"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029585, HPA029587"	Approved		Approved	Vesicles,Centrosome		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 57: B-cells - Immune response"	Vesicles	Centrosome	"HPA029585: AB_10599823, HPA029587: AB_10602311"	"unprognostic (1.86e-3)"	"unprognostic (5.58e-2)"	"unprognostic (6.19e-3)"	"unprognostic (3.45e-1)"	"unprognostic (2.11e-3)"	"unprognostic (1.31e-2)"	"prognostic unfavorable (7.97e-5)"	"unprognostic (8.36e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.03e-2)"	"unprognostic (1.66e-1)"	"prognostic favorable (3.83e-4)"	"unprognostic (2.06e-1)"	"unprognostic (2.09e-1)"	"unprognostic (2.04e-1)"	"unprognostic (3.46e-1)"	5.0	5.7	4.0	8.6	5.2	6.4	7.4	4.7	5.0	4.8	5.8	8.2	7.8	6.3	6.1	5.7	5.4	4.8	10.1	4.1	4.5	9.3	7.8	4.6	15.9	4.6	4.5	5.6	6.0	9.4	4.3	5.7	5.0	5.3	9.1	8.4	6.1	5.6	19.4	5.9	8.9	5.8	4.1	10.5	6.7	6.6	4.5	8.2	9.2	21.3	15.5	5.7	4.9	7.4	9.0	9.1	12.3	17.8	7.8	9.7	17.3	10.0	10.2	13.1	13.0	10.7	7.1	29.7	8.9	11.2	13.5	15.5	18.6	12.1	16.4	14.2	14.1	14.5	9.7	11.1	12.2	33.2	12.5	9.6	18.6	14.0	20.6	9.9	9.5	18.4	26.8	9.4	11.0	10.1	10.7	16.1	12.9	15.6	10.5	28.9	15.8	7.5	14.3	10.2	10.7	11.0	8.0	18.4	15.3	10.7	12.1	25.3	9.3	9.2	7.6	10.0	15.7	5.4	8.3	17.2	12.6	22.1	14.0	5.0	6.4	1.0	6.4	9.6	6.3	86.4	7.1	5.6	10.7	71.0	6.6	6.4	1.6	7.0	13.0	8.5	8.5	5.7	4.0	5.2	4.7	5.0	4.1	4.5	4.6	4.5	5.0	4.1	4.5	7.4	9.0	19.2	12.5	20.2	64.6	4.0	8.4	12.8	6.2	14.9	10.3	6.1	24.8	7.2	9.3	11.0	16.7	21.5	12.3	11.0	17.6	15.4	15.5	28.2	12.0	10.8	17.4	13.7	14.6	18.4	23.0	9.9	15.3	14.8	18.9	15.3	8.2	14.6	12.9	3.3	18.9	11.2	14.2	12.4	6.1	8.4	8.4	10.0	8.8	12.2	18.3	9.9	19.6	22.6	26.5	14.2	8.3	9.1	13.2	9.3	12.2	19.5	19.9	19.1	0.0	10.0	10.0	25.6	14.2	12.2	5.4	12.3	14.3	21.1	18.7	8.9
CD24	CD24A	ENSG00000272398	"CD24 molecule"	P25063	6	106969831-106975627	"Cancer-related genes, CD markers, Disease related genes, Predicted intracellular proteins"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"thyroid gland: 1630.2"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 1572.7;Distal tubular cells: 1590.6;Exocrine glandular cells: 3454.1;Glandular and luminal cells: 1441.8;Pancreatic endocrine cells: 1694.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	28	"eosinophil: 86.2;memory B-cell: 61.1;naive B-cell: 39.7"	"Group enriched"	"Detected in many"	237	"B-cells: 61.1;granulocytes: 86.2"	"Cell line enhanced"	"Detected in many"		"NTERA-2: 989.4;RPTEC TERT1: 4702.6;RT4: 931.5;SK-BR-3: 1352.5"									"HPA045879, CAB078471"	Approved		Enhanced	Vesicles	"Intracellular and membrane"	NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 30: Mammary glandular cells - Lactation"	Vesicles		"CAB078471: AB_10983158, HPA045879: AB_2732523"	"prognostic unfavorable (2.44e-5)"	"unprognostic (6.64e-2)"	"prognostic favorable (3.29e-4)"	"unprognostic (1.87e-1)"	"unprognostic (1.41e-2)"	"unprognostic (9.98e-2)"	"prognostic unfavorable (7.58e-4)"	"unprognostic (2.32e-1)"	"unprognostic (2.74e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.51e-1)"	"unprognostic (5.10e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.01e-1)"	"unprognostic (3.13e-1)"	7.1	61.9	23.3	139.1	28.8	704.5	468.1	6.4	30.0	288.0	36.7	1071.8	89.0	181.5	229.6	1456.5	242.9	874.3	5.1	45.0	29.2	775.6	30.2	61.6	77.8	26.6	26.0	2.2	1383.4	2.5	12.5	151.7	17.2	148.8	740.8	2.6	952.4	546.9	1.4	77.2	69.8	117.7	19.5	29.6	601.7	4.9	38.6	15.2	1630.2	1.1	445.0	168.9	468.3	50.7	363.2	225.2	3.9	28.6	0.7	0.3	405.8	0.4	2.6	2.0	1.2	3.3	1.9	35.4	106.0	0.1	14.6	730.6	124.1	275.6	1.5	1.0	1.7	1.0	254.2	16.3	0.2	5.1	1.8	2.1	316.1	3.6	18.0	16.9	1.6	1.4	8.3	0.8	6.6	465.6	2.4	2.6	989.4	800.1	85.6	846.8	0.5	3.5	4702.6	931.5	612.4	448.7	250.0	1352.5	1.4	437.1	635.6	2.1	1.6	0.8	4.0	3.1	11.8	1.0	2.0	475.2	5.0	2.9	1.6	0.3	0.1	86.2	0.0	0.0	0.0	61.1	0.0	0.0	0.0	39.7	0.0	0.1	2.1	0.1	0.3	0.1	0.0	2.0	23.3	28.8	6.4	30.0	45.0	29.2	26.6	26.0	17.2	19.5	38.6	50.7	10.2	157.0	83.5	0.7	157.5	0.0	70.4	0.0	7.4	5.8	1109.4	325.4	1.5	1112.3	98.4	1302.1	2.1	749.2	13.7	1572.7	1590.6	1274.1	22.5	1237.6	254.2	38.6	575.4	5.3	0.6	3454.1	885.0	29.9	567.2	1441.8	10.8	0.6	97.5	9.7	70.8	0.0	5.7	463.6	0.0	7.6	0.0	53.4	10.2	17.6	0.0	1.0	32.6	1.0	0.0	0.0	0.1	1694.3	865.2	2.2	1.0	810.2	12.3	538.5	376.8	0.7	6.6	2.9	18.1	0.6	7.2	587.7	0.0	558.3	28.1	0.0	932.8	1043.7
MTRES1	"C6orf203, HSPC230, PRED31"	ENSG00000130349	"Mitochondrial transcription rescue factor 1"	Q9P0P8	6	107028199-107051586	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"Cardiomyocytes: 47.4;Cytotrophoblasts: 31.6;Extravillous trophoblasts: 14.3;Hofbauer cells: 24.3;Syncytiotrophoblasts: 18.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049535	Approved					NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 24: Non-specific - Transcription regulation"			"HPA049535: AB_2680808"	"unprognostic (1.34e-3)"	"unprognostic (9.38e-2)"	"unprognostic (1.14e-2)"	"unprognostic (2.97e-2)"	"unprognostic (8.11e-2)"	"unprognostic (2.71e-2)"	"unprognostic (3.44e-2)"	"unprognostic (1.89e-2)"	"unprognostic (4.24e-2)"	"unprognostic (1.05e-2)"	"prognostic favorable (3.29e-4)"	"unprognostic (2.28e-1)"	"prognostic favorable (4.09e-5)"	"unprognostic (2.64e-1)"	"unprognostic (9.98e-2)"	"unprognostic (3.19e-2)"	"prognostic favorable (2.11e-5)"	14.5	33.1	22.3	8.8	22.6	5.6	12.5	23.9	35.7	11.0	24.7	19.6	17.4	11.4	19.0	14.7	11.1	8.2	33.9	22.2	23.3	25.1	28.7	7.9	11.3	22.2	22.6	11.2	13.7	14.0	12.1	8.8	22.0	11.1	17.8	12.3	16.1	11.7	41.8	10.8	14.8	10.1	22.1	13.1	15.4	9.5	22.4	10.4	16.3	36.8	12.2	13.3	11.4	23.1	11.6	7.1	21.5	30.5	39.1	33.6	8.9	24.1	19.1	15.7	20.2	4.6	8.7	31.8	17.6	17.5	17.2	16.1	15.4	20.9	21.6	25.9	11.5	19.5	7.0	7.7	26.0	23.0	10.2	24.3	29.2	13.6	19.6	21.1	22.3	24.5	22.7	23.8	33.5	15.9	10.5	34.3	10.3	36.9	12.0	19.0	17.8	14.7	41.0	16.2	13.6	14.1	11.9	15.6	22.5	16.0	12.6	40.7	17.4	10.6	10.3	13.4	13.0	5.0	7.8	17.2	18.5	35.6	22.7	1.4	14.9	14.2	16.0	15.9	16.7	20.6	18.4	17.8	21.1	19.6	25.0	21.8	1.7	20.3	14.6	21.0	26.5	13.6	22.3	22.6	23.9	35.7	22.2	23.3	22.2	22.6	22.0	22.1	22.4	23.1	2.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	47.4	0.0	0.0	0.0	0.0	31.6	1.6	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	14.3	5.6	0.0	0.0	0.0	0.0	0.0	0.0	24.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	18.2	0.2	0.0	0.0	0.0
BEND3	KIAA1553	ENSG00000178409	"BEN domain containing 3"	Q5T5X7	6	107065182-107115515	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 6.2;Late spermatids: 6.9"	"Cancer enriched"	"Detected in all"	4	"testis cancer: 12.0"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"HPA017891, HPA062067"	Uncertain		Approved	Nucleoplasm		NA	NA				"Cluster 22: Non-specific - Unknown function"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoplasm		"HPA017891: AB_2064595, HPA062067: AB_2684675"	"unprognostic (2.86e-2)"	"unprognostic (3.16e-1)"	"unprognostic (9.47e-3)"	"unprognostic (4.25e-3)"	"unprognostic (1.04e-1)"	"unprognostic (2.43e-2)"	"unprognostic (8.37e-8)"	"unprognostic (1.59e-1)"	"unprognostic (9.71e-2)"	"unprognostic (3.99e-2)"	"unprognostic (2.71e-2)"	"unprognostic (6.89e-2)"	"unprognostic (1.12e-2)"	"unprognostic (8.65e-2)"	"unprognostic (3.49e-1)"	"unprognostic (1.09e-1)"	"unprognostic (4.37e-1)"	0.8	0.7	1.0	0.9	0.8	0.9	0.7	2.1	0.9	0.7	0.4	1.5	1.2	0.8	1.0	0.9	0.9	0.6	1.0	0.7	0.7	1.2	0.7	0.9	0.8	0.7	0.7	0.7	1.5	0.6	0.8	0.5	0.7	1.0	1.5	0.8	1.5	0.4	1.2	0.6	1.1	0.7	0.8	0.6	2.0	1.8	1.0	1.0	0.8	0.6	0.8	0.7	0.5	0.9	2.9	4.0	11.3	6.4	1.3	0.9	9.3	1.1	1.4	1.4	1.6	4.7	2.1	8.6	2.8	3.0	2.6	2.8	12.2	6.3	2.3	3.4	6.1	2.2	3.1	5.2	1.0	6.1	2.9	2.4	2.6	2.2	3.1	1.0	1.9	4.0	6.7	3.4	1.9	5.8	5.3	4.7	15.9	7.4	2.5	7.3	3.2	5.7	2.4	8.6	11.3	5.5	3.6	6.0	2.2	5.7	3.6	4.9	2.2	4.1	3.7	1.8	5.5	2.3	3.4	8.7	1.3	4.7	3.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.8	2.1	0.9	0.7	0.7	0.7	0.7	0.7	0.8	1.0	0.9	1.3	3.2	2.7	1.3	0.7	2.9	1.1	0.8	1.8	1.0	1.3	0.8	3.0	4.3	1.8	0.0	6.2	1.1	0.8	0.6	0.0	1.0	5.8	1.3	1.8	1.2	1.2	0.8	1.2	1.8	1.2	1.2	2.6	1.5	0.0	1.9	0.0	0.5	0.6	0.0	2.1	2.4	0.0	1.0	1.2	6.9	0.9	1.0	0.0	1.0	0.1	0.5	0.0	3.0	1.6	1.4	0.8	0.0	1.6	1.6	0.5	0.9	1.1	1.5	0.0	2.1	2.5	0.7	2.5	1.8	3.0	0.8	1.1	0.5	3.3	0.9
PDSS2	"bA59I9.3, C6orf210, COQ1B"	ENSG00000164494	"Decaprenyl diphosphate synthase subunit 2"	Q86YH6	6	107152562-107459564	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Isoprene biosynthesis, Ubiquinone biosynthesis"	Transferase	"Cancer-related genes, Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Microglial cells: 82.4;Oligodendrocyte precursor cells: 72.9;Oligodendrocytes: 74.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029685, HPA029686"	Approved		Supported	Cytosol		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 32: U-937 - Innate immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Cytosol		"HPA029685: AB_10600219, HPA029686: AB_10602309"	"prognostic unfavorable (1.34e-5)"	"unprognostic (1.44e-1)"	"prognostic favorable (5.74e-5)"	"unprognostic (5.76e-2)"	"unprognostic (1.42e-1)"	"unprognostic (3.30e-2)"	"unprognostic (3.26e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.18e-1)"	"unprognostic (9.38e-2)"	"unprognostic (2.19e-1)"	"prognostic favorable (3.75e-7)"	"unprognostic (2.25e-1)"	"unprognostic (2.86e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.11e-2)"	7.9	17.9	4.6	6.3	5.2	9.0	8.1	6.1	5.7	9.2	6.8	12.4	9.3	6.8	6.5	8.6	8.6	8.7	13.9	4.6	5.2	21.6	27.1	8.0	7.6	4.9	4.7	9.1	8.4	13.2	8.5	6.8	5.0	14.6	13.2	6.0	15.3	7.4	12.5	6.3	9.6	8.5	4.7	6.7	9.6	7.7	5.3	8.1	13.3	13.7	7.1	7.6	6.1	6.1	7.6	10.0	8.3	13.2	14.2	18.0	19.2	13.1	16.5	12.4	11.8	10.0	10.8	14.4	11.7	14.7	13.1	10.2	20.3	16.5	16.7	9.1	9.8	14.4	11.4	16.9	15.0	18.5	11.1	13.5	19.1	19.5	15.3	10.8	13.1	16.5	20.7	19.0	12.2	9.3	5.4	19.7	5.3	17.3	12.7	9.7	7.4	11.7	15.2	10.2	8.2	7.1	9.0	15.4	19.7	9.0	12.7	22.3	8.3	8.8	5.2	12.4	11.4	5.3	6.8	11.3	16.3	27.4	16.3	3.2	5.1	2.8	3.7	5.9	5.9	4.7	3.8	4.7	7.0	5.5	5.0	4.8	0.6	3.6	9.9	3.3	5.5	3.4	4.6	5.2	6.1	5.7	4.6	5.2	4.9	4.7	5.0	4.7	5.3	6.1	11.4	16.0	19.1	64.9	12.3	4.2	13.8	11.7	13.6	8.2	9.7	8.3	17.4	12.8	13.9	14.7	2.1	26.9	8.3	15.1	35.2	12.7	37.3	16.3	9.3	8.4	10.3	8.0	53.5	14.5	17.3	9.5	8.2	10.9	14.0	11.9	7.5	32.6	11.8	6.7	67.3	15.3	14.2	9.8	5.1	12.7	5.3	10.2	7.2	82.4	8.5	11.8	6.2	72.9	74.5	13.7	14.4	9.4	13.0	12.2	14.2	40.8	21.0	11.5	26.3	8.7	7.9	21.7	11.5	14.3	5.8	11.9	9.8	13.4	17.0	12.5
SOBP	FLJ10159	ENSG00000112320	"Sine oculis binding protein homolog"	A7XYQ1	6	107490106-107661306	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 175.3;Excitatory neurons: 260.1;Granulosa cells: 149.3;Inhibitory neurons: 287.7;Oligodendrocyte precursor cells: 263.9;Oligodendrocytes: 278.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"naive B-cell: 1.3"	"Lineage enriched"	"Detected in single"	13	"B-cells: 1.3"	"Cell line enhanced"	"Detected in many"		"AF22: 10.5;AN3-CA: 13.9;ASC diff: 12.9;HDLM-2: 9.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029242	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 47: Non-specific - Unknown function"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	Vesicles	"HPA029242: AB_10603340"	"unprognostic (7.11e-2)"	"unprognostic (1.35e-3)"	"unprognostic (9.01e-2)"	"unprognostic (2.04e-3)"	"unprognostic (3.09e-1)"	"unprognostic (1.12e-1)"	"unprognostic (3.80e-2)"	"unprognostic (5.63e-2)"	"unprognostic (9.84e-2)"	"unprognostic (5.35e-3)"	"prognostic favorable (1.55e-5)"	"unprognostic (6.64e-2)"	"unprognostic (2.00e-3)"	"unprognostic (5.41e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.95e-3)"	4.5	6.6	12.4	1.7	14.5	0.0	3.4	9.0	16.9	6.2	0.4	14.6	1.2	5.6	2.0	2.0	4.3	2.7	10.9	15.3	8.2	3.4	1.6	2.4	0.9	6.7	9.1	10.8	1.4	3.1	9.4	2.3	6.2	8.2	1.3	5.3	10.4	2.6	16.7	1.2	3.2	3.9	6.5	1.9	4.8	4.2	9.5	2.7	4.2	5.9	1.1	11.9	4.4	11.4	0.0	0.3	10.5	13.9	12.9	4.9	1.2	0.0	0.0	0.3	0.6	0.0	0.0	5.7	0.3	0.0	0.9	0.0	7.0	0.2	0.2	9.0	6.8	0.6	0.0	6.8	1.6	3.0	0.5	5.2	0.0	5.1	0.0	1.1	4.2	2.6	0.0	0.3	0.0	2.9	1.3	0.3	2.5	0.3	0.9	3.1	1.3	0.0	0.0	0.2	3.3	5.6	1.2	0.0	0.1	0.4	0.4	2.0	0.0	3.3	1.1	5.7	0.5	2.6	0.5	3.5	0.1	1.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.4	14.5	9.0	16.9	15.3	8.2	6.7	9.1	6.2	6.5	9.5	11.4	6.0	3.2	9.8	175.3	9.2	0.5	10.3	11.4	3.4	40.4	0.5	7.4	19.4	17.2	6.1	23.9	0.0	0.2	1.8	0.2	0.0	2.5	96.2	0.6	15.8	4.4	10.8	5.3	260.1	0.2	0.7	23.6	3.1	0.4	0.0	149.3	5.3	1.4	3.0	92.5	287.7	0.1	4.1	9.6	4.1	61.4	45.1	1.8	3.6	51.5	0.1	7.6	0.0	263.9	278.8	0.4	0.0	48.9	0.2	9.3	0.0	11.9	10.9	10.1	26.3	42.8	21.0	61.2	5.6	0.6	0.9	0.1	1.3	13.3	0.2	1.0
SCML4	dJ47M23.1	ENSG00000146285	"Scm polycomb group protein like 4"	Q8N228	6	107702154-107824317	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 10.1;lymphoid tissue: 12.1"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 31.7;Early spermatids: 72.1;Late spermatids: 168.4;NK-cells: 35.0;T-cells: 73.3"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	6	"gdT-cell: 48.2;MAIT T-cell: 47.7;memory CD4 T-cell: 74.8;memory CD8 T-cell: 65.7;naive CD4 T-cell: 69.1;naive CD8 T-cell: 59.5;NK-cell: 53.2"	"Group enriched"	"Detected in many"	6	"NK-cells: 53.2;T-cells: 74.8"	"Cell line enriched"	"Detected in some"	5	"HDLM-2: 65.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA063326, HPA065958"	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 58: T-cells - T-cell receptor"	Nucleoplasm		"HPA063326: AB_2684986, HPA065958: AB_2685587"	"unprognostic (4.00e-5)"	"unprognostic (2.10e-3)"	"unprognostic (4.71e-2)"	"unprognostic (4.24e-3)"	"unprognostic (1.38e-3)"	"unprognostic (4.75e-4)"	"unprognostic (3.84e-3)"	"unprognostic (6.65e-3)"	"unprognostic (4.26e-1)"	"unprognostic (1.53e-2)"	"unprognostic (2.13e-4)"	"unprognostic (3.68e-1)"	"unprognostic (3.77e-4)"	"unprognostic (8.65e-2)"	"unprognostic (3.68e-2)"	"unprognostic (2.52e-3)"	"unprognostic (5.09e-3)"	0.6	0.8	0.8	7.2	0.6	3.3	1.0	1.2	0.7	0.5	0.2	2.3	10.1	0.5	4.6	0.9	0.7	1.4	0.6	0.6	0.9	0.6	1.6	1.7	12.1	0.5	0.5	0.6	0.7	0.2	1.9	0.3	0.3	0.6	2.0	0.9	1.0	0.4	0.4	0.9	8.2	0.5	0.1	7.4	2.8	2.2	1.3	9.3	0.8	0.2	9.8	1.1	0.7	0.6	0.1	0.1	0.1	0.1	0.1	0.3	0.8	0.1	0.0	0.0	0.0	1.4	0.2	0.2	0.1	0.0	0.1	0.2	0.0	0.0	0.1	65.1	0.0	0.1	0.4	0.2	0.0	0.3	0.1	0.1	0.0	0.0	0.1	0.2	0.2	0.7	0.1	0.1	0.0	0.1	0.0	0.2	0.1	0.1	0.0	0.1	0.3	0.1	0.0	0.2	0.1	0.3	0.1	0.1	13.8	0.2	0.1	0.1	0.0	0.1	0.2	0.3	0.1	0.3	0.2	0.7	0.1	0.1	0.1	4.2	0.3	3.5	48.2	0.1	47.7	10.1	74.8	65.7	0.2	5.8	69.1	59.5	6.6	53.2	0.4	1.2	5.8	26.6	0.8	0.6	1.2	0.7	0.6	0.9	0.5	0.5	0.3	0.1	1.3	0.6	0.5	0.0	0.0	0.7	18.0	1.5	0.0	0.0	0.6	0.6	0.4	0.4	1.1	0.0	0.0	0.0	0.0	1.3	31.7	0.4	0.0	1.2	72.1	0.0	0.1	0.7	0.0	1.3	2.7	0.0	0.2	1.0	4.6	0.1	1.3	0.0	1.1	1.8	0.2	1.7	2.5	1.4	0.0	0.8	1.4	168.4	0.9	1.2	3.6	1.9	2.0	0.0	35.0	0.5	0.1	0.1	2.6	0.7	11.6	0.0	5.5	0.4	0.7	0.0	0.0	0.3	0.6	1.1	0.5	0.3	0.1	0.1	73.3	0.0	4.7	0.1
SEC63	"DNAJC23, ERdj2, PRO2507, SEC63L"	ENSG00000025796	"SEC63 homolog, protein translocation regulator"	Q9UGP8	6	107867756-107958208	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Protein transport, Transport"	Chaperone	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Theca cells: 354.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053295, HPA060535"	Supported		Supported	"Endoplasmic reticulum"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 52: Non-specific - Transcription"	"Endoplasmic reticulum"		"HPA053295: AB_2682105, HPA060535: AB_2684312"	"prognostic unfavorable (3.32e-4)"	"prognostic unfavorable (4.01e-4)"	"unprognostic (4.08e-1)"	"unprognostic (1.56e-1)"	"unprognostic (4.36e-3)"	"unprognostic (1.51e-2)"	"unprognostic (8.33e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.27e-1)"	"unprognostic (1.72e-1)"	"prognostic unfavorable (6.16e-4)"	"unprognostic (2.35e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.56e-1)"	"unprognostic (4.41e-2)"	27.5	33.0	11.6	22.0	14.3	32.9	23.3	14.4	12.9	30.2	25.7	19.2	16.8	25.2	29.6	19.5	21.8	22.0	19.0	12.4	15.3	20.0	46.6	21.7	16.7	13.3	12.0	40.4	61.2	31.7	14.4	20.9	14.2	27.7	18.6	21.2	77.8	23.3	14.3	15.5	18.0	22.2	12.3	16.1	23.1	33.0	12.1	22.6	52.1	14.1	17.3	21.8	14.0	17.7	28.5	17.1	46.0	57.6	47.1	55.2	41.4	59.2	65.0	27.8	39.2	30.8	34.6	52.8	49.4	53.7	34.4	40.9	32.3	38.3	42.5	63.8	35.7	57.2	25.2	31.6	73.2	65.9	32.5	43.5	61.4	44.5	97.6	50.0	39.3	31.7	48.5	82.8	57.7	22.7	20.6	29.5	36.4	30.0	18.1	65.2	54.4	43.7	33.5	37.1	40.3	45.7	32.9	48.8	59.1	31.2	34.9	95.8	42.5	41.6	25.8	42.2	46.6	31.4	25.0	52.9	45.9	56.4	48.7	5.6	5.2	5.0	4.8	4.7	7.5	4.4	3.9	3.9	5.4	4.0	4.3	3.4	1.7	7.1	9.8	6.9	2.2	3.5	11.6	14.3	14.4	12.9	12.4	15.3	13.3	12.0	14.2	12.3	12.1	17.7	55.6	118.6	143.3	38.2	64.4	85.0	70.5	90.9	42.7	57.7	67.8	54.2	78.8	81.5	125.5	53.3	39.6	80.8	71.6	39.2	11.7	86.0	40.3	48.7	102.8	61.6	53.5	31.5	52.5	125.4	96.4	107.1	46.9	54.8	68.9	84.8	59.6	126.7	62.7	47.1	50.8	80.0	83.4	56.7	78.9	23.9	106.2	54.8	80.0	42.2	54.3	61.0	59.8	60.3	64.8	81.9	53.5	118.8	144.6	91.1	37.2	38.4	116.7	49.9	46.0	108.2	77.2	143.1	75.0	44.7	80.0	91.0	52.3	354.8	60.8	73.8
OSTM1	"GL, HSPC019"	ENSG00000081087	"Osteoclastogenesis associated transmembrane protein 1"	Q86WC4	6	108041409-108165854	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			Osteopetrosis	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Melanocytes: 151.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010851	Uncertain		Approved	Nucleoplasm,Vesicles,Cytosol		No	No		210000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 18: U-2197 - ECM organization"	"Cluster 4: Macrophages - Innate immune response"	Cytosol	"Nucleoplasm, Vesicles"	"HPA010851: AB_1079533"	"prognostic unfavorable (4.36e-4)"	"unprognostic (4.03e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.72e-3)"	"prognostic unfavorable (4.26e-4)"	"unprognostic (9.40e-2)"	"unprognostic (2.56e-1)"	"unprognostic (2.25e-1)"	"unprognostic (4.06e-2)"	"unprognostic (2.65e-1)"	"prognostic unfavorable (1.34e-6)"	"prognostic unfavorable (1.20e-4)"	"unprognostic (2.32e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.77e-1)"	26.1	19.1	4.7	17.9	5.2	5.7	9.8	5.1	5.8	10.4	33.1	12.2	7.9	13.7	9.0	12.7	9.5	12.5	19.2	5.3	9.2	15.6	13.1	16.2	14.7	6.0	7.6	7.5	5.8	15.3	8.3	14.1	7.9	13.8	11.1	17.6	8.9	16.7	11.8	9.8	9.0	23.3	5.3	18.3	8.5	10.1	7.4	13.7	10.7	11.5	13.5	16.9	7.0	8.3	6.0	17.2	20.1	29.4	59.0	19.0	28.6	42.8	42.7	30.7	50.4	10.0	9.8	13.7	34.4	30.0	82.5	11.1	20.2	14.6	47.0	31.6	15.7	28.9	10.9	12.8	45.6	32.1	64.6	28.1	35.7	37.7	30.0	28.2	15.8	15.2	23.3	48.7	50.3	8.4	7.1	7.3	8.0	7.1	13.0	11.4	29.1	7.5	22.0	15.7	2.2	11.8	34.7	8.7	79.9	26.6	10.0	45.8	19.3	26.7	9.8	59.7	61.4	18.6	34.4	11.9	78.9	21.3	60.3	31.4	20.2	22.8	20.3	29.4	21.5	14.7	16.9	22.3	17.8	8.6	15.6	19.8	29.8	22.0	43.5	12.9	22.6	27.0	4.7	5.2	5.1	5.8	5.3	9.2	6.0	7.6	7.9	5.3	7.4	8.3	28.5	9.6	19.0	26.4	26.0	46.7	19.8	11.7	21.6	28.3	10.0	7.0	24.8	12.8	9.4	12.9	10.4	21.7	32.3	21.9	1.9	12.4	12.0	7.5	15.7	20.7	4.2	4.6	36.6	22.9	33.9	24.4	15.8	9.6	24.1	6.9	26.7	13.2	52.8	28.6	40.1	5.8	6.1	46.5	29.5	5.4	14.3	43.1	151.2	20.6	25.6	23.7	40.2	21.1	36.6	16.8	17.0	28.6	25.0	17.9	7.6	25.5	9.8	17.5	26.3	18.5	29.6	28.0	18.7	12.4	31.1	61.2	29.5	23.7	3.3	16.0
NR2E1	"TLL, TLX, XTLL"	ENSG00000112333	"Nuclear receptor subfamily 2 group E member 1"	Q9Y466	6	108166022-108188805	"Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding, Receptor, Repressor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	57	"brain: 19.7;choroid plexus: 14.3;retina: 30.6"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 22.2;Inhibitory neurons: 8.5;Muller glia cells: 44.9;Oligodendrocyte precursor cells: 4.5"	"Cancer enriched"	"Detected in single"	14	"glioma: 6.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 3.0;GAMG: 1.4;HEK 293: 1.0;U-251 MG: 4.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA036954, HPA055642"	Uncertain		Approved	"Nuclear bodies"		NA	NA				"Cluster 58: Brain - Synaptic function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 5: Muller glia cells - Visual perception"	"Nuclear bodies"		"HPA036954: AB_10670958, HPA055642: AB_2682871"	"unprognostic (3.43e-1)"	"unprognostic (1.41e-1)"			"unprognostic (1.77e-1)"	"unprognostic (9.60e-2)"	"unprognostic (6.27e-2)"	"unprognostic (6.00e-1)"	"unprognostic (1.78e-2)"		"unprognostic (7.31e-2)"	"unprognostic (8.64e-2)"	"unprognostic (9.59e-8)"	"unprognostic (2.87e-1)"	"unprognostic (2.49e-1)"		"unprognostic (3.07e-1)"	0.0	0.3	16.9	0.0	19.7	0.0	0.0	7.3	18.6	0.0	14.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.6	14.3	0.1	0.0	0.0	0.0	7.4	13.0	0.0	0.0	0.0	0.2	0.0	7.8	0.0	0.0	30.6	0.1	0.0	0.0	0.1	0.0	0.0	7.2	0.0	0.0	0.0	16.4	0.0	0.0	0.0	0.0	0.0	0.0	12.9	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.9	19.7	7.3	18.6	16.6	14.3	7.4	13.0	7.8	7.2	16.4	12.9	0.0	0.0	0.0	22.2	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.1	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	8.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	44.9	0.0	4.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	1.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SNX3	Grd19	ENSG00000112335	"Sorting nexin 3"	O60493	6	108211222-108261246	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Protein transport, Transport"		Microphthalmia	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA		270000	"Cluster 26: Non-specific - Mitochondria"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 41: Macrophages - Immune response"				"prognostic unfavorable (4.37e-5)"	"unprognostic (1.70e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.04e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.82e-2)"	"unprognostic (7.74e-3)"	"unprognostic (2.16e-2)"	"unprognostic (2.36e-1)"	"unprognostic (5.76e-2)"	"unprognostic (1.87e-1)"	"unprognostic (7.66e-2)"	"prognostic unfavorable (2.30e-4)"	"unprognostic (2.32e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.67e-1)"	224.3	220.8	217.3	131.3	220.4	296.3	182.6	216.5	304.6	169.5	208.3	167.6	119.4	137.9	152.8	172.4	144.5	132.0	266.6	224.3	219.6	168.6	199.0	147.3	184.0	214.2	219.8	187.5	123.6	124.4	95.4	199.3	215.8	104.6	112.9	88.3	134.5	119.4	323.0	129.0	125.2	157.0	221.1	145.1	122.0	109.8	218.9	123.4	123.2	285.3	163.6	166.5	147.8	234.9	164.9	98.2	94.9	314.3	505.0	377.9	147.6	241.3	240.3	187.5	231.2	155.0	118.8	138.5	232.8	315.3	328.8	128.6	212.5	207.9	254.6	161.2	136.7	268.1	110.2	182.6	272.9	183.9	175.3	324.4	279.9	180.1	202.1	296.9	312.9	131.0	261.6	161.1	263.1	156.6	70.4	403.7	80.1	199.1	166.2	76.2	229.7	145.4	300.0	225.1	111.0	154.9	155.5	197.7	260.4	212.2	100.6	623.8	235.8	161.0	108.2	218.0	319.7	65.0	90.7	148.9	284.2	332.5	197.2	118.5	75.9	169.1	37.4	70.5	48.2	215.3	43.8	39.5	109.8	181.6	44.6	37.0	48.4	64.5	68.6	132.1	48.8	70.4	217.3	220.4	216.5	304.6	224.3	219.6	214.2	219.8	215.8	221.1	218.9	234.9	329.6	105.8	70.0	39.2	332.6	378.9	328.7	264.3	231.1	44.6	254.0	244.3	395.2	161.5	160.3	191.3	16.7	685.3	219.3	199.1	643.7	307.1	387.8	144.6	161.1	352.6	128.0	611.8	55.7	253.8	581.2	323.0	101.9	120.0	167.1	127.2	275.9	240.6	974.2	43.7	43.1	154.7	189.2	451.6	786.3	496.6	288.6	415.7	368.2	31.9	409.1	325.7	209.1	27.2	39.7	260.1	200.9	266.7	187.1	247.7	321.4	697.8	198.8	53.7	256.4	186.0	304.1	316.5	173.3	354.5	440.8	618.3	181.0	259.4	180.6	337.9
AFG1L	"AFG1, LACE1"	ENSG00000135537	"AFG1 like ATPase"	Q8WV93	6	108294991-108526796	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 6.4;Distal tubular cells: 9.8;Hofbauer cells: 5.7;Proximal tubular cells: 6.3;Respiratory ciliated cells: 5.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030154, HPA030155, HPA030659"	Approved		Approved	"Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 7: Non-specific - Mitochondria"	"Plasma membrane, Cytosol"		"HPA030154: AB_10600769, HPA030155: AB_10601232, HPA030659: AB_10602415"	"unprognostic (9.76e-5)"	"unprognostic (1.72e-1)"	"unprognostic (1.68e-1)"	"unprognostic (3.76e-2)"	"unprognostic (1.62e-1)"	"unprognostic (7.04e-2)"	"unprognostic (2.57e-1)"	"unprognostic (5.53e-2)"	"unprognostic (2.35e-3)"	"unprognostic (1.48e-1)"	"unprognostic (2.73e-2)"	"unprognostic (9.61e-2)"	"unprognostic (8.40e-8)"	"unprognostic (2.03e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.23e-1)"	1.8	2.1	2.2	1.3	2.7	2.1	2.2	2.0	3.3	1.7	2.7	2.6	4.2	1.5	1.9	1.6	2.2	1.5	4.6	1.7	1.9	5.0	3.7	1.7	1.8	1.8	2.0	1.7	2.1	5.4	1.5	2.2	2.0	1.6	3.1	3.1	1.8	1.7	3.7	1.2	3.0	1.7	1.7	2.0	2.8	10.7	2.7	2.3	3.0	4.0	2.1	1.7	1.1	3.2	2.7	1.4	3.4	6.1	3.5	5.1	3.3	3.0	4.4	4.8	4.7	5.7	3.3	4.8	3.8	4.7	5.8	1.5	4.4	4.5	5.4	2.8	2.6	5.7	1.8	6.6	3.5	5.3	2.7	4.7	3.6	3.6	5.8	3.1	2.6	3.5	5.9	2.2	4.5	2.6	0.9	4.8	2.2	4.6	2.8	3.3	4.6	2.8	6.1	2.9	3.7	3.2	2.4	3.5	6.4	4.5	2.8	9.8	3.2	2.9	0.7	2.6	3.4	1.5	2.6	3.7	3.6	6.0	4.5	0.0	1.6	2.8	1.0	1.2	1.3	2.5	1.5	1.9	1.4	3.4	2.1	1.4	0.4	2.4	4.3	1.6	2.3	0.7	2.2	2.7	2.0	3.3	1.7	1.9	1.8	2.0	2.0	1.7	2.7	3.2	2.4	0.0	4.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	2.0	2.2	0.0	0.0	5.0	3.7	0.0	6.4	1.1	0.0	9.8	3.1	0.0	2.6	2.6	2.2	0.0	0.0	0.0	3.8	4.6	1.2	0.0	1.8	2.5	5.1	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	1.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.4	0.0	0.0	6.3	5.8	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	5.2	0.9	4.5	0.0	0.0
FOXO3	"AF6q21, FKHRL1, FOXO2, FOXO3A"	ENSG00000118689	"Forkhead box O3"	O43524	6	108559835-108684774	"Cancer-related genes, Disease related genes, Predicted intracellular proteins, Transcription factors"	"Apoptosis, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 15.6"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 94.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004074, HPA063104"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 59: Non-specific - Translation"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 41: Macrophages - Immune response"	Nucleoplasm		"CAB004074: AB_2106672, HPA063104: AB_2684941"	"unprognostic (3.42e-2)"	"unprognostic (3.76e-2)"	"unprognostic (4.28e-2)"	"unprognostic (1.96e-2)"	"unprognostic (6.68e-2)"	"unprognostic (4.63e-2)"	"unprognostic (4.08e-3)"	"unprognostic (1.73e-1)"	"unprognostic (3.81e-2)"	"unprognostic (5.18e-2)"	"unprognostic (1.98e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.54e-2)"	"unprognostic (9.09e-2)"	"unprognostic (1.13e-1)"	"unprognostic (5.81e-2)"	"unprognostic (5.68e-2)"	46.7	11.4	14.7	13.4	15.1	68.5	43.1	34.0	19.6	28.1	19.3	21.7	12.4	23.5	15.3	35.4	25.4	28.2	18.6	14.3	9.8	16.3	23.1	30.3	12.8	17.4	15.5	43.0	86.9	30.2	8.6	21.3	13.3	20.0	17.0	28.7	25.1	11.5	84.1	30.6	16.9	21.1	11.5	18.8	22.2	11.9	17.1	18.5	18.0	51.4	15.8	23.2	27.4	17.0	21.6	6.8	9.1	20.4	41.2	48.4	16.1	17.0	17.7	13.5	19.9	11.9	19.5	11.7	14.8	20.0	22.3	15.0	12.1	20.8	20.4	12.9	18.3	32.5	6.2	9.8	47.4	8.6	24.8	56.0	43.2	29.3	40.4	19.8	10.3	10.2	21.8	94.5	26.9	12.2	9.4	12.6	6.1	10.1	11.6	12.1	32.4	48.7	30.7	16.5	23.4	59.9	12.7	11.8	16.6	18.1	12.1	27.7	18.3	24.9	12.9	13.8	20.6	0.9	16.8	13.5	13.4	16.2	16.4	7.8	2.8	6.1	3.2	1.5	3.8	0.8	1.7	2.6	1.7	1.7	1.4	2.0	15.6	3.7	5.3	2.7	1.9	1.1	14.7	15.1	34.0	19.6	14.3	9.8	17.4	15.5	13.3	11.5	17.1	17.0	88.2	44.8	46.0	112.6	41.2	67.7	73.3	34.4	91.6	63.4	64.1	46.9	31.6	71.4	44.4	25.8	70.9	25.4	41.4	86.9	17.6	50.4	19.9	91.2	41.8	55.6	66.9	246.9	102.7	30.9	36.9	105.8	46.9	105.6	15.2	46.2	84.6	77.7	46.4	52.2	99.9	55.0	20.3	85.2	83.3	17.7	106.6	96.6	56.9	160.2	55.9	78.9	22.6	108.6	133.2	73.3	44.2	100.4	83.3	122.2	28.3	21.1	57.7	68.6	32.9	236.6	81.6	9.1	17.8	61.1	46.5	41.2	37.6	30.6	34.5	184.2
ARMC2	"bA787I22.1, DKFZp434P0714"	ENSG00000118690	"Armadillo repeat containing 2"	Q8NEN0	6	108848416-108974476	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Differentiation, Spermatogenesis"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 33.4"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 80.0;Early spermatids: 117.7;Excitatory neurons: 86.1;Inhibitory neurons: 69.3;Late spermatids: 145.3;Respiratory ciliated cells: 61.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025809, HPA053696"	Enhanced		Approved	Nucleoplasm		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm		"HPA025809: AB_1845032, HPA053696: AB_2682233"	"unprognostic (4.42e-2)"	"unprognostic (9.64e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.09e-2)"	"unprognostic (1.45e-2)"	"unprognostic (2.11e-1)"	"unprognostic (4.00e-4)"	"unprognostic (1.13e-2)"	"unprognostic (3.74e-2)"	"unprognostic (5.71e-2)"	"unprognostic (5.19e-5)"	"unprognostic (7.55e-2)"	"unprognostic (1.55e-3)"	"unprognostic (9.38e-2)"	"unprognostic (6.44e-2)"	"unprognostic (4.65e-2)"	"unprognostic (2.28e-1)"	5.3	3.8	3.8	3.9	7.8	8.8	7.0	0.9	6.8	6.6	31.8	2.9	1.8	7.5	7.6	3.4	20.4	5.2	9.3	3.0	2.3	3.6	2.6	8.6	4.2	2.7	5.9	5.4	2.4	9.4	6.7	6.9	1.2	3.9	4.6	26.7	3.4	4.7	4.0	5.2	3.4	4.1	1.1	5.9	5.0	33.4	7.6	3.8	10.6	1.3	4.2	2.4	2.7	3.6	3.5	2.1	10.1	6.5	4.9	5.9	2.2	2.1	2.9	5.3	7.0	3.2	3.0	5.5	2.6	3.4	8.1	3.0	5.6	4.2	9.1	1.5	4.9	5.1	5.2	3.4	2.6	8.0	2.2	6.8	5.8	6.1	1.7	7.1	5.0	16.6	2.2	8.4	5.5	2.7	7.0	7.3	3.2	3.4	2.6	7.8	8.3	4.3	4.9	4.1	14.0	5.2	7.3	1.8	5.1	5.6	3.7	4.1	2.5	4.4	2.3	3.8	2.9	3.8	5.5	4.7	7.6	5.5	5.6	3.7	2.1	0.6	2.0	3.0	1.8	0.8	1.5	2.2	1.7	1.9	0.9	2.2	6.0	2.9	2.4	2.8	4.7	1.0	3.8	7.8	0.9	6.8	3.0	2.3	2.7	5.9	1.2	1.1	7.6	3.6	2.0	9.6	3.7	80.0	3.4	1.0	1.1	1.9	0.6	2.0	1.2	1.5	6.8	1.5	10.9	0.0	0.0	1.5	2.9	0.3	0.0	1.2	117.7	33.0	2.7	2.2	1.8	2.1	86.1	1.0	2.1	3.0	1.5	1.8	0.0	2.8	0.7	0.3	3.9	1.7	69.3	0.4	4.1	4.4	0.4	145.3	6.8	3.1	5.4	11.2	0.5	1.7	3.1	35.7	24.4	0.7	0.0	10.1	5.9	0.6	0.4	1.8	61.8	4.9	0.0	4.2	4.2	41.5	6.3	1.9	1.4	0.5	5.1	2.5	0.6	0.7
SESN1	"PA26, SEST1"	ENSG00000080546	"Sestrin 1"	Q9Y6P5	6	108986437-109094819	"Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 137.2;Excitatory neurons: 134.9;Inhibitory neurons: 127.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"B-cells: 48.0;NK-cells: 58.9;T-cells: 74.6"	"Cell line enhanced"	"Detected in all"		"BEWO: 80.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA073659			Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 4: Macrophages - Innate immune response"	"Nucleoli fibrillar center"	Nucleoplasm	"HPA073659: AB_2686622"	"unprognostic (2.22e-1)"	"unprognostic (5.97e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.52e-2)"	"unprognostic (1.17e-1)"	"prognostic favorable (6.47e-5)"	"unprognostic (2.68e-1)"	"unprognostic (6.91e-2)"	"unprognostic (1.01e-1)"	"unprognostic (8.33e-2)"	"unprognostic (1.83e-3)"	"prognostic favorable (2.07e-4)"	"unprognostic (3.54e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.08e-1)"	"unprognostic (5.72e-2)"	"unprognostic (7.95e-2)"	30.7	26.6	29.1	23.2	30.7	50.2	42.3	29.8	35.9	29.9	29.8	31.6	20.2	31.7	26.6	22.7	32.5	18.5	36.2	31.1	29.4	16.7	29.2	25.6	33.8	27.9	27.9	62.6	31.6	50.3	25.8	53.4	28.7	25.1	23.9	25.0	18.3	23.6	151.2	43.1	38.1	32.9	28.7	37.0	31.0	42.0	29.9	21.9	32.1	140.0	33.8	28.3	28.2	30.8	3.5	5.7	25.7	12.2	32.1	40.6	80.5	13.8	15.7	4.7	9.0	10.9	3.6	29.3	11.4	10.2	3.7	4.1	7.0	27.6	5.8	2.6	34.7	13.0	6.9	40.9	19.7	5.1	12.7	44.2	43.0	8.5	13.7	20.5	24.7	8.3	9.7	20.5	23.3	6.9	11.3	16.4	10.6	5.7	3.6	9.0	7.3	13.7	10.1	17.4	6.3	12.7	7.5	4.7	5.7	41.3	4.5	33.5	15.3	3.6	7.1	3.3	4.5	20.5	12.5	12.0	7.9	12.8	7.9	11.9	2.7	3.4	34.4	6.3	74.6	13.3	32.4	27.3	2.7	48.0	39.6	20.8	10.0	58.9	8.7	5.4	15.1	20.3	29.1	30.7	29.8	35.9	31.1	29.4	27.9	27.9	28.7	28.7	29.9	30.8	13.9	64.1	22.4	79.0	37.3	6.5	4.9	7.4	25.0	23.8	14.2	14.5	30.0	17.2	15.2	14.7	45.9	57.8	22.9	12.7	9.8	4.3	137.2	10.3	15.2	9.8	15.5	24.2	134.9	5.3	13.7	21.9	28.5	8.2	3.8	17.4	10.8	14.7	44.9	26.9	127.7	10.0	2.0	43.1	11.3	104.8	34.5	56.5	16.0	71.2	9.4	39.1	25.7	64.3	119.1	3.1	11.9	35.3	26.2	9.4	7.8	9.3	26.4	44.3	26.3	43.9	15.9	18.4	16.2	25.4	8.4	44.6	41.8	102.9	13.6	4.3
CEP57L1	"bA487F23.2, C6orf182, MGC21731"	ENSG00000183137	"Centrosomal protein 57 like 1"	Q8IYX8	6	109095110-109174418	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 50.3;Spermatocytes: 75.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040378	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Plasma membrane, Cytosol"		"HPA040378: AB_10794028"	"unprognostic (5.93e-3)"	"unprognostic (4.95e-2)"	"unprognostic (1.40e-2)"	"unprognostic (2.13e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.41e-2)"	"unprognostic (4.69e-3)"	"unprognostic (3.63e-2)"	"unprognostic (7.25e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.33e-1)"	"unprognostic (9.97e-2)"	"unprognostic (2.42e-5)"	"unprognostic (2.37e-1)"	"unprognostic (2.00e-1)"	"unprognostic (8.48e-2)"	"unprognostic (1.72e-1)"	10.5	7.6	5.1	7.8	5.9	10.2	10.2	10.8	7.8	8.2	4.6	8.5	8.7	9.3	10.5	6.2	6.0	9.4	7.7	5.8	4.1	8.0	10.0	6.6	8.9	4.9	4.2	6.5	7.5	16.9	5.6	10.1	5.5	6.4	10.9	12.0	5.2	6.3	6.1	6.8	7.8	10.8	3.9	7.7	7.3	26.2	5.5	14.4	8.7	6.6	7.4	6.4	6.5	7.9	17.9	7.9	23.1	22.9	21.2	35.2	18.1	40.3	22.1	35.8	39.8	11.9	15.3	16.0	18.4	20.9	30.8	9.1	16.1	15.4	56.1	20.3	16.1	34.8	18.9	12.3	19.6	28.5	14.5	21.2	11.0	30.3	29.9	19.2	32.4	52.5	63.9	52.5	32.4	11.8	32.0	24.6	7.6	14.7	14.6	25.7	17.4	15.7	17.0	7.4	17.4	14.4	19.8	14.7	12.9	15.0	18.2	43.9	14.7	23.1	13.6	24.4	42.9	15.4	19.1	25.3	21.8	43.1	18.9	15.9	5.2	6.6	4.7	6.1	5.1	3.3	4.8	6.7	5.7	6.3	4.5	6.7	3.6	11.6	9.6	6.0	6.9	4.6	5.1	5.9	10.8	7.8	5.8	4.1	4.9	4.2	5.5	3.9	5.5	7.9	12.9	6.4	5.3	12.4	6.3	3.3	7.6	7.4	7.4	6.6	6.8	7.2	10.3	2.8	6.8	5.5	20.9	9.8	9.7	4.2	7.9	7.0	50.3	12.8	18.5	10.6	5.4	18.1	31.9	5.4	13.2	15.5	8.2	6.9	5.1	20.5	8.2	6.3	10.2	5.0	31.1	3.1	8.2	4.1	6.8	39.3	17.4	7.7	8.8	27.2	7.7	10.4	8.2	26.2	36.1	6.0	4.5	12.4	13.2	4.4	5.7	13.4	9.8	12.3	13.1	21.8	14.1	75.7	13.0	5.8	4.4	8.5	6.7	13.6	6.1	5.0
CD164	"DFNA66, MGC-24, MUC-24"	ENSG00000135535	"CD164 molecule"	Q04900	6	109366514-109382467	"CD markers, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion, Myogenesis"		"Deafness, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010636	Uncertain				"Intracellular and membrane"	NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA010636: AB_1078447"	"unprognostic (1.23e-2)"	"unprognostic (1.61e-2)"	"unprognostic (3.89e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.97e-3)"	"unprognostic (1.80e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.09e-1)"	"unprognostic (8.88e-2)"	"unprognostic (1.38e-1)"	"unprognostic (7.11e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.84e-1)"	"unprognostic (3.01e-1)"	"unprognostic (1.51e-1)"	260.9	123.6	43.6	119.1	53.6	213.9	211.2	57.4	69.5	151.0	68.9	264.8	252.0	117.0	161.9	95.0	124.8	159.3	91.8	40.6	57.7	298.1	256.8	121.9	137.8	65.3	56.1	126.4	124.1	219.2	89.5	190.1	64.1	146.1	270.5	36.4	303.8	112.7	96.0	89.2	277.6	116.1	52.3	121.0	272.8	113.6	50.7	132.0	360.4	91.7	122.9	154.2	76.0	70.7	130.0	73.0	34.6	242.9	503.0	496.6	235.7	230.8	304.0	213.7	308.0	148.1	194.9	105.7	218.0	261.5	198.0	125.4	136.9	152.7	315.4	220.1	144.5	177.8	72.0	173.9	294.9	209.5	399.0	384.6	279.7	211.3	186.5	270.3	196.9	86.9	178.9	279.9	287.8	141.1	191.5	251.2	52.9	273.1	119.6	126.3	109.0	135.1	292.2	180.5	40.2	80.9	144.6	184.0	348.6	168.0	167.7	265.0	205.6	138.8	99.1	199.5	188.6	96.3	147.4	121.2	244.0	242.8	147.2	349.0	192.3	167.0	166.8	198.6	175.0	126.2	135.2	155.1	189.7	111.0	138.0	150.1	128.5	255.2	197.5	214.1	192.9	413.8	43.6	53.6	57.4	69.5	40.6	57.7	65.3	56.1	64.1	52.3	50.7	70.7	76.5	163.5	78.9	22.5	168.1	200.1	180.2	149.6	128.7	33.8	251.1	123.3	70.9	174.5	153.5	281.4	25.0	244.9	372.7	600.0	93.9	178.8	103.8	111.9	109.2	89.2	166.5	92.8	22.1	136.8	407.2	176.3	175.8	151.2	128.6	76.7	98.2	177.4	311.9	33.7	16.4	427.3	215.7	360.4	223.9	97.3	158.8	237.3	247.3	38.4	147.1	113.3	266.8	15.6	83.1	177.6	430.0	182.1	173.6	230.3	425.5	348.0	351.2	44.4	124.9	110.0	138.1	160.5	184.4	143.0	231.0	674.5	165.9	87.7	285.0	334.7
PPIL6	"bA425D10.6, dJ919F19.1, MGC41939, RSPH12"	ENSG00000185250	"Peptidylprolyl isomerase like 6"	Q8IXY8	6	109390215-109441171	"Metabolic proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 35.6;testis: 18.9"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 374.4;Endometrial ciliated cells: 226.5;Late spermatids: 75.1;Respiratory ciliated cells: 228.6;Spermatocytes: 101.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"memory B-cell: 1.5"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 6.0;ASC diff: 9.2;ASC TERT1: 11.5;hTERT-RPE1: 8.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA036717, HPA058165"	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 49: Ciliated cells - Cilium organization"	"Nucleoplasm, Cytosol"	"Golgi apparatus"	"HPA036717: AB_10671969, HPA058165: "	"unprognostic (1.24e-1)"	"unprognostic (2.40e-1)"	"unprognostic (5.68e-2)"	"unprognostic (2.68e-2)"	"unprognostic (3.12e-1)"	"unprognostic (3.61e-2)"	"unprognostic (1.26e-1)"	"unprognostic (5.53e-2)"	"unprognostic (3.14e-1)"	"unprognostic (8.03e-2)"	"unprognostic (1.42e-3)"	"unprognostic (2.51e-2)"	"unprognostic (4.71e-2)"	"unprognostic (1.95e-1)"	"unprognostic (3.29e-2)"	"unprognostic (5.86e-2)"	"unprognostic (2.32e-1)"	1.1	0.9	4.7	0.6	5.2	0.2	3.0	5.7	5.3	3.8	12.2	1.3	1.4	3.0	9.0	1.4	35.6	1.1	2.1	4.8	5.2	4.3	0.6	4.7	0.6	7.5	8.2	5.3	2.3	5.2	2.7	1.1	5.5	1.2	1.0	7.4	2.3	2.7	4.3	1.3	0.7	2.0	7.2	0.8	1.7	18.9	5.1	0.8	11.1	1.7	0.6	1.5	1.2	7.6	1.4	1.2	1.1	6.0	9.2	11.5	0.6	0.0	2.2	0.5	0.1	0.1	1.6	0.0	0.4	0.6	0.8	0.9	1.0	0.0	0.3	0.4	0.4	0.5	0.1	0.0	4.6	0.5	0.2	2.4	5.6	0.2	3.5	8.6	0.7	1.3	0.6	0.4	0.4	0.6	0.1	0.7	0.2	4.0	0.8	0.6	0.0	0.5	4.7	0.1	1.3	2.1	0.1	0.3	3.9	0.3	0.4	0.9	0.3	0.1	0.2	1.0	0.2	0.2	0.1	0.1	1.9	0.1	0.4	0.8	0.1	0.2	0.1	0.1	0.1	1.5	0.2	0.1	0.3	0.5	0.1	0.1	0.4	0.4	0.1	0.4	0.1	0.2	4.7	5.2	5.7	5.3	4.8	5.2	7.5	8.2	5.5	7.2	5.1	7.6	2.6	6.4	6.9	11.8	1.8	2.2	3.7	18.2	2.8	2.4	5.7	7.0	3.7	2.8	22.1	3.7	2.1	0.8	0.4	0.9	25.4	1.9	374.4	226.5	7.3	1.8	3.0	0.4	15.0	1.2	0.8	3.9	2.6	5.8	0.0	4.1	1.1	0.2	0.4	1.7	6.1	2.0	22.4	0.0	0.3	75.1	5.3	1.1	3.6	3.7	0.6	7.8	0.0	8.5	6.2	0.7	0.8	5.3	0.8	3.8	1.5	13.0	228.6	13.4	0.0	5.2	5.6	101.4	21.5	1.9	3.0	0.7	1.2	3.0	2.0	1.5
SMPD2	"ISC1, nSMase"	ENSG00000135587	"Sphingomyelin phosphodiesterase 2"	O60906	6	109440724-109443919	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid metabolism, Sphingolipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 53.0"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 179.4;Late spermatids: 359.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018110, HPA018125"	Uncertain		Approved	"Vesicles,Plasma membrane,Cell Junctions"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 71: Testis - DNA repair"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 31: Spermatids - Spermatogenesis"	"Vesicles, Plasma membrane"	"Cell Junctions"	"HPA018110: AB_1857292, HPA018125: AB_1857293"	"unprognostic (1.61e-1)"	"unprognostic (8.01e-2)"	"unprognostic (1.97e-1)"	"unprognostic (8.79e-3)"	"unprognostic (3.88e-2)"	"unprognostic (2.38e-1)"	"prognostic unfavorable (1.17e-4)"	"unprognostic (7.08e-2)"	"unprognostic (7.59e-2)"	"unprognostic (1.41e-1)"	"prognostic favorable (1.00e-3)"	"unprognostic (3.60e-2)"	"unprognostic (2.14e-3)"	"unprognostic (7.94e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.45e-2)"	"prognostic favorable (1.70e-4)"	6.9	8.8	7.6	8.6	7.4	12.7	10.5	9.6	7.8	12.6	15.1	12.7	13.5	7.1	15.5	24.5	21.4	8.7	6.7	7.7	6.9	12.2	7.6	9.7	13.3	7.6	7.9	8.2	17.7	22.1	11.1	6.0	7.2	13.2	12.6	6.5	15.6	5.8	4.1	21.7	12.3	4.9	7.6	13.3	14.2	53.0	7.0	10.3	13.3	1.7	17.1	10.4	14.3	8.8	13.1	14.8	7.7	12.2	13.2	7.1	25.5	4.3	15.7	10.5	9.8	14.0	10.3	7.1	9.0	9.3	22.1	16.4	7.8	18.7	6.3	9.1	20.5	8.2	15.9	8.7	11.0	9.1	9.4	7.7	21.3	9.3	18.4	11.8	9.8	12.4	16.3	12.2	5.3	18.7	14.8	19.7	2.1	17.3	7.5	10.4	3.6	7.7	19.3	21.8	10.1	8.4	8.2	24.9	19.3	6.2	7.9	17.2	6.3	4.7	6.8	3.8	16.3	8.3	2.3	4.6	9.1	8.6	8.5	6.2	9.0	10.8	6.9	8.6	7.8	14.4	7.8	8.2	11.2	20.4	5.6	5.9	2.5	7.3	7.8	14.3	8.2	6.0	7.6	7.4	9.6	7.8	7.7	6.9	7.6	7.9	7.2	7.6	7.0	8.8	3.9	12.8	7.2	1.6	15.9	9.8	12.9	13.8	8.6	1.3	8.9	6.7	2.1	7.2	11.8	12.9	4.2	10.3	9.1	26.1	1.9	19.2	179.4	28.4	4.0	4.4	8.4	4.2	1.4	19.8	18.5	6.1	25.0	4.3	0.0	3.5	3.6	3.6	9.5	0.0	0.5	27.1	14.2	4.1	11.2	359.7	9.3	7.2	8.8	2.8	9.9	3.7	6.2	0.0	1.7	15.4	27.7	9.1	9.8	15.0	37.5	9.3	67.1	4.9	13.1	3.1	5.8	69.9	10.9	13.8	18.6	17.0	7.6	8.7	17.8	16.9
MICAL1	"DKFZp434B1517, FLJ11937, FLJ21739, MICAL, NICAL"	ENSG00000135596	"Microtubule associated monooxygenase, calponin and LIM domain containing 1"	Q8TDZ2	6	109444062-109465968	"Enzymes, Predicted intracellular proteins"		"Actin-binding, Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Gastric mucus-secreting cells: 76.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"THP-1: 148.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA030175, HPA030176, HPA030178"	Approved					NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 45: Enterocytes - Digestion"			"HPA030175: AB_2673359, HPA030176: AB_2673360, HPA030178: AB_10600824"	"unprognostic (1.07e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.21e-1)"	"unprognostic (2.71e-3)"	"unprognostic (1.52e-2)"	"unprognostic (1.92e-2)"	"unprognostic (6.93e-2)"	"unprognostic (1.94e-1)"	"prognostic favorable (2.63e-7)"	"unprognostic (2.31e-1)"	"prognostic unfavorable (6.71e-7)"	"unprognostic (2.05e-1)"	"unprognostic (3.27e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.22e-1)"	20.6	6.3	17.8	27.6	17.5	65.9	14.2	17.8	25.6	48.6	16.1	21.7	37.8	29.6	2.5	11.8	32.7	14.7	11.1	17.8	19.9	18.8	5.4	35.2	32.8	20.7	18.4	13.6	8.7	9.2	17.9	10.7	20.6	30.8	10.1	6.2	11.0	18.8	5.1	16.0	43.2	9.1	18.1	56.7	18.3	18.7	20.3	18.3	12.6	3.9	16.6	62.2	30.8	22.4	4.1	5.1	15.8	0.2	55.9	43.6	10.7	31.3	22.0	6.7	11.0	7.3	4.7	23.2	6.6	33.1	19.4	5.4	9.6	12.3	2.8	20.3	4.0	9.9	12.0	11.5	22.8	6.5	0.3	25.7	6.2	15.5	12.6	25.2	20.0	14.0	2.7	40.2	40.6	5.1	8.0	36.0	9.9	5.5	5.4	21.9	10.0	3.3	15.0	10.0	5.3	28.1	2.9	2.7	50.4	10.0	4.9	148.8	21.6	16.7	5.9	9.8	12.2	29.7	9.6	20.8	13.9	21.4	12.3	14.6	7.3	13.6	6.5	13.2	3.9	3.5	6.4	5.2	12.8	5.1	4.3	3.1	9.3	5.1	14.2	14.4	9.4	6.8	17.8	17.5	17.8	25.6	17.8	19.9	20.7	18.4	20.6	18.1	20.3	22.4	5.3	44.8	14.4	3.3	26.2	6.1	1.3	2.3	1.2	3.4	2.5	3.6	4.4	0.0	4.2	1.8	4.2	1.3	31.0	24.9	1.9	7.8	13.2	2.0	29.8	5.9	32.2	4.6	13.8	6.5	10.9	9.7	76.9	2.4	15.2	3.1	4.6	0.3	32.2	0.0	12.9	34.9	6.1	28.3	44.5	23.1	20.8	34.7	16.0	8.4	34.0	2.2	21.6	12.5	4.2	11.6	27.6	37.6	15.4	1.3	49.6	4.6	10.7	18.3	0.0	31.6	27.3	7.9	9.5	0.7	4.8	4.8	22.5	2.9	13.9	1.5
ZBTB24	"BIF1, KIAA0441, PATZ2, ZNF450"	ENSG00000112365	"Zinc finger and BTB domain containing 24"	O43167	6	109462594-109483219	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Rod photoreceptor cells: 65.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017872, HPA049003"	Uncertain		Approved	"Nucleoplasm,Cytokinetic bridge,Centrosome"		Yes	No			"Cluster 37: B-cells - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 46: Photoreceptor cells - Phototransduction"	Nucleoplasm	"Cytokinetic bridge, Centrosome"	"HPA017872: AB_2669673, HPA049003: AB_2680596"	"unprognostic (8.15e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.41e-1)"	"unprognostic (4.80e-2)"	"unprognostic (1.98e-2)"	"prognostic unfavorable (3.15e-4)"	"unprognostic (4.53e-2)"	"unprognostic (5.09e-2)"	"unprognostic (3.31e-2)"	"unprognostic (1.22e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.75e-3)"	"unprognostic (1.26e-1)"	"unprognostic (2.69e-1)"	"unprognostic (2.60e-1)"	"unprognostic (6.77e-2)"	3.1	2.2	1.5	5.4	2.4	8.9	4.6	2.4	2.4	4.0	1.0	3.5	3.6	3.1	3.2	3.0	2.9	2.5	2.2	1.6	1.9	3.9	2.6	3.9	8.7	1.5	1.2	3.4	3.5	7.4	1.8	3.2	1.6	3.5	3.8	10.1	4.4	3.3	3.2	4.7	3.7	2.8	1.3	5.5	4.1	4.3	1.6	6.9	4.9	2.9	7.3	3.5	2.7	2.9	4.7	4.8	4.3	10.8	6.8	6.9	7.0	5.3	7.3	6.5	7.4	6.7	3.6	20.0	6.7	6.7	7.8	6.0	10.9	8.3	9.8	12.4	10.7	16.2	6.5	5.1	5.0	13.3	8.0	7.0	6.7	6.6	11.4	4.6	5.5	9.3	13.8	11.0	6.8	8.0	19.2	9.0	10.7	4.7	5.3	11.9	6.1	8.3	8.0	8.0	7.3	6.4	6.8	7.1	16.9	5.9	5.0	14.5	5.4	5.3	5.3	4.4	11.5	5.3	4.4	20.2	7.0	10.4	9.0	0.1	0.6	0.9	0.7	0.6	0.4	3.4	1.5	0.9	0.7	2.8	1.9	1.1	0.4	1.3	0.8	1.1	2.9	0.5	1.5	2.4	2.4	2.4	1.6	1.9	1.5	1.2	1.6	1.3	1.6	2.9	8.4	12.8	9.1	2.6	32.8	10.1	11.2	5.3	7.4	21.7	8.6	7.4	3.8	7.2	5.2	3.7	31.3	8.5	16.8	4.5	3.9	6.6	1.4	7.3	14.3	6.6	9.6	12.0	3.3	9.1	9.9	8.6	12.8	10.7	9.5	14.1	3.6	7.3	7.7	10.1	2.8	11.0	6.1	12.5	12.1	1.8	7.2	10.3	8.8	5.6	20.5	10.0	14.4	1.0	5.4	6.4	5.1	6.4	16.8	8.2	7.4	6.4	6.0	65.2	0.0	13.2	7.4	6.2	27.8	9.3	9.7	7.8	17.8	15.0	8.5	7.3
AK9	"AKD1, AKD2, C6orf199, C6orf224, dJ70A9.1, FLJ25791, FLJ42177, MGC26954"	ENSG00000155085	"Adenylate kinase 9"	Q5TCS8	6	109492856-109691217	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Nucleotide metabolism"	"Kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 76.3;Respiratory ciliated cells: 152.0;Spermatocytes: 174.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"midbrain: 3.6"	"HPA030804, HPA030805, HPA031779, HPA031781, HPA036324, HPA036711"	Enhanced		Enhanced	"Nucleoplasm,Nuclear membrane"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 77: Retina - Visual perception"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 49: Ciliated cells - Cilium organization"	"Nucleoplasm, Nuclear membrane"		"HPA030804: AB_2673617, HPA030805: AB_2673618, HPA031779: AB_10603674, HPA031781: AB_2674044, HPA036324: AB_2675060, HPA036711: AB_2675265"	"unprognostic (9.68e-3)"	"unprognostic (2.15e-1)"	"unprognostic (1.66e-2)"	"unprognostic (2.36e-2)"	"unprognostic (3.42e-1)"	"unprognostic (7.28e-2)"	"unprognostic (1.41e-3)"	"unprognostic (6.76e-3)"	"unprognostic (1.89e-1)"	"unprognostic (3.50e-2)"	"unprognostic (1.67e-4)"	"unprognostic (2.58e-1)"	"unprognostic (2.98e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.30e-1)"	"unprognostic (8.39e-2)"	"unprognostic (5.56e-2)"	3.5	3.1	8.1	3.3	9.9	3.7	4.8	13.5	17.2	3.5	10.9	4.6	3.6	4.3	7.6	4.3	7.9	3.5	4.9	6.4	11.0	5.3	3.1	4.1	4.2	8.8	10.7	3.6	3.4	9.2	7.7	3.1	9.5	3.9	4.5	14.1	5.1	3.9	4.8	3.9	3.6	3.9	10.7	4.0	4.5	16.6	8.7	7.6	6.9	3.5	3.6	3.4	3.2	13.4	2.3	1.6	6.6	11.5	6.1	3.7	4.8	3.5	4.3	3.6	4.9	2.6	4.6	4.9	1.7	3.4	7.9	3.7	1.9	3.9	7.6	10.2	4.0	3.8	3.8	2.6	4.8	4.4	2.3	3.1	7.3	6.6	8.6	8.8	4.2	7.2	3.6	4.0	2.7	4.7	4.1	3.2	1.5	5.1	2.5	5.5	3.7	4.7	5.0	4.3	7.8	6.4	4.2	3.9	5.9	3.7	5.1	5.8	5.2	3.1	2.2	5.1	2.3	2.0	1.8	2.8	6.8	5.9	2.0	17.1	2.8	7.1	5.1	1.5	4.4	13.1	4.9	6.2	2.1	10.8	6.2	5.4	5.6	5.6	4.8	3.1	3.9	1.6	8.1	9.9	13.5	17.2	6.4	11.0	8.8	10.7	9.5	10.7	8.7	13.4	13.3	28.9	17.2	21.2	13.6	2.7	7.7	14.7	3.4	18.3	10.4	6.7	18.9	5.7	19.9	9.2	14.6	3.4	8.6	13.1	0.0	9.1	70.9	76.3	5.4	10.0	19.8	4.2	34.8	4.5	1.5	6.0	12.2	7.3	22.1	10.6	8.9	2.1	3.6	20.2	37.0	15.5	14.2	5.3	3.9	41.7	7.5	5.6	5.4	25.3	5.0	12.6	18.6	22.6	46.9	7.4	8.9	6.4	5.5	5.6	22.9	6.8	152.0	50.7	26.3	9.1	6.9	174.3	34.1	4.0	2.6	5.6	10.3	4.7	11.4	7.9
FIG4	"ALS11, CMT4J, dJ249I4.1, hSac3, KIAA0274, SAC3"	ENSG00000112367	"FIG4 phosphoinositide 5-phosphatase"	Q92562	6	109690609-109878098	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase	"Amyotrophic lateral sclerosis, Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 49.5;Oligodendrocyte precursor cells: 46.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017823, HPA068859"	Approved		Supported	"Vesicles,Lipid droplets"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Vesicles, Lipid droplets"		"CAB017823: , HPA068859: AB_2686049"	"prognostic unfavorable (5.91e-4)"	"unprognostic (4.12e-2)"	"prognostic favorable (8.42e-4)"	"unprognostic (3.17e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.16e-1)"	"prognostic unfavorable (4.73e-4)"	"unprognostic (7.06e-2)"	"unprognostic (2.69e-1)"	"unprognostic (8.67e-2)"	"unprognostic (3.44e-3)"	"unprognostic (4.22e-2)"	"prognostic favorable (8.19e-4)"	"unprognostic (1.48e-1)"	"unprognostic (2.02e-1)"	"unprognostic (5.45e-2)"	"unprognostic (2.00e-2)"	9.3	10.2	5.5	7.1	7.2	5.6	8.1	5.9	7.7	8.2	12.9	10.1	5.0	8.5	7.8	9.4	7.2	7.6	7.7	6.0	8.8	9.5	6.1	13.4	10.1	6.4	7.3	8.2	7.5	17.4	11.9	8.8	8.9	7.7	9.5	10.8	10.7	7.8	10.6	7.6	9.1	10.3	5.6	13.8	8.7	8.2	6.1	12.3	9.3	8.3	10.1	9.2	8.4	7.0	8.3	8.4	11.7	14.9	11.8	17.2	7.8	9.9	14.1	8.3	23.2	4.6	7.2	23.2	5.8	18.9	14.9	5.2	12.6	8.5	20.7	13.3	16.5	10.9	5.9	5.5	11.4	9.5	10.0	8.8	9.9	12.8	10.6	22.8	18.3	13.9	6.8	8.8	12.7	6.8	12.0	8.4	5.9	12.0	4.7	7.9	6.1	7.3	13.3	18.4	12.8	11.7	7.1	10.7	21.1	15.6	6.0	23.1	11.2	4.2	3.8	5.4	9.5	3.4	2.6	7.9	27.3	8.5	4.6	15.4	24.9	14.2	8.8	24.5	7.7	18.9	6.3	8.5	19.2	21.2	7.5	7.5	7.4	10.0	15.2	8.1	9.4	11.7	5.5	7.2	5.9	7.7	6.0	8.8	6.4	7.3	8.9	5.6	6.1	7.0	4.9	16.0	9.0	24.5	15.7	4.6	7.1	7.3	5.2	8.8	5.4	3.3	6.7	2.8	6.9	9.2	2.1	13.4	9.5	7.0	5.9	9.8	18.0	7.5	5.3	5.2	10.2	3.0	49.5	11.4	7.0	6.0	8.2	7.9	8.8	8.6	7.1	4.1	23.3	1.7	32.4	8.6	8.2	19.2	6.8	17.7	3.4	17.3	8.8	29.0	16.4	8.5	11.3	46.8	37.4	7.6	6.3	6.8	6.5	4.0	6.3	8.2	9.1	7.6	0.0	5.1	6.6	5.5	12.1	8.3	4.4	12.3	9.3	5.6	6.4	8.9
GPR6		ENSG00000146360	"G protein-coupled receptor 6"	P46095	6	109978256-109980718	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"brain: 24.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"basal ganglia: 24.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	11	"basal ganglia: 91.1"	"Region enriched"	"Detected in many"	4	"basal ganglia: 29.7"							NA	NA				"Cluster 65: Brain - Ion transport"		"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"								"unprognostic (1.14e-2)"						"unprognostic (1.59e-2)"				"unprognostic (7.10e-3)"			0.0	0.0	3.6	0.0	24.5	0.0	0.0	0.0	5.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	4.5	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	3.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	6.9	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	24.5	0.0	5.1	3.2	4.5	0.1	0.3	0.2	0.2	6.9	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
WASF1	"KIAA0269, SCAR1, WAVE, WAVE1"	ENSG00000112290	"WASP family member 1"	Q92558	6	110099819-110180004	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		Actin-binding	"Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 82.8;testis: 78.6"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 192.5;Excitatory neurons: 220.2;Late spermatids: 476.1;Oligodendrocytes: 106.5"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in many"	8	"amygdala: 25.5;basal ganglia: 43.8;cerebral cortex: 82.8;hippocampal formation: 58.8;white matter: 36.1"	"Group enriched"	"Detected in some"	8	"memory B-cell: 3.3;naive B-cell: 4.2;plasmacytoid DC: 8.4"	"Group enriched"	"Detected in many"	9	"B-cells: 4.2;dendritic cells: 8.4"	"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 124.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004105, CAB022161"	Approved	Supported				NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 25: Spermatids - Spermatogenesis"			"CAB022161: , HPA004105: AB_1080583"	"unprognostic (8.22e-2)"	"unprognostic (1.07e-1)"	"unprognostic (8.02e-2)"	"unprognostic (1.30e-3)"	"unprognostic (5.50e-2)"	"unprognostic (2.28e-1)"	"prognostic unfavorable (2.82e-8)"	"unprognostic (9.20e-2)"	"unprognostic (5.06e-2)"	"unprognostic (2.52e-1)"	"unprognostic (3.33e-3)"	"unprognostic (2.73e-1)"	"prognostic unfavorable (2.79e-5)"	"unprognostic (1.95e-2)"	"unprognostic (3.09e-2)"	"unprognostic (9.03e-2)"	"unprognostic (3.38e-1)"	9.2	9.1	25.5	3.7	43.8	9.6	7.6	6.1	82.8	10.1	0.0	13.6	2.1	12.3	5.6	12.9	11.6	7.9	3.7	58.8	3.8	7.8	7.6	4.7	3.6	4.3	0.6	22.5	5.3	3.0	13.4	2.8	5.1	5.5	3.6	16.4	6.8	4.5	1.6	6.4	6.3	13.4	1.3	2.4	8.4	78.6	3.7	8.1	3.9	2.4	3.7	6.5	9.0	36.1	10.3	11.1	60.1	48.9	25.4	32.2	6.6	21.9	24.8	18.2	31.5	19.8	9.9	59.9	13.9	34.3	27.1	11.7	94.7	29.2	31.1	0.9	43.1	116.3	22.9	17.8	45.3	6.4	17.2	25.5	41.4	24.9	124.2	26.4	27.7	29.3	42.6	13.6	21.3	8.2	60.7	2.0	54.3	7.9	15.0	56.3	21.9	2.4	29.4	11.8	46.8	73.9	15.6	11.3	14.0	62.0	13.6	30.2	21.1	16.8	17.0	48.1	28.6	0.4	9.4	53.0	18.4	50.5	12.7	0.0	0.6	0.0	0.0	0.2	0.2	3.3	0.2	0.0	0.6	4.2	0.1	0.1	0.1	0.6	0.6	8.4	0.0	0.4	25.5	43.8	6.1	82.8	58.8	3.8	4.3	0.6	5.1	1.3	3.7	36.1	1.5	0.0	0.0	16.0	2.6	14.8	2.1	7.4	22.8	14.4	5.1	4.7	1.7	1.5	2.3	0.0	6.2	3.8	2.8	0.0	1.9	4.8	192.5	2.9	15.3	2.9	12.6	10.3	220.2	0.9	3.1	11.8	3.1	7.0	0.0	57.5	6.4	6.1	1.1	10.1	63.1	2.1	2.0	1.8	4.4	476.1	18.0	1.6	3.6	12.2	0.8	4.4	0.0	67.3	106.5	1.2	2.8	9.4	1.8	3.0	0.2	12.6	0.5	7.1	6.6	2.6	9.8	85.0	38.5	33.5	8.8	1.8	0.7	26.3	1.2	1.9
CDC40	"EHB3, FLJ10564, PRP17, PRPF17"	ENSG00000168438	"Cell division cycle 40"	O60508	6	110180141-110254275	"Predicted intracellular proteins"	"mRNA processing, mRNA splicing"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 257.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046620			Supported	Nucleoplasm	"Intracellular and membrane"	NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoplasm		"HPA046620: AB_2679722"	"unprognostic (4.19e-3)"	"unprognostic (2.41e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.10e-2)"	"unprognostic (4.25e-2)"	"unprognostic (3.64e-2)"	"unprognostic (3.42e-2)"	"unprognostic (5.24e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.08e-1)"	"unprognostic (9.27e-2)"	"unprognostic (1.92e-1)"	"unprognostic (4.68e-2)"	"unprognostic (7.36e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.01e-1)"	"unprognostic (2.09e-1)"	11.1	14.7	6.9	13.3	10.3	38.2	13.6	6.5	10.9	11.3	7.3	11.1	11.1	11.7	10.4	10.7	11.0	10.4	10.5	10.2	6.1	16.3	16.9	11.0	19.6	4.7	5.0	16.1	12.4	14.0	9.4	9.9	5.0	12.5	12.1	14.8	11.0	9.4	11.6	10.6	11.0	10.1	5.2	16.0	11.4	11.8	5.2	18.6	15.9	11.6	18.6	12.6	8.5	9.2	11.3	10.4	18.2	31.8	18.3	18.8	14.8	21.5	26.4	21.3	26.9	22.8	11.3	37.8	23.7	19.2	22.7	15.8	28.2	17.5	30.1	30.5	21.3	31.0	14.4	12.4	24.2	40.2	39.8	17.1	16.4	22.5	18.1	15.9	21.6	24.3	31.5	22.0	21.3	11.0	29.9	14.9	18.1	15.1	11.2	26.0	21.4	13.1	15.5	23.6	19.4	19.1	15.8	13.8	15.9	16.6	12.8	38.1	24.5	11.5	11.4	27.3	24.1	11.0	15.9	33.8	18.6	33.2	17.4	28.6	18.7	20.4	13.8	20.3	13.7	29.5	13.7	14.3	15.9	28.3	16.2	14.1	20.8	16.5	23.4	24.9	16.8	10.2	6.9	10.3	6.5	10.9	10.2	6.1	4.7	5.0	5.0	5.2	5.2	9.2	38.9	32.1	37.6	18.3	85.7	26.4	26.2	43.1	36.5	94.4	32.2	32.8	21.5	30.0	37.5	27.6	43.8	32.9	79.2	20.9	56.7	35.8	257.8	34.6	48.4	35.5	26.4	44.2	65.4	37.3	30.9	35.8	35.2	30.4	49.4	43.0	38.9	56.6	37.8	94.2	25.6	29.8	22.4	44.9	28.6	84.6	67.4	49.6	10.6	24.4	76.0	46.1	57.7	27.2	43.6	28.5	28.9	45.1	27.8	23.4	29.1	74.0	31.0	84.0	78.9	38.2	39.3	20.9	22.5	37.6	27.1	28.7	59.0	70.6	35.5	22.4
METTL24	"C6orf186, dJ71D21.2"	ENSG00000053328	"Methyltransferase like 24"	Q5JXM2	6	110245928-110358272	"Predicted secreted proteins"		"Methyltransferase, Transferase"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 14.2"	"Group enriched"	"Detected in some"	4	"Astrocytes: 30.0;Excitatory neurons: 23.8;Inhibitory neurons: 28.7;Late spermatids: 8.6;Oligodendrocyte precursor cells: 31.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	4	"MAIT T-cell: 3.5"	"Lineage enriched"	"Detected in single"	29	"T-cells: 3.5"	"Cell line enhanced"	"Detected in some"		"HHSteC: 1.0;SCLC-21H: 1.6;SuSa: 1.3"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA037441, HPA037442"	Uncertain				"Secreted - unknown location"	NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA037441: AB_10670933, HPA037442: AB_10696931"	"unprognostic (6.62e-2)"	"unprognostic (1.15e-1)"	"unprognostic (9.31e-3)"	"unprognostic (5.02e-2)"	"unprognostic (5.21e-3)"	"unprognostic (1.46e-1)"	"unprognostic (6.12e-2)"	"unprognostic (2.06e-1)"	"unprognostic (3.98e-1)"	"unprognostic (1.42e-1)"	"unprognostic (8.45e-2)"	"unprognostic (5.96e-2)"	"unprognostic (1.54e-4)"	"unprognostic (4.08e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.63e-2)"	"unprognostic (4.78e-3)"	1.8	1.6	1.4	1.6	2.3	0.0	1.7	2.1	1.9	3.9	8.1	5.9	1.4	7.5	2.2	4.0	6.0	5.8	3.0	1.7	1.8	3.9	0.9	1.6	0.1	1.6	2.2	5.6	1.3	2.5	2.1	0.4	1.4	4.9	4.2	1.4	0.4	7.1	0.0	0.5	2.1	14.2	2.0	0.7	2.4	2.1	1.8	1.0	1.3	1.1	0.6	4.7	1.6	1.2	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.9	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.5	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.4	2.3	2.1	1.9	1.7	1.8	1.6	2.2	1.4	2.0	1.8	1.2	0.0	0.0	0.0	30.0	0.3	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	4.9	0.4	1.5	0.1	0.0	0.0	23.8	0.0	0.0	0.8	0.0	0.4	0.0	0.5	0.0	0.0	0.0	1.7	28.7	0.0	0.0	0.0	0.0	8.6	0.0	0.0	0.0	3.7	0.0	0.6	0.0	31.7	5.4	0.0	0.0	0.4	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.0	0.3	2.1	0.0	1.0	0.0	0.0	0.3	0.1	0.0	0.0
DDO		ENSG00000203797	"D-aspartate oxidase"	Q99489	6	110391771-110415575	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 18.4"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 17.4;Muller glia cells: 8.2;Oligodendrocytes: 13.3;Paneth cells: 8.5;Proximal enterocytes: 8.5;Proximal tubular cells: 12.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"intermediate monocyte: 3.3;myeloid DC: 4.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"GAMG: 11.5;RPMI-8226: 15.9;U-937: 17.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037525, HPA037526"	Enhanced		Enhanced	Cytosol		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Cytosol		"HPA037525: AB_2675523, HPA037526: AB_10672352"	"unprognostic (1.37e-1)"	"unprognostic (1.54e-1)"	"unprognostic (6.51e-2)"	"unprognostic (1.30e-2)"	"unprognostic (2.00e-1)"	"unprognostic (3.28e-2)"	"unprognostic (3.71e-2)"	"unprognostic (1.01e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.91e-1)"	"unprognostic (6.97e-2)"	"unprognostic (1.43e-1)"	"prognostic favorable (8.69e-5)"	"unprognostic (3.51e-4)"	"unprognostic (3.36e-3)"	"unprognostic (1.27e-3)"	"unprognostic (9.06e-2)"	1.9	8.2	4.5	0.8	7.0	1.4	2.5	5.0	4.8	1.9	4.3	2.3	7.4	2.1	2.7	0.8	4.9	2.9	18.4	4.4	4.5	10.6	11.1	3.2	1.0	5.4	4.9	0.3	2.6	5.3	1.2	1.6	5.3	2.0	3.2	2.4	4.2	2.3	10.9	0.4	7.0	2.2	4.8	2.1	1.1	0.1	4.7	0.4	1.3	7.4	0.2	1.6	0.9	5.9	0.2	0.0	0.0	0.1	0.0	0.2	1.1	0.1	5.4	1.3	0.9	0.0	0.1	0.0	0.7	0.7	11.5	0.0	0.0	0.0	2.3	5.0	0.0	5.1	0.1	4.3	1.6	0.0	0.0	0.1	0.0	2.7	0.1	2.3	0.0	0.0	0.0	1.9	4.5	0.0	0.0	0.2	0.0	0.0	0.1	0.1	3.0	15.9	0.0	4.9	0.1	0.2	0.0	0.5	0.6	0.0	0.7	1.1	0.9	1.0	0.1	0.0	2.6	0.1	0.4	0.0	2.0	17.4	0.0	0.0	2.9	0.0	0.0	3.3	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	1.1	1.0	0.0	0.0	1.1	4.5	7.0	5.0	4.8	4.4	4.5	5.4	4.9	5.3	4.8	4.7	5.9	1.1	0.0	0.0	4.9	0.0	0.0	0.7	0.7	0.6	0.0	1.4	1.1	17.4	0.0	0.4	0.0	2.1	0.2	0.1	1.8	3.9	4.5	0.3	3.6	0.5	0.7	4.2	0.0	0.0	2.2	0.2	0.6	0.0	0.9	0.0	0.1	2.5	4.9	1.7	0.0	0.1	6.0	0.0	3.1	0.4	0.0	0.3	1.6	0.0	0.0	2.0	8.2	0.0	3.5	13.3	0.8	8.5	0.0	0.0	0.4	8.5	12.9	2.2	0.2	0.0	2.1	1.2	0.0	0.0	0.2	0.0	0.0	0.2	0.3	5.0	0.5
SLC22A16	"CT2, FLIPT2, OAT6, OKB1"	ENSG00000004809	"Solute carrier family 22 member 16"	Q86VW1	6	110424687-110476641	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Differentiation, Ion transport, Spermatogenesis, Transport"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"bone marrow: 20.5;testis: 21.4"	"Group enriched"	"Detected in some"	10	"Early spermatids: 34.9;Erythroid cells: 60.4;Late spermatids: 31.8;Spermatocytes: 43.1"	"Cancer enriched"	"Detected in single"	5	"endometrial cancer: 0.8"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"basophil: 5.7;classical monocyte: 6.9"	"Group enriched"	"Detected in many"	56	"dendritic cells: 4.0;granulocytes: 5.7;monocytes: 6.9"	"Group enriched"	"Detected in some"	18	"NB-4: 16.9;REH: 14.6;THP-1: 53.1;U-937: 30.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA036902	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 6: Erythroid cells - Oxygen transport"	"Plasma membrane, Cytosol"		"HPA036902: AB_10672274"	"unprognostic (1.01e-1)"	"unprognostic (1.88e-2)"	"unprognostic (5.11e-3)"	"unprognostic (2.19e-3)"	"unprognostic (2.70e-4)"	"unprognostic (1.45e-1)"	"unprognostic (8.15e-2)"	"unprognostic (6.93e-2)"	"unprognostic (1.48e-2)"	"unprognostic (4.98e-2)"	"unprognostic (1.02e-3)"	"unprognostic (2.49e-1)"	"unprognostic (2.61e-6)"	"unprognostic (5.78e-4)"	"unprognostic (2.72e-2)"	"unprognostic (2.74e-2)"	"unprognostic (2.65e-2)"	0.3	0.0	0.1	0.6	0.2	20.5	0.1	0.2	0.2	0.2	0.0	0.0	0.0	0.9	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.1	0.4	0.0	0.2	0.2	0.0	0.0	3.8	0.0	0.5	0.3	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	1.8	0.2	0.5	0.0	21.4	0.1	1.2	0.0	0.1	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.9	0.0	0.0	0.0	14.6	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	53.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	30.9	0.0	5.7	6.9	1.3	0.0	1.5	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	1.5	0.1	0.2	0.2	0.2	0.1	0.1	0.2	0.2	0.3	0.2	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	34.9	0.4	0.1	0.0	0.0	60.4	0.1	0.0	0.1	0.3	0.0	0.2	0.0	0.0	0.0	0.0	2.7	0.0	0.1	0.0	0.0	1.8	0.5	31.8	1.5	1.1	0.0	0.0	1.8	0.0	0.0	0.0	0.5	0.0	0.0	0.4	0.3	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.1	43.1	0.4	0.0	0.4	0.0	0.1	0.0	0.0	0.0
CDK19	"bA346C16.3, CDC2L6, CDK11, KIAA1028"	ENSG00000155111	"Cyclin dependent kinase 19"	Q9BWU1	6	110609978-110815958	"Enzymes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 40.8"	"Cell type enhanced"	"Detected in all"		"Late spermatids: 137.1;Oligodendrocyte precursor cells: 154.8;Oligodendrocytes: 476.3"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 23.3"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 4.6"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007053, HPA007062"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 18: U-2197 - ECM organization"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Cytosol	Nucleoplasm	"HPA007053: AB_1233803, HPA007062: "	"unprognostic (1.66e-2)"	"unprognostic (1.84e-1)"	"unprognostic (3.63e-1)"	"unprognostic (3.00e-3)"	"unprognostic (1.62e-1)"	"unprognostic (2.66e-3)"	"prognostic unfavorable (3.56e-4)"	"unprognostic (1.47e-2)"	"unprognostic (2.96e-2)"	"unprognostic (2.00e-3)"	"unprognostic (3.94e-1)"	"unprognostic (4.04e-1)"	"prognostic unfavorable (4.72e-5)"	"unprognostic (1.75e-1)"	"unprognostic (9.78e-2)"	"unprognostic (6.51e-2)"	"unprognostic (9.50e-3)"	6.2	3.4	22.7	7.2	32.1	11.7	6.4	17.9	29.0	6.6	7.5	6.9	5.3	10.2	3.8	8.2	5.4	8.3	4.4	20.8	19.3	6.4	5.0	6.7	9.4	28.8	24.7	9.8	3.9	6.5	2.3	11.5	22.7	26.7	6.4	8.8	4.4	5.9	3.3	8.5	6.7	7.3	19.4	8.0	7.1	18.5	26.9	13.6	6.1	5.4	9.2	5.3	6.6	40.8	5.7	6.1	21.8	26.4	11.1	15.6	10.8	18.8	19.4	6.7	8.8	7.6	6.4	14.7	6.5	13.2	13.9	3.2	8.0	3.9	15.4	18.2	4.5	26.0	8.8	8.9	6.8	10.5	18.2	10.7	8.6	9.7	14.1	17.0	6.8	12.3	7.6	20.2	14.5	9.7	14.3	15.0	2.0	8.1	4.1	14.8	11.3	5.8	7.8	11.0	10.6	19.8	14.4	11.3	17.0	7.2	3.9	37.1	7.7	14.2	7.6	29.6	11.4	2.1	3.2	12.8	15.6	13.7	14.9	2.1	1.2	0.9	0.4	0.7	0.4	0.6	0.3	0.3	1.0	0.6	0.2	0.3	4.6	0.7	0.4	0.5	0.4	0.3	22.7	32.1	17.9	29.0	20.8	19.3	28.8	24.7	22.7	19.4	26.9	40.8	15.9	3.2	17.8	50.6	19.2	9.8	14.4	6.7	12.0	19.2	14.6	9.4	8.2	18.6	8.7	16.5	16.7	7.0	17.8	27.0	1.9	10.5	102.3	13.7	16.5	13.6	12.6	21.6	85.3	4.7	18.4	12.0	13.7	25.6	7.0	23.0	20.0	12.2	16.4	23.5	51.5	13.5	8.2	33.9	19.9	137.1	10.8	22.1	26.6	62.8	19.6	33.9	22.6	154.8	476.3	7.0	20.0	16.1	5.9	30.0	16.1	7.7	6.9	13.9	6.6	11.2	12.3	56.6	15.8	20.3	16.2	7.9	13.3	10.1	13.8	11.1
AMD1	SAMDC	ENSG00000123505	"Adenosylmethionine decarboxylase 1"	P17707	6	110874770-110898879	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Polyamine biosynthesis, Spermidine biosynthesis"	"Decarboxylase, Lyase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"prostate: 202.9"	"Low cell type specificity"	"Detected in all"			"Cancer enhanced"	"Detected in all"		"prostate cancer: 70.4"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029281, HPA029282"	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 18: U-2197 - ECM organization"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA029281: AB_10600101, HPA029282: AB_10599965"	"prognostic unfavorable (3.87e-4)"	"unprognostic (4.68e-2)"	"unprognostic (1.85e-3)"	"unprognostic (1.01e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (1.91e-6)"	"unprognostic (1.18e-1)"	"unprognostic (2.03e-2)"	"unprognostic (6.50e-2)"	"unprognostic (2.25e-1)"	"unprognostic (4.20e-1)"	"prognostic favorable (4.28e-4)"	"unprognostic (8.62e-3)"	"unprognostic (1.55e-1)"	"unprognostic (4.41e-2)"	"unprognostic (7.71e-2)"	31.8	28.3	35.0	34.7	44.9	89.9	33.9	39.6	56.1	32.8	32.0	36.9	29.2	35.5	25.7	56.0	25.6	33.3	40.2	37.5	38.2	48.6	33.6	33.4	39.9	45.6	38.5	30.0	39.7	40.3	26.0	59.9	42.2	202.9	36.5	35.9	37.4	34.5	26.7	26.9	26.5	35.4	45.5	27.3	31.2	31.9	37.6	40.5	46.2	50.2	50.3	37.4	25.8	67.1	85.8	57.4	68.6	130.6	101.1	63.9	89.8	119.9	131.8	91.4	106.7	92.2	52.3	149.7	56.7	76.7	97.0	57.4	163.9	108.6	125.1	88.5	94.6	155.4	47.5	96.5	60.2	135.7	88.9	43.4	98.0	63.4	126.4	31.8	81.0	75.4	118.2	126.8	156.3	51.8	181.9	103.3	84.7	84.1	51.9	98.5	68.9	89.3	103.9	112.9	87.4	62.2	73.2	91.7	110.7	55.5	59.5	114.9	53.8	60.5	45.7	325.0	131.5	34.4	59.7	152.8	69.6	106.7	79.4	42.9	23.9	37.7	17.4	28.9	20.2	14.5	17.4	20.3	31.5	14.8	20.4	20.8	102.6	15.5	37.3	13.9	22.5	17.0	35.0	44.9	39.6	56.1	37.5	38.2	45.6	38.5	42.2	45.5	37.6	67.1	169.5	38.5	92.5	23.2	164.8	315.3	241.5	49.5	262.4	101.4	178.5	151.1	95.7	125.8	82.7	55.2	60.5	44.5	208.7	144.1	146.8	67.2	31.8	145.0	106.2	104.4	124.4	184.1	39.2	70.0	152.0	132.1	96.4	214.8	93.9	36.9	53.6	59.3	77.0	77.4	37.9	108.2	28.5	109.1	244.2	53.6	43.8	176.7	131.6	23.4	92.0	303.7	60.8	36.7	111.6	87.6	95.9	50.0	118.9	379.4	66.2	89.9	29.3	105.6	19.7	170.5	124.9	93.0	76.7	246.4	288.1	54.6	184.6	45.7	128.8	147.7
GTF3C6	"bA397G5.3, C6orf51, TFIIIC35"	ENSG00000155115	"General transcription factor IIIC subunit 6"	Q969F1	6	110958706-110967890	"Predicted intracellular proteins"	Transcription	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056179, HPA061345"	Approved		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm	"Nuclear bodies"	"HPA056179: AB_2683058, HPA061345: AB_2684485"	"unprognostic (6.98e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.66e-1)"	"unprognostic (3.04e-1)"	"unprognostic (6.99e-2)"	"unprognostic (2.34e-1)"	"prognostic unfavorable (7.27e-6)"	"unprognostic (2.08e-2)"	"unprognostic (9.79e-3)"	"unprognostic (2.89e-1)"	"unprognostic (5.42e-2)"	"unprognostic (7.75e-2)"	"unprognostic (1.42e-3)"	"unprognostic (9.31e-2)"	"unprognostic (1.69e-1)"	"unprognostic (2.39e-2)"	"unprognostic (1.14e-2)"	53.2	55.0	71.5	53.5	73.6	53.5	47.1	73.7	114.9	42.0	73.4	66.9	52.3	30.8	45.8	44.8	45.2	57.8	86.6	70.8	76.3	76.2	51.3	33.9	55.8	72.4	72.6	28.2	30.8	65.3	37.1	32.5	72.7	94.6	65.4	39.0	38.3	41.6	231.2	31.1	46.7	48.7	72.9	33.6	49.8	61.9	72.3	49.7	40.2	168.0	58.1	61.1	27.5	74.9	85.8	154.0	166.5	155.7	59.9	121.9	145.4	143.8	105.1	131.9	109.2	229.0	74.7	121.1	137.8	132.9	30.4	38.6	141.1	120.0	145.5	175.9	205.3	234.2	145.9	347.5	113.4	360.9	190.8	121.4	103.3	115.2	112.8	89.7	155.2	154.3	281.7	79.4	246.8	166.5	198.6	371.4	169.9	109.6	121.0	183.2	95.6	109.7	221.5	214.7	105.4	148.5	107.0	16.8	133.0	98.6	58.7	244.2	163.0	38.2	112.0	260.5	232.3	51.7	127.2	235.9	39.7	208.1	191.3	112.6	116.9	71.0	104.2	170.7	117.9	164.1	130.0	131.0	158.3	133.7	100.9	118.9	18.5	116.2	141.1	173.4	292.4	167.5	71.5	73.6	73.7	114.9	70.8	76.3	72.4	72.6	72.7	72.9	72.3	74.9	58.0	70.5	47.1	12.7	67.1	30.3	70.9	169.2	34.1	37.6	85.3	90.4	279.1	203.0	99.5	104.8	16.7	94.6	75.0	138.8	305.2	190.4	169.1	119.1	82.0	66.0	109.8	86.9	4.9	293.0	251.1	66.4	47.9	167.8	54.4	71.2	55.6	94.5	284.6	26.9	6.7	98.6	144.5	79.8	50.1	223.9	65.0	104.5	55.2	6.5	172.4	133.2	81.4	7.1	13.4	210.8	125.2	68.4	78.3	126.9	118.9	404.7	74.9	37.0	65.7	63.5	88.1	153.1	105.8	72.5	29.7	90.4	72.3	120.2	121.4	117.8
RPF2	"bA397G5.4, BXDC1, FLJ21087"	ENSG00000197498	"Ribosome production factor 2 homolog"	Q9H7B2	6	110982015-111028263	"Predicted intracellular proteins"	"Ribosome biogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"U-2197: 234.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035475	Supported		Supported	"Nucleoplasm,Nucleoli,Nucleoli rim,Mitotic chromosome"		Yes	No			"Cluster 15: NK-cells - Transcription"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 18: U-2197 - ECM organization"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoli, Nucleoli rim"	"Nucleoplasm, Mitotic chromosome"	"HPA035475: AB_10669861"	"unprognostic (2.85e-3)"	"unprognostic (2.19e-2)"	"unprognostic (6.00e-2)"	"unprognostic (2.90e-3)"	"unprognostic (4.45e-1)"	"prognostic unfavorable (2.04e-4)"	"prognostic unfavorable (2.25e-4)"	"unprognostic (1.14e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.99e-1)"	"unprognostic (8.43e-2)"	"unprognostic (9.16e-2)"	"prognostic unfavorable (2.07e-6)"	"unprognostic (2.39e-2)"	"unprognostic (2.35e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.86e-1)"	16.4	12.2	6.6	9.5	7.4	10.8	14.9	7.3	8.7	12.9	7.2	11.9	6.6	11.2	5.4	15.2	12.5	9.1	15.3	7.0	7.1	15.8	17.2	9.7	10.4	6.9	6.9	13.2	19.9	9.7	8.1	10.2	7.0	11.4	8.8	5.6	9.9	7.1	22.2	13.9	8.1	8.1	6.9	9.3	11.7	13.5	7.1	7.6	13.0	14.0	10.9	15.3	12.5	7.9	23.3	16.6	12.7	50.5	26.4	34.7	32.6	32.5	23.6	32.3	32.6	39.2	18.5	50.2	29.4	22.8	38.8	27.0	51.5	37.6	84.2	19.4	38.7	29.5	14.2	27.4	35.9	45.9	16.6	26.5	31.4	46.5	83.5	20.3	24.9	22.1	99.0	29.9	52.2	23.4	39.2	45.5	45.2	37.7	20.2	40.2	22.4	43.6	37.4	22.9	20.3	28.7	14.1	23.7	61.3	16.8	18.8	47.3	17.5	24.7	21.2	234.1	81.4	13.4	22.0	65.0	36.4	60.8	55.2	0.2	4.4	0.7	4.1	5.5	8.5	6.6	6.1	5.0	5.8	5.7	6.8	7.0	0.3	8.8	3.5	5.8	5.0	4.0	6.6	7.4	7.3	8.7	7.0	7.1	6.9	6.9	7.0	6.9	7.1	7.9	40.0	19.2	26.9	6.5	25.0	78.4	119.6	90.1	35.9	14.1	33.6	52.3	71.9	47.1	67.6	18.4	0.0	44.9	18.0	15.8	68.4	48.2	105.7	49.8	57.6	35.2	11.4	26.1	15.7	47.4	53.8	50.0	17.3	60.9	46.2	18.9	23.6	83.6	56.0	18.5	14.0	30.3	36.7	27.7	19.5	32.1	34.5	28.2	37.4	5.6	21.8	21.0	19.6	9.0	13.5	42.2	18.7	27.1	18.8	80.4	15.2	87.2	55.0	8.9	13.1	61.7	49.9	76.8	28.4	33.0	66.2	34.6	22.9	29.8	44.0	70.2
SLC16A10	"MCT10, TAT1"	ENSG00000112394	"Solute carrier family 16 member 10"	Q8TF71	6	111087503-111231194	"Metabolic proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 53.7;skeletal muscle: 41.2"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 32.8;Excitatory neurons: 33.9;Inhibitory neurons: 47.8;Macrophages: 33.8;Melanocytes: 44.4"	"Cancer enriched"	"Detected in many"	6	"testis cancer: 4.5"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"naive CD4 T-cell: 1.7;T-reg: 1.6"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HAP1: 49.4;HEK 293: 20.2;RPMI-8226: 37.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA016860	Approved		Supported	"Vesicles,Cell Junctions"		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 41: Macrophages - Immune response"	"Vesicles, Cell Junctions"		"HPA016860: AB_2189211"	"unprognostic (2.03e-1)"	"unprognostic (2.08e-1)"	"unprognostic (6.11e-2)"	"unprognostic (3.56e-4)"	"unprognostic (2.24e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.86e-3)"	"unprognostic (5.22e-1)"	"unprognostic (1.74e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.10e-3)"	"unprognostic (2.73e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.91e-1)"	2.9	5.5	1.4	3.0	8.6	0.8	0.8	4.2	3.4	0.6	53.7	1.2	8.5	0.5	1.4	0.8	0.8	1.5	2.3	2.0	1.2	10.0	13.5	4.6	0.9	1.1	5.0	0.9	29.7	7.9	1.0	23.7	2.8	1.3	1.8	0.7	3.1	0.2	41.2	15.3	5.0	0.3	0.2	1.8	5.3	4.2	9.6	10.9	2.7	6.0	1.3	1.9	1.2	1.1	0.9	1.0	0.4	2.2	0.1	0.1	3.1	0.0	0.2	0.8	1.2	9.0	0.4	5.2	1.4	0.3	2.5	0.1	49.4	0.1	1.0	0.1	20.2	8.2	0.7	7.4	0.1	7.6	7.4	0.0	0.0	0.1	0.0	0.2	0.0	10.9	1.4	0.2	0.1	3.6	9.8	0.8	14.6	0.2	3.2	5.4	6.8	37.2	0.0	0.5	10.7	3.3	0.2	0.7	1.8	3.6	1.8	0.9	0.1	0.1	1.8	0.5	2.5	2.6	0.1	1.5	0.3	5.8	0.8	0.4	0.0	0.0	0.1	0.0	0.1	0.1	0.4	0.1	0.0	0.2	1.7	1.5	0.3	0.1	0.0	0.1	1.6	0.1	1.4	8.6	4.2	3.4	2.0	1.2	1.1	5.0	2.8	0.2	9.6	1.1	0.4	9.6	32.8	2.0	1.5	9.7	10.7	0.0	4.6	6.9	2.0	1.3	9.1	0.0	3.1	5.5	2.1	1.9	0.7	2.1	1.9	0.2	9.0	0.4	0.8	1.4	6.6	1.7	33.9	12.5	1.8	8.9	3.6	1.3	1.3	2.5	4.2	25.4	21.4	1.7	47.8	4.8	0.0	12.4	12.4	8.2	0.0	33.8	44.4	0.0	0.7	1.6	0.0	16.6	0.3	2.0	0.9	0.0	4.8	3.9	10.9	17.7	0.7	0.7	0.0	18.5	1.0	11.6	11.2	1.2	14.8	1.2	5.8	9.2	8.5	1.2
MFSD4B	"KIAA1919, MGC33953"	ENSG00000173214	"Major facilitator superfamily domain containing 4B"	Q5TF39	6	111259327-111445354	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Sugar transport, Symport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 30.7;Cytotrophoblasts: 24.5;Glandular and luminal cells: 22.4;granulocytes: 20.2;Granulosa cells: 34.4;Syncytiotrophoblasts: 31.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-2197: 16.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031784	Approved				"Intracellular and membrane"	NA	NA			"Cluster 42: Non-specific - Transcription"	"Cluster 77: Retina - Visual perception"	"Cluster 18: U-2197 - ECM organization"	"Cluster 40: Granulosa cells - Unknown function"			"HPA031784: AB_10603775"	"unprognostic (2.98e-2)"	"unprognostic (1.64e-2)"	"unprognostic (1.89e-2)"	"unprognostic (3.00e-1)"	"unprognostic (1.94e-1)"	"unprognostic (3.07e-2)"	"unprognostic (7.50e-5)"	"unprognostic (3.51e-2)"	"unprognostic (2.33e-1)"	"unprognostic (6.84e-2)"	"unprognostic (2.94e-2)"	"unprognostic (3.41e-1)"	"unprognostic (6.04e-3)"	"unprognostic (9.27e-2)"	"unprognostic (3.68e-1)"	"unprognostic (6.32e-2)"	"unprognostic (1.98e-4)"	1.3	1.7	1.5	1.8	1.6	2.2	2.1	2.0	1.5	2.3	7.2	1.4	3.6	1.5	2.4	1.3	1.7	1.3	1.1	1.3	1.6	2.9	2.6	1.4	1.6	1.0	0.7	1.1	1.3	1.8	1.6	4.7	0.5	1.3	1.7	3.0	1.7	1.8	2.0	2.5	3.4	1.6	0.1	1.6	1.6	4.3	1.7	1.4	2.0	0.9	1.3	1.5	1.1	0.8	1.5	3.3	2.8	7.1	2.8	1.7	4.4	2.1	3.1	3.2	4.2	5.5	2.7	3.9	3.3	2.7	3.1	3.4	5.5	2.2	5.1	2.6	1.4	5.0	5.4	3.6	3.9	3.9	8.3	1.2	3.8	3.7	3.0	4.2	2.7	4.9	5.5	5.9	3.5	2.7	3.5	2.4	2.2	3.5	0.9	3.9	2.4	1.6	4.1	4.0	2.0	2.5	2.2	2.7	1.3	3.0	2.2	5.4	2.1	3.3	1.8	16.7	4.0	2.0	2.9	3.9	4.5	3.2	4.0	4.4	1.4	1.9	1.7	1.7	2.0	2.1	1.1	1.1	1.5	1.2	1.5	1.7	1.9	1.7	1.6	1.8	0.9	1.0	1.5	1.6	2.0	1.5	1.3	1.6	1.0	0.7	0.5	0.1	1.7	0.8	4.2	9.6	30.7	0.0	3.2	0.0	0.0	0.0	0.0	0.0	3.7	2.2	0.0	0.0	13.6	5.5	0.0	24.5	5.3	0.0	1.9	5.6	0.0	15.0	9.4	4.1	0.0	0.0	0.0	3.6	11.5	4.9	0.0	22.4	20.2	34.4	0.0	0.0	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	2.6	0.0	0.0	0.0	0.0	4.4	0.0	0.0	1.8	0.0	0.0	6.6	10.2	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	31.1	2.8	5.7	0.0	0.0
REV3L	"POLZ, REV3"	ENSG00000009413	"REV3 like, DNA directed polymerase zeta catalytic subunit"	O60673	6	111299028-111483715	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, DNA replication"	"DNA-binding, DNA-directed DNA polymerase, Nucleotidyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 28.8"	"Cell type enhanced"	"Detected in all"		"Astrocytes: 290.6;Endometrial stromal cells: 610.1;Inhibitory neurons: 360.2;Oligodendrocyte precursor cells: 594.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA064853, HPA069382"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 77: Retina - Visual perception"	"Cluster 18: U-2197 - ECM organization"	"Cluster 36: Stromal cells - Cell proliferation"	Nucleoplasm		"HPA064853: AB_2685369, HPA069382: AB_2686134"	"unprognostic (5.54e-2)"	"unprognostic (2.06e-1)"	"unprognostic (5.09e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.59e-1)"	"unprognostic (8.59e-3)"	"unprognostic (4.42e-2)"	"unprognostic (1.56e-2)"	"unprognostic (8.09e-2)"	"unprognostic (1.17e-1)"	"unprognostic (6.87e-3)"	"unprognostic (1.27e-1)"	"unprognostic (4.34e-2)"	"unprognostic (2.80e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.03e-3)"	6.1	3.6	11.2	6.4	9.2	7.2	3.1	28.8	11.9	16.6	11.3	4.8	4.3	10.3	2.3	4.6	6.2	4.9	4.4	7.2	10.0	4.1	3.5	4.4	5.6	3.6	7.9	7.6	4.2	3.2	0.9	6.8	4.4	4.8	3.5	26.2	3.2	5.0	5.0	4.7	3.6	8.0	1.8	4.6	4.5	7.5	8.4	6.0	6.6	12.2	2.5	4.8	1.0	10.7	9.2	6.3	11.4	13.3	35.2	35.0	11.9	13.6	16.7	6.4	9.6	8.1	5.0	17.0	9.3	15.9	12.0	9.4	17.6	5.7	10.7	13.9	10.0	13.9	13.9	13.3	9.1	13.5	6.9	21.0	3.2	12.0	15.4	10.3	10.2	10.0	18.3	13.9	10.8	7.2	16.7	3.6	3.2	3.8	10.2	11.6	12.7	6.6	2.5	7.9	15.7	11.8	17.5	3.2	12.4	8.5	7.1	14.2	13.7	9.6	9.6	47.0	15.4	14.0	17.1	17.6	9.1	10.5	12.4	0.6	0.6	1.2	1.0	0.5	1.6	1.0	0.8	1.0	0.6	1.6	0.5	1.0	1.9	0.4	0.9	0.9	0.7	0.3	11.2	9.2	28.8	11.9	7.2	10.0	3.6	7.9	4.4	1.8	8.4	10.7	133.4	48.1	82.4	290.6	65.7	30.5	19.5	12.8	45.5	117.5	20.2	17.9	34.5	11.5	29.1	20.2	56.3	27.2	35.3	11.8	3.9	17.3	40.0	151.1	610.1	57.4	59.8	27.5	161.7	11.5	11.9	82.7	41.3	107.5	46.9	61.5	21.8	16.0	11.8	35.3	360.2	18.6	10.2	19.9	87.4	16.3	50.4	57.2	21.4	105.9	23.7	59.6	33.0	594.7	190.3	8.5	12.3	39.1	41.3	21.3	18.4	15.9	43.5	57.6	39.5	122.3	62.3	68.5	70.4	26.1	26.9	33.0	46.4	30.3	21.5	8.2
TRAF3IP2	"ACT1, C6orf2, C6orf4, C6orf5, C6orf6, CIKS, DKFZP586G0522"	ENSG00000056972	"TRAF3 interacting protein 2"	O43734	6	111555381-111606906	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"Inflammatory response, Ubl conjugation pathway"	Transferase	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 61.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-2197: 149.7"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA036352	Approved		Approved	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 68: Epididymis - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 22: Epithelial cell types - Mixed function"	"Golgi apparatus"	Vesicles	"HPA036352: AB_10672085"	"unprognostic (1.94e-1)"	"prognostic unfavorable (3.21e-4)"	"unprognostic (1.79e-1)"	"prognostic favorable (4.73e-5)"	"unprognostic (2.81e-2)"	"unprognostic (3.03e-2)"	"unprognostic (1.01e-2)"	"unprognostic (9.93e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.13e-2)"	"unprognostic (2.64e-2)"	"unprognostic (1.05e-2)"	"prognostic unfavorable (5.16e-5)"	"unprognostic (1.11e-1)"	"unprognostic (4.88e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.31e-1)"	19.7	16.3	24.8	19.5	24.8	32.4	19.9	24.3	29.4	24.9	23.7	34.0	28.6	36.2	47.2	26.5	34.7	14.2	8.3	24.4	26.0	9.3	8.6	17.5	16.3	27.2	28.2	13.9	21.6	13.6	9.3	14.2	25.6	19.2	26.4	5.9	25.3	30.8	11.4	35.0	25.1	22.1	21.7	6.8	35.5	3.0	28.7	21.0	14.8	14.8	22.5	26.5	18.1	22.9	32.2	11.0	6.8	15.7	35.9	39.0	15.6	39.8	62.2	9.9	14.1	8.7	14.1	6.2	13.2	33.5	35.5	58.2	8.0	86.2	18.4	43.2	11.6	12.7	10.6	11.9	13.9	6.9	22.6	47.1	57.5	29.9	110.1	24.9	20.0	15.2	13.6	1.9	13.2	22.0	51.2	19.4	9.0	30.6	8.8	53.3	12.4	2.7	29.5	52.4	27.3	6.9	12.1	71.8	47.8	12.7	31.6	18.0	9.2	19.2	7.6	149.7	35.5	0.8	12.4	16.8	45.8	10.8	50.1	25.8	2.5	5.3	3.8	0.8	12.7	6.4	7.6	5.6	2.6	8.6	7.6	7.4	3.5	5.7	0.3	0.8	17.9	3.1	24.8	24.8	24.3	29.4	24.4	26.0	27.2	28.2	25.6	21.7	28.7	22.9	24.7	3.2	13.8	26.1	10.8	30.1	61.5	46.3	11.4	7.5	8.3	8.6	4.9	7.2	21.6	3.7	12.5	19.3	3.8	30.0	5.9	35.4	0.1	20.9	14.5	18.3	13.2	5.2	5.9	31.9	28.8	14.4	18.3	32.7	20.2	7.7	3.9	5.5	6.0	6.7	10.8	16.9	16.2	1.3	10.7	0.5	7.2	5.8	12.4	7.5	6.2	14.2	8.2	19.6	6.6	20.2	26.3	7.5	4.5	42.9	18.5	5.9	18.3	5.5	0.0	14.7	10.5	0.8	2.1	16.2	24.6	20.9	7.9	4.6	21.9	45.0
FYN	"MGC45350, SLK, SYN"	ENSG00000010810	"FYN proto-oncogene, Src family tyrosine kinase"	P06241	6	111660332-111873452	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Adaptive immunity, Host-virus interaction, Immunity"	"Developmental protein, Kinase, Transferase, Tyrosine-protein kinase"	Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 382.6;dendritic cells: 291.6;NK-cells: 228.6;Oligodendrocyte precursor cells: 342.8;Proximal tubular cells: 212.2;T-cells: 275.8"	"Cancer enhanced"	"Detected in all"		"glioma: 42.5"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in all"	16	"NK-cells: 69.0;T-cells: 174.8"	"Cell line enhanced"	"Detected in many"		"U-2197: 538.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005034, CAB018387, HPA023887, HPA063770"	Approved		Enhanced	"Plasma membrane,Cytosol"		NA	NA		820000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 18: U-2197 - ECM organization"	"Cluster 24: Non-specific - Transcription regulation"	"Plasma membrane"	Cytosol	"CAB005034: AB_562117, CAB018387: AB_627642, HPA023887: AB_1849226, HPA063770: AB_2685119"	"unprognostic (8.62e-3)"	"unprognostic (8.25e-2)"	"unprognostic (2.11e-1)"	"unprognostic (2.00e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.43e-2)"	"prognostic favorable (1.84e-4)"	"unprognostic (4.60e-2)"	"unprognostic (2.89e-2)"	"unprognostic (2.92e-1)"	"prognostic favorable (4.78e-4)"	"unprognostic (1.43e-1)"	"prognostic unfavorable (1.43e-4)"	"unprognostic (6.95e-2)"	"unprognostic (3.10e-1)"	"unprognostic (6.62e-3)"	"unprognostic (2.40e-1)"	76.6	10.8	117.1	52.4	106.4	32.3	46.8	83.8	104.3	45.5	33.3	32.9	16.4	45.6	33.8	16.0	51.4	32.1	40.5	102.1	121.5	23.9	20.4	63.5	108.9	136.3	104.9	28.8	8.5	18.7	22.9	29.7	107.0	17.6	15.6	26.9	12.9	12.5	12.3	41.5	47.1	38.0	109.9	71.9	29.3	16.5	105.7	86.1	45.7	18.3	67.6	48.4	33.4	109.8	10.4	1.5	178.6	30.2	133.4	81.4	3.2	29.1	90.8	24.2	42.9	1.3	1.6	21.0	18.3	56.1	21.0	1.3	25.8	39.9	46.8	0.7	66.5	57.0	13.6	2.7	78.7	19.5	19.0	78.8	59.1	90.5	76.8	62.9	99.5	99.6	4.9	140.3	86.8	1.5	92.7	17.9	26.0	3.3	18.0	29.1	24.0	1.4	0.0	9.1	124.6	50.7	5.7	2.4	124.7	39.6	1.3	57.0	63.9	72.3	13.5	538.7	18.5	20.0	19.7	32.5	136.0	44.3	128.9	1.1	6.4	0.2	137.0	5.6	174.8	4.8	83.9	152.7	7.4	6.4	27.9	72.3	3.0	69.0	4.2	4.3	79.2	51.5	117.1	106.4	83.8	104.3	102.1	121.5	136.3	104.9	107.0	109.9	105.7	109.8	87.8	0.0	8.3	382.6	26.0	17.1	2.5	0.6	1.8	57.2	2.9	6.9	11.3	14.3	2.1	7.3	0.0	2.7	291.6	1.2	17.6	9.3	3.7	5.6	51.7	70.3	13.2	20.9	118.7	1.0	2.4	61.9	17.9	4.9	52.0	20.9	76.4	60.3	3.0	47.1	127.6	3.8	2.0	35.8	96.1	3.2	26.4	42.7	37.4	88.1	64.5	89.1	228.6	342.8	162.3	9.7	0.1	7.2	96.2	3.9	17.7	212.2	4.4	8.3	13.1	48.8	32.9	3.9	8.6	0.7	13.4	52.0	275.8	71.1	2.9	1.1
CCN6	"WISP-3, WISP3"	ENSG00000112761	"Cellular communication network factor 6"	O95389	6	112054075-112069686	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins"		"Growth factor"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"epididymis: 10.2"	"Cell type enriched"	"Detected in single"	7	"Cardiomyocytes: 2.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	49	"RT4: 12.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA064196			Supported	Mitochondria	"Secreted to extracellular matrix"	NA	NA				"Cluster 30: Epididymis - Antimicrobial activity"	"Cluster 15: RT4 - Unknown function"	"Cluster 43: Cardiomyocytes - Nuclear processes"	Mitochondria		"HPA064196: AB_2685209"	"unprognostic (2.13e-2)"	"unprognostic (7.90e-3)"	"unprognostic (5.00e-2)"	"unprognostic (2.22e-2)"	"unprognostic (3.76e-1)"	"unprognostic (6.52e-2)"	"unprognostic (1.98e-3)"	"unprognostic (4.07e-3)"	"unprognostic (1.82e-1)"	"unprognostic (3.90e-1)"	"unprognostic (1.02e-2)"	"unprognostic (4.81e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.50e-2)"	"unprognostic (3.11e-1)"	"unprognostic (4.91e-2)"	"unprognostic (2.93e-2)"	0.0	0.0	0.0	0.0	0.2	0.0	1.6	0.0	0.0	0.3	0.0	0.0	0.1	0.0	10.2	0.0	2.3	0.1	0.0	0.0	0.0	1.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.1	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.2	0.2	0.0	0.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	12.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0
TUBE1	"dJ142L7.2, FLJ22589, TUBE"	ENSG00000074935	"Tubulin epsilon 1"	Q9UJT0	6	112070663-112087529	"FDA approved drug targets, Predicted intracellular proteins"			"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 199.6;Spermatocytes: 97.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"U-2197: 48.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA032073, HPA032074"	Approved					NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 15: Liver - Metabolism"	"Cluster 18: U-2197 - ECM organization"	"Cluster 23: Spermatids - Flagellum & Golgi organization"			"HPA032073: AB_10601773, HPA032074: AB_10601216"	"unprognostic (4.79e-2)"	"unprognostic (1.61e-1)"	"unprognostic (3.76e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.22e-2)"	"unprognostic (7.36e-2)"	"unprognostic (1.22e-1)"	"unprognostic (8.36e-3)"	"unprognostic (2.18e-1)"	"unprognostic (1.04e-1)"	"unprognostic (4.99e-3)"	"unprognostic (1.70e-1)"	"unprognostic (5.15e-3)"	"unprognostic (1.64e-1)"	"unprognostic (7.68e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.59e-3)"	12.3	9.0	9.8	5.0	10.1	4.1	11.0	11.7	16.8	15.6	9.9	11.8	5.0	17.0	8.3	6.8	16.4	8.8	17.5	9.7	10.0	12.3	40.1	7.9	7.3	10.4	10.2	15.2	10.9	7.5	14.4	9.1	10.4	11.0	6.2	10.1	6.7	8.4	5.8	11.3	7.6	10.3	10.2	6.9	11.7	27.1	10.1	4.8	10.6	4.8	5.4	12.6	10.4	11.4	2.1	2.8	7.6	24.0	17.5	9.2	6.3	8.6	13.7	5.9	11.6	4.2	4.2	8.0	5.4	3.6	9.2	6.4	8.7	3.8	12.2	4.1	7.8	2.8	2.0	6.1	25.0	15.4	10.1	10.0	25.1	8.1	20.9	8.5	7.4	22.8	15.6	10.8	4.8	1.7	8.8	20.5	7.6	12.1	5.2	10.3	4.7	5.2	9.0	2.0	11.5	10.1	7.0	6.0	26.4	6.6	4.8	36.5	4.3	5.3	4.9	48.2	9.2	3.2	1.1	8.7	7.7	18.2	13.8	0.0	0.4	1.1	1.1	0.5	3.3	1.5	2.4	1.5	0.8	1.1	3.2	2.7	0.3	1.8	0.8	0.6	2.5	0.9	9.8	10.1	11.7	16.8	9.7	10.0	10.4	10.2	10.4	10.2	10.1	11.4	27.6	6.4	16.7	25.8	13.4	24.6	17.8	12.3	15.4	23.0	15.0	13.3	17.5	11.5	13.5	22.0	35.5	4.1	9.8	6.8	15.6	12.5	199.6	12.1	12.0	16.7	6.1	19.1	58.2	18.0	12.3	18.8	7.7	7.7	16.5	11.5	18.5	71.9	7.2	13.5	68.3	11.4	4.1	6.7	10.2	49.8	15.5	6.2	7.2	21.5	4.6	11.8	9.2	31.7	82.0	12.6	9.0	19.9	10.9	13.2	12.7	25.6	14.6	28.0	19.7	13.3	13.4	97.0	27.0	12.7	12.5	3.3	14.8	35.0	8.0	14.8
FAM229B	"C6orf225, DKFZp586F0922, LOC619208"	ENSG00000203778	"Family with sequence similarity 229 member B"	Q4G0N7	6	112087591-112102790	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"testis: 448.1"	"Group enriched"	"Detected in many"	8	"Early spermatids: 3403.2;Late spermatids: 7607.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA036068			Approved	"Nucleoplasm,Nucleoli,Golgi apparatus"		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 18: U-2197 - ECM organization"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm	"Nucleoli, Golgi apparatus"	"HPA036068: AB_10673495"	"unprognostic (1.65e-1)"	"unprognostic (9.41e-2)"	"unprognostic (4.29e-2)"	"unprognostic (4.67e-3)"	"unprognostic (3.17e-2)"	"unprognostic (2.00e-2)"	"unprognostic (2.71e-2)"	"unprognostic (1.76e-2)"	"unprognostic (5.08e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.07e-3)"	"unprognostic (4.74e-2)"	"prognostic favorable (8.76e-4)"	"unprognostic (3.74e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.80e-2)"	"unprognostic (2.06e-2)"	18.2	21.7	62.1	3.6	69.4	3.7	16.9	68.5	85.4	20.7	67.9	21.1	3.5	25.8	36.4	7.2	53.4	19.1	69.9	60.5	68.7	29.2	25.0	15.3	3.5	70.0	69.7	25.9	8.6	43.6	66.1	10.6	71.3	19.2	5.4	35.4	9.0	22.6	13.6	7.7	7.4	18.4	72.8	5.2	18.7	448.1	65.2	10.9	21.1	15.3	3.3	19.0	11.3	77.1	4.0	9.9	39.9	19.5	34.3	34.0	1.9	14.9	56.6	21.0	44.0	1.7	9.4	3.1	43.0	27.7	21.9	2.5	8.4	21.7	33.4	1.0	27.7	3.7	4.1	15.7	21.3	8.1	1.8	20.7	14.3	34.8	5.9	48.6	20.9	35.2	4.9	7.8	26.0	1.0	15.1	12.9	10.4	2.9	23.2	23.3	10.0	3.2	31.3	0.6	37.0	15.5	11.9	1.3	23.9	21.4	19.1	7.4	12.0	17.5	7.4	67.1	20.2	5.8	0.3	28.6	27.7	6.8	23.5	0.1	0.0	2.1	3.0	0.0	3.9	1.8	2.6	2.4	0.4	2.6	5.6	5.1	0.2	4.6	0.2	2.5	0.3	1.9	62.1	69.4	68.5	85.4	60.5	68.7	70.0	69.7	71.3	72.8	65.2	77.1	53.7	3.2	11.4	10.4	4.7	8.4	18.8	48.6	12.0	31.3	23.6	34.7	93.9	21.5	42.1	51.5	12.5	1.5	1.9	0.3	133.1	31.7	3403.2	207.7	18.5	24.6	3.0	9.0	17.2	10.4	6.9	32.9	7.1	11.6	1.3	36.1	33.2	54.4	3.1	16.8	14.8	0.6	52.9	3.2	7.3	7607.9	72.7	6.2	24.9	6.5	2.1	83.5	4.1	12.1	35.8	6.7	0.1	90.7	5.0	11.6	0.1	93.0	409.9	36.9	59.2	26.5	32.6	663.2	51.1	5.5	8.7	0.5	4.4	64.0	0.7	12.2
LAMA4	LAMA3	ENSG00000112769	"Laminin subunit alpha 4"	Q16363	6	112107931-112254939	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"		"Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 115.7;Early spermatids: 114.7;Extravillous trophoblasts: 119.1;Fibroblasts: 149.2;Leydig cells: 166.5;Microglial cells: 124.6;Oligodendrocyte precursor cells: 160.4;Theca cells: 117.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 330.5;ASC TERT1: 512.5;HSkMC: 405.5;hTERT-RPE1: 256.0;HUVEC TERT2: 441.3;TIME: 404.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015693, CAB078156"	Enhanced		Approved	"Plasma membrane,Cytosol"	"Secreted to extracellular matrix"	NA	NA		320000		"Cluster 46: Fibroblasts - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane, Cytosol"		"CAB078156: AB_2665814, HPA015693: AB_1852687"	"unprognostic (1.87e-2)"	"unprognostic (6.48e-2)"	"unprognostic (8.37e-2)"	"unprognostic (2.39e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.52e-2)"	"unprognostic (5.07e-2)"	"unprognostic (4.59e-2)"	"unprognostic (2.93e-2)"	"unprognostic (9.06e-2)"	"unprognostic (1.78e-1)"	"prognostic unfavorable (2.00e-4)"	"unprognostic (4.40e-3)"	"unprognostic (1.85e-1)"	"unprognostic (2.80e-2)"	"unprognostic (1.15e-2)"	116.2	9.4	17.6	34.0	17.1	0.5	59.9	11.7	12.9	77.0	12.6	82.6	17.2	77.5	18.5	35.6	115.2	37.3	51.2	12.3	17.9	9.9	4.4	80.8	11.5	12.7	16.3	23.2	4.9	8.6	13.6	68.0	14.7	35.4	34.0	1.3	38.4	40.7	10.6	17.7	34.5	107.8	11.4	1.5	36.7	18.7	22.6	5.0	23.2	18.6	8.9	65.1	40.3	11.4	0.3	0.1	18.8	0.6	330.5	512.5	0.3	91.4	55.8	8.9	1.4	0.0	36.1	0.0	58.0	154.9	19.8	0.3	4.0	0.6	1.5	0.3	46.4	0.0	44.4	0.0	69.6	0.1	0.3	405.5	0.1	64.9	0.2	256.0	441.3	0.0	0.4	0.4	1.7	0.0	0.1	0.3	1.1	0.0	15.1	0.2	0.2	0.3	134.0	2.8	0.4	2.1	14.2	0.4	68.5	1.5	0.4	0.2	404.9	145.1	7.6	160.6	29.1	0.0	0.3	0.3	33.5	0.2	191.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.6	17.1	11.7	12.9	12.3	17.9	12.7	16.3	14.7	11.4	22.6	11.4	115.7	3.2	4.5	45.4	0.1	22.7	1.4	2.9	8.6	1.6	5.4	9.4	53.3	2.8	10.4	3.7	0.0	1.0	0.6	0.0	3.9	0.7	114.7	6.2	24.8	103.5	0.0	2.7	27.4	0.7	119.1	149.2	3.6	10.5	1.3	3.5	36.0	35.3	3.0	0.0	6.3	0.8	20.3	1.6	20.8	47.0	166.5	2.0	56.9	124.6	0.6	0.0	0.0	160.4	2.0	0.7	0.0	81.3	1.5	1.5	0.0	0.1	1.7	0.5	65.7	5.4	98.2	1.3	1.2	5.0	18.6	3.0	2.7	117.4	0.0	12.9
AL365214.2		ENSG00000281613	"Novel ret finger protein-like 4B"		6	112236806-112350094	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enriched"	"Detected in single"	12	"testis: 4.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	14	"RPTEC TERT1: 3.4"									HPA059324	Uncertain					NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 35: RPTEC-TERT1 - Kidney processes"				"HPA059324: "																		0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
RFPL4B	RNF211	ENSG00000251258	"Ret finger protein like 4B"	Q6ZWI9	6	112347330-112351294	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	4	"testis: 1.6"	"Cell type enriched"	"Detected in some"	5	"Extravillous trophoblasts: 15.7"	"Group enriched"	"Detected in some"	7	"liver cancer: 0.6;testis cancer: 1.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"K-562: 1.9;RPTEC TERT1: 2.3;U-266/70: 1.0;U-266/84: 8.0"									"HPA059324, HPA066464"	Uncertain					NA	NA				"Cluster 83: Testis - Spermatogenesis"	"Cluster 16: U-266 - Nucleosome"	"Cluster 38: Extravillous trophoblasts - Unknown function"			"HPA059324: , HPA066464: "	"unprognostic (4.26e-1)"				"unprognostic (1.45e-1)"						"unprognostic (6.66e-2)"	"unprognostic (3.78e-1)"	"unprognostic (2.80e-3)"		"unprognostic (3.73e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.1	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	1.0	8.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	15.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	3.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0
MARCKS	"80K-L, MACS, PKCSL"	ENSG00000277443	"Myristoylated alanine rich protein kinase C substrate"	P29966	6	113857345-113863475	"Plasma proteins, Predicted intracellular proteins"		"Actin-binding, Calmodulin-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"intermediate monocyte: 12.7;neutrophil: 18.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 405.8;TIME: 326.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022062, HPA054820, HPA067595, HPA069443"	Enhanced		Approved	"Nucleoplasm,Endoplasmic reticulum,Plasma membrane,Cytosol"		NA	NA		19000000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 70: Brain - Nervous system development"	"Cluster 12: NES - Nervous system development"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane"	"Nucleoplasm, Endoplasmic reticulum, Cytosol"	"CAB022062: AB_309681, HPA054820: AB_2682613, HPA067595: AB_2732772, HPA069443: AB_2732133"	"unprognostic (4.71e-1)"	"unprognostic (1.91e-2)"	"unprognostic (2.46e-1)"	"unprognostic (5.51e-3)"	"unprognostic (8.22e-3)"	"unprognostic (2.38e-2)"	"prognostic unfavorable (2.78e-8)"	"unprognostic (7.82e-2)"	"unprognostic (2.57e-1)"	"unprognostic (6.92e-2)"	"unprognostic (2.27e-1)"	"unprognostic (3.56e-2)"	"prognostic unfavorable (4.85e-4)"	"unprognostic (1.36e-3)"	"unprognostic (2.77e-2)"	"unprognostic (8.07e-2)"	"unprognostic (2.70e-2)"	42.8	16.8	65.1	58.2	64.1	104.6	50.2	73.2	78.5	31.9	21.6	75.7	38.9	31.2	13.5	45.1	27.3	35.8	18.2	56.8	89.2	24.6	26.1	35.0	45.4	81.0	87.6	39.0	42.4	7.0	20.6	63.0	73.1	37.8	68.2	22.0	28.0	18.0	15.7	32.1	43.3	30.1	106.8	57.0	62.8	10.3	85.5	44.8	16.2	12.9	45.3	86.2	34.5	102.8	39.2	22.6	405.8	22.3	134.0	86.6	2.2	123.0	171.4	84.9	140.6	40.7	54.1	0.1	25.3	228.0	67.3	118.0	67.9	35.7	109.7	0.3	40.2	0.0	22.2	53.3	89.2	10.3	0.7	90.2	68.8	81.8	77.4	231.9	243.1	0.4	4.6	107.6	122.1	0.4	1.3	0.3	52.7	43.5	29.4	0.2	40.7	4.1	26.9	73.6	56.4	163.4	78.7	39.6	89.6	95.0	2.1	11.3	326.0	78.3	0.5	129.9	212.7	288.3	22.4	11.4	60.2	55.8	153.4	0.0	3.9	0.0	0.0	12.7	0.0	4.6	0.0	0.0	1.1	1.9	0.0	0.0	18.7	0.0	7.5	0.0	0.0	0.5	65.1	64.1	73.2	78.5	56.8	89.2	81.0	87.6	73.1	106.8	85.5	102.8	211.2	9.6	15.5	44.7	139.0	504.1	540.7	232.3	275.4	157.0	213.2	176.7	16.6	57.2	115.0	38.6	29.2	7.2	5.5	629.5	37.2	144.3	55.7	111.2	444.0	271.6	336.3	2.5	33.0	229.9	11.2	372.6	135.1	130.4	2.5	526.1	236.0	8.8	371.6	84.1	21.0	369.4	126.1	286.3	605.5	35.7	120.5	381.3	273.9	60.0	447.2	315.5	2.1	194.5	9.7	208.1	223.1	67.0	105.2	380.1	89.9	6.9	145.0	37.7	39.5	89.8	222.8	22.7	16.2	326.3	638.5	29.4	22.3	62.3	352.3	620.2
HDAC2	"KDAC2, RPD3, YAF1"	ENSG00000196591	"Histone deacetylase 2"	Q92769	6	113933028-114011308	"Cancer-related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Biological rhythms, Transcription, Transcription regulation"	"Chromatin regulator, Hydrolase, Repressor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005054, HPA011727"	Supported		Supported	Nucleoplasm		NA	NA		25000	"Cluster 27: Non-specific - Gene expression"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Nucleoplasm		"CAB005054: AB_562295, HPA011727: AB_1850540"	"prognostic unfavorable (7.07e-4)"	"unprognostic (1.44e-1)"	"unprognostic (2.67e-1)"	"unprognostic (2.56e-2)"	"unprognostic (2.61e-2)"	"unprognostic (1.89e-2)"	"prognostic unfavorable (5.39e-10)"	"unprognostic (2.03e-1)"	"unprognostic (2.63e-2)"	"unprognostic (9.00e-2)"	"unprognostic (2.01e-1)"	"unprognostic (3.92e-1)"	"unprognostic (1.84e-2)"	"unprognostic (1.96e-1)"	"unprognostic (2.42e-1)"	"unprognostic (9.80e-2)"	"unprognostic (3.51e-1)"	35.9	42.7	26.6	37.4	31.5	63.4	54.8	32.8	40.0	45.2	22.3	48.0	34.4	57.3	53.4	43.3	48.7	34.6	41.1	26.7	34.7	46.3	34.6	33.0	42.6	31.2	29.5	53.4	37.1	45.7	35.9	56.1	31.2	47.0	53.6	37.2	34.3	45.3	48.6	46.1	36.7	54.3	28.8	35.9	40.5	76.7	31.1	68.5	45.6	43.4	52.1	63.2	37.5	37.5	126.7	84.9	387.1	224.3	97.7	110.5	162.6	146.6	119.0	168.5	200.1	226.3	90.1	103.6	119.0	132.5	173.1	96.6	266.0	148.1	281.4	148.9	185.0	249.2	102.1	131.8	129.7	256.1	107.7	90.0	97.6	180.0	167.2	164.4	199.6	179.2	326.4	101.6	282.7	105.5	231.9	229.6	220.0	133.4	116.3	155.0	193.0	95.2	174.4	148.9	258.3	219.1	115.9	107.5	127.7	231.4	78.6	294.0	163.2	107.0	122.9	113.7	246.9	80.6	113.9	244.6	90.9	242.6	185.3	43.5	39.0	42.1	28.0	38.6	37.3	37.0	34.0	30.3	51.0	31.4	41.8	39.1	23.1	39.8	50.2	44.2	36.0	37.2	26.6	31.5	32.8	40.0	26.7	34.7	31.2	29.5	31.2	28.8	31.1	37.5	40.2	57.7	57.8	13.4	51.4	192.1	91.3	152.6	85.4	31.0	61.0	54.6	64.0	25.8	116.4	53.3	4.2	157.7	42.6	43.5	43.0	154.9	86.8	74.3	91.6	73.8	100.5	129.4	29.9	105.0	140.7	76.2	53.5	63.2	55.1	103.9	50.0	31.9	102.0	15.2	26.3	73.4	175.0	64.1	89.8	109.1	83.0	63.3	83.6	26.2	107.7	30.9	33.0	29.1	34.0	133.6	51.3	67.4	56.2	90.0	37.4	71.7	98.7	28.1	39.5	94.7	88.0	199.0	215.5	96.5	193.1	207.7	45.5	53.9	94.6	100.5
HS3ST5	3-OST-5	ENSG00000249853	"Heparan sulfate-glucosamine 3-sulfotransferase 5"	Q8IZT8	6	114055586-114343045	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 9.7;skeletal muscle: 3.2"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 102.5;Excitatory neurons: 154.8;Inhibitory neurons: 130.9;Oligodendrocytes: 606.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"PC-3: 4.6;RT4: 6.8;SCLC-21H: 14.2;U-266/70: 4.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA021823, HPA064677"	Approved					NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"			"HPA021823: AB_1851100, HPA064677: AB_2685318"	"unprognostic (1.19e-1)"	"unprognostic (2.63e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.72e-2)"	"unprognostic (3.00e-2)"		"unprognostic (7.98e-4)"	"unprognostic (5.39e-2)"	"unprognostic (6.29e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.91e-1)"	"unprognostic (5.72e-2)"	"unprognostic (3.28e-2)"	"unprognostic (3.01e-1)"	"unprognostic (3.48e-1)"	"unprognostic (1.53e-2)"	0.0	0.3	3.5	0.1	9.7	0.2	0.0	3.6	4.4	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.8	4.5	0.1	0.0	0.1	0.0	7.2	7.0	0.0	0.2	0.0	0.0	0.0	7.3	0.0	0.1	1.1	0.0	1.3	3.2	0.2	0.1	0.1	6.5	0.0	0.2	0.1	7.6	0.0	0.0	1.4	0.0	2.2	0.0	6.0	0.1	0.0	2.5	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.7	1.9	4.6	0.0	0.8	0.0	0.0	6.8	14.2	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.6	0.0	0.1	4.1	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	9.7	3.6	4.4	2.8	4.5	7.2	7.0	7.3	6.5	7.6	6.0	0.0	0.0	0.0	102.5	0.0	1.3	0.0	0.0	0.0	3.8	0.0	0.0	0.6	0.0	0.0	11.0	18.8	0.0	0.0	0.0	0.0	0.0	2.8	0.1	0.0	0.1	0.0	0.0	154.8	0.2	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	130.9	0.4	0.0	0.0	0.0	0.8	3.7	0.0	0.0	9.4	0.0	0.0	0.0	11.6	606.0	0.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.8	0.0	7.9	0.1	1.3	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.5
FRK	"GTK, PTK5, RAK"	ENSG00000111816	"Fyn related Src family tyrosine kinase"	P42685	6	115931149-116060891	"Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Kinase, Transferase, Tyrosine-protein kinase"	"FDA approved drug targets, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 13.7"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 89.4;Oligodendrocytes: 97.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"OE19: 18.3;RT4: 7.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB025217, HPA030479, HPA072590"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	Cytosol	"CAB025217: , HPA030479: AB_2732457, HPA072590: "	"unprognostic (7.70e-3)"	"unprognostic (1.99e-2)"	"unprognostic (1.11e-1)"	"unprognostic (4.68e-3)"	"unprognostic (1.96e-1)"	"unprognostic (3.49e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.58e-1)"	"unprognostic (4.23e-2)"	"unprognostic (5.82e-3)"	"unprognostic (1.45e-1)"	"unprognostic (7.54e-2)"	"prognostic favorable (9.66e-7)"	"unprognostic (1.52e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.02e-2)"	"unprognostic (1.10e-1)"	0.8	1.1	1.3	1.2	2.1	1.5	2.4	5.8	5.0	1.8	13.7	4.6	6.2	1.0	2.5	2.9	2.6	2.6	1.8	1.8	0.0	9.0	6.8	1.8	0.7	0.3	0.1	0.9	2.8	1.0	0.4	0.8	1.0	2.2	4.8	2.9	4.0	2.4	2.2	1.9	6.3	0.8	0.2	0.9	4.9	1.9	1.1	1.2	1.0	0.8	1.6	2.1	1.0	5.7	2.5	4.0	0.5	0.9	0.2	0.2	0.6	0.5	0.1	0.0	0.1	3.1	3.8	0.9	3.5	0.5	0.5	5.8	0.2	1.1	0.1	3.3	0.3	1.3	3.3	2.7	0.2	0.9	0.7	0.2	1.5	0.3	0.4	0.4	0.2	0.6	0.6	2.3	1.0	1.3	0.7	0.5	1.0	18.3	0.7	1.1	3.3	1.2	4.8	7.6	0.7	0.8	0.7	5.1	0.5	0.9	1.5	0.7	0.8	1.0	1.0	0.7	0.5	3.6	2.7	1.6	1.1	0.6	0.6	0.9	0.2	0.2	0.4	0.1	0.5	0.2	0.3	0.4	0.1	0.4	0.2	0.3	0.8	0.3	0.2	0.3	0.2	0.0	1.3	2.1	5.8	5.0	1.8	0.0	0.3	0.1	1.0	0.2	1.1	5.7	0.4	0.0	10.3	10.4	0.5	2.7	20.8	23.3	6.8	0.6	7.3	2.9	9.2	11.5	22.6	23.9	0.0	4.4	0.1	34.9	11.7	20.3	89.4	28.1	1.7	0.7	19.8	0.0	12.2	16.4	4.3	3.5	29.0	30.4	3.8	0.2	1.4	21.9	0.9	6.7	7.7	14.5	34.6	0.6	0.4	38.1	0.6	0.6	0.0	1.0	1.0	0.2	0.0	2.5	97.8	21.9	23.3	1.2	0.5	23.4	49.3	28.4	36.6	0.3	13.1	9.9	16.2	4.6	1.0	16.4	3.1	0.8	1.0	2.3	19.1	46.2
NT5DC1	"dJ486I3.1, MGC24302, NT5C2L1"	ENSG00000178425	"5'-nucleotidase domain containing 1"	Q5TFE4	6	116100851-116249497	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"choroid plexus: 117.6"	"Cell type enriched"	"Detected in all"	4	"Oligodendrocytes: 429.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030352, HPA079264"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA		140000	"Cluster 37: B-cells - Transcription"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm	Cytosol	"HPA030352: AB_2154066, HPA079264: "	"unprognostic (1.30e-1)"	"unprognostic (2.92e-1)"	"prognostic favorable (2.61e-4)"	"unprognostic (1.14e-1)"	"unprognostic (3.13e-2)"	"unprognostic (7.80e-2)"	"unprognostic (3.46e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.32e-1)"	"unprognostic (2.31e-2)"	"unprognostic (4.61e-1)"	"unprognostic (1.47e-1)"	"prognostic favorable (7.49e-7)"	"unprognostic (1.41e-1)"	"unprognostic (8.53e-2)"	"unprognostic (2.79e-1)"	"unprognostic (9.63e-2)"	19.5	24.0	11.4	12.7	24.6	10.0	19.2	22.7	15.0	10.4	117.6	19.8	29.5	9.1	22.4	16.5	20.6	15.7	25.9	11.0	16.3	28.2	42.6	16.7	21.4	24.1	20.9	13.2	22.2	23.8	9.6	8.3	24.1	28.3	19.9	11.2	22.7	16.6	21.5	10.7	26.8	11.3	21.0	13.5	21.6	10.6	19.3	14.5	28.3	23.2	22.4	15.8	9.4	40.9	24.7	20.3	17.7	23.7	19.2	11.6	31.0	17.7	40.3	27.4	32.2	29.4	24.8	50.3	37.4	15.9	29.7	38.7	12.1	28.1	23.8	78.4	26.7	21.0	16.7	31.0	20.9	46.8	1.9	21.7	22.2	17.6	15.0	59.2	24.7	30.0	26.6	27.5	34.8	25.3	9.0	16.3	16.2	54.1	27.0	52.3	48.3	27.2	25.5	29.2	11.8	17.6	37.9	28.7	26.5	19.4	26.6	9.3	21.6	12.3	20.8	23.7	35.6	40.2	59.2	39.8	29.3	31.0	22.4	14.5	18.2	33.2	20.2	10.5	31.4	41.3	29.8	25.4	24.6	30.1	28.2	24.3	12.9	23.1	12.7	12.4	32.4	19.7	11.4	24.6	22.7	15.0	11.0	16.3	24.1	20.9	24.1	21.0	19.3	40.9	15.4	64.1	45.7	62.3	37.9	26.1	37.9	66.5	29.6	14.0	30.3	23.6	44.2	25.8	44.5	18.4	27.1	41.6	24.9	19.1	64.6	39.6	19.8	32.9	10.7	21.7	26.5	16.2	96.1	40.8	30.4	14.0	26.5	19.0	23.5	16.2	33.5	49.3	31.8	45.4	70.1	30.6	30.5	29.2	14.2	8.3	19.0	18.5	19.6	54.4	49.6	19.8	10.3	29.7	429.4	28.8	19.6	20.7	25.3	28.0	54.6	57.4	76.7	20.2	32.9	29.2	23.9	17.2	28.5	27.4	21.5	25.6	23.8	18.3	35.9	31.5
COL10A1		ENSG00000123500	"Collagen type X alpha 1 chain"	Q03692	6	116118909-116158747	"Disease related genes, Human disease related genes, Predicted secreted proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 15.5;choroid plexus: 39.9"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 26.6;Inhibitory neurons: 6.3;Microglial cells: 8.4;Oligodendrocytes: 27.9"	"Cancer enhanced"	"Detected in many"		"breast cancer: 42.8;pancreatic cancer: 51.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"hTEC/SVTERT24-B: 39.7"					"Low region specificity"	"Detected in many"			HPA053268			Approved	"Endoplasmic reticulum"	"Secreted to extracellular matrix"	NA	NA		160000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Endoplasmic reticulum"		"HPA053268: "	"unprognostic (3.83e-2)"	"unprognostic (6.81e-2)"	"unprognostic (7.20e-2)"	"unprognostic (7.45e-3)"	"unprognostic (2.33e-2)"	"unprognostic (1.28e-1)"	"unprognostic (3.84e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.14e-1)"	"unprognostic (4.37e-2)"	"unprognostic (7.03e-2)"	"unprognostic (1.38e-11)"	"unprognostic (2.16e-3)"	"unprognostic (7.22e-2)"	"unprognostic (3.60e-1)"	"unprognostic (2.06e-3)"	0.3	0.0	2.2	0.2	8.6	0.3	0.3	4.6	4.5	1.2	39.9	0.2	0.0	0.3	0.0	0.0	0.0	8.9	0.3	1.3	3.3	0.4	0.2	2.8	0.6	7.7	5.6	3.9	3.3	2.5	0.4	0.1	7.1	1.9	0.1	0.9	2.6	0.8	0.1	0.4	0.1	0.5	4.3	2.5	0.1	0.2	6.3	0.1	0.7	0.0	1.9	0.2	0.1	15.5	0.0	0.0	0.0	0.0	0.0	3.1	0.1	0.2	2.9	0.4	6.0	0.1	0.0	0.1	0.0	1.0	0.0	0.7	0.0	0.0	0.8	0.1	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.8	0.0	39.7	0.0	0.2	0.0	0.1	0.2	0.0	0.3	0.0	0.3	0.0	0.4	0.0	0.0	0.5	0.0	0.1	0.0	0.1	0.2	0.3	0.1	0.1	0.0	0.0	0.2	0.0	0.0	6.3	0.1	0.4	0.5	0.0	0.0	0.1	0.6	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	2.2	8.6	4.6	4.5	1.3	3.3	7.7	5.6	7.1	4.3	6.3	15.5	2.6	0.0	0.6	3.9	0.1	0.1	0.1	0.0	0.0	0.6	0.0	0.1	0.6	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.1	0.3	0.0	0.4	26.6	0.0	0.0	1.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.7	6.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	8.4	0.0	2.2	0.0	2.5	27.9	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	1.2	0.0	0.2	5.0	0.2	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.1
TSPYL4	"dJ486I3.2, KIAA0721"	ENSG00000187189	"TSPY like 4"	Q9UJ04	6	116249964-116254075	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 109.7"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA044863	Approved					NA	Yes			"Cluster 39: Non-specific - mRNA processing"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 36: Stromal cells - Cell proliferation"			"HPA044863: AB_10962578"	"unprognostic (5.10e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.65e-3)"	"unprognostic (1.67e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.80e-2)"	"unprognostic (3.34e-1)"	"unprognostic (7.41e-3)"	"prognostic favorable (8.46e-5)"	"unprognostic (1.30e-1)"	"prognostic favorable (5.13e-7)"	"unprognostic (3.34e-3)"	"unprognostic (2.57e-1)"	"unprognostic (3.61e-1)"	"unprognostic (5.38e-2)"	8.2	35.4	57.5	7.5	61.8	10.4	14.0	56.2	109.7	17.1	15.5	12.3	5.8	21.5	18.0	11.6	21.0	10.6	20.4	62.8	72.8	14.9	9.0	10.2	10.3	44.9	55.9	25.4	12.2	28.7	28.4	10.7	60.0	22.4	8.1	30.1	9.6	18.5	5.1	10.5	9.3	15.4	43.1	11.0	15.3	14.8	69.5	17.7	14.3	7.8	9.2	11.8	11.9	48.5	6.2	3.4	47.6	39.7	19.2	16.4	8.9	24.3	16.4	30.6	18.2	9.6	5.9	5.0	9.0	37.5	16.1	13.6	20.7	21.6	45.8	20.7	7.0	10.1	18.8	22.7	15.1	19.1	6.4	16.0	10.0	23.7	12.0	23.9	21.0	28.0	15.7	16.4	25.7	19.2	36.9	11.7	11.5	2.1	8.1	20.9	2.6	4.9	9.2	9.0	55.9	37.6	21.6	9.0	4.3	16.9	16.3	10.5	24.4	25.4	21.3	14.6	14.1	6.6	8.2	0.8	11.7	12.5	16.2	0.5	2.1	2.5	3.2	1.8	3.8	2.4	3.9	3.3	1.9	3.0	4.1	3.1	2.8	3.8	2.8	3.1	3.6	4.0	57.5	61.8	56.2	109.7	62.8	72.8	44.9	55.9	60.0	43.1	69.5	48.5	7.0	3.2	7.7	11.8	9.2	4.8	11.9	4.9	30.1	21.4	11.8	13.2	44.2	11.5	7.2	11.0	20.9	3.3	13.0	3.2	19.6	5.4	20.3	30.8	31.9	11.5	31.7	6.1	16.2	7.4	2.0	13.3	8.6	25.8	11.4	27.5	11.7	3.7	3.6	40.4	16.8	5.8	6.1	6.8	3.5	6.7	10.2	8.8	5.4	7.5	5.9	20.7	6.2	4.5	8.5	7.1	2.5	10.9	7.3	7.0	0.7	6.4	27.5	28.7	0.0	14.8	16.8	20.1	3.6	14.1	5.3	3.4	11.9	18.9	4.5	8.0
DSE	"DS-Epi1, DSEPI, SART2"	ENSG00000111817	"Dermatan sulfate epimerase"	Q9UL01	6	116254173-116444861	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		Isomerase	"Disease variant, Ehlers-Danlos syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Macrophages: 112.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"myeloid DC: 5.9"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in many"			HPA014764	Uncertain				"Intracellular and membrane"	NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 40: Granulosa cells - Unknown function"			"HPA014764: AB_1856587"	"unprognostic (1.28e-1)"	"prognostic unfavorable (3.36e-4)"	"unprognostic (1.38e-1)"	"unprognostic (3.23e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.48e-2)"	"unprognostic (6.76e-2)"	"unprognostic (1.02e-2)"	"unprognostic (7.81e-2)"	"prognostic unfavorable (6.34e-4)"	"unprognostic (5.11e-2)"	"unprognostic (1.54e-1)"	"prognostic unfavorable (1.50e-4)"	"unprognostic (6.19e-3)"	"unprognostic (2.54e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.10e-2)"	27.8	10.7	3.6	26.8	4.5	18.4	18.3	3.9	4.4	13.8	10.4	7.7	6.4	10.5	8.3	13.7	14.6	14.9	12.4	3.2	4.3	8.6	11.3	15.3	16.4	7.0	5.8	13.8	3.8	11.1	6.0	23.1	5.6	8.5	8.0	3.5	6.9	10.2	6.9	13.8	9.0	15.0	4.6	18.6	6.4	6.1	8.5	10.3	6.6	10.7	9.7	19.7	14.3	5.9	32.7	7.0	23.6	22.2	62.0	40.7	26.5	37.6	88.2	46.4	67.4	0.2	8.9	0.9	3.3	66.3	46.4	60.8	3.3	88.7	60.1	33.9	14.6	2.2	9.8	0.3	69.0	1.5	1.7	86.8	37.4	51.5	50.0	24.0	27.7	8.3	0.8	14.4	22.4	1.0	4.4	1.8	12.7	0.2	1.8	5.6	21.6	15.6	30.4	2.2	7.8	5.9	36.4	0.1	0.8	16.2	0.3	3.9	10.5	46.4	13.4	11.8	30.6	3.1	1.1	1.6	24.6	4.0	5.5	0.4	2.0	0.1	0.6	2.5	0.3	2.0	0.5	0.3	5.9	2.1	0.6	0.3	1.6	0.1	1.6	2.7	0.1	0.8	3.6	4.5	3.9	4.4	3.2	4.3	7.0	5.8	5.6	4.6	8.5	5.9	9.4	16.0	4.1	64.9	15.4	52.0	26.4	42.2	78.6	6.3	7.4	10.7	8.3	2.8	20.7	3.7	0.0	2.9	16.5	0.3	7.9	4.8	52.2	11.0	21.9	15.4	1.2	11.4	46.8	8.5	7.0	73.7	3.6	3.1	22.8	100.9	56.4	5.7	39.8	1.7	48.9	0.6	8.2	83.6	77.1	24.9	55.0	112.2	10.6	51.5	79.4	3.4	5.2	73.4	86.4	13.6	0.4	30.1	8.9	32.0	0.4	7.7	30.3	3.0	32.9	16.4	33.4	6.1	5.5	76.6	39.9	4.9	14.0	17.2	1.0	51.0
TSPYL1	TSPYL	ENSG00000189241	"TSPY like 1"	Q9H0U9	6	116267760-116279930	"Disease related genes, Human disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031970	Supported		Supported	Nucleoplasm,Nucleoli		No	No			"Cluster 38: Basophils - Unknown function"	"Cluster 47: Non-specific - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nucleoplasm, Nucleoli"		"HPA031970: AB_2674092"	"unprognostic (1.05e-2)"	"unprognostic (1.09e-1)"	"unprognostic (6.11e-2)"	"unprognostic (9.99e-2)"	"unprognostic (1.70e-1)"	"unprognostic (3.54e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.76e-1)"	"unprognostic (9.18e-3)"	"prognostic favorable (5.40e-4)"	"unprognostic (5.12e-1)"	"prognostic favorable (1.48e-13)"	"unprognostic (1.61e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.34e-2)"	"unprognostic (2.47e-1)"	26.5	73.8	51.1	17.1	56.4	34.4	23.4	35.2	78.2	22.5	25.5	30.8	24.4	28.4	33.0	34.0	31.4	20.5	43.3	64.9	38.1	50.4	40.9	21.4	21.4	25.9	22.2	34.9	33.3	63.9	40.1	16.0	26.0	42.0	17.7	26.1	30.2	33.9	114.9	29.4	30.0	24.3	17.1	29.5	35.5	28.9	34.6	22.3	39.6	91.9	25.6	31.4	22.7	44.5	22.2	21.5	27.3	50.3	47.2	30.9	22.7	35.2	34.7	31.3	35.8	27.7	15.9	47.3	43.0	40.8	28.2	38.5	21.6	59.8	33.2	19.4	56.0	19.1	29.9	50.8	29.8	31.9	11.2	36.2	46.0	32.5	31.2	32.9	30.3	20.7	34.3	36.1	44.2	48.9	21.5	18.9	13.6	21.3	19.8	19.1	23.5	26.3	54.9	42.9	23.7	23.6	29.2	38.8	18.0	30.6	51.0	39.1	37.3	21.2	18.7	17.2	38.7	19.8	22.7	25.2	35.1	20.3	14.1	121.0	30.1	51.5	40.5	51.0	61.4	46.4	52.4	45.4	26.1	52.2	51.1	50.0	24.1	33.2	57.7	44.9	44.8	34.0	51.1	56.4	35.2	78.2	64.9	38.1	25.9	22.2	26.0	17.1	34.6	44.5	29.4	35.3	45.9	15.7	65.2	166.1	100.6	37.6	70.6	81.0	91.7	47.5	100.0	61.5	40.5	104.8	27.1	54.8	54.2	49.3	154.6	40.8	33.0	40.5	42.0	40.4	74.6	49.7	65.4	43.9	25.5	63.1	41.3	34.9	31.7	67.5	73.9	81.3	42.4	38.7	50.5	59.3	46.8	82.1	116.0	20.2	75.5	40.2	87.2	22.5	38.3	82.6	42.2	15.6	20.2	48.8	52.5	95.5	24.1	77.0	60.3	218.9	41.4	58.1	131.5	87.6	63.5	61.9	39.8	55.5	162.0	59.7	69.1	101.3	70.2	75.8
Z84488.1		ENSG00000285446	"Novel protein"		6	116399395-116463696	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in some"		"brain: 1.3;choroid plexus: 1.7"	"Not detected"	"Not detected"							"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ: 1.3;GAMG: 1.1;HDLM-2: 1.4;hTEC/SVTERT24-B: 1.0;Karpas-707: 1.6;RPMI-8226: 1.3"															NA	NA			"Cluster 46: Basophils - DNA binding"		"Cluster 44: HDLM-2 - Immune response"																						0.1	0.0	0.3	0.0	0.3	0.1	0.0	0.2	0.6	0.0	1.7	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.0	0.2	0.8	0.0	0.1	0.1	0.0	0.8	0.5	0.1	0.0	0.0		0.0	0.8	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.6	0.7	0.2	0.0	1.3	0.1	0.0	0.0	0.1	0.0		0.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.3	0.0	0.4	0.0	0.0	0.0	0.3	0.0	1.1	0.5	0.0	0.7	0.3	1.4	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.0	0.0	0.3	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	1.3	0.0	0.2	0.0	0.0	0.9	0.0	0.2	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.1	0.0	0.0	0.1	0.3	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.3	0.2	0.6	0.2	0.8	0.8	0.5	0.8	0.6	1.3	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CALHM6	"C6orf187, dJ93H18.5, FAM26F, INAM, OTTHUMP00000017061, OTTHUMP00000017062, RP1-93H18.5"	ENSG00000188820	"Calcium homeostasis modulator family member 6"	Q5R3K3	6	116461370-116463771	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 136.6"	"Cell type enriched"	"Detected in some"	5	"Hofbauer cells: 138.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"intermediate monocyte: 724.6;non-classical monocyte: 861.9"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 28.0;Karpas-707: 45.1;RPMI-8226: 159.8;U-937: 59.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 2: Immune cells - Immune response"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 4: Macrophages - Innate immune response"				"unprognostic (1.14e-2)"	"unprognostic (2.31e-2)"	"unprognostic (6.46e-3)"	"unprognostic (7.15e-3)"	"unprognostic (9.53e-3)"	"unprognostic (4.10e-2)"	"unprognostic (2.69e-1)"	"unprognostic (1.68e-1)"	"unprognostic (8.19e-2)"	"unprognostic (1.24e-1)"	"unprognostic (4.19e-1)"	"unprognostic (1.20e-1)"	"prognostic unfavorable (9.31e-10)"	"unprognostic (1.69e-1)"	"unprognostic (2.12e-2)"	"unprognostic (3.85e-3)"	"unprognostic (9.25e-3)"	7.4	7.3	4.9	60.2	5.2	41.4	10.0	4.5	6.6	4.3	5.0	10.4	12.2	2.4	3.6	4.1	4.1	7.2	4.3	4.7	5.2	4.1	24.7	10.8	73.0	8.1	4.7	4.5	1.8	1.7	4.8	12.5	5.3	5.4	7.0	1.1	5.7	3.0	1.6	1.9	20.9	11.8	5.6	136.6	7.9	8.2	5.3	14.0	2.4	2.6	23.1	11.4	3.0	5.4	6.4	0.0	0.6	0.4	0.5	2.0	11.7	0.2	1.3	2.0	1.3	0.0	1.0	0.2	3.5	1.5	0.0	0.0	0.3	0.2	4.2	0.7	0.4	28.0	0.0	0.0	2.8	0.1	0.1	2.2	0.0	0.2	0.2	0.5	0.7	0.0	0.0	45.1	5.5	0.0	2.7	4.8	3.6	0.0	0.0	2.4	0.0	159.8	2.2	0.3	2.7	0.1	14.9	0.1	11.7	1.6	0.2	7.3	0.1	0.0	0.2	0.1	0.9	11.4	0.2	0.0	0.3	59.7	3.9	22.0	205.7	50.1	16.6	724.6	16.6	231.8	23.0	15.5	193.8	308.9	28.9	15.2	115.8	27.4	861.9	86.5	2.7	175.6	4.9	5.2	4.5	6.6	4.7	5.2	8.1	4.7	5.3	5.6	5.3	5.4	0.6	0.0	1.7	0.0	9.7	0.0	0.0	0.0	0.0	0.0	0.8	3.2	0.0	0.0	0.0	0.0	0.0	1.7	2.7	0.0	0.0	0.6	0.0	0.2	0.3	0.8	0.0	0.0	0.0	10.0	9.0	0.7	0.0	0.1	0.0	1.4	0.0	0.0	138.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.8	0.0	0.0	10.3	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.7	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	2.2	1.2	1.8	0.0	0.0
TRAPPC3L	"bA259P20.2, BET3L, FLJ11180"	ENSG00000173626	"Trafficking protein particle complex 3 like"	Q5T215	6	116494989-116545684	"Predicted intracellular proteins"	"ER-Golgi transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 8.1"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 1.6;Early spermatids: 1.8;Endothelial cells: 1.5;Hepatic stellate cells: 6.1;Kupffer cells: 4.2;Macrophages: 3.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Karpas-707: 6.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA060912			Approved	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 6: Brain - Smell perception"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 51: Myeloid cells - Hemostasis"	"Golgi apparatus, Vesicles"		"HPA060912: "	"unprognostic (1.34e-1)"	"unprognostic (7.24e-2)"	"unprognostic (1.93e-2)"	"unprognostic (2.91e-1)"	"unprognostic (5.25e-2)"	"unprognostic (1.15e-2)"	"unprognostic (8.98e-2)"	"unprognostic (9.09e-4)"	"unprognostic (8.41e-2)"	"unprognostic (3.23e-2)"	"unprognostic (1.96e-1)"	"unprognostic (2.91e-3)"	"unprognostic (2.59e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.52e-1)"	"unprognostic (8.11e-2)"	"unprognostic (7.47e-3)"	0.7	0.7	1.6	0.8	1.7	3.7	1.0	8.1	5.0	0.4	0.3	0.7	1.0	1.2	1.8	0.7	0.5	1.1	0.9	2.3	0.0	0.7	1.4	1.2	1.7	0.6	0.1	1.0	0.7	3.0	0.0	3.9	1.6	0.7	0.5	4.2	1.2	0.7	1.2	2.3	1.0	0.4	0.1	4.7	1.1	1.5	0.7	0.5	1.8	0.2	0.6	0.5	0.0	3.9	0.8	0.4	1.0	1.5	0.3	1.0	1.1	0.5	0.5	0.4	0.5	0.5	0.7	1.3	0.6	0.2	0.8	1.0	0.3	0.6	0.5	0.6	0.6	1.4	1.9	0.6	0.5	0.9	0.6	0.4	0.3	0.2	0.3	1.5	0.8	1.0	0.8	6.6	0.3	1.5	0.9	1.0	0.9	0.3	0.6	0.8	0.7	2.2	0.7	1.3	1.0	0.7	0.8	0.4	0.5	1.2	0.7	0.8	1.0	1.2	0.9	1.2	0.6	1.2	0.8	0.8	0.8	0.9	0.7	0.6	0.1	0.2	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.2	0.9	0.1	0.2	0.3	0.1	2.8	1.6	1.7	8.1	5.0	2.3	0.0	0.6	0.1	1.6	0.1	0.7	3.9	1.6	0.0	0.0	0.0	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.1	1.5	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.1	0.0	0.4	6.1	0.1	1.1	0.0	0.1	0.0	0.0	4.2	0.0	0.4	0.3	3.7	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	1.2	0.1	0.0	0.1	0.0	0.1	0.5	0.0	0.0
CALHM5	"C6orf188, dJ493F7.3, FAM26E, MGC45451"	ENSG00000178033	"Calcium homeostasis modulator family member 5"	Q8N5C1	6	116511639-116524788	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 10.6;Endothelial cells: 2.6;Fibroblasts: 2.0;Granulosa cells: 2.6;Smooth muscle cells: 3.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 5.3;fHDF/TERT166: 5.6;HUVEC TERT2: 5.6;LHCN-M2: 5.9;TIME: 8.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA034969, HPA034970"	Uncertain		Approved	"Golgi apparatus"		NA	NA				"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Golgi apparatus"		"HPA034969: AB_10670299, HPA034970: AB_2674390"	"unprognostic (2.71e-2)"	"unprognostic (1.56e-1)"	"unprognostic (8.12e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.36e-1)"	"unprognostic (3.92e-1)"	"unprognostic (1.93e-2)"	"unprognostic (5.37e-2)"	"unprognostic (4.09e-2)"	"unprognostic (4.21e-2)"	"unprognostic (1.06e-1)"	"unprognostic (9.16e-2)"	"unprognostic (1.24e-7)"	"unprognostic (1.16e-2)"	"unprognostic (2.98e-2)"	"unprognostic (7.69e-2)"	"unprognostic (6.65e-3)"	3.3	0.5	0.6	1.1	0.7	0.0	1.6	0.5	0.6	1.3	0.7	1.5	0.6	1.3	0.6	1.2	0.9	1.5	2.3	0.6	0.5	1.9	0.5	1.7	0.9	0.6	0.5	0.5	0.1	0.5	0.3	4.4	0.6	0.9	1.0	0.0	0.6	0.7	1.6	1.0	0.9	2.1	0.5	1.7	0.6	0.7	0.8	0.1	0.8	2.5	0.5	1.4	1.2	0.6	0.0	0.0	4.5	0.0	2.7	4.3	0.0	3.6	5.3	1.4	3.8	0.2	0.0	0.0	0.3	5.6	3.8	0.0	0.0	0.0	1.5	0.0	0.2	0.8	0.0	0.0	0.6	0.0	0.0	2.6	0.0	3.4	0.0	1.0	5.6	0.0	0.0	1.0	5.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.4	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	8.9	2.5	0.8	0.3	0.2	0.0	0.0	0.0	2.1	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.7	0.5	0.6	0.6	0.5	0.6	0.5	0.6	0.5	0.8	0.6	10.6	0.0	0.6	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.1	2.6	0.0	0.0	0.0	0.7	0.0	2.0	0.0	0.0	0.0	2.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.7	0.0	1.2	0.0	0.0
CALHM4	"C6orf78, FAM26D, FLJ32239"	ENSG00000164451	"Calcium homeostasis modulator family member 4"	Q5JW98	6	116529013-116558868	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"placenta: 23.1"	"Group enriched"	"Detected in some"	24	"Cytotrophoblasts: 28.2;Syncytiotrophoblasts: 54.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"SuSa: 1.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA048014			Approved	"Plasma membrane"	"Intracellular and membrane"	NA	NA				"Cluster 28: Placenta - Pregnancy"	"Cluster 12: NES - Nervous system development"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	"Plasma membrane"		"HPA048014: "										"unprognostic (7.95e-2)"			"unprognostic (3.44e-4)"		"unprognostic (1.99e-1)"	"unprognostic (1.44e-2)"		0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.2	0.0	1.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.3	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.3	0.0	23.1	0.1	0.0	0.0	0.0	0.0	0.0	0.3	4.0	0.0	0.0	0.1	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.0	0.8	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.2	0.1	0.3	0.1	0.1	0.1	0.1	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.1	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	54.6	0.0	0.2	0.0	0.0
RWDD1	PTD013	ENSG00000111832	"RWD domain containing 1"	Q9H446	6	116571409-116597675	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028712, HPA028713"	Approved					NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA028712: AB_10602793, HPA028713: AB_10601485"	"unprognostic (1.44e-2)"	"unprognostic (4.20e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.46e-1)"	"unprognostic (7.36e-2)"	"unprognostic (2.36e-1)"	"prognostic unfavorable (5.16e-4)"	"unprognostic (3.65e-1)"	"unprognostic (2.15e-2)"	"unprognostic (1.64e-1)"	"unprognostic (6.37e-2)"	"unprognostic (4.30e-2)"	"unprognostic (9.24e-2)"	"unprognostic (9.58e-2)"	"unprognostic (9.60e-2)"	"unprognostic (4.83e-3)"	"unprognostic (1.63e-1)"	58.9	47.4	39.7	31.0	45.0	59.9	51.5	47.0	51.5	51.0	36.7	70.1	36.2	47.3	37.3	41.0	47.3	34.8	67.2	38.3	46.2	50.8	45.2	41.3	40.8	44.4	42.7	54.0	72.0	47.1	32.3	31.4	44.2	45.5	33.7	60.5	59.1	37.1	128.5	34.8	35.5	36.0	46.7	33.0	49.9	23.9	43.9	35.0	36.1	96.6	38.8	55.3	45.3	49.9	48.4	30.1	65.5	142.2	102.8	127.3	41.4	111.7	69.8	66.3	74.5	53.8	27.9	70.5	68.2	74.7	78.6	37.7	52.6	70.1	90.7	84.6	81.5	62.4	45.8	77.7	81.4	102.7	51.2	79.3	81.3	44.8	77.0	95.4	78.1	69.9	99.8	96.9	101.2	44.1	97.9	136.0	32.9	82.2	58.4	82.0	43.0	63.3	84.9	38.2	57.1	56.5	35.1	70.1	133.7	64.5	46.6	93.3	57.9	78.1	42.1	74.6	120.9	70.3	86.6	133.3	69.9	79.4	84.7	63.9	42.2	44.7	64.7	55.0	83.2	69.7	85.3	74.6	51.0	57.7	78.0	78.3	16.7	89.0	73.4	75.5	118.0	51.9	39.7	45.0	47.0	51.5	38.3	46.2	44.4	42.7	44.2	46.7	43.9	49.9	139.4	70.5	75.9	14.4	118.0	206.5	166.2	212.3	135.5	133.5	153.3	211.5	205.0	134.4	120.1	130.6	116.7	106.5	130.5	105.1	440.3	130.2	191.5	68.0	120.8	148.5	90.3	108.2	15.5	184.4	147.0	151.9	67.2	76.3	107.2	100.8	172.1	209.3	162.1	106.0	17.6	131.2	150.5	194.0	173.3	149.3	220.3	121.0	209.9	2.8	146.9	169.7	196.7	7.5	19.4	145.4	114.1	222.3	145.1	226.5	183.5	479.7	75.9	179.2	170.9	176.9	188.4	164.4	119.5	164.1	213.5	97.4	144.8	166.2	138.5	159.3
RSPH4A	"CILD11, dJ412I7.1, FLJ37974, RSHL3, RSPH6B"	ENSG00000111834	"Radial spoke head component 4A"	Q5TD94	6	116616479-116632985	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"		"Ciliopathy, Disease variant, Kartagener syndrome, Primary ciliary dyskinesia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"choroid plexus: 21.0;fallopian tube: 37.2"	"Group enriched"	"Detected in many"	5	"Endometrial ciliated cells: 92.4;Respiratory ciliated cells: 260.6"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 4.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"RPMI-8226: 3.3;U-266/84: 2.4"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"midbrain: 14.5"	"HPA031196, HPA031197, HPA031198"	Enhanced		Approved	Nucleoplasm		No	NA				"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm		"HPA031196: AB_10601612, HPA031197: AB_10671097, HPA031198: AB_10670025"	"unprognostic (9.83e-4)"	"unprognostic (1.26e-1)"	"unprognostic (6.94e-2)"	"unprognostic (9.69e-3)"	"unprognostic (9.37e-2)"	"unprognostic (1.13e-3)"	"unprognostic (4.52e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.06e-1)"	"unprognostic (5.08e-2)"	"unprognostic (9.56e-5)"	"unprognostic (2.87e-1)"	"unprognostic (2.69e-4)"	"unprognostic (1.96e-2)"	"unprognostic (2.51e-1)"	"unprognostic (3.55e-2)"	"unprognostic (5.21e-2)"	0.6	0.5	1.5	0.3	1.6	0.9	0.6	1.3	0.6	1.7	21.0	0.3	0.3	1.6	0.5	0.2	37.2	0.5	0.4	1.5	2.0	0.7	0.5	4.6	0.3	6.1	6.2	0.8	0.8	2.0	4.3	0.1	3.8	0.5	0.2	6.0	0.4	0.2	0.9	0.5	0.5	0.4	4.5	0.9	0.5	2.8	2.4	0.5	0.8	0.2	0.3	0.3	0.3	2.8	0.0	0.1	0.6	1.4	0.0	0.0	0.1	0.1	0.3	0.2	0.3	0.3	0.5	0.4	0.1	0.0	0.5	0.1	0.1	0.2	0.2	0.3	0.5	0.2	0.2	0.5	0.0	0.3	0.4	0.1	0.1	0.4	0.1	0.0	0.0	0.3	0.1	0.0	0.2	0.1	0.3	0.0	0.2	0.0	0.0	0.3	0.7	3.3	1.3	0.2	1.2	0.5	0.1	0.1	0.2	0.1	0.2	0.3	0.2	0.2	0.2	0.1	0.2	0.2	2.4	0.1	0.0	0.1	0.2	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	1.6	1.3	0.6	1.5	2.0	6.1	6.2	3.8	4.5	2.4	2.8	0.8	3.2	3.4	7.2	0.3	0.0	0.1	4.9	0.0	3.3	0.4	0.8	0.6	0.0	22.9	0.0	2.1	0.0	0.1	0.1	1.9	0.4	33.1	92.4	1.6	2.2	0.0	0.0	10.6	0.4	0.1	1.1	0.5	1.4	2.5	0.7	1.8	0.0	0.1	1.7	12.9	0.0	10.2	0.0	0.0	9.3	0.3	0.4	1.8	0.0	0.0	2.0	0.0	3.5	5.0	0.2	0.0	0.0	0.2	0.3	0.0	0.1	260.6	3.7	0.0	2.0	2.4	9.3	1.6	0.0	0.1	0.3	0.5	5.7	0.0	0.1
ZUP1	"C6orf113, dJ412I7.3, ZUFSP"	ENSG00000153975	"Zinc finger containing ubiquitin peptidase 1"	Q96AP4	6	116635618-116668794	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 10.4;dendritic cells: 12.8;monocytes: 12.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044426	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	Cytosol	"HPA044426: AB_10960887"	"unprognostic (2.28e-3)"	"unprognostic (2.45e-3)"	"unprognostic (3.91e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.63e-1)"	"prognostic unfavorable (2.11e-4)"	"unprognostic (3.27e-1)"	"unprognostic (5.88e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.90e-3)"	"unprognostic (2.54e-2)"	"unprognostic (1.48e-1)"	"unprognostic (7.33e-2)"	"unprognostic (7.92e-3)"	4.4	4.5	4.2	6.2	4.7	13.5	5.6	7.2	6.3	4.0	3.0	5.1	10.5	3.6	4.1	5.6	3.1	5.5	2.7	4.3	4.6	4.6	4.3	5.0	8.7	4.4	4.4	2.5	5.7	4.2	3.9	5.3	4.6	5.0	5.7	6.0	3.8	4.0	3.1	5.5	7.1	4.1	4.5	6.0	4.7	6.1	4.7	7.5	4.6	3.3	8.7	6.1	4.1	5.9	6.6	6.3	13.9	26.2	7.9	10.3	10.4	14.0	13.3	13.5	16.3	11.5	7.3	23.3	11.6	8.9	15.2	10.3	15.8	10.1	17.9	14.0	18.1	18.0	9.5	20.0	12.3	21.1	21.3	9.2	15.7	11.0	18.7	10.0	12.5	17.4	32.1	11.6	17.9	10.7	10.2	16.0	10.3	9.9	6.8	13.9	12.1	9.6	15.0	6.6	12.1	14.0	10.0	8.3	8.6	11.8	4.9	15.9	10.7	8.6	5.8	5.3	11.9	10.7	14.9	24.0	7.7	12.8	12.8	19.5	7.5	7.6	7.0	8.9	8.2	9.5	7.9	8.1	10.1	10.4	8.6	6.4	2.9	8.3	11.0	6.9	11.7	6.5	4.2	4.7	7.2	6.3	4.3	4.6	4.4	4.4	4.6	4.5	4.7	5.9	6.7	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.0	5.3	5.2	0.0	0.0	0.0	1.8	0.0	10.4	12.8	0.0	9.8	9.7	0.0	7.4	8.7	2.2	0.0	0.0	0.0	8.0	8.3	2.2	0.0	8.4	0.0	10.0	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	12.4	0.0	0.0	0.0	0.0	10.0	0.0	0.0	3.0	0.0	0.0	9.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	9.3	4.4	6.0	0.0	0.0
KPNA5	"IPOA6, SRP6"	ENSG00000196911	"Karyopherin subunit alpha 5"	O15131	6	116681187-116741867	"Predicted intracellular proteins, Transporters"	"Host-virus interaction, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 44.1"	"Cell type enhanced"	"Detected in all"		"Alveolar cells type 1: 227.6;Alveolar cells type 2: 240.9;granulocytes: 129.3;Respiratory ciliated cells: 143.6;Spermatocytes: 173.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"CAB026464, HPA054037"	Enhanced		Supported	Cytosol		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 21: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 11: Alveolar cells - Smell perception"	Cytosol		"CAB026464: , HPA054037: AB_2682351"	"unprognostic (9.64e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.72e-2)"	"unprognostic (3.56e-1)"	"unprognostic (6.60e-3)"	"unprognostic (6.98e-2)"	"unprognostic (1.75e-3)"	"unprognostic (5.19e-2)"	"unprognostic (1.10e-1)"	"unprognostic (6.12e-2)"	"unprognostic (1.51e-3)"	"unprognostic (3.02e-1)"	"unprognostic (6.12e-2)"	"unprognostic (8.00e-2)"	"unprognostic (4.79e-1)"	"unprognostic (7.89e-2)"	"unprognostic (1.43e-1)"	4.1	5.4	7.0	5.0	8.2	7.1	6.1	15.9	13.0	6.4	1.9	3.4	3.2	9.4	3.7	5.0	8.1	5.2	4.6	7.6	5.9	5.0	2.5	6.0	8.9	7.7	4.4	19.0	2.5	6.4	4.7	4.4	8.4	6.7	3.2	18.9	4.1	5.3	13.8	3.5	3.6	6.8	3.6	6.5	3.6	44.1	4.8	8.9	10.2	12.7	6.3	4.8	3.6	11.7	2.9	1.7	12.0	7.5	4.4	8.5	4.9	4.2	11.7	7.4	10.5	8.1	3.0	10.8	5.6	4.6	8.4	4.7	6.3	3.7	9.2	6.8	18.1	10.1	5.6	4.5	5.5	7.8	6.0	7.7	2.2	9.0	5.6	8.6	8.3	10.3	15.0	4.6	8.3	3.9	12.5	5.5	5.4	2.0	4.7	10.1	3.9	3.0	5.5	5.5	12.8	11.9	3.2	2.7	4.6	7.7	5.3	7.9	6.8	3.0	6.2	3.2	7.5	11.6	13.4	12.2	3.8	5.6	6.4	27.6	4.7	6.4	13.1	5.1	16.3	25.3	14.8	15.7	2.7	26.6	24.1	17.9	1.3	11.2	6.9	16.7	12.1	4.1	7.0	8.2	15.9	13.0	7.6	5.9	7.7	4.4	8.4	3.6	4.8	11.7	12.5	227.6	240.9	63.0	35.2	13.6	7.1	8.9	13.6	50.9	12.8	13.3	17.1	10.0	118.6	9.2	29.2	4.2	24.2	1.6	9.8	6.1	80.3	22.0	13.0	28.8	33.7	7.6	63.7	5.6	1.8	30.5	6.1	7.9	129.3	18.8	20.3	4.7	4.4	47.1	70.9	7.1	8.2	9.1	9.5	15.2	17.7	21.5	10.6	41.2	7.6	34.7	10.3	64.3	56.7	6.0	1.5	16.6	15.8	8.9	2.4	6.5	143.6	38.8	13.1	16.8	15.4	173.4	10.6	8.8	8.9	3.3	31.9	15.9	4.2	3.8
FAM162B	"bA86F4.2, C6orf189"	ENSG00000183807	"Family with sequence similarity 162 member B"	Q5T6X4	6	116752197-116765719	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 65.2"	"Group enriched"	"Detected in some"	4	"Adipocytes: 34.6;Sertoli cells: 65.7;Smooth muscle cells: 105.1"	"Cancer enriched"	"Detected in many"	18	"testis cancer: 32.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ: 8.7;BJ hTERT+: 23.5;BJ hTERT+ SV40 Large T+ RasG12V: 22.1;HHSteC: 6.3;HSkMC: 7.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA036112, HPA060342"	Enhanced					NA	NA				"Cluster 28: Placenta - Pregnancy"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"			"HPA036112: AB_10696649, HPA060342: AB_2684258"	"unprognostic (1.81e-1)"	"unprognostic (5.65e-3)"	"unprognostic (1.54e-1)"	"unprognostic (3.38e-1)"	"unprognostic (5.45e-2)"	"unprognostic (1.86e-5)"	"unprognostic (8.29e-2)"	"unprognostic (1.24e-1)"	"unprognostic (4.19e-2)"	"unprognostic (2.44e-2)"	"unprognostic (7.32e-2)"	"unprognostic (6.27e-3)"	"prognostic unfavorable (2.48e-4)"	"unprognostic (1.22e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.73e-3)"	"unprognostic (4.34e-2)"	14.7	14.9	3.3	0.8	4.4	0.0	10.9	1.9	7.0	13.2	2.5	3.3	0.9	5.8	7.5	4.4	10.1	5.2	9.1	4.6	2.7	4.5	0.9	17.9	1.5	3.0	2.5	5.7	1.7	3.7	6.6	65.2	2.7	6.2	2.1	0.2	8.2	13.4	5.4	3.0	2.3	3.7	2.7	0.1	3.5	2.5	2.8	1.8	9.7	10.6	1.2	7.9	9.9	4.7	0.0	0.0	0.0	0.0	2.3	0.1	0.0	8.7	23.5	3.7	22.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	2.3	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.0	7.7	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	4.4	1.9	7.0	4.6	2.7	3.0	2.5	2.7	2.7	2.8	4.7	34.6	0.0	0.0	1.3	0.0	1.3	0.1	0.0	1.2	0.0	0.9	0.8	0.9	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	16.9	0.7	15.7	13.7	0.0	0.0	14.8	0.0	0.2	14.1	0.0	0.4	0.0	0.1	3.6	0.0	0.5	0.0	6.9	0.0	0.0	0.0	2.1	2.2	2.1	0.7	1.8	3.7	0.0	0.0	0.0	6.6	0.5	0.2	0.0	5.3	0.0	0.2	0.0	0.1	0.0	0.1	65.7	2.2	105.1	10.3	5.9	0.6	0.9	0.5	2.3	0.1	0.0	0.0
GPRC6A	bA86F4.3	ENSG00000173612	"G protein-coupled receptor class C group 6 member A"	Q5T6X5	6	116792085-116829083	"G-protein coupled receptors, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"Enteroendocrine cells: 1.8"	"Cancer enriched"	"Detected in single"	11	"renal cancer: 0.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"U-266/70: 1.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"									NA	NA					"Cluster 29: U-266 - Adaptive immune response"	"Cluster 30: Mammary glandular cells - Lactation"						"unprognostic (9.16e-2)"									"unprognostic (2.48e-1)"			"unprognostic (4.38e-3)"			0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
RFX6	"dJ955L16.1, MGC33442, RFXDC1"	ENSG00000185002	"Regulatory factor X6"	Q8HWS3	6	116877212-116932161	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Developmental protein, DNA-binding"	"Diabetes mellitus, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"adrenal gland: 4.5;intestine: 2.2;pancreas: 2.3;stomach 1: 6.5"	"Cell type enriched"	"Detected in some"	14	"Enteroendocrine cells: 68.6"	"Cancer enhanced"	"Detected in some"		"pancreatic cancer: 1.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"HEK 293: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA037696	Approved					NA	NA				"Cluster 4: Stomach - Digestion"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 17: Intestinal endocrine cells - Hormone signaling"			"HPA037696: AB_2675616"	"unprognostic (2.92e-1)"		"unprognostic (4.66e-2)"				"unprognostic (2.49e-2)"	"unprognostic (1.55e-1)"			"prognostic favorable (3.59e-4)"	"unprognostic (2.59e-2)"		"unprognostic (1.63e-1)"	"unprognostic (1.25e-1)"			0.0	4.5	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.6	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.1	0.7	0.0	0.1	1.3	0.0	0.3	0.0	0.0	0.0	1.3	0.0	0.0	0.0	6.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.3	0.0	0.0	0.0	0.0	4.6	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	68.6	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	3.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	2.3	0.0	0.0	0.4	0.0
VGLL2		ENSG00000170162	"Vestigial like family member 2"	Q8N8G2	6	117265558-117273565	"Predicted intracellular proteins"	"Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"skeletal muscle: 129.4"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 3.2;Hofbauer cells: 1.5;Skeletal myocytes: 7.7;Spermatogonia: 1.8"	"Cancer enhanced"	"Detected in single"		"glioma: 0.5"	"Region enhanced"	"Detected in some"		"thalamus: 2.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"RH-30: 13.8;U-2 OS: 4.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"									NA	NA				"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 37: Myocytes - Muscle contraction"								"unprognostic (3.02e-2)"	"unprognostic (3.09e-2)"				"unprognostic (1.75e-1)"					"unprognostic (4.92e-1)"			0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	5.5	0.0	1.0	0.0	0.0	0.0	0.0	0.7	0.6	0.1	0.0	0.0	0.0	0.1	0.8	0.6	0.0	0.0	0.7	0.2	129.4	0.2	0.0	0.0	0.3	0.0	0.0	0.4	2.3	0.0	0.0	30.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	2.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.1	0.0	1.7	0.0	13.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.7	0.0	1.4	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	1.0	0.7	0.6	0.8	0.3	2.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.7	0.1	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ROS1	"c-ros-1, MCF3, ROS"	ENSG00000047936	"ROS proto-oncogene 1, receptor tyrosine kinase"	P08922	6	117287353-117425942	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	18	"epididymis: 58.6;lung: 31.7"	"Cell type enriched"	"Detected in some"	4	"Alveolar cells type 2: 78.5"	"Cancer enriched"	"Detected in some"	13	"lung cancer: 6.9"	"Region enriched"	"Detected in single"	4	"cerebral cortex: 2.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"GAMG: 19.3;HSkMC: 10.1;hTCEpi: 21.7;LHCN-M2: 14.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA049098, HPA072424"	Uncertain		Approved	Vesicles		NA	NA				"Cluster 30: Epididymis - Antimicrobial activity"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 11: Alveolar cells - Smell perception"	Vesicles		"HPA049098: AB_2680628, HPA072424: AB_2686519"	"unprognostic (8.18e-2)"	"unprognostic (4.64e-3)"	"unprognostic (1.60e-1)"	"unprognostic (2.37e-2)"	"unprognostic (7.57e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.79e-2)"	"unprognostic (1.00e-2)"	"unprognostic (2.42e-1)"	"unprognostic (5.20e-2)"	"unprognostic (1.56e-12)"	"unprognostic (1.09e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.12e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.2	0.0	0.4	0.0	0.0	58.6	0.0	0.1	0.0	0.0	0.6	0.0	0.3	0.1	31.7	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.4	0.0	0.0	0.4	0.0	0.0	2.2	0.4	0.3	0.2	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.3	0.3	0.0	0.0	0.1	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	10.1	21.7	0.2	1.9	0.0	0.0	0.0	0.0	0.0	14.9	0.0	0.0	0.2	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	2.0	0.0	3.1	1.7	0.2	2.1	0.0	0.0	0.0	1.9	3.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	16.0	78.5	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.6	0.0	0.8	0.0	3.7	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.3	1.8	0.2	0.0	0.0	0.0	17.8	0.0	0.0	0.2	0.0	1.5	1.3	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	1.3	0.0	0.1	0.0	1.0	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0
AL132671.2		ENSG00000282218	"Novel protein, GOPC-ROS1 readthrough"		6	117318211-117573571	"Predicted intracellular proteins"				"No human protein/transcript evidence"	"No human protein/transcript evidence"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	15	"Alveolar cells type 2: 1.5"					"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	36	"U-138 MG: 8.9"	"Low region specificity"	"Detected in all"							HPA019477	Uncertain		Approved	"Golgi apparatus"		NA	NA					"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 11: Alveolar cells - Smell perception"	"Golgi apparatus"		"HPA019477: AB_1849890"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.4	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DCBLD1	"dJ94G16.1, MGC46341"	ENSG00000164465	"Discoidin, CUB and LCCL domain containing 1"	Q8N8Z6	6	117453817-117569858	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA059667	Approved		Approved	Cytosol		NA	NA		22000000	"Cluster 32: T-cells - Unknown function"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	Cytosol		"HPA059667: AB_2684099"	"unprognostic (1.00e-1)"	"prognostic unfavorable (6.44e-5)"	"unprognostic (1.08e-1)"	"unprognostic (3.23e-3)"	"unprognostic (2.47e-1)"	"unprognostic (2.29e-3)"	"unprognostic (1.53e-2)"	"unprognostic (5.94e-3)"	"unprognostic (3.74e-2)"	"unprognostic (8.99e-2)"	"unprognostic (5.69e-3)"	"unprognostic (6.33e-2)"	"prognostic unfavorable (8.57e-8)"	"unprognostic (6.99e-2)"	"unprognostic (4.72e-2)"	"unprognostic (7.44e-2)"	"unprognostic (1.36e-1)"	8.3	3.5	3.7	6.0	4.6	0.6	5.7	3.5	4.9	9.1	2.6	6.6	6.5	5.1	3.3	5.4	2.5	9.1	6.0	5.5	2.7	4.8	9.6	9.9	3.4	3.5	3.6	1.9	6.3	6.8	8.3	8.7	3.7	2.6	6.1	1.0	4.8	2.8	5.5	2.9	8.1	3.8	3.4	3.8	7.6	5.6	3.0	1.2	5.9	5.1	2.5	6.3	5.8	4.3	8.0	17.9	6.3	7.0	10.8	13.5	17.9	45.1	58.1	36.9	27.8	37.9	16.7	0.0	21.8	19.1	45.9	17.9	12.1	19.9	38.7	3.5	9.4	6.8	18.5	62.3	46.7	10.0	5.7	15.4	45.5	33.6	31.4	42.5	52.3	6.7	14.8	6.7	48.9	6.4	0.1	6.7	4.7	21.4	7.4	0.0	1.3	4.7	8.2	9.4	19.0	0.3	33.0	3.6	5.3	9.0	4.7	13.1	38.9	0.0	44.1	12.6	19.8	18.9	5.4	5.3	18.7	9.6	16.5	0.0	0.2	0.0	0.6	0.2	0.1	0.0	0.8	1.2	0.2	0.0	1.0	1.3	0.0	0.4	0.1	0.4	0.9	0.5	3.7	4.6	3.5	4.9	5.5	2.7	3.5	3.6	3.7	3.4	3.0	4.3	16.0	16.0	18.8	5.2	3.0	5.2	3.7	12.3	0.6	8.4	4.8	3.6	5.3	12.8	14.4	5.5	6.2	31.5	4.9	9.5	1.9	7.0	33.0	5.3	15.1	11.0	4.2	3.2	20.8	4.8	6.1	6.6	13.7	7.9	1.3	13.9	17.2	9.6	5.8	5.0	3.3	8.5	6.1	7.0	15.0	10.9	0.9	5.8	8.8	13.1	2.5	1.1	6.2	12.1	11.6	10.4	7.7	0.4	1.6	3.0	11.1	2.7	5.7	3.5	13.1	5.1	27.6	2.2	10.6	6.8	6.0	18.2	5.1	2.1	11.1	5.4
GOPC	"CAL, dJ94G16.2, FIG, GOPC1, PIST"	ENSG00000047932	"Golgi associated PDZ and coiled-coil motif containing"	Q9HD26	6	117560269-117602542	"Cancer-related genes, Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Protein transport, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA019477, HPA024018"	Approved		Enhanced	"Golgi apparatus"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 59: Non-specific - Transcription"	"Golgi apparatus"		"HPA019477: AB_1849890, HPA024018: AB_1849891"	"unprognostic (2.48e-2)"	"unprognostic (1.63e-3)"	"unprognostic (1.71e-1)"	"unprognostic (5.56e-2)"	"unprognostic (1.84e-2)"	"unprognostic (3.17e-2)"	"unprognostic (3.12e-2)"	"unprognostic (9.21e-2)"	"unprognostic (6.22e-2)"	"unprognostic (6.77e-2)"	"unprognostic (8.23e-2)"	"unprognostic (9.46e-2)"	"unprognostic (1.40e-2)"	"unprognostic (2.67e-2)"	"unprognostic (1.38e-1)"	"unprognostic (9.55e-2)"	"unprognostic (3.01e-2)"	15.5	14.2	14.6	15.8	14.9	7.1	20.2	15.6	18.0	23.4	11.0	18.7	12.2	23.5	18.0	12.1	17.4	16.3	22.1	15.9	13.3	14.5	16.4	13.6	19.9	12.5	12.5	25.6	12.7	22.1	16.1	19.9	13.1	16.2	20.3	13.5	14.3	17.3	15.8	18.7	15.0	18.4	13.6	16.9	14.9	17.7	12.6	21.0	23.9	17.4	17.2	15.1	14.7	16.8	14.1	15.0	19.1	25.6	40.1	47.9	30.3	57.1	41.7	30.6	31.5	23.1	15.5	42.2	24.3	32.4	60.4	31.2	37.2	27.6	42.8	21.2	20.8	38.7	39.9	37.5	42.4	52.2	24.8	57.4	74.9	22.8	65.7	60.6	26.5	29.0	36.7	16.8	62.2	12.9	21.8	40.3	16.5	24.0	16.0	33.0	37.0	30.8	23.3	12.9	26.7	21.0	57.6	19.7	15.8	36.3	14.3	49.7	31.8	2.2	27.9	28.5	62.6	29.9	28.8	35.4	37.9	43.4	23.9	10.5	4.2	3.2	6.7	3.9	9.3	7.9	7.1	7.1	5.5	7.7	8.2	8.5	2.9	9.2	4.7	9.2	7.7	4.1	14.6	14.9	15.6	18.0	15.9	13.3	12.5	12.5	13.1	13.6	12.6	16.8	43.2	22.4	22.7	46.4	33.4	46.7	25.1	63.9	46.7	59.2	47.0	67.3	46.2	34.3	32.2	20.2	22.9	77.0	28.6	40.4	27.4	27.9	35.1	30.4	77.4	38.1	33.6	26.5	52.9	25.6	62.4	48.3	30.1	30.6	31.1	50.4	35.0	38.7	38.5	74.0	46.2	65.2	24.4	24.2	22.9	13.7	42.3	27.0	28.4	32.8	24.1	39.3	35.0	73.9	64.5	21.1	40.9	42.2	38.7	40.3	20.9	27.1	35.3	35.9	32.9	50.0	44.3	115.6	51.4	36.7	59.8	52.3	38.7	43.3	37.7	27.3
NUS1	"C6orf68, MGC7199, NgBR, TANGO14"	ENSG00000153989	"NUS1 dehydrodolichyl diphosphate synthase subunit"	Q96E22	6	117675469-117710727	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted membrane proteins"	"Angiogenesis, Differentiation, Lipid metabolism"	"Developmental protein, Receptor, Transferase"	"Congenital disorder of glycosylation, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027504	Supported		Approved	"Vesicles,Plasma membrane"		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 55: Plasma cells - Humoral immune response"	Vesicles	"Plasma membrane"	"HPA027504: AB_10603124"	"unprognostic (1.21e-2)"	"prognostic unfavorable (6.99e-4)"	"unprognostic (1.09e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.21e-1)"	"unprognostic (8.26e-3)"	"unprognostic (1.42e-3)"	"unprognostic (2.42e-2)"	"unprognostic (8.62e-2)"	"unprognostic (2.99e-1)"	"unprognostic (2.62e-1)"	"unprognostic (8.35e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.27e-1)"	"unprognostic (3.22e-2)"	"unprognostic (1.56e-1)"	"unprognostic (7.97e-2)"	17.8	20.0	12.1	22.2	13.0	19.4	22.2	11.4	15.5	60.3	16.1	19.8	16.5	20.6	28.4	15.7	18.4	16.1	11.7	12.9	13.8	28.4	31.6	18.2	21.4	10.8	12.5	16.5	20.4	29.8	11.9	21.6	11.9	20.6	20.3	12.5	30.5	17.6	10.0	11.1	17.6	18.7	11.7	17.8	24.2	12.6	13.5	18.5	35.4	12.6	20.6	23.5	11.7	12.4	27.1	19.5	41.3	46.4	40.7	52.9	101.0	48.3	50.1	39.5	45.1	44.6	29.5	63.4	51.1	44.7	50.0	24.0	62.1	47.2	73.0	47.9	57.0	72.8	31.5	80.2	62.6	92.8	41.2	46.6	52.5	43.3	87.7	40.3	41.3	46.5	88.4	54.9	59.7	30.5	43.9	58.8	48.0	36.9	35.3	41.7	29.7	45.7	79.0	26.6	48.7	38.5	29.1	37.4	36.9	45.6	23.8	95.9	36.4	24.3	30.1	39.2	70.5	75.6	60.8	66.8	57.6	70.0	49.7	1.9	1.3	0.8	1.3	1.4	1.9	1.1	1.6	1.8	1.5	1.0	1.3	1.7	0.1	1.9	2.5	3.8	1.7	1.0	12.1	13.0	11.4	15.5	12.9	13.8	10.8	12.5	11.9	11.7	13.5	12.4	18.7	0.0	22.3	30.3	28.5	60.5	41.9	32.6	19.4	15.3	26.6	13.7	6.3	15.7	24.0	25.8	10.4	26.8	38.1	26.4	27.4	23.4	16.0	15.7	28.9	24.3	13.1	19.1	33.4	30.2	63.6	22.8	38.2	21.4	31.1	15.8	28.2	39.7	35.3	15.2	37.1	29.3	20.3	37.0	42.2	14.0	18.0	30.2	32.0	20.6	28.4	8.3	24.7	35.7	36.5	37.4	22.7	20.3	57.5	73.1	18.6	33.6	23.1	9.6	6.6	21.3	25.9	24.9	25.4	25.7	56.1	57.9	26.2	14.5	26.1	77.5
SLC35F1	"C6orf169, dJ230I3.1"	ENSG00000196376	"Solute carrier family 35 member F1"	Q5T1Q4	6	117907264-118317676	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 21.3;retina: 13.2"	"Group enriched"	"Detected in some"	17	"Astrocytes: 380.0;Excitatory neurons: 394.8;Inhibitory neurons: 503.6;Oligodendrocyte precursor cells: 1344.6"	"Cancer enriched"	"Detected in some"	4	"glioma: 15.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"AF22: 47.8;WM-115: 81.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019576	Enhanced		Approved	"Nucleoplasm,Centriolar satellite,Cytosol"		NA	NA				"Cluster 58: Brain - Synaptic function"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 68: Oligodendrocytes - Mixed function"	Nucleoplasm	"Centriolar satellite, Cytosol"	"HPA019576: AB_2190216"	"unprognostic (1.46e-1)"	"unprognostic (5.67e-2)"	"unprognostic (7.08e-2)"	"unprognostic (1.37e-3)"	"unprognostic (3.31e-1)"	"unprognostic (4.99e-2)"	"unprognostic (1.39e-1)"	"unprognostic (4.04e-1)"	"unprognostic (3.64e-2)"	"unprognostic (3.04e-2)"	"unprognostic (4.44e-3)"	"unprognostic (2.19e-1)"	"unprognostic (8.83e-4)"	"unprognostic (3.04e-3)"	"unprognostic (6.03e-2)"	"unprognostic (8.32e-2)"	"unprognostic (2.02e-1)"	1.4	1.2	17.1	0.9	19.0	0.0	0.6	6.3	21.3	1.2	0.6	4.9	0.4	1.2	3.0	0.6	1.8	0.6	3.4	16.2	11.0	0.6	0.0	0.1	0.0	8.5	12.4	0.3	0.4	0.1	0.5	0.0	8.3	1.2	0.9	13.2	0.5	1.3	0.3	0.4	1.4	1.1	9.0	0.7	1.1	0.6	12.3	0.0	0.6	0.3	0.0	0.7	0.9	16.4	0.0	0.0	47.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	6.3	0.0	0.0	0.0	6.5	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.1	1.6	0.0	0.9	0.0	0.0	0.4	0.0	6.1	6.9	0.0	0.0	0.3	0.0	81.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.1	19.0	6.3	21.3	16.2	11.0	8.5	12.4	8.3	9.0	12.3	16.4	0.9	0.0	0.0	380.0	0.1	0.4	0.1	0.0	0.0	15.8	0.1	0.0	6.9	0.0	1.3	0.0	2.1	0.0	0.3	0.0	0.0	0.0	17.9	0.0	0.2	0.2	0.0	0.0	394.8	0.4	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.1	16.8	503.6	0.0	0.0	0.0	0.0	38.3	0.6	0.3	14.2	27.2	0.0	27.6	0.0	1344.6	10.3	0.0	0.0	1.2	0.1	1.0	0.0	0.1	0.0	2.2	0.0	1.1	5.4	3.0	2.6	0.0	0.0	0.0	0.1	0.1	0.0	0.1
CEP85L	"bA57K17.2, C6orf204, NY-BR-15"	ENSG00000111860	"Centrosomal protein 85 like"	Q5SZL2	6	118460772-118710075	"Disease related genes, Predicted intracellular proteins"			"Disease variant, Lissencephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 29.9"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 266.1;Early spermatids: 445.2;Late spermatids: 742.5;Oligodendrocyte precursor cells: 251.9;Oligodendrocytes: 189.4"	"Cancer enhanced"	"Detected in many"		"testis cancer: 3.2"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 25.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029137, HPA029138, HPA029139"	Uncertain					NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 25: Spermatids - Spermatogenesis"			"HPA029137: AB_10600657, HPA029138: AB_10600874, HPA029139: AB_10601220"	"unprognostic (3.25e-2)"	"unprognostic (1.22e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.82e-1)"	"unprognostic (2.19e-2)"	"unprognostic (2.34e-1)"	"unprognostic (7.24e-2)"	"unprognostic (1.01e-2)"	"unprognostic (8.37e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.39e-3)"	"unprognostic (8.45e-2)"	"unprognostic (2.87e-5)"	"unprognostic (2.72e-3)"	"unprognostic (2.44e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.85e-2)"	3.3	5.2	4.0	7.1	5.5	11.5	2.5	11.7	5.2	3.9	0.0	2.6	1.8	4.1	2.1	3.0	3.8	3.2	4.6	3.8	5.2	1.4	2.2	3.3	13.5	5.1	7.4	7.5	2.6	3.5	5.1	4.2	5.5	2.2	2.4	3.3	4.5	2.0	8.5	1.3	4.1	3.1	4.0	7.7	8.0	29.9	6.8	19.1	2.2	11.8	9.7	5.2	2.6	5.4	1.3	1.1	6.5	3.7	3.5	6.5	25.7	3.4	5.1	3.0	3.4	0.2	0.3	6.6	1.0	5.0	2.5	1.7	2.9	4.9	5.5	3.6	3.4	8.8	2.0	0.8	2.8	0.6	2.5	3.8	2.6	3.7	4.0	6.0	4.4	9.5	8.7	6.1	5.0	1.0	16.0	4.0	2.0	0.2	1.8	3.8	5.1	1.5	3.6	2.9	4.0	2.3	2.6	0.1	5.0	5.2	0.8	3.3	3.6	4.8	2.7	4.2	5.6	7.8	6.1	6.0	4.0	2.9	5.0	1.5	10.7	9.0	6.6	11.6	6.7	3.4	5.4	5.4	5.5	4.6	7.1	5.9	15.7	6.9	11.2	2.6	4.7	4.0	4.0	5.5	11.7	5.2	3.8	5.2	5.1	7.4	5.5	4.0	6.8	5.4	24.1	6.4	4.6	266.1	26.3	6.9	10.7	10.6	9.6	31.6	4.5	7.1	33.9	0.0	3.5	3.7	10.4	26.7	35.5	0.2	1.9	3.7	445.2	7.5	43.2	25.8	3.0	2.5	156.1	4.3	5.9	23.4	33.1	16.6	8.8	12.5	14.6	6.5	8.4	33.7	147.1	0.6	2.0	25.7	16.7	742.5	32.0	24.0	23.2	80.6	22.9	4.7	19.6	251.9	189.4	9.4	1.2	29.0	28.7	7.1	0.0	2.1	5.2	9.8	19.7	53.4	32.2	38.2	49.7	3.5	4.8	22.2	48.3	48.3	0.6	8.1
PLN	"CMD1P, PLB"	ENSG00000198523	Phospholamban	P26678	6	118548296-118561716	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			"Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"heart muscle: 1563.4;skeletal muscle: 507.3"	"Cell type enriched"	"Detected in some"	8	"Cardiomyocytes: 2452.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"							"CAB005597, HPA026900"	Enhanced					NA	NA				"Cluster 38: Heart - Muscle contraction"		"Cluster 54: Cardiomyocytes - Muscle contraction"			"CAB005597: AB_2252716, HPA026900: AB_1855314"	"unprognostic (2.49e-1)"	"unprognostic (5.67e-2)"	"unprognostic (1.96e-3)"	"unprognostic (4.81e-2)"	"unprognostic (1.20e-1)"	"unprognostic (5.54e-2)"	"unprognostic (2.35e-3)"	"unprognostic (4.66e-2)"	"unprognostic (3.97e-1)"	"unprognostic (8.98e-2)"	"unprognostic (8.98e-2)"	"unprognostic (3.28e-1)"	"prognostic unfavorable (4.11e-4)"	"unprognostic (2.98e-3)"	"unprognostic (1.80e-1)"	"unprognostic (2.11e-1)"	"prognostic unfavorable (5.59e-4)"	40.1	12.3	1.5	12.3	3.0	0.6	15.9	2.9	4.0	31.7	2.0	148.7	13.6	121.7	21.8	43.9	81.9	92.2	1563.4	1.6	1.6	15.0	1.2	15.4	2.7	1.8	2.0	20.4	3.2	1.3	1.5	0.3	1.8	35.1	24.4	0.2	5.3	37.0	507.3	8.3	41.6	128.4	1.5	3.0	34.1	4.3	2.2	1.0	12.7	230.2	0.9	44.1	22.9	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	3.0	2.9	4.0	1.6	1.6	1.8	2.0	1.8	1.5	2.2	2.0	4.5	0.0	0.0	0.3	0.2	4.2	0.2	0.0	1.2	1.8	0.4	0.6	2452.8	0.0	0.0	0.0	2.1	0.0	0.2	0.0	0.0	0.0	108.2	0.2	0.7	21.4	0.0	0.0	1.0	0.0	0.0	49.1	0.5	0.1	0.0	0.1	0.7	0.1	0.1	0.0	0.9	0.0	0.0	0.0	4.7	25.0	0.9	0.4	3.6	1.0	0.0	0.0	0.0	2.0	1.1	0.1	0.0	11.7	0.0	0.7	0.0	0.0	0.0	0.3	276.1	16.7	248.0	9.2	0.8	0.3	1.6	0.0	0.8	0.0	0.0	0.4
MCM9	"C6orf61, dJ329L24.3, FLJ20170, MCMDC1, MGC35304"	ENSG00000111877	"Minichromosome maintenance 9 homologous recombination repair factor"	Q9NXL9	6	118813442-118935162	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair"	"DNA-binding, Helicase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 32.0;Microglial cells: 40.3;Oligodendrocyte precursor cells: 35.7;Oligodendrocytes: 39.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031137	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm		"HPA031137: AB_10602027"	"unprognostic (3.11e-2)"	"unprognostic (1.99e-1)"	"unprognostic (4.33e-3)"	"unprognostic (2.90e-1)"	"unprognostic (2.78e-2)"	"unprognostic (2.82e-1)"	"unprognostic (3.00e-2)"	"unprognostic (2.29e-1)"	"unprognostic (3.61e-2)"	"unprognostic (7.76e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.99e-1)"	"unprognostic (8.30e-2)"	"unprognostic (2.16e-1)"	"unprognostic (3.95e-1)"	"unprognostic (2.26e-1)"	"unprognostic (8.79e-2)"	5.7	4.4	2.5	5.7	3.3	12.7	7.0	2.4	2.9	6.8	3.5	5.1	4.9	5.3	10.2	6.5	5.8	3.7	3.4	2.2	2.5	6.6	5.0	5.2	7.5	3.2	3.2	5.1	6.9	5.3	4.6	7.0	3.1	6.8	5.7	4.1	7.5	4.7	2.6	6.5	5.8	4.2	2.8	6.3	4.9	5.7	3.0	8.0	8.0	2.1	7.1	5.8	6.9	3.7	4.2	6.5	10.3	11.8	4.2	4.8	7.3	3.9	7.1	5.4	6.8	5.2	6.7	12.1	4.5	6.2	3.9	12.5	7.1	4.7	7.2	7.5	10.1	11.4	9.5	5.5	3.0	11.7	7.3	5.2	5.7	6.0	7.3	3.7	5.5	8.0	12.9	6.3	4.2	9.4	10.0	9.4	4.7	7.3	3.1	8.3	7.0	4.2	5.4	7.9	8.5	6.0	6.9	5.7	3.7	2.9	7.3	15.8	6.0	4.3	3.7	2.9	5.7	7.8	7.2	13.9	5.5	8.7	5.6	4.3	2.6	4.4	2.2	2.7	1.8	1.5	1.4	2.3	2.9	1.4	1.7	1.6	2.9	4.8	1.7	2.1	3.5	2.1	2.5	3.3	2.4	2.9	2.2	2.5	3.2	3.2	3.1	2.8	3.0	3.7	6.6	6.4	6.7	32.0	10.8	2.9	3.8	2.9	7.4	3.5	6.4	4.1	6.0	2.8	4.4	7.3	10.4	11.8	7.6	7.2	3.9	3.0	2.9	7.4	6.0	6.3	7.2	4.6	16.8	2.8	3.4	5.0	9.2	6.9	7.0	8.1	2.9	3.9	3.5	1.7	15.2	6.0	6.1	5.5	2.8	2.6	3.7	7.4	0.0	40.3	6.3	1.6	11.3	35.7	39.7	2.7	5.6	4.1	10.9	3.9	6.8	3.3	10.6	5.6	0.0	5.7	5.8	6.3	4.6	8.6	2.0	7.3	9.8	4.7	4.1	4.3
ASF1A	"CIA, DKFZP547E2110"	ENSG00000111875	"Anti-silencing function 1A histone chaperone"	Q9Y294	6	118894152-118909171	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chaperone, Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030502, HPA071495"			Enhanced	Nucleoplasm		No	No			"Cluster 13: T-cells - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 6: Erythroid cells - Oxygen transport"	Nucleoplasm		"HPA030502: AB_2673504, HPA071495: AB_2686404"	"unprognostic (7.09e-2)"	"unprognostic (1.33e-1)"	"unprognostic (4.78e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.95e-3)"	"unprognostic (2.09e-1)"	"prognostic unfavorable (5.02e-7)"	"unprognostic (8.28e-2)"	"unprognostic (8.42e-2)"	"unprognostic (8.37e-3)"	"unprognostic (3.28e-2)"	"unprognostic (4.95e-1)"	"unprognostic (9.07e-3)"	"unprognostic (2.90e-2)"	"unprognostic (7.37e-2)"	"unprognostic (1.42e-2)"	"unprognostic (5.09e-3)"	7.4	10.2	13.0	8.7	14.4	8.3	12.5	14.8	17.1	8.5	11.2	9.4	7.7	10.6	13.0	8.9	10.5	7.9	13.3	12.4	14.2	12.6	12.0	13.4	16.0	13.6	13.7	17.5	9.4	15.8	6.3	8.2	14.0	9.8	10.9	11.5	10.7	11.0	16.6	11.6	8.8	7.4	14.5	11.5	10.9	9.7	13.9	24.4	15.1	16.1	15.1	9.4	6.7	15.7	14.7	9.2	31.2	21.2	26.0	15.2	25.3	19.3	18.8	24.3	27.2	11.7	12.2	24.0	30.8	13.7	21.5	15.3	27.2	24.7	30.8	17.5	25.4	35.1	20.7	72.9	18.5	60.6	17.4	13.8	24.3	21.2	32.0	32.6	32.9	75.2	55.2	61.9	28.9	15.7	70.8	47.4	12.9	21.6	30.5	38.7	13.1	30.1	32.7	18.4	20.1	15.8	19.6	19.4	23.3	9.8	11.4	55.3	29.1	11.3	17.0	16.1	30.1	19.4	34.5	35.6	29.7	47.5	25.0	18.8	15.4	32.9	40.3	17.1	56.5	35.7	64.0	51.8	34.1	24.7	69.0	56.8	2.7	34.3	23.1	26.1	83.9	47.4	13.0	14.4	14.8	17.1	12.4	14.2	13.6	13.7	14.0	14.5	13.9	15.7	16.0	16.0	22.6	11.1	24.7	29.4	14.8	36.7	28.5	16.7	14.0	19.2	27.1	18.6	23.0	9.2	4.2	67.5	19.8	11.6	62.6	33.9	40.9	10.2	13.9	23.3	29.5	82.1	5.8	23.5	71.5	24.0	17.9	9.1	22.8	39.9	17.2	15.1	24.6	25.2	6.3	12.4	10.2	16.3	16.7	10.8	25.4	16.5	16.0	9.4	24.9	27.8	24.7	9.0	10.0	20.7	10.1	23.3	22.7	10.9	11.5	27.2	21.2	13.7	13.1	17.0	37.2	32.7	48.0	20.8	33.0	46.7	49.1	28.1	17.5	12.5
FAM184A	"C6orf60, FLJ13942"	ENSG00000111879	"Family with sequence similarity 184 member A"	Q8NB25	6	118959763-119149387	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 43.3;choroid plexus: 30.5"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 103.0;Astrocytes: 261.2;Oligodendrocyte precursor cells: 88.4;Syncytiotrophoblasts: 266.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 11.8;HEK 293: 11.1;Hep G2: 7.9;JURKAT: 11.6;K-562: 10.4;SCLC-21H: 8.5;SH-SY5Y: 8.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034571, HPA034572, HPA041955"	Uncertain		Supported	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA034571: AB_10602498, HPA034572: AB_2674228, HPA041955: AB_2677768"	"unprognostic (1.21e-1)"	"unprognostic (4.11e-3)"	"unprognostic (6.95e-2)"	"unprognostic (3.40e-3)"	"unprognostic (6.80e-2)"	"unprognostic (1.64e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.18e-4)"	"unprognostic (2.59e-1)"	"unprognostic (3.19e-1)"	"unprognostic (5.16e-4)"	"unprognostic (8.38e-3)"	"unprognostic (4.02e-2)"	"unprognostic (9.11e-3)"	"unprognostic (8.16e-3)"	"unprognostic (5.70e-2)"	"unprognostic (2.32e-1)"	3.1	1.6	33.3	1.3	36.3	0.2	4.7	37.3	43.3	3.6	30.5	3.5	3.0	2.5	3.0	1.4	3.2	1.8	2.5	34.3	33.0	6.7	6.3	9.9	3.5	31.9	32.4	4.5	3.2	4.8	11.0	23.0	32.4	3.9	0.9	16.3	3.3	2.8	0.9	1.7	1.6	1.6	29.1	0.6	1.7	16.9	32.6	0.6	7.0	2.2	3.5	2.4	2.1	34.5	0.1	0.3	11.8	0.9	0.3	0.3	0.0	0.6	0.4	0.5	0.9	2.0	1.1	0.9	0.0	0.2	5.3	0.0	3.4	0.0	0.2	1.3	11.1	0.1	0.9	7.9	0.2	0.0	0.6	0.4	0.1	0.1	0.0	0.3	0.0	11.6	10.4	0.7	0.3	0.3	0.4	0.1	6.0	0.6	1.3	0.0	0.1	0.0	0.1	0.1	8.5	8.0	0.7	0.6	1.8	2.2	2.1	1.4	0.3	0.8	0.5	0.2	2.9	4.9	3.3	0.3	1.5	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.3	0.0	33.3	36.3	37.3	43.3	34.3	33.0	31.9	32.4	32.4	29.1	32.6	34.5	21.0	48.1	103.0	261.2	0.7	2.4	5.9	0.4	11.4	35.2	3.8	8.8	6.4	2.8	17.7	3.7	29.2	61.4	0.6	0.4	17.6	1.0	22.9	2.0	2.0	5.3	6.0	0.4	66.9	1.1	18.9	11.8	1.5	0.8	6.3	8.9	1.8	4.0	5.6	13.5	55.5	0.6	0.0	0.3	1.8	9.2	3.7	1.0	0.0	34.7	0.0	11.1	0.0	88.4	20.6	0.3	1.2	7.2	2.7	1.6	0.4	3.1	37.3	28.4	6.6	45.2	4.1	61.8	16.0	4.2	3.4	266.4	5.8	1.4	0.7	2.0
MAN1A1		ENSG00000111885	"Mannosidase alpha class 1A member 1"	P33908	6	119177205-119349761	"Enzymes, Metabolic proteins, Plasma proteins, Predicted membrane proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 154.6"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 232.5;Excitatory neurons: 165.0;Hepatocytes: 270.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 273.1;Hep G2: 204.0;Karpas-707: 219.6;U-266/70: 294.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037058, HPA053198, HPA063561"	Uncertain		Supported	"Golgi apparatus"		NA	NA		460000000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 4: Macrophages - Innate immune response"	"Golgi apparatus"		"CAB037058: AB_477183, HPA053198: AB_2682078, HPA063561: AB_2685042"	"unprognostic (1.50e-1)"	"unprognostic (7.36e-3)"	"unprognostic (4.83e-2)"	"unprognostic (2.21e-2)"	"unprognostic (2.95e-2)"	"unprognostic (2.19e-1)"	"unprognostic (3.33e-3)"	"unprognostic (3.44e-2)"	"unprognostic (2.04e-1)"	"unprognostic (5.11e-2)"	"unprognostic (1.68e-3)"	"unprognostic (4.62e-1)"	"unprognostic (2.37e-2)"	"unprognostic (3.49e-2)"	"unprognostic (2.25e-1)"	"unprognostic (6.89e-2)"	"unprognostic (3.40e-1)"	102.2	48.5	4.2	32.8	12.3	28.9	34.3	1.2	8.9	25.9	5.1	36.1	52.7	23.8	8.8	22.7	16.0	47.1	15.3	8.0	4.6	66.6	154.6	35.8	34.8	2.9	5.0	20.1	32.7	25.8	4.6	79.4	2.5	18.1	29.3	6.2	42.7	15.0	7.6	14.3	69.8	27.2	3.3	36.5	25.9	7.0	8.4	18.9	22.6	31.0	25.9	56.0	17.1	5.9	0.2	0.0	3.4	0.0	273.1	119.9	6.6	6.9	41.4	5.1	12.5	19.8	2.6	43.2	0.3	26.5	65.7	0.4	7.6	0.1	6.4	64.5	19.4	36.3	3.9	204.0	27.2	0.1	17.7	82.4	5.3	41.6	25.3	22.1	3.4	12.6	128.1	219.6	39.7	6.1	1.7	0.3	2.3	20.0	10.0	12.1	4.2	66.6	13.4	35.4	14.1	21.0	0.1	0.6	0.0	8.3	10.4	4.8	24.8	16.9	15.4	32.0	15.8	294.5	44.6	84.8	50.2	0.7	10.4	4.3	0.3	1.1	1.1	0.5	2.3	0.7	0.6	0.6	0.3	0.4	0.3	0.9	1.9	0.9	0.5	2.8	0.7	0.3	4.2	12.3	1.2	8.9	8.0	4.6	2.9	5.0	2.5	3.3	8.4	5.9	37.1	9.6	46.1	19.9	31.0	31.7	5.7	1.2	5.2	28.1	18.8	5.8	4.4	44.3	6.9	106.7	0.0	6.8	40.6	23.3	5.9	9.4	232.5	5.9	63.9	42.1	48.0	40.4	165.0	37.8	12.4	98.4	18.8	10.7	3.8	24.0	97.5	270.5	101.1	0.0	79.4	61.1	0.0	84.6	91.2	39.3	26.4	98.0	28.4	128.4	13.5	1.7	42.2	4.5	3.7	14.8	18.9	4.1	147.5	5.3	92.2	33.5	4.6	5.0	6.6	12.9	27.8	2.8	3.9	3.4	27.8	6.2	24.3	14.6	18.9	9.7
TBC1D32	"bA57L9.1, BROMI, C6orf170, C6orf171, dJ310J6.1, FLJ30899, FLJ34235"	ENSG00000146350	"TBC1 domain family member 32"	Q96NH3	6	121079494-121334745	"Predicted intracellular proteins, Predicted membrane proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 7.4"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 68.2;Excitatory neurons: 124.1;Inhibitory neurons: 87.4;Oligodendrocyte precursor cells: 105.6;Oligodendrocytes: 102.6;Rod photoreceptor cells: 110.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 22.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013413	Uncertain		Approved	Mitochondria		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 77: Retina - Visual perception"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 46: Photoreceptor cells - Phototransduction"	Mitochondria		"HPA013413: AB_10602702"	"unprognostic (3.31e-2)"	"unprognostic (1.28e-1)"	"unprognostic (9.12e-3)"	"unprognostic (4.82e-2)"	"unprognostic (2.44e-2)"	"unprognostic (1.98e-2)"	"unprognostic (3.60e-4)"	"unprognostic (7.28e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.83e-1)"	"unprognostic (8.14e-2)"	"unprognostic (2.01e-2)"	"unprognostic (3.73e-2)"	"unprognostic (1.57e-2)"	"unprognostic (7.62e-2)"	"unprognostic (2.17e-1)"	"unprognostic (2.06e-1)"	1.2	2.4	0.8	0.9	1.5	0.8	1.7	0.6	1.4	1.8	0.9	1.1	1.8	1.7	0.8	1.0	1.6	1.9	0.7	0.8	1.6	1.4	0.4	0.9	1.0	1.1	1.4	1.8	1.3	2.3	1.5	2.9	1.2	1.6	0.7	7.4	0.8	0.9	0.2	1.2	1.4	0.8	0.6	1.0	1.3	3.6	1.8	1.6	2.4	0.5	1.1	1.0	0.9	2.5	1.7	2.0	3.4	4.4	2.8	4.5	1.8	1.9	2.9	3.2	4.6	0.1	1.3	3.4	3.2	2.0	4.7	1.5	1.6	1.6	4.0	22.7	2.2	3.9	0.7	0.7	1.2	2.1	1.5	1.7	1.2	2.8	2.1	3.8	0.7	3.9	2.2	0.0	2.5	1.0	2.3	1.3	1.9	1.1	0.7	2.1	1.6	0.3	1.6	0.8	6.5	3.5	2.2	1.4	1.0	1.8	2.1	1.6	0.4	2.1	2.1	0.6	2.2	1.6	0.0	1.3	3.0	1.1	3.3	6.1	0.9	1.3	1.8	0.5	1.3	2.5	1.4	1.3	0.7	4.5	2.6	2.0	0.8	2.6	0.9	8.2	1.6	0.3	0.8	1.5	0.6	1.4	0.8	1.6	1.1	1.4	1.2	0.6	1.8	2.5	3.9	3.2	8.4	68.2	6.4	6.1	3.7	3.1	9.6	26.2	6.1	5.0	3.1	4.3	10.1	7.3	43.8	4.4	8.7	3.4	0.0	2.4	9.8	8.8	9.5	3.5	5.4	1.7	124.1	2.2	1.7	6.2	10.2	4.7	3.8	26.7	2.9	1.1	1.4	13.5	87.4	6.0	4.1	1.6	2.9	3.5	2.5	2.8	1.8	36.5	1.5	6.7	3.1	105.6	102.6	1.0	3.9	1.9	1.8	2.3	8.0	1.5	20.3	110.4	0.0	6.6	5.3	21.5	7.9	3.4	5.1	2.3	4.9	4.8	4.8	2.3
GJA1	"CX43, GJAL, ODD, ODDD, ODOD, SDTY3"	ENSG00000152661	"Gap junction protein alpha 1"	P17302	6	121435595-121449727	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted membrane proteins"			"Cancer-related genes, Cataract, Disease variant, Hypotrichosis, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 250.0;Astrocytes: 276.2;Basal keratinocytes: 234.9;Cardiomyocytes: 199.7;Endometrial stromal cells: 215.5;Granulosa cells: 494.3;Suprabasal keratinocytes: 378.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 462.7;HUVEC TERT2: 362.3;NTERA-2: 365.8;SuSa: 453.4;U-87 MG: 350.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB010753, HPA035097, HPA047551, HPA069245"	Enhanced	Supported	Supported	"Nucleoplasm,Vesicles,Cell Junctions"		NA	NA				"Cluster 27: Brain & Skin - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 40: Granulosa cells - Unknown function"	"Vesicles, Cell Junctions"	Nucleoplasm	"CAB010753: AB_476857, HPA035097: AB_2674460, HPA047551: AB_2732540, HPA069245: "	"unprognostic (3.37e-2)"	"unprognostic (3.41e-3)"	"unprognostic (2.95e-1)"	"unprognostic (4.18e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.27e-1)"	"unprognostic (6.78e-2)"	"unprognostic (2.89e-2)"	"unprognostic (1.56e-1)"	"unprognostic (5.47e-2)"	"unprognostic (1.00e-1)"	"unprognostic (4.88e-2)"	"prognostic unfavorable (4.99e-5)"	"unprognostic (2.39e-1)"	"unprognostic (1.29e-1)"	"unprognostic (3.00e-3)"	121.2	287.6	313.5	24.7	310.2	0.9	60.6	260.1	409.0	261.7	193.1	17.5	18.2	98.7	10.6	74.9	32.7	99.9	168.9	273.6	362.6	21.2	10.6	67.9	21.1	340.3	380.9	43.5	19.4	236.2	31.3	290.2	307.4	83.3	19.7	3.3	35.6	148.0	10.3	388.2	24.7	112.5	335.9	4.2	30.7	36.9	373.3	24.3	169.1	22.1	34.9	116.0	184.9	341.0	0.1	43.5	186.8	0.4	99.7	61.5	0.4	142.5	286.9	46.9	113.7	0.7	0.4	0.0	15.8	55.8	40.2	18.3	5.1	87.4	151.3	0.1	51.6	2.3	15.7	0.0	124.1	0.0	0.4	164.6	92.1	172.5	61.7	462.7	362.3	0.0	0.1	4.3	9.4	8.4	0.1	80.6	365.8	0.1	47.2	0.1	0.0	3.7	188.6	21.0	0.4	2.9	0.0	0.3	0.1	453.4	14.9	0.3	269.5	143.8	39.4	122.8	93.5	0.1	0.1	0.1	350.4	0.1	20.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	313.5	310.2	260.1	409.0	273.6	362.6	340.3	380.9	307.4	335.9	373.3	341.0	152.2	250.0	80.0	276.2	0.1	234.9	133.6	71.1	77.4	0.3	9.5	20.1	199.7	0.0	17.5	1.8	2.1	53.4	0.4	0.0	0.0	76.9	0.5	21.5	215.5	166.6	0.0	0.0	0.3	4.2	7.9	124.4	0.5	51.7	8.8	494.3	33.9	0.1	8.6	0.0	0.6	0.0	4.1	0.9	55.3	1.7	2.5	3.6	44.4	15.0	0.6	0.3	0.0	4.0	1.0	10.8	0.0	4.1	0.1	29.7	0.0	0.1	6.2	0.3	0.0	5.9	80.2	0.9	1.8	68.3	378.2	20.0	4.9	127.1	0.4	52.7
HSF2		ENSG00000025156	"Heat shock transcription factor 2"	Q03933	6	122399551-122433119	"Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Stress response, Transcription, Transcription regulation"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 97.1;Spermatocytes: 73.8;Spermatogonia: 97.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016067, HPA031455"	Approved		Supported	Nucleoplasm		No	No			"Cluster 32: T-cells - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 12: NES - Nervous system development"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	Nucleoplasm		"CAB016067: AB_627754, HPA031455: AB_10670702"	"unprognostic (1.62e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.55e-1)"	"unprognostic (5.42e-2)"	"unprognostic (2.27e-3)"	"unprognostic (1.45e-1)"	"prognostic unfavorable (1.51e-6)"	"unprognostic (3.40e-3)"	"unprognostic (2.60e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.25e-3)"	"unprognostic (3.03e-1)"	"prognostic unfavorable (7.65e-4)"	"unprognostic (9.27e-2)"	"unprognostic (5.44e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.42e-1)"	9.5	15.2	12.2	7.9	12.3	29.6	12.7	15.0	13.5	13.1	15.9	11.6	6.9	14.5	10.3	8.2	11.9	7.5	23.3	11.5	12.6	6.8	5.5	8.8	12.7	10.5	10.9	14.6	6.4	14.0	10.6	8.2	11.3	11.1	6.9	44.5	8.5	12.7	48.6	12.7	9.1	14.0	10.7	9.2	9.4	37.9	13.0	17.9	8.8	64.3	12.5	9.6	9.0	13.1	8.5	8.7	44.5	35.8	19.6	15.6	12.2	14.6	35.5	26.9	41.6	13.0	7.0	32.2	12.4	18.9	30.2	10.5	30.1	14.4	37.4	32.7	36.4	31.8	8.6	27.1	19.9	23.5	15.4	20.0	21.6	22.3	25.2	24.9	16.4	28.8	34.0	15.5	25.6	11.5	38.8	30.9	13.6	12.2	12.3	35.6	18.0	10.3	20.5	9.7	46.5	31.5	15.1	12.5	14.5	32.5	10.8	25.5	10.4	14.3	16.2	16.1	22.6	22.1	22.7	41.4	15.5	15.3	18.9	6.9	3.9	6.1	11.7	4.7	12.6	9.2	11.0	10.3	5.5	7.0	27.9	22.0	0.6	11.0	6.8	3.8	13.2	11.4	12.2	12.3	15.0	13.5	11.5	12.6	10.5	10.9	11.3	10.7	13.0	13.1	10.6	19.2	10.3	17.0	11.9	31.7	11.4	8.1	27.3	21.8	12.1	10.9	36.6	4.3	11.1	0.0	27.1	15.5	14.4	1.9	11.7	7.7	97.1	21.3	14.6	10.3	6.6	16.2	26.6	4.2	7.4	16.2	10.2	9.6	8.8	19.4	6.1	4.9	7.9	21.9	29.4	6.1	24.4	4.8	7.8	21.3	10.2	6.0	19.6	14.0	2.9	15.2	7.2	24.1	23.5	4.8	5.2	9.8	7.9	8.7	3.2	7.5	23.3	34.2	26.3	14.9	12.1	73.8	97.0	16.1	25.7	3.1	20.5	39.6	5.4	6.4
SERINC1	"KIAA1253, TDE1L, TDE2, TMS-2"	ENSG00000111897	"Serine incorporator 1"	Q9NRX5	6	122443351-122471807	"Plasma proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035738, HPA035739"	Uncertain		Approved	Cytosol		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol		"HPA035738: AB_10672990, HPA035739: AB_10669536"	"unprognostic (2.83e-3)"	"unprognostic (2.68e-3)"	"unprognostic (1.59e-1)"	"unprognostic (7.67e-2)"	"unprognostic (2.65e-1)"	"unprognostic (2.84e-2)"	"unprognostic (2.04e-1)"	"unprognostic (7.45e-2)"	"unprognostic (9.84e-2)"	"unprognostic (8.27e-2)"	"unprognostic (9.07e-3)"	"unprognostic (2.84e-1)"	"unprognostic (5.50e-3)"	"unprognostic (1.80e-3)"	"unprognostic (9.22e-2)"	"unprognostic (3.58e-1)"	"unprognostic (1.00e-2)"	213.6	242.8	220.4	93.2	248.8	148.2	157.8	237.5	334.0	151.4	178.5	104.6	99.4	146.6	108.1	94.9	104.4	128.0	163.7	248.3	257.3	194.1	241.3	160.5	96.8	258.9	243.3	164.4	100.4	243.3	71.7	195.1	282.9	139.6	100.1	225.5	97.1	143.3	152.6	79.0	114.3	141.7	268.4	123.6	96.5	65.6	241.3	89.7	203.1	194.8	79.5	121.7	84.8	306.8	40.5	49.1	121.7	111.8	450.2	245.1	64.5	208.4	259.8	111.6	171.6	57.8	106.9	27.1	159.7	236.5	127.9	78.7	72.6	90.2	166.1	87.1	86.0	76.9	79.0	105.9	201.3	77.5	146.3	256.7	173.0	139.0	190.8	256.4	98.1	69.9	77.4	149.3	233.8	46.8	35.1	51.4	39.7	63.5	61.9	42.5	60.0	66.5	240.3	70.1	63.6	114.5	92.3	101.2	146.8	107.4	70.0	107.1	201.3	133.7	57.9	110.8	109.9	112.4	134.4	35.9	176.8	62.1	159.5	158.3	43.0	92.6	44.7	53.2	48.1	27.7	45.9	43.3	35.9	23.7	53.2	46.9	108.7	51.7	62.0	28.0	54.2	56.0	220.4	248.8	237.5	334.0	248.3	257.3	258.9	243.3	282.9	268.4	241.3	306.8	167.8	150.6	99.2	44.4	73.9	66.2	81.1	55.7	61.5	114.4	71.7	57.1	156.2	87.2	58.9	77.3	70.9	53.8	80.9	88.8	9.8	63.0	3.2	54.9	103.3	130.0	84.5	81.5	92.5	48.7	57.7	131.4	39.8	106.8	124.0	58.1	127.8	132.1	73.1	138.0	145.7	41.8	36.7	158.2	86.4	10.0	126.8	107.4	94.3	65.6	58.1	97.2	58.7	48.2	134.0	78.4	43.6	131.3	80.0	86.1	80.1	44.0	56.1	70.6	59.2	105.1	110.6	25.7	17.0	39.0	74.9	119.7	100.7	99.8	32.7	97.1
PKIB	PRKACN2	ENSG00000135549	"CAMP-dependent protein kinase inhibitor beta"	Q9C010	6	122471917-122726373	"Predicted intracellular proteins"		"Protein kinase inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 70.4;intestine: 90.8;parathyroid gland: 63.7;placenta: 60.4"	"Group enriched"	"Detected in many"	4	"Cytotrophoblasts: 542.7;Distal enterocytes: 750.2;Extravillous trophoblasts: 420.5;Langerhans cells: 251.9;Late spermatids: 251.1;Paneth cells: 355.4;Proximal enterocytes: 255.0;Syncytiotrophoblasts: 959.8"	"Cancer enhanced"	"Detected in all"		"breast cancer: 16.3"	"Region enriched"	"Detected in all"	5	"cerebellum: 70.4"	"Immune cell enriched"	"Detected in some"	11	"myeloid DC: 34.8"	"Lineage enriched"	"Detected in many"	11	"dendritic cells: 34.8"	"Cell line enhanced"	"Detected in many"		"AF22: 71.8;MCF7: 84.9;OE19: 91.2;PC-3: 112.5;RPTEC TERT1: 187.1;SCLC-21H: 157.7"	"Region enhanced"	"Detected in all"		"cerebellum: 63.0"	"Region enhanced"	"Detected in all"		"cerebellum: 45.0"	HPA030156	Approved					NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 56: Intestine - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA030156: AB_10602816"	"unprognostic (1.59e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.57e-3)"	"unprognostic (1.39e-1)"	"unprognostic (9.45e-2)"	"prognostic unfavorable (4.72e-7)"	"unprognostic (1.94e-2)"	"unprognostic (5.88e-2)"	"unprognostic (3.91e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.58e-2)"	"prognostic favorable (2.47e-7)"	"unprognostic (1.82e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.57e-1)"	"unprognostic (1.48e-1)"	2.2	5.8	4.4	9.0	3.9	0.2	23.3	70.4	5.2	4.9	3.4	90.8	15.5	3.4	3.4	5.2	5.5	5.7	0.5	5.9	6.9	2.8	8.2	4.1	2.2	13.9	7.4	0.8	6.3	63.7	22.1	60.4	14.6	6.2	62.4	56.1	8.5	2.4	0.7	9.1	28.3	3.9	3.9	3.2	34.4	4.2	6.8	3.7	1.1	0.6	4.1	5.4	1.2	5.0	0.1	2.8	71.8	0.3	0.6	0.3	62.4	0.0	0.8	0.3	1.2	0.4	3.0	0.0	0.4	0.0	3.8	0.3	0.0	1.5	0.8	0.4	3.7	1.2	3.9	1.7	0.2	0.0	12.3	0.3	1.2	1.2	15.3	34.0	0.3	0.5	22.3	0.4	0.2	84.9	0.3	0.4	29.6	91.2	112.5	0.6	10.8	0.4	187.1	10.6	157.7	0.2	0.0	17.1	2.0	39.4	12.0	1.8	5.7	0.2	47.3	0.2	6.2	0.2	0.3	0.2	46.7	1.5	0.4	0.0	0.6	0.0	0.0	3.2	0.7	0.0	0.0	0.0	34.8	0.1	0.4	0.1	0.1	1.9	0.3	0.5	0.4	0.7	4.4	3.9	70.4	5.2	5.9	6.9	13.9	7.4	14.6	3.9	6.8	5.0	3.0	3.2	3.9	17.0	4.6	19.8	2.3	2.5	2.8	23.6	94.8	53.3	0.3	2.8	10.2	1.8	4.2	542.7	0.9	750.2	19.6	22.6	106.0	5.3	1.6	3.9	98.0	4.0	5.5	35.8	420.5	6.9	52.0	5.5	38.7	0.3	1.1	3.8	53.1	6.7	15.5	94.9	14.2	75.5	251.9	251.1	1.2	51.2	44.4	9.4	25.5	15.2	0.0	6.0	8.5	50.4	355.4	0.4	1.2	13.8	255.0	26.9	58.3	54.8	6.6	0.3	2.7	3.3	5.8	12.4	17.0	959.8	3.5	0.2	92.9	8.3
FABP7	"B-FABP, BLBP"	ENSG00000164434	"Fatty acid binding protein 7"	O15540	6	122779716-122784074	"Metabolic proteins, Predicted intracellular proteins"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 366.1;choroid plexus: 164.8;retina: 175.3;tongue: 199.3"	"Cell type enriched"	"Detected in some"	6	"Muller glia cells: 1407.3"	"Group enriched"	"Detected in many"	6	"glioma: 139.3;renal cancer: 51.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"AF22: 105.5;U-251 MG: 28.8;WM-115: 63.7"	"Region enriched"	"Detected in all"	5	"olfactory bulb: 1195.2"	"Low region specificity"	"Detected in all"			"CAB025488, HPA028825, CAB058697"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 58: Brain - Synaptic function"	"Cluster 12: NES - Nervous system development"	"Cluster 5: Muller glia cells - Visual perception"	Nucleoplasm	"Golgi apparatus, Cytosol"	"CAB025488: , CAB058697: AB_2665600, HPA028825: AB_10602130"	"prognostic favorable (2.49e-4)"	"unprognostic (1.56e-2)"		"unprognostic (2.53e-3)"	"unprognostic (5.80e-2)"	"unprognostic (2.29e-1)"		"unprognostic (1.14e-1)"	"unprognostic (7.11e-2)"		"unprognostic (2.09e-2)"	"unprognostic (3.42e-2)"	"prognostic unfavorable (1.65e-6)"	"unprognostic (9.83e-2)"	"unprognostic (1.30e-2)"	"unprognostic (2.50e-1)"	"unprognostic (8.66e-2)"	1.9	0.4	184.8	0.1	210.5	0.3	38.0	228.1	366.1	1.2	164.8	0.7	0.1	0.1	0.2	0.8	0.1	0.1	0.3	198.7	176.2	0.8	0.3	0.0	0.1	188.0	175.5	0.1	0.1	0.0	8.0	0.4	171.2	0.3	0.1	175.3	8.8	3.9	8.8	41.8	0.1	0.0	170.8	0.0	0.4	0.2	174.0	1.8	0.0	199.3	0.1	0.2	0.4	182.9	0.0	0.1	105.5	0.0	0.0	0.0	3.8	0.0	0.9	0.0	0.0	0.2	0.1	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	1.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	8.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	1.0	0.1	0.2	0.1	0.2	0.0	0.1	28.8	0.0	0.0	0.0	1.2	0.1	63.7	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	184.8	210.5	228.1	366.1	198.7	176.2	188.0	175.5	171.2	170.8	174.0	182.9	0.1	0.0	0.0	14.0	0.0	12.2	0.3	0.0	0.0	11.6	44.5	38.9	1.3	0.0	0.0	0.0	12.5	4.8	0.4	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	2.9	0.0	228.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	2.9	5.0	1.1	0.0	0.0	0.0	1.4	0.0	0.0	0.1	30.2	0.0	0.0	1407.3	0.0	41.7	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	48.0	0.0	0.5	0.3	0.0	0.3	0.0	18.9	7.1	0.3	0.0	0.0	0.0
SMPDL3A	"ASM3A, ASML3a, FLJ20177, yR36GH4.1"	ENSG00000172594	"Sphingomyelin phosphodiesterase acid like 3A"	Q92484	6	122789049-122809720	"Predicted intracellular proteins, Predicted secreted proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 156.3;Distal enterocytes: 291.5;Paneth cells: 157.5;Proximal enterocytes: 383.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	11	"basophil: 80.9"	"Lineage enriched"	"Detected in many"	11	"granulocytes: 80.9"	"Cell line enhanced"	"Detected in many"		"ASC diff: 44.2;hTCEpi: 36.9;OE19: 58.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030148	Uncertain		Approved	Nucleoplasm,Nucleoli,Mitochondria	"Secreted to blood"	No	No		26000000	"Cluster 46: Basophils - DNA binding"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 21: OE19 - Mitochondria"	"Cluster 45: Enterocytes - Digestion"	"Nucleoplasm, Nucleoli, Mitochondria"		"HPA030148: AB_10601591"	"unprognostic (2.60e-1)"	"unprognostic (1.22e-1)"	"prognostic favorable (6.11e-4)"	"unprognostic (1.23e-1)"	"unprognostic (1.15e-1)"	"unprognostic (8.30e-3)"	"unprognostic (3.37e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.39e-1)"	"unprognostic (7.72e-2)"	"unprognostic (2.27e-2)"	"unprognostic (3.44e-2)"	"unprognostic (8.46e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.11e-1)"	15.0	23.3	4.6	18.7	5.1	22.9	23.7	8.2	9.4	72.8	8.9	60.7	45.5	13.3	6.5	13.6	7.9	17.2	5.6	5.3	5.7	47.4	80.0	14.1	21.4	5.9	5.4	9.1	20.8	32.4	7.5	44.0	5.9	21.8	65.7	6.0	13.7	16.6	39.8	64.5	77.3	8.5	5.7	27.0	30.5	2.9	5.4	5.1	9.1	55.8	16.2	35.5	30.9	7.7	0.3	2.6	6.1	2.8	44.2	19.9	19.5	10.4	27.8	3.1	6.6	3.3	2.7	0.0	1.4	6.6	8.2	4.9	1.7	5.3	2.6	0.0	5.4	2.5	9.8	9.0	28.3	0.0	0.1	24.4	36.9	3.0	5.3	12.0	5.5	0.0	3.8	0.0	12.7	9.3	0.0	0.2	1.1	58.8	8.0	0.0	10.8	0.4	15.1	4.2	4.4	0.1	1.5	18.5	27.9	3.9	3.1	1.4	11.0	5.9	3.5	0.6	6.8	0.0	0.0	0.0	8.7	4.9	13.7	80.9	4.0	1.1	0.0	4.3	0.0	0.2	0.0	0.0	0.9	0.0	0.0	0.0	1.3	0.0	7.5	0.0	0.0	1.4	4.6	5.1	8.2	9.4	5.3	5.7	5.9	5.4	5.9	5.7	5.4	7.7	11.8	3.2	17.8	5.2	2.4	53.7	24.5	13.7	15.9	3.0	12.2	6.6	4.0	25.8	9.7	5.5	4.2	156.3	0.4	291.5	56.7	24.6	0.2	4.2	12.6	7.1	48.7	5.7	7.4	25.7	40.4	46.3	34.7	5.2	10.1	0.8	18.9	77.8	62.7	3.3	10.5	61.7	59.0	126.3	10.0	1.2	15.5	33.4	35.6	11.2	9.9	11.5	2.1	11.1	11.0	19.5	157.5	14.3	0.9	16.7	383.1	129.3	7.5	6.2	13.1	12.8	9.9	1.1	3.7	15.5	76.0	115.1	2.0	11.4	38.9	16.6
CLVS2	"bA160A10.4, C6orf212, C6orf213, RLBP1L2"	ENSG00000146352	"Clavesin 2"	Q5SYC1	6	122996235-123072925	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 41.1"	"Group enriched"	"Detected in some"	4	"Excitatory neurons: 137.8;Inhibitory neurons: 171.5;Muller glia cells: 60.8"	"Cancer enhanced"	"Detected in single"		"glioma: 0.5"	"Region enriched"	"Detected in many"	4	"cerebellum: 41.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"HEL: 12.2;SCLC-21H: 9.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043764	Uncertain					NA	NA				"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 36: HEL - Hemostasis"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA043764: AB_10960281"	"unprognostic (1.35e-1)"		"unprognostic (3.28e-2)"		"unprognostic (4.68e-2)"				"unprognostic (3.60e-1)"		"unprognostic (2.38e-1)"	"unprognostic (7.04e-2)"	"unprognostic (1.43e-2)"	"unprognostic (5.72e-3)"	"unprognostic (9.60e-2)"		"unprognostic (8.71e-2)"	0.0	0.9	5.8	0.0	5.7	0.0	0.0	41.1	9.2	0.2	0.0	0.3	0.0	1.0	0.0	0.0	0.0	0.0	0.0	5.8	8.5	0.0	0.0	0.0	0.0	5.3	0.3	0.0	0.0	0.0	1.9	0.0	5.2	3.0	0.1	8.2	0.0	0.1	0.2	0.0	0.0	0.8	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.3	0.0	0.1	0.2	1.9	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	5.7	41.1	9.2	5.8	8.5	5.3	0.3	5.2	0.0	0.2	1.9	0.4	0.0	0.0	22.2	0.0	0.0	17.9	0.0	0.0	5.6	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	5.9	0.0	0.0	0.3	0.0	0.0	137.8	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	171.5	0.0	0.0	0.0	0.0	0.7	0.3	0.2	0.0	2.8	0.0	60.8	0.0	27.2	4.0	0.0	0.0	0.4	0.0	4.6	0.0	0.0	0.0	4.8	0.0	0.2	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.6
TRDN	TRISK	ENSG00000186439	Triadin	Q13061	6	123216339-123637093	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 421.6;skeletal muscle: 1944.1;tongue: 1018.2"	"Group enriched"	"Detected in some"	11	"Cardiomyocytes: 1145.1;Muller glia cells: 765.7;Skeletal myocytes: 398.6"	"Group enriched"	"Detected in some"	5	"head and neck cancer: 2.2;prostate cancer: 0.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"MCF7: 1.9"	"Region enriched"	"Detected in some"	10	"olfactory bulb: 11.0"	"Region enriched"	"Detected in some"	23	"olfactory bulb: 28.9"	"HPA038226, HPA058226"	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Plasma membrane, Cytosol"		"HPA038226: AB_10795574, HPA058226: AB_2683643"	"unprognostic (1.05e-2)"			"unprognostic (1.99e-1)"	"unprognostic (9.20e-2)"	"unprognostic (3.06e-3)"		"unprognostic (2.40e-1)"	"unprognostic (2.38e-1)"	"unprognostic (2.42e-1)"	"unprognostic (8.42e-2)"	"unprognostic (8.71e-2)"	"unprognostic (9.93e-3)"	"unprognostic (2.12e-1)"	"unprognostic (2.55e-2)"		"unprognostic (3.97e-2)"	16.3	2.6	4.2	0.0	3.7	0.0	2.0	4.0	5.8	0.7	3.1	0.4	0.0	1.7	10.4	18.5	12.5	0.2	421.6	3.0	12.5	0.4	0.1	0.4	0.1	6.7	7.0	1.3	0.1	0.0	15.3	0.2	7.9	17.0	0.3	83.5	13.1	0.9	1944.1	0.6	0.2	1.0	9.2	0.1	0.1	5.1	10.2	0.3	0.3	1018.2	0.1	0.0	0.6	6.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	1.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	3.7	4.0	5.8	3.0	12.5	6.7	7.0	7.9	9.2	10.2	6.3	0.3	0.0	0.0	4.2	0.0	0.0	0.5	0.0	0.0	7.9	0.0	0.3	1145.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	68.0	0.0	0.0	6.0	0.0	0.0	1.1	0.0	0.0	38.4	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	1.6	0.0	0.0	0.0	0.4	35.5	13.1	0.5	1.8	0.0	0.0	765.7	0.0	3.0	3.2	0.0	0.0	11.3	0.0	0.0	0.0	0.2	0.0	21.8	0.0	398.6	7.1	1.3	0.9	0.0	0.0	0.0	0.3	0.0	0.0	0.0
NKAIN2	"FAM77B, TCBA1"	ENSG00000188580	"Sodium/potassium transporting ATPase interacting 2"	Q5VXU1	6	123803865-124825640	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	6	"brain: 56.8"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 1721.6;Inhibitory neurons: 636.4;Oligodendrocytes: 2869.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	19	"basophil: 1.8"	"Lineage enriched"	"Detected in single"	19	"granulocytes: 1.8"	"Cell line enhanced"	"Detected in some"		"BEWO: 2.1;Daudi: 3.0;HEL: 6.4;Karpas-707: 10.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045860			Approved	Cytosol		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 70: Brain - Nervous system development"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Cytosol		"HPA045860: AB_10983192"	"unprognostic (3.09e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.33e-2)"	"unprognostic (4.53e-3)"	"unprognostic (5.67e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.32e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.19e-1)"	"unprognostic (5.41e-3)"	"unprognostic (2.02e-3)"	"unprognostic (2.61e-1)"	"unprognostic (5.95e-3)"	"unprognostic (3.63e-3)"	"unprognostic (1.77e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.63e-1)"	0.9	0.4	24.2	0.1	33.6	0.7	0.3	30.1	39.3	0.3	9.8	1.0	0.0	0.1	0.3	0.2	0.3	0.2	1.1	29.2	25.3	0.1	0.2	0.2	0.2	40.7	28.0	0.1	0.1	0.0	1.8	0.1	37.4	0.2	0.1	6.6	0.3	0.2	2.9	0.1	0.3	0.3	34.8	0.1	0.2	0.4	28.8	0.5	0.1	3.4	0.2	0.5	0.3	56.8	0.0	0.0	1.6	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	6.4	0.0	0.0	0.4	0.0	0.0	1.2	0.1	0.0	0.3	0.1	0.0	0.0	0.0	10.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.2	33.6	30.1	39.3	29.2	25.3	40.7	28.0	37.4	34.8	28.8	56.8	0.5	0.0	0.0	97.3	0.0	0.1	0.0	0.2	0.0	3.0	0.0	0.1	1.3	0.0	0.1	0.0	2.1	0.2	0.0	0.0	0.0	0.1	1.7	0.2	0.1	0.3	1.8	2.1	1721.6	0.0	0.0	0.1	0.0	0.1	0.0	0.5	0.0	0.0	0.1	47.1	636.4	0.1	0.0	0.0	0.0	0.0	0.3	1.0	0.0	47.8	0.0	15.8	0.0	19.1	2869.5	0.0	0.0	0.7	0.0	0.2	0.0	0.0	0.2	1.1	0.0	0.8	0.1	0.1	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.1
RNF217	"C6orf172, dJ84N20.1, IBRDC1, MGC26996"	ENSG00000146373	"Ring finger protein 217"	Q8TC41	6	124962545-125092633	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 42.7"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 127.8;Oligodendrocytes: 102.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029598	Uncertain					NA	NA				"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 23: Spermatids - Flagellum & Golgi organization"			"HPA029598: AB_10602297"	"unprognostic (2.96e-2)"	"unprognostic (2.34e-3)"	"unprognostic (8.07e-2)"	"unprognostic (8.62e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.06e-1)"	"unprognostic (7.22e-3)"	"unprognostic (4.94e-2)"	"unprognostic (6.69e-2)"	"unprognostic (2.47e-1)"	"unprognostic (2.61e-1)"	"prognostic unfavorable (4.60e-5)"	"unprognostic (8.29e-4)"	"unprognostic (2.16e-1)"	"unprognostic (7.52e-2)"	"prognostic unfavorable (1.92e-4)"	8.0	3.0	3.4	2.0	2.5	11.0	6.0	3.0	2.3	6.3	4.9	7.2	1.3	4.4	2.0	5.0	7.4	4.2	5.1	3.0	2.7	1.9	5.7	6.3	0.7	3.0	1.8	8.6	2.8	42.7	2.9	3.9	2.4	3.5	1.3	3.6	4.7	3.6	7.6	9.1	2.5	4.1	1.1	1.8	3.5	6.9	2.6	1.5	5.8	5.9	0.4	5.3	5.7	5.4	4.9	5.0	1.7	0.6	6.1	2.4	9.7	6.6	8.9	4.4	5.8	0.0	4.6	0.0	9.0	6.3	10.1	7.0	1.0	5.9	6.2	0.0	5.5	2.7	7.6	1.5	5.7	0.0	0.2	6.5	5.4	3.3	9.7	5.2	5.0	0.0	14.0	0.0	7.8	0.0	0.0	0.0	1.5	0.0	1.3	0.1	6.8	0.0	4.5	2.2	0.8	0.0	2.9	0.7	2.5	4.8	4.8	0.8	8.1	3.6	11.5	0.0	14.3	0.0	0.0	0.0	2.7	0.0	4.4	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	2.5	3.0	2.3	3.0	2.7	3.0	1.8	2.4	1.1	2.6	5.4	25.0	22.4	21.0	49.0	0.6	48.2	15.8	17.5	18.2	6.3	10.0	10.7	14.4	4.3	12.1	5.5	16.7	24.2	0.9	1.3	0.0	8.1	127.8	11.4	21.5	19.0	3.0	6.5	56.3	9.6	29.7	23.1	4.6	22.8	1.3	9.0	15.7	26.9	9.8	21.9	65.0	2.4	12.2	14.6	20.9	62.1	25.7	11.3	19.6	51.5	9.8	4.2	1.0	37.7	102.1	11.8	2.0	21.1	0.4	21.6	6.9	2.3	9.6	5.7	6.6	44.9	12.3	1.7	2.9	17.5	47.0	17.9	1.8	5.3	4.3	16.3
TPD52L1	"D53, hD53, TPD53"	ENSG00000111907	"TPD52 like 1"	Q16890	6	125119049-125264407	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 258.3;salivary gland: 298.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 390.1;Squamous epithelial cells: 272.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 269.1;hTCEpi: 234.3;MCF7: 365.5;RPTEC TERT1: 271.4;SK-BR-3: 189.4;T-47d: 162.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027915, HPA027916"	Enhanced		Approved	"Plasma membrane,Cell Junctions,Cytosol"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 44: Endometrium - Transcription"	"Plasma membrane, Cell Junctions, Cytosol"		"HPA027915: AB_10602074, HPA027916: AB_10601860"	"unprognostic (1.44e-1)"	"unprognostic (2.01e-2)"	"unprognostic (2.76e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.87e-2)"	"unprognostic (1.38e-2)"	"unprognostic (2.14e-1)"	"unprognostic (7.85e-2)"	"unprognostic (7.80e-2)"	"unprognostic (9.42e-3)"	"unprognostic (1.76e-1)"	"prognostic favorable (3.26e-4)"	"unprognostic (1.06e-1)"	"unprognostic (6.83e-2)"	"prognostic favorable (3.97e-4)"	"prognostic unfavorable (5.34e-4)"	44.7	258.3	83.9	10.1	96.2	0.8	67.0	72.6	97.4	35.8	103.4	36.2	9.7	15.2	68.8	152.4	34.6	27.3	71.4	78.4	81.3	40.6	58.4	10.9	6.6	81.4	76.8	20.7	47.1	67.3	24.8	8.9	78.8	41.0	13.0	1.9	298.3	79.1	111.9	47.9	10.6	12.3	68.5	2.0	43.1	5.1	81.5	3.4	60.7	126.2	12.3	59.6	60.8	76.6	37.7	42.0	0.5	269.1	2.4	0.6	63.3	6.2	5.9	0.0	0.7	67.3	46.9	0.1	136.2	31.2	9.1	83.8	8.4	58.2	0.2	0.8	58.0	0.8	58.0	0.5	5.7	0.2	0.1	7.4	234.3	0.1	30.7	82.5	0.0	0.0	30.5	0.6	4.7	365.5	0.0	0.7	4.4	36.8	22.7	0.4	0.1	0.0	271.4	9.8	9.1	0.2	70.5	189.4	4.6	9.6	162.3	0.8	0.2	1.8	5.9	0.5	2.0	0.1	0.1	0.2	1.0	0.3	0.7	1.8	0.5	0.3	0.3	0.2	0.3	0.3	0.6	0.2	0.2	0.4	0.7	0.5	2.7	2.6	0.1	0.4	0.2	0.4	83.9	96.2	72.6	97.4	78.4	81.3	81.4	76.8	78.8	68.5	81.5	76.6	141.6	0.0	28.3	390.1	2.2	19.6	44.6	70.2	128.1	3.8	164.4	154.9	45.8	25.8	51.7	125.0	4.2	32.7	3.2	3.9	176.1	30.7	6.9	71.7	21.1	87.2	16.2	0.0	16.4	110.8	140.2	18.8	13.7	184.5	2.5	29.5	15.4	59.9	10.9	0.0	48.2	11.3	83.4	2.1	5.2	4.9	17.4	3.4	131.6	28.1	0.6	3.9	1.0	11.6	2.9	35.3	2.3	36.5	2.6	37.1	10.9	45.4	15.7	1.3	0.0	177.1	10.1	5.7	9.2	272.2	37.2	14.4	3.5	53.8	17.8	19.2
HDDC2	"C6orf74, CGI-130, dJ167O5.2"	ENSG00000111906	"HD domain containing 2"	Q7Z4H3	6	125219962-125302078	"Enzymes, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 338.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035677	Approved		Approved	Nucleoplasm,Nucleoli		NA	NA		44000	"Cluster 37: B-cells - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoli	Nucleoplasm	"HPA035677: AB_10603768"	"unprognostic (8.34e-2)"	"unprognostic (5.41e-2)"	"unprognostic (6.52e-2)"	"unprognostic (6.25e-2)"	"unprognostic (2.78e-2)"	"unprognostic (6.39e-3)"	"unprognostic (1.04e-3)"	"unprognostic (1.76e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.38e-2)"	"unprognostic (8.59e-3)"	"unprognostic (5.13e-2)"	"unprognostic (4.56e-2)"	"unprognostic (2.54e-1)"	"unprognostic (3.68e-2)"	"unprognostic (1.80e-2)"	"unprognostic (9.54e-2)"	47.4	84.4	58.0	20.1	65.9	19.7	42.1	59.5	98.5	47.2	78.4	38.8	20.3	36.2	29.6	49.7	37.0	15.1	82.3	60.8	64.5	75.6	22.9	31.9	27.1	65.1	66.8	41.1	44.5	49.4	50.0	15.7	63.0	38.5	22.1	31.5	45.8	23.8	118.1	39.0	30.6	13.6	60.8	27.6	43.7	58.7	61.6	22.2	40.3	60.7	24.8	39.2	39.5	60.7	29.7	81.2	46.2	191.3	23.0	30.8	59.7	36.4	41.4	30.9	33.1	122.7	30.4	119.9	80.8	57.4	89.0	26.5	53.1	41.1	36.5	46.7	166.8	55.2	43.6	125.1	65.0	76.6	45.3	56.0	61.8	49.6	104.6	44.6	20.2	67.8	205.1	51.4	59.5	162.7	61.2	73.8	57.7	79.9	58.8	92.8	37.2	25.2	68.7	34.1	84.0	44.5	43.9	84.8	88.8	35.4	50.2	126.6	18.2	37.7	44.5	58.8	75.8	72.1	48.2	110.1	56.0	122.6	80.4	13.8	33.4	6.7	53.3	30.6	43.8	71.2	57.7	72.6	36.1	59.4	71.3	78.2	7.3	62.1	29.0	38.3	55.7	44.0	58.0	65.9	59.5	98.5	60.8	64.5	65.1	66.8	63.0	60.8	61.6	60.7	23.0	25.6	41.2	22.5	39.3	44.6	64.3	114.9	70.6	62.6	73.5	114.4	119.9	37.1	55.3	62.5	14.6	86.6	56.0	35.0	338.5	86.0	61.3	50.9	60.7	24.2	64.5	33.4	17.1	98.0	156.4	67.5	33.6	37.5	38.0	84.8	9.3	21.3	112.2	69.0	17.9	76.4	77.3	54.2	20.4	42.1	91.0	34.6	80.0	15.0	31.7	90.5	155.5	19.1	10.6	58.5	45.3	114.7	47.4	101.9	72.3	254.8	38.9	25.0	39.5	83.9	72.6	124.5	74.6	88.6	43.0	45.7	47.6	145.8	84.1	57.9
HEY2	"bHLHb32, HERP1, HESR2"	ENSG00000135547	"Hes related family bHLH transcription factor with YRPW motif 2"	Q9UBP5	6	125747664-125761269	"Predicted intracellular proteins, Transcription factors, Transporters"	"Notch signaling pathway, Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 30.7"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 49.9;Endometrial ciliated cells: 46.1;Granulosa cells: 73.9;Late spermatids: 80.6;Sertoli cells: 52.6;Smooth muscle cells: 41.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 5.5;HEK 293: 7.1;SK-MEL-30: 6.6;TIME: 14.8;U-266/70: 17.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030205, HPA074851"	Approved		Approved	"Nuclear bodies,Aggresome"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 40: Granulosa cells - Unknown function"	"Nuclear bodies"	Aggresome	"HPA030205: AB_10600712, HPA074851: AB_2686718"	"unprognostic (5.10e-2)"	"unprognostic (4.34e-2)"	"unprognostic (1.41e-3)"	"unprognostic (2.43e-3)"	"unprognostic (1.99e-1)"	"unprognostic (2.52e-3)"	"unprognostic (2.56e-1)"	"unprognostic (1.38e-2)"	"unprognostic (2.01e-1)"	"unprognostic (9.10e-3)"	"unprognostic (7.34e-2)"	"unprognostic (6.20e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.28e-1)"	"unprognostic (6.74e-2)"	"unprognostic (1.51e-3)"	"unprognostic (1.19e-1)"	6.5	0.9	8.8	1.0	12.0	0.1	5.7	9.4	7.6	8.0	3.0	2.5	1.3	7.5	16.4	1.8	13.5	1.7	30.7	7.2	10.4	3.1	5.3	3.2	0.5	12.7	10.0	7.1	3.3	2.6	5.5	3.7	10.6	2.1	1.3	5.7	2.0	2.7	16.2	2.4	2.1	1.7	14.1	1.9	2.0	6.6	11.8	0.7	3.1	4.9	0.6	2.7	4.7	12.2	0.0	0.0	0.0	5.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	4.0	0.0	0.0	0.8	0.2	0.2	0.1	0.0	0.5	7.1	1.6	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.5	0.0	0.6	0.0	0.4	0.0	0.0	3.2	0.0	0.3	0.5	0.6	0.9	0.0	0.1	2.3	0.0	0.0	0.0	6.6	3.2	1.9	0.0	14.8	0.3	0.0	0.1	0.8	17.6	0.3	0.1	0.6	0.0	2.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	8.8	12.0	9.4	7.6	7.2	10.4	12.7	10.0	10.6	14.1	11.8	12.2	2.8	3.2	1.1	12.4	0.7	3.8	0.5	8.7	3.4	0.4	9.8	5.7	21.5	0.0	2.7	0.0	8.4	0.0	1.4	0.1	9.8	0.1	49.9	46.1	4.2	6.0	0.0	2.7	0.1	1.8	0.1	3.3	1.1	36.8	0.0	73.9	1.8	8.0	0.1	1.7	0.4	0.0	2.0	0.8	3.0	80.6	6.5	0.6	3.6	5.6	0.0	34.8	3.1	2.5	23.4	1.1	0.1	23.3	3.1	0.3	0.0	6.4	5.4	5.2	52.6	17.5	41.8	16.2	15.1	7.7	2.0	0.0	2.0	2.8	0.1	0.3
NCOA7	"dJ187J11.3, ERAP140, TLDC4"	ENSG00000111912	"Nuclear receptor coactivator 7"	Q8NI08	6	125781161-125932034	"Predicted intracellular proteins, Transporters"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 709.7;Squamous epithelial cells: 515.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030289, HPA030290, HPA030291, HPA030292"	Approved		Approved	"Nucleoplasm,Nuclear bodies,Golgi apparatus"		No	No			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 15: RT4 - Unknown function"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Nucleoplasm, Nuclear bodies"	"Golgi apparatus"	"HPA030289: AB_10670031, HPA030290: AB_10601971, HPA030291: AB_10669597, HPA030292: AB_10670834"	"unprognostic (1.01e-2)"	"unprognostic (3.21e-2)"	"unprognostic (7.32e-3)"	"unprognostic (7.27e-3)"	"unprognostic (1.54e-1)"	"unprognostic (4.67e-2)"	"unprognostic (1.26e-1)"	"unprognostic (6.27e-2)"	"unprognostic (2.73e-1)"	"unprognostic (2.14e-1)"	"unprognostic (6.08e-2)"	"unprognostic (4.37e-2)"	"prognostic favorable (1.78e-6)"	"unprognostic (2.10e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.14e-1)"	"unprognostic (8.10e-2)"	53.9	60.4	19.5	45.8	30.6	42.7	27.4	21.4	50.2	29.0	0.0	30.1	33.0	22.3	5.2	30.4	15.9	46.6	16.0	28.2	23.9	56.6	32.9	52.1	30.1	47.5	12.3	14.8	19.9	8.8	29.7	12.9	45.0	18.6	29.2	18.2	38.2	12.9	6.9	11.1	39.2	28.3	10.6	24.4	30.8	7.8	19.0	21.7	25.1	9.2	28.5	101.8	19.7	48.3	13.7	36.6	2.2	16.0	78.2	46.3	23.7	18.2	71.9	22.1	30.1	34.3	12.7	55.2	96.5	10.0	108.0	78.7	12.6	12.4	13.3	120.2	16.5	28.0	43.7	12.3	44.5	16.4	25.4	33.3	29.4	21.1	16.3	39.1	46.7	18.0	38.7	30.6	13.9	13.7	16.1	16.2	2.7	33.8	7.6	12.3	5.7	10.3	39.1	90.4	36.9	33.5	93.7	22.6	42.1	6.5	3.8	19.3	27.7	5.1	10.9	26.3	14.1	39.9	34.1	28.8	11.5	21.2	18.7	17.0	11.4	4.0	19.2	9.1	24.1	17.7	18.1	15.6	10.0	11.1	9.6	9.4	6.4	13.6	14.2	34.1	8.1	5.1	19.5	30.6	21.4	50.2	28.2	23.9	47.5	12.3	45.0	10.6	19.0	48.3	144.6	314.1	371.9	27.7	33.7	98.1	270.8	311.2	709.7	50.2	94.2	47.9	11.4	98.7	324.1	62.5	43.8	9.3	84.6	113.2	80.3	241.7	0.9	160.1	90.2	130.2	35.8	29.8	144.9	139.2	8.9	94.8	142.8	298.2	37.3	18.5	106.7	23.2	13.6	37.0	89.5	119.3	288.9	33.8	57.4	6.8	42.3	41.9	51.6	75.9	33.4	76.8	59.8	34.2	303.9	108.7	160.1	29.3	44.1	129.5	24.3	103.2	335.8	53.3	13.1	33.8	49.3	11.2	33.9	515.9	59.2	3.8	63.5	36.5	130.6	294.4
HINT3	"FLJ33126, HINT4"	ENSG00000111911	"Histidine triad nucleotide binding protein 3"	Q9NQE9	6	125956770-125980244	"Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 112.8"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 352.2;Spermatocytes: 110.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027914	Approved		Approved	Nucleoli,Mitochondria,Cytosol		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	"Nucleoli, Mitochondria"	Cytosol	"HPA027914: AB_10602424"	"prognostic unfavorable (4.99e-4)"	"unprognostic (4.75e-3)"	"unprognostic (3.75e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.74e-1)"	"unprognostic (4.88e-3)"	"unprognostic (3.82e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.18e-2)"	"unprognostic (1.05e-1)"	"prognostic favorable (1.05e-6)"	"unprognostic (4.09e-2)"	"unprognostic (4.76e-2)"	"unprognostic (9.56e-2)"	"unprognostic (1.64e-1)"	18.1	23.4	31.2	12.6	33.9	12.3	23.0	31.0	43.3	18.3	22.8	19.6	15.7	16.6	17.8	22.3	16.4	16.2	28.4	29.4	31.4	22.2	28.3	21.0	11.3	33.9	32.1	14.7	19.3	30.6	14.4	14.5	33.8	29.7	17.6	15.3	25.5	22.4	112.8	17.5	16.0	17.3	36.6	10.5	24.8	12.3	32.5	13.6	23.5	84.6	11.4	18.4	10.8	38.0	13.2	10.3	14.1	29.5	5.5	14.8	17.5	14.1	20.2	10.6	11.0	25.6	7.2	28.4	25.5	9.4	23.7	19.5	18.2	11.9	12.3	27.4	23.5	12.0	15.1	21.6	25.4	19.2	19.6	11.8	25.9	10.7	27.0	27.3	16.1	21.0	38.3	18.7	10.6	20.1	15.5	13.7	4.8	27.1	9.9	12.8	9.7	9.7	21.8	24.0	28.2	17.4	12.9	18.0	67.8	10.2	18.4	28.9	11.4	7.2	10.1	34.8	20.3	27.1	33.3	18.2	20.4	18.1	9.5	12.5	9.3	8.9	4.4	5.9	4.6	7.0	5.9	4.8	7.7	6.3	6.0	5.3	11.2	5.9	8.6	4.3	6.3	5.3	31.2	33.9	31.0	43.3	29.4	31.4	33.9	32.1	33.8	36.6	32.5	38.0	11.7	80.1	61.2	11.8	16.7	18.1	10.2	22.1	24.5	21.8	26.5	18.4	38.7	10.0	29.8	16.5	8.4	19.2	13.4	17.2	33.2	29.3	352.2	23.6	11.5	12.3	16.3	6.9	27.0	20.2	6.4	13.7	19.4	25.8	9.5	15.2	10.4	17.5	27.2	6.7	29.8	25.1	20.3	15.3	14.6	78.3	9.9	19.3	21.4	5.6	17.3	43.4	11.3	21.6	40.0	21.4	28.7	17.3	8.1	20.9	15.3	28.0	25.7	25.4	6.6	18.3	15.1	110.7	40.2	21.5	17.3	26.4	11.3	14.6	18.5	19.9
TRMT11	"C6orf75, dJ187J11.2, MDS024, TRM11, TRMT11-1"	ENSG00000066651	"TRNA methyltransferase 11 homolog"	Q7Z4G4	6	125986479-126203817	"Metabolic proteins, Predicted intracellular proteins"	"tRNA processing"	"Methyltransferase, RNA-binding, Transferase, tRNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030473			Approved	"Nuclear bodies"		Yes	No			"Cluster 30: Non-specific - Translation"	"Cluster 85: Liver - Metabolism"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Nuclear bodies"		"HPA030473: AB_2673493"	"unprognostic (2.55e-1)"	"unprognostic (6.12e-3)"	"unprognostic (1.44e-1)"	"unprognostic (1.13e-2)"	"unprognostic (7.62e-2)"	"unprognostic (9.69e-2)"	"unprognostic (2.12e-1)"	"unprognostic (7.38e-2)"	"unprognostic (3.54e-2)"	"unprognostic (5.73e-2)"	"unprognostic (7.35e-2)"	"unprognostic (1.06e-2)"	"unprognostic (4.74e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.69e-1)"	"unprognostic (2.06e-1)"	8.4	10.2	7.3	8.1	7.5	2.9	11.7	12.9	9.9	9.5	6.6	8.8	12.8	13.5	9.9	8.0	9.7	9.0	10.9	7.3	7.8	13.3	19.8	7.9	10.5	6.7	7.4	12.5	6.4	12.6	13.3	9.4	7.2	9.1	9.4	16.9	8.8	8.5	7.6	6.6	10.7	10.7	5.8	6.8	8.8	7.7	7.2	8.7	12.9	8.8	10.4	9.6	8.9	9.0	17.4	11.0	24.2	11.4	12.9	13.7	16.6	13.1	21.7	15.6	24.3	30.8	19.8	26.0	24.2	8.3	29.1	20.7	26.1	14.3	26.4	19.5	37.6	17.8	20.1	46.2	21.9	29.0	5.4	14.3	15.5	15.9	25.6	22.4	7.6	9.1	44.5	5.3	17.7	22.0	15.3	34.6	20.4	15.4	15.1	9.1	16.3	17.6	22.3	9.8	32.4	16.9	13.9	18.0	36.3	18.0	13.1	28.3	5.4	9.7	10.7	27.3	25.8	13.9	1.3	6.6	23.2	24.5	17.7	1.0	1.6	0.0	5.6	1.3	11.0	7.0	7.9	6.5	3.5	6.0	9.5	8.6	0.5	7.7	0.7	4.3	6.0	3.2	7.3	7.5	12.9	9.9	7.3	7.8	6.7	7.4	7.2	5.8	7.2	9.0	11.0	6.4	22.0	24.8	17.4	13.4	27.8	29.4	23.3	59.5	11.2	13.7	12.2	21.5	26.1	7.3	73.0	18.7	14.9	8.5	19.6	19.2	10.1	13.1	25.5	10.4	9.1	8.4	56.1	16.3	13.7	27.3	27.0	12.3	18.4	20.0	6.8	22.5	7.2	20.2	63.8	11.1	18.3	6.0	3.7	4.7	25.7	7.1	3.6	23.4	11.8	21.1	9.2	31.7	48.5	13.2	15.5	24.5	12.3	22.6	22.6	30.2	24.3	74.7	6.6	21.0	17.2	15.6	9.2	14.3	10.1	14.9	14.7	27.2	13.7	17.9
CENPW	"C6orf173, CUG2"	ENSG00000203760	"Centromere protein W"	Q5EE01	6	126340115-126348875	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 50.6;testis: 39.5"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 329.7;Extravillous trophoblasts: 155.9;Spermatocytes: 148.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			HPA067285			Supported	Nucleoplasm		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"HPA067285: AB_2685818"	"unprognostic (3.51e-3)"	"unprognostic (2.35e-1)"	"unprognostic (3.26e-3)"	"unprognostic (9.61e-3)"	"unprognostic (3.78e-1)"	"unprognostic (9.80e-3)"	"prognostic unfavorable (1.21e-5)"	"unprognostic (1.11e-2)"	"unprognostic (2.82e-2)"	"unprognostic (9.07e-2)"	"unprognostic (5.86e-3)"	"unprognostic (1.08e-1)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (1.07e-1)"	"unprognostic (1.85e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.22e-1)"	8.2	4.3	2.5	12.8	2.3	50.6	6.6	2.0	3.5	14.4	1.4	15.0	8.3	21.6	7.0	23.1	9.2	5.4	1.7	4.2	2.0	3.4	3.6	4.9	15.5	1.9	2.0	4.1	2.1	2.8	2.5	7.8	1.7	6.3	17.5	1.6	8.5	4.4	3.0	8.3	10.8	16.1	1.9	6.8	6.3	39.5	2.0	27.4	2.5	1.9	20.5	6.6	10.9	2.4	73.4	49.0	94.7	82.9	10.3	10.4	81.2	60.0	43.6	81.3	98.3	148.0	50.1	86.8	48.8	38.3	128.7	88.0	78.0	94.3	114.6	94.0	140.2	84.7	141.4	166.3	3.4	123.8	59.1	6.4	10.0	69.1	51.2	23.1	88.3	116.8	144.1	56.5	69.6	119.3	103.1	204.4	60.5	64.0	74.3	107.7	63.2	62.6	38.0	33.0	99.1	44.0	50.8	46.5	67.4	76.9	43.7	119.5	48.0	76.6	78.3	104.6	163.7	36.9	72.7	156.8	45.9	147.0	92.8	3.2	16.9	2.3	2.0	20.3	0.6	6.0	4.4	4.3	15.9	3.5	3.4	2.7	2.9	6.9	14.1	18.9	12.0	5.9	2.5	2.3	2.0	3.5	4.2	2.0	1.9	2.0	1.7	1.9	2.0	2.4	2.5	0.0	2.6	1.0	18.6	38.0	13.4	54.3	6.2	1.3	10.3	18.7	0.3	11.5	29.4	1.8	2.1	52.2	6.1	23.5	5.9	16.6	329.7	18.0	26.5	11.0	7.8	75.1	23.7	17.9	155.9	25.1	17.3	12.7	13.4	31.4	10.8	6.0	63.6	3.3	22.0	27.1	42.7	15.6	40.1	39.3	19.3	19.3	8.8	1.0	12.6	3.1	3.1	1.0	2.4	17.2	10.6	9.1	38.6	24.7	18.1	1.6	7.0	1.4	0.0	6.4	18.1	148.3	83.8	60.9	29.0	21.2	8.6	11.4	51.7	35.8
RSPO3	"FLJ14440, THSD2"	ENSG00000146374	"R-spondin 3"	Q9BXY4	6	127118671-127199481	"Cancer-related genes, Predicted secreted proteins"	"Sensory transduction, Wnt signaling pathway"	Heparin-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 51.4"	"Cell type enhanced"	"Detected in some"		"Endometrial stromal cells: 18.5;Endothelial cells: 42.4;Fibroblasts: 73.0;Hepatic stellate cells: 26.4;Inhibitory neurons: 17.8;Leydig cells: 27.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 21.9;BJ hTERT+: 3.6;hTERT-RPE1: 6.3;U-138 MG: 4.6;U-87 MG: 4.6"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"hippocampal formation: 21.2"	HPA029957	Uncertain				"Secreted to blood"	NA	NA				"Cluster 46: Fibroblasts - ECM organization"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 33: Fibroblasts - ECM organization"			"HPA029957: AB_10602087"	"unprognostic (4.77e-2)"	"unprognostic (3.95e-2)"	"unprognostic (1.27e-2)"	"unprognostic (2.27e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.99e-1)"	"unprognostic (9.71e-2)"	"unprognostic (1.49e-2)"	"unprognostic (3.77e-2)"	"unprognostic (3.21e-1)"	"unprognostic (1.37e-1)"	"unprognostic (3.37e-1)"	"unprognostic (1.07e-3)"	"unprognostic (7.94e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.64e-2)"	"unprognostic (7.89e-3)"	30.9	15.1	2.1	16.1	2.4	0.0	12.4	3.3	4.9	13.8	0.0	7.4	2.2	51.4	28.4	5.4	25.3	11.1	0.9	8.5	1.5	4.0	6.5	5.1	3.7	1.6	1.4	3.6	1.6	0.1	3.1	35.4	0.3	6.3	6.6	0.1	5.4	20.0	39.8	2.8	10.3	48.1	0.0	1.8	13.3	1.0	1.0	2.4	3.6	5.0	1.4	8.6	7.1	0.9	0.0	21.9	0.0	0.0	1.0	0.0	0.0	0.0	3.6	0.3	0.4	0.0	0.0	0.0	0.4	0.0	0.5	0.0	0.6	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	6.3	2.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.0	0.0	0.0	0.2	0.0	0.0	0.0	4.6	1.8	0.6	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	2.4	3.3	4.9	8.5	1.5	1.6	1.4	0.3	0.0	1.0	0.9	3.6	0.0	0.0	0.7	0.1	0.9	0.1	0.0	0.6	1.5	0.2	0.9	0.5	0.0	0.0	0.0	0.0	0.9	0.2	0.0	0.0	0.4	12.3	0.3	18.5	42.4	0.0	0.0	5.9	0.0	1.1	73.0	5.1	0.3	0.0	0.0	26.4	0.4	1.6	0.0	17.8	0.0	0.0	1.0	0.8	2.2	27.4	0.4	1.8	1.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.3	0.9	0.0	0.0	0.0	0.2	6.6	2.1	3.5	0.1	0.4	0.4	0.1	1.6	0.1	0.1	0.0	0.2
RNF146	"dactylidin, dJ351K20.1, DKFZp434O1427"	ENSG00000118518	"Ring finger protein 146"	Q9NTX7	6	127266682-127288567	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Ubl conjugation pathway, Wnt signaling pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027158, HPA027209"	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		No	No			"Cluster 14: Monocytes - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane, Cytosol"	Nucleoplasm	"HPA027158: AB_10600772, HPA027209: AB_10602312"	"unprognostic (8.22e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.37e-1)"	"unprognostic (5.47e-3)"	"unprognostic (1.87e-1)"	"unprognostic (6.74e-2)"	"prognostic favorable (5.26e-5)"	"unprognostic (2.65e-2)"	"prognostic favorable (7.32e-4)"	"unprognostic (4.04e-2)"	"unprognostic (1.29e-1)"	"unprognostic (6.13e-2)"	"unprognostic (2.15e-2)"	52.9	37.0	49.5	32.4	56.0	10.6	42.7	79.4	61.2	48.1	36.2	40.5	21.9	57.4	60.8	25.3	42.4	38.6	46.9	50.7	51.6	37.1	31.8	38.7	35.1	53.2	52.1	49.5	23.3	40.0	33.3	51.8	56.8	31.7	30.9	48.1	31.2	34.5	114.9	29.5	31.1	45.9	55.2	47.1	29.9	31.3	52.5	24.3	47.1	91.5	33.3	36.9	34.3	61.5	13.2	16.2	60.3	53.6	54.7	54.3	22.2	43.5	69.0	22.8	32.4	21.3	19.3	23.6	30.3	35.7	36.2	16.4	18.1	20.4	32.9	27.6	16.0	30.3	21.8	30.0	54.0	18.0	20.6	47.6	42.1	26.1	51.1	52.5	40.6	23.2	33.0	22.5	50.7	25.2	17.9	32.0	22.1	8.1	17.1	22.6	15.7	12.1	32.4	14.3	36.0	36.6	17.1	23.6	27.7	35.5	16.1	60.8	48.3	39.7	13.1	41.8	31.7	32.3	22.0	15.6	30.5	31.0	38.5	27.5	30.0	26.6	14.3	32.4	14.7	17.4	12.2	16.3	22.8	17.9	11.0	15.5	37.0	19.8	40.1	11.7	15.0	16.1	49.5	56.0	79.4	61.2	50.7	51.6	53.2	52.1	56.8	55.2	52.5	61.5	24.6	35.3	29.3	35.6	23.7	17.7	14.3	15.1	18.8	34.7	16.9	14.7	38.9	31.5	16.7	9.2	4.2	29.0	14.7	13.5	41.1	28.0	52.5	15.7	29.5	30.5	20.4	12.8	53.5	15.8	27.2	50.6	7.1	11.5	22.2	28.1	31.4	30.5	26.3	30.3	54.5	12.1	38.7	68.4	24.6	45.4	69.6	29.9	46.2	42.2	31.1	41.1	28.8	56.3	76.5	18.0	17.0	66.5	9.3	26.3	15.7	51.7	23.9	20.9	32.9	36.2	31.9	41.7	24.9	15.0	20.0	38.4	20.8	36.0	10.9	25.9
ECHDC1	dJ351K20.2	ENSG00000093144	"Ethylmalonyl-CoA decarboxylase 1"	Q9NTX5	6	127288712-127343609	"Enzymes, Plasma proteins, Predicted intracellular proteins"		Lyase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal tubular cells: 230.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035445, HPA035446"	Uncertain		Approved	Vesicles		NA	NA		56000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Vesicles		"HPA035445: AB_10669860, HPA035446: AB_2732468"	"unprognostic (9.57e-2)"	"unprognostic (1.63e-2)"	"unprognostic (2.46e-3)"	"unprognostic (1.34e-1)"	"unprognostic (4.09e-1)"	"unprognostic (3.68e-2)"	"unprognostic (5.03e-3)"	"unprognostic (4.89e-3)"	"unprognostic (4.97e-2)"	"unprognostic (1.76e-1)"	"unprognostic (3.99e-1)"	"unprognostic (9.97e-2)"	"unprognostic (8.21e-3)"	"unprognostic (6.83e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.40e-2)"	92.9	29.4	21.8	36.8	24.5	16.2	37.3	26.4	28.6	36.4	32.3	58.4	46.8	21.4	23.0	33.5	23.2	27.5	42.6	22.0	27.0	92.5	93.8	56.8	41.3	28.1	24.7	21.1	27.9	26.2	14.1	36.2	28.5	33.8	53.8	30.0	46.3	28.4	39.3	22.7	40.7	33.4	24.4	28.4	37.0	18.2	24.7	41.1	38.7	52.2	42.6	43.4	23.4	32.3	58.3	45.6	64.0	59.3	92.9	87.7	54.1	92.7	112.1	78.0	99.0	79.7	43.1	87.6	77.8	88.6	88.4	46.9	0.1	69.6	98.3	52.4	43.3	116.9	58.4	128.3	82.6	158.0	63.4	99.6	81.9	73.1	61.6	70.6	71.8	63.2	147.6	51.6	105.7	55.1	105.7	73.5	52.9	29.0	55.8	49.0	78.7	72.3	142.8	70.8	73.3	71.2	52.1	1.8	131.3	48.3	1.8	182.6	75.2	47.8	76.9	121.8	104.8	65.7	141.0	116.3	87.2	136.4	114.7	19.0	71.6	24.0	23.4	57.5	24.7	28.6	19.8	22.9	66.6	29.2	23.7	24.2	28.6	15.3	43.1	50.5	22.1	43.9	21.8	24.5	26.4	28.6	22.0	27.0	28.1	24.7	28.5	24.4	24.7	32.3	37.0	96.1	114.0	32.3	59.7	26.1	42.3	94.2	35.3	26.4	30.8	28.3	60.8	32.9	102.4	31.3	31.3	106.8	49.3	35.6	127.2	76.1	64.7	47.0	48.3	32.6	13.8	22.9	47.4	79.5	85.6	45.8	38.2	40.2	43.7	32.9	26.0	68.8	85.8	28.6	41.0	35.7	59.0	48.4	38.7	24.4	32.9	55.9	35.6	40.3	55.3	33.5	47.4	55.3	95.0	54.4	41.1	31.2	48.3	31.1	74.4	230.3	47.0	42.3	26.3	55.7	33.0	27.6	28.6	34.7	22.9	65.5	46.3	88.2	56.9	52.7
KIAA0408		ENSG00000189367	KIAA0408	Q6ZU52	6	127438406-127459389	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 32.6;skeletal muscle: 28.3"	"Group enriched"	"Detected in some"	6	"Alveolar cells type 1: 93.0;Alveolar cells type 2: 27.1;Skeletal myocytes: 34.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 10.4;SCLC-21H: 33.3;SH-SY5Y: 17.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044035, HPA053341"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 80: Striated muscle - Unknown function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 11: Alveolar cells - Smell perception"	Nucleoplasm	Cytosol	"HPA044035: AB_10964274, HPA053341: AB_2732578"	"unprognostic (1.06e-1)"				"unprognostic (4.36e-2)"	"unprognostic (3.06e-1)"		"unprognostic (1.09e-1)"			"unprognostic (8.56e-4)"	"unprognostic (1.00e-1)"	"unprognostic (4.95e-2)"	"unprognostic (6.05e-3)"	"unprognostic (2.29e-1)"	"unprognostic (5.94e-2)"	"unprognostic (3.20e-2)"	16.8	2.3	16.9	0.9	18.4	0.0	3.7	20.1	32.6	4.3	8.0	9.7	0.9	2.9	1.8	6.2	2.0	1.6	2.1	18.2	17.4	1.2	0.7	13.2	0.3	16.7	16.9	2.5	0.8	0.0	13.9	0.3	17.2	4.3	3.6	8.7	1.8	1.1	28.3	1.0	4.3	1.8	18.0	2.0	5.4	4.0	17.7	0.3	0.9	10.4	0.2	6.0	3.6	19.6	0.0	2.1	10.4	0.0	0.8	1.7	0.0	0.2	1.3	1.1	2.7	0.0	0.0	0.0	0.0	0.2	7.0	0.0	1.0	0.0	1.6	0.8	0.2	0.0	0.0	0.0	0.1	0.0	0.0	4.0	0.0	4.3	0.0	0.9	0.0	1.2	0.0	0.0	1.2	0.0	4.7	0.0	4.8	0.0	0.0	0.0	2.6	0.0	0.2	0.0	33.3	17.8	0.0	0.0	0.2	0.0	0.0	1.1	0.0	5.3	0.8	0.0	1.9	0.0	0.0	0.0	4.7	0.3	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.9	18.4	20.1	32.6	18.2	17.4	16.7	16.9	17.2	18.0	17.7	19.6	0.4	93.0	27.1	0.0	0.0	0.0	0.1	0.0	0.0	3.3	0.0	0.4	0.2	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	8.2	0.0	0.0	0.0	0.1	0.7	0.0	0.3	8.4	0.0	0.0	0.0	0.3	0.3	0.6	0.9	0.1	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.2	0.0	0.1	3.6	1.1	0.0	34.3	0.5	1.0	0.1	0.0	0.0	0.1	0.1	3.4	0.0	0.0
SOGA3	"C6orf174, dJ403A15.3"	ENSG00000214338	"SOGA family member 3"	Q5TF21	6	127472794-127519191	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 6.6"	"Group enriched"	"Detected in some"	9	"Excitatory neurons: 78.1;Inhibitory neurons: 57.4;Oligodendrocyte precursor cells: 44.2;Oligodendrocytes: 32.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 9.3;SCLC-21H: 28.9;SH-SY5Y: 16.9"									"HPA035388, HPA035389"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoplasm, Cytosol"		"HPA035388: AB_2674601, HPA035389: AB_10669857"	"unprognostic (1.70e-1)"	"unprognostic (3.56e-2)"	"unprognostic (1.57e-1)"		"unprognostic (2.53e-2)"	"unprognostic (1.19e-1)"		"unprognostic (8.58e-3)"	"unprognostic (8.45e-2)"	"unprognostic (7.31e-4)"	"unprognostic (5.65e-3)"	"unprognostic (1.58e-1)"	"unprognostic (3.33e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.30e-2)"	"unprognostic (1.72e-1)"	"unprognostic (8.26e-3)"	0.3	0.9	2.3	0.6	2.5	0.0	0.1	2.4	6.6	0.4	0.0	0.3	0.1	0.7	0.0	0.8	0.3	0.7	0.2	2.6	1.7	0.2	0.1	1.0	0.2	3.8	1.2	1.2	0.6	0.0	2.0	0.4	1.9	0.4	0.2	1.2	0.4	0.1	0.1	0.3	0.6	0.1	0.7	0.4	1.3	0.7	3.8	0.0	0.6	0.1	0.0	0.4	0.3	4.4	0.3	4.2	9.3	1.5	0.0	0.8	0.4	0.9	1.1	1.2	2.9	0.3	0.4	0.6	0.3	0.2	7.3	0.0	1.0	0.0	0.7	1.1	0.1	0.8	0.0	0.1	0.0	0.4	0.2	1.5	0.0	4.4	0.0	1.0	0.0	1.5	0.4	0.2	0.7	0.7	6.5	0.0	4.3	0.0	1.0	0.6	2.2	0.0	0.2	0.0	28.9	16.9	0.0	0.0	0.2	1.1	0.0	0.4	0.2	6.8	1.5	0.5	2.2	0.3	0.1	0.1	5.4	1.5	7.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	2.3	2.5	2.4	6.6	2.6	1.7	3.8	1.2	1.9	0.7	3.8	4.4	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	78.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	57.4	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.0	0.0	0.0	0.0	44.2	32.9	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	1.9	0.0	0.2	0.1	0.6	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0
C6orf58	LEG1	ENSG00000184530	"Chromosome 6 open reading frame 58"	Q6P5S2	6	127519455-127591820	"Predicted secreted proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"intestine: 612.7;salivary gland: 2257.3"	"Group enriched"	"Detected in some"	12	"Early spermatids: 14.3;Gastric mucus-secreting cells: 41.3"	"Group enriched"	"Detected in some"	6	"pancreatic cancer: 17.1;stomach cancer: 14.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"GAMG: 2.0;RPMI-8226: 2.8;WM-115: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA036263, HPA041449"	Enhanced				"Secreted to digestive system"	NA	NA		30000		"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 23: Spermatids - Flagellum & Golgi organization"			"HPA036263: AB_10673349, HPA041449: AB_2677486"	"unprognostic (1.49e-1)"	"unprognostic (8.55e-2)"	"unprognostic (2.71e-1)"	"unprognostic (5.69e-2)"	"unprognostic (3.86e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.02e-1)"	"unprognostic (3.26e-2)"	"unprognostic (7.72e-3)"	"unprognostic (1.69e-1)"	"unprognostic (6.62e-4)"	"unprognostic (2.10e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.53e-2)"	"unprognostic (8.99e-3)"	0.1	0.6	0.0	0.0	0.4	0.0	0.3	0.0	0.3	0.1	0.1	0.1	612.7	0.0	0.0	16.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.1	0.0	0.0	0.0	0.1	1.0	0.0	0.3	0.1	0.0	0.0	0.0	0.1	2257.3	0.0	0.2	0.0	0.2	0.1	0.0	0.3	268.0	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.3	0.1	0.1	0.2	2.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.1	0.3	0.1	0.0	0.0	0.1	0.0	2.8	0.2	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.3	0.2	0.0	0.1	0.0	0.0	0.8	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	14.3	0.1	0.1	0.0	0.0	0.0	0.3	0.5	0.0	0.2	41.3	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.3	2.3	0.6	0.0	0.0	0.0	0.0	0.1	0.0	1.5	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.0	0.1	0.1	0.8	0.7	0.0	0.1	0.3	0.0	0.2	0.0	0.3
THEMIS	"bA325O24.3, bA325O24.4, C6orf190, C6orf207, FLJ40584, TSEPA"	ENSG00000172673	"Thymocyte selection associated"	Q8N1K5	6	127708072-127918631	"Predicted intracellular proteins"	"Adaptive immunity, Immunity"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"lymphoid tissue: 32.9"	"Group enriched"	"Detected in some"	4	"Excitatory neurons: 47.1;Microglial cells: 15.0;T-cells: 59.9"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	22	"gdT-cell: 26.7;MAIT T-cell: 34.0;memory CD4 T-cell: 33.5;memory CD8 T-cell: 48.9;naive CD4 T-cell: 30.0;naive CD8 T-cell: 58.3"	"Lineage enriched"	"Detected in single"	88	"T-cells: 58.3"	"Group enriched"	"Detected in some"	4	"HDLM-2: 32.6;JURKAT: 54.1;MOLT-4: 51.6;RPMI-8226: 21.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA031422, HPA031425"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 58: T-cells - T-cell receptor"	Cytosol	Nucleoplasm	"HPA031422: AB_2673874, HPA031425: AB_10670129"	"unprognostic (1.47e-4)"	"unprognostic (2.50e-3)"	"unprognostic (1.31e-2)"	"unprognostic (1.41e-4)"	"unprognostic (1.41e-1)"	"unprognostic (5.20e-3)"	"unprognostic (7.48e-3)"	"unprognostic (9.01e-3)"	"unprognostic (1.47e-1)"	"unprognostic (7.41e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.65e-4)"	"unprognostic (2.04e-1)"	"unprognostic (3.91e-2)"	"unprognostic (4.98e-2)"	"unprognostic (1.60e-2)"	0.4	0.5	0.5	3.3	3.2	1.7	0.6	0.1	2.3	0.4	0.3	0.7	1.6	0.2	0.4	0.6	0.2	1.4	0.1	0.9	0.1	0.2	0.7	1.4	7.5	0.6	0.3	0.1	0.3	0.0	0.0	0.1	0.4	0.4	0.9	0.0	0.9	0.1	0.1	0.2	2.3	0.3	0.3	3.2	1.5	0.1	0.3	32.9	0.4	0.1	4.0	1.1	0.3	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	54.1	0.0	0.0	0.0	0.0	51.6	0.0	0.0	0.0	0.0	0.0	0.0	21.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.1	26.7	0.1	34.0	0.1	33.5	48.9	0.2	0.2	30.0	58.3	0.6	0.1	0.2	0.2	1.7	20.3	0.5	3.2	0.1	2.3	0.9	0.1	0.6	0.3	0.4	0.3	0.3	1.9	0.5	0.0	3.0	2.9	2.0	0.5	0.0	0.0	0.0	0.0	0.4	0.3	0.4	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.9	0.1	0.2	0.4	0.0	1.7	47.1	0.0	0.0	0.7	5.1	0.1	1.3	0.0	1.1	0.1	0.1	0.0	0.9	0.0	0.0	0.8	0.8	0.2	0.0	1.5	7.2	15.0	1.4	0.0	0.0	0.0	9.7	0.0	0.0	0.0	4.6	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.5	0.1	0.0	0.1	1.4	0.0	59.9	0.0	0.0	0.1
PTPRK	R-PTP-kappa	ENSG00000152894	"Protein tyrosine phosphatase receptor type K"	Q15262	6	127968785-128520616	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Hydrolase, Protein phosphatase, Receptor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 889.9;Oligodendrocyte precursor cells: 313.1;Oligodendrocytes: 1278.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"memory B-cell: 1.6;naive B-cell: 2.9"	"Lineage enriched"	"Detected in single"	7	"B-cells: 2.9"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054056, HPA054822"	Uncertain		Supported	"Vesicles,Plasma membrane,Cell Junctions"		NA	NA		13000000	"Cluster 21: B-cells - Adaptive immune response"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Cell Junctions"	"Vesicles, Plasma membrane"	"HPA054056: AB_2682359, HPA054822: AB_2682614"	"unprognostic (3.15e-2)"	"unprognostic (1.07e-2)"	"unprognostic (5.79e-3)"	"unprognostic (4.95e-3)"	"unprognostic (1.89e-2)"	"unprognostic (7.26e-2)"	"unprognostic (3.27e-1)"	"unprognostic (6.06e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.08e-1)"	"prognostic unfavorable (1.99e-4)"	"unprognostic (1.46e-1)"	"prognostic favorable (9.33e-5)"	"unprognostic (2.10e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.59e-1)"	"unprognostic (9.32e-2)"	10.7	4.2	13.4	9.7	20.6	0.2	25.6	16.7	18.6	13.5	8.6	27.3	32.8	12.1	8.2	9.7	14.9	32.5	12.4	15.9	14.5	14.9	29.6	19.4	6.9	16.8	16.7	15.1	26.2	10.2	7.0	21.8	17.8	18.9	27.6	4.6	15.3	19.0	5.9	12.2	28.5	15.9	14.5	7.9	30.5	2.2	16.4	10.2	11.7	9.9	8.7	20.9	12.3	29.8	17.3	16.7	10.9	1.0	24.9	31.9	11.0	43.6	86.3	18.4	16.6	28.8	15.0	0.1	13.4	40.7	50.8	49.0	10.2	35.9	26.7	50.3	19.4	0.3	23.6	45.7	29.7	0.0	1.7	23.9	35.4	35.9	49.6	50.8	54.0	14.7	0.0	1.1	49.3	33.6	26.6	0.1	11.9	34.5	22.6	94.8	21.7	3.1	51.1	33.4	43.8	0.1	45.2	55.6	2.7	12.4	14.6	1.1	86.9	30.0	18.4	54.8	42.2	0.7	6.0	0.0	38.1	0.0	31.1	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	2.9	0.1	0.3	0.0	0.2	0.0	0.0	0.1	0.1	13.4	20.6	16.7	18.6	15.9	14.5	16.8	16.7	17.8	14.5	16.4	29.8	39.2	25.6	33.5	155.7	17.5	63.5	88.1	45.2	60.3	7.3	56.6	26.5	22.2	101.5	44.1	18.4	4.2	24.8	0.8	75.2	0.0	63.2	4.6	30.6	11.5	46.6	43.9	0.0	889.9	61.3	4.1	28.6	77.5	77.5	1.3	13.4	11.4	40.9	6.4	10.1	55.3	44.2	8.2	1.6	8.8	2.7	17.1	2.2	17.8	200.5	1.7	5.1	0.0	313.1	1278.1	124.2	53.8	18.0	1.0	115.8	68.7	13.4	25.9	0.7	59.2	20.1	41.5	11.3	8.9	27.0	38.1	26.8	3.4	14.1	56.6	157.0
LAMA2	LAMM	ENSG00000196569	"Laminin subunit alpha 2"	P24043	6	128883138-129516566	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Cell adhesion"		"Congenital muscular dystrophy, Disease variant, Limb-girdle muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 106.0"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 363.1;Fibroblasts: 151.1;Leydig cells: 184.2;Microglial cells: 692.3;Oligodendrocytes: 160.9;Peritubular cells: 224.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 255.1;ASC TERT1: 184.5;HHSteC: 55.5;HSkMC: 156.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB040310, CAB078182"	Enhanced				"Secreted to extracellular matrix"	NA	NA		55000000	"Cluster 15: NK-cells - Transcription"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"			"CAB040310: , CAB078182: AB_2665829"	"unprognostic (1.17e-1)"	"unprognostic (5.87e-2)"	"unprognostic (2.17e-2)"	"unprognostic (3.17e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.65e-2)"	"unprognostic (9.73e-2)"	"unprognostic (3.67e-2)"	"unprognostic (2.44e-3)"	"unprognostic (1.55e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.04e-2)"	"unprognostic (1.24e-3)"	"unprognostic (6.16e-2)"	"unprognostic (5.41e-3)"	"prognostic unfavorable (3.65e-5)"	37.6	9.2	2.7	2.6	10.2	0.0	25.0	4.1	5.8	24.1	10.8	14.8	1.7	17.1	4.1	8.0	34.9	18.0	64.0	1.8	3.4	4.1	4.4	26.5	1.0	13.8	4.6	53.4	8.0	2.8	6.9	106.0	8.3	7.3	4.7	2.5	14.9	9.0	22.0	14.1	13.7	14.2	4.7	5.0	17.4	9.2	7.5	2.7	14.6	42.9	0.7	18.1	18.1	6.4	0.0	0.1	2.8	0.1	255.1	184.5	0.0	26.1	9.5	0.6	0.6	0.0	0.2	0.0	0.3	28.2	0.2	0.1	1.6	0.1	0.6	0.1	0.0	0.1	0.0	0.0	55.5	0.0	0.3	156.4	0.1	13.5	0.3	0.2	0.3	0.0	0.0	1.0	44.1	0.0	0.0	0.1	0.5	0.8	0.0	0.0	14.5	0.2	0.4	0.1	0.0	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.2	22.2	1.4	0.1	0.3	8.9	0.3	0.0	1.7	0.0	2.9	0.0	0.0	0.0	0.4	0.0	0.5	0.0	0.2	0.2	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.1	0.0	2.7	10.2	4.1	5.8	1.8	3.4	13.8	4.6	8.3	4.7	7.5	6.4	7.7	0.0	0.5	24.8	0.0	3.7	2.2	0.5	1.2	1.3	1.1	0.8	90.7	0.0	0.9	0.0	0.0	2.1	0.5	0.0	0.0	1.4	7.5	6.5	75.1	8.5	0.0	0.0	363.1	0.2	1.9	151.1	11.7	6.5	0.0	1.0	3.6	0.0	3.0	0.0	8.6	0.0	0.0	0.0	4.4	11.7	184.2	1.9	1.8	692.3	0.1	11.1	3.1	8.0	160.9	0.9	0.0	224.2	0.5	1.0	0.0	0.6	4.5	1.1	118.3	122.1	8.8	2.6	1.9	1.2	2.8	3.8	1.7	44.5	0.0	1.1
ARHGAP18	"bA307O14.2, MacGAP"	ENSG00000146376	"Rho GTPase activating protein 18"	Q8N392	6	129576132-129710177	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"granulocytes: 253.6;Respiratory ciliated cells: 265.3;Syncytiotrophoblasts: 212.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 395.8;LHCN-M2: 113.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031595	Approved		Supported	"Nuclear speckles,Plasma membrane,Cytosol"		NA	NA		1900000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 51: Myeloid cells - Hemostasis"	Cytosol	"Nuclear speckles, Plasma membrane"	"HPA031595: AB_10959905"	"unprognostic (6.39e-2)"	"unprognostic (1.60e-1)"	"unprognostic (5.45e-2)"	"unprognostic (5.49e-2)"	"unprognostic (3.05e-1)"	"unprognostic (3.17e-1)"	"unprognostic (9.32e-3)"	"unprognostic (1.25e-2)"	"unprognostic (2.98e-2)"	"unprognostic (3.12e-2)"	"prognostic unfavorable (2.54e-4)"	"unprognostic (4.08e-1)"	"unprognostic (2.29e-3)"	"unprognostic (2.22e-1)"	"unprognostic (3.05e-2)"	"unprognostic (5.52e-2)"	"unprognostic (1.08e-1)"	20.5	37.2	3.4	13.0	2.5	4.3	13.4	2.4	2.8	14.9	15.1	14.8	24.8	6.7	20.2	6.0	28.3	15.4	6.0	2.9	4.1	28.4	6.3	28.7	9.4	4.7	5.7	6.0	33.2	14.2	6.7	20.8	4.3	9.9	15.0	2.6	14.6	8.4	10.6	4.0	27.3	10.6	3.5	9.0	27.9	8.3	6.4	6.1	23.0	13.0	7.9	12.6	4.1	3.7	8.6	18.8	1.9	2.6	17.8	25.0	15.1	64.0	48.8	27.7	18.5	10.0	14.1	7.1	30.6	43.2	8.8	11.0	13.4	20.9	51.3	7.0	5.7	46.7	13.8	57.3	25.4	6.9	395.8	15.9	3.2	50.4	44.7	57.8	79.8	0.0	25.3	17.4	113.1	2.3	0.1	6.8	2.0	16.0	4.5	0.3	8.5	13.7	84.6	4.8	0.0	0.1	5.3	8.8	32.3	9.3	9.7	8.1	61.6	28.8	4.1	2.3	51.8	7.8	6.0	4.8	9.7	12.7	40.9	12.0	5.1	13.5	4.9	5.8	3.1	2.9	2.5	5.5	4.8	1.7	0.4	2.6	3.9	2.5	3.2	11.8	2.8	6.0	3.4	2.5	2.4	2.8	2.9	4.1	4.7	5.7	4.3	3.5	6.4	3.7	139.5	57.7	33.3	1.6	13.0	13.0	17.7	15.7	10.8	0.7	53.4	14.7	4.1	17.2	39.5	38.6	2.1	92.7	31.0	19.0	150.6	48.2	20.7	176.1	5.8	89.2	13.1	10.9	16.8	120.5	24.9	45.3	63.2	35.7	253.6	34.7	11.0	5.0	110.4	0.0	23.1	22.1	63.1	48.4	112.4	21.2	3.7	163.9	7.2	43.1	23.9	16.4	28.8	12.5	2.2	102.4	25.0	1.2	26.4	18.5	69.8	31.7	265.3	0.9	26.3	38.9	32.5	10.6	1.1	11.2	12.9	212.3	35.9	69.1	31.3	19.1
TMEM244	"bA174C7.4, C6orf191"	ENSG00000203756	"Transmembrane protein 244"	Q5VVB8	6	129831244-129861547	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	39	"retina: 64.2"	"Cell type enhanced"	"Detected in some"		"Cone photoreceptor cells: 18.8;Excitatory neurons: 4.9;Oligodendrocytes: 7.0;Rod photoreceptor cells: 27.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"memory CD4 T-cell: 1.4;T-reg: 1.6"	"Lineage enriched"	"Detected in single"	9	"T-cells: 1.6"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 4.3;LHCN-M2: 5.0;U-2 OS: 1.7;U-251 MG: 4.1;U-266/70: 3.6;WM-115: 2.4"					"Not detected"	"Not detected"									NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 79: Retina - Phototransduction"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 46: Photoreceptor cells - Phototransduction"				"unprognostic (4.65e-1)"	"unprognostic (3.65e-2)"				"unprognostic (1.10e-1)"		"unprognostic (1.54e-1)"			"unprognostic (1.15e-1)"			"unprognostic (2.15e-1)"	"unprognostic (9.57e-2)"			0.0	0.0	0.3	0.0	1.3	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	1.1	0.3	0.1	0.0	0.1	0.5	0.2	0.3	0.0	0.0	0.0	1.6	0.0	0.5	0.2	0.1	64.2	0.2	0.0	0.2	0.0	0.0	0.0	0.2	0.1	0.2	0.0	0.1	0.0	0.0	0.2	0.4	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.5	5.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	1.7	0.6	4.1	3.6	0.0	0.0	1.0	0.0	2.4	0.0	0.0	0.0	0.8	0.0	0.0	0.1	1.4	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.6	0.1	0.3	1.3	0.0	1.1	1.1	0.3	0.2	0.3	0.5	0.2	0.1	1.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	18.8	0.0	0.4	0.0	0.0	0.0	1.1	0.0	0.0	0.1	0.0	0.0	4.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	1.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.9	0.0	3.7	0.0	0.0	7.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	27.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.0
L3MBTL3	KIAA1798	ENSG00000198945	"L3MBTL histone methyl-lysine binding protein 3"	Q96JM7	6	130013699-130141449	"Predicted intracellular proteins"	"Transcription, Transcription regulation"	"Chromatin regulator"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"granulocytes: 40.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 63.5;HUVEC TERT2: 62.5;TIME: 43.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044382, HPA053035"	Approved		Supported	"Nucleoplasm,Nucleoli,Nucleoli rim"		NA	No			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 34: Non-specific - Transcription"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 44: Endometrium - Transcription"	"Nucleoli, Nucleoli rim"	Nucleoplasm	"HPA044382: AB_2678920, HPA053035: AB_2682021"	"unprognostic (2.33e-1)"	"unprognostic (9.92e-2)"	"unprognostic (1.40e-1)"	"unprognostic (7.82e-2)"	"unprognostic (4.22e-3)"	"unprognostic (1.28e-2)"	"unprognostic (4.51e-2)"	"unprognostic (1.48e-2)"	"unprognostic (2.90e-1)"	"unprognostic (2.63e-1)"	"unprognostic (7.56e-3)"	"unprognostic (1.07e-1)"	"unprognostic (8.44e-2)"	"unprognostic (3.94e-3)"	"unprognostic (2.88e-1)"	"unprognostic (2.45e-2)"	"unprognostic (1.60e-2)"	4.5	11.0	3.3	9.9	3.3	7.7	4.7	1.7	3.6	9.5	9.6	4.6	2.8	11.2	11.7	2.3	5.5	5.3	2.4	4.1	3.8	4.8	5.8	4.0	11.1	2.5	3.1	10.1	2.3	5.6	5.5	5.7	2.4	7.0	5.0	2.1	4.9	6.2	2.5	2.7	5.1	8.3	2.5	12.6	3.3	7.6	4.5	7.7	6.0	2.1	8.9	5.7	5.3	2.6	1.7	6.5	15.2	2.4	10.4	13.4	3.1	7.8	15.9	3.0	5.5	8.0	8.1	2.7	11.0	9.9	9.3	6.5	8.7	13.6	4.6	6.1	8.8	18.3	3.2	2.0	5.2	10.8	63.5	8.8	9.6	3.6	10.2	15.1	62.5	8.3	13.3	7.1	7.7	0.7	23.2	1.9	7.0	1.7	3.3	8.7	4.2	0.0	9.8	2.5	0.5	2.0	2.9	0.7	6.1	18.2	16.4	9.3	43.0	5.1	6.9	0.9	5.3	1.4	0.1	4.7	2.5	4.5	5.2	8.2	4.9	4.8	3.7	5.5	3.2	10.7	3.5	4.7	1.9	13.4	3.2	4.1	4.9	2.1	22.7	14.8	5.9	1.0	3.3	3.3	1.7	3.6	4.1	3.8	2.5	3.1	2.4	2.5	4.5	2.6	9.1	3.2	6.5	6.5	20.5	5.1	5.1	2.4	10.2	4.2	5.3	2.8	3.9	1.5	3.8	9.2	2.1	13.4	20.7	2.8	1.9	5.6	24.2	6.1	12.8	9.4	3.6	5.0	20.8	5.4	7.1	7.3	4.6	16.1	40.4	24.7	8.9	6.3	4.0	0.0	10.5	9.3	6.1	8.2	4.0	3.1	9.6	9.5	1.8	11.2	12.9	5.3	13.4	15.6	8.5	10.9	5.2	6.0	5.2	4.7	0.5	5.9	4.1	0.7	6.6	11.2	8.6	5.8	7.6	4.0	4.4	6.2	15.6	9.5	5.0	5.5
SAMD3	"bA73O6.2, FLJ34032"	ENSG00000164483	"Sterile alpha motif domain containing 3"	Q8N6K7	6	130144315-130365425	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 10.4"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 157.0;NK-cells: 271.9;Plasma cells: 43.7;T-cells: 84.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	47	"NK-cells: 128.4;T-cells: 113.8"	"Cell line enhanced"	"Detected in some"		"HBF TERT88: 1.8;HDLM-2: 3.4;hTEC/SVTERT24-B: 2.2;hTERT-RPE1: 1.9;NTERA-2: 1.7"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in some"		"cerebellum: 2.1"	"HPA028992, HPA028993"	Uncertain					NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"			"HPA028992: AB_10598914, HPA028993: AB_10601891"	"unprognostic (2.91e-3)"	"unprognostic (5.35e-3)"	"unprognostic (4.15e-2)"	"unprognostic (2.70e-2)"	"unprognostic (1.50e-2)"	"unprognostic (2.48e-4)"	"unprognostic (1.20e-2)"	"unprognostic (2.42e-3)"	"unprognostic (2.39e-2)"	"unprognostic (2.46e-2)"	"unprognostic (5.61e-2)"	"unprognostic (1.98e-1)"	"unprognostic (5.07e-6)"	"unprognostic (7.09e-2)"	"unprognostic (1.14e-1)"	"unprognostic (6.62e-2)"	"unprognostic (3.45e-2)"	1.1	2.3	1.4	4.0	2.0	4.2	0.9	0.6	1.6	2.9	0.6	1.2	0.7	4.4	1.9	0.7	1.5	2.3	0.5	2.9	1.2	1.1	1.7	3.3	10.4	0.8	2.0	1.8	1.2	0.1	4.8	0.7	0.9	0.7	2.3	1.4	0.7	0.4	0.8	0.5	1.4	1.7	0.4	9.3	1.6	3.2	1.9	6.3	0.8	0.7	4.2	1.3	0.8	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.4	0.1	0.3	0.5	0.1	0.0	0.0	0.4	0.1	0.0	0.0	0.0	1.8	3.4	0.0	0.2	0.0	0.1	0.0	0.0	0.3	0.3	0.0	2.2	0.1	1.9	0.2	0.4	0.1	0.0	0.2	0.0	0.1	0.0	1.7	0.0	1.1	0.0	0.0	0.0	0.4	0.0	0.1	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.4	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.3	0.5	113.8	0.4	90.0	2.5	39.8	102.1	0.6	0.3	28.8	68.9	2.3	128.4	0.6	0.6	41.7	41.4	1.4	2.0	0.6	1.6	2.9	1.2	0.8	2.0	0.9	0.4	1.9	0.4	1.1	0.0	2.3	1.3	2.3	0.4	0.0	0.0	0.6	3.0	0.6	0.5	0.8	0.0	0.0	0.0	0.0	0.0	157.0	1.6	0.0	0.2	25.4	1.0	2.1	0.8	3.6	6.6	12.1	0.0	0.0	0.7	0.0	0.5	1.3	14.8	2.9	0.4	0.0	0.0	5.7	0.3	0.0	3.4	1.4	6.7	0.6	1.8	5.4	12.2	2.3	0.0	271.9	1.5	0.6	0.0	1.5	1.9	43.7	0.0	0.1	0.6	0.7	0.4	0.0	0.3	1.4	2.3	1.6	0.2	0.4	0.0	84.3	2.0	0.5	0.1
TMEM200A	"KIAA1913, TTMC"	ENSG00000164484	"Transmembrane protein 200A"	Q86VY9	6	130366017-130443067	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 39.3"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 26.5;Distal enterocytes: 23.3;Endometrial stromal cells: 18.6;Enteroendocrine cells: 24.6;Granulosa cells: 49.9"	"Cancer enhanced"	"Detected in many"		"renal cancer: 7.7"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	5	"NK-cell: 4.0"	"Lineage enriched"	"Detected in single"	5	"NK-cells: 4.0"	"Cell line enhanced"	"Detected in many"		"HBF TERT88: 40.8;hTEC/SVTERT24-B: 67.1;hTERT-RPE1: 33.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014396	Uncertain					NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 40: Granulosa cells - Unknown function"			"HPA014396: AB_2204904"	"unprognostic (1.07e-1)"	"unprognostic (4.89e-2)"	"unprognostic (2.33e-1)"	"unprognostic (4.19e-2)"	"unprognostic (7.62e-2)"	"unprognostic (2.35e-1)"	"unprognostic (3.28e-2)"	"unprognostic (2.91e-1)"	"unprognostic (7.25e-2)"	"unprognostic (9.29e-2)"	"unprognostic (3.10e-1)"	"unprognostic (2.27e-1)"	"prognostic favorable (3.92e-4)"	"unprognostic (1.27e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.91e-3)"	5.7	17.1	1.7	3.9	2.5	0.1	5.9	0.1	2.2	11.1	0.0	11.1	7.3	39.3	5.3	1.2	12.9	6.4	0.6	4.5	2.7	13.6	0.4	6.8	3.8	0.9	4.6	15.6	1.5	0.8	5.3	3.3	1.5	2.7	22.3	11.2	1.6	1.4	0.6	2.0	8.3	18.7	0.8	1.0	6.3	2.7	3.8	4.7	5.6	0.4	3.4	5.6	3.5	0.8	0.1	0.1	0.2	0.0	11.7	14.6	0.1	10.6	13.0	11.1	19.6	16.6	0.0	0.0	0.0	22.3	2.5	2.5	1.0	0.0	40.8	15.5	0.0	0.0	0.0	0.8	5.3	0.3	0.0	16.7	0.0	67.1	13.3	33.5	0.4	0.3	0.0	1.5	5.2	0.0	0.0	0.1	8.4	0.0	1.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	13.4	12.5	4.0	1.1	1.9	8.2	0.0	0.0	7.4	0.0	1.3	0.0	0.0	0.0	0.3	0.0	0.5	0.2	0.8	0.4	0.0	0.0	0.1	0.0	0.0	4.0	0.0	0.0	0.0	0.1	1.7	2.5	0.1	2.2	4.5	2.7	0.9	4.6	1.5	0.8	3.8	0.8	0.5	0.0	0.5	1.3	0.2	2.0	0.1	0.1	1.2	26.5	0.5	0.4	0.6	0.0	0.0	0.0	0.0	0.5	0.4	23.3	0.0	0.0	2.0	5.2	18.6	0.8	24.6	2.7	7.1	0.0	1.7	3.6	2.0	0.7	0.0	49.9	0.0	0.0	0.2	13.5	4.3	1.6	0.0	0.0	0.9	1.8	5.9	0.3	1.8	1.9	0.0	0.5	0.0	1.0	0.3	0.1	6.0	10.5	3.3	0.0	4.6	9.9	0.0	2.1	0.0	0.8	8.4	3.3	2.6	0.1	1.4	0.5	5.8	11.3	4.0	0.1
SMLR1		ENSG00000256162	"Small leucine rich protein 1"	H3BR10	6	130827406-130837135	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"liver: 56.6"	"Group enriched"	"Detected in some"	11	"Hepatocytes: 243.3;Proximal enterocytes: 144.8"	"Cancer enriched"	"Detected in some"	20	"liver cancer: 16.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	12	"Hep G2: 81.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA066060	Uncertain					NA	NA				"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"			"HPA066060: AB_2685607"	"unprognostic (1.73e-1)"		"unprognostic (7.37e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.32e-2)"		"unprognostic (2.35e-1)"			"unprognostic (1.31e-1)"	"unprognostic (1.50e-1)"		"unprognostic (6.43e-3)"	"unprognostic (2.68e-3)"	"unprognostic (3.29e-1)"			0.0	0.3	0.0	0.0	0.8	0.0	0.0	0.0	0.5	0.0	0.0	0.0	12.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	3.2	56.6	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	10.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	81.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.5	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.5	0.1	0.1	0.1	10.0	0.0	1.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	14.7	1.4	243.3	0.1	0.0	0.0	3.1	0.0	5.2	0.0	0.2	0.0	0.1	0.0	2.8	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	144.8	17.5	0.0	1.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.2	2.0	1.5	0.0
EPB41L2	"4.1-G, 4.1G"	ENSG00000079819	"Erythrocyte membrane protein band 4.1 like 2"	O43491	6	130839347-131063322	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Cell cycle, Cell division, Mitosis, Transport"	Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"retina: 368.5"	"Cell type enhanced"	"Detected in many"		"Microglial cells: 433.8;Muller glia cells: 472.5;Rod photoreceptor cells: 1272.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005730, HPA006642"	Supported		Enhanced	"Nucleoplasm,Plasma membrane,Cell Junctions"		NA	NA		54000	"Cluster 7: Monocytes - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Plasma membrane"	"Nucleoplasm, Cell Junctions"	"HPA005730: AB_1848195, HPA006642: AB_1848194"	"unprognostic (3.18e-2)"	"unprognostic (1.04e-1)"	"unprognostic (8.34e-3)"	"unprognostic (3.40e-3)"	"unprognostic (1.41e-1)"	"unprognostic (5.17e-2)"	"prognostic unfavorable (2.41e-5)"	"unprognostic (1.25e-1)"	"unprognostic (1.23e-1)"	"prognostic unfavorable (2.16e-4)"	"unprognostic (3.24e-1)"	"unprognostic (1.63e-1)"	"unprognostic (5.63e-2)"	"unprognostic (3.64e-2)"	"unprognostic (3.82e-1)"	"unprognostic (3.48e-2)"	"unprognostic (9.19e-2)"	121.0	35.0	57.8	40.9	108.2	10.0	50.1	62.4	90.2	41.4	6.0	59.1	27.5	49.2	24.1	28.6	55.2	39.6	52.5	57.5	58.2	24.3	26.7	58.6	37.7	101.3	65.5	92.6	20.2	14.8	18.0	58.8	102.1	23.6	49.7	368.5	23.3	32.9	38.7	16.0	47.8	43.1	66.8	59.7	26.6	74.5	73.4	30.7	33.7	67.8	26.4	36.0	34.8	120.8	34.0	35.6	78.0	109.5	53.4	85.7	23.9	56.4	72.2	57.9	79.9	67.5	47.7	41.7	102.9	79.6	46.6	17.1	30.6	53.2	114.2	178.4	70.9	74.0	42.5	38.5	31.5	0.1	87.4	42.3	1.1	101.7	38.8	91.8	89.3	62.5	206.1	115.8	37.2	8.5	59.4	13.1	72.6	146.3	38.5	90.9	94.4	4.0	96.5	31.9	8.4	0.3	23.7	0.7	45.4	80.1	12.2	78.3	108.9	66.9	125.0	113.6	172.1	95.6	1.7	38.5	45.8	0.5	103.8	0.1	2.9	0.5	0.9	8.0	0.8	2.5	0.9	1.1	8.2	8.4	1.4	0.6	0.0	1.1	3.2	2.2	2.6	1.2	57.8	108.2	62.4	90.2	57.5	58.2	101.3	65.5	102.1	66.8	73.4	120.8	132.5	6.4	12.0	150.5	17.0	15.4	13.3	5.3	24.5	63.1	10.2	19.9	16.5	21.5	16.0	1.8	225.2	4.4	4.8	54.7	0.0	32.7	332.6	72.3	83.3	92.9	10.2	5.9	300.9	16.6	5.7	120.5	9.7	113.2	44.3	100.3	43.9	5.4	33.5	28.6	144.0	41.9	0.0	166.7	63.3	332.1	73.0	50.8	10.6	433.8	14.0	472.5	2.1	119.1	288.8	57.9	25.0	46.3	10.2	6.2	28.0	10.4	11.2	1272.4	118.3	149.6	89.2	102.8	97.6	12.1	10.2	2.5	9.4	82.8	39.3	7.2
AKAP7	"AKAP15, AKAP18"	ENSG00000118507	"A-kinase anchoring protein 7"	"O43687, Q9P0M2"	6	131135467-131283535	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 56.6"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 88.8;Cholangiocytes: 177.3;Oligodendrocyte precursor cells: 123.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NTERA-2: 27.2;RPTEC TERT1: 23.5;RT4: 27.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027172, HPA027200, HPA028327"	Approved		Approved	Vesicles		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 68: Oligodendrocytes - Mixed function"	Vesicles		"HPA027172: AB_1844689, HPA027200: , HPA028327: AB_10601353"	"unprognostic (2.83e-2)"	"unprognostic (2.70e-1)"	"unprognostic (2.88e-2)"	"unprognostic (1.45e-3)"	"unprognostic (4.57e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.93e-1)"	"unprognostic (2.70e-2)"	"unprognostic (4.41e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.89e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.32e-3)"	"unprognostic (2.52e-1)"	"unprognostic (6.03e-3)"	"unprognostic (2.53e-1)"	"prognostic favorable (2.56e-4)"	9.0	56.6	15.8	6.4	16.3	10.9	6.7	17.7	20.7	8.1	11.5	19.1	29.8	6.4	5.7	4.2	6.8	9.9	6.7	16.0	16.7	8.1	24.4	6.6	11.2	15.3	16.2	9.8	42.0	4.0	4.3	4.0	15.3	14.0	18.9	7.6	4.6	6.4	15.9	2.8	16.5	5.9	16.7	9.6	5.3	8.8	17.0	11.9	5.9	14.4	7.6	8.7	5.6	15.8	1.2	2.1	7.8	3.8	4.4	9.0	5.4	3.3	5.3	5.5	7.3	2.8	2.2	0.1	6.1	5.7	4.1	0.1	2.3	3.6	4.0	0.0	3.3	8.0	2.7	12.2	6.1	0.4	2.5	7.8	2.4	3.6	4.6	5.1	5.8	4.6	1.4	11.7	5.3	2.1	3.6	2.1	27.2	0.8	2.9	7.3	5.1	0.1	23.5	27.2	0.1	2.7	4.5	0.4	11.1	4.5	1.8	17.1	2.1	2.5	3.5	7.5	8.3	10.5	0.1	2.0	6.3	8.1	5.9	15.2	1.9	0.3	8.1	3.8	12.8	3.7	11.1	11.0	2.4	5.5	17.6	11.0	0.5	4.4	4.7	0.1	4.3	6.0	15.8	16.3	17.7	20.7	16.0	16.7	15.3	16.2	15.3	16.7	17.0	15.8	11.7	19.2	9.1	88.8	16.4	6.2	6.5	0.8	6.8	22.3	10.1	13.2	10.4	177.3	1.6	5.5	16.7	8.2	18.0	22.1	19.6	35.7	8.2	31.6	13.4	6.5	1.2	63.8	44.7	4.2	10.2	7.4	6.1	35.6	10.8	22.9	9.7	39.9	8.6	8.4	79.1	14.8	10.2	20.8	9.9	2.7	8.4	12.9	1.8	68.4	9.8	38.2	25.7	123.6	62.7	2.2	33.2	5.7	3.4	8.2	13.6	26.5	1.4	13.2	0.0	12.6	6.9	4.6	10.0	7.0	4.1	4.7	23.9	26.0	22.0	4.9
ARG1		ENSG00000118520	"Arginase 1"	P05089	6	131470832-131584332	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Adaptive immunity, Arginine metabolism, Immunity, Innate immunity, Urea cycle"	Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"liver: 1203.5"	"Cell type enriched"	"Detected in some"	22	"Hepatocytes: 991.4"	"Cancer enriched"	"Detected in some"	45	"liver cancer: 167.7"	"Low region specificity"	"Detected in single"			"Immune cell enriched"	"Detected in some"	5	"neutrophil: 44.9"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 44.9"	"Cell line enhanced"	"Detected in single"		"HL-60: 1.4"	"Region enhanced"	"Detected in single"		"cerebellum: 2.4"	"Low region specificity"	"Detected in all"			"HPA003595, CAB009434, HPA024006, CAB056159, CAB080011"	Enhanced					NA	NA		9500000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 2: Hepatocytes - Metabolism"			"CAB009434: AB_2058955, CAB056159: AB_2665582, CAB080011: , HPA003595: AB_1078190, HPA024006: AB_1844987"	"unprognostic (2.00e-1)"	"unprognostic (2.09e-1)"	"unprognostic (2.49e-1)"	"unprognostic (1.74e-1)"	"unprognostic (9.95e-2)"	"unprognostic (7.96e-2)"	"unprognostic (7.73e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.56e-2)"	"unprognostic (7.55e-3)"	"unprognostic (8.35e-2)"	"unprognostic (1.25e-2)"	"unprognostic (2.90e-2)"	"unprognostic (2.75e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.79e-2)"	2.2	0.2	0.1	0.3	0.2	292.0	4.8	1.0	0.5	0.3	0.2	0.2	0.0	0.1	0.0	2.1	1.9	0.0	0.8	0.3	0.2	0.3	1203.5	6.5	0.3	0.4	0.2	0.2	0.4	0.0	0.2	1.7	0.3	0.3	0.0	0.3	0.9	0.0	0.5	92.8	0.3	0.2	0.1	20.6	0.4	0.1	0.2	1.2	0.5	0.6	0.7	0.2	2.2	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.5	0.0	1.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.3	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.1	1.0	0.1	0.0	0.2	0.7	0.3	44.9	0.0	0.9	0.2	9.3	0.4	0.1	0.2	1.0	0.5	0.3	0.2	0.4	0.2	0.3	0.1	0.2	0.2	0.0	0.0	0.0	0.3	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	17.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.3	0.1	0.1	1.5	0.0	43.6	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	23.2	991.4	0.0	0.0	0.1	0.1	0.0	27.6	0.0	0.6	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.1
MED23	"CRSP130, CRSP3, DRIP130, MRT18, Sur2"	ENSG00000112282	"Mediator complex subunit 23"	Q9ULK4	6	131573966-131628242	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Transcription, Transcription regulation"	Activator	"Cancer-related genes, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 72.0;Inhibitory neurons: 67.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA070341			Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Vesicles"		"HPA070341: AB_2686257"	"unprognostic (1.11e-2)"	"unprognostic (4.66e-2)"	"unprognostic (5.51e-3)"	"unprognostic (1.80e-1)"	"unprognostic (3.06e-2)"	"unprognostic (1.14e-2)"	"unprognostic (6.62e-3)"	"unprognostic (4.47e-1)"	"unprognostic (1.64e-1)"	"unprognostic (6.81e-3)"	"unprognostic (1.44e-2)"	"unprognostic (3.59e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.82e-2)"	"unprognostic (2.21e-1)"	"unprognostic (2.44e-2)"	"unprognostic (2.53e-2)"	7.7	10.5	3.4	11.5	3.7	22.0	14.3	9.8	5.0	12.0	3.7	10.6	11.4	13.3	10.6	8.5	11.0	8.9	6.5	3.5	3.6	10.3	7.9	9.9	14.8	2.4	2.8	14.2	10.7	18.3	6.0	11.0	3.1	11.7	12.4	11.5	12.7	11.6	7.4	11.5	10.6	10.4	2.7	12.8	11.6	10.5	3.5	18.0	14.4	10.1	15.3	10.1	7.8	6.4	7.2	7.8	18.2	23.0	22.1	16.8	16.7	17.6	19.8	16.0	23.0	8.2	9.8	15.9	12.5	18.2	15.4	12.6	9.9	11.4	24.7	18.1	13.8	16.6	14.9	14.0	16.0	27.8	27.1	14.9	13.3	17.7	17.8	18.6	20.1	16.9	21.7	16.2	17.0	11.0	21.3	17.4	8.7	12.3	7.8	18.9	11.4	9.6	12.2	10.4	13.6	12.3	12.6	17.4	11.6	20.9	4.8	19.3	20.4	11.8	13.3	19.0	16.2	17.0	12.3	22.6	14.5	12.6	16.1	4.9	4.5	7.6	5.5	4.6	8.3	4.7	5.5	6.2	5.6	4.2	5.5	5.1	3.6	12.9	3.3	2.9	6.6	3.9	3.4	3.7	9.8	5.0	3.5	3.6	2.4	2.8	3.1	2.7	3.5	6.4	16.3	19.2	9.6	24.8	21.5	9.2	6.3	11.9	13.6	23.7	15.5	10.9	6.5	8.6	15.7	23.9	16.7	8.7	23.7	15.5	3.9	7.6	2.1	14.8	14.7	13.9	14.4	12.0	72.0	7.7	6.8	12.5	14.3	16.6	14.0	18.3	14.3	12.4	8.1	11.8	67.1	17.4	6.1	17.6	9.5	3.2	14.3	12.8	5.4	36.5	16.9	7.7	21.6	42.3	60.8	9.1	14.9	10.1	19.4	10.7	14.7	8.5	13.4	24.4	13.1	13.8	10.2	13.5	5.3	12.0	8.7	7.8	20.7	14.6	14.3	12.8
ENPP3	"B10, CD203c, gp130RB13-6, PD-IBETA, PDNP3"	ENSG00000154269	"Ectonucleotide pyrophosphatase/phosphodiesterase 3"	O14638	6	131628442-131747418	"CD markers, Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted secreted proteins"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 32.1;intestine: 44.5"	"Group enriched"	"Detected in many"	5	"Endometrial ciliated cells: 160.0;Glandular and luminal cells: 387.2"	"Cancer enriched"	"Detected in many"	8	"renal cancer: 49.6"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	86	"basophil: 30.6"	"Lineage enriched"	"Detected in single"	86	"granulocytes: 30.6"	"Group enriched"	"Detected in some"	18	"HEL: 4.4;Hep G2: 14.6;HMC-1: 6.2"	"Low region specificity"	"Detected in some"			"Region enriched"	"Detected in single"	4	"spinal cord: 2.6"	HPA043772	Enhanced				"Secreted - unknown location"	NA	NA		1100000	"Cluster 38: Basophils - Unknown function"	"Cluster 9: Intestine - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 44: Endometrium - Transcription"			"HPA043772: AB_10795616"	"unprognostic (2.74e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.84e-1)"	"unprognostic (5.41e-3)"	"unprognostic (6.07e-2)"	"unprognostic (4.86e-5)"	"unprognostic (1.13e-1)"	"unprognostic (7.20e-3)"	"unprognostic (1.17e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.21e-3)"	"unprognostic (2.34e-1)"	"prognostic unfavorable (1.96e-4)"	"unprognostic (2.80e-2)"	"unprognostic (7.85e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.31e-3)"	1.2	6.2	0.4	1.1	0.4	0.1	6.6	0.9	0.5	32.1	0.2	9.3	16.2	3.8	1.2	0.5	2.3	1.3	0.1	0.3	0.5	10.0	5.0	0.9	0.5	0.5	0.6	0.5	0.1	0.3	0.1	0.1	0.5	2.4	8.4	0.3	18.1	15.6	0.1	0.6	44.5	0.8	0.4	0.3	0.5	0.8	0.5	9.6	0.3	0.2	0.4	0.4	0.7	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	4.4	0.0	14.6	0.0	0.1	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	30.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.4	0.9	0.5	0.3	0.5	0.5	0.6	0.5	0.4	0.5	0.4	0.4	0.0	1.1	5.2	0.2	0.0	2.6	0.7	1.2	0.2	1.0	0.6	0.3	0.0	2.5	0.0	0.0	0.0	0.2	9.2	1.9	0.0	1.6	160.0	46.3	1.4	0.0	2.1	2.1	0.0	0.1	0.5	0.0	387.2	36.0	0.1	0.7	1.7	0.1	0.0	4.1	1.5	0.0	0.6	1.1	0.4	1.2	1.5	1.8	2.8	0.0	0.1	1.0	3.5	0.9	0.0	1.9	0.7	0.3	2.7	53.3	9.1	5.4	0.1	0.0	0.2	1.0	2.5	0.8	0.0	0.6	0.1	2.2	0.1	4.9	1.1
OR2A4	OR2A10	ENSG00000180658	"Olfactory receptor family 2 subfamily A member 4"	O95047	6	131699644-131701401	"G-protein coupled receptors, Predicted membrane proteins"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"Endothelial cells: 1.6"	"Cancer enriched"	"Detected in single"	17	"renal cancer: 0.8"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in some"	4	"basophil: 12.0"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 12.0"	"Not detected"	"Not detected"											HPA058272	Uncertain					NA	NA			"Cluster 38: Basophils - Unknown function"			"Cluster 43: Cardiomyocytes - Nuclear processes"			"HPA058272: AB_2683662"													"unprognostic (1.22e-5)"	"unprognostic (3.60e-2)"				0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.2	0.2	0.0	0.0	0.1	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CTAGE9		ENSG00000236761	"CTAGE family member 9"	A4FU28	6	131708441-131711017	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	30	"testis: 8.3"	"Group enriched"	"Detected in some"	5	"Early spermatids: 8.6;Spermatocytes: 5.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA000387, HPA000922"	Uncertain					NA	NA				"Cluster 83: Testis - Spermatogenesis"		"Cluster 66: Spermatocytes - Spermatogenesis"			"HPA000387: AB_1078582, HPA000922: AB_1078581"	"unprognostic (3.92e-2)"	"unprognostic (6.84e-2)"	"unprognostic (3.48e-2)"			"unprognostic (1.92e-1)"	"unprognostic (9.89e-3)"	"unprognostic (2.36e-1)"		"unprognostic (5.55e-2)"	"unprognostic (2.34e-1)"	"unprognostic (2.52e-2)"	"unprognostic (5.74e-4)"	"unprognostic (3.15e-2)"	"unprognostic (9.98e-2)"	"unprognostic (2.02e-1)"	"unprognostic (2.41e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	8.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.8	0.0	0.4	0.0	0.0	0.0	0.0	0.6	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.6	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	5.5	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0
ENPP1	"M6S1, NPPS, PC-1, PCA1, PDNP1"	ENSG00000197594	"Ectonucleotide pyrophosphatase/phosphodiesterase 1"	P22413	6	131808016-131895155	"CD markers, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Predicted secreted proteins"	Biomineralization	Hydrolase	"Diabetes mellitus, Disease variant, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 44.0"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 80.2;Fibroblasts: 56.9;Hepatocytes: 111.6;Peritubular cells: 70.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in single"		"NK-cell: 1.6"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"ASC diff: 34.1;LHCN-M2: 21.1;U-138 MG: 27.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB032904, HPA062066"	Enhanced				"Secreted - unknown location"	NA	NA		4400000	"Cluster 48: NK-cells - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"			"CAB032904: AB_2099635, HPA062066: AB_2684674"	"unprognostic (1.47e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.60e-3)"	"unprognostic (2.40e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.60e-2)"	"unprognostic (7.22e-3)"	"unprognostic (8.96e-2)"	"unprognostic (1.95e-1)"	"unprognostic (3.00e-1)"	"unprognostic (2.61e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.84e-1)"	"unprognostic (3.28e-3)"	8.4	3.1	0.4	1.4	0.5	0.1	7.1	0.7	0.4	7.1	0.4	2.3	1.8	22.1	7.4	2.3	6.9	1.2	1.6	0.4	0.7	4.2	31.9	0.8	1.4	1.2	1.4	8.3	28.5	27.8	10.9	44.0	0.9	3.4	2.0	0.5	4.2	5.8	2.7	1.7	1.3	10.2	0.8	1.9	1.7	1.6	1.0	2.2	20.1	3.2	0.8	2.7	4.9	0.8	0.0	1.3	1.2	0.1	34.1	5.3	0.0	9.2	9.4	3.5	9.5	4.1	1.1	0.0	0.8	5.9	7.2	0.0	1.3	0.2	14.8	0.3	1.8	0.0	1.1	12.0	1.0	0.0	4.2	8.8	0.4	9.6	0.4	4.1	4.3	0.7	0.0	1.8	21.1	2.6	0.0	0.0	7.9	1.6	1.3	0.0	10.2	0.3	0.2	0.4	3.4	0.0	0.2	1.3	4.2	5.7	3.9	0.0	2.9	27.6	1.0	1.9	9.1	3.4	0.0	0.0	12.6	0.0	3.5	0.6	0.0	0.1	0.1	0.0	0.5	0.1	0.1	0.1	0.7	0.2	0.0	0.0	0.3	1.6	0.1	0.1	0.0	0.0	0.4	0.5	0.7	0.4	0.4	0.7	1.2	1.4	0.9	0.8	1.0	0.8	2.6	0.0	1.7	0.3	1.5	1.5	9.9	0.0	0.6	4.5	28.7	19.9	6.4	5.7	0.1	1.8	0.0	3.0	1.2	16.7	5.9	0.3	4.8	3.9	80.2	4.1	0.0	8.0	3.5	10.6	2.1	56.9	6.1	3.2	0.0	9.4	3.3	111.6	4.6	1.7	10.5	12.7	0.0	2.9	5.9	6.7	25.1	3.9	1.8	12.2	0.2	3.6	0.0	21.6	1.6	5.2	3.9	70.0	0.4	2.3	6.7	25.2	0.1	0.5	13.1	12.6	18.8	4.1	2.2	0.1	1.3	6.2	2.6	1.9	2.5	1.7
CCN2	"CTGF, IGFBP8"	ENSG00000118523	"Cellular communication network factor 2"	P29279	6	131948176-131951372	"Cancer-related genes, Metabolic proteins, Plasma proteins, Predicted secreted proteins"	"Cell adhesion, DNA synthesis"	Heparin-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 101.2;Cardiomyocytes: 38.7;Extravillous trophoblasts: 47.1;Fibroblasts: 261.8;Smooth muscle cells: 104.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	7	"naive B-cell: 8.1"	"Lineage enriched"	"Detected in single"	81	"B-cells: 8.1"	"Cell line enhanced"	"Detected in many"		"EFO-21: 1605.0;HUVEC TERT2: 1377.0;TIME: 2874.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005123, HPA031074, HPA031075"	Approved		Approved	"Golgi apparatus,Vesicles"	"Secreted in other tissues"	No	No	1010000	5900000	"Cluster 21: B-cells - Adaptive immune response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 50: Fibroblasts - ECM organization"	"Golgi apparatus, Vesicles"		"CAB005123: AB_638805, HPA031074: AB_10599618, HPA031075: AB_10611248"	"unprognostic (2.87e-1)"	"unprognostic (1.43e-1)"	"unprognostic (4.41e-2)"	"unprognostic (5.68e-2)"	"unprognostic (9.79e-2)"	"unprognostic (1.82e-2)"	"unprognostic (3.38e-1)"	"unprognostic (4.96e-2)"	"unprognostic (1.68e-1)"	"unprognostic (3.89e-2)"	"unprognostic (2.39e-1)"	"unprognostic (2.06e-1)"	"unprognostic (1.27e-3)"	"prognostic unfavorable (5.04e-4)"	"unprognostic (1.62e-1)"	"unprognostic (1.77e-2)"	"unprognostic (3.84e-3)"	265.9	107.5	18.9	168.0	18.8	2.0	206.4	16.3	34.0	531.0	31.5	148.8	43.7	418.5	34.4	271.9	243.8	441.4	371.8	25.8	14.2	235.7	82.9	226.3	73.6	18.8	32.1	77.0	194.0	43.0	44.8	198.2	20.2	364.6	136.1	2.4	138.2	154.3	51.8	155.1	151.2	576.3	14.2	569.1	182.6	24.7	20.8	49.5	464.7	61.9	14.9	324.0	102.5	18.2	4.6	7.5	126.8	3.7	279.9	158.5	1.8	373.1	178.2	226.8	119.4	0.2	12.2	0.6	1605.0	482.7	185.0	6.2	4.2	26.4	211.3	2.5	3.5	0.2	55.7	137.3	109.6	0.3	0.5	232.2	5.9	163.9	40.2	340.7	1377.0	0.0	0.4	0.3	650.8	2.5	0.5	1.2	61.8	41.3	21.7	32.6	6.0	0.7	81.9	0.4	0.5	0.8	38.3	62.2	18.3	308.5	6.1	3.1	2874.4	311.6	242.4	397.8	694.0	11.5	1.7	4.1	42.5	0.7	399.2	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	8.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	18.9	18.8	16.3	34.0	25.8	14.2	18.8	32.1	20.2	14.2	20.8	18.2	101.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	38.7	0.0	0.0	0.0	0.0	17.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	26.5	0.0	0.0	0.0	0.0	47.1	261.8	0.0	0.0	0.0	0.0	0.0	0.0	13.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	104.4	0.0	0.0	0.0	0.0	16.3	0.0	0.0	0.0	0.0
MOXD1	"dJ248E1.1, DKFZP564G202, MOX"	ENSG00000079931	"Monooxygenase DBH like 1"	Q6UVY6	6	132296055-132401475	"Predicted intracellular proteins, Predicted membrane proteins"		"Monooxygenase, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 64.2;smooth muscle: 78.6"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 92.7;Basal squamous epithelial cells: 153.1;Early spermatids: 70.2;Endometrial stromal cells: 57.8;Excitatory neurons: 36.0;Oligodendrocyte precursor cells: 33.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	33	"memory B-cell: 3.1;naive B-cell: 1.7;plasmacytoid DC: 5.1"	"Group enriched"	"Detected in many"	41	"B-cells: 3.1;dendritic cells: 5.1"	"Cell line enhanced"	"Detected in many"		"ASC diff: 164.8;ASC TERT1: 131.7;BJ: 106.1;fHDF/TERT166: 196.5;HBF TERT88: 120.6;U-2197: 310.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035740	Approved		Approved	Cytosol		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 18: U-2197 - ECM organization"	"Cluster 36: Stromal cells - Cell proliferation"	Cytosol		"HPA035740: AB_10610141"	"unprognostic (1.74e-1)"	"unprognostic (1.28e-1)"	"unprognostic (8.05e-2)"	"unprognostic (9.87e-3)"	"unprognostic (5.62e-2)"	"prognostic favorable (7.09e-5)"	"unprognostic (5.77e-2)"	"unprognostic (2.48e-1)"	"unprognostic (6.55e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.60e-1)"	"unprognostic (9.54e-2)"	"unprognostic (2.56e-3)"	"prognostic unfavorable (3.72e-4)"	"unprognostic (2.92e-2)"	"unprognostic (6.24e-2)"	"unprognostic (1.73e-2)"	2.8	36.5	18.0	5.7	10.6	0.1	2.5	3.1	11.7	25.7	3.5	13.4	5.2	64.2	11.0	23.5	3.4	28.7	5.4	10.9	4.0	37.0	1.8	25.3	6.2	3.5	3.8	0.8	2.2	0.5	4.5	1.4	3.9	32.0	8.8	5.0	12.2	39.6	0.3	14.4	7.5	78.6	3.6	4.7	5.2	1.8	6.7	2.1	1.8	0.5	15.6	19.1	12.8	10.8	0.1	0.9	4.1	0.0	164.8	131.7	0.2	106.1	71.0	37.7	65.8	0.2	1.2	0.4	0.1	196.5	30.9	0.1	1.4	0.5	120.6	0.0	19.3	0.0	0.1	0.0	1.5	0.1	0.1	31.8	0.0	76.6	2.5	46.6	0.0	0.0	0.0	7.8	22.4	0.0	0.1	0.2	3.5	0.0	0.7	1.1	0.4	0.2	46.3	0.4	2.8	0.2	0.0	0.4	2.4	9.6	0.1	5.9	0.5	17.4	15.9	310.0	56.1	4.1	0.0	0.0	43.9	0.0	51.9	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.1	18.0	10.6	3.1	11.7	10.9	4.0	3.5	3.8	3.9	3.6	6.7	10.8	0.4	0.0	1.3	92.7	5.4	28.0	0.4	0.1	153.1	0.3	0.4	0.6	0.7	0.0	2.5	1.8	0.0	0.9	2.7	0.0	0.0	0.6	70.2	1.0	57.8	0.6	0.0	0.0	36.0	0.0	1.5	23.9	0.5	1.2	3.8	0.0	0.0	0.0	0.4	0.0	8.6	0.0	0.0	0.3	4.7	11.8	0.3	0.3	7.2	4.7	0.0	16.4	0.0	33.7	1.1	0.4	0.0	0.4	9.5	1.5	0.0	0.3	0.0	0.8	0.0	6.2	3.3	0.5	0.8	14.6	6.8	0.0	0.5	0.1	0.1	0.0
STX7		ENSG00000079950	"Syntaxin 7"	O15400	6	132445867-132513198	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"basophil: 53.6;classical monocyte: 51.6;eosinophil: 49.1;intermediate monocyte: 58.1;memory B-cell: 85.9;myeloid DC: 61.6;naive B-cell: 106.8;neutrophil: 83.2;non-classical monocyte: 61.6;plasmacytoid DC: 73.9"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001467, CAB062564"	Enhanced		Supported	Lysosomes		NA	NA		380000	"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 16: Immune cells - Immune response"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 57: B-cells - Immune response"	Lysosomes		"CAB062564: AB_2665605, HPA001467: AB_1857623"	"unprognostic (1.91e-3)"	"unprognostic (1.06e-3)"	"unprognostic (2.67e-2)"	"unprognostic (7.95e-3)"	"unprognostic (1.21e-1)"	"unprognostic (2.04e-1)"	"prognostic unfavorable (1.60e-4)"	"unprognostic (4.52e-2)"	"unprognostic (4.46e-1)"	"unprognostic (4.19e-2)"	"unprognostic (2.84e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.65e-3)"	"unprognostic (2.16e-1)"	"unprognostic (2.06e-1)"	"unprognostic (1.67e-1)"	"unprognostic (8.42e-2)"	35.1	17.7	17.6	41.5	20.4	21.6	21.2	20.8	21.1	22.5	11.5	25.1	37.2	27.2	12.1	33.7	22.1	33.5	36.0	19.8	21.0	51.1	18.3	31.5	76.3	23.2	22.2	30.9	14.3	20.5	7.4	42.9	22.4	19.5	29.1	15.9	20.6	25.9	23.1	20.4	37.9	29.2	21.2	45.5	28.3	8.2	18.0	17.7	30.8	22.7	71.8	26.2	16.6	29.3	17.5	17.5	28.7	20.6	56.4	49.9	22.6	33.9	34.7	34.4	49.3	30.9	28.9	87.6	32.7	41.1	51.0	22.8	25.5	31.2	46.6	30.2	30.4	33.1	14.6	33.0	44.6	22.8	24.2	28.6	28.5	35.3	31.6	46.5	37.8	19.2	36.1	30.7	39.8	24.8	10.4	18.2	11.0	25.4	20.2	24.6	22.5	25.5	57.9	20.4	23.5	7.1	15.3	24.9	91.9	42.2	17.0	21.2	66.4	20.1	20.5	44.1	36.6	29.1	18.2	37.2	28.3	17.9	23.2	53.6	51.6	49.1	10.8	58.1	4.4	85.9	8.0	7.7	61.6	106.8	5.7	6.8	83.2	9.5	61.6	73.9	12.8	31.3	17.6	20.4	20.8	21.1	19.8	21.0	23.2	22.2	22.4	21.2	18.0	29.3	37.7	70.5	36.5	34.0	151.6	42.1	23.5	33.8	26.7	26.8	26.7	22.2	51.0	85.8	33.1	42.3	2.1	85.7	111.5	50.8	64.6	56.9	1.2	27.9	33.4	38.3	13.2	57.9	61.3	30.9	54.5	34.1	42.3	28.0	40.6	25.9	43.5	19.4	177.6	37.0	60.6	39.8	38.7	99.4	78.7	2.1	30.7	109.6	133.4	109.6	110.7	25.7	54.6	44.2	77.9	57.6	63.1	46.3	37.3	24.7	113.5	155.0	43.9	16.5	39.5	30.2	38.6	2.7	17.6	36.2	41.2	55.4	24.4	17.9	28.4	24.9
TAAR9	"TA3, TAR3, TRAR3"	ENSG00000237110	"Trace amine associated receptor 9"	Q96RI9	6	132538290-132539336	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA																											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TAAR8	"GPR102, TA5, TAR5, TRAR5"	ENSG00000146385	"Trace amine associated receptor 8"	Q969N4	6	132552693-132553721	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA																											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TAAR6	"TA4, TRAR4"	ENSG00000146383	"Trace amine associated receptor 6"	Q96RI8	6	132570322-132571359	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"									NA	NA																						"unprognostic (1.70e-1)"					0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TAAR5	PNR	ENSG00000135569	"Trace amine associated receptor 5"	O14804	6	132588673-132589686	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							HPA051703	Uncertain					NA	NA									"HPA051703: AB_2681580"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TAAR2	GPR58	ENSG00000146378	"Trace amine associated receptor 2"	Q9P1P5	6	132617022-132624275	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	18	"Astrocytes: 1.0;Early spermatids: 2.4;Late spermatids: 2.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA						"Cluster 34: Spermatids - Unknown function"																					0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TAAR1	"TA1, TAR1, TRAR1"	ENSG00000146399	"Trace amine associated receptor 1"	Q96RJ0	6	132644898-132646051	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	5	"stomach 1: 6.2"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in single"		"cervical cancer: 1.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							HPA055614	Approved					NA	NA				"Cluster 4: Stomach - Digestion"					"HPA055614: AB_2682862"											"unprognostic (2.19e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.68e-2)"				0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.2	0.1	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
VNN1	Tiff66	ENSG00000112299	"Vanin 1"	O95497	6	132680849-132714055	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"gallbladder: 89.2;intestine: 136.3;liver: 218.7"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 50.1;Ductal cells: 244.2;Hepatocytes: 70.6;Pancreatic endocrine cells: 98.0;Proximal enterocytes: 61.7"	"Cancer enhanced"	"Detected in many"		"liver cancer: 41.5"	"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in many"		"classical monocyte: 13.7;non-classical monocyte: 11.9"	"Group enriched"	"Detected in many"	80	"dendritic cells: 5.0;granulocytes: 8.5;monocytes: 13.7"	"Cell line enhanced"	"Detected in some"		"A-431: 2.5;CAPAN-2: 2.5;EFO-21: 8.7;HBEC3-KT: 2.3;LHCN-M2: 2.5"	"Region enhanced"	"Detected in single"		"white matter: 2.4"	"Not detected"	"Not detected"			"HPA046103, HPA064145"	Approved		Approved	Vesicles	"Intracellular and membrane"	NA	NA		980000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 1: Pancreatic cells - Digestion"	Vesicles		"HPA046103: , HPA064145: AB_2685197"	"unprognostic (9.53e-2)"	"unprognostic (5.01e-2)"	"unprognostic (9.95e-2)"	"unprognostic (1.35e-3)"	"unprognostic (6.11e-2)"	"unprognostic (1.16e-2)"	"unprognostic (2.20e-1)"	"unprognostic (4.20e-2)"	"unprognostic (2.06e-2)"	"unprognostic (3.64e-2)"	"unprognostic (2.11e-2)"	"unprognostic (4.62e-1)"	"prognostic unfavorable (2.52e-4)"	"unprognostic (2.26e-2)"	"unprognostic (4.42e-2)"	"unprognostic (2.16e-1)"	"unprognostic (2.34e-1)"	2.7	0.6	0.3	3.1	0.6	9.4	1.1	0.5	1.5	1.0	0.0	6.2	136.3	8.9	0.2	0.6	2.6	89.2	0.6	0.2	0.3	21.7	218.7	4.7	2.5	0.6	0.3	0.3	1.4	0.1	0.1	2.7	1.2	0.3	1.8	1.0	2.3	0.2	0.3	0.9	79.5	0.9	0.2	10.1	1.5	0.5	0.5	0.6	0.4	1.1	2.5	1.6	0.7	0.9	2.5	0.0	0.3	0.1	0.0	0.7	0.5	0.2	0.2	0.0	0.0	0.0	2.5	0.1	8.7	0.0	0.4	0.0	0.0	2.3	0.6	0.0	0.0	0.1	0.1	1.4	1.3	0.2	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	2.5	0.1	0.0	0.3	0.0	0.0	0.1	0.0	0.1	1.1	0.5	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.6	0.0	0.2	0.1	0.2	0.0	0.1	0.2	0.1	0.3	3.0	13.7	0.0	0.0	8.0	0.0	0.0	0.0	0.0	5.0	0.1	0.0	0.0	8.5	0.0	11.9	0.2	0.0	3.8	0.3	0.6	0.5	1.5	0.2	0.3	0.6	0.3	1.2	0.2	0.5	0.9	0.0	0.0	3.0	0.0	0.3	1.3	0.2	14.9	0.0	0.0	1.2	0.4	0.2	50.1	11.4	1.8	0.0	0.1	0.2	12.5	0.0	244.2	0.0	7.6	4.1	0.2	0.0	0.0	0.0	19.4	0.1	0.3	4.6	39.6	0.0	0.0	1.1	70.6	18.1	0.0	0.0	11.2	22.4	12.0	3.9	0.0	0.0	23.1	0.0	0.0	17.6	0.0	0.0	0.0	0.0	98.0	1.6	0.0	0.5	6.6	61.7	21.9	16.0	0.0	0.0	0.4	1.1	0.1	0.0	0.1	0.1	0.1	0.5	0.0	2.0	14.7
VNN3	HSA238982	ENSG00000093134	"Vanin 3"	Q9NY84	6	132722787-132736935	"Enzymes, Metabolic proteins, Predicted secreted proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"bone marrow: 34.9;liver: 34.7"	"Cell type enhanced"	"Detected in some"		"Basal respiratory cells: 20.7;Club cells: 42.5;Gastric mucus-secreting cells: 15.8;Respiratory ciliated cells: 86.1"	"Cancer enriched"	"Detected in some"	4	"liver cancer: 3.9"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in some"	4	"neutrophil: 76.2"	"Lineage enriched"	"Detected in many"	33	"granulocytes: 76.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted to blood"	NA	NA	150000000		"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 55: Non-specific - Mitochondria & Proteasome"		"Cluster 26: Respiratory epithelial cells - Mucosal defense"				"unprognostic (3.20e-2)"	"unprognostic (2.70e-1)"	"unprognostic (7.92e-3)"	"unprognostic (1.71e-2)"	"unprognostic (3.05e-3)"	"unprognostic (1.06e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.42e-2)"	"unprognostic (7.68e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.63e-1)"	"unprognostic (5.84e-8)"	"unprognostic (1.25e-2)"	"unprognostic (1.52e-1)"	"unprognostic (9.32e-2)"	"unprognostic (1.56e-1)"	1.2	0.1	0.1	2.2	0.1	34.9	0.2	0.1	0.5	1.6	0.2	0.1	0.0	0.1	0.0	0.8	1.9	1.0	0.4	0.1	0.1	0.3	34.7	4.5	0.4	0.1	0.1	0.0	0.1	0.0	0.1	1.3	0.2	0.3	0.0	0.0	1.0	0.1	0.1	0.2	0.2	0.2	0.1	5.5	0.4	0.1	0.2	0.4	0.1	1.1	0.4	0.5	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.7	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	76.2	0.0	0.1	0.0	0.0	0.3	0.1	0.1	0.1	0.5	0.1	0.1	0.1	0.1	0.2	0.1	0.2	0.1	0.0	0.0	2.8	0.0	0.0	0.0	0.1	20.7	0.0	0.0	0.2	0.0	0.4	0.0	42.5	0.0	0.0	0.0	0.1	0.2	0.0	3.7	0.2	2.3	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.8	15.8	1.7	0.0	0.0	0.4	10.0	0.1	0.0	0.0	0.0	6.1	5.8	0.0	0.2	0.0	3.6	0.0	0.0	4.5	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.1	2.0	0.0	0.1	86.1	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	1.0	0.2	0.2	0.3	4.1
VNN2	"FOAP-4, GPI-80"	ENSG00000112303	"Vanin 2"	O95498	6	132743870-132763459	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 31.6;lymphoid tissue: 56.6"	"Cell type enhanced"	"Detected in many"		"Ductal cells: 63.6;Ionocytes: 22.4;Macrophages: 41.1;monocytes: 57.5;Respiratory ciliated cells: 25.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in many"	7	"neutrophil: 477.4"	"Lineage enriched"	"Detected in all"	7	"granulocytes: 477.4"	"Cell line enriched"	"Detected in some"	7	"Daudi: 59.7"					"Low region specificity"	"Detected in some"									NA	NA		240000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 2: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"				"unprognostic (2.13e-1)"	"unprognostic (1.15e-1)"	"unprognostic (9.60e-3)"	"unprognostic (5.71e-2)"	"unprognostic (2.14e-1)"	"unprognostic (5.61e-3)"	"unprognostic (1.98e-3)"	"unprognostic (4.38e-1)"	"unprognostic (3.07e-1)"	"unprognostic (3.46e-1)"	"unprognostic (2.84e-1)"	"unprognostic (8.30e-2)"	"prognostic unfavorable (2.72e-7)"	"unprognostic (1.62e-1)"	"unprognostic (8.17e-2)"	"unprognostic (2.01e-1)"	"unprognostic (5.45e-2)"	21.7	2.7	0.6	23.9	0.9	31.6	1.3	0.7	2.8	4.3	1.4	3.8	2.4	1.3	0.4	4.1	5.3	22.5	2.3	0.5	0.7	2.4	10.1	22.5	39.0	1.5	1.0	1.5	4.3	0.7	0.9	20.7	1.7	1.8	3.0	0.1	1.5	0.9	0.6	0.3	4.6	6.3	0.8	56.6	7.3	0.6	1.0	11.7	1.2	7.9	42.0	17.8	1.2	1.0	0.2	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	59.7	1.1	0.0	1.0	0.0	0.0	0.0	0.0	8.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.9	0.0	0.0	1.3	0.0	0.0	0.0	0.0	1.1	0.1	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.6	0.0	1.1	1.4	0.0	0.0	11.6	65.2	0.3	24.6	14.5	10.3	40.3	8.4	29.0	14.1	32.2	27.0	39.4	477.4	36.1	9.9	2.6	6.1	40.4	0.6	0.9	0.7	2.8	0.5	0.7	1.5	1.0	1.7	0.8	1.0	1.0	0.2	0.0	6.7	0.0	11.0	0.0	0.5	4.3	0.0	0.0	0.2	0.0	1.5	7.2	11.8	0.0	0.0	0.8	10.9	0.1	0.0	63.6	0.0	0.3	0.0	1.4	0.0	1.3	0.2	0.4	0.2	1.9	13.3	0.2	5.1	0.1	3.3	1.0	13.9	0.0	0.0	0.0	22.4	18.6	1.0	0.0	0.0	41.1	0.0	1.9	57.5	0.3	20.6	0.0	0.1	3.6	0.0	0.0	2.7	8.0	0.0	0.6	25.4	0.1	6.6	2.5	1.2	0.1	0.0	0.1	0.0	1.4	10.9	6.5	0.2	14.5
SLC18B1	"C6orf192, dJ55C23.6"	ENSG00000146409	"Solute carrier family 18 member B1"	Q6NT16	6	132769370-132813339	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 93.4;Hofbauer cells: 65.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"K-562: 40.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029747	Approved		Approved	"Golgi apparatus,Cytosol"		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 4: Macrophages - Innate immune response"	"Golgi apparatus"	Cytosol	"HPA029747: AB_10600797"	"unprognostic (1.84e-2)"	"unprognostic (3.94e-1)"	"unprognostic (4.22e-2)"	"unprognostic (2.85e-1)"	"unprognostic (2.41e-2)"	"prognostic favorable (3.55e-4)"	"prognostic unfavorable (7.90e-4)"	"unprognostic (1.53e-1)"	"unprognostic (2.39e-1)"	"unprognostic (4.09e-1)"	"unprognostic (6.97e-3)"	"unprognostic (1.13e-1)"	"prognostic favorable (9.24e-4)"	"unprognostic (7.20e-3)"	"unprognostic (1.08e-1)"	"unprognostic (2.08e-2)"	"unprognostic (7.88e-2)"	9.9	8.9	21.0	6.3	21.6	4.6	9.7	22.5	28.0	9.4	23.1	9.7	14.5	6.4	5.8	13.6	9.8	11.9	3.9	21.2	22.2	12.7	7.6	5.7	7.7	21.6	22.3	6.9	9.9	12.9	8.3	15.7	21.0	5.4	10.1	2.6	13.1	4.5	3.2	9.5	10.5	5.9	22.8	8.3	16.1	2.0	25.1	7.9	10.2	3.5	8.1	11.1	7.2	22.8	6.8	6.5	10.0	0.0	1.5	3.2	5.7	2.5	7.2	4.4	13.4	14.9	13.8	0.2	9.2	1.5	7.9	17.3	13.4	15.4	3.3	10.3	27.6	3.6	11.3	16.8	7.5	3.0	0.3	9.3	13.7	7.2	14.5	7.3	13.6	20.7	40.4	2.5	3.8	9.4	10.5	0.3	14.1	15.8	8.7	15.7	11.7	11.8	36.6	11.4	21.2	0.0	12.9	25.2	20.1	6.0	8.9	0.1	6.0	1.9	5.3	2.1	5.7	8.5	0.5	0.4	11.5	0.1	1.7	0.0	14.4	0.8	4.3	3.2	8.1	6.6	6.5	6.0	19.9	9.7	9.5	6.6	0.8	3.4	0.3	15.5	11.9	8.1	21.0	21.6	22.5	28.0	21.2	22.2	21.6	22.3	21.0	22.8	25.1	22.8	10.4	0.0	6.5	93.4	15.2	10.1	10.3	30.4	22.8	5.5	13.0	7.4	3.1	40.0	20.6	27.6	2.1	53.1	8.2	5.4	9.8	32.0	0.2	12.6	4.8	7.8	16.3	49.1	32.2	15.1	19.3	7.8	20.4	5.8	0.0	5.8	18.2	15.6	65.6	0.0	25.3	11.9	32.6	21.5	9.0	0.5	6.8	26.7	14.2	27.2	11.4	9.3	5.2	51.3	4.4	14.6	6.0	4.5	6.6	8.8	7.2	6.4	27.9	3.5	0.0	8.6	4.8	0.3	0.5	25.5	10.9	28.5	7.3	21.7	15.3	13.2
RPS12	S12	ENSG00000112306	"Ribosomal protein S12"	P25398	6	132814569-132817564	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins"		"Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA006124, HPA006365"	Approved		Supported	"Golgi apparatus,Vesicles,Cytosol"		NA	NA		450000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 32: Non-specific - Translation"	Cytosol	"Golgi apparatus, Vesicles"	"HPA006124: AB_1856460, HPA006365: AB_2667570"	"unprognostic (6.58e-2)"	"unprognostic (3.31e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.04e-2)"	"unprognostic (6.37e-2)"	"unprognostic (4.95e-3)"	"unprognostic (1.46e-1)"	"unprognostic (3.95e-2)"	"unprognostic (1.01e-2)"	"unprognostic (2.31e-1)"	"unprognostic (7.04e-2)"	"prognostic unfavorable (1.06e-4)"	"unprognostic (2.04e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.26e-1)"	"unprognostic (5.66e-2)"	2199.7	1325.2	1393.3	1767.2	1454.1	5388.1	3551.2	1388.1	2027.8	2357.3	1375.8	1849.3	1597.8	1747.6	1664.7	2450.9	2149.5	1415.7	1311.3	1347.6	1419.0	1576.6	1443.7	1565.4	3948.0	1445.0	1406.0	4883.9	3660.2	1000.1	871.2	1633.7	1443.1	1696.0	1905.2	608.3	2167.8	1216.4	1965.9	3365.2	1692.7	1357.1	1484.2	2110.3	1718.3	682.0	1446.6	2534.1	1959.6	1376.9	3053.4	2011.6	2108.4	1482.0	1993.8	1568.3	2260.4	3581.3	4521.2	5855.0	2728.8	2502.9	3598.4	2772.7	2665.2	3294.5	1880.3	4497.8	3443.9	3368.1	1338.8	1900.3	2613.1	4373.5	2576.9	2895.0	3346.5	3013.3	1944.0	4743.1	5047.1	8481.4	2221.0	6167.0	7332.7	2340.5	8322.4	4658.3	3754.7	3556.4	5166.0	2858.9	3487.9	4342.3	3620.8	5030.3	2772.9	3420.0	2533.0	3993.0	1799.7	2884.6	3698.6	2185.9	1991.3	1573.0	833.4	5314.3	7184.2	2173.7	2276.5	8489.5	3027.8	1121.1	3111.7	3721.2	4696.8	4153.6	4104.8	3493.8	3635.1	5063.0	1621.7	599.0	1545.5	220.8	2412.5	1426.7	3728.9	4156.1	4210.9	3131.6	1971.7	3564.5	5201.1	4454.7	151.1	2031.9	1170.8	2722.3	2519.7	7450.3	1393.3	1454.1	1388.1	2027.8	1347.6	1419.0	1445.0	1406.0	1443.1	1484.2	1446.6	1482.0	3755.5	1660.2	3063.5	22.9	9470.7	8277.4	8259.7	3758.1	8926.6	531.5	10637.2	15674.0	827.7	3777.4	2693.4	1237.8	179.3	7566.9	6150.1	1808.1	4574.3	4058.0	792.6	1406.5	4602.8	3829.0	2863.4	5499.5	18.9	8085.7	9433.9	3353.4	3537.2	2309.6	1773.2	3890.7	4755.4	5136.7	5871.9	212.0	17.7	6806.4	1116.9	6161.6	5357.0	2335.6	6075.0	4790.9	3938.0	20.6	6667.5	2216.0	5160.7	10.1	25.0	6009.9	4480.8	2990.3	4762.0	10484.3	3517.1	5647.3	792.4	713.1	1617.2	5397.5	3117.8	1035.0	3063.2	11325.5	10512.6	7894.9	7990.4	4517.7	6783.0	9815.1
EYA4	"CMD1J, DFNA10"	ENSG00000112319	"EYA transcriptional coactivator and phosphatase 4"	O95677	6	133240598-133532128	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"DNA damage, DNA repair, Transcription, Transcription regulation"	"Activator, Chromatin regulator, Developmental protein, Hydrolase, Protein phosphatase"	"Cardiomyopathy, Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 27.6;tongue: 21.3"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 46.0;Inhibitory neurons: 139.0;Oligodendrocytes: 79.2;Skeletal myocytes: 26.2"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A549: 25.4;GAMG: 25.6;HeLa: 74.3;RH-30: 23.8;U-87 MG: 24.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA004805, HPA038771, HPA038772"	Enhanced		Approved	Nucleoplasm		No	NA				"Cluster 80: Striated muscle - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"HPA004805: AB_10669750, HPA038771: AB_10671865, HPA038772: AB_10673119"	"unprognostic (1.60e-1)"	"unprognostic (3.34e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.04e-9)"	"unprognostic (1.64e-1)"	"unprognostic (3.08e-2)"	"unprognostic (3.44e-2)"	"unprognostic (7.21e-2)"	"unprognostic (9.07e-2)"	"unprognostic (2.04e-2)"	"unprognostic (2.80e-1)"	"unprognostic (2.29e-1)"	"unprognostic (8.27e-4)"	"unprognostic (1.82e-3)"	"unprognostic (6.67e-2)"	"unprognostic (9.55e-2)"	"unprognostic (2.51e-2)"	1.1	2.5	2.6	0.1	1.9	0.0	0.4	2.2	1.9	2.6	13.3	0.2	0.2	0.5	1.2	0.4	7.4	0.5	5.8	2.3	1.2	5.0	0.0	1.8	0.1	5.6	7.9	1.2	0.2	0.0	0.8	0.0	4.5	5.7	0.2	0.1	0.2	11.8	27.6	0.0	0.1	0.3	4.5	0.4	0.4	3.0	3.3	6.6	2.1	21.3	0.5	2.2	2.3	4.9	0.0	25.4	2.4	0.0	0.0	0.0	0.0	0.0	20.4	0.5	2.9	0.1	0.1	0.1	19.6	0.0	25.6	0.0	15.4	6.7	0.0	0.0	20.2	2.8	74.3	0.0	0.6	0.0	6.8	5.1	0.0	14.4	4.5	3.4	0.0	0.0	0.0	10.7	8.1	0.0	0.0	0.0	0.0	0.3	1.6	0.3	23.8	0.0	0.0	3.9	3.7	4.1	0.2	0.0	11.4	0.1	0.0	0.0	0.0	0.0	0.0	0.1	18.4	7.2	3.4	0.0	24.6	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	1.9	2.2	1.9	2.3	1.2	5.6	7.9	4.5	4.5	3.3	4.9	0.3	12.8	1.8	2.6	0.0	0.1	0.1	13.3	0.0	0.0	0.0	0.0	14.4	0.0	6.7	46.0	0.0	0.0	0.0	0.1	0.0	0.1	4.4	0.1	0.1	0.5	1.8	0.0	4.8	0.2	0.0	2.9	0.0	0.1	0.0	1.5	0.4	0.1	0.0	0.0	139.0	0.0	8.2	1.0	0.0	2.6	0.6	0.2	0.0	2.8	7.2	0.0	0.0	1.5	79.2	0.0	0.0	0.0	0.0	0.2	0.0	0.2	4.8	0.0	0.0	26.2	3.3	7.9	7.1	0.0	0.0	0.0	0.1	1.5	0.0	0.2
TCF21	"bHLHa23, POD1"	ENSG00000118526	"Transcription factor 21"	O43680	6	133889113-133895553	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 100.4;ovary: 88.3;placenta: 137.2"	"Group enriched"	"Detected in some"	5	"Fibroblasts: 123.8;Leydig cells: 102.2;Peritubular cells: 116.9;Sertoli cells: 118.3"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in some"		"cerebral cortex: 1.7;hippocampal formation: 1.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"HHSteC: 51.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA013189	Uncertain					NA	NA				"Cluster 19: Lung - Lung function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 33: Fibroblasts - ECM organization"			"HPA013189: AB_10601215"	"unprognostic (2.43e-2)"	"unprognostic (8.45e-2)"	"unprognostic (2.22e-2)"	"unprognostic (1.60e-1)"		"unprognostic (8.60e-2)"	"unprognostic (4.78e-5)"	"unprognostic (2.58e-2)"		"unprognostic (6.66e-2)"	"unprognostic (9.74e-2)"	"unprognostic (2.88e-2)"	"unprognostic (2.91e-3)"	"unprognostic (2.01e-2)"	"unprognostic (8.48e-2)"	"unprognostic (5.37e-2)"	"unprognostic (2.95e-1)"	8.9	10.7	0.1	11.0	0.0	0.0	0.3	0.4	1.7	3.3	2.7	24.6	23.4	9.4	13.1	19.4	3.5	20.2	22.6	1.6	0.0	38.3	5.1	58.5	0.3	0.2	0.0	88.3	10.4	1.3	3.5	137.2	0.1	37.0	21.2	0.0	0.1	42.2	1.1	0.1	26.7	14.3	0.0	100.4	21.0	3.4	0.1	0.1	0.3	0.7	0.0	40.3	8.5	0.1	0.0	1.3	0.0	0.2	0.2	0.0	0.6	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.4	0.1	0.0	0.0	0.0	0.3	0.1	0.0	0.3	0.0	51.1	0.0	0.0	1.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.3	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	1.0	2.2	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	1.7	1.6	0.0	0.2	0.0	0.1	0.0	0.1	0.1	0.2	3.2	1.1	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.5	0.0	0.0	5.5	0.0	2.2	0.0	0.0	0.0	0.0	0.5	0.0	0.6	1.3	0.0	0.0	0.0	0.0	1.9	123.8	0.5	0.0	0.0	0.5	0.7	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	2.2	102.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	116.9	0.1	0.3	0.0	0.0	0.0	0.0	118.3	0.3	20.8	0.3	0.4	1.4	0.0	5.7	0.1	14.5	0.0	0.4
TBPL1	"STUD, TLF, TLP, TRF2"	ENSG00000028839	"TATA-box binding protein like 1"	P62380	6	133952170-133990432	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 126.7"	"Group enriched"	"Detected in all"	5	"Early spermatids: 407.5;Spermatocytes: 557.4;Syncytiotrophoblasts: 244.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA071810, HPA071813"	Enhanced		Supported	Nucleoplasm,Nucleoli		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm	Nucleoli	"HPA071810: AB_2686451, HPA071813: AB_2686452"	"unprognostic (2.21e-3)"	"unprognostic (1.95e-2)"	"unprognostic (5.11e-2)"	"unprognostic (6.67e-3)"	"prognostic favorable (7.22e-4)"	"unprognostic (5.16e-3)"	"prognostic unfavorable (7.91e-5)"	"unprognostic (1.19e-1)"	"unprognostic (3.94e-2)"	"unprognostic (4.66e-2)"	"prognostic favorable (7.23e-4)"	"unprognostic (2.56e-1)"	"prognostic unfavorable (4.14e-4)"	"unprognostic (1.03e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.82e-1)"	"unprognostic (8.16e-2)"	12.1	11.7	16.9	12.0	18.9	37.5	10.5	19.0	23.0	10.4	12.7	11.7	13.3	12.3	8.1	11.7	13.1	11.8	11.9	19.3	19.4	9.2	13.7	9.7	21.3	14.2	12.9	12.5	8.1	10.4	11.7	14.8	14.2	12.2	14.3	15.0	9.1	12.3	6.4	9.0	12.9	11.1	11.7	12.6	11.7	126.7	20.0	19.8	16.8	9.2	16.9	15.1	9.8	16.5	16.5	19.6	43.9	28.5	32.6	33.3	24.5	29.9	31.5	39.1	51.1	23.0	13.0	49.8	20.2	24.1	43.8	21.2	28.0	32.3	46.8	38.3	35.9	87.8	11.5	25.5	33.0	46.4	32.8	20.8	32.2	43.8	47.1	30.7	37.6	43.3	129.3	33.4	28.1	37.0	39.2	27.8	49.2	23.6	25.1	26.7	26.4	19.5	23.2	14.3	56.5	56.2	17.7	23.2	37.8	36.9	10.5	18.5	34.4	22.5	32.4	50.0	33.6	27.2	31.5	32.8	37.7	30.0	27.4	133.1	31.7	81.8	62.7	33.3	69.8	67.6	53.1	67.1	29.8	60.2	50.6	59.5	74.8	52.5	38.3	35.4	60.5	64.0	16.9	18.9	19.0	23.0	19.3	19.4	14.2	12.9	14.2	11.7	20.0	16.5	35.6	6.4	12.2	10.7	43.2	70.7	27.0	46.7	46.1	22.8	29.8	34.2	12.8	28.6	21.1	7.3	18.8	40.7	59.1	16.8	29.4	29.1	407.5	20.6	17.1	40.8	71.0	51.4	35.3	25.2	69.7	30.8	36.7	14.8	40.0	13.5	22.9	11.2	24.4	15.2	25.2	26.5	48.8	14.8	43.2	75.1	21.1	38.3	32.0	22.5	21.3	23.3	42.2	27.2	27.7	31.4	24.2	18.4	35.2	39.7	17.9	28.4	28.2	12.3	19.7	27.3	35.1	557.4	72.8	36.7	65.8	244.9	50.0	11.0	24.3	37.6
AL035699.1		ENSG00000288529	"Novel protein"		6	133953304-133980088	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in some"		"brain: 4.7;choroid plexus: 2.5;skeletal muscle: 2.1"	"Not detected"	"Not detected"							"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in single"	10	"REH: 2.7"															NA	NA			"Cluster 12: Non-specific - Basic cellular processes"		"Cluster 14: REH - Unknown function"																						0.0	0.1	2.0	0.0	2.3	0.0	0.0	0.5	4.7	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.0	2.4	1.9	0.0	1.2	0.0		0.0	2.7	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.5	0.7	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0		1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.8	12.5	28.7	23.9	12.4	16.3	44.8	15.9	22.4	9.6	38.7	18.7	19.0	25.7	14.0	14.2	9.4	26.5	28.8	2.0	2.3	0.5	4.7	0.8	0.1	2.4	1.9	2.7	0.5	1.2	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SLC2A12	"GLUT12, GLUT8"	ENSG00000146411	"Solute carrier family 2 member 12"	Q8TD20	6	133987581-134052624	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Sugar transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 87.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 24.8;Oligodendrocytes: 14.5;Syncytiotrophoblasts: 36.7"	"Cancer enriched"	"Detected in many"	6	"prostate cancer: 18.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 7.6;hTERT-RPE1: 14.8;SuSa: 21.7;U-2 OS: 7.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031593, HPA031594"	Approved		Supported	"Plasma membrane,Cell Junctions"		NA	NA				"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 12: NES - Nervous system development"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	"Plasma membrane"	"Cell Junctions"	"HPA031593: AB_10600810, HPA031594: AB_2673948"	"unprognostic (2.06e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.69e-2)"	"unprognostic (5.55e-3)"	"unprognostic (2.18e-1)"	"unprognostic (6.02e-2)"	"unprognostic (2.24e-3)"	"unprognostic (2.54e-2)"	"unprognostic (2.08e-2)"	"unprognostic (3.69e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.83e-1)"	"unprognostic (2.33e-3)"	"unprognostic (3.04e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.55e-3)"	0.5	1.0	3.6	0.3	4.8	0.0	1.1	7.8	4.6	3.0	87.3	2.1	7.3	8.2	2.1	6.1	2.8	2.6	10.7	5.7	2.6	5.8	6.8	3.1	0.1	2.3	3.1	1.2	1.1	2.3	1.4	1.6	2.5	22.4	1.0	2.3	5.1	9.3	3.8	2.7	9.8	3.1	1.6	0.1	14.3	0.4	3.4	1.0	0.2	4.1	1.2	3.5	1.2	3.1	2.5	0.9	2.3	0.0	1.4	0.7	0.1	1.5	5.4	0.7	2.9	0.0	7.6	0.3	1.2	0.1	5.7	5.9	0.0	0.5	1.0	0.0	5.3	0.0	0.8	0.1	0.2	0.0	0.0	1.0	0.5	0.6	0.1	14.8	0.4	0.4	0.5	0.8	0.1	0.8	0.1	0.1	2.0	0.0	0.5	0.0	1.0	2.2	1.6	0.8	0.2	0.7	0.1	2.1	0.0	21.7	0.1	0.0	0.1	0.2	7.6	0.2	0.9	3.2	2.4	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.6	4.8	7.8	4.6	5.7	2.6	2.3	3.1	2.5	1.6	3.4	3.1	0.2	0.0	7.7	24.8	0.1	2.0	1.0	3.3	8.6	0.4	0.5	2.2	6.3	0.0	2.2	0.0	0.0	2.0	0.1	1.2	3.9	1.5	0.1	3.4	0.4	2.3	4.2	0.0	8.0	0.2	0.6	2.2	2.6	1.6	0.0	0.4	0.0	1.1	0.3	0.0	3.2	0.2	6.1	0.0	0.3	0.0	0.0	0.1	0.0	4.7	0.1	9.8	0.0	4.5	14.5	1.1	2.4	1.5	1.6	10.5	0.5	0.5	10.4	0.5	0.0	2.1	1.3	0.0	0.0	8.6	1.8	36.7	0.2	3.5	0.4	1.3
SGK1	SGK	ENSG00000118515	"Serum/glucocorticoid regulated kinase 1"	O00141	6	134169246-134318112	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Apoptosis, Stress response"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 1007.1"	"Cell type enhanced"	"Detected in many"		"Langerhans cells: 1238.4;Proximal enterocytes: 789.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 43.4;eosinophil: 170.2;neutrophil: 91.6"	"Group enriched"	"Detected in all"	8	"granulocytes: 170.2;monocytes: 43.4"	"Cell line enhanced"	"Detected in many"		"HHSteC: 298.1;RPTEC TERT1: 469.5;SK-MEL-30: 319.7;TIME: 373.9;U-266/84: 358.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022085, CAB025148, HPA051251"	Approved		Enhanced	"Nuclear speckles"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 41: Macrophages - Immune response"	"Nuclear speckles"		"CAB022085: , CAB025148: , HPA051251: AB_2681407"	"unprognostic (2.05e-2)"	"prognostic favorable (5.26e-4)"	"unprognostic (1.12e-1)"	"unprognostic (5.09e-3)"	"unprognostic (2.76e-1)"	"unprognostic (4.20e-2)"	"unprognostic (4.53e-2)"	"unprognostic (5.62e-2)"	"unprognostic (4.03e-1)"	"unprognostic (7.94e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.55e-1)"	"unprognostic (5.82e-3)"	"unprognostic (9.10e-2)"	"unprognostic (3.81e-2)"	"unprognostic (1.79e-1)"	"unprognostic (6.59e-2)"	147.5	121.5	35.8	47.4	57.3	68.9	83.2	40.0	51.4	61.1	96.9	68.4	51.4	37.0	9.5	108.4	36.5	170.0	35.8	41.2	42.7	105.2	99.3	81.8	33.6	64.5	44.9	125.8	177.1	1007.1	12.0	70.6	49.6	47.6	39.0	14.1	70.8	60.3	50.2	75.7	282.5	48.4	35.8	21.5	104.2	30.4	53.6	39.7	56.7	33.9	78.1	141.3	96.7	94.0	4.1	6.9	4.2	0.4	51.7	12.9	5.9	76.7	159.4	98.4	79.8	12.2	10.6	13.1	11.3	79.8	48.0	2.5	6.8	12.2	72.0	0.5	3.1	0.6	175.7	9.2	298.1	0.7	6.8	77.3	75.4	96.7	124.3	39.3	167.1	2.3	25.6	192.8	35.6	0.6	1.1	3.0	4.8	20.3	8.3	2.4	8.9	1.5	469.5	1.4	2.2	18.6	241.7	0.7	319.7	43.2	0.5	2.1	373.9	28.8	12.3	176.9	17.1	36.2	358.5	40.3	26.7	12.0	39.5	2.2	43.4	170.2	0.7	24.4	1.6	1.9	1.3	0.8	14.1	1.4	1.6	2.0	91.6	3.6	14.5	0.9	2.5	12.6	35.8	57.3	40.0	51.4	41.2	42.7	64.5	44.9	49.6	35.8	53.6	94.0	346.2	38.5	177.8	34.0	68.0	183.3	133.7	277.3	329.0	12.0	87.1	112.0	28.4	88.6	168.6	68.0	35.5	41.0	27.0	132.2	21.5	81.3	9.6	145.8	73.1	232.1	10.7	14.7	68.2	171.2	33.6	88.8	206.4	483.4	271.8	33.9	353.4	21.9	284.2	0.0	225.7	65.1	91.6	181.3	1238.4	7.7	15.2	492.5	268.6	58.1	29.6	4.6	2.1	270.9	377.7	36.2	123.9	15.8	92.4	51.0	789.1	124.3	61.5	29.3	13.1	43.5	102.9	38.1	10.2	348.1	116.2	579.8	46.9	48.9	36.3	123.8
ALDH8A1	ALDH12	ENSG00000118514	"Aldehyde dehydrogenase 8 family member A1"	Q9H2A2	6	134917393-134950115	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	16	"kidney: 72.2;liver: 247.2"	"Group enriched"	"Detected in some"	4	"Hepatocytes: 142.5;Proximal tubular cells: 136.9"	"Group enriched"	"Detected in some"	7	"liver cancer: 26.3;renal cancer: 17.6"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"basophil: 2.5"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"HEK 293: 2.9;Hep G2: 2.9;K-562: 3.0;RPTEC TERT1: 3.3;U-266/70: 2.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA026292, HPA055414"	Enhanced		Approved	Nucleoplasm,Centrosome		NA	NA		110000	"Cluster 46: Basophils - DNA binding"	"Cluster 85: Liver - Metabolism"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Centrosome	Nucleoplasm	"HPA026292: AB_1844741, HPA055414: AB_2682810"	"unprognostic (1.12e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.70e-2)"	"unprognostic (6.32e-2)"	"unprognostic (4.30e-3)"	"unprognostic (1.12e-1)"	"unprognostic (3.98e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.39e-2)"	"unprognostic (3.99e-2)"	"prognostic favorable (9.87e-4)"	"unprognostic (1.25e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.36e-2)"	"unprognostic (5.86e-5)"	1.3	1.3	6.4	0.7	7.1	2.4	1.2	6.9	9.8	1.5	2.2	3.3	0.8	1.2	2.1	0.8	1.0	0.9	0.7	6.5	3.8	72.2	247.2	0.9	0.6	5.3	4.4	0.5	0.9	0.4	0.8	0.5	6.2	1.7	0.8	2.8	0.8	0.8	3.6	1.7	1.1	0.9	3.1	1.3	1.2	0.5	5.4	0.7	0.6	0.3	0.6	1.9	0.9	8.3	0.1	0.5	0.8	0.5	0.2	0.1	0.6	0.2	0.2	0.0	0.5	0.2	0.3	0.1	0.2	0.0	0.1	0.6	0.6	0.0	0.4	0.6	2.9	2.0	2.1	2.9	0.3	0.8	1.0	0.8	0.9	0.2	0.4	0.6	0.2	0.8	3.0	1.1	0.1	0.0	0.9	1.0	0.2	0.2	0.3	0.0	0.2	0.2	3.3	0.4	0.8	0.2	0.1	0.0	0.5	0.2	0.3	0.2	0.2	0.2	1.6	0.6	0.8	2.8	1.0	0.5	0.3	0.7	0.2	2.5	0.3	0.3	0.4	0.1	0.1	0.4	0.4	0.2	0.0	0.4	0.3	0.3	0.8	0.8	0.1	0.4	0.5	0.3	6.4	7.1	6.9	9.8	6.5	3.8	5.3	4.4	6.2	3.1	5.4	8.3	0.3	3.2	0.6	3.6	0.8	0.0	0.2	0.2	0.0	2.6	0.7	0.9	0.6	1.5	0.7	31.3	0.0	0.2	0.3	0.1	19.6	0.2	0.1	0.4	0.4	0.7	0.0	0.0	14.3	0.0	1.7	0.4	0.0	1.6	0.0	0.5	2.5	142.5	0.1	3.3	12.9	0.1	0.0	2.5	0.3	0.0	0.0	0.8	0.0	1.0	0.7	0.3	0.0	3.0	9.6	0.0	0.1	0.0	0.3	0.1	0.0	136.9	0.0	1.8	0.0	1.2	0.5	0.0	0.0	0.0	0.4	0.0	0.9	0.5	0.2	0.1
HBS1L	"DKFZp434g247, EF-1a, eRF3c, ERFS, HBS1, HSPC276, KIAA1038"	ENSG00000112339	"HBS1 like translational GTPase"	Q9Y450	6	134960378-135103056	"Predicted intracellular proteins, Predicted membrane proteins"	"Protein biosynthesis, Translation regulation"	"Elongation factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 198.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029728, HPA029729"	Approved		Approved	"Nuclear bodies,Cytosol"		NA	NA		9200	"Cluster 44: Non-specific - Transcription"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 36: HEL - Hemostasis"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nuclear bodies, Cytosol"		"HPA029728: AB_10611112, HPA029729: AB_10601228"	"unprognostic (3.68e-3)"	"unprognostic (6.39e-2)"	"prognostic favorable (6.77e-4)"	"unprognostic (1.26e-1)"	"unprognostic (2.51e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.89e-2)"	"unprognostic (8.66e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.23e-1)"	"unprognostic (7.73e-2)"	"unprognostic (3.84e-1)"	"unprognostic (4.98e-2)"	"unprognostic (1.47e-1)"	"unprognostic (4.20e-2)"	35.3	32.5	29.7	31.2	51.8	82.5	39.7	37.9	48.1	31.8	23.6	29.9	23.0	31.8	23.0	43.9	29.9	26.6	50.9	28.3	44.6	36.9	63.1	24.5	40.3	41.2	34.7	32.6	39.5	47.1	17.1	35.4	43.0	28.7	29.5	44.8	42.3	29.4	167.2	26.9	26.9	38.5	33.2	23.5	29.6	32.8	39.4	65.5	38.6	123.4	43.4	34.0	20.0	87.1	63.9	41.9	85.7	124.8	76.7	67.9	65.4	125.5	107.7	116.7	143.6	70.7	46.8	109.5	55.3	111.9	84.3	46.6	121.1	92.4	181.2	111.8	82.9	335.3	113.6	95.5	91.9	209.5	87.9	67.8	68.7	111.0	135.0	87.2	98.5	128.2	182.7	89.4	125.1	60.0	129.6	53.0	55.4	75.6	45.3	120.0	95.3	74.9	72.3	59.7	84.2	57.4	85.6	88.7	88.4	67.4	74.1	124.6	93.6	82.4	85.5	103.3	134.8	202.5	158.3	184.8	125.5	106.8	104.9	108.7	47.8	52.0	44.0	44.9	48.9	49.3	51.2	44.2	55.9	42.7	68.9	57.0	22.0	66.4	44.9	44.6	67.5	57.7	29.7	51.8	37.9	48.1	28.3	44.6	41.2	34.7	43.0	33.2	39.4	87.1	25.9	25.6	25.7	27.1	32.0	27.3	26.9	23.2	31.3	42.7	22.1	17.8	56.0	17.2	30.4	11.0	14.6	32.2	36.8	11.1	25.4	25.2	36.3	27.1	28.9	24.4	16.3	58.0	61.4	20.4	33.7	26.2	20.4	27.1	60.0	23.9	18.2	39.3	13.5	21.9	56.2	11.1	16.2	18.0	18.9	12.6	18.6	17.6	30.2	29.0	28.0	26.5	19.6	47.3	198.7	18.7	12.3	22.2	53.7	21.6	13.9	23.5	24.0	26.6	39.5	36.6	25.9	28.3	25.8	24.9	18.6	40.5	34.5	27.5	14.6	25.7
MYB	c-myb	ENSG00000118513	"MYB proto-oncogene, transcription factor"	P10242	6	135181308-135219173	"Cancer-related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 35.2;breast: 20.1;intestine: 26.5;lymphoid tissue: 66.1"	"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 47.8;Erythroid cells: 83.2;granulocytes: 26.0;Intestinal goblet cells: 32.7;Ionocytes: 26.4;Respiratory ciliated cells: 37.2;Undifferentiated cells: 52.0"	"Group enriched"	"Detected in many"	5	"breast cancer: 17.7;colorectal cancer: 16.4;stomach cancer: 5.6"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	5	"basophil: 4.6;eosinophil: 5.4;plasmacytoid DC: 1.5"	"Group enriched"	"Detected in many"	5	"dendritic cells: 1.5;granulocytes: 5.4"	"Cell line enhanced"	"Detected in many"		"HL-60: 219.8;MOLT-4: 403.1;NB-4: 208.5;REH: 244.9;THP-1: 343.8;U-937: 186.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB017704, HPA071605"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	Cytosol	"CAB017704: , HPA071605: "	"unprognostic (1.69e-1)"	"unprognostic (5.82e-2)"	"unprognostic (1.82e-3)"	"unprognostic (1.37e-2)"	"unprognostic (4.06e-1)"	"unprognostic (8.35e-3)"	"unprognostic (1.13e-3)"	"unprognostic (2.48e-2)"	"unprognostic (6.44e-2)"	"unprognostic (1.00e-1)"	"unprognostic (3.71e-2)"	"prognostic favorable (9.65e-4)"	"unprognostic (2.41e-11)"	"prognostic favorable (9.87e-4)"	"unprognostic (8.35e-2)"	"unprognostic (3.04e-2)"	"unprognostic (9.40e-2)"	0.3	0.5	1.6	5.3	1.7	35.2	20.1	0.0	0.7	1.6	0.4	25.3	10.9	1.0	0.1	3.0	8.4	0.9	0.1	0.3	0.2	0.1	0.4	2.0	6.3	0.9	1.0	0.0	0.3	3.6	0.0	0.4	0.6	1.4	26.5	0.3	0.6	0.9	0.1	3.0	9.4	1.4	0.2	1.2	2.0	0.7	0.3	66.1	0.1	0.0	7.0	1.1	1.3	0.1	1.8	0.3	1.9	3.0	0.0	0.1	0.3	1.0	0.6	1.1	1.1	0.3	1.4	10.9	0.4	0.3	0.4	0.9	5.6	0.0	0.7	18.0	2.5	138.8	1.0	0.5	0.1	219.8	105.1	0.0	0.1	0.6	0.0	0.5	0.3	133.4	114.6	20.1	1.1	11.6	403.1	208.5	1.5	19.2	1.7	244.9	5.9	33.2	0.3	1.5	10.5	6.9	0.5	10.4	0.6	0.5	7.9	343.8	0.4	0.3	1.6	7.9	2.4	27.7	7.7	66.0	0.1	186.1	2.3	4.6	0.7	5.4	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	1.5	0.4	0.2	1.6	1.7	0.0	0.7	0.3	0.2	0.9	1.0	0.6	0.2	0.3	0.1	0.2	0.0	1.3	0.0	2.3	2.7	1.3	1.3	0.6	0.9	47.8	12.6	0.4	2.8	7.1	0.0	0.0	1.4	9.1	18.1	0.0	0.0	0.1	24.3	0.3	0.3	17.6	83.2	0.6	0.8	0.4	0.5	4.6	2.2	26.0	0.4	0.0	0.0	1.1	0.0	2.7	32.7	26.4	1.2	1.7	0.2	0.0	2.1	8.8	0.0	2.8	0.9	0.0	0.0	0.2	0.1	10.2	0.0	4.6	2.1	2.3	0.0	37.2	0.0	0.0	0.6	0.9	0.0	1.8	10.2	7.0	0.3	3.6	0.1	52.0	2.2
AHI1	"FLJ20069, JBTS3, ORF1"	ENSG00000135541	"Abelson helper integration site 1"	Q8N157	6	135283407-135498434	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation, Differentiation"	"Developmental protein"	"Ciliopathy, Disease variant, Joubert syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 1121.7;Excitatory neurons: 633.2;Inhibitory neurons: 655.2;Rod photoreceptor cells: 1631.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031698, HPA046684"	Approved		Approved	Centrosome		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 77: Retina - Visual perception"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 9: Photoreceptor cells - Phototransduction"	Centrosome		"HPA031698: AB_2673997, HPA046684: AB_2679752"	"unprognostic (4.00e-2)"	"unprognostic (2.86e-1)"	"unprognostic (8.13e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.17e-2)"	"unprognostic (2.18e-2)"	"unprognostic (2.70e-3)"	"unprognostic (2.11e-1)"	"unprognostic (2.11e-1)"	"unprognostic (4.58e-2)"	"prognostic favorable (7.51e-5)"	"unprognostic (2.81e-2)"	"prognostic unfavorable (4.07e-9)"	"unprognostic (2.49e-2)"	"unprognostic (1.88e-1)"	"unprognostic (3.36e-2)"	"unprognostic (6.19e-3)"	5.8	9.4	6.2	2.8	4.9	1.7	5.8	12.6	10.6	8.0	5.7	7.0	1.9	7.8	6.1	3.8	8.6	3.2	5.9	4.1	16.4	5.5	5.3	6.4	1.9	5.9	9.2	10.6	9.1	7.0	29.6	3.3	4.8	9.3	3.9	27.2	6.6	5.7	5.5	4.5	4.8	5.0	2.2	2.8	7.0	13.3	19.5	3.6	7.2	3.4	1.9	7.0	6.2	12.7	4.8	6.7	7.9	8.8	11.6	15.0	3.0	9.3	11.7	8.3	14.5	1.7	3.4	6.8	4.6	9.1	8.4	3.2	6.3	1.7	12.5	6.2	6.3	2.5	15.0	4.2	6.0	14.5	2.8	6.2	3.4	12.7	5.1	15.3	8.8	8.1	14.8	0.6	14.0	4.4	4.4	1.7	5.9	2.8	4.9	6.8	4.3	2.7	3.4	3.0	12.2	6.5	12.2	3.9	5.6	5.3	3.2	7.1	6.9	6.9	8.7	11.3	8.2	6.7	11.0	3.5	8.5	2.3	12.7	11.1	2.5	0.1	6.0	0.8	3.4	11.5	5.7	6.0	3.6	14.1	4.3	5.6	0.2	6.4	0.8	21.9	3.3	0.9	6.2	4.9	12.6	10.6	4.1	16.4	5.9	9.2	4.8	2.2	19.5	12.7	32.7	38.5	93.8	162.6	35.6	28.7	38.2	11.2	37.0	296.1	41.1	38.6	26.7	25.8	35.1	58.8	1121.7	25.8	64.0	43.9	13.7	29.5	327.4	92.7	65.1	43.8	101.8	10.7	633.2	44.4	18.2	66.8	61.7	50.7	58.3	49.8	21.0	17.5	13.3	329.7	655.2	52.4	24.4	6.5	19.3	375.4	67.7	20.7	32.0	89.9	9.0	93.4	11.3	171.9	272.1	22.5	43.1	65.1	36.6	30.5	7.1	13.6	65.2	1631.4	52.6	81.6	37.6	137.4	127.1	18.1	22.6	28.6	38.6	52.8	42.5	24.9
PDE7B		ENSG00000171408	"Phosphodiesterase 7B"	Q9NP56	6	135851701-136195574	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 22.1"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 346.4;Excitatory neurons: 136.7;Inhibitory neurons: 166.0;Oligodendrocyte precursor cells: 343.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"naive B-cell: 1.3"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"ASC diff: 8.7;ASC TERT1: 10.2;EFO-21: 16.2;HeLa: 9.6;HSkMC: 22.4;HUVEC TERT2: 10.8;U-2197: 11.4"	"Region enriched"	"Detected in all"	5	"basal ganglia: 125.3"	"Low region specificity"	"Detected in all"			HPA023967	Uncertain		Approved	Nucleoplasm		No	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"HPA023967: AB_1855128"	"unprognostic (3.18e-1)"	"unprognostic (3.47e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.79e-3)"	"unprognostic (3.34e-1)"	"unprognostic (3.22e-4)"	"unprognostic (1.37e-2)"	"unprognostic (3.00e-1)"	"unprognostic (2.80e-1)"	"unprognostic (6.73e-3)"	"unprognostic (1.11e-2)"	"unprognostic (7.85e-2)"	"prognostic favorable (1.59e-4)"	"unprognostic (3.14e-3)"	"unprognostic (2.68e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.34e-2)"	5.2	2.3	6.5	2.2	22.1	0.1	2.6	3.6	8.1	3.9	2.8	2.5	1.9	7.8	2.2	1.3	2.8	3.4	6.6	2.6	8.7	5.5	3.7	1.7	1.5	6.2	11.6	13.0	0.8	6.2	4.8	1.0	6.0	4.3	2.7	2.4	2.9	10.3	4.7	0.8	2.2	7.6	4.6	1.1	3.6	1.5	15.8	3.8	4.7	8.9	0.8	6.0	3.6	2.8	0.0	5.7	0.2	0.0	8.7	10.2	0.1	0.5	2.9	2.1	1.1	0.0	0.1	0.1	16.2	3.6	0.0	0.0	0.0	0.0	0.7	0.0	0.2	0.0	9.6	0.0	3.7	0.1	0.0	22.4	0.0	4.2	0.0	0.9	10.8	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	3.8	0.7	3.9	3.7	0.1	0.2	0.0	0.0	1.8	0.0	2.3	0.0	11.4	0.0	0.1	0.0	0.0	0.6	0.0	0.9	0.0	0.3	0.2	0.0	0.0	0.0	0.4	0.1	0.0	0.8	1.3	0.5	0.3	0.0	0.2	0.0	0.0	0.0	0.1	6.5	22.1	3.6	8.1	2.6	8.7	6.2	11.6	6.0	4.6	15.8	2.8	8.3	0.0	0.5	346.4	11.9	0.4	0.3	0.5	0.0	4.4	0.9	0.4	8.4	2.8	0.2	22.0	0.0	0.1	0.7	0.1	0.0	0.2	0.5	3.1	1.4	23.1	7.3	0.8	136.7	1.6	0.0	9.8	4.6	2.1	10.2	31.1	35.3	3.8	0.3	6.7	166.0	0.0	0.0	1.9	4.8	0.9	12.2	3.2	0.0	70.3	0.7	11.5	0.0	343.8	10.4	0.1	0.0	7.9	0.2	0.4	0.0	1.6	1.6	0.9	13.1	30.6	9.1	0.3	0.1	0.2	1.4	0.0	2.9	4.4	0.0	0.3
MTFR2	"DUFD1, FAM54A"	ENSG00000146410	"Mitochondrial fission regulator 2"	Q6P444	6	136231024-136250335	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 16.3;lymphoid tissue: 6.4;testis: 7.0"	"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 23.6;Spermatocytes: 27.6;Spermatogonia: 13.0"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA029792, HPA029794"	Approved		Uncertain	Vesicles		NA	Yes			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 32: U-937 - Innate immune response"	"Cluster 12: Non-specific - Cell cycle regulation"	Vesicles		"HPA029792: AB_10600210, HPA029794: AB_10600535"	"unprognostic (6.49e-3)"	"unprognostic (6.29e-2)"	"unprognostic (1.65e-1)"	"prognostic unfavorable (9.64e-4)"	"unprognostic (3.93e-1)"	"unprognostic (1.75e-2)"	"unprognostic (4.60e-6)"	"prognostic unfavorable (8.28e-4)"	"unprognostic (3.77e-2)"	"unprognostic (1.22e-1)"	"unprognostic (6.27e-2)"	"unprognostic (6.54e-2)"	"unprognostic (1.11e-16)"	"unprognostic (8.82e-3)"	"unprognostic (1.55e-1)"	"unprognostic (4.10e-2)"	"unprognostic (3.64e-2)"	0.8	0.5	0.4	3.6	0.3	16.3	1.0	0.4	0.6	0.6	0.2	2.9	2.8	0.5	0.3	2.6	0.3	0.3	0.3	0.4	0.3	0.6	0.4	1.2	6.4	0.4	0.5	0.3	0.4	0.0	0.4	1.8	0.3	0.4	3.8	0.5	0.8	0.2	1.2	1.9	2.3	1.1	0.4	2.2	1.2	7.0	0.4	6.2	0.3	0.1	5.3	0.8	0.9	0.4	15.2	11.5	9.7	18.2	1.6	2.8	17.4	19.6	13.6	22.8	31.7	20.7	12.2	39.2	11.7	7.9	30.1	23.1	22.3	14.4	33.8	22.1	17.1	31.0	7.8	18.9	1.0	57.4	28.1	2.3	3.1	25.5	16.1	2.7	12.4	33.8	33.9	29.6	17.2	20.2	32.5	47.8	9.8	20.2	14.1	29.3	15.5	19.7	9.9	11.6	7.7	7.6	12.4	21.5	11.3	11.9	9.1	39.1	6.8	11.3	11.8	40.2	30.4	11.2	28.3	26.1	6.5	38.5	17.6	0.0	0.2	0.0	0.3	0.9	0.1	0.4	0.4	0.7	0.9	0.3	0.0	0.4	0.0	0.0	0.7	0.7	0.7	0.3	0.4	0.3	0.4	0.6	0.4	0.3	0.4	0.5	0.3	0.4	0.4	0.4	2.0	0.0	1.1	0.0	2.2	1.0	0.6	3.1	0.0	0.0	3.4	3.6	0.4	0.0	2.3	0.0	0.0	8.4	1.3	2.2	0.0	1.1	7.9	2.4	1.3	1.7	0.0	9.9	0.5	2.5	23.6	1.5	2.6	2.5	1.3	3.5	0.7	0.5	6.6	0.0	0.4	2.1	4.1	3.8	2.1	5.9	0.3	2.5	0.0	1.0	2.3	0.0	1.0	0.5	0.0	1.3	0.4	0.0	7.4	1.2	1.3	1.4	2.5	0.0	0.0	5.3	1.8	27.6	13.0	5.3	0.3	3.0	3.1	0.8	4.6	0.9
BCLAF1	"BTF, KIAA0164"	ENSG00000029363	"BCL2 associated transcription factor 1"	Q9NYF8	6	136256627-136289851	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	"DNA-binding, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 135.0"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006484, HPA006669, HPA027770"	Enhanced		Enhanced	"Nuclear speckles"		NA	NA		21000	"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	"Nuclear speckles"		"HPA006484: AB_2667600, HPA006669: AB_1078302, HPA027770: AB_1845484"	"prognostic unfavorable (1.64e-4)"	"unprognostic (1.60e-1)"	"prognostic favorable (3.44e-4)"	"unprognostic (1.45e-1)"	"unprognostic (9.46e-3)"	"unprognostic (2.29e-1)"	"unprognostic (2.13e-3)"	"unprognostic (1.63e-1)"	"unprognostic (5.07e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.69e-1)"	"unprognostic (1.40e-1)"	"unprognostic (7.20e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.56e-1)"	"unprognostic (7.93e-2)"	"unprognostic (4.19e-3)"	24.4	22.3	14.3	26.9	17.3	135.0	32.9	23.6	18.6	21.4	19.7	29.5	18.8	23.2	24.0	24.3	21.3	14.8	16.7	15.9	19.2	21.5	27.4	24.6	28.2	11.1	12.9	24.4	25.5	33.4	18.0	21.3	12.0	21.2	28.4	34.8	21.2	20.5	27.5	21.8	21.1	28.3	14.7	24.8	27.9	21.3	16.7	35.2	30.4	24.3	32.9	23.0	19.3	19.3	82.4	70.0	162.5	136.2	50.4	42.6	82.3	153.0	94.4	100.6	106.5	100.4	54.4	172.7	92.8	117.9	112.8	78.0	183.5	101.1	125.5	95.1	114.2	213.7	96.0	110.3	58.6	362.6	131.0	58.3	49.2	142.8	88.6	37.2	90.9	77.6	193.6	82.3	107.0	97.4	145.3	40.2	120.2	55.2	72.0	130.3	203.2	76.4	76.3	155.0	137.2	94.5	150.0	71.3	60.4	60.6	66.9	71.5	125.7	79.2	116.7	95.9	151.2	69.5	134.8	227.9	47.2	113.3	94.2	32.6	27.1	42.1	32.4	33.2	32.7	36.6	29.9	28.1	42.3	32.9	37.7	34.5	57.9	49.5	35.3	24.7	25.5	24.5	14.3	17.3	23.6	18.6	15.9	19.2	11.1	12.9	12.0	14.7	16.7	19.3	165.3	205.1	178.7	68.9	174.3	68.2	118.9	99.5	104.2	129.7	86.9	71.5	88.4	65.8	131.6	57.0	210.6	111.9	173.3	86.3	33.2	96.8	12.6	157.2	173.5	117.5	118.9	134.6	80.5	65.2	99.4	138.0	128.0	169.8	156.4	130.5	74.3	60.0	74.0	102.6	82.6	106.0	93.6	92.5	88.9	13.8	122.1	121.8	69.4	56.2	136.9	91.6	118.4	63.3	93.4	77.5	81.4	109.4	197.8	128.6	83.3	42.9	147.1	139.9	111.7	259.8	130.7	102.2	129.7	121.4	71.2	128.3	174.8	154.8	101.6	123.8
MAP7	E-MAP-115	ENSG00000135525	"Microtubule associated protein 7"	Q14244	6	136342281-136550819	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 130.4"	"Cell type enriched"	"Detected in many"	4	"Oligodendrocytes: 1501.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 12.2"	"Group enriched"	"Detected in many"	4	"dendritic cells: 5.7;granulocytes: 12.2;monocytes: 3.1"	"Cell line enhanced"	"Detected in many"		"CACO-2: 59.8;HeLa: 69.2;MCF7: 88.5;OE19: 55.3;RT4: 68.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029712, HPA029713"	Enhanced		Supported	Microtubules,Cytosol		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 45: Intestine - Brush border"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Cytosol	Microtubules	"HPA029712: AB_10600303, HPA029713: AB_10601339"	"unprognostic (8.68e-3)"	"prognostic unfavorable (9.70e-5)"	"unprognostic (2.33e-3)"	"unprognostic (4.35e-3)"	"unprognostic (6.95e-2)"	"unprognostic (3.35e-1)"	"prognostic favorable (9.22e-4)"	"unprognostic (1.24e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.72e-1)"	"unprognostic (4.61e-2)"	"unprognostic (3.33e-1)"	"prognostic favorable (5.07e-7)"	"unprognostic (1.62e-3)"	"unprognostic (7.84e-2)"	"unprognostic (3.62e-1)"	"unprognostic (6.51e-2)"	2.7	8.4	36.6	4.9	81.2	4.8	13.1	53.0	49.8	6.1	0.6	24.6	29.0	2.4	19.5	15.8	10.0	8.2	1.4	40.2	59.8	32.6	17.2	7.0	1.5	78.0	67.2	1.5	25.1	24.9	12.0	6.8	75.8	20.0	23.2	57.3	20.3	6.4	0.8	17.1	26.6	2.4	43.3	1.8	18.7	27.4	63.0	5.1	16.1	0.2	5.1	12.0	9.6	130.4	25.6	39.2	0.3	0.1	0.2	0.2	40.4	0.7	1.2	0.4	0.7	59.8	26.3	0.1	5.3	0.8	6.7	38.2	11.1	34.6	0.7	0.2	24.6	26.6	69.2	0.5	0.3	26.1	3.0	0.1	31.5	0.2	2.4	1.0	0.2	2.0	18.4	0.6	0.1	88.5	0.2	2.6	5.2	55.3	5.7	0.1	1.0	4.8	23.6	68.4	24.4	5.2	27.4	51.7	0.6	9.1	20.5	2.6	0.5	0.1	1.9	0.4	1.7	4.6	6.4	0.2	0.5	10.1	0.7	2.8	2.3	0.0	0.0	1.6	0.3	1.4	0.5	0.0	5.7	1.6	0.1	0.0	12.2	0.7	3.1	0.0	0.2	0.7	36.6	81.2	53.0	49.8	40.2	59.8	78.0	67.2	75.8	43.3	63.0	130.4	4.0	57.7	51.4	117.2	1.9	28.2	48.7	21.7	33.6	367.0	29.5	18.4	3.0	28.6	42.9	18.4	146.0	33.1	0.7	67.9	31.3	35.8	293.9	30.4	5.9	4.9	117.7	35.1	217.1	49.0	23.1	4.4	42.8	60.8	0.0	1.2	0.7	37.0	16.3	304.5	258.6	81.5	22.4	3.2	8.5	53.1	6.8	6.2	17.8	15.0	3.2	50.9	0.0	26.2	1501.2	37.2	51.9	3.4	4.4	56.6	60.7	81.8	56.0	104.7	19.7	2.0	5.2	37.5	23.4	49.0	30.4	76.2	3.4	2.8	64.2	62.8
MAP3K5	"ASK1, MAPKKK5, MEKK5"	ENSG00000197442	"Mitogen-activated protein kinase kinase kinase 5"	Q99683	6	136557046-136792477	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"	"Apoptosis, Host-virus interaction, Immunity, Innate immunity, Stress response"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 88.1"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 383.6;Excitatory neurons: 170.4;Inhibitory neurons: 204.8;Microglial cells: 216.4;Oligodendrocyte precursor cells: 210.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 42.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB007824, HPA063245"	Supported		Supported	Cytosol		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 35: Non-specific - Unknown function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol		"CAB007824: AB_598175, HPA063245: AB_2684969"	"unprognostic (1.37e-1)"	"unprognostic (3.21e-2)"	"unprognostic (2.85e-2)"	"unprognostic (1.38e-1)"	"unprognostic (3.19e-1)"	"prognostic favorable (6.08e-4)"	"unprognostic (8.76e-2)"	"unprognostic (1.41e-2)"	"unprognostic (2.84e-1)"	"unprognostic (1.90e-2)"	"prognostic unfavorable (5.91e-4)"	"unprognostic (3.97e-1)"	"unprognostic (3.75e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.72e-1)"	"unprognostic (2.72e-2)"	"unprognostic (6.59e-3)"	13.2	88.1	21.7	11.7	23.6	14.1	9.5	21.6	18.9	8.4	7.0	8.7	7.3	11.3	7.7	10.0	12.9	7.5	11.3	18.6	18.9	10.6	9.0	11.9	12.1	17.2	20.7	49.3	30.9	1.9	16.2	5.3	16.1	18.0	9.7	14.5	7.1	7.1	6.3	8.0	9.0	5.1	16.6	11.7	14.8	12.0	24.8	8.2	12.8	6.1	12.3	18.5	9.2	15.7	5.6	3.4	0.0	0.0	7.6	20.2	1.9	8.0	42.6	4.0	3.8	0.3	5.6	3.3	11.5	11.1	3.0	7.6	13.6	4.1	10.5	4.6	10.6	28.9	7.6	0.0	36.3	13.6	0.1	26.8	5.3	6.3	17.9	15.4	13.6	4.1	7.3	31.2	28.7	10.9	0.3	11.6	1.3	10.9	4.5	7.6	8.9	13.2	16.2	35.3	9.7	6.4	6.6	6.3	1.8	1.4	1.4	12.0	12.0	6.7	2.1	0.4	7.5	25.3	18.0	0.0	5.3	18.6	6.0	3.5	1.8	2.1	1.5	1.4	2.9	1.1	2.5	2.2	1.5	1.5	0.2	0.8	5.2	2.3	1.4	1.5	4.6	0.9	21.7	23.6	21.6	18.9	18.6	18.9	17.2	20.7	16.1	16.6	24.8	15.7	11.9	6.4	22.0	383.6	14.3	5.0	20.5	32.0	3.4	18.2	10.0	5.0	21.2	4.3	35.1	11.0	6.2	1.0	25.9	12.3	3.9	3.0	6.4	17.3	31.4	7.7	34.8	14.9	170.4	23.1	1.1	12.1	20.9	62.5	5.7	67.7	9.7	11.2	8.0	0.0	204.8	18.2	14.2	23.5	10.2	4.2	23.6	26.6	0.0	216.4	21.7	43.3	12.3	210.1	4.2	17.8	8.7	14.3	13.5	18.8	7.2	8.3	20.5	2.6	13.1	5.3	17.9	3.4	15.5	13.1	10.1	2.7	18.5	16.2	11.2	23.4
PEX7	"PTS2R, RD"	ENSG00000112357	"Peroxisomal biogenesis factor 7"	O00628	6	136822564-136913934	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Protein transport, Transport"		"Cataract, Deafness, Disease variant, Ichthyosis, Peroxisome biogenesis disorder, Retinitis pigmentosa, Rhizomelic chondrodysplasia punctata"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 60.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049202	Uncertain		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Vesicles"		"HPA049202: AB_2680674"	"unprognostic (1.36e-2)"	"unprognostic (2.07e-2)"	"prognostic favorable (1.61e-4)"	"unprognostic (4.01e-3)"	"unprognostic (2.50e-2)"	"unprognostic (6.38e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.71e-2)"	"unprognostic (4.87e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.49e-1)"	"unprognostic (6.88e-2)"	"prognostic favorable (1.85e-10)"	"unprognostic (3.57e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.52e-2)"	"unprognostic (2.65e-1)"	5.2	14.8	4.6	2.0	4.8	3.8	11.9	6.0	5.2	6.8	5.1	7.9	5.3	4.2	17.2	7.3	8.7	4.5	11.7	4.2	4.2	15.6	9.1	4.9	3.2	4.3	4.4	5.0	26.9	17.1	6.0	4.1	4.5	10.4	8.4	6.9	10.6	6.4	10.7	11.2	4.7	3.3	4.4	3.3	15.6	10.0	4.7	3.7	11.0	9.8	3.3	5.4	6.7	5.5	4.4	4.3	4.4	6.2	6.6	9.8	2.4	6.1	8.9	7.5	7.4	4.9	6.0	1.5	11.3	8.3	8.5	5.3	3.3	13.8	9.8	5.7	7.5	6.4	4.3	0.9	13.9	8.1	5.3	9.6	13.1	5.4	7.9	8.7	5.4	12.0	13.0	5.2	10.6	13.4	3.5	7.9	5.0	13.9	8.3	4.8	3.4	5.7	17.4	6.4	8.3	10.6	6.5	9.0	8.4	4.9	5.8	7.7	2.5	4.8	1.7	7.3	5.3	6.9	5.1	0.0	4.2	6.4	4.9	2.9	1.3	2.2	0.7	1.0	0.7	1.5	1.3	1.6	2.3	1.0	2.4	1.5	0.9	1.6	1.9	1.8	2.3	0.9	4.6	4.8	6.0	5.2	4.2	4.2	4.3	4.4	4.5	4.4	4.7	5.5	4.9	3.2	9.4	10.7	6.3	12.1	14.9	16.5	9.1	9.1	19.5	13.8	18.7	11.5	14.7	11.0	8.4	19.6	2.3	11.6	60.7	16.5	12.5	18.7	6.4	5.6	10.3	15.8	12.4	22.7	21.0	6.8	10.2	11.1	14.0	7.9	6.1	7.0	12.4	0.0	14.7	21.8	30.5	5.7	6.2	10.2	9.0	6.4	14.2	5.6	11.9	20.8	4.1	17.6	19.9	16.7	13.2	9.8	3.7	16.0	15.0	38.3	16.1	9.9	6.6	5.7	8.2	30.6	16.7	15.4	18.2	17.1	6.6	24.3	17.2	17.4
SLC35D3	FRCL1	ENSG00000182747	"Solute carrier family 35 member D3"	Q5M8T2	6	136922301-136925660	"Predicted membrane proteins, Transporters"	"Sugar transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	6	"brain: 5.3"	"Cell type enriched"	"Detected in single"	9	"Ionocytes: 8.2"	"Group enriched"	"Detected in some"	5	"colorectal cancer: 3.3;stomach cancer: 0.9"	"Group enriched"	"Detected in many"	7	"basal ganglia: 3.4;cerebral cortex: 1.5;hypothalamus: 5.2;midbrain: 2.1;thalamus: 5.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"SH-SY5Y: 15.4"	"Group enriched"	"Detected in many"	5	"basal ganglia: 29.6;olfactory bulb: 8.5"	"Region enriched"	"Detected in many"	6	"basal ganglia: 20.1"	"HPA030431, HPA067497"	Uncertain		Approved	"Centriolar satellite"		NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 51: Myeloid cells - Hemostasis"	"Centriolar satellite"		"HPA030431: AB_10601716, HPA067497: AB_2685854"	"unprognostic (6.56e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.43e-1)"	"unprognostic (5.45e-2)"	"unprognostic (1.08e-1)"	"unprognostic (5.84e-2)"		"unprognostic (2.48e-1)"		"unprognostic (9.94e-2)"	"unprognostic (7.36e-2)"	"unprognostic (4.65e-2)"		"unprognostic (1.37e-1)"	"unprognostic (1.62e-1)"	"unprognostic (4.45e-1)"	"unprognostic (1.03e-1)"	0.0	0.9	0.4	0.0	3.4	0.2	0.0	0.0	1.5	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.4	0.0	0.3	2.1	0.0	0.4	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.6	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.6	15.4	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	3.4	0.0	1.5	0.0	5.2	0.3	2.1	0.2	0.2	5.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	8.2	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.3	0.0	0.1	0.1	0.1
IL20RA	"IL-20R1, ZCYTOR7"	ENSG00000016402	"Interleukin 20 receptor subunit alpha"	Q9UHF4	6	136999971-137045180	"Predicted intracellular proteins, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 26.4;skin 1: 37.7"	"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 58.6;Endometrial ciliated cells: 110.4;Glandular and luminal cells: 69.8;Muller glia cells: 54.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 9.5;HaCaT: 6.9;OE19: 10.1;RT4: 11.5;SH-SY5Y: 10.8;T-47d: 10.7"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"CAB024990, HPA042281"	Approved		Approved	Cytosol		NA	NA				"Cluster 31: Skin - Epidermis development"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 44: Endometrium - Transcription"	Cytosol		"CAB024990: , HPA042281: AB_10806235"	"unprognostic (3.75e-2)"	"unprognostic (8.23e-2)"	"unprognostic (1.96e-2)"	"prognostic favorable (1.43e-6)"	"unprognostic (1.57e-2)"	"prognostic favorable (2.29e-5)"	"unprognostic (9.87e-3)"	"unprognostic (1.64e-1)"	"unprognostic (2.43e-1)"	"unprognostic (3.78e-1)"	"unprognostic (8.03e-3)"	"unprognostic (2.18e-1)"	"unprognostic (1.85e-6)"	"unprognostic (9.38e-2)"	"unprognostic (1.88e-1)"	"unprognostic (3.09e-3)"	"unprognostic (1.64e-3)"	0.9	8.8	3.0	0.7	3.5	0.1	26.4	3.9	2.7	17.1	4.9	4.6	3.1	5.9	4.4	7.0	17.3	4.9	2.4	2.4	3.9	0.4	0.4	5.9	0.0	3.7	4.7	4.9	7.9	2.8	1.6	0.2	4.0	8.6	4.6	4.9	9.7	5.5	0.7	37.7	1.3	3.0	4.3	0.0	6.2	2.0	4.2	1.6	1.1	2.4	2.6	6.0	11.9	3.5	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.2	0.1	0.0	9.5	0.0	0.1	1.5	0.1	6.9	1.2	0.1	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.6	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	1.3	10.1	1.4	0.0	0.4	0.0	0.0	11.5	0.7	10.8	0.5	0.0	0.0	0.0	10.7	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	3.5	3.9	2.7	2.4	3.9	3.7	4.7	4.0	4.3	4.2	3.5	1.4	3.2	26.1	6.2	0.0	21.9	12.0	12.7	6.2	3.5	58.6	39.5	4.6	37.1	22.3	3.7	0.0	2.7	0.5	12.1	0.0	15.3	0.8	110.4	8.0	1.1	7.3	0.0	0.1	0.7	10.6	5.0	19.9	69.8	2.5	0.1	0.4	0.0	0.5	0.0	1.3	23.1	28.5	0.0	1.6	0.9	8.7	0.8	14.2	0.0	0.0	54.6	0.0	3.0	0.3	13.1	11.7	15.1	0.0	18.7	1.7	1.2	36.0	1.3	0.0	2.3	1.7	0.3	3.8	25.3	18.0	8.2	1.3	6.4	12.3	21.1
IL22RA2	"CRF2-S1, IL-22BP"	ENSG00000164485	"Interleukin 22 receptor subunit alpha 2"	Q969J5	6	137143820-137173648	"Predicted secreted proteins"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"breast: 3.6;lymphoid tissue: 3.2"	"Group enriched"	"Detected in some"	5	"Breast glandular cells: 8.9;Breast myoepithelial cells: 9.8"	"Low cancer specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"U-937: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA030582, CAB034906"	Uncertain				"Secreted to blood"	NA	NA	40500000			"Cluster 16: Immune cells - Immune response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 35: Glandular cells - Unknown function"			"CAB034906: AB_2124501, HPA030582: AB_10600716"	"unprognostic (1.09e-1)"	"unprognostic (7.97e-4)"	"unprognostic (1.32e-3)"	"unprognostic (1.24e-2)"		"unprognostic (4.03e-3)"		"unprognostic (1.11e-1)"	"unprognostic (4.51e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.10e-1)"		"unprognostic (7.58e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.62e-1)"	"unprognostic (6.61e-2)"	0.0	0.0	0.0	1.4	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.6	0.2	0.0	0.0	1.1	0.3	0.0	0.0	0.3	0.0	0.0	3.2	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.6	0.3	0.1	0.0	0.0	0.0	8.9	9.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.1	0.0	0.0	0.1
IFNGR1	"CD119, IFNGR"	ENSG00000027697	"Interferon gamma receptor 1"	P15260	6	137197485-137219449	"CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		Receptor	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Basal respiratory cells: 867.1;Club cells: 405.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025889, HPA029213, HPA063871"	Approved		Supported	"Plasma membrane"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 2: Immune cells - Immune response"	"Cluster 21: OE19 - Mitochondria"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Plasma membrane"		"CAB025889: , HPA029213: AB_10601023, HPA063871: AB_2685138"	"unprognostic (1.73e-1)"	"unprognostic (8.86e-2)"	"unprognostic (9.85e-3)"	"unprognostic (1.71e-1)"	"unprognostic (6.55e-2)"	"unprognostic (1.25e-1)"	"unprognostic (4.05e-1)"	"unprognostic (6.97e-2)"	"unprognostic (9.86e-2)"	"unprognostic (1.57e-2)"	"unprognostic (4.09e-2)"	"unprognostic (2.85e-1)"	"prognostic unfavorable (5.48e-4)"	"unprognostic (1.58e-1)"	"unprognostic (2.87e-2)"	"unprognostic (1.81e-2)"	"unprognostic (5.38e-3)"	155.5	59.3	54.6	131.5	57.8	146.2	121.4	64.5	72.1	74.1	56.8	74.7	97.9	58.1	67.4	65.0	55.7	88.4	103.7	53.1	59.9	44.4	104.0	153.8	140.2	71.9	60.3	43.3	44.5	47.4	26.3	86.1	75.9	53.2	74.4	40.4	57.7	57.4	58.3	66.2	101.2	75.9	69.2	165.9	51.3	27.9	59.9	69.2	58.3	75.5	135.2	112.6	58.0	85.0	23.2	23.4	25.1	33.4	166.8	86.7	23.0	67.0	90.0	38.0	53.3	148.7	39.8	24.5	99.2	36.1	55.1	130.0	24.1	62.6	51.5	49.4	37.4	36.1	23.3	192.9	97.3	112.9	46.6	195.9	232.6	33.3	51.4	36.1	48.7	29.1	32.0	34.9	29.2	27.7	17.7	47.0	22.0	191.9	18.6	51.3	28.4	32.1	65.5	104.4	27.4	39.5	77.3	41.9	57.5	47.8	15.5	68.7	71.1	36.2	27.7	48.5	31.8	25.3	25.5	23.8	19.4	69.2	36.5	158.6	518.4	356.3	106.9	502.6	224.7	91.3	60.0	90.0	309.4	98.3	39.2	43.1	736.0	48.4	375.6	85.1	48.0	519.3	54.6	57.8	64.5	72.1	53.1	59.9	71.9	60.3	75.9	69.2	59.9	85.0	298.7	80.1	59.9	21.5	76.4	127.6	177.6	867.1	84.2	15.4	49.8	37.3	49.6	37.1	405.7	27.6	12.5	78.5	240.8	111.0	7.9	74.2	11.6	91.4	52.7	110.7	13.1	25.7	21.4	101.4	67.1	94.7	33.6	112.8	63.3	10.3	62.8	56.5	149.8	10.1	24.2	25.5	270.6	326.2	220.0	6.1	44.1	261.7	49.8	147.1	138.4	23.5	52.5	25.1	44.9	76.0	57.6	49.2	74.5	129.6	82.0	17.2	150.6	28.1	13.1	45.7	75.7	14.6	22.4	47.3	113.2	209.9	121.5	48.3	33.9	140.2
OLIG3	"Bhlhb7, bHLHe20"	ENSG00000177468	"Oligodendrocyte transcription factor 3"	Q7RTU3	6	137492199-137494394	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"NTERA-2: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA018303, CAB024865"	Uncertain					NA	NA					"Cluster 12: NES - Nervous system development"	"Cluster 44: Endometrium - Transcription"			"CAB024865: , HPA018303: AB_1854796"				"unprognostic (1.07e-3)"							"unprognostic (1.44e-1)"	"unprognostic (2.77e-1)"			"unprognostic (2.03e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TNFAIP3	"A20, OTUD7C"	ENSG00000118503	"TNF alpha induced protein 3"	P21580	6	137867214-137883312	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins"	"Apoptosis, Inflammatory response, Ubl conjugation pathway"	"DNA-binding, Hydrolase, Multifunctional enzyme, Protease, Thiol protease, Transferase"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 519.5"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 774.9;Endometrial ciliated cells: 605.2;Glandular and luminal cells: 1498.3;Macrophages: 596.6;Suprabasal keratinocytes: 745.7;T-cells: 624.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"GAMG: 106.5;Karpas-707: 161.3;REH: 151.5;U-266/84: 131.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002116	Approved		Approved	Centrosome,Cytosol		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 41: Macrophages - Immune response"	"Centrosome, Cytosol"		"HPA002116: AB_1858162"	"unprognostic (5.50e-3)"	"unprognostic (9.98e-3)"	"unprognostic (3.06e-2)"	"unprognostic (1.01e-2)"	"unprognostic (4.01e-2)"	"unprognostic (9.47e-2)"	"unprognostic (5.01e-3)"	"unprognostic (4.40e-2)"	"unprognostic (2.92e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.06e-1)"	"prognostic unfavorable (6.05e-4)"	"unprognostic (6.06e-2)"	"unprognostic (3.55e-3)"	"unprognostic (1.27e-1)"	"unprognostic (6.29e-2)"	57.0	15.6	4.4	114.6	3.8	519.5	23.3	2.9	23.9	27.5	12.0	22.6	21.4	31.3	5.2	26.6	23.4	47.8	23.0	3.2	2.8	13.8	27.4	56.2	76.8	6.1	3.9	73.2	25.8	25.8	7.5	28.9	6.7	17.3	24.7	19.1	16.1	10.3	8.6	50.5	30.7	33.5	6.6	46.1	22.8	8.3	9.5	71.1	11.7	3.8	55.7	171.1	14.6	6.2	32.6	4.8	1.8	2.8	10.1	16.9	7.8	18.8	67.6	4.8	5.7	34.9	8.8	7.3	43.1	20.0	106.5	22.6	1.1	50.4	8.9	46.8	2.2	7.5	19.8	21.1	11.2	10.3	12.8	15.6	7.3	56.4	53.6	5.6	2.9	21.2	17.4	161.3	8.4	1.8	56.2	41.4	1.5	2.1	1.4	151.5	39.4	6.1	14.8	15.1	0.7	0.3	3.6	5.3	16.9	7.0	3.4	11.7	14.8	46.9	6.8	46.0	9.6	48.7	131.4	14.0	16.9	13.1	6.1	7.3	12.6	9.6	19.6	9.3	27.9	7.4	19.4	18.0	14.3	7.8	13.1	10.1	13.6	11.1	5.1	26.2	19.2	14.8	4.4	3.8	2.9	23.9	3.2	2.8	6.1	3.9	6.7	6.6	9.5	6.2	71.8	38.5	76.3	2.0	94.5	774.9	150.2	102.1	384.7	1.1	29.0	42.3	4.6	25.8	53.7	0.0	29.2	8.1	395.5	53.9	1.9	60.0	2.6	605.2	365.9	114.8	11.9	5.2	0.1	26.9	104.8	110.1	111.1	1498.3	255.9	2.3	48.5	13.5	45.7	0.0	0.3	38.6	67.1	125.2	461.8	3.2	6.8	596.6	129.9	8.4	59.1	1.7	14.4	2.0	0.3	30.5	29.5	6.0	331.4	170.2	37.3	3.1	84.3	13.3	6.6	29.0	94.9	2.7	2.2	367.9	745.7	23.1	624.2	14.9	20.9	78.1
PERP	"dJ496H19.1, KCP1, KRTCAP1, PIGPC1, THW"	ENSG00000112378	"P53 apoptosis effector related to PMP22"	Q96FX8	6	138088505-138107419	"Predicted membrane proteins"	"Apoptosis, Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 782.9;skin 1: 1115.1"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 3312.8;Squamous epithelial cells: 3451.4;Suprabasal keratinocytes: 5828.3"	"Cancer enhanced"	"Detected in all"		"head and neck cancer: 555.1"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	4	"basophil: 39.8"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 39.8"	"Cell line enhanced"	"Detected in many"		"hTCEpi: 1024.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA022269	Enhanced					NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 61: Squamous epithelial cells - Keratinization"			"HPA022269: AB_1855219"	"prognostic unfavorable (5.46e-4)"	"unprognostic (2.90e-1)"	"unprognostic (1.94e-1)"	"unprognostic (5.18e-2)"	"unprognostic (2.82e-2)"	"unprognostic (1.27e-1)"	"unprognostic (6.28e-3)"	"prognostic unfavorable (3.73e-4)"	"unprognostic (1.92e-1)"	"unprognostic (1.57e-1)"	"prognostic unfavorable (1.05e-5)"	"unprognostic (4.02e-2)"	"unprognostic (6.05e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.51e-2)"	27.1	9.3	7.0	9.9	7.1	1.5	131.0	7.8	8.6	201.6	13.7	40.9	50.2	23.2	47.9	782.9	61.2	37.9	53.9	6.8	8.1	21.9	93.7	27.0	3.3	9.2	7.8	6.4	33.1	40.6	13.1	38.7	8.6	60.7	38.4	8.7	295.9	46.8	5.7	1115.1	52.0	19.8	7.8	1.4	65.1	3.1	9.3	23.3	24.6	16.3	149.4	60.2	426.4	6.3	81.5	80.3	3.7	11.3	60.0	63.1	172.7	115.5	129.8	17.6	12.9	64.8	143.1	1.5	45.5	37.5	144.0	268.4	15.6	207.6	4.5	126.9	64.6	1.5	70.7	69.8	42.6	1.7	1.0	44.3	1024.8	2.2	111.8	91.7	71.3	5.8	2.4	31.3	3.0	53.4	1.5	4.6	34.4	174.6	47.1	1.5	28.6	0.9	108.2	94.0	29.3	3.7	141.2	68.7	59.6	90.7	36.4	18.4	82.6	29.4	12.1	31.7	2.1	11.1	17.4	1.3	23.0	1.5	65.5	39.8	0.0	0.0	4.3	0.0	7.6	2.0	5.3	3.8	0.0	1.0	0.6	2.3	0.3	0.1	0.0	0.0	8.9	1.3	7.0	7.1	7.8	8.6	6.8	8.1	9.2	7.8	8.6	7.8	9.3	6.3	13.9	211.5	84.2	0.7	8.1	3312.8	1415.8	1383.2	1110.4	3.3	371.4	305.0	137.7	260.2	728.5	154.5	16.7	994.5	17.6	374.8	62.6	588.0	2.1	1013.4	78.1	71.8	147.2	13.9	1.2	305.1	990.1	83.8	197.2	777.1	10.8	0.5	21.4	171.3	82.0	3.3	2.1	185.0	736.5	3.8	259.2	2.7	10.5	12.8	350.4	12.2	10.3	29.1	3.1	2.0	0.5	655.0	316.7	2.6	43.2	789.2	355.0	10.6	743.5	28.3	6.6	15.4	82.6	2.4	1.4	3451.4	5828.3	824.0	67.2	73.5	218.6	1546.6
ARFGEF3	"BIG3, C6orf92, dJ171N11.1, KIAA1244, PPP1R33"	ENSG00000112379	"ARFGEF family member 3"	Q5TH69	6	138161939-138344663	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 28.4;salivary gland: 18.0"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 114.6;Excitatory neurons: 200.9;Inhibitory neurons: 207.8;Oligodendrocyte precursor cells: 173.9;Oligodendrocytes: 378.1"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 24.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"MCF7: 14.8;RH-30: 13.4;RT4: 19.4;SK-BR-3: 22.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036350	Uncertain					NA	NA				"Cluster 22: Non-specific - Unknown function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"			"HPA036350: AB_10672084"	"prognostic unfavorable (8.20e-4)"	"unprognostic (4.31e-2)"	"unprognostic (9.91e-3)"	"unprognostic (5.91e-2)"	"unprognostic (2.20e-2)"	"unprognostic (4.53e-2)"	"unprognostic (4.30e-3)"	"unprognostic (1.21e-2)"	"unprognostic (7.41e-2)"	"unprognostic (7.82e-2)"	"unprognostic (3.46e-2)"	"unprognostic (4.93e-2)"	"unprognostic (1.31e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.38e-1)"	"unprognostic (8.87e-2)"	"unprognostic (1.69e-2)"	1.2	3.8	13.4	0.7	16.4	0.4	7.9	20.1	17.7	5.0	0.0	4.2	2.2	0.7	0.9	0.4	2.2	1.7	1.0	16.7	13.0	2.1	0.1	6.4	0.2	11.1	17.7	0.1	8.7	15.8	7.0	1.4	14.4	12.0	4.8	2.8	18.0	1.0	0.2	1.2	1.9	0.7	7.5	0.4	10.0	0.6	15.2	0.1	1.9	0.7	0.2	3.4	0.4	28.4	8.0	3.1	0.0	0.6	0.0	0.0	4.7	0.3	0.2	0.2	0.0	0.1	0.4	0.0	3.1	0.3	2.7	2.6	3.8	2.0	0.0	0.0	4.9	0.0	1.5	0.9	0.0	3.0	0.0	0.0	0.9	0.0	0.9	3.5	4.1	2.7	0.0	4.9	0.0	14.8	0.0	0.0	2.7	8.5	3.4	0.6	13.4	2.6	2.6	19.4	6.9	0.0	7.8	22.2	0.9	0.3	4.4	0.0	0.4	0.2	2.2	0.0	7.9	1.7	6.7	0.0	3.2	1.8	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.4	16.4	20.1	17.7	16.7	13.0	11.1	17.7	14.4	7.5	15.2	28.4	9.4	16.0	114.6	34.3	0.5	0.0	18.8	0.0	6.2	19.0	39.9	12.6	6.4	14.3	44.6	3.7	0.0	16.5	0.8	2.5	3.9	11.4	83.0	8.6	1.4	11.9	66.7	2.7	200.9	24.7	2.4	4.1	41.3	17.7	2.5	0.1	8.2	0.3	1.4	11.8	207.8	44.2	0.0	0.0	0.0	22.0	0.0	0.5	0.0	36.5	2.0	0.9	0.0	173.9	378.1	14.2	8.4	0.0	0.9	67.6	2.5	0.3	37.2	3.3	0.0	3.5	0.9	4.1	1.1	3.0	0.0	6.2	0.8	0.1	13.2	42.7
PBOV1	"UC28, UROC28"	ENSG00000254440	"Prostate and breast cancer overexpressed 1"	Q9GZY1	6	138215986-138218491	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in single"	12	"brain: 3.1"	"Cell type enhanced"	"Detected in single"		"Bipolar cells: 1.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA063021, HPA069649"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 69: Cerebellum - Gene expression regulation"		"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm	Cytosol	"HPA063021: AB_2684923, HPA069649: "	"unprognostic (3.32e-3)"							"unprognostic (8.23e-2)"		"unprognostic (9.35e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.77e-2)"		"unprognostic (2.51e-1)"			"unprognostic (1.35e-4)"	0.0	0.0	0.7	0.0	1.1	0.2	0.0	2.7	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.7	0.1	0.0	0.0	0.0	0.9	0.6	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.7	1.1	2.7	0.9	1.2	0.7	0.9	0.6	0.7	0.3	0.8	3.1	0.0	0.0	0.5	0.3	0.0	0.0	0.3	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.7	0.3	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2
SMIM28		ENSG00000262543	"Small integral membrane protein 28"	A0A1B0GU29	6	138377905-138383486	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enriched"	"Detected in single"	4	"intestine: 2.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"									NA	NA				"Cluster 37: Intestine - Unknown function"																	"unprognostic (2.50e-2)"		"unprognostic (5.48e-2)"				0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
HEBP2	"C6orf34, SOUL"	ENSG00000051620	"Heme binding protein 2"	Q9Y5Z4	6	138403531-138422197	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Pancreatic endocrine cells: 678.8;Urothelial cells: 1174.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"THP-1: 219.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016928	Approved					NA	NA		690000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 22: Epithelial cell types - Mixed function"			"HPA016928: AB_1850572"	"unprognostic (8.53e-2)"	"unprognostic (1.54e-1)"	"unprognostic (7.92e-2)"	"unprognostic (6.88e-2)"	"unprognostic (7.96e-2)"	"unprognostic (1.48e-1)"	"unprognostic (5.60e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.48e-1)"	"unprognostic (3.49e-2)"	"unprognostic (2.37e-1)"	"prognostic unfavorable (2.47e-5)"	"unprognostic (2.76e-3)"	"unprognostic (2.64e-1)"	"unprognostic (1.11e-1)"	"prognostic favorable (3.07e-4)"	168.1	34.4	13.9	15.0	11.2	31.8	147.3	13.8	13.8	50.6	14.8	51.7	21.9	35.2	28.0	131.1	30.4	12.8	78.5	11.2	15.8	42.4	72.3	26.4	7.0	14.1	17.4	27.8	37.2	14.6	27.2	13.3	14.8	52.7	19.2	10.1	72.2	10.5	132.8	80.4	32.7	13.3	13.4	17.6	54.3	7.5	22.9	8.6	27.0	33.5	12.3	51.5	81.5	12.5	42.8	8.6	13.6	45.4	42.5	17.1	88.2	45.7	12.8	6.0	9.9	23.2	28.3	1.3	74.0	24.0	29.0	40.0	13.2	22.7	3.4	31.0	60.8	17.4	8.7	42.9	24.8	27.4	0.1	20.8	25.8	6.5	22.6	32.2	23.7	31.5	40.7	23.4	10.5	34.9	9.0	83.7	17.7	22.2	33.1	29.1	20.5	26.1	26.5	31.8	31.0	5.7	47.5	85.5	29.4	21.0	27.6	219.5	28.9	14.5	40.8	18.7	46.1	36.5	31.5	17.2	25.2	41.6	9.4	5.6	7.9	5.6	1.5	8.2	2.0	5.0	4.3	2.5	7.4	2.9	2.0	1.7	14.6	1.9	5.0	4.6	6.4	2.3	13.9	11.2	13.8	13.8	11.2	15.8	14.1	17.4	14.8	13.4	22.9	12.5	106.3	19.2	31.6	5.9	48.7	117.5	387.1	73.4	71.7	28.6	274.7	262.4	160.8	190.1	98.1	121.4	14.6	273.3	49.2	231.9	295.4	304.3	4.5	167.0	104.2	91.7	102.2	38.3	1.1	578.1	408.5	70.7	72.9	229.9	45.1	38.4	74.6	547.6	93.6	18.5	1.0	169.4	79.3	84.7	58.5	10.9	67.7	70.9	58.7	8.4	98.3	90.5	51.5	3.5	1.8	678.8	224.6	66.5	68.2	510.0	115.2	353.0	72.7	38.9	59.2	78.4	89.0	11.7	58.2	201.2	204.9	291.3	59.9	29.2	141.8	1174.8
NHSL1	"bA43P8.1, C6orf63, KIAA1357"	ENSG00000135540	"NHS like 1"	Q5SYE7	6	138422043-138692571	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 23.2"	"Cell type enriched"	"Detected in many"	4	"Astrocytes: 502.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"intermediate monocyte: 1.6;non-classical monocyte: 1.6"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"Hep G2: 46.2;TIME: 64.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029966, HPA029967"	Uncertain		Approved	"Nucleoplasm,Nuclear membrane"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 45: Intestine - Brush border"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Nuclear membrane"	Nucleoplasm	"HPA029966: AB_10601972, HPA029967: AB_2673271"	"unprognostic (1.85e-1)"	"unprognostic (9.71e-2)"	"unprognostic (6.19e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.93e-1)"	"unprognostic (3.27e-1)"	"unprognostic (8.34e-2)"	"unprognostic (5.21e-2)"	"unprognostic (9.99e-2)"	"unprognostic (1.10e-1)"	"unprognostic (8.00e-2)"	"unprognostic (4.19e-2)"	"unprognostic (3.73e-2)"	"unprognostic (1.52e-1)"	"unprognostic (6.55e-2)"	"unprognostic (4.06e-2)"	4.1	1.2	15.7	2.4	14.1	0.3	2.5	9.7	8.5	2.4	16.6	13.2	15.8	1.2	4.6	10.4	1.0	3.0	15.7	14.6	11.2	5.8	14.8	12.8	1.0	16.2	15.9	0.5	3.3	2.1	1.1	4.3	10.7	0.8	11.4	2.6	3.5	0.5	0.5	11.4	23.2	3.2	9.2	2.6	7.8	0.4	14.4	0.6	1.4	0.8	2.1	2.7	4.5	5.6	5.5	4.7	32.8	13.8	9.4	11.4	12.2	4.8	2.3	1.7	1.6	6.2	3.1	0.0	6.0	4.1	3.1	12.3	20.0	12.5	0.9	0.4	13.4	3.4	2.2	46.2	13.8	12.4	2.3	16.7	7.0	0.9	14.1	1.8	23.3	1.9	0.0	1.8	7.2	10.7	1.3	1.0	13.1	3.1	8.8	14.1	3.4	1.0	11.2	13.7	12.4	0.0	5.1	10.3	33.4	21.5	3.3	3.9	64.3	4.6	4.5	4.6	13.3	1.2	2.7	0.0	0.4	5.0	25.5	0.4	1.2	0.2	0.0	1.6	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	1.6	0.3	0.0	0.2	15.7	14.1	9.7	8.5	14.6	11.2	16.2	15.9	10.7	9.2	14.4	5.6	6.2	60.9	66.9	502.1	0.5	42.8	3.1	6.6	4.0	0.6	4.1	6.0	22.7	15.7	9.9	29.5	29.2	14.2	0.1	84.1	9.8	3.7	1.1	19.0	1.8	9.3	20.3	2.7	3.3	3.6	3.5	15.6	16.8	16.9	8.8	1.5	26.4	38.1	4.5	37.0	2.9	32.3	6.1	9.4	7.1	0.4	0.6	7.5	21.4	104.0	0.6	15.4	0.0	79.9	2.3	3.9	43.0	0.0	0.1	5.4	87.3	15.8	22.0	1.4	6.6	2.3	4.7	0.0	1.1	7.7	49.2	43.4	1.8	0.8	45.4	10.5
CCDC28A	"C6orf80, CCRL1AP, DKFZp586D0623"	ENSG00000024862	"Coiled-coil domain containing 28A"		6	138773769-138793319	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 146.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055125	Approved		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 24: NB-4 - Immune response"	"Cluster 39: Non-specific - Basic cellular processes"	"Plasma membrane"	Nucleoplasm	"HPA055125: AB_2682705"	"unprognostic (1.51e-1)"	"unprognostic (6.88e-3)"	"unprognostic (2.70e-1)"	"unprognostic (6.67e-2)"	"unprognostic (7.96e-2)"	"unprognostic (9.66e-3)"	"unprognostic (1.16e-1)"	"unprognostic (2.58e-3)"	"unprognostic (3.80e-1)"	"unprognostic (8.34e-3)"	"unprognostic (4.29e-3)"	"unprognostic (1.02e-1)"	"prognostic favorable (1.11e-5)"	"unprognostic (1.63e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.28e-2)"	"unprognostic (2.37e-2)"	21.8	48.4	41.8	19.6	42.5	40.1	28.1	38.4	48.7	23.8	47.1	23.8	30.4	16.7	38.1	16.4	35.8	23.8	19.1	43.8	43.2	59.9	67.8	26.2	35.4	38.5	38.8	21.8	35.5	53.0	29.5	32.1	39.3	25.0	24.3	25.6	52.3	20.2	15.7	18.0	30.7	15.9	37.8	29.8	29.3	23.8	41.1	46.5	54.2	21.3	33.6	26.2	17.2	39.0	7.2	12.9	9.5	17.4	17.5	24.4	19.4	11.7	20.3	15.2	24.6	11.1	14.1	31.1	22.3	11.8	21.3	12.3	15.6	16.2	24.4	35.9	35.7	25.3	16.3	22.1	27.6	43.8	25.6	15.7	20.2	10.9	32.0	31.0	25.1	43.1	25.8	42.2	17.1	15.9	36.3	58.0	8.9	28.9	13.2	21.7	9.5	29.2	18.3	10.6	11.8	18.4	15.6	13.8	34.9	18.6	6.7	47.6	19.5	11.9	13.5	22.3	18.0	55.8	53.0	23.1	12.7	27.1	10.6	137.8	91.6	120.6	84.5	96.5	76.4	107.1	88.4	92.8	102.1	106.6	101.5	93.3	249.6	115.8	85.0	90.0	159.8	93.6	41.8	42.5	38.4	48.7	43.8	43.2	38.5	38.8	39.3	37.8	41.1	39.0	24.5	32.1	35.4	12.7	36.5	13.4	25.0	36.9	29.0	16.0	24.6	25.1	11.0	24.3	31.6	36.8	18.8	82.7	42.7	31.7	123.3	19.3	146.8	83.5	11.4	20.7	24.7	39.2	25.6	31.6	49.2	23.2	16.3	15.6	43.1	25.3	29.3	50.8	38.0	10.1	22.3	30.6	38.7	41.5	31.5	99.9	16.8	36.1	32.0	3.7	39.5	24.6	42.2	5.5	17.9	16.8	35.9	15.1	29.7	31.2	81.0	130.9	89.0	14.2	13.1	14.0	15.8	48.6	27.2	15.5	14.9	108.9	35.4	18.1	23.1	36.2
ECT2L	"ARHGEF32, C6orf91, FBXO49, LFDH"	ENSG00000203734	"Epithelial cell transforming 2 like"	Q008S8	6	138795911-138904070	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"fallopian tube: 8.7"	"Cell type enriched"	"Detected in some"	6	"Respiratory ciliated cells: 91.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"HEL: 1.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA035488	Uncertain					NA	NA				"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 36: HEL - Hemostasis"	"Cluster 49: Ciliated cells - Cilium organization"			"HPA035488: AB_10672865"	"unprognostic (2.88e-2)"	"unprognostic (7.88e-2)"	"unprognostic (2.52e-2)"	"unprognostic (5.53e-3)"	"unprognostic (3.48e-2)"	"unprognostic (8.45e-3)"	"unprognostic (9.42e-2)"	"unprognostic (2.44e-2)"	"unprognostic (1.18e-1)"	"unprognostic (7.03e-2)"	"unprognostic (5.90e-4)"	"unprognostic (2.32e-1)"	"unprognostic (5.21e-2)"	"unprognostic (1.38e-2)"	"unprognostic (7.27e-2)"	"unprognostic (7.07e-3)"	"unprognostic (2.65e-3)"	0.1	0.3	1.2	0.1	0.4	0.3	0.3	0.8	0.7	0.4	1.7	0.1	0.0	0.2	0.0	0.1	8.7	0.0	1.7	1.3	0.4	0.0	0.0	1.5	0.1	1.9	1.6	0.0	0.0	0.0	0.1	0.0	0.6	0.1	0.0	0.4	0.2	0.0	0.2	0.4	0.0	0.1	1.2	0.1	0.1	0.4	0.5	0.0	0.1	0.0	0.0	0.3	0.1	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	1.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.7	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.4	0.8	0.7	1.3	0.4	1.9	1.6	0.6	1.2	0.5	0.7	0.2	0.0	1.1	2.3	0.1	0.5	0.7	1.6	0.0	2.1	0.3	0.1	2.3	0.0	12.7	0.0	2.1	0.1	0.6	0.1	0.0	0.0	5.1	15.0	0.5	0.8	0.0	0.0	6.1	0.0	0.0	0.9	0.0	1.4	0.0	0.3	0.0	0.0	0.1	0.0	6.7	0.0	0.0	0.0	0.4	5.4	0.0	0.1	0.0	1.0	0.0	2.0	0.0	2.0	3.2	0.0	0.0	0.0	0.4	0.3	0.0	0.0	91.4	3.2	0.0	1.2	0.5	0.5	0.1	0.0	0.0	0.3	0.6	0.2	0.0	0.3
REPS1		ENSG00000135597	"RALBP1 associated Eps domain containing 1"	Q96D71	6	138903493-138988261	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 207.3;Excitatory neurons: 114.3;Inhibitory neurons: 138.1;Oligodendrocyte precursor cells: 99.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029961, HPA029962"	Approved		Approved	"Vesicles,Plasma membrane,Cytosol"		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 68: Epididymis - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Vesicles, Plasma membrane, Cytosol"		"HPA029961: AB_10603233, HPA029962: AB_2673269"	"unprognostic (1.72e-3)"	"unprognostic (9.61e-2)"	"unprognostic (5.82e-3)"	"unprognostic (2.77e-2)"	"unprognostic (6.30e-3)"	"unprognostic (1.90e-1)"	"prognostic unfavorable (9.47e-4)"	"unprognostic (3.79e-1)"	"unprognostic (2.49e-1)"	"unprognostic (9.71e-3)"	"unprognostic (4.29e-3)"	"unprognostic (4.42e-2)"	"unprognostic (2.69e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.83e-2)"	"unprognostic (2.69e-2)"	13.5	11.9	24.7	14.9	25.4	23.2	23.6	27.7	36.8	19.2	14.8	17.4	15.4	21.9	40.2	28.0	18.4	14.0	23.9	27.4	24.0	17.4	31.3	15.2	19.4	25.2	23.9	21.1	18.8	41.0	31.7	17.2	21.3	15.9	17.3	38.8	26.1	16.2	17.5	30.0	16.4	19.5	21.5	22.1	18.1	35.6	25.9	36.0	17.8	12.6	22.2	19.5	20.1	25.3	29.3	22.6	42.3	53.1	23.4	41.6	46.2	27.8	30.7	31.9	38.2	54.1	24.8	35.2	22.9	38.9	38.0	33.6	48.7	42.0	42.1	37.6	41.9	29.6	12.9	32.9	35.3	94.6	45.9	34.1	33.7	58.6	70.3	30.2	33.5	51.2	40.2	35.1	41.4	49.4	53.9	51.3	40.4	37.4	21.3	62.4	26.0	20.0	26.5	43.6	37.7	37.2	25.7	38.7	38.0	62.0	18.6	64.4	32.9	17.8	29.6	48.5	38.8	34.4	33.7	49.2	21.1	38.3	26.4	5.9	1.3	1.9	2.2	4.0	3.8	3.0	2.9	3.2	1.9	1.6	2.9	3.6	0.7	2.9	4.5	3.5	3.3	1.2	24.7	25.4	27.7	36.8	27.4	24.0	25.2	23.9	21.3	21.5	25.9	25.3	11.8	19.2	7.4	207.3	18.0	13.4	11.7	7.9	22.2	12.6	13.7	9.5	28.4	10.0	12.2	5.5	16.7	25.6	18.9	11.9	7.9	7.8	13.7	17.5	9.7	10.3	6.0	5.0	114.3	7.1	28.3	11.5	16.3	23.3	15.9	14.4	15.7	43.8	13.3	13.5	138.1	12.8	6.1	24.0	10.3	7.7	7.2	17.2	5.4	47.8	10.5	36.8	15.5	99.5	71.2	8.9	14.7	8.6	23.9	11.2	13.5	8.6	16.5	14.4	19.7	16.8	10.9	41.7	33.8	26.4	14.9	28.6	18.7	7.6	15.2	18.1
ABRACL	"C6orf115, Costars, HSPC280, PRO2013"	ENSG00000146386	"ABRA C-terminal like"	Q9P1F3	6	139028745-139043302	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Proximal tubular cells: 440.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HL-60: 501.5;NB-4: 530.8;U-937: 515.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030217	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA		9200000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 34: Non-specific - Transcription"	"Cluster 32: U-937 - Innate immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm	Cytosol	"HPA030217: AB_10602335"	"unprognostic (1.10e-2)"	"unprognostic (1.63e-1)"	"unprognostic (9.30e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.72e-1)"	"unprognostic (7.93e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.21e-1)"	"unprognostic (8.17e-2)"	"unprognostic (2.16e-1)"	"unprognostic (3.07e-3)"	"unprognostic (5.90e-3)"	"unprognostic (3.63e-2)"	"unprognostic (3.29e-2)"	"prognostic favorable (1.65e-6)"	20.1	9.6	16.8	73.7	16.2	87.7	44.9	13.5	20.8	20.7	14.7	95.0	74.1	22.0	136.0	42.0	12.4	36.0	13.3	18.6	15.7	50.0	60.7	31.2	123.1	14.7	14.6	4.1	16.1	49.1	14.4	29.1	16.2	16.3	86.5	5.4	40.8	12.2	3.0	38.8	74.4	23.5	14.9	73.9	34.4	32.3	16.4	139.6	42.4	7.5	87.9	79.6	17.1	16.0	76.8	40.7	100.7	94.8	39.7	62.2	110.6	59.7	42.9	44.5	91.2	91.2	87.4	0.4	105.8	59.8	189.5	112.9	90.4	130.0	51.9	204.4	167.4	297.8	20.7	31.6	57.6	501.5	130.5	55.9	108.2	59.9	49.1	79.4	237.5	204.9	38.4	100.4	129.5	162.7	314.2	530.8	120.9	119.1	78.5	199.8	62.3	23.8	121.7	225.0	225.4	24.8	40.5	112.3	194.5	141.9	45.1	369.8	175.7	28.2	24.0	58.9	107.7	54.1	169.2	20.9	35.7	515.5	84.2	232.3	178.0	114.2	161.1	334.3	252.2	93.8	259.3	208.2	193.9	96.9	250.9	235.9	48.8	152.1	514.5	215.9	260.2	347.8	16.8	16.2	13.5	20.8	18.6	15.7	14.7	14.6	16.2	14.9	16.4	16.0	54.2	19.2	22.2	2.0	87.1	139.6	71.4	195.2	108.1	0.3	86.6	67.8	3.8	27.1	126.2	44.1	0.0	77.1	151.3	304.5	60.7	145.3	4.8	85.8	20.1	55.0	43.1	75.7	12.8	145.0	207.7	23.5	55.5	129.0	79.4	59.9	53.6	254.3	353.1	0.0	9.1	116.8	162.8	286.1	133.9	13.7	4.7	187.6	87.2	5.6	167.9	49.8	189.5	1.0	1.0	167.4	250.6	12.8	121.0	47.9	247.5	440.3	74.1	1.3	32.9	7.2	37.3	3.6	7.7	116.6	90.1	48.6	198.5	17.7	123.6	133.8
HECA	"dJ225E12.1, HDC, HDCL, hHDC"	ENSG00000112406	"Hdc homolog, cell cycle regulator"	Q9UBI9	6	139135080-139180802	"Predicted intracellular proteins"		"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 125.8;Langerhans cells: 153.3;Suprabasal keratinocytes: 142.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012581, HPA042313"	Uncertain		Approved	Cytosol		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol		"HPA012581: , HPA042313: AB_10796903"	"unprognostic (2.98e-2)"	"unprognostic (2.39e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.40e-1)"	"unprognostic (7.31e-2)"	"unprognostic (3.38e-3)"	"unprognostic (4.29e-2)"	"unprognostic (3.27e-1)"	"unprognostic (7.39e-2)"	"unprognostic (2.00e-2)"	"unprognostic (5.77e-2)"	"unprognostic (1.80e-1)"	"prognostic unfavorable (8.09e-4)"	"unprognostic (3.47e-1)"	"unprognostic (2.59e-1)"	"unprognostic (4.72e-3)"	"unprognostic (5.77e-2)"	17.2	8.7	10.5	21.5	10.4	39.2	14.2	10.1	13.8	13.8	7.8	12.7	16.5	13.4	6.4	19.3	12.6	13.1	17.4	12.1	11.3	6.4	10.8	19.2	28.8	10.7	11.1	16.7	9.9	9.7	7.0	10.9	12.6	9.5	12.4	3.9	17.9	8.1	20.3	26.1	17.6	13.8	11.9	27.5	12.0	9.5	12.4	31.6	9.6	15.8	25.8	14.2	15.9	14.1	4.8	1.0	9.2	10.5	20.8	19.0	6.8	8.6	14.4	3.8	8.8	1.9	5.3	20.9	12.2	17.9	9.1	7.9	5.6	7.8	7.0	32.9	11.9	10.5	4.6	0.3	6.5	18.6	9.2	21.7	18.8	8.3	10.1	10.4	12.9	13.8	4.5	27.5	7.1	4.9	9.0	15.1	1.7	4.2	1.7	14.0	9.3	10.6	3.3	15.2	8.8	2.6	7.1	19.1	5.5	10.2	4.4	24.4	16.4	6.7	6.3	15.2	7.5	16.4	13.1	18.8	2.4	10.7	3.8	7.0	1.3	2.0	2.8	1.8	3.5	1.5	4.3	3.8	1.0	1.9	4.1	4.1	5.0	1.5	5.5	1.1	3.9	1.4	10.5	10.4	10.1	13.8	12.1	11.3	10.7	11.1	12.6	11.9	12.4	14.1	35.6	6.4	13.9	10.1	38.2	125.8	22.4	15.9	38.7	1.8	29.1	14.4	41.9	8.6	11.6	11.0	2.1	7.3	70.2	53.4	0.0	7.0	12.0	37.8	18.5	34.9	13.1	22.5	20.4	9.8	6.2	22.3	11.7	53.4	13.3	11.7	36.8	13.0	19.1	1.7	23.2	25.5	16.2	84.3	153.3	12.4	15.5	65.7	44.4	38.4	25.7	6.6	29.9	13.0	10.9	14.7	28.4	19.5	48.8	42.4	34.8	4.7	12.3	2.7	52.6	26.4	23.7	12.6	6.7	33.7	142.2	17.4	76.7	10.8	17.2	59.1
TXLNB	"C6orf198, dJ522B19.2, DKFZp451A175, MDP77"	ENSG00000164440	"Taxilin beta"	Q8N3L3	6	139240061-139291998	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	17	"heart muscle: 82.0;skeletal muscle: 300.0;tongue: 189.1"	"Group enriched"	"Detected in many"	4	"Cardiomyocytes: 260.7;Late spermatids: 67.2"	"Cancer enhanced"	"Detected in some"		"glioma: 2.1"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in single"		"memory B-cell: 1.8"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"Daudi: 5.0;HSkMC: 3.0;REH: 2.6;RPMI-8226: 3.8;U-698: 7.1"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"HPA030401, HPA030402, HPA030403"	Enhanced					NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 54: Cardiomyocytes - Muscle contraction"			"HPA030401: AB_2673459, HPA030402: AB_10602486, HPA030403: AB_2673461"	"unprognostic (1.54e-1)"	"unprognostic (7.01e-3)"	"unprognostic (1.50e-1)"	"unprognostic (1.32e-1)"	"unprognostic (5.75e-3)"	"unprognostic (2.94e-1)"	"unprognostic (1.09e-2)"	"unprognostic (6.00e-2)"	"unprognostic (2.06e-1)"	"unprognostic (8.10e-3)"	"unprognostic (4.79e-1)"	"unprognostic (5.15e-2)"	"unprognostic (2.16e-4)"	"unprognostic (2.19e-2)"	"unprognostic (2.21e-1)"	"unprognostic (2.65e-1)"	"unprognostic (8.05e-4)"	1.1	1.5	0.7	2.5	0.5	0.2	2.2	0.4	0.8	0.9	0.3	1.3	0.6	2.8	0.6	4.4	1.8	2.2	82.0	1.2	1.5	0.1	0.3	1.2	3.1	1.1	1.1	11.4	0.2	2.8	1.2	0.6	1.8	3.0	0.9	0.3	2.4	0.3	300.0	0.6	1.5	2.2	2.0	2.2	0.9	3.8	0.8	7.7	0.3	189.1	3.5	1.1	0.6	1.9	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.5	0.6	0.0	0.0	0.0	1.3	0.2	3.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	1.4	0.2	0.2	0.5	0.6	0.1	0.0	0.3	2.6	1.1	3.8	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.6	1.5	0.9	0.0	0.0	0.0	0.1	0.8	1.4	7.1	0.2	1.4	0.0	0.0	0.0	0.0	0.1	0.1	0.2	1.8	0.1	0.3	0.0	0.8	0.1	0.0	0.7	0.1	0.1	0.1	0.1	0.1	0.7	0.5	0.4	0.8	1.2	1.5	1.1	1.1	1.8	2.0	0.8	1.9	2.0	0.0	0.0	4.9	5.9	0.5	0.3	0.6	0.0	0.1	2.0	0.5	260.7	0.0	1.6	1.8	0.0	0.1	0.7	0.0	0.0	0.0	38.5	4.3	0.3	4.9	0.0	2.7	8.7	0.0	0.0	11.4	0.5	0.4	0.0	0.2	0.7	0.4	1.7	0.0	17.4	0.0	0.0	6.6	6.0	67.2	0.6	4.1	5.4	12.2	0.6	6.5	2.1	2.5	4.0	0.0	0.0	2.2	7.4	0.1	0.0	0.0	17.8	0.1	0.0	25.8	2.2	3.8	1.2	0.3	0.4	0.0	2.0	5.9	0.0	0.1
CITED2	MRG1	ENSG00000164442	"Cbp/p300 interacting transactivator with Glu/Asp rich carboxy-terminal domain 2"	Q99967	6	139371807-139374648	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Differentiation, Stress response, Transcription, Transcription regulation"	"Activator, Developmental protein, Repressor"	"Atrial septal defect, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Extravillous trophoblasts: 685.3;Plasma cells: 619.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 27.7"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ: 618.3;fHDF/TERT166: 1070.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016157, CAB069879"	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 55: Plasma cells - Humoral immune response"	Nucleoplasm		"CAB016157: AB_668099, CAB069879: AB_10003446"	"unprognostic (7.42e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.56e-2)"	"unprognostic (8.34e-2)"	"unprognostic (4.03e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.87e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.05e-2)"	"unprognostic (1.11e-2)"	"unprognostic (3.61e-3)"	"unprognostic (1.00e-2)"	"prognostic favorable (3.40e-4)"	"prognostic unfavorable (3.33e-4)"	"unprognostic (1.08e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.03e-1)"	177.7	107.4	3.8	49.8	2.2	313.6	117.5	29.3	24.0	60.5	5.4	88.0	36.7	188.0	38.7	75.5	207.7	32.6	70.9	1.9	9.3	70.7	203.4	134.0	37.9	8.5	6.5	270.3	74.7	179.0	17.7	104.1	8.3	44.2	42.5	36.4	120.5	42.8	107.6	131.7	65.3	81.9	0.9	136.5	69.5	22.0	19.4	25.1	227.7	24.9	30.4	37.9	64.0	0.7	23.7	13.7	46.7	138.2	191.8	203.7	175.6	618.3	456.0	274.7	255.7	122.5	35.2	17.0	88.5	1070.3	58.5	28.0	14.2	14.5	192.4	467.0	45.8	346.9	76.0	10.1	157.1	103.1	36.5	164.6	64.4	121.3	91.4	177.9	51.2	10.1	132.9	80.1	359.2	51.0	17.5	128.3	43.8	15.0	21.2	24.7	34.2	152.3	131.7	52.5	51.8	0.8	45.2	167.6	21.2	106.8	72.3	348.3	283.6	219.9	69.5	66.4	35.0	23.4	22.6	26.3	68.0	86.9	15.8	3.1	8.2	27.7	3.4	4.6	5.0	1.2	5.4	4.9	3.6	3.1	4.7	2.4	4.0	3.0	6.6	1.6	3.6	3.3	3.8	2.2	29.3	24.0	1.9	9.3	8.5	6.5	8.3	0.9	19.4	0.7	157.1	115.4	272.8	3.6	138.8	35.8	111.5	12.7	347.8	30.6	164.4	180.0	114.1	80.1	36.5	103.0	12.5	173.1	156.5	159.6	185.9	20.5	1.5	122.6	131.7	68.9	99.7	274.3	6.9	14.9	685.3	200.3	121.8	262.3	46.9	133.9	61.1	65.5	372.6	30.3	22.2	111.6	20.3	124.4	67.7	7.7	99.4	188.9	83.6	9.4	44.2	51.9	55.6	1.0	1.3	23.1	97.7	60.9	619.4	46.6	88.8	121.0	27.4	52.5	98.6	107.9	179.1	1.8	20.8	200.8	33.8	269.3	291.8	272.9	112.6	38.4
NMBR	"BB1, BB1R"	ENSG00000135577	"Neuromedin B receptor"	P28336	6	142058330-142088799	"G-protein coupled receptors, Plasma proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 1.5;testis: 1.4"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 3.3;Early spermatids: 7.0;Excitatory neurons: 2.3;Inhibitory neurons: 4.5;Late spermatids: 2.1;Oligodendrocyte precursor cells: 2.0;Oligodendrocytes: 2.5;Spermatocytes: 3.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA026665			Supported	"Plasma membrane,Cytosol"		NA	NA				"Cluster 49: Ciliated cells - Cilium organization"		"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane, Cytosol"		"HPA026665: AB_1854527"	"unprognostic (6.24e-2)"	"unprognostic (3.05e-1)"		"unprognostic (2.77e-2)"	"unprognostic (7.88e-2)"			"unprognostic (3.54e-2)"		"unprognostic (8.21e-2)"	"unprognostic (3.63e-2)"	"unprognostic (1.54e-1)"	"unprognostic (3.95e-1)"	"unprognostic (7.94e-3)"	"unprognostic (3.44e-1)"	"unprognostic (2.11e-1)"	"unprognostic (8.45e-2)"	0.0	0.0	0.7	0.0	1.0	0.0	0.1	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.8	0.0	0.0	0.2	1.3	0.0	0.0	0.1	0.0	1.0	1.1	0.1	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	1.1	0.0	0.0	1.4	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.4	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	1.0	0.0	0.6	0.2	1.3	1.0	1.1	1.5	1.1	0.5	0.2	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.0	0.3	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	2.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GJE1	CX23	ENSG00000203733	"Gap junction protein epsilon 1"	A6NN92	6	142133090-142135151	"Predicted membrane proteins"				"No human protein/transcript evidence"	"No human protein/transcript evidence"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA014916	Uncertain					NA	NA									"HPA014916: AB_1847134"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
VTA1	"C6orf55, HSPC228, My012"	ENSG00000009844	"Vesicle trafficking 1"	Q9NP79	6	142147162-142224685	"Plasma proteins, Predicted intracellular proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030968, HPA030969"	Approved		Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA		220000	"Cluster 18: Basophils - Vesicular transport"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Vesicles, Cytosol"		"HPA030968: AB_10602585, HPA030969: AB_2673679"	"prognostic unfavorable (7.02e-4)"	"unprognostic (1.84e-2)"	"unprognostic (2.12e-3)"	"unprognostic (1.17e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.56e-2)"	"prognostic unfavorable (6.58e-6)"	"unprognostic (2.83e-2)"	"unprognostic (3.61e-1)"	"unprognostic (5.18e-2)"	"unprognostic (2.84e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.85e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.96e-1)"	"unprognostic (3.24e-1)"	22.2	20.9	16.6	25.7	19.0	30.6	31.6	20.2	20.3	23.2	12.5	34.9	38.2	23.4	25.4	39.1	27.3	23.0	33.9	18.9	18.9	34.5	45.4	21.5	33.4	17.4	18.1	21.0	19.3	28.3	9.9	32.1	17.8	22.5	39.9	29.2	18.2	19.6	55.7	30.7	37.0	26.3	21.1	23.1	23.5	18.3	18.2	45.4	27.6	58.3	39.1	35.8	20.3	22.2	56.5	47.5	75.8	116.8	65.3	71.4	52.3	124.7	74.0	111.6	105.8	80.9	43.0	91.2	82.1	112.6	84.6	70.2	81.5	85.1	153.4	62.3	71.7	99.2	46.2	97.0	48.2	155.6	55.2	59.4	97.7	111.8	71.7	59.8	72.4	69.7	93.7	44.5	94.5	82.1	101.8	80.7	57.0	72.1	53.8	92.1	60.8	55.8	86.4	61.5	79.0	61.5	70.1	53.3	63.7	62.9	57.8	104.4	53.0	50.0	69.6	84.7	90.8	43.5	80.9	103.8	32.7	85.5	77.8	222.4	90.0	151.9	64.3	114.5	83.5	85.6	72.8	76.0	90.9	84.8	79.8	80.4	56.0	97.5	120.3	55.9	79.0	121.5	16.6	19.0	20.2	20.3	18.9	18.9	17.4	18.1	17.8	21.1	18.2	22.2	16.7	22.4	20.3	22.5	25.8	25.2	19.2	25.5	25.6	9.7	16.5	18.3	47.8	12.8	24.5	16.5	0.0	32.7	23.9	40.2	17.6	31.5	4.5	30.7	30.4	17.5	21.6	23.1	40.1	28.0	36.4	25.4	16.8	28.0	12.6	18.1	11.4	24.7	27.9	11.8	38.7	24.7	14.2	20.9	14.3	2.2	11.8	20.0	8.8	40.3	28.0	23.9	35.0	25.6	48.7	30.1	18.3	12.4	16.4	17.2	30.0	31.6	36.6	12.6	6.6	16.8	18.4	23.6	24.9	28.8	31.0	31.7	23.8	25.3	25.9	18.8
ADGRG6	"FLJ14937, GPR126"	ENSG00000112414	"Adhesion G protein-coupled receptor G6"	Q86SQ4	6	142301854-142446266	"Disease related genes, G-protein coupled receptors, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 71.9;placenta: 47.4"	"Cell type enhanced"	"Detected in many"		"Endothelial cells: 41.7;Hepatocytes: 143.8;Kupffer cells: 40.5;Pancreatic endocrine cells: 37.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A549: 88.6;Hep G2: 84.8;hTERT-HME1: 81.5;HUVEC TERT2: 161.4;MCF7: 155.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA017346	Approved					NA	NA		110000000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 15: Hepatocytes - Hemostasis"			"HPA017346: AB_1849260"	"unprognostic (1.04e-2)"	"unprognostic (2.72e-2)"	"unprognostic (7.37e-2)"	"unprognostic (3.00e-2)"	"unprognostic (8.64e-4)"	"unprognostic (1.67e-1)"	"unprognostic (2.98e-1)"	"prognostic unfavorable (8.78e-4)"	"unprognostic (1.80e-1)"	"unprognostic (1.26e-1)"	"prognostic unfavorable (2.78e-5)"	"unprognostic (4.46e-1)"	"unprognostic (6.49e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.36e-2)"	"unprognostic (2.97e-2)"	"unprognostic (4.59e-2)"	5.8	2.8	2.6	4.1	2.3	0.4	5.2	1.6	1.9	3.0	1.9	6.2	17.5	1.1	1.3	11.6	5.2	8.3	4.0	1.8	1.7	7.2	71.9	15.2	1.7	2.4	2.9	1.4	3.2	1.3	0.3	47.4	2.2	3.2	6.4	0.1	9.0	6.5	0.5	14.5	10.2	2.2	2.5	7.5	12.3	2.1	4.6	4.6	1.6	1.2	4.0	15.1	5.6	1.9	17.0	88.6	1.9	9.4	0.5	0.0	0.2	23.1	4.3	17.2	10.7	71.3	51.0	0.0	20.3	13.4	4.9	41.3	2.6	22.1	28.3	0.0	6.8	3.6	14.5	84.8	16.7	14.6	0.0	0.1	34.9	0.4	81.5	10.0	161.4	0.4	0.6	0.1	6.9	155.6	0.3	0.0	0.7	6.2	20.0	0.0	7.7	17.7	9.0	37.9	0.1	0.1	6.8	30.8	14.5	14.1	16.7	0.3	5.6	0.1	7.6	7.7	11.5	0.0	0.1	0.0	0.1	0.1	76.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	2.3	1.6	1.9	1.8	1.7	2.4	2.9	2.2	2.5	4.6	1.9	5.1	6.4	5.9	0.0	0.3	0.0	21.9	0.0	18.8	0.0	5.3	2.7	1.9	24.3	8.1	9.2	0.0	5.3	0.0	0.6	0.0	13.2	0.1	0.1	0.5	41.7	0.0	17.0	1.6	5.4	33.5	14.5	32.1	0.5	0.0	0.0	27.1	143.8	2.2	0.0	12.7	3.5	0.0	40.5	0.0	0.6	0.6	8.1	0.0	15.0	0.9	0.0	0.0	0.5	0.3	37.9	8.8	0.4	0.1	18.7	9.5	11.8	2.9	0.0	6.6	0.4	1.3	2.6	5.3	30.2	0.0	13.5	1.6	0.0	1.7	25.0
HIVEP2	"HIV-EP2, MBP-2, MIBP1, Schnurri-2, ZAS2, ZNF40B"	ENSG00000010818	"HIVEP zinc finger 2"	P31629	6	142751469-142956698	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 326.2;Inhibitory neurons: 223.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 37.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055954			Supported	Nucleoplasm		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 52: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm		"HPA055954: "	"unprognostic (1.35e-2)"	"unprognostic (1.61e-2)"	"unprognostic (8.48e-2)"	"unprognostic (2.03e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.20e-2)"	"unprognostic (7.71e-2)"	"unprognostic (8.44e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.34e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.93e-1)"	"unprognostic (8.09e-3)"	"unprognostic (1.25e-2)"	"unprognostic (5.32e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.10e-1)"	7.9	6.9	5.2	10.4	7.8	3.1	6.2	10.1	15.6	4.2	0.0	5.4	4.5	6.1	5.0	8.5	11.4	9.8	7.4	9.5	1.3	6.0	5.6	7.9	12.0	1.0	4.9	13.1	10.1	8.3	5.9	7.2	1.2	5.0	4.3	5.7	8.7	5.1	21.0	8.0	6.0	5.5	0.8	8.2	4.9	1.8	5.8	19.0	8.2	13.9	12.1	13.8	5.5	10.5	6.0	1.1	1.4	5.2	11.1	12.3	4.1	8.5	21.8	5.2	6.3	0.4	4.9	9.5	5.2	37.7	9.9	3.8	2.3	17.4	12.7	3.7	2.7	2.6	3.9	2.4	8.4	8.4	0.1	11.4	16.9	21.3	24.3	12.1	2.8	7.5	0.1	8.4	8.9	6.8	11.1	3.6	1.3	1.4	8.5	14.4	9.3	0.8	4.8	10.4	14.0	5.9	11.3	9.2	6.3	2.5	1.7	4.9	3.0	17.5	4.4	14.8	7.5	17.4	3.1	19.8	4.9	6.4	8.3	0.0	0.1	0.0	0.6	0.2	1.4	0.9	1.4	1.2	0.4	0.4	1.4	1.1	0.9	0.7	0.2	0.2	1.2	0.5	5.2	7.8	10.1	15.6	9.5	1.3	1.0	4.9	1.2	0.8	5.8	10.5	22.2	22.4	25.5	65.6	18.4	94.3	45.2	9.1	5.2	15.1	13.7	7.6	18.3	5.7	27.6	7.3	25.0	2.8	22.4	5.1	0.0	12.5	2.1	53.2	29.4	26.5	3.5	4.2	326.2	14.8	1.2	30.5	2.0	101.0	3.8	6.1	8.6	4.5	2.8	30.3	223.0	4.9	16.2	4.4	52.7	1.2	11.8	17.5	24.9	67.5	5.1	2.5	4.1	98.0	75.3	22.8	6.6	15.8	22.1	53.6	5.3	3.3	25.1	2.2	0.0	37.6	25.7	0.6	0.9	11.5	94.6	4.7	29.5	2.6	3.4	56.8
AIG1	"AIG-1, dJ95L4.1, FLJ10485"	ENSG00000146416	"Androgen induced 1"	Q9NVV5	6	143060496-143341058	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 235.8"	"Cell type enhanced"	"Detected in all"		"Inhibitory neurons: 245.4;Proximal tubular cells: 261.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA060766	Approved		Approved	"Golgi apparatus"		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 15: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Golgi apparatus"		"HPA060766: AB_2684356"	"unprognostic (2.70e-2)"	"prognostic unfavorable (3.26e-6)"	"unprognostic (4.27e-2)"	"prognostic unfavorable (3.06e-4)"	"unprognostic (5.34e-2)"	"prognostic unfavorable (3.25e-7)"	"unprognostic (1.91e-2)"	"unprognostic (8.75e-3)"	"unprognostic (2.17e-1)"	"unprognostic (5.53e-2)"	"unprognostic (2.75e-1)"	"unprognostic (1.93e-1)"	"unprognostic (2.74e-2)"	"unprognostic (3.07e-2)"	"unprognostic (1.43e-1)"	"unprognostic (9.11e-2)"	"unprognostic (2.75e-1)"	42.0	29.8	43.7	10.4	44.6	31.6	30.0	43.3	46.1	17.6	48.2	23.0	46.6	14.4	33.0	34.1	34.4	24.5	54.1	44.1	49.1	102.0	235.8	19.9	10.7	45.0	43.4	34.7	31.0	31.0	36.6	11.9	46.4	22.7	18.8	33.9	19.8	24.1	23.7	16.8	45.9	15.2	47.1	20.1	20.8	15.7	51.0	6.8	42.9	32.5	14.8	29.4	26.1	52.5	32.6	25.2	20.6	56.9	29.7	22.3	7.6	28.3	57.1	26.8	61.9	37.5	81.5	20.0	40.5	66.1	41.7	42.0	26.5	79.2	64.2	67.2	63.0	5.6	35.6	157.3	40.8	46.0	2.7	32.9	76.7	35.7	129.6	88.2	10.9	30.8	4.0	67.6	59.3	45.6	14.2	9.8	40.8	37.4	27.6	20.2	61.6	36.6	100.6	77.6	75.5	42.4	35.5	33.2	17.2	36.0	31.7	96.0	3.0	25.2	27.8	22.7	33.4	99.6	95.1	2.1	59.7	9.5	26.9	12.0	6.2	9.6	6.6	29.3	15.1	9.6	12.4	10.6	33.0	5.6	13.1	10.0	11.3	11.8	35.4	2.9	9.7	9.2	43.7	44.6	43.3	46.1	44.1	49.1	45.0	43.4	46.4	47.1	51.0	52.5	40.8	16.0	27.7	114.9	22.0	25.0	51.8	82.5	27.9	68.3	69.9	65.4	73.7	72.9	66.9	51.5	25.0	79.6	8.6	12.6	52.8	60.3	22.4	99.8	25.9	32.8	39.5	29.3	204.3	31.5	10.5	42.2	26.0	83.1	36.8	90.9	36.8	229.6	32.7	53.8	245.4	33.3	59.0	40.1	42.3	7.0	32.0	37.2	55.2	100.2	18.2	74.3	8.2	105.1	172.9	25.8	65.2	38.4	47.7	35.3	232.9	261.5	69.1	36.9	32.9	41.7	50.8	5.6	17.3	53.1	45.7	108.1	18.5	61.5	42.4	53.2
ADAT2	"DEADC1, dJ20N2.1, TAD2"	ENSG00000189007	"Adenosine deaminase tRNA specific 2"	Q7Z6V5	6	143422832-143450695	"Enzymes, Predicted intracellular proteins"	"tRNA processing"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035479	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 32: U-937 - Innate immune response"	"Cluster 32: Non-specific - Translation"	"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA035479: AB_10611672"	"unprognostic (2.24e-1)"	"unprognostic (3.07e-3)"	"unprognostic (1.55e-1)"	"unprognostic (8.20e-2)"	"unprognostic (3.05e-2)"	"unprognostic (8.58e-2)"	"unprognostic (1.07e-3)"	"unprognostic (3.31e-2)"	"unprognostic (1.34e-1)"	"unprognostic (7.30e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.25e-2)"	"unprognostic (9.28e-5)"	"unprognostic (4.88e-2)"	"unprognostic (6.96e-2)"	"unprognostic (7.29e-2)"	"unprognostic (4.08e-2)"	6.8	8.8	1.4	3.1	1.3	5.4	6.3	1.9	1.5	6.3	1.8	7.8	3.1	4.8	1.4	10.3	6.1	1.2	3.4	1.3	1.2	7.7	12.0	8.5	4.2	1.2	1.2	5.8	10.5	1.5	6.6	1.1	1.3	7.3	4.1	1.4	5.4	1.1	3.1	8.9	8.8	1.7	1.0	10.7	8.9	2.8	1.5	1.9	8.6	0.7	3.5	6.5	7.9	1.4	1.8	1.6	2.2	7.2	1.7	5.3	2.7	2.6	1.1	1.6	2.2	4.0	4.4	7.0	2.7	1.7	1.7	5.8	4.3	4.1	3.4	3.5	9.2	10.4	7.3	8.3	2.1	15.0	4.6	2.4	6.0	3.2	6.3	1.8	3.7	6.5	11.3	5.4	2.7	2.5	6.0	7.6	2.5	2.6	2.8	7.0	5.7	5.6	3.0	1.9	4.7	3.1	2.1	6.0	1.8	1.2	2.4	5.0	3.4	2.6	1.9	5.6	4.8	5.9	4.2	4.9	2.7	13.0	2.8	0.0	0.2	0.0	0.6	0.3	0.8	0.5	0.5	0.5	0.6	0.3	0.7	1.0	0.1	0.4	0.0	0.6	1.3	0.4	1.4	1.3	1.9	1.5	1.3	1.2	1.2	1.2	1.3	1.0	1.5	1.4	4.6	6.4	12.9	8.8	6.9	6.6	4.3	4.1	6.2	3.7	5.6	6.3	4.0	5.7	4.1	1.8	0.0	2.4	11.9	4.3	3.9	5.6	1.2	2.7	11.1	4.8	4.2	14.9	11.2	4.1	2.6	5.3	12.2	5.9	7.6	7.1	3.9	5.2	4.9	1.7	10.4	6.0	4.1	4.3	6.1	1.6	6.8	5.3	5.4	7.5	2.1	1.9	8.2	12.5	4.2	6.6	2.4	3.4	4.2	6.8	1.6	1.4	2.1	4.3	0.0	5.1	5.1	2.4	5.6	9.8	9.2	0.8	8.9	6.2	8.8	4.5
PEX3		ENSG00000034693	"Peroxisomal biogenesis factor 3"	P56589	6	143450805-143490616	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Peroxisome biogenesis"		"Disease variant, Peroxisome biogenesis disorder, Zellweger syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 80.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042830, HPA058006"	Supported		Approved	Nucleoplasm,Peroxisomes		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoplasm, Peroxisomes"		"HPA042830: AB_10794918, HPA058006: AB_2683576"	"unprognostic (3.52e-3)"	"unprognostic (6.28e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.21e-1)"	"unprognostic (4.16e-1)"	"unprognostic (8.45e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.56e-2)"	"unprognostic (2.50e-2)"	"unprognostic (2.16e-1)"	"prognostic favorable (3.80e-4)"	"unprognostic (1.87e-1)"	"unprognostic (7.30e-2)"	"unprognostic (3.80e-2)"	"unprognostic (2.12e-1)"	8.7	38.4	4.4	7.6	4.8	3.2	11.8	4.5	5.6	11.7	7.3	7.5	6.0	9.8	12.5	17.8	9.6	7.3	12.6	4.2	5.3	18.3	24.4	7.9	8.8	3.6	3.4	10.7	6.7	24.4	9.0	9.4	3.9	11.7	6.2	10.0	10.6	11.2	11.6	12.8	7.4	8.9	3.9	7.2	9.7	12.2	3.6	8.3	15.5	9.6	9.5	8.9	13.4	7.5	21.4	4.6	11.0	21.1	17.8	15.6	12.2	17.8	13.8	23.7	28.3	31.5	12.8	31.7	21.1	17.4	27.8	17.3	14.4	23.9	30.8	19.4	16.5	22.8	10.2	20.0	15.0	38.7	9.6	18.1	16.6	22.4	17.2	10.3	13.0	18.5	21.1	15.7	24.0	14.1	20.2	15.3	6.1	12.6	18.2	15.3	22.2	14.0	28.0	9.2	15.3	5.3	23.0	19.3	14.7	9.5	10.2	12.7	10.3	16.7	15.9	26.9	20.9	10.7	16.4	36.1	21.1	26.0	13.3	12.9	6.3	6.4	15.5	10.1	17.2	23.2	16.3	15.5	9.9	18.6	21.1	20.7	1.0	15.6	13.4	10.6	21.2	9.8	4.4	4.8	4.5	5.6	4.2	5.3	3.6	3.4	3.9	3.9	3.6	7.5	13.1	16.0	14.4	23.8	19.7	26.6	12.7	19.2	14.8	14.5	9.9	11.8	14.8	5.7	19.0	9.2	4.2	41.7	9.0	4.1	19.6	12.3	12.6	15.2	10.4	12.0	6.0	5.9	61.0	9.5	11.6	13.5	10.2	13.1	25.3	9.6	13.6	20.5	11.5	16.8	67.4	5.4	16.2	7.6	6.6	4.9	13.7	6.0	8.8	28.1	8.0	15.4	10.3	40.7	59.6	9.6	2.3	11.3	18.1	6.6	8.2	28.8	27.2	12.1	6.6	12.2	13.6	80.0	18.5	20.2	34.8	58.7	13.7	20.9	7.6	8.5
FUCA2	"dJ20N2.5, MGC1314"	ENSG00000001036	"Alpha-L-fucosidase 2"	Q9BTY2	6	143494812-143511720	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"		"Glycosidase, Hydrolase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 165.8"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031659, HPA031661"	Approved				"Secreted to blood"	NA	NA		56000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 18: U-2197 - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"			"HPA031659: AB_10600661, HPA031661: AB_10601681"	"unprognostic (1.83e-2)"	"unprognostic (1.70e-3)"	"unprognostic (1.11e-2)"	"unprognostic (1.01e-2)"	"unprognostic (4.89e-2)"	"unprognostic (1.41e-2)"	"prognostic unfavorable (2.70e-9)"	"unprognostic (1.54e-3)"	"unprognostic (1.08e-1)"	"unprognostic (7.79e-2)"	"unprognostic (2.89e-1)"	"unprognostic (1.90e-1)"	"unprognostic (8.76e-3)"	"unprognostic (9.18e-2)"	"unprognostic (2.69e-1)"	"unprognostic (7.25e-2)"	"unprognostic (5.07e-2)"	28.9	41.4	13.5	25.4	16.4	25.8	26.3	16.0	15.3	29.2	30.2	41.5	42.6	25.6	44.9	14.2	23.7	27.8	27.9	12.4	16.5	54.8	52.3	28.9	17.2	17.1	14.2	30.4	34.6	165.8	15.8	50.5	17.8	21.9	52.8	6.1	25.4	25.8	6.9	12.3	39.3	27.6	16.4	24.6	38.3	12.6	15.9	6.6	32.0	11.6	17.0	33.5	20.4	20.9	97.4	55.7	47.6	86.9	69.0	134.4	90.1	89.9	95.4	108.1	182.0	107.1	94.8	0.2	66.1	120.8	33.9	0.6	24.1	11.7	148.9	87.2	92.6	32.6	100.1	163.2	99.3	0.3	15.8	72.3	69.4	96.6	41.5	91.6	111.4	0.2	117.6	49.3	123.2	114.6	0.2	75.9	62.1	44.2	76.0	0.2	99.7	72.1	129.0	59.5	36.0	23.6	98.7	65.3	82.3	36.3	32.1	79.6	65.9	64.1	54.0	161.6	175.4	18.3	21.3	0.7	74.1	59.1	22.5	38.8	84.9	26.2	13.2	84.0	15.0	11.3	9.8	11.3	65.4	8.3	4.4	7.9	5.5	29.6	62.0	10.3	19.8	51.9	13.5	16.4	16.0	15.3	12.4	16.5	17.1	14.2	17.8	16.4	15.9	20.9	27.3	41.7	35.9	9.1	13.5	11.2	12.6	30.3	9.1	3.7	19.2	12.6	28.0	38.6	37.9	25.8	0.0	52.5	10.3	47.6	11.7	81.9	2.0	26.8	55.2	25.0	9.6	18.7	8.7	124.9	109.8	62.6	34.7	28.9	37.4	38.1	23.6	35.2	110.3	1.7	11.8	38.1	46.8	57.5	29.2	2.6	66.8	51.7	42.7	9.4	49.1	11.1	13.4	5.5	14.5	74.6	38.2	45.5	47.7	13.8	60.3	51.4	34.8	1.1	6.6	33.8	35.0	4.8	4.6	13.2	8.0	46.4	11.5	78.8	50.4	18.4
PHACTR2	"C6orf56, KIAA0680"	ENSG00000112419	"Phosphatase and actin regulator 2"	O75167	6	143536845-143831185	"Predicted intracellular proteins"		"Actin-binding, Protein phosphatase inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"choroid plexus: 164.2;placenta: 83.8"	"Cell type enhanced"	"Detected in all"		"Alveolar cells type 1: 214.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"TIME: 82.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031719, HPA031720, HPA031725"	Approved		Approved	"Golgi apparatus,Plasma membrane"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"	"Golgi apparatus"	"Plasma membrane"	"HPA031719: AB_10696055, HPA031720: AB_10670553, HPA031725: AB_10610279"	"unprognostic (3.25e-3)"	"unprognostic (1.07e-1)"	"unprognostic (4.39e-2)"	"unprognostic (5.25e-2)"	"unprognostic (1.90e-2)"	"unprognostic (8.38e-2)"	"unprognostic (3.19e-2)"	"unprognostic (9.92e-2)"	"unprognostic (7.46e-2)"	"unprognostic (3.61e-2)"	"unprognostic (2.49e-1)"	"unprognostic (2.80e-1)"	"prognostic favorable (1.99e-4)"	"unprognostic (3.60e-1)"	"unprognostic (5.08e-2)"	"unprognostic (9.92e-2)"	"unprognostic (1.17e-1)"	11.6	25.4	7.0	7.8	9.0	7.6	5.5	4.3	5.7	8.1	164.2	8.5	7.5	9.9	3.6	22.0	5.7	8.4	12.4	10.0	4.9	5.9	7.9	15.7	7.8	12.3	10.3	6.5	4.9	13.1	4.0	83.8	15.1	10.3	8.5	2.7	6.0	6.9	4.5	2.7	6.1	9.8	3.5	13.5	12.0	6.5	16.5	2.7	15.5	7.3	6.7	7.6	6.4	4.5	21.9	13.5	3.6	26.6	3.7	8.0	15.3	18.0	27.2	7.7	9.6	23.9	9.5	1.2	47.5	51.7	5.4	6.5	2.0	17.9	9.1	18.1	8.5	35.5	14.7	14.0	6.1	9.1	10.5	11.2	9.8	7.7	24.9	11.8	47.0	6.7	10.2	0.1	12.4	24.0	1.3	2.1	26.8	7.7	3.8	3.3	26.3	0.2	9.3	19.2	5.2	5.2	20.0	26.1	0.3	13.4	9.8	13.1	82.2	34.9	18.2	15.2	11.8	0.2	0.1	0.3	8.6	9.5	3.2	6.0	3.5	6.7	3.3	2.5	12.3	0.4	4.0	4.4	3.3	0.2	2.4	1.6	1.8	3.5	2.7	3.2	5.5	1.9	7.0	9.0	4.3	5.7	10.0	4.9	12.3	10.3	15.1	3.5	16.5	4.5	160.9	214.7	94.5	41.4	11.7	24.2	16.0	19.5	47.3	37.0	14.2	13.8	71.8	32.9	73.2	22.0	2.1	84.7	27.5	58.9	13.7	30.5	10.1	49.6	43.7	158.6	21.6	32.8	55.2	22.5	49.8	144.8	54.6	64.7	38.7	34.9	157.1	27.6	35.4	101.0	133.8	19.2	24.4	121.1	40.2	23.2	103.2	52.5	24.9	77.8	71.7	10.3	15.5	5.5	20.9	49.4	22.3	120.0	10.6	63.3	20.2	24.8	51.1	3.0	98.6	95.9	83.5	3.1	2.3	33.0	17.2	52.5	51.3	127.9	26.3	30.9
LTV1	"C6orf93, dJ468K18.4, FLJ14909"	ENSG00000135521	"LTV1 ribosome biogenesis factor"	Q96GA3	6	143843338-143863812	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030159, HPA030160, HPA030161"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 39: Non-specific - Basic cellular processes"	Cytosol	Nucleoplasm	"HPA030159: AB_10600770, HPA030160: AB_10600056, HPA030161: AB_10602001"	"unprognostic (2.26e-2)"	"unprognostic (1.52e-1)"	"unprognostic (3.88e-2)"	"unprognostic (5.45e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.99e-2)"	"prognostic unfavorable (4.95e-5)"	"unprognostic (7.09e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.55e-2)"	"unprognostic (1.26e-1)"	"unprognostic (4.70e-2)"	"prognostic unfavorable (6.01e-13)"	"unprognostic (2.94e-1)"	"unprognostic (6.83e-2)"	"unprognostic (8.62e-3)"	"unprognostic (1.41e-1)"	26.3	22.6	12.2	22.4	13.2	52.5	24.1	13.4	16.3	18.8	12.9	20.3	15.7	22.2	15.6	23.3	19.4	12.4	18.7	12.6	13.7	18.5	24.6	19.0	26.2	13.0	12.9	21.2	23.5	14.1	14.0	19.6	13.0	17.5	20.5	10.3	18.0	17.4	36.9	29.3	20.0	21.0	12.6	22.2	20.6	20.7	13.5	16.8	17.0	18.5	25.6	23.1	19.4	14.7	42.5	39.0	45.3	101.4	32.9	39.7	52.5	64.5	47.2	69.7	55.2	63.6	21.6	88.7	50.6	58.7	76.5	46.8	76.3	63.2	96.8	51.2	74.4	175.8	45.1	98.4	57.9	219.0	97.8	45.1	45.5	77.7	84.4	28.7	49.0	51.1	170.3	57.2	54.4	71.7	75.2	92.8	53.6	48.5	42.5	64.1	85.6	40.1	51.9	58.1	40.0	48.2	65.8	53.8	62.3	41.1	30.2	138.1	44.7	44.4	51.6	100.0	120.0	70.9	93.6	118.9	44.5	112.3	63.8	2.0	16.7	7.3	18.9	21.8	20.6	28.6	19.6	20.5	25.3	24.5	21.5	24.9	0.5	36.0	19.5	30.7	18.7	14.2	12.2	13.2	13.4	16.3	12.6	13.7	13.0	12.9	13.0	12.6	13.5	14.7	19.8	6.4	34.1	9.1	22.1	25.6	22.3	28.8	13.1	9.9	10.8	15.7	25.6	10.0	28.3	7.3	2.1	25.5	22.1	9.0	13.7	29.4	25.0	11.5	29.0	20.6	19.7	18.3	13.7	28.7	30.5	27.6	12.8	14.0	24.7	17.6	11.4	18.0	27.9	11.8	14.2	13.3	38.7	13.1	14.8	10.7	25.7	17.0	5.4	10.3	33.6	9.9	23.7	13.6	13.7	29.9	10.4	27.4	17.6	21.9	6.9	17.3	24.1	10.2	6.6	29.0	24.5	57.5	62.5	18.9	32.1	16.3	16.2	57.8	19.7	16.3
ZC2HC1B	"C6orf94, dJ468K18.5, FAM164B"	ENSG00000118491	"Zinc finger C2HC-type containing 1B"	Q5TFG8	6	143864436-143938343	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	48	"testis: 14.8"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 2.6;Early spermatids: 9.6;Excitatory neurons: 3.1;Inhibitory neurons: 5.7;Late spermatids: 5.5;Oligodendrocyte precursor cells: 4.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA				"Cluster 83: Testis - Spermatogenesis"		"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"																					0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	14.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.6	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.6	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.3	5.5	0.0	0.0	1.8	1.0	0.0	0.0	0.0	4.5	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0
PLAGL1	"LOT1, ZAC"	ENSG00000118495	"PLAG1 like zinc finger 1"	Q9UM63	6	143940300-144064599	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding"	"Diabetes mellitus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 252.3"	"Cell type enhanced"	"Detected in many"		"Fibroblasts: 143.6;Leydig cells: 138.5;Theca cells: 205.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AF22: 99.0;RH-30: 94.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055706			Supported	"Nuclear bodies,Golgi apparatus,Vesicles"		No	No			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 28: Placenta - Pregnancy"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 33: Fibroblasts - ECM organization"	"Nuclear bodies"	"Golgi apparatus, Vesicles"	"HPA055706: AB_2682893"	"unprognostic (4.74e-3)"	"unprognostic (8.35e-3)"	"unprognostic (5.43e-2)"	"unprognostic (1.74e-3)"	"unprognostic (5.09e-2)"	"unprognostic (1.95e-1)"	"unprognostic (9.32e-2)"	"unprognostic (6.17e-2)"	"unprognostic (3.49e-2)"	"unprognostic (5.02e-2)"	"unprognostic (1.78e-3)"	"unprognostic (2.07e-1)"	"prognostic unfavorable (4.94e-6)"	"prognostic unfavorable (6.61e-4)"	"unprognostic (4.69e-2)"	"unprognostic (5.17e-3)"	"unprognostic (4.93e-3)"	37.7	74.8	4.1	18.5	5.2	21.7	29.6	1.9	7.0	31.4	5.8	28.8	9.6	29.5	9.0	32.9	20.8	26.9	26.4	3.8	2.9	17.0	3.6	26.7	12.1	3.6	4.1	36.5	27.7	9.5	81.6	252.3	3.9	26.0	21.3	1.6	30.1	12.1	12.2	61.9	20.6	19.7	3.2	15.6	26.9	8.7	6.0	6.6	13.8	22.3	12.1	39.6	34.4	4.0	0.2	5.0	99.0	0.1	39.4	78.0	0.3	32.9	21.6	16.1	33.5	0.3	6.0	2.7	16.0	30.4	4.0	0.0	0.8	12.0	32.2	3.1	4.4	45.2	58.7	0.9	13.9	40.9	8.9	60.5	4.6	15.8	13.8	23.4	33.5	16.1	4.4	0.8	18.0	6.2	16.9	19.8	17.2	0.0	3.7	20.7	94.1	0.1	33.1	1.1	8.7	10.3	51.0	0.1	0.1	29.6	0.1	50.1	19.8	0.2	35.2	77.7	36.4	9.1	9.0	0.6	25.3	16.6	2.0	4.9	12.0	25.1	1.4	9.1	1.4	3.7	1.3	1.9	14.9	5.8	0.9	1.5	21.7	2.2	2.9	6.7	2.0	3.8	4.1	5.2	1.9	7.0	3.8	2.9	3.6	4.1	3.9	3.2	6.0	4.0	19.5	51.3	51.0	28.4	15.2	21.7	14.6	5.3	34.1	2.1	16.8	14.0	8.4	5.7	12.6	5.5	0.0	4.6	19.0	16.1	7.9	11.8	1.8	8.6	91.9	23.8	16.7	19.3	60.3	11.3	15.0	143.6	11.7	13.0	18.4	38.7	8.6	0.2	20.3	8.4	76.6	33.6	18.3	26.8	27.8	5.5	138.5	26.8	8.8	49.6	37.6	0.9	2.1	10.6	5.5	13.0	22.5	97.0	5.7	52.0	4.3	15.3	4.4	0.4	13.1	61.7	31.1	0.9	1.0	24.1	43.3	9.9	10.0	205.8	28.5	19.7
SF3B5	"MGC3133, SF3b10, Ysf3"	ENSG00000169976	"Splicing factor 3b subunit 5"	Q9BWJ5	6	144094884-144095573	"Plasma proteins, Predicted intracellular proteins"	"mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA054408	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"HPA054408: AB_2682479"	"unprognostic (1.22e-1)"	"unprognostic (7.12e-2)"	"unprognostic (4.54e-2)"	"unprognostic (6.86e-2)"	"unprognostic (1.42e-1)"	"unprognostic (3.08e-2)"	"unprognostic (1.07e-3)"	"unprognostic (1.74e-1)"	"unprognostic (6.47e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.33e-3)"	"unprognostic (2.47e-1)"	"unprognostic (3.61e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.77e-1)"	"unprognostic (1.90e-2)"	"unprognostic (1.49e-1)"	105.8	180.4	121.2	79.5	125.6	251.9	110.1	130.7	140.7	99.1	128.0	121.8	93.1	101.8	100.8	152.3	127.8	86.0	149.3	126.2	124.8	159.8	191.1	94.3	129.7	128.0	122.9	107.2	146.9	132.5	149.6	75.6	126.8	104.3	111.0	32.3	112.4	83.8	158.5	133.0	104.6	91.7	125.9	119.3	113.6	93.7	126.2	147.1	114.2	161.2	125.5	116.8	97.7	129.2	124.1	164.2	184.6	343.4	211.9	239.3	109.8	125.5	209.6	252.3	286.8	175.0	110.2	204.7	219.7	205.3	244.5	143.6	214.0	288.5	177.2	213.0	302.5	223.8	136.0	391.3	203.4	441.2	138.0	246.0	382.5	277.7	275.3	162.8	310.0	278.0	292.3	290.1	229.7	436.5	287.1	396.2	119.3	192.9	196.8	176.5	241.7	208.0	276.0	109.8	252.6	159.6	175.1	211.5	242.2	93.0	154.1	266.9	169.0	129.0	175.5	233.6	276.7	216.3	284.6	197.3	208.8	366.8	162.5	181.9	377.9	191.8	171.5	277.7	213.0	211.2	192.2	203.6	326.2	197.2	190.3	189.1	101.0	199.0	256.3	364.0	241.3	364.1	121.2	125.6	130.7	140.7	126.2	124.8	128.0	122.9	126.8	125.9	126.2	129.2	97.8	89.8	137.8	5.2	151.9	271.1	168.4	282.5	97.3	45.5	178.4	238.9	87.2	170.1	171.2	123.2	12.5	224.5	180.9	244.9	457.8	253.7	240.9	149.3	159.3	136.6	267.7	157.8	3.8	315.5	221.8	151.6	100.4	138.5	178.7	156.6	163.9	265.6	328.1	43.7	4.9	423.3	201.4	224.0	239.5	109.8	134.8	165.3	252.5	7.5	258.0	132.2	176.1	6.6	13.2	259.8	259.6	108.7	214.7	233.7	304.2	625.7	153.3	58.4	105.2	119.8	135.6	169.6	59.1	164.7	324.2	206.5	168.9	203.9	342.4	222.7
STX11		ENSG00000135604	"Syntaxin 11"	O75558	6	144150517-144191939	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Protein transport, Transport"		"Familial hemophagocytic lymphohistiocytosis"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 25.1;bone marrow: 56.5"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 85.0;granulocytes: 90.3;Langerhans cells: 271.6;Macrophages: 158.0;monocytes: 85.5;Suprabasal keratinocytes: 154.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in all"	7	"basophil: 22.6;classical monocyte: 68.4;eosinophil: 43.5;intermediate monocyte: 81.1;myeloid DC: 25.4;neutrophil: 81.7;non-classical monocyte: 87.0"	"Group enriched"	"Detected in all"	8	"dendritic cells: 25.4;granulocytes: 81.7;monocytes: 87.0"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 17.2;Karpas-707: 10.1;RH-30: 6.9;TIME: 8.3;U-266/70: 11.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA007992	Approved					NA	NA		1100000	"Cluster 7: Monocytes - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 41: Macrophages - Immune response"			"HPA007992: AB_1857620"	"unprognostic (1.30e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.62e-2)"	"unprognostic (3.73e-2)"	"unprognostic (8.96e-2)"	"unprognostic (3.04e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.03e-2)"	"unprognostic (8.65e-2)"	"unprognostic (1.36e-1)"	"unprognostic (4.47e-3)"	"unprognostic (7.07e-2)"	"unprognostic (3.91e-2)"	"unprognostic (8.50e-3)"	"unprognostic (1.07e-1)"	25.1	4.4	0.6	5.8	0.6	56.5	14.5	0.6	1.1	1.9	0.7	2.8	1.0	1.4	0.3	5.1	2.6	2.1	7.3	0.7	0.8	3.6	3.1	21.3	5.5	1.0	0.7	0.9	1.1	0.6	2.1	2.4	0.9	1.3	0.9	0.2	2.1	0.3	2.5	8.2	3.3	1.9	0.8	14.1	2.0	1.1	0.9	1.8	7.5	0.9	3.5	4.0	3.2	1.1	0.4	0.1	0.1	3.9	0.2	0.3	0.6	0.4	0.3	0.4	0.7	0.1	0.4	0.1	0.4	0.6	0.7	0.6	0.0	0.1	0.2	17.2	0.6	3.0	0.6	0.1	1.0	0.9	0.5	0.0	0.0	0.2	0.1	0.2	4.3	0.8	0.1	10.1	0.5	0.2	0.4	0.9	0.0	0.0	0.3	0.1	6.9	0.6	0.0	1.9	0.2	0.1	1.2	0.1	1.7	0.3	0.1	3.8	8.3	0.2	1.0	0.4	0.3	11.6	4.6	0.1	0.2	2.1	0.4	22.6	68.4	43.5	6.0	81.1	3.8	1.4	2.7	5.1	25.4	2.4	1.0	3.0	81.7	3.2	87.0	2.7	8.3	43.9	0.6	0.6	0.6	1.1	0.7	0.8	1.0	0.7	0.9	0.8	0.9	1.1	41.9	54.5	10.7	0.0	16.6	85.0	11.3	6.3	3.4	0.0	11.1	4.6	4.5	4.3	6.6	1.8	0.0	0.9	38.1	0.1	0.0	6.4	0.4	3.7	0.7	23.7	3.5	6.1	0.1	2.6	5.7	11.2	0.5	5.0	90.3	0.2	8.2	1.4	30.1	0.0	0.1	0.4	2.0	73.7	271.6	1.2	0.6	158.0	44.4	2.8	85.5	0.0	21.6	0.0	0.1	6.1	3.3	0.0	63.1	14.4	0.0	0.1	10.7	0.1	0.0	46.6	9.7	3.0	3.8	11.2	154.6	28.0	36.6	3.2	0.6	33.3
UTRN	"DMDL, DRP, DRP1"	ENSG00000152818	Utrophin	P46939	6	144285701-144853034	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 410.3;Early spermatids: 527.1;Late spermatids: 332.1;Microglial cells: 425.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HAP1: 219.4;HUVEC TERT2: 157.0;TIME: 203.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016348, HPA018894"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA		4200	"Cluster 51: Monocytes - Innate immune response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nucleoplasm, Plasma membrane"		"CAB016348: AB_628424, HPA018894: AB_10600839"	"unprognostic (3.47e-2)"	"unprognostic (2.82e-1)"	"unprognostic (2.32e-1)"	"unprognostic (6.87e-3)"	"unprognostic (1.75e-1)"	"unprognostic (3.30e-2)"	"unprognostic (3.99e-3)"	"unprognostic (2.44e-1)"	"unprognostic (9.24e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.72e-1)"	"unprognostic (7.10e-2)"	"prognostic favorable (7.61e-5)"	"unprognostic (6.32e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.49e-2)"	52.6	17.4	26.8	25.8	40.5	56.6	40.5	32.7	18.3	40.4	35.6	33.8	17.0	29.8	16.8	27.9	43.5	31.2	24.8	18.4	67.9	30.9	25.3	49.3	34.9	48.6	52.1	37.2	52.1	69.4	7.9	45.8	49.7	39.7	31.7	11.0	26.0	26.1	14.0	27.5	22.3	25.9	40.0	71.5	27.2	59.2	48.8	43.2	68.4	38.9	35.8	25.2	16.0	31.0	27.2	22.6	39.3	51.0	66.5	60.5	23.4	39.0	37.8	31.1	45.2	86.1	9.8	8.4	33.6	88.4	36.6	15.6	219.4	32.9	44.6	90.6	25.5	32.2	24.9	51.6	26.3	36.1	0.7	35.5	6.8	46.2	24.1	29.3	157.0	25.1	2.0	22.7	44.1	18.1	28.7	15.5	15.9	16.6	23.9	25.7	70.2	0.8	35.9	0.7	49.7	0.9	60.8	8.4	23.5	59.5	33.3	48.2	203.6	29.8	37.0	15.5	37.6	17.7	25.3	1.3	18.2	21.5	49.5	41.2	40.9	23.2	39.5	120.8	28.3	25.7	24.9	33.0	17.2	35.7	21.8	22.8	34.5	37.6	173.9	50.4	22.2	13.9	26.8	40.5	32.7	18.3	18.4	67.9	48.6	52.1	49.7	40.0	48.8	31.0	267.0	410.3	138.7	148.2	101.2	29.4	31.7	17.2	40.9	6.5	47.4	32.1	56.0	28.6	111.0	31.3	0.0	94.4	175.1	10.9	0.0	25.3	527.1	61.2	51.5	171.8	31.2	19.8	61.2	32.0	6.9	51.6	76.5	87.5	29.7	22.8	83.6	15.6	22.3	60.6	161.4	16.9	8.2	109.7	45.9	332.1	23.9	97.6	39.2	425.3	79.8	29.1	171.0	68.9	4.1	28.1	9.3	33.4	70.3	25.4	3.6	7.1	87.3	4.3	144.7	151.0	157.8	6.6	6.6	33.7	45.5	129.3	108.0	32.0	22.3	19.2
EPM2A	"LD, LDE"	ENSG00000112425	"EPM2A glucan phosphatase, laforin"	O95278	6	145382535-145736023	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Autophagy, Carbohydrate metabolism, Glycogen metabolism"	"Hydrolase, Protein phosphatase"	"Disease variant, Epilepsy, Glycogen storage disease, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 76.8;tongue: 79.5"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 66.9;Early spermatids: 33.0;Excitatory neurons: 30.4;Inhibitory neurons: 50.7;Oligodendrocyte precursor cells: 56.8;Oligodendrocytes: 60.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"NK-cell: 1.9"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"Daudi: 23.2"	"Low region specificity"	"Detected in all"							"HPA053643, HPA055468"			Enhanced	Nucleoplasm		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm		"HPA053643: AB_2797247, HPA055468: AB_2797252"	"unprognostic (2.37e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.99e-1)"	"unprognostic (3.34e-3)"	"unprognostic (2.92e-3)"	"unprognostic (1.22e-1)"	"unprognostic (2.15e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.37e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.52e-4)"	"unprognostic (2.28e-1)"	"prognostic favorable (4.08e-7)"	"unprognostic (4.12e-4)"	"unprognostic (2.17e-1)"	"unprognostic (2.99e-3)"	"unprognostic (1.23e-1)"	5.8	6.0	11.4	1.5	11.7	1.8	3.2	11.9	17.8	3.1	7.3	17.2	3.2	6.0	4.3	9.3	4.4	3.6	24.4	11.6	12.6	8.5	5.7	3.0	3.3	11.9	11.5	5.7	2.4	5.2	3.8	1.5	11.1	6.1	2.9	12.1	3.1	8.8	76.8	2.1	3.8	6.3	10.3	2.1	5.3	3.0	11.5	4.8	3.9	79.5	2.6	9.8	2.7	13.3	1.3	2.1	3.4	6.6	8.6	2.3	1.6	3.1	3.8	2.9	3.5	1.7	1.7	23.2	2.7	3.8	3.5	1.8	1.3	1.6	2.6	9.3	1.9	3.6	2.5	2.7	4.8	12.7	2.4	2.0	7.0	1.7	0.7	3.8	2.0	5.0	1.8	5.4	3.8	3.1	8.4	3.2	3.9	3.2	1.9	4.8	3.1	6.7	2.5	1.8	6.3	6.4	5.5	3.3	7.8	3.1	1.9	7.3	4.6	2.9	1.1	2.7	2.6	4.1	4.6	8.6	2.6	2.8	4.8	0.0	0.0	0.0	0.1	0.5	0.4	0.4	0.4	0.3	0.3	0.4	0.4	0.9	0.1	1.9	0.1	0.3	0.0	0.3	11.4	11.7	11.9	17.8	11.6	12.6	11.9	11.5	11.1	10.3	11.5	13.3	3.9	6.4	1.5	66.9	4.4	0.9	1.0	0.8	0.6	8.4	3.5	2.2	27.8	2.8	2.2	1.8	6.2	1.0	1.9	0.2	11.7	1.0	33.0	1.9	3.6	2.2	1.2	4.4	30.4	2.3	0.7	2.3	1.1	1.4	2.5	6.0	1.4	6.6	2.3	30.3	50.7	1.5	2.0	3.3	1.4	19.8	3.1	3.1	7.2	15.9	1.7	7.9	2.1	56.8	60.1	1.2	1.7	2.2	1.7	1.5	0.5	7.1	2.2	6.3	0.0	6.2	2.4	4.9	1.6	0.8	0.4	0.4	1.8	5.1	1.2	0.3
FBXO30	"Fbx30, MGC21674"	ENSG00000118496	"F-box protein 30"	Q8TB52	6	145793502-145814795	"Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	6	"basophil: 9.3"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 9.3"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012583	Approved		Approved	Microtubules		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 40: Granulosa cells - Unknown function"	Microtubules		"HPA012583: AB_2668686"	"unprognostic (8.69e-2)"	"unprognostic (3.35e-3)"	"unprognostic (2.92e-2)"	"unprognostic (4.29e-2)"	"unprognostic (5.47e-3)"	"unprognostic (8.36e-2)"	"unprognostic (7.61e-7)"	"unprognostic (5.79e-2)"	"unprognostic (1.63e-1)"	"unprognostic (6.32e-2)"	"unprognostic (1.18e-2)"	"unprognostic (9.25e-2)"	"unprognostic (2.35e-1)"	"unprognostic (3.28e-2)"	"unprognostic (5.72e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.78e-1)"	4.5	4.0	3.8	4.2	5.0	7.2	4.0	4.6	3.9	4.1	2.7	9.7	4.1	6.7	3.1	9.6	3.2	5.6	7.2	3.1	6.0	4.1	3.4	3.2	4.3	4.5	5.5	5.9	3.8	4.0	1.6	4.8	4.7	6.0	4.7	5.3	4.4	6.8	11.5	2.6	3.5	8.0	4.2	3.7	3.7	6.5	5.1	2.9	8.0	9.1	4.1	5.7	2.9	5.3	3.7	6.9	9.7	13.2	9.9	8.8	9.9	10.3	9.6	6.9	6.8	8.7	3.3	17.0	7.8	11.8	12.6	5.7	8.4	7.5	10.4	10.0	5.8	10.8	9.1	8.8	17.8	14.1	10.8	14.6	8.3	8.6	11.4	9.0	10.1	4.1	12.6	11.9	13.6	2.9	6.4	7.5	11.2	2.4	5.1	8.2	21.7	5.9	7.2	3.8	4.3	6.9	12.6	6.5	6.1	9.6	3.0	13.8	13.4	7.1	6.0	9.1	10.4	8.8	7.2	6.8	11.4	6.0	7.7	9.3	1.3	1.6	0.4	1.1	0.3	0.6	0.4	0.8	1.6	1.3	0.6	0.6	1.2	0.5	0.9	0.5	0.3	0.6	3.8	5.0	4.6	3.9	3.1	6.0	4.5	5.5	4.7	4.2	5.1	5.3	11.1	3.2	5.9	7.2	5.4	14.3	5.3	4.2	12.5	8.8	10.5	8.3	22.9	10.0	4.7	3.7	4.2	5.8	5.7	4.9	11.7	4.7	10.9	4.1	13.7	13.8	6.0	36.7	5.3	3.2	3.4	15.4	7.1	6.2	12.0	37.1	11.4	9.7	7.5	26.9	6.4	5.0	2.0	11.9	20.8	4.4	11.1	10.2	7.2	7.5	7.5	12.0	0.0	5.0	7.6	5.1	3.2	10.1	11.1	7.1	4.3	8.2	2.8	8.7	0.0	26.5	18.4	19.7	10.5	12.4	17.3	5.6	6.2	7.2	5.0	5.0
SHPRH	"bA545I5.2, FLJ90837, KIAA2023"	ENSG00000146414	"SNF2 histone linker PHD RING helicase"	Q149N8	6	145864245-145964423	"Enzymes, Metabolic proteins, Predicted intracellular proteins"	"DNA damage, DNA repair, Ubl conjugation pathway"	"Helicase, Hydrolase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 210.6;Oligodendrocytes: 164.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034854, HPA044852"	Approved		Approved	"Nucleoplasm,Nuclear membrane,Cytosol"		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 34: Non-specific - Transcription"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Nuclear membrane"	Cytosol	"HPA034854: AB_10964488, HPA044852: "	"unprognostic (3.10e-2)"	"unprognostic (4.46e-2)"	"unprognostic (5.61e-3)"	"unprognostic (1.53e-2)"	"unprognostic (7.40e-3)"	"unprognostic (2.20e-2)"	"unprognostic (2.63e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.36e-1)"	"unprognostic (8.66e-3)"	"unprognostic (5.03e-1)"	"unprognostic (7.90e-2)"	"unprognostic (6.01e-3)"	"unprognostic (3.29e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.01e-1)"	4.9	4.2	3.1	4.7	3.7	4.2	7.2	18.4	5.1	5.4	3.2	4.3	4.2	7.7	6.0	4.3	5.2	4.6	3.5	3.0	2.5	5.5	4.6	4.2	6.9	2.8	2.6	12.2	3.9	6.7	2.0	4.5	4.5	5.5	5.0	16.3	5.8	5.1	4.2	9.7	4.5	5.7	2.5	6.4	5.4	7.6	2.9	7.2	8.4	5.2	5.8	4.3	3.3	5.5	4.2	3.2	15.3	9.1	7.0	7.3	7.2	4.9	3.9	5.9	7.6	7.0	2.9	14.5	5.9	3.7	4.6	7.0	9.5	6.9	7.7	6.5	10.9	14.6	7.6	6.1	5.2	31.2	8.6	5.2	7.8	5.6	8.0	5.8	6.4	10.0	20.3	7.9	5.1	3.7	19.8	11.6	10.3	6.9	5.4	14.1	23.6	5.0	8.0	4.1	12.6	8.8	8.7	7.9	5.4	10.5	4.2	14.6	7.2	3.7	7.0	7.4	5.8	6.4	9.4	17.1	3.9	13.0	6.0	0.7	0.9	1.9	1.7	0.9	1.5	1.5	1.4	1.1	1.1	2.5	1.5	1.3	0.0	1.5	1.0	2.0	1.4	0.5	3.1	3.7	18.4	5.1	3.0	2.5	2.8	2.6	4.5	2.5	2.9	5.5	31.4	28.9	23.4	106.7	31.0	21.2	17.9	14.5	19.4	117.2	21.5	20.3	17.2	20.0	20.7	22.0	210.6	16.1	34.6	9.1	7.9	18.6	20.4	20.9	52.8	26.0	19.2	15.3	131.0	12.9	7.0	25.9	23.9	18.1	13.3	145.7	15.7	20.5	12.0	94.2	140.3	14.7	6.1	21.4	9.8	8.0	50.7	19.8	14.2	93.7	30.6	40.7	36.0	143.7	164.6	15.9	8.8	34.3	23.5	18.8	17.2	7.5	14.9	158.5	72.3	47.1	39.1	83.2	65.0	16.5	19.7	6.6	26.4	61.5	18.0	12.5
GRM1	"GPRC1A, mGlu1, MGLUR1, PPP1R85"	ENSG00000152822	"Glutamate metabotropic receptor 1"	Q13255	6	146027646-146437601	"Disease related genes, G-protein coupled receptors, Human disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"Disease variant, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 27.6"	"Group enriched"	"Detected in some"	6	"Excitatory neurons: 215.5;Inhibitory neurons: 138.8;Rod photoreceptor cells: 124.9"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"cerebellum: 27.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA015701	Approved	Supported	Approved	Vesicles		NA	NA				"Cluster 69: Cerebellum - Gene expression regulation"		"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Vesicles		"HPA015701: AB_1853917"	"unprognostic (1.04e-2)"	"unprognostic (7.33e-2)"	"unprognostic (3.73e-3)"	"unprognostic (9.77e-3)"	"unprognostic (6.75e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.09e-1)"	"unprognostic (5.78e-2)"	"unprognostic (4.31e-2)"	"unprognostic (2.93e-2)"	"unprognostic (9.48e-3)"	"unprognostic (7.92e-2)"	"unprognostic (1.84e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.50e-2)"	"unprognostic (8.33e-3)"	"unprognostic (9.76e-2)"	0.0	0.0	3.3	0.0	3.6	0.0	0.0	27.6	6.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.8	7.3	2.3	0.7	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	5.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	7.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	3.6	27.6	6.8	7.3	2.3	0.0	3.1	0.9	0.0	7.7	0.0	0.0	0.0	0.0	23.5	0.0	0.0	0.0	0.0	0.0	13.8	0.0	0.0	3.7	0.0	0.0	1.8	16.7	0.0	0.0	0.0	1.9	0.0	8.5	0.1	0.0	0.2	0.0	0.0	215.5	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.6	6.7	138.8	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	3.7	0.0	4.0	0.0	8.0	8.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	124.9	0.0	0.0	0.1	1.1	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0
RAB32		ENSG00000118508	"RAB32, member RAS oncogene family"	Q13637	6	146543833-146554953	"Plasma proteins, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 175.1"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 232.6;Kupffer cells: 254.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 86.5"	"Group enriched"	"Detected in many"	42	"dendritic cells: 42.5;granulocytes: 86.5;monocytes: 46.8"	"Low cell line specificity"	"Detected in many"											HPA025731	Approved		Approved	Cytosol		NA	NA		63000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 51: Myeloid cells - Hemostasis"	Cytosol		"HPA025731: AB_1856001"	"unprognostic (3.07e-1)"	"unprognostic (5.32e-2)"	"prognostic favorable (1.56e-4)"	"prognostic unfavorable (6.51e-4)"	"unprognostic (1.26e-1)"	"unprognostic (2.34e-3)"	"prognostic unfavorable (1.08e-7)"	"unprognostic (2.64e-2)"	"unprognostic (9.71e-2)"	"unprognostic (3.38e-2)"	"unprognostic (2.80e-1)"	"unprognostic (1.79e-1)"	"prognostic unfavorable (8.62e-4)"	"unprognostic (1.54e-1)"	"unprognostic (6.31e-2)"	"unprognostic (1.73e-1)"	"unprognostic (2.67e-1)"	35.0	16.5	7.5	29.7	7.8	175.1	27.0	8.6	11.0	19.0	9.2	38.3	17.4	26.5	14.6	11.6	20.8	24.1	17.9	7.1	8.2	21.3	50.2	32.1	22.3	9.9	8.2	13.0	12.2	8.3	5.0	14.8	8.9	14.5	37.7	2.2	18.1	16.9	4.6	20.2	18.4	46.5	9.2	54.1	19.4	33.3	8.8	22.5	11.0	8.3	15.2	28.6	15.4	11.7	65.5	34.5	38.7	65.3	58.0	98.5	0.1	123.3	138.4	167.7	276.7	21.2	31.6	0.1	43.9	132.2	183.5	84.2	2.4	80.4	225.2	0.4	29.1	82.4	78.3	77.3	252.1	114.2	115.9	87.6	133.1	95.8	135.3	86.7	110.5	0.0	15.8	0.4	92.8	15.8	52.0	61.8	5.0	0.0	65.2	0.0	41.5	0.9	65.6	45.2	0.1	50.6	144.7	17.6	219.3	34.3	33.7	91.7	88.0	50.2	67.7	133.1	152.6	0.2	9.4	0.4	115.1	86.0	69.3	86.5	46.8	8.2	0.0	21.2	0.0	0.0	0.0	0.1	42.5	0.0	0.1	0.0	16.5	1.3	15.4	2.2	0.0	14.4	7.5	7.8	8.6	11.0	7.1	8.2	9.9	8.2	8.9	9.2	8.8	11.7	30.8	48.1	9.4	2.9	4.1	53.5	95.3	92.6	17.6	1.4	29.0	38.9	2.0	52.9	36.8	11.0	4.2	2.2	3.4	64.1	25.4	164.4	96.9	8.5	40.3	34.3	60.1	14.9	2.3	105.7	6.9	51.5	18.3	12.4	57.8	27.7	27.5	75.4	232.6	0.0	1.3	31.3	22.4	254.6	101.7	156.7	24.5	146.7	168.9	24.4	147.2	9.0	2.1	4.0	4.6	154.3	46.3	25.6	0.5	99.6	33.3	83.2	9.5	1.4	19.7	46.1	46.3	70.9	14.2	2.5	19.0	3.1	7.0	33.1	62.5	65.6
ADGB	"C6orf103, CAPN16, dJ408K24.1, FLJ23121"	ENSG00000118492	Androglobin	Q8N7X0	6	146598967-146815462	"Enzymes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 5.5;choroid plexus: 6.0;fallopian tube: 7.5;testis: 26.1"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 305.4;Endometrial ciliated cells: 57.1;Late spermatids: 74.8;Respiratory ciliated cells: 92.5;Spermatocytes: 68.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	18	"HDLM-2: 7.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA036340, HPA036341"	Enhanced		Uncertain	Nucleoplasm,Mitochondria		No	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 49: Ciliated cells - Cilium organization"	Mitochondria	Nucleoplasm	"HPA036340: AB_2675071, HPA036341: AB_10672241"	"unprognostic (4.15e-3)"		"unprognostic (1.23e-2)"	"unprognostic (9.30e-3)"	"unprognostic (1.09e-1)"	"unprognostic (2.07e-2)"		"unprognostic (3.11e-2)"	"unprognostic (5.05e-1)"	"unprognostic (2.34e-1)"	"unprognostic (4.83e-3)"	"unprognostic (1.05e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.77e-2)"	"unprognostic (3.66e-2)"	"unprognostic (2.68e-1)"		0.0	0.0	0.8	0.0	0.5	0.0	0.0	0.3	0.1	0.4	6.0	0.3	0.0	0.1	0.2	0.0	7.5	0.0	0.0	0.8	0.8	0.0	0.0	1.4	0.0	5.5	3.8	0.0	0.0	0.0	0.3	0.0	2.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	26.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.5	0.3	0.1	0.8	0.8	5.5	3.8	2.4	3.0	1.0	1.0	0.0	3.2	1.5	0.7	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.7	0.0	9.5	0.0	4.2	0.0	0.0	0.4	0.0	0.0	305.4	57.1	0.3	0.1	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.4	2.0	0.0	1.9	74.8	2.8	0.4	0.0	1.0	0.0	0.2	0.0	0.5	0.2	0.0	0.3	2.6	0.0	0.1	0.0	0.1	92.5	0.1	0.0	0.0	0.9	68.4	3.3	0.0	0.0	0.0	0.1	0.0	0.7	0.0
STXBP5	"LLGL3, tomosyn"	ENSG00000164506	"Syntaxin binding protein 5"	Q5T5C0	6	147204425-147390476	"Predicted intracellular proteins"	"Exocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 115.8"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 325.8;Excitatory neurons: 441.9;Inhibitory neurons: 300.1;Oligodendrocyte precursor cells: 206.1;Oligodendrocytes: 150.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"basophil: 3.8;eosinophil: 9.2;neutrophil: 3.1"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 9.2"	"Cell line enhanced"	"Detected in many"		"HEL: 210.2;HMC-1: 219.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039991, HPA049727, CAB079016"	Enhanced	Supported	Enhanced	Cytosol		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Cytosol		"CAB079016: , HPA039991: AB_10673368, HPA049727: AB_2680863"	"prognostic unfavorable (4.48e-4)"	"unprognostic (4.60e-3)"	"unprognostic (2.28e-3)"	"unprognostic (1.14e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.52e-1)"	"unprognostic (9.56e-4)"	"unprognostic (6.01e-2)"	"unprognostic (3.60e-1)"	"unprognostic (2.74e-2)"	"unprognostic (1.70e-2)"	"unprognostic (6.37e-3)"	"prognostic unfavorable (2.74e-7)"	"unprognostic (8.01e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.55e-1)"	"unprognostic (1.35e-3)"	7.0	9.1	7.2	9.5	12.7	34.3	7.8	24.2	13.2	9.5	0.0	14.2	8.0	8.3	7.7	13.7	5.9	9.5	5.9	9.5	6.5	3.6	3.9	6.6	7.8	0.6	0.5	5.5	15.5	115.8	7.7	6.3	0.5	11.4	16.3	20.1	5.5	14.5	7.7	15.4	11.2	10.9	0.0	8.3	8.0	22.2	0.6	9.4	6.3	8.1	9.6	8.5	9.9	8.5	10.8	9.4	4.9	16.5	23.4	48.8	5.4	24.5	36.1	17.8	19.9	8.0	7.0	7.8	5.6	48.8	30.5	12.7	14.1	21.5	21.6	17.1	11.0	210.2	27.2	9.0	26.8	72.7	219.6	35.6	15.0	35.6	72.0	42.1	23.2	12.2	57.8	9.6	35.4	15.7	11.6	18.8	4.0	8.9	21.4	1.7	25.4	3.0	9.7	18.4	10.6	7.6	18.9	13.3	8.2	8.7	3.9	28.0	26.9	25.4	9.2	12.6	22.5	7.9	0.1	9.1	14.0	26.2	18.5	3.8	0.3	9.2	0.9	0.4	0.9	0.3	0.5	1.1	0.4	0.9	0.8	1.3	3.1	0.4	0.5	0.3	0.2	0.3	7.2	12.7	24.2	13.2	9.5	6.5	0.6	0.5	0.5	0.0	0.6	8.5	12.1	16.0	8.8	325.8	5.7	3.6	2.6	1.9	3.4	38.8	6.7	7.7	14.1	11.5	6.7	16.5	31.3	5.2	9.5	18.7	0.0	4.8	39.0	10.1	10.5	10.8	41.1	10.1	441.9	12.9	4.6	10.1	14.3	20.5	44.2	5.1	8.9	4.5	4.7	33.7	300.1	30.3	0.0	7.8	3.1	42.8	7.8	7.8	10.6	97.4	8.5	5.4	6.2	206.1	150.4	11.7	21.4	7.2	5.8	10.4	29.3	1.9	2.2	29.0	13.1	12.7	5.6	13.1	11.5	11.0	6.7	3.8	9.3	5.4	19.3	3.6
SAMD5	dJ875H10.1	ENSG00000203727	"Sterile alpha motif domain containing 5"	Q5TGI4	6	147508690-147737547	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"Bipolar cells: 96.0;Inhibitory neurons: 276.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CACO-2: 16.6;Hep G2: 65.6;K-562: 44.7;RH-30: 29.0;WM-115: 20.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067811	Uncertain		Supported	Vesicles		No	No				"Cluster 77: Retina - Visual perception"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Vesicles		"HPA067811: AB_2685901"	"unprognostic (4.16e-2)"	"unprognostic (4.52e-2)"	"unprognostic (9.65e-3)"	"unprognostic (1.41e-2)"	"unprognostic (1.82e-2)"	"unprognostic (5.88e-2)"	"prognostic unfavorable (2.23e-4)"	"unprognostic (2.31e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.61e-2)"	"unprognostic (8.55e-3)"	"unprognostic (3.09e-2)"	"unprognostic (5.40e-3)"	"unprognostic (1.72e-1)"	"unprognostic (4.51e-2)"	"unprognostic (9.82e-3)"	"unprognostic (1.50e-1)"	0.6	1.8	2.8	1.3	5.6	0.1	4.1	1.0	2.6	1.4	0.1	6.0	3.0	4.2	0.8	8.9	0.9	2.2	1.2	2.7	4.0	7.4	7.5	3.4	0.3	8.7	4.1	0.4	1.3	5.7	3.8	12.2	9.1	1.4	8.1	8.9	2.3	2.4	0.2	1.9	4.4	3.1	0.0	1.4	4.5	7.6	7.2	0.1	2.1	0.1	0.7	1.5	1.9	0.8	11.2	1.4	1.4	2.0	0.0	0.0	0.1	3.6	1.3	0.3	0.2	16.6	0.1	0.6	3.6	0.0	0.6	0.1	0.3	2.5	0.4	0.0	2.0	0.8	1.5	65.6	0.2	0.0	1.3	0.0	0.1	0.3	0.1	0.0	6.8	0.0	44.7	0.6	4.8	0.1	0.0	0.0	0.1	8.4	2.8	0.0	29.0	6.5	0.1	2.3	0.5	0.1	0.9	0.2	2.8	0.3	0.0	0.0	4.9	0.5	1.5	0.5	1.3	0.1	1.1	0.0	0.1	0.1	20.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.8	5.6	1.0	2.6	2.7	4.0	8.7	4.1	9.1	0.0	7.2	0.8	1.7	3.2	5.9	1.3	1.0	1.8	5.6	0.5	2.2	96.0	2.9	23.5	2.6	0.0	0.0	18.4	2.1	0.2	0.0	5.4	9.8	2.2	0.5	1.1	10.7	11.1	16.9	0.0	15.7	0.2	0.3	6.9	19.4	1.8	0.0	7.0	6.1	28.1	0.8	0.0	276.9	11.6	0.0	1.0	1.4	1.3	0.3	0.7	0.0	45.0	0.0	9.2	0.0	5.5	0.9	0.6	3.4	3.4	0.1	3.0	5.2	19.7	0.0	4.0	0.0	3.1	2.0	0.5	0.2	36.4	1.6	0.3	0.5	3.6	25.7	4.2
SASH1	"dJ323M4.1, KIAA0790, SH3D6A"	ENSG00000111961	"SAM and SH3 domain containing 1"	O94885	6	148272304-148552048	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant, Hypotrichosis, Palmoplantar keratoderma, Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 194.8;Astrocytes: 426.7;Microglial cells: 179.9;Oligodendrocyte precursor cells: 186.5;Oligodendrocytes: 328.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	17	"classical monocyte: 1.2;intermediate monocyte: 2.6;non-classical monocyte: 1.3"	"Lineage enriched"	"Detected in single"	26	"monocytes: 2.6"	"Cell line enhanced"	"Detected in many"		"ASC diff: 198.0;ASC TERT1: 74.7;fHDF/TERT166: 73.4;HUVEC TERT2: 75.0;WM-115: 95.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029947, HPA029949"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 68: Oligodendrocytes - Mixed function"	Nucleoplasm	Cytosol	"HPA029947: AB_10598915, HPA029949: AB_10602280"	"unprognostic (9.71e-2)"	"unprognostic (4.74e-2)"	"unprognostic (5.32e-2)"	"prognostic unfavorable (2.42e-4)"	"unprognostic (3.55e-2)"	"unprognostic (4.79e-3)"	"unprognostic (6.69e-2)"	"unprognostic (4.76e-2)"	"unprognostic (2.06e-1)"	"unprognostic (8.65e-3)"	"unprognostic (9.94e-2)"	"unprognostic (2.96e-1)"	"unprognostic (2.13e-3)"	"unprognostic (5.45e-2)"	"unprognostic (3.53e-1)"	"unprognostic (8.04e-3)"	"unprognostic (1.54e-1)"	76.1	6.1	45.5	6.6	62.5	0.3	47.6	58.2	35.4	24.5	10.3	18.1	6.8	13.6	5.1	45.2	15.9	19.7	17.0	40.0	43.0	15.0	9.3	26.5	6.2	72.1	60.0	6.5	9.5	14.2	5.1	30.3	59.4	11.6	9.8	15.4	19.8	9.2	17.9	31.0	11.8	16.1	49.1	13.7	9.5	4.6	65.1	5.1	39.0	22.5	7.8	13.8	27.9	59.3	4.8	2.9	23.6	7.9	198.0	74.7	3.9	27.3	65.6	20.2	30.7	6.2	5.7	0.0	14.1	73.4	10.1	5.7	7.3	6.7	16.9	0.0	5.3	0.0	13.6	5.7	6.1	0.0	1.3	35.1	6.8	30.6	8.3	8.3	75.0	0.0	0.4	0.1	19.1	5.5	0.0	0.0	6.9	2.6	3.8	0.0	16.8	0.2	15.1	15.1	0.9	0.0	8.4	30.8	21.5	6.1	2.4	14.0	65.6	19.7	4.0	63.1	5.9	0.0	0.0	0.0	31.6	0.0	95.6	0.0	1.2	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.3	45.5	62.5	58.2	35.4	40.0	43.0	72.1	60.0	59.4	49.1	65.1	59.3	194.8	16.0	21.7	426.7	0.6	41.0	6.2	5.1	29.6	21.9	17.7	24.0	18.5	5.7	18.3	46.0	6.2	20.6	0.8	4.4	7.9	3.1	0.8	45.3	36.2	104.7	4.8	0.0	16.4	2.4	59.5	66.5	8.2	40.1	2.5	2.3	60.3	8.1	8.8	3.3	120.7	5.3	10.2	42.4	18.5	1.6	18.3	15.6	42.7	179.9	4.9	100.4	0.0	186.5	328.6	1.5	2.9	28.2	1.3	6.4	2.3	15.0	15.5	4.7	78.9	49.9	73.2	0.5	3.7	46.3	33.0	32.7	1.6	3.1	7.2	7.4
UST	2OST	ENSG00000111962	"Uronyl 2-sulfotransferase"	Q9Y2C2	6	148747030-149076990	"Metabolic proteins, Predicted membrane proteins"		Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	4	"Oligodendrocyte precursor cells: 339.8"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 15.7"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"NK-cell: 2.5"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"OE19: 32.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA032022	Approved					NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 21: OE19 - Mitochondria"	"Cluster 68: Oligodendrocytes - Mixed function"			"HPA032022: AB_10603326"	"unprognostic (3.43e-1)"	"unprognostic (1.90e-1)"	"unprognostic (7.87e-3)"	"unprognostic (3.22e-5)"	"unprognostic (1.83e-3)"	"unprognostic (1.50e-1)"	"unprognostic (5.71e-2)"	"unprognostic (1.96e-2)"	"unprognostic (8.31e-3)"	"unprognostic (2.67e-2)"	"unprognostic (3.63e-2)"	"unprognostic (1.11e-1)"	"unprognostic (9.25e-3)"	"unprognostic (9.48e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.51e-2)"	"unprognostic (3.02e-2)"	6.0	12.2	6.3	3.0	7.4	0.2	6.2	10.0	7.9	7.6	7.5	9.2	1.7	6.8	5.6	4.6	9.2	6.0	4.3	5.8	16.0	3.6	1.3	5.2	3.9	28.2	17.2	11.6	13.1	4.6	1.9	4.6	14.1	6.3	2.7	6.8	3.2	4.8	1.7	6.7	5.7	8.8	13.5	6.5	5.0	6.7	22.7	6.5	27.5	5.8	3.7	8.8	7.7	15.6	0.1	3.2	18.2	14.0	21.5	17.8	0.1	7.9	20.5	3.8	9.8	0.0	1.2	6.7	1.7	12.3	9.5	5.7	13.0	6.6	7.6	9.1	9.9	0.2	10.0	0.1	7.9	0.3	2.8	9.2	14.6	9.8	18.1	7.6	0.2	11.1	0.0	0.0	3.0	8.3	0.1	0.0	10.7	32.4	4.2	3.3	2.5	7.7	0.1	14.8	9.4	0.0	26.4	6.3	5.0	13.0	4.7	0.3	0.4	10.9	1.3	2.5	7.4	0.0	0.0	0.0	12.1	5.4	6.3	0.0	0.0	0.0	0.6	0.2	0.4	0.3	0.4	0.5	0.4	0.5	0.0	0.2	0.0	2.5	0.3	0.4	0.1	0.1	6.3	7.4	10.0	7.9	5.8	16.0	28.2	17.2	14.1	13.5	22.7	15.6	0.9	3.2	3.2	70.2	4.5	9.4	5.4	2.6	3.4	0.1	1.7	1.5	1.7	0.0	2.7	1.8	0.0	2.0	8.9	0.2	0.0	0.1	1.1	0.3	8.7	0.6	0.0	0.0	36.3	2.0	0.3	16.3	7.1	0.4	0.0	12.3	1.4	0.3	1.7	0.0	39.7	1.8	10.2	1.0	20.9	3.4	18.3	2.8	5.4	80.6	1.0	14.6	5.2	339.8	3.2	1.1	0.3	11.3	0.4	5.9	0.0	0.6	2.3	0.8	0.0	6.8	3.5	2.9	5.7	1.9	11.6	1.4	2.0	10.2	0.5	6.8
TAB2	"KIAA0733, MAP3K7IP2"	ENSG00000055208	"TGF-beta activated kinase 1 (MAP3K7) binding protein 2"	Q9NYJ8	6	149218641-149411613	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 238.0;Microglial cells: 188.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065436, HPA070137"	Approved					NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 70: Brain - Nervous system development"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 44: Endometrium - Transcription"			"HPA065436: AB_2732735, HPA070137: AB_2732148"	"unprognostic (1.08e-2)"	"unprognostic (4.81e-3)"	"unprognostic (1.27e-2)"	"unprognostic (1.07e-2)"	"unprognostic (7.05e-2)"	"unprognostic (3.85e-1)"	"unprognostic (1.85e-2)"	"unprognostic (2.95e-3)"	"unprognostic (2.05e-1)"	"unprognostic (3.08e-2)"	"unprognostic (3.08e-2)"	"unprognostic (8.88e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.29e-3)"	"unprognostic (1.93e-1)"	"unprognostic (7.57e-2)"	"unprognostic (2.49e-1)"	27.6	25.6	55.1	32.9	52.2	48.4	33.3	45.2	58.5	36.4	39.9	47.5	24.1	32.7	27.9	35.7	27.3	26.0	32.3	54.5	84.4	34.5	58.8	31.0	38.8	91.7	73.2	40.9	33.1	41.7	15.3	27.6	67.0	32.8	32.9	20.0	54.8	36.0	69.4	24.6	26.3	37.1	79.7	35.1	27.2	21.3	56.2	47.2	35.7	59.8	37.8	37.5	28.2	71.8	32.0	19.8	51.8	56.0	49.6	42.7	40.1	35.8	65.6	55.4	71.6	30.1	44.9	33.8	44.8	42.8	72.0	31.8	42.3	49.2	86.1	112.0	30.2	55.0	25.8	43.4	49.1	47.8	32.4	51.4	68.8	55.9	73.8	85.1	53.1	33.4	42.1	32.9	57.6	39.8	44.9	27.0	33.0	27.2	22.2	37.7	36.4	21.7	51.9	45.7	39.3	35.7	49.0	81.4	27.6	59.4	50.8	52.1	57.6	42.2	51.8	47.0	63.5	28.9	18.2	50.4	70.8	29.9	44.7	0.0	0.9	0.3	1.4	1.7	1.3	1.9	4.1	2.7	2.1	0.9	2.6	2.3	4.7	4.7	1.4	2.4	4.6	1.2	55.1	52.2	45.2	58.5	54.5	84.4	91.7	73.2	67.0	79.7	56.2	71.8	19.9	67.3	28.3	238.0	27.5	47.0	26.5	17.0	17.1	9.1	29.3	19.4	48.0	11.5	19.5	16.5	2.1	13.1	24.3	42.1	11.7	15.0	40.0	28.5	31.9	22.8	16.3	23.1	82.1	19.8	11.8	26.7	21.9	47.8	28.5	28.0	22.9	41.4	28.9	11.8	83.3	21.5	14.2	43.1	81.7	13.7	29.2	42.4	17.8	188.3	42.8	10.9	21.6	82.9	81.3	26.3	17.2	28.6	23.1	43.7	19.9	19.7	18.5	5.9	19.7	29.9	19.0	16.4	12.4	18.2	42.9	10.7	40.0	12.7	22.2	57.2
SUMO4	"dJ281H8.4, IDDM5, SMT3H4"	ENSG00000177688	"Small ubiquitin like modifier 4"	Q6EEV6	6	149400262-149401278	"Disease related genes, Predicted intracellular proteins"	"Ubl conjugation pathway"		"Diabetes mellitus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in some"			"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 11.1;Glandular and luminal cells: 8.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in single"		"HeLa: 1.0"									"HPA042123, HPA048064"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 15: Liver - Metabolism"	"Cluster 20: HeLa - Mitochondria"	"Cluster 43: Cardiomyocytes - Nuclear processes"	"Nucleoplasm, Nuclear bodies"		"HPA042123: AB_2677860, HPA048064: AB_2680244"	"unprognostic (1.16e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.16e-2)"	"unprognostic (3.24e-3)"	"unprognostic (8.61e-2)"	"unprognostic (6.84e-2)"	"unprognostic (2.24e-1)"	"unprognostic (7.75e-2)"	"unprognostic (4.32e-2)"	"unprognostic (1.35e-1)"	"unprognostic (4.72e-2)"	"unprognostic (5.36e-2)"	"unprognostic (2.44e-11)"	"unprognostic (4.94e-3)"	"unprognostic (5.88e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.19e-2)"	0.5	0.3	1.0	0.3	0.7	0.7	0.3	1.7	1.2	1.1	1.2	0.4	0.2	0.2	0.1	0.6	0.5	0.2	0.8	0.5	0.7	0.8	1.3	1.0	0.5	1.9	0.9	0.9	0.4	0.0	0.8	0.3	1.2	1.0	0.2	0.7	0.4	0.1	0.2	0.4	0.3	0.1	1.0	0.6	0.3	0.6	1.5	0.1	0.6	0.0	0.2	0.6	1.1	1.6	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.1	0.0	0.1	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.7	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.3	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.4	0.3	0.2	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.2	0.4	0.5	0.2	0.2	0.4	1.0	0.7	0.2	0.6	0.6	0.9	2.2	1.0	0.5	0.2	1.1	0.2	1.0	0.7	1.7	1.2	0.5	0.7	1.9	0.9	1.2	1.0	1.5	1.6	2.0	3.2	1.5	0.0	3.1	2.9	1.8	0.9	0.0	4.3	2.5	1.8	11.1	1.5	0.9	1.8	4.2	0.7	6.4	1.3	0.0	0.7	0.1	4.5	4.0	2.7	1.8	0.8	0.0	0.9	0.4	2.9	2.0	8.4	1.3	7.2	1.4	1.6	1.1	0.0	0.0	0.5	0.0	1.3	4.7	0.9	2.1	5.1	0.0	0.0	3.9	1.7	1.0	0.0	0.0	1.1	1.2	1.2	3.5	3.5	1.0	0.4	1.0	3.9	6.6	1.8	3.6	1.9	0.8	0.5	0.9	0.3	4.3	2.7	0.4	3.9
ZC3H12D	"C6orf95, dJ281H8.1, MCPIP4"	ENSG00000178199	"Zinc finger CCCH-type containing 12D"	A2A288	6	149446795-149485014	"Disease related genes, Predicted intracellular proteins"		"Endonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"bone marrow: 3.6;intestine: 4.7;lymphoid tissue: 12.6"	"Cell type enhanced"	"Detected in many"		"B-cells: 14.6;Distal enterocytes: 7.7;Kupffer cells: 12.4;Macrophages: 7.4;Proximal enterocytes: 7.5;T-cells: 17.4"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	4	"HDLM-2: 34.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA036897	Uncertain		Supported	"Nucleoplasm,Cytoplasmic bodies"		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 16: Immune cells - Immune response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Cytoplasmic bodies"		"HPA036897: AB_10672104"	"unprognostic (2.89e-2)"	"unprognostic (3.91e-4)"	"unprognostic (1.68e-2)"	"unprognostic (1.88e-2)"	"unprognostic (3.12e-1)"	"unprognostic (2.47e-6)"	"unprognostic (2.20e-2)"	"unprognostic (2.50e-3)"	"unprognostic (1.34e-1)"	"unprognostic (3.30e-2)"	"unprognostic (2.33e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.28e-4)"	"unprognostic (1.21e-2)"	"unprognostic (9.24e-3)"	"unprognostic (6.99e-2)"	"unprognostic (5.52e-2)"	0.7	0.4	1.0	7.2	0.5	3.6	0.4	0.4	0.9	0.3	0.3	1.5	2.8	0.2	0.2	0.3	0.3	0.6	0.3	0.8	0.9	0.6	0.3	0.8	9.8	1.0	0.5	0.3	0.1	0.0	0.2	0.3	0.8	0.3	1.4	0.5	0.7	0.3	0.4	1.1	4.7	0.5	0.4	5.8	0.8	0.3	0.9	1.1	0.5	0.0	12.6	1.0	0.2	0.9	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.6	0.1	8.0	0.1	0.0	0.2	0.2	0.0	0.0	0.1	34.3	0.2	0.3	1.2	2.7	0.0	2.8	0.5	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.7	0.0	0.1	0.0	2.5	0.0	0.0	0.0	7.1	0.0	0.9	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.3	4.6	0.0	0.2	0.1	0.1	0.1	0.1	0.2	2.9	0.4	2.5	0.1	0.7	0.8	0.1	0.1	0.5	0.2	1.4	1.5	0.7	0.8	1.3	0.9	0.2	0.5	0.3	1.4	0.4	3.5	0.8	1.0	0.5	0.4	0.9	0.8	0.9	1.0	0.5	0.8	0.4	0.9	0.9	1.0	3.2	3.9	1.3	14.6	0.4	0.5	0.0	0.0	0.7	0.3	0.3	1.4	1.5	0.6	0.0	4.2	0.0	3.7	7.7	1.9	0.0	0.4	0.4	0.4	1.3	0.0	0.4	1.2	0.4	0.0	0.7	0.5	0.6	0.0	0.2	1.4	0.3	3.7	0.0	0.7	1.1	0.0	12.4	4.4	0.5	0.0	7.4	1.8	1.0	1.6	0.8	0.0	0.0	0.7	0.3	0.8	0.0	4.6	0.4	7.5	1.6	0.0	1.1	0.0	0.9	0.4	0.2	0.4	0.1	1.4	0.0	17.4	0.0	2.6	0.4
PPIL4		ENSG00000131013	"Peptidylprolyl isomerase like 4"	Q8WUA2	6	149504495-149546043	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Isomerase, RNA-binding, Rotamase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031599, HPA031600"	Approved		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 18: U-2197 - ECM organization"	"Cluster 22: Epithelial cell types - Mixed function"	Nucleoplasm	Cytosol	"HPA031599: AB_2673950, HPA031600: AB_10600928"	"unprognostic (6.12e-2)"	"unprognostic (4.90e-2)"	"unprognostic (3.85e-2)"	"unprognostic (8.42e-2)"	"unprognostic (7.53e-2)"	"unprognostic (6.36e-3)"	"unprognostic (2.91e-3)"	"unprognostic (2.22e-1)"	"unprognostic (4.22e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.38e-1)"	"unprognostic (4.62e-2)"	"unprognostic (3.88e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.59e-1)"	"unprognostic (8.50e-2)"	"unprognostic (7.94e-2)"	19.6	19.2	12.3	15.6	15.0	36.4	20.3	19.8	18.3	18.1	9.6	15.4	14.2	20.1	25.7	13.7	16.5	18.9	15.9	13.1	18.0	17.9	22.9	16.1	17.2	10.6	12.8	27.3	14.8	18.8	18.8	22.7	10.9	19.2	16.0	13.1	15.8	15.2	10.7	14.4	14.6	14.7	11.1	17.4	16.4	16.3	17.0	18.5	25.7	11.5	17.1	20.9	16.9	15.8	22.7	12.0	41.0	34.7	23.8	30.9	38.1	43.8	41.1	46.4	49.2	25.1	22.8	23.8	29.4	33.9	27.9	20.1	31.5	16.5	73.1	34.7	29.7	26.4	27.0	43.9	37.3	49.2	21.6	24.3	27.8	47.6	39.7	26.2	25.7	17.1	58.1	14.0	36.5	24.2	28.1	41.8	32.6	22.6	18.5	37.2	37.7	11.9	35.6	17.0	24.1	18.4	52.0	22.4	31.7	28.2	26.5	35.1	31.0	30.8	24.3	55.1	42.3	18.4	9.9	37.0	26.3	38.7	45.5	34.1	17.1	20.4	15.1	19.9	21.0	23.7	19.5	17.5	18.2	17.9	24.5	18.8	14.5	32.0	19.3	17.9	23.7	16.5	12.3	15.0	19.8	18.3	13.1	18.0	10.6	12.8	10.9	11.1	17.0	15.8	54.8	67.3	70.7	25.1	49.7	48.8	56.4	49.0	30.7	46.2	29.5	34.9	45.6	18.6	59.7	46.0	8.4	50.4	48.4	16.9	43.0	42.0	24.4	57.6	55.7	43.2	23.3	25.4	37.3	26.3	46.2	76.2	20.9	48.2	77.1	30.9	33.5	21.3	37.3	28.6	34.7	22.9	48.8	25.2	43.8	12.0	61.8	38.3	40.9	21.5	45.5	42.0	28.8	27.2	41.1	32.2	21.9	56.1	29.4	33.8	19.7	37.6	71.9	37.1	52.6	66.1	70.5	75.9	59.3	22.5	45.3	65.3	53.4	47.7	22.3	43.0
GINM1	"C6orf72, dJ12G14.2"	ENSG00000055211	"Glycoprotein integral membrane 1"	Q9NU53	6	149566294-149591748	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 369.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017210, HPA041679"	Approved		Approved	"Nucleoli fibrillar center,Plasma membrane"		NA	NA		35000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 25: Spermatids - Spermatogenesis"	"Nucleoli fibrillar center, Plasma membrane"		"HPA017210: AB_1845743, HPA041679: AB_2677611"	"unprognostic (6.09e-3)"	"unprognostic (2.19e-2)"	"unprognostic (2.38e-1)"	"unprognostic (2.48e-1)"	"unprognostic (7.24e-2)"	"unprognostic (1.32e-3)"	"unprognostic (3.18e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.31e-1)"	"unprognostic (8.23e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.10e-2)"	"unprognostic (2.09e-2)"	"unprognostic (2.88e-2)"	"unprognostic (2.64e-2)"	"unprognostic (4.87e-2)"	"unprognostic (4.79e-3)"	56.0	44.0	25.7	24.0	31.4	41.2	45.0	33.9	36.1	47.8	38.5	43.0	25.9	46.4	44.6	32.2	39.2	38.2	58.6	25.0	28.9	92.7	45.7	36.0	26.1	30.6	29.0	50.5	36.8	55.3	24.7	62.6	30.6	40.3	34.8	21.9	32.2	47.4	47.1	36.4	28.1	50.5	29.3	35.1	34.1	48.0	26.9	21.7	73.9	42.3	24.7	42.2	34.0	38.9	27.2	19.5	30.5	41.4	162.6	96.1	48.3	89.0	107.5	68.1	85.1	25.4	35.7	19.4	46.9	87.6	62.9	53.8	20.1	46.0	89.0	33.6	39.6	18.9	17.5	30.5	62.0	37.2	17.2	107.8	39.1	58.0	39.6	74.7	74.7	27.0	24.6	31.8	65.1	35.3	22.9	27.9	10.1	40.2	20.1	25.2	54.0	15.1	97.7	23.9	19.2	18.1	90.1	53.2	18.9	33.5	32.9	38.4	51.3	35.9	37.0	92.9	60.9	30.6	38.6	24.5	67.4	33.1	34.3	21.0	18.5	25.1	8.8	17.8	10.5	22.8	10.2	9.7	13.9	17.0	9.8	8.0	32.1	11.4	23.4	16.9	10.7	10.6	25.7	31.4	33.9	36.1	25.0	28.9	30.6	29.0	30.6	29.3	26.9	38.9	120.5	80.1	53.7	10.1	44.6	46.8	58.6	75.1	46.7	21.3	50.1	50.3	54.1	38.6	53.4	66.2	29.2	81.1	31.4	64.5	39.2	92.7	191.0	42.2	77.3	78.9	26.8	32.2	11.9	80.7	77.1	103.4	18.3	60.7	29.1	48.2	104.6	41.9	45.6	16.8	13.9	23.1	46.8	56.0	47.7	369.6	129.5	46.6	42.7	5.6	75.7	86.5	18.6	17.1	25.0	67.8	33.5	112.8	45.3	65.0	49.8	132.1	33.8	22.6	98.6	85.9	71.1	166.5	82.8	48.7	47.0	122.7	32.0	65.7	22.4	64.0
KATNA1		ENSG00000186625	"Katanin catalytic subunit A1"	O75449	6	149594873-149648972	"Enzymes, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	Isomerase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"Early spermatids: 416.6;Late spermatids: 194.2;Spermatocytes: 109.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036207	Approved		Supported	"Nucleoplasm,Centriolar satellite"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 32: U-937 - Innate immune response"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	"Centriolar satellite"	Nucleoplasm	"HPA036207: AB_10672238"	"unprognostic (1.57e-1)"	"unprognostic (2.41e-2)"	"unprognostic (2.95e-2)"	"unprognostic (3.57e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.12e-1)"	"prognostic unfavorable (3.57e-7)"	"unprognostic (9.78e-2)"	"unprognostic (8.89e-2)"	"unprognostic (7.40e-2)"	"unprognostic (2.70e-2)"	"unprognostic (4.50e-2)"	"unprognostic (3.92e-2)"	"unprognostic (2.10e-1)"	"unprognostic (3.37e-1)"	"unprognostic (1.74e-3)"	"unprognostic (8.85e-2)"	12.9	8.2	7.2	10.3	8.4	19.2	12.6	9.6	9.1	13.3	12.3	13.1	8.5	13.3	9.8	12.5	11.8	9.7	11.6	7.0	7.9	13.2	9.0	11.2	14.1	8.2	7.9	19.5	9.5	7.3	7.4	12.7	8.4	9.9	9.9	16.8	9.7	10.9	23.0	12.3	10.0	12.4	7.9	11.8	10.1	45.1	7.8	17.0	11.2	14.3	15.8	12.0	12.7	9.6	22.5	8.3	18.6	42.1	22.9	32.7	28.9	28.7	24.3	29.4	37.2	17.9	11.4	33.7	16.9	28.4	20.4	17.1	34.5	18.5	37.8	30.4	33.8	42.7	17.6	27.9	31.0	60.0	16.4	22.8	22.5	33.3	27.3	27.3	27.8	44.4	46.1	20.7	26.2	32.0	41.2	40.4	19.1	26.2	15.1	30.5	33.3	15.2	21.6	11.6	13.7	20.7	48.9	15.0	22.2	24.3	14.4	61.6	23.7	14.6	23.4	39.2	33.9	20.4	20.3	43.9	19.8	42.7	26.4	39.8	20.4	29.1	25.9	28.5	22.2	27.7	25.2	25.8	26.1	18.3	21.4	20.9	8.7	18.2	25.6	22.3	34.0	20.5	7.2	8.4	9.6	9.1	7.0	7.9	8.2	7.9	8.4	7.9	7.8	9.6	27.6	16.0	11.3	11.8	20.2	29.3	35.7	23.0	12.5	9.1	17.3	26.9	15.5	10.0	15.0	14.7	29.2	23.6	31.4	12.1	17.6	19.5	416.6	23.2	21.6	19.3	6.0	27.4	8.6	12.4	19.4	25.9	11.7	19.3	20.3	23.9	10.0	7.7	17.4	13.5	9.4	9.7	24.4	12.5	19.4	194.2	21.1	17.3	10.6	7.5	22.1	12.2	27.8	13.6	16.3	15.9	12.5	16.6	9.0	19.4	9.7	20.9	23.8	36.1	6.6	40.0	28.5	109.3	58.8	17.7	28.7	25.6	25.6	17.7	12.1	15.4
LATS1	WARTS	ENSG00000131023	"Large tumor suppressor kinase 1"	O95835	6	149658153-149718105	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031804	Approved					NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 59: Non-specific - Transcription"			"HPA031804: AB_10601688"	"unprognostic (4.02e-3)"	"unprognostic (3.80e-3)"	"unprognostic (1.28e-2)"	"unprognostic (1.00e-1)"	"unprognostic (4.40e-2)"	"unprognostic (2.09e-1)"	"unprognostic (6.15e-3)"	"unprognostic (1.29e-2)"	"unprognostic (9.67e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.52e-1)"	"unprognostic (5.62e-2)"	"unprognostic (1.92e-1)"	"unprognostic (8.43e-2)"	"unprognostic (2.63e-1)"	"unprognostic (2.65e-1)"	8.1	8.0	4.8	8.6	4.9	15.4	9.2	11.0	7.0	10.1	5.5	7.3	7.2	12.1	7.4	8.2	9.7	7.7	5.6	5.2	4.6	7.7	7.8	9.1	9.8	4.7	4.3	15.6	6.8	11.7	5.2	8.8	5.0	11.0	8.5	11.0	8.7	7.7	6.4	9.1	7.7	10.7	4.3	10.2	7.7	6.2	5.1	11.7	8.9	8.1	8.4	9.0	7.2	7.6	8.7	6.8	13.7	19.8	12.9	16.6	10.7	11.3	11.4	11.8	11.7	11.1	7.3	14.0	11.1	15.7	9.4	11.8	18.3	12.0	18.5	12.9	14.7	28.1	8.2	9.9	11.9	26.5	19.8	11.3	19.1	13.5	22.7	12.2	14.8	12.1	35.3	13.9	11.9	10.4	13.8	11.0	8.5	8.0	6.5	13.6	16.4	6.5	11.0	12.2	9.3	14.7	16.1	11.5	8.4	9.3	12.0	22.9	18.7	9.5	14.8	11.4	18.2	11.6	13.5	15.8	8.7	14.8	14.3	8.2	3.0	4.8	5.9	5.3	5.3	3.8	4.5	5.0	3.3	4.7	3.8	5.1	2.0	3.0	8.9	2.8	4.8	2.4	4.8	4.9	11.0	7.0	5.2	4.6	4.7	4.3	5.0	4.3	5.1	7.6	21.1	12.8	21.3	33.0	21.9	16.3	11.2	9.7	27.9	20.3	15.2	10.2	9.6	12.8	12.5	7.3	18.8	8.5	18.7	15.3	1.9	7.5	23.0	14.1	23.4	16.2	16.8	17.7	51.4	6.6	11.4	19.7	20.9	17.1	14.0	19.8	21.0	13.3	11.0	13.5	48.0	12.6	6.1	14.7	11.6	6.9	13.7	16.6	14.2	32.8	15.0	10.7	10.3	54.8	64.0	9.9	11.5	25.9	21.9	15.4	13.6	6.6	12.8	22.0	19.7	28.8	15.1	8.8	9.6	18.8	18.0	13.1	23.3	13.8	11.7	11.8
NUP43	"bA350J20.1, FLJ13287"	ENSG00000120253	"Nucleoporin 43"	Q8NFH3	6	149724315-149749665	"Metabolic proteins, Predicted intracellular proteins, Transporters"	"Cell cycle, Cell division, Chromosome partition, Mitosis, mRNA transport, Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 78.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027126, HPA027291, HPA028500"	Enhanced		Approved	"Nucleoplasm,Nuclear speckles,Cytosol"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 16: Immune cells - Immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Nuclear speckles"	Cytosol	"HPA027126: AB_10599301, HPA027291: AB_10601851, HPA028500: AB_10602287"	"prognostic unfavorable (2.08e-4)"	"unprognostic (3.02e-1)"	"unprognostic (3.86e-2)"	"unprognostic (1.45e-3)"	"unprognostic (2.29e-1)"	"unprognostic (8.19e-3)"	"prognostic unfavorable (7.13e-7)"	"unprognostic (5.14e-2)"	"unprognostic (2.45e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.06e-2)"	"unprognostic (2.74e-2)"	"unprognostic (6.25e-3)"	"unprognostic (2.02e-1)"	"unprognostic (2.72e-2)"	"unprognostic (3.60e-2)"	8.4	8.6	6.2	11.4	7.5	6.2	13.6	7.2	6.9	9.7	6.5	9.4	8.7	9.8	7.5	9.5	8.2	6.4	10.8	5.6	6.6	9.9	9.6	8.0	15.9	6.6	6.6	9.1	12.2	8.9	5.6	11.4	6.9	10.3	9.7	9.8	8.8	9.2	14.2	13.5	10.9	9.4	6.6	13.6	9.8	7.9	6.5	12.8	11.1	11.6	17.0	9.0	9.1	8.3	21.1	34.9	31.1	49.6	20.0	23.7	48.9	36.3	20.3	34.0	43.0	49.5	19.5	61.4	36.6	20.2	32.1	33.5	54.6	31.6	58.3	27.8	38.2	70.9	35.5	49.6	13.4	73.2	44.1	15.3	16.4	49.9	33.1	13.0	27.5	34.6	71.4	33.6	29.6	20.7	52.2	30.4	28.3	24.1	21.0	50.2	43.2	20.6	23.2	28.9	12.9	21.2	43.4	27.1	14.2	25.6	28.7	30.9	21.3	28.3	30.2	41.2	53.9	20.5	43.3	63.9	25.2	49.3	40.5	2.9	4.9	3.4	3.5	5.4	3.8	4.3	4.2	3.5	2.6	6.2	4.3	5.5	1.9	3.7	4.8	5.0	4.9	2.2	6.2	7.5	7.2	6.9	5.6	6.6	6.6	6.6	6.9	6.6	6.5	8.3	5.8	3.2	7.8	9.1	11.5	7.9	5.5	4.7	2.8	11.9	4.5	5.0	14.3	11.5	5.2	3.7	6.2	10.9	11.3	4.7	3.9	9.0	33.3	4.3	8.7	5.7	10.2	7.6	4.8	7.8	12.2	6.4	6.1	6.0	0.0	12.8	8.2	4.4	7.8	6.7	5.1	6.9	2.0	11.9	6.9	78.9	10.2	6.5	8.8	9.4	15.1	10.5	9.2	11.1	17.4	6.6	2.3	10.5	8.7	6.2	3.9	5.4	4.2	9.5	13.1	6.9	22.1	7.1	9.2	5.5	8.5	6.6	7.6	7.4	8.4	6.7
PCMT1		ENSG00000120265	"Protein-L-isoaspartate (D-aspartate) O-methyltransferase"	P22061	6	149749443-149811420	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"		"Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 1022.2;Late spermatids: 428.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003239	Approved		Supported	Cytosol		No	No		4100000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 47: Non-specific - Unknown function"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 29: Early spermatids - Spermatogenesis"	Cytosol		"HPA003239: AB_1079580"	"prognostic unfavorable (4.02e-7)"	"prognostic unfavorable (9.58e-4)"	"unprognostic (1.35e-2)"	"prognostic unfavorable (4.27e-4)"	"unprognostic (1.02e-1)"	"prognostic unfavorable (1.88e-4)"	"prognostic unfavorable (2.58e-4)"	"unprognostic (1.91e-2)"	"unprognostic (1.58e-2)"	"unprognostic (9.02e-2)"	"unprognostic (6.45e-2)"	"unprognostic (6.77e-2)"	"unprognostic (6.14e-2)"	"unprognostic (4.38e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.17e-2)"	"prognostic unfavorable (6.38e-4)"	48.7	43.2	77.5	32.8	85.1	75.9	46.2	70.2	107.1	46.4	56.4	45.5	36.6	38.8	48.5	45.3	39.2	28.4	121.7	87.5	84.8	51.1	73.8	37.9	41.4	80.3	73.0	39.3	38.1	46.3	43.3	42.9	86.2	52.1	43.1	55.8	39.8	50.1	211.9	44.6	34.6	48.9	71.1	34.5	37.8	76.7	72.3	57.4	49.0	163.3	46.7	40.7	38.0	79.2	87.3	68.4	70.4	88.6	152.1	125.9	77.6	140.7	82.9	114.7	143.4	200.1	65.4	117.9	113.0	127.5	126.5	106.6	123.9	143.6	159.9	79.2	180.0	175.5	122.2	192.1	99.2	203.7	197.7	62.8	105.2	128.5	138.5	80.7	107.6	89.8	256.5	107.7	142.3	258.9	98.5	150.4	56.5	84.7	78.6	83.4	89.7	82.6	108.9	62.4	137.5	52.4	111.2	173.9	97.7	82.5	107.8	146.1	83.3	67.2	80.7	124.7	151.2	64.1	109.9	115.4	103.6	135.8	137.7	162.9	193.2	178.0	93.0	182.4	94.7	105.0	93.7	102.8	176.0	81.5	86.5	98.0	101.6	108.5	185.7	79.9	129.2	204.1	77.5	85.1	70.2	107.1	87.5	84.8	80.3	73.0	86.2	71.1	72.3	79.2	57.0	54.5	41.4	21.2	62.6	175.1	74.4	204.4	56.3	72.6	48.0	40.6	154.1	60.1	96.4	79.1	37.5	169.3	66.8	56.6	78.2	113.5	1022.2	51.9	58.4	69.8	55.2	170.1	77.0	110.7	214.0	79.2	26.0	48.8	107.7	38.8	53.9	115.6	119.1	65.6	52.8	72.9	187.2	78.7	127.5	428.1	71.7	78.2	138.7	31.9	143.7	121.2	74.2	30.7	72.2	106.6	57.9	73.7	71.8	67.8	65.1	89.3	106.2	66.3	111.7	64.0	110.4	224.9	96.3	60.7	157.6	148.3	83.0	55.0	58.7	59.1
LRP11	"bA350J20.3, MANSC3"	ENSG00000120256	"LDL receptor related protein 11"	Q86VZ4	6	149818757-149864359	"Predicted intracellular proteins, Predicted membrane proteins"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 61.3;Respiratory ciliated cells: 107.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017267			Approved	"Vesicles,Plasma membrane"		NA	NA		1500000		"Cluster 27: Brain & Skin - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 49: Ciliated cells - Cilium organization"	"Plasma membrane"	Vesicles	"HPA017267: "	"prognostic unfavorable (2.31e-8)"	"unprognostic (3.85e-3)"	"unprognostic (1.68e-1)"	"unprognostic (1.30e-2)"	"unprognostic (5.17e-2)"	"unprognostic (4.25e-3)"	"prognostic unfavorable (2.01e-5)"	"unprognostic (5.05e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.49e-1)"	"unprognostic (3.29e-1)"	"unprognostic (2.63e-1)"	"unprognostic (4.76e-2)"	"unprognostic (2.47e-1)"	"unprognostic (6.75e-2)"	"unprognostic (1.34e-2)"	"unprognostic (4.23e-2)"	14.5	18.0	25.2	5.3	25.8	1.4	11.8	18.7	31.5	17.2	13.8	13.1	11.7	11.4	16.4	28.6	22.3	11.3	10.8	26.7	23.3	20.3	10.0	13.6	2.9	23.6	24.9	16.5	19.8	42.8	17.6	12.5	25.0	25.5	12.3	13.5	20.1	13.0	5.2	20.6	9.1	12.0	19.7	4.1	16.3	8.0	26.0	2.4	22.9	4.8	5.9	18.0	20.8	25.0	26.5	22.9	17.2	15.0	37.8	67.2	3.5	27.7	52.1	18.5	22.4	7.3	52.9	0.2	36.7	43.3	79.4	69.4	19.2	47.1	13.3	43.7	19.4	13.3	74.3	30.4	22.6	13.2	0.8	42.8	93.1	23.0	46.5	52.5	28.9	11.8	26.8	11.0	22.3	45.4	0.5	1.3	10.4	52.0	19.6	14.5	25.5	6.4	33.9	53.8	22.4	15.6	86.7	46.3	17.0	8.5	38.8	26.4	21.1	22.6	4.8	48.4	21.3	0.1	8.7	6.3	40.9	12.9	13.9	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.2	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	25.2	25.8	18.7	31.5	26.7	23.3	23.6	24.9	25.0	19.7	26.0	25.0	7.3	6.4	2.8	17.6	0.5	11.3	14.3	17.9	5.7	12.2	10.2	6.0	8.8	12.8	18.3	20.2	2.1	2.1	0.5	7.7	5.9	6.5	27.0	61.3	6.4	7.4	29.4	5.5	42.5	22.7	1.8	20.5	15.3	16.5	0.0	12.4	9.3	9.5	3.6	8.4	44.3	5.0	16.2	1.9	6.2	31.7	16.4	1.7	14.2	11.2	0.1	6.0	0.0	17.6	40.1	19.7	4.2	14.7	0.6	22.2	4.0	7.0	107.7	5.5	0.0	10.0	11.7	14.7	10.4	14.9	14.3	5.6	1.8	15.7	13.2	23.6
RAET1E	"bA350J20.7, LETAL, ULBP4"	ENSG00000164520	"Retinoic acid early transcript 1E"	Q8TD07	6	149883375-149898102	"Predicted intracellular proteins, Predicted membrane proteins"	Immunity			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 21.9;esophagus: 62.8;skin 1: 21.6;vagina: 27.5"	"Cell type enhanced"	"Detected in some"		"Basal respiratory cells: 12.4;Early spermatids: 10.0;Late spermatids: 5.6;Respiratory ciliated cells: 14.6;Squamous epithelial cells: 17.2;Suprabasal keratinocytes: 6.5"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 3.9"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HBEC3-KT: 19.6;HeLa: 24.4;hTCEpi: 19.1;SiHa: 9.9;U-87 MG: 7.7"									HPA054022			Supported	"Focal adhesion sites,Cytosol"	"Intracellular and membrane"	NA	NA				"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Focal adhesion sites"	Cytosol	"HPA054022: AB_2797250"	"unprognostic (1.67e-2)"	"unprognostic (2.10e-1)"	"unprognostic (3.49e-3)"	"unprognostic (1.26e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.71e-2)"	"unprognostic (1.36e-3)"	"unprognostic (4.80e-4)"	"unprognostic (1.11e-1)"	"unprognostic (3.39e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.69e-1)"	"unprognostic (7.47e-5)"	"unprognostic (2.41e-2)"	"unprognostic (3.18e-2)"	"unprognostic (3.17e-2)"	"unprognostic (1.06e-1)"	3.7	0.8	0.6	0.1	0.4	0.1	1.9	1.0	0.7	21.9	0.8	0.2	0.1	0.3	0.0	62.8	0.8	0.1	0.5	0.5	0.5	2.2	0.1	0.3	0.1	0.4	0.3	0.1	0.1	0.0	0.2	0.5	0.5	0.3	0.3	0.1	12.9	0.3	1.6	21.6	0.1	0.5	0.1	0.9	0.3	0.4	0.4	0.1	0.3	0.2	11.6	1.9	27.5	0.5	1.8	1.0	0.0	0.0	0.2	1.3	0.0	0.1	0.9	0.1	0.3	0.0	4.3	0.0	2.6	4.4	1.4	1.7	0.0	19.6	0.2	0.3	0.0	0.1	24.4	0.0	0.0	0.0	0.0	0.4	19.1	1.0	3.9	0.4	0.1	0.1	0.0	1.3	0.8	0.0	0.0	0.0	0.1	0.3	0.8	0.0	0.0	0.3	0.4	0.9	0.2	0.0	9.9	1.5	0.0	0.0	1.2	0.0	1.8	0.8	0.3	0.2	0.9	0.0	0.0	0.0	7.7	0.4	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.6	0.4	1.0	0.7	0.5	0.5	0.4	0.3	0.5	0.1	0.4	0.5	1.0	0.0	0.0	0.3	0.0	2.2	1.1	12.4	1.8	0.6	0.3	0.6	0.3	1.5	3.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	10.0	2.5	0.1	1.0	0.0	0.0	0.9	0.0	0.0	2.0	0.0	0.1	0.0	0.0	0.7	0.0	0.1	0.0	1.1	0.1	0.0	0.0	0.3	5.6	0.0	0.0	0.0	1.9	0.0	0.2	0.0	0.5	1.1	0.4	0.0	0.0	0.0	0.2	0.0	0.0	14.6	0.4	0.0	0.3	0.4	0.0	0.2	17.2	6.5	0.0	0.2	0.1	0.2	1.6
RAET1G	ULBP5	ENSG00000203722	"Retinoic acid early transcript 1G"	Q6H3X3	6	149916878-149923121	"Predicted membrane proteins, Predicted secreted proteins"	"Host-virus interaction, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adrenal gland: 8.4;esophagus: 15.1"	"Cell type enhanced"	"Detected in some"		"Basal respiratory cells: 42.9;Club cells: 14.8;Ionocytes: 12.2;Respiratory ciliated cells: 23.3;Squamous epithelial cells: 8.9;Urothelial cells: 8.1"	"Group enriched"	"Detected in many"	4	"cervical cancer: 4.5;head and neck cancer: 4.7;lung cancer: 1.2;thyroid cancer: 1.5;urothelial cancer: 4.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HeLa: 29.5;hTCEpi: 22.6;SiHa: 11.9;U-87 MG: 9.3"									"HPA062673, HPA066741"			Supported	"Vesicles,Plasma membrane"	"Secreted - unknown location"	NA	NA				"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Vesicles, Plasma membrane"		"HPA062673: , HPA066741: "	"unprognostic (4.46e-3)"	"unprognostic (4.92e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.87e-3)"	"unprognostic (1.49e-1)"	"unprognostic (4.61e-3)"	"prognostic unfavorable (5.35e-4)"	"unprognostic (3.05e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.49e-2)"	"unprognostic (2.48e-1)"	"unprognostic (8.85e-2)"	"unprognostic (9.11e-2)"	2.8	8.4	0.4	0.4	0.3	0.0	0.6	0.0	0.4	4.1	0.0	0.2	0.1	0.3	0.7	15.1	0.6	0.7	0.6	0.4	0.3	0.9	0.1	0.5	0.1	0.3	0.6	0.7	0.1	0.2	0.3	0.1	0.1	0.7	0.1	0.1	3.7	1.0	0.2	2.7	0.2	0.6	0.0	0.1	0.4	0.3	0.7	0.0	0.4	0.1	1.1	1.8	6.0	0.0	1.0	1.4	0.0	1.7	2.3	1.7	0.0	0.8	3.0	1.3	1.9	0.0	1.5	0.0	0.6	1.7	1.4	2.7	0.9	5.3	1.1	0.3	1.6	0.5	29.5	0.0	0.7	0.0	0.0	3.3	22.6	3.5	1.7	1.5	0.3	0.7	0.3	0.2	0.6	1.3	0.0	0.0	0.0	0.3	2.3	0.0	0.0	0.0	1.0	3.2	0.3	0.3	11.9	0.5	0.0	0.1	0.4	0.4	1.6	0.6	0.5	1.6	0.8	0.0	0.0	0.0	9.3	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.4	0.4	0.3	0.3	0.6	0.1	0.0	0.7	0.0	1.4	0.0	0.0	0.0	0.0	3.1	5.1	42.9	2.8	0.0	0.4	0.4	0.1	1.5	14.8	0.0	0.0	0.0	0.2	0.1	0.0	0.2	0.1	0.4	0.1	1.3	0.0	0.0	0.0	1.3	0.0	1.9	0.0	0.1	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.0	12.2	0.0	0.7	0.1	0.9	0.0	3.6	0.0	0.0	0.8	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.4	0.0	0.0	23.3	0.0	0.0	0.2	1.1	0.0	0.3	8.9	1.7	0.1	0.3	0.5	0.0	8.1
ULBP2	RAET1H	ENSG00000131015	"UL16 binding protein 2"	Q9BZM5	6	149942014-149949235	"Predicted membrane proteins, Predicted secreted proteins"	"Host-virus interaction, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 6.1"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 28.9;Basal respiratory cells: 17.9;dendritic cells: 12.1"	"Cancer enhanced"	"Detected in all"		"head and neck cancer: 12.9"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"gdT-cell: 2.7"	"Lineage enriched"	"Detected in single"	6	"T-cells: 2.7"	"Cell line enhanced"	"Detected in many"		"SiHa: 66.7;U-2197: 47.4"									"CAB018974, HPA066741"	Approved		Supported	"Vesicles,Plasma membrane"	"Secreted in other tissues"	NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 18: U-2197 - ECM organization"	"Cluster 7: Non-specific - Mitochondria"	"Vesicles, Plasma membrane"		"CAB018974: , HPA066741: "	"unprognostic (2.09e-5)"	"prognostic unfavorable (8.07e-4)"	"unprognostic (2.38e-3)"	"unprognostic (3.90e-1)"	"prognostic unfavorable (2.44e-4)"	"unprognostic (1.26e-2)"	"unprognostic (2.38e-3)"	"unprognostic (1.47e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.75e-2)"	"unprognostic (1.42e-4)"	"unprognostic (1.68e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.14e-1)"	"unprognostic (4.86e-1)"	1.5	0.7	1.3	0.6	1.6	1.8	0.7	1.6	2.6	0.9	0.7	0.2	0.2	0.1	0.1	6.1	0.2	0.5	2.0	3.0	1.0	2.1	0.5	3.4	0.3	1.8	1.2	0.0	0.4	0.6	0.5	1.6	1.8	0.2	0.1	0.2	0.7	0.1	0.3	0.5	0.2	0.7	0.8	0.2	0.3	1.5	1.1	0.7	1.2	0.7	0.8	1.4	1.6	1.7	19.9	1.8	0.5	6.1	1.1	5.6	3.3	20.1	11.8	20.6	16.8	7.4	11.0	0.0	29.9	23.0	29.6	13.9	7.6	18.4	11.8	9.1	3.9	1.1	2.8	0.0	7.1	0.0	1.5	2.7	13.9	18.3	8.0	16.7	11.9	16.6	2.5	0.0	15.4	13.9	1.8	0.0	0.0	3.6	10.2	3.0	4.5	0.0	29.0	5.7	0.6	0.0	66.7	1.4	1.9	3.2	1.8	8.5	18.8	13.5	17.1	47.4	23.5	0.0	0.1	0.9	19.2	10.7	9.9	0.0	0.0	0.0	2.7	0.0	0.3	0.0	0.8	1.5	0.0	0.0	0.3	1.8	0.0	0.4	0.0	0.0	1.7	0.5	1.3	1.6	1.6	2.6	3.0	1.0	1.8	1.2	1.8	0.8	1.1	1.7	28.9	0.0	1.3	0.0	1.2	3.7	6.5	17.9	7.4	0.0	1.3	4.4	0.3	0.0	9.4	1.8	0.0	0.0	12.1	0.5	0.0	7.5	7.0	0.3	0.5	9.1	0.0	0.0	3.0	8.8	0.5	3.0	1.1	0.2	0.0	0.1	7.1	0.2	2.2	0.0	0.7	0.3	2.0	0.8	2.1	8.0	0.0	3.1	1.8	0.0	0.0	0.4	4.1	0.5	0.3	4.5	0.0	0.0	1.4	1.4	0.0	0.1	1.4	0.0	0.0	1.0	4.2	3.1	7.0	11.8	2.8	0.0	11.0	0.6	0.4	5.2
ULBP1	RAET1I	ENSG00000111981	"UL16 binding protein 1"	Q9BZM6	6	149963943-149973715	"Predicted membrane proteins"	"Host-virus interaction, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"brain: 4.4;lung: 1.7;testis: 3.3"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 6.4;Alveolar cells type 2: 2.2;Breast myoepithelial cells: 3.0;Respiratory ciliated cells: 2.2;Squamous epithelial cells: 2.5"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"cerebellum: 4.4;cerebral cortex: 1.9;hippocampal formation: 1.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 16.5;HAP1: 29.3;HDLM-2: 17.1;HHSteC: 18.0;JURKAT: 26.1"									"HPA007547, HPA071005"	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 7: Non-specific - Mitochondria"	"Plasma membrane, Cytosol"		"HPA007547: AB_1079430, HPA071005: AB_2686332"	"unprognostic (8.94e-3)"	"unprognostic (2.44e-1)"	"unprognostic (2.85e-2)"	"unprognostic (2.33e-2)"	"unprognostic (3.28e-4)"	"unprognostic (6.69e-3)"	"unprognostic (5.27e-2)"	"unprognostic (2.47e-2)"	"unprognostic (5.75e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.15e-2)"	"unprognostic (5.57e-12)"	"unprognostic (1.95e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.12e-1)"	"unprognostic (7.16e-2)"	0.2	0.1	0.1	0.2	0.1	0.3	0.0	4.4	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	1.6	0.2	0.4	0.1	1.7	0.1	0.1	0.2	0.0	0.1	0.2	0.1	0.5	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	3.3	0.1	0.1	0.4	0.1	0.1	0.0	0.0	0.2	2.1	1.0	1.6	0.0	3.3	6.8	3.2	3.0	0.9	0.6	2.0	0.2	3.1	3.5	0.7	16.5	6.9	0.7	29.3	1.4	2.7	17.1	3.8	0.3	0.6	0.0	18.0	0.1	1.2	9.1	6.8	13.6	2.5	0.0	1.1	26.1	3.3	0.0	3.5	2.7	4.3	0.0	0.5	1.4	2.3	0.0	1.3	0.5	0.0	0.4	1.0	0.4	4.4	2.0	0.0	1.3	2.9	6.4	0.3	1.6	0.0	1.4	0.0	0.5	0.7	2.3	8.7	5.0	3.6	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.1	0.1	4.4	1.9	1.6	0.2	0.1	0.2	0.5	0.1	0.1	0.2	1.6	6.4	2.2	0.0	0.5	0.1	0.5	0.0	0.6	0.0	1.0	3.0	0.9	0.0	0.6	0.0	0.0	0.0	0.3	0.4	0.0	0.3	0.1	0.2	0.6	1.1	0.0	0.0	0.1	0.6	0.0	1.6	0.0	0.7	0.0	0.1	0.7	0.0	0.1	0.0	0.0	0.5	0.0	0.3	0.3	0.4	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.1	2.2	0.0	0.0	1.6	1.3	0.2	0.2	2.5	0.6	0.0	0.7	0.2	0.3	0.1
RAET1L		ENSG00000155918	"Retinoic acid early transcript 1L"	Q5VY80	6	150018334-150025532	"Predicted membrane proteins"	"Host-virus interaction, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"esophagus: 58.1;vagina: 17.3"	"Cell type enhanced"	"Detected in some"		"Basal keratinocytes: 6.4;Basal prostatic cells: 11.3;Basal respiratory cells: 6.4;Prostatic glandular cells: 7.1;Squamous epithelial cells: 7.2;Suprabasal keratinocytes: 17.0;Urothelial cells: 8.1"	"Group enriched"	"Detected in many"	4	"cervical cancer: 4.8;head and neck cancer: 10.1;lung cancer: 4.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"HaCaT: 14.3"									HPA066741			Supported	"Vesicles,Plasma membrane"		NA	NA				"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 22: Epithelial cell types - Mixed function"	"Vesicles, Plasma membrane"		"HPA066741: "	"unprognostic (1.80e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.84e-1)"	"unprognostic (4.24e-3)"	"unprognostic (1.51e-1)"		"prognostic unfavorable (4.09e-4)"	"unprognostic (8.34e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.26e-2)"	"unprognostic (7.48e-2)"	"unprognostic (1.46e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.29e-1)"	"unprognostic (5.14e-2)"	"unprognostic (7.43e-3)"	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.1	8.1	0.0	0.0	0.0	0.0	0.0	58.1	0.0	0.1	0.0	0.2	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.7	0.0	0.1	5.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	5.2	0.3	17.3	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	1.2	0.0	0.7	14.3	0.3	0.4	0.0	0.5	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	2.4	0.0	0.0	0.0	2.6	0.7	0.0	0.0	1.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	1.7	0.2	0.4	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	11.3	6.4	1.2	0.0	0.4	0.3	0.0	0.0	2.9	0.0	0.0	0.0	0.0	1.0	0.0	2.8	0.8	0.5	0.1	0.2	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	7.1	0.0	0.2	0.9	0.0	0.0	0.0	0.4	0.0	0.1	7.2	17.0	0.0	0.0	0.0	0.1	8.1
ULBP3	RAET1N	ENSG00000131019	"UL16 binding protein 3"	Q9BZM4	6	150061053-150069121	"Predicted intracellular proteins"	"Host-virus interaction, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 6.5;testis: 6.3"	"Cell type enhanced"	"Detected in single"		"Gastric mucus-secreting cells: 1.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"											"HPA056541, HPA063007"	Approved		Uncertain	"Vesicles,Centriolar satellite"	"Intracellular and membrane"	NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 18: U-2197 - ECM organization"	"Cluster 59: Non-specific - Transcription"	Vesicles	"Centriolar satellite"	"HPA056541: , HPA063007: AB_2684920"	"unprognostic (4.87e-2)"	"unprognostic (4.49e-2)"	"unprognostic (3.14e-3)"	"unprognostic (1.50e-2)"	"unprognostic (1.86e-2)"	"unprognostic (2.99e-2)"	"unprognostic (8.47e-2)"	"unprognostic (1.96e-1)"	"unprognostic (5.87e-2)"	"unprognostic (8.71e-2)"	"unprognostic (1.66e-2)"	"unprognostic (3.54e-2)"	"unprognostic (6.26e-2)"	"unprognostic (3.43e-1)"	"unprognostic (2.12e-1)"	"unprognostic (5.45e-2)"	"unprognostic (5.16e-2)"	1.3	1.2	1.6	0.7	1.8	0.7	1.0	1.6	2.4	0.5	0.4	0.8	1.1	1.0	0.9	1.5	2.0	1.3	0.7	1.7	1.4	1.7	1.0	1.5	0.5	0.9	0.9	0.8	0.7	0.9	0.1	0.9	0.9	0.7	0.8	0.8	0.4	0.5	6.5	1.1	0.5	0.5	0.2	0.6	1.9	6.3	1.3	0.5	4.9	0.4	0.9	1.0	0.5	1.9	6.2	2.0	6.5	7.3	1.6	11.9	2.3	6.1	2.6	7.2	8.0	11.0	5.1	0.2	11.8	9.9	10.9	8.3	17.7	20.5	7.7	3.7	7.8	0.6	2.9	0.5	2.5	0.1	1.1	10.2	3.5	15.0	8.1	6.9	9.7	0.2	0.5	0.8	6.3	7.0	0.3	0.5	3.1	2.6	14.8	6.2	5.9	0.3	17.5	12.4	1.2	0.5	12.2	8.2	3.0	3.4	2.5	1.7	5.6	1.2	9.8	20.5	13.3	0.3	0.2	4.1	9.6	3.7	5.1	0.8	0.2	0.2	2.2	0.2	2.9	0.8	1.5	2.4	0.2	0.5	0.8	1.2	1.0	0.6	0.2	0.3	2.3	0.4	1.6	1.8	1.6	2.4	1.7	1.4	0.9	0.9	0.9	0.2	1.3	1.9	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.1	1.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.4	0.0	0.0	0.2	0.1	0.0	0.0
PPP1R14C	"CPI17-like, KEPI, NY-BR-81"	ENSG00000198729	"Protein phosphatase 1 regulatory inhibitor subunit 14C"	Q8TAE6	6	150143044-150250392	"Predicted intracellular proteins"		"Protein phosphatase inhibitor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 75.5;skeletal muscle: 66.5;skin 1: 97.2;thyroid gland: 58.7"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 280.2;Cardiomyocytes: 79.5;Skeletal myocytes: 80.9;Suprabasal keratinocytes: 336.6"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 53.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HaCaT: 40.7;HBEC3-KT: 86.1;HEK 293: 36.2;hTCEpi: 103.0;hTERT-HME1: 41.1;RPTEC TERT1: 35.5;SK-BR-3: 37.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB044667, HPA047907"	Approved					NA	NA				"Cluster 31: Skin - Epidermis development"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 28: Keratinocytes - Keratinization"			"CAB044667: , HPA047907: "	"unprognostic (1.81e-3)"	"unprognostic (7.65e-2)"	"unprognostic (4.25e-3)"	"unprognostic (6.92e-2)"	"unprognostic (3.96e-3)"	"unprognostic (2.20e-2)"	"unprognostic (3.81e-3)"	"unprognostic (1.55e-1)"	"unprognostic (6.63e-2)"	"unprognostic (5.13e-2)"	"unprognostic (4.50e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.86e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.98e-1)"	"unprognostic (7.49e-3)"	"unprognostic (6.77e-2)"	0.4	0.2	5.1	1.4	6.6	0.2	6.0	5.9	8.0	10.2	6.0	12.5	10.4	1.4	0.9	18.4	16.0	0.1	75.5	7.8	5.0	9.5	0.0	12.3	0.3	5.6	5.4	0.1	0.7	5.1	1.7	3.4	5.6	1.3	8.6	0.6	3.2	0.2	66.5	97.2	2.7	0.9	4.4	0.1	0.8	6.7	5.0	0.5	58.7	8.5	5.8	0.5	22.0	5.0	27.9	0.1	11.7	0.1	0.1	0.6	0.0	3.7	0.0	0.0	0.1	1.3	3.8	0.7	8.0	5.3	1.8	40.7	6.1	86.1	0.0	0.0	36.2	0.3	0.0	0.0	0.0	0.0	1.1	0.0	103.0	0.2	41.1	0.0	0.0	0.5	23.6	0.0	0.0	3.8	0.0	0.0	0.4	0.0	0.2	0.7	0.0	0.0	35.5	1.5	6.2	0.0	0.6	37.7	2.2	0.7	0.2	1.9	0.0	0.1	20.4	32.5	9.5	0.0	0.0	0.0	14.2	16.1	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	6.6	5.9	8.0	7.8	5.0	5.6	5.4	5.6	4.4	5.0	5.0	0.3	19.2	41.1	1.3	0.5	280.2	17.9	19.6	12.0	1.1	6.5	4.3	79.5	0.0	17.1	14.7	0.0	0.1	0.4	24.5	1.9	3.8	0.2	37.9	0.6	3.0	28.2	0.0	28.0	0.2	0.1	6.7	0.0	5.1	1.3	4.1	0.0	0.0	3.0	1.7	13.3	3.1	14.2	0.0	19.7	1.6	0.0	0.6	30.2	2.8	1.1	0.0	0.0	37.2	2.5	12.8	41.5	0.4	0.0	16.6	5.0	38.6	61.5	0.5	0.0	80.9	4.3	0.5	1.8	14.7	336.6	1.9	1.4	0.5	8.7	1.9
IYD	"C6orf71, DEHAL1, dJ422F24.1"	ENSG00000009765	"Iodotyrosine deiodinase"	Q6PHW0	6	150368892-150405969	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted membrane proteins"		Oxidoreductase	"Congenital hypothyroidism, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"thyroid gland: 472.7"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 23.7;Hepatocytes: 25.1;Intestinal goblet cells: 21.8;Paneth cells: 22.5;Proximal enterocytes: 89.1;Proximal tubular cells: 35.4"	"Cancer enriched"	"Detected in many"	20	"thyroid cancer: 80.7"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 1.9"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	7	"CACO-2: 1.3;OE19: 3.0;SK-BR-3: 3.2"	"Group enriched"	"Detected in some"	13	"hippocampal formation: 7.4;thalamus: 2.4"	"Low region specificity"	"Detected in all"			HPA059627	Enhanced		Supported	"Plasma membrane"		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 45: Enterocytes - Digestion"	"Plasma membrane"		"HPA059627: AB_2684086"	"unprognostic (3.73e-4)"	"unprognostic (2.93e-2)"	"unprognostic (5.97e-2)"	"unprognostic (1.95e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.98e-2)"	"prognostic favorable (6.22e-4)"	"unprognostic (1.11e-1)"	"unprognostic (3.80e-2)"	"unprognostic (1.17e-1)"	"unprognostic (7.41e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.07e-9)"	"unprognostic (9.79e-3)"	"unprognostic (2.04e-1)"	"unprognostic (2.03e-2)"	"unprognostic (2.18e-2)"	0.1	0.0	0.4	0.6	0.3	0.3	0.5	0.6	0.6	0.1	0.2	6.4	18.1	0.2	0.6	0.0	0.0	8.9	0.5	0.3	0.1	26.6	33.6	0.7	0.5	0.5	0.4	0.0	0.4	0.0	0.0	0.0	0.6	0.2	6.5	0.2	0.1	0.0	0.0	0.2	19.6	0.2	0.0	0.1	2.0	0.2	0.5	0.0	472.7	0.0	0.2	0.1	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.3	0.1	0.0	0.0	0.0	0.0	1.3	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.1	3.0	0.1	0.0	0.1	0.1	0.0	0.2	0.1	0.0	0.0	3.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.0	1.6	0.5	0.3	0.2	0.4	0.2	0.2	0.1	0.1	0.0	0.4	0.2	0.2	1.9	0.7	0.2	0.3	0.2	1.3	0.4	0.3	0.6	0.6	0.3	0.1	0.5	0.4	0.6	0.0	0.5	0.5	0.7	3.2	7.8	0.0	0.0	0.1	0.6	0.2	0.0	0.1	0.3	0.4	0.8	14.3	8.9	0.0	0.0	0.1	0.0	23.7	1.9	0.3	0.0	0.9	0.3	0.4	3.6	2.7	0.1	0.2	0.0	0.7	0.0	2.2	1.3	0.1	1.1	25.1	0.1	0.0	0.1	21.8	0.0	0.0	1.2	0.1	0.0	0.7	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.4	22.5	0.0	0.0	1.0	89.1	35.4	3.6	1.3	0.0	1.7	0.3	0.1	0.1	0.0	0.4	0.3	0.9	0.4	11.5	0.7
PLEKHG1	"ARHGEF41, KIAA1209"	ENSG00000120278	"Pleckstrin homology and RhoGEF domain containing G1"	Q9ULL1	6	150599883-150843665	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 31.2"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 91.2;Astrocytes: 98.6;Endothelial cells: 58.4;Microglial cells: 131.2;Oligodendrocytes: 168.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	31	"memory B-cell: 23.9;naive B-cell: 22.9"	"Lineage enriched"	"Detected in single"	31	"B-cells: 23.9"	"Cell line enhanced"	"Detected in many"		"AF22: 17.6;HAP1: 26.4;Karpas-707: 23.4;U-698: 16.6"	"Region enhanced"	"Detected in all"		"thalamus: 51.3"	"Low region specificity"	"Detected in all"			"HPA027128, HPA027319, HPA028270"	Approved		Enhanced	Nucleoplasm		Yes	No			"Cluster 37: B-cells - Transcription"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 57: B-cells - Immune response"	Nucleoplasm		"HPA027128: AB_2672124, HPA027319: AB_10600306, HPA028270: AB_10611388"	"unprognostic (2.93e-1)"	"unprognostic (3.44e-1)"	"unprognostic (3.04e-3)"	"unprognostic (2.34e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.80e-3)"	"unprognostic (1.85e-1)"	"unprognostic (4.82e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.60e-1)"	"unprognostic (3.47e-2)"	"unprognostic (1.50e-1)"	"unprognostic (4.62e-3)"	"unprognostic (3.63e-1)"	"unprognostic (4.30e-2)"	"unprognostic (3.83e-1)"	"unprognostic (2.15e-2)"	15.1	1.6	9.8	9.4	12.3	2.4	13.7	15.5	8.9	7.5	3.9	5.9	4.9	5.6	10.8	9.4	8.7	7.9	6.9	5.8	8.7	7.7	4.9	10.4	14.7	19.5	16.2	3.1	2.7	6.7	3.6	14.2	18.3	2.7	5.9	4.7	3.5	4.9	3.5	7.4	6.6	5.6	18.2	31.2	4.5	6.3	19.1	22.4	5.7	5.0	13.9	9.1	5.3	21.5	0.0	0.2	17.6	0.1	0.0	0.0	12.6	0.0	0.0	0.0	0.0	10.1	4.4	7.2	6.8	0.0	1.6	2.5	26.4	2.4	0.0	11.4	2.9	0.4	1.4	0.0	0.0	0.0	1.9	1.1	6.7	0.0	0.2	0.0	11.0	5.9	0.0	23.4	0.0	0.3	2.3	0.1	1.3	7.0	0.7	1.2	0.0	0.0	5.1	11.9	0.5	0.1	0.1	3.1	2.2	1.9	0.0	0.1	11.2	0.1	2.4	0.0	4.9	0.0	0.0	16.6	0.0	0.0	3.6	0.0	0.0	0.0	0.1	0.0	0.7	23.9	0.4	0.6	0.0	22.9	0.0	0.6	0.0	0.0	0.0	0.0	0.5	0.7	9.8	12.3	15.5	8.9	5.8	8.7	19.5	16.2	18.3	18.2	19.1	21.5	91.2	0.0	6.2	98.6	50.3	4.2	0.5	5.5	2.8	0.9	2.0	3.3	2.1	1.5	6.8	7.3	0.0	5.5	0.7	7.2	3.9	2.6	3.8	20.7	6.2	58.4	5.4	5.0	12.8	1.1	1.6	11.8	7.1	19.2	0.0	7.9	35.0	4.3	0.6	0.0	5.8	8.2	8.2	5.9	3.8	1.6	0.3	2.0	5.4	131.2	4.7	11.3	0.0	14.1	168.5	9.4	12.4	0.4	5.2	1.1	3.9	3.6	9.6	0.7	0.0	2.0	3.0	0.7	1.5	6.2	3.7	2.9	5.1	1.1	5.5	3.6
MTHFD1L	"DKFZP586G1517, FLJ21145, FTHFSDC1"	ENSG00000120254	"Methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 1 like"	Q6UB35	6	150865679-151101887	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"One-carbon metabolism"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 84.0;Extravillous trophoblasts: 166.5;Granulosa cells: 86.9;Microglial cells: 126.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Group enriched"	"Detected in many"	4	"dendritic cells: 1.1;T-cells: 1.8"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015006, HPA029040, HPA029041, HPA050052, HPA074911"	Approved		Enhanced	Mitochondria		NA	NA		89000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 21: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Mitochondria		"HPA015006: AB_1854178, HPA029040: AB_2672879, HPA029041: AB_2672880, HPA050052: AB_2680998, HPA074911: AB_2686723"	"unprognostic (3.66e-2)"	"prognostic unfavorable (1.68e-5)"	"unprognostic (1.02e-1)"	"prognostic unfavorable (7.28e-4)"	"unprognostic (3.25e-1)"	"prognostic unfavorable (5.10e-4)"	"prognostic unfavorable (8.33e-5)"	"unprognostic (6.35e-3)"	"unprognostic (2.45e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.11e-2)"	"unprognostic (2.93e-2)"	"unprognostic (3.51e-1)"	"unprognostic (2.91e-1)"	"prognostic unfavorable (8.69e-5)"	12.5	12.2	7.1	11.4	6.7	13.2	7.9	25.1	7.4	7.1	8.3	7.4	3.2	8.4	6.2	6.7	7.1	5.9	11.5	6.4	9.8	12.7	5.6	19.5	11.1	11.5	10.1	14.6	10.7	6.8	9.2	14.3	11.0	5.5	7.9	7.5	3.2	7.0	1.3	6.0	5.2	10.0	11.6	9.2	6.0	9.9	8.4	8.6	10.9	0.5	10.8	12.8	4.2	15.4	40.6	35.1	44.9	110.0	11.5	40.0	108.4	63.0	68.3	62.1	75.7	71.8	37.4	152.3	41.1	96.9	36.8	42.7	72.4	61.8	76.8	63.4	65.3	62.7	60.4	66.1	72.4	115.7	9.8	47.7	76.9	60.6	109.8	55.5	105.5	81.6	150.9	76.2	65.0	86.1	57.1	23.9	45.5	40.7	32.1	67.2	33.2	67.1	42.1	19.6	44.1	32.5	83.9	36.7	53.0	40.6	11.5	79.5	80.6	41.4	90.6	91.9	90.5	62.3	63.5	154.0	68.8	105.7	54.0	0.0	0.2	0.0	0.2	0.3	0.4	0.2	0.6	0.7	1.1	0.3	0.5	0.6	0.0	0.3	0.3	0.5	1.8	0.2	7.1	6.7	25.1	7.4	6.4	9.8	11.5	10.1	11.0	11.6	8.4	15.4	6.9	0.0	1.7	47.7	6.9	6.5	8.0	15.7	1.8	0.0	3.3	4.1	2.4	1.5	9.8	14.7	0.0	25.8	1.4	2.6	7.9	9.0	44.9	11.3	18.4	10.7	1.2	5.0	84.0	18.1	166.5	14.4	8.2	22.2	0.0	86.9	6.1	1.7	24.9	0.0	73.8	3.0	46.8	3.0	13.3	6.2	0.6	13.8	35.6	126.5	2.4	0.0	2.1	60.8	59.3	19.2	1.4	7.9	14.0	31.3	0.9	15.2	5.3	0.0	0.0	8.7	13.1	0.5	6.8	2.3	3.4	73.6	4.0	42.9	4.0	35.1
AKAP12	"AKAP250, SSeCKS"	ENSG00000131016	"A-kinase anchoring protein 12"	Q02952	6	151239967-151358559	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"		Calmodulin-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 352.6;Endothelial cells: 278.4;Fibroblasts: 270.0;Muller glia cells: 583.0;Pancreatic endocrine cells: 322.1;Spermatocytes: 325.4"	"Cancer enhanced"	"Detected in all"		"testis cancer: 39.5"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	235	"basophil: 37.2"	"Lineage enriched"	"Detected in single"	235	"granulocytes: 37.2"	"Cell line enhanced"	"Detected in many"		"REH: 193.0;TIME: 188.2;U-251 MG: 202.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006344, CAB026379, HPA056230"	Enhanced		Enhanced	"Plasma membrane,Cytosol"		No	No		10000000	"Cluster 38: Basophils - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane, Cytosol"		"CAB026379: , HPA006344: AB_1078118, HPA056230: AB_2683073"	"unprognostic (6.66e-2)"	"unprognostic (1.51e-1)"	"unprognostic (9.90e-3)"	"prognostic unfavorable (7.08e-4)"	"unprognostic (2.61e-2)"	"unprognostic (8.88e-2)"	"unprognostic (5.05e-2)"	"prognostic unfavorable (6.34e-5)"	"unprognostic (1.34e-1)"	"unprognostic (8.26e-3)"	"unprognostic (2.59e-1)"	"unprognostic (4.72e-2)"	"unprognostic (4.51e-3)"	"unprognostic (1.10e-3)"	"unprognostic (3.51e-1)"	"unprognostic (7.03e-3)"	"unprognostic (2.34e-2)"	105.6	16.0	13.8	17.1	16.6	2.2	59.7	99.7	57.5	19.8	4.5	60.1	8.6	31.1	9.3	18.6	31.2	31.5	51.8	14.7	66.8	35.8	30.6	44.3	6.9	67.0	35.3	87.8	10.8	1.6	23.3	38.3	74.7	23.1	13.2	109.4	6.5	20.8	11.9	9.4	24.9	42.9	10.9	14.3	25.6	100.0	39.4	5.9	22.1	14.5	3.4	33.0	21.2	24.3	7.8	37.8	53.2	0.1	98.2	145.9	18.8	43.9	23.7	19.3	19.4	0.9	141.6	0.0	17.1	33.2	160.4	1.0	102.2	32.5	17.2	50.2	37.6	0.6	40.8	35.6	10.9	0.0	9.6	104.0	0.0	81.9	4.3	25.4	127.8	0.6	9.8	0.9	70.7	0.5	0.3	0.1	33.3	0.1	43.9	193.0	2.3	0.2	110.2	6.3	37.9	22.0	14.1	0.5	24.9	74.6	2.8	0.5	188.2	2.6	34.0	110.4	202.9	0.4	0.1	0.2	63.2	0.1	37.4	37.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.8	16.6	99.7	57.5	14.7	66.8	67.0	35.3	74.7	10.9	39.4	24.3	352.6	12.8	16.2	34.3	6.8	19.6	19.6	63.2	1.2	14.5	1.2	3.9	12.1	5.7	31.1	51.5	2.1	2.4	0.9	1.2	1.9	107.0	101.4	14.2	195.4	278.4	1.8	3.2	75.8	6.7	10.1	270.0	3.6	31.6	64.2	14.7	194.5	4.8	26.9	0.0	33.3	0.7	4.1	15.7	45.4	116.3	39.7	13.9	58.7	37.5	0.6	583.0	1.0	59.8	5.1	322.1	1.1	110.6	6.7	49.5	0.0	89.4	6.0	31.0	98.6	208.3	243.0	325.4	33.0	1.6	11.4	10.0	5.1	9.3	2.5	105.3
ZBTB2	"bA351K16.2, KIAA1483, ZNF437"	ENSG00000181472	"Zinc finger and BTB domain containing 2"	Q8N680	6	151364115-151391559	"Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 42.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023136, HPA023137, HPA023458, HPA023487"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	"Nucleoplasm, Cytosol"		"HPA023136: AB_1858941, HPA023137: AB_1858942, HPA023458: AB_1858944, HPA023487: AB_1858945"	"unprognostic (1.13e-2)"	"unprognostic (8.14e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.42e-2)"	"unprognostic (8.36e-3)"	"unprognostic (1.08e-1)"	"prognostic unfavorable (1.21e-5)"	"unprognostic (6.36e-2)"	"unprognostic (2.21e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.72e-2)"	"unprognostic (8.27e-2)"	"prognostic unfavorable (9.36e-6)"	"unprognostic (1.45e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.44e-3)"	"unprognostic (7.73e-2)"	8.4	4.8	4.8	8.5	5.1	16.1	8.5	6.0	6.3	6.9	4.5	8.0	7.5	8.5	6.9	5.9	7.7	7.9	6.0	5.2	5.1	6.9	9.4	9.7	14.4	5.4	5.3	13.3	8.3	7.1	3.0	8.7	5.4	6.1	9.0	3.2	7.1	5.9	9.1	6.9	8.2	9.4	5.0	9.3	7.4	6.7	5.2	20.8	29.7	9.7	12.6	11.0	5.4	6.6	15.3	10.9	16.3	12.4	17.1	17.9	17.4	23.6	33.9	29.2	27.7	21.1	12.2	38.9	12.8	23.9	29.5	17.8	26.5	28.7	36.1	17.7	19.7	17.5	12.6	32.2	25.3	47.9	20.8	19.0	16.9	26.8	32.6	16.6	17.4	18.1	32.5	22.2	20.8	34.2	26.1	22.3	19.8	18.8	16.4	24.6	15.4	15.6	22.2	22.7	18.1	12.6	18.6	24.2	18.8	16.3	16.3	28.4	14.4	24.5	26.8	11.3	31.8	29.4	32.9	43.2	10.1	25.7	17.8	18.7	6.5	16.8	11.3	7.1	14.2	6.3	10.2	13.5	7.1	4.5	8.4	10.4	7.3	8.9	12.9	2.9	9.2	7.1	4.8	5.1	6.0	6.3	5.2	5.1	5.4	5.3	5.4	5.0	5.2	6.6	13.3	9.6	4.6	4.6	13.2	15.7	11.4	5.8	42.7	3.0	14.4	7.4	8.8	5.7	9.1	0.0	0.0	5.9	18.0	4.6	13.7	4.8	9.4	18.7	14.2	12.7	9.0	8.2	5.6	2.9	19.6	9.9	6.6	29.5	9.5	4.9	5.7	3.3	7.5	1.7	4.4	6.3	18.3	8.8	17.4	10.5	8.7	10.8	10.6	1.0	4.4	3.1	12.3	5.5	11.1	5.0	2.0	4.1	11.1	14.8	5.8	5.3	7.1	2.3	6.6	6.2	10.8	4.1	6.7	23.8	18.3	12.4	16.3	3.7	7.3	9.6
RMND1	"bA351K16.3, C6orf96, FLJ20627, RMD1"	ENSG00000155906	"Required for meiotic nuclear division 1 homolog"	Q9NWS8	6	151404762-151452158	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Protein biosynthesis"		"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031397, HPA031398, HPA031399"	Approved		Supported	Mitochondria		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Mitochondria		"HPA031397: AB_2673861, HPA031398: AB_2673862, HPA031399: AB_10601156"	"unprognostic (1.12e-1)"	"unprognostic (4.45e-2)"	"unprognostic (9.70e-3)"	"unprognostic (6.67e-2)"	"unprognostic (2.65e-2)"	"prognostic unfavorable (6.96e-4)"	"unprognostic (1.50e-3)"	"unprognostic (6.56e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.03e-1)"	"unprognostic (3.57e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.80e-1)"	"unprognostic (9.74e-2)"	"unprognostic (1.04e-1)"	12.6	13.9	7.7	6.4	8.1	4.4	13.6	7.8	8.9	9.9	8.2	10.3	13.4	8.9	11.7	7.5	11.9	8.0	12.1	7.8	8.6	36.9	30.5	7.5	9.2	8.2	8.1	14.6	9.5	8.9	6.3	9.6	8.4	6.8	11.3	7.1	7.1	7.7	10.9	7.7	12.1	7.5	8.0	7.3	8.0	9.1	8.6	8.1	18.6	10.0	10.1	9.2	8.1	8.2	16.0	7.2	15.1	32.3	20.6	46.7	21.3	24.6	23.4	18.6	25.4	21.5	11.7	14.9	17.4	16.1	23.1	13.5	29.3	14.9	32.1	17.7	23.8	24.1	11.0	44.5	43.4	53.9	7.2	33.4	19.5	26.9	39.7	22.8	25.0	22.6	26.3	11.5	29.0	54.1	18.6	18.1	11.1	16.8	14.3	21.0	19.7	18.2	26.7	7.2	26.1	25.5	17.9	22.2	29.5	18.6	36.6	34.8	13.8	14.6	19.0	30.6	20.0	12.1	17.5	17.6	36.7	42.3	17.5	1.9	5.6	7.1	6.4	8.2	10.4	11.6	7.6	9.1	7.0	8.9	10.1	9.3	2.8	13.3	13.3	3.2	11.8	4.5	7.7	8.1	7.8	8.9	7.8	8.6	8.2	8.1	8.4	8.0	8.6	8.2	11.6	0.0	11.2	12.1	6.9	3.8	6.4	10.2	9.1	8.9	15.4	13.7	11.9	5.7	11.9	12.9	12.5	27.0	7.4	7.6	17.6	15.6	9.4	10.9	18.4	7.8	3.0	8.0	22.4	10.7	21.7	8.8	4.1	12.4	9.5	25.0	10.8	16.7	13.7	5.0	20.6	9.7	6.1	12.5	5.7	6.4	6.8	9.8	3.6	8.4	12.3	7.7	10.3	15.6	21.7	9.9	11.2	6.4	5.8	3.6	33.8	45.1	9.3	6.9	0.0	6.7	14.9	13.0	16.8	8.3	2.7	16.8	8.4	27.3	15.3	5.3
ARMT1	"C6orf211, FLJ12910"	ENSG00000146476	"Acidic residue methyltransferase 1"	Q9H993	6	151452258-151470101	"Predicted intracellular proteins"	"DNA damage"	"Hydrolase, Methyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Proximal tubular cells: 79.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003004, HPA005819"	Uncertain		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA		410000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	"Nuclear bodies"	"Nucleoplasm, Cytosol"	"HPA003004: AB_1078358, HPA005819: AB_1845741"	"unprognostic (5.16e-3)"	"prognostic unfavorable (7.09e-4)"	"prognostic favorable (4.14e-4)"	"unprognostic (6.39e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.37e-2)"	"unprognostic (9.47e-2)"	"unprognostic (2.33e-2)"	"unprognostic (2.16e-1)"	"unprognostic (2.24e-1)"	"unprognostic (3.28e-1)"	"unprognostic (3.16e-2)"	"unprognostic (1.49e-1)"	"unprognostic (9.78e-2)"	"unprognostic (4.12e-1)"	"unprognostic (1.22e-1)"	17.1	16.0	8.5	15.3	9.5	5.5	25.0	9.6	12.2	16.1	8.3	16.6	18.9	16.0	16.1	12.0	12.6	11.3	16.8	8.6	10.0	41.5	37.6	19.5	21.0	9.0	9.1	11.9	6.8	11.6	5.3	22.2	9.1	12.2	17.6	16.4	7.6	11.1	19.0	8.8	14.5	14.9	9.6	12.8	14.1	14.1	9.8	15.6	27.7	22.6	18.5	17.3	8.1	9.0	24.6	18.4	37.9	34.2	30.3	47.4	60.9	44.8	39.1	36.9	48.4	47.8	19.7	36.2	29.5	31.8	33.7	24.2	112.7	33.5	61.7	40.6	34.9	26.0	21.7	55.9	37.8	50.1	31.7	38.2	23.3	49.3	29.2	30.6	52.8	27.0	38.5	44.3	46.4	101.8	31.7	47.4	64.4	23.7	15.3	41.0	32.7	28.6	112.6	31.2	15.6	10.2	37.5	34.9	23.8	67.4	98.9	38.6	44.6	17.9	25.0	66.8	36.3	21.1	28.5	43.7	31.7	60.7	21.6	53.8	26.9	52.0	13.5	34.5	18.1	17.5	17.4	14.5	22.9	14.7	15.9	14.8	22.1	21.0	33.4	8.5	25.1	21.1	8.5	9.5	9.6	12.2	8.6	10.0	9.0	9.1	9.1	9.6	9.8	9.0	16.3	25.6	40.4	6.5	13.2	0.0	8.4	0.0	11.4	10.0	33.5	16.3	18.6	14.3	6.2	23.9	8.4	31.7	12.6	10.6	45.0	19.5	1.4	19.4	29.3	10.6	4.9	6.5	11.4	17.8	39.0	14.2	12.2	23.3	3.8	7.7	15.4	48.7	35.4	8.4	9.8	8.9	0.0	34.0	0.0	3.1	19.3	23.6	0.0	5.6	36.0	17.3	18.6	6.6	8.9	19.5	7.2	14.7	15.2	5.4	18.6	79.3	10.9	20.9	0.0	6.7	14.3	25.2	14.8	11.1	0.0	36.0	14.0	15.5	10.7	9.6
CCDC170	"bA282P11.1, C6orf97, FLJ23305"	ENSG00000120262	"Coiled-coil domain containing 170"	Q8IYT3	6	151494017-151621193	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"fallopian tube: 33.4"	"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 236.6;Late spermatids: 82.6;Respiratory ciliated cells: 379.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 6.2"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"MCF7: 10.4;T-47d: 5.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA027114, HPA027185"	Enhanced		Approved	"Golgi apparatus,Cell Junctions"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 49: Ciliated cells - Cilium organization"	"Golgi apparatus"	"Cell Junctions"	"HPA027114: AB_2732435, HPA027185: AB_2672151"	"unprognostic (7.46e-2)"	"unprognostic (3.54e-2)"	"unprognostic (6.93e-2)"	"prognostic favorable (3.64e-4)"	"unprognostic (2.13e-1)"	"unprognostic (8.79e-3)"	"unprognostic (2.74e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.36e-1)"	"unprognostic (2.18e-2)"	"unprognostic (3.56e-2)"	"unprognostic (1.40e-2)"	"unprognostic (3.93e-2)"	"unprognostic (2.17e-1)"	"unprognostic (5.21e-2)"	3.0	4.2	1.5	1.3	1.4	0.1	3.7	0.9	0.7	3.0	8.0	0.7	2.5	3.6	0.4	0.4	33.4	1.3	0.8	1.3	1.8	0.8	1.3	4.1	1.4	3.6	4.9	5.6	0.1	0.1	0.2	1.4	3.1	0.4	0.6	0.2	0.2	0.4	0.3	0.2	1.1	0.9	3.2	2.2	1.7	2.7	1.7	0.3	5.6	0.1	0.6	1.1	0.5	2.8	0.0	0.1	0.3	0.0	0.3	0.3	0.0	0.1	0.4	0.0	0.0	0.2	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.1	0.1	10.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.1	0.0	0.0	0.1	5.9	0.0	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	2.1	6.2	0.0	2.8	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	1.8	0.1	2.8	0.1	0.0	0.6	1.5	1.4	0.9	0.7	1.3	1.8	3.6	4.9	3.1	3.2	1.7	2.8	1.2	3.2	1.5	7.5	0.4	0.6	0.3	6.5	1.2	0.3	27.3	8.9	0.7	0.0	39.5	0.0	22.9	0.1	0.4	1.1	0.0	0.3	53.0	236.6	23.6	1.2	0.0	0.0	5.5	1.1	0.4	5.2	3.1	14.1	3.8	3.5	1.1	1.5	11.9	0.0	5.9	0.0	12.2	17.5	11.3	82.6	7.2	16.8	0.0	0.0	11.0	2.5	0.0	3.0	0.8	2.7	5.8	0.0	0.1	0.9	0.5	5.8	379.4	1.0	0.0	0.4	6.5	19.1	1.1	0.2	1.0	0.0	1.2	14.0	0.3	0.5
ESR1	"ER-alpha, Era, ESR, NR3A1"	ENSG00000091831	"Estrogen receptor 1"	P03372	6	151656691-152129619	"Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Receptor"	"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 83.8;endometrium 1: 110.9;fallopian tube: 64.9"	"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 86.6;Endometrial ciliated cells: 77.9;Endometrial stromal cells: 79.9;Glandular and luminal cells: 98.9;Hepatocytes: 52.1;Horizontal cells: 62.2;Skeletal myocytes: 56.7"	"Cancer enhanced"	"Detected in many"		"breast cancer: 40.2;endometrial cancer: 24.3"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	10	"MCF7: 46.0;T-47d: 57.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB000037, HPA000449, HPA000450, CAB055099, CAB072858"	Enhanced		Approved	Nucleoplasm,Vesicles		NA	NA				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 6: T47d - Mammary gland"	"Cluster 44: Endometrium - Transcription"	Vesicles	Nucleoplasm	"CAB000037: AB_563706, CAB055099: AB_2101946, CAB072858: AB_2665701, HPA000449: AB_1078753, HPA000450: AB_1078754"	"unprognostic (8.28e-2)"	"unprognostic (3.02e-2)"	"unprognostic (1.43e-2)"	"prognostic favorable (5.47e-7)"	"unprognostic (4.79e-1)"	"unprognostic (2.43e-3)"	"unprognostic (4.10e-5)"	"unprognostic (9.92e-2)"	"unprognostic (2.20e-1)"	"unprognostic (7.17e-2)"	"unprognostic (7.35e-2)"	"unprognostic (3.45e-1)"	"unprognostic (1.20e-2)"	"unprognostic (7.91e-3)"	"unprognostic (6.45e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.52e-1)"	4.2	1.8	3.2	1.5	1.3	0.8	29.1	2.9	1.3	83.8	3.2	0.9	0.4	110.9	1.2	0.5	64.9	1.2	1.8	0.6	6.7	2.8	16.9	2.0	1.6	0.4	0.5	9.0	1.0	0.2	6.6	0.4	0.3	6.1	0.5	3.5	0.9	9.8	5.8	1.1	0.8	50.4	0.2	1.7	0.6	2.3	5.9	1.0	3.4	2.6	2.3	2.1	46.9	0.3	0.6	0.0	0.1	0.1	0.1	1.9	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.2	0.0	1.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.2	0.6	0.0	0.0	0.0	1.2	0.1	46.0	0.1	0.0	0.0	0.0	0.0	1.4	0.0	0.7	0.0	3.3	0.1	0.0	0.0	0.6	0.0	0.2	57.4	0.0	0.1	0.2	0.2	0.5	0.0	5.2	1.1	0.1	0.2	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.2	0.0	0.1	0.1	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.1	3.2	1.3	2.9	1.3	0.6	6.7	0.4	0.5	0.3	0.2	5.9	0.3	0.6	0.0	1.1	1.3	2.3	1.0	1.7	0.0	0.0	3.9	86.6	16.4	4.4	0.0	1.0	0.0	8.4	0.1	0.4	0.1	1.9	0.0	40.1	77.9	79.9	2.7	1.8	0.0	4.5	0.2	0.1	11.3	0.0	98.9	2.5	36.9	5.0	52.1	0.9	62.2	5.4	0.0	0.0	4.0	3.1	10.3	4.1	2.5	1.8	1.0	0.2	2.4	0.0	25.1	0.6	0.1	0.0	2.2	8.5	0.6	0.0	3.7	1.3	4.6	0.0	56.7	11.7	1.8	1.3	0.4	1.7	0.1	2.2	4.8	0.1	6.8
SYNE1	"8B, ARCA1, C6orf98, CPG2, dJ45H2.2, enaptin, KIAA0796, MYNE1, Nesp1, Nesprin-1, SCAR8, SYNE-1B"	ENSG00000131018	"Spectrin repeat containing nuclear envelope protein 1"	Q8NF91	6	152121684-152637801	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Spermatogenesis"	Actin-binding	"Cancer-related genes, Disease variant, Emery-Dreifuss muscular dystrophy, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 152.5;choroid plexus: 182.9"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 550.1;Bipolar cells: 332.1;Excitatory neurons: 494.6;Inhibitory neurons: 482.6;Microglial cells: 315.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	4	"eosinophil: 56.8"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 56.8"	"Cell line enhanced"	"Detected in many"		"U-2 OS: 29.8;U-266/70: 29.1"	"Low region specificity"	"Detected in all"							HPA019113	Approved		Supported	"Nucleoplasm,Nuclear membrane"		NA	NA		72000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 43: Cardiomyocytes - Nuclear processes"	"Nucleoplasm, Nuclear membrane"		"HPA019113: AB_1857707"	"unprognostic (9.99e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.22e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.28e-1)"	"unprognostic (9.58e-3)"	"unprognostic (1.11e-1)"	"unprognostic (3.55e-3)"	"unprognostic (1.58e-1)"	"unprognostic (9.85e-2)"	"unprognostic (8.87e-3)"	"unprognostic (2.70e-1)"	"unprognostic (4.14e-3)"	"unprognostic (5.83e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.78e-1)"	15.4	17.8	60.2	7.5	68.8	53.6	14.4	152.5	70.2	18.9	182.9	17.2	2.3	19.1	23.7	5.6	26.4	7.9	32.3	92.4	58.1	34.7	14.6	31.3	17.1	55.0	58.8	44.5	20.6	23.6	56.8	4.4	55.6	17.0	6.2	66.3	5.0	12.6	28.0	19.6	11.4	13.1	38.3	32.9	21.6	17.6	55.4	23.9	44.7	16.5	13.4	16.3	12.9	51.5	0.2	5.8	3.7	4.4	5.7	12.1	1.5	14.7	6.9	3.4	6.0	1.3	0.2	13.5	0.7	7.5	11.2	0.3	1.6	3.8	3.5	11.6	4.0	5.2	4.1	4.0	12.8	1.1	2.7	7.9	0.8	7.5	14.9	9.2	6.8	6.9	0.0	14.2	9.2	0.7	2.4	0.2	0.9	1.3	2.2	2.9	8.1	3.5	15.7	0.2	2.6	3.9	2.7	0.8	9.8	3.7	0.8	0.5	9.0	16.3	29.8	5.9	7.6	29.1	12.5	23.3	8.8	2.9	4.6	10.2	2.3	56.8	11.8	1.8	7.9	6.9	10.3	13.4	1.8	8.2	9.7	10.9	1.6	9.9	3.9	1.5	13.2	3.5	60.2	68.8	152.5	70.2	92.4	58.1	55.0	58.8	55.6	38.3	55.4	51.5	139.7	166.7	215.2	550.1	29.1	12.7	5.4	3.0	3.4	332.1	4.9	9.7	117.2	7.2	53.1	44.1	200.1	0.9	132.9	0.4	3.9	24.0	11.5	132.0	118.2	127.5	3.0	11.6	494.6	7.7	14.2	79.6	7.7	17.8	15.2	13.1	90.0	21.8	8.0	138.0	482.6	11.5	2.0	10.1	15.0	12.6	33.2	16.0	16.0	315.7	12.8	27.3	210.1	256.4	108.6	4.2	0.1	39.9	79.6	5.1	0.0	17.8	146.7	145.5	26.3	145.8	85.6	3.9	5.7	2.2	9.7	1.2	74.7	62.2	0.4	2.2
MYCT1	"FLJ21269, MTLC"	ENSG00000120279	"MYC target 1"	Q8N699	6	152697895-152724567	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 49.6"	"Group enriched"	"Detected in some"	5	"Adipocytes: 123.0;Endothelial cells: 141.3;Hepatic stellate cells: 230.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	33	"eosinophil: 30.7"	"Lineage enriched"	"Detected in single"	248	"granulocytes: 30.7"	"Group enriched"	"Detected in some"	5	"HUVEC TERT2: 124.6;TIME: 104.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA047992			Approved	Nucleoplasm,Vesicles		NA	NA		120000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm	Vesicles	"HPA047992: "	"unprognostic (2.92e-1)"	"unprognostic (1.82e-1)"	"unprognostic (5.95e-2)"	"unprognostic (2.06e-1)"	"unprognostic (6.73e-2)"	"unprognostic (6.80e-2)"	"unprognostic (4.64e-3)"	"unprognostic (6.78e-2)"	"unprognostic (9.90e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.66e-2)"	"unprognostic (2.18e-2)"	"prognostic unfavorable (4.73e-4)"	"unprognostic (1.26e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.36e-2)"	26.6	3.2	6.8	5.2	6.9	1.2	21.4	6.9	10.2	9.0	5.2	6.1	3.5	10.1	4.5	4.6	9.2	10.5	17.1	6.3	7.1	6.6	13.1	15.6	6.2	7.7	6.9	3.6	2.7	4.3	2.2	20.7	8.6	4.4	5.8	1.0	3.7	3.8	12.8	4.7	5.6	12.4	6.8	49.6	4.5	1.8	10.0	2.5	12.2	20.5	3.0	8.1	7.3	7.5	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.9	0.0	17.7	0.1	0.0	0.2	0.0	0.1	0.0	23.0	0.3	0.0	0.7	0.1	0.1	0.0	0.2	0.2	0.3	0.0	124.6	0.0	0.3	0.3	0.4	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	2.1	0.0	0.0	104.4	0.5	0.8	1.5	0.0	1.1	0.0	15.6	0.0	0.0	0.0	0.9	0.0	30.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.1	0.0	0.1	0.0	0.6	6.8	6.9	6.9	10.2	6.3	7.1	7.7	6.9	8.6	6.8	10.0	7.5	123.0	0.0	5.2	0.7	0.8	7.1	0.2	0.1	2.8	0.2	0.4	0.9	3.1	2.8	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.2	10.2	1.3	0.2	141.3	0.0	13.7	0.1	0.2	0.0	4.0	0.0	0.1	1.3	0.0	230.6	2.1	0.1	0.0	0.1	0.0	0.0	7.3	7.3	3.7	0.3	13.3	14.2	30.9	0.1	0.0	0.0	0.5	0.2	0.1	0.0	0.0	0.6	0.5	0.0	0.0	17.7	0.0	0.0	1.5	2.2	0.1	0.1	0.5	5.5	0.0	0.9	0.5	0.0	0.7
VIP		ENSG00000146469	"Vasoactive intestinal peptide"	P01282	6	152750797-152759765	"Cancer-related genes, Predicted intracellular proteins, Predicted secreted proteins"		Hormone	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 72.2;lymphoid tissue: 155.5"	"Group enriched"	"Detected in some"	5	"Inhibitory neurons: 80.6;Melanocytes: 28.4"	"Group enriched"	"Detected in some"	6	"colorectal cancer: 3.7;pancreatic cancer: 4.3;stomach cancer: 2.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"SH-SY5Y: 2.7;TIME: 1.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA017324, CAB018649, HPA072701, CAB079780"	Supported	Supported	Approved	"Endoplasmic reticulum"	"Secreted to blood"	NA	NA	122000			"Cluster 14: B-cells - Humoral immune response"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Endoplasmic reticulum"		"CAB018649: AB_2304501, CAB079780: , HPA017324: AB_1858754, HPA072701: AB_2686550"	"unprognostic (9.58e-2)"	"unprognostic (2.29e-2)"	"unprognostic (2.60e-2)"	"unprognostic (1.13e-1)"	"unprognostic (3.34e-2)"	"unprognostic (3.33e-2)"	"unprognostic (2.48e-2)"	"unprognostic (7.21e-2)"	"unprognostic (2.22e-2)"	"unprognostic (2.89e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.62e-1)"	"unprognostic (2.92e-3)"	"unprognostic (7.47e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.30e-1)"	"unprognostic (5.90e-2)"	2.7	12.2	5.5	155.5	7.9	0.1	1.9	4.9	10.9	1.8	4.6	72.2	16.6	1.2	0.4	4.3	1.5	3.7	4.3	7.3	28.7	2.5	1.1	3.4	0.4	6.9	40.0	0.8	8.3	0.3	0.8	0.6	7.7	2.7	61.4	1.0	0.5	0.5	1.4	0.4	45.8	41.6	4.8	9.7	22.2	1.0	11.9	0.1	2.3	1.7	0.1	1.6	9.4	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.8	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	7.9	4.9	10.9	7.3	28.7	6.9	40.0	7.7	4.8	11.9	5.9	2.5	0.0	0.0	3.3	0.2	0.4	0.0	0.0	0.0	1.3	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.9	0.0	0.0	2.8	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	80.6	0.0	0.0	0.3	0.0	6.5	0.0	0.0	28.4	4.7	0.0	0.0	0.0	2.5	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FBXO5	"EMI1, FBX5, Fbxo31"	ENSG00000112029	"F-box protein 5"	Q9UKT4	6	152970519-152983579	"Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"bone marrow: 44.1;lymphoid tissue: 27.3"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 36.0;Extravillous trophoblasts: 30.5;Spermatocytes: 32.3;Spermatogonia: 26.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB008106, HPA029048"	Approved		Supported	Nucleoplasm		NA	Yes			"Cluster 27: Non-specific - Gene expression"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"CAB008106: AB_828450, HPA029048: AB_10602132"	"unprognostic (1.22e-2)"	"unprognostic (7.21e-2)"	"unprognostic (4.61e-3)"	"unprognostic (1.24e-2)"	"unprognostic (5.92e-2)"	"unprognostic (2.94e-2)"	"unprognostic (2.43e-8)"	"unprognostic (2.46e-2)"	"unprognostic (1.55e-2)"	"unprognostic (7.32e-2)"	"unprognostic (2.89e-1)"	"unprognostic (5.86e-2)"	"unprognostic (1.25e-9)"	"prognostic favorable (8.65e-4)"	"unprognostic (1.20e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.51e-1)"	3.1	3.1	1.5	7.3	1.6	44.1	4.5	2.6	2.1	4.0	1.9	5.0	4.6	5.3	4.5	3.7	3.0	2.6	1.8	1.4	1.7	3.1	4.4	3.4	14.9	1.6	1.6	4.1	3.0	2.3	2.1	6.3	1.7	3.0	5.1	3.3	2.7	2.9	0.9	4.3	4.3	5.0	1.6	5.5	4.6	3.9	1.8	27.3	4.4	2.6	14.6	4.0	3.0	2.0	33.7	17.2	70.8	48.1	5.3	10.8	22.6	79.9	35.5	58.7	65.6	35.6	19.8	81.6	23.9	21.3	39.7	31.4	56.4	26.7	70.0	44.2	50.6	82.3	24.1	38.7	10.2	74.4	48.6	7.7	4.9	39.8	30.9	14.3	27.3	42.3	88.2	74.5	53.9	25.7	85.2	47.6	41.5	25.8	25.0	71.0	56.8	52.8	20.8	18.0	46.1	47.9	56.6	30.2	15.6	24.7	21.8	68.7	20.6	43.9	57.4	51.1	94.8	24.9	29.5	120.4	31.9	54.3	54.2	0.0	1.9	0.0	2.8	2.5	4.0	5.1	4.7	5.2	3.7	5.0	4.6	4.8	0.0	7.1	3.2	4.3	6.6	2.5	1.5	1.6	2.6	2.1	1.4	1.7	1.6	1.6	1.7	1.6	1.8	2.0	6.0	0.0	1.1	1.3	9.8	9.9	3.7	4.0	7.4	3.2	5.7	5.2	1.8	2.8	3.9	1.8	6.2	15.2	13.5	2.6	3.9	3.0	0.4	2.3	10.5	5.7	4.8	36.0	1.0	1.6	30.5	9.1	7.7	4.0	2.5	16.6	5.0	1.9	7.9	1.7	0.9	6.1	2.0	3.2	6.1	0.1	4.4	5.3	1.8	1.9	4.2	4.1	9.2	1.5	2.1	1.5	0.5	6.0	24.7	3.6	1.5	3.6	1.9	3.6	13.1	8.6	8.9	32.3	26.1	10.2	5.3	5.9	7.9	8.0	6.3	2.0
MTRF1L	"HMRF1L, mtRF1a"	ENSG00000112031	"Mitochondrial translational release factor 1 like"	Q9UGC7	6	152987362-153002709	"Predicted intracellular proteins"	"Protein biosynthesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036367	Uncertain					NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 48: Smooth muscle cells - ECM organization"			"HPA036367: AB_10670715"	"prognostic unfavorable (4.82e-4)"	"unprognostic (4.64e-2)"	"unprognostic (1.65e-2)"	"unprognostic (3.56e-3)"	"unprognostic (4.21e-2)"	"unprognostic (2.43e-2)"	"unprognostic (1.01e-3)"	"unprognostic (4.80e-3)"	"unprognostic (2.88e-1)"	"unprognostic (3.82e-2)"	"unprognostic (8.82e-2)"	"unprognostic (3.61e-2)"	"unprognostic (1.97e-1)"	"unprognostic (7.46e-3)"	"unprognostic (1.91e-1)"	"unprognostic (2.61e-2)"	"unprognostic (4.84e-1)"	6.8	6.2	8.4	5.8	10.3	7.1	4.6	12.6	10.3	4.8	13.0	7.6	8.2	4.0	5.9	5.4	3.6	5.1	11.4	8.3	9.6	10.1	7.7	4.6	6.6	9.7	9.5	4.2	6.2	8.6	3.8	5.5	11.0	5.1	6.2	10.3	5.5	5.5	17.9	7.7	6.2	6.7	9.4	5.4	5.7	4.6	9.7	4.8	7.6	21.9	5.8	6.0	3.5	10.7	7.8	8.9	14.8	20.4	16.1	8.5	14.7	13.9	13.4	12.8	18.6	15.4	6.1	14.0	10.7	14.3	22.0	11.7	21.3	12.3	18.5	16.0	14.7	14.0	12.8	20.9	13.9	14.3	14.4	13.4	14.1	16.2	17.9	12.4	18.4	15.3	22.4	8.8	15.4	12.8	10.8	12.1	8.9	17.2	13.1	10.3	11.0	11.2	19.2	13.7	15.6	19.6	18.1	12.9	10.3	16.4	8.6	15.6	12.8	10.2	16.3	17.3	18.2	15.6	15.7	14.8	19.6	10.7	13.1	10.3	3.5	7.1	3.2	5.2	2.8	3.3	3.4	2.9	3.7	2.4	3.1	3.5	3.4	3.3	6.9	2.7	4.0	4.0	8.4	10.3	12.6	10.3	8.3	9.6	9.7	9.5	11.0	9.4	9.7	10.7	29.9	12.8	16.4	11.8	19.9	33.9	24.2	14.5	20.5	0.0	13.8	11.4	28.0	8.6	13.7	18.4	0.0	15.7	15.7	26.3	25.4	34.1	59.8	15.2	22.8	34.5	17.3	14.9	13.0	26.7	24.3	23.6	14.3	20.3	18.4	17.7	62.8	17.6	17.1	0.0	13.2	12.9	12.2	21.2	15.4	54.5	20.2	23.5	16.0	9.4	31.2	0.0	21.6	11.1	11.8	34.0	22.9	25.6	24.0	21.2	27.9	39.2	6.8	0.0	39.5	23.7	30.0	43.4	13.8	29.1	32.7	19.7	16.5	33.8	17.9	23.4
RGS17	"RGS-17, RGSZ2"	ENSG00000091844	"Regulator of G protein signaling 17"	Q9UGC6	6	153004459-153131282	"Predicted intracellular proteins"		"GTPase activation, Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 3.5"	"Cell type enhanced"	"Detected in many"		"Enteroendocrine cells: 41.9;Excitatory neurons: 54.4;Inhibitory neurons: 57.2;Oligodendrocyte precursor cells: 62.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 7.9;hTERT-HME1: 7.0;LHCN-M2: 8.7;RH-30: 6.7;U-87 MG: 9.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022276, HPA056493"	Approved		Approved	Vesicles		NA	NA				"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Vesicles		"HPA022276: AB_10794628, HPA056493: AB_2683152"	"unprognostic (2.77e-2)"	"unprognostic (6.81e-2)"	"unprognostic (3.11e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.81e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.03e-3)"	"unprognostic (3.12e-1)"	"unprognostic (3.79e-2)"	"unprognostic (7.95e-3)"	"unprognostic (1.92e-1)"	"unprognostic (5.33e-2)"	"unprognostic (5.96e-12)"	"unprognostic (2.70e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.04e-1)"	0.8	0.3	2.0	0.4	1.8	1.3	0.6	3.5	1.8	1.4	0.0	0.4	0.5	0.5	0.2	1.6	0.5	1.1	0.2	1.8	3.2	0.6	0.1	0.3	0.5	1.7	3.1	0.9	1.0	0.0	1.9	0.1	1.4	1.3	0.4	1.7	0.7	0.3	0.1	0.6	0.5	0.2	2.2	0.3	0.9	0.9	2.8	0.6	2.3	0.0	0.1	0.9	0.7	1.2	0.1	2.0	2.2	0.2	1.0	7.9	0.1	0.2	0.7	0.5	1.3	0.0	0.3	0.3	0.4	0.4	4.2	0.3	2.0	1.9	1.0	0.2	0.3	0.4	0.4	0.1	1.9	0.2	1.0	2.3	0.1	3.3	7.0	1.8	3.8	1.1	0.1	0.3	8.7	0.9	0.1	0.3	1.4	0.1	1.4	0.1	6.7	0.1	2.3	0.9	1.7	4.3	0.1	0.0	0.0	0.4	0.1	0.3	1.8	1.4	1.1	1.5	2.5	0.3	0.1	0.1	9.3	0.1	2.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	2.0	1.8	3.5	1.8	1.8	3.2	1.7	3.1	1.4	2.2	2.8	1.2	0.3	0.0	0.0	12.7	0.6	0.3	1.2	1.4	0.0	15.9	0.6	0.6	1.0	2.8	7.2	0.0	0.0	0.2	3.7	0.0	0.0	17.1	0.2	0.7	3.5	1.4	41.9	0.4	54.4	0.4	0.2	4.2	4.6	0.8	11.4	0.6	0.0	0.2	0.3	3.3	57.2	0.1	0.0	0.8	3.2	0.6	3.1	0.8	0.0	1.9	0.5	2.7	7.2	62.8	2.2	1.4	1.6	9.1	0.9	6.6	0.0	0.1	3.4	3.5	0.0	3.6	2.4	1.4	9.2	0.1	0.0	0.3	1.7	0.5	0.3	8.7
OPRM1	MOR1	ENSG00000112038	"Opioid receptor mu 1"	P35372	6	154010496-154246867	"FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"brain: 10.6;testis: 2.8"	"Group enriched"	"Detected in some"	13	"Early spermatids: 29.2;Excitatory neurons: 41.1;Inhibitory neurons: 23.5;Late spermatids: 29.7;Microglial cells: 10.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in single"	11	"SH-SY5Y: 6.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA014509, HPA067435"	Enhanced	Supported				NA	NA			"Cluster 42: Non-specific - Transcription"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA014509: AB_1854801, HPA067435: "											"unprognostic (7.34e-2)"			"unprognostic (6.91e-2)"				0.1	0.8	2.9	0.3	2.5	0.7	0.4	8.8	3.5	0.2	0.0	0.2	0.2	0.3	0.6	1.1	0.2	0.3	0.1	1.5	2.6	0.2	0.2	0.2	0.4	2.2	5.2	0.4	0.2	0.2	0.0	0.2	1.0	0.3	0.2	0.9	0.3	0.2	0.4	0.6	0.2	0.2	1.7	0.4	0.4	2.8	10.6	0.2	0.5	0.1	0.3	0.1	0.0	0.0	0.1	0.0	0.3	0.3	0.1	0.3	0.2	0.3	0.2	0.2	0.1	0.2	0.5	0.4	0.2	0.1	0.4	0.2	0.4	0.4	0.2	0.3	0.2	0.3	0.5	0.2	0.3	0.4	0.3	0.2	0.6	0.2	0.5	0.2	0.2	0.3	0.3	0.6	0.4	0.2	0.2	0.4	0.1	0.2	0.1	0.3	0.2	0.2	0.3	0.4	0.4	6.8	0.1	0.2	0.4	0.4	0.3	0.2	0.1	0.4	0.2	0.3	0.1	0.5	0.2	0.3	0.3	0.3	0.2	1.1	0.1	0.3	0.2	0.1	0.3	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.7	0.4	0.2	0.4	0.2	0.1	2.9	2.5	8.8	3.5	1.5	2.6	2.2	5.2	1.0	1.7	10.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	29.2	0.0	0.0	0.0	0.0	0.0	41.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	23.5	0.0	0.0	0.0	0.0	29.7	0.0	0.2	0.0	10.3	0.0	0.0	0.0	1.5	2.0	0.0	0.0	0.7	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.6	0.4	0.0	0.0	0.0	1.0	0.0	0.0	0.2
IPCEF1	"KIAA0403, PIP3-E"	ENSG00000074706	"Interaction protein for cytohesin exchange factors 1"	Q8WWN9	6	154154496-154356792	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"bone marrow: 17.7;brain: 13.6;lymphoid tissue: 13.5;thyroid gland: 39.1"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 46.1;Excitatory neurons: 120.0;Microglial cells: 252.9;T-cells: 65.5"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 2.3"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 71.6"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"HMC-1: 19.8;THP-1: 10.5;U-937: 11.0"	"Low region specificity"	"Detected in all"							"HPA028708, HPA028710"	Supported		Approved	"Nucleoli,Nuclear speckles,Plasma membrane,Cytoplasmic bodies"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 34: Non-specific - Transcription"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Nuclear speckles, Plasma membrane"	"Nucleoli, Cytoplasmic bodies"	"HPA028708: AB_10601916, HPA028710: AB_2732442"	"unprognostic (1.23e-2)"	"unprognostic (8.93e-3)"	"unprognostic (4.18e-2)"	"unprognostic (5.63e-3)"	"unprognostic (2.05e-1)"	"unprognostic (6.55e-3)"	"unprognostic (1.30e-3)"	"unprognostic (2.57e-2)"	"unprognostic (3.87e-1)"	"unprognostic (5.84e-2)"	"unprognostic (3.27e-2)"	"unprognostic (4.87e-2)"	"unprognostic (5.01e-2)"	"unprognostic (8.64e-2)"	"unprognostic (5.45e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.51e-4)"	0.7	0.2	8.4	7.9	5.4	17.7	1.5	4.1	13.6	2.7	0.0	1.3	0.7	1.1	1.4	1.4	2.1	2.9	0.6	5.4	3.2	2.8	2.0	1.5	13.5	0.0	7.4	0.6	0.7	0.1	0.6	1.6	0.0	0.8	1.2	0.2	1.2	0.4	0.2	0.5	2.3	0.9	0.0	6.8	2.4	0.9	12.2	10.6	39.1	0.2	12.8	2.1	0.5	5.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	1.6	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.1	19.8	0.1	0.0	0.0	0.0	0.2	0.0	0.6	0.0	0.0	0.0	0.0	3.1	1.2	0.8	0.0	0.5	0.1	0.1	0.3	0.7	2.1	0.2	0.1	0.0	0.1	0.0	0.0	0.0	10.5	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	11.0	0.0	3.2	14.5	71.6	13.0	6.5	27.6	0.0	16.3	12.5	16.2	0.1	27.9	16.8	42.7	14.3	8.5	0.4	22.6	12.6	8.4	5.4	4.1	13.6	5.4	3.2	0.0	7.4	0.0	0.0	12.2	5.4	1.1	0.0	1.7	7.8	3.5	0.6	0.5	0.4	12.0	0.6	1.8	1.0	1.1	1.5	1.7	1.8	0.0	1.7	46.1	0.0	7.9	2.1	1.3	2.0	1.2	2.3	0.0	3.2	120.0	0.0	0.1	1.0	3.1	2.5	0.0	0.1	3.3	1.1	2.8	3.3	9.8	0.5	2.0	23.4	15.2	0.3	0.3	15.2	0.0	252.9	17.9	0.2	27.8	9.0	14.6	0.0	0.1	0.4	20.7	0.6	0.1	2.0	1.3	0.2	0.0	3.4	0.4	0.2	1.1	4.0	0.6	2.7	65.5	2.0	0.3	1.3
AL357075.4		ENSG00000288520	"Novel protein"	G9CGD6	6	154159828-154510114	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in some"			"Not detected"	"Not detected"							"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEL: 1.4;HMC-1: 1.0"									"HPA028708, HPA028710, HPA049651"	Uncertain		Approved	"Nucleoli,Nuclear speckles,Plasma membrane,Cytoplasmic bodies"		NA	NA					"Cluster 3: HMC-1 - Innate immune response"		"Nuclear speckles, Plasma membrane"	"Nucleoli, Cytoplasmic bodies"	"HPA028708: AB_10601916, HPA028710: AB_2732442, HPA049651: AB_2680841"																		0.2	0.1	0.0	0.1	0.2	0.1	0.3	0.3	0.4	0.5	0.5	0.3	0.5	0.7	0.1	1.0	0.4	0.3	0.2	0.0	0.2	0.8	0.6	0.2	0.0	0.3	0.2	0.5	1.4	0.0		0.5	0.3	0.4	0.3	0.1	0.0	0.3	0.0	0.0	0.6	0.6	0.3	0.5	0.3	0.6	0.2	0.0	0.2	0.0	0.4	0.5		0.6	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.1	0.1	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	1.4	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.1	0.1	0.3	0.0	0.1	0.4	0.3	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.4	0.0	0.2	0.3	0.2	0.3	0.3	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CNKSR3	"FLJ31349, MAGI1"	ENSG00000153721	"CNKSR family member 3"	Q6P9H4	6	154387515-154510685	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 109.6;Glandular and luminal cells: 155.4;Oligodendrocytes: 142.3;Skeletal myocytes: 211.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CACO-2: 21.1"									"CAB037133, HPA049651"	Approved		Supported	Mitochondria,Cytosol		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 44: Endometrium - Transcription"	Cytosol	Mitochondria	"CAB037133: AB_477217, HPA049651: AB_2680841"	"unprognostic (3.07e-1)"	"unprognostic (3.25e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.34e-1)"	"unprognostic (5.62e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.37e-1)"	"unprognostic (5.78e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.40e-1)"	"unprognostic (4.67e-3)"	"unprognostic (4.90e-2)"	"prognostic favorable (6.00e-4)"	"unprognostic (4.23e-2)"	"unprognostic (8.79e-2)"	"unprognostic (1.57e-3)"	"unprognostic (3.38e-1)"	3.7	1.1	6.4	1.9	7.6	0.9	3.2	4.8	5.5	4.0	15.0	6.5	5.8	7.6	1.9	13.3	4.1	4.9	6.4	3.6	4.2	7.7	9.7	3.7	1.4	7.8	8.3	6.1	18.9	0.7	2.3	5.6	7.2	3.3	3.4	2.6	5.7	4.8	1.1	3.9	6.4	6.6	5.3	4.5	4.0	4.4	12.7	2.1	2.1	1.4	2.5	4.3	5.3	13.3	0.4	4.9	3.3	6.8	5.8	4.1	0.4	6.0	3.5	10.2	8.3	21.1	0.5	0.1	6.4	6.6	3.4	2.1	9.5	0.7	5.3	0.0	6.3	15.4	1.0	12.1	2.5	0.0	2.7	6.1	3.2	3.9	4.1	1.6	3.2	1.3	2.2	0.1	2.8	1.2	0.1	0.2	2.3	4.1	6.2	4.6	5.9	8.0	11.7	3.1	2.0	12.6	2.8	1.5	1.3	1.4	0.0	1.3	3.7	0.9	3.0	7.7	4.0	0.1	0.0	0.2	0.2	0.3	4.4	0.6	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.7	0.1	0.1	0.2	0.0	0.0	6.4	7.6	4.8	5.5	3.6	4.2	7.8	8.3	7.2	5.3	12.7	13.3	24.7	12.8	38.4	9.4	0.9	26.5	15.4	7.8	12.5	2.0	11.0	8.3	33.8	30.0	20.2	25.8	0.0	9.2	0.4	31.0	9.8	20.3	42.5	109.6	14.7	66.8	43.2	15.6	23.8	12.3	1.1	12.9	9.2	155.4	5.7	10.8	61.8	65.9	1.7	0.0	1.5	18.4	10.2	7.1	22.5	23.6	5.9	3.5	32.0	24.4	0.8	22.8	0.0	54.8	142.3	7.3	18.5	10.5	0.5	18.7	43.6	31.8	11.7	2.5	0.0	211.8	8.0	1.2	6.3	29.4	23.9	21.5	2.6	14.8	14.1	10.0
SCAF8	"KIAA1116, RBM16"	ENSG00000213079	"SR-related CTD associated factor 8"	Q9UPN6	6	154733378-154834244	"Plasma proteins, Predicted intracellular proteins"	"Transcription, Transcription regulation"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 105.4;Inhibitory neurons: 114.2;Microglial cells: 119.9;Oligodendrocyte precursor cells: 121.2;Oligodendrocytes: 145.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035601, HPA035602"	Enhanced		Enhanced	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm		"HPA035601: AB_2674698, HPA035602: AB_10673220"	"unprognostic (4.60e-3)"	"unprognostic (3.67e-2)"	"unprognostic (7.90e-3)"	"unprognostic (2.50e-2)"	"unprognostic (6.18e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.01e-2)"	"unprognostic (3.41e-2)"	"unprognostic (2.05e-1)"	"prognostic unfavorable (6.61e-4)"	"unprognostic (3.65e-1)"	"unprognostic (2.08e-1)"	"unprognostic (9.08e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.11e-1)"	19.2	11.8	7.9	15.6	10.3	37.2	18.9	17.8	9.9	18.2	2.7	14.9	12.7	22.1	16.4	13.2	17.4	13.6	14.8	6.9	8.5	16.6	15.4	16.2	22.6	7.3	8.5	27.0	14.9	21.3	10.2	18.9	6.2	16.9	17.6	23.2	15.6	15.6	18.7	18.3	14.3	20.3	6.8	19.1	15.2	23.5	8.7	26.8	21.3	19.1	20.8	15.3	14.7	10.4	16.2	15.3	44.6	27.1	29.3	29.8	27.2	25.7	35.8	33.1	33.4	24.2	16.0	49.7	20.4	29.6	29.4	21.1	39.5	33.8	44.2	21.7	19.7	44.6	16.0	29.8	33.8	41.7	28.8	32.3	35.0	29.0	45.0	25.7	28.6	21.6	52.6	29.4	30.8	29.1	44.6	28.2	31.0	24.4	11.3	42.3	24.4	27.1	28.1	29.0	27.4	32.3	26.7	34.7	19.9	32.1	22.8	47.8	26.3	18.8	23.0	24.6	26.2	27.2	21.7	54.0	23.4	25.6	30.0	0.6	1.5	1.8	2.8	2.0	2.8	2.4	3.0	2.9	1.7	2.6	3.0	2.7	1.9	3.1	3.8	1.6	4.0	1.4	7.9	10.3	17.8	9.9	6.9	8.5	7.3	8.5	6.2	6.8	8.7	10.4	23.1	25.6	18.1	89.8	22.6	12.6	12.2	11.9	17.6	19.5	14.6	12.4	33.9	7.2	11.7	12.9	25.0	11.1	23.2	15.8	1.9	11.3	3.6	18.8	25.4	16.6	13.1	18.7	105.4	11.8	8.8	17.5	23.0	25.0	34.2	29.3	18.5	11.6	13.3	13.5	114.2	14.1	6.1	20.8	9.7	5.4	16.4	16.6	10.6	119.9	13.5	16.1	8.2	121.2	145.8	13.6	11.8	12.4	13.7	13.7	11.7	6.5	15.8	21.4	26.3	24.5	16.3	21.4	21.2	14.8	10.7	10.7	19.2	19.5	16.1	15.4
TIAM2	STEF	ENSG00000146426	"TIAM Rac1 associated GEF 2"	Q8IVF5	6	154832697-155257723	"Metabolic proteins, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 11.8;testis: 13.3"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 81.3;Early spermatids: 141.5;Excitatory neurons: 74.2;Late spermatids: 347.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 6.4;non-classical monocyte: 9.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 65.7;HDLM-2: 27.8;RH-30: 43.3"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"olfactory bulb: 36.9"	"HPA011134, HPA013903"	Approved		Supported	"Nucleoplasm,Nucleoli fibrillar center,Cytosol"		No	No			"Cluster 51: Monocytes - Innate immune response"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 12: NES - Nervous system development"	"Cluster 34: Spermatids - Unknown function"	"Nucleoplasm, Nucleoli fibrillar center"	Cytosol	"HPA011134: AB_1858005, HPA013903: AB_1858004"	"unprognostic (9.14e-2)"	"unprognostic (5.79e-2)"	"unprognostic (1.44e-1)"	"unprognostic (6.38e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.69e-1)"	"unprognostic (4.36e-2)"	"unprognostic (1.89e-1)"	"unprognostic (5.74e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.84e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.38e-3)"	"unprognostic (1.82e-1)"	"unprognostic (8.13e-2)"	"unprognostic (6.04e-2)"	"unprognostic (1.05e-1)"	0.4	1.2	2.8	0.9	7.1	0.4	1.2	5.4	11.8	1.1	0.0	1.2	8.3	0.8	0.6	0.6	0.8	2.2	2.2	6.1	0.0	0.3	0.3	0.5	1.2	0.4	1.0	0.3	1.3	0.1	1.4	0.5	0.0	2.0	0.8	3.3	1.3	2.7	2.5	0.6	7.9	1.1	0.4	0.7	3.0	13.3	0.8	0.6	5.5	1.7	2.0	2.0	0.7	6.1	8.3	1.5	65.7	6.1	2.9	7.9	0.4	3.2	2.2	3.3	5.5	0.7	4.8	1.1	3.1	6.3	0.9	0.5	2.4	0.0	2.3	27.8	3.3	0.0	1.1	1.9	1.8	0.2	1.7	5.4	0.2	1.1	0.2	2.5	4.7	0.5	0.2	0.1	7.5	0.5	0.7	0.7	4.1	0.1	1.3	8.4	43.3	0.3	0.2	0.2	1.1	14.5	0.1	0.3	0.2	11.9	0.3	0.6	1.5	0.2	15.5	0.4	1.5	0.2	3.6	0.2	0.0	0.3	3.9	0.0	0.0	2.1	0.0	2.0	0.0	2.0	0.1	0.1	0.3	0.7	0.0	0.0	6.4	0.4	9.5	0.0	1.2	0.1	2.8	7.1	5.4	11.8	6.1	0.0	0.4	1.0	0.0	0.4	0.8	6.1	2.9	3.2	2.6	8.8	9.6	3.1	22.5	2.8	1.8	14.3	3.3	5.3	8.3	7.2	2.1	1.8	81.3	1.8	4.3	2.2	0.0	5.3	141.5	8.3	4.9	2.7	0.0	3.6	74.2	3.1	2.6	4.4	6.1	12.1	19.7	6.8	11.0	1.5	1.9	23.5	31.4	3.9	6.1	2.2	2.2	347.4	9.9	5.2	12.4	4.7	9.8	7.6	4.1	28.6	5.1	5.9	5.8	7.9	13.3	9.6	23.9	1.0	3.3	23.9	0.0	7.0	4.3	6.7	7.3	2.1	2.6	0.4	5.0	5.3	3.9	11.6
TFB1M	"CGI-75, mtTFB"	ENSG00000029639	"Transcription factor B1, mitochondrial"	Q8WVM0	6	155256134-155314493	"Disease related genes, Metabolic proteins, Predicted intracellular proteins"	"rRNA processing, Transcription, Transcription regulation"	"DNA-binding, Methyltransferase, RNA-binding, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in all"	5	"Early spermatids: 239.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029428	Approved					NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 23: Spermatids - Flagellum & Golgi organization"			"HPA029428: AB_2673038"	"unprognostic (2.20e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.33e-3)"	"unprognostic (7.73e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.23e-2)"	"unprognostic (1.32e-1)"	"unprognostic (3.54e-2)"	"unprognostic (7.86e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.95e-3)"	"unprognostic (3.39e-2)"	"unprognostic (2.68e-1)"	"unprognostic (7.68e-3)"	"unprognostic (7.77e-2)"	4.9	17.3	1.9	3.1	2.8	1.5	5.2	2.9	4.1	6.2	0.6	7.2	5.0	5.0	3.9	9.4	4.8	2.8	10.8	2.8	1.7	6.8	15.0	4.6	5.6	0.8	1.3	6.1	7.1	3.8	7.3	2.1	1.1	5.6	4.8	5.2	6.7	3.1	17.3	7.9	6.4	3.9	1.1	8.5	6.9	11.3	1.9	3.9	7.2	5.5	4.9	7.0	6.9	2.6	7.3	3.5	7.9	12.5	5.9	11.8	6.5	8.9	8.4	8.9	11.9	5.8	6.3	11.6	5.4	3.5	6.5	11.8	5.6	8.8	15.1	11.1	7.3	5.2	4.2	33.2	16.4	6.9	3.8	11.7	3.8	13.3	11.8	10.9	10.6	9.0	13.5	3.1	11.4	4.5	5.2	10.0	8.3	7.3	9.4	6.5	4.7	11.3	9.7	4.9	5.9	14.4	2.4	8.2	8.1	10.6	5.1	9.6	4.2	3.6	7.6	8.5	9.3	5.2	7.0	7.0	12.5	11.8	9.2	5.9	2.8	4.5	4.1	5.0	6.4	7.5	6.3	5.7	6.5	7.0	7.9	6.2	2.5	6.7	5.2	5.3	7.8	3.6	1.9	2.8	2.9	4.1	2.8	1.7	0.8	1.3	1.1	1.1	1.9	2.6	5.9	22.4	12.0	25.8	16.5	6.2	14.1	31.7	16.5	16.2	9.6	10.2	21.6	8.6	14.6	12.9	22.9	19.6	8.9	4.8	31.3	20.9	239.4	7.4	6.2	5.1	6.0	19.1	41.9	17.8	19.0	9.0	11.2	5.1	27.8	10.7	4.2	24.3	14.9	30.3	47.4	8.9	24.4	10.7	5.1	24.6	5.0	9.9	3.6	44.0	13.3	13.4	9.2	42.3	46.3	13.8	8.5	8.6	9.3	8.0	5.9	21.4	11.5	21.6	13.1	7.1	11.6	35.1	17.2	17.1	11.4	7.3	14.2	28.6	13.7	9.6
CLDN20		ENSG00000171217	"Claudin 20"	P56880	6	155264013-155276548	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 1.5"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 1.6;Excitatory neurons: 1.8;Inhibitory neurons: 1.7;Oligodendrocytes: 2.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Hep G2: 1.2;WM-115: 1.2"															NA	NA				"Cluster 6: Brain - Smell perception"	"Cluster 20: HeLa - Mitochondria"	"Cluster 56: Bipolar cells - Visual perception"				"unprognostic (3.75e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.85e-1)"	"unprognostic (2.84e-1)"	"unprognostic (4.04e-2)"	"unprognostic (2.38e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.67e-1)"	"unprognostic (5.22e-2)"	"unprognostic (6.26e-2)"	"unprognostic (6.40e-2)"	"unprognostic (7.33e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.30e-2)"	"unprognostic (3.29e-2)"	"unprognostic (2.05e-1)"	0.1	0.3	0.4	0.1	0.8	0.8	0.1	1.2	0.9	0.2	0.6	0.2	0.1	0.4	0.0	0.2	0.1	0.3	0.1	0.5	0.7	0.3	0.2	0.1	0.3	0.8	0.7	0.2	0.2	0.0	0.1	0.0	0.7	0.1	0.0	1.0	0.3	0.0	0.2	0.8	0.2	0.5	0.1	0.3	0.2	0.3	1.0	0.0	0.4	0.0	0.0	0.1	0.3	1.5	0.1	0.5	0.1	0.4	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.3	0.2	0.9	0.1	0.0	0.1	0.5	0.0	0.0	0.0	0.1	0.3	0.3	0.8	1.2	0.1	0.6	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.5	0.0	0.8	0.0	0.5	0.0	0.1	0.0	0.3	0.1	0.0	0.0	1.1	0.1	0.3	0.1	0.1	0.1	0.0	0.3	0.0	0.6	0.4	0.2	0.2	0.6	0.2	0.1	0.6	0.2	0.3	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.8	1.2	0.9	0.5	0.7	0.8	0.7	0.7	0.1	1.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	1.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.1	0.1	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	2.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1
NOX3	GP91-3	ENSG00000074771	"NADPH oxidase 3"	Q9HBY0	6	155395368-155455839	"Predicted membrane proteins, Transporters"		Oxidoreductase		"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	10	"MCF7: 4.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA073837			Uncertain	Vesicles		NA	NA					"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Vesicles		"HPA073837: "					"unprognostic (3.42e-1)"													0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ARID1B	"6A3-5, BAF250b, DAN15, ELD/OSA1, KIAA1235, p250R"	ENSG00000049618	"AT-rich interaction domain 1B"	Q8NFD5	6	156776020-157210779	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Neurogenesis, Transcription, Transcription regulation"	"Chromatin regulator, DNA-binding"	"Cancer-related genes, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 404.3;Inhibitory neurons: 475.4;Microglial cells: 327.0;Oligodendrocyte precursor cells: 417.7;Oligodendrocytes: 503.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016511, HPA075291"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 50: Non-specific - Ribosome"	"Cluster 14: REH - Unknown function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm		"HPA016511: AB_1845008, HPA075291: AB_2686743"	"prognostic unfavorable (1.04e-4)"	"unprognostic (9.82e-2)"	"unprognostic (1.73e-1)"	"unprognostic (5.42e-2)"	"unprognostic (7.47e-2)"	"unprognostic (1.40e-2)"	"unprognostic (2.73e-2)"	"unprognostic (2.89e-1)"	"unprognostic (1.18e-1)"	"prognostic unfavorable (4.16e-4)"	"unprognostic (2.53e-1)"	"unprognostic (5.33e-2)"	"unprognostic (1.07e-3)"	"unprognostic (2.46e-1)"	"unprognostic (1.80e-1)"	"unprognostic (3.53e-1)"	"unprognostic (1.16e-1)"	15.2	12.0	14.6	14.5	13.4	28.7	15.6	29.0	16.0	19.0	2.2	15.9	14.2	17.0	11.3	15.7	18.6	14.4	14.4	20.4	10.1	13.2	9.7	14.6	18.2	13.4	10.9	27.5	17.1	28.2	12.2	11.7	11.1	14.6	12.1	11.7	20.4	12.7	33.6	23.2	15.3	15.8	7.3	18.4	12.5	9.8	12.5	25.4	22.0	25.4	18.8	17.4	17.4	17.2	13.0	19.4	29.6	41.2	24.7	21.5	20.4	14.6	18.6	18.1	18.0	17.7	20.0	43.0	8.1	23.9	22.4	16.5	25.2	23.3	18.1	40.4	18.1	30.6	19.6	22.1	17.1	25.3	21.8	25.5	18.4	27.1	24.6	20.4	25.6	26.8	35.8	32.3	13.2	15.9	29.1	30.5	15.3	18.3	10.5	66.3	12.7	22.9	12.7	24.3	28.0	34.7	28.3	29.4	15.8	15.7	19.6	40.2	26.4	23.4	23.6	22.0	27.5	21.8	18.2	52.7	19.7	30.3	32.0	5.0	2.3	2.3	4.1	1.9	3.7	5.3	3.5	2.8	1.8	6.9	2.9	4.1	4.2	2.4	2.1	9.4	3.7	1.2	14.6	13.4	29.0	16.0	20.4	10.1	13.4	10.9	11.1	7.3	12.5	17.2	85.7	48.1	51.8	282.7	83.3	47.5	22.3	22.3	41.5	36.0	70.9	44.4	36.9	27.1	32.6	126.9	29.2	14.7	103.7	21.8	7.9	40.8	15.0	70.8	124.5	43.9	40.8	37.8	404.3	34.5	7.5	49.9	31.1	78.0	38.7	137.1	33.9	27.3	14.1	47.1	475.4	33.7	20.3	32.6	36.1	19.4	56.8	49.1	30.2	327.0	59.4	21.9	24.7	417.7	503.7	46.6	26.9	62.8	70.2	28.1	26.8	18.4	29.5	29.6	46.0	43.1	56.7	8.0	12.2	39.7	55.7	17.5	51.9	72.9	36.3	27.1
TMEM242	"BM033, C6orf35"	ENSG00000215712	"Transmembrane protein 242"	Q9NWH2	6	157289025-157323601	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA025764	Approved					NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"			"HPA025764: AB_1845742"	"unprognostic (5.42e-3)"	"unprognostic (6.02e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.23e-1)"	"unprognostic (6.24e-2)"	"unprognostic (2.21e-3)"	"unprognostic (2.27e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.36e-1)"	"unprognostic (7.14e-2)"	"unprognostic (1.18e-3)"	"unprognostic (1.28e-1)"	"unprognostic (6.50e-2)"	"unprognostic (2.17e-1)"	"unprognostic (2.06e-1)"	6.7	9.2	9.2	5.0	9.9	11.0	6.4	9.6	10.6	7.5	8.4	7.3	5.9	7.6	8.0	6.0	5.8	5.0	14.1	10.0	9.1	8.2	10.2	5.4	5.4	8.8	8.4	6.5	5.5	10.7	6.2	6.1	9.0	6.5	6.2	9.5	6.8	5.4	12.1	6.1	5.7	7.9	8.3	5.2	6.5	4.7	9.4	6.0	7.4	11.9	5.8	7.2	6.9	9.3	5.1	4.0	8.3	8.8	15.4	10.0	6.2	9.7	9.1	9.7	10.7	5.3	4.9	7.7	12.5	10.6	13.3	9.0	8.7	8.7	9.9	11.1	14.3	10.9	9.1	10.8	16.0	11.3	8.3	10.2	9.3	6.9	14.1	13.4	11.8	10.3	17.1	10.1	8.7	5.2	6.6	14.9	5.6	3.2	7.8	3.8	5.4	11.1	13.9	4.5	10.9	5.7	8.7	5.8	11.8	7.6	5.9	11.9	9.9	6.7	7.6	14.5	13.0	9.7	10.5	7.3	13.7	13.0	11.2	15.0	19.5	12.4	13.9	16.8	13.4	18.5	14.0	13.9	18.6	19.5	12.1	13.8	3.0	17.1	11.6	29.8	16.7	12.1	9.2	9.9	9.6	10.6	10.0	9.1	8.8	8.4	9.0	8.3	9.4	9.3	28.8	12.8	10.0	7.5	21.6	27.5	18.8	62.2	25.6	25.1	20.3	25.4	51.8	20.0	27.1	22.0	4.2	51.2	28.0	19.6	33.2	49.1	11.7	25.8	32.8	28.0	9.6	40.0	23.0	39.1	53.2	27.5	13.3	28.6	15.8	16.9	25.4	28.5	36.5	38.7	28.3	21.8	32.6	17.3	26.7	6.8	21.1	17.7	42.7	14.0	21.7	26.9	27.8	15.1	22.0	39.6	26.9	26.7	23.7	17.9	32.0	38.2	29.7	30.5	59.2	22.8	36.0	34.7	37.1	24.4	24.3	41.6	24.8	24.6	24.6	16.8
ZDHHC14	"FLJ20984, NEW1CP"	ENSG00000175048	"Zinc finger DHHC-type palmitoyltransferase 14"	Q8IZN3	6	157381133-157678157	"Enzymes, Metabolic proteins, Predicted membrane proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 22.7"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 161.7;Horizontal cells: 122.8;Inhibitory neurons: 108.1;Oligodendrocyte precursor cells: 315.2;Oligodendrocytes: 221.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"plasmacytoid DC: 1.3"	"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in many"	4	"HDLM-2: 50.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013437, HPA063754"	Approved		Uncertain	Vesicles		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 70: Brain - Nervous system development"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Vesicles		"HPA013437: , HPA063754: AB_2685113"	"unprognostic (1.66e-2)"	"unprognostic (1.27e-2)"	"unprognostic (1.58e-2)"	"unprognostic (3.98e-2)"	"unprognostic (1.59e-1)"	"unprognostic (6.78e-3)"	"unprognostic (1.84e-1)"	"unprognostic (6.02e-2)"	"unprognostic (2.87e-2)"	"unprognostic (1.63e-1)"	"prognostic favorable (6.93e-4)"	"unprognostic (3.94e-2)"	"unprognostic (5.01e-3)"	"unprognostic (1.89e-1)"	"unprognostic (7.95e-2)"	"unprognostic (4.43e-1)"	"unprognostic (2.63e-1)"	2.9	1.6	7.3	1.8	7.6	2.5	1.6	9.7	6.8	5.3	1.1	2.4	2.8	12.4	0.4	1.7	2.0	2.3	5.2	7.5	5.1	4.6	4.4	3.0	2.4	12.5	9.1	1.4	2.5	5.6	1.6	2.2	10.9	3.5	1.7	1.3	2.1	1.4	2.3	1.4	4.1	6.1	13.5	3.1	3.8	3.3	10.8	0.9	1.7	3.9	2.4	2.4	1.9	22.7	2.6	2.7	0.8	3.8	2.0	1.5	8.7	4.1	3.7	2.8	2.5	3.3	1.9	6.4	1.4	3.3	5.4	1.3	2.2	2.2	2.5	50.9	3.2	12.7	1.0	1.5	2.7	1.7	2.8	1.1	2.3	2.9	1.2	2.4	4.3	2.8	10.4	4.7	1.6	1.7	1.1	4.2	1.6	5.1	3.2	0.2	0.4	3.9	5.8	1.1	6.3	1.9	4.8	3.1	3.5	1.6	0.4	2.0	6.0	4.2	3.1	8.3	5.2	1.1	1.3	0.9	1.5	4.5	4.7	0.0	0.0	0.0	0.1	0.0	0.2	0.4	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.0	1.3	0.0	0.1	7.3	7.6	9.7	6.8	7.5	5.1	12.5	9.1	10.9	13.5	10.8	22.7	23.4	3.2	0.0	45.4	9.8	12.9	2.1	3.0	4.0	25.3	5.8	8.0	18.3	12.8	1.4	7.3	6.2	12.5	11.2	7.4	11.7	7.5	10.7	5.0	16.6	15.1	2.4	4.2	161.7	3.1	2.2	11.4	6.1	9.4	0.0	7.7	22.5	23.1	11.4	122.8	108.1	9.8	6.1	15.5	6.7	5.9	8.1	8.8	10.6	65.6	3.8	5.4	7.2	315.2	221.0	2.7	8.5	10.1	4.5	14.2	6.0	3.8	0.4	6.0	0.0	6.2	8.4	7.2	10.0	1.5	8.4	21.1	6.6	4.6	11.5	2.7
SNX9	"SDP1, SH3PX1, SH3PXD3A"	ENSG00000130340	"Sorting nexin 9"	Q9Y5X1	6	157700387-157945077	"Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Endocytosis, Mitosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Glandular and luminal cells: 251.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 10.0"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 146.6;GAMG: 145.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031410, HPA057203"	Approved		Supported	"Plasma membrane,Cytosol"		No	No			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 18: U-2197 - ECM organization"	"Cluster 44: Endometrium - Transcription"	"Plasma membrane"	Cytosol	"HPA031410: AB_10603339, HPA057203: AB_2683368"	"unprognostic (1.63e-3)"	"prognostic unfavorable (5.95e-4)"	"unprognostic (1.39e-1)"	"unprognostic (8.09e-2)"	"unprognostic (8.09e-2)"	"unprognostic (1.40e-2)"	"unprognostic (4.06e-2)"	"prognostic unfavorable (3.77e-4)"	"unprognostic (7.93e-2)"	"unprognostic (4.99e-3)"	"unprognostic (4.45e-2)"	"unprognostic (2.42e-1)"	"prognostic favorable (9.95e-4)"	"unprognostic (2.14e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.13e-2)"	"unprognostic (2.57e-1)"	57.9	25.2	19.2	25.7	20.6	14.3	41.4	21.2	20.9	38.8	20.6	34.2	33.2	41.8	20.8	57.8	26.2	46.9	33.2	18.8	19.9	26.2	39.0	21.0	24.2	22.2	21.1	28.0	28.5	37.7	13.4	48.5	21.8	31.0	29.5	2.7	35.1	41.7	24.4	30.4	35.6	41.2	20.9	18.4	37.5	11.0	20.7	13.9	29.8	34.2	21.7	49.8	33.7	23.0	26.0	19.1	18.9	22.1	96.6	78.6	37.7	46.3	146.6	36.4	48.9	16.6	27.6	0.0	25.0	85.6	145.8	18.7	22.7	36.3	21.1	23.9	23.4	17.7	25.7	23.9	48.6	7.6	31.6	51.1	33.9	37.8	37.1	63.9	49.8	23.3	80.9	0.0	15.8	17.2	0.0	15.6	14.4	18.7	21.3	0.0	17.9	32.7	59.7	15.9	11.8	20.9	34.1	16.4	90.5	16.2	6.8	20.0	41.7	41.3	16.6	128.8	30.4	0.0	0.0	0.0	84.8	6.4	25.4	0.0	0.7	0.1	0.4	2.1	1.5	3.2	0.7	0.6	1.4	2.4	5.3	1.2	0.0	0.1	6.8	10.0	2.2	0.6	19.2	20.6	21.2	20.9	18.8	19.9	22.2	21.1	21.8	20.9	20.7	23.0	71.5	0.0	1.1	40.5	102.6	43.3	109.7	17.3	30.1	15.6	28.7	18.4	28.4	28.6	19.0	9.2	0.0	40.6	37.6	97.7	21.5	57.5	73.4	112.8	53.0	57.9	15.7	17.7	105.4	55.9	41.1	83.0	70.3	251.1	12.0	16.4	37.1	34.3	41.6	3.3	90.4	43.0	8.2	59.0	74.2	26.8	44.7	84.3	21.4	48.7	39.5	11.1	7.2	100.5	161.2	107.0	108.9	46.6	14.9	127.5	52.5	46.2	14.3	1.8	39.5	43.6	49.6	21.9	15.4	22.9	29.8	109.9	48.8	9.1	29.7	137.0
SYNJ2	INPP5H	ENSG00000078269	"Synaptojanin 2"	O15056	6	157981863-158099176	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"brain: 116.2"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 102.1;Glandular and luminal cells: 114.2;Oligodendrocytes: 502.1;Pancreatic endocrine cells: 140.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"GAMG: 133.4;TIME: 109.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031575	Approved		Approved	Microtubules,Cytosol		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 70: Brain - Nervous system development"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Microtubules	Cytosol	"HPA031575: AB_10604101"	"prognostic unfavorable (2.63e-4)"	"unprognostic (1.94e-2)"	"unprognostic (7.61e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.48e-2)"	"unprognostic (7.68e-2)"	"unprognostic (1.24e-1)"	"unprognostic (7.06e-2)"	"unprognostic (2.91e-1)"	"unprognostic (7.29e-3)"	"unprognostic (1.26e-1)"	"unprognostic (1.36e-1)"	"prognostic unfavorable (4.02e-6)"	"unprognostic (1.66e-2)"	"unprognostic (3.75e-2)"	"unprognostic (1.75e-1)"	"unprognostic (9.45e-2)"	4.2	5.8	26.1	6.2	69.9	20.0	8.0	58.6	42.0	4.5	1.9	10.6	7.1	7.6	10.5	7.7	5.5	9.4	10.7	22.5	32.4	8.4	4.9	4.5	5.9	98.1	74.7	3.6	8.1	1.5	4.1	3.5	78.9	6.9	10.4	2.3	16.5	5.8	7.2	4.3	6.8	7.7	57.8	4.2	8.5	9.4	58.2	6.5	5.2	9.5	6.5	11.0	4.6	116.2	16.4	56.6	4.5	7.3	3.4	11.2	24.2	29.8	60.4	35.0	41.1	28.7	13.5	0.5	19.8	57.9	133.4	15.4	10.1	18.5	40.1	22.9	9.3	31.8	29.8	30.9	6.5	10.9	32.6	5.9	9.9	53.3	12.4	47.1	61.7	16.4	24.7	6.5	16.1	7.6	14.0	12.2	5.1	51.4	31.2	6.0	19.1	13.4	11.8	18.8	34.8	2.0	22.7	14.2	5.9	17.2	10.9	7.1	109.7	25.8	26.8	61.4	36.5	2.5	7.8	0.4	49.2	17.5	18.4	3.0	0.6	0.5	0.9	0.3	1.9	1.0	1.3	0.8	0.6	2.0	1.1	0.8	4.3	1.0	0.4	0.5	1.2	0.5	26.1	69.9	58.6	42.0	22.5	32.4	98.1	74.7	78.9	57.8	58.2	116.2	17.2	3.2	3.3	5.2	15.4	21.7	19.9	7.5	14.2	2.4	25.4	18.4	13.9	21.5	8.6	18.4	0.0	7.7	12.8	20.0	3.9	59.0	35.5	48.5	13.7	26.4	17.4	5.5	102.1	35.2	5.0	16.6	34.1	114.2	5.1	37.7	7.9	5.2	2.0	0.0	10.1	14.8	10.2	2.2	17.6	56.5	1.2	12.5	10.6	7.5	6.9	1.6	16.5	8.5	502.1	140.2	7.1	6.4	13.5	50.6	13.1	1.7	14.4	0.6	0.0	7.3	18.9	0.9	1.1	11.5	17.2	15.9	17.1	2.2	15.7	36.2
SERAC1	FLJ14917	ENSG00000122335	"Serine active site containing 1"	Q96JX3	6	158109519-158168280	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"		"Deafness, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 95.8;Late spermatids: 111.7;Oligodendrocytes: 47.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025715, HPA025716"	Enhanced					NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 34: Spermatids - Unknown function"			"HPA025715: AB_1856697, HPA025716: AB_2185128"	"unprognostic (1.14e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.16e-2)"	"unprognostic (2.17e-1)"	"unprognostic (6.92e-2)"	"unprognostic (2.04e-2)"	"unprognostic (1.20e-3)"	"unprognostic (2.50e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.61e-2)"	"unprognostic (4.46e-1)"	"unprognostic (5.98e-2)"	"unprognostic (6.11e-3)"	"unprognostic (4.21e-2)"	"unprognostic (7.56e-2)"	"unprognostic (1.34e-2)"	"unprognostic (4.03e-2)"	2.8	7.1	3.7	1.6	3.9	0.6	3.1	3.7	5.3	3.2	4.1	3.7	3.1	3.6	3.5	6.2	2.2	3.7	3.0	4.1	3.7	4.7	2.9	2.7	2.0	3.9	3.9	2.5	7.8	3.4	2.5	2.4	4.6	3.9	3.2	6.3	4.4	3.8	5.7	4.6	3.1	6.0	3.6	2.5	3.8	6.2	3.7	1.9	5.2	4.5	2.5	3.6	3.8	4.3	4.0	5.9	9.4	11.3	6.7	4.8	4.1	5.0	5.2	8.6	11.2	3.1	1.5	1.9	3.6	10.3	6.1	3.5	9.1	3.8	7.2	2.1	5.2	6.2	2.1	5.3	6.9	2.7	2.8	3.0	6.5	6.7	6.8	13.3	5.6	4.4	5.5	1.3	7.5	1.8	2.6	3.1	4.1	6.3	3.0	1.7	6.5	2.5	9.4	3.3	6.4	4.9	5.4	6.3	4.6	7.7	2.9	4.4	6.6	5.8	4.4	13.4	10.8	1.5	2.9	1.7	4.0	3.3	5.8	1.2	2.2	0.6	1.0	2.5	1.1	0.3	0.7	0.9	2.4	0.3	0.7	0.8	1.1	1.1	1.7	0.6	0.8	1.1	3.7	3.9	3.7	5.3	4.1	3.7	3.9	3.9	4.6	3.6	3.7	4.3	4.3	3.2	14.1	9.4	3.2	6.9	4.3	4.7	4.0	9.5	5.6	2.8	5.8	7.2	10.7	1.8	4.2	2.7	6.5	7.2	1.9	11.7	95.8	18.0	3.1	5.3	5.4	3.8	22.4	5.8	1.1	4.6	5.1	11.1	12.0	14.7	4.6	4.6	4.9	5.0	19.1	4.4	10.2	7.6	17.7	111.7	5.0	6.8	10.6	7.5	6.4	5.0	4.1	10.6	47.5	6.3	8.3	6.4	4.0	8.0	7.4	5.5	9.8	10.7	0.0	4.5	4.8	16.8	9.7	5.8	11.5	5.7	6.3	7.3	5.0	8.1
GTF2H5	"bA120J8.2, C6orf175, FLJ30544, TFB5, TFIIH, TTD, TTD-A, TTDA"	ENSG00000272047	"General transcription factor IIH subunit 5"	Q6ZYL4	6	158168350-158199344	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"DNA damage, DNA repair, Transcription, Transcription regulation"		"Disease variant, Ichthyosis"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 425.8;Proximal tubular cells: 504.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 39: Non-specific - Basic cellular processes"				"unprognostic (1.04e-2)"	"unprognostic (2.02e-2)"	"unprognostic (2.50e-1)"	"unprognostic (8.59e-3)"	"unprognostic (3.56e-1)"	"unprognostic (1.03e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.02e-1)"	"unprognostic (5.22e-3)"	"prognostic unfavorable (6.11e-4)"	"unprognostic (3.13e-1)"	"unprognostic (8.46e-2)"	"unprognostic (3.58e-3)"	"unprognostic (1.33e-2)"	18.0	21.5	18.9	8.3	20.7	5.1	14.1	19.0	32.5	9.1	17.9	9.6	7.4	8.0	20.8	10.1	10.7	7.8	14.0	19.7	20.1	17.7	21.8	7.7	9.9	19.3	18.7	10.2	11.3	13.5	3.2	8.3	19.6	12.7	7.8	18.2	9.0	10.8	27.7	7.2	8.2	9.6	19.7	9.2	8.9	15.1	19.3	15.4	8.4	18.1	9.8	11.3	3.1	21.3	18.5	14.6	24.3	27.5	32.2	40.7	20.8	30.2	26.4	24.7	30.4	10.2	17.4	20.6	48.5	29.6	42.7	13.7	12.0	29.4	29.3	26.6	33.3	28.1	16.1	44.2	29.4	16.1	14.4	36.2	30.2	23.8	29.0	48.5	19.9	29.3	34.3	14.7	46.7	11.1	24.7	39.1	25.2	23.2	17.3	15.6	15.1	32.4	50.3	16.2	18.4	14.7	26.9	26.1	27.0	31.0	21.6	38.1	31.8	18.4	22.5	25.5	39.4	14.1	16.9	30.0	37.1	15.3	38.0	11.6	23.8	16.9	25.4	31.1	22.4	32.7	27.9	25.9	30.6	27.8	33.0	31.7	5.6	31.9	33.4	41.9	35.9	24.3	18.9	20.7	19.0	32.5	19.7	20.1	19.3	18.7	19.6	19.7	19.3	21.3	79.5	44.8	58.4	16.6	49.6	45.5	113.4	232.9	46.1	45.7	91.3	122.2	86.8	88.6	130.4	141.6	16.7	187.8	62.9	44.6	418.7	130.1	425.8	207.5	76.0	61.8	46.6	33.7	15.6	122.4	167.4	93.0	54.0	120.6	65.2	126.7	92.4	180.4	162.0	47.1	18.7	75.1	166.8	80.0	49.2	103.3	112.5	80.3	80.0	11.2	120.6	120.5	117.4	14.1	25.9	92.1	52.7	110.2	24.6	94.3	71.2	504.1	205.0	50.2	72.3	71.8	87.7	227.3	130.6	98.4	63.1	132.8	57.8	177.5	76.1	127.2
TULP4	"KIAA1397, TUSP"	ENSG00000130338	"TUB like protein 4"	Q9NRJ4	6	158232236-158511828	"Plasma proteins, Predicted intracellular proteins"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 32.7"	"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 171.0;Oligodendrocytes: 544.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005445	Approved					NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 65: Brain - Ion transport"	"Cluster 12: NES - Nervous system development"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"			"HPA005445: AB_1080421"	"unprognostic (6.51e-3)"	"unprognostic (1.83e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.39e-1)"	"unprognostic (3.41e-1)"	"unprognostic (9.77e-2)"	"unprognostic (6.07e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.32e-1)"	"unprognostic (4.79e-2)"	"unprognostic (1.42e-2)"	"unprognostic (3.04e-1)"	"unprognostic (2.01e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.27e-1)"	"unprognostic (9.65e-2)"	2.4	2.5	27.1	2.1	32.7	1.1	3.1	15.0	16.1	2.8	0.0	2.5	4.0	3.0	2.8	3.5	2.1	2.2	2.6	15.2	13.1	3.1	2.3	2.7	3.1	16.1	23.9	2.5	2.7	5.0	4.6	2.6	10.8	2.4	2.0	7.0	3.1	2.4	6.3	6.0	4.3	2.4	14.8	2.9	3.0	4.0	19.3	3.2	4.6	3.6	3.0	2.4	3.0	27.1	2.7	5.7	4.1	9.1	7.2	4.5	8.6	2.6	3.7	2.4	2.9	8.4	1.7	7.4	2.5	5.3	7.0	4.7	4.9	6.4	4.4	4.8	2.7	3.7	4.2	8.7	5.2	3.4	3.9	3.5	7.3	4.0	8.3	8.7	6.2	7.0	5.8	11.3	6.8	4.1	3.5	3.9	2.8	3.2	2.6	7.4	9.8	4.7	4.0	4.3	7.9	9.8	7.5	11.1	8.0	3.9	6.5	4.5	10.0	6.2	7.4	9.2	10.1	7.7	10.1	6.2	5.9	2.6	7.8	0.3	1.4	0.0	1.8	1.5	2.4	1.8	2.1	2.4	0.9	1.9	1.5	1.7	0.1	1.3	2.1	3.2	2.9	1.6	27.1	32.7	15.0	16.1	15.2	13.1	16.1	23.9	10.8	14.8	19.3	27.1	27.0	3.2	25.4	62.7	25.8	21.4	16.4	12.3	16.5	51.2	31.3	22.5	52.8	12.8	20.6	25.8	171.0	29.4	25.9	16.5	15.6	18.0	5.3	46.5	51.2	25.7	20.4	7.8	157.3	15.7	8.9	20.0	13.7	51.6	5.1	17.7	16.8	15.2	12.9	158.2	153.4	13.3	8.2	17.9	10.7	8.4	28.3	15.4	16.0	76.8	13.0	16.1	14.4	137.2	544.9	22.5	15.3	41.8	24.7	20.8	53.2	26.0	18.8	79.8	13.1	33.9	26.8	21.8	33.5	19.6	39.2	18.9	21.1	52.4	17.3	23.6
TMEM181	"GPR178, KIAA1423"	ENSG00000146433	"Transmembrane protein 181"	Q9P2C4	6	158536436-158635428	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040189	Enhanced		Approved	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 24: Non-specific - Transcription regulation"	Vesicles	"Golgi apparatus"	"HPA040189: AB_10793959"	"unprognostic (1.93e-2)"	"prognostic unfavorable (7.26e-4)"	"unprognostic (9.87e-2)"	"unprognostic (6.51e-2)"	"unprognostic (3.09e-1)"	"unprognostic (1.49e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.07e-1)"	"prognostic unfavorable (1.09e-4)"	"unprognostic (1.14e-1)"	"unprognostic (2.34e-1)"	"unprognostic (4.07e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.93e-1)"	"unprognostic (4.36e-1)"	"unprognostic (3.26e-1)"	14.6	12.4	16.6	12.2	17.0	9.1	18.7	9.7	17.5	27.3	8.3	22.7	24.6	15.2	9.0	13.1	12.7	16.5	10.3	17.6	17.5	7.9	14.9	13.3	9.4	13.3	15.1	10.3	34.3	13.4	11.8	15.0	14.1	20.0	24.8	10.5	52.3	20.9	10.2	16.1	28.5	17.4	12.9	14.3	35.7	21.3	22.3	6.3	21.3	8.7	8.2	20.6	13.4	14.9	22.1	12.6	17.5	27.0	45.1	41.1	33.4	49.1	28.6	25.1	28.4	21.5	26.5	9.3	24.7	41.0	53.5	32.0	26.1	32.4	39.6	13.7	18.7	17.3	18.9	45.6	36.8	21.9	15.8	34.3	31.2	27.9	37.6	37.6	40.7	13.1	33.4	11.3	41.4	13.3	9.7	27.1	13.6	43.8	15.9	9.3	20.1	10.6	23.9	17.1	51.3	35.3	36.0	33.3	24.2	23.9	12.7	30.4	39.1	25.7	17.4	43.1	43.0	6.6	4.9	10.0	31.0	26.8	25.1	5.7	1.1	3.0	2.2	1.1	1.7	0.4	1.2	1.8	0.8	0.4	1.1	1.5	0.7	2.0	1.9	1.0	1.3	0.8	16.6	17.0	9.7	17.5	17.6	17.5	13.3	15.1	14.1	12.9	22.3	14.9	26.7	12.8	33.1	19.9	9.4	20.4	15.6	20.5	17.6	15.6	30.0	18.8	14.2	27.1	23.1	16.5	18.8	8.8	46.0	47.2	3.9	23.3	4.2	16.8	27.7	27.5	44.3	21.5	61.1	32.7	12.5	16.6	49.5	40.5	11.4	36.8	21.0	22.5	10.2	20.2	66.3	35.9	18.3	15.3	16.4	6.7	13.1	14.7	14.2	28.1	13.3	6.0	51.5	43.2	61.7	35.3	25.7	17.7	26.6	37.5	39.4	4.6	25.8	14.6	6.6	12.7	17.8	13.1	22.7	23.6	21.0	5.2	27.0	24.2	30.5	37.1
DYNLT1	TCTEL1	ENSG00000146425	"Dynein light chain Tctex-type 1"	P63172	6	158636474-158644743	"Predicted intracellular proteins"	"Cell cycle, Cell division, Cytoplasmic inwards viral transport, Host-virus interaction, Microtubular inwards viral transport, Mitosis, Neurogenesis, Transport, Virus entry into host cell"	"Motor protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Basal respiratory cells: 946.1;Ionocytes: 830.0;Respiratory ciliated cells: 1335.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046559			Approved	Nucleoplasm		NA	Yes			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Nucleoplasm		"HPA046559: AB_2679698"	"unprognostic (1.80e-3)"	"unprognostic (3.09e-1)"	"unprognostic (3.69e-2)"	"unprognostic (2.22e-3)"	"unprognostic (5.31e-2)"	"unprognostic (7.45e-2)"	"prognostic unfavorable (1.59e-4)"	"unprognostic (5.62e-2)"	"unprognostic (1.83e-1)"	"unprognostic (3.07e-2)"	"unprognostic (1.43e-1)"	"unprognostic (9.58e-2)"	"unprognostic (2.72e-3)"	"unprognostic (2.61e-1)"	"unprognostic (1.74e-1)"	"unprognostic (4.73e-2)"	"unprognostic (2.92e-2)"	80.8	114.4	65.9	71.2	66.6	40.7	114.7	69.4	87.5	109.8	83.8	126.9	109.3	100.5	144.2	155.3	165.3	84.6	131.1	64.7	71.0	171.2	100.6	96.6	62.8	73.1	72.2	79.6	52.8	115.1	72.4	81.1	72.6	101.8	129.6	34.3	99.5	115.1	125.3	52.4	123.2	164.5	70.7	80.7	90.7	129.3	67.6	54.3	119.7	94.9	84.7	127.8	98.8	75.1	188.4	130.6	211.8	208.2	214.3	216.7	87.3	190.6	152.7	229.9	270.2	155.8	165.5	45.1	77.5	398.0	172.7	169.1	134.4	205.6	277.5	64.3	187.2	71.2	115.8	182.7	225.4	33.4	48.1	187.9	217.5	190.0	188.8	198.7	295.1	62.2	139.0	52.4	342.4	166.7	14.9	86.6	116.0	336.5	106.0	29.7	113.9	41.3	323.7	126.9	421.7	211.1	268.1	216.7	83.0	178.8	147.7	73.6	258.9	113.6	143.9	123.2	174.8	31.6	42.2	75.7	161.6	136.9	125.9	158.9	383.6	39.2	106.0	374.8	119.5	76.4	112.7	122.1	192.6	51.7	93.8	96.8	681.1	92.4	290.9	93.4	146.0	254.2	65.9	66.6	69.4	87.5	64.7	71.0	73.1	72.2	72.6	70.7	67.6	75.1	91.4	96.1	96.1	7.5	56.7	54.0	253.2	946.1	62.0	16.9	186.0	206.5	150.7	160.2	610.7	211.5	12.5	227.8	84.5	227.3	416.7	422.0	137.3	710.6	152.7	107.3	172.6	43.7	16.4	274.4	197.9	124.8	86.2	271.7	60.8	137.7	116.4	93.6	155.1	23.5	19.4	238.6	830.0	108.7	67.9	68.4	107.8	126.1	113.8	13.1	201.3	114.1	143.2	16.1	19.3	451.4	317.4	127.9	51.8	291.4	379.8	661.2	1335.9	42.0	138.1	55.2	241.5	452.0	177.7	172.3	61.1	215.1	106.8	187.5	168.6	443.0
SYTL3	"exophilin-6, SLP3"	ENSG00000164674	"Synaptotagmin like 3"	Q4VX76	6	158650014-158764876	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"dendritic cells: 334.2;granulocytes: 135.4;NK-cells: 132.8;Plasma cells: 135.2;T-cells: 230.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	5	"basophil: 232.0"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 232.0"	"Cell line enhanced"	"Detected in many"		"HMC-1: 23.9;U-138 MG: 18.9;U-2 OS: 19.1;U-266/70: 28.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA030584, HPA030585, HPA030586"	Approved		Approved	"Nucleoli fibrillar center,Vesicles"		NA	Yes			"Cluster 38: Basophils - Unknown function"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoli fibrillar center, Vesicles"		"HPA030584: AB_10600196, HPA030585: AB_10601239, HPA030586: AB_10601226"	"unprognostic (3.56e-3)"	"prognostic favorable (8.84e-5)"	"unprognostic (6.37e-2)"	"unprognostic (1.96e-3)"	"unprognostic (3.88e-2)"	"unprognostic (1.42e-1)"	"unprognostic (7.76e-2)"	"unprognostic (5.45e-3)"	"unprognostic (9.33e-3)"	"unprognostic (1.75e-1)"	"unprognostic (3.07e-1)"	"unprognostic (5.63e-2)"	"unprognostic (8.58e-3)"	"unprognostic (1.55e-1)"	"unprognostic (6.28e-2)"	"unprognostic (2.80e-2)"	"unprognostic (1.83e-1)"	5.5	1.8	1.5	7.5	1.7	13.9	4.3	2.2	1.6	6.0	23.9	4.2	3.8	3.5	6.4	4.0	14.4	4.8	7.1	2.3	2.7	5.3	2.5	16.8	8.4	3.8	2.9	2.8	1.5	1.8	2.1	1.6	3.4	5.4	2.4	0.4	15.3	5.8	14.9	3.3	9.9	2.8	2.9	19.8	7.1	3.8	2.9	17.4	25.2	8.2	6.0	5.0	3.6	4.6	7.1	1.0	0.1	0.5	0.9	0.9	0.4	3.1	2.0	0.8	2.1	0.6	5.8	0.1	0.5	5.3	2.6	0.8	0.1	0.9	2.9	15.1	0.4	5.8	0.2	0.0	1.7	1.7	23.9	3.1	2.1	6.1	1.0	2.6	1.4	1.1	0.3	5.6	6.8	0.3	0.1	2.0	0.1	1.3	1.0	0.0	5.6	0.7	2.8	0.4	15.6	1.2	1.0	9.7	0.8	0.3	2.0	0.3	8.8	18.9	19.1	0.5	0.6	28.5	7.1	0.6	12.0	8.3	0.6	232.0	16.0	0.8	37.3	3.3	22.0	1.0	14.7	25.3	4.6	0.3	15.7	19.3	35.5	43.1	1.4	1.3	16.4	18.9	1.5	1.7	2.2	1.6	2.3	2.7	3.8	2.9	3.4	2.9	2.9	4.6	2.8	16.0	13.1	2.3	23.5	4.6	2.9	4.4	1.8	0.2	4.4	3.7	4.1	1.5	15.9	14.7	2.1	1.3	334.2	1.0	5.9	0.8	10.8	51.0	3.0	4.2	0.0	4.4	3.4	0.6	0.5	4.8	17.3	37.4	135.4	0.4	3.9	1.9	4.2	0.0	4.8	1.8	4.1	11.5	20.3	18.1	0.0	26.6	10.6	28.1	17.6	0.1	132.8	2.0	2.5	0.6	0.1	0.7	135.2	1.8	2.0	1.9	51.5	0.5	0.0	2.3	2.4	2.1	8.4	2.6	4.4	1.9	230.2	0.9	1.3	3.1
EZR	VIL2	ENSG00000092820	Ezrin	P15311	6	158765741-158819368	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Cell shape"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004035, HPA021616, CAB047324, CAB075739"	Enhanced		Enhanced	"Plasma membrane"		NA	NA		42000000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	"Plasma membrane"		"CAB004035: AB_2100309, CAB047324: , CAB075739: AB_2665745, HPA021616: AB_1848342"	"unprognostic (4.79e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.97e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.31e-3)"	"unprognostic (1.76e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.32e-1)"	"unprognostic (7.53e-2)"	"prognostic unfavorable (1.70e-4)"	"unprognostic (5.59e-2)"	"prognostic favorable (9.56e-8)"	"unprognostic (1.16e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.34e-2)"	"unprognostic (9.00e-2)"	88.2	186.6	100.7	98.4	99.5	135.2	59.8	86.0	96.8	77.1	224.4	133.5	158.8	35.6	78.4	260.3	114.6	116.1	116.3	96.2	95.6	159.1	57.9	173.2	185.6	97.6	105.3	44.7	112.6	447.4	42.8	233.0	91.7	81.4	103.6	10.7	89.9	72.2	46.9	187.8	257.1	36.6	99.3	75.6	273.7	55.9	98.9	108.8	126.1	25.5	216.3	219.0	98.6	91.1	668.3	355.4	86.5	125.0	9.3	10.3	502.7	204.7	67.1	225.7	189.2	420.9	357.7	667.1	197.2	235.2	108.5	497.7	172.2	228.0	259.5	235.3	111.2	14.0	204.9	187.5	223.2	167.7	98.9	16.6	172.9	212.9	205.1	191.4	150.2	90.8	134.9	316.7	132.3	175.9	239.3	199.6	144.5	180.6	117.6	176.9	40.7	152.5	462.1	198.6	156.3	127.2	358.5	507.7	37.9	391.5	124.1	218.5	195.3	72.6	233.4	101.1	319.9	216.5	212.8	566.9	45.4	84.9	88.5	177.2	83.4	103.7	195.9	190.8	233.2	466.5	205.6	245.1	181.9	389.7	108.6	146.3	36.2	133.6	202.9	84.5	385.7	298.2	100.7	99.5	86.0	96.8	96.2	95.6	97.6	105.3	91.7	99.3	98.9	91.1	47.4	951.9	547.8	111.3	799.6	614.7	809.5	202.4	247.0	11.2	240.4	144.4	311.0	154.4	726.2	156.3	0.0	406.1	372.4	806.8	97.8	302.3	10.2	782.9	75.4	71.0	159.9	46.5	0.4	256.1	560.3	213.1	500.5	844.5	119.0	40.8	25.4	37.5	113.3	0.0	0.5	415.3	179.0	79.1	820.5	32.8	135.5	297.5	321.9	12.2	110.5	35.7	62.8	2.0	0.7	618.3	631.2	294.2	564.9	416.7	694.2	238.1	1248.4	5.1	249.8	205.5	136.3	52.5	61.7	430.4	726.5	1243.4	483.8	102.3	312.9	1142.8
RSPH3	"dJ111C20.1, RSHL2, RSP3"	ENSG00000130363	"Radial spoke head 3"		6	158972871-159000202	"Human disease related genes, Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 149.3;Respiratory ciliated cells: 120.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 10.5"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039109	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 18: U-2197 - ECM organization"	"Cluster 49: Ciliated cells - Cilium organization"	"Plasma membrane"	Cytosol	"HPA039109: AB_10794423"	"unprognostic (6.18e-3)"	"unprognostic (3.62e-3)"	"unprognostic (4.54e-2)"	"unprognostic (6.20e-2)"	"unprognostic (1.88e-1)"	"unprognostic (9.18e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.15e-1)"	"unprognostic (6.74e-3)"	"unprognostic (6.98e-2)"	"unprognostic (2.52e-1)"	"prognostic favorable (2.19e-4)"	"unprognostic (5.89e-2)"	"unprognostic (1.67e-1)"	"unprognostic (5.14e-2)"	"unprognostic (1.79e-2)"	2.9	4.7	0.8	2.2	1.0	1.6	3.7	0.2	4.7	3.9	14.5	4.2	5.9	3.4	4.6	5.7	6.1	3.3	3.8	2.0	1.0	6.3	2.7	4.6	1.4	1.9	2.6	3.4	4.3	13.2	3.5	3.1	1.5	5.2	3.7	6.7	4.4	4.1	1.5	3.8	5.6	3.7	1.6	2.3	4.1	9.9	1.1	1.8	7.6	2.2	2.0	2.9	3.0	1.6	8.5	3.7	2.1	4.9	4.8	6.3	2.2	6.2	7.0	1.9	2.8	1.2	4.6	1.7	4.8	7.2	6.3	6.1	1.4	5.6	2.8	4.4	2.9	2.2	3.9	2.6	4.6	2.4	1.6	7.1	9.5	3.8	6.9	10.0	2.5	2.5	2.8	2.6	4.5	4.3	1.5	2.7	1.2	3.8	2.7	2.2	0.3	1.6	8.6	2.6	2.8	4.0	11.6	3.8	2.2	2.4	4.7	5.3	5.4	2.0	5.5	4.8	3.0	2.9	6.1	1.2	10.1	2.9	3.9	0.9	4.0	0.6	0.6	3.0	1.2	0.9	0.9	1.2	4.0	2.4	0.7	1.1	10.5	1.7	7.0	4.6	1.3	1.5	0.8	1.0	0.2	4.7	2.0	1.0	1.9	2.6	1.5	1.6	1.1	1.6	2.3	25.6	17.9	15.0	4.0	7.4	17.2	19.1	6.2	14.2	12.2	7.6	17.5	17.2	25.1	22.0	35.5	10.3	5.7	25.6	13.7	15.8	149.3	67.0	6.9	6.0	13.1	2.1	32.8	10.2	11.4	7.6	10.2	12.7	2.5	9.2	7.9	8.4	10.1	3.3	18.5	17.6	16.2	9.5	16.5	62.9	14.0	12.6	7.2	4.7	8.3	14.4	4.1	6.0	3.5	13.1	21.1	17.7	5.7	18.4	33.1	19.7	120.4	32.5	6.6	5.9	10.2	57.3	10.9	18.6	8.8	5.9	6.1	12.2	13.1	23.1
TAGAP	"ARHGAP47, FLJ32631, IDDM21"	ENSG00000164691	"T cell activation RhoGTPase activating protein"	Q8N103	6	159034468-159045152	"Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 146.6;lymphoid tissue: 47.6"	"Cell type enhanced"	"Detected in many"		"B-cells: 249.5;dendritic cells: 152.3;Macrophages: 91.1;NK-cells: 86.5;Plasma cells: 272.1;T-cells: 223.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 30.1;HMC-1: 42.5;Karpas-707: 43.8;U-266/84: 20.6;U-698: 39.6;U-937: 33.4"					"Low region specificity"	"Detected in all"			"HPA031000, HPA039982"	Uncertain		Approved	Cytosol		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 59: Non-specific - Transcription"	Cytosol		"HPA031000: AB_10610560, HPA039982: "	"unprognostic (9.86e-3)"	"unprognostic (7.55e-2)"	"unprognostic (2.41e-2)"	"unprognostic (1.56e-2)"	"unprognostic (6.36e-2)"	"unprognostic (3.10e-3)"	"unprognostic (1.04e-1)"	"unprognostic (5.25e-2)"	"unprognostic (3.35e-3)"	"unprognostic (8.39e-2)"	"unprognostic (6.19e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.49e-1)"	"unprognostic (7.25e-2)"	"unprognostic (1.15e-1)"	"unprognostic (5.24e-2)"	"unprognostic (7.39e-2)"	5.0	2.8	1.0	28.9	1.1	146.6	3.9	1.3	2.1	3.4	3.0	5.9	4.4	9.5	2.3	4.1	2.0	6.9	1.6	1.2	3.4	1.3	4.1	8.4	39.6	2.7	2.0	2.2	0.9	0.7	0.8	3.4	2.1	2.8	8.2	1.5	3.0	1.8	0.7	1.2	10.2	26.0	2.2	22.8	7.2	1.6	2.2	24.3	1.6	2.3	47.6	10.0	1.2	4.2	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	30.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.2	6.2	0.0	0.0	0.0	15.6	42.5	0.3	0.0	0.0	0.0	0.0	0.0	9.0	0.1	43.8	0.0	0.0	4.0	8.2	12.0	0.0	0.0	1.4	0.0	1.4	0.0	0.0	0.3	0.2	0.0	0.1	0.1	1.2	0.0	6.9	0.2	0.0	0.0	0.0	0.0	4.7	20.6	39.6	0.0	33.4	0.0	163.6	27.8	88.4	54.8	20.4	62.6	45.9	73.9	64.6	27.9	46.6	56.9	40.8	169.7	45.6	27.6	9.3	57.5	60.9	1.0	1.1	1.3	2.1	1.2	3.4	2.7	2.0	2.1	2.2	2.2	4.2	5.2	3.2	6.6	0.0	249.5	2.8	0.3	0.2	3.4	0.3	4.4	6.0	0.6	0.0	1.4	0.0	0.0	0.7	152.3	0.2	0.0	0.1	0.3	0.5	0.4	5.2	0.0	8.8	1.2	0.0	0.6	4.3	16.8	0.5	19.0	1.8	1.4	0.8	24.9	0.0	1.0	0.0	0.0	21.9	60.2	1.1	1.2	91.1	28.4	20.6	21.5	0.4	86.5	1.5	0.0	0.0	0.0	22.6	272.1	0.3	0.0	0.3	1.2	0.2	0.0	0.8	2.0	0.1	0.1	2.0	2.7	0.8	223.6	4.6	0.4	0.3
FNDC1	"bA243O10.1, dJ322A24.1, FNDC2, KIAA1866"	ENSG00000164694	"Fibronectin type III domain containing 1"	Q4ZHG4	6	159169400-159272108	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 14.2;thyroid gland: 20.3"	"Group enriched"	"Detected in some"	4	"Fibroblasts: 28.7;Smooth muscle cells: 11.5"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 32.5"	"Group enriched"	"Detected in many"	6	"cerebral cortex: 5.4;hippocampal formation: 8.7"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 1.0;fHDF/TERT166: 2.9;SuSa: 3.1"	"Region enhanced"	"Detected in many"		"olfactory bulb: 7.0"	"Region enhanced"	"Detected in many"		"spinal cord: 10.3"	"HPA030962, HPA030963"	Approved		Approved	"Nuclear speckles"	"Secreted to extracellular matrix"	NA	NA		14000		"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 12: NES - Nervous system development"	"Cluster 50: Fibroblasts - ECM organization"	"Nuclear speckles"		"HPA030962: AB_10696212, HPA030963: AB_2673676"	"unprognostic (4.59e-2)"	"unprognostic (9.17e-3)"	"unprognostic (7.62e-2)"	"prognostic favorable (6.10e-5)"	"unprognostic (4.57e-1)"	"unprognostic (2.11e-1)"	"unprognostic (5.52e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.18e-2)"	"unprognostic (1.74e-1)"	"prognostic unfavorable (1.93e-6)"	"unprognostic (6.49e-3)"	"unprognostic (1.12e-1)"	"unprognostic (3.10e-1)"	"unprognostic (1.76e-3)"	5.4	0.5	0.5	1.9	0.3	0.0	2.1	0.1	5.4	6.5	0.2	12.9	2.5	2.2	0.0	1.1	0.6	14.2	3.9	8.7	0.3	0.6	0.7	1.6	2.8	0.1	1.0	1.2	1.1	0.3	0.2	0.9	0.0	0.4	1.8	0.1	0.9	0.8	2.1	0.9	4.2	11.7	0.3	0.5	0.4	0.4	0.4	0.1	20.3	9.6	2.4	1.0	1.6	1.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	1.0	2.9	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.0	3.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.3	0.1	5.4	8.7	0.3	0.1	1.0	0.0	0.3	0.4	1.2	2.6	0.0	0.6	0.0	0.0	3.2	0.0	0.0	0.0	0.3	0.1	0.5	2.1	0.0	0.6	0.0	0.0	0.1	0.0	0.0	1.9	0.0	0.3	0.4	4.7	0.7	0.0	0.0	0.2	0.0	0.2	28.7	0.0	0.3	0.0	0.1	1.4	0.0	0.2	0.0	1.7	0.0	0.0	0.0	3.1	0.0	0.3	0.2	1.8	2.8	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	3.0	11.5	1.1	1.4	0.0	1.4	0.1	0.5	0.1	0.0	0.0
SOD2	GClnc1	ENSG00000112096	"Superoxide dismutase 2"	P04179	6	159669069-159762529	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins"		Oxidoreductase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"bone marrow: 1083.7;skeletal muscle: 3230.1"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 2508.2;Prostatic glandular cells: 3524.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	10	"neutrophil: 4470.5"	"Lineage enriched"	"Detected in all"	10	"granulocytes: 4470.5"	"Cell line enhanced"	"Detected in all"		"BJ hTERT+: 1611.9;GAMG: 614.3;HSkMC: 688.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001814, CAB002013"	Supported		Enhanced	Mitochondria		NA	NA		55000000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 59: Non-specific - Translation"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 41: Macrophages - Immune response"	Mitochondria		"CAB002013: , HPA001814: AB_1080134"	"unprognostic (2.47e-2)"	"unprognostic (2.77e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.49e-1)"	"unprognostic (3.10e-2)"	"unprognostic (1.37e-1)"	"unprognostic (6.67e-2)"	"unprognostic (2.76e-2)"	"unprognostic (7.14e-2)"	"prognostic unfavorable (1.72e-4)"	"unprognostic (8.12e-2)"	"unprognostic (4.14e-2)"	"unprognostic (5.99e-2)"	"unprognostic (1.82e-1)"	324.8	245.9	66.8	522.8	43.2	1083.7	169.0	37.8	125.8	92.6	99.7	126.4	60.5	105.4	7.2	136.5	118.5	121.8	178.5	37.0	101.0	252.4	459.8	266.5	64.8	250.0	96.1	55.8	212.3	69.1	42.7	62.9	192.9	130.8	37.9	25.1	328.8	43.9	3230.1	90.0	83.7	108.4	62.5	81.4	120.4	39.6	153.1	38.2	67.2	312.6	65.0	514.9	97.9	85.4	35.8	46.3	37.3	85.1	229.0	378.7	20.5	52.7	1611.9	57.7	131.1	91.3	19.4	70.7	144.5	54.1	614.3	58.9	39.1	42.5	42.4	71.2	87.2	74.5	71.8	152.3	169.5	74.0	31.9	688.9	68.5	180.9	133.6	40.7	30.0	44.9	106.7	82.2	55.4	37.6	60.3	46.6	63.3	41.5	55.4	79.6	50.3	63.9	106.2	56.6	71.5	29.5	105.1	52.4	21.4	14.1	33.1	33.7	30.4	168.6	62.1	92.5	87.9	37.8	100.2	86.5	186.7	57.4	23.6	146.3	364.4	181.1	38.8	273.9	43.4	43.4	54.9	38.5	105.2	38.3	45.0	36.9	4470.5	19.1	445.3	14.8	87.9	340.0	66.8	43.2	37.8	125.8	37.0	101.0	250.0	96.1	192.9	62.5	153.1	85.4	303.2	201.9	746.1	13.4	99.0	684.7	1144.9	2508.2	114.4	45.6	150.2	96.6	0.0	287.4	613.3	237.3	45.9	18.3	43.8	153.9	86.1	1400.2	318.2	281.7	649.8	593.0	79.6	101.2	31.1	1389.7	51.2	1098.4	103.5	1080.1	112.3	23.1	58.9	395.0	292.0	32.0	30.1	92.7	339.7	333.3	1425.8	111.5	58.1	1031.2	521.2	15.9	339.9	50.4	35.0	8.5	12.2	581.6	111.3	65.1	101.2	3524.0	128.6	530.1	269.6	61.8	39.5	1164.0	407.3	91.7	51.4	258.7	681.8	27.2	119.4	38.3	148.1	1195.7
WTAP	"KIAA0105, MGC3925, Mum2"	ENSG00000146457	"WT1 associated protein"	Q15007	6	159725585-159756319	"Predicted intracellular proteins"	"Cell cycle, mRNA processing, mRNA splicing"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Langerhans cells: 560.1;Suprabasal keratinocytes: 455.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010550	Supported		Enhanced	"Nuclear speckles"		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 48: Smooth muscle cells - ECM organization"	"Nuclear speckles"		"HPA010550: AB_1858866"	"unprognostic (9.57e-2)"	"unprognostic (1.58e-2)"	"unprognostic (5.10e-2)"	"unprognostic (2.32e-1)"	"unprognostic (7.19e-2)"	"unprognostic (1.62e-1)"	"prognostic unfavorable (6.57e-6)"	"unprognostic (8.65e-2)"	"unprognostic (3.75e-1)"	"prognostic unfavorable (7.51e-4)"	"unprognostic (7.72e-2)"	"unprognostic (4.92e-2)"	"prognostic unfavorable (3.01e-5)"	"unprognostic (7.92e-2)"	"unprognostic (2.62e-1)"	"unprognostic (4.00e-2)"	"unprognostic (1.32e-2)"	86.2	63.7	35.3	62.3	35.7	245.1	74.9	40.0	41.3	71.7	41.3	54.6	34.9	64.7	65.1	65.0	64.2	52.2	54.3	35.0	42.5	54.8	50.7	68.6	77.5	38.2	38.3	70.5	63.3	53.2	49.8	61.8	39.4	65.1	55.2	35.6	62.0	44.6	179.7	72.5	61.6	51.5	36.9	67.0	58.5	34.9	40.1	89.7	57.4	67.4	80.7	102.6	65.1	41.2	55.5	51.1	115.8	100.2	136.5	147.7	67.1	86.2	299.4	108.7	145.4	95.7	49.0	126.8	50.8	92.6	238.4	70.4	112.2	94.3	138.1	70.0	71.9	135.0	46.7	144.2	108.4	116.1	75.4	172.0	94.7	120.0	155.0	82.6	81.6	130.7	149.1	114.2	116.0	53.5	170.5	165.0	91.9	88.6	44.2	107.4	74.3	94.4	114.0	62.6	104.5	74.5	158.2	83.5	45.7	77.5	41.3	152.6	72.6	70.0	81.4	100.1	125.0	83.9	109.6	206.5	67.8	120.9	76.8	46.6	24.5	31.0	28.1	31.7	31.7	33.1	33.9	34.3	29.1	27.5	29.9	31.4	42.9	32.1	38.3	24.3	40.2	20.2	35.3	35.7	40.0	41.3	35.0	42.5	38.2	38.3	39.4	36.9	40.1	41.2	131.1	35.3	57.3	31.3	138.1	419.0	198.0	52.9	113.8	30.0	144.2	123.6	58.1	74.4	39.9	60.7	35.5	107.3	138.5	61.2	86.1	128.1	47.1	86.4	125.5	118.8	61.6	59.3	41.5	81.4	126.7	226.9	97.9	171.9	40.0	56.7	58.2	90.5	75.4	37.0	36.6	65.7	24.4	99.7	560.1	50.7	65.3	168.6	243.7	33.7	113.7	49.7	88.6	44.7	57.0	75.8	59.7	50.8	111.5	307.5	49.6	106.5	35.3	36.2	72.3	222.2	124.5	93.8	73.9	113.0	455.3	149.3	138.6	54.7	74.0	150.9
ACAT2		ENSG00000120437	"Acetyl-CoA acetyltransferase 2"	Q9BWD1	6	159762045-159779112	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"liver: 231.3"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 262.1;Early spermatids: 187.0;Exocrine glandular cells: 176.6;Hepatocytes: 214.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB021106, HPA025736, HPA025765, HPA025811"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA		14000000	"Cluster 44: Non-specific - Transcription"	"Cluster 85: Liver - Metabolism"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Cytosol	Nucleoplasm	"CAB021106: AB_10058215, HPA025736: AB_1844487, HPA025765: AB_1844485, HPA025811: AB_1844488"	"unprognostic (3.31e-1)"	"unprognostic (2.44e-2)"	"prognostic favorable (1.12e-4)"	"prognostic unfavorable (7.25e-4)"	"unprognostic (1.38e-1)"	"unprognostic (2.03e-1)"	"unprognostic (9.25e-2)"	"unprognostic (4.76e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.59e-1)"	"prognostic unfavorable (7.38e-4)"	"unprognostic (1.39e-1)"	"unprognostic (1.50e-2)"	"unprognostic (8.56e-2)"	"unprognostic (2.54e-2)"	10.9	21.6	22.2	18.5	24.4	22.4	23.6	30.2	30.0	12.8	20.1	38.5	31.2	10.9	40.0	32.6	11.4	10.6	9.4	22.7	27.6	27.0	231.3	20.2	25.0	39.4	26.3	17.3	9.4	12.5	3.2	11.8	39.1	35.6	33.8	19.5	15.5	9.3	4.9	18.1	17.9	15.8	24.8	9.7	19.5	28.6	24.4	39.4	9.0	7.1	36.7	13.7	9.1	28.1	70.1	58.8	451.9	160.8	57.2	111.6	14.4	57.4	70.5	141.8	244.5	234.0	87.1	55.9	29.0	48.7	458.2	64.5	174.8	465.8	166.7	35.2	174.4	127.4	97.2	418.8	62.0	81.4	35.8	62.2	40.1	231.1	92.9	21.4	68.8	160.1	139.9	104.3	85.5	113.0	137.0	154.0	142.8	65.5	41.7	83.9	94.4	173.1	377.2	93.7	107.8	63.2	67.5	43.3	26.2	18.5	83.4	157.3	39.2	50.3	45.7	72.1	154.0	47.7	89.0	142.0	15.7	151.2	77.1	30.1	24.9	46.7	47.9	33.9	47.3	46.6	54.1	47.8	34.7	51.4	53.3	43.2	11.0	41.3	23.6	30.4	79.0	46.2	22.2	24.4	30.2	30.0	22.7	27.6	39.4	26.3	39.1	24.8	24.4	28.1	11.8	12.8	45.4	15.3	25.8	26.1	32.4	262.1	22.2	19.4	33.4	24.5	1.2	42.9	115.5	20.2	2.1	53.7	28.6	34.7	70.5	78.8	187.0	14.3	9.9	18.8	17.2	38.5	14.3	176.6	97.0	21.6	9.7	25.9	13.3	47.7	16.1	214.8	58.1	13.5	14.7	23.6	83.4	14.8	29.8	128.8	13.7	25.7	30.2	1.0	58.9	22.5	30.9	13.0	17.5	65.6	28.8	19.2	25.5	38.7	15.4	50.0	30.1	24.7	0.0	25.1	44.9	28.5	45.6	43.0	21.0	35.2	31.0	102.5	33.0	38.9
TCP1	"CCT1, Ccta, D6S230E"	ENSG00000120438	"T-complex 1"	P17987	6	159778498-159789703	"Plasma proteins, Predicted intracellular proteins"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 586.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017460, HPA027337, HPA031082"	Approved					NA	NA		2300000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"			"CAB017460: AB_10618875, HPA027337: AB_10600774, HPA031082: AB_10600990"	"prognostic unfavorable (8.88e-5)"	"unprognostic (1.34e-2)"	"unprognostic (1.64e-3)"	"unprognostic (2.67e-2)"	"unprognostic (5.50e-2)"	"unprognostic (1.39e-3)"	"prognostic unfavorable (1.49e-5)"	"unprognostic (1.54e-2)"	"unprognostic (2.44e-1)"	"unprognostic (2.64e-2)"	"unprognostic (9.34e-2)"	"unprognostic (5.17e-2)"	"unprognostic (2.10e-3)"	"unprognostic (1.81e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.54e-1)"	114.1	92.9	110.5	90.8	117.0	181.5	106.0	119.2	179.4	88.3	118.1	103.6	71.7	97.8	84.9	103.8	93.2	69.2	114.8	117.4	120.5	105.8	98.0	89.5	105.7	117.3	118.1	122.8	96.0	98.2	57.0	83.5	120.9	81.0	108.1	76.8	92.2	72.6	171.8	101.3	84.7	99.7	122.2	82.2	92.3	174.0	118.0	98.2	77.1	125.4	128.3	101.9	84.8	141.4	236.3	284.1	296.9	405.2	260.5	209.0	456.5	344.6	170.4	423.3	320.9	571.4	170.9	579.5	233.4	275.2	494.7	339.0	793.5	350.2	601.5	301.8	380.6	606.7	292.7	545.9	199.1	496.7	308.9	204.3	215.0	417.5	392.0	241.8	381.7	498.8	856.1	262.8	399.4	201.5	620.2	590.4	321.6	305.0	310.3	447.8	219.7	474.7	345.1	170.7	365.8	237.7	323.3	452.3	161.3	386.2	212.6	464.2	264.0	203.9	310.0	467.0	717.6	238.5	531.7	638.4	293.8	571.8	329.1	92.0	73.8	93.6	84.3	99.1	110.1	95.8	92.6	91.7	90.4	74.2	94.4	92.4	34.4	101.1	131.5	55.4	105.0	114.2	110.5	117.0	119.2	179.4	117.4	120.5	117.3	118.1	120.9	122.2	118.0	141.4	122.4	51.3	38.8	12.4	95.4	171.7	304.4	153.2	75.7	39.1	95.2	75.2	68.2	81.5	108.6	27.6	29.2	161.7	80.7	93.8	115.4	191.9	427.4	113.4	140.1	106.4	104.4	119.5	22.8	134.6	288.7	98.6	64.2	122.2	104.6	109.8	51.0	43.8	118.7	30.3	24.3	84.6	120.1	65.7	134.4	586.4	86.0	91.5	108.5	22.5	99.9	73.3	77.2	18.1	25.3	151.1	75.7	92.2	93.0	235.2	84.0	152.3	127.1	53.1	72.3	111.9	247.2	307.3	237.1	93.4	148.0	240.4	116.6	100.6	133.8	249.3
MRPL18	HSPC071	ENSG00000112110	"Mitochondrial ribosomal protein L18"	Q9H0U6	6	159789812-159798436	"Predicted intracellular proteins, Ribosomal proteins"	Transport	"Chaperone, Ribonucleoprotein, Ribosomal protein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028774, HPA028775"	Enhanced					NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 22: Epithelial cell types - Mixed function"			"HPA028774: AB_10600113, HPA028775: AB_10601440"	"unprognostic (4.73e-3)"	"unprognostic (9.67e-2)"	"unprognostic (5.90e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.34e-3)"	"prognostic unfavorable (3.61e-4)"	"unprognostic (3.44e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.56e-1)"	"unprognostic (7.91e-2)"	"prognostic unfavorable (9.02e-5)"	"unprognostic (3.51e-1)"	"unprognostic (7.14e-2)"	"unprognostic (1.35e-2)"	"unprognostic (5.22e-2)"	45.1	55.8	75.0	42.0	77.6	45.8	39.0	78.6	122.5	41.1	76.3	55.6	43.0	45.8	51.3	52.0	53.7	35.9	64.6	76.1	77.4	55.1	65.2	36.8	54.8	76.6	75.0	42.9	40.6	43.6	38.4	41.2	76.8	42.4	46.5	28.1	44.5	43.9	77.4	40.9	38.8	48.7	77.4	35.0	45.0	30.2	77.0	50.3	34.9	74.1	48.6	50.1	42.8	82.3	77.5	148.5	55.1	140.1	78.4	86.7	109.7	105.6	89.7	124.1	128.8	172.4	68.5	118.1	88.5	88.8	185.9	107.4	205.1	129.9	118.4	81.4	166.7	117.9	119.8	303.1	87.6	117.6	100.4	67.9	113.0	132.5	97.1	80.0	110.3	121.4	172.4	120.2	115.1	119.5	155.4	256.2	77.2	149.2	143.6	106.6	54.6	196.1	140.3	49.6	92.2	59.1	102.6	165.9	65.7	56.0	102.3	283.7	70.5	93.8	106.0	159.8	212.8	98.5	196.7	139.8	142.7	245.1	116.6	130.6	116.3	108.9	92.6	152.9	107.6	154.3	118.2	103.9	134.4	132.2	131.4	117.6	23.2	110.8	175.9	167.9	137.5	193.0	75.0	77.6	78.6	122.5	76.1	77.4	76.6	75.0	76.8	77.4	77.0	82.3	93.8	51.3	30.5	9.1	62.2	127.3	271.8	170.1	63.2	29.8	98.3	127.6	61.4	108.7	98.6	53.3	16.7	103.8	66.1	94.9	211.3	125.4	226.8	95.9	74.2	73.6	143.5	49.2	11.8	110.9	194.2	77.5	44.9	74.0	93.4	56.0	41.4	86.7	126.8	23.5	12.7	131.5	124.1	48.9	170.4	58.8	90.4	106.1	106.7	11.2	81.7	92.1	75.2	8.5	15.6	126.7	116.2	83.1	54.5	210.4	75.6	192.5	120.4	42.4	85.5	51.1	106.3	258.2	125.8	72.8	119.2	74.8	90.1	108.9	138.7	172.6
PNLDC1	"dJ195P10.2, FLJ40240"	ENSG00000146453	"PARN like, ribonuclease domain containing 1"	Q8NA58	6	159800249-159820704	"Enzymes, Predicted membrane proteins"	"Nonsense-mediated mRNA decay"	"Exonuclease, Hydrolase, Nuclease, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 10.2;testis: 8.1"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 19.9;Late spermatids: 13.6;Spermatocytes: 14.3;Spermatogonia: 13.3"	"Cancer enhanced"	"Detected in many"		"testis cancer: 4.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA052026	Uncertain					NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 78: Testis - Spermatogenesis"		"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"			"HPA052026: AB_2681699"	"unprognostic (1.58e-1)"	"unprognostic (3.88e-2)"	"unprognostic (1.01e-2)"	"unprognostic (2.39e-3)"	"unprognostic (8.47e-3)"	"unprognostic (3.55e-2)"	"unprognostic (2.04e-1)"	"unprognostic (4.24e-1)"	"unprognostic (1.01e-1)"	"unprognostic (5.37e-2)"	"unprognostic (4.19e-1)"	"unprognostic (9.98e-2)"	"unprognostic (2.69e-9)"	"unprognostic (1.14e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.69e-1)"	"unprognostic (2.24e-1)"	0.2	0.2	2.1	0.1	3.7	0.1	0.5	2.5	10.2	0.1	1.6	0.3	0.0	0.1	0.0	0.2	1.9	0.0	0.2	2.2	2.0	0.2	0.5	0.2	0.4	1.9	1.9	0.4	1.7	0.0	0.3	0.0	3.0	0.3	0.0	0.1	0.1	0.0	0.1	1.1	0.1	0.0	1.8	0.4	0.2	8.1	2.3	0.2	0.2	0.0	0.2	0.2	0.2	2.7	0.0	0.1	0.0	0.4	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.2	0.0	0.2	0.0	0.2	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	2.1	3.7	2.5	10.2	2.2	2.0	1.9	1.9	3.0	1.8	2.3	2.7	0.1	0.0	0.0	0.3	0.2	0.3	0.0	0.3	0.0	0.0	0.3	0.5	0.3	4.3	0.2	0.0	0.0	0.0	0.1	0.1	0.0	3.8	19.9	2.1	0.1	0.1	0.0	0.0	1.5	0.9	0.0	0.2	0.0	0.1	4.5	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.8	13.6	0.3	0.1	0.0	3.7	0.0	0.0	0.0	0.5	1.3	1.3	0.0	0.0	0.0	0.1	0.0	0.9	2.7	0.0	0.0	0.5	0.2	14.3	13.3	0.0	0.0	0.0	0.1	0.0	0.0	0.2
MAS1		ENSG00000130368	"MAS1 proto-oncogene, G protein-coupled receptor"	P04201	6	159890988-159917447	"Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	Proto-oncogene	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	15	"brain: 9.8"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 3.2;B-cells: 2.0;Cone photoreceptor cells: 2.1;Rod photoreceptor cells: 2.1;Urothelial cells: 1.9"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"cerebral cortex: 5.1;hippocampal formation: 9.8"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	8	"HMC-1: 7.5"	"Group enriched"	"Detected in many"	22	"amygdala: 38.5;basal ganglia: 26.6;cerebral cortex: 32.4;hippocampal formation: 64.6;white matter: 18.1"	"Group enriched"	"Detected in some"	4	"amygdala: 5.2;cerebral cortex: 8.0;hippocampal formation: 15.1"	HPA079325	Uncertain					NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 50: Fibroblasts - ECM organization"			"HPA079325: "	"unprognostic (3.31e-1)"	"unprognostic (2.25e-3)"		"unprognostic (2.91e-1)"	"unprognostic (2.22e-3)"	"unprognostic (8.15e-3)"		"unprognostic (7.05e-2)"		"unprognostic (1.88e-1)"	"unprognostic (5.53e-2)"	"unprognostic (6.52e-2)"	"unprognostic (1.48e-5)"	"unprognostic (1.69e-1)"	"unprognostic (7.67e-2)"	"unprognostic (6.28e-1)"		0.0	0.0	1.7	0.0	0.7	0.3	0.0	0.0	5.1	0.6	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	9.8	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.7	0.7	0.0	5.1	9.8	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	3.2	0.6	0.0	2.0	0.0	1.4	0.0	0.0	1.2	0.1	0.3	0.8	0.0	0.6	0.0	2.1	0.2	0.2	0.0	0.0	0.0	0.1	0.4	0.3	0.8	0.0	0.0	0.1	0.0	0.3	0.7	0.0	0.3	0.0	0.4	1.1	0.4	0.2	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.9	0.7	0.0	0.0	0.5	0.7	1.0	0.0	0.0	0.1	0.0	0.7	0.0	1.4	0.0	0.3	0.0	2.1	0.0	1.3	1.0	0.4	0.5	0.0	0.0	0.3	0.5	0.2	0.2	1.9
IGF2R	"CD222, CI-M6PR, CI-MPR, CIMPR, M6P-R, MPR1, MPR300, MPRI"	ENSG00000197081	"Insulin like growth factor 2 receptor"	P11717	6	159969082-160113507	"Cancer-related genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport	Receptor	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 69.5"	"Cell type enhanced"	"Detected in many"		"NK-cells: 264.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 4.4"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009661, HPA011332"	Supported		Enhanced	"Golgi apparatus,Vesicles"		NA	NA		190000000	"Cluster 49: Eosinophils - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 65: Plasmacytoid DCs - Unknown function"	"Golgi apparatus, Vesicles"		"CAB009661: AB_2122795, HPA011332: AB_1846276"	"prognostic unfavorable (3.01e-4)"	"prognostic unfavorable (2.92e-5)"	"unprognostic (5.83e-2)"	"unprognostic (1.72e-1)"	"unprognostic (4.15e-1)"	"unprognostic (3.25e-1)"	"unprognostic (7.32e-3)"	"unprognostic (2.32e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.07e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.45e-1)"	"unprognostic (5.74e-3)"	"unprognostic (1.16e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.85e-1)"	"prognostic unfavorable (6.08e-4)"	20.3	21.9	1.8	11.4	3.7	13.3	16.0	3.9	4.3	15.2	11.7	17.4	7.4	19.3	4.8	16.7	13.9	10.7	21.8	3.2	4.2	14.8	23.9	22.2	8.2	4.3	3.6	17.0	16.6	14.3	9.5	15.3	3.8	11.0	11.6	3.2	18.4	6.7	69.5	16.5	14.7	16.0	3.2	23.2	15.5	7.7	4.8	15.9	14.5	27.2	7.8	15.3	16.5	5.9	20.8	18.1	32.6	44.6	108.4	76.4	36.9	30.1	80.4	30.3	52.8	28.3	37.2	7.3	30.9	38.4	101.7	25.4	27.0	140.0	52.0	47.7	19.4	3.6	30.0	32.1	49.2	20.7	31.2	52.7	45.4	57.6	144.8	65.4	19.2	36.0	42.2	48.2	46.4	10.1	8.8	13.4	13.1	19.3	23.2	23.2	20.6	46.1	29.9	20.8	11.3	25.4	45.0	34.5	44.8	41.4	15.7	49.4	25.3	27.0	27.9	57.3	60.4	16.7	40.2	9.1	49.0	23.7	38.9	0.5	1.0	0.8	1.1	0.3	0.4	0.2	0.5	0.4	0.2	0.2	0.5	0.7	4.4	0.7	0.4	1.3	0.2	0.3	1.8	3.7	3.9	4.3	3.2	4.2	4.3	3.6	3.8	3.2	4.8	5.9	44.7	48.1	47.3	34.6	16.7	22.2	10.0	16.0	17.1	13.0	20.2	14.7	33.6	24.3	22.1	16.5	20.9	7.5	107.0	46.2	0.0	29.3	7.5	25.8	38.7	29.6	22.3	9.5	33.0	19.4	12.3	29.9	16.8	39.7	3.8	41.7	28.9	63.4	22.2	15.2	34.2	18.4	12.2	59.4	12.8	5.2	47.5	37.6	12.4	31.9	65.9	11.7	264.7	30.7	40.0	40.8	17.2	38.4	35.9	17.1	23.2	23.6	12.2	15.1	65.7	63.7	32.6	10.9	10.4	28.9	19.7	9.3	38.8	38.8	20.9	16.7
SLC22A1	OCT1	ENSG00000175003	"Solute carrier family 22 member 1"	O15245	6	160121815-160158718	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	381	"liver: 609.6"	"Cell type enriched"	"Detected in some"	20	"Hepatocytes: 966.3"	"Cancer enriched"	"Detected in some"	81	"liver cancer: 83.0"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	12	"neutrophil: 3.5"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 3.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA029846	Approved					NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 62: Liver - Hemostasis"		"Cluster 2: Hepatocytes - Metabolism"			"HPA029846: AB_10603026"	"unprognostic (8.28e-2)"	"unprognostic (2.10e-1)"	"unprognostic (7.80e-2)"	"unprognostic (2.68e-1)"	"unprognostic (1.93e-1)"	"unprognostic (2.10e-2)"	"prognostic favorable (1.35e-5)"	"unprognostic (2.28e-1)"	"unprognostic (8.61e-2)"	"unprognostic (3.35e-1)"	"unprognostic (9.11e-2)"	"unprognostic (9.94e-2)"	"unprognostic (1.46e-7)"	"unprognostic (1.58e-1)"	"unprognostic (1.24e-1)"	"unprognostic (4.72e-2)"	"unprognostic (8.07e-4)"	0.3	0.3	0.2	0.1	0.1	0.4	0.3	0.0	0.9	0.3	0.3	0.2	0.0	0.3	0.1	0.2	0.3	0.7	0.1	0.5	0.0	0.9	609.6	0.4	0.2	0.1	0.1	0.4	0.4	0.0	0.3	0.0	0.3	0.4	0.1	0.1	0.4	0.1	1.0	0.5	0.3	0.0	0.0	1.6	0.3	0.3	0.1	0.1	0.7	0.1	0.0	0.1	0.3	0.0	0.0	0.2	0.2	0.4	0.4	0.1	0.1	0.1	0.0	0.1	0.1	0.3	0.1	0.1	0.2	0.0	0.8	0.0	0.0	0.4	0.1	0.4	0.2	0.1	0.2	0.6	0.0	0.3	0.3	0.0	0.5	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.4	0.4	0.0	0.2	0.1	0.0	0.6	0.0	0.4	0.3	0.0	0.0	0.0	0.1	0.1	0.4	0.3	0.3	0.7	0.2	0.0	0.2	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	3.5	0.0	0.0	0.1	0.1	0.0	0.2	0.1	0.0	0.9	0.5	0.0	0.1	0.1	0.3	0.0	0.1	0.0	0.2	0.0	1.3	2.0	1.4	0.0	0.1	0.0	0.0	0.0	0.5	0.3	0.5	47.1	0.0	0.0	2.1	0.0	0.4	0.1	0.0	0.5	0.3	0.5	0.1	0.9	0.0	13.5	6.1	0.2	0.1	0.2	0.0	0.7	0.0	0.2	11.4	966.3	0.1	0.0	3.7	0.1	0.0	16.3	0.0	0.2	0.3	0.4	0.0	1.0	0.0	0.9	0.0	0.0	0.9	0.1	0.0	0.7	0.1	0.3	0.1	1.8	0.1	0.0	0.0	0.7	0.3	0.0	0.4	0.0	0.3	0.1	1.2	0.3	0.1	0.2
SLC22A2	OCT2	ENSG00000112499	"Solute carrier family 22 member 2"	O15244	6	160171061-160277638	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	105	"kidney: 153.9"	"Group enriched"	"Detected in some"	13	"Distal tubular cells: 92.0;Proximal tubular cells: 198.3"	"Cancer enriched"	"Detected in single"	493	"renal cancer: 30.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in some"		"midbrain: 1.9"	"HPA008549, CAB068236, CAB068237"	Enhanced					NA	NA				"Cluster 7: Kidney - Transmembrane transport"		"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"CAB068236: AB_2665668, CAB068237: AB_2665669, HPA008549: "	"unprognostic (1.01e-1)"	"unprognostic (3.67e-1)"	"unprognostic (2.26e-1)"	"unprognostic (3.67e-2)"	"unprognostic (4.24e-1)"	"unprognostic (3.33e-1)"	"unprognostic (2.51e-2)"	"unprognostic (3.30e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.15e-4)"	"unprognostic (1.41e-1)"	"unprognostic (3.68e-1)"	"prognostic favorable (1.85e-7)"	"unprognostic (1.65e-2)"	"unprognostic (8.20e-2)"	"unprognostic (4.11e-1)"	"unprognostic (2.45e-2)"	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.7	0.0	1.0	0.1	0.2	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.1	153.9	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.1	0.0	0.0	0.1	1.4	0.2	0.0	0.2	0.2	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.7	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.3	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	11.0	0.0	0.0	0.0	0.1	92.0	0.6	7.2	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.2	0.3	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	198.3	0.0	0.0	0.0	1.0	0.6	0.1	0.3	0.0	0.3	0.1	1.4	0.0	0.0	0.0
SLC22A3	"EMT, OCT3"	ENSG00000146477	"Solute carrier family 22 member 3"	O75751	6	160348378-160452577	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 67.4"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 78.9;Hepatocytes: 68.8;Leydig cells: 33.8;Pancreatic endocrine cells: 57.3;Skeletal myocytes: 29.8"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 19.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 27.6;HeLa: 38.1;Hep G2: 23.7;OE19: 12.0;RPTEC TERT1: 13.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA029750	Approved		Approved	Vesicles,Cytosol		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 20: HeLa - Mitochondria"	"Cluster 15: Hepatocytes - Hemostasis"	Vesicles	Cytosol	"HPA029750: AB_10603888"	"unprognostic (8.61e-2)"	"prognostic unfavorable (7.19e-5)"	"unprognostic (4.14e-1)"	"unprognostic (1.49e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.28e-1)"	"unprognostic (3.36e-2)"	"unprognostic (9.74e-2)"	"unprognostic (9.36e-4)"	"unprognostic (1.33e-2)"	"unprognostic (2.58e-2)"	"unprognostic (7.28e-2)"	"unprognostic (7.96e-2)"	"unprognostic (5.21e-2)"	"unprognostic (8.13e-4)"	"prognostic unfavorable (7.26e-4)"	11.7	15.2	2.1	3.8	2.7	0.0	6.6	3.3	2.1	15.9	1.8	8.8	1.7	18.4	27.6	7.7	18.7	11.0	1.5	2.0	3.5	6.3	34.9	16.4	16.2	6.2	3.8	21.1	0.7	0.2	1.3	44.3	4.5	43.4	2.4	0.2	51.8	52.6	67.4	10.7	5.7	26.3	3.3	0.6	6.0	2.6	4.2	0.5	2.0	8.5	4.9	6.2	15.7	3.2	0.0	27.6	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.3	1.5	0.0	0.0	0.0	0.0	7.3	0.0	0.0	0.4	0.0	0.0	0.0	38.1	23.7	1.2	0.0	0.0	0.8	6.9	3.4	0.0	9.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.0	12.0	7.7	0.0	0.0	0.0	13.8	0.0	0.0	0.0	3.1	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	2.7	3.3	2.1	2.0	3.5	6.2	3.8	4.5	3.3	4.2	3.2	0.6	16.0	78.9	6.2	0.1	4.7	0.3	2.1	2.8	0.2	0.2	0.3	2.9	5.7	6.4	0.0	0.0	0.3	0.1	0.2	5.9	8.2	0.6	0.2	10.2	1.0	0.0	0.0	0.5	3.0	0.3	10.0	12.8	0.3	2.5	0.8	0.0	68.8	0.7	0.0	25.1	1.6	2.0	1.0	2.4	1.6	33.8	0.3	3.6	7.5	0.0	0.0	0.0	19.6	0.2	57.3	0.1	24.5	0.1	6.1	2.1	2.9	0.8	0.1	0.0	29.8	12.3	0.3	0.2	3.7	6.7	0.4	1.2	0.0	2.8	0.8
LPA	"LP, Lp(a)"	ENSG00000198670	Lipoprotein(a)	P08519	6	160531482-160664275	"Candidate cardiovascular disease genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Lipid transport, Transport"	"Hydrolase, Protease, Serine protease"	Atherosclerosis	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"liver: 76.7"	"Cell type enriched"	"Detected in some"	28	"Hepatocytes: 80.7"	"Cancer enriched"	"Detected in single"	38	"liver cancer: 3.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	6	"RT4: 1.0"									"CAB016072, HPA060604"	Supported				"Secreted to blood"	NA	NA	78800000000	1800000000		"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 15: RT4 - Unknown function"	"Cluster 15: Hepatocytes - Hemostasis"			"CAB016072: AB_2135240, HPA060604: AB_2684330"		"unprognostic (2.16e-1)"	"unprognostic (5.10e-1)"	"unprognostic (7.75e-3)"	"unprognostic (6.70e-2)"	"unprognostic (1.60e-1)"	"unprognostic (4.17e-3)"	"unprognostic (1.59e-1)"		"unprognostic (6.38e-3)"	"unprognostic (3.63e-2)"	"unprognostic (3.18e-1)"	"unprognostic (7.45e-3)"	"unprognostic (2.56e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.72e-2)"	0.0	0.1	2.0	0.0	1.2	0.0	0.0	0.0	1.1	0.1	0.0	0.0	0.0	0.2	0.4	0.1	0.8	0.0	0.0	0.8	6.3	0.5	76.7	0.1	0.0	1.8	1.9	0.2	0.6	0.0	0.0	0.0	1.3	0.6	0.0	0.2	0.0	1.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.5	4.2	1.1	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	1.2	0.0	1.1	0.8	6.3	1.8	1.9	1.3	0.2	4.2	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.5	2.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.1	0.1	0.0	0.2	0.0	2.7	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	80.7	0.0	0.0	1.3	0.0	0.0	2.5	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.9	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.3
PLG		ENSG00000122194	Plasminogen	P00747	6	160702238-160754097	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted secreted proteins"	"Blood coagulation, Fibrinolysis, Hemostasis, Tissue remodeling"	"Hydrolase, Protease, Serine protease"	"Cancer-related genes, Disease variant, FDA approved drug targets, Thrombophilia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"liver: 2666.4"	"Cell type enriched"	"Detected in some"	7	"Hepatocytes: 1772.7"	"Cancer enriched"	"Detected in some"	84	"liver cancer: 180.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in many"			"CAB000668, CAB016678, HPA021602, HPA048823"	Supported				"Secreted to blood"	NA	NA	140000000000	45000000000		"Cluster 85: Liver - Metabolism"		"Cluster 15: Hepatocytes - Hemostasis"			"CAB000668: , CAB016678: AB_1621208, HPA021602: AB_1855453, HPA048823: AB_2680532"		"unprognostic (1.70e-1)"		"unprognostic (2.16e-3)"	"unprognostic (2.44e-1)"		"unprognostic (8.54e-3)"	"unprognostic (1.41e-1)"		"unprognostic (1.76e-3)"	"unprognostic (6.28e-2)"	"unprognostic (7.25e-2)"	"prognostic favorable (4.22e-4)"	"unprognostic (3.97e-3)"	"unprognostic (5.21e-2)"		"unprognostic (2.33e-2)"	0.4	0.4	0.3	0.2	0.4	0.0	0.0	0.0	0.3	0.1	0.0	0.1	0.3	0.2	0.0	0.1	2.4	0.5	0.1	0.2	0.3	240.9	2666.4	0.4	0.7	0.0	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.6	0.0	0.1	0.9	0.0	0.1	0.2	0.1	0.0	0.0	0.5	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.5	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.1	0.3	0.2	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.5	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.3	0.2	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	5.4	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.6	30.0	0.0	1.8	0.0	0.0	0.3	0.0	19.6	0.0	0.2	3.0	0.1	1.2	0.0	24.0	0.6	0.0	0.0	0.0	0.0	0.1	1.3	0.0	28.5	1772.7	0.1	0.0	0.5	0.0	0.0	35.4	0.0	0.2	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	235.7	1.5	0.1	0.0	0.4	0.2	0.4	0.4	0.0	0.0	0.0	2.3	0.1	0.0	0.0
MAP3K4	"KIAA0213, MAPKKK4, MEKK4, MTK1"	ENSG00000085511	"Mitogen-activated protein kinase kinase kinase 4"	Q9Y6R4	6	160991727-161117385	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Oligodendrocyte precursor cells: 87.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 31.5"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007625	Uncertain		Approved	Cytosol		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 44: Endometrium - Transcription"	Cytosol		"HPA007625: AB_1853770"	"unprognostic (3.05e-3)"	"unprognostic (2.19e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.06e-1)"	"unprognostic (7.65e-2)"	"unprognostic (1.35e-3)"	"unprognostic (6.38e-2)"	"unprognostic (2.09e-1)"	"unprognostic (3.81e-3)"	"unprognostic (2.09e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.16e-2)"	"unprognostic (5.86e-2)"	"unprognostic (3.45e-1)"	"unprognostic (1.93e-1)"	"unprognostic (6.84e-2)"	4.9	3.9	5.1	6.4	4.4	5.8	6.0	9.4	7.7	7.8	0.0	6.0	5.3	9.3	3.6	8.5	7.2	4.5	5.5	6.4	4.8	5.0	4.5	6.2	7.3	2.7	2.0	8.6	6.4	8.0	3.9	7.1	3.6	7.3	5.3	4.1	7.3	6.3	11.1	8.5	5.5	7.6	2.7	6.3	5.8	7.5	3.1	9.6	5.5	10.2	9.8	7.1	6.7	5.6	8.1	9.0	16.8	14.7	9.9	11.9	11.1	9.0	7.9	10.2	10.7	12.6	5.8	16.7	6.4	23.2	14.6	19.7	17.4	18.0	12.4	12.4	14.3	21.8	8.5	12.9	7.9	22.9	10.1	7.6	20.5	10.7	9.6	15.8	13.5	12.4	56.1	18.8	11.0	8.3	15.6	11.9	10.3	5.8	13.8	16.9	15.6	13.3	9.0	5.8	9.7	8.5	17.0	17.8	1.5	14.7	7.4	27.6	13.0	12.4	15.9	11.7	43.3	10.8	9.3	15.3	14.6	23.2	13.2	31.5	4.0	2.7	5.2	3.2	9.3	6.7	7.5	4.8	4.9	9.1	5.2	5.2	0.2	4.1	1.9	6.1	5.7	3.0	5.1	4.4	9.4	7.7	6.4	4.8	2.7	2.0	3.6	2.7	3.1	5.6	19.9	19.2	12.2	32.7	20.8	9.8	10.5	9.7	30.7	18.5	13.3	16.8	20.9	10.0	14.9	14.7	22.9	20.6	17.0	7.1	3.9	9.7	5.5	35.3	55.4	14.5	15.4	12.8	66.1	7.5	11.5	16.1	15.8	39.4	3.8	35.3	6.1	8.3	7.3	23.5	64.5	9.3	6.1	8.2	6.4	4.4	11.5	15.3	0.0	45.9	18.8	14.9	10.3	87.4	57.1	12.5	8.1	12.4	18.2	13.6	9.3	6.9	10.6	29.8	6.6	21.8	19.4	14.7	25.7	28.1	11.8	33.1	25.2	8.1	11.7	16.7
AGPAT4	"dJ473J16.2, LPAAT-delta"	ENSG00000026652	"1-acylglycerol-3-phosphate O-acyltransferase 4"	Q9NRZ5	6	161129967-161274061	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 51.3"	"Cell type enriched"	"Detected in many"	4	"Oligodendrocytes: 407.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 25.5;HEL: 19.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053287, HPA060525"	Approved		Approved	"Nucleoli,Golgi apparatus,Vesicles"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 70: Brain - Nervous system development"	"Cluster 12: NES - Nervous system development"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Golgi apparatus"	"Nucleoli, Vesicles"	"HPA053287: AB_2682101, HPA060525: AB_2684306"	"unprognostic (5.69e-2)"	"prognostic unfavorable (1.45e-4)"	"unprognostic (1.73e-1)"	"unprognostic (3.43e-2)"	"unprognostic (4.14e-2)"	"unprognostic (6.67e-3)"	"unprognostic (1.94e-4)"	"unprognostic (1.05e-1)"	"unprognostic (3.42e-2)"	"unprognostic (2.77e-2)"	"unprognostic (1.76e-3)"	"unprognostic (1.67e-1)"	"prognostic unfavorable (4.08e-4)"	"unprognostic (1.82e-2)"	"unprognostic (8.87e-2)"	"unprognostic (3.63e-4)"	"unprognostic (5.51e-2)"	4.8	2.1	14.7	1.8	30.5	5.2	4.5	24.6	22.5	7.2	5.6	6.4	1.2	7.8	2.2	3.7	6.1	4.2	2.6	14.9	22.7	6.0	0.8	6.7	0.9	47.1	26.3	7.4	2.1	0.3	11.4	8.7	34.3	3.6	2.1	2.2	2.7	2.4	1.0	2.3	2.6	4.7	25.5	4.6	2.3	2.8	28.6	1.3	4.1	1.0	1.0	3.0	5.0	51.3	0.5	1.0	25.5	5.1	4.7	9.5	1.1	0.9	0.3	1.9	3.2	1.5	4.6	0.7	1.8	4.2	11.8	0.5	4.8	4.0	1.8	2.9	8.1	19.4	4.9	0.1	3.7	0.2	2.8	11.4	1.9	5.0	2.7	9.1	6.1	3.1	9.8	8.9	2.4	0.0	1.4	2.2	6.2	0.0	9.7	0.0	1.1	0.5	5.6	0.4	14.8	5.6	4.0	2.1	1.1	9.9	1.1	1.2	6.8	2.6	3.3	1.8	4.4	0.7	1.0	0.0	9.9	1.0	1.6	0.0	1.8	0.0	3.4	1.5	1.1	0.2	1.6	2.1	1.0	0.5	0.8	1.2	0.3	2.9	1.3	0.8	1.7	1.3	14.7	30.5	24.6	22.5	14.9	22.7	47.1	26.3	34.3	25.5	28.6	51.3	12.0	3.2	5.5	7.5	4.5	3.2	5.5	9.7	6.2	2.4	3.5	2.7	5.6	5.7	6.9	5.5	0.0	20.3	31.1	6.1	0.0	5.2	52.1	23.8	12.5	13.5	1.8	31.5	87.9	8.2	12.0	17.8	4.6	5.1	11.4	20.6	10.4	0.2	18.2	0.0	95.8	0.7	10.2	7.2	16.4	72.8	5.9	17.0	3.6	23.4	9.4	4.0	9.2	56.3	407.6	5.5	18.7	8.6	15.7	1.3	0.0	0.6	21.4	1.2	19.7	5.3	6.9	4.9	2.8	1.1	2.6	22.2	14.1	3.7	1.4	3.6
PRKN	"AR-JP, PARK2, parkin, PDJ"	ENSG00000185345	"Parkin RBR E3 ubiquitin protein ligase"	O60260	6	161347417-162727775	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins"	"Autophagy, Transcription, Transcription regulation, Ubl conjugation pathway"	Transferase	"Disease variant, Neurodegeneration, Parkinson disease, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 28.3;tongue: 15.9"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 9.6;Alveolar cells type 2: 4.8;Distal tubular cells: 19.6;Proximal tubular cells: 6.8"	"Cancer enhanced"	"Detected in many"		"renal cancer: 3.3"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 2.0;HEL: 4.1;HSkMC: 1.7;Karpas-707: 2.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB016257, HPA036012"	Enhanced		Supported	"Nuclear speckles,Cytosol"		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 47: Non-specific - Unknown function"	"Cluster 36: HEL - Hemostasis"	"Cluster 39: Non-specific - Basic cellular processes"	"Nuclear speckles"	Cytosol	"CAB016257: AB_628104, HPA036012: AB_2732471"	"unprognostic (9.23e-2)"	"unprognostic (3.29e-2)"	"unprognostic (6.48e-2)"	"unprognostic (2.69e-3)"	"unprognostic (9.85e-2)"	"unprognostic (5.85e-2)"	"unprognostic (7.07e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.68e-2)"	"unprognostic (1.03e-3)"	"unprognostic (8.16e-2)"	"prognostic favorable (6.75e-12)"	"unprognostic (9.93e-2)"	"unprognostic (1.51e-1)"	"unprognostic (5.24e-2)"	"unprognostic (2.50e-1)"	3.4	3.3	4.1	0.1	3.6	0.3	1.9	0.4	5.7	1.3	0.6	2.7	1.2	1.6	1.2	3.2	1.2	1.5	9.1	4.6	1.8	5.2	1.2	1.0	0.5	1.0	1.9	2.8	1.2	2.3	1.8	0.4	1.6	1.2	0.6	1.5	1.3	1.4	28.3	2.0	1.0	1.2	1.0	1.0	1.9	5.3	1.9	0.5	1.3	15.9	0.3	2.5	1.0	2.4	0.0	0.0	0.3	2.0	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.5	0.0	0.3	0.0	0.1	0.0	0.0	0.1	0.5	4.1	0.1	0.6	0.3	0.0	0.0	1.7	0.0	0.0	0.2	0.3	0.0	0.2	0.2	2.2	0.0	0.2	0.0	0.0	0.0	0.2	0.8	0.0	0.0	0.7	0.0	0.0	0.5	1.0	0.0	0.2	0.2	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.7	1.7	0.3	2.2	0.8	0.1	1.3	0.6	0.8	0.9	0.7	1.6	1.8	1.8	0.5	0.6	0.4	0.0	0.1	0.8	4.1	3.6	0.4	5.7	4.6	1.8	1.0	1.9	1.6	1.0	1.9	2.4	2.3	9.6	4.8	0.0	0.6	0.0	0.0	0.0	0.0	0.0	2.1	1.5	0.0	0.0	1.8	1.8	0.0	0.5	0.4	0.0	19.6	1.1	0.0	3.4	1.8	0.7	0.0	0.0	0.0	2.2	0.1	1.8	0.0	3.2	2.5	3.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	6.8	1.5	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.3	0.4	3.7	0.0	0.0
PACRG	"FLJ32724, Glup, HAK005771, PARK2CRG"	ENSG00000112530	"Parkin coregulated"	Q96M98	6	162727132-163315492	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 35.7;testis: 29.5"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 310.9;Excitatory neurons: 124.3;Inhibitory neurons: 174.9;Late spermatids: 369.8;Respiratory ciliated cells: 118.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SCLC-21H: 6.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA066293	Enhanced					NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA066293: AB_2685652"	"unprognostic (3.06e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.56e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.84e-1)"	"unprognostic (6.26e-4)"	"unprognostic (1.37e-1)"	"unprognostic (1.76e-1)"	"unprognostic (3.34e-1)"	"unprognostic (8.31e-3)"	"unprognostic (1.48e-1)"	"prognostic favorable (2.55e-6)"	"unprognostic (1.00e-1)"	"unprognostic (3.68e-2)"	"unprognostic (8.35e-2)"	"unprognostic (2.93e-3)"	0.8	2.5	13.6	1.1	15.2	5.7	2.0	5.9	14.2	2.3	13.2	1.2	1.4	5.3	9.7	3.0	35.7	5.1	13.0	11.9	12.5	10.2	4.8	3.8	1.4	15.1	15.7	4.2	4.3	2.0	23.7	0.4	10.9	3.4	2.4	7.5	2.2	3.6	2.1	4.6	0.8	2.1	9.4	1.8	2.3	29.5	13.5	0.7	4.0	1.3	1.0	4.4	0.9	24.2	0.5	1.7	0.7	1.0	0.0	0.6	1.2	0.4	1.6	0.0	0.3	3.5	0.4	3.2	0.4	0.0	0.3	1.4	0.8	0.0	1.7	0.0	1.1	0.0	1.9	0.0	0.0	0.4	0.5	1.0	0.0	0.5	0.0	0.6	0.0	1.1	0.5	0.7	0.3	0.1	0.2	1.2	0.0	2.8	2.9	0.6	0.0	0.0	3.6	3.6	6.9	3.1	0.0	0.0	0.0	0.2	0.0	1.1	1.2	0.7	0.3	0.0	0.2	1.3	0.5	1.2	0.3	0.8	1.3	2.3	0.7	0.7	0.7	0.2	0.5	0.3	1.1	0.4	0.1	0.6	1.4	0.6	2.5	0.0	0.1	0.5	0.5	0.2	13.6	15.2	5.9	14.2	11.9	12.5	15.1	15.7	10.9	9.4	13.5	24.2	0.3	0.0	1.7	61.0	0.1	0.3	4.2	8.7	2.8	1.3	1.3	3.0	41.0	0.0	8.9	5.5	8.4	0.1	0.0	0.1	54.8	3.4	310.9	67.0	3.1	1.2	6.6	0.0	124.3	7.1	0.1	1.2	0.0	1.9	0.0	0.7	0.7	3.9	0.1	0.0	174.9	0.3	10.2	0.6	0.3	369.8	3.7	0.4	0.0	11.2	0.0	6.0	0.0	59.3	20.0	1.6	1.2	2.6	0.1	3.2	0.0	6.3	118.4	8.1	0.0	1.1	2.2	53.4	6.1	1.1	0.3	0.3	0.3	2.9	0.4	2.7
QKI	QK3	ENSG00000112531	"QKI, KH domain containing RNA binding"	Q96PU8	6	163414000-163578592	"Cancer-related genes, Predicted intracellular proteins"	"Differentiation, mRNA processing, mRNA splicing, mRNA transport, Translation regulation, Transport"	"Developmental protein, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 628.6"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 1140.0;Microglial cells: 713.0;Oligodendrocyte precursor cells: 1421.0;Oligodendrocytes: 4573.8"	"Cancer enriched"	"Detected in all"	6	"glioma: 42.0"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"AF22: 250.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019123, CAB022602"	Enhanced	Supported	Supported	Nucleoplasm		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 70: Brain - Nervous system development"	"Cluster 12: NES - Nervous system development"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm		"CAB022602: , HPA019123: AB_1855980"	"unprognostic (2.42e-1)"	"unprognostic (5.81e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.06e-2)"	"unprognostic (8.57e-2)"	"unprognostic (1.65e-1)"	"prognostic unfavorable (1.27e-4)"	"unprognostic (1.34e-1)"	"unprognostic (7.06e-2)"	"unprognostic (1.76e-3)"	"unprognostic (1.08e-1)"	"unprognostic (5.15e-2)"	"prognostic unfavorable (2.31e-5)"	"prognostic unfavorable (3.69e-4)"	"unprognostic (1.16e-1)"	"unprognostic (3.86e-1)"	"unprognostic (4.09e-2)"	76.3	24.2	208.2	36.8	437.7	69.7	27.8	355.8	207.9	29.2	2.5	22.2	7.9	28.4	8.7	34.4	25.3	33.8	149.3	211.1	301.1	22.7	41.1	55.9	27.4	431.2	367.9	38.2	16.0	15.0	6.9	53.0	451.4	15.3	16.7	26.9	15.3	22.3	157.0	18.6	11.9	46.3	304.5	39.8	12.1	47.3	365.7	28.5	22.1	222.1	25.3	38.2	16.4	628.6	17.8	72.0	250.8	83.7	74.3	81.9	58.4	46.8	109.0	74.5	89.4	49.3	15.8	21.3	38.6	117.2	50.8	25.9	134.4	48.4	120.2	43.7	43.3	83.4	38.4	55.3	90.4	44.8	24.9	96.8	19.5	80.0	125.8	72.4	104.4	30.9	124.3	48.2	48.6	32.8	30.1	9.5	32.4	17.3	36.0	45.9	156.5	42.3	40.5	54.4	5.2	28.7	49.9	26.7	19.2	101.2	10.5	71.8	107.2	51.3	42.7	55.9	86.1	30.9	40.9	26.3	44.2	38.7	122.8	3.6	7.1	3.4	1.8	4.7	3.0	1.2	1.3	1.6	3.7	1.2	1.1	2.0	9.2	6.3	5.1	6.2	1.0	1.1	208.2	437.7	355.8	207.9	211.1	301.1	431.2	367.9	451.4	304.5	365.7	628.6	180.6	150.6	51.5	1140.0	35.4	153.7	34.1	25.3	43.9	60.4	42.8	47.2	355.5	37.1	30.5	20.2	58.4	51.1	77.7	0.2	21.5	21.8	53.0	60.7	156.7	130.0	0.0	40.4	58.4	12.0	51.3	92.2	10.2	71.1	60.9	64.8	131.0	72.9	86.8	32.0	471.4	0.0	14.2	221.9	188.0	102.5	86.6	165.7	113.8	713.0	107.9	113.5	32.0	1421.0	4573.8	19.8	0.1	98.6	34.4	46.5	0.0	33.2	23.7	31.5	46.0	197.7	83.5	46.1	19.7	47.4	136.1	55.1	32.2	69.9	0.2	46.4
C6orf118	"bA85G2.1, MGC23884"	ENSG00000112539	"Chromosome 6 open reading frame 118"	Q5T5N4	6	165279664-165309605	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 10.6;choroid plexus: 29.8;fallopian tube: 16.4"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 145.5;Endometrial ciliated cells: 140.4;Late spermatids: 57.6;Respiratory ciliated cells: 243.9"	"Cancer enhanced"	"Detected in some"		"endometrial cancer: 2.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"AF22: 2.7;SCLC-21H: 1.6"	"Low region specificity"	"Detected in many"							"HPA029787, HPA029789"	Approved		Uncertain	Mitochondria		NA	NA				"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 12: NES - Nervous system development"	"Cluster 49: Ciliated cells - Cilium organization"	Mitochondria		"HPA029787: AB_10599999, HPA029789: AB_10601002"	"unprognostic (2.84e-1)"	"unprognostic (3.09e-4)"		"unprognostic (2.70e-2)"	"unprognostic (7.99e-2)"	"unprognostic (5.34e-2)"		"unprognostic (1.41e-1)"		"unprognostic (2.50e-1)"	"unprognostic (4.27e-2)"	"unprognostic (4.89e-2)"	"unprognostic (8.18e-9)"	"unprognostic (3.22e-3)"	"unprognostic (3.03e-2)"	"unprognostic (6.55e-3)"	"unprognostic (4.50e-1)"	0.0	0.0	2.7	0.0	2.3	0.0	0.0	0.9	1.1	0.6	29.8	0.0	0.0	0.4	0.0	0.0	16.4	0.0	0.0	4.0	2.6	0.0	0.0	2.1	0.0	8.4	10.6	0.0	0.0	0.0	1.5	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	0.0	0.0	7.0	2.8	0.0	0.1	0.0	0.0	0.0	0.0	3.7	0.0	0.2	2.7	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.1	0.0	1.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	2.3	0.9	1.1	4.0	2.6	8.4	10.6	5.3	6.4	2.8	3.7	0.0	0.0	1.5	0.3	0.0	0.0	0.2	6.6	0.0	0.0	0.0	0.1	0.4	0.0	16.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	145.5	140.4	1.4	0.1	0.0	0.0	0.4	0.0	0.0	1.3	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	10.2	0.0	0.0	57.6	0.6	0.4	0.0	0.0	0.0	0.0	0.0	7.1	0.1	0.0	0.0	0.4	0.0	0.2	0.0	0.1	243.9	0.0	0.0	0.0	1.8	16.8	1.3	0.0	0.0	0.0	0.1	0.1	0.0	0.1
PDE10A		ENSG00000112541	"Phosphodiesterase 10A"	Q9Y233	6	165327287-165988078	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins"		"Allosteric enzyme, Hydrolase"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	11	"brain: 67.2"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 204.7;Inhibitory neurons: 209.6;Microglial cells: 89.0;Oligodendrocyte precursor cells: 48.7;Oligodendrocytes: 51.8"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	6	"basal ganglia: 67.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HeLa: 9.0;LHCN-M2: 12.5;RT4: 6.9;SH-SY5Y: 8.1;TIME: 11.3;U-2 OS: 7.0"	"Region enriched"	"Detected in all"	11	"basal ganglia: 350.1"	"Region enriched"	"Detected in all"	5	"basal ganglia: 194.1"	"CAB045998, HPA047200"	Supported					NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"CAB045998: AB_2162589, HPA047200: AB_2679981"	"unprognostic (1.02e-1)"	"unprognostic (3.63e-2)"	"unprognostic (3.58e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.23e-1)"	"unprognostic (9.36e-2)"	"unprognostic (6.03e-2)"	"unprognostic (3.79e-2)"	"unprognostic (9.24e-2)"	"prognostic unfavorable (4.44e-7)"	"unprognostic (3.59e-3)"	"unprognostic (2.37e-2)"	"unprognostic (3.44e-2)"	"unprognostic (5.90e-3)"	2.6	1.3	3.1	0.8	67.2	0.0	2.3	5.5	10.7	1.3	0.0	1.0	0.2	2.0	2.4	0.4	2.4	1.5	3.6	2.1	2.5	3.8	0.3	1.0	0.5	1.6	2.3	2.3	0.5	0.5	2.7	2.5	0.9	1.7	0.2	1.9	0.4	1.7	0.4	0.3	0.7	2.1	0.5	1.4	1.1	3.4	9.6	0.3	6.0	0.5	0.4	3.2	0.9	0.1	0.0	2.4	5.5	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	6.3	0.8	0.0	0.0	0.0	3.8	0.1	2.2	0.0	0.0	0.1	3.9	0.0	9.0	0.0	0.4	0.0	0.0	0.0	0.0	0.6	0.0	0.0	5.5	0.0	0.0	0.0	12.5	0.3	0.9	0.0	1.1	0.0	4.7	1.5	5.8	0.0	5.9	6.9	1.8	8.1	0.0	0.0	0.4	0.7	0.0	0.0	11.3	0.1	7.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	3.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	67.2	5.5	10.7	2.1	2.5	1.6	2.3	0.9	0.5	9.6	0.1	13.8	0.0	0.0	10.4	0.1	0.4	3.3	0.4	0.0	7.2	0.3	0.3	7.3	0.0	1.2	5.5	2.1	7.8	0.0	0.0	3.9	2.0	14.3	0.2	1.7	13.4	0.0	0.0	204.7	0.0	6.1	6.6	1.1	0.4	1.3	0.1	7.9	0.0	0.8	16.8	209.6	0.0	0.0	0.0	0.0	14.9	0.0	0.2	1.8	89.0	0.0	12.6	0.0	48.7	51.8	0.1	0.0	0.4	0.0	17.9	0.0	7.2	0.9	1.1	0.0	12.4	5.0	8.8	2.1	0.1	0.3	2.9	0.1	1.6	0.1	6.9
TBXT	T	ENSG00000164458	"T-box transcription factor T"	O15178	6	166157656-166168700	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"parathyroid gland: 2.6;pituitary gland: 1.3"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in single"	22	"testis cancer: 6.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"HeLa: 16.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA003322	Uncertain		Supported	Nucleoplasm		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 20: HeLa - Mitochondria"	"Cluster 4: Macrophages - Innate immune response"	Nucleoplasm		"HPA003322: AB_1080176"						"unprognostic (5.68e-2)"		"unprognostic (4.59e-2)"						"unprognostic (6.21e-3)"	"unprognostic (8.64e-3)"	"unprognostic (9.34e-3)"		0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	2.6	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	16.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	1.1	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PRR18	MGC35308	ENSG00000176381	"Proline rich 18"	Q8N4B5	6	166305300-166308448	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	13	"brain: 127.0"	"Cell type enriched"	"Detected in some"	5	"Oligodendrocytes: 27.3"	"Group enriched"	"Detected in some"	5	"glioma: 3.1;liver cancer: 1.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"SCLC-21H: 4.3;SH-SY5Y: 2.5"	"Low region specificity"	"Detected in all"							HPA077250	Enhanced					NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"			"HPA077250: AB_2732336"	"unprognostic (2.91e-1)"	"unprognostic (7.18e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.39e-2)"	"unprognostic (1.44e-1)"	"unprognostic (9.65e-2)"	"unprognostic (5.60e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.10e-1)"	"unprognostic (3.16e-2)"	"unprognostic (2.44e-3)"	"unprognostic (4.79e-3)"	"unprognostic (2.43e-1)"	"unprognostic (3.35e-3)"	"unprognostic (9.49e-2)"	"unprognostic (9.58e-2)"	"unprognostic (1.07e-1)"	0.3	0.0	36.1	0.0	90.6	0.0	0.1	38.8	63.8	0.1	10.0	0.0	0.3	0.0	0.0	0.0	2.1	0.0	0.0	34.3	37.2	0.2	3.3	0.2	0.0	54.5	61.1	0.0	0.2	1.2	0.9	0.0	42.6	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	32.8	0.0	0.1	0.0	60.2	0.0	0.1	0.0	0.0	0.0	0.0	127.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	2.5	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	36.1	90.6	38.8	63.8	34.3	37.2	54.5	61.1	42.6	32.8	60.2	127.0	0.0	0.0	0.0	2.3	0.0	0.0	0.2	0.0	0.0	1.1	0.1	0.0	0.6	2.8	0.0	1.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	5.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	3.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.5	27.3	0.1	0.0	0.0	0.0	0.4	0.0	1.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SFT2D1	"C6orf83, MGC19825, pRGR1"	ENSG00000198818	"SFT2 domain containing 1"	Q8WV19	6	166319728-166342576	"Predicted membrane proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014677	Approved		Approved	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 22: Non-specific - Unknown function"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Nuclear bodies"	"Nucleoplasm, Cytosol"	"HPA014677: AB_2238986"	"unprognostic (8.45e-2)"	"unprognostic (1.43e-3)"	"unprognostic (2.29e-1)"	"unprognostic (1.41e-2)"	"unprognostic (6.77e-2)"	"prognostic unfavorable (7.47e-4)"	"prognostic unfavorable (2.19e-5)"	"unprognostic (3.64e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.68e-1)"	"unprognostic (6.53e-2)"	"unprognostic (1.67e-1)"	"prognostic unfavorable (3.59e-4)"	"unprognostic (4.20e-2)"	"unprognostic (5.05e-2)"	"prognostic favorable (5.90e-4)"	"unprognostic (2.75e-2)"	40.8	43.9	55.0	35.6	61.7	35.8	45.9	62.3	76.2	35.4	54.0	52.1	39.2	26.5	68.2	36.6	33.8	34.4	30.5	54.5	59.0	51.0	24.5	37.0	50.9	64.0	59.0	31.9	51.1	36.1	17.3	48.9	65.3	47.5	50.1	12.9	70.7	28.0	22.2	24.7	39.0	24.8	62.9	41.9	50.7	26.9	57.2	41.7	46.3	27.5	47.9	40.4	29.4	72.4	47.1	39.9	41.9	86.3	76.1	65.9	56.4	70.7	69.6	56.8	85.5	80.2	103.3	43.9	55.7	68.8	90.2	59.7	62.5	67.0	88.3	58.8	88.4	53.0	35.4	133.4	65.9	134.9	106.5	61.1	78.9	65.5	58.3	81.8	31.3	73.1	96.1	46.8	90.3	68.5	42.1	241.5	40.2	154.5	36.2	28.6	45.0	105.4	141.6	46.1	8.0	34.3	45.6	87.8	73.0	48.1	46.4	252.3	28.6	33.4	60.4	87.4	79.7	40.7	32.3	50.6	70.4	84.8	85.5	141.1	90.7	126.3	62.1	98.6	38.7	88.1	47.3	52.3	103.4	72.5	50.3	51.7	166.0	58.9	107.3	204.9	79.4	92.7	55.0	61.7	62.3	76.2	54.5	59.0	64.0	59.0	65.3	62.9	57.2	72.4	45.6	41.7	66.5	25.1	103.4	86.5	127.8	262.4	59.2	10.0	136.0	103.6	25.0	51.5	143.9	108.5	0.0	153.0	154.2	109.3	90.1	154.5	70.3	52.0	49.9	55.8	28.8	63.3	15.6	126.8	259.4	81.5	61.2	73.9	149.0	31.3	65.3	30.6	211.6	15.2	13.6	162.5	168.9	178.5	178.4	25.2	85.1	143.5	99.6	21.5	198.3	31.7	111.2	16.6	71.5	155.4	146.5	47.4	108.5	239.2	115.5	140.4	96.0	9.1	85.5	69.5	64.0	159.0	93.4	72.9	102.9	131.2	74.9	63.2	131.4	194.0
MPC1	"BRP44L, CGI-129, dJ68L15.3, SLC54A1"	ENSG00000060762	"Mitochondrial pyruvate carrier 1"	Q9Y5U8	6	166364919-166383013	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 739.7;tongue: 559.2"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 950.0;Distal tubular cells: 1721.8;Proximal tubular cells: 573.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045119, HPA055790"	Enhanced		Enhanced	Mitochondria		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA045119: AB_10960421, HPA055790: AB_2682923"	"unprognostic (3.30e-2)"	"prognostic favorable (1.45e-4)"	"unprognostic (5.24e-3)"	"unprognostic (1.68e-1)"	"unprognostic (3.17e-2)"	"unprognostic (2.85e-2)"	"unprognostic (7.61e-2)"	"prognostic favorable (1.29e-4)"	"unprognostic (3.27e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.11e-3)"	"unprognostic (5.64e-2)"	"prognostic favorable (4.79e-11)"	"unprognostic (4.13e-2)"	"unprognostic (1.03e-1)"	"unprognostic (7.48e-2)"	"unprognostic (8.45e-2)"	61.7	39.6	105.9	33.4	119.5	57.0	52.8	129.7	153.1	52.4	108.0	97.7	84.8	35.7	44.8	71.5	34.7	41.7	739.7	101.2	127.8	259.9	411.2	44.6	44.3	119.2	123.9	43.4	66.0	141.8	38.1	23.7	119.5	43.5	89.9	57.3	87.7	42.3	319.4	40.9	63.8	38.5	117.1	35.0	96.1	22.2	121.5	48.6	82.9	559.2	44.2	47.4	34.9	132.4	25.6	7.5	31.3	107.7	88.4	49.8	45.2	29.1	47.1	45.1	43.9	38.8	17.9	53.6	50.9	45.4	36.1	24.5	47.0	36.7	31.9	36.1	79.0	27.5	35.4	132.6	36.6	104.9	34.1	40.0	51.0	36.8	26.7	13.7	36.9	80.8	94.2	84.1	28.6	40.5	73.1	193.7	16.1	148.0	35.5	39.1	51.7	134.9	85.4	20.5	96.7	85.7	33.6	145.8	34.0	25.9	34.5	154.3	25.3	25.7	26.8	91.6	30.0	55.8	42.2	46.3	23.5	127.0	42.1	60.7	60.0	90.1	41.7	98.3	39.4	33.1	48.5	45.1	72.2	25.4	44.7	43.3	54.6	40.5	128.5	43.0	69.1	49.8	105.9	119.5	129.7	153.1	101.2	127.8	119.2	123.9	119.5	117.1	121.5	132.4	56.1	118.6	48.0	64.6	51.7	45.6	44.2	83.6	29.0	61.1	74.2	79.1	950.0	187.3	67.6	106.7	10.4	22.0	54.2	219.1	1721.8	89.3	66.8	73.7	50.7	51.7	37.2	72.6	49.0	140.3	78.3	74.1	63.7	93.2	71.0	28.0	47.5	391.0	121.4	48.8	74.7	122.1	166.8	89.6	81.7	10.2	66.5	80.3	129.9	20.6	104.7	199.9	58.7	32.2	108.0	65.2	125.0	89.9	114.5	32.0	162.0	573.6	46.3	66.7	92.1	76.9	80.4	163.2	79.6	67.3	55.8	24.4	58.4	39.9	146.7	53.6
RPS6KA2	"HU-2, RSK3"	ENSG00000071242	"Ribosomal protein S6 kinase A2"	Q15349	6	166409364-166906451	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins"		"Kinase, Serine/threonine-protein kinase, Transferase"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 399.6;Excitatory neurons: 204.1;Horizontal cells: 287.7;Inhibitory neurons: 552.3;Oligodendrocyte precursor cells: 244.8"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 26.9"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	5	"eosinophil: 22.4"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 22.4"	"Cell line enhanced"	"Detected in many"		"ASC diff: 214.5;ASC TERT1: 156.1;HHSteC: 158.5;HSkMC: 141.4;hTERT-HME1: 173.0;hTERT-RPE1: 316.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB026243, HPA045061, HPA054237, CAB069428"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"CAB026243: , CAB069428: AB_1622639, HPA045061: AB_2679203, HPA054237: AB_2682425"	"unprognostic (8.71e-2)"	"unprognostic (3.14e-3)"	"unprognostic (7.29e-2)"	"unprognostic (1.72e-1)"	"unprognostic (3.80e-1)"	"unprognostic (2.45e-1)"	"unprognostic (6.44e-3)"	"unprognostic (8.63e-2)"	"unprognostic (1.40e-1)"	"prognostic unfavorable (8.63e-5)"	"unprognostic (8.68e-2)"	"unprognostic (4.11e-2)"	"prognostic favorable (2.86e-5)"	"unprognostic (3.12e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.56e-2)"	"unprognostic (2.01e-1)"	34.2	9.0	40.3	8.0	41.0	10.5	27.8	35.0	35.2	18.1	8.6	16.6	6.1	26.0	7.1	20.1	18.7	18.2	61.8	37.8	42.1	13.6	6.6	45.1	7.5	48.3	41.7	29.2	19.4	49.6	27.2	17.9	42.0	14.9	10.3	28.9	14.7	14.2	24.1	16.4	16.5	22.7	35.3	26.0	21.4	7.7	47.3	5.9	36.3	30.5	7.3	24.5	14.9	49.3	9.1	0.0	17.9	26.0	214.5	156.1	0.4	19.3	37.4	10.6	14.6	0.0	5.8	1.1	6.2	68.2	8.4	8.2	9.4	41.8	9.4	4.2	2.3	0.1	40.2	0.4	158.5	0.6	7.2	141.4	29.4	56.6	173.0	316.2	58.0	19.2	0.2	0.2	43.6	1.9	0.8	2.1	4.5	9.1	10.5	3.0	9.2	27.3	11.1	10.1	9.8	68.8	6.7	17.9	24.8	4.4	0.5	14.3	21.7	37.3	3.7	103.8	5.6	5.2	8.4	2.6	24.8	1.2	36.0	0.2	0.6	22.4	0.6	0.8	0.3	0.3	0.6	0.3	0.8	0.5	0.7	0.3	0.5	4.4	2.2	4.7	0.5	0.4	40.3	41.0	35.0	35.2	37.8	42.1	48.3	41.7	42.0	35.3	47.3	49.3	60.9	22.4	46.2	399.6	2.7	4.7	5.4	4.6	3.4	37.1	7.1	5.0	60.0	15.7	11.6	36.8	8.4	0.2	8.0	1.9	11.7	15.2	14.8	20.6	4.6	58.2	5.4	0.0	204.1	24.0	0.3	16.3	16.8	20.3	2.5	10.5	45.3	11.9	7.2	287.7	552.3	5.3	2.0	6.0	6.7	69.3	5.3	8.0	19.6	144.3	3.5	10.1	1.0	244.8	97.7	26.8	1.7	4.5	2.4	9.9	0.3	7.0	9.4	17.1	13.1	10.0	14.5	3.5	2.3	1.2	3.4	0.3	2.0	9.5	1.4	6.6
RAMACL	"C6orf119, dJ427A4.2, FAM103A2P, RAMMETL"	ENSG00000235272	"RNA guanine-7 methyltransferase activating subunit like (pseudogene)"		6	166585604-166587594	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"			"Tissue enhanced"	"Detected in single"		"brain: 2.9"	"Not detected"	"Not detected"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"ASC diff: 3.5;ASC TERT1: 2.8;HEK 293: 5.9;HeLa: 2.2;HHSteC: 4.9;TIME: 1.8"									"HPA041923, HPA041948"	Uncertain		Approved	Nucleoplasm		No	NA			"Cluster 8: Neutrophils - Inflammatory response"		"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm		"HPA041923: AB_10796467, HPA041948: AB_10797270"	"unprognostic (3.49e-2)"	"unprognostic (1.17e-3)"	"unprognostic (1.33e-2)"	"unprognostic (8.15e-2)"	"unprognostic (8.71e-2)"	"unprognostic (5.31e-3)"	"unprognostic (2.04e-1)"	"unprognostic (4.69e-2)"	"unprognostic (1.96e-1)"	"unprognostic (2.95e-2)"	"unprognostic (2.73e-2)"	"unprognostic (1.61e-1)"	"unprognostic (4.43e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.62e-3)"	"unprognostic (2.33e-2)"	0.0	0.4	1.3	0.0	1.2	0.7	0.0	0.2	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	1.0	0.0	0.0	0.0	0.0	1.8	0.9	0.0	0.0	0.0		0.0	1.5	0.0	0.0	0.2	0.0	0.0	0.1	0.6	0.0	0.0	0.7	0.3	0.0	0.0	1.6	0.7	0.4	0.0	0.0	0.0		2.9	0.0	0.0	0.0	0.2	3.5	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	5.9	0.0	2.2	0.0	4.9	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.5	0.0	0.0	0.1	0.0	0.1	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	2.3	3.9	1.7	2.1	1.9	2.9	2.0	1.9	2.6	2.8	1.9	1.7	4.4	2.2	1.1	1.7	2.6	2.1	1.3	1.2	0.2	0.8	0.7	1.0	1.8	0.9	1.5	0.7	1.6	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AL159163.1		ENSG00000249141	"Novel protein"		6	166858094-166956124	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in some"		"pancreas: 3.5"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 1.3;Hofbauer cells: 4.6;Pancreatic endocrine cells: 1.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"NB-4: 4.7;OE19: 6.2;U-937: 2.6"															NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 4: Stomach - Digestion"	"Cluster 21: OE19 - Mitochondria"	"Cluster 4: Macrophages - Innate immune response"				"unprognostic (1.22e-1)"	"unprognostic (1.22e-1)"	"unprognostic (7.52e-2)"	"unprognostic (7.60e-2)"	"unprognostic (1.51e-2)"	"unprognostic (4.47e-2)"	"unprognostic (7.13e-3)"	"unprognostic (1.87e-1)"	"unprognostic (2.27e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.95e-1)"	"unprognostic (2.90e-3)"	"unprognostic (1.76e-10)"	"unprognostic (2.10e-1)"	"unprognostic (1.24e-3)"	"unprognostic (1.52e-1)"	"unprognostic (9.28e-3)"	0.5	0.6	1.1	0.4	1.6	0.6	0.3	0.2	1.1	0.8	0.2	2.6	1.0	0.2	2.1	0.5	0.0	1.0	0.0	1.0	1.0	0.2	0.4	0.4	1.0	0.7	0.9	0.0	3.5	0.1	0.4	0.4	0.6	0.1	2.1	0.4	1.5	0.1	0.4	0.3	0.4	0.6	0.7	1.0	1.3	0.2	1.5	0.1	0.2	0.0	1.7	0.4	0.1	0.9	0.3	0.0	0.7	0.4	0.0	0.0	0.2	0.8	0.0	0.0	0.0	0.0	0.0	0.6	0.9	0.0	0.6	1.1	0.2	0.0	0.6	0.6	0.5	1.1	0.4	1.2	0.0	0.6	2.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.7	0.6	0.0	0.3	1.0	4.7	0.1	6.2	0.0	0.0	0.0	1.2	1.5	0.2	0.2	0.5	0.0	2.5	0.0	0.5	0.2	1.0	0.0	0.0	0.6	2.4	0.0	0.9	1.9	0.0	0.7	2.6	0.0	1.7	3.5	0.2	0.5	5.0	0.8	0.9	1.8	0.6	5.5	1.8	1.1	0.2	1.6	0.2	7.9	5.5	2.1	1.7	1.1	1.6	0.2	1.1	1.0	1.0	0.7	0.9	0.6	0.7	1.5	0.9	0.1	0.0	1.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.9	0.8	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.7	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.2	0.6	0.1	0.0	0.7	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0
RNASET2	"bA514O12.3, FLJ10907, RNASE6PL"	ENSG00000026297	"Ribonuclease T2"	O00584	6	166922113-166957191	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	"Immunity, Innate immunity"	"Endonuclease, Hydrolase, Lyase, Nuclease"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 490.2;Glandular and luminal cells: 761.3;Hofbauer cells: 382.2;Kupffer cells: 484.7;Macrophages: 418.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"THP-1: 497.9"									"HPA029013, HPA066509"	Approved				"Secreted to blood"	NA	NA		15000000	"Cluster 52: Eosinophils - Transcription"	"Cluster 50: Non-specific - Ribosome"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 44: Endometrium - Transcription"			"HPA029013: AB_10602922, HPA066509: AB_2685682"	"unprognostic (4.18e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.13e-2)"	"unprognostic (9.33e-2)"	"unprognostic (1.76e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.15e-2)"	"unprognostic (8.11e-2)"	"unprognostic (1.79e-1)"	"unprognostic (5.06e-2)"	"prognostic unfavorable (1.70e-14)"	"unprognostic (5.03e-2)"	"unprognostic (7.34e-2)"	"unprognostic (6.29e-2)"	"unprognostic (1.01e-2)"	34.9	35.0	50.1	68.6	50.4	124.3	50.2	52.2	65.9	161.5	52.3	74.0	57.6	49.1	140.7	24.8	134.6	69.6	19.8	49.5	53.5	31.2	52.4	47.2	117.4	68.2	54.3	36.2	144.7	40.7	26.3	43.5	66.2	51.9	89.9	8.3	112.8	94.1	7.3	25.4	65.4	27.8	61.9	195.1	72.9	13.3	59.1	43.8	76.7	12.1	86.9	54.9	32.2	79.8	12.8	14.2	12.6	37.8	57.0	40.6	8.4	15.8	21.2	7.3	7.4	33.7	19.9	11.1	149.8	41.3	16.7	41.0	20.8	18.6	4.3	15.9	35.1	10.2	20.6	84.6	19.1	152.7	37.3	23.9	33.6	4.3	2.7	30.4	10.1	21.7	20.9	94.5	10.9	44.9	12.6	109.5	6.4	140.0	13.0	25.0	16.6	131.7	136.3	9.9	4.4	28.7	32.0	100.4	8.3	22.3	13.1	497.9	19.3	14.9	9.8	43.7	13.5	15.0	19.5	1.4	32.3	149.2	10.3	116.9	185.6	674.8	29.1	277.0	53.4	136.7	159.9	72.3	226.4	119.6	128.4	41.4	438.9	30.7	368.8	369.3	90.8	179.8	50.1	50.4	52.2	65.9	49.5	53.5	68.2	54.3	66.2	61.9	59.1	79.8	21.8	19.2	29.3	10.1	270.1	43.3	116.4	45.1	72.3	10.5	97.0	95.1	9.5	47.1	28.0	38.6	0.0	63.4	286.8	133.7	23.5	59.2	10.3	490.2	78.9	44.9	75.4	27.6	13.6	27.4	58.8	45.8	80.0	761.3	71.7	38.6	19.2	20.0	382.2	13.5	37.1	204.0	24.4	484.7	187.7	11.3	35.4	418.2	58.7	113.4	146.1	24.4	64.9	14.6	1.7	74.1	324.8	29.3	158.6	61.2	178.5	19.6	19.0	7.1	26.3	31.9	18.6	10.0	23.1	58.3	34.5	27.8	149.2	15.3	193.0	103.9
CEP43	"FGFR1OP, FOP"	ENSG00000213066	"Centrosomal protein 43"	O95684	6	166999317-167094789	"Cancer-related genes, Disease related genes, Predicted intracellular proteins"	"Cilium biogenesis/degradation"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 12.3;Cytotrophoblasts: 14.2;Extravillous trophoblasts: 16.2;Hofbauer cells: 10.3;Syncytiotrophoblasts: 6.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071876	Approved		Supported	Centrosome		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 45: Intestine - Brush border"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 24: Non-specific - Transcription regulation"	Centrosome		"HPA071876: AB_2686467"	"unprognostic (9.14e-2)"	"unprognostic (2.24e-1)"	"unprognostic (3.98e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.69e-2)"	"unprognostic (9.59e-2)"	"unprognostic (1.00e-1)"	"unprognostic (6.95e-2)"	"unprognostic (8.83e-2)"	"unprognostic (1.08e-3)"	"unprognostic (4.06e-2)"	"prognostic unfavorable (7.32e-4)"	"unprognostic (1.29e-2)"	"unprognostic (2.49e-1)"	"unprognostic (3.15e-1)"	"unprognostic (2.09e-3)"	6.9	14.8	8.8	12.6	8.3	16.7	14.3	8.3	10.0	13.5	9.2	12.4	15.9	14.9	16.9	9.0	27.0	11.2	8.9	8.1	8.3	17.4	36.3	7.3	14.8	8.7	11.4	13.0	11.3	10.5	14.1	8.4	9.4	9.4	16.9	25.4	8.8	9.1	8.5	11.6	15.8	10.4	7.7	11.1	11.3	58.4	8.4	15.7	15.5	10.4	17.7	9.2	9.3	9.4	26.1	14.3	35.3	24.2	20.3	15.1	42.7	33.0	21.9	26.4	25.3	53.1	21.6	31.0	18.3	20.2	70.3	24.0	31.4	23.3	49.3	19.5	27.0	21.4	26.7	58.2	10.8	38.4	21.6	8.4	16.8	54.2	25.2	16.4	18.5	34.5	70.9	25.8	34.2	24.0	31.1	55.8	30.2	50.0	10.9	35.3	23.9	25.7	27.8	13.8	26.2	26.2	26.9	28.6	11.7	24.6	23.5	46.7	12.2	26.1	43.7	31.6	42.1	21.8	32.3	31.4	29.4	35.4	32.7	0.4	6.5	23.5	5.1	6.1	7.6	12.1	5.8	4.8	10.7	8.4	3.4	5.5	38.8	6.3	6.7	16.4	11.7	4.9	8.8	8.3	8.3	10.0	8.1	8.3	8.7	11.4	9.4	7.7	8.4	9.4	3.3	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.3	0.0	0.0	0.0	0.0	14.2	3.8	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	16.2	2.1	0.0	0.0	0.0	0.0	0.0	0.0	10.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	6.3	1.3	0.0	0.0	0.0
CCR6	"BN-1, CD196, CKR-L3, CMKBR6, DCR2, DRY-6, GPR-CY4, GPR29, STRL22"	ENSG00000112486	"C-C motif chemokine receptor 6"	P51684	6	167111807-167139696	"CD markers, G-protein coupled receptors, Human disease related genes, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"lymphoid tissue: 35.8"	"Group enriched"	"Detected in many"	4	"B-cells: 44.0;Late spermatids: 26.4;T-cells: 40.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"B-cells: 77.4;T-cells: 74.5"	"Group enriched"	"Detected in some"	6	"Hep G2: 9.4;OE19: 3.2"	"Region enriched"	"Detected in single"	7	"basal ganglia: 1.8"	"Not detected"	"Not detected"			"CAB006820, HPA014488"	Approved					NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 24: Non-specific - Transcription regulation"			"CAB006820: , HPA014488: AB_1846639"	"unprognostic (1.12e-2)"	"unprognostic (2.92e-2)"	"unprognostic (2.07e-3)"	"unprognostic (2.08e-1)"	"unprognostic (8.43e-2)"	"unprognostic (2.05e-4)"	"unprognostic (2.39e-1)"	"unprognostic (4.98e-3)"	"unprognostic (1.29e-1)"	"unprognostic (1.40e-1)"	"unprognostic (4.19e-2)"	"unprognostic (4.26e-2)"	"unprognostic (2.68e-4)"	"unprognostic (3.74e-2)"	"unprognostic (7.96e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.77e-1)"	0.5	0.2	0.5	11.4	0.5	2.5	2.2	0.2	0.7	0.9	0.1	1.9	2.8	0.4	0.6	1.4	0.6	2.1	0.1	0.6	0.3	0.5	0.6	1.2	18.1	0.3	0.3	0.2	0.1	0.1	0.0	0.1	0.3	1.0	2.2	1.4	0.6	0.3	0.1	2.4	6.6	0.4	0.2	12.5	3.6	2.7	0.5	3.6	0.6	0.1	35.8	4.4	0.0	0.4	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.0	0.1	0.8	0.2	0.0	0.0	0.0	0.2	0.1	0.0	0.9	0.3	0.0	0.2	9.4	0.0	0.5	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.1	0.0	3.2	0.0	0.1	0.1	0.1	0.2	0.0	0.5	0.2	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.5	0.0	0.2	0.3	0.2	0.1	0.0	0.1	0.4	0.3	0.2	0.4	4.5	0.0	74.5	69.0	30.7	11.6	17.5	77.4	0.3	0.2	0.7	1.5	0.1	2.1	58.7	6.9	0.5	0.5	0.2	0.7	0.6	0.3	0.3	0.3	0.3	0.2	0.5	0.4	0.7	0.0	4.2	1.0	44.0	1.0	0.3	0.0	0.0	0.8	2.1	1.1	0.0	0.0	1.9	0.0	2.1	0.1	3.0	0.0	1.9	0.2	8.6	0.8	0.3	1.0	0.0	0.4	1.8	0.2	0.0	0.9	4.1	0.3	2.5	0.2	1.1	0.8	0.1	0.0	1.1	2.0	0.0	0.0	7.3	26.4	0.0	5.5	1.8	0.0	3.7	0.5	0.0	1.0	0.3	0.1	0.1	0.4	5.5	0.2	4.6	0.4	0.9	3.8	0.0	0.7	0.5	2.2	0.4	0.1	0.4	0.1	40.1	0.1	0.8	0.1
TCP10L2	bA517H2.3	ENSG00000166984	"T-complex 10 like 2, pseudogene"	B9ZVM9	6	167146414-167196913	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in some"		"epididymis: 1.3;testis: 1.1"	"Group enriched"	"Detected in some"	13	"Early spermatids: 11.7;Late spermatids: 10.8;Spermatocytes: 39.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"CAB034197, HPA044709"	Uncertain					NA	NA				"Cluster 68: Epididymis - Unknown function"		"Cluster 66: Spermatocytes - Spermatogenesis"			"CAB034197: AB_2202388, HPA044709: AB_10961410"			"unprognostic (5.07e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.35e-1)"		"unprognostic (2.52e-1)"			"unprognostic (1.24e-1)"	"unprognostic (1.12e-1)"		"unprognostic (5.40e-4)"	"unprognostic (1.73e-1)"	"unprognostic (1.19e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	11.7	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.5	0.0	0.0	0.0	10.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.1	39.5	0.5	0.0	0.0	0.0	0.2	0.0	0.3	0.0
GPR31	"12-HETER, HETER1"	ENSG00000120436	"G protein-coupled receptor 31"	O00270	6	167155247-167157980	"G-protein coupled receptors, Predicted membrane proteins"	"Lipid metabolism"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"lymphoid tissue: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"HPA014014, HPA027108"	Uncertain					NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 16: Immune cells - Immune response"		"Cluster 41: Macrophages - Immune response"			"HPA014014: AB_1849292, HPA027108: AB_10601474"	"unprognostic (9.92e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.69e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.42e-3)"		"unprognostic (2.20e-3)"	"unprognostic (5.95e-3)"	"unprognostic (4.03e-2)"	"unprognostic (3.64e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.54e-2)"	"unprognostic (2.86e-1)"	"unprognostic (8.10e-4)"	"unprognostic (2.45e-1)"	"unprognostic (6.01e-2)"	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.1	0.0	0.0	0.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
UNC93A	"dJ366N23.1, dJ366N23.2"	ENSG00000112494	"Unc-93 homolog A"	Q86WB7	6	167271169-167316014	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	10	"esophagus: 5.1;intestine: 9.6;liver: 14.1;skin 1: 19.0"	"Cell type enhanced"	"Detected in some"		"Collecting duct cells: 11.0;Endometrial ciliated cells: 2.5;Erythroid cells: 2.7;Hepatocytes: 6.9;Intestinal goblet cells: 2.4;Proximal enterocytes: 3.4"	"Cancer enhanced"	"Detected in many"		"liver cancer: 4.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	11	"CACO-2: 7.4;Hep G2: 3.1;OE19: 7.5;SCLC-21H: 3.1"					"Not detected"	"Not detected"			HPA035729	Uncertain					NA	NA				"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 21: OE19 - Mitochondria"	"Cluster 2: Hepatocytes - Metabolism"			"HPA035729: AB_10696508"		"unprognostic (2.49e-1)"	"unprognostic (2.67e-1)"	"unprognostic (2.32e-1)"		"unprognostic (1.28e-1)"	"unprognostic (2.28e-1)"	"unprognostic (2.26e-1)"	"unprognostic (2.32e-1)"	"unprognostic (2.10e-1)"	"unprognostic (3.32e-3)"	"unprognostic (2.99e-2)"	"unprognostic (5.97e-3)"	"unprognostic (1.85e-1)"	"unprognostic (4.92e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.4	0.0	0.2	9.6	0.2	0.5	5.1	1.1	0.8	0.0	0.0	0.0	1.1	14.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.3	0.0	0.0	19.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	1.1	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	1.4	0.0	0.0	11.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	2.7	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.4	6.9	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.4	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0
TTLL2	"C6orf104, dJ366N23.3, NYD-TSPG"	ENSG00000120440	"Tubulin tyrosine ligase like 2"	Q9BWV7	6	167325071-167359503	"Predicted intracellular proteins"		Ligase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"testis: 18.4"	"Group enriched"	"Detected in some"	184	"Early spermatids: 389.3;Late spermatids: 274.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"CACO-2: 1.9"	"Not detected"	"Not detected"							HPA027985			Approved	"Nuclear membrane,Nucleoli"		NA	NA				"Cluster 83: Testis - Spermatogenesis"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 34: Spermatids - Unknown function"	"Nuclear membrane, Nucleoli"		"HPA027985: AB_2211832"	"unprognostic (5.98e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.47e-1)"	"unprognostic (6.69e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.79e-1)"	"unprognostic (5.29e-2)"	"unprognostic (9.47e-4)"		"unprognostic (7.57e-2)"	"unprognostic (2.63e-4)"	"unprognostic (3.50e-2)"	"unprognostic (2.39e-1)"	"unprognostic (8.14e-3)"	"unprognostic (1.94e-1)"	"unprognostic (8.02e-2)"		0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.1	0.1	1.6	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.0	18.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	389.3	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	274.1	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AFDN	"AF-6, AF6, MLLT4"	ENSG00000130396	"Afadin, adherens junction formation factor"	P55196	6	167826922-167972023	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins"	"Cell adhesion"		"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 173.8;Alveolar cells type 1: 169.9;Breast glandular cells: 119.1;Endometrial ciliated cells: 194.3;Glandular and luminal cells: 273.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"memory B-cell: 1.1"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013496, HPA030212, HPA030213, HPA030214, HPA030215, HPA049868"	Approved		Enhanced	"Nucleoplasm,Plasma membrane,Cell Junctions"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 37: Intestine - Unknown function"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 44: Endometrium - Transcription"	"Plasma membrane, Cell Junctions"	Nucleoplasm	"CAB013496: , HPA030212: AB_10599291, HPA030213: AB_10601340, HPA030214: AB_10601005, HPA030215: AB_10601556, HPA049868: AB_2680924"	"prognostic unfavorable (7.43e-5)"	"unprognostic (2.66e-3)"	"unprognostic (2.07e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.13e-1)"	"unprognostic (9.06e-2)"	"unprognostic (4.12e-1)"	"unprognostic (3.12e-2)"	"unprognostic (4.12e-1)"	"unprognostic (1.09e-3)"	"unprognostic (1.75e-1)"	"unprognostic (1.73e-2)"	"unprognostic (5.56e-2)"	"unprognostic (5.43e-3)"	"unprognostic (1.59e-1)"	"unprognostic (4.72e-2)"	"unprognostic (5.68e-2)"	39.7	15.0	25.1	23.1	34.8	5.5	49.5	27.2	27.9	46.0	35.1	55.3	53.1	35.8	39.8	126.3	63.8	33.6	47.3	21.0	29.7	45.0	66.8	57.0	10.9	30.2	30.0	31.2	61.2	32.8	38.3	44.9	29.5	47.0	62.7	47.1	79.0	28.6	34.0	54.7	71.1	23.9	12.3	34.2	50.6	31.3	31.2	7.3	51.4	28.4	27.3	29.2	61.8	35.3	67.7	20.7	141.2	50.8	13.5	11.3	104.8	26.8	13.7	22.7	27.9	88.8	41.1	12.0	48.3	16.3	35.5	31.8	59.2	55.1	40.3	76.1	61.1	0.4	9.1	67.9	20.3	7.7	30.8	8.0	36.2	38.1	89.0	36.1	42.8	25.6	137.4	45.5	14.9	29.2	0.8	0.6	34.7	95.6	9.5	43.6	37.1	51.2	41.3	32.5	65.1	39.6	27.2	101.7	40.5	131.1	12.2	2.8	62.9	10.6	50.5	45.7	44.9	0.8	59.3	24.5	31.4	15.4	93.7	0.0	0.1	0.0	0.3	0.1	0.2	1.1	0.3	0.1	0.2	0.7	0.0	0.1	0.9	0.0	0.1	0.0	0.2	0.0	25.1	34.8	27.2	27.9	21.0	29.7	30.2	30.0	29.5	12.3	31.2	35.3	173.8	169.9	89.3	0.0	6.4	0.0	0.0	0.0	0.0	0.0	119.1	83.3	0.0	0.0	40.9	95.6	0.0	30.6	4.7	0.0	21.5	70.1	0.0	194.3	42.0	36.3	0.0	0.0	0.0	39.4	35.0	20.5	0.0	273.4	8.8	65.0	0.0	0.0	20.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.8	0.0	0.0	10.9	0.0	0.0	0.0	0.0	65.7	0.0	0.0	4.5	0.0	0.0	35.0	46.7	0.0	0.0	0.0	8.1	0.0	0.0	0.0	0.0	42.1	5.6	13.2	0.0	0.0
KIF25	KNSL3	ENSG00000125337	"Kinesin family member 25"	Q9UIL4	6	167996241-168045095	"Predicted intracellular proteins"		"Motor protein"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"adipose tissue: 3.1;brain: 4.2;retina: 2.5"	"Cell type enriched"	"Detected in some"	4	"Adipocytes: 165.2"	"Cancer enhanced"	"Detected in some"		"testis cancer: 1.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"HDLM-2: 2.0"					"Not detected"	"Not detected"			HPA046153	Uncertain					NA	NA				"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"HPA046153: AB_10960550"	"unprognostic (1.11e-1)"	"unprognostic (9.32e-3)"	"unprognostic (1.39e-1)"	"unprognostic (6.65e-2)"	"unprognostic (1.60e-1)"	"unprognostic (4.46e-3)"	"unprognostic (1.66e-3)"	"unprognostic (2.27e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.07e-3)"	"unprognostic (2.45e-1)"	"unprognostic (7.08e-5)"	"unprognostic (1.55e-2)"	"unprognostic (5.09e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.77e-3)"	3.1	0.1	1.4	0.2	1.7	0.1	1.3	4.2	4.0	0.4	0.2	0.2	0.1	0.1	0.1	0.1	0.0	0.1	0.7	1.1	1.8	0.9	0.6	0.4	0.5	2.2	1.5	0.5	0.0	0.1	0.0	0.4	2.8	0.3	0.1	2.5	0.2	0.0	1.3	0.4	0.3	0.0	1.3	0.2	0.3	0.5	1.9	0.1	0.1	0.0	0.1	0.2	0.1	2.3	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.9	0.0	0.0	0.5	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	1.7	4.2	4.0	1.1	1.8	2.2	1.5	2.8	1.3	1.9	2.3	165.2	0.0	0.0	0.7	0.0	0.4	0.1	0.0	0.0	4.2	1.3	1.1	1.0	0.0	0.0	3.7	0.0	1.1	0.3	0.1	0.0	0.2	0.0	0.1	0.4	9.3	0.0	0.0	6.0	0.0	0.3	0.6	0.0	0.3	4.5	0.1	0.7	0.1	0.1	3.3	4.7	0.3	0.0	0.0	0.0	0.5	0.0	0.1	1.8	1.0	0.0	0.7	0.0	3.5	34.4	0.0	0.1	0.4	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.3	1.0	0.3	3.2	0.0	0.4	0.0	0.1	0.1	0.0	0.2
FRMD1	"bA164L23.1, DKFZp434O0117, FLJ00181, FLJ22615, FLJ40260"	ENSG00000153303	"FERM domain containing 1"	Q8N878	6	168053166-168101511	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 6.8;lymphoid tissue: 13.1;stomach 1: 5.7;testis: 5.1"	"Group enriched"	"Detected in some"	4	"Distal enterocytes: 68.9;Paneth cells: 167.2"	"Cancer enriched"	"Detected in single"	6	"colorectal cancer: 1.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"K-562: 1.9;RPMI-8226: 3.0"					"Low region specificity"	"Detected in many"			HPA030347	Enhanced		Approved	"Actin filaments"		NA	NA				"Cluster 3: T-cells - Adaptive immune response"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Actin filaments"		"HPA030347: AB_10600207"	"unprognostic (2.43e-2)"	"unprognostic (2.74e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.28e-1)"		"unprognostic (1.25e-1)"	"unprognostic (2.58e-4)"	"unprognostic (8.63e-2)"	"unprognostic (2.62e-1)"	"unprognostic (7.51e-2)"	"unprognostic (9.12e-2)"	"unprognostic (8.23e-2)"	"unprognostic (1.71e-2)"	"unprognostic (1.01e-1)"	"unprognostic (9.11e-3)"			3.6	0.0	0.0	0.4	0.0	0.0	1.4	0.0	0.0	0.0	0.0	6.8	1.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.6	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.1	0.0	0.2	0.0	3.1	0.1	0.0	2.1	5.7	5.1	0.0	13.1	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.5	0.0	0.0	1.8	0.0	0.0	0.0	68.9	0.0	0.0	15.3	0.0	0.0	0.2	7.8	0.0	0.0	1.8	0.0	0.4	4.6	0.1	0.0	0.3	0.4	0.6	0.0	0.0	0.0	16.0	0.0	0.0	0.0	20.2	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	167.2	1.5	0.0	0.0	19.6	23.8	0.0	0.0	0.0	0.3	0.7	13.4	8.2	0.0	0.0	0.1	0.1	15.2	12.6	0.2
DACT2	"bA503C24.7, C6orf116, DAPPER2"	ENSG00000164488	"Dishevelled binding antagonist of beta catenin 2"	Q5SW24	6	168292830-168319777	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 19.4;placenta: 12.9"	"Group enriched"	"Detected in many"	5	"Cytotrophoblasts: 58.2;Syncytiotrophoblasts: 216.3"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 14.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 3.2;CACO-2: 2.7;hTCEpi: 1.8;NTERA-2: 2.2;OE19: 11.2;SCLC-21H: 2.5"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	10	"basal ganglia: 16.9;cerebral cortex: 21.4;hippocampal formation: 16.8"	HPA030251	Enhanced	Supported				NA	NA				"Cluster 57: Non-specific - Angiogenesis"	"Cluster 21: OE19 - Mitochondria"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"			"HPA030251: AB_10611108"	"unprognostic (5.22e-6)"	"unprognostic (3.13e-2)"	"unprognostic (1.04e-2)"	"prognostic favorable (1.07e-5)"	"unprognostic (1.21e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.64e-2)"	"unprognostic (1.08e-1)"	"unprognostic (4.04e-1)"	"unprognostic (1.31e-1)"	"unprognostic (7.05e-3)"	"unprognostic (2.48e-1)"	"prognostic favorable (5.76e-5)"	"unprognostic (1.51e-2)"	"unprognostic (1.66e-2)"	"unprognostic (2.03e-4)"	"unprognostic (4.23e-2)"	2.3	3.3	3.7	0.4	19.4	0.0	0.6	2.9	6.2	1.7	1.4	1.0	0.8	2.7	0.1	1.5	1.7	0.4	5.2	2.7	2.7	3.6	5.8	1.6	0.4	4.1	3.5	0.1	2.9	0.0	0.6	12.9	4.6	7.3	0.3	5.8	6.5	0.4	0.2	5.7	0.6	0.2	2.8	0.0	0.7	1.0	4.1	1.9	0.3	0.0	0.6	1.1	1.2	3.0	0.0	3.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.4	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.2	11.2	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	19.4	2.9	6.2	2.7	2.7	4.1	3.5	4.6	2.8	4.1	3.0	0.0	0.0	2.0	0.0	0.0	3.1	1.9	0.8	0.0	10.7	0.1	3.0	0.6	1.5	1.3	1.8	0.0	58.2	0.0	0.1	0.0	1.3	0.0	11.8	0.5	0.7	5.3	0.0	0.1	0.2	6.1	3.4	0.0	11.0	0.0	3.3	0.0	0.3	5.3	0.0	0.3	1.3	0.0	0.0	0.0	0.0	0.0	0.1	3.6	6.5	0.0	26.3	0.0	0.0	0.1	0.3	1.2	0.0	0.0	1.1	0.0	5.7	0.0	0.9	0.0	0.5	0.1	0.0	0.3	0.0	1.4	216.3	0.2	0.0	1.9	0.1
SMOC2	SMAP2	ENSG00000112562	"SPARC related modular calcium binding 2"	Q9H3U7	6	168441151-168673445	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Fibroblasts: 149.8;Leydig cells: 321.8;Peritubular cells: 769.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 8.1;EFO-21: 2.8;RPMI-8226: 11.3;RPTEC TERT1: 3.8;SuSa: 9.1"	"Region enhanced"	"Detected in many"		"hippocampal formation: 25.7"	"Region enhanced"	"Detected in single"		"spinal cord: 1.4"						"Secreted to extracellular matrix"	NA	NA		120000	"Cluster 21: B-cells - Adaptive immune response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 50: Fibroblasts - ECM organization"				"unprognostic (3.23e-1)"	"unprognostic (5.29e-2)"	"unprognostic (3.70e-2)"	"unprognostic (1.53e-2)"	"unprognostic (2.43e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.20e-1)"	"unprognostic (4.77e-2)"	"unprognostic (4.41e-1)"	"unprognostic (1.40e-2)"	"unprognostic (2.60e-1)"	"unprognostic (6.44e-2)"	"prognostic unfavorable (1.16e-6)"	"unprognostic (3.50e-2)"	"unprognostic (2.68e-1)"	"unprognostic (6.35e-2)"	"unprognostic (6.20e-3)"	67.8	14.0	10.6	13.0	12.7	0.0	61.0	10.8	16.2	82.1	42.3	44.1	21.4	164.0	147.2	53.1	119.6	100.8	57.2	10.6	11.3	13.0	4.0	14.7	14.7	11.8	11.8	124.1	25.2	12.2	4.5	18.8	11.9	31.0	24.9	2.8	17.1	54.6	42.1	28.9	27.8	76.5	10.2	4.4	144.7	44.2	12.2	10.9	43.5	54.8	11.1	68.7	21.8	10.0	2.4	0.0	8.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.4	1.0	0.0	0.0	0.0	0.0	11.3	3.8	0.0	1.7	0.3	0.0	0.3	0.1	9.1	0.0	0.0	0.0	0.0	1.7	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	10.6	12.7	10.8	16.2	10.6	11.3	11.8	11.8	11.9	10.2	12.2	10.0	8.1	0.0	1.7	0.7	0.0	11.1	8.0	0.0	1.2	7.1	12.5	12.1	7.7	0.0	1.8	11.0	0.0	2.5	0.0	3.6	0.0	0.0	2.6	40.3	42.3	11.0	19.7	0.0	0.5	0.0	1.7	149.8	1.1	58.4	0.0	17.2	3.3	0.0	1.2	0.0	9.7	4.5	0.0	0.0	3.9	17.2	321.8	2.9	3.6	6.5	0.0	0.4	0.0	2.0	0.1	0.1	0.4	769.2	0.1	6.7	2.0	0.0	2.2	0.8	46.0	14.7	63.3	3.9	5.1	0.8	2.7	2.6	1.7	17.3	47.4	1.1
THBS2	TSP2	ENSG00000186340	"Thrombospondin 2"	P35442	6	169215780-169254050	"Cancer-related genes, Disease related genes, Plasma proteins, Predicted secreted proteins"	"Cell adhesion"	Heparin-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"Basal keratinocytes: 86.8;Endometrial stromal cells: 71.1;Fibroblasts: 127.7;Langerhans cells: 69.8;Melanocytes: 56.9;Oligodendrocyte precursor cells: 40.7;Oligodendrocytes: 55.8;Smooth muscle cells: 33.7;Suprabasal keratinocytes: 42.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 250.2;ASC TERT1: 200.3;BJ hTERT+: 88.6;BJ hTERT+ SV40 Large T+: 96.3;BJ hTERT+ SV40 Large T+ RasG12V: 117.8;HSkMC: 113.2;hTEC/SVTERT24-B: 127.2;U-2197: 107.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017716, HPA044304"	Approved		Approved	"Nuclear speckles,Plasma membrane,Cytosol"	"Secreted to extracellular matrix"	NA	NA		21000000		"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane"	"Nuclear speckles, Cytosol"	"CAB017716: , HPA044304: AB_2678891"	"unprognostic (2.85e-2)"	"unprognostic (1.41e-1)"	"unprognostic (5.87e-2)"	"unprognostic (8.90e-2)"	"unprognostic (3.64e-2)"	"unprognostic (8.73e-2)"	"unprognostic (2.93e-1)"	"unprognostic (5.10e-3)"	"unprognostic (1.39e-1)"	"unprognostic (4.71e-2)"	"unprognostic (4.00e-2)"	"unprognostic (2.56e-1)"	"prognostic unfavorable (3.77e-6)"	"unprognostic (2.19e-3)"	"unprognostic (4.38e-2)"	"unprognostic (4.16e-2)"	"unprognostic (2.48e-3)"	52.9	7.9	5.5	14.8	15.4	0.0	36.2	10.9	7.7	63.1	0.2	20.4	2.5	50.0	0.7	12.0	34.7	50.4	44.2	6.5	13.1	8.3	8.2	19.8	3.3	17.1	18.2	33.2	5.6	1.7	9.5	2.2	21.4	9.7	2.4	0.1	8.2	2.5	3.4	41.1	9.2	21.3	11.3	3.3	5.4	2.3	15.0	0.6	17.0	1.8	1.2	29.1	30.8	19.3	0.2	0.0	2.5	1.1	250.2	200.3	0.0	76.8	88.6	96.3	117.8	0.4	0.0	0.1	0.1	76.1	0.2	0.1	2.4	3.2	22.5	0.0	0.0	0.0	0.0	0.0	73.1	0.3	0.0	113.2	0.0	127.2	0.0	0.2	0.0	0.0	0.0	0.1	3.7	0.0	0.1	1.7	16.3	0.0	0.6	0.0	0.1	1.1	0.0	0.4	0.3	0.2	0.2	0.1	0.0	0.2	0.0	0.7	0.0	46.1	0.4	107.6	9.3	0.1	0.7	0.0	30.6	0.1	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	15.4	10.9	7.7	6.5	13.1	17.1	18.2	21.4	11.3	15.0	19.3	3.5	6.4	0.0	6.8	0.0	86.8	1.6	0.1	1.8	0.4	2.2	1.8	5.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.2	0.2	3.1	71.1	4.6	0.0	0.0	1.2	0.0	0.0	127.7	1.1	1.4	0.0	0.0	15.4	0.0	0.3	0.0	1.7	0.0	0.0	0.0	69.8	0.3	8.1	1.2	56.9	6.5	0.0	0.2	0.0	40.7	55.8	0.5	0.0	16.1	0.0	1.9	0.0	4.4	0.0	0.2	0.0	1.0	33.7	0.0	0.4	1.2	42.3	0.1	2.1	5.5	0.0	0.9
AL031315.1		ENSG00000285733	"Novel protein"		6	169419969-169702047	"Predicted intracellular proteins"				"Evidence at transcript level"	"Evidence at transcript level"			"Tissue enhanced"	"Detected in single"		"brain: 1.5"	"Not detected"	"Not detected"							"Low region specificity"	"Detected in single"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"A-431: 1.5;OE19: 1.4"															NA	NA			"Cluster 17: Basophils - Unknown function"		"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 49: Ciliated cells - Cilium organization"																					0.2	0.2	0.5	0.1	0.6	0.9	0.1	1.5	0.8	0.1	0.0	0.0	0.1	0.2	0.1	0.1	0.1	0.1	0.0	0.4	0.1	0.1	0.1	0.1	0.1	0.6	0.0	0.3	0.1	0.0		0.1	0.4	0.1	0.0	0.3	0.1	0.1	0.0	0.4	0.1	0.1	0.0	0.2	0.2	0.4	0.2	0.0	0.1	0.0	0.0	0.0		0.7	1.5	0.0	0.1	0.7	0.6	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.5	0.1	0.4	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.3	0.0	0.3	0.0	0.1	0.1	0.9	0.0	0.4	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.7	0.0	0.3	0.4	0.1	1.4	0.6	0.1	0.1	0.3	0.0	0.0	0.1	0.3	0.1	0.1	0.3	0.2	0.1	0.2	0.3	0.2	0.1	0.0	0.1	0.5	0.4	0.1	0.2	0.3	0.1	1.3	0.2	0.2	0.3	0.1	0.2	0.2	0.1	0.3	0.1	0.4	0.2	0.3	0.7	0.5	0.0	0.2	0.1	0.2	0.5	0.6	1.5	0.8	0.4	0.1	0.6	0.0	0.4	0.0	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
WDR27	MGC43690	ENSG00000184465	"WD repeat domain 27"	A2RRH5	6	169457212-169702067	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 44.1;Excitatory neurons: 57.2;Inhibitory neurons: 52.6;Oligodendrocyte precursor cells: 51.3;Oligodendrocytes: 47.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA037497, HPA037498"	Uncertain		Enhanced	Nucleoplasm		NA	NA			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 71: Testis - DNA repair"	"Cluster 12: NES - Nervous system development"	"Cluster 49: Ciliated cells - Cilium organization"	Nucleoplasm		"HPA037497: AB_10671503, HPA037498: AB_2675509"	"unprognostic (2.10e-1)"	"unprognostic (8.66e-3)"	"unprognostic (1.32e-1)"	"unprognostic (1.78e-2)"	"unprognostic (8.59e-2)"	"unprognostic (1.98e-3)"	"unprognostic (3.81e-3)"	"unprognostic (2.59e-2)"	"unprognostic (1.83e-1)"	"unprognostic (8.63e-2)"	"unprognostic (2.43e-2)"	"unprognostic (3.62e-2)"	"prognostic unfavorable (1.78e-5)"	"unprognostic (3.15e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.55e-1)"	"unprognostic (4.30e-3)"	5.1	4.5	2.8	3.1	2.2	2.6	6.7	3.1	3.1	9.5	5.9	6.7	3.4	8.1	4.8	6.3	9.9	3.3	3.5	2.3	2.0	5.0	4.4	4.7	4.1	2.4	2.5	10.9	6.1	3.1	5.1	3.0	2.2	6.8	3.6	2.5	6.2	2.0	4.1	4.7	6.1	2.2	1.7	4.8	5.8	10.5	2.7	3.5	10.0	0.8	3.0	6.4	8.0	2.0	3.8	6.5	17.6	6.4	4.2	8.3	4.4	5.8	1.6	3.5	4.1	6.1	4.8	3.1	3.5	1.8	5.0	8.5	3.1	4.4	5.1	4.0	6.0	6.7	13.4	6.1	2.5	3.3	1.0	4.3	4.1	4.4	3.3	6.5	6.5	7.3	15.6	6.1	4.6	4.9	2.1	12.3	4.6	2.8	3.3	5.0	3.6	5.6	3.3	3.5	7.3	7.5	3.8	3.6	2.1	4.7	4.3	6.1	5.6	4.6	3.7	4.3	5.1	5.8	2.2	7.5	4.2	7.7	4.7	0.0	0.1	0.3	0.3	0.1	0.8	0.3	0.4	0.4	0.1	0.8	1.6	0.2	0.0	0.1	0.1	0.4	0.4	0.3	2.8	2.2	3.1	3.1	2.3	2.0	2.4	2.5	2.2	1.7	2.7	2.0	7.0	9.6	3.9	44.1	6.6	2.2	5.6	6.7	8.0	13.5	8.5	9.0	4.3	7.2	5.4	12.9	6.2	5.2	3.2	3.2	0.0	2.3	28.3	26.9	15.5	7.2	4.2	7.8	57.2	1.5	2.8	7.3	11.2	6.2	3.8	13.7	9.3	4.1	2.2	21.9	52.6	4.7	2.0	2.4	2.5	10.3	8.1	3.4	3.6	38.4	1.4	5.9	4.1	51.3	47.4	2.1	5.7	9.8	4.8	4.3	4.2	2.1	25.7	12.7	0.0	5.2	6.3	21.7	10.7	8.1	1.1	1.9	5.4	6.3	7.0	5.4
C6orf120	bA160E12.4	ENSG00000185127	"Chromosome 6 open reading frame 120"	Q7Z4R8	6	169702190-169704856	"Predicted secreted proteins"	Apoptosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"Early spermatids: 116.9;Late spermatids: 272.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039626	Uncertain				"Secreted to blood"	NA	NA		620000	"Cluster 26: Non-specific - Mitochondria"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 31: Spermatids - Spermatogenesis"			"HPA039626: AB_10673361"	"unprognostic (2.98e-2)"	"prognostic unfavorable (2.26e-4)"	"unprognostic (3.43e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.30e-3)"	"prognostic unfavorable (9.52e-5)"	"unprognostic (1.78e-1)"	"unprognostic (2.84e-1)"	"prognostic unfavorable (8.37e-4)"	"unprognostic (1.56e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.63e-1)"	"unprognostic (6.21e-3)"	"unprognostic (2.88e-1)"	"unprognostic (2.80e-1)"	"unprognostic (3.14e-3)"	21.6	16.6	10.2	14.5	10.7	7.7	15.2	10.8	11.5	13.1	9.8	15.5	16.3	11.2	9.3	13.4	10.3	13.1	9.6	10.6	10.6	19.3	28.0	10.6	16.4	8.8	10.8	15.6	14.2	12.0	6.1	20.0	9.5	12.0	14.4	26.3	13.7	12.0	13.8	9.0	15.9	13.4	10.7	13.7	14.8	8.7	11.2	12.4	10.4	13.2	15.5	15.2	6.7	12.2	13.9	10.9	26.2	40.1	71.4	59.3	29.6	28.5	40.9	23.3	27.2	14.9	12.7	11.8	22.4	35.0	38.7	20.8	17.2	26.1	38.9	20.0	41.6	16.8	10.5	31.4	50.6	28.2	25.7	73.2	21.0	27.8	32.0	40.8	28.6	26.7	45.0	32.8	40.6	25.1	15.3	19.3	22.4	24.3	12.7	11.1	14.4	32.0	28.9	15.3	10.6	24.0	23.7	14.9	19.6	29.7	24.9	36.7	31.8	9.8	19.2	52.3	19.6	42.2	69.3	16.7	32.5	25.7	26.3	6.2	7.9	7.1	3.2	7.6	4.3	3.2	4.7	5.6	6.3	4.9	6.2	5.2	4.2	3.1	6.0	2.1	3.4	3.9	10.2	10.7	10.8	11.5	10.6	10.6	8.8	10.8	9.5	10.7	11.2	12.2	11.3	16.0	5.3	7.2	14.1	9.8	12.6	9.9	12.0	15.3	12.5	9.4	8.8	5.7	10.3	14.7	25.0	27.5	13.2	20.2	9.8	10.6	116.9	9.7	18.5	9.7	14.3	18.3	9.5	15.8	31.6	19.5	16.3	10.8	9.5	11.3	8.9	18.9	16.6	8.4	12.9	12.7	14.2	16.9	6.5	272.5	17.7	13.6	19.6	1.9	15.2	28.6	10.3	11.1	10.3	10.9	10.3	11.7	18.8	13.1	22.4	12.7	12.4	24.6	0.0	10.3	10.8	15.4	12.3	12.6	10.2	29.0	10.9	9.2	12.9	14.7
PHF10	"BAF45a, FLJ10975, XAP135"	ENSG00000130024	"PHD finger protein 10"	Q8WUB8	6	169703902-169725566	"Predicted intracellular proteins"	"Neurogenesis, Transcription, Transcription regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055649	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA055649: AB_2682875"	"unprognostic (1.74e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.40e-2)"	"unprognostic (4.25e-2)"	"unprognostic (4.45e-2)"	"unprognostic (6.76e-3)"	"prognostic unfavorable (3.42e-4)"	"unprognostic (1.28e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.48e-1)"	"prognostic favorable (1.12e-5)"	"unprognostic (5.92e-2)"	"prognostic unfavorable (1.56e-5)"	"unprognostic (2.63e-1)"	"unprognostic (6.82e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.76e-2)"	41.9	78.5	49.1	39.0	55.4	53.4	40.9	52.2	53.9	43.1	46.3	49.2	32.3	40.0	39.2	46.7	39.7	34.6	46.5	43.0	54.2	38.4	52.4	40.4	61.7	52.5	56.2	80.7	41.0	47.7	36.3	43.7	54.8	48.4	34.6	59.1	44.5	44.7	81.3	50.9	40.7	33.4	56.6	49.8	42.7	41.7	55.0	53.2	48.6	63.7	61.3	42.3	41.9	57.4	31.2	30.7	119.2	125.5	40.7	24.5	49.0	41.2	37.3	49.8	54.3	88.9	31.4	91.1	24.4	29.2	31.7	38.4	92.5	45.3	72.0	73.3	82.1	91.1	54.8	116.9	41.5	134.2	5.4	18.5	46.7	32.1	29.4	82.3	80.2	64.4	102.7	57.5	36.0	53.4	25.6	115.0	37.6	68.3	18.9	121.0	84.4	73.7	62.1	32.5	56.7	75.9	56.4	18.4	41.5	49.7	36.3	158.6	54.0	28.1	46.6	36.3	53.2	50.7	46.1	112.3	36.7	88.6	45.6	1.6	1.4	3.2	1.5	1.5	1.4	2.6	2.7	2.1	1.4	1.7	2.6	2.8	0.2	1.2	1.6	1.2	1.8	0.8	49.1	55.4	52.2	53.9	43.0	54.2	52.5	56.2	54.8	56.6	55.0	57.4	42.5	25.6	30.1	17.9	24.5	29.8	22.7	13.3	13.1	12.1	38.1	31.8	59.3	35.8	23.7	11.0	41.7	14.8	25.9	11.0	13.7	12.5	15.3	32.1	27.4	28.2	25.9	7.4	14.9	12.6	8.9	27.6	12.8	42.1	6.3	38.1	29.3	27.5	11.6	11.8	19.0	22.8	18.3	13.9	28.7	9.7	22.4	21.5	19.6	28.1	11.8	33.4	10.3	17.6	33.6	17.1	19.4	21.1	16.4	27.6	18.6	12.4	22.7	26.8	19.7	27.9	53.1	18.9	22.0	21.2	23.4	17.4	21.2	33.2	20.0	27.4
DYNLT2	"TCTE3, TCTEX1D3, TCTEX2, Tctex4"	ENSG00000184786	"Dynein light chain Tctex-type 2"	Q8IZS6	6	169740109-169751587	"Predicted intracellular proteins"	Transport	"Motor protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	30	"testis: 18.2"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 1.8;B-cells: 1.3;Cytotrophoblasts: 1.5;dendritic cells: 3.4;Endothelial cells: 1.1;Extravillous trophoblasts: 1.3;Plasma cells: 2.2;Smooth muscle cells: 1.7;Syncytiotrophoblasts: 1.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"									NA	NA				"Cluster 78: Testis - Spermatogenesis"		"Cluster 24: Non-specific - Transcription regulation"				"unprognostic (1.29e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.69e-1)"	"unprognostic (2.22e-2)"	"unprognostic (1.05e-2)"	"unprognostic (6.15e-2)"	"unprognostic (1.70e-2)"	"unprognostic (2.63e-2)"	"unprognostic (5.11e-2)"	"unprognostic (1.87e-1)"	"unprognostic (6.11e-5)"	"unprognostic (1.58e-1)"	"unprognostic (2.04e-10)"	"unprognostic (1.16e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.35e-1)"	"unprognostic (3.56e-5)"	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.6	0.2	0.2	0.2	0.0	0.2	0.2	1.8	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	1.5	3.4	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	1.3	0.8	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	1.6	0.4	0.0	0.0	0.0
ERMARD	"C6orf70, dJ266L20.3, FLJ11152"	ENSG00000130023	"ER membrane associated RNA degradation"	Q5T6L9	6	169751622-169781600	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"		"Developmental protein"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 49.9;Late spermatids: 48.5;Spermatocytes: 37.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA041741	Approved		Approved	Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 71: Testis - DNA repair"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Cytosol		"HPA041741: AB_10804116"	"unprognostic (2.66e-3)"	"unprognostic (2.75e-1)"	"unprognostic (2.33e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.18e-1)"	"unprognostic (2.24e-2)"	"unprognostic (7.41e-3)"	"unprognostic (1.96e-1)"	"unprognostic (8.14e-2)"	"unprognostic (1.66e-3)"	"unprognostic (4.74e-2)"	"unprognostic (3.06e-2)"	"unprognostic (3.08e-1)"	"unprognostic (1.88e-1)"	"unprognostic (2.71e-1)"	"unprognostic (1.31e-2)"	13.8	14.6	5.3	8.4	7.1	10.1	13.1	5.4	6.7	13.7	5.6	11.2	6.3	13.8	20.5	10.5	13.2	7.7	6.8	5.3	5.9	16.1	18.6	9.7	13.8	6.9	6.1	17.4	11.4	6.9	15.4	7.4	7.2	12.7	7.4	14.6	11.0	8.6	14.9	18.7	13.6	6.4	6.5	17.3	10.9	22.1	6.1	9.9	13.2	2.5	13.6	11.2	10.8	9.1	5.1	7.5	9.7	14.8	6.9	11.4	5.1	5.3	7.7	5.0	6.3	2.0	8.3	8.0	4.8	6.5	6.1	13.3	4.0	10.3	4.4	8.6	4.4	11.5	9.9	3.0	13.7	16.1	7.6	13.4	10.4	6.1	15.5	12.8	3.4	14.0	8.0	11.4	6.5	7.7	6.8	14.4	3.2	5.7	5.4	7.5	6.0	13.0	6.2	4.0	3.8	7.0	9.0	9.0	4.9	6.3	7.1	12.8	5.3	5.7	3.4	9.1	6.5	13.1	17.5	6.7	7.2	9.7	6.6	1.6	4.2	1.8	5.2	7.9	5.2	5.1	6.0	5.9	4.4	6.0	4.7	4.4	0.4	5.2	9.7	3.7	7.6	3.9	5.3	7.1	5.4	6.7	5.3	5.9	6.9	6.1	7.2	6.5	6.1	9.1	8.5	3.2	11.1	20.2	6.2	4.1	4.4	7.7	5.2	12.0	5.9	5.1	2.8	5.7	7.7	5.5	10.4	12.2	4.7	3.0	11.7	9.8	49.9	10.8	9.4	5.0	6.0	4.6	9.3	8.5	8.3	7.0	5.6	6.9	2.5	11.7	7.9	10.1	5.9	5.0	11.8	2.9	6.1	5.7	4.4	48.5	4.4	6.1	3.6	8.4	5.6	14.6	5.2	17.1	20.7	5.3	2.4	4.5	4.4	2.5	5.7	9.5	15.5	10.8	6.6	5.5	5.8	37.8	18.0	5.5	3.1	7.1	4.7	10.3	3.4	3.4
DLL1		ENSG00000198719	"Delta like canonical Notch ligand 1"	O00548	6	170282206-170306565	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Differentiation, Notch signaling pathway"	"Developmental protein"	"Autism spectrum disorder, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 53.9"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 88.8;Basal keratinocytes: 66.9;Basal squamous epithelial cells: 82.0;Enteroendocrine cells: 51.9;Intestinal goblet cells: 80.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	8	"NK-cell: 3.3"	"Lineage enriched"	"Detected in single"	8	"NK-cells: 3.3"	"Cell line enhanced"	"Detected in some"		"HaCaT: 6.8;HBEC3-KT: 4.5;NB-4: 14.2;THP-1: 14.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA001255			Approved	"Plasma membrane"		NA	NA		690000	"Cluster 48: NK-cells - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Plasma membrane"		"HPA001255: "	"unprognostic (1.03e-1)"	"unprognostic (9.22e-2)"	"unprognostic (2.17e-3)"	"unprognostic (1.95e-1)"	"unprognostic (2.89e-2)"	"unprognostic (6.35e-2)"	"unprognostic (1.63e-2)"	"unprognostic (1.89e-1)"	"unprognostic (9.22e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.39e-2)"	"unprognostic (2.64e-2)"	"unprognostic (5.23e-3)"	"unprognostic (3.50e-1)"	"unprognostic (1.83e-1)"	"unprognostic (4.33e-2)"	"unprognostic (1.66e-1)"	20.9	8.6	2.8	2.1	6.9	0.7	19.2	3.3	4.5	21.1	0.2	15.4	3.9	10.1	0.3	21.9	11.5	0.8	15.9	2.2	2.9	12.5	6.4	13.1	1.9	6.0	5.1	4.2	16.9	0.3	6.2	1.2	4.8	28.7	0.9	0.4	17.7	1.1	5.3	26.2	19.3	0.8	2.0	53.9	10.9	1.6	4.0	0.2	12.4	0.7	0.4	9.6	22.9	11.0	0.7	0.1	3.3	2.0	0.1	0.1	1.5	0.3	0.2	0.2	0.3	1.0	0.1	0.0	0.3	0.1	0.6	6.8	1.4	4.5	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	3.6	0.1	0.6	0.0	0.4	0.1	0.7	0.0	0.0	0.0	0.1	0.8	0.0	14.2	0.2	0.1	0.0	1.1	2.8	0.0	0.0	0.4	1.6	0.2	0.1	0.0	0.0	1.1	0.4	14.8	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	1.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	3.3	0.4	0.0	0.0	0.1	2.8	6.9	3.3	4.5	2.2	2.9	6.0	5.1	4.8	2.0	4.0	11.0	88.8	0.0	0.5	26.1	2.7	66.9	14.9	31.2	82.0	1.4	5.4	14.7	11.8	0.0	7.2	1.8	22.9	3.1	3.0	3.0	0.0	0.3	0.4	5.1	10.1	28.5	51.9	0.4	6.9	1.8	5.9	19.2	1.5	5.3	5.7	0.2	21.4	0.2	1.3	0.0	6.4	80.3	16.2	4.8	6.6	1.9	0.3	2.7	7.2	4.7	0.2	1.1	0.0	28.6	26.7	0.7	2.5	1.2	0.3	4.8	2.5	0.1	9.0	0.6	13.1	12.3	8.2	0.5	2.0	8.5	12.8	3.7	4.7	0.1	3.6	1.1
FAM120B	"CCPG, KIAA1838, PGCC1, SAN1"	ENSG00000112584	"Family with sequence similarity 120B"	Q96EK7	6	170290703-170407067	"Predicted intracellular proteins"	"Differentiation, Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	19	"Early spermatids: 556.1;Late spermatids: 1847.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037518, HPA037519"	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 72: Non-specific - Transcription"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA037518: AB_10671626, HPA037519: AB_10696935"	"unprognostic (7.99e-3)"	"unprognostic (7.81e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.23e-2)"	"unprognostic (6.02e-2)"	"unprognostic (2.76e-2)"	"unprognostic (1.88e-1)"	"unprognostic (9.87e-2)"	"prognostic unfavorable (1.60e-4)"	"prognostic favorable (2.70e-4)"	"unprognostic (1.41e-1)"	"unprognostic (9.27e-2)"	"unprognostic (3.15e-2)"	"unprognostic (2.50e-1)"	"unprognostic (4.98e-2)"	"unprognostic (1.36e-1)"	12.3	12.2	9.3	5.7	8.7	4.5	12.5	11.2	11.2	11.6	9.9	11.5	6.2	12.1	8.9	10.0	12.2	6.1	10.7	7.7	9.0	8.3	8.8	9.4	7.1	10.0	9.8	11.0	9.6	7.1	11.4	6.6	10.3	11.0	8.6	9.2	13.8	6.2	17.4	12.3	10.1	7.6	7.7	10.1	10.2	14.4	9.1	7.4	9.8	6.8	6.6	10.9	10.4	10.5	7.0	7.1	8.7	12.7	15.4	14.2	6.2	6.4	13.4	8.5	7.2	6.4	5.2	8.0	5.2	14.2	9.2	8.2	11.0	13.1	13.0	9.0	5.2	10.5	6.5	8.4	10.5	10.5	6.5	14.0	11.2	9.2	12.2	14.6	15.7	6.3	9.5	7.8	17.0	13.7	6.3	11.8	5.3	12.5	4.8	6.5	9.8	10.3	10.3	6.2	6.0	9.6	6.2	8.7	2.9	13.0	7.0	20.6	13.4	4.2	6.3	11.3	6.4	6.6	7.3	9.9	11.6	7.4	15.9	16.5	5.9	7.5	5.4	6.4	6.3	4.4	5.1	6.1	6.4	5.3	6.4	5.3	10.0	11.9	10.1	3.5	6.6	6.7	9.3	8.7	11.2	11.2	7.7	9.0	10.0	9.8	10.3	7.7	9.1	10.5	17.8	22.4	17.6	36.9	13.2	3.6	5.2	11.1	16.5	16.7	13.7	13.6	15.7	11.5	13.0	14.7	33.3	10.5	7.3	11.8	0.0	8.4	556.1	18.8	16.7	15.4	9.6	11.1	48.8	9.1	7.6	13.1	14.3	22.5	10.1	14.1	10.4	10.7	11.0	6.7	53.2	12.5	12.2	9.8	5.6	1847.0	19.3	10.2	19.6	40.3	8.8	7.7	8.2	50.3	62.6	9.2	6.5	14.3	12.0	9.3	10.1	5.4	19.9	14.2	32.9	12.9	10.1	18.4	12.7	10.8	5.8	13.4	13.9	11.2	8.8	6.4
PSMB1	"HC5, PMSB1"	ENSG00000008018	"Proteasome 20S subunit beta 1"	P20618	6	170535120-170553307	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Host-virus interaction"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 1197.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029635, HPA029637, CAB033911"	Enhanced		Supported	Nucleoplasm		NA	NA		15000000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"CAB033911: AB_2268890, HPA029635: AB_10599738, HPA029637: AB_10601793"	"unprognostic (2.78e-2)"	"unprognostic (3.10e-2)"	"unprognostic (6.73e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.20e-1)"	"unprognostic (5.41e-3)"	"unprognostic (2.36e-2)"	"unprognostic (3.32e-2)"	"unprognostic (8.39e-2)"	"unprognostic (4.28e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (3.76e-6)"	"unprognostic (3.63e-1)"	"unprognostic (7.50e-2)"	"unprognostic (1.45e-3)"	"unprognostic (9.62e-2)"	214.3	191.2	127.8	138.1	131.9	206.8	186.4	129.8	150.7	146.1	131.9	175.9	147.4	174.9	279.4	175.2	157.1	114.5	222.3	127.7	139.0	179.7	308.6	158.3	175.8	129.2	127.5	136.6	153.1	169.2	151.8	173.8	133.2	130.9	166.9	98.5	141.7	151.3	355.2	192.2	149.1	164.3	137.6	165.7	156.8	114.3	132.9	180.5	142.4	239.2	206.8	168.8	143.4	143.0	309.8	284.9	396.2	514.9	347.3	271.2	421.6	288.3	422.7	471.6	478.5	628.9	259.3	449.1	366.2	390.0	430.8	303.7	446.0	459.8	488.7	460.2	502.1	384.4	277.6	799.6	406.3	455.8	327.1	311.5	277.6	455.6	293.1	322.4	409.9	278.1	774.3	373.2	436.9	835.1	343.5	633.0	362.7	558.1	387.9	326.9	314.1	571.6	495.1	183.6	394.5	321.6	277.1	424.5	231.5	351.1	290.9	648.4	313.3	190.4	304.8	466.9	543.2	315.8	454.8	565.8	443.7	510.9	417.5	258.4	431.9	290.2	265.2	416.1	313.5	386.4	306.0	290.7	523.1	305.7	288.1	279.8	249.3	408.2	384.4	297.4	442.6	652.5	127.8	131.9	129.8	150.7	127.7	139.0	129.2	127.5	133.2	137.6	132.9	143.0	242.7	112.2	148.5	19.9	182.1	217.2	351.4	750.7	117.8	120.2	168.2	236.3	232.3	208.8	335.5	141.6	41.7	876.6	175.0	222.0	401.1	498.3	332.4	224.6	190.2	243.8	165.3	223.9	23.5	651.4	790.8	245.5	109.6	215.1	189.5	226.1	168.8	349.8	394.3	119.5	25.1	251.6	417.1	165.3	222.3	81.9	256.3	207.3	231.3	20.6	364.5	237.8	206.0	19.6	43.3	525.5	240.1	235.9	253.4	334.9	327.6	537.0	310.0	135.9	190.7	181.2	500.2	247.8	196.3	153.3	215.8	1197.8	182.1	283.7	276.7	365.4
TBP	"GTF2D1, SCA17, TFIID"	ENSG00000112592	"TATA-box binding protein"	P20226	6	170554302-170572870	"Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Host-virus interaction, Transcription, Transcription regulation"	DNA-binding	"Disease variant, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 88.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009442, HPA049805"	Enhanced		Supported	Nucleoplasm		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm		"CAB009442: AB_632480, HPA049805: AB_2680890"	"unprognostic (2.86e-3)"	"unprognostic (1.73e-2)"	"unprognostic (3.90e-2)"	"unprognostic (4.55e-3)"	"unprognostic (7.10e-2)"	"unprognostic (2.33e-2)"	"prognostic unfavorable (1.51e-7)"	"unprognostic (1.46e-1)"	"unprognostic (4.28e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.54e-2)"	"unprognostic (8.13e-2)"	"unprognostic (2.62e-1)"	"unprognostic (3.70e-2)"	"unprognostic (3.05e-1)"	10.2	10.5	9.4	9.6	9.6	15.6	10.4	10.8	15.1	10.5	9.1	11.8	8.5	12.6	8.1	11.3	11.7	8.2	9.9	10.1	11.5	11.0	11.5	9.7	14.0	10.2	10.2	12.8	11.7	9.3	9.3	10.8	10.2	10.5	8.5	8.9	10.3	7.6	12.8	10.7	11.9	9.6	8.7	14.9	11.7	34.5	9.7	11.9	10.5	10.6	12.2	10.6	10.8	12.3	12.9	14.0	24.4	31.2	12.5	14.2	23.0	20.5	15.6	19.9	21.1	28.9	12.7	27.1	16.4	16.7	28.6	18.9	31.6	16.8	21.2	31.5	23.2	27.6	16.6	26.1	18.1	32.7	23.1	13.8	19.2	22.9	25.8	16.3	15.9	37.2	49.7	16.5	18.3	19.3	32.8	31.8	24.5	27.3	11.0	28.6	20.0	23.8	14.5	6.5	10.4	24.9	24.1	17.8	16.0	20.7	12.4	40.7	17.6	13.5	19.1	22.2	32.0	24.4	35.1	42.3	18.5	27.0	21.9	67.4	30.8	39.8	37.8	32.2	44.4	52.9	36.7	38.6	30.2	49.9	47.3	40.0	44.4	35.0	45.4	42.6	37.2	21.8	9.4	9.6	10.8	15.1	10.1	11.5	10.2	10.2	10.2	8.7	9.7	12.3	8.4	9.6	6.9	6.8	16.5	5.5	5.3	11.6	20.5	7.5	8.3	7.4	9.9	15.7	10.0	12.9	8.4	15.8	10.5	6.2	3.9	6.6	26.9	7.8	9.3	9.5	7.2	17.5	13.7	4.7	13.5	9.2	7.7	10.7	1.3	13.0	13.2	8.0	10.1	0.0	12.8	7.5	22.4	14.0	5.3	7.7	10.8	9.8	1.8	10.3	8.5	5.4	6.2	11.1	16.2	6.6	7.9	10.5	18.7	8.5	8.2	8.9	7.2	6.7	13.1	6.6	11.1	88.1	17.4	18.3	6.7	13.5	11.1	10.1	8.0	6.7
PDCD2	"RP8, ZMYND7"	ENSG00000071994	"Programmed cell death 2"	Q16342	6	170575295-170584692	"Predicted intracellular proteins"	Apoptosis	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA026713, HPA075534"	Approved		Approved	"Nucleoplasm,Cytokinetic bridge"		Yes	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 32: Non-specific - Translation"	Nucleoplasm	"Cytokinetic bridge"	"HPA026713: AB_1855103, HPA075534: AB_2686754"	"unprognostic (3.80e-3)"	"unprognostic (1.90e-2)"	"unprognostic (1.37e-2)"	"unprognostic (4.61e-2)"	"unprognostic (5.83e-2)"	"unprognostic (8.91e-3)"	"prognostic unfavorable (1.42e-6)"	"unprognostic (9.91e-2)"	"unprognostic (7.75e-2)"	"unprognostic (1.25e-2)"	"unprognostic (3.17e-2)"	"unprognostic (3.85e-2)"	"unprognostic (4.45e-3)"	"unprognostic (9.16e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.09e-1)"	26.3	25.6	18.9	30.0	19.1	35.4	43.0	20.2	23.7	27.1	18.4	31.1	32.4	25.9	39.9	32.6	33.7	23.4	22.8	19.3	20.2	33.2	32.7	23.4	43.2	19.2	20.0	29.8	45.4	29.6	16.9	28.4	19.3	25.9	38.4	17.7	31.7	30.3	36.4	25.8	25.9	28.7	19.0	27.5	30.6	19.9	19.5	42.3	34.6	27.0	50.6	32.8	21.6	19.3	50.5	36.2	53.8	126.7	75.8	82.6	59.3	58.6	66.7	67.9	75.3	65.2	43.1	90.6	46.6	64.8	90.8	70.5	116.5	97.1	98.9	74.7	127.2	128.6	46.2	119.3	91.9	161.6	83.3	75.6	93.4	86.2	138.7	71.2	95.8	123.9	260.3	57.7	84.1	109.5	113.0	116.6	77.5	161.6	54.9	79.4	41.5	117.8	103.7	29.3	98.4	102.4	66.7	107.8	71.6	58.1	54.8	162.8	73.0	33.3	71.4	80.1	105.1	76.5	96.4	97.9	62.1	154.9	87.0	4.1	12.4	11.5	14.1	12.0	16.5	14.2	15.9	14.9	17.3	13.8	15.5	14.8	5.3	18.8	15.2	15.9	20.3	12.0	18.9	19.1	20.2	23.7	19.3	20.2	19.2	20.0	19.3	19.0	19.5	19.3	47.2	12.8	15.3	9.4	54.1	49.5	76.4	14.6	40.5	36.9	58.0	59.7	27.4	52.9	14.0	29.5	12.5	63.9	82.2	29.2	78.2	55.3	17.0	36.1	38.5	38.8	47.2	64.1	13.2	74.1	71.6	32.2	32.1	33.5	15.9	59.8	44.6	28.2	49.2	16.8	12.7	44.0	22.4	41.9	33.2	15.0	49.0	40.9	35.6	8.4	62.8	34.7	84.5	8.0	12.4	58.6	36.4	40.6	58.0	103.9	47.8	83.6	16.0	35.3	19.7	43.8	55.5	33.0	85.8	58.7	46.0	46.7	60.7	60.8	68.0	84.1